<SEC-DOCUMENT>0001104659-21-098288.txt : 20210730
<SEC-HEADER>0001104659-21-098288.hdr.sgml : 20210730
<ACCEPTANCE-DATETIME>20210730163410
ACCESSION NUMBER:		0001104659-21-098288
CONFORMED SUBMISSION TYPE:	424B4
PUBLIC DOCUMENT COUNT:		33
FILED AS OF DATE:		20210730
DATE AS OF CHANGE:		20210730

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IN8BIO, INC.
		CENTRAL INDEX KEY:			0001740279
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				825462585
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B4
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-249530
		FILM NUMBER:		211133084

	BUSINESS ADDRESS:	
		STREET 1:		79 MADISON AVENUE, 2ND FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016
		BUSINESS PHONE:		(646) 600-6438

	MAIL ADDRESS:	
		STREET 1:		79 MADISON AVENUE, 2ND FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Incysus Therapeutics, Inc.
		DATE OF NAME CHANGE:	20180510
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B4
<SEQUENCE>1
<FILENAME>tm2030088-27_424b4.htm
<DESCRIPTION>424B4
<TEXT>
<html>
  <head>
    <title>tm2030088-27_424b4 - none - 26.0001562s</title>
  </head>
  <body style="margin-left:auto;margin-right:auto;width:595.31pt;">
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;margin-bottom:21.86pt;margin-left:45.65pt;width:504pt;">
        <div style="text-align:right; width:504pt; line-height:10pt;">
          <font style="letter-spacing:-0.111pt;">&#8202;Filed Pursuant to Rule 424(b)(4)</font>&#8203;</div>
        <div style="text-align:right; width:504pt; line-height:10pt;">
          <font style="letter-spacing:-0.111pt;">&#8202;Registration No. 333-249530</font>&#8203;</div>
        <div style="width:504pt; line-height:12pt;font-weight:normal;">
          <font style="text-transform:uppercase;letter-spacing:-0.025pt;">PROSPECTUS</font><font style="letter-spacing:-0.025pt;"> </font>
        </div>
        <div style="margin-top:4.5pt; width:504pt;">
          <div style="margin-left: 0pt; width: 504pt; margin-top: 0pt; font-size: 3pt; line-height: 0pt; border-bottom: 3pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:47pt; text-align:center; width:504pt; line-height:16pt;font-size:14pt;">
          <font style="text-transform:uppercase;letter-spacing:-0.155pt;">4,000,000 </font><font style="letter-spacing:-0.155pt;">Shares</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="position:relative;margin-top:20pt; text-align:center; width:504pt;">
          <img src="lg_in8bio-4c.jpg" alt="[MISSING IMAGE: lg_in8bio-4c.jpg]" height="44" width="115" >
        </div>
        <div style="margin-top:26pt; text-align:center; width:504pt; line-height:16pt;font-size:14pt;">
          <font style="letter-spacing:-0.155pt;">Common Stock</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="margin-top:30pt; width:504pt; line-height:12pt;font-weight:normal;">
          <font style="letter-spacing:-0.025pt;">This is the initial public offering of common stock of IN8bio, Inc. We are selling 4,000,000 shares of our common stock in this offering. The initial public offering price is $10.00 per share. Our common stock has been approved for listing on The Nasdaq Global Market under the symbol &quot;INAB.&quot;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:9pt; width:504pt; line-height:12pt;font-weight:normal;">
          <font style="letter-spacing:-0.025pt;">We are an &quot;emerging growth company&quot; and a &quot;smaller reporting company&quot; as defined under the federal securities laws and, as such, may elect to comply with certain reduced public company reporting requirements for future filings. See &quot;Prospectus Summary&#8212;Implications of Being an Emerging Growth Company and a Smaller Reporting Company.&quot;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:19.5pt; text-align:center; width:504pt;">
          <div style="margin-left: 38.095%; margin-right: 38.095%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:28pt; text-align:justify; width:504pt; line-height:12pt;">
          <font style="letter-spacing:-0.111pt;">Investing in our common stock involves risks. See &#8220;Risk Factors&#8221; beginning on page <a href="#tRIFA">11</a> of this prospectus. </font>
        </div>
        <table style="width:504pt;margin-top:29pt;border-collapse: collapse;border-top:0.75pt solid #63D05A; font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <tr style="line-height:10pt;min-height:20.75pt;height:20.75pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:358pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:8.5pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">Per share </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:8.5pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">Total </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.75pt 0pt 2pt 0pt; width:358pt;text-align:left;">
              <font style="letter-spacing:-0.111pt;">Initial public offering price </font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">10.00 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2pt 0pt; min-width:46.5pt; text-align:right; white-space:nowrap;">40,000,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3pt 0pt 2pt 0pt; width:358pt;text-align:left;">
              <font style="letter-spacing:-0.111pt;">Underwriting discounts and commissions</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.083pt;">(1)</font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3pt 0pt 2pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">0.70 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3pt 0pt 2pt 0pt; min-width:46.5pt; text-align:right; white-space:nowrap;">2,800,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3pt 0pt 2pt 0pt; width:358pt;text-align:left;">
              <font style="letter-spacing:-0.111pt;">Proceeds to us, before expenses </font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3pt 0pt 2pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">9.30 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3pt 0pt 2pt 0pt; min-width:46.5pt; text-align:right; white-space:nowrap;">37,200,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.5pt; width:504pt;">
          <div style="margin-left: 0pt; width: 120pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;font-weight:normal;">
          <font style="letter-spacing:-0.025pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;font-weight:normal;">
          <font style="letter-spacing:-0.025pt;">We have agreed to reimburse the underwriters for certain expenses. See &quot;Underwriting&quot; on page <a href="#tUND">167</a> for additional information regarding underwriting compensation.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:9pt; width:504pt; line-height:12pt;font-weight:normal;">
          <font style="letter-spacing:-0.025pt;">Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:9pt; width:504pt; line-height:12pt;font-weight:normal;">
          <font style="letter-spacing:-0.025pt;">We have granted the underwriters an option to purchase up to 600,000&#160;additional shares of common stock to cover overallotments, if any.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:9pt; width:504pt; line-height:12pt;font-weight:normal;">
          <font style="letter-spacing:-0.025pt;">The underwriters expect to deliver the shares of our common stock to purchasers on or about August 3, 2021.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:-1pt; width:504pt; line-height:12pt;font-weight:normal;">
          <font style="letter-spacing:-0.025pt;">&nbsp;&nbsp;&nbsp;</font>
        </div>
        <div style="margin-top:2.5pt; width:504pt;">
          <div style="margin-left: 0pt; width: 504pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #63D05A; ">&#8203;</div>
        </div>
        <div style="margin-top:46pt; text-align:center; width:504pt; line-height:18pt;font-size:16pt;">
          <font style="text-transform:uppercase;letter-spacing:-0.178pt;">B. R</font><font style="letter-spacing:-0.178pt;">iley Securities</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.32pt;"> </font>
        </div>
        <div style="margin-top:38pt; width:504pt; line-height:12pt;font-weight:normal;">
          <font style="letter-spacing:-0.025pt;">Prospectus dated July 29, 2021</font>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="TOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">TABLE OF CONTENTS</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:340.5pt;margin-top:20pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:419pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.111pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:419pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tPRSU"><font style="letter-spacing:-0.025pt;">Prospectus Summary </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#tPRSU">1</a></font> <a href="#tPRSU"></a></td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tRIFA"><font style="letter-spacing:-0.025pt;">Risk Factors </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#tRIFA">11</a></font> <a href="#tRIFA"></a></td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tSNRF"><font style="letter-spacing:-0.025pt;">Special Note Regarding Forward-Looking Statements </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#tSNRF">61</a></font> <a href="#tSNRF"></a></td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tMAID"><font style="letter-spacing:-0.025pt;">Market and Industry Data </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#tMAID">63</a></font> <a href="#tMAID"></a></td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tUOP"><font style="letter-spacing:-0.025pt;">Use of Proceeds </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#tUOP">64</a></font> <a href="#tUOP"></a></td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDIPO"><font style="letter-spacing:-0.025pt;">Dividend Policy </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#tDIPO">66</a></font> <a href="#tDIPO"></a></td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCAP"><font style="letter-spacing:-0.025pt;">Capitalization </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#tCAP">67</a></font> <a href="#tCAP"></a></td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDIL"><font style="letter-spacing:-0.025pt;">Dilution </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#tDIL">69</a></font> <a href="#tDIL"></a></td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tMDAA"><font style="letter-spacing:-0.025pt;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#tMDAA">71</a></font> <a href="#tMDAA"></a></td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tBUS"><font style="letter-spacing:-0.025pt;">Business </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#tBUS">82</a></font> <a href="#tBUS"></a></td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tMAN"><font style="letter-spacing:-0.025pt;">Management </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#tMAN">131</a></font> <a href="#tMAN"></a></td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tEADC"><font style="letter-spacing:-0.025pt;">Executive and Director Compensation </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#tEADC">137</a></font> <a href="#tEADC"></a></td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCRAR"><font style="letter-spacing:-0.025pt;">Certain Relationships and Related Party Transactions </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#tCRAR">150</a></font> <a href="#tCRAR"></a></td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tPRST"><font style="letter-spacing:-0.025pt;">Principal Stockholders </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#tPRST">154</a></font> <a href="#tPRST"></a></td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDOCS"><font style="letter-spacing:-0.025pt;">Description of Capital Stock </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#tDOCS">156</a></font> <a href="#tDOCS"></a></td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tSEFF"><font style="letter-spacing:-0.025pt;">Shares Eligible for Future Sale </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#tSEFF">161</a></font> <a href="#tSEFF"></a></td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tMUFI"><font style="letter-spacing:-0.025pt;">Material U.S. Federal Income Tax Consequences for Non-U.S. Holders </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#tMUFI">163</a></font> <a href="#tMUFI"></a></td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tUND"><font style="letter-spacing:-0.025pt;">Underwriting </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#tUND">167</a></font> <a href="#tUND"></a></td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tLEMA"><font style="letter-spacing:-0.025pt;">Legal Matters </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#tLEMA">175</a></font> <a href="#tLEMA"></a></td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tEXP"><font style="letter-spacing:-0.025pt;">Experts </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#tEXP">175</a></font> <a href="#tEXP"></a></td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tWYCF"><font style="letter-spacing:-0.025pt;">Where You Can Find Additional Information </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#tWYCF">175</a></font> <a href="#tWYCF"></a></td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tITFS"><font style="letter-spacing:-0.025pt;">Index to Financial Statements </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#tITFS">F-1</a></font>
            </td>
            <td style="padding:0pt;padding-left:9.665pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:10pt; margin-top:10.3pt; text-align:center; width:446pt;">
          <div style="margin-left: 36.842%; margin-right: 36.842%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="text-indent:20pt; margin-top:10.01pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">&#8220;IN8BIO,&#8221; &#8220;INEIGHTBIO,&#8221; the IN8BIO logo, DeltEx and other trademarks, trade names or service marks of IN8bio, Inc. appearing in this prospectus are the property of IN8bio, Inc. All other trademarks, trade names and service marks appearing in this prospectus are the property of their respective owners. Solely for convenience, the trademarks and trade names in this prospectus may be referred to without the </font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">&#174;</font><font style="letter-spacing:-0.025pt;"> and </font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">&#8482;</font><font style="letter-spacing:-0.025pt;"> symbols, but such references should not be construed as any indicator that their respective owners will not assert their rights thereto. The images found on pages 93, 95, 102, 108 and 112 of this prospectus were created with biorender.com.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Neither we nor the underwriters have authorized anyone to provide any information or to make any representations other than those contained in this prospectus or in any free writing prospectuses prepared by or on behalf of us or to which we have referred you. We and the underwriters take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only the shares offered hereby, but only under circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus or in any applicable free writing prospectus is current only as of its date, regardless of its time of delivery or any sale of shares of our common stock. Our business, financial condition, results of operations and prospects may have changed since that date.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Neither we nor the underwriters have done anything that would permit this offering or possession or distribution of this prospectus or any free writing prospectus we may provide to you in connection with this offering in any jurisdiction where action for that purpose is required, other than in the United States. You are required to inform yourselves about and to observe any restrictions relating to this offering and the distribution of this prospectus and any such free writing prospectus outside the United States.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">i</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:580pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;font-weight:bold;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <font style="letter-spacing:-0.111pt;">Until August 23, 2021 (25&#160;days after the date of this prospectus), all dealers that buy, sell or trade shares of our common stock, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers&#8217; obligation to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">ii</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPRSU">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:10pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="text-transform:uppercase;letter-spacing:-0.111pt;">PROSPECTUS SUMMARY</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:18pt; width:456pt; line-height:12pt;font-style:italic;">This summary highlights information contained elsewhere in this prospectus. This summary is not complete and does not contain all of the information you should consider in making your investment decision. Before investing in our common stock, you should carefully read this entire prospectus, especially the sections titled &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and our financial statements and the related notes included elsewhere in this prospectus. Unless the context otherwise requires, the terms &#8220;IN8bio, Inc.,&#8221; &#8220;the company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and similar references in this prospectus refer to IN8bio, Inc.<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.111pt;">Overview</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">We are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell therapies for the treatment of cancer. Gamma-delta T cells are naturally occurring immune cells that embody properties of both the innate and adaptive immune systems, and can intrinsically differentiate between healthy and diseased tissue. These cells serve as a functional bridge between innate and adaptive immunity to contribute to direct tumor killing as well as immune cell recruitment and activation to drive deeper immune responses. The pivotal role of gamma-delta T cells in immune function and activation, against diseases such as cancer, underscores their therapeutic potential across a wide range of solid and hematologic malignancies. We develop </font><font style="font-style:italic;">ex vivo</font><font style="letter-spacing:-0.025pt;">-expanded and activated gamma-delta T cell candidates based upon our deep expertise in gamma-delta T cell biology, proprietary genetic engineering and cell-type specific manufacturing capabilities, which we refer to collectively as our DeltEx platform. Our platform employs allogeneic, autologous and genetically modified approaches to develop novel cell therapies, which are designed to effectively identify and eradicate tumor cells. We are currently the most clinically advanced gamma-delta T cell company. Our lead product candidates are currently in Phase&#160;1 clinical trials: INB-200, for the treatment of newly diagnosed glioblastoma, or GBM, and INB-100, for the treatment of patients with leukemia that are undergoing hematopoietic stem cell transplantation, or HSCT. For INB-200, we expect to report initial results from the second cohort in this Phase&#160;1 trial by the end of 2021 and initial Phase 1 results from the third cohort in this Phase 1 trial in 2022. For INB-100, we expect to report initial results from the first cohort in our Phase&#160;1 clinical trial in 2022, with topline results for all cohorts in 2023. In addition, our DeltEx platform has yielded a broad portfolio of preclinical programs, including INB-400 and INB-300, focused on addressing other solid tumor types. We expect to file three INDs for our pipeline product candidates in the first half of 2022 and in 2023.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">Chemotherapy, a mainstay of solid tumor treatment, can deplete and damage immune cells, limiting their ability to seek and kill tumors. Despite these limitations, chemotherapy continues to be used in standard-of-care regimens because of its ability to directly kill tumors. However, residual tumor cells, which are chemotherapy resistant, often remain and lead to disease recurrence. This is further compounded by the lymphodepleting properties of chemotherapy, which can severely reduce the number of immune cells, such as gamma-delta T cells, that can seek out and kill the residual tumor cells. We have leveraged our proprietary genetic modifications of gamma-delta T cells to protect the cells from chemotherapy-induced damage, potentially allowing for their concurrent delivery with chemotherapy. This could potentially enable our product candidates to recognize and kill residual tumor cells, including chemotherapy resistant cells, by attacking at the time when the tumor is experiencing maximum chemotherapy-induced stress and vulnerability. We have termed this approach as our &#8220;DeltEx drug resistant immunotherapy,&#8221; or DeltEx DRI, and it is the basis for several of our programs, including INB-200. We are the first company to advance genetically modified gamma-delta T cells into the clinic. In order to develop an off-the-shelf therapy, we are developing a donor-derived, expanded, activated, non-genetically modified gamma-delta T cell therapeutic candidate for the treatment of leukemia.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">Our DeltEx platform is designed to overcome many of the challenges associated with the expansion, genetic engineering and scalable manufacturing of gamma-delta T cells. This approach allows us to expand the cells </font><font style="font-style:italic;">ex vivo</font><font style="letter-spacing:-0.025pt;"> to administer a potentially therapeutic dose to patients, harnessing the unique properties of gamma-delta T cells, including their ability to broadly recognize cellular stress signals on tumor cells. We have used our DeltEx platform to create our deep pipeline of innovative allogeneic, </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:10pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:-0.025pt;">autologous and/or genetically modified product candidates designed to effectively target and potentially eradicate disease and improve patient outcomes.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:-0.025pt;">The following chart shows the developmental status of our clinical and preclinical product candidates, all of which are wholly owned:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="position:relative;margin-top:9.7pt; width:456pt;">
            <img src="tm2030088d23-fc_overv4c.jpg" alt="[MISSING IMAGE: tm2030088d23-fc_overv4c.jpg]" height="283" width="608" >
          </div>
          <div style="margin-top:12.4pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
            <font style="letter-spacing:-0.089pt;">Figure 1. Pipeline Chart</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:-0.025pt;">To date, cell therapies utilizing chimeric antigen receptor T cells, or CAR-T cells, while impactful in liquid tumors, have demonstrated limited efficacy in the treatment of solid tumors. The American Cancer Society estimates that there are 1.7&#160;million new solid tumor cases annually in the United States, nine times the rate of blood cancers. This represents a high unmet medical need not adequately addressed by current cell therapies in development. One of our lead product candidates, INB-200, is a genetically modified autologous gamma-delta T cell product candidate in Phase&#160;1 development. Our initial indication is newly diagnosed glioblastoma, or GBM, for which the standard-of-care has been largely unchanged since the implementation of the Stupp regimen, surgical resection followed by radiation and chemotherapy, in 2005. Despite current treatments, the majority of patients relapse within one year, with very few patients surviving beyond five&#160;years. We engineered INB-200 to be resistant to alkylating agents, a class of chemotherapeutic drugs used in the treatment of GBM and other cancers. This could allow INB-200 to be administered as an adjuvant to the current standard-of-care in the newly diagnosed treatment setting. In preclinical studies, our DeltEx DRI technology has been shown to maintain immune cell function in toxic chemotherapeutic environments, demonstrating potential to be used concomitantly in combination with chemotherapy for the treatment of multiple solid tumor cancers. We are conducting a Phase&#160;1 repeat dose escalation clinical trial of INB-200 in newly diagnosed GBM patients at the O&#8217;Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, or UAB. We expect to report initial results from the second cohort in this Phase&#160;1 trial by the end of 2021 and initial Phase 1 results from the third cohort in this Phase 1 trial in 2022.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:-0.025pt;">We are also seeking to develop off-the-shelf DeltEx therapeutic candidates, which has led to our first allogeneic clinical program, INB-100, to demonstrate the safety of donor derived gamma-delta T cells. This therapeutic candidate is in initial development for the treatment of patients with leukemia that are undergoing HSCT. The number of HSCT procedures has been increasing over the last 20&#160;years, with more than 9,000 patients treated in the United States in 2018. Acute myeloid leukemia, or AML, and acute lymphoblastic leukemia, or ALL, represent two of the three most common allogeneic HSCT-treated cancers, accounting for approximately 50% of all allogeneic HSCTs. We have developed scalable methods to expand and activate gamma-delta T cells from peripheral blood in an automated manufacturing device. Prior clinical observations have shown that high numbers of circulating gamma-delta T cells have been correlated with improved survival outcomes in HSCT patients. The potential ability of INB-100 to kill residual leukemic cells, coupled with historically observed survival benefits, may </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:10pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:-0.025pt;">reduce leukemic relapse in HSCT patients. We are conducting a Phase&#160;1 dose-escalation clinical trial of INB-100 in allogeneic HSCT patients at the University of Kansas Cancer Center. We currently expect to report initial data from the first cohort in this trial in 2022, and topline data from all cohorts in 2023.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:-0.025pt;">INB-400 is our first program developing allogeneic DeltEx therapeutic candidates for solid tumor cancers. We plan to utilize clinical data from our ongoing Phase&#160;1 clinical trials of INB-200 and INB-100 to provide the safety data necessary to support submission of an investigational new drug application, or IND, for INB-400, by first half of 2022 to initiate a clinical trial for the treatment of newly diagnosed GBM. INB-300 is our second preclinical program focused on developing DeltEx DRI product candidates with an added CAR.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:-0.025pt;">We are also developing a broad portfolio of preclinical programs focused on expanding the application of our DeltEx platform into other solid tumor types, as well as combinations with other therapies approved by the U.S. Food and Drug Administration, or FDA, to enhance their antitumor activity. We believe that our preclinical data support the development of DeltEx DRI gamma-delta T cells in combination with approved therapies, such as checkpoint inhibitors and inhibitors of DNA damage repair, or DDR, pathways, such as poly (ADP-ribose) polymerase, or PARP, inhibitors. Our future product candidates could incorporate additional proprietary genetic alterations designed to make them resistant to the chemotherapies utilized to treat multiple types of solid tumor cancers.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:-0.025pt;">As of June 30, 2021, our intellectual property portfolio currently consists of seven patent families that broadly protect our DeltEx platform and our product candidates, both through composition of matter and method of use. Our patents broadly cover any genetic modification to gamma-delta T-cells that confers chemotherapy resistance. They also cover the method of generating these genetically engineered cells from patients or donors and their use in multiple solid and liquid tumors. Our portfolio broadly covers the use of allogeneic gamma-delta T cells in HSCT. Finally, we have patent families that cover the composition of our CAR constructs in gamma-delta T cells, specifically in out DeltEx DRI cells, and their use in multiple solid and liquid tumors.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:-0.025pt;">We have assembled a team of experts in the discovery and development of gamma-delta T cell-based therapies. We are led by William Ho, our founder and Chief Executive Officer, who has approximately 20&#160;years of combined experience in the management of biotechnology companies and healthcare finance and investing. Our scientific founder and Chief Scientific Officer, Dr.&#160;Lawrence Lamb, is a pioneer in the field of gamma-delta T cell biology and manufacturing, who published the foundational work that identified the potential antileukemic effect of these cells and their association with improved overall survival. Dr.&#160;Lamb was the first to describe the cell-type specific expansion of Vd1+ gamma-delta T cells in the 1990s, and his expertise has led the development of our DeltEx platform. Dr.&#160;Lamb also chairs our Scientific Advisory Board, which includes a globally renowned group of clinicians, oncologists and immunologists. Patrick McCall, CPA, our Chief Financial Officer, previously served as Vice President of Finance at Turnstone Biologics Inc., where he managed strategic and financial operations and supported investor relations. Dr.&#160;Kate Rochlin, our Vice President, Operations and Innovation, is an accomplished scientist and entrepreneur with 14&#160;years of experience in research, development and operations, previously serving as Chief Business Officer at Cambridge-based Curadigm.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.111pt;">Our Strategy</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:-0.025pt;">We are dedicated to leveraging our DeltEx platform to develop next generation cell therapies that we believe can dramatically improve outcomes for cancer patients. To achieve this goal, our strategy is as follows:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.91pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:1.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">Continue clinical development of our lead product candidates, INB-200 and INB-100.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">Advance INB-400 and INB-300 into clinical development, subject to receiving regulatory authorization to proceed pursuant to INDs.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">Leverage our DeltEx platform for additional indications and product candidates.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">Advance and continue to scale our manufacturing.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">Independently develop and commercialize our product candidates where we believe we can maximize their value and benefit to patients.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:10pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.111pt;">Risk Factor Summary</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:-0.025pt;">Our business and our ability to execute our strategy are subject to many risks. Before making a decision to invest in our common stock, you should carefully consider all of the risks and uncertainties described in the section titled &#8220;Risk Factors&#8221; immediately following this prospectus summary section and all of the other information in this prospectus. These risks include, but are not limited to the following:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">We have incurred significant operating losses since inception and anticipate that we will continue to incur substantial operating losses for the foreseeable future and may never achieve or maintain profitability.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">We have a limited operating history and have no products approved for commercial sale, which may make it difficult for you to evaluate the success of our business to date and to assess our future viability.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">Even if this offering is successful, we will require substantial additional funding to finance our operations. If we are unable to raise capital when needed, we could be forced to delay, reduce or terminate certain of our development programs or other operations.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">We are dependent on the successful clinical development, regulatory approval and commercialization of our gamma-delta T cell product candidates. If we are not able to obtain required regulatory approvals, we will not be able to commercialize our product candidates and our ability to generate product revenue will be adversely affected.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">Our DeltEx products candidates utilize novel approaches to cell therapies, including cancer treatment, which presents significant challenges in order to successfully develop, manufacture and commercialize our product candidates.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">The clinical and commercial utility of our DeltEx platform is uncertain and may never be realized. Additionally, certain aspects of the function and production of gamma-delta T cells are poorly understood or currently unknown, and may only become known through further preclinical and clinical testing.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">If we encounter difficulties in enrolling patients in our clinical trials, our clinical development activities could be delayed or otherwise adversely affected.</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">The ongoing COVID-19 pandemic could continue to adversely impact our business, including our clinical trials, supply chain and business development activities.</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">Interim, &#8220;top-line&#8221; and preliminary data from our clinical trials that we announce or publish from time to time may change as more patient data become available and are subject to audit and verification procedures that could result in material changes in the final data.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">We face significant competition, and many of our competitors have substantially greater experience and resources than we have.</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">Our manufacturing process is complex and we may encounter difficulties in production, which would delay or prevent our ability to provide a sufficient supply of our product candidates for future clinical trials or commercialization, if approved.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">Clinical product candidate development involves a lengthy and expensive process and involve uncertain outcomes. We may incur additional costs and encounter substantial delays or difficulties in our clinical trials.</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">If we encounter difficulties in enrolling patients in our clinical trials, our clinical development activities could be delayed or otherwise adversely affected.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">We currently store our gamma-delta T cells at our research and development facility, and any damage or loss to our storage freezers would cause delays in replacement, and our business could suffer.</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">We are currently dependent on a single third-party supplier for manufacture of our automated manufacturing device and our lentiviral vectors. These are critical products required for the manufacturing of our product candidates, including INB-200 and INB-100. Any damage or loss to the ability of our suppliers to deliver supplies in a timely manner could cause delays in manufacturing, and our business could suffer.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">Licensing of intellectual property is of critical importance to our business and involves complex legal, business and scientific issues. If we breach our license agreements with the University of Alabama at Birmingham Research Foundation and Emory University, or any of the </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:10pt;margin-left:12pt;width:456pt;">
          <div style="margin-left:40pt; width:416pt; line-height:11.5pt;">
            <font style="letter-spacing:-0.025pt;">other agreements under which we acquired, or will acquire, the intellectual property rights to our product candidates, we could lose the ability to continue the development and commercialization of the related product.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">If we are unable to obtain and maintain patent protection for our product candidates and technology, or if the scope of the patent protection obtained is not sufficiently broad or robust, our competitors could develop and commercialize products and technology similar or identical to ours, and our ability to successfully commercialize our product candidates and technology may be adversely affected.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-top:4pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.111pt;">Corporate Information</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:-0.025pt;">Incysus, Ltd. was incorporated in Bermuda on February&#160;8, 2016. On May&#160;7, 2018, Incysus, Ltd. reincorporated in the United States in a domestication transaction in which Incysus, Ltd. converted into a newly formed Delaware corporation, Incysus Therapeutics, Inc. Upon the domestication, each Class&#160;A share of Incysus, Ltd. was automatically converted into one share of common stock of Incysus Therapeutics, Inc. and each Class&#160;B share of Incysus, Ltd. was automatically cancelled and did not convert into any shares of any class of capital stock of Incysus Therapeutics, Inc. In August&#160;2020, we amended our certificate of incorporation, as amended, to change our name to IN8bio, Inc. Our principal executive offices are located at 79 Madison Avenue, New York, New York 10016, and our telephone number is (646) 600-6438. Our corporate website address is www.in8bio.com. Information contained on, or accessible through, our website is not a part of this prospectus. We have included our website in this prospectus solely as an inactive textual reference.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-top:3pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.111pt;">Implications of Being an Emerging Growth Company and a Smaller Reporting Company</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:-0.025pt;">We are an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act, or the JOBS Act, enacted in April&#160;2012, and we will remain an emerging growth company until the earliest to occur of: the last day of the fiscal year in which we have more than $1.07&#160;billion in annual revenue; the date we qualify as a &#8220;large accelerated filer,&#8221; with at least $700.0&#160;million of equity securities held by non-affiliates; the issuance, in any three-year period, by us of more than $1.0&#160;billion in non-convertible debt securities; and the last day of the fiscal year ending after the fifth anniversary of our initial public offering. For so long as we remain an emerging growth company, we are permitted and intend to rely on certain exemptions from various public company reporting requirements, including not being required to have our internal control over financial reporting audited by our independent registered public accounting firm pursuant to Section&#160;404(b) of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and any golden parachute payments not previously approved. In particular, in this prospectus, we have provided only two&#160;years of audited financial statements and have not included all of the executive compensation-related information that would be required if we were not an emerging growth company. Accordingly, the information contained herein may be different than the information you receive from other public companies in which you hold stock.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">In addition, the JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. This provision allows an emerging growth company to delay the adoption of some accounting standards until those standards would otherwise apply to private companies. We have elected to take advantage of the extended transition period to comply with new or revised accounting standards and to adopt certain of the reduced disclosure requirements available to emerging growth companies. As a result, we will not be subject to the same implementation timing for new or revised accounting standards as other public companies that are not emerging growth companies which may make comparison of our financial statements to those of other public companies more difficult. As a result of this election, the information that we provide in this prospectus may be different than the information you may receive from other public companies in which you hold equity interests.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:3pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">We are also a smaller reporting company as defined in the Securities Exchange Act of 1934, as amended. We may continue to be a smaller reporting company even after we are no longer an emerging growth company. We may take advantage of certain of the scaled disclosures available to smaller reporting companies and will be able to take advantage of these scaled disclosures for so long as (i)&#160;the market value of our voting and non-voting common stock held by non-affiliates is less than $250&#160;million </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:10pt;min-height:660pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">measured on the last business day of our second fiscal quarter or (ii)&#160;our annual revenue is less than $100&#160;million during the most recently completed fiscal year and the market value of our voting and non-voting common stock held by non-affiliates is less than $700&#160;million measured on the last business day of our second fiscal quarter. Specifically, as a smaller reporting company, we may choose to present only the two most recent fiscal&#160;years of audited financial statements in our Annual Report on Form 10-K and have reduced disclosure obligations regarding executive compensation, and, similar to emerging growth companies, if we are a smaller reporting company with less than $100&#160;million in annual revenue, we would not be required to obtain an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:10pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.111pt;">The Offering</font><font style="font-weight:normal;text-transform:uppercase;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:-0.025pt;">Common stock to be offered </font>
            </div>
          </div>
          <div style="margin-left:145pt; margin-top:-12pt; width:311pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">4,000,000 shares</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:-0.025pt;">Common stock to be outstanding after this </font>
              <br >
              <font style="letter-spacing:-0.025pt;">offering </font>
            </div>
          </div>
          <div style="margin-left:145pt; margin-top:-12pt; width:311pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">18,754,553 shares (or 19,354,553 shares if the underwriters exercise their option to purchase additional shares in full)</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="width:144pt;">
            <div style="white-space:nowrap; margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:-0.025pt;">Option to purchase additional </font>
              <br >
              <font style="letter-spacing:-0.025pt;">shares </font>
            </div>
          </div>
          <div style="margin-left:145pt; margin-top:-12pt; width:311pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">600,000 shares</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:-0.025pt;">Use of proceeds </font>
            </div>
          </div>
          <div style="margin-left:145pt; margin-top:-12pt; width:311pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">We estimate that the net proceeds from this offering will be approximately $32.6 million (or approximately $38.1 million if the underwriters exercise their option to purchase additional shares in full), based on the initial public offering price of $10.00 per share, after deducting underwriting discounts and commissions and estimated offering expenses payable by us.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-left:145pt; margin-top:8pt; width:311pt; line-height:11.5pt;">
            <font style="letter-spacing:-0.025pt;">We currently intend to use the net proceeds from this offering, together with our existing cash, as follows:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style=" float:left; margin-left:165pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:185pt;">
            <font style="letter-spacing:-0.025pt;">approximately $8.0 million to $13.0 million to advance the clinical development of INB-200, including the completion of our ongoing Phase&#160;1 clinical trial and the initiation of a Phase&#160;2 clinical trial for the treatment of newly diagnosed GBM, and for the evaluation of additional indications;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:165pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:185pt;">
            <font style="letter-spacing:-0.025pt;">approximately $1.0 million to $2.0 million to advance the clinical development of INB-100, including the completion of our ongoing Phase&#160;1 clinical trial for the treatment of leukemia patients undergoing HSCT;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:165pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:185pt;">
            <font style="letter-spacing:-0.025pt;">approximately $4.0 million to $5.0 million to advance the clinical development of INB-400, including the IND submission and the initiation of a Phase&#160;1 clinical trial for the treatment of newly diagnosed GBM; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:165pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:185pt;">
            <font style="letter-spacing:-0.025pt;">the remainder to fund other research and development activities, including preclinical development, development of our manufacturing capabilities, working capital and other general corporate purposes.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-left:145pt; margin-top:8pt; width:311pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">See the section titled &#8220;Use of Proceeds&#8221; for additional information.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="width:144pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:-0.025pt;">Risk factors </font>
            </div>
          </div>
          <div style="margin-left:145pt; margin-top:-12pt; width:311pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">You should read the section titled &#8220;Risk Factors&#8221; for a discussion of factors to consider carefully, together with all the other information included in this prospectus, before deciding to invest in our common stock.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="width:144pt;">
            <div style="white-space:nowrap; margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:-0.025pt;">Nasdaq Global Market </font>
              <br >
              <font style="letter-spacing:-0.025pt;">symbol </font>
            </div>
          </div>
          <div style="margin-left:145pt; margin-top:-12pt; width:311pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">&#8220;INAB&#8221;</font>
          </div>
          <div style="text-indent:20pt; margin-top:18pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">The number of shares of our common stock to be outstanding after this offering is based on 14,754,553 shares of common stock outstanding as of March 31, 2021, and excludes:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">1,552,290 shares of our common stock issuable upon the exercise of outstanding stock options as of March 31, 2021 under our 2018 Equity Incentive Plan, as amended, or the 2018 Plan, with a weighted-average exercise price of $5.20 per share;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">86,258 shares of our common stock issuable upon the exercise of stock options that will be granted to a director upon the completion of this offering pursuant to an antidilution right, as </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:10pt;min-height:660pt;margin-left:12pt;width:456pt;">
          <div style="margin-left:40pt; width:416pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">more fully described in the section titled &#8216;&#8216;Certain Relationships and Related Party Transactions&#8212;Director Antidilution Rights&#8217;&#8217;;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">4,200,000 shares of our common stock reserved for future issuance under our 2020 Equity Incentive Plan, or the 2020 Plan, which became effective immediately prior to the execution of the underwriting agreement related to this offering, plus any future increases in the number of shares of common stock reserved for issuance, as more fully described in the section titled &#8220;Executive and Director Compensation&#8212;Employee Benefit Plans&#8212;2020 Equity Incentive Plan&#8221; (of which options to purchase an aggregate of 481,275 shares of our common stock were granted to certain of our non-employee directors, executive officers, other employees and a consultant at the time of effectiveness of the 2020 Plan with an exercise price equal to the initial public offering price per share); and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">200,000 shares of our common stock reserved for future issuance under our 2020 Employee Stock Purchase Plan, or the ESPP, which became effective immediately prior to the execution of the underwriting agreement related to this offering, plus any future increases, including annual automatic evergreen increases, in the number of shares of common stock reserved for issuance under our ESPP, as more fully described in the section titled &#8220;Executive and Director Compensation&#8212;Employee Benefit Plans&#8212;2020 Employee Stock Purchase Plan.&#8221;</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">In addition, unless we specifically state otherwise, the information in this prospectus assumes:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">the filing and effectiveness of our amended and restated certificate of incorporation immediately after the completion of this offering and the adoption of our amended and restated bylaws immediately prior to the completion of this offering;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">the automatic conversion of all outstanding shares of our preferred stock into an aggregate of 10,990,065 shares of our common stock upon the completion of this offering;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">a 0.365-for-1 reverse stock split of our common stock and preferred stock effected on November&#160;5, 2020;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">no exercise of the outstanding options described above; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style="letter-spacing:-0.025pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
            <font style="letter-spacing:-0.025pt;">no exercise by the underwriters of their option to purchase up to 600,000 additional shares of our common stock. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:10pt;margin-bottom:9.12pt; margin-left:12pt;width:456pt;">
          <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.111pt;">Summary Financial Data</font><font style="font-weight:normal;text-transform:uppercase;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:18pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">The following tables set forth a summary of our financial data. We have derived the statement of operations and balance sheet data as of and for the&#160;years ended December&#160;31, 2019 and 2020 from our audited financial statements appearing elsewhere in this prospectus. The statement of operations data for the three months ended March 31, 2020 and March 31, 2021 and the balance sheet data as of March 31, 2021 have been derived from unaudited condensed interim unaudited financial statements included elsewhere in this prospectus. Our unaudited condensed interim financial statements were prepared in accordance with U.S. generally accepted accounting principles, or U.S. GAAP, on the same basis as our audited financial statements and include, in the opinion of management, all adjustments, consisting of normal recurring adjustments, that are necessary for the fair presentation of the financial information set forth in those financial statements. Our historical results are not necessarily indicative of the results to be expected for any future periods. The following summary financial data should be read with the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and our financial statements and the related notes included elsewhere in this prospectus.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <table style="width:456pt;height:398.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:208.4pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.089pt;">Years Ended</font>
                  <br >
                  <font style="letter-spacing:-0.089pt;">December&#160;31, </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.089pt;">Three Months </font>
                  <br >
                  <font style="letter-spacing:-0.089pt;">Ended March 31, </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:208.4pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.089pt;">(in thousands, except share and per share data) </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.089pt;">2019 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.089pt;">2020 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.089pt;">2020 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.089pt;">2021 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:208.4pt;text-align:left;">
                <font style="letter-spacing:-0.111pt;">Statement of Operations Data:</font>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:42pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:208.4pt;text-align:left;">
                <font style="letter-spacing:-0.025pt;">Operating expenses: </font>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:42pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:208.4pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:-0.025pt;">Research and development </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">2,358</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">5,378</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">1,052</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:42pt; text-align:right; white-space:nowrap;">1,245</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:208.4pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:-0.025pt;">General and administrative </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">2,708</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">3,179</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">639</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:42pt; text-align:right; white-space:nowrap;">1,118</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
              <td style="border-bottom:1px solid #CCEEFF;padding:2.167pt 0pt 1.833pt 0pt; width:208.4pt;text-align:left;">
                <div style="margin-left:20pt; text-indent:-10pt;">
                  <font style="letter-spacing:-0.025pt;">Loss on disposal of property and </font>
                  <br >
                  <font style="letter-spacing:-0.025pt;">equipment </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">68</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:42pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:208.4pt;text-align:left;">
                <div style="margin-left:20pt;">
                  <font style="letter-spacing:-0.025pt;">Total operating expenses </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">5,134</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">8,557</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">1,691</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:42pt; text-align:right; white-space:nowrap;">2,363</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
              <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:208.4pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.025pt;">Loss from operations </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(5,134<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(8,557<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(1,691<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:42pt; text-align:right; white-space:nowrap;">(2,363<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
              <td style="padding:3.25pt 0pt 3.25pt 0pt; width:208.4pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.025pt;">Net loss </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(5,134<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(8,557<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(1,691<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:42pt; text-align:right; white-space:nowrap;">(2,363<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
              <td style="padding:1.417pt 0pt 2.583pt 0pt; width:208.4pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:-0.025pt;">Net loss attributable to common stockholders</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">&#65279;(1)</font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(5,912<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(10,340<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(1,951<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:42pt; text-align:right; white-space:nowrap;">(3,069<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
              <td style="padding:1.417pt 0pt 2.583pt 0pt; width:208.4pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:-0.025pt;">Net loss per share attributable to common stockholders: basic and </font>
                  <br >
                  <font style="letter-spacing:-0.025pt;">diluted </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(1.85<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(3.02<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(0.59<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:42pt; text-align:right; white-space:nowrap;">(0.82<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
              <td style="padding:1.417pt 0pt 2.583pt 0pt; width:208.4pt;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:-0.025pt;">Weighted-average shares used to compute net </font>
                  <br >
                  <font style="letter-spacing:-0.025pt;">loss per share attributable to common </font>
                  <br >
                  <font style="letter-spacing:-0.025pt;">stockholders: basic and diluted </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">3,188,165</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">3,419,075</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">3,305,367</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:42pt; text-align:right; white-space:nowrap;">3,764,488</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
              <td style="padding:1.417pt 0pt 2.583pt 0pt; width:208.4pt;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:-0.025pt;">Pro forma net loss attributable to common </font>
                  <br >
                  <font style="letter-spacing:-0.025pt;">stockholders</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">&#65279;(1)</font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(8,557<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
              <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:42pt; text-align:right; white-space:nowrap;">(2,363<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
              <td style="padding:2.667pt 0pt 2.583pt 0pt; width:208.4pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:-0.025pt;">Pro&#160;forma net loss per share attributable to common stockholders (unaudited): basic and diluted</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">&#65279;(1)</font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
              <td style="padding:2.667pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(0.91<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:2.667pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
              <td style="padding:2.667pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:42pt; text-align:right; white-space:nowrap;">(0.16<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
              <td style="padding:2.667pt 0pt 1.583pt 0pt; width:208.4pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:-0.025pt;">Weighted-average shares used to compute pro&#160;forma net loss per share attributable to common stockholders (unaudited): basic and diluted</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">&#65279;(1)</font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.333pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.333pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">9,382,360</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.333pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.667pt 0pt 0.333pt 0pt;border-bottom:3pt double #000000; min-width:42pt; text-align:right; white-space:nowrap;">14,754,553</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>
          <div style="margin-top:6.69pt; width:456pt;">
            <div style="margin-left: 0pt; width: 120pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
          </div>
          <div style=" float:left; margin-top:10.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">(1)</font>
            <br >
          </div>
          <div style=" margin-top:9.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:-0.025pt;">The unaudited pro forma basic and diluted weighted-average common stock used in the calculation of unaudited pro forma basic and diluted net loss per share attributable to common stockholders for the year ended December 31, 2020 and the three months ended March 31, 2021 have been </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:10pt;min-height:660pt;margin-left:12pt;width:456pt;">
          <div style="margin-left:20pt; width:436pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">prepared to reflect the automatic conversion of all outstanding shares of our convertible preferred stock into common stock upon the completion of this offering.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <table style="width:456pt;height:134.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:289.03pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="16">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.089pt;">As of March 31, 2021 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:2.583pt 0pt 2.167pt 0pt; width:289.03pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.089pt;">(in thousands) </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.089pt;">Actual </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.089pt;">Pro</font>
                  <br >
                  <font style="letter-spacing:-0.089pt;">Forma</font><font style=" position:relative; bottom:3.25pt;font-size:6pt;letter-spacing:-0.067pt;">(1)</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.089pt;">Pro Forma </font>
                  <br >
                  <font style="letter-spacing:-0.089pt;">As Adjusted</font><font style=" position:relative; bottom:3.25pt;font-size:6pt;letter-spacing:-0.067pt;">(2)</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:289.03pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.089pt;">(unaudited)</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.089pt;">(unaudited) </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:289.03pt;text-align:left;">
                <font style="letter-spacing:-0.111pt;">Balance Sheet Data:</font>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.63pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:15.08pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:289.03pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.025pt;">Cash </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">15,052</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.63pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8201;15,052</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:15.08pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">&#8201;49,488 </td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:289.03pt;text-align:left;">
                <div style="white-space:nowrap;font-size:7.5pt;">
                  <font style="font-size:10pt;letter-spacing:-0.025pt;">Working capital</font><font style=" position:relative; bottom:4.25pt;letter-spacing:-0.019pt;">(</font><font style=" position:relative; bottom:4.25pt;letter-spacing:-0.019pt;">3</font><font style=" position:relative; bottom:4.25pt;letter-spacing:-0.019pt;">)</font><font style="font-size:10pt;">&#8203;</font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">12,310</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.63pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">12,310</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:15.08pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">47,994</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:289.03pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.025pt;">Total assets </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">20,423</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.63pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">20,423</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:15.08pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">51,725</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:289.03pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.025pt;">Preferred stock </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">34,900</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.63pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:15.08pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:289.03pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.025pt;">Total stockholders&#8217; (deficit) equity </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">(18,581<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:4.63pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">16,319</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:15.08pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:33.75pt; text-align:right; white-space:nowrap;">48,869</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>
          <div style="margin-top:12.5pt; width:456pt;">
            <div style="margin-left: 0pt; width: 120pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
          </div>
          <div style=" float:left; margin-top:9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">(1)</font>
            <br >
          </div>
          <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:-0.025pt;">The pro&#160;forma column reflects the automatic conversion of all of the outstanding shares of our preferred stock into an aggregate of 10,990,065 shares of common stock upon the completion of this offering.</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
            <font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">(2)</font>
            <br >
          </div>
          <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
            <font style="letter-spacing:-0.025pt;">The pro&#160;forma as adjusted column reflects the pro&#160;forma adjustments set forth above and the sale of 4,000,000 shares of our common stock in this offering at the initial public offering price of $10.00 per share, after deducting underwriting discounts and commissions and estimated offering expenses payable by us.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:7.5pt;">
            <font style=" position:relative; bottom:4.25pt;letter-spacing:-0.019pt;">(3)</font>
            <br >
          </div>
          <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-size:7.5pt;">
            <font style="font-size:10pt;letter-spacing:-0.025pt;">We define working capital as current assets less current liabilities.</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:-0.025pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tRIFA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">RISK FACTORS</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:18pt; width:456pt; line-height:11.5pt;font-style:italic;">Investing in our common stock involves a high degree of risk. You should carefully consider the risks described below, as well as the other information in this prospectus, including our financial statements and the related notes and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; before deciding whether to invest in our common stock. The occurrence of any of the events or developments described below could harm our business, financial condition, results of operations and prospects. In such an event, the market price of our common stock could decline and you may lose all or part of your investment.<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Risks Related to Our Financial Position and Capital Needs</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">We have incurred significant operating losses since inception and anticipate that we will continue to incur substantial operating losses for the foreseeable future and may never achieve or maintain profitability.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We have incurred significant operating losses since inception. Our net loss was $5.1 million and $8.6 million for the&#160;years ended December&#160;31, 2019 and 2020, respectively, and $2.4 million for the three months ended March&#160;31, 2021. As of March&#160;31, 2021, we had an accumulated deficit of $20.4&#160;million. We expect to continue to incur significant expenses and increasing operating losses for the foreseeable future. Since inception, we have devoted substantially all of our efforts to research and preclinical and clinical development of our product candidates, organizing and staffing our company, business planning, raising capital, establishing our intellectual property portfolio and conducting clinical trials. To date, we have never obtained regulatory approval for, or commercialized, any product candidates. It could be several&#160;years, if ever, before we have a commercialized product. The net losses we incur may fluctuate significantly from quarter to quarter and year to year. We anticipate that our expenses will increase substantially if, and as, we:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">conduct our current and future clinical trials with INB-100 and INB-200;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">continue to develop our preclinical product candidates, INB-300 and INB-400;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">seek regulatory and marketing approvals for any of our current and future product candidates that successfully complete clinical trials;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">establish our manufacturing capability, including developing our contract development and manufacturing relationships, and building our internal manufacturing facilities;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">maintain, expand and protect our intellectual property portfolio;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">expand our operational, financial, and management systems and increase personnel, including personnel to support our preclinical and clinical development, manufacturing and commercialization efforts;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">establish a sales, marketing and distribution infrastructure in the future to commercialize any current or future product candidate for which we may obtain marketing approval;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">seek to identify, discover, develop and commercialize additional product candidates; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">incur additional legal, accounting or other expenses in operating our business, including the additional costs associated with operating as a public company.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">To become and remain profitable, we must succeed in developing and eventually commercializing products that generate significant revenue. This will require us to be successful in a range of challenging activities, including completing preclinical studies and clinical trials of our current and future product candidates, obtaining regulatory approval, establishing and validating commercial-scale current good manufacturing practices, or cGMP, facilities, marketing and selling any products for which we obtain regulatory approval (including through third parties), as well as discovering or acquiring and developing additional product candidates. We are only in the preliminary stages of some of these activities. We may never succeed in these activities and, even if we do, may never generate revenues that are sufficient to offset our expenses and achieve profitability.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Because of the numerous risks and uncertainties associated with product candidate development, we are unable to accurately predict the timing or amount of expenses or when, or if, we will be able to achieve profitability. If we are required by regulatory authorities to perform clinical trials or preclinical </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">studies in addition to those currently expected, or if there are any delays in the initiation and completion of our clinical trials or the development of any of our product candidates, our expenses could increase. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Even if we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis. Our failure to become and remain profitable would decrease the value of our company and could impair our ability to raise capital, maintain our research and development efforts, expand our business or continue our operations. A decline in the value of our common stock could also cause you to lose all or part of your investment.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">We have a limited operating history and have no products approved for commercial sale, which may make it difficult for you to evaluate the success of our business to date and to assess our future viability.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We are an early clinical-stage biotechnology company with a limited operating history upon which you can evaluate our business and prospects. Our operations to date have been limited to financing and staffing our company, developing our technology, identifying and developing INB-200 and INB-100 and our other product candidates, undertaking preclinical studies, initiating and conducting clinical trials for INB-200 and INB-100, business planning and raising capital. Other than INB-200 and INB-100, all of our research programs are still in the preclinical or research stage of development, and the risk of failure in the biopharmaceutical industry for programs or products candidates at such stage of development is even higher than those in the clinical stage of development. We have not yet demonstrated an ability to successfully conduct or complete any clinical trials, including large-scale, pivotal clinical trials, obtain marketing approval, manufacture a clinical or commercial scale product or arrange for a third party to do so on our behalf or conduct sales and marketing activities necessary for successful product commercialization. Typically, it takes about six to 10&#160;years to develop a new drug from the time it enters Phase&#160;1 clinical trials to when it is approved for treating patients, but in many cases it may take longer. Consequently, predictions about our future success or viability may not be as accurate as they could be if we had a longer operating history or a history of successfully developing and commercializing genetic medicine product candidates.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In addition, as a business with a limited operating history, we may encounter unforeseen expenses, difficulties, complications, delays and other known and unknown factors. We will eventually need to transition from a company with a research and clinical focus to a company, if any of our product candidates are approved, capable of supporting commercial activities. We may not be successful in such a transition.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">Even if this offering is successful, we will require substantial additional funding to finance our operations. If we are unable to raise capital when needed, we could be forced to delay, reduce or terminate certain of our development programs or other operations.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Developing pharmaceutical products, including conducting preclinical studies and clinical trials, is a very time-consuming, expensive and uncertain process that takes&#160;years to complete. Our operations have consumed substantial amounts of cash since inception, and we expect our expenses to increase in connection with our ongoing activities, particularly as we conduct clinical trials of, and seek marketing approval for, our product candidates and advance our other programs. Other unanticipated costs may also arise. Because the design and outcome of our ongoing and anticipated clinical trials are highly uncertain, we cannot reasonably estimate the actual amount of resources and funding that will be necessary to successfully complete the development and commercialization of any product candidate we develop. Based on our research and development plans, we believe that the net proceeds from this offering, together with our existing cash, will be sufficient to fund our operations into &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; . Moreover, we will need to obtain substantial additional funding in connection with our continuing operations and planned research and clinical development activities. Our future capital requirements will depend on many factors, including:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the timing, progress, costs and results of our ongoing preclinical studies and clinical trials of our product candidates, including accounting for any COVID-19-related delays or other related impacts on our development programs;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the scope, progress, results and costs of preclinical development, laboratory testing and clinical trials of other product candidates that we may pursue;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our ability to establish collaborations on favorable terms, if at all;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the costs, timing and outcome of regulatory review of our product candidates;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the costs and timing of future commercialization activities, including product manufacturing, marketing, sales, reimbursement and distribution, for any of our product candidates for which we may receive marketing approval;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the revenue, if any, received from commercial sales of our product candidates for which we may receive marketing approval;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the cost of any milestone and royalty payments with respect to any approved product candidates;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the costs and timing of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending any intellectual property-related claims; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the costs of operating as a public company; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the extent to which we acquire or in-license other product candidates and technologies.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Identifying potential product candidates and conducting preclinical studies and clinical trials is a time-consuming, expensive and uncertain process that takes&#160;years to complete, and we may never generate the necessary data or results required to obtain regulatory approval in order to generate revenue from product sales. In addition, our product candidates, if approved, may not achieve commercial success. Our commercial revenues, if any, will be derived from sales of products that we do not expect to be commercially available for several&#160;years, if at all. Accordingly, we will need to continue to rely on additional financing to achieve our business objectives. Adequate additional financing may not be available to us on acceptable terms, or at all. In addition, we may seek additional capital due to favorable market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans. Our ability to raise additional capital may be adversely impacted by potential worsening global economic conditions and the recent disruptions to and volatility in the credit and financial markets in the United States and worldwide resulting from the ongoing COVID-19 pandemic. If we are unable to raise capital when needed or on attractive terms, we could be forced to delay, reduce or altogether terminate our research and development programs or future commercialization efforts.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Risks Related to the Development of Our Product Candidates</font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">We are dependent on the successful clinical development, regulatory approval and commercialization of our gamma-delta T cell product candidates. If we are not able to obtain required regulatory approvals, we will not be able to commercialize our product candidates and our ability to generate product revenue will be adversely affected.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our business is dependent on our ability to successfully complete development of, obtain regulatory approval for, and, if approved, successfully commercialize our product candidates in a timely manner. We may face unforeseen challenges in our product candidate development strategy, and we can provide no assurances that our product candidate or clinical trial design will prove to be effective, that we will be able to take advantage of abbreviated regulatory pathways for any of our product candidates, or that we will ultimately be successful in our future clinical trials. We expect that a substantial portion of our efforts and expenses over the next several years will be devoted to the development of our lead product candidates, INB-200 and INB-100, in our ongoing clinical trials. Our DeltEx platform, including our INB-200 and INB-100 product candidates, are in early stages of development and may never be commercialized.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We currently anticipate seeking initial regulatory approvals in the United States and the European Union, but may in the future submit applications for the regulatory approval of one or more of our product candidates to additional foreign regulatory authorities. We have not applied or obtained regulatory approval for any product candidate in the United States or abroad, and it is possible that neither our current product candidates nor any product candidates we may seek to develop in the future will obtain regulatory approval. Neither we nor any of our partners are permitted to market any of our product candidates in the United States or abroad until we receive regulatory approval from the FDA or the applicable foreign regulatory agency.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">All of our product candidates will require additional clinical and non-clinical development, regulatory review and approval in multiple jurisdictions, substantial investment, access to sufficient commercial </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">manufacturing capacity and significant marketing efforts before they can be successfully commercialized. Prior to obtaining approval to commercialize any product candidate in the United States or abroad, we must demonstrate with substantial evidence from well-controlled clinical trials, and to the satisfaction of the FDA or comparable foreign regulatory authorities, that such product candidate is safe and effective for its intended uses. Results from preclinical studies and clinical trials can be interpreted in different ways. Even if we believe that the preclinical or clinical data for our product candidates are promising, such data may not be sufficient to support approval by the FDA and other regulatory authorities. The FDA may also require us to conduct additional preclinical studies, assay development or clinical trials for our product candidates either pre- or post-approval, or it may object to elements of our clinical development program, requiring their alteration. We may also decide to modify clinical protocols or procedures in future clinical trials based on clinical and experimental data.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Of the large number of products in development, only a small&#160;percentage successfully complete the FDA or comparable foreign regulatory authorities&#8217; approval processes and are commercialized. The lengthy approval or marketing authorization process as well as the unpredictability of future clinical trial results may result in our failing to obtain regulatory approval or marketing authorization to market our product candidates, which would significantly harm our business, financial condition, results of operations and prospects.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Our product candidates could fail to receive regulatory approval from the FDA or a comparable foreign regulatory authority for many reasons, including, among others:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">disagreement with the design or conduct of any of our clinical trials;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">failure to demonstrate to the satisfaction of regulatory agencies that our product candidates are safe and effective, or have a positive benefit/risk profile for its proposed indication;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">failure of clinical trials to meet the level of statistical significance required for approval;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">disagreement with our interpretation of data from preclinical studies or clinical trials;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the insufficiency of data collected from clinical trials of our product candidates to support the submission and filing of a Biologics License Application, or BLA, or other submission or to obtain regulatory approval;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">failure to obtain approval of our manufacturing processes or facilities of third-party manufacturers with whom we contract for clinical and commercial supplies or our own manufacturing facility; or</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">changes in the approval policies or regulations that render our preclinical and clinical data insufficient for approval.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Additionally, any delay in, or termination of, our clinical trials will delay the submission of a BLA to the FDA or other similar applications with other relevant foreign regulatory authorities and, ultimately, our ability to commercialize our product candidates, if approved, and generate product revenue.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Even if we eventually complete clinical testing and receive approval of a BLA, or foreign marketing application for our product candidates, the FDA or the comparable foreign regulatory authorities may grant approval or other marketing authorization contingent on the performance of costly additional clinical trials, including post-market clinical trials. The FDA or the comparable foreign regulatory authorities also may approve or authorize for marketing a product candidate for a more limited indication or patient population than we originally request, and the FDA or comparable foreign regulatory authorities may not approve or authorize the labeling that we believe is necessary or desirable for the successful commercialization of a product candidate. Any delay in obtaining, or inability to obtain, applicable regulatory approval or other marketing authorization would delay or prevent commercialization of that product candidate and would adversely impact our business and prospects.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Moreover, because all of our product candidates are based on the same core gamma-delta T cell technology, if any of our product candidates encounter safety or efficacy problems, developmental delays or regulatory issues or other problems, these could impact the development plans for our other product candidates. Our failure to timely complete clinical trials, obtain regulatory approval or, if approved, commercialize our product candidates could adversely affect our business, financial condition and results of operations.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Our product candidates are in early stages of development, and therefore they will require extensive additional preclinical and clinical testing. Success in preclinical studies or early-stage clinical trials may not be indicative of results in future clinical trials and we cannot assure you that any ongoing, planned or future clinical trials will lead to results sufficient for the necessary regulatory approvals.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Because our product candidates are in early stages of development, they will require extensive preclinical and clinical testing. INB-200 and INB-100 are our only product candidates in clinical trials. Success in preclinical testing and early-stage clinical trials does not ensure that later clinical trials will generate the same results or otherwise provide adequate data to demonstrate the efficacy and safety of a product candidate. Preclinical studies and Phase&#160;1 clinical trials are primarily designed to test safety, to study pharmacokinetics and pharmacodynamics and to understand the side effects of product candidates at various doses and schedules. Success in preclinical studies and earlier clinical trials does not ensure that later efficacy trials will be successful, nor does it predict final results. Our product candidates may fail to show the desired safety and efficacy in clinical development despite positive results in preclinical studies or even if they successfully advance through earlier clinical trials.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">For example, although we have commenced Phase&#160;1 clinical trials for INB-200 and INB-100, the FDA has not yet made any determination regarding safety and efficacy of either product candidate in the targeted indications. Further, our novel approaches to immune cell therapies are unproven and as such, the cost and time needed to develop our product candidates is difficult to predict and our efforts may not be successful. If we do not observe favorable results in clinical trials of our product candidates, we may decide to delay or abandon clinical development of such product candidate. Any such delay or abandonment could harm our business, financial condition, results of operations and prospects.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In addition, the design of a clinical trial can determine whether its results will support approval of a product, and flaws in the design of a clinical trial may not become apparent until the clinical trial is well advanced. As an organization, we have limited experience designing clinical trials and may be unable to design and execute a clinical trial to support regulatory approval. Many companies in the pharmaceutical and biotechnology industries have suffered significant setbacks, including failure in late-stage clinical trials even after achieving promising results in preclinical testing and earlier clinical trials. Data obtained from preclinical and clinical activities are subject to varying interpretations, which may delay, limit or prevent regulatory approval.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Further, we cannot predict with any certainty if or when we might submit a BLA for regulatory approval for any of our product candidates or whether any such BLA will be accepted for review by the FDA, or whether any BLA will be approved upon review. Even if our clinical trials are completed as planned, we cannot be certain that their results will support our proposed indications. Success in preclinical testing and early clinical trials does not ensure that later clinical trials will be successful, and we cannot be sure that the results of later clinical trials will replicate the results of prior clinical trials and preclinical testing. The clinical trial process may fail to demonstrate that our product candidates are safe and effective for their proposed uses. This failure could cause us to abandon a product candidate and may delay development of other product candidates. Any delay in, or termination of, our clinical trials will delay and possibly preclude the filing of any BLAs with the FDA and, ultimately, our ability to commercialize our product candidates and generate product revenues.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Our DeltEx product candidates utilize novel approaches to cell therapies, including cancer treatment, which presents significant challenges in order to successfully develop, manufacture and commercialize our product candidates.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We believe that our product candidates represent a novel approach to immunotherapy, including cancer treatment, and we have concentrated significant research and development efforts to date developing our INB-100 and INB-200 product candidates, as well as our additional drug-resistant immunotherapy, or DRI, gamma-delta T cell preclinical product candidates. Gamma-delta T cell immunotherapy is a newly emerging field and our approaches in particular, including genetic modification and DeltEx DRI gamma-delta T cells, have not been extensively tested over any significant period of time. We have not yet succeeded and may never succeed in demonstrating efficacy and safety for any of our product candidates in clinical trials or in obtaining marketing approval thereafter.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">For example, INB-100, our novel allogeneic gamma-delta T cell product candidate that we are initially developing for the treatment of patients with acute leukemia undergoing hematopoietic stem cell transplantation, is manufactured from healthy donor T cells using our proprietary manufacturing process. Allogeneic versions of cell therapy and gamma-delta T cell product candidates in particular is an unproven field of development and is subject to particular risks that are difficult to quantify, including understanding and addressing variability in the quality and quantity of a donor&#8217;s T cells and the patient&#8217;s potential immune reaction to the foreign donor cells, which could ultimately affect safety, efficacy and our ability to produce product in a reliable and consistent manner. As such, we may be faced with unforeseen delays and setbacks, in addition to the other foreseeable risks and uncertainties associated with developing immune cell therapies.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Additionally, we are the first company to advance a genetically modified gamma-delta T cell product candidate, INB-200, that we are currently developing for the treatment of certain solid tumors, into the clinic. The manufacture of our cell therapies involves complex processes, including, for INB-100, where blood cells are isolated from an allogeneic donor via leukapheresis, gamma-delta T cells are expanded and activated and other cells are removed through magnetic separation and then cryopreserved. For INB-200, blood cells are isolated from the patient via leukapheresis, the gamma-delta T cells are transduced, expanded and activated, and, if required, other cells are removed through magnetic separation prior to cryopreservation.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Any delay or difficulties in manufacturing clinical supply of INB-200, INB-100 or any of our other current or future product candidates would adversely affect our business and operations. For additional details surrounding risks related to our manufacturing process, see the risks highlighted in &#8220;Risks related to manufacturing and our dependence on third parties,&#8221; including &#8220;&#8212;</font><font style="font-style:italic;">Our manufacturing process is complex and we may encounter difficulties in production, which would delay or prevent our ability to provide a sufficient supply of our product candidates for future clinical trials or commercialization, if approved.</font><font style="letter-spacing:-0.025pt;">&#8221;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Advancing product candidates utilizing such novel approaches to immunotherapy creates significant challenges for us, including, among others:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">manufacturing our product candidate to our specifications and in a timely manner to support our clinical trials, and, if approved, commercialization;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">sourcing clinical and, if approved, commercial supplies for the raw materials used to manufacture our product candidates;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">understanding and addressing variability in the quality of a donor&#8217;s T cells, which could ultimately affect our ability to produce our product candidates in a reliable and consistent manner;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">conditioning patients with chemotherapy or other lymphodepletion agents in advance of administering our product candidates, which may increase the risk of adverse side effects;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">educating medical personnel regarding how to properly administer our cells and the potential side effect profile of our product candidates, such as cytokine release syndrome, neurotoxicity, graft versus host disease, prolonged cytopenia, infections, hygromas and neutropenic sepsis, among others;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">enrolling sufficient numbers of patients in clinical trials;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">training a sufficient number of technicians in how to properly manufacture our cells;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">developing a reliable, safe, effective and cost-effective means of consistently expanding and manufacturing our cells;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">understanding and addressing variability in demand for manufacturing and its impact on capacity utilization of available infrastructure and costs;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">developing a reliable, safe and effective means of genetically modifying our cells;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">submitting applications for and obtaining regulatory approval, as the FDA and other regulatory authorities have limited experience with commercial development of immunotherapies for cancer and viral associated infectious diseases; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">establishing sales and marketing capabilities, as well as developing a manufacturing process and distribution network to support the commercialization of any approved products.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We must be able to overcome these challenges in order for us to successfully develop, commercialize and manufacture our product candidates utilizing our novel approaches to gamma-delta T cell therapies.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">The clinical and commercial utility of our DeltEx platform is uncertain and may never be realized. Additionally, certain aspects of the function and production of gamma-delta T cells are poorly understood or currently unknown, and may only become known through further preclinical and clinical testing.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">To date, gamma-delta T cells have only been evaluated in early clinical trials. These clinical trials were primarily designed to evaluate safety and tolerability, and not designed to produce statistically significant results as to efficacy. Most of the data to date regarding gamma-delta T cells were derived from clinical trials not conducted by us, including physician-sponsored clinical trials, and utilizing gamma-delta T cells not manufactured by us. We currently have two ongoing clinical trials to evaluate gamma-delta T cells in investigator-sponsored clinical trials, which have enrolled and dosed only a limited number of patients to date. Success in early clinical trials does not ensure that large-scale clinical trials will be successful nor does it predict final results. Even after the completion of our ongoing Phase&#160;1 clinical trials, our gamma-delta T cell product candidates will have only been tested in a small number of patients. Results from these clinical trials may not necessarily be indicative of the safety and tolerability or efficacy of our product candidates as we expand into larger clinical trials.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We may not ultimately be able to provide the FDA with substantial clinical evidence to support a claim of safety, efficacy, purity and potency sufficient to enable the FDA to approve our DeltEx platform product candidates for any indication. This may be because early clinical trials do not meet their endpoints, because later clinical trials fail to reproduce favorable data obtained in earlier clinical trials, because the results of such trials are not statistically significant, because the FDA disagrees with how we interpret the data from these clinical trials, or because the FDA does not accept these therapeutic effects as valid endpoints in pivotal clinical trials necessary for market approval. For example, we are developing INB-100 for the treatment of patients undergoing hematopoietic stem cell transplantation for the treatment of hematological malignancies, and our &#8220;point-of-care&#8221; manufacturing process is predominantly based on cells received from healthy haploidentical related donors with at least half of the major human leukoycte antigen, or HLA, types matched. Our clinical development plan for INB-100 will seek to determine the safety of HLA mismatched, donor-derived gamma-delta T cells and establish the risk of graft versus host disease, or GvHD, if any. We will also seek to better understand the persistence of mismatched gamma-delta T cells and their potential impact on immune reconstitution, clinical activity and duration of response. While we believe that a high degree of HLA matching will not be required to prevent GvHD or for clinically meaningful activity and durability of response, if it becomes apparent through preclinical testing or clinical trials that such matching is required, an allogeneic or an &#8220;off-the-shelf&#8221; product may not be attainable, which would prevent the further advancement of our INB-100 allogeneic product candidate and adversely affect our business and current development plans. We will also need to demonstrate that our DeltEx platform product candidates are safe. We do not have data on possible harmful long-term effects of our DeltEx platform product candidates and do not expect to have this data in the near future. As a result, our ability to generate clinical safety and efficacy data sufficient to support submission of a marketing application or commercialization of our DeltEx platform product candidates is uncertain and is subject to significant risk.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Moreover, actual or perceived safety issues, including adoption of new therapeutics or novel approaches to treatment, may adversely influence the willingness of subjects to participate in clinical trials, or if approved by applicable regulatory authorities, of physicians to subscribe to the novel treatment mechanics. The FDA or other applicable regulatory authorities may impose specific post-market requirements, such as establishment of a Risk Evaluation and Mitigation Strategy, or REMS, and request additional information informing benefits or risks of our products may emerge at any time prior to or after regulatory approval.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Physicians, hospitals and third-party payors are often slow to adopt new products, technologies and treatment practices that require additional upfront costs and training. Based on these and other factors, hospitals and payors may decide that the benefits of this new therapy do not or will not outweigh its costs.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">Clinical product candidate development involves a lengthy and expensive process and involve uncertain outcomes. We may incur additional costs and encounter substantial delays or difficulties in our clinical trials.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We may not commercialize, market, promote or sell any product candidate without obtaining marketing approval from the FDA or other comparable regulatory authority, and we may never receive such approvals. It is impossible to predict when or if any of our product candidates will prove effective or safe in humans and will receive regulatory approval. Before obtaining marketing approval from regulatory authorities for the sale of our product candidates, we must complete preclinical development and then conduct extensive clinical trials to demonstrate the safety and efficacy of our product candidates in humans. Clinical testing is expensive, is difficult to design and implement, can take many&#160;years to complete and is uncertain as to outcome.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">A failure of one or more clinical trials can occur at any stage of testing. Moreover, preclinical and clinical data are often susceptible to varying interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in preclinical studies and clinical trials have nonetheless failed to obtain marketing approval of their products. Additionally, our ongoing Phase&#160;1 trials for INB-200 and INB-100 involve studying a relatively small patient population, which makes it difficult to predict whether the favorable results observed in such clinical trial will be repeated in larger and more advanced clinical trials.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We may experience numerous unforeseen events prior to, during, or as a result of, clinical trials that could delay or prevent our ability to receive marketing approval or commercialize our product candidates, including the following (among other unforeseen events included in this &#8220;&#8212;Risks related to the development of our product candidates&#8221; subsection):</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">delays in reaching a consensus with regulatory authorities on the design, location or implementation of our clinical trials;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">delays or setbacks in patient enrollment;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">clinical trials of our product candidates may produce negative or inconclusive results;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the number of patients required for clinical trials for our product candidates may be larger than we anticipate, enrollment in these clinical trials may be slower than we anticipate or may be lower than we anticipate due to challenges in recruiting and enrolling suitable patients that meet the study criteria, participants may drop out of these clinical trials at a higher rate than we anticipate or the duration of these clinical trials may be longer than we anticipate;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the impact of the ongoing COVID-19 pandemic, which may slow potential enrollment, impact hospital clinical and/or administrative support staff, reduce the number of eligible patients for clinical trials, or reduce the number of patients that remain in our trials;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">imposition of a clinical hold by regulatory authorities as a result of, among other reasons, a serious adverse event, a failure in the chemistry manufacturing and controls requirements, or a failed inspection of our clinical trial operations, trial sites or manufacturing facilities;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">occurrence of serious adverse events associated with the product candidate that are viewed to outweigh its potential benefits; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">need to conduct additional clinical trials or abandon product development programs.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Any inability to successfully complete preclinical and clinical development could result in additional costs to us or impair our ability to generate revenue from future product sales or other sources. In addition, if we make manufacturing or formulation changes to our product candidates, we may need to conduct additional testing to bridge our modified product candidate to earlier versions. Clinical trial delays could also shorten any periods during which we may have the exclusive right to commercialize our product candidates, if approved, or allow our competitors to bring competing products to market before we do, which could impair our ability to successfully commercialize our product candidates and may harm our business, financial condition, results of operations and prospects.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In addition, the clinical trial requirements of the FDA and other regulatory authorities and the criteria these regulators use to determine the safety and efficacy of a product candidate vary substantially according to the type, complexity, novelty, and intended use and market of the potential products. The regulatory approval process for product candidates such as ours can be more expensive </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">18</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">and take longer than for other, better known, or more extensively studied pharmaceutical or other product candidates. Regulatory agencies administering existing or future regulations or legislation may not allow production and marketing of products utilizing gene regulation technology in a timely manner or under technically or commercially feasible conditions. Regulatory action or private litigation could result in expenses, delays or other impediments to our research programs or the commercialization of resulting products.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Further, if the results of our clinical trials are inconclusive or if there are safety concerns or serious adverse events associated with our product candidates, we may be delayed in obtaining marketing approval, or not obtain marketing approval at all, obtain approval with labeling that includes significant use or distribution restrictions or safety warnings, and/or have regulatory authorities withdraw or suspend their approval or impose restrictions on distribution in the form of a modified risk evaluation and mitigation strategy, or REMS, among other results. We could also encounter delays if physicians encounter unresolved ethical issues associated with enrolling patients in clinical trials of our product candidates in lieu of prescribing existing treatments that have established safety and efficacy profiles.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Additionally, the FDA or an independent institutional review board, or IRB, may also suspend our clinical trials at any time if it appears that we or our collaborators are failing to conduct a trial in accordance with regulatory requirements, including the FDA&#8217;s current Good Clinical Practice, or GCP, regulations, that we are exposing participants to unacceptable health risks, or if the FDA finds deficiencies in our investigational new drug applications, or INDs, or the conduct of these trials. Therefore, we cannot predict with any certainty the schedule for commencement and completion of future clinical trials. If we experience delays in the commencement or completion of our clinical trials, or if we terminate a clinical trial prior to completion, the commercial prospects of our product candidates could be negatively impacted, and our ability to generate revenues from our product candidates may be delayed.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Development of a product candidate intended for use in combination with an already approved therapy may present increased complexity and more or different challenges than development of a product candidate for use as a single agent or monotherapy.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We are developing certain of our product candidates, including INB-200, to be used in combination with approved therapies, such as chemotherapy, which may present additional challenges. For example, the FDA may require us to use more complex clinical trial designs, in order to evaluate the contribution of each product and product candidate to any observed effects. It is possible that the results of these trials could show that most or any positive results are attributable to the already approved product. Moreover, following product approval, the FDA may require that products used in conjunction with each other be cross-labeled. To the extent that we do not have rights to already approved products, this may require us to work with another company to satisfy such a requirement. Moreover, developments related to the already approved therapies may impact our clinical trials for the combination as well as our commercial prospects should we receive marketing approval. Such developments may include changes to the approved therapy&#8217;s safety or efficacy profile, changes to the availability of the approved therapy, and changes to the standard of care.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">If we encounter difficulties in enrolling patients in our clinical trials, our clinical development activities could be delayed or otherwise adversely affected.</div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The timely completion of clinical trials in part depends on patient enrollment, and as such identifying and qualifying patients to participate in our clinical trials is critical to our success. We may encounter difficulties in enrolling a sufficient number of eligible patients to participate in our clinical trials, thereby delaying or preventing development and approval of our product candidates. Even once enrolled, we may be unable to retain a sufficient number of patients to complete any of our trials. Because our focus includes rare disorders, there are limited patient pools from which to draw in order to complete our clinical trials in a timely and cost-effective manner. Additionally, some of the initial indications for which we are developing our current product candidates, including glioblastoma, primarily affect an elderly population over the age of 65, who might suffer from other age-related and unknown and/or pre-existing ailments or health concerns. If any such patient enrolled in our smaller-scale Phase&#160;1 trials has to drop out due to pre-existing health issues or due to a serious adverse effect, or otherwise dies, and we are not able to recruit additional patients in a timely manner, or at all, our clinical trials could be delayed or otherwise halted. As such, despite diligent planning of our clinical trials and analysis of their feasibility regarding </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">19</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">patient recruitment, we may experience difficulties, delays or inability in patient enrollment in our clinical trials for a variety of reasons, including:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the size and nature of the patient population;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the severity and incidence of the disease under investigation;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the design of the trial and the complexity for patients and clinical sites;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the general health condition of the patient and their gamma-delta T cells and immune cells broadly;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the risk that patients&#8217; general health conditions do not allow the conduct of study/screening procedures (such as leukapheresis) the manufacture of therapeutic product or application of the appropriate standard-of-care treatment or application of the Stupp regimen;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the ability to consistently manufacture gamma-delta T cell product candidates in sufficient quantities at sufficient activity and/or transduction efficiency to provide a suitable therapeutic dose of gamma-delta T cells;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">competing clinical trials for similar therapies, other new therapeutics, new combination treatments, new medicinal products;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">clinicians&#8217; and patients&#8217; perceptions as to the potential advantages and side effects of the product candidate being studied in relation to other available therapies, including any new drugs or treatments that may be approved or become standard of care for the indications we are investigating;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the ability to obtain and maintain patient consents due to various reasons, including but not limited to, patients&#8217; unwillingness to participate due to the ongoing COVID-19 pandemic;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the risk that enrolled subjects will drop out or die before completion of the trial;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the ability to develop and provide appropriate screening, product characterization and release assays;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">patients failing to complete a clinical trial or returning for post-treatment follow-up;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our ability to manufacture the requisite materials for a patient and clinical trial; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">inability of clinical sites to enroll patients as health care capacities are required to cope with natural disasters, epidemics or other health system emergencies, such as the evolving and ongoing COVID-19 pandemic.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Our efforts to build relationships with patient communities may not succeed, which could result in delays in patient enrollment in our clinical trials. Any negative results we may report in clinical trials of our product candidates may make it difficult or impossible to recruit and retain patients in other clinical trials of that same product candidate. Delays or failures in planned patient enrollment or retention may result in increased costs, program delays or both, which could have a harmful effect on our ability to develop our product candidates or could render further development impossible. In addition, we may rely on clinical research organizations, or CROs, and clinical trial sites to ensure proper and timely conduct of our future clinical trials and, while we intend to enter into agreements governing their services, we will be limited in our ability to ensure their actual performance.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Serious adverse events, undesirable side effects or other unexpected properties of our product candidates may be identified during development or after approval, which could lead to the discontinuation of our clinical development programs, refusal by regulatory authorities to approve our product candidates or, if discovered following marketing approval, revocation of marketing authorizations or limitations on the use of our product candidates thereby limiting the commercial potential of such product candidate.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">During the conduct of clinical trials, patients report changes in their health, including illnesses, injuries and discomforts, to their doctor. Often, it is not possible to determine whether or not the product candidate being studied caused these conditions. Regulatory authorities may draw different conclusions or require additional testing to confirm these determinations, if they occur. Many times, side effects are only detectable after investigational drugs are tested in large-scale pivotal trials or, in some cases, after they are made available to patients on a commercial scale after approval. If additional clinical experience indicates that any of our product candidates have side effects or cause serious or life-threatening side effects, the development of the product candidate may fail or be delayed, or, if the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">20</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">product candidate has received regulatory approval, such approval may be revoked, which would harm our business, prospects, operating results and financial condition.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Undesirable side effects caused by our product candidates, implanted devices, delivery methods or dosage levels could cause us or regulatory authorities to interrupt, delay or halt clinical trials and could result in a more restrictive label or the delay or denial of regulatory approval by the FDA or other comparable foreign regulatory authority. As a result of safety or toxicity issues that we may experience in our clinical trials, we may be placed on clinical hold and not receive approval to market any product candidates, which could prevent us from ever generating revenues or achieving profitability. Results of our trials could reveal an unacceptably high severity and incidence of side effects, or side effects outweighing the benefits of our product candidates. In such an event, our studies could be delayed, suspended or terminated and the FDA or comparable foreign regulatory authorities could order us to cease further development of or deny approval of our product candidates for any or all targeted indications. The drug-related side effects could affect patient recruitment or the ability of enrolled subjects to complete the trial or result in potential product liability claims.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">To date, we have only tested INB-200 and INB-100 in a limited number of patients with cancer and these clinical trial participants have only been observed for a limited period of time after dosing. As we continue developing our lead product candidates and initiate clinical trials of our additional product candidates, serious adverse events, or SAEs, undesirable or potentially fatal side effects, cytokine release syndrome, viral or bacterial infections, relapse of disease or unexpected characteristics may emerge causing us to abandon these product candidates or limit their development to more narrow uses or subpopulations in which the SAEs or undesirable side effects or other characteristics are less prevalent, less severe or more acceptable from a risk-benefit perspective or in which efficacy is more pronounced or durable. Treatment-related side effects could also affect patient recruitment or the ability of enrolled patients to complete the trial or result in potential product liability claims. In addition, these side effects may not be appropriately recognized or managed by the treating medical staff, and inadequate training in recognizing or managing the potential side effects of our product candidates could result in patient injury or death. Should we observe SAEs in our clinical trials or identify undesirable side effects or other unexpected findings, our trials could be delayed or even terminated and our development programs may be halted entirely.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Additionally, if any of our product candidates receives regulatory approval, and we or others later identify undesirable side effects caused by such product, a number of potentially significant negative consequences could result. For example, the FDA could require us to adopt a REMS to ensure that the benefits of treatment with such product candidate outweigh the risks for each potential patient, which may include, among other things, a communication plan to health care practitioners, patient education, extensive patient monitoring or distribution systems and processes that are highly controlled, restrictive and more costly than what is typical for the industry. We or our collaborators may also be required to adopt a REMS or engage in similar actions, such as patient education, certification of health care professionals or specific monitoring, if we or others later identify undesirable side effects caused by any product that we develop alone or with collaborators.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Any of these events could diminish the usage or otherwise limit the commercial success of our product candidates and prevent us from achieving or maintaining market acceptance of the affected product candidate, if approved by applicable regulatory authorities.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">The ongoing COVID-19 pandemic could continue to adversely impact our business, including our clinical trials, supply chain and business development activities.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In connection with the ongoing COVID-19 pandemic, governments have implemented significant measures, including closures of businesses, quarantines, travel restrictions and other social distancing directives, intended to control the spread of the virus. Companies have also taken precautions, such as requiring employees to work remotely, imposing travel restrictions and temporarily closing businesses. In response to these public health directives and orders, we have implemented certain travel restrictions and work-from-home policies for our employees, and as a result we have experienced limitations on employee resources. The effects of government actions and our own policies and those of third parties to reduce the spread of COVID-19 may negatively impact productivity and slow down or delay our ongoing and future clinical trials, preclinical studies and research and development activities, may cause </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">21</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">disruptions to our supply chain, to the administrative functions of clinical trial sites and/or to the operations of our other partners, and as a result may impair our ability to execute our programs and/or business development strategy. In the event that government authorities were to enhance current restrictions, our employees who currently are not telecommuting may no longer be able to access our facilities, including our laboratories and our operations may be further limited or curtailed.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our clinical trials have been, and may in the future be, affected by the ongoing COVID-19 pandemic. If a patient in any of our clinical trials contracts COVID-19, it could cause a serious adverse event to occur, especially in light of the immunosuppressive conditioning to which such patients are subject. To date, the spread of COVID-19 in the states of Alabama and Kansas has impacted the intensive care unit capacity at the hospitals participating in our clinical trials, and has slowed the rate of patient enrollment. The hospitals also experienced shortages in personal protective equipment, or PPE, that could in the future result in significant delays to our clinical trials. In addition, due to the ongoing COVID-19 pandemic, there was an increasing risk that a patient could undergo a conditioning or myeloablative preparative process only to find that their donor has been infected with COVID-19, making donor HSCs unavailable to the patient. This would result in patient death. Accordingly, we have submitted to the FDA and the IRB a modified clinical protocol to allow the usage of previously frozen HSCs to mitigate such risks associated with COVID-19 exposure. This potentially could result in lower potency, but allows the leukapheresis and harvest of the HSCs from the donor and the confirmation of a negative COVID-19 result prior to initiating the conditioning and/or myeloablation of the patient. We may experience other disruptions due to the ongoing COVID-19 pandemic that could severely impact our business, preclinical studies and clinical trials, including:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">delays or difficulties in enrolling and maintaining patients in our clinical trials;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">delays or difficulties in shipping and delivering in a timely manner supplies, samples or products required for our clinical trials due to the impact of the ongoing COVID-19 pandemic on the United States Postal Service, FedEx, United Parcel Service and/or other commercial shipping organizations;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">delays or difficulties in clinical site initiation, including difficulties completing any required contracts, successfully completing IRB review in a timely manner, or in recruiting clinical site investigators and clinical site staff;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">disruptions in our supply chain that result in shortages of reagents or materials to conduct our laboratory experiments and/or clinical trials, including PPE, PCR reagents and/or pipette tips;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">changes in local regulations as part of a response to the ongoing COVID-19 outbreak which may require us to change the ways in which our clinical trials are conducted, which may result in unexpected costs, or cause us to discontinue the clinical trials altogether;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">diversion of healthcare resources away from the conduct of clinical trials, including the diversion of hospitals serving as our clinical trial sites and hospital staff supporting the conduct of our clinical trials;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">difficulties in recruiting and retaining principal investigators and site staff who, as healthcare providers, may have heightened exposure to COVID-19;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">interruption of key clinical trial activities, such as clinical trial site monitoring, manufacturing and equipment maintenance due to limitations on travel or access imposed or recommended by federal or state governments, hospitals, employers and others, or interruption of clinical trial subject visits and study procedures;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">interruption or delays in the operations of the FDA or other regulatory authorities, which may impact review and approval timelines;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">risk that participants enrolled in our clinical trials will acquire COVID-19 while the clinical trial is ongoing, which could result in the reporting of an SAE, potentially including patient deaths, and impact the results of the clinical trial, including by increasing the number of observed adverse events; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">refusal of the FDA to accept data from clinical trials in affected geographies.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">These and other disruptions in our operations and the global economy could negatively impact our business, operating results and financial condition.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">22</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The spread of COVID-19 and actions taken to reduce its spread may also materially affect us economically. While the potential economic impact brought by, and the duration of, the ongoing COVID-19 pandemic may be difficult to assess or predict, there have recently been, and could in the future be, significant disruptions of global financial markets, reducing our ability to access capital, which could in the future negatively affect our liquidity and financial position. In addition, the trading prices for other biopharmaceutical companies have been highly volatile as a result of the ongoing COVID-19 pandemic. As a result, we may face difficulties raising capital or such capital raises may be on unfavorable terms.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">COVID-19 and actions taken to reduce its spread continue to rapidly evolve. The extent to which COVID-19 may impede the development of our product candidates, reduce the productivity of our employees, disrupt our supply chains, delay our clinical trials, reduce our access to capital or limit our business development activities, will depend on future developments, which are highly uncertain and cannot be predicted with confidence. To the extent the ongoing COVID-19 pandemic adversely affects our business and financial results, it may also have the effect of heightening many of the other risks described in this &#8220;Risk Factors&#8221; section, such as those relating to the timing and results of our clinical trials and our financing needs.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In April&#160;2020, the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act, which was intended to provide economic relief to United States businesses affected by the ongoing COVID-19 pandemic, was signed into law. In April&#160;2020, we received a $0.2&#160;million loan, or the PPP Loan, under the small business Paycheck Protection Program, established under the CARES Act and administered by the Small Business Administration, or the SBA. The loan is forgivable subject to certain limitations, including that the loan proceeds be used to retain workers and for payroll, rent, mortgage payments and utility costs. In order to apply for the PPP Loan, we were required to certify that, among other things, the current economic uncertainty made the PPP Loan request necessary to support our ongoing operations. While we made this certification in good faith after analyzing, among other things, our financial situation and access to alternative forms of capital, and believe that we satisfied all eligibility criteria for the PPP Loan and that our receipt of the PPP Loan is consistent with the broad objectives of the Paycheck Protection Program of the CARES Act, the certification described above does not contain any objective criteria and is subject to interpretation. If, despite our good-faith belief that we satisfied all eligible requirements for the PPP Loan, we are found to be in violation of any of the laws or governmental regulations that apply to us in connection with the PPP Loan, including the False Claims Act, or it is otherwise determined that we were not eligible to receive the PPP Loan, we may be subject to penalties, including significant civil, criminal and administrative penalties and could be required to repay the PPP Loan in its entirety. In addition, our receipt of the PPP Loan may result in adverse publicity and damage to our reputation, a review or audit by the SBA or other government entity, or claims under the False Claims Act. Any of these events could have a material adverse effect on our business, results of operations and financial condition.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Interim, &#8220;top-line&#8221; and preliminary data from our clinical trials that we announce or publish from time to time may change as more patient data become available and are subject to audit and verification procedures that could result in material changes in the final data.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">From time to time, we may publish interim, &#8220;top-line&#8221; or preliminary data from our clinical trials. Interim, &#8220;top-line&#8221; or preliminary data from clinical trials that we may complete are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available. Interim, &#8220;top-line&#8221; and preliminary data also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data we previously published. As a result, interim, &#8220;top-line,&#8221; and preliminary data should be viewed with caution until the final data are available. Differences between interim, &#8220;top-line&#8221; and preliminary data and final data could significantly harm our business prospects and may cause the trading price of our common stock to fluctuate significantly.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Further, others, including regulatory agencies, may not accept or agree with our assumptions, estimates, calculations, conclusions or analyses or may interpret or weigh the importance of data differently, which could impact the value of the particular program, the approvability or commercialization of the particular product candidate or product and our business in general. In addition, the information we choose to publicly disclose regarding a particular study or clinical trial is based on what is typically </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">23</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">extensive information, and you or others may not agree with what we determine is the material or otherwise appropriate information to include in our disclosure, and any information we determine not to disclose may ultimately be deemed significant with respect to future decisions, conclusions, views, activities or otherwise regarding a particular product candidate or our business. If the interim, &#8220;top-line,&#8221; or preliminary data that we report differ from actual results, or if others, including regulatory authorities, disagree with the conclusions reached, our ability to obtain approval for and commercialize our product candidates, our business, operating results, prospects or financial condition may be harmed.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">We may seek breakthrough therapy or fast track designations and may pursue accelerated approval for some or all of our current product candidates, but we may be unable to obtain such designations or, where obtained, we may be unable to maintain breakthrough therapy designation or obtain or maintain the benefits associated with such designations.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We may seek breakthrough therapy or fast track designations and may pursue accelerated approval for INB-100, INB-200, INB-400 and some or all of our current product candidates. Breakthrough therapy designation is intended to expedite the development and review of products that treat serious or life-threatening diseases when preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. The designation of a product candidate as a breakthrough therapy provides potential benefits that include intensive guidance on an efficient drug development program, beginning as early as Phase&#160;1, organizational commitment involving senior managers; and eligibility for rolling review and priority review. Breakthrough therapy designation does not change the standards for product approval. There can be no assurance that we will receive breakthrough therapy designation for any product candidate or any particular indication.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We may also seek fast track designation. If a drug or biologic candidate is intended for the treatment of a serious or life-threatening condition or disease and the drug demonstrates the potential to address unmet medical needs for the condition, the sponsor may apply for fast track designation. Even if we do apply for and receive fast track designation, we may not experience a faster development, review or approval process compared to conventional FDA procedures. The FDA may rescind fast track designation if it believes that the designation is no longer supported by data from our clinical development program.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Additionally, we may also seek accelerated approval under the FDA&#8217;s accelerated approval programs. The FDA may approve a drug or biologic for a serious or life-threatening disease or condition that generally provides meaningful advantages over available treatments and demonstrates an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit, or on a clinical endpoint that can be measured earlier than irreversible morbidity or mortality, that is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit, taking into account the severity, rarity, or prevalence of the condition and the availability or lack of alternative treatments.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Seeking and obtaining these designations is dependent upon results of our clinical program, and we cannot guarantee whether and when we may have the data from our clinical programs to support an application to obtain any such designation. The FDA and comparable foreign regulatory agencies have broad discretion whether or not to grant any of these or similar designations, so even if we believe a particular product candidate is eligible for one or more of these designations, we cannot assure you that the applicable regulatory authority would decide to grant it. Even if we do receive the designations we may apply for, we may not experience a faster development process, review or approval compared to conventional procedures, as applicable. The FDA or other regulatory agencies may also rescind any granted designations if it believes that the designation is no longer supported by data from our clinical development program.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">We may seek orphan drug designation for some or all of our current or future product candidates, we may be unsuccessful or may be unable to maintain the benefits associated with orphan drug designation, including the potential for supplemental market exclusivity.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We may seek orphan drug designation for one or more of our current or future product candidates. Regulatory authorities in some jurisdictions, including the United States and Europe, may designate drugs or biologics for relatively small patient populations as orphan drugs. Under the Orphan Drug Act, the FDA may grant orphan designation to a drug intended to treat a rare disease or condition, defined </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">24</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">as a disease or condition with a patient population of fewer than 200,000 in the United States, or a patient population greater than 200,000 in the United States when there is no reasonable expectation that the cost of developing and making available the drug in the United States will be recovered from sales in the United States for that drug. In the United States, orphan drug designation entitles a party to financial incentives such as opportunities for grant funding towards clinical trial costs, tax advantages and user-fee waivers. After the FDA grants orphan drug designation, the identity of the biologic and its potential orphan use are disclosed publicly by the FDA. Orphan drug designation does not convey any advantage in, or shorten the duration of, the regulatory review and approval process.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">If a product that has orphan drug designation subsequently receives the first FDA approval for a particular active ingredient for the disease for which it has such designation, the product is entitled to orphan product exclusivity, which means that the FDA may not approve any other applications, including a BLA, to market the same product for the same indication for seven&#160;years, except in limited circumstances such as a showing of clinical superiority to the product with orphan drug exclusivity or if the FDA finds that the holder of the orphan drug exclusivity has not shown that it can assure the availability of sufficient quantities of the orphan drug to meet the needs of patients with the disease or condition for which the drug was designated. As a result, even if one of our product candidates receives orphan exclusivity, the FDA can still approve other products that have a different active ingredient for use in treating the same indication or disease. Further, the FDA can waive orphan exclusivity if we are unable to manufacture sufficient supply of our product.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We may seek orphan drug designation for INB-100, INB-200, INB-400 and some or all of our other current or future product candidates in additional orphan indications in which there is a medically plausible basis for the use of these product candidates. Even when we obtain orphan drug designation, exclusive marketing rights in the United States may be limited if we seek approval for an indication broader than the orphan designated indication and may be lost if the FDA later determines that the request for designation was materially defective or if we, through our manufacturer, are unable to assure sufficient quantities of the product to meet the needs of patients with the rare disease or condition. In addition, although we intend to seek orphan drug designation for other product candidates, we may never receive these designations. For example, the FDA has expressed concerns regarding the regulatory considerations for orphan drug designation as applied to tissue agnostic therapies, and the FDA may interpret the Federal Food, Drug and Cosmetic Act, and regulations promulgated thereunder, in a way that limits or blocks our ability to obtain orphan drug designation or orphan drug exclusivity, if our product candidates are approved, for our targeted indications.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">We may not be able identify or discover other product candidates and may fail to capitalize on programs or product candidates that may present a greater commercial opportunity or for which there is a greater likelihood of success.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our efforts to identify and develop, additional product candidates will require substantial technical, financial and human resources, whether or not any product candidates are ultimately identified. We may also broaden the reach of our DeltEX platform by selectively in-licensing technologies or product candidates. Our efforts may initially show promise in identifying potential product candidates, yet fail to yield product candidates for clinical development, approved products or commercial revenues for many reasons, including the following:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the methodology used may not be successful in identifying potential product candidates;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">competitors may develop alternatives that render any product candidates we develop obsolete; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">any product candidates we develop may be covered by third parties&#8217; patents or other exclusive rights;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">a product candidate may demonstrate harmful side effects or other characteristics that indicate it is unlikely to be effective or otherwise does not meet applicable regulatory criteria;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">a product candidate may not be capable of being produced in commercial quantities at an acceptable cost, or at all; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">a product candidate may not be accepted as safe and effective by physicians, patients, the medical community or third-party payors.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We have limited financial and management resources and, as a result, we may forego or delay pursuit of opportunities with other product candidates or for other indications that later prove to have </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">25</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">greater market potential. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products, including attractive or profitable market opportunities. If we do not accurately evaluate the commercial potential or target market for a particular product candidate, we may relinquish valuable rights to that product candidate through collaboration, licensing or other royalty arrangements in circumstances under which it would have been more advantageous for us to retain sole development and commercialization rights to such product candidate. In addition, we may not be successful in replicating our approach to product candidate development for other disease indications. If we are unsuccessful in identifying and developing additional product candidates or are unable to do so, our business may be harmed.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">Public opinion and scrutiny of cell-based immunotherapy and genetic modification approaches may impact public perception of our company and product candidates, or may adversely affect our ability to conduct our business and our business plans.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our DeltEX platform utilizes a relatively novel technology involving the genetic modification of human cells and utilization of those modified cells in other individuals. Public perception may be influenced by negative claims about our DeltEX platform, such as claims that cell-based immunotherapy is unsafe, unethical, expensive or immoral and, consequently, our approach may not gain the acceptance of the public or the medical community. Negative public reaction to cell-based immunotherapy in general could result in greater government regulation and stricter labeling requirements of cell-based immunotherapy products, including any of our product candidates, and could cause a decrease in the demand for any products we may develop. Negative public attitudes may adversely impact our ability to enroll patients in clinical trials. Moreover, our success will depend upon physicians specializing in the treatment of those diseases that our product candidates target prescribing, and their patients being willing to receive, treatments that involve the use of our product candidates in lieu of, or in addition to, existing treatments they are already familiar with and for which greater clinical data may be available. More restrictive government regulations or negative public opinion could have an adverse effect on our business or financial condition and may delay or impair the development and commercialization of our product candidates or demand for any products we may develop. Adverse events in our clinical trials, even if not ultimately attributable to our product candidates, and the resulting publicity could result in increased governmental regulation, unfavorable public perception, potential regulatory delays in the testing or approval of our potential product candidates, stricter labeling requirements for those product candidates that are approved and a decrease in demand for any such product candidates.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">We face significant competition, and many of our competitors have substantially greater experience and resources than we have.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The clinical and commercial landscape in the indications we are targeting, as well as in the field of immune-oncology, is highly competitive. We may face potential competition with respect to our current product candidates and may face competition with respect to any other product candidates that we may seek to develop or commercialize in the future from pharmaceutical and biotechnology companies, academic institutions, government agencies and other public and private research institutions.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Many of our current or potential competitors have greater financial and other resources, larger research and development staffs, and more experienced capabilities in researching, developing and testing products than we do. Many of these companies also have more experience in conducting clinical trials, obtaining FDA and other regulatory approvals, and manufacturing, marketing and distributing therapeutic products. Smaller or clinical-stage companies like us may successfully compete by establishing collaborative relationships with larger pharmaceutical companies or academic institutions. Mergers and acquisitions in the pharmaceutical and biotechnology industries may result in even more resources being concentrated among a smaller number of our competitors. These competitors also compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs. Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, have fewer or less severe side effects, are more convenient, or are less expensive than any products that we may develop. Furthermore, currently approved products could be discovered to have application for treatment of cancer and other diseases, which could give such products significant regulatory and market timing advantages over any of our product candidates. In addition, large pharmaceutical companies or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">26</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">other companies with greater resources or experience than us may choose to forgo therapy opportunities that would have otherwise been complementary to our product development and collaboration plans. Our competitors may succeed in developing, obtaining patent protection for, or commercializing their products more rapidly than us, which could result in our competitors establishing a strong market position before we are able to enter the market. A competing company developing or acquiring rights to a more effective therapeutic product for the same diseases targeted by us, or one that offers significantly lower costs of treatment could render our products noncompetitive or obsolete. We may not be successful in marketing any product candidates we may develop against competitors.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">We expect the product candidates we develop will be regulated as biologics, and therefore they may be subject to competition sooner than anticipated.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The Biologics Price Competition and Innovation Act of 2009, or BPCIA, was enacted as part of the Affordable Care Act to establish an abbreviated pathway for the approval of biosimilar and interchangeable biological products. The regulatory pathway establishes legal authority for the FDA to review and approve biosimilar biologics, including the possible designation of a biosimilar as &#8220;interchangeable&#8221; based on its similarity to an approved biologic. Under the BPCIA, an application for a biosimilar product cannot be approved by the FDA until 12&#160;years after the reference product was approved under a BLA. The law is complex and is still being interpreted and implemented by the FDA. As a result, its ultimate impact, implementation, and meaning are subject to uncertainty. While it is uncertain when processes intended to implement BPCIA may be fully adopted by the FDA, any of these processes could have a material adverse effect on the future commercial prospects for our biological products.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We believe that any of the product candidates we develop that is approved in the United States as a biological product under a BLA should qualify for the 12-year period of exclusivity. However, there is a risk that this exclusivity could be shortened due to congressional action or otherwise, or that the FDA will not consider the subject product candidates to be reference products for competing products, potentially creating the opportunity for generic competition sooner than anticipated. Moreover, the extent to which a biosimilar, once approved, will be substituted for any one of the reference products in a way that is similar to traditional generic substitution for non-biological products is not yet clear, and will depend on a number of marketplace and regulatory factors that are still developing.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In addition, the approval of a biologic product biosimilar to one of our products could have a material adverse impact on our business as it may be significantly less costly to bring to market and may be priced significantly lower than our products.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Risks Related to Manufacturing and Our Dependence on Third Parties</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">Our manufacturing process is complex and we may encounter difficulties in production, which would delay or prevent our ability to provide a sufficient supply of our product candidates for future clinical trials or commercialization, if approved.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Some of our product candidates, including INB-200, are genetically engineered human cells, and the process of manufacturing such product candidates, as well as the lentiviral vectors, is complex, highly regulated, variable and subject to numerous risks. Manufacturing our product candidates involves harvesting cells from a donor, isolating cells via leukapheresis, activating and expanding the gamma-delta T cells, cryopreservation, testing, storage and eventually shipment and infusion of the cell product into the patient&#8217;s body.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our manufacturing process will be susceptible to product loss or failure, or product variation that may negatively impact patient outcomes, due to logistical issues associated with the collection of starting material from the donor, shipping such material to the manufacturing site, shipping the final product back to the recipient, preparing the product for administration, infusing the patient with the product, manufacturing issues or different product characteristics resulting from the inherent differences in donor starting materials, variations between reagent lots, interruptions in the manufacturing process, contamination, equipment or reagent failure, improper installation or operation of equipment and/or programs, vendor or operator error, inconsistency in cell growth and variability in product characteristics. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Even minor variations in starting reagents and materials, or deviations from normal manufacturing processes could result in reduced production yields, product defects, manufacturing failure and other </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">27</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">supply disruptions. If, for any reason in our ongoing Phase&#160;1 clinical trials, we lose the starting material for a manufactured product for one of our patients at any point in the process, or the expansion or transduction procedures in the manufacturing process should fail for any reason, such patient would no longer receive a dose of the therapy and may end participation in our clinical trial. For instance, operator errors impacting machine function, gas or airflow, or reagent addition can negatively impact the process. Manufacturing by a previously contracted facility has resulted in such operator errors; however, we identified these errors through our quality control procedures prior to patient administration. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">If microbial, viral or other contaminations are discovered in our product candidates or in any of the manufacturing facilities in which products or other materials are made, such manufacturing facilities may need to be closed for an extended period of time to investigate and remedy the contamination. We will be required to maintain a chain of identity with respect to materials as they move from the donor to the manufacturing facility, through the manufacturing process and back to the clinical trial recipient. Maintaining a chain of identity is difficult and complex, and failure to do so could result in adverse patient outcomes, loss of product or regulatory action, including withdrawal of our products from the market, if licensed. Any failure in the foregoing processes could render a batch of product unusable, could affect the regulatory approval of such product candidate, could cause us to incur fines or penalties or could harm our reputation and that of our product candidates.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We may make changes to our manufacturing process for various reasons, such as to control costs, increase yield or dose, achieve commercial scale, decrease processing time, increase manufacturing success rate or for other reasons. We recently relocated clinical trial manufacturing for one of our clinical development programs to an academic GMP facility closer to our laboratory headquarters in Birmingham, Alabama to permit us contractual direct access as a means of preventing manufacturing errors. However, even with this contractual direct access and closer collaboration with the facility&#8217;s manufacturing staff, there can be no guarantee that manufacturing errors will not occur.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Changes to our process made during the course of clinical development could require us to show the comparability of the product used in earlier clinical phases or at earlier portions of a trial to the product used in later clinical phases or later portions of the trial. Other changes to our manufacturing process made before or after commercialization could require us to show the comparability of the resulting product to the product candidate used in the clinical trials using earlier processes. Such showings could require us to collect additional nonclinical or clinical data from any modified process prior to obtaining marketing approval for the product candidate produced with such modified process. If such data are not ultimately comparable to that seen in the earlier trials or earlier in the same trial in terms of safety or efficacy, we may be required to make further changes to our process and/or undertake additional clinical testing, either of which could significantly delay the clinical development or commercialization of the associated product candidate, which would materially adversely affect our business, financial condition, results of operations and growth prospects.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">We may rely on third parties for the manufacturing process of our product candidates, and failure by those parties to adequately perform their obligations could harm our business.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Although we endeavor to build a manufacturing facility in the future, we do not currently own any facility that may be used as our clinical or commercial-scale manufacturing and processing facility and expect that we will rely on outside vendors for at least a portion of the manufacturing process of our product candidates that we develop. The facilities used by our contract manufacturers must be approved by the FDA or other foreign regulatory agencies pursuant to inspections that will be conducted after we submit an application for approval to the FDA or other foreign regulatory agencies. To the extent that we engage third parties for manufacturing services, we will not control the manufacturing process of, and will be completely dependent on, our contract manufacturing partners for compliance with confidentiality agreements and the cGMP requirements for manufacture of our product candidates. We have not yet caused any product candidates to be manufactured or processed on a commercial scale and may not be able to do so. We will make changes as we work to optimize the manufacturing process, and we cannot be sure that even minor changes in the process will result in products that are capable or safe and effective. If such contract manufacturers cannot successfully manufacture material that conforms to our specifications and the strict regulatory requirements of the FDA or others, we will not be able to secure and/or maintain regulatory approval for our product candidates. In addition, we have no control </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">28</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">over the ability of third parties to maintain adequate quality control, quality assurance and qualified personnel. If the FDA or a comparable foreign regulatory authority does not approve these facilities for the manufacture of our product candidates or if it withdraws any such approval in the future, we may need to find alternative manufacturing facilities, which would significantly impact our ability to develop, obtain regulatory approval for or market our product candidates, if approved. Any significant delay in the supply of a product candidate, or the raw material components thereof, for an ongoing clinical trial due to the need to replace a third-party manufacturer could considerably delay completion of our clinical trials, product testing and potential regulatory approval of our product candidates.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Moreover, the process of manufacturing cell therapies is susceptible to product loss due to contamination, equipment failure or improper installation, maintenance or operation of equipment, or vendor or operator error. Even minor deviations from normal manufacturing and distribution processes for any of our product candidates could result in reduced production yields, increased costs, impact to key product quality attributes, and other supply disruptions. Such minor deviations did in fact occur in our previously contracted manufacturing facility due to operator error.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Product defects can also occur unexpectedly. If microbial, viral or other contaminations are discovered in our product candidates or in the manufacturing facilities in which our product candidates are made, these manufacturing facilities may need to be closed for an extended period of time to allow us to investigate and remedy the contamination. Because our cell therapy product candidates are manufactured from the blood of third-party donors, the process of manufacturing is susceptible to the availability and variability of the third-party donor material. The process of developing products that can be commercialized may be particularly challenging, even if they otherwise prove to be safe and effective. The manufacture of these product candidates involves complex processes. Some of these processes require specialized equipment and highly skilled and trained personnel. The process of manufacturing these product candidates will be susceptible to additional risks, given the need to maintain aseptic conditions throughout the manufacturing process. Contamination with viruses or other pathogens in either the donor material or materials utilized in the manufacturing process or ingress of microbiological material at any point in the process may result in contaminated or unusable product and patients may not receive a dose. This type of contaminations could result in delays in the manufacture of products which could result in delays in the development of our product candidates. These contaminations could also increase the risk of adverse side effects. Furthermore, the selection and distribution of the appropriate cell line for therapeutic use in a patient requires close coordination between clinical operations, supply chain and quality assurance personnel.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We also intend to rely on third-party manufacturers to supply us with additional quantities of our product candidates to be used, if approved, for commercialization. We do not yet have a commercial supply agreement for commercial quantities of product. If we are not able to meet market demand for any approved product, it would negatively impact our ability to generate revenue, harm our reputation, and could have an adverse effect on our business and financial condition.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Further, our reliance on third-party manufacturers entails risks to which we would not be subject if we manufactured product candidates ourselves, including:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">inability to meet our product specifications and quality requirements consistently;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">delay or inability to procure or expand sufficient manufacturing capacity;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.91pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">issues related to scale-up of manufacturing;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">costs and validation of new equipment and facilities required for scale-up;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our third-party manufacturers may not be able to execute our manufacturing procedures and other logistical support requirements appropriately;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our third-party manufacturers may fail to comply with cGMP requirements and other inspections by the FDA or other comparable regulatory authorities;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our inability to negotiate manufacturing agreements with third parties under commercially reasonable terms, if at all;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">breach, termination or nonrenewal of manufacturing agreements with third parties in a manner or at a time that is costly or damaging to us;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">reliance on single sources for reagents and components;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">29</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">lack of qualified backup suppliers for those components that are currently purchased from a sole or single-source supplier;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our third-party manufacturers may not devote sufficient resources to our product candidates;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">we may not own, or may have to share, the intellectual property rights to any improvements made by our third-party manufacturers in the manufacturing process for our product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">operations of our third-party manufacturers or suppliers could be disrupted by conditions unrelated to our business or operations, including the bankruptcy of the manufacturer or supplier; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">carrier disruptions or increased costs that are beyond our control.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In addition, if we enter into a strategic collaboration with a third party for the commercialization of our current or any future product candidates, we will not be able to control the amount of time or resources that they devote to such efforts. If any strategic collaborator does not commit adequate resources to the marketing and distribution of our current or any future product candidates, it could limit our potential revenues.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Any adverse developments affecting manufacturing operations for our product candidates may result in lot failures, inventory shortages, shipment delays, product withdrawals or recalls or other interruptions in the supply of our drug product which could prevent the administration to patients and delay the development of our product candidates. We may also have to write off inventory, incur other charges and expenses for supply of drug product that fails to meet specifications, undertake costly remediation efforts, or seek more costly manufacturing alternatives.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Any of these events could lead to clinical trial delays or failure to obtain regulatory approval, or impact our ability to successfully commercialize our current or any future product candidates once approved. Some of these events could be the basis for FDA action, including injunction, request for recall, seizure, or total or partial suspension of production.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">We currently store our gamma-delta T cells at our research and development facility, and any damage or loss to our storage freezers would cause delays in replacement, and our business could suffer.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Our gamma-delta T cells and samples are stored in our freezers at our research and development facility. If these cells are damaged, including by the loss or malfunction of our freezers or our back-up power systems, as well as by damage from fire, power loss or other natural disasters, we would need to establish replacement cell banks, which could impact clinical supply and could delay our clinical trials. We would need another supplier with a GMP facility, available supply and would need to potentially conduct additional animal studies to determine equivalence of the vector. If we or our third-party contractors are unable to establish replacement cell banks, cells, samples and vectors, as applicable, we could incur significant additional expenses and liability, our development programs could be delayed or terminated and our business could suffer.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">We are currently dependent on a single third-party supplier for manufacture of our automated manufacturing device and our lentiviral vectors. These are critical products required for the manufacturing of our product candidates, including INB-200 and INB-100. Any damage or loss to the ability of our suppliers to deliver supplies in a timely manner could cause delays in manufacturing, and our business could suffer.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Our gamma-delta T cell products for INB-200 and INB-100 are manufactured in a programmable, closed system device at GMP standards. If the devices are damaged and cannot be repaired or the supplier cannot deliver new devices in a timely manner, or at all, our ability to manufacture and supply sufficient quantities of our products for clinical or commercial usage will be delayed, or potentially hindered.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">There is currently a significant backlog for lentiviral vector manufacturing due to increased demand. Our current supply of vectors will only cover approximately 30 patients. If our third-party contractor is unable to provide adequate lentiviral vectors in a timely manner, our ability to manufacture and supply sufficient quantities of our product candidates for clinical or commercial usage will be delayed or hindered, and our business could suffer.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">30</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">We rely on third party healthcare professionals to administer gamma-delta T cells to patients, and our business could be harmed if these third parties administer these cells incorrectly.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We rely on the expertise of physicians, nurses and other associated medical personnel to administer gamma-delta T cells to clinical trial patients. If these medical personnel are not properly trained to administer, or do not properly administer, gamma-delta T cells, the therapeutic effect of gamma-delta T cells may be diminished or the patient may suffer injury.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In addition, if we achieve the ability to freeze and thaw our gamma-delta T cells, third party medical personnel will have to be trained on proper methodology for thawing gamma-delta T cells received from us. If this thawing is not performed correctly, the cells may become damaged and/or the patient may suffer injury. While we intend to provide training materials and other resources to these third-party medical personnel, the thawing of gamma-delta T cells will occur outside our supervision and may not be administered properly. If, due to a third-party error, people believe that gamma-delta T cells are ineffective or harmful, the desire to use gamma-delta T cells may decline, which would negatively impact our business, reputation and prospects. We may also face significant liability even though we may not be responsible for the actions of these third parties.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">We believe we may require an updated and validated protocol for commercial-scale expansion and manufacturing of gamma-delta T cells for conducting pivotal trials and for commercialization of our product candidates, if approved.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Future clinical trials that we conduct, as well as any potential commercialization of our product candidates when approved, will depend on the reliability, safety and efficacy of our for expanding, transducing and manufacturing gamma-delta T cells at scale. Our efforts to scale up production of our gamma-delta T cells in anticipation of future clinical trials or commercialization may reveal, an inability to overcome biology or may otherwise encounter challenges, including scrutiny from regulatory authorities. To the extent we encounter any such difficulties, our ability to conduct additional clinical trials or to scale for commercialization will be hindered or prevented, which would have an adverse effect on our business.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">We have not yet developed commercial-scale infrastructure for freezing and thawing large quantities of gamma-delta T cells, which we believe will be required for the storage and distribution of our gamma-delta T cell product candidates at commercial scale.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We have not demonstrated that gamma-delta T cells can be frozen and thawed in large commercial-scale quantities without damage, in a cost-efficient manner and without degradation over long periods of time. We may encounter difficulties not only in developing freezing and thawing, but also in obtaining the necessary regulatory approvals for using such in treatment. If we cannot adequately demonstrate similarity of our frozen product to the unfrozen form to the satisfaction of the FDA, we could face substantial delays in our regulatory approvals. If we are unable to freeze gamma-delta T cells for shipping purposes, our ability to promote adoption and standardization of our products, as well as achieve economies of scale by centralizing our production facility, will be limited. Even if we are able to successfully freeze and thaw gamma-delta T&#160;cells in large quantities, we will still need to develop a cost-effective and reliable distribution and logistics network, which we may be unable to accomplish. For these and other reasons, we may not be able to commercialize gamma-delta T cells on a large scale or in a cost-effective manner.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">Our business involves the use of hazardous materials and we and our third-party manufacturers and suppliers must comply with environmental, health and safety laws and regulations, which can be expensive and restrict or interrupt our business.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our research and development activities and our third-party manufacturers&#8217; and suppliers&#8217; activities involve the generation, storage, use and disposal of hazardous materials, including the components of our product candidates, such as genetically modified cells, and other hazardous compounds and wastes. We and our manufacturers and suppliers are subject to environmental, health and safety laws and regulations governing, among other matters, the use, manufacture, generation, storage, handling, transportation, discharge and disposal of these hazardous materials and wastes and worker health and safety. In some cases, these hazardous materials and various wastes resulting from their use are stored at our and our manufacturers&#8217; facilities pending their use and disposal. We cannot eliminate the risk of contamination or injury, which could result in an interruption of our commercialization efforts, research and development efforts and business operations, damages and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">31</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">significant cleanup costs and liabilities under applicable environmental, health and safety laws and regulations. We also cannot guarantee that the safety procedures utilized by our third-party manufacturers for handling and disposing of these materials and wastes generally comply with the standards prescribed by these laws and regulations. We may be held liable for any resulting damages costs or liabilities, which could exceed our resources, and state or federal or other applicable authorities may curtail our use of certain materials and/or interrupt our business operations. Furthermore, environmental, health and safety laws and regulations are complex, change frequently and have tended to become more stringent. We cannot predict the impact of such changes and cannot be certain of our future compliance. Failure to comply with these environmental, health and safety laws and regulations may result in substantial fines, penalties or other sanctions. We do not currently carry hazardous waste insurance coverage.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">We intend to partner with third parties, such as academic institutions and CROs, to conduct, supervise and monitor some of our preclinical studies and clinical trials, and if those third parties perform in an unsatisfactory manner, it may harm our business and delay or impair our ability to obtain regulatory approval or otherwise commercialize our product candidates.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Although we are conducting our current Phase&#160;1 clinical trials through our direct contractual agreements with hospitals, we intend to rely on CROs and clinical trial sites to conduct our future preclinical studies and clinical trials, and we expect to have limited influence over their actual performance. We intend to rely upon CROs to monitor and manage data for our clinical programs, as well as the execution of future preclinical studies. We expect to control only certain aspects of the activities of our third-party service providers, including investigators and CROs. Nevertheless, we will be responsible for ensuring that each of our preclinical studies and clinical trials is conducted in accordance with the applicable protocol, legal, regulatory and scientific standards, and our reliance on third parties does not relieve us of our regulatory responsibilities.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We are, and our future CROs will be, required to comply with the good laboratory practices, or GLPs, and GCPs, which are regulations and guidelines enforced by the FDA and comparable foreign regulatory authorities in the form of International Council for Harmonization guidelines for any of our product candidates that are in preclinical and clinical development. The regulatory authorities enforce GCPs through periodic inspections of trial sponsors, principal investigators and clinical trial sites. Although we rely on CROs to conduct GCP-compliant clinical trials, we remain responsible for ensuring that each of our GLP preclinical studies and clinical trials is conducted in accordance with its investigational plan and protocol and applicable laws and regulations. If we or our future CROs fail to comply with GCPs, the clinical data generated in our clinical trials may be deemed unreliable, and the FDA or comparable foreign regulatory authorities may require us to perform additional clinical trials before approving our marketing applications. Accordingly, if CROs fail to comply with these regulations or fail to recruit a sufficient number of subjects, we may be required to repeat clinical trials, which would delay the regulatory approval process.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our reliance on third parties to conduct clinical trials will result in less direct control over the management of data developed through clinical trials than would be the case if we were relying entirely upon our own staff. Communicating with CROs and other third parties can be challenging, potentially leading to mistakes as well as difficulties in coordinating activities. Such parties may:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">have staffing difficulties;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.91pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">fail to comply with contractual obligations;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">experience regulatory compliance issues; or</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">undergo changes in priorities or become financially distressed.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">These factors may adversely affect the willingness or ability of third parties to conduct our clinical trials and may subject us to unexpected cost increases that are beyond our control. If our future CROs, or hospitals where we conduct our clinical trials, do not successfully carry out their contractual duties or obligations with us or regulatory agencies, fail to meet necessary safety measures and protocols, fail to meet expected deadlines, or fail to comply with regulatory and/or IRB requirements, or if the quality or accuracy of the clinical data they obtain is compromised due to the failure to adhere to our clinical protocols or regulatory requirements or for any other reasons, our clinical trials may be extended, delayed or terminated, and we may not be able to obtain regulatory approval for, or successfully </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">32</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">commercialize, any product candidate that we develop. As a result, our financial results and the commercial prospects for any product candidate that we develop would be harmed, our costs could increase, and our ability to generate revenue could be delayed. While we will have agreements governing their activities, our CROs will not be our employees, and we will not control whether or not they devote sufficient time and resources to our future clinical and preclinical programs. These CROs may also have relationships with other commercial entities, including our competitors, for whom they may also be conducting clinical trials, or other drug development activities which could harm our business. We face the risk of potential unauthorized disclosure or misappropriation of our intellectual property by CROs, which may reduce our trade secret protection and allow our potential competitors to access and exploit our proprietary technology.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Additionally, the FDA or other regulatory authorities may disagree with the sufficiency of our right of reference to the preclinical, manufacturing or clinical data generated by investigator-initiated trials or our interpretation of preclinical, manufacturing or clinical data from these investigator-initiated trials. If so, regulatory authorities may require us to obtain and submit additional preclinical, manufacturing or clinical data before we may initiate further clinical trials and/or obtain any regulatory approvals.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">If our relationships with any CROs or hospitals where we conduct our current clinical trials terminate, we may not be able to enter into arrangements with alternative CROs and other third parties or do so on commercially reasonable terms. Switching or adding additional CROs involves substantial cost and requires management time and focus. In addition, there is a natural transition period when a new CRO commences work. As a result, delays occur, which can negatively impact our ability to meet our desired clinical development timelines. While we intend to carefully manage our relationships with our CROs, there can be no assurance that we will not encounter challenges or delays in the future or that these delays or challenges will not have a negative impact on our business, financial condition and prospects.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In addition, principal investigators for our clinical trials may serve as scientific advisors or consultants to us from time to time and receive compensation in connection with such services. Under certain circumstances, we may be required to report some of these relationships to the FDA. The FDA may conclude that a financial relationship between us and a principal investigator has created a conflict of interest or otherwise affected interpretation of the trial. The FDA may therefore question the integrity of the data generated at the applicable clinical trial site and the utility of the clinical trial itself may be jeopardized. This could result in a delay in approval, or rejection, of our marketing applications by the FDA and may ultimately lead to the denial of marketing approval of our product candidates.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Our employees, principal investigators, consultants and commercial partners may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements and insider trading.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We are exposed to the risk of fraud or other misconduct by our employees, collaborators, principal investigators, consultants, commercial partners and outside actors. Misconduct by these parties could include intentional failures to comply with FDA regulations or the regulations applicable in other jurisdictions, provide accurate information to the FDA and other regulatory authorities, comply with healthcare fraud and abuse laws and regulations in the United States and abroad, report financial information or data accurately or disclose unauthorized activities to us. In particular, sales, marketing and business arrangements in the healthcare industry are subject to extensive laws and regulations intended to prevent fraud, misconduct, kickbacks, self-dealing and other abusive practices. These laws and regulations restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs, and other business arrangements. Such misconduct also could involve the improper use of information obtained in the course of clinical trials or interactions with the FDA or other regulatory authorities, which could result in regulatory sanctions and cause serious harm to our reputation. It is not always possible to identify and deter employee misconduct, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from government investigations or other actions or lawsuits stemming from a failure to comply with these laws or regulations. If any such actions are instituted against us and we are not successful in defending ourselves or asserting our rights, those actions could result in significant civil, criminal and administrative penalties, damages, fines, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">33</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">disgorgement, imprisonment, exclusion from participating in government-funded healthcare programs, such as Medicare and Medicaid, additional reporting requirements and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of noncompliance with these laws, contractual damages, reputational harm and the curtailment or restructuring of our operations, any of which could have a negative impact on our business, financial condition, results of operations and prospects.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">Disruptions at the FDA and other government agencies caused by funding shortages or global health concerns could hinder their ability to hire, retain or deploy key leadership and other personnel, or otherwise prevent new or modified products from being advanced, developed, cleared or approved or commercialized in a timely manner or at all, which could negatively impact our business.</div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The ability of the FDA to review and approve new products or regulatory submissions can be affected by a variety of factors, including government budget and funding levels, statutory, regulatory, and policy changes, the FDA&#8217;s ability to hire and retain key personnel and accept the payment of user fees, and other events, such as the ongoing COVID-19 pandemic, that may otherwise affect the FDA&#8217;s ability to perform routine functions. Average review times at the agency have fluctuated in recent years as a result. In addition, government funding of other government agencies that fund research and development activities is subject to the political process, which is inherently fluid and unpredictable. Disruptions at the FDA and other agencies may also slow the time necessary for new biologics or modifications to cleared or approved biologics to be reviewed and/or approved by necessary government agencies, which would adversely affect our business. For example, over the last several years, including for 35 days beginning on December 22, 2018, the U.S. government has shut down several times and certain regulatory agencies, such as the FDA, have had to furlough critical FDA employees and stop critical activities.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Separately, in response to the ongoing COVID-19 pandemic, in March 2020, the FDA announced its intention to postpone most inspections of foreign manufacturing facilities, and on March 18, 2020, the FDA temporarily postponed routine surveillance inspections of domestic manufacturing facilities. Subsequently, on July 10, 2020 the FDA announced its intention to resume certain on-site inspections of domestic manufacturing facilities subject to a risk-based prioritization system. The FDA intends to use this risk-based assessment system to identify the categories of regulatory activity that can occur within a given geographic area, ranging from mission critical inspections to resumption of all regulatory activities. Additionally, on April&#160;15, 2021, the FDA issued a guidance document in which the FDA described its plans to conduct voluntary remote interactive evaluations of certain drug manufacturing facilities and clinical research sites. According to the guidance, the FDA intends to request such remote interactive evaluations in situations where an in-person inspection would not be prioritized, deemed mission-critical, or where direct inspection is otherwise limited by travel restrictions, but where the FDA determines that remote evaluation would still be appropriate. Regulatory authorities outside the United States may adopt similar restrictions or other policy measures in response to the ongoing COVID-19 pandemic. If a prolonged government shutdown occurs, or if global health concerns continue to prevent the FDA or other regulatory authorities from conducting their regular inspections, reviews, or other regulatory activities, it could significantly impact the ability of the FDA or other regulatory authorities to timely review and process our regulatory submissions, which could have a material adverse effect on our business.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Risks Related to Our Intellectual Property</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Licensing of intellectual property is of critical importance to our business and involves complex legal, business and scientific issues. If we breach our license agreements with the University of Alabama at Birmingham Research Foundation, Children&#8217;s Healthcare of Atlanta, Inc. and Emory University, or any of the other agreements under which we acquired, or will acquire, the intellectual property rights to our product candidates, we could lose the ability to continue the development and commercialization of the related product.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The licensing of intellectual property is of critical importance to our business and to our current and future product candidates, and we expect to enter into additional such agreements in the future. In particular, our current product candidates INB-200 and INB-100 are dependent on our license </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">34</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">agreements with the The UAB Research Foundation, or UABRF, Children&#39;s Healthcare of Atlanta, Inc., or CHOA, and Emory University, or Emory, together with UABRF and CHOA, the &quot;Licensors.&quot; pursuant to which we have obtained exclusive worldwide licenses under certain immunotherapy related patents and know-how that are critically important for these product candidates.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Although we have been granted exclusive licenses under the UABRF, CHOA and Emory license agreements, we do not have the right to control the preparation, filing, prosecution and maintenance of patents and patent applications covering the technology that we license from UABRF and Emory. Therefore, we cannot always be certain that these patents and patent applications will be prepared, filed, prosecuted and maintained in a manner consistent with the best interests of our business. Although we have a right to have our comments considered in connection with the prosecution process, if the Licensors fail to prosecute and maintain such patents, or loses rights to those patents or patent applications as a result of its control of the prosecution activities, the rights we have licensed may be reduced or eliminated, and our right to develop and commercialize any of our product candidates that are the subject of such licensed rights could be adversely affected.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">If we fail to meet our obligations under the UABRF, CHOA or Emory license agreements in any material respect, and fail to cure such breach in a timely fashion, then the Licensors may terminate their applicable license agreement. If the license agreements are terminated, and we lose our intellectual property rights thereunder, this may result in a complete termination of our product development and any commercialization efforts for INB-200 and INB-100. While we would expect to exercise all rights and remedies available to us, including seeking to cure any breach by us, and otherwise seek to preserve our rights under the license agreements, we may not be able to do so in a timely manner, at an acceptable cost or at all. For more information on the UABRF, CHOA and Emory license agreements, see the section titled &#8220;Business&#8212;License Agreements.&#8221;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Furthermore, license agreements we enter into in the future may not provide exclusive rights to use intellectual property and technology in all relevant fields of use and in all territories in which we may wish to develop or commercialize our technology and products. As a result, we may not be able to prevent competitors from developing and commercializing competitive products in territories included in all of our licenses.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In addition, the research resulting in certain of our in-licensed patent rights may have been funded in part by the U.S. federal or state governments. As a result, the government may have certain rights, including march-in rights, to such patent rights. When new technologies are developed with government funding, the government generally obtains certain rights in any resulting patents, including a non-exclusive license authorizing the government to use the invention for noncommercial purposes. These rights may permit the government to disclose our confidential information to third parties or allow third parties to use our licensed technology. The government can exercise its march-in rights if it determines that action is necessary because we fail to achieve practical application of the government-funded technology, because action is necessary to alleviate health or safety needs, to meet requirements of federal regulations, or to give preference to U.S. industry. In addition, our rights in such inventions may be subject to certain requirements to manufacture products embodying such inventions in the United States. Any of the foregoing could harm our competitive position, business, financial condition, results of operations and prospects.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">If we are unable to obtain and maintain patent protection for our product candidates and technology, or if the scope of the patent protection obtained is not sufficiently broad or robust, our competitors could develop and commercialize products and technology similar or identical to ours, and our ability to successfully commercialize our product candidates and technology may be adversely affected.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our success depends, in large part, on our ability to obtain and maintain patent protection in the United States and other countries with respect to our product candidates and our technology. We and our licensors have sought, and intend to seek, to protect our proprietary position by filing patent applications in the United States and abroad related to our product candidates and our technology that are important to our business. As of June&#160;30, 2021, we owned, co-owned or exclusively licensed two issued U.S. patents, two issued European patents, one allowed patent application in Europe, one allowed patent application in Australia, one allowed patent application in Israel, eight pending U.S. applications, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">35</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">one pending PCT application and 47 other foreign national-stage applications, including four European regional-phase applications that are important to the development of our business. For more information relating to our patent portfolio, see the section titled &#8220;Business&#8212;Intellectual Property.&#8221;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The patent position of biotechnology and pharmaceutical companies generally is highly uncertain, involves complex legal and factual questions and has, in recent&#160;years, been the subject of much litigation. As a result, the issuance, scope, validity, enforceability and commercial value of our patent rights are highly uncertain. Our pending and future patent applications may not result in patents being issued which protect our technology or product candidates or which effectively prevent others from commercializing competitive technologies and product candidates. Since patent applications in the United States and most other countries are confidential for a period of time after filing, and some remain so until issued, we cannot be certain that we or our licensors were the first to file a patent application relating to any particular aspect of a product candidate. Furthermore, if third parties have filed such patent applications, an interference proceeding in the United States can be initiated by such third party, or by the U.S. Patent and Trademark Office, or USPTO, itself, to determine who was the first to invent any of the subject matter covered by the patent claims of our applications. As a result of these and other factors, the issuance, scope, validity, enforceability, and commercial value of our patent rights are highly uncertain. Our pending and future patent applications may not result in patents being issued which protect our technology or products, in whole or in part, or which effectively prevent others from commercializing competitive technologies and products. Changes in either the patent laws or interpretation of the patent laws in the United States and other countries may diminish the value of our patents or narrow the scope of our patent protection.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Moreover, we may be subject to a third-party pre-issuance submission of prior art or become involved in opposition, derivation, reexamination, </font><font style="font-style:italic;">inter partes</font><font style="letter-spacing:-0.025pt;"> review, post-grant review or interference proceedings challenging our patent rights or the patent rights of others. The costs of defending our patents or enforcing our proprietary rights in post-issuance administrative proceedings and litigation can be substantial and the outcome can be uncertain. An adverse determination in any such submission, proceeding or litigation could reduce the scope of, or invalidate, our patent rights, allow third parties to commercialize our technology or products and compete directly with us, without payment to us, or result in our inability to manufacture or commercialize products without infringing third-party patent rights. In addition, if the breadth or strength of protection provided by our patents and patent applications is threatened, it could dissuade companies from collaborating with us to license, develop or commercialize current or future product candidates.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The patent prosecution process is expensive, time-consuming and complex, and we may not be able to file, prosecute, maintain, enforce or license all necessary or desirable patent applications at a reasonable cost or in a timely manner. It is also possible that we will fail to identify patentable aspects of our research and development output before it is too late to obtain patent protection.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We or our licensors have not pursued or maintained, and may not pursue or maintain in the future, patent protection for our product candidates in every country or territory in which we may sell our products, if approved. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the United States. Consequently, we may not be able to prevent third parties from infringing our patents in all countries outside the United States, or from selling or importing products that infringe our patents in and into the United States or other jurisdictions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Moreover, the coverage claimed in a patent application can be significantly reduced before the patent is issued, and its scope can be reinterpreted after issuance. Even if the patent applications we license or own do issue as patents, they may not issue in a form that will provide us with any meaningful protection, prevent competitors or other third parties from competing with us or otherwise provide us with any competitive advantage. Our competitors or other third parties may be able to circumvent our patents by developing similar or alternative products in a non-infringing manner.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and our patents may be challenged in the courts or patent offices in the United States and abroad. Such challenges may result in loss of exclusivity or in patent claims being narrowed, invalidated or held unenforceable, which could limit our ability to stop others from using or commercializing similar or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">36</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">identical technology and products, or limit the duration of the patent protection of our technology and product candidates. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result, our intellectual property may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Furthermore, our owned and in-licensed patents may be subject to a reservation of rights by one or more third parties. For example, the research resulting in certain of our owned and in-licensed patent rights and technology was funded in part by the U.S. government. As a result, the government may have certain rights, or march-in rights, to such patent rights and technology. When new technologies are developed with government funding, the government generally obtains certain rights in any resulting patents, including a nonexclusive license authorizing the government to use the invention for noncommercial purposes. These rights may permit the government to disclose our confidential information to third parties and to exercise march-in rights to use or allow third parties to use our licensed technology. The government can exercise its march-in rights if it determines that action is necessary because we fail to achieve practical application of the government-funded technology, because action is necessary to alleviate health or safety needs, to meet requirements of federal regulations, or to give preference to U.S. industry. In addition, our rights in such inventions may be subject to certain requirements to manufacture products embodying such inventions in the United States. Any exercise by the government of such rights could harm our competitive position, business, financial condition, results of operations and prospects.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">Obtaining and maintaining our patent rights depends on compliance with various procedural, document submission, fee payment and other requirements imposed by government patent agencies, and our patent protection could be reduced or eliminated for noncompliance with these requirements.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process. In addition, periodic maintenance fees, renewal fees, annuity fees and various other government fees on patents and/or patent applications will have to be paid to the USPTO and various government patent agencies outside the United States over the lifetime of our owned and licensed patents and/or applications and any patent rights we may own or license in the future. We rely on our service providers or our licensors to pay these fees. The USPTO and various non-U.S. government patent agencies require compliance with several procedural, documentary, fee payment and other similar provisions during the patent application process. We employ reputable law firms and other professionals to help us comply, and we are also dependent on our licensors to take the necessary action to comply with these requirements with respect to our licensed intellectual property. Noncompliance events that could result in abandonment or lapse of a patent or patent application include, but are not limited to, failure to respond to official actions within prescribed time limits, nonpayment of fees and failure to properly legalize and submit formal documents. If we, our service providers or our licensors fail to maintain the patents and patent applications covering our products or technologies, we may not be able to stop a competitor from marketing products that are the same as or similar to our product candidates, which would have an adverse effect on our business. In many cases, an inadvertent lapse can be cured by payment of a late fee or by other means in accordance with the applicable rules. There are situations, however, in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. In such an event, potential competitors might be able to enter the market and this circumstance could harm our business.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In addition, if we fail to apply for or otherwise fail to obtain applicable patent term extensions or adjustments, we will have a more limited time during which we can enforce our granted patent rights. In addition, if we are responsible for patent prosecution and maintenance of patent rights in-licensed to us, any of the foregoing could expose us to liability to the applicable patent owner.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">Patent terms may be inadequate to protect our competitive position on our product candidates for an adequate amount of time.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Given the amount of time required for the development, testing and regulatory review of product candidates such as INB-200 and INB-100, patents protecting such candidates might expire before or shortly after such candidates are commercialized. We expect to seek extensions of patent terms in the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">37</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">United States and, if available, in other countries where we have or will obtain patent rights. In the United States, the Drug Price Competition and Patent Term Restoration Act of 1984 permits a patent term extension of up to five&#160;years beyond the normal expiration of the patent. However, the extension cannot extend the total patent term beyond 14&#160;years from the date of drug approval, which is limited to the approved indication (or any additional indications approved during the period of extension). Furthermore, only one patent per approved product can be extended and only those claims covering the approved product, a method for using it or a method for manufacturing it may be extended. However, the applicable authorities, including the FDA and the USPTO in the United States, and any equivalent regulatory authority in other countries, may not agree with our assessment of whether such extensions are available, and may refuse to grant extensions to our patents, or may grant more limited extensions than we request. If this occurs, the period during which we can enforce our patent rights for the applicable product candidate will be shortened and our competitors may obtain approval to market competing products sooner. Additionally, our competitors may be able to take advantage of our investment in development and clinical trials by referencing our clinical and preclinical data and launch their product earlier than might otherwise be the case.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Third parties may initiate legal proceedings alleging that we are infringing, misappropriating or otherwise violating their intellectual property rights and/or trademark, the outcome of which would be uncertain and could have a negative impact on the success of our business.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Our commercial success depends, in part, upon our ability and the ability of others with whom we may collaborate to develop, manufacture, market and sell our current and any future product candidates and use our proprietary technologies without infringing, misappropriating or otherwise violating the intellectual property, trademarks and other proprietary rights of third parties. The biotechnology and pharmaceutical industries are characterized by extensive and complex litigation regarding patents and other intellectual property rights. We may in the future become party to, or be threatened with, adversarial proceedings or litigation regarding intellectual property rights with respect to our current and any future product candidates and technology, names, including interference proceedings, post grant review and inter partes review before the USPTO. Third parties may assert infringement claims against us based on existing patents or patents that may be granted in the future, regardless of their merit. There is a risk that third parties may choose to engage in litigation with us to enforce or to otherwise assert their patent rights against us. Even if we believe such claims are without merit, a court of competent jurisdiction could hold that these third-party patents are valid, enforceable and infringed, which could have a negative impact on our ability to commercialize our current and any future product candidates. In order to successfully challenge the validity of any such U.S. patent in federal court, we would need to overcome a presumption of validity. As this is a high burden and requires us to present clear and convincing evidence as to the invalidity of any such U.S. patent claim, there is no assurance that a court of competent jurisdiction would invalidate the claims of any such U.S. patent. Moreover, given the vast number of patents in our field of technology, we cannot be certain that we do not infringe existing patents or that we will not infringe patents that may be granted in the future. Other companies and research institutions have filed, and may file in the future, patent applications related to gamma-delta T cell immunotherapy. Some of these patent applications have already been allowed or issued, and others may issue in the future. While we may decide to initiate proceedings to challenge the validity of these or other patents in the future, we may be unsuccessful, and courts or patent offices in the United States and abroad could uphold the validity of any such patent. Furthermore, because patent applications can take many&#160;years to issue and may be confidential for 18&#160;months or more after filing, and because pending patent claims can be revised before issuance, there may be applications now pending which may later result in issued patents that may be infringed by the manufacture, use or sale of our product candidates. Regardless of when filed, we may fail to identify relevant third-party patents or patent applications, or we may incorrectly conclude that a third-party patent is invalid or not infringed by our product candidates or activities. If a patent holder believes that our product candidate infringes its patent, the patent holder may sue us even if we have received patent protection for our technology. Moreover, we may face patent infringement claims from nonpracticing entities that have no relevant drug revenue and against whom our own patent portfolio may thus have no deterrent effect. If a patent infringement suit were threatened or brought against us, we could be forced to stop or delay research, development, manufacturing or sales of the drug or product candidate that is the subject of the actual or threatened suit.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">38</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">If we are found to infringe a third party&#8217;s valid and enforceable intellectual property rights, we could be required to obtain a license from such third party to continue developing, manufacturing and marketing our product candidate(s) and technology. Under any such license, we would most likely be required to pay various types of fees, milestones, royalties or other amounts. Moreover, we may not be able to obtain any required license on commercially reasonable terms or at all.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The licensing or acquisition of third-party intellectual property rights is a competitive area, and more established companies may also pursue strategies to license or acquire third-party intellectual property rights that we may consider attractive or necessary. These established companies may have a competitive advantage over us due to their size, capital resources and greater clinical development and commercialization capabilities. In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us. We also may be unable to license or acquire third-party intellectual property rights on terms that would allow us to make an appropriate return on our investment or at all. If we are unable to successfully obtain rights to required third-party intellectual property rights or maintain the existing intellectual property rights we have, we may have to abandon development of the relevant program or product candidate, which could have an adverse effect on our business, financial condition, results of operations and prospects. Furthermore, even if we were able to obtain a license, it could be nonexclusive, thereby giving our competitors and other third parties access to the same technologies licensed to us, and it could require us to make substantial licensing and royalty payments. We could be forced, including by court order, to cease developing, manufacturing and commercializing the infringing technology or product candidate. In addition, we could be found liable for monetary damages, including treble damages and attorneys&#8217; fees, if we are found to have willfully infringed a patent or other intellectual property right. We may be required to indemnify collaborators or contractors against such claims. A finding of infringement could prevent us from manufacturing and commercializing our current or any future product candidates or force us to cease some or all of our business operations, which could harm our business. Even if we are successful in defending against such claims, litigation can be expensive and time-consuming and would divert management&#8217;s attention from our core business. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. There could also be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have an adverse effect on the price of our common stock.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Claims that we have misappropriated the confidential information or trade secrets of third parties could have a similar negative impact on our business, financial condition, results of operations and prospects.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">We may be subject to claims asserting that our employees, consultants or advisors have wrongfully used or disclosed alleged trade secrets of their current or former employers or claims asserting ownership of what we regard as our own intellectual property.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Certain of our employees, consultants or advisors are currently, or were previously, employed at universities or other biotechnology or pharmaceutical companies, including our competitors or potential competitors. Although we try to ensure that our employees, consultants and advisors do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that these individuals or we have used or disclosed intellectual property, including trade secrets or other proprietary information, of any such individual&#8217;s current or former employer. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In addition, we may in the future be subject to claims by our former employees or consultants asserting an ownership right in our patents or patent applications, as a result of the work they performed on our behalf. Although it is our policy to require our employees and contractors who may be involved in the conception or development of intellectual property to execute agreements assigning such intellectual property to us, we may be unsuccessful in executing such an agreement with each party </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">39</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">who, in fact, conceives or develops intellectual property that we regard as our own, and we cannot be certain that our agreements with such parties will be upheld in the face of a potential challenge or that they will not be breached, for which we may not have an adequate remedy. The assignment of intellectual property rights may not be self-executing or the assignment agreements may be breached, and we may be forced to bring claims against third parties, or defend claims that they may bring against us, to determine the ownership of what we regard as our intellectual property.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">We may be involved in lawsuits to protect or enforce our patents, the patents of our licensors or our other intellectual property rights, which could be expensive, time-consuming and unsuccessful.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Competitors may infringe, misappropriate or otherwise violate our patents, the patents of our licensors or our other intellectual property rights. To counter infringement or unauthorized use, we may be required to file legal claims, which can be expensive and time-consuming and are likely to divert significant resources from our core business, including distracting our technical and management personnel from their normal responsibilities. In addition, in an infringement proceeding, a court may decide that a patent of ours or our licensors is not valid or is unenforceable, or may refuse to stop the other party from using the technology at issue on the grounds that our patents do not cover the technology in question. An adverse result in any litigation or defense proceedings could put one or more of our owned or licensed patents at risk of being invalidated or interpreted narrowly and could put our owned or licensed patent applications at risk of not issuing. The initiation of a claim against a third party might also cause the third party to bring counterclaims against us, such as claims asserting that our patent rights are invalid or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity or unenforceability are commonplace. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including lack of novelty, obviousness, non-enablement or lack of statutory subject matter. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant material information from the USPTO, or made a materially misleading statement, during prosecution. Third parties may also raise similar validity claims before the USPTO in post-grant proceedings such as ex parte reexaminations, inter partes review, post-grant review, or oppositions or similar proceedings outside the United States, in parallel with litigation or even outside the context of litigation. The outcome following legal assertions of invalidity and unenforceability is unpredictable. We cannot be certain that there is or will be no invalidating prior art, of which we and the patent examiner were unaware during prosecution. For the patents and patent applications that we have licensed, we may have limited or no right to participate in the defense of any licensed patents against challenge by a third party. If a defendant were to prevail on a legal assertion of invalidity or unenforceability, we would lose at least part, and perhaps all, of any future patent protection on our current or future product candidates. Such a loss of patent protection could harm our business.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We may not be able to prevent, alone or with our licensors, misappropriation of our intellectual property rights, particularly in countries where the laws may not protect those rights as fully as in the United States. Our business could be harmed if in litigation the prevailing party does not offer us a license, or if the license offered as a result is not on commercially reasonable terms. Any litigation or other proceedings to enforce our intellectual property rights may fail, and even if successful, may result in substantial costs and distract our management and other employees.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. There could also be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have an adverse effect on the price of our common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We may not have sufficient financial or other resources to adequately conduct such litigation or proceedings. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial resources and more mature and developed intellectual property portfolios. Accordingly, despite our efforts, we may not be able to prevent third parties from infringing upon or misappropriating or from successfully challenging our intellectual property rights. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could have an adverse effect on our ability to compete in the marketplace.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">40</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">Changes in U.S. patent law or the patent law of other countries or jurisdictions could diminish the value of patents in general, thereby impairing our ability to protect our current and any future product candidates.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Changes in either the patent laws or interpretation of the patent laws in the United States could increase the uncertainties and costs surrounding the prosecution of patent applications and the enforcement or defense of issued patents. Assuming that other requirements for patentability are met, prior to March&#160;2013, in the United States, the first to invent the claimed invention was entitled to the patent, while outside the United States, the first to file a patent application was entitled to the patent. After March&#160;2013, under the Leahy-Smith America Invents Act, or the America Invents Act, the United States transitioned to a first inventor to file system in which, assuming that other requirements for patentability are met, the first inventor to file a patent application will be entitled to the patent on an invention regardless of whether a third party was the first to invent the claimed invention. The America Invents Act also includes a number of significant changes that affect the way patent applications are prosecuted and also may affect patent litigation. These include allowing third-party submission of prior art to the USPTO during patent prosecution and additional procedures to attack the validity of a patent by USPTO-administered post-grant proceedings, including post-grant review, </font><font style="font-style:italic;">inter partes</font><font style="letter-spacing:-0.025pt;"> review, and derivation proceedings. The America Invents Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have an adverse effect on our business, financial condition, results of operations, and prospects.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In addition, the U.S. Supreme Court has ruled on several patent cases in recent&#160;years, either narrowing the scope of patent protection available in certain circumstances or weakening the rights of patent owners in certain situations. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents, once obtained. Depending on actions by the U.S. Congress, the federal courts, and the USPTO, the laws and regulations governing patents could change in unpredictable ways that could weaken our ability to obtain new patents or to enforce patents that we own, have licensed or might obtain in the future. Similarly, changes in patent law and regulations in other countries or jurisdictions, changes in the governmental bodies that enforce them or changes in how the relevant governmental authority enforces patent laws or regulations may weaken our ability to obtain new patents or to enforce patents that we own or have licensed or that we may obtain in the future.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">We may not be able to protect our intellectual property rights throughout the world, which could negatively impact our business.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Filing, prosecuting and defending patents covering our current and any future product candidates in all countries throughout the world would be prohibitively expensive. Competitors may use our technologies in jurisdictions where we or our licensors have not obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories where we may obtain patent protection but where patent enforcement is not as strong as that in the United States. These products may compete with our products in jurisdictions where we do not have any issued or licensed patents, and any future patent claims or other intellectual property rights may not be effective or sufficient to prevent them from so competing.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets and other intellectual property protection, particularly those relating to biotechnology products, which could make it difficult for us to stop the infringement of our patents or marketing of competing products in violation of our intellectual property and proprietary rights generally. Proceedings to enforce our intellectual property and proprietary rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly, could put our patent applications at risk of not issuing, and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property and proprietary rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">41</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Many countries have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. In addition, many countries limit the enforceability of patents against government agencies or government contractors. In these countries, the patent owner may have limited remedies, which could materially diminish the value of such patent. If we or any of our licensors is forced to grant a license to third parties with respect to any patents relevant to our business, our competitive position may be impaired, and our business, financial condition, results of operations and prospects may be adversely affected.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">Reliance on third parties requires us to share our trade secrets, which increases the possibility that a competitor will discover them or that our trade secrets will be misappropriated or disclosed.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Since we rely on third parties to help us discover, develop and manufacture our current and any future product candidates, or if we collaborate with third parties for the development, manufacturing or commercialization of our current or any future product candidates, we must, at times, share trade secrets with them. We may also conduct joint research and development programs that may require us to share trade secrets under the terms of our research and development partnerships or similar agreements. We seek to protect our proprietary technology in part by entering into confidentiality agreements and, if applicable, material transfer agreements, consulting agreements or other similar agreements with our advisors, employees, third-party contractors and consultants prior to beginning research or disclosing proprietary information. These agreements typically limit the rights of the third parties to use or disclose our confidential information, including our trade secrets. Despite the contractual provisions employed when working with third parties, the need to share trade secrets and other confidential information increases the risk that such trade secrets become known by our competitors, are inadvertently incorporated into the technology of others, or are disclosed or used in violation of these agreements. Given that our proprietary position is based, in part, on our know-how and trade secrets, a competitor&#8217;s discovery of our trade secrets or other unauthorized use or disclosure could have an adverse effect on our business and results of operations. In addition, from time to time we may hire scientists or other employees or consultants who originate from jurisdictions, including China, that have a history of engaging in misappropriation or theft of trade secrets or other acts of trade secret espionage; if any such individuals are found to be engaging in such illegal behavior, it could have a material adverse effect on our ability to protect our intellectual property and our business prospects more generally.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In addition, these agreements typically restrict the ability of our advisors, employees, third-party contractors and consultants to publish data potentially relating to our trade secrets. Despite our efforts to protect our trade secrets, we may not be able to prevent the unauthorized disclosure or use of our technical know-how or other trade secrets by the parties to these agreements. Moreover, we cannot guarantee that we have entered into such agreements with each party that may have or have had access to our confidential information or proprietary technology and processes. Monitoring unauthorized uses and disclosures is difficult, and we do not know whether the steps we have taken to protect our proprietary technologies will be effective. If any of the collaborators, scientific advisors, employees, contractors and consultants who are parties to these agreements breaches or violates the terms of any of these agreements, we may not have adequate remedies for any such breach or violation, and we could lose our trade secrets as a result. Moreover, if confidential information that is licensed or disclosed to us by our partners, collaborators, or others is inadvertently disclosed or subject to a breach or violation, we may be exposed to liability to the owner of that confidential information. Enforcing a claim that a third-party illegally or unlawfully obtained and is using our trade secrets, like patent litigation, is expensive and time-consuming, and the outcome is unpredictable. In addition, courts outside the United States are sometimes less willing to protect trade secrets.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In addition to seeking patent and trademark protection for our product candidates, we also rely on trade secrets, including unpatented know-how, technology and other proprietary information, to maintain our competitive position. We seek to protect our trade secrets, in part, by entering into nondisclosure and confidentiality agreements with parties who have access to them, such as our employees, corporate collaborators, outside scientific collaborators, contract manufacturers, consultants, advisors and other third parties. We also enter into confidentiality and invention or patent assignment agreements with our </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">42</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">employees, advisors and consultants. Despite these efforts, any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets. Further, we cannot guarantee that we have entered into such agreements with each party that may have or has had access to our trade secrets or other proprietary information. Monitoring unauthorized uses and disclosures of our intellectual property is difficult, and we do not know whether the steps we have taken to protect our intellectual property will be effective. In addition, we may not be able to obtain adequate remedies for any such breaches. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, some courts inside and outside the United States are less willing or unwilling to protect trade secrets.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Moreover, our competitors may independently develop knowledge, methods and know-how equivalent to our trade secrets. Competitors could purchase our products and replicate some or all of the competitive advantages we derive from our development efforts for technologies on which we do not have patent protection. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor, we would have no right to prevent them, or those to whom they communicate it, from using that technology or information to compete with us. If any of our trade secrets were to be disclosed to or independently developed by a competitor, our competitive position would be harmed.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We also seek to preserve the integrity and confidentiality of our data and other confidential information by maintaining physical security of our premises and physical and electronic security of our information technology systems. While we have confidence in these individuals, organizations and systems, agreements or security measures may be breached, and detecting the disclosure or misappropriation of confidential information and enforcing a claim that a party illegally disclosed or misappropriated confidential information is difficult, expensive and time-consuming, and the outcome is unpredictable. Further, we may not be able to obtain adequate remedies for any breach. In addition, our confidential information may otherwise become known or be independently discovered by competitors, in which case we would have no right to prevent them, or those to whom they communicate it, from using that technology or information to compete with us.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">Any trademarks we may obtain may be infringed or successfully challenged, resulting in harm to our business.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We expect to rely on trademarks as one means to distinguish any of our product candidates that are approved for marketing from the products of our competitors. We have not yet selected trademarks for our product candidates and have not yet begun the process of applying to register trademarks for our current or any future product candidates. Once we select trademarks and apply to register them, our trademark applications may not be approved. Third parties may oppose our trademark applications or otherwise challenge our use of the trademarks. In the event that our trademarks are successfully challenged, we could be forced to rebrand our products, which could result in loss of brand recognition and could require us to devote resources to advertising and marketing new brands. Our competitors may infringe our trademarks, and we may not have adequate resources to enforce our trademarks.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In addition, any proprietary name we propose to use with our current or any other product candidate in the United States must be approved by the FDA, regardless of whether we have registered it, or applied to register it, as a trademark. The FDA typically conducts a review of proposed product names, including an evaluation of the potential for confusion with other product names. If the FDA objects to any of our proposed proprietary product names, we may be required to expend significant additional resources in an effort to identify a suitable proprietary product name that would qualify under applicable trademark laws, not infringe the existing rights of third parties and be acceptable to the FDA.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Intellectual property rights do not necessarily address all potential threats to our business.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations and may not adequately protect our business. The following examples are illustrative:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">others may be able to make compounds or formulations that are similar to our product candidates but that are not covered by the claims of any patents, should they issue, that we own or license;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">we or our licensors might not have been the first to make the inventions covered by the issued patents or pending patent applications that we own or license;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">43</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">we or our licensors might not have been the first to file patent applications covering certain of our inventions;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing our intellectual property rights;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">it is possible that our pending patent applications will not lead to issued patents;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">issued patents that we own or license may not provide us with any competitive advantages, or may be held invalid or unenforceable as a result of legal challenges;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our competitors might conduct research and development activities in the United States and other countries that provide a safe harbor from patent infringement claims for certain research and development activities, as well as in countries where we do not have patent rights, and then use the information learned from such activities to develop competitive drugs for sale in our major commercial markets;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">we may not develop additional proprietary technologies that are patentable; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the patents of others may have an adverse effect on our business.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Risks Related to Our Business Operations, Employee Matters and Managing Growth</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">We are highly dependent on the services of our co-founders, William Ho, our President and Chief Executive Officer, and Dr.&#160;Lawrence Lamb, our Chief Scientific Officer, and if we are not able to retain these members of our management team or recruit and retain additional management, clinical and scientific personnel, our business will be harmed.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We are highly dependent on our co-founders, President and Chief Executive Officer, William Ho, and our Chief Scientific Officer, Dr.&#160;Lawrence Lamb. Each of them may currently terminate their employment with us at any time and will continue to be able to do so after the completion of this offering. The loss of the services of either of these persons could impede the achievement of our research, development and commercialization objectives.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Recruiting and retaining other senior executives, qualified scientific and clinical personnel and, if we progress the development of any of our product candidates, commercialization, manufacturing and sales and marketing personnel, will be critical to our success. The loss of the services of our executive officers or other key employees could impede the achievement of our research, development and commercialization objectives and seriously harm our ability to successfully implement our business strategy. Furthermore, replacing executive officers and key employees may be difficult and may take an extended period of time because of the limited number of individuals in our industry with the breadth of skills and experience required to successfully lead, develop, gain regulatory approval of and commercialize our product candidates. Competition to hire from this limited pool is intense, and we may be unable to hire, train, retain or motivate these key personnel on acceptable terms given the competition among numerous pharmaceutical and biotechnology companies for similar personnel. We also experience competition for the hiring of scientific and clinical personnel from universities and research institutions. In addition, we rely on consultants and advisors, including scientific and clinical advisors, to assist us in formulating our research and development and commercialization strategy. Our consultants and advisors may have commitments under consulting or advisory contracts with other entities that may limit their availability to us. If we are unable to continue to attract and retain high-quality personnel, our ability to pursue our growth strategy will be limited.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our future performance will also depend, in part, on our ability to successfully integrate newly hired executive officers into our management team and our ability to develop an effective working relationship among senior management. Our failure to integrate these individuals and create effective working relationships among them and other members of management could result in inefficiencies in the development and commercialization of our product candidates, harming future regulatory approvals, sales of our product candidates and our results of operations. Additionally, we currently only maintain &#8220;key person&#8221; life insurance for our President and Chief Executive Officer.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">We plan to expand our organization, and we may experience difficulties in managing this growth, which could disrupt our operations.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">As of June&#160;30, 2021, we had 13 full-time employees. As the clinical development of our product candidates progresses, we also expect to experience significant growth in the number of our employees </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">44</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">and the scope of our operations, particularly in the areas of research, drug development, regulatory affairs and, if any of our product candidates receives marketing approval, sales, marketing and distribution. To manage our anticipated future growth, we must continue to implement and improve our managerial, operational and financial systems, expand our facilities, and continue to recruit and train additional qualified personnel. Due to our limited financial resources and the limited experience of our management team in managing a company with such anticipated growth, we may not be able to effectively manage the expansion of our operations or recruit and train additional qualified personnel. The expansion of our operations may lead to significant costs and may divert our management and business development resources. Any inability to manage growth could delay the execution of our business plans or disrupt our operations.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">We may explore strategic collaborations that may never materialize or we may be required to relinquish important rights to and control over the development and commercialization of our product candidates to any future collaborators.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our business strategy includes broadening our DeltEx platform by exploring strategic partnerships that maximize the potential of our gamma-delta T cell programs. As a result, we intend to periodically explore a variety of possible strategic partnerships in an effort to gain access to additional product candidates or resources. These strategic partnerships may include partnerships with large strategic partners. At the current time however, we cannot predict what form such a strategic collaboration might take. We are likely to face significant competition in seeking appropriate strategic collaborators, and strategic collaborations can be complicated and time consuming to negotiate and document. We may not be able to negotiate strategic collaborations on acceptable terms, if at all. If and when we collaborate with a third party for development and commercialization of a product candidate, we can expect to relinquish some or all of the control over the future success of that product candidate to the third party. We are unable to predict when, if ever, we will enter into any strategic partnerships because of the numerous risks and uncertainties associated with establishing them, including:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.91pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">expenditure of substantial operational, financial and management resources;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">dilutive issuances of our securities;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">substantial actual or contingent liabilities; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">termination or expiration of the arrangement, which would delay the development and may increase the cost of developing our product candidates.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Strategic partners may also delay clinical trials, experience financial difficulties, provide insufficient funding, terminate a clinical trial or abandon a product candidate, which could negatively impact our development efforts. Additionally, strategic partners may not properly maintain, enforce or defend our intellectual property rights or may use our proprietary information in a manner that could jeopardize or invalidate our proprietary information or expose us to potential litigation, any of which could adversely affect our business, financial position and operations.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">Our internal computer systems, or those of our collaborators or other contractors or consultants, may fail or suffer security breaches, which could result in a significant disruption of our product development programs and our ability to operate our business effectively, and adversely affect our business and operating results.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We are increasingly dependent upon information technology systems, infrastructure and data to operate our business. In the ordinary course of business, we collect, store and transmit confidential information (including but not limited to intellectual property, proprietary business information and personal information). It is critical that we do so in a secure manner to maintain the confidentiality and integrity of such confidential information. We also have outsourced elements of our operations to third parties, and as a result we manage a number of third-party vendors and other contractors and consultants who have access to our confidential information.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our internal computer systems, cloud-based computing services and those of our current and any future collaborators and other contractors or consultants are vulnerable to damage or interruption from a variety of sources, including computer viruses, data corruption, cyber-based attacks, intentional or accidental actions or inactions by our employees or others with access to our network, unauthorized access, cyberattacks by malicious third parties, supply chain attacks, and other means to affect service reliability and threaten the confidentiality, integrity, and availability of information, natural disasters, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">45</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">terrorism, war and telecommunication and electrical failures. Attacks upon information technology systems are increasing in their frequency, levels of persistence, sophistication and intensity, and are being conducted by sophisticated and organized groups and individuals with a wide range of motives and expertise. As a result of the COVID-19 pandemic, we may also face increased cybersecurity risks due to our reliance on internet technology and the number of our employees who are working remotely, which may create additional opportunities for cybercriminals to exploit vulnerabilities. Furthermore, because the techniques used to obtain unauthorized access to, or to sabotage, systems change frequently and often are not recognized until launched against a target, we may be unable to anticipate these techniques or implement adequate preventative measures. We may also experience security breaches that may remain undetected for an extended period. If such an event were to occur and cause interruptions in our operations, it could result in a disruption of our development programs and our business operations, whether due to a loss of our trade secrets or other proprietary information or other similar disruptions. For example, the loss of clinical trial data from completed or future clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. Furthermore, federal, state and international laws and regulations, such as HIPAA, the GDPR, or CCPA, can expose us to enforcement actions and investigations by regulatory authorities, and potentially result in regulatory penalties and significant legal liability, if our information technology security efforts fail. In addition, our software systems include cloud-based applications that are hosted by third-party service providers with security and information technology systems subject to similar risks. To the extent that any disruption or security breach were to result in a loss of, or damage to, our data or applications, or inappropriate disclosure of confidential or proprietary information, we could incur liability, our competitive position could be harmed and the further development and commercialization of our product candidates could be delayed.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">Our ability to use our net operating losses to offset future taxable income may be subject to certain limitations.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We have incurred substantial losses since inception and do not expect to become profitable in the near future, if ever. In general, under Section&#160;382 of the United States Internal Revenue Code of 1986, as amended, or the Code, a corporation that undergoes an &#8220;ownership change&#8221; is subject to limitations on its ability to utilize its pre-change net operating losses, or NOLs, to offset future taxable income. We may have experienced ownership changes in the past and may experience ownership changes in the future as a result of this offering and/or subsequent changes in our stock ownership (some of which shifts are outside our control). As a result, if, and to the extent that we earn net taxable income, our ability to use our pre-change NOLs to offset such taxable income may be subject to limitations.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The Tax Cuts and Jobs Act of 2017, or the Tax Act, among other things, changed U.S. federal income tax rates and the rules governing net operating loss carryforwards. Under the Tax Act, as modified by the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act, NOLs arising in tax&#160;years beginning after December&#160;31, 2017 can be carried forward indefinitely, but the deduction for these carryforwards in taxable&#160;years beginning after December&#160;31, 2020 is limited to 80% of current-year taxable income. NOLs generated in tax&#160;years beginning before January&#160;1, 2018 are not subject to the taxable income limitation, and continue to have a 20-year carryforward period. Deferred tax assets for NOLs are measured at the applicable tax rate in effect when the NOL is expected to be utilized. The changes in the carryforward/carryback periods, as well as the new limitation on use of NOLs, may significantly impact our ability to utilize our NOLs to offset taxable income in the future.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">It is uncertain if and to what extent various states will conform to the Tax Act or the CARES Act. In addition, at the state level, there may be periods during which the use of NOLs is suspended or otherwise limited, which could accelerate or permanently increase the state taxes owed.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In order to realize the future tax benefits of our NOL carryforwards, we must generate taxable income, of which there is no assurance. Accordingly, we have provided a full valuation allowance for deferred tax assets as of March&#160;31, 2021.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">There are risks inherent in our business that may subject us to potential product liability suits and other claims, which may require us to engage in expensive and time-consuming litigation or pay substantial damages and may harm our reputation and reduce the demand for our product. </div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our business exposes us to product liability risks, which are inherent in the testing, manufacturing, marketing and sale of biopharmaceutical products. For example, we may be sued if any product we </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">46</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">develop allegedly causes or is perceived to cause injury or is found to be otherwise unsuitable during product testing, manufacturing, marketing or sale. Any such product liability claims may include allegations of defects in manufacturing, defects in design, a failure to warn of dangers inherent in the product, negligence, strict liability and a breach of warranties and/or trademarks. Claims could also be asserted under state consumer protection acts. If we cannot successfully defend ourselves against product liability claims, we may incur substantial liabilities or be required to limit commercialization of our products. Even a successful defense would require significant financial and management resources.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Certain aspects of how gamma-delta T cells are processed and administered may increase our exposure to liability. Medical personnel administer gamma-delta T cells to patients intravenously in an outpatient procedure. This procedure poses risks to the patient similar to those occurring with infusions of other cell products, such as T cells and stem cells, including blood clots, infection and mild to severe allergic reactions. Additionally, gamma-delta T cells or components of our gamma-delta T cell therapy may cause unforeseen harmful side effects. For example, a patient receiving gamma-delta T cells could have a severe allergic reaction, severe graft versus host disease, cytokine release syndrome, or could develop an autoimmune condition to materials infused with gamma-delta T cells.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In addition, we have not conducted studies on the long-term effects associated with the media and/or expansion process that we use to grow our gamma-delta T cells. Similarly, we expect to use media in freezing our gamma-delta T cells for storage and shipment. These media and other reagents used in the manufacturing process could contain substances that have proved harmful if used in certain quantities. As we continue to develop our gamma-delta T cell therapy, we may encounter harmful side effects that we did not observe in our prior studies and clinical trials. Additionally, the discovery of unforeseen side effects of gamma-delta T cells could also lead to lawsuits against us.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Regardless of merit or eventual outcome, product liability or other claims may, among other things, result in:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">decreased demand for any approved products;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">injury to our reputation and significant negative media attention;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">withdrawal of clinical trial participants or cancellation of clinical trials;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">costs to defend the related litigation;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">a diversion of management&#8217;s time and our resources;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">substantial monetary awards to clinical trial participants or patients;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">regulatory investigations, product recalls, withdrawals or labeling, marketing or promotional restrictions;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">exhaustion of any available insurance and our capital resources;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">loss of revenue;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">a potential decrease in our stock price; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the inability to commercialize any products we develop.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Our inability to obtain and maintain sufficient product liability insurance at an acceptable cost and scope of coverage to protect against potential product liability claims could prevent or inhibit the commercialization of our products. We obtained product liability insurance covering our clinical trials with policy limits that we believe are customary for similarly situated companies and adequate to provide us with coverage for foreseeable risks. Although we maintain such insurance, any claim that may be brought against us could result in a court judgment or settlement in an amount that is not covered, in whole or in part, by our insurance or that is in excess of the limits of our insurance coverage. Moreover, in the future, we may not be able to maintain insurance coverage at a reasonable cost or in sufficient amounts to protect us against losses. If we determine that it is prudent to increase our product liability coverage due to the commercial launch of any approved product, we may be unable to obtain such increased coverage on acceptable terms, or at all. Our insurance policies also have various exclusions and deductibles, and we may be subject to a product liability claim for which we have no coverage. We will have to pay any amounts awarded by a court or negotiated in a settlement that exceed our coverage limitations or that are not covered by our insurance, and we may not have, or be able to obtain, sufficient capital to pay such amounts.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">47</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Risks Related to Commercialization and Regulatory Compliance</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">Even if we obtain regulatory approvals for our product candidates, they will remain subject to ongoing regulatory oversight.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Even if we obtain regulatory approvals for our product candidates, such approvals will be subject to ongoing regulatory requirements for manufacturing, labeling, packaging, storage, advertising, promotion, sampling, record keeping and submission of safety and other post-market information. Any regulatory approvals that we receive for our product candidates may also be subject to a REMS, to limitations on the approved indicated uses for which the product candidate may be marketed or to the conditions of approval, or may contain requirements for potentially costly post-marketing testing, including Phase&#160;4 trials, and for surveillance to monitor the quality, safety and efficacy of the product candidate. Such regulatory requirements may differ from country to country depending on where we have received regulatory approval.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In addition, product candidate manufacturers and their facilities are subject to payment of user fees and continual review and periodic inspections by the FDA and other regulatory authorities for compliance with cGMP requirements and adherence to commitments made in the BLA or foreign marketing application. If we, or a regulatory authority, discover previously unknown problems with a product candidate, such as adverse events of unanticipated severity or frequency, or problems with the facility where the product candidate is manufactured or if a regulatory authority disagrees with the promotion, marketing or labeling of that product candidate, a regulatory authority may impose restrictions relative to that product candidate, the manufacturing facility or us, including requesting a recall or requiring withdrawal of the product candidate from the market or suspension of manufacturing.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">If we fail to comply with applicable regulatory requirements following approval of our product candidates, a regulatory authority may, among other things, issue warning letters or untitled letters, mandate modifications to promotional materials or require us to provide corrective information to healthcare practitioners, or require other restrictions on the labeling or marketing of such products, require us to enter into a consent decree, which can include imposition of various fines, reimbursements for inspection costs, required due dates for specific actions and penalties for noncompliance, seek an injunction or impose administrative, civil or criminal penalties or monetary fines, suspend or modify any ongoing clinical trials, or suspend, modify withdraw regulatory approval or restrict the marketing or manufacturing of the product candidate.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Moreover, the FDA and other regulatory authorities strictly regulate the promotional claims that may be made about biologic products. In particular, a product may not be promoted for uses that are not approved by the FDA as reflected in the product&#8217;s approved labeling. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant civil, criminal and administrative penalties.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Any government investigation of alleged violations of law could require us to expend significant time and resources in response and could generate negative publicity. The occurrence of any event or penalty described above may inhibit our ability to commercialize our product candidates and harm our business, financial condition, results of operations and prospects.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The FDA&#8217;s and other regulatory authorities&#8217; policies may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval of our product candidates.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative or executive action, either in the United States or abroad.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">Even if any product candidate receives marketing approval, it may fail to achieve market acceptance by physicians, patients, third-party payors or others in the medical community necessary for commercial success.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Even if any product candidate receives marketing approval, it may fail to gain market acceptance by physicians, patients, third-party payors and others in the medical community. If any such product candidate does not achieve an adequate level of acceptance, we may not generate significant product </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">48</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">revenue and may not become profitable. The degree of market acceptance of any product candidate, if approved for commercial sale, will depend on a number of factors, including but not limited to:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the cost, efficacy, safety profile, convenience, ease of administration and other potential advantages compared to alternative treatments and therapies;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the willingness of the target patient population to try new therapies and of physicians to prescribe these therapies;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the strength of our relationships with patient communities;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the availability of third-party coverage and adequate reimbursement;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the prevalence and severity of any side effects; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">any restrictions on the use of the product candidate together with other medications.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our efforts to educate physicians, patients, third-party payors and others in the medical community on the benefits of our product candidates may require significant resources and may never be successful. Such efforts may require more resources than are typically required due to the complexity and uniqueness of our product candidates. Because we expect sales of our product candidates, if approved, to generate substantially all of our revenues for the foreseeable future, the failure of our product candidates to find market acceptance would harm our business.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Furthermore, the attention to different types of prospective treatments and proposed cures for cancers has historically varied. In recent&#160;years, various forms of oncological immunotherapy have been prominent areas for academic and clinical advancement. While gamma-delta T cell therapy has not yet received prominent negative attention from the mainstream media or the scientific press, it is possible that it could, and it is possible that if immunotherapy generally falls out of favor with these key constituencies, whether due to the failure of one or more competitive products or technologies or otherwise, our business, including our ability to conduct our planned clinical trials and to raise capital, may in turn suffer.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">If we are unable to establish sales and marketing capabilities or enter into agreements with third parties to market and sell our product candidates, we may not be successful in commercializing them, if and when they are approved.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">To successfully commercialize any product candidate that may result from our development programs, we will need to build out our sales and marketing capabilities, either on our own or with others. The establishment and development of our own commercial team or the establishment of a contract sales force to market any product candidate we may develop will be expensive and time-consuming and could delay any product launch. Moreover, we cannot be certain that we will be able to successfully develop this capability. We may seek to enter into collaborations with other entities to utilize their established marketing and distribution capabilities, but we may be unable to enter into such agreements on favorable terms, if at all. If any current or future collaborators do not commit sufficient resources to commercialize our product candidates, or we are unable to develop the necessary capabilities on our own, we may be unable to generate sufficient revenue to sustain our business. We compete with many companies that currently have extensive, experienced and well-funded marketing and sales operations to recruit, hire, train and retain marketing and sales personnel. We will likely also face competition if we seek third parties to assist us with the sales and marketing efforts of our product candidates. Without an internal team or the support of a third party to perform marketing and sales functions, we may be unable to compete successfully against these more established companies. </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">Even if we obtain and maintain approval for our product candidates from the FDA, we may never obtain approval outside the United States, which would limit our market opportunities.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Approval of a product candidate in the United States by the FDA does not ensure approval of such product candidate by regulatory authorities in other countries or jurisdictions, and approval by one foreign regulatory authority does not ensure approval by regulatory authorities in other foreign countries or by the FDA. Sales of our product candidates outside the United States will be subject to foreign regulatory requirements governing clinical trials and marketing approval. Even if the FDA grants marketing approval for a product candidate, comparable foreign regulatory authorities also must approve the manufacturing and marketing of the product candidate in those countries. Approval procedures vary among jurisdictions and can involve requirements and administrative review periods different from, and more onerous than, those in the United States, including additional preclinical studies or clinical </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">49</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">trials. In many countries outside the United States, a product candidate must be approved for reimbursement before it can be approved for sale in that country. In some cases, the price that we intend to charge for any product candidates, if approved, is also subject to approval. Obtaining approval for our product candidates in the European Union from the European Commission following the opinion of the European Medicines Agency, or the EMA, if we choose to submit a marketing authorization application there, would be a lengthy and expensive process. Even if a product candidate is approved, the EMA may limit the indications for which the product may be marketed, require extensive warnings on the labeling or require expensive and time-consuming additional clinical trials or reporting as conditions of approval. Obtaining foreign regulatory approvals and compliance with foreign regulatory requirements could result in significant delays, difficulties and costs for us and could delay or prevent the introduction of our product candidates in certain countries.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">If we commercialize our product candidates outside the United States, a variety of risks associated with international operations could harm our business.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">While we have not taken any steps to obtain approval of our product candidates outside of the United States, and do not plan to seek approval in the near term, we may do so in the future. If we market approved products outside the United States, we expect that we will be subject to additional risks in commercialization, including:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">different regulatory requirements for approval of therapies in foreign countries;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">reduced protection for intellectual property rights;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">unexpected changes in tariffs, trade barriers and regulatory requirements;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">economic weakness, including inflation, or political instability in particular foreign economies and markets;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">compliance with tax, employment, immigration and labor laws for employees living or traveling abroad;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.91pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">foreign currency fluctuations, which could result in increased operating expenses and reduced revenues, and other obligations incident to doing business in another country;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">foreign reimbursement, pricing and insurance regimes;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">workforce uncertainty due to labor unrest;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">production shortages resulting from any events affecting raw material supply or manufacturing capabilities abroad; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">business interruptions resulting from geopolitical actions, including war and terrorism, natural disasters including earthquakes, typhoons, floods and fires, and public health emergencies, such as the ongoing COVID-19 pandemic.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We have no prior experience in these areas. In addition, there are complex regulatory, immigration, tax, labor and other legal requirements imposed by many of the individual countries in which we may operate, including the United States and, with which we will need to comply. Many biopharmaceutical companies have found the process of marketing their products in foreign countries to be challenging.</font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">Our relationships with customers, physicians, and third-party payors are subject, directly or indirectly, to federal and state healthcare fraud and abuse laws, including anti-kickback and false claims laws, transparency laws, and other healthcare laws and regulations. If we are unable to comply, or have not fully complied, with such laws, we could face substantial penalties.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Healthcare providers, including physicians, and third-party payors in the United States and elsewhere will play a primary role in the recommendation and prescription of any product candidates for which we obtain marketing approval. Our current and future arrangements with healthcare professionals, principal investigators, consultants, customers and third-party payors subject us to various federal and state fraud and abuse laws and other healthcare laws, including, without limitation, the federal Anti-Kickback Statute, the federal civil and criminal false claims laws and the law commonly referred to as the Physician Payments Sunshine Act and the regulations promulgated thereunder. For additional information on the healthcare laws and regulations that we may be subject to, see &#8220;Business&#8212;</font>&#8203;<font style="letter-spacing:-0.025pt;">Government Regulation and Product Approval.&#8221;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Ensuring that our business arrangements with third parties comply with applicable healthcare laws and regulations will likely be costly. It is possible that governmental authorities will conclude that our </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">50</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">business practices, including our relationships with physicians, some of whom are compensated with a stipend or stock options for services performed for the Company, may not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of these laws or any other governmental regulations that may apply to us, we may be subject to significant civil, criminal and administrative penalties, damages, fines, disgorgement, imprisonment, exclusion from participating in government-funded healthcare programs, such as Medicare and Medicaid, additional reporting requirements and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of noncompliance with these laws, contractual damages, reputational harm and the curtailment or restructuring of our operations. If the physicians or other providers or entities with whom we expect to do business are found not to be in compliance with applicable laws, they may be subject to significant criminal, civil or administrative sanctions, including exclusions from government-funded healthcare programs.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Litigation or other legal proceedings relating to healthcare laws and regulations may cause us to incur significant expenses and could distract our technical and management personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development, manufacturing, sales, marketing or distribution activities. Uncertainties resulting from the initiation and continuation of litigation or other proceedings relating to applicable healthcare laws and regulations could have an adverse effect on our ability to compete in the marketplace.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">Coverage and adequate reimbursement may not be available for our product candidates, which could make it difficult for us to sell profitably, if approved.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Market acceptance and sales of any product candidates that we commercialize, if approved, will depend in part on the extent to which reimbursement for these products and related treatments will be available from third-party payors, including government health administration authorities, managed care organizations and other private health insurers. Third-party payors decide which therapies they will pay for and establish reimbursement levels. While no uniform policy for coverage and reimbursement exists in the United States, third-party payors often rely upon Medicare coverage policy and payment limitations in setting their own coverage and reimbursement policies. However, decisions regarding the extent of coverage and amount of reimbursement to be provided for any product candidates that we develop will be made on a payor-by-payor basis. Therefore, one payor&#8217;s determination to provide coverage for a product does not assure that other payors will also provide coverage, and adequate reimbursement, for the product. Additionally, a third-party payor&#8217;s decision to provide coverage for a therapy does not imply that an adequate reimbursement rate will be approved. Each payor determines whether or not it will provide coverage for a therapy, what amount it will pay the manufacturer for the therapy, and on what tier of its formulary it will be placed. The position on a payor&#8217;s list of covered products, or formulary, generally determines the co-payment that a patient will need to make to obtain the therapy and can strongly influence the adoption of such therapy by patients and physicians. Patients who are prescribed treatments for their conditions and providers prescribing such services generally rely on third-party payors to reimburse all or part of the associated healthcare costs. Patients are unlikely to use our products unless coverage is provided and reimbursement is adequate to cover a significant portion of the cost of our products.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Third-party payors have attempted to control costs by limiting coverage and the amount of reimbursement for particular medications. Currently, in the allogeneic transplant setting, reimbursement is often made based on a capitated payment system, and obtaining reimbursement for our products may be particularly difficult because of the higher prices often associated with drugs administered under the supervision of a physician. Therefore, our product candidates may not be reimbursed separately but their cost may instead be bundled as part of a capitated payment received by the provider for the procedure only. We cannot be sure that the clinical results of our trials will be sufficient or meaningful to convince hospitals and/or clinicians to utilize our product or to get third-party payors to change reimbursement to separate outside of the current bundle. A decision by a third-party payor not to cover or separately reimburse for our product candidates or procedures using our product candidates, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">51</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">could reduce physician utilization of our products once approved. We cannot be sure that coverage and reimbursement will be available for any product that we commercialize and, if reimbursement is available, what the level of reimbursement will be. Inadequate coverage and reimbursement may impact the demand for, or the price of, any product for which we obtain marketing approval. If coverage and adequate reimbursement are not available, or are available only at limited levels, we may not be able to successfully commercialize any product candidates that we develop.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Healthcare legislative reform measures may have a negative impact on our business and results of operations.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In the United States and some foreign jurisdictions, there have been, and continue to be, legislative and regulatory changes and proposed changes regarding the healthcare system that could prevent or delay marketing approval of product candidates, restrict or regulate post-approval activities, and affect our ability to profitably sell any product candidates for which we obtain marketing approval. In particular, there have been and continue to be a number of initiatives at the U.S. federal and state levels that seek to reduce healthcare costs and improve the quality of healthcare.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">For example, in March&#160;2010, the Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010, or, collectively, the ACA, was passed, which substantially changed the way healthcare is financed by both governmental and private payors in the United States. Since its enactment, however, there have been executive, judicial and Congressional challenges to the ACA. For example, the Tax Act included a provision that repealed, effective January&#160;1, 2019, the tax-based shared responsibility payment imposed by the ACA on certain individuals who fail to maintain qualifying health coverage for all or part of a year, which is commonly referred to as the &#8220;individual mandate.&#8221;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">On December&#160;14, 2018, a U.S. District Court Judge in the Northern District of Texas, or Texas District Court Judge, ruled that the individual mandate is a critical and inseverable feature of the ACA, and therefore, because it was repealed as part of the Tax Act, the remaining provisions of the ACA are invalid as well. Additionally, on December&#160;18, 2019, the U.S. Court of Appeals for the 5th Circuit upheld the District Court ruling that the individual mandate was unconstitutional and remanded the case back to the District Court to determine whether the remaining provisions of the ACA are invalid as well. The United States Supreme Court is currently reviewing this case, although it remains unclear when or how the Supreme Court will rule. Although the U.S. Supreme Court has yet to rule on the constitutionality of the ACA, President Biden issued an executive order to initiate a special enrollment period from February 15, 2021 through August 15, 2021 for purposes of obtaining health insurance coverage through the ACA marketplace. The executive order also instructs certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare, including among others, reexamining Medicaid demonstration projects and waiver programs that include work requirements, and policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the ACA. It is unclear how the Supreme Court ruling, other such litigation, and the healthcare reform measures of the Biden administration will impact the ACA and our business.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Other legislative changes have been proposed and adopted since the ACA was enacted. These changes include aggregate reductions to Medicare payments to providers of 2% per fiscal year pursuant to the Budget Control Act of 2011, which began in 2013, and due to subsequent legislative amendments to the statute, including the BBA, which will remain in effect through 2030, with a temporary suspension from May&#160;1, 2020 through December 31, 2021 due to the COVID-19 pandemic, unless additional Congressional action is taken. The American Taxpayer Relief Act of 2012, among other things, further reduced Medicare payments to several providers, including hospitals and cancer treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five&#160;years.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Additional changes that may affect our business include the expansion of new programs such as Medicare payment for performance initiatives for physicians under the Medicare Access and CHIP Reauthorization Act of 2015. At this time, the full impact to overall physician reimbursement as a result of the introduction of the Medicare quality payment program remains unclear.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">52</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Further, in the United States there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products, which has resulted in several Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under government payor programs, and review the relationship between pricing and manufacturer patient programs. It is unclear whether the Biden administration will work to reverse these measures or pursue similar policy initiatives. Further, we expect that additional U.S. federal healthcare reform measures will be adopted in the future, any of which could limit the amounts that the U.S. federal government will pay for healthcare products and services, which could result in reduced demand for our current or any future product candidates or additional pricing pressures. We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action in the United States or any other jurisdiction, particularly in light of the new presidential administration. If we or any third parties we may engage are slow or unable to adapt to changes in existing or new requirements or policies, or if we or such third parties are not able to maintain regulatory compliance, our current or any future product candidates we may develop may lose any regulatory approval that may have been obtained and we may not achieve or sustain profitability.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We expect that these and other healthcare reform measures that may be adopted in the future may result in more rigorous coverage criteria and in additional downward pressure on the price that we receive for any approved drug, which could have an adverse effect on demand for our product candidates. Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability or commercialize our products. Further, it is possible that additional governmental action is taken in response to the ongoing COVID-19 pandemic. For additional information on healthcare reform, see &#8220;Business&#8201;&#8212;&#8201;Government Regulation and Product Approval.&#8221;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">Actual or perceived failures to comply with applicable data protection, privacy and security laws, regulations, standards and other requirements could adversely affect our business, results of operations, and financial condition.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The global data protection landscape is rapidly evolving, and we are or may become subject to numerous state, federal and foreign laws, requirements and regulations governing the collection, use, disclosure, retention, and security of personal data, such as information that we may collect in connection with clinical trials in the U.S. and abroad. Implementation standards and enforcement practices are likely to remain uncertain for the foreseeable future, and we cannot yet determine the impact future laws, regulations, standards, or perception of their requirements may have on our business. This evolution may create uncertainty in our business, affect our ability to operate in certain jurisdictions or to collect, store, transfer use and share personal information, necessitate the acceptance of more onerous obligations in our contracts, result in liability or impose additional costs on us. The cost of compliance with these laws, regulations and standards is high and is likely to increase in the future. Any failure or perceived failure by us to comply with federal, state or foreign laws or regulation, our internal policies and procedures or our contracts governing our processing of personal information could result in negative publicity, government investigations and enforcement actions, claims by third parties and damage to our reputation, any of which could have a material adverse effect on our operations, financial performance and business.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">As our operations and business grow, we may become subject to or affected by new or additional data protection laws and regulations and face increased scrutiny or attention from regulatory authorities. In the United States, numerous federal and state laws and regulations, including state data breach notification laws, state health information privacy laws, and federal and state consumer protection laws and regulations (e.g., Section&#160;5 of the FTC Act), that govern the collection, use, disclosure, and protection of health-related and other personal information could apply to our operations or the operations of our partners. In addition, we may obtain health information from third parties (including research institutions from which we obtain clinical trial data) that are subject to privacy and security requirements under the Health Insurance Portability and Accountability Act of 1996, as amended, and regulations promulgated thereunder, or HIPAA. Depending on the facts and circumstances, we could be subject to significant penalties if we violate HIPAA.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">53</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Certain states have also adopted comparable privacy and security laws and regulations, some of which may be more stringent than HIPAA. For example, California enacted the California Consumer Privacy Act, or the CCPA, which took effect on January&#160;1, 2020 and gives California residents expanded rights to access and delete their personal information, opt out of certain personal information sharing and receive detailed information about how their personal information is used by requiring covered companies to provide new disclosures to California consumers (as that term is broadly defined) and provide such consumers new ways to opt-out of certain sales of personal information. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches that is expected to increase data breach litigation. Further, the California Privacy Rights Act, or CPRA, recently passed in California. The CPRA will impose additional data protection obligations on covered businesses, including additional consumer rights processes, limitations on data uses, new audit requirements for higher risk data, and opt outs for certain uses of sensitive data. It will also create a new California data protection agency authorized to issue substantive regulations and could result in increased privacy and information security enforcement. The majority of the provisions will go into effect on January&#160;1, 2023, and additional compliance investment and potential business process changes may be required. The CCPA, CPRA, and other similar bills pending in several states may impact our business activities and exemplifies the vulnerability of our business to the evolving regulatory environment related to personal data and protected health information.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In addition, all 50 U.S. states and the District of Columbia have enacted breach notification laws that may require us to notify patients, employees or regulators in the event of unauthorized access to or disclosure of personal or confidential information experienced by us or our service providers. These laws are not consistent, and compliance in the event of a widespread data breach is difficult and may be costly. Any contractual protections we may have from our service providers may not be sufficient to adequately protect us from any such liabilities and losses, and we may be unable to enforce any such contractual protections. In addition to government regulation, privacy advocates and industry groups have and may in the future propose self-regulatory standards from time to time. These and other industry standards may legally or contractually apply to us, or we may elect to comply with such standards.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In addition, the European Union&#8217;s General Data Protection Regulation (EU) 2016/679, or GDPR, became applicable on May&#160;25, 2018. The GDPR imposes onerous accountability obligations requiring data controllers and processors to maintain a record of their data processing and policies.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Further, the Court of Justice of the European Union ruled in July&#160;2020 that the Privacy Shield, used by thousands of companies to transfer data between the European Union and United States, was invalid and could no longer be used. In September&#160;2020, Switzerland concluded that the Swiss-U.S. Privacy Shield Framework does not provide an adequate level of protection for data transfers from Switzerland to the United States. Alternative transfer mechanisms may be used, including the standard contractual clauses (&#8220;SCCs&#8221;), while the authorities interpret the decisions and scope of the invalidated Privacy Shield, but the SCCs have also been called into question in the same ruling that invalidated Privacy Shield. At present, there are few if any viable alternatives to the SCCs, so future developments may necessitate further expenditures on local infrastructure, changes to internal business processes, or may otherwise affect or restrict sales and operations.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Further, from January&#160;1, 2021, companies have to comply with the GDPR and also the United Kingdom GDPR, or the UK GDPR, which, together with the amended UK Data Protection Act 2018, retains the GDPR in UK national law. The UK GDPR mirrors the fines under the GDPR, i.e., fines up to the greater of &euro;20&#160;million (&#163;17.5&#160;million) or 4% of global turnover. The relationship between the United Kingdom and the European Union in relation to certain aspects of data protection law remains unclear, and it is unclear how United Kingdom data protection laws and regulations will develop in the medium to longer term, and how data transfers to and from the United Kingdom will be regulated in the long term. These changes will lead to additional costs and increase our overall risk exposure. Currently there is a four to six-month grace period agreed in the EU and United Kingdom Trade and Cooperation Agreement, ending June&#160;30, 2021 at the latest, while the parties discuss an adequacy decision. The European Commission published a draft adequacy decision on February&#160;19, 2021. If adopted, the decision will enable data transfers from EU member states to the United Kingdom for a four-year period, subject to subsequent extensions.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">54</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Although we work to comply with applicable laws, regulations and standards, our contractual obligations and other legal obligations, these requirements are evolving and may be modified, interpreted and applied in an inconsistent manner from one jurisdiction to another, and may conflict with one another or other legal obligations with which we must comply. Any failure or perceived failure by us or our employees, representatives, contractors, consultants, CROs, collaborators, or other third parties to comply with such requirements or adequately address privacy and security concerns, even if unfounded, could result in additional cost and liability to us, damage our reputation, and adversely affect our business and results of operations.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Risks Related to this Offering and Ownership of Our Common Stock</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">No public market for our common stock currently exists, and a public market may not develop or be liquid enough for you to sell your shares quickly or at market price.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Prior to this offering, there has not been a public market for our common stock. If an active trading market for our common stock does not develop following this offering, you may not be able to sell your shares quickly or at the market price. An inactive market may also impair our ability to raise capital to continue to fund operations by selling shares of our common stock and may impair our ability to acquire other companies or technologies by using our common stock as consideration. The initial public offering price of our common stock was determined by negotiations between us and the representative of the underwriters and may not be indicative of the market prices of our common stock that will prevail in the trading market.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">The market price of our common stock may be volatile and fluctuate substantially, which could result in substantial losses for purchasers of our common stock in this offering and may subject us to securities litigation suits.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The market price of our common stock is likely to be volatile. The stock market in general and the market for biopharmaceutical and pharmaceutical companies in particular, has experienced extreme volatility that has often been unrelated to the operating performance of particular companies. As a result of this volatility, you may not be able to sell your common stock at or above the initial public offering price. In addition to the factors discussed in this &#8220;Risk Factors&#8221; section and elsewhere in this prospectus, the market price for our common stock may be influenced by, among others, the following:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the commencement, enrollment or results of our planned or future clinical trials of our product candidates or those of our competitors;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the success of competitive products or therapies or announcements by potential competitors of their product development efforts;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">regulatory or legal developments in the United States and other countries;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">changes in the structure of healthcare payment systems;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">coordinated buying or selling activity in our common stock, including market manipulation;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">unusual trading in our common stock or securities derivative thereof, including pursuant to naked, or uncovered, short positions or &#8220;short squeezes;&#8221;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">commentary by investors on the prospects for our business or our common stock on the internet, including blogs, articles and message board, and/or social media and resulting in trading of our common stock;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">developments or disputes concerning patent applications, issued patents or other proprietary rights;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">actual or anticipated changes in estimates as to financial results, development timelines or recommendations by securities analysts;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">disputes or other developments relating to proprietary rights, including patents, litigation matters and our ability to obtain patent protection for our technologies;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">significant lawsuits, including patent or stockholder litigation;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">market volatility due to the continued effects of and responses to the ongoing COVID-19 pandemic;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">stock price and volume fluctuations attributable to inconsistent trading volume levels of our common stock;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">announcement or expectation of additional financing efforts or sales by our stockholders;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">55</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">general economic, political, and market conditions and overall fluctuations in the financial markets in the United States and abroad, including due to government intervention; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">investors&#8217; general perception of us and our business.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In addition, some companies that have experienced volatility in the trading price of their shares have been the subject of securities class action litigation. Any lawsuit to which we are a party, with or without merit, may result in an unfavorable judgment. We also may decide to settle lawsuits on unfavorable terms. Any such negative outcome could result in payments of substantial damages or fines, damage to our reputation or adverse changes to our business practices. Defending against litigation is costly and time-consuming, and could divert our management&#8217;s attention and our resources. Furthermore, during the course of litigation, there could be negative public announcements of the results of hearings, motions or other interim proceedings or developments, which could have a negative effect on the market price of our common stock.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">Concentration of ownership of our common stock among our existing executive officers, directors and principal stockholders may prevent new investors from influencing significant corporate decisions.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Based upon shares of our common stock outstanding as of June 30, 2021, and upon the completion of this offering and without giving effect to any purchases in this offering, our executive officers, directors and stockholders who owned more than 5% of our outstanding common stock before this offering will, in the aggregate, beneficially own shares representing 68.7% of our outstanding common stock (or 66.6% if the underwriters exercise in full their option to purchase additional shares to cover overallotments, if any). If our executive officers, directors and stockholders who owned more than 5% of our outstanding common stock acted together, they may be able to significantly influence all matters requiring stockholder approval, including the election and removal of directors and approval of any merger, consolidation or sale of all or substantially all of our assets. The concentration of voting power and transfer restrictions could delay or prevent an acquisition of our company on terms that other stockholders may desire or result in the management of our company in ways with which other stockholders disagree.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">Raising additional capital may cause dilution to our stockholders, including investors in this offering, restrict our operations or require us to relinquish rights to our product candidates.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Until such time, if ever, as we can generate substantial product revenue, we expect to finance our cash needs through public or private equity or debt financings, third-party funding, marketing and distribution arrangements, as well as other collaborations, strategic alliances and licensing arrangements, or any combination of these approaches. We do not have any committed external source of funds. To the extent that we raise additional capital, if available, through the sale of equity or convertible debt securities, your ownership interest in our company may be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect your rights as a stockholder. Debt and equity financings, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as redeeming our shares, making investments, incurring additional debt, making capital expenditures, declaring dividends or placing limitations on our ability to acquire, sell or license intellectual property rights.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">If we raise additional capital through future collaborations, strategic alliances or third-party licensing arrangements, we may have to relinquish valuable rights to our intellectual property, future revenue streams, research programs or product candidates, or grant licenses on terms that may not be favorable to us, if at all. If we are unable to raise additional capital when needed, we may be required to delay, limit, reduce or terminate our product candidate development or future commercialization efforts, or grant rights to develop and market product candidates that we would otherwise develop and market ourselves.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">Because we do not anticipate paying any cash dividends on our capital stock in the foreseeable future, capital appreciation, if any, will be your sole source of gain.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">You should not rely on an investment in our common stock to provide dividend income. We have never declared or paid cash dividends on our capital stock. We currently intend to retain all of our future earnings, if any, to finance the growth and development of our business. In addition, the terms of any future debt agreements may preclude us from paying dividends. As a result, capital appreciation, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">56</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">if any, of our common stock will be your sole source of gain for the foreseeable future. Investors seeking cash dividends should not purchase our common stock in this offering.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">A significant portion of our total outstanding shares are restricted or will be restricted from immediate resale but may be sold into the market in the near future, which could cause the market price of our common stock to drop significantly, even if our business is performing well.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Sales of a substantial number of shares of our common stock in the public market could occur at any time, subject to certain restrictions described below. These sales, or the perception in the market that holders of a large number of shares intend to sell shares, could reduce the market price of our common stock. After this offering, we will have outstanding 18,754,553 shares of common stock based on the number of shares outstanding as of June 30, 2021, and assuming no exercise of the underwriters&#8217; overallotment option. This includes the 4,000,000 shares that we are selling in this offering, which may be resold in the public market immediately without restriction, unless purchased by our affiliates. Substantially all of the remaining shares are currently restricted as a result of securities laws or lock-up agreements but will be able to be sold after the offering, as further described in the sections titled &#8220;Shares Eligible for Future Sale&#8221; and &#8220;Underwriting&#8221; herein. Moreover, upon the completion of this offering, holders of an aggregate of 13,684,805 shares of our common stock will have rights, subject to certain conditions, to require us to file registration statements covering their shares or to include their shares in registration statements that we may file for ourselves or other stockholders. We further intend to register all shares of common stock that we may issue in the future or have issued to date under our equity compensation plans. Once we register these shares, they can be freely sold in the public market upon issuance, subject to volume limitations applicable to affiliates and to the lock-up agreements described in the section titled &#8220;Underwriting&#8221; herein.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">Provisions in our corporate charter documents and under Delaware law could make an acquisition of us, which may be beneficial to our stockholders, more difficult and may prevent attempts by our stockholders to replace or remove our current management.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Provisions in our certificate of incorporation, which will become effective immediately after the completion of this offering, and our bylaws, which will become effective immediately prior to the completion of this offering, may discourage, delay or prevent a merger, acquisition or other change in control of us that stockholders may consider favorable, including transactions in which you might otherwise receive a premium for your shares. These provisions also could limit the price that investors might be willing to pay in the future for shares of our common stock, thereby depressing the market price of our common stock. In addition, because our board of directors is responsible for appointing the members of our management team, these provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of directors. Among other things, these provisions:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">establish a classified board of directors such that not all members of the board are elected at one time;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">allow the authorized number of our directors to be changed only by resolution of our board of directors;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">provide that our directors may be removed for cause only upon the vote of at least 66</font><font style=" position:relative; bottom:2.66pt;font-size:7pt;letter-spacing:-0.018pt;">2</font><font style="letter-spacing:-0.025pt;">&#8725;</font><font style="font-size:7pt;letter-spacing:-0.018pt;">3</font><font style="letter-spacing:-0.025pt;">% of our outstanding shares of voting stock;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">establish advance notice requirements for stockholder proposals that can be acted on at stockholder meetings and nominations to our board of directors;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">require that stockholder actions must be effected at a duly called stockholder meeting and prohibit actions by our stockholders by written consent;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">limit who may call stockholder meetings;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">authorize our board of directors to issue, without further action by the stockholders, shares of undesignated preferred stock with terms, rights and preferences determined by our board of directors that may be senior to our common stock; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">require the approval of the holders of at least 66</font><font style=" position:relative; bottom:2.66pt;font-size:7pt;letter-spacing:-0.018pt;">2</font><font style="letter-spacing:-0.025pt;">&#8725;</font><font style="font-size:7pt;letter-spacing:-0.018pt;">3</font><font style="letter-spacing:-0.025pt;">% of the votes that all our stockholders would be entitled to cast to amend or repeal certain provisions of our charter or bylaws.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Moreover, because we are incorporated in Delaware, we are governed by the provisions of Section&#160;203 of the Delaware General Corporation Law, or DGCL, which prohibits a person who owns </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">57</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">in excess of 15% of our outstanding voting stock from merging or combining with us for a period of three&#160;years after the date of the transaction in which the person acquired in excess of 15% of our outstanding voting stock, unless the merger or combination is approved in a prescribed manner. We have not elected to opt out of DGCL Section&#160;203. These provisions could discourage potential acquisition proposals and could delay or prevent a change in control transaction. They could also have the effect of discouraging others from making tender offers for our common stock, including transactions that may be in your best interests. These provisions may also prevent changes in our management or limit the price that investors are willing to pay for our common stock.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">Our amended and restated certificate of incorporation provides that the Court of Chancery of the State of Delaware will be the exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our amended and restated certificate of incorporation, which will become effective immediately after the completion of this offering, provides that, with respect to any state actions or proceedings under Delaware statutory or common law, the Court of Chancery of the State of Delaware is the exclusive forum for:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">any derivative action or proceeding brought on our behalf;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">any action or proceeding asserting a breach of fiduciary duty;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">any action or proceeding asserting a claim against us or any of our directors, officers, employees or agents arising under the DGCL, our amended and restated certificate of incorporation or our amended and restated bylaws;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">any action or proceeding to interpret, apply, enforce or determine the validity of our amended and restated certificate of incorporation or our amended and restated bylaws; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">any action or proceeding asserting a claim against us or any of our directors, officers, employees or agents that is governed by the internal-affairs doctrine.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">This provision would not apply to suits brought to enforce a duty or liability created by the Exchange Act. Furthermore, Section&#160;22 of the Securities Act of 1933, as amended, or the Securities Act, creates concurrent jurisdiction for federal and state courts over all such Securities Act actions. Accordingly, both state and federal courts have jurisdiction to entertain such claims. To prevent having to litigate claims in multiple jurisdictions and the threat of inconsistent or contrary rulings by different courts, among other considerations, our amended and restated certificate of incorporation further provides that the federal district courts of the United States of America will be the exclusive forum for resolving any complaint asserting a cause or causes of action arising under the Securities Act, including all causes of action asserted against any defendant to such complaint. While the Delaware courts have determined that such choice of forum provisions are facially valid, a stockholder may nevertheless seek to bring a claim in a venue other than those designated in the exclusive forum provisions. In such instance, we would expect to vigorously assert the validity and enforceability of the exclusive forum provisions of our amended and restated certificate of incorporation. This may require significant additional costs associated with resolving such action in other jurisdictions and there can be no assurance that the provisions will be enforced by a court in those other jurisdictions.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">These exclusive-forum provisions may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees, which may discourage lawsuits against us and our directors, officers and other employees. If a court were to find an exclusive-forum provision in our amended and restated certificate of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving the dispute in other jurisdictions, which could harm our business.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">General Risk Factors</font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">If research analysts do not publish research or reports, or publish unfavorable research or reports, about us, our business or our market, our stock price and trading volume could decline. </div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The trading market for our common stock will be influenced by the research and reports that industry or financial analysts publish about us or our business. We do not currently have, and may never obtain, research coverage by industry or financial analysts. Equity research analysts may elect </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">58</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">not to provide research coverage of our common stock after the completion of this offering, and such lack of research coverage may adversely affect the market price of our common stock. In the event we do have equity research analyst coverage, we will not have any control over the analysts or the content and opinions included in their reports. The price of our shares could decline if one or more equity research analysts downgrade our shares or issue other unfavorable commentary or research about us. If one or more equity research analysts cease coverage of us or fail to publish reports on us regularly, demand for our shares could decrease, which in turn could cause the trading price or trading volume of our common stock to decline.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">We have broad discretion in the use of our cash resources, including the net proceeds from this offering, and may use them ineffectively, in ways with which you do not agree or in ways that do not increase the value of your investment.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our management will have broad discretion in the application of our cash, including the net proceeds from this offering, and could spend the proceeds in ways that do not improve our results of operations or enhance the value of our common stock. The failure by our management to apply these funds effectively could result in additional operating losses that could have a negative impact on our business, cause the price of our common stock to decline and delay the development of our product candidates. Pending their use, we may invest our cash, including the net proceeds from this offering, in a manner that does not produce income or that loses value. See the section titled &#8220;Use of Proceeds&#8221; herein for additional information.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">We will incur increased costs as a result of operating as a public company, and our management will be required to devote substantial time to new compliance initiatives.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">As a public company, and particularly after we are no longer an emerging growth company, as defined under the Jobs Act, or EGC, or smaller reporting company, we will incur significant legal, accounting and other expenses that we did not incur as a private company. In addition, the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, and rules subsequently implemented by the SEC and The Nasdaq Stock Market LLC impose various requirements on public companies, including establishment and maintenance of effective disclosure and financial controls and corporate governance practices. Our management and other personnel will need to devote a substantial amount of time to comply with these requirements. Moreover, these rules and regulations will increase our legal and financial compliance costs and will make some activities more time-consuming and costly.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Pursuant to Section&#160;404 of the Sarbanes-Oxley Act, or Section&#160;404, we will be required to furnish a report by our management on our internal control over financial reporting, including an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. However, while we remain an EGC or a smaller reporting company with less than $100&#160;million in annual revenue, we will not be required to include an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. We could be an EGC for up to five&#160;years. To achieve compliance with Section&#160;404 within the prescribed period, we will be engaged in a process to document and evaluate our internal control over financial reporting, which is both costly and challenging. In this regard, we will need to continue to dedicate internal resources, potentially engage outside consultants and adopt a detailed work plan to assess and document the adequacy of internal control over financial reporting, continue steps to improve control processes as appropriate, validate through testing that controls are functioning as documented and implement a continuous reporting and improvement process for internal control over financial reporting. Despite our efforts, there is a risk that neither we nor our independent registered public accounting firm will be able to conclude within the prescribed timeframe that our internal control over financial reporting is effective as required by Section&#160;404. This could result in an adverse reaction in the financial markets due to a loss of confidence in the reliability of our financial statements.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">If we fail to maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results or prevent fraud. As a result, stockholders could lose confidence in our financial and other public reporting, which would harm our business and the trading price of our common stock.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Effective internal control over financial reporting are necessary for us to provide reliable financial reports and, together with adequate disclosure controls and procedures, are designed to prevent fraud. Any failure to implement required new or improved controls, or difficulties encountered in their </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">59</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:302pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">implementation could cause us to fail to meet our reporting obligations. In addition, any testing by us conducted in connection with Section&#160;404, or any subsequent testing by our independent registered public accounting firm, may reveal deficiencies in our internal control over financial reporting that are deemed to be material weaknesses or that may require prospective or retroactive changes to our financial statements or identify other areas for further attention or improvement. Inferior internal controls could also cause investors to lose confidence in our reported financial information, which could harm our business and have a negative effect on the trading price of our stock.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We will be required to disclose changes made in our internal controls and procedures on a quarterly basis and our management will be required to assess the effectiveness of these controls annually. Our assessment of internal controls and procedures may not detect material weaknesses in our internal control over financial reporting. Undetected material weaknesses in our internal control over financial reporting could lead to financial statement restatements and require us to incur the expense of remediation, which could have a negative effect on the trading price of our stock.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Our disclosure controls and procedures may not prevent or detect all errors or acts of fraud.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Upon the completion of this offering, we will become subject to certain reporting requirements of the Exchange Act. Our disclosure controls and procedures are designed to reasonably assure that information required to be disclosed by us in reports we file or submit under the Exchange Act is accumulated and communicated to management, recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the SEC. We believe that any disclosure controls and procedures or internal controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements or insufficient disclosures due to error or fraud may occur and not be detected. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">60</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSNRF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:18pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">This prospectus contains forward-looking statements about us and our industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this prospectus, including statements regarding our strategy, future financial condition, future operations, projected costs, prospects, plans, objectives of management and expected market growth, are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as &#8220;aim,&#8221; &#8220;anticipate,&#8221; &#8220;assume,&#8221; &#8220;believe,&#8221; &#8220;contemplate,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;design,&#8221; &#8220;due,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;goal,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;objective,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;positioned,&#8221; &#8220;potential,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221; &#8220;target,&#8221; &#8220;will,&#8221; &#8220;would&#8221; and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. These forward-looking statements are subject to a number of known and unknown risks, uncertainties and assumptions, including risks described in the section titled &#8220;Risk Factors&#8221; and elsewhere in this prospectus, regarding, among other things:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our plans to develop and commercialize our product candidates;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the initiation, timing, progress and results of our current and future preclinical studies and clinical trials and our research and development programs;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our ability to take advantage of abbreviated regulatory pathways for any of our product candidates;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our expectations regarding the impact of the ongoing COVID-19 pandemic on our business, our industry and the economy;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our estimates regarding expenses, future revenue, capital requirements and needs for additional financing;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our ability to successfully acquire or in-license additional product candidates on reasonable terms;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our ability to maintain and establish collaborations or obtain additional funding;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our ability to obtain regulatory approval of our current and future product candidates;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our expectations regarding the potential market size and the rate and degree of market acceptance of such product candidates;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our continued reliance on third parties to conduct clinical trials of our product candidates, and for the manufacture of our product candidates for preclinical studies and clinical trials;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our ability to fund our working capital requirements and expectations regarding the sufficiency of our capital resources;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the implementation of our business model and strategic plans for our business and product candidates;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our intellectual property position and the duration of our patent rights;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">developments or disputes concerning our intellectual property or other proprietary rights;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our expectations regarding government and third-party payor coverage and reimbursement;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our ability to compete in the markets we serve;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the impact of government laws and regulations and liabilities thereunder;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our expected use of proceeds from this offering;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our need to hire additional personnel and our ability to attract and retain such personnel;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">developments relating to our competitors and our industry; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">other factors that may impact our financial results.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The foregoing list of risks is not exhaustive. Other sections of this prospectus may include additional factors that could harm our business and financial performance. Moreover, we operate in a very competitive and rapidly changing environment. New risk factors emerge from time to time, and it is not possible for our management to predict all risk factors nor can we assess the impact of all factors </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">61</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:420pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in, or implied by, any forward-looking statements.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In light of the significant uncertainties in these forward-looking statements, you should not rely upon forward-looking statements as predictions of future events. Although we believe that we have a reasonable basis for each forward-looking statement contained in this prospectus, we cannot guarantee that the future results, levels of activity, performance or events and circumstances reflected in the forward-looking statements will be achieved or occur at all. You should refer to the section titled &#8220;Risk Factors&#8221; for a discussion of important factors that may cause our actual results to differ materially from those expressed or implied by our forward-looking statements. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material. Except as required by law, we undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">You should read this prospectus and the documents that we reference in this prospectus and have filed as exhibits to the registration statement, of which this prospectus is a part, completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of the forward-looking statements in this prospectus by these cautionary statements.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">62</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tMAID">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:466pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">MARKET AND INDUSTRY DATA</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:18pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Certain market and industry data included in this prospectus were obtained from market research, publicly available information, reports of governmental agencies and industry publications and surveys. All of the market and industry data used in this prospectus involve a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. Although we are responsible for all of the disclosure contained in this prospectus and we believe the information from the industry publications and other third-party sources included in this prospectus is reliable, such information is inherently imprecise. The industry in which we operate is subject to a high degree of uncertainty and risk due to a variety of factors, including those described in the sections titled &#8220;Risk Factors&#8221; and &#8220;Special Note Regarding Forward-Looking Statements.&#8221; These and other factors could cause results to differ materially from those expressed in the estimates made by the independent parties and by us. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">63</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tUOP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">USE OF PROCEEDS</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:18pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We estimate that the net proceeds to us from this offering will be approximately $32.6&#160;million (or approximately $38.1&#160;million if the underwriters exercise in full their option to purchase up to 600,000 additional shares of common stock), based on the initial public offering price of $10.00 per share, after deducting underwriting discounts and commissions and estimated offering expenses payable by us.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The principal purposes of this offering are to obtain additional capital to support our operations, establish a public market for our common stock and facilitate our future access to the public capital markets.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We intend to use the net proceeds from this offering, together with our existing cash, as follows:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">approximately $8.0&#160;million to $13.0&#160;million to advance the clinical development of INB-200, including the completion of our ongoing Phase&#160;1 clinical trial and the initiation of a Phase&#160;2 clinical trial for the treatment of newly diagnosed GBM, and for the evaluation of additional indications;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">approximately $1.0&#160;million to $2.0&#160;million to advance the clinical development of INB-100, including the completion of our ongoing Phase&#160;1 clinical trial for the treatment of leukemia patients undergoing HSCT;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">approximately $4.0&#160;million to $5.0&#160;million to advance the clinical development of INB-400, including the IND submission and the initiation of a Phase&#160;1 clinical trial for the treatment of newly diagnosed GBM; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the remainder to fund other research and development activities, including preclinical development, development of our manufacturing capabilities, working capital and other general corporate purposes.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We may also use a portion of the net proceeds from this offering designated for working capital and general corporate purposes, or to in-license, acquire or invest in complementary businesses, technologies, products or assets. Although we currently have no agreements, commitments or obligations to do so, we evaluate such opportunities and engage in related discussions with third parties from time to time.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our expected use of the net proceeds from this offering represents our intentions based upon our current plans and business conditions. As of the date of this prospectus, we cannot predict with certainty all of the particular uses for the net proceeds to be received upon the completion of this offering or the amounts that we will actually spend on the uses set forth above. The amounts and timing of our actual expenditures and the extent of our preclinical, clinical and future development activities may vary significantly depending on numerous factors, including the progress of our development efforts, the status of and results from our ongoing and planned clinical trials, our ability to take advantage of expedited programs or to obtain regulatory approval for product candidates, the timing and costs associated with the manufacture and supply of product candidates for clinical development or commercialization and any unforeseen cash needs. As a result, our management will retain broad discretion over the allocation of the net proceeds from this offering.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Based on our research and development plans, we believe that the net proceeds from this offering, together with our existing cash, will be sufficient to fund our operations into the first quarter of 2023. We have based this estimate on assumptions that may prove to be wrong, and we could exhaust our available capital resources sooner than we expect.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We do not anticipate that the expected net proceeds from this offering, together with our existing cash, will be sufficient for us to fund any of our product candidates through regulatory approval, and we will need to raise substantial additional capital to complete the development and commercialization of our product candidates. Because the time and costs to complete development of our product candidates will depend on the results of future preclinical studies and clinical trials and discussions with and decisions by regulatory authorities, we cannot reasonably estimate the amount of additional capital we will require to complete development. In particular, the cost and timing of completing development of any product candidate will vary widely depending on the outcome of ongoing and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">64</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:548pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">future preclinical studies and clinical trials, as well as future guidance from regulatory authorities as to the number, scope and design of clinical trials that will be necessary to support regulatory applications.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">Pending the use of the net proceeds from this offering as described above, we intend to invest the net proceeds in a variety of capital preservation instruments, including short-term, interest-bearing obligations, investment-grade instruments, certificates of deposit or direct or guaranteed obligations of the U.S. government. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">65</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDIPO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:550pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">DIVIDEND POLICY</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:18pt; width:456pt; line-height:12pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">We have never declared or paid cash dividends on our capital stock, and we do not currently intend to pay any cash dividends on our capital stock in the foreseeable future. We currently intend to retain all available funds and any future earnings, if any, to fund the development and expansion of our business. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">66</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tCAP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">CAPITALIZATION</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:18pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The following table sets forth our cash and our capitalization as of March 31, 2021 on:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">an actual basis;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.99pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">a pro&#160;forma basis, to reflect the automatic conversion of all of the outstanding shares of our preferred stock into an aggregate of 10,990,065 shares of common stock upon the completion of this offering; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">a pro&#160;forma as adjusted basis, giving effect to the pro&#160;forma adjustments discussed above, and giving further effect to (i)&#160;the sale of 4,000,000 shares of our common stock in this offering at the initial public offering price of $10.00 per share, after deducting underwriting discounts and commissions and estimated offering expenses payable by us and (ii)&#160;the filing and effectiveness of our amended and restated certificate of incorporation.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">You should read this table together with the sections titled &#8220;Selected Financial Data&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and our financial statements and the related notes included elsewhere in this prospectus.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;margin-bottom:7pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:309.56pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">As of March 31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.583pt 0pt 2.167pt 0pt; width:309.56pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.089pt;">(in thousands, except share and per share amounts) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Actual </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Pro</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Forma </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Pro Forma</font>
                <br >
                <font style="letter-spacing:-0.089pt;">As</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Adjusted</font><font style=" position:relative; bottom:3.25pt;font-size:6pt;letter-spacing:-0.067pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:309.56pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Cash </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">15,052</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">15,052</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.09pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">49,489 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:1.417pt 0pt 0.833pt 0pt; width:309.56pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:-0.025pt;">Convertible preferred stock, Series A, par value, $0.0001 per share; 27,564,260 shares authorized, 9,993,727 shares issued and outstanding, actual; 27,564,260 shares authorized and no shares issued or outstanding, pro&#160;forma; no shares authorized, issued or outstanding, pro&#160;forma as adjusted </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 0.833pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:1.417pt 0pt 0.833pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">34,900</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 0.833pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:1.417pt 0pt 0.833pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.09pt;width:0pt;">&#8203;</td>
            <td style="padding:1.417pt 0pt 0.833pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.417pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:309.56pt;text-align:left;">
              <font style="letter-spacing:-0.025pt;">Stockholders&#8217; (deficit) equity: </font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.09pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:309.56pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:-0.025pt;">Preferred stock, par value $0.0001 per share; no shares authorized, issued and outstanding, actual; 10,000,000 shares authorized, no shares issued or outstanding, pro forma and pro&#160;forma as adjusted </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.09pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:309.56pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:-0.025pt;">Common stock, par value $0.0001 per share; 50,700,000 shares </font>
                <br >
                <font style="letter-spacing:-0.025pt;">authorized, 3,764,488 shares issued and outstanding, actual; </font>
                <br >
                <font style="letter-spacing:-0.025pt;">50,700,000&#160;shares authorized and 14,754,553&#160;shares issued and </font>
                <br >
                <font style="letter-spacing:-0.025pt;">outstanding, pro&#160;forma; 490,000,000 shares authorized and </font>
                <br >
                <font style="letter-spacing:-0.025pt;">18,754,553&#160;shares issued and outstanding, pro&#160;forma as </font>
                <br >
                <font style="letter-spacing:-0.025pt;">adjusted </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.09pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">5</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:309.56pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Additional paid-in capital </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">1,819</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">36,719</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.09pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">69,265</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:309.56pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Accumulated deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">(20,401<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">(20,401<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.09pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">(20,401<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:309.56pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Total stockholders&#8217; (deficit) equity </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">(18,581<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">16,319</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.09pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">48,869</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:309.56pt;text-align:left;">
              <div style="margin-left:30pt;">
                <font style="letter-spacing:-0.025pt;">Total capitalization </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">16,319</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">16,319</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.09pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">48,869</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13.2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The foregoing discussion and tables above are based on 3,764,488&#160;shares of common stock outstanding as of March 31, 2021, and excludes as of such date:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">1,552,290 shares of our common stock issuable upon the exercise of outstanding stock options under our 2018 Plan as of March 31, 2021, with a weighted-average exercise price of $5.20 per share;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.99pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">86,258 shares of our common stock issuable upon the exercise of stock options that will be granted to a director upon the completion of this offering pursuant to an antidilution right, as more fully described in the section titled &#8216;&#8216;Certain Relationships and Related Party Transactions&#8212;Director Antidilution Rights&#8217;&#8217;;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">67</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:494pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">4,200,000 shares of our common stock reserved for future issuance under the 2020 Plan, which became effective immediately prior to the execution of the underwriting agreement related to this offering, as well as any future increases in the number of shares of common stock reserved for issuance under the 2020 Plan (of which options to purchase an aggregate of 481,275 shares of our common stock were granted to certain of our non-employee directors, executive officers, other employees and a consultant at the time of effectiveness of the 2020 Plan with an exercise price equal to the initial public offering price per share); and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">200,000 shares of our common stock reserved for future issuance under our ESPP, which became effective immediately prior to the execution of the underwriting agreement related to this offering, as well as any future increases in the number of shares of common stock reserved for issuance under our ESPP. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">68</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDIL">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">DILUTION</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:18pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">If you invest in our common stock in this offering, your ownership interest will be diluted to the extent of the difference between the initial public offering price per share of our common stock and the pro&#160;forma as adjusted net tangible book value per share of our common stock after this offering.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Our historical net tangible book deficit as of March 31, 2021 was $23.3 million, or $(6.20) per share of our common stock. Our historical net tangible book deficit represents our total tangible assets less total liabilities and preferred stock. Historical net tangible book deficit per share is our historical net tangible book deficit divided by the number of shares of our common stock outstanding as of March&#160;31, 2021.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Our pro&#160;forma net tangible book value as of March 31, 2021 was $11.6&#160;million, or $0.78&#160;per share of our common stock, based on the total number of shares of our common stock outstanding as of March&#160;31, 2021. Pro&#160;forma net tangible book value per share represents our total tangible assets less our total liabilities, divided by the number of outstanding shares of common stock, after giving effect to the automatic conversion of all of the outstanding shares of our preferred stock into an aggregate of 10,990,065 shares of common stock upon the completion of this offering.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">After giving effect to the sale of 4,000,000 shares of common stock in this offering at the initial public offering price of $10.00 per share, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us, our pro&#160;forma as adjusted net tangible book value as of March 31, 2021 would have been $50.1&#160;million, or $2.52&#160;per share. This represents an immediate increase in pro&#160;forma as adjusted net tangible book value of $1.74&#160;per share to our existing stockholders and an immediate dilution of $7.48&#160;per share to new investors participating in this offering.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The following table illustrates this dilution on a per share basis:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:116.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:383.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Initial public offering price per share </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="margin-left:6.11pt;letter-spacing:-0.025pt;">&#8199;&#8199;&#8199;&#8199;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">10.00 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:383.1pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Historical net tangible book deficit per share as of March 31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(6.20<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:0pt;border-bottom:2px solid #CCEEFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:2px solid #CCEEFF;padding:1.417pt 0pt 1.583pt 0pt; width:383.1pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:-0.025pt;">Pro&#160;forma increase in net tangible book value per share as of March 31, 2021 attributable to the pro&#160;forma transactions described above </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:2px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:2px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:0.5pt solid #000000;">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.083pt 0pt;border-bottom:0.5pt solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.083pt 0pt;border-bottom:0.5pt solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">6.98</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:0.5pt solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:2px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:2px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:2px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:2px solid #CCEEFF; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:2px solid #CCEEFF; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:2px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:2px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.75pt 0pt; width:383.1pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Pro&#160;forma net tangible book value per share as of March 31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.75pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.75pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">0.78</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:0pt;border-bottom:2px solid #CCEEFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:2px solid #CCEEFF;padding:1.417pt 0pt 1.583pt 0pt; width:383.1pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:-0.025pt;">Increase in pro&#160;forma net tangible book value per share attributable to new investors </font>
                <br >
                <font style="letter-spacing:-0.025pt;">participating in this offering </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:2px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:2px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:0.5pt solid #000000;">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.083pt 0pt;border-bottom:0.5pt solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.083pt 0pt;border-bottom:0.5pt solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">1.74</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:0.5pt solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:2px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:2px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:2px solid #CCEEFF;padding:1.417pt 0pt 1.583pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="margin-left:8.34pt;letter-spacing:-0.025pt;">&#8199;&#8199;&#8199;&#8199;</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:2px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:0pt;border-bottom:2px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:2px solid #FFFFFF;padding:2.5pt 0pt 2.25pt 0pt; width:383.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Pro&#160;forma as adjusted net tangible book value per share after this offering </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:2px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:2px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:2px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:2px solid #FFFFFF; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:2px solid #FFFFFF; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:2px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:2px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:2px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:0.5pt solid #000000;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:0.5pt solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:0.5pt solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">2.52</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:0.5pt solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:2px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 2.5pt 0pt; width:383.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Dilution per share to new investors participating in this offering </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">7.48</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13.9pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">If the underwriters exercise in full their option to purchase up to 600,000 additional shares of common stock from us, the pro&#160;forma as adjusted net tangible book value per share after giving effect to this offering would be $2.73&#160;per share, representing an immediate increase to existing stockholders of $1.95&#160;per share, and dilution to new investors participating in this offering of $7.27&#160;per share.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The following table summarizes on the pro&#160;forma as adjusted basis described above, the differences between the number of shares purchased from us on an as converted basis, the total consideration paid and the weighted-average price per share paid by existing stockholders and by investors purchasing shares in this offering at the initial public offering price of $10.00 per share, before deducting underwriting discounts and commissions and estimated offering expenses payable by us:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:70.5pt;margin-top:5pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;height:17.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:198.86pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.417pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Shares Purchased </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.417pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Total</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Consideration </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:7.5pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.417pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.089pt;">Average</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Price Per</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Share </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;" rowspan="2">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:198.86pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 1.75pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Number </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 1.75pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Percent </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 1.75pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 1.75pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Percent </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:7.5pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:198.86pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Existing stockholders </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:42pt; text-align:right; white-space:nowrap;">14,754,553</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.6pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">78.7<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:46.5pt; text-align:right; white-space:nowrap;">35,559,158</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.04pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">47.1<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.91pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">2.41</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.75pt 0pt 0.5pt 0pt; width:198.86pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">New investors </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:42pt; text-align:right; white-space:nowrap;">4,000,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.6pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">21.3</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:46.5pt; text-align:right; white-space:nowrap;">40,000,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.04pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">52.9</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.91pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">10.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.5pt 0pt 2.5pt 0pt; width:198.86pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:42pt; text-align:right; white-space:nowrap;">18,754,553</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.6pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">100<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:46.5pt; text-align:right; white-space:nowrap;">75,559,158 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.04pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">100.0<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.91pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt;padding-bottom:1.75pt; min-width:21.75pt; text-align:right; white-space:nowrap;">4.03</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">69</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:292pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">If the underwriters exercise their option to purchase additional shares in full, our existing stockholders would own 76.2% and our new investors would own 23.8% of the total number of shares of our common stock outstanding upon the completion of this offering.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The foregoing discussion and tables above are based on 3,764,488 shares of common stock outstanding as of March 31, 2021, and excludes:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">1,552,290 shares of our common stock issuable upon the exercise of outstanding stock options under the 2018 Plan as of March 31, 2021, with a weighted-average exercise price of $5.20 per share;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">86,258 shares of our common stock issuable upon the exercise of stock options that will be granted to a director upon the completion of this offering pursuant to an antidilution right, as more fully described in the section titled &#8216;&#8216;Certain Relationships and Related Party Transactions&#8212;Director Antidilution Rights&#8217;&#8217;;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">4,200,000 shares of our common stock reserved for future issuance under the 2020 Plan, which became effective immediately prior to the execution of the underwriting agreement related to this offering, as well as any future increases in the number of shares of common stock reserved for issuance under our 2020 Plan (of which options to purchase an aggregate of 481,275 shares of our common stock were granted to certain of our non-employee directors, executive officers, other employees and a consultant at the time of effectiveness of the 2020 Plan with an exercise price equal to the initial public offering price per share); and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">200,000 shares of our common stock reserved for future issuance under our ESPP, which became effective immediately prior to the execution of the underwriting agreement related to this offering, as well as any future increases in the number of shares of common stock reserved for issuance under our ESPP.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">To the extent that any outstanding options or warrants are exercised, new options or other equity awards are issued under our equity incentive plans, or we issue additional shares in the future, there will be further dilution to new investors participating in this offering. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">70</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tMDAA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:18pt; width:456pt; line-height:11.5pt;font-style:italic;">You should read the following discussion and analysis of our financial condition and results of operations together with our financial statements and the related notes included elsewhere in this prospectus. Some of the information contained in this discussion and analysis or set forth elsewhere in this prospectus, including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks and uncertainties. As a result of many factors, including those factors set forth in the &#8220;Risk Factors&#8221; section of this prospectus, our actual results could differ materially from the results described in or implied by these forward-looking statements.<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Overview</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell therapies for the treatment of cancer. Gamma-delta T cells are naturally occurring immune cells that embody properties of both the innate and adaptive immune systems, and can intrinsically differentiate between healthy and diseased tissue. These cells serve as a functional bridge between innate and adaptive immunity to contribute to direct tumor killing, as well as immune cell recruitment and activation to drive deeper immune responses. The pivotal role of gamma-delta T cells in immune function and activation, against diseases such as cancer, underscores their therapeutic potential across a wide range of solid and hematologic malignancies. We develop </font><font style="font-style:italic;">ex vivo</font><font style="letter-spacing:-0.025pt;">-expanded and activated gamma-delta T cell candidates based upon our deep expertise in gamma-delta T cell biology, proprietary genetic engineering and cell-type specific manufacturing capabilities, which we refer to collectively as our DeltEx platform. Our platform employs allogeneic, autologous and genetically modified approaches to develop novel cell therapies, which are designed to effectively identify and eradicate tumor cells. We are currently the most clinically advanced gamma-delta T cell company. Our lead product candidates are currently in Phase 1 clinical trials: INB-200, for the treatment of newly diagnosed glioblastoma, or GBM, and INB-100, for the treatment of patients with leukemia that are undergoing hematopoietic stem cell transplantation, or HSCT. For INB-200, we expect to report the initial results from the second cohort in this Phase 1 trial by the end of 2021 and initial Phase&#160;1 results from the third cohort in this Phase 1 trial in 2022. For INB-100, we expect to report initial results from the first cohort in our Phase 1 clinical trial in 2022, with topline results for all cohorts in 2023. In addition, our DeltEx platform has yielded a broad portfolio of preclinical programs, including INB-400 and INB-300, focused on addressing other solid tumor types. We expect to file three INDs for our pipeline product candidates in the first half of 2022 and in 2023 with a total of four planned INDs over the next three years, including one in an undisclosed indication.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Since inception in 2016, our operations have focused on identifying and developing potential product candidates, conducting clinical trials, organizing and staffing the company, business planning, establishing our intellectual property portfolio, raising capital, and providing general and administrative support for these operations. We do not have any product candidates approved for sale and have not generated any revenue. We have funded our operations primarily through the sale of equity and equity-linked securities. Since inception, we have raised an aggregate of $35.6&#160;million of gross proceeds from the sale of our securities.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We have incurred significant operating losses since our inception. Our ability to generate product revenue sufficient to achieve profitability will depend on the successful development and commercialization of one or more of our product candidates. Our net losses were $5.1&#160;million, $8.6&#160;million and $2.4&#160;million for the&#160;years ended December&#160;31, 2019 and 2020 and the three months ended March&#160;31, 2021, respectively. As of March&#160;31, 2021, we had an accumulated deficit of $20.4&#160;million. We expect to continue to incur significant expenses and increasing operating losses for the foreseeable future in connection with our ongoing activities.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We anticipate that our expenses and capital requirements will increase substantially in connection with our ongoing activities, particularly as we advance the preclinical activities and clinical trials of our product candidates. In addition, we expect to incur additional costs associated with operating as a public </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">71</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">company following the completion of this offering. We expect that our expenses and capital requirements will increase substantially if and as we:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">conduct our current and future clinical trials with INB-100 and INB-200;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.99pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">continue to develop our preclinical product candidates, INB-300 and INB-400;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">seek regulatory and marketing approvals for any of our current and future product candidates that successfully complete clinical trials;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.99pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">establish our manufacturing capability, including developing our contract development and manufacturing relationships, and building our internal manufacturing facilities;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.99pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">maintain, expand and protect our intellectual property portfolio;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">expand our operational, financial, and management systems and increase personnel, including personnel to support our preclinical and clinical development, manufacturing and commercialization efforts;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">establish a sales, marketing and distribution infrastructure in the future to commercialize any current or future product candidate for which we may obtain marketing approval;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.99pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.99pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">seek to identify, discover, develop and commercialize additional product candidates; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">incur additional legal, accounting or other expenses in operating our business, including the additional costs associated with operating as a public company.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We will need substantial additional funding to support our continuing operations and pursue our growth strategy. Until we can generate significant revenue from product sales, if ever, we expect to finance our operations through a combination of equity offerings, debt financings, collaborations or other strategic transactions. We may be unable to raise additional funds or enter into such other agreements or arrangements when needed on favorable terms, or at all. If we fail to raise capital or enter into such agreements as, and when, needed, we may have to significantly delay, scale back or discontinue the development and commercialization of one or more of our product candidates.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Based on our current operating plan, we believe that the net proceeds from this offering, together with our existing cash and cash equivalents, will be sufficient to fund our operating expenses and capital expenditure requirements through the first quarter of 2023. We have based this estimate on assumptions that may prove to be wrong, and we could exhaust our available capital resources sooner than we expect. See &#8220;&#8212;Liquidity and Capital Resources&#8221; below.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">COVID-19<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The ongoing COVID-19 pandemic, which began in December&#160;2019 and has spread worldwide, may continue to affect our ability to initiate and complete preclinical studies, delay the initiation of our planned clinical trials or future clinical trials or the progress or completion of our ongoing clinical trials, disrupt regulatory activities, or have other adverse effects on our business, results of operations, and financial condition. In addition, the pandemic has caused substantial disruption in the financial markets and may adversely impact economies worldwide, both of which could result in adverse effects on our business and operations and our ability to raise additional funds to support our operations.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We are continuing to monitor the potential impact of the COVID-19 pandemic on our business and financial statements. From December&#160;2020 through February&#160;2021, we experienced delays in additional patient enrollment in both of our ongoing Phase&#160;1 trials due to the second surge of the COVID-19 pandemic. In our INB-100 trial for leukemia patients, due to the risks of potential donor COVID-19 infection, making HSCs unavailable to patients who are undergoing a myeloablative process, necessitated a modification to our clinical protocol. We submitted a protocol modification to the FDA and IRB in January&#160;2021, and as of February&#160;2021, we were cleared to re-initiate enrollment of patients in the INB-100 trial. We are following, and will continue to follow, recommendations from the U.S. Centers for Disease Control and Prevention as well as federal, state, and local governments regarding working-from-home practices for non-essential employees as well as return-to-work policies and procedures. We expect to continue to take actions as may be required or recommended by government authorities or as we determine are in the best interests of our employees and other business partners in light of the pandemic.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">72</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We cannot be certain what the overall impact of the COVID-19 pandemic will be on our business, and it has the potential to adversely affect our business, financial condition, results of operations and prospects.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Components of Our Results of Operations</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Revenue<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Since inception, we have not generated any revenue and do not expect to generate any revenue from the sale of products in the foreseeable future. If our development efforts for one or more of our product candidates are successful and result in regulatory approval, or if we enter into collaboration or license agreements with third parties, we may generate revenue in the future from a combination of product sales or payments from collaboration or license agreements.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Operating Expenses<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Research and Development Expenses<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Research and development expenses consist primarily of costs incurred for our research activities, including our discovery efforts and the development of our product candidates, and include:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">employee-related expenses, including salaries, related-benefits and stock-based compensation expense for employees engaged in research and development functions;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">fees paid to consultants for services directly related to our product development and regulatory efforts;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">preclinical studies&#8212;expenses associated with conducting preclinical studies performed by ourselves, outside vendors or academic collaborators;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">expenses incurred under agreements with contract research organizations, or CROs, as well as contract manufacturing organizations, or CMOs, and consultants that conduct and provide supplies for our preclinical studies and clinical trials;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">costs associated with preclinical activities and development activities;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">costs associated with our intellectual property portfolio; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">costs related to compliance with regulatory requirements.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We expense research and development costs as incurred. Costs for external development activities are recognized based on an evaluation of the progress to completion of specific tasks using information provided to us by our vendors. Payments for these activities are based on the terms of the individual agreements, which may differ from the pattern of costs incurred, and are reflected in our financial statements as prepaid or accrued research and development expenses. Beginning with fiscal year 2020, we allocate our direct external research and development costs across each product candidate. Preclinical expenses consist of external research and development costs associated with activities to support our current and future clinical programs, but are not allocated by product candidate due to the overlap of the potential benefit of those efforts across multiple product candidates.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Research and development activities are central to our business. We expect that our research and development expenses will continue to increase for the foreseeable future as we continue clinical development for our product candidates and continue to discover and develop additional product candidates. If any of our product candidates enter into later stages of clinical development, they will generally have higher development costs than those in earlier stages of clinical development, primarily due to the increased size and duration of later-stage clinical trials.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">General and Administrative Expenses<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">General and administrative expenses consist primarily of salaries and other related costs, including stock-based compensation, for personnel in our executive and finance functions. General and administrative expenses also include professional fees for legal, accounting, auditing, tax and consulting services; travel expenses; and facility-related expenses, which include allocated expenses for rent and maintenance of facilities and other operating costs not included in research and development.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We expect that our general and administrative expenses will increase in the near-term as we continue to build a team to support our administrative, accounting and finance, communications, legal and business development efforts. Following this offering, we expect to incur increased expenses </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">73</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:23.37pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">associated with being a public company, including costs of accounting, audit, legal, regulatory and tax compliance services; director and officer insurance costs; and investor and public relations costs.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Results of Operations</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Comparison of the Three Months Ended March&#160;31, 2020 and 2021<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">The following table summarizes our results of operations for the three&#160;months ended March&#160;31, 2020 and 2021:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:127pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:278.74pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Three Months Ended March&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.88pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.88pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:278.74pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Change </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:278.74pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.88pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.88pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:278.74pt;text-align:left;">
              <font style="letter-spacing:-0.025pt;">Operating expenses: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:278.74pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.08pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">1,052</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.08pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">1,245</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">193</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:278.74pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.08pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">639</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.08pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">1,118</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.76pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">479</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:278.74pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Total operating expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.08pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">1,691</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.08pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">2,363</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.76pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">672</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:278.74pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Loss from operations </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.08pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(1,691<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.08pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(2,363<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.76pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(672<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:278.74pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.08pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">(1,691<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.08pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">(2,363<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.76pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(672<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:10.19pt; width:456pt; line-height:12pt;font-style:italic;">Research and Development Expenses<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">The following table summarizes our research and development expenses for the three&#160;months ended March&#160;31, 2020 and 2021:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:156pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:278.74pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Three Months Ended March&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.88pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.88pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:278.74pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Change </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:278.74pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.88pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.88pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:278.74pt;text-align:left;">
              <font style="letter-spacing:-0.111pt;">Direct research and development expenses: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:278.74pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">INB-100 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">102</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">67</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">(35<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:278.74pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">INB-200 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">3</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">7</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">4</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:278.74pt;text-align:left;">
              <font style="letter-spacing:-0.111pt;">Unallocated expenses </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.76pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:278.74pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Preclinical </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">291</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">166</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">(125<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:278.74pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Personnel expenses</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">439</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">712</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.76pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">273</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:278.74pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Facility related and other </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.41pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">217</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.41pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">293</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.76pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">76</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:278.74pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Total research and development expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.41pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">1,052</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.41pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">1,245</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.76pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">193</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:6.69pt; width:456pt;">
          <div style="margin-left: 0pt; width: 120pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:9.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:-0.02pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:10pt; text-align:left; margin-left:20pt;font-size:8pt;">
          <font style="letter-spacing:-0.02pt;">Includes stock-based compensation of $16,000 and $0.2&#160;million, respectively.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">Research and development expenses were $1.2&#160;million for the three&#160;months ended March&#160;31, 2021, compared to $1.0&#160;million for the three&#160;months ended March&#160;31, 2020. The increase of $0.2&#160;million was primarily a result of higher personnel-related costs due to an increase in stock-based compensation expense.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">General and Administrative Expenses<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">General and administrative expenses were $1.1&#160;million for the three&#160;months ended March&#160;31, 2021, compared to $0.6&#160;million for the three&#160;months ended March&#160;31, 2020. The increase of $0.5&#160;million was primarily a result of higher personnel-related costs due to an increase in stock-based compensation expense.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">74</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Comparison of the Years Ended December&#160;31, 2019 and 2020<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The following table summarizes our results of operations for the&#160;years ended December&#160;31, 2019 and 2020:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:142pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:295.52pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Year ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:295.52pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Change </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:295.52pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">(in thousands)</font>
              </div>
            </td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:295.52pt;text-align:left;">
              <font style="letter-spacing:-0.025pt;">Operating expenses: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:295.52pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">2,358</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">5,378</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">3,020</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:295.52pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">2,708</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">3,179</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">471</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:295.52pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Loss on disposal of equipment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">68</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(68<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:295.52pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Total operating expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">5,134</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">8,557</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">3,423</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:295.52pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Loss from operations </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(5,134<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(8,557<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(3,423<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:295.52pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">(5,134<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.41pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">(8,557<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">(3,423<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:8.9pt; width:456pt; line-height:12pt;font-style:italic;">Research and Development Expenses<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The following table summarizes our research and development expenses for the&#160;years ended December&#160;31, 2019 and 2020:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:156pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:298.85pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Year ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt;border-bottom:1px solid #FFFFFF; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:298.85pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Change </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:298.85pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">(in thousands)</font>
              </div>
            </td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:298.85pt;text-align:left;">
              <font style="letter-spacing:-0.111pt;">Direct research and development expenses:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:298.85pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">INB-100 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">706</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">706</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:298.85pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">INB-200 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">689</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">689</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:298.85pt;text-align:left;">
              <font style="letter-spacing:-0.111pt;">Unallocated expenses</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:298.85pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Preclinical </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">595</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">1,319</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">724</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:298.85pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Personnel expenses</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">1,144</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">1,687</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">543</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:298.85pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Facility related and other </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.74pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">619</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.74pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">977</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">358</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:298.85pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Total research and development expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.74pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">2,358</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.74pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">5,378</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">3,020</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:5.4pt; width:456pt;">
          <div style="margin-left: 0pt; width: 120pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:-0.02pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:8pt; text-align:left; margin-left:20pt;font-size:8pt;">
          <font style="letter-spacing:-0.02pt;">Includes stock-based compensation of $0.2&#160;million.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:7.9pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Research and development expenses were $2.4&#160;million for the year ended December&#160;31, 2019, compared to $5.4&#160;million for the year ended December&#160;31, 2020. The increase of $3.0&#160;million was primarily due to $1.4&#160;million for the continued development and the advancement of INB-100 and INB-200 into Phase&#160;1 clinical trials, $0.7&#160;million in preclinical expenses related to additional reagents and laboratory supplies in preparation of any additional impacts of the ongoing COVID-19 pandemic on our operations and supply chains, $0.5&#160;million in personnel expenses which was primarily due to an increase in stock-based compensation expense, and $0.4&#160;million in facility and other expenses related to office space.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">General and Administrative Expenses<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">General and administrative expenses were $2.7&#160;million for the year ended December&#160;31, 2019, compared to $3.2&#160;million for the year ended December&#160;31, 2020. The increase of $0.5&#160;million was primarily due to increased personnel expenses of $0.4&#160;million and other expenses of $0.1&#160;million.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Liquidity and Capital Resources</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">To date we have funded our operations primarily through the sale of equity and equity-linked securities. Through March&#160;31, 2021, we have raised an aggregate of $35.6&#160;million of gross proceeds from the sale of our securities. As of March&#160;31, 2021, we had cash of $15.1&#160;million. Our net loss was $5.1&#160;million, $8.6&#160;million and $2.4&#160;million for the&#160;years ended December&#160;31, 2019 and 2020 and the three </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">75</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">months ended March&#160;31, 2021, respectively. As of March&#160;31, 2021, we had an accumulated deficit of $20.4&#160;million. Since our inception, we have not generated any revenue from product sales and have incurred significant operating losses and negative cash flows from our operations. We have not yet commercialized any of our product candidates, which are in various phases of preclinical and clinical development, and we do not expect to generate revenue from sales of any products for the foreseeable future, if at all. Since our inception, we have incurred losses and negative cash flows from operations and expect these conditions to continue for the foreseeable future.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Cash Flows<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="margin-left:20pt; margin-top:2pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The following table summarizes our cash flows for each of the periods presented:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:105pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:243.63pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Year ended December&#160;31,</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Three Months Ended </font>
                <br >
                <font style="letter-spacing:-0.089pt;">March&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:243.63pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">2020</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:243.63pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">(in thousands)</font>
              </div>
            </td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:243.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Net cash used in operating activities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(4,801<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">(7,133<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(1,623<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(2,507<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:243.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Net cash provided by investing activities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">356</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:243.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Net cash provided by (used in) financing activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.29pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">65</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.29pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">24,517</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">5,680</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(435<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:243.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Net (decrease) increase in cash and restricted cash </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.29pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">(4,380<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.29pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">17,384</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">4,057</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">(2,942<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:8.6pt; width:456pt; line-height:12pt;font-style:italic;">Operating Activities<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">During the three&#160;months ended March&#160;31, 2020, net cash used in operating activities was $1.6&#160;million, primarily due to our net loss of $1.7&#160;million offset by an increase of $0.1&#160;million in prepaid expenses and other current assets.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">During the three&#160;months ended March&#160;31, 2021, net cash used in operating activities was $2.5&#160;million, primarily due to our net loss of $2.4&#160;million and decrease in our operating assets and liabilities of $0.7&#160;million partially offset by increases in non-cash charges of $0.5&#160;million. Decreases in our operating assets and liabilities consisted primarily of $0.3&#160;million in accrued expenses and other current liabilities, $0.2&#160;million increase in accounts payable and a decrease of $0.1&#160;million in prepaid expenses and other current assets. Increases in our non-cash charges consisted primarily of $0.4&#160;million in stock-based compensation.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">During the year ended December&#160;31, 2019, net cash used in operating activities was $4.8&#160;million, primarily due to our net loss of $5.1&#160;million partially offset by increases in our operating assets and liabilities of $0.3&#160;million. Increases in our operating assets and liabilities consisted primarily of $0.1&#160;million prepaid expenses, $0.1&#160;million other current assets, and $0.1&#160;million increase in accounts payable and accrued expenses and other current liabilities of $0.1&#160;million.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">During the year ended December&#160;31, 2020, net cash used in operating activities was $7.1&#160;million, primarily due to our net loss of $8.6&#160;million partially offset by increases in our operating assets and liabilities of $0.6&#160;million and increases in non-cash charges of $0.9&#160;million. Increases in our operating assets and liabilities consisted primarily of $0.8&#160;million in accrued expenses and other current liabilities offset by a $0.2&#160;million decrease in accounts payable. Increases in our non-cash charges consisted primarily of $0.4&#160;million in stock-based compensation, $0.4&#160;million in non-cash common stock issuances, and $0.1 million in depreciation.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Investing Activities</div>
        <div style="margin-left:20pt; margin-top:2pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">There were no investing activities during the three&#160;months ended March&#160;31, 2020 and 2021.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Net cash provided by investing activities during the year ended December&#160;31, 2019 was $0.4&#160;million, primarily due to $0.7&#160;million for the disposal of property and equipment, partially offset by $0.3&#160;million for the purchase of property and equipment.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">There were no investing activities during the year ended December&#160;31, 2020.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Financing Activities</div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">During the three&#160;months ended March&#160;31, 2020, net cash provided by financing activities was $5.7&#160;million primarily due to the sale of Series&#160;A Preferred Stock.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">76</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">During the three&#160;months ended March&#160;31, 2021, net cash used by financing activities was $0.4&#160;million from the payment of deferred offering costs and payment of financing lease obligations.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">During the year ended December&#160;31, 2019, net cash provided by financing activities was $0.1&#160;million from the proceeds of the exercise of employee stock options.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">During the year ended December&#160;31, 2020, net cash provided by financing activities was $24.5&#160;million primarily due to the sale of Series&#160;A Preferred Stock.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Funding Requirements<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our plan of operation is to continue implementing our business strategy, continue research and development of INB-100 and INB-200 and our other product candidates and continue to expand our research pipeline and our internal research and development capabilities. We expect our expenses to increase substantially in connection with our ongoing activities, particularly as we advance the preclinical activities and clinical trials of our product candidates. In addition, we expect to incur additional costs associated with operating as a public company following the completion of this offering. Our future capital requirements will depend on many factors, including:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the scope, timing, progress, costs, and results of discovery, preclinical development, and clinical trials for our current and future product candidates;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the number of clinical trials required for regulatory approval of our current and future product candidates;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the costs, timing, and outcome of regulatory review of any of our current and future product candidates;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the cost of manufacturing clinical and commercial supplies of our current and future product candidates;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the costs and timing of future commercialization activities, including manufacturing, marketing, sales, and distribution, for any of our product candidates for which we receive marketing approval;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the costs and timing of preparing, filing, and prosecuting patent applications, maintaining and enforcing our intellectual property rights, and defending any intellectual property-related claims, including any claims by third parties that we are infringing upon their intellectual property rights;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our ability to maintain existing, and establish new, strategic collaborations, licensing, or other arrangements and the financial terms of any such agreements, including the timing and amount of any future milestone, royalty, or other payments due under any such agreement;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the revenue, if any, received from commercial sales of our product candidates for which we receive marketing approval;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">expenses to attract, hire and retain, skilled personnel;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the costs of operating as a public company;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our ability to establish a commercially viable pricing structure and obtain approval for coverage and adequate reimbursement from third-party and government payers;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">addressing any potential interruptions or delays resulting from factors related to the ongoing COVID-19 pandemic;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the effect of competing technological and market developments; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the extent to which we acquire or invest in businesses, products and technologies.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">A change in the outcome of any of these variables with respect to the development of a product candidate could mean a significant change in the costs and timing associated with the development of that product candidate. As of March&#160;31, 2021, we had cash of $15.1&#160;million. Based on our research and development plans, we believe that the net proceeds from this offering, together with our existing cash, will be sufficient to fund our operations the first quarter of 2023. We have based this estimate on assumptions that may prove to be wrong, and we could exhaust our available capital resources sooner than we expect.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Until such time as we can generate significant revenue from product sales, if ever, we expect to finance our operations from the sale of additional equity or debt financings, or other capital which </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">77</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">comes in the form of strategic collaborations, licensing, or other arrangements. In the event that additional financing is required, we may not be able to raise it on terms acceptable to us, or at all. If we raise additional funds through the issuance of equity or convertible debt securities, it may result in dilution to our existing stockholders. Debt financing or preferred equity financing, if available, may result in increased fixed payment obligations, and the existence of securities with rights that may be senior to those of our common stock. If we incur indebtedness, we could become subject to covenants that would restrict our operations.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">If we raise funds through strategic collaboration, licensing or other arrangements, we may relinquish significant rights or grant licenses on terms that are not favorable to us. Our ability to raise additional funds may be adversely impacted by potential worsening global economic conditions and the recent disruptions to, and volatility in, the credit and financial markets in the United States and worldwide resulting from the ongoing COVID-19 pandemic and otherwise. If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit, reduce or terminate our product development or future commercialization efforts or grant rights to develop and market products or product candidates that we would otherwise prefer to develop and market ourselves.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Contractual Obligations and Commitments</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The following table summarizes our contractual obligations and commitments as of December&#160;31, 2020:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:76.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:231.63pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="28">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Payments Due by Period </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:231.63pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Less than</font>
                <br >
                <font style="letter-spacing:-0.089pt;">1 Year </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">1 to 3</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Years </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">4 to 5</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Years </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">More than</font>
                <br >
                <font style="letter-spacing:-0.089pt;">5 Years </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:231.63pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="28">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:231.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Operating lease commitments </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">2,266</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.1pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:15pt; text-align:right; white-space:nowrap;">832</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">1,157</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8199;277</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.02pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8199;&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:231.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">2,266</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.1pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:15pt; text-align:right; white-space:nowrap;">832</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">1,157</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8199;277</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.02pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8199;&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.6pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Except as disclosed in the table above, we have no long-term debt or capital leases and no material non-cancelable purchase commitments with service providers, as we have generally contracted on a cancelable, purchase-order basis. We enter into contracts in the normal course of business with equipment and reagent vendors, CROs, CMOs and other third parties for clinical trials, preclinical research studies and testing and manufacturing services. These contracts are cancelable by us upon prior notice. Payments due upon cancellation consist only of payments for services provided or expenses incurred, including noncancelable obligations of our service providers, up to the date of cancellation. These payments are not included in the preceding table as the amount and timing of such payments are not known.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Critical Accounting Policies and Significant Judgments and Estimates</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our management&#8217;s discussion and analysis of financial condition and results of operations is based on our financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles, or U.S. GAAP. The preparation of our financial statements and related disclosures requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, costs and expenses and the disclosure of contingent assets and liabilities in our financial statements. We base our estimates on historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions or conditions.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">While our significant accounting policies are described in greater detail in Note 2 to our financial statements appearing elsewhere in this prospectus, we believe that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our financial statements. </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Research and Development Costs<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We expense all costs in performing research and development activities in the periods in which they are incurred. Research and development expenses include salaries and benefits, stock-based </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">78</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">compensation expense, lab supplies and facility costs, as well as fees paid to nonemployees and entities that conduct certain research and development activities on the Company&#8217;s behalf and expenses incurred in connection with license agreements. Non-refundable advance payments for goods or services that will be used for rendered or future research and development activities are deferred and amortized over the period that the goods are delivered, or the related services are performed, subject to an assessment of recoverability.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">As part of the process of preparing our financial statements, we are required to estimate our accrued research and development expenses. We make estimates of our accrued expenses as of each balance sheet date in the financial statements based on facts and circumstances known to us at that time. There may be instances in which payments made to our vendors will exceed the level of services provided and result in a prepayment of the expense. In accruing service fees, we estimate the time period over which services will be performed and the level of effort to be expended in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, we adjust the accrual or the amount of prepaid expenses accordingly. Although we do not expect our estimates to be materially different from amounts actually incurred, our understanding of the status and timing of services performed relative to the actual status and timing of services performed may vary and may result in reporting amounts that are too high or too low in any particular period. To date, there have not been any material adjustments to our prior estimates of accrued research and development expenses.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Stock-Based Compensation<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We account for our stock-based compensation as expense in the statements of operations based on the awards&#8217; grant date fair values. We account for forfeitures as they occur by reversing any expense recognized for unvested awards.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We estimate the fair value of options granted using the Black-Scholes option pricing model. The Black-Scholes option pricing model requires inputs based on certain subjective assumptions, including (a)&#160;the expected stock price volatility, (b)&#160;the calculation of expected term of the award, (c)&#160;the risk-free interest rate and (d)&#160;expected dividends. Due to the lack of a public market for our common stock and a lack of company-specific historical and implied volatility data, we have based our estimate of expected volatility on the historical volatility of a group of similar companies that are publicly traded. The historical volatility is calculated based on a period of time commensurate with the expected term assumption. The computation of expected volatility is based on the historical volatility of a representative group of companies with similar characteristics to us, including stage of product development and life science industry focus. We use the simplified method as allowed by the Securities and Exchange Commission, or SEC, Staff Accounting Bulletin, or SAB, No. 107, </font><font style="font-style:italic;">Share-Based Payment</font><font style="letter-spacing:-0.025pt;">, to calculate the expected term for options granted to employees as we do not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected term of the stock options. The expected dividend yield is assumed to be zero as we have never paid dividends and have no current plans to pay any dividends on our common stock. The fair value of stock-based payments is recognized as expense over the requisite service period which is generally the vesting period.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Determination of the Fair Value of Common Stock<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">As there has been no public market for our common stock to date, the estimated fair value of our common stock has been determined by our board of directors, with input from management, considering third-party valuations of our common stock as well as our board of directors&#8217; assessment of additional objective and subjective factors that it believed were relevant and which may have changed from the date of the most recent third-party valuation through the date of the option grant. These third-party valuations were performed in accordance with the guidance outlined in the American Institute of Certified Public Accountants&#8217; Accounting and Valuation Guide, </font><font style="font-style:italic;">Valuation of Privately-Held-Company Equity Securities Issued as Compensation</font><font style="letter-spacing:-0.025pt;">.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In addition to considering the results of these third-party valuations, our board of directors considered various objective and subjective factors to determine the fair value of our common stock as of each grant date, including:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the prices at which we sold shares of preferred stock and the superior rights and preferences of the preferred stock relative to our common stock at the time of each grant;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">79</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the progress of our research and development programs, including the status and results of preclinical studies for our product candidates;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:3.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:3.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our stage of development and commercialization and our business strategy;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:3.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:3.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">external market conditions affecting the biotechnology industry and trends within the biotechnology industry;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:3.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:3.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our financial position, including cash on hand, and our historical and forecasted performance and operating results;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:3.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:3.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the lack of an active public market for our common stock and our preferred stock;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:3.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:3.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the likelihood of achieving a liquidity event, such as an initial public offering, or sale of our company in light of prevailing market conditions; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:3.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:3.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the analysis of initial public offerings and the market performance of similar companies in the biotechnology industry.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">The assumptions underlying these valuations represented management&#8217;s best estimate, which involved inherent uncertainties and the application of management&#8217;s judgment. As a result, if we had used different assumptions or estimates, the fair value of our common stock and our stock-based compensation expense could have been materially different.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">Following the completion of this offering, the fair value of our common stock will be determined based on the quoted market price of our common stock on the date of option grant.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Options Granted<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">The following table sets forth, by grant date, the number of shares subject to options granted from January&#160;1, 2020 through the date of this prospectus, the per share exercise price of the options, the fair value of common stock per share on each grant date, and the per share estimated fair value of the options:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:110.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:0pt 0pt 2.167pt 0pt; width:167.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-right:1pt;letter-spacing:-0.089pt;">Grant Date </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Number of Common</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Shares Subject</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:2pt;padding-right:2pt;letter-spacing:-0.089pt;">to Options Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Exercise</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Price per</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;letter-spacing:-0.089pt;">Common Share </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Estimated</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Per-Share</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Fair Value</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;letter-spacing:-0.089pt;">of Options </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Estimated</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Fair Value</font>
                <br >
                <font style="letter-spacing:-0.089pt;">per Common Share</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:12pt;padding-right:12pt;letter-spacing:-0.089pt;">at Grant Date </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:167.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">February&#160;3, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:41.33pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,825</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:34.01pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.10</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.57pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.96</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:48.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.10</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:167.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">May&#160;5, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:41.33pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">28,287</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:34.01pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.23</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.57pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.96</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:48.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.23</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:167.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">October&#160;5, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:41.33pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">896,628</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:34.01pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">6.74</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.57pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">4.79</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:48.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">6.74</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:167.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">October&#160;15, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:41.33pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">3,066</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:34.01pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">6.74</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.57pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">4.79</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:48.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">6.74</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:167.25pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">February&#160;1, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:41.33pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">305,132</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:34.01pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5.36</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.57pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">4.02</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:48.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5.36</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:13.2pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Off-Balance Sheet Arrangements</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We have not entered into any off-balance sheet arrangements and do not have any holdings in variable interest entities.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Recently Issued Accounting Pronouncements</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">A description of recently issued accounting pronouncements that may potentially impact our financial position and results of operations is disclosed in Note 2 to our financial statements appearing elsewhere in this prospectus.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Quantitative and Qualitative Disclosures about Market Risks</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">We are exposed to market risks in the ordinary course of our business. These risks primarily include interest rate sensitivities. As of March&#160;31, 2021, we had cash of $15.1&#160;million. Our exposure to interest rate sensitivity is impacted by changes in the underlying U.S. bank interest rates but is minimal. We have not entered into investments for trading or speculative purposes.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">80</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:448pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Emerging Growth Company Status</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The Jumpstart Our Business Startups Act of 2012, or the JOBS Act, permits that an &#8220;emerging growth company&#8221; may take advantage of the extended transition period to comply with new or revised accounting standards applicable to public companies until those standards would otherwise apply to private companies. We have elected to use the extended transition period under the JOBS Act. Accordingly, our financial statements may not be comparable to the financial statements of public companies that comply with such new or revised accounting standards. The JOBS Act also exempts us from having to provide an auditor attestation of internal control over financial reporting under Sarbanes-Oxley Act Section&#160;404(b).</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We will remain an &#8220;emerging growth company&#8221; until the earliest of: the last day of the fiscal year in which we have more than $1.07&#160;billion in annual revenue; the date we qualify as a &#8220;large accelerated filer,&#8221; with at least $700.0&#160;million of equity securities held by non-affiliates; the issuance, in any three-year period, by us of more than $1.0&#160;billion in non-convertible debt securities; and the last day of the fiscal year ending after the fifth anniversary of our initial public offering.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">81</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tBUS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:44pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">BUSINESS</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Overview</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell therapies for the treatment of cancer. Gamma-delta T cells are naturally occurring immune cells that embody properties of both the innate and adaptive immune systems, and can intrinsically differentiate between healthy and diseased tissue. These cells serve as a functional bridge between innate and adaptive immunity to contribute to direct tumor killing, as well as immune cell recruitment and activation to drive deeper immune responses. The pivotal role of gamma-delta T cells in immune function and activation, against diseases such as cancer, underscores their therapeutic potential across a wide range of solid and hematologic malignancies. We develop </font><font style="font-style:italic;">ex vivo</font><font style="letter-spacing:-0.025pt;">-expanded and activated gamma-delta T cell candidates based upon our deep expertise in gamma-delta T cell biology, proprietary genetic engineering and cell-type specific manufacturing capabilities, which we refer to collectively as our DeltEx platform. Our platform employs allogeneic, autologous and genetically modified approaches to develop novel cell therapies, which are designed to effectively identify and eradicate tumor cells. We are currently the most clinically advanced gamma-delta T cell company. Our lead product candidates are currently in Phase&#160;1 clinical trials: INB-200, for the treatment of newly diagnosed glioblastoma, or GBM, and INB-100, for the treatment of patients with leukemia that are undergoing hematopoietic stem cell transplantation, or HSCT. For INB-200, we expect to report the initial results from the second cohort in this Phase&#160;1 trial by the end of 2021 and initial Phase 1 results from the third cohort in this Phase 1 trial in 2022. For INB-100, we expect to report initial results from the first cohort in our Phase&#160;1 clinical trial in 2022, with topline results for all cohorts in 2023. In addition, our DeltEx platform has yielded a broad portfolio of preclinical programs, including INB-400 and INB-300, focused on addressing other solid tumor types. We expect to file three INDs for our pipeline product candidates in the first half of 2022 and in 2023.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Chemotherapy, a mainstay of solid tumor treatment, can deplete and damage immune cells, limiting their ability to seek and kill tumors. Despite these limitations, chemotherapy continues to be used in standard-of-care regimens because of its ability to directly kill tumors. However, residual tumor cells, which are chemotherapy resistant, often remain and lead to disease recurrence. This is further compounded by the lymphodepleting properties of chemotherapy, which can severely reduce the number of immune cells, such as gamma-delta T cells, that can seek out and kill the residual tumor cells. We have leveraged our proprietary genetic modifications of gamma-delta T cells to protect the cells from chemotherapy-induced damage, potentially allowing for their concurrent delivery with chemotherapy. This could potentially enable our candidates to recognize and kill residual tumor cells, including chemotherapy resistant cells, by attacking at the time when the tumor is experiencing maximum chemotherapy-induced stress and vulnerability. We have termed this approach as our &#8220;DeltEx drug resistant immunotherapy,&#8221; or DeltEx DRI, and it is the basis for several of our programs, including INB-200. We are the first company to advance genetically modified gamma-delta T cells into the clinic. In order to develop an off-the-shelf therapy, we are testing the safety of a donor-derived, expanded, activated, non-genetically modified gamma-delta T cell therapeutic candidate for the treatment of leukemia.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Our DeltEx platform is designed to overcome many of the challenges associated with the expansion, genetic engineering and scalable manufacturing of gamma-delta T cells. This approach allows us to expand the cells </font><font style="font-style:italic;">ex vivo</font><font style="letter-spacing:-0.025pt;"> to administer a potentially therapeutic dose to patients, harnessing the unique properties of gamma-delta T cells, including their ability to broadly recognize cellular stress signals on tumor cells. We have used the DeltEx platform to create our deep pipeline of innovative allogeneic, autologous and/or genetically modified product candidates designed to effectively target and potentially eradicate disease and improve patient outcomes. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">82</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The following chart shows the developmental status of our clinical and preclinical product candidates, all of which are wholly owned:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:9.9pt; width:456pt;">
          <img src="tm2030088d23-fc_overv4c.jpg" alt="[MISSING IMAGE: tm2030088d23-fc_overv4c.jpg]" height="283" width="608" >
        </div>
        <div style="margin-top:12.8pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 1. Pipeline Chart</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">To date, cell therapies utilizing chimeric antigen receptor T cells, or CAR-T cells, while impactful in liquid tumors, have demonstrated limited efficacy in the treatment of solid tumors. The American Cancer Society estimates that there are 1.7&#160;million new solid tumor cases annually in the United States, nine times the rate of blood cancers. This represents a high unmet medical need not adequately addressed by current cell therapies in development. One of our lead candidates, INB-200, is a genetically modified autologous gamma-delta T cell product candidate in Phase&#160;1 development. Our initial indication is newly diagnosed glioblastoma, or GBM, for which the standard-of-care has been largely unchanged since the implementation of the Stupp regimen, surgical resection followed by radiation and chemotherapy, in 2005. Despite current treatments, the majority of patients relapse within one year, with very few patients surviving beyond five&#160;years. We engineered INB-200 to be resistant to alkylating agents, a class of chemotherapeutic drugs used in the treatment of GBM and other cancers. This could allow INB-200 to be administered as an adjuvant to the current standard-of-care in the newly diagnosed treatment setting. In preclinical studies, our DeltEx DRI technology has been shown to maintain immune cell function in toxic chemotherapeutic environments, demonstrating potential to be used concomitantly in combination with chemotherapy for the treatment of multiple solid tumor cancers. We are conducting a Phase&#160;1 repeat dose escalation clinical trial of INB-200 in newly diagnosed GBM patients at the O&#8217;Neal Comprehensive Cancer Center at the University of Alabama at Birmingham, or UAB. We expect to report the initial results from the second cohort in this Phase&#160;1 trial by the end of 2021.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We are also seeking to develop off-the-shelf DeltEx therapeutic candidates, which has led to our first allogeneic clinical program, INB-100, to demonstrate the safety of donor derived gamma-delta T cells. This therapeutic candidate is in initial development for the treatment of patients with leukemia that are undergoing HSCT. The number of HSCT procedures has been increasing over the last 20&#160;years, with more than 9,000 patients treated in the United States in 2018. Acute myeloid leukemia, or AML, and acute lymphoblastic leukemia, or ALL, represent two of the three most common allogeneic HSCT-treated cancers, accounting for approximately 50% of all allogeneic HSCTs. We have developed scalable methods to expand and activate gamma-delta T cells from peripheral blood in an automated manufacturing device. Prior clinical observations have shown that high numbers of circulating gamma-delta T cells have been correlated with improved survival outcomes in HSCT patients. The potential ability of INB-100 to kill residual leukemic cells, coupled with historically observed survival benefits, may reduce leukemic relapse in HSCT patients. We are conducting a Phase&#160;1 dose-escalation clinical trial of INB-100 in allogeneic HSCT patients at the University of Kansas Cancer Center. We currently expect to report initial data from the first cohort in this trial in 2022, and topline data from all cohorts in 2023.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">83</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">INB-400 is our first program developing allogeneic DeltEx therapeutic candidates for solid tumor cancers. We plan to utilize clinical data from our ongoing Phase&#160;1 clinical trials of INB-200 and INB-100 to provide the safety data necessary to support submission of an investigational new drug application, or IND, for INB-400, by first half of 2022 to initiate a clinical trial for the treatment of newly diagnosed GBM. INB-300 is our second preclinical program focused on developing DeltEx DRI product candidates with an added CAR, for which we expect to target certain brain tumors and other solid tumor cancers.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We are also developing a broad portfolio of preclinical programs focused on expanding the application of our DeltEx platform into other solid tumor types, as well as combinations with other therapies approved by the U.S. Food and Drug Administration, or FDA, to enhance their antitumor activity. We believe that our preclinical data support the development of DeltEx DRI gamma-delta T cells in combination with approved therapies, such as checkpoint inhibitors and inhibitors of DNA damage repair, or DDR, pathways, such as poly (ADP-ribose) polymerase, or PARP, inhibitors. Our future product candidates could incorporate additional proprietary genetic alterations designed to make them resistant to the chemotherapies utilized to treat multiple types of solid tumor cancers.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">As of June 30, 2021, our intellectual property portfolio currently consists of seven patent families that broadly protect our DeltEx platform and our product candidates, both through composition of matter and method of use. Our patents broadly cover any genetic modification to gamma-delta T-cells that confers chemotherapy resistance. They also cover the method of generating these genetically engineered cells from patients or donors and their use in multiple solid and liquid tumors. Our portfolio broadly covers the use of allogeneic gamma-delta T cells in HSCT. Finally, we have patent families that cover the composition of our CAR constructs in gamma-delta T cells, specifically in our DeltEx DRI cells, and their use in multiple solid and liquid tumors.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We have assembled a team of experts in the discovery and development of gamma-delta T cell-based therapies. We are led by William Ho, our founder and Chief Executive Officer, who has 20&#160;years of combined experience in the management of biotechnology companies and healthcare finance and investing. Our scientific founder and Chief Scientific Officer, Dr.&#160;Lawrence Lamb, a pioneer in the field of gamma-delta T cell biology and manufacturing, published the foundational work that identified the potential antileukemic effect of these cells and their association with improved overall survival. Dr.&#160;Lamb was the first to describe the cell-type specific expansion of Vd1+ gamma-delta T cells in the 1990s, and his expertise has led to the development of our DeltEx platform. Dr.&#160;Lamb also chairs our Scientific Advisory Board, which includes a globally renowned group of clinicians, oncologists and immunologists. Patrick McCall, CPA, our Chief Financial Officer, previously served as Vice President of Finance at Turnstone Biologics Inc., where he managed strategic and financial operations and supported investor relations. Dr.&#160;Kate Rochlin, our Vice President, Operations and Innovation, is an accomplished scientist and entrepreneur with 14&#160;years of experience in research, development and operations, previously serving as Chief Business Officer at Cambridge-based Curadigm.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Our Strategy</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We are dedicated to leveraging our DeltEx platform to develop next generation cell therapies that we believe can dramatically improve outcomes for cancer patients. To achieve this goal, our strategy is as follows:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="font-style:italic;font-weight:bold;">Continue advancing our lead clinical product candidates, INB-200 and INB-100.</font><font style="letter-spacing:-0.025pt;">&nbsp;&nbsp;&nbsp;INB-200 is our lead autologous DeltEx DRI program that we are initially developing for the treatment of newly diagnosed GBM. We are conducting an ongoing Phase&#160;1 repeat dose escalation clinical trial at the O&#8217;Neal Comprehensive Cancer Center at UAB. We expect to report initial results from the second cohort in this Phase&#160;1 trial by the end of 2021. We are also conducting a Phase&#160;1 dose escalation clinical trial of INB-100, our allogeneic DeltEx product candidate in allogeneic HSCT patients, from which we currently expect to report initial results from the first cohort in 2022 and topline results from all cohorts in 2023.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="font-style:italic;font-weight:bold;">Advance INB-400 and INB-300 into clinical development, subject to receiving authorization from FDA pursuant to INDs</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;We plan to submit an IND for INB-400, our first allogeneic DeltEx DRI therapy for solid tumors, in the first half of 2022. We intend to leverage the clinical data from our ongoing Phase&#160;1 clinical trials, INB-200 and INB-100, to provide the </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">84</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">safety data necessary to support the IND submission in newly diagnosed GBM. INB-300 is a DeltEx DRI with a chlorotoxin CAR, for which a construct has been created and we are testing its ability to kill various tumors in preclinical studies.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:3.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:3.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="font-style:italic;font-weight:bold;">Leverage our DeltEx platform for additional indications and product candidates.</font><font style="letter-spacing:-0.025pt;">&nbsp;&nbsp;&nbsp;We will continue to advance internal research including the application of our proprietary DeltEx DRI approach into additional solid tumor indications. We are also developing additional discovery programs that could incorporate additional proprietary genetic modifications in our DeltEx platform designed to address both solid and liquid tumors. We expect to submit three additional INDs using INB-200 in combination with other therapeutics for cancer over the next few&#160;years. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:3.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:3.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="font-style:italic;font-weight:bold;">Advance and continue to scale our manufacturing.</font><font style="letter-spacing:-0.025pt;">&nbsp;&nbsp;&nbsp;We have established an automated, closed-system, reproducible, scalable manufacturing platform. We will continue to focus on expanding manufacturing capacity and capabilities to support our ongoing and anticipated clinical development. In addition to using collaborators and contract manufacturers, we plan to build internal manufacturing capabilities as we demonstrate clinical proof-of-concept, leveraging our company know-how and collaborators for product delivery, logistics and capacity expansion across our parallel processes.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:3.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:3.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="font-style:italic;font-weight:bold;">Independently develop and commercialize our product candidates where we believe we can maximize their value and benefit to patients.</font><font style="letter-spacing:-0.025pt;">&nbsp;&nbsp;&nbsp;Given the broad applicability of our DeltEx technology pipeline across multiple solid and liquid tumor indications, we plan to maximize its value by retaining development and commercialization rights to the product candidates, indications and geographies that we believe we can commercialize successfully on our own, pending regulatory approval. We plan to collaborate on candidates that show promising utility in disease indications, patient populations or geographies that we believe would be better served by the resources, specific expertise or commercial abilities of other biopharmaceutical companies or partners.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Gamma-Delta T Cells: Leveraging the Nexus of the Immune System</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">The Rise of Cell Therapy<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">There has been significant recent innovation in the treatment of cancer, including novel biological and cell therapies. Immuno-oncology, utilizes the immune system to identify and kill cancer cells. Such therapies can either prevent the tumor&#8217;s ability to suppress immune attack or to directly utilize immune cells to target and kill cancer cells. The immune system consists of complex and highly evolved cells that have the ability to target dangerous pathogens and damaged or sick tissue to keep the body safe. The system is generally comprised of two functional branches, the innate and the adaptive. The innate immune system consists of natural killer, or NK cells, dendritic and other cell types, and is the first line of defense for the body. It mobilizes rapidly and alerts other elements of the immune system so that they can become active. The innate immune system is primarily activated by broadly-expressed stress signals caused by pathogen invasion, tissue damage or cellular transformation. Once the innate immune system has been activated, chemokine signaling orchestrates the interaction between the innate and adaptive immune systems to send effector cells to seek out and destroy specific antigens and the cells that express them. The adaptive immune system is primarily comprised of alpha-beta T cells and B cells that deepen and narrow the response to the specific peptide or antibody target. The adaptive immune response is specific and potent with the ability to provide long-lasting immune memory.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">The innate and adaptive immune responses both play critical roles in the fight against cancer. While both systems possess critical functions, the most effective tumor killing occurs when they work in concert. As shown in Figure 2 below, gamma-delta T cells sit at the nexus of the two systems and possess a powerful combination of both innate and adaptive cell properties. They can directly kill without previous antigen priming similar to certain innate cells, such as NK cells, but can also function to present antigen directly to drive cytokine release and to target neoantigens through antigen mediated cell killing. Gamma-delta T cells are endowed with at least two independent recognition systems to sense tumor cells and to initiate anticancer killing by recruiting and activating multiple immune cell types.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">85</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="tm2030088d18-fc_rise4c.jpg" alt="[MISSING IMAGE: tm2030088d18-fc_rise4c.jpg]" height="324" width="608" >
        </div>
        <div style="margin-top:12.8pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 2. Gamma-Delta T Cells: Innate and Adaptive Immune System Characteristics</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Cellular immunotherapy is a type of immuno-oncology therapy whereby human immune cells are enhanced to boost immune function to fight cancer. These cells can be unmodified or genetically modified to enhance some aspect of tumor recognition, binding or the direct killing of cancer cells. Most cell therapy approaches utilize either the adaptive immune system, such as alpha-beta T cells, or the innate immune system, such as NK cells. These approaches have certain inherent limitations, particularly against solid tumors. We believe that gamma-delta T cell therapeutics can overcome many of these challenges due to their unique properties and role across both sides of the immune system.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Inherent Limitations of Current Cell Therapy Approaches<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">A common approach in cell therapy involves the use of genetically engineered CARs on a T or NK cell that enable it to recognize a specific protein or antigen that may be present on the surface of tumor cells. The CAR bypasses the normal biology of T and NK cells, by driving their activation through the binding of the CAR-directed antigen. While effective for direct antigen recognition, the inherent heterogeneity of solid tumors means that it is unlikely that any single antigen will be expressed by all tumor cells.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Since 2017, FDA has approved five autologous CAR-T cell therapies, Kymriah&#174;, Yescarta&#174;, Breyanzi&#174;, Abecma&#174; and Tecartus&#174;, which have been transformative in the treatment of liquid tumors, but CAR-Ts have had extremely limited efficacy in solid tumors to date. This lack of efficacy in solid tumors underscores the inherent challenges of CAR-T approaches. Many of the limitations of CAR-T cell therapies are related to the fundamental dynamics of solid tumors and T cell biology. This includes (i)&#160;the potential inability to effectively target the entire tumor using a single antigen CAR due to tumor heterogeneity, (ii)&#160;the potential inability to effectively penetrate the tumor microenvironment, or TME, due to physical barriers such as tumor bulk, (iii)&#160;the lack of tumor antigens, which are ubiquitously and uniquely expressed on tumor cells, (iv)&#160;potential limited T cell function due to the immunosuppressive TME, including regulatory T cells, or Tregs, and other immune-suppressive cells, (v)&#160;limited ability to efficiently deliver cells directly to the tumor site, and (vi)&#160;the inability to combine with effective chemotherapeutic regimens due to the chemosensitivity of immune cells. Additional challenges that have potentially hampered widespread adoption of existing CAR-T technologies include scalability, safety and cost.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In recent&#160;years, there has been increasing focus on CAR-NK cell therapies, with multiple programs currently in development. NK cells are innate immune cells that possess the ability to detect and kill cancer cells by recognizing common antigens without highly selective adapted receptors towards specific </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">86</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:146.31pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">antigens. Their cytotoxicity is mainly dependent on the balance between activating and inhibitory signals, such as killer cell immunoglobulin-like receptors, or KIRs, which can be overcome with the addition of CARs to allow for their use in cell therapy. CAR-NKs are attractive over alpha-beta CARs for two primary reasons: (i)&#160;CAR-NKs do not express the cytokine IL-6, which is one of the major drivers of cytokine release syndrome, or CRS, which can lead to substantial morbidity as well as patient deaths, and (ii)&#160;CAR-NKs are not major histocompatibility complex, or MHC, restricted and can be infused from a donor to a patient without complex and expensive genetic engineering to prevent graft versus host disease, or GvHD.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">Despite these advantages, the development of CAR-NKs have faced several key challenges&#8201;&#8212;&#8201;in particular, manufacturing difficulties and limited scalability, their sensitivity to cryopreservation leading to a loss of viability and cytotoxicity, and a limited ability to efficiently introduce genetic modifications. Importantly, against solid tumors, the addition of a CAR to overcome KIR inhibition in an NK cell overrides their endogenous ability to target multiple receptors and results in a single antigen targeting CAR with the same limitation towards relapse due to tumor heterogeneity and ultimately antigen escape as a CAR-T.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">The inherent and engineered limitations of these therapies, particularly in the solid tumor setting, creates substantial opportunity for improved and differentiated cell therapies for cancer.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Why Gamma-Delta T Cells?<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">Gamma-delta T cells are a unique subset of immune cells that sit at the nexus of the innate and adaptive immune systems and possess properties of both, performing diverse immune functions including protection against tumors. This combination of features conveys functional abilities that make them ideally suited for use in cell therapy against cancer. They typically account for up to 10% of T&#160;cells but can undergo rapid activation and expansion in response to diseased or damaged tissue. Gamma-delta T cells are multifunctional with a complex receptor repertoire including the semi-invariant T cell receptor, or TCR, which allows them to distinguish between healthy and diseased or stressed tissue. This distinct mode of antigen recognition is a critical feature that distinguishes them from not only alpha-beta T cells but also B cells and NK cells. Gamma-delta T cells can kill effectively, both by direct cellular killing as well as the recruitment of additional immune cell types to induce killing. Importantly, gamma-delta T cells can kill in situations where other immune cells cannot, such as a downregulation of MHC expression or matched KIR.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">Gamma-delta T cells have been referred to as &#8220;nature&#8217;s CAR-T cells&#8221; because their complex antigen recognition allows them to naturally and effectively target and eliminate diseased tissues, such as tumor tissue. As shown in Figure 3 below, their diverse receptor repertoire may enable them to recognize and target the array of multiple antigens expressed by solid tumors, which has been a significant challenge to existing single-antigen targeting CAR technologies using NK and alpha-beta T&#160;cells.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">87</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:4pt; text-align:center; width:456pt;">
          <img src="tm2030088d18-ph_target4c.jpg" alt="[MISSING IMAGE: tm2030088d18-ph_target4c.jpg]" height="312" width="524" >
        </div>
        <div style="margin-top:7.2pt; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:-0.02pt;">&alpha;&beta;= alpha-beta; &#947;&#948; = gamma-delta</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 3. &#8220;Nature&#8217;s CAR-T Cell&#8221;</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Gamma-delta T cells also have the inherent ability to recognize a broad array of cellular stress signals, leading to both direct tumor cell killing as well as activation of a multifaceted immune response. Gamma-delta T cells have been observed to directly recognize and respond to a variety of MHC-like stress-induced self-antigens expressed by malignant cells without previously having the antigen presented, similar to NK cells. This recognition of stress antigens is achieved through a combination of gamma-delta TCRs, natural killer receptors, or NKRs, such as NKG2D, and toll-like receptors, or TLRs. This diversity of receptors is central to gamma-delta T cells&#8217; ability to identify healthy versus diseased tissue and may also contribute to their ability to effectively target cells, such as tumor cells with high variability and/or heterogeneity, thereby reducing antigen escape.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10.5pt; text-align:center; width:456pt;">
          <img src="tm2030088d18-ph_targ4c.jpg" alt="[MISSING IMAGE: tm2030088d18-ph_targ4c.jpg]" height="215" width="511" >
        </div>
        <div style="margin-top:13.7pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 4. Innate Immune Cell Receptors of Gamma-Delta T Cells</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The following highlights key potential advantages of gamma-delta T cells in comparison to other cell therapies for cancer:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="font-style:italic;font-weight:bold;">Differentiate between healthy and cancer cells</font><font style="font-style:italic;">.</font><font style="letter-spacing:-0.025pt;">&nbsp;&nbsp;&nbsp;By using a combination of signaling receptors, including gamma-delta TCR, NKG2D and TLR, among others, gamma-delta T cells can safely distinguish between safe and dangerous tissues, such as cancerous tissues, within the body.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">88</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:158.92pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="font-style:italic;font-weight:bold;">Attack the heterogeneity of solid tumor cancers</font><font style="font-style:italic;">.</font><font style="letter-spacing:-0.025pt;">&nbsp;&nbsp;&nbsp;The tumor contains cells that express a variety of antigen targets at different levels of expression. The complex and polyclonal binding abilities of gamma-delta TCR and NKG2D receptor allow them to broadly target diseased tissue and cover the heterogeneity of the tumor.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:3.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:3.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="font-style:italic;font-weight:bold;">Recruit and activate additional immune effector cells</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;Gamma-delta T cells broaden the immune response both through secretion of effector cytokines and chemokines that recruit and stimulate immune cells at the tumor. Gamma-delta T cells can elicit dendritic cell, or DC maturation by conveying danger associated molecular patterns, or DAMPs, and pathogen associated molecular patterns, or PAMPs to such cells. Certain subtypes of gamma-delta T cells also function directly as professional antigen presenting cells, or APCs, that activate and instruct alpha-beta T cells, similar to other innate immune cells like DCs, in order to elicit a potent and selective adaptive immune response</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:3.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:3.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="font-style:italic;font-weight:bold;">Safety advantages over other cell therapies</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;Gamma-delta T cells do not recognize allogeneic MHC restricted antigens and thereby can be obtained from a partially matched or even unmatched donor, which may eventually allow these cells to be used &#8216;off-the-shelf&#8217;. Gamma-delta T cells also do not secrete IL-6, a significant driver of cytokine release syndrome, or CRS, which has been a fatal complication in CAR-T in acute leukemias.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">How Gamma-Delta T Cells Kill<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">The biology of gamma-delta T cells is complex, with multiple mechanistic approaches to effectively recognize, target and directly kill tumor cells, as shown in Figure 5 below. This allows them to drive towards deeper immune responses through immune cell recruitment and activation, cytokine release and antigen presentation:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:3.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:3.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="font-style:italic;font-weight:bold;">Induction of cellular apoptosis</font><font style="font-style:italic;">.</font><font style="letter-spacing:-0.025pt;">&nbsp;&nbsp;&nbsp;Fas ligand, or CD95L, and tumor necrosis factor-related apoptosis-inducing ligand, or TRAIL, are both well-known triggers of cell death. These proteins are expressed on gamma-delta T cells, which allows them to engage the death receptors on target cells, leading to the direct destruction of cancer cells.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:3.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:3.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="font-style:italic;font-weight:bold;">Secretion of cell-killing enzymes and proteins</font><font style="font-style:italic;">.</font><font style="letter-spacing:-0.025pt;">&nbsp;&nbsp;&nbsp;Gamma-delta T cells secrete granzymes, cell killing enzymes, that are typical of killer cells and cytotoxic T cells, and perforin, a protein that opens a hole in the target cell, allowing for the entry of granzymes. This can lead to apoptosis, or programmed cell death, in the same manner as NK cells.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:3.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:3.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="font-style:italic;font-weight:bold;">Antibody-dependent cellular cytotoxicity</font><font style="font-style:italic;">.</font><font style="letter-spacing:-0.025pt;">&nbsp;&nbsp;&nbsp;Antibody-dependent cellular cytotoxicity, or ADCC, is cell-mediated cell killing, an efficient killing mechanism employed by the immune system. ADCC is triggered by the recognition of tumor-targeting antibodies through the CD16 expressed on gamma-delta T cells, similar to NK cells. This mechanism could allow the combination of gamma-delta T cell therapy with FDA-approved monoclonal antibody therapeutics, such as Rituxan, designed to enhance the effect of the antibody.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">89</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="tm2030088d18-ph_activa4c.jpg" alt="[MISSING IMAGE: tm2030088d18-ph_activa4c.jpg]" height="308" width="475" >
        </div>
        <div style="margin-top:12.01pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 5. Multiple Cell-Killing Mechanisms of Activated Gamma-Delta T Cells</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Opportunities for Gamma-Delta T Cells in Cancer<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The therapeutic potential of gamma-delta T cells is supported by observations over the last 20&#160;years demonstrating a significant clinical correlation between naturally occurring high levels of gamma-delta T cells and better survival outcomes in both hematologic and solid tumor cancers. Our founder and Chief Scientific Officer, Dr.&#160;Lamb, was the first person to report an association between levels of gamma-delta T cells and improved survival in leukemia patients undergoing allogeneic HSCT. His work, published in </font><font style="font-style:italic;">J. Hematotherapy</font><font style="letter-spacing:-0.025pt;"> in 1996, as depicted in Figure 6 below, and expanded on in a publication in </font><font style="font-style:italic;">Cytotherapy</font><font style="letter-spacing:-0.025pt;"> in 1999, found that the disease-free survival rate of HSCT patients who received T-cell depleted, or TCD, cells from a partially matched donor increased in those with high levels of gamma-delta T cells. These findings have been supported by the reported studies of other scientists. In 2007, Dr.&#160;Lamb and his collaborators found that the association between post-transplant gamma-delta T cells and survival extended to at least seven&#160;years, and that 71% of patients with high levels of gamma-delta T cells survived up to seven&#160;years compared to 20% of patients with low levels of gamma-delta T cells.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:9.11pt; text-align:center; width:456pt;">
          <img src="tm2030088d18-lc_overallbw.jpg" alt="[MISSING IMAGE: tm2030088d18-lc_overallbw.jpg]" height="283" width="404" >
        </div>
        <div style="margin-top:11.8pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 6. Correlation of Naturally Occurring Gamma&#8209;Delta T cells and Long&#8209;Term Survival in Leukemia</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">90</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">A Stanford University analysis of tumor-infiltrating immune cells in approximately 18,000 human tumor samples found that among all the subtypes of immune cells analyzed, the presence of gamma-delta T cells as tumor infiltrating lymphocytes, or TILs, was the most highly correlated with overall survival, as shown in Figure 7 below. Patients with solid tumors containing gamma-delta T cells were significantly more likely to improve and potentially survive than those without gamma-delta T cells present.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10.1pt; text-align:center; width:456pt;">
          <img src="tm2030088d18-bc_pancan4clr.jpg" alt="[MISSING IMAGE: tm2030088d18-bc_pancan4clr.jpg]" height="425" width="567" >
        </div>
        <div style="margin-top:13.2pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 7. Prognostic Association of Tumor Infiltrating Lymphocytes and Survival Outcomes</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">While gamma-delta T cells have demonstrated clinical association with specific tumor responses, there have been significant hurdles to developing them as cell therapies, particularly for solid tumors. Gamma-delta T cells comprise less than 10% of all lymphocytes found in the body, and as such have been challenging to manufacture in quantities sufficient to meet the significant doses generally required for efficacious cell therapy. In addition, as cancer progresses, the levels of gamma-delta T cells are further reduced, making it challenging to engage them </font><font style="font-style:italic;">in vivo.</font><font style="letter-spacing:-0.025pt;"> Finally, gamma-delta T cells are critical in identifying stress antigens on diseased tissue, such as tumor cells. These signals can be dramatically upregulated by chemotherapy, which stresses both the chemotherapy-sensitive and chemotherapy-resistant tumor cells, making them readily identifiable by gamma-delta T-cells. Chemotherapy can both kill the immuno-suppressive cells and induce tumor cell death to break up or &#8220;de-bulk&#8221; the tumor. This opens up the TME to effector cells, such as gamma-delta T cells. However, chemotherapy also depletes and damages immune cells, including gamma-delta T cells, limiting their ability to seek and kill tumor cells.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Preclinical Studies Have Demonstrated a Role for Gamma-Delta T Cells in Cancer<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The clinical observations described above are supported by a broad base of preclinical research. Gamma-delta T cells have been shown to play a significant role in tumor immunosurveillance. Preclinical studies have demonstrated that genetically engineered mice deficient in gamma-delta T cells were highly susceptible to carcinogen-induced skin cancers. Similarly, prostate cancer growth was accelerated in mice deficient for gamma-delta T cells compared to fully immunocompetent mice. Gamma-delta T cells have been detected in a variety of human tumor types, including GBM, neuroblastoma and lung </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">91</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">cancer, demonstrating that gamma-delta T cells infiltrated such solid tumors and thus may have an important correlation with anti-cancer activity. Prior data, including our own unpublished studies, have indicated that levels of gamma-delta T cells were diminished as cancer progresses and were depleted in end-stage disease.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Our DeltEx Platform</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We develop </font><font style="font-style:italic;">ex vivo</font><font style="letter-spacing:-0.025pt;">-expanded activated gamma-delta T cells based upon our deep expertise in gamma-delta T cell biology, proprietary genetic engineering and cell-type specific manufacturing capabilities, which we refer to collectively as our DeltEx platform. Our platform is designed to overcome many of the challenges associated with expansion, genetic engineering and scalable manufacturing of gamma-delta T cells. This allows us to expand the cells </font><font style="font-style:italic;">ex vivo</font><font style="letter-spacing:-0.025pt;"> to administer a potentially therapeutic dose to patients, harnessing the unique properties of gamma-delta T cells, including their ability to broadly recognize cellular stress signals on tumor cells. DeltEx has enabled our deep pipeline of innovative allogeneic, autologous and/or genetically modified product candidates designed to effectively target and potentially eradicate disease and improve patient outcomes. Key elements of our platform include:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="font-style:italic;font-weight:bold;">Expertise in ex vivo-expanded activated gamma-delta T cells.</font><font style="letter-spacing:-0.025pt;">&nbsp;&nbsp;&nbsp;Gamma-delta T cells, while critical to immune function and disease response, account for a small&#160;percentage of our immune cells. Our approach leverages our scientific expertise in gamma-delta T cell biology, encompassing the work of our scientific founder Dr.&#160;Lamb, to perform precise cell-type specific </font><font style="font-style:italic;">ex vivo</font><font style="letter-spacing:-0.025pt;"> expansion. This enables us to take peripheral blood from the patient and selectively expand the low numbers of gamma-delta T cells in order to generate a sufficient dose for treatment of solid tumors. Our expertise allows us to expand the desired subtypes of the gamma-delta T cell population, perform specific genetic modifications, and complete a quality review of these cells before returning precisely controlled doses to patients. This precision, control and quality provides significant advantages over </font><font style="font-style:italic;">in vivo</font><font style="letter-spacing:-0.025pt;"> expansion, which may not be cell-type specific, and we believe it uniquely enables us to potentially develop a therapeutic candidate at scale.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.09pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="font-style:italic;font-weight:bold;">Intelligent gamma-delta T cell genetic engineering.</font><font style="letter-spacing:-0.025pt;">&nbsp;&nbsp;&nbsp;We have developed proprietary methods of engineering gamma-delta T cells that are designed to take advantage of their inherent biology. Our engineering is designed to increase their ability to survive chemotherapy or to identify cancer cells while maintaining their natural ability to broadly recognize, engage and kill these cells. This enables the cells to be delivered concurrently with chemotherapies that activate the DNA damage response, or DDR pathway to generate an immune signal that should be expressed on all cells throughout the tumor and recognized by gamma-delta T cells. This intelligent engineering is broadly applicable across multiple solid tumor indications. Our approaches have overcome the historical problems in genetically modifying gamma-delta T cells, and we are currently the first company to advance a Phase&#160;1 clinical trial using genetically modified gamma-delta T cells.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="font-style:italic;font-weight:bold;">Next-generation gamma-delta T cell manufacturing</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;We have devoted significant time and resources to process development and manufacturing to improve the quality and reproducibility of our processes. Through our intellectual property and scientific know-how, we have designed and implemented a manufacturing process, including proprietary programs, which is designed to be reliable and scalable. We have automated our manufacturing processes, which are currently operating at clinical scale, in a system designed to minimize touchpoints and potential contamination and increase throughput. Our cell-type specific manufacturing platform is designed to support rapid development of our DeltEx product candidates through clinical trials and the regulatory approval process. We are using an automated, fully enclosed system for cell manufacturing, as shown in Figure 8 below, that is designed to be applicable across all our product candidates. Our manufacturing allows us to scale, while maintaining quality controls, which would be challenging with a manual lab-scale process. We have optimized transduction and cell expansion in a process we believe can be rapidly scaled for commercial supply in a controlled environment at a reasonable cost, if any of our product candidates are successfully developed and approved. We have also demonstrated successful cryopreservation </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">92</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">and delivery of our thawed product candidates to patients in our clinical trials, while maintaining cell viability and functionality.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:9.7pt; text-align:center; width:456pt;">
          <img src="tm2030088d18-ph_ingbio4c.jpg" alt="[MISSING IMAGE: tm2030088d18-ph_ingbio4c.jpg]" height="241" width="576" >
        </div>
        <div style="margin-top:12.41pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 8. Reproducible &amp; Scalable Manufacturing Process</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Scientific Basis for Harnessing Vd2+ Gamma-Delta T Cells</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">There are several diverse subsets of gamma-delta T cells. The most predominant circulating subsets are the Vdelta2 positive, or Vd2+, and the Vdelta1 positive, or Vd1+. These cell types have specific features that impact their therapeutic potential across different indications. Vd2+ cells comprise approximately 2 to 10% of the circulating cell population. The Vd1+ cells are a minor (&lt;2%) circulating subset, but abundant in specific tissues, such as the intestines and the skin. While both subsets express NKG2D receptors that recognize stress ligands, only the Vd2+ subset can function as a professional antigen presenting cell, which can process and present antigens, recruit and activate additional immune cell types. While there may be a potential utility for the Vd1+ subset for some cancers, we are currently focused on developing therapeutic candidates using Vd2+ cells, which we believe have certain advantages over the Vd1+ subset. The use of Vd1+ cells as a therapeutic has two potential challenges. First, while Vd1+ cells have shown greater persistence, research indicates that there is tissue specific tropism, or a signal, which functions to drive cells into specific tissues and maintain them there, potentially making it difficult to traffic to tumors outside these tissues. As an example, a third-party 2019 study demonstrated that skin-derived Vd1+ cells express the receptors that prevent them from migrating out from the dermis. The second challenge is the potential for Th1 effector Vd1+ cells to undergo reprogramming to a tumor promoting Th17, or IL-17 secreting, subtype. While current </font><font style="font-style:italic;">ex vivo</font><font style="letter-spacing:-0.025pt;"> expansion methods for Vd1+ cells have not resulted in pro-tumorigenic Th17-type responses to date, the potential for reprogramming of therapeutic Vd1+ cells remains a possibility. In contrast, Vd2+ cells are not known to produce Th17 or pro-tumoral subtypes.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We are currently focused on advancing programs utilizing Vd2+ cells, using our cell-type specific expansion protocol, which produces cytotoxic Th1 gamma-delta T cells at scale. We have developed our DeltEx platform to enable us to expand, activate and genetically modify Vd2+ cells at scale, producing cells which are viable, functional and can be cryopreserved while maintaining their cytotoxicity.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Our Lead Gamma-Delta T Cell Product Candidates</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">INB-200 for the Treatment of Solid Tumors<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">INB-200 is our novel genetically modified autologous DeltEx product candidate that we are developing for the treatment of solid tumors. We engineered INB-200 to be used as an adjuvant to the current standard-of-care treatment by engineering it to be resistant to certain types of alkylating chemotherapies. Alkylating chemotherapies function by creating DNA damage and strand breaks that lead to cell suicide or apoptosis. The protein O-6-Methylguanine-DNA Methyltransferase, or MGMT is a primary DNA repair protein capable of repairing damage to DNA caused by certain chemotherapies that prevents cell death. Through the introduction of a gene encoding MGMT into gamma-delta T cells, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">93</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">these genetically modified DeltEx DRI cells are designed to survive concurrent dosing with chemotherapy and remain functional. In preclinical studies in patient derived xenografts, INB-200 demonstrated antitumor activity, including long-term survival and eradication of the tumor as evidenced by histopathology. We are initially developing INB-200 to treat newly diagnosed patients with GBM during the maintenance phase following resection and initial radiotherapy and chemotherapy. We are conducting an investigator-initiated Phase&#160;1 repeat dose escalation clinical trial in patients with newly diagnosed GBM, which has been initiated by L. Burt Nabors, M.D. at the O&#8217;Neal Comprehensive Cancer Center at UAB. We expect to report the initial results from the second cohort in this Phase&#160;1 trial by the end of 2021.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Glioblastoma (GBM) Overview<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">GBM is a particularly aggressive form of brain cancer, in which tumor cells invade the surrounding tissue, rendering surgical resection and chemotherapy less effective. The incidence of GBM in the United States is estimated to be approximately three in 100,000 individuals, with more than 10,500 new cases estimated in 2020. Surgical resection followed by radiation and TMZ has been the current standard-of-care since 2005, but it is only able to control tumor growth in approximately 30% of patients. Based on current standard-of-care, tumor recurrence typically occurs within one year after initial diagnosis and treatment. A third-party trial published in 2017 indicated that older newly diagnosed GBM patients with unmethylated MGMT treated with radiation therapy and TMZ had median progression free survival of only 4.8&#160;months (95% CI (4.3-5.6)). Ultimately, virtually all patients will relapse, creating a significant unmet medical need with a potential global market opportunity greater than $3 billion.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Our Solution&#8201;&#8212;&#8201;INB-200 for the Treatment of Newly Diagnosed GBM<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We engineered INB-200 using a lentiviral vector to introduce the gene for MGMT, which is the primary protein capable of repairing DNA damage caused by alkylating chemotherapeutic drugs, such as TMZ. Tumor cells that over-express MGMT are resistant to TMZ and the current standard-of-care in GBM. By introducing MGMT into our DeltEx gamma-delta T cells, these genetically modified cells are designed to avoid TMZ-induced cell death. There is also considerable preclinical support for the use of gamma-delta T cells for the treatment of GBM.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">There is a significant unmet need as most patients with GBM die within 15&#160;months of diagnosis and the five-year survival rate is approximately 5%. Over 80% of treated GBM patients recur within 2cm of the original resection site, suggesting that recurrence is not due to metastases, but due to microscopic residual tumor that was not surgically resectable and is resistant to radiotherapy and chemotherapy. We believe that to have a clinically meaningful impact to patient outcomes, we must be able to target three categories of cells within the tumor: (i)&#160;cells sensitive to radiotherapy and chemotherapy, (ii)&#160;cells resistant to chemotherapy and (iii)&#160;cancer stem-like cells that are able to avoid immune detection. By combining our INB-200 therapeutic candidate concurrently with alkylating chemotherapies, our approach can promote the upregulation of stress ligands across all three of these categories, making the GBM cells identifiable by our DeltEx DRI cells. We believe this may be able to drive to deeper antitumor immune responses that could lead to prolonged progression free survival and increased overall survival. If our INB-200 clinical trials demonstrate antitumor activity at a level that the FDA deems to be clinically meaningful, we may be able to pursue accelerated approval pathways.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We believe newly diagnosed GBM is well suited initial indication to assess the potential of INB-200 to drive clinical antitumor activity. A recent third-party paper analyzing the impact of pre-conditioning on the TME to enhance solid tumor CAR-T cell therapy indicated that CAR-Ts have been hampered by immune suppression, escape of tumor antigens from single antigen targeting CARs, and T cell trafficking as adoptively transferred cells are trapped in first-pass tissues such as the lung and liver. Our DeltEx DRI approach in newly diagnosed GBM was specifically designed to overcome these challenges, among others. The administration of INB-200, through a cranial catheter, directly to the tumor site may increase the effector:target ratio, or E:T, and limit the ability of the introduced cells to migrate out of the brain, which has been shown to improve the antitumor activity of cell therapies over intravenous delivery. In the past, other novel modalities, such as treatment with adeno-associated virus or siRNAs, demonstrated early clinical response by also targeting locally deliverable organ systems such as the eye or liver.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">94</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;">INB-200&#8201;&#8212;&#8201;Investigator-Initiated Phase&#160;1 Clinical Trial<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We are conducting an investigator-initiated Phase&#160;1 repeat dose escalation trial of INB-200 at the O&#8217;Neil Comprehensive Cancer Center. We expect this trial to enroll up to 12 patients with newly diagnosed GBM who have completed a standard TMZ chemotherapy and radiotherapy treatment and are eligible to initiate maintenance therapy with TMZ.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The primary endpoint of this trial is to assess the safety and tolerability, in a small number of individuals, of expanded and activated autologous MGMT genetically modified gamma-delta T cell infusion. Safety will initially be assessed at single and multiple infusions at a dose level of 1x10</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">7</font><font style="letter-spacing:-0.025pt;"> DeltEx DRI gamma-delta T cells through a fenestrated intracranial catheter. Secondary endpoints include overall survival, time to progression and response. We will also assess biologic activity including cytokine and cellular analysis, both peripherally and from the cerebral spinal fluid, or CSF, if available. This clinical strategy takes advantage of gamma-delta T cell cytotoxicity against GBM since it is administered during chemotherapy, when a tumor is experiencing maximum stress and increased immunogenicity.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Eligible patients will receive standard-of-care therapy, which includes surgical resection of the GBM tumor, post-surgical TMZ and radiation therapy, followed by maintenance TMZ in combination with INB-200, as shown in Figure 9 below. During resection, an intracranial catheter is placed for injection of the INB-200 product. Blood cells for genetic modification are taken from the patient by leukapheresis several weeks following resection, after the patient&#8217;s immune system has been allowed to recover. Gamma-delta T cells are then isolated, genetically modified and expanded into the INB-200 product candidate, and then cryopreserved. No more than six weeks post-surgery, patients are treated with daily radiation and TMZ for six weeks followed by a four-week break. Following the four-week period, corticosteroid use is usually tapered, and the patient begins a maintenance phase of TMZ for the first five days of each 28-day cycle for up to six cycles.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:9.5pt; text-align:center; width:456pt;">
          <img src="tm2030088d18-bc_inb4004c.jpg" alt="[MISSING IMAGE: tm2030088d18-bc_inb4004c.jpg]" height="310" width="547" >
        </div>
        <div style="margin-top:12.01pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 9. INB-200 Administration Protocol</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The decision to combine INB-200 in the newly diagnosed GBM setting as an adjuvant to standard-of-care therapy was driven by biology, data and the desire to overcome challenges as outlined above. In this trial, we seek to attack any residual tumor cells when they are most vulnerable and with immune cells that are as healthy as possible. By combining INB-200 with surgical resection, chemotherapy and radiotherapy, we hope to eliminate the bulk of the tumor and target the residual tumor with a different biological mechanism that could potentially drive both deeper antitumor immune responses and improved safety due to the lower tumor burden.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Patients are dosed with adjuvant INB-200 via intracranial catheter injection, as shown in Figure 9 above, within four hours of receiving intravenous dosing with TMZ on day one of the maintenance cycle. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">95</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Oral dosing of TMZ will continue for the four subsequent days during each 28-day treatment cycle, as shown in Figure 10 below. Depending on which dose cohort they are enrolled in, patients will be administered either one, three or potentially up to six injections of INB-200.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:9.41pt; text-align:center; width:456pt;">
          <img src="tm2030088d23-ph_inppha4c.jpg" alt="[MISSING IMAGE: tm2030088d23-ph_inppha4c.jpg]" height="179" width="589" >
        </div>
        <div style="margin-top:12.1pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 10. Treatment and Manufacturing Timeline of the INB-200 Phase&#160;1 Trial</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">To date, nine patients with newly diagnosed GBM have been enrolled in this trial and four patients comprising the complete first cohort and one in the repeat dose cohort have been dosed with INB-200, our DeltEx DRI product. Three patients in the multi-dose cohort, or dose level 2, have been enrolled and recently initiated their treatment protocols. The patients in cohort 1 each received a single dose of INB-200, following a minimum of 30&#160;days for safety observation. As of June&#160;30, 2021, four patients have received a single dose of INB-200. No infusion reactions, cytokine release syndrome, neurotoxicity, or other dose limiting toxicities or serious treatment-emergent adverse events were observed in the first cohort, allowing us to proceed to the next cohort. This second cohort will receive three doses of INB-200, 28&#160;days apart. We have amended the protocol to add a third cohort where patients will receive up to six doses of INB-200, 28&#160;days apart. Following treatment, all patients will be monitored for time to disease progression and for overall survival.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The first patient (001) had several poor prognostic factors, including age (older at 68&#160;years old), male, MGMT unmethylated (non-responsive to TMZ), and IDH wild-type GBM. Figure 11 below depicts patient 001&#8217;s treatment timeline. Following treatment with INB-200, MRI reports indicated no nodular masses or evidence of disease progression observed as indicated in representative image 4 below. At 8.3&#160;months following tumor resection, patient 001 showed evidence of local recurrence on routine MRI examination but remained clinically asymptomatic and off corticosteroids (image 5). Tumor re-resection confirmed progression and histologic examination of the resected tumor revealed large areas of necrosis and a high concentration of TILs, including CD3+, CD4+ and CD8+ T cells and a few CD20+ B cells.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:9.3pt; text-align:center; width:456pt;">
          <img src="tm2030088d23-ph_mainten4c.jpg" alt="[MISSING IMAGE: tm2030088d23-ph_mainten4c.jpg]" height="252" width="572" >
        </div>
        <div style="margin-top:8.31pt; width:456pt; line-height:10pt;font-style:italic;font-size:8pt;">*Results from one patient are not indicative of future results, including the outcome of this trial.<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font></div>
        <div style="margin-top:2pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 11. Patient 001</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">96</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">This patient died at 477&#160;days following complications related to the treatment of a pancreatic cyst unrelated to the GBM. An MRI two days prior to death demonstrated that the tumor remained stable 7.4&#160;months following progression. The patient&#8217;s overall survival was 15.6&#160;months post initial surgical resection and enrollment into this Phase&#160;1 trial, which was beyond his expected median overall survival of 10&#160;months based on his greater age and MGMT status.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">A second patient (002) is a 48 year-old male with MGMT unmethylated, IDH wild-type GBM, who experienced non-expansion of gamma-delta T cells after leukapheresis, and therefore, was not given INB-200, but consented to continue to be monitored for disease progression. This expansion failure was likely due to the highly globally immunosuppressive nature of his tumor. This patient demonstrated enhancement on MRI on day 182 and was subsequently confirmed to have progressed at day 231 or 7.6 months. We continued to monitor this patient for overall survival, and to collect peripheral blood samples to determine the patient&#8217;s immunologic status as a comparator to patients who received INB-200. Patient&#160;002 died due to progression of disease at day 354 or 11.6 months.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The third patient (003) is a 74 year-old female with MGMT methylated (sensitive to TMZ), IDH wild-type GBM. Following surgical resection and prior to initiation of treatment with chemoradiation, this patient experienced a serious adverse event of dehydration associated with a urinary tract infection and fever. In addition, grade 2 cranial incision site drainage and edema further complicated this patient&#8217;s course. Both events were determined not to be INB-200 infusion related since the events occurred prior to the INB-200 injection. The events resolved and the patient continued on protocol. Following chemoradiation, she was treated with INB-200 in November&#160;2020, did not experience any infusion related treatment-emergent adverse events, and was determined to have stable disease following cycle 2 of maintenance TMZ. This patient experienced a grade 3 thrombocytopenia, likely related to her TMZ standard of care therapy, but recovered with spontaneous platelet recovery without additional intervention or platelet infusions. As of June 30, 2021, this patient remained clinically stable beyond her expected median progression free survival of 7.9 months with no disease progression, remains on study at 354 days or approximately 11 months, and has not required the use of steroids.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:9.7pt; text-align:center; width:456pt;">
          <img src="tm2030088d20-ph_patien34c.jpg" alt="[MISSING IMAGE: tm2030088d20-ph_patien34c.jpg]" height="268" width="608" >
        </div>
        <div style="margin-top:12.41pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 12. Patient 003</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The fourth patient (004) is a 21 year-old female also with multiple poor prognostic factors including MGMT unmethylated, IDH wild-type GBM, who received a left frontal lobe surgical resection in September&#160;2020. Post resection, as shown in the MRI (image 2 in Figure 13 below), there was residual tumor present in the medial and inferior margins of the resection cavity. Prior to receiving treatment with INB-200, in December&#160;2020, MRI scans were performed which noted an interval increase in the residual tumor and appreciation in abnormal enhancement (image 3 below) relative to scans made post-resection in September&#160;2020 (image 2). Importantly, this increase was observed following six weeks of daily radiation and TMZ treatment. The patient was then treated with a single dose of INB-200. One month later in January&#160;2021, during a follow-up scan after treatment with INB-200, a slight interval </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">97</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">improvement was observed in the nodular hyperintense changes and on administration of contrast, a reduction in enhancement was observed. As shown in image 4 below, residual disease remained with no new or satellite areas noted, but there was a reduction in the size of the nodular areas and in vasogenic edema. In February&#160;2021 a follow-up MRI demonstrated stable-disease with no new areas of abnormal enhancement and no tumor progression. Following this MRI, during cycle 3 of TMZ treatment, patient 004 experienced a grade 4 thrombocytopenia in February&#160;2021 that is likely associated with her treatment with TMZ on the Stupp regimen. Grade 3/4 thrombocytopenia occurs in approximately 25% of newly diagnosed GBM patients being treated with the Stupp regimen. The patient&#8217;s platelets recovered spontaneously with no intervention and no transfusions following a delay of additional treatment with TMZ. A follow up MRI after the delayed treatment of cycle 4 of TMZ demonstrated aggressive progressive disease at 224&#160;days or 7.4 months. MRI demonstrated increased hyperintensity, new enhancement along the resection cavity and into the ventricles and additional enhancement demonstrating contralateral extension. The patient initiated treatment with radiation, TMZ and bevacizumab, and died due to progressive disease at 293 days or 9.6 months.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="tm2030088d20-ph_patien44c.jpg" alt="[MISSING IMAGE: tm2030088d20-ph_patien44c.jpg]" height="269" width="608" >
        </div>
        <div style="margin-top:9pt; width:456pt; line-height:10pt;font-style:italic;font-size:8pt;">*Results from one patient are not indicative of future results, including the outcome of this trial.<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font></div>
        <div style="margin-top:2pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 13. Patient 004</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In 2020, we enrolled two additional patients (005 and 006) and initiated their treatment protocols, but both subsequently withdrew from the trial for personal reasons. Patient 005 had their surgical resection with catheter insertion, had successfully completed leukapheresis and DRI manufacturing and had begun the standard-of-care radiation and concurrent chemotherapy. During this phase of standard-of-care therapy, patient 005 experienced seizures which led to hospitalization and did not have any local family support due to COVID-19. In late December&#160;2020, patient 005 made the personal decision to discontinue treatment and move on to hospice care. Patient 005 did not receive an infusion of INB-200 and died on day 142 or 4.7 months due to progression of disease. Treatment for patient 006 included surgical resection with catheter insertion. Prior to apheresis, patient 006 withdrew consent for personal reasons and chose to discontinue participation in the trial but is being monitored for overall survival.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Three patients in the first multidose cohort have been enrolled. Patient 007 is a 74 year-old male with MGMT unmethylated and IDH-wild-type GBM, who has completed treatment with radiation and chemotherapy and initiated the planned first of three doses of INB-200 in June&#160;2021. Patient 008 is a 76 year-old male with MGMT methylated and IDH wild-type GBM, who had been surgically resected, apheresed and during manufacturing their T cells failed to adequately expand. We will continue to monitor this patient for tumor progression and overall survival. Patient 009 is a 32 year-old male with MGMT unmethylated and IDH mutant GBM, who has been surgically resected, had a successful manufacturing, and awaits initiation of radiation and chemotherapy. We are actively recruiting additional patients into this trial.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">98</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">As of June&#160;30, 2021, we have treated the first three patients with a single dose of INB-200 and have not observed any injection reactions, severe adverse events, or adverse events deemed related to the injection of INB-200, including cytokine release syndrome or neurotoxicity. One patient experienced a subdural hygroma with no neurological symptoms deemed related to the surgical procedure prior to the INB-200 treatment. Reported grade 3/4 adverse events include dehydration, seizure related to disease, thrombocytopenia and urinary tract infection. The other adverse events reported to date were grade 1/2 anorexia, anosmia, edema, fatigue, fever, headache, leukopenia, nausea and vomiting, related to radiation and TMZ chemotherapy. The data from this first dose level were reviewed by the data safety monitoring board (DSMB) in February&#160;2021. The DSMB determined it was safe to proceed and progress to the repeat dose cohort (or dose level 2).</font>
        </div>
        <div style="position:relative;margin-top:10.1pt; text-align:center; width:456pt;">
          <img src="tm2030088d23-bc_summar4c.jpg" alt="[MISSING IMAGE: tm2030088d23-bc_summar4c.jpg]" height="237" width="565" >
        </div>
        <div style="margin-top:13.2pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 14. Summary of Patients Enrolled in INB-200 Phase&#160;1 Trial</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Figure 14 depicts subject disposition. To date, two patients dosed with INB-200 injection remain alive. Patient 001 lived to 15.6 months and died due to complications related to the treatment of a pancreatic cyst and not due to progression of GBM. Patients 001 and 004 had progressive disease, which occurred beyond their expected median time to progression. Patient 003 remains on study with stable disease at 11 months post resection. Of the untreated patients enrolled, two of three have died due to progression of disease.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We expect to report initial results from the second cohort in this Phase&#160;1 trial by the end of 2021. In the second quarter of 2020, we amended the protocol to add a third cohort of patients that will receive up to six doses of INB-200, with data expected in 2022.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">ASCO 2021 Annual Meeting Presentation<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">At the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting, we presented additional immunologic and correlative analysis data from the three patients in the first cohort who received INB-200 (Figure&#160;15). In the treated patients, circulating T cells were suppressed in two of three subjects at diagnosis due to the globally immunosuppressive GBM. The third patient, 004, a 21 year-old female, initially showed a higher than normal T cell count which decreased into the normal range following resection. GBM resection temporarily reverses systemic immunosuppression causing T cell counts to normalize, however, the following 6-week chemotherapy regimen then followed by lymphodepleting effects of maintenance-phase TMZ, generally keep T and NK cell counts at low/</font>&#8203;<font style="letter-spacing:-0.025pt;">normal or below normal range. This continuous suppression of peripheral lymphocyte effector cells demonstrates the advantage of direct placement of TMZ-resistant gamma-delta T-cells in the resection cavity. Infusion of a single 1x10</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">7</font><font style="letter-spacing:-0.025pt;"> DeltEx DRI gamma-delta T cells dose directly into the brain revealed measurable changes in circulating lymphocyte populations, specifically a transient increase in circulating gamma delta T cells in all three patients. We continue to study correlative immune activity by examining peripheral blood and local CSF cytokine activity as well as circulating tumor DNA, exosomes, proteins, and cell-free nucleic acids for the purpose of understanding disease state, response to therapy, and potential toxicities.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">99</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:154.09pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="tm2030088d23-lc_tcell4c.jpg" alt="[MISSING IMAGE: tm2030088d23-lc_tcell4c.jpg]" height="143" width="608" >
        </div>
        <div style="margin-top:14.69pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 15. Immunologic and Correlative Analysis from Subject Peripheral Blood Samples</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">INB-200&#8201;&#8212;&#8201;Preclinical Studies in GBM<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">Malignant high-grade GBM in both humans and mice express stress ligands that are known to activate NKG2D and are targets for gamma-delta T cell attack. In preclinical testing, gamma-delta T cells exhibited strong cytotoxic activity against several GBM cell lines and primary explant cultures. Normal human brain cells do not express these stress ligands and are not affected.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">To assess the antitumor activity of exogenous gamma-delta T cells in GBM as an initial proof-of-concept, it was observed that </font><font style="font-style:italic;">ex vivo-</font><font style="letter-spacing:-0.025pt;">expanded and activated human gamma-delta T cells prevented emergence of tumors in a U251 GBM model in immunocompromised mice, leading to increased overall survival.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">In immunocompetent mice, we found that implantation of GL261 GBM cell line tumors led to a significant increase in levels of endogenous gamma-delta T cells, however these levels decreased over time coincident with tumor progression. Previous clinical studies in GBM and in extracranial malignancies have shown that this decrease is likely a result of T cell exhaustion due to their continuous stimulation by a large and highly aggressive tumor. Indeed, in this study we showed that the increased peripheral blood gamma-delta T cells seen in response to the tumor were already expressing the pre-apoptotic marker Annexin V. Exogenous administration of gamma-delta T cells into the brain immediately after tumor implantation increased overall survival in this model, however these results were not statistically significant.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Improved Antitumor Activity in Combination with Chemotherapy<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">Based on several&#160;years of peer-reviewed and published preclinical work, as well as early human cancer trials, we believe that INB-200 can work in synergy with chemotherapy by causing changes in cancer cells that result in increased expression of activating ligands of gamma-delta T cell and NK cell function, such as NKG2D. In preclinical studies, treatment of TMZ-resistant GBM cells derived from the U87 human GBM cell line with TMZ led to transient increases in a broad panel of stress ligands recognized by the NKG2D receptor, as shown in Figure 16 below.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">100</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:149.25pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="tm2030088d18-lc_increabwlr.jpg" alt="[MISSING IMAGE: tm2030088d18-lc_increabwlr.jpg]" height="304" width="608" >
        </div>
        <div style="margin-top:14.69pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 16. Increased NKG2D Ligand Expression Observed on TMZ-Resistant Tumor Cells Treated With TMZ</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">As shown in Figure 17 below, additional studies in glioma cells have demonstrated that NKG2D ligands are also expressed on cancer stem cells, considered as cells that express factors, such as Klf-4, Oct-4, Sox-2, Nanog and Musashi-1. Treatment with TMZ demonstrated that NKG2D ligand expression can also be upregulated several fold on GBM stem-like cells, as depicted in Figure 18 below. This increase in stress ligand expression, even in TMZ-resistant and stem-like cancer cells, has the potential to increase the vulnerability of tumor cells to gamma-delta T cell targeting during the period of pharmacokinetic activity of TMZ.</font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2030088d18-tbl_cancerbw.jpg" alt="[MISSING IMAGE: tm2030088d18-tbl_cancerbw.jpg]" height="128" width="549" >
        </div>
        <div style="margin-top:14.69pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 17. Cancer Stem-Like Cells Co-Express Stem-Cell Markers and NKG2D Ligands</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">101</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="tm2030088d18-bc_cancerbw.jpg" alt="[MISSING IMAGE: tm2030088d18-bc_cancerbw.jpg]" height="279" width="369" >
        </div>
        <div style="margin-top:12.4pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 18. Increased NKG2D Ligand Expression in Glioma Stem Cells Treated with TMZ</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">There are two principal challenges to clinical application of TMZ treatment in conjunction with gamma-delta T cells:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">TMZ is cytotoxic to immune cells, including gamma-delta T cells; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the increased expression of stress ligands is transient due to resistance mechanisms of the tumor.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Therefore, we believe the ideal gamma-delta T cell exposure would occur when TMZ is still pharmacokinetically active. We developed INB-200 in a way that could enable it to overcome both of these challenges by engineering the cells that make up INB-200 to be resistant to TMZ, an approach we refer to as DeltEx DRI. Treatment of GBM using TMZ increases the levels of NKG2D stress ligands expressed on the tumor cells leading to activation of INB-200. The introduction of the drug-resistant genes is designed to allow INB-200 to survive even when it is administered while TMZ is present even in concentrations above the clinical range. As depicted in in Figure 19 below, concurrent treatment with TMZ causes the direct killing of some tumor cells and immunosuppressive cells while activating gamma-delta T&#160;cells, which could lead to stimulating the antitumor activity of INB-200.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:9.8pt; text-align:center; width:456pt;">
          <img src="tm2030088d18-ph_genetic4c.jpg" alt="[MISSING IMAGE: tm2030088d18-ph_genetic4c.jpg]" height="291" width="443" >
        </div>
        <div style="margin-top:12.6pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 19. DeltEx DRI Mechanism of Action Targeting the DNA Damage Response (DDR)</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">102</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We have developed a process to genetically modify gamma-delta T cells in order to add a gene that codes for MGMT production. MGMT, a primary DNA repair protein, prevents cell death by repairing the DNA double-stranded breaks caused by alkylating chemotherapy, such as TMZ. As shown in Figure 20 below, introduction of the gene encoding MGMT into gamma-delta T cells using a lentiviral vector decreased the sensitivity of these modified gamma-delta T cells to TMZ by approximately six-fold. A concentration of 63 micromolar, or &#956;M, of TMZ inhibited the proliferation of unaltered gamma-delta T cells by 50%, whereas a concentration of 383 &#956;M of TMZ was required to have a similar effect in DeltEx DRI gamma-delta T cells. We observed that this gene modification did not alter other properties of these gamma-delta T cells, including their cytotoxicity against target cells.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11pt; text-align:center; width:456pt;">
          <img src="tm2030088d18-lc_chemop4c.jpg" alt="[MISSING IMAGE: tm2030088d18-lc_chemop4c.jpg]" height="247" width="373" >
        </div>
        <div style="margin-top:14.19pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 20. MGMT-Modified Gamma-Delta T Cells Demonstrate Protection Against Killing Effects of TMZ</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In preclinical studies, we have observed that the </font><font style="font-style:italic;">in vitro</font><font style="letter-spacing:-0.025pt;"> anti-tumor effect of DeltEx DRI gamma-delta T cells remained fully intact in therapeutic concentrations of TMZ. As depicted in Figure 21 below, the stepwise killing effect of increasing the E:T ratio of DeltEx DRI gamma-delta T cells on TMZ-resistant SNB-19 and U373 GBM cell line clones prepared for this study was amplified when the assay was conducted in therapeutic concentrations of TMZ. Both SNB-19 and U373 clones prepared for this study were resistant to TMZ and were not affected by the concentration of TMZ used in this assay. Our findings from this study suggest that this increased cytotoxicity is due to the upregulated expression of NKG2D stress-associated ligands on the tumor cells, which increased even in cells that were resistant to the direct cytotoxic effects of TMZ.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11pt; text-align:center; width:456pt;">
          <img src="tm2030088d18-lc_mgmt4clr.jpg" alt="[MISSING IMAGE: tm2030088d18-lc_mgmt4clr.jpg]" height="233" width="512" >
        </div>
        <div style="margin-top:14.19pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 21. MGMT-Modified Gamma-Delta T Cells Demonstrated Increased Cytotoxicity Against GBM Cells in the Presence of TMZ</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">103</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:47.49pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">Driving to higher E:T ratios by using available therapies to debulk a solid tumor mass may be important </font><font style="font-style:italic;">in vivo</font><font style="letter-spacing:-0.025pt;">. As depicted in Figure 22 below, a recent third-party paper in ovarian cancer patients demonstrated that the proportion of endogenous cytokine-producing gamma-delta T cells was inversely proportional to the amount of residual tumor following primary surgery. Patients with residual tumor burden of 0 cm or 0-2 cm produced significantly greater interferon-gamma, or IFN-g, and tumor necrosis factor-alpha, or TNF-a, than those tumors that had greater than 2 cm of residual tumor post-surgery.&#160;</font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2030088d18-ph_resid4c.jpg" alt="[MISSING IMAGE: tm2030088d18-ph_resid4c.jpg]" height="268" width="407" >
        </div>
        <div style="margin-top:14.69pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 22. Gamma-Delta T Cell Cytokine Production is Inversely Related to Residual Tumor Burden in Ovarian Cancer</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">In preclinical studies of INB-200 in GBM patient-derived xenograft models, we observed that the combined dosing of TMZ and treatment with our DeltEx DRI gamma-delta T cells led to a statistically significant (p-value &le; 0.05) increase in overall survival in primary GBM xenograft tumors, as compared to mice treated separately with either chemotherapy or gamma-delta T cells. Unmodified gamma-delta cells showed no survival benefit. Subsequent histopathological analysis demonstrated no visible residual tumors in INB-200-treated animals at 150&#160;days, as shown in Figure 24 below. This is important, since xenograft models convey the heterogeneity of a human-derived tumor and not the monotonous population of a cell line used in syngenic models. Separately, we also examined the potential for sequencing chemotherapy and cell therapy, separating gamma-delta T cells from TMZ therapy by 24 hours (condition 1) and outside the effective concentration of TMZ. As shown in Figure 23 below, we observed that in TMZ-sensitive tumors treated with the sequenced regimen, delivery of the DeltEx DRI gamma-delta T cells led to modest improvement in median overall survival of 75&#160;days compared to 60&#160;days with TMZ alone but with no overall survival benefit over TMZ. Conversely, as discussed above, the combined and concomitant delivery of TMZ and DeltEx DRI gamma-delta T cell regimen (condition&#160;2) resulted in 80% of mice surviving beyond 150&#160;days. These results are consistent with our observations in cell lines, in which we observed that treatment with TMZ led to transient increase in the levels of NKG2D stress ligands. We believe the increased expression of these stress ligands, in turn, led to increased cytotoxic activity of the DeltEx DRI gamma-delta T cells. In preclinical studies, we observed that, even in TMZ-resistant tumors, administration of MGMT-modified gamma-delta T cells led to an increase in median and overall survival while sequencing TMZ and gamma-delta T cells showed no benefit.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">104</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:38.26pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="tm2030088d18-lc_improve4clr.jpg" alt="[MISSING IMAGE: tm2030088d18-lc_improve4clr.jpg]" height="273" width="511" >
        </div>
        <div style="margin-top:14.69pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 23. Improved Survival Observed in Both TMZ-Sensitive and TMZ-Resistant GBM Models</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2030088d18-ph_cells4c.jpg" alt="[MISSING IMAGE: tm2030088d18-ph_cells4c.jpg]" height="240" width="561" >
        </div>
        <div style="margin-top:14.69pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 24. Histopathology Demonstrates No Residual GBM in Mice</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">These preclinical results are supported by observations of gamma-delta T cells in human cancer patients. As shown in Figure 25 below, in 2011, a group in Japan published results of an early clinical trial testing the adoptive transfer of </font><font style="font-style:italic;">ex vivo</font><font style="letter-spacing:-0.025pt;">-expanded autologous gamma-delta T cells for the treatment of advanced solid tumors in the British Journal of Cancer. The paper discusses the need to evaluate combinations of gamma-delta T cell therapies with other therapies and how to appropriately time administration of such combination therapies to generate synergy and avoid damage to gamma-delta T cells. However, while no dose limiting toxicity was observed, most patients progressed, with progressive disease (n=12) or stable disease (n=3) being the predominant tumor responses reported. Three patients who were receiving other therapies and were progressing or considered unlikely to respond to standard therapy received gamma-delta T cells in parallel. All three patients demonstrated tumor responses with two partial remissions and one complete remission.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">105</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="tm2030088d18-tbl_treat4clr.jpg" alt="[MISSING IMAGE: tm2030088d18-tbl_treat4clr.jpg]" height="350" width="552" >
        </div>
        <div style="margin-top:12.4pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 25. Treatment and Clinical Outcomes for </font><font style="font-style:italic;">Ex Vivo</font><font style="letter-spacing:-0.089pt;"> Expansion of Vg9Vd2 T Cells</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">INB-200 for Other Oncology Indications and Use in Combination with Other Therapies<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">As we look to expand the potential applications for INB-200, we intend to evaluate its antitumor activity in other tumors commonly treated with TMZ or other alkylating agents such as darcarbazine or the nitrosoureas. These tumors may include additional brain tumors, melanoma, uveal melanoma, neuroendocrine and adrenal tumors, soft tissue sarcomas, uterine sarcoma, small cell lung cancer, and ovarian cancer, among others.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Based on extensive preclinical data, we also intend to investigate the potential combination of drug resistant gamma-delta T cells with other immune oncology drugs, such as checkpoint inhibitors, which may enhance the immunostimulatory activity of these cells. We also plan to assess the potential of combinations of drug-resistant gamma-delta T cells with inhibitors of DNA damage repair proteins, such as the PARP inhibitors that have been shown to increase the expression of stress signals such as NKG2D ligand expression in tumor cells. Consistent with our previous work, we anticipate that this significant increase in stress signaling may improve the ability of gamma-delta T cells to target these tumors.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">INB-100 for the Treatment of Patients with Hematological Malignancies Undergoing HSCT<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">INB-100 is an allogeneic DeltEx product candidate created from healthy donors. INB-100 is allogeneic, expanded activated gamma-delta T cells. We are developing INB-100 for the treatment of patients with hematological malignancies that are undergoing HSCT. We are collaborating with Joseph McGuirk, D.O., at the University of Kansas Cancer Center, to conduct an investigator-initiated Phase&#160;1 dose escalation trial of INB-100 to assess the safety and tolerability of INB-100. An expansion cohort is anticipated to follow at the recommended highest tolerable dose. We expect to enroll up to 18 patients in the dose escalation portion of this trial. As of June 30, 2021, we have enrolled six patients in this trial, of whom three have been dosed. A fourth patient was dosed to complete the first cohort subsequent to June 30, 2021.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Hematological Malignancies Overview<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Hematological malignancies are characterized by an abnormal and excessive proliferation of blood cells that invade the bone marrow and then the blood. In some patients, these cancerous cells proliferate rapidly, requiring urgent treatment. These include AML, ALL, chronic myeloid leukemia, or CML and myelodysplastic syndromes, or MDS. There are few treatment options for these patients. One </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">106</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">of the most effective is allogeneic HSCT, where the patient&#8217;s blood forming cells, including cancerous cells, are first destroyed using chemotherapy, radiation or a combination of both. The patient then receives new bone marrow stem cells from a healthy donor.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Allogeneic Hematopoietic Stem Cell Transplantation Overview<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">HSCTs are generally for patients with various hematological malignancies where additional therapy can lead to longer-term durability and survival. As depicted in Figure 26 below, the number of HSCT procedures has been increasing over the last 20&#160;years, with more than 9,000 patients treated in the United States in 2018.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The challenge facing many patients who are in need of an allogeneic HSCT is the identification of an appropriately matched donor. Histocompatibility, or tissue compatibility, is the property of having the same, or sufficiently similar, alleles of a set of genes called human leukocyte antigens, or HLAs, between a donor and recipient. Differences in histocompatibility and other tissue antigens between the host and the transferred alpha-beta T cells derived from the donor can trigger a series of potentially life-threatening consequences, such as GvHD. While immunosuppressive drugs can help reduce GvHD, they are not always successful, and their long-term use is associated with multiple complications including leukemic relapse. A match of 8/8 HLA alleles is considered fully matched and is associated with the lowest frequency of GvHD.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="tm2030088d18-lc_alloge4clr.jpg" alt="[MISSING IMAGE: tm2030088d18-lc_alloge4clr.jpg]" height="207" width="371" >
        </div>
        <div style="margin-top:13pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 26. Annual allogeneic HSCT procedures in the United States</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In some cases, a donor can be identified who is a close relative and in other cases it may be someone who volunteered to be included in a national donor registry. Because of underrepresentation of the HLA alleles found in many ethnic groups, the probability of identifying a donor with a full match varies widely. Up to 75% of patients of White European descent can find a donor with a full match, but that number drops to 19% for African American patients. Patients who cannot find a fully matched donor must either accept a non-ideal match, which is associated with a higher risk of GvHD, or forgo HSCT entirely. Haploidentical, or partially matched donors, who are relatives, that share alleles with the transplant recipient provide one option for patients lacking a matched donor.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Our Solution&#8201;&#8212;&#8201;INB-100 for the Treatment of Patients with Hematological Malignancies Undergoing HSCT<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We are developing INB-100, an expanded and activated gamma-delta T cell product, with the goal of improving overall survival in patients with hematological malignancies who have undergone allogeneic HSCT. We believe that supplementing the patient&#8217;s immune system with allogeneic gamma-delta T cells will lead to reduced incidence of relapse and improved survival in these patients.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Multiple retrospective studies of leukemia patients treated with alpha-beta TCD allogeneic HSCT showed that high levels of gamma-delta T cells were associated with a significantly higher rate of disease-free survival. In a foundational study led by Dr.&#160;Lamb, patients with high levels of gamma-delta T cells had a disease-free survival rate at seven&#160;years of over 70% compared to less than 20% for patients with low levels of gamma-delta T cells, which has been supported by subsequent studies. The majority of this effect was observed within six&#160;months of treatment. The primary cause of death for patients with low </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">107</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">or normal levels of gamma-delta T cells was leukemic relapse. Often, leukemic relapse is due to a loss of MHC in any residual cancerous cells and gamma-delta T cells may offer a solution as their killing through stress signaling is independent of MHC. Approximately 60% of the high gamma-delta T cell patients who relapsed were still surviving at the time of the publication compared to only 2%, or one patient, with low levels of gamma-delta T cells.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">To produce INB-100, we developed and are testing an automated, programmed and functionally closed &#8220;point-of- care&#8221; manufacturing process that is designed to routinely and cost effectively generate the quantities of the cells required for the treatment of patients. In the past, the high cost for cell therapy and CAR-T therapy has resulted in high prices to patients and a challenging business model towards profitability. Our &#8220;point-of-care&#8221; manufacturing approach for this program tested the ability to potentially allow us to take advantage of already available infrastructure, as major academic and transplant centers across the country are building cell manufacturing facilities designed to comply with Good Manufacturing Practice, or GMP, that are often underutilized. This approach could potentially enable one to deliver widespread access to therapies and reduce costs required to commercialize products, if successfully developed and approved. Initially we utilized the manufacturing facility at the University of Kansas Cancer Center, the site of our Phase&#160;1 dose-escalation trial with INB-100. Recently, we have shifted our manufacturing to the GMP facility at UAB, in which we have contracted access for several years, to streamline the process. We are currently implementing process improvements that we believe could substantially increase the yield and the number of gamma-delta T cells.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Investigator-Initiated Phase&#160;1 Clinical Trial of INB-100<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We are conducting an investigator-initiated Phase&#160;1 dose escalation trial of INB-100 in patients with leukemias who are undergoing allogeneic haploidentical HSCT. The primary endpoints of this trial are safety and tolerability, and secondary endpoints include rates of acute and chronic GvHD, relapse rate and overall survival. Following completion of the dose escalation phase, which we currently expect to be completed in 2022, our goal is to enroll nine to 12 patients, with the ability to enroll up to 18 patients if clinically necessary, in an expansion cohort where they will be followed for up to a year.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">INB-100 is prepared from peripheral blood cells, while in parallel, patients undergo HSCT. As depicted in Figure 27 below, INB-100 cells are administered post-engraftment with the goal of providing immunity during the period of immune cell reconstitution.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="tm2030088d18-ph_admin4clr.jpg" alt="[MISSING IMAGE: tm2030088d18-ph_admin4clr.jpg]" height="266" width="443" >
        </div>
        <div style="margin-top:13pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 27. INB-100 Administration</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">As depicted in Figure 28 below, patients will initially be treated using a standard HSCT protocol, originally developed at Johns Hopkins University, or the Hopkins protocol, under which these patients undergo myeloablative therapy using chemotherapeutic agents that destroy their tumor cells as well as their healthy immune cells. They then undergo allogeneic bone marrow transplant. Prior to the bone marrow transplant, donors will undergo leukapheresis to provide the starting material for INB-100 at least </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">108</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">seven days ahead of the transplant. The INB-100 starting material will then be prepared and cryopreserved. After approximately 15 to 20&#160;days, hematopoietic stem cells from the donor engraft in the patient&#8217;s bone marrow and begin reconstituting the immune system. While the Hopkins protocol has decreased the risk of GvHD, there is also a reduced anti-leukemic effect. Accordingly, the rate of leukemic relapse has increased to approximately 51% at one year. Within five days of neutrophil engraftment, our INB-100 product candidate will be thawed and administered as a single weight-based dose, leading to an increase in the levels of gamma-delta T cells and potentially providing greater anti-leukemic effect.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">As of December&#160;2020, with the increase of COVID-19 infections across the United States, additional enrollment in this clinical trial has been delayed. With the ongoing COVID-19 pandemic, there was an increasing risk that a patient could undergo a conditioning process only to find that their donor has been infected with COVID-19, making donor HSCs unavailable to the patient. This would result in patient death. Accordingly, we submitted to the FDA and the IRB a modified clinical protocol to allow the usage of previously frozen HSCs. This allows us to perform leukapheresis and to harvest HSCs from the donor and confirm a negative COVID-19 result prior to initiating the myeloablation of the patient. We have been cleared to resume enrollment in this trial pursuant to the amended protocol following the implementation of any required changes.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:9.9pt; text-align:center; width:456pt;">
          <img src="tm2030088d18-lc_host4clr.jpg" alt="[MISSING IMAGE: tm2030088d18-lc_host4clr.jpg]" height="307" width="601" >
        </div>
        <div style="margin-top:12.8pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 28. The Projected Composition of Immune Cells in the INB-100 Phase&#160;1 Trial</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">As represented in Figure 29 below, as of June 30, 2021, six patients have been enrolled in this trial to date in the first dose cohort, three of whom have been infused with INB-100, our DeltEx Allo therapeutic candidate. The six subjects ranged between 44 to 73&#160;years of age. Three subjects were dosed with INB-100 and one subject (001) died prior to receiving INB-100 due to cardiogenic shock most likely from post-HSCT cyclophosphamide.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The first subject to receive INB-100 was patient 002, a 54 year-old female with high risk AML including multiple cytogenetic abnormalities consistent with a poor prognosis. She received the INB-100 infusion in May&#160;2020. This patient achieved full engraftment with 100% chimerism. Day 60 and 100 post-HSCT safety observation periods passed without the occurrence of grade 3+ acute GvHD. Patient 002 subsequently developed a rash which was later determined to possibly be grade 2 skin GvHD related to the INB-100 infusion or to the HSCT as the donor previously had a skin condition. This rash has resolved and the patient is off of any steroids. A&#160;cytogenetic abnormality was observed at post-transplant follow-up resulting in tapering of immune suppression and initiation of maintenance chemotherapy. As of June 30, 2021, this patient was at day 442 or 14.5 months post-HSCT and remained in remission of their leukemia with 100% donor chimerism.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">109</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Patient 003 is a 45 year-old female with intermediate risk AML. She was treated with an INB-100 infusion in July&#160;2020 and reached 100% chimerism by day 43 post-HSCT. She did not experience any grade 3 acute GvHD at the 60 and 100 day safety observation periods but developed gastrointestinal related grade 2 GvHD approximately 7 weeks post-HSCT and 5 weeks post INB-100 infusion. This event resolved with treatment and was possibly related to HSCT and the INB-100 infusion. As of June 30, 2021, this patient is past a year without relapse, having remained on study at day 370 or 12.2 months post-HSCT in continuous complete remission with no further evidence of GvHD.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Patients 004 and 005 were enrolled, but a product could not be manufactured due to a manufacturing complication. In order to prevent future delays, we relocated clinical trial product manufacturing to an academic GMP facility closer to our laboratory headquarters in Birmingham, Alabama, which provides us with direct access and closer collaboration with the facility&#39;s manufacturing staff.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Patient 006 is a 66 year-old male with high-risk relapsed AML. The patient has undergone HSCT and a product has been successfully manufactured. This patient engrafted in July&#160;2021 and received an infusion of INB-100.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">No severe treatment-emergent or infusion related adverse events have been reported in this trial to date.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We expect to report initial results from the first cohort in this Phase&#160;1 trial in 2022, with topline results for all cohorts in 2023.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:9.8pt; text-align:center; width:456pt;">
          <img src="tm2030088d23-bc_study4c.jpg" alt="[MISSING IMAGE: tm2030088d23-bc_study4c.jpg]" height="219" width="543" >
        </div>
        <div style="margin-top:12.61pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 29. Summary of Patients Enrolled in INB-100 Phase 1 Trial</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">INB-100 Preclinical Studies&#160;</div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Animal studies and indirect evidence from human allogeneic transplant studies suggest that gamma-delta T cells can facilitate engraftment, which may translate into faster reconstitution of the immune system. In a murine allogeneic transplant model, donor gamma-delta T cells facilitated the engraftment of TCD donor bone marrow. When TCD donor marrow was supplemented with up to 3x10</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">6</font><font style="letter-spacing:-0.025pt;"> gamma-delta T cells prior to infusion into mismatched recipients, donor chimerism increased by approximately 40%. A separate study revealed similar findings in MHC-mismatched mice, and later demonstrated that the gamma-delta T cell dose necessary to facilitate engraftment did not result in lethal murine GvHD. Improved engraftment was also observed in lethally irradiated rats reconstituted with 1x10</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">8</font><font style="letter-spacing:-0.025pt;"> alpha-beta T cell depleted bone marrow, suggesting that gamma-delta T cells are able to facilitate improved engraftment even in the absence of alpha-beta T cells. In this study, all rats engrafted with a mean of 92% (&#177; 4%) donor cells and showed no clinical evidence of GvHD. Studies comparing patients who received alpha-beta TCD grafts with those receiving pan-TCD grafts also show a positive association between the number of gamma-delta T cells in the graft and less time to engraftment.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Both murine and human studies suggest that gamma-delta T cells are not primary initiators of GvHD and may in fact modulate the GvHD activity of alpha-beta T cells. Indeed, large doses of expanded gamma-delta T cells have been infused into lethally irradiated MHC-disparate mice without causing GvHD. Although it has been observed that gamma-delta T cells have activated GvHD response, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">110</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">the investigators reporting this study found no direct evidence that GvHD was initiated by gamma-delta T cells. In two separate human trials, it was observed that gamma-delta T cells were not substantially activated in the </font><font style="font-style:italic;">in vitro</font><font style="letter-spacing:-0.025pt;"> allogeneic mixed lymphocyte culture. Several studies post-HSCT have shown transient increases in gamma-delta T cells, but have not associated this finding with GvHD. Studies comparing outcomes of patients that received alpha-beta T cell depleted grafts with pan-T cell depleted grafts all showed a lower incidence of GvHD in the alpha-beta T cell depleted group, suggesting that infusion of gamma-delta T cells in the graft does not subject the recipient to increased risk of GvHD. Whether gamma-delta T cells are truly less likely to contribute to the development of GvHD and the contribution of any residual alpha-beta T cells in the graft remains untested. However, from the above reasoning, it is logical to propose that in future studies, gamma-delta T cells might indeed be introduced in the setting of allogeneic HSCT, specifically to provide innate anti-tumor effect with only minimal risk of GvHD.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Future Development for Our Lead Product Candidates</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Our goal is to ultimately treat solid tumor cancers with an allogeneic cellular immunotherapy. Delivering a previously manufactured and cryopreserved therapeutic product from donor to patient could have the ability to create a product that is produced and sold as &#8220;off-the-shelf.&#8221; We believe this could improve the availability of cell therapy products, as well as potentially reduce the cost of the product to both us and to the patients. Ultimately a donor-derived product may be superior to a patient-derived product, as cells can be harvested and manufactured from younger, healthy individuals who do not have a potentially immune-suppressive tumor impacting the function of their immune cells. The goal of an allogeneically delivered product for solid tumor cancers is complex and we are not aware of any solid tumor cancers currently treated with transplant or lymphodepletion protocols.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The necessity to add transplant and lymphodepletion protocols increases the complexity of treatment due to the risk of potentially fatal GvHD from HLA-mismatched cells in the solid tumor setting. Further, this may also bring to question the direct impact of the lymphodepleting regimen on the tumor itself. In our INB-200 program for GBM, the standard-of-care chemotherapy with TMZ is our lymphodepleting regimen and has been in use in this setting for over 16&#160;years.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">To reach our goal of creating an allogeneic genetically modified product candidate for solid tumors, we are pursuing two clinical protocols that could provide the data required for applicable regulatory filings. INB-100 is an unmodified, allogeneic product candidate tested in the transplant setting, results from which will help assess the risk of GvHD from HLA-mismatched gamma-delta T cells, or potentially any residual alpha-beta T cells that may remain. INB-200 is an autologous, genetically modified gamma-delta T cell product candidate that tests the safety and efficacy of our DRI approach in our first solid tumor indication. Our goal is to combine the prior safety data from both of the ongoing clinical trials for INB-200 and INB-100 in order to create the regulatory package for an allogeneic-sourced product for the treatment of GBM and other solid tumor cancers.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Our Additional Product Candidates</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">INB-400: Allogeneic Drug-Resistant Gamma-Delta T Cells<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">INB-400 is our allogeneic genetically modified product candidate, or DeltEx DRI for solid tumor cancers. We initially we intend to develop INB-400 in a treatment protocol similar to INB-200, in newly diagnosed GBM, but with allogeneically sourced gamma-delta T cells as shown below in Figure 30. Our primary goal with INB-200 is to demonstrate the antitumor activity of our technology in a difficult-to-treat solid tumors, such as GBM. Initially, we eliminated the additional risk and complexity of GvHD complications in allogeneic cell therapies by using autologous cells. Based on preclinical data, we anticipate that there will be a low risk of patients developing GvHD upon administration of an allogeneic gamma-delta T cell product candidate. We expect that results obtained from our INB-100 clinical program, in which gamma-delta T cells are expanded and activated using a process similar to that used for INB-200, will help inform our assessment of the risk of GvHD with our allogeneic gamma-delta T cell product candidates, such as INB-400. Assuming that the FDA agrees with our assessment, and we receive authorization to proceed under an IND, we intend to use cells from healthy donors to develop INB-400. We are initially developing INB-400 to treat newly diagnosed GBM and we expect to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">111</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:80.97pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">submit an IND by first half of 2022, dependent on FDA guidance and anticipated safety data from our ongoing Phase&#160;1 clinical trials in INB-200 and INB-100.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2030088d18-bc_inb400new4c.jpg" alt="[MISSING IMAGE: tm2030088d18-bc_inb400new4c.jpg]" height="327" width="608" >
        </div>
        <div style="margin-top:14.69pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 30. INB-400 Administration&#160;</font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">INB-300: Drug-Resistant CAR Gamma-Delta T Cells<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">INB-300 is our DeltEx DRI and CAR gamma-delta T cell preclinical product candidate that combines our expertise in gamma-delta T cells, our DeltEx DRI technology and a novel CAR directed against the chlorotoxin peptide. Chlorotoxin is a 36-amino acid peptide isolated from the venom of </font><font style="font-style:italic;">Leiurus quinquestriatus,</font><font style="letter-spacing:-0.025pt;"> the deathstalker scorpion. The GBM-binding potential of chlorotoxin was first identified through conjugation with the radioisotope and subsequently developed as a tumor paint. Chlorotoxin binds broadly and specifically to GBM while showing minimal off-target binding to normal brain tissues. Chlorotoxin has also been observed to bind multiple solid tumor cancers, including lung, breast and prostate cancers, among others. We have developed a signaling, or cytotoxic, and non-signaling chlorotoxin CAR-T construct that incorporates the gene for MGMT from INB-200, our DeltEx DRI candidate, as shown in Figure 31 below. This CAR-T construct is designed to confer both TMZ- resistance and GBM-targeting capability to transduce gamma-delta T cells. </font><font style="font-style:italic;">In vitro</font><font style="letter-spacing:-0.025pt;"> testing reveals that MGMT-chlorotoxin CAR-modified Jurkat T cell lines specifically bind GBM cell lines and upregulate CD69, indicating CAR-associated activation. We have also created more advanced constructs that include dual chlorotoxin-binding domains that also incorporate the DeltEx DRI technology. Early data show that our new constructs generated synergies with significantly greater CD69 activation than expected from the activity of a single chlorotoxin domain. We are currently transducing the MGMT-chlorotoxin-CAR into gamma-delta T cells and have documented CAR-T expression. We continue to generate animal data to support continued development.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">112</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="tm2030088d20-ph_inb3004c.jpg" alt="[MISSING IMAGE: tm2030088d20-ph_inb3004c.jpg]" height="449" width="421" >
        </div>
        <div style="margin-top:12.2pt; text-align:center; width:456pt; line-height:10pt;font-weight:bold;font-size:8pt;">
          <font style="letter-spacing:-0.089pt;">Figure 31. INB-300, a DeltEx DRI, Dual Chlorotoxin (CLTX) CAR</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">License Agreements</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">Exclusive License Agreement with Emory University, Children&#8217;s Healthcare of Atlanta, Inc. and The UAB Research Foundation<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In June&#160;2016, we entered into an Exclusive License Agreement with the Emory University, Children&#8217;s Healthcare of Atlanta, Inc. and The UAB Research Foundation, or UABRF, as amended from time to time, which we refer to as the Emory license agreement. We amended the Emory license agreement in October&#160;2017 and July&#160;2020. Under the Emory license agreement, we obtained an exclusive worldwide license under certain immunotherapy-related patents and know-how related to gamma-delta T cells developed by the Emory University, Children&#8217;s Healthcare of Atlanta, Inc. and UABRF&#8217;s affiliate, UAB, to develop, make, have made, use, sell, import and otherwise commercialize products that are covered by such patents or otherwise incorporate or use the licensed technology. Such exclusive license is subject to certain rights retained by these institutions and also the U.S. government.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In consideration of the license granted to us under the Emory license agreement, we paid Emory a nominal upfront payment. We are required to pay Emory development milestones totaling up to an aggregate of $1.4&#160;million, low-single-digit to mid-single-digit tiered running royalties on the net sales of the licensed products, including an annual minimum royalty of $0.5 million beginning in the third year following the first sale of a licensed product, increasing to $1.0 million in the fourth year and $1.5 million in the fifth year and thereafter. In addition, we are also required to pay Emory between 1% and 15% of any fees or payments we may receive from our sublicensees, depending on when the sublicense executed. In the event no milestone payments have been paid in certain&#160;years, we will be required to pay an annual license maintenance fee: prior to the 78th-month anniversary of the agreement, $250,000; prior to the 90th-month anniversary of the agreement, $0.5 million; and on or after the eight-year anniversary of the agreement, $1.0 million. The Emory license agreement also requires us to reimburse Emory for the cost of the prosecution and maintenance of the licensed patents.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">113</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Pursuant to the Emory license agreement, we are required to use our best efforts to develop, manufacture and commercialize the licensed product, and are obligated to meet certain specified deadlines in the development of the licensed products.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The term of the Emory license agreement will continue until 15&#160;years after the first commercial sale of the licensed product, or the expiration of the relevant licensed patents, whichever is later. We may terminate the Emory license agreement at will at any time upon prior written notice to Emory. Emory has the right to terminate the Emory license agreement if we materially breach the agreement (including failure to meet our diligence obligations) and fail to cure such breach within specified cure period, if we become bankrupt or insolvent or decide to cease development and commercialization of the licensed product, or if we challenge the validity or enforceability of any licensed patents. For more information related to the intellectual property acquired pursuant to the Emory license agreement, see the section titled &#8220;Business&#8212;Intellectual Property.&#8221;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Exclusive License Agreement with UABRF<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In March&#160;2016, we entered into an Exclusive License Agreement with UABRF, as amended from time to time, which we refer to as the UABRF license agreement. We amended the UABRF license agreement in December&#160;2016, January&#160;2017, June&#160;2017 and November&#160;2018. Under the UABRF license agreement, we obtained an exclusive worldwide license under certain immunotherapy-related patents related to the use of gamma-delta T cells, certain CAR-T cells and combination treatments for cell therapies developed by UAB and owned by UABRF to develop, make, have made, use, sell, import and otherwise commercialize products that are covered by such patents. Such exclusive license is subject to certain rights retained by UABRF and also the U.S. government.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In consideration of the license granted to us under the UABRF license agreement, we paid UABRF a nominal upfront payment and issued 91,250 shares of our common stock to UABRF, which were subject to certain antidilution rights. The antidilution provision required us to issue additional shares of common stock such that UABRF maintained a 2.5% ownership interest in the company until we raised at least $20.0&#160;million through one or more rounds of investment. As of August&#160;2020, we raised an aggregate of $36.6 million through the sale of our securities. Between March&#160;2017 and August&#160;2020, we issued UABRF an additional 151,382 shares of our common stock in satisfaction of this antidilution provision. Accordingly, beginning in September&#160;2020, the shares held by UABRF may be diluted only upon the same terms and conditions of certain founders until the completion of our initial public offering. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In addition, we are required to pay UABRF development milestones totaling up to an aggregate of $1.4&#160;million, lump sum royalties on cumulative net sales totaling up to an aggregate of $22.5&#160;million, mid-single-digit running royalties on our net sales of the licensed products, low single-digit running royalties on net sales of the licensed products by our sublicensees, and a share of certain non-royalty income ranging between 2.5% to 25%, depending on the status of certain clinical trials, that we may receive, including from any sublicensees. The UABRF license agreement also requires us to reimburse UABRF for the cost of the prosecution and maintenance of the licensed patents.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Pursuant to the UABRF license agreement, we are required to use good faith reasonable commercial efforts to develop, manufacture and commercialize the licensed product.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The term of the UABRF license agreement will continue until the expiration of the licensed patents. We may terminate the UABRF license agreement at will at any time upon prior written notice to UABRF. UABRF has the right to terminate the UABRF license agreement if we materially breach the agreement and fail to cure such breach within a specified cure period, if we fail to diligently undertake development and commercialization activities as set forth in the development and commercialization plan, if we underreport our payment obligations or underpay by more than a specified threshold, if we challenge the validity or enforceability of any licensed patents, or if we become bankrupt or insolvent. For more information related to the intellectual property acquired pursuant to the UABRF license agreement, see the section titled &#8220;Business&#8212;Intellectual Property.&#8221;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Sales and Marketing</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Given our stage of development, we have not yet established a commercial organization or distribution capabilities. We plan to build focused capabilities in the United States to commercialize our </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">114</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">development programs focused on allogeneic or autologous, genetically modified gamma-delta T cell therapies for the treatment of cancer, where the patient populations and medical specialists for the indications we are targeting are sufficiently concentrated to allow us to effectively promote our products, if approved for commercial sale, with a targeted sales team. In other markets for which commercialization may be less capital efficient for us, we may selectively pursue strategic collaborations with third parties in order to maximize the commercial potential of our product candidates.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Manufacturing</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We do not own or operate manufacturing facilities for the production of our current product candidates. We currently rely on third-party contract manufacturers for all of our required raw materials, manufacturing devices, active pharmaceutical ingredients, lentiviral vectors and finished product for our preclinical research and clinical trials. We have an agreement with an academic GMP cell therapy lab to manufacture product candidates for our Phase 1 clinical trials. The multi-year agreement allows our medical technologists direct access to the facility to assist the GMP facility staff. The agreement provides for manufacturing on a per-patient basis, We do not have any current contractual relationship for the manufacture of Phase&#160;2/3 clinical trials or commercial supplies. We intend to enter into agreements with third-party contract manufacturers and one or more backup manufacturers for future production. We are analyzing the feasibility of building manufacturing capabilities for future development and commercial quantities of any products that we develop. Such products will need to be manufactured in facilities, and by processes, that comply with the requirements of the FDA and the regulatory agencies of other jurisdictions in which we are seeking approval.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Competition</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The biotechnology industry is characterized by intense and dynamic competition to develop new technologies and proprietary therapies. Any product candidates that we successfully develop and commercialize will have to compete with existing therapies and new therapies that may become available in the future. We believe that our proprietary gamma-delta T cell platform and our product candidates, strategic collaborations and scientific and clinical expertise may provide us with competitive advantages. However, we face potential competition from various sources, including larger and better-funded pharmaceutical, specialty pharmaceutical and biotechnology companies, as well as from academic institutions, governmental agencies and public and private research institutions. The key competitive factors affecting the success of any product that may be approved by regulators will include the efficacy, safety profile, pricing, method of administration and level of promotional activity.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our competitors in the field of gamma-delta T cell therapy include Adaptate Biotherapeutics Ltd, American Gene Technologies International Inc., CytoMed Therapeutics Pte Ltd, Editas Medicine, Inc., Enochian BioSciences, Inc. GammaDelta Therapeutics Limited, ImCheck Therapeutics SAS, Immatics Biotechnologies GmbH, Lava Therapeutics B.V., Leucid Bio Ltd, PhosphoGam Inc., Sandhill Therapeutics, Inc. and Shattuck Labs, Inc., all of which remain preclinical. Four competitors, Adicet Bio, Inc., Avalon Globocare Corp., Gadeta BV and TC BioPharm Limited, have initiated Phase&#160;1 clinical trials. Our gamma-delta T cell product candidates may also compete with other cell and molecule-based immunotherapy approaches using and/or targeting natural killer cells, T-cells and dendritic cells.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Many of our current or potential competitors have greater financial and other resources, larger research and development staffs, and more experienced capabilities in researching, developing and testing products than we do. Many of these companies also have more experience in conducting clinical trials, obtaining FDA and other regulatory approvals, and manufacturing, marketing and distributing therapeutic products. Smaller or clinical-stage companies like us may successfully compete by establishing collaborative relationships with larger pharmaceutical companies or academic institutions. Accordingly, our competitors may be more successful than us in obtaining approval for treatments and achieving widespread market acceptance. Our competitors&#8217; treatments may be more effective, or more effectively marketed and sold, than any treatment we may commercialize and they may render our treatments obsolete or non-competitive before we can recover the expenses of developing and commercializing any of our treatments.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Mergers and acquisitions in the biotechnology and pharmaceutical industries may result in even more resources being concentrated among a smaller number of our competitors. These competitors </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">115</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">also compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical study sites and subject registration for clinical studies, as well as in acquiring technologies complementary to, or necessary for, our programs. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We anticipate that we will face intense and increasing competition as new therapies enter the market and advanced technologies become available. We expect any treatments that we develop and commercialize to compete on the basis of, among other things, efficacy, safety, convenience of administration and delivery, price, the level of generic competition and the availability of reimbursement from government and other third-party payers.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize products that are safer, more effective, have a better safety profile, are more convenient or are less expensive than any products that we may develop. Our competitors also may obtain FDA or other regulatory approval for their products more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market position before we are able to enter the market.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Intellectual Property</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Overview<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We actively seek to protect our proprietary technology, inventions, improvements to inventions and other intellectual property that is commercially important to the development of our business by a variety of means, such as seeking, maintaining and defending patent rights, whether developed internally or licensed from third parties. We also may rely on trade secrets and know-how relating to our proprietary technology platform, on continuing technological innovation and on future in-licensing opportunities to develop, strengthen and maintain the strength of our position in the field of gene therapy that may be important for the development of our business. Additional regulatory protection may also be afforded through data exclusivity, market exclusivity and patent-term extensions where available.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">As of June 30, 2021, we owned, co-owned or exclusively licensed two issued U.S. patents, two issued European patents, one allowed patent application in Europe, one issued patent in Australia, one allowed patent application in Israel, eight pending U.S. applications 47 other foreign national-stage applications, including four European regional-phase applications that are important to the development of our business.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Our policy is to file patent applications to protect proprietary technology, inventions and improvements to inventions and other intellectual property that may be commercially important to the development of our business. We also intend to seek additional patent protection or rely upon trade secret rights to protect other technologies that may be used to manufacture and develop our gamma-delta T cell products. We are a party to exclusive license agreements that grant us rights to use specific technologies in our gamma-delta T cell products and in the manufacturing and development of our products. For more information, see the section titled &#8220;Business&#8212;License Agreements.&#8221;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Our Patent Portfolio<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="margin-left:20pt; margin-top:2pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Patent applications directed to our most advanced programs are summarized below.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:4pt; width:436pt; line-height:12pt;font-style:italic;">INB-200<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Pursuant to the Emory license agreement, we have licensed two issued U.S. patents, two issued European patents (each which have been widely validated in Europe), one allowed European patent application and one U.S pending patent application. These patents and applications contain claims or supporting disclosures directed to the INB-200 composition of matter and to methods of treating diseases of interest using INB-200. Issued patents and patents issuing from the pending applications, if any, are expected to expire in 2030, without accounting for potential patent term extensions and adjustments. </font>
        </div>
        <div style="margin-left:20pt; margin-top:4pt; width:436pt; line-height:12pt;font-style:italic;">INB-200 and Immune Checkpoint Inhibitor Combination Therapy<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We co-own one pending U.S. patent application, one issued Australian patent and nine other national stage patent applications including a European regional phase application with The UAB </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">116</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Research Foundation. These patents and applications contain claims or supporting disclosures directed to methods of treating diseases of interest using INB-200 in combination with immune checkpoint inhibitor therapies. Patents issuing from these patent applications, if any, are expected to expire in 2037, without accounting for potential patent term extensions and adjustments.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:4pt; width:436pt; line-height:12pt;font-style:italic;">INB-200 and PARP Inhibitor Combination Therapy<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We own one pending U.S. patent application and eight other foreign national stage applications that contain claims or supporting disclosures directed to methods of treating diseases of interest using INB-200 in combination with PARP inhibitor therapies. Patents issuing from these patent applications, if any, are expected to expire in 2039, without accounting for potential patent term extensions and adjustments.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:4pt; width:436pt; line-height:12pt;font-style:italic;">INB-100<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Pursuant to the UABRF license agreement, we have licensed one U.S patent application and 10 foreign national-stage applications, including a European regional phase application. These patent applications contain claims or supporting disclosures directed to the INB-100 composition of matter and to methods of treating diseases of interest using INB-100. Patents issuing from these patent applications, if any, are expected to expire in 2036, without accounting for potential patent term extensions and adjustments.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:4pt; width:436pt; line-height:12pt;font-style:italic;">INB-300<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Pursuant to the UABRF license agreement, we have also licensed one pending U.S. patent application and nine foreign national-stage applications, including a European regional phase application. These patent applications contain claims or supporting disclosures directed to the INB-300 composition of matter and to methods of treating diseases of interest using INB-300. Patents issuing from these patent applications, if any, are expected to expire in 2037, without accounting for potential patent term extensions and adjustments.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We also own two pending U.S. provisional application that contains claims or supporting disclosures directed to additional INB-300 compositions and to methods of treating diseases of interest. Patents issuing from this patent application, if any, are expected to expire in 2042, without accounting for potential patent term extensions and adjustments.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Patent Term and Term Extensions<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Individual patents have terms for varying periods depending on the date of filing of the patent application or the date of patent issuance and the legal term of patents in the countries in which they are obtained. Generally, utility patents issued for applications filed in the United States are granted a term of 20&#160;years from the earliest effective filing date of a non-provisional patent application. In addition, in certain instances, the term of a U.S. patent can be extended to recapture a portion of the United States Patent and Trademark Office, or the USPTO, delay in issuing the patent as well as a portion of the term effectively lost as a result of the FDA regulatory review period. However, as to the FDA component, the restoration period cannot be longer than five&#160;years and the restoration period cannot extend the patent term beyond 14&#160;years from FDA approval. In addition, only one patent applicable to an approved drug is eligible for the extension, and only those claims covering the approved drug, a method for using it, or a method of manufacturing may be extended. The duration of foreign patents varies in accordance with provisions of applicable local law, but typically is also 20&#160;years from the earliest effective filing date. All taxes, annuities or maintenance fees for a patent, as required by the USPTO and various foreign jurisdictions, must be timely paid in order for the patent to remain in force during this period of time.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The actual protection afforded by a patent may vary on a product by product basis, from country to country, and can depend upon many factors, including the type of patent, the scope of its coverage, the availability of regulatory-related extensions and the availability of legal remedies in a particular country and the validity and enforceability of the patent.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Our patents and patent applications may be subject to procedural or legal challenges by others. We may be unable to obtain, maintain and protect the intellectual property rights necessary to conduct our business, and we may be subject to claims that we infringe or otherwise violate the intellectual </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">117</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">property rights of others, which could materially harm our business. For more information, see the section titled &#8220;Risk Factors&#8212;Risks Related to Our Intellectual Property.&#8221;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Trade Secrets and Know-How<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We also rely on trade secrets, know-how, continuing technological innovation and confidential information to develop and maintain our proprietary position and protect aspects of our business that are not amenable to, or that we do not consider appropriate for, patent protection, including our proprietary processes for expanding and activating therapeutic quantities of gamma-delta T cells and modified gamma-delta T cells. We seek to protect our proprietary technology and processes, in part, by confidentiality agreements and invention assignment agreements with our employees, consultants, scientific advisors, contractors and others who may have access to proprietary information, under which they are bound to assign to us inventions made during the term of their employment or term of service. These agreements may be breached, and we may not have adequate remedies for any breach. In addition, our trade secrets may otherwise become known or be independently discovered by competitors. To the extent that our contractors, commercial partners, collaborators, employees, and consultants use intellectual property owned by others in their work for us, disputes may arise as to the rights in related or resulting know-how and inventions. For more information, see the section titled &#8220;Risk Factors&#8212;Risks Related to Our Intellectual Property.&#8221;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We also seek to preserve the integrity and confidentiality of our data and trade secrets by maintaining physical security of our premises and physical and electronic security of our information technology systems.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Government Regulation</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The FDA and other regulatory authorities at federal, state, and local levels, as well as in foreign countries, extensively regulate, among other things, the research, development, testing, manufacture, quality control, import, export, safety, effectiveness, labeling, packaging, storage, distribution, record keeping, approval, advertising, promotion, marketing, post-approval monitoring, and post-approval reporting of biologics such as those we are developing. We, along with third-party contractors, will be required to navigate the various preclinical, clinical and commercial approval requirements of the governing regulatory agencies of the countries in which we wish to conduct studies or seek approval or licensure of our product candidates.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The process required by the FDA before biologic product candidates may be marketed in the United States generally involves the following:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">completion of preclinical laboratory tests and animal studies performed in accordance with the FDA&#8217;s current Good Laboratory Practices regulation;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">submission to the FDA of an IND, which must become effective before clinical trials may begin and must be updated annually or when significant changes are made;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">approval by an independent Institutional Review Board, or IRB, or ethics committee at each treatment site before the trial is commenced;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">performance of adequate and well controlled human clinical trials to establish the safety, purity and potency of the proposed biologic product candidate for its intended purpose;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">preparation of and submission to the FDA of a BLA after completion of all pivotal clinical trials;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">satisfactory completion of an FDA Advisory Committee review, if applicable;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">a determination by the FDA within 60&#160;days of its receipt of a BLA to file the application for review;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">satisfactory completion of an FDA pre-approval inspection of the manufacturing facility or facilities at which the proposed product is produced to assess compliance with cGMP and to assure that the facilities, methods and controls are adequate to preserve the biological product&#8217;s continued safety, purity and potency, and of selected clinical investigation sites to assess compliance with Good Clinical Practices, or GCP; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">FDA review and approval of the BLA to permit commercial marketing of the product for particular indications for use in the United States.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">118</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Preclinical and Clinical Development<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Prior to beginning the first clinical trial with a product candidate, we must submit an IND to the FDA. An IND is a request for authorization from the FDA to administer an investigational new drug product to humans. The central focus of an IND submission is on the general investigational plan and the protocol(s) for clinical studies. The IND also includes results of animal and in vitro studies assessing the toxicology, pharmacokinetics, pharmacology, and pharmacodynamic characteristics of the product; chemistry, manufacturing, and controls information; and any available human data or literature to support the use of the investigational product. An IND must become effective before human clinical trials may begin. The IND automatically becomes effective 30&#160;days after receipt by the FDA, unless the FDA, within the 30-day time period, raises safety concerns or questions about the proposed clinical trial. In such a case, the IND may be placed on clinical hold and the IND sponsor and the FDA must resolve any outstanding concerns or questions before the clinical trial can begin. Submission of an IND therefore may or may not result in FDA authorization to begin a clinical trial.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Supervision of human gene transfer trials includes evaluation and assessment by an Institutional Biosafety Committee, or IBC, a local institutional committee that reviews and oversees research utilizing recombinant or synthetic nucleic acid molecules at that institution, as set forth in the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, or NIH Guidelines. The IBC assesses the safety of the research and identifies any potential risk to public health or the environment, and such review may result in some delay before initiation of a clinical trial. While the NIH Guidelines are not mandatory unless the research in question is being conducted at or sponsored by institutions receiving NIH funding of recombinant or synthetic nucleic acid molecule research, many companies and other institutions not otherwise subject to the NIH Guidelines voluntarily follow them.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Clinical trials involve the administration of the investigational product to human subjects under the supervision of qualified investigators in accordance with GCPs, which include the requirement that all research subjects provide their informed consent for their participation in any clinical study. Clinical trials are conducted under protocols detailing, among other things, the objectives of the study, the parameters to be used in monitoring safety and the effectiveness criteria to be evaluated. A separate submission to the existing IND must be made for each successive clinical trial conducted during product development and for any subsequent protocol amendments. Furthermore, an independent IRB for each site proposing to conduct the clinical trial must review and approve the plan for any clinical trial and its informed consent form before the clinical trial begins at that site and must monitor the study until completed. Regulatory authorities, the IRB or the sponsor may suspend a clinical trial at any time on various grounds, including a finding that the subjects are being exposed to an unacceptable health risk or that the trial is unlikely to meet its stated objectives. Some studies also include oversight by an independent group of qualified experts organized by the clinical study sponsor, known as a data safety monitoring board, which provides authorization for whether or not a study may move forward at designated check points based on access to certain data from the study and may halt the clinical trial if it determines that there is an unacceptable safety risk for subjects or other grounds, such as no demonstration of efficacy. There are also requirements governing the reporting of ongoing clinical studies and clinical study results to public registries.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">For purposes of BLA approval, human clinical trials are typically conducted in three sequential phases that may overlap.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">Phase&#160;1&#8212;The investigational product is initially introduced into healthy human subjects or patients with the target disease or condition. These studies are designed to test the safety, dosage tolerance, absorption, metabolism and distribution of the investigational product in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">Phase&#160;2&#8212;The investigational product is administered to a limited patient population with a specified disease or condition to evaluate the preliminary efficacy, optimal dosages and dosing schedule and to identify possible adverse side effects and safety risks. Multiple Phase&#160;2 clinical trials may be conducted to obtain information prior to beginning larger and more expensive Phase&#160;3 clinical trials.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">Phase&#160;3&#8212;The investigational product is administered to an expanded patient population to further evaluate dosage, to provide statistically significant evidence of clinical efficacy and to </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">119</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">further test for safety, generally at multiple geographically dispersed clinical trial sites. These clinical trials are intended to establish the overall risk/benefit ratio of the investigational product and to provide an adequate basis for product approval.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In some cases, the FDA may require, or companies may voluntarily pursue, additional clinical trials after a product is approved to gain more information about the product. These so- called Phase&#160;4 studies may be made a condition to approval of the BLA. Concurrent with clinical trials, companies may complete additional animal studies and develop additional information about the biological characteristics of the product candidate and must finalize a process for manufacturing the product in commercial quantities in accordance with cGMP requirements. The manufacturing process must be capable of consistently producing quality batches of the product candidate and, among other things, must develop methods for testing the identity, strength, quality and purity of the final product, or for biologics, the safety, purity and potency. Additionally, appropriate packaging must be selected and tested, and stability studies must be conducted to demonstrate that the product candidate does not undergo unacceptable deterioration over its shelf life.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">BLA Submission and Review<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Assuming successful completion of all required testing in accordance with all applicable regulatory requirements, the results of product development, nonclinical studies and clinical trials are submitted to the FDA as part of a BLA requesting approval to market the product for one or more indications. The BLA must include all relevant data available from pertinent preclinical and clinical studies, including negative or ambiguous results as well as positive findings, together with detailed information relating to the product&#8217;s chemistry, manufacturing, controls, and proposed labeling, among other things. The submission of a BLA requires payment of a substantial application user fee to FDA, unless a waiver or exemption applies, and the sponsor of an approved BLA is also subject to an annual program fee.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Once a BLA has been submitted, the FDA&#8217;s goal is to review standard applications within ten&#160;months after it accepts the application for filing, or, if the application qualifies for priority review, six&#160;months after the FDA accepts the application for filing. In both standard and priority reviews, the review process is often significantly extended by FDA requests for additional information or clarification. The FDA reviews a BLA to determine, among other things, whether a product is safe, pure and potent and the facility in which it is manufactured, processed, packed, or held meets standards designed to assure the product&#8217;s continued safety, purity and potency. The FDA may convene an advisory committee to provide clinical insight on application review questions. Before approving a BLA, the FDA will typically inspect the facility or facilities where the product is manufactured, including, as applicable, for compliance with Good Tissue Practices. The FDA will not approve an application unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications. Additionally, before approving a BLA, the FDA will typically inspect one or more treatment sites to assure compliance with GCP. If the FDA determines that the application, manufacturing process or manufacturing facilities are not acceptable, it will outline the deficiencies in the submission and often will request additional testing or information. Notwithstanding the submission of any requested additional information, the FDA ultimately may decide that the application does not satisfy the regulatory criteria for approval.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">After the FDA evaluates a BLA and conducts inspections of manufacturing facilities where the investigational product and/or its drug substance will be produced, the FDA may issue an approval letter or a Complete Response letter. An approval letter authorizes commercial marketing of the product with specific prescribing information for specific indications. A Complete Response letter will describe all of the deficiencies that the FDA has identified in the BLA, except that where the FDA determines that the data supporting the application are inadequate to support approval, the FDA may issue the Complete Response letter without first conducting required inspections, testing submitted product lots, and/or reviewing proposed labeling. In issuing the Complete Response letter, the FDA may recommend actions that the applicant might take to place the BLA in condition for approval, including requests for additional information or clarification. The FDA may delay or refuse approval of a BLA if applicable regulatory criteria are not satisfied, require additional testing or information and/or require post-marketing testing and surveillance to monitor safety or efficacy of a product.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">120</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">If regulatory approval of a product is granted, such approval will be granted for particular indications and may entail limitations on the indicated uses for which such product may be marketed. For example, the FDA may approve the BLA with a Risk Evaluation and Mitigation Strategy, or REMS, to ensure the benefits of the product outweigh its risks. A REMS is a safety strategy to manage a known or potential serious risk associated with a product and to enable patients to have continued access to such medicines by managing their safe use, and could include medication guides, physician communication plans, or elements to assure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. The FDA also may condition approval on, among other things, changes to proposed labeling or the development of adequate controls and specifications. Once approved, the FDA may withdraw the product approval if compliance with pre- and post-marketing requirements is not maintained or if problems occur after the product reaches the marketplace. The FDA may require one or more Phase&#160;4 post market studies and surveillance to further assess and monitor the product&#8217;s safety and effectiveness after commercialization and may limit further marketing of the product based on the results of these post-marketing studies.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Expedited Development and Review Programs<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The FDA offers a number of expedited development and review programs for qualifying product candidates, including fast track designation, breakthrough therapy designation, accelerate approval and priority review. The fast track program is intended to expedite or facilitate the process for reviewing new product candidates that meet certain criteria. Specifically, new products are eligible for fast track designation if they are intended to treat a serious or life-threatening disease or condition and demonstrate the potential to address unmet medical needs for the disease or condition. Fast track designation applies to the combination of the product and the specific indication for which it is being studied. The sponsor of a fast track product has opportunities for frequent interactions with the review team during product development and, once a BLA is submitted, the product may be eligible for priority review. A fast track product may also be eligible for rolling review, where the FDA may consider for review sections of the BLA on a rolling basis before the complete application is submitted, if the sponsor provides a schedule for the submission of the sections of the BLA and the payment of applicable user fees, the FDA agrees to accept sections of the BLA and determines that the schedule is acceptable, and the sponsor pays any required user fees upon submission of the first section of the BLA.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">A product candidate intended to treat a serious or life-threatening disease or condition may also be eligible for breakthrough therapy designation to expedite its development and review. Such a product candidate can receive breakthrough therapy designation if preliminary clinical evidence indicates that the product may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. The designation includes all of the fast track program features, which means that the sponsor may file sections of the BLA for review on a rolling basis if certain conditions are satisfied, including an agreement with the FDA on the proposed schedule for submission of portions of the application and the payment of applicable user fees before the FDA may initiate a review. The FDA may take other actions appropriate to expedite the development and review of the product candidate, including holding meetings with the sponsor and providing timely advice to, and interactive communication with, the sponsor regarding the development program.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Any marketing application for a biologic submitted to the FDA for approval, including a product with a fast track designation and/or breakthrough therapy designation, may be eligible for other types of FDA programs intended to expedite the FDA review and approval process, such as priority review and accelerated approval. A product candidate is eligible for priority review if it treats a serious or life-threatening disease or condition and, if approved, would provide a significant improvement in the safety or effectiveness of the treatment, diagnosis or prevention of a serious disease or condition. For products containing new molecular entities, priority review designation means the FDA&#8217;s goal is to take action on the marketing application within six&#160;months of the 60-day filing date (compared with ten&#160;months under standard review).</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Additionally, product candidates studied for their safety and effectiveness in treating serious or life-threatening diseases or conditions may be eligible for accelerated approval upon a determination that the product candidate has an effect on a surrogate endpoint that is reasonably likely to predict clinical </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">121</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">benefit, or on a clinical endpoint that can be measured earlier than irreversible morbidity or mortality, that is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit, taking into account the severity, rarity, or prevalence of the condition and the availability or lack of alternative treatments. As a condition of accelerated approval, the FDA will generally require the sponsor to perform adequate and well controlled post-marketing clinical studies to verify the clinical benefit in relationship to the surrogate endpoint or ultimate outcome in relationship to the clinical benefit and describe the anticipated effect on irreversible morbidity or mortality or other clinical benefit. In addition, the FDA currently requires as a condition for accelerated approval pre-approval of promotional materials, which could adversely impact the timing of the commercial launch of the product. The FDA may withdraw approval of a drug or indication approved under accelerated approval if, for example, the confirmatory trial fails to verify the predicted clinical benefit of the product.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In 2017, FDA established a new regenerative medicine advanced therapy, or RMAT, designation as part of its implementation of the 21st Century Cures Act. The RMAT designation is intended to fulfill the 21st Century Cures Act requirement that FDA facilitate an efficient development program for, and expedite review of, any drug that meets the following criteria: (1)&#160;it qualifies as a RMAT, which is defined as a cell therapy, therapeutic tissue engineering product, human cell and tissue product, or any combination product using such therapies or products, with limited exceptions; (2)&#160;it is intended to treat, modify, reverse, or cure a serious or life-threatening disease or condition; and (3)&#160;preliminary clinical evidence indicates that the drug has the potential to address unmet medical needs for such a disease or condition. Like breakthrough therapy designation, RMAT designation provides potential benefits that include more frequent meetings with FDA to discuss the development plan for the product candidate and eligibility for rolling review and priority review. Products granted RMAT designation may also be eligible for accelerated approval on the basis of a surrogate or intermediate endpoint reasonably likely to predict long-term clinical benefit, or reliance upon data obtained from a meaningful number of sites, including through expansion to additional sites. Once approved, when appropriate, the FDA can permit fulfillment of post-approval requirements under accelerated approval through the submission of clinical evidence, clinical studies, patient registries, or other sources of real world evidence such as electronic health records; through the collection of larger confirmatory datasets; or through post-approval monitoring of all patients treated with the therapy prior to approval.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Fast track designation, breakthrough therapy designation, priority review, and RMAT designation do not change the standards for approval but may expedite the development or approval process. Even if a product qualifies for one or more of these programs, the FDA may later decide that the product no longer meets the conditions for qualification or decide that the time period for FDA review and approval will not be shortened.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Orphan Drug Designation<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Under the Orphan Drug Act, the FDA may grant orphan designation to a drug or biologic intended to treat a rare disease or condition, which is a disease or condition that affects fewer than 200,000 individuals in the United States, or more than 200,000 individuals in the United States for which there is no reasonable expectation that the cost of developing and making available in the United States a drug or biologic for this type of disease or condition will be recovered from sales in the United States for that drug or biologic. Orphan drug designation must be requested before submitting a BLA. After the FDA grants orphan drug designation, the generic identity of the therapeutic agent and its potential orphan use are disclosed publicly by the FDA. The orphan drug designation does not convey any advantage in, or shorten the duration of, the regulatory review or approval process.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">If a product that has orphan drug designation subsequently receives the first FDA approval for the disease for which it has such designation, the product is entitled to orphan drug exclusive approval (or exclusivity), which means that the FDA may not approve any other applications, including a full BLA, to market the same biologic for the same indication for seven&#160;years, except in limited circumstances, such as a showing of clinical superiority to the product with orphan drug exclusivity. Orphan drug exclusivity does not prevent FDA from approving a different drug or biologic for the same disease or condition, or the same drug or biologic for a different disease or condition. Among the other benefits of orphan drug designation are tax credits for certain research and a waiver of the BLA application fee.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">122</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">A designated orphan drug may not receive orphan drug exclusivity if it is approved for a use that is broader than the indication for which it received orphan designation. In addition, exclusive marketing rights in the United States may be lost if the FDA later determines that the request for designation was materially defective, if the second applicant demonstrates its product is clinically superior to the approved product with orphan exclusivity, or if the manufacturer is unable to assure sufficient quantities of the product to meet the needs of patients with the rare disease or condition. Orphan drug designation may also entitle a party to financial incentives such as opportunities for grant funding towards clinical trial costs, tax advantages and user-fee waivers.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Post-Approval Requirements<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Any products manufactured or distributed by us pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including, among other things, requirements relating to record-keeping, reporting of adverse experiences, periodic reporting, product sampling and distribution, and advertising and promotion of the product. After approval, most changes to the approved product, such as adding new indications or other labeling claims, are subject to prior FDA review and approval. There also are continuing user fee requirements, under which FDA assesses an annual program fee for each product identified in an approved BLA. Biologic manufacturers and their subcontractors are required to register their establishments with the FDA and certain state agencies, and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with cGMP, which impose certain procedural and documentation requirements upon us and our third-party manufacturers. Changes to the manufacturing process are strictly regulated, and, depending on the significance of the change, may require prior FDA approval before being implemented. FDA regulations also require investigation and correction of any deviations from cGMP and impose reporting requirements upon us and any third-party manufacturers that we may decide to use. Accordingly, manufacturers must continue to expend time, money and effort in the area of production and quality control to maintain compliance with cGMP and other aspects of regulatory compliance.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The FDA may withdraw approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information; imposition of post-market studies or clinical studies to assess new safety risks; or imposition of distribution restrictions or other restrictions under a REMS program. Other potential consequences include, among other things:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">restrictions on the marketing or manufacturing of a product, complete withdrawal of the product from the market or product recalls;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">fines, warning letters or holds on post-approval clinical studies;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">refusal of the FDA to approve pending applications or supplements to approved applications, or suspension or revocation of existing product approvals;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">product seizure or detention, or refusal of the FDA to permit the import or export of products;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">consent decrees, corporate integrity agreements, debarment or exclusion from federal healthcare programs;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">mandated modification of promotional materials and labeling and the issuance of corrective information;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.91pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the issuance of safety alerts, Dear Healthcare Provider letters, press releases and other communications containing warnings or other safety information about the product; or</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">injunctions or the imposition of civil or criminal penalties.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The FDA closely regulates the marketing, labeling, advertising and promotion of biologics. A company can make only those claims relating to safety and efficacy, purity and potency that are approved by the FDA and in accordance with the provisions of the approved label. Manufacturers also must comply with the FDA&#8217;s advertising and promotion requirements, such as those related to direct-to-consumer advertising, the prohibition on promoting products for uses or in patient populations that are not described in the product&#8217;s approved labeling (known as &#8220;off-label use&#8221;), industry-sponsored scientific and educational activities, and promotional activities involving the internet. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off label uses. Failure to comply </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">123</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">with these requirements can result in, among other things, adverse publicity, warning letters, corrective advertising and potential civil and criminal penalties. Physicians may prescribe legally available products for uses that are not described in the product&#8217;s labeling and that differ from those tested by us and approved by the FDA. Such off-label uses are common across medical specialties. Physicians may believe that such off-label uses are the best treatment for many patients in varied circumstances. The FDA does not regulate the behavior of physicians in their choice of treatments. The FDA does, however, restrict manufacturer&#8217;s communications on the subject of off-label use of their products.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Biosimilars and Reference Product Exclusivity<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, or collectively, the ACA, signed into law in 2010, includes a subtitle called the Biologics Price Competition and Innovation Act of 2009, or BPCIA, which created an abbreviated approval pathway for biological products that are biosimilar to or interchangeable with an FDA-approved reference biological product. To date, a number of biosimilars have been licensed under the BPCIA, and numerous biosimilars have been approved in Europe. The FDA has issued several guidance documents outlining an approach to review and approval of biosimilars.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Biosimilarity, which requires that there be no clinically meaningful differences between the biological product and the reference product in terms of safety, purity, and potency, can be shown through analytical studies, animal studies, and a clinical study or studies. Interchangeability requires that a product is biosimilar to the reference product and the product must demonstrate that it can be expected to produce the same clinical results as the reference product in any given patient and, for products that are administered multiple times to an individual, the biologic and the reference biologic may be alternated or switched after one has been previously administered without increasing safety risks or risks of diminished efficacy relative to exclusive use of the reference biologic. Complexities associated with the larger, and often more complex, structures of biological products, as well as the processes by which such products are manufactured, pose significant hurdles to implementation of the abbreviated approval pathway that are still being worked out by the FDA.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Under the BPCIA, an application for a biosimilar product may not be submitted to the FDA until four&#160;years following the date that the reference product was first licensed by the FDA. In addition, the approval of a biosimilar product may not be made effective by the FDA until 12&#160;years from the date on which the reference product was first licensed. During this 12-year period of exclusivity, another company may still market a competing version of the reference product if the FDA approves a full BLA for the competing product containing that applicant&#8217;s own preclinical data and data from adequate and well controlled clinical trials to demonstrate the safety, purity and potency of its product. The BPCIA also created certain exclusivity periods for biosimilars approved as interchangeable products. At this juncture, it is unclear whether products deemed &#8220;interchangeable&#8221; by the FDA will, in fact, be readily substituted by pharmacies, which are governed by state pharmacy law.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">A biological product can also obtain pediatric market exclusivity in the United States. Pediatric exclusivity, if granted, adds six&#160;months to existing exclusivity periods and patent terms. This six-month exclusivity, which runs from the end of other exclusivity protection or patent term, may be granted based on the voluntary completion of a pediatric study in accordance with an FDA-issued &#8220;Written Request&#8221; for such a study.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The BPCIA is complex and continues to be interpreted and implemented by the FDA. In addition, recent government proposals have sought to reduce the 12-year reference product exclusivity period. Other aspects of the BPCIA, some of which may impact the BPCIA exclusivity provisions, have also been the subject of recent litigation. As a result, the ultimate impact, implementation, and impact of the BPCIA is subject to significant uncertainty.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Other Healthcare Laws and Compliance Requirements<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In the United States, our activities are potentially subject to regulation by various federal, state and local authorities in addition to the FDA, including but not limited to, the Centers for Medicare &amp; Medicaid Services, or CMS, other divisions of the U.S. Department of Health and Human Services, or HHS, (such as the Office of Inspector General and the Health Resources and Service Administration), the Department of Justice, or the DOJ, and individual U.S. Attorney offices within the DOJ, and state and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">124</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">local governments. For example, research, sales, marketing activities and scientific/educational grant programs must have to comply with the anti-fraud and abuse provisions of the Social Security Act, the false claims laws, transparency laws, the health information privacy and security laws, and similar state laws, each as amended, as applicable.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The federal Anti-Kickback Statute prohibits, among other things, any person or entity, from knowingly and willfully offering, paying, soliciting or receiving any remuneration, directly or indirectly, overtly or covertly, in cash or in kind, to induce or in return for purchasing, leasing, ordering or arranging for the purchase, lease or order of any item or service reimbursable, in whole or in part, under Medicare, Medicaid or other federal healthcare programs. The term remuneration has been interpreted broadly to include anything of value. The federal Anti-Kickback Statute has been interpreted to apply to arrangements between therapeutic product manufacturers on one hand and prescribers and purchasers on the other. In addition, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The federal false claims laws, including the False Claims Act, or FCA, which can be enforced by private citizens through civil qui tam actions and civil monetary penalty laws prohibit any person or entity from, among other things, knowingly presenting, or causing to be presented, a false or fraudulent claim for payment to, or approval by, the federal healthcare programs, including Medicare and Medicaid, or knowingly making, using, or causing to be made or used a false record or statement material to a false or fraudulent claim to the federal government. A claim includes &#8220;any request or demand&#8221; for money or property presented to the U.S. government. For instance, historically, pharmaceutical and other healthcare companies have been prosecuted under these laws for allegedly providing free product to customers with the expectation that the customers would bill federal programs for the product. Additionally, companies have been prosecuted for, among other things, causing false claims to be submitted because of the companies&#8217; marketing of the product for unapproved, off-label, and thus generally non-reimbursable, uses. Further, a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the FCA.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The Health Insurance Portability and Accountability, or HIPAA created additional federal criminal statutes that prohibit, among other things, knowingly and willfully executing, or attempting to execute, a scheme to defraud or to obtain, by means of false or fraudulent pretenses, representations or promises, any money or property owned by, or under the control or custody of, any healthcare benefit program, including private third-party payors, willfully obstructing a criminal investigation of a healthcare offense, and knowingly and willfully falsifying, concealing or covering up by trick, scheme or device, a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services. Like the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We may be subject to data privacy and security regulations by both the federal government and the states in which we conduct our business. HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH, and their implementing regulations, impose requirements relating to the privacy, security and transmission of individually identifiable health information on certain healthcare providers, healthcare clearinghouses, and health plans, known as covered entities, as well as independent contractors, or agents of covered entities that receive or obtain individually identifiable health information in connection with providing a service on behalf of a covered entity, known as a business associates and their covered subcontractors. Among other things, HITECH makes HIPAA&#8217;s privacy and security standards directly applicable to business associates. HITECH also created four new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce HIPAA and seek attorneys&#8217; fees and costs associated with pursuing federal civil actions. In addition, many state laws govern the privacy and security of health information in specified circumstances, many of which differ from each other in significant ways, are often not pre-empted by HIPAA, and may have a more prohibitive effect than HIPAA, thus complicating compliance efforts.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">125</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In addition, many pharmaceutical manufacturers must calculate and report certain price reporting metrics to the government, such as average sales price and best price. Further, these prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs or private payors and by any future relaxation of laws that presently restrict imports of drugs from countries where they may be sold at lower prices than in the United States. It is difficult to predict how Medicare coverage and reimbursement policies will be applied to our products in the future and coverage and reimbursement under different federal healthcare programs are not always consistent. Medicare reimbursement rates may also reflect budgetary constraints placed on the Medicare program.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Additionally, the federal Physician Payments Sunshine Act, or the Sunshine Act, within the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, or ACA, and its implementing regulations, require that certain manufacturers of drugs, devices, biological and medical supplies for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program (with certain exceptions) report annually to CMS information related to certain payments or other transfers of value made or distributed to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, or to entities or individuals at the request of, or designated on behalf of, the physicians and teaching hospitals and to report annually certain ownership and investment interests held by physicians and their immediate family members. Beginning in 2022, applicable manufacturers also will be required to report such information regarding payments and transfers of value provided, during the previous year to physician assistants, nurse practitioners, clinical nurse specialists, anesthesiologist assistants, certified nurse anesthetists and certified nurse-midwives. In addition, many states also govern the reporting of payments or other transfers of value, many of which differ from each other in significant ways, are often not pre-empted, and may have a more prohibitive effect than the Sunshine Act, thus further complicating compliance efforts.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In addition, many states and foreign jurisdictions have enacted analogous versions of these laws. For example, many states have similar, and typically more prohibitive, fraud and abuse statutes or regulations that apply to items and services reimbursed under Medicaid and other state programs, or, in several states, apply regardless of the payor. In addition, many states also govern the reporting of payments or other transfers of value, many of which differ from each other in significant ways, are often not pre-empted, and may have a more prohibitive effect than the Sunshine Act, thus further complicating compliance efforts. Further, some states require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and relevant federal government compliance guidance and restrict marketing practices or require disclosure of marketing expenditures and pricing information. State and foreign laws may also govern the privacy and security of health information in some circumstances. These data privacy and security laws may differ from each other in significant ways and often are not pre-empted by HIPAA, which may complicate compliance efforts. In&#160;particular, numerous federal and state laws and regulations, including state data breach notification laws, state health information privacy laws, and federal and state consumer protection laws, govern the collection, use, disclosure, and protection of health-related and other personal information. For example, the California Consumer Privacy Act of 2018, or CCPA came into effect on January 1, 2020 and provides new data privacy rights for consumers and new operational requirements for companies.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In addition, the collection, use, storage, disclosure, transfer, or other processing of personal data regarding individuals in the European Economic Area or EEA or the United Kingdom, or otherwise carried out in the context of EEA or United Kingdom establishments (regardless of where any processing in question occurs), including personal data related to health and genetic information, is subject to the GDPR including, where relevant, as implemented in the United Kingdom. The GDPR is wide-ranging in scope and imposes numerous requirements on companies that process personal data, including requirements relating to processing health and other sensitive data. For more information, see the section titled &#8220;Risk Factors&#8212;Risks Related to Commercialization and Regulatory Compliance.&#8221;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In order to distribute products commercially, we must comply with state laws that require the registration of manufacturers and wholesale distributors of drug and biological products in a state, including, in certain states, manufacturers and distributors who ship products into the state even if such manufacturers or distributors have no place of business within the state. Some states also impose </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">126</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">requirements on manufacturers and distributors to establish the pedigree of product in the chain of distribution, including some states that require manufacturers and others to adopt new technology capable of tracking and tracing product as it moves through the distribution chain. Several states have enacted legislation requiring pharmaceutical and biotechnology companies to establish marketing compliance programs, file periodic reports with the state, make periodic public disclosures on sales, marketing, pricing, clinical trials and other activities, and/or register their sales representatives, as well as to prohibit pharmacies and other healthcare entities from providing certain physician prescribing data to pharmaceutical and biotechnology companies for use in sales and marketing, and to prohibit certain other sales and marketing practices. All of our activities are potentially subject to federal and state consumer protection and unfair competition laws.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Ensuring business arrangements with third parties comply with applicable healthcare laws and regulations is a costly endeavor. If our operations are found to be in violation of any of the federal and state healthcare laws described above or any other current or future governmental regulations that apply to us, we may be subject to penalties, including without limitation, civil, criminal and/or administrative penalties, damages, fines, disgorgement, imprisonment, exclusion from participation in government programs, such as Medicare and Medicaid, injunctions, private &#8220;qui tam&#8221; actions brought by individual whistleblowers in the name of the government, or refusal to allow us to enter into government contracts, contractual damages, reputational harm, administrative burdens, diminished profits and future earnings, additional reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with these laws, and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our results of operations. Additionally, if any of the physicians or other providers or entities with whom we expect to do business are found not to be in compliance with applicable laws, they may be subject to significant civil, criminal and administrative sanctions, including exclusion from government funded healthcare programs.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Coverage, Pricing and Reimbursement<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In the United States and in foreign markets, sales of any products for which we receive regulatory approval for commercial sale will depend, in part, on the extent to which third-party payors provide coverage and establish adequate reimbursement levels for such products. Coverage and reimbursement by a third-party payor may depend upon a number of factors, including the third-party payor&#8217;s determination that use of a therapeutic is:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">a covered benefit under its health plan;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">safe, effective and medically necessary;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">appropriate for the specific patient;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">cost-effective; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">neither experimental nor investigational.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Third-party payors are increasingly challenging the price, examining the medical necessity, and reviewing the cost-effectiveness of medical products, therapies and services, in addition to questioning their safety and efficacy. Obtaining coverage and reimbursement approval of a product from a third-party payor is a time-consuming and costly process that could require us to provide to each payor supporting scientific, clinical and cost-effectiveness data for the use of our product on a payor-by-payor basis, with no assurance that coverage and adequate reimbursement will be obtained. In particular, obtaining reimbursement for our products may be particularly difficult because of the higher prices often associated with branded drugs and drugs administered under the supervision of a physician. We may need to conduct expensive pharmacoeconomic studies in order to demonstrate the medical necessity and cost-effectiveness of our products, in addition to the costs required to obtain FDA approvals. We cannot be sure that reimbursement will be available for any product that we commercialize and, if coverage and reimbursement are available, we cannot be sure that the level of reimbursement will be adequate. Limited coverage and less than adequate reimbursement may reduce the demand for, or the price of, any product for which we obtain regulatory approval. Even if favorable coverage and reimbursement status is attained for one or more products for which we receive regulatory approval, less favorable coverage policies and reimbursement rates may be implemented in the future.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">127</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Additionally, in the United States there is no uniform policy among third-party payors for coverage or reimbursement. Third-party payors often rely upon Medicare coverage policy and payment limitations in setting their own coverage and reimbursement policies, but also have their own methods and approval processes. Therefore, one third-party payor&#8217;s determination to provide coverage for a product does not assure that other payors will also provide coverage for the product. Adequate third-party payor reimbursement may not be available to enable us to maintain price levels sufficient to realize an appropriate return on our investment in product development. If reimbursement is not available or is available only at limited levels, we may not be able to successfully commercialize any product candidate that we successfully develop.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Under currently applicable U.S. law, certain products not usually self-administered (including injectable drugs), such as our product candidates, once approved, may be eligible for coverage under Medicare Part&#160;B. As a condition of receiving Medicare Part&#160;B reimbursement for a manufacturer&#8217;s eligible drugs or biologicals, the manufacturer is required to participate in other government healthcare programs, including the Medicaid Drug Rebate Program and the 340B Drug Pricing Program.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Healthcare Reform<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In the United States and some foreign jurisdictions, there have been, and continue to be, legislative and regulatory changes and proposed changes regarding the healthcare system that could prevent or delay marketing approval of product candidates, restrict or regulate post-approval activities, and affect the ability to profitably sell product candidates for which marketing approval is obtained. Among policy makers and payors in the United States and elsewhere, there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality and/or expanding access. In the United States, the pharmaceutical industry has been a particular focus of these efforts and has been significantly affected by major legislative initiatives.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">For example, the ACA has substantially changed healthcare financing and delivery by both governmental and private insurers. Among the ACA provisions of importance to the pharmaceutical and biotechnology industries, in addition to those otherwise described above, are the following:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">an annual, nondeductible fee on any entity that manufactures or imports certain specified branded prescription drugs and biologic agents apportioned among these entities according to their market share in some government healthcare programs that began in 2011;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">an increase in the statutory minimum rebates a manufacturer must pay under the Medicaid Drug Rebate Program, retroactive to January&#160;1, 2010, to 23.1% and 13% of the average manufacturer price for most branded and generic drugs, respectively, and capped the total rebate amount for innovator drugs at 100% of the average manufacturer price;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">a new Medicare Part&#160;D coverage gap discount program, in which manufacturers must now agree to offer 70% point-of-sale discounts off negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap period, as a condition for the manufacturers&#8217; outpatient drugs to be covered under Medicare Part&#160;D;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">extension of manufacturers&#8217; Medicaid rebate liability to covered drugs dispensed to individuals who are enrolled in Medicaid managed care organizations;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">expansion of eligibility criteria for Medicaid programs by, among other things, allowing states to offer Medicaid coverage to additional individuals and by adding new mandatory eligibility categories for individuals with income at or below 133% of the federal poverty level, thereby potentially increasing manufacturers&#8217; Medicaid rebate liability;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">expansion of the entities eligible for discounts under the 340B Drug Discount Program;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative clinical effectiveness research, along with funding for such research;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted, or injected;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">a requirement to annually report certain information regarding drug samples that manufacturers and distributors provide to physicians;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">128</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">establishment of a Center for Medicare and Medicaid Innovation at CMS to test innovative payment and service delivery models to lower Medicare and Medicaid spending, potentially including prescription drug spending; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">a licensure framework for follow on biologic products.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">By way of example, in December&#160;2017, the Tax Act was enacted which repealed, effective January&#160;1, 2019, the tax penalty for an individual&#8217;s failure to maintain ACA-mandated health insurance, commonly referred to as the &#8220;individual mandate.&#8221; On December&#160;14, 2018, a Texas U.S. District Court Judge ruled that the ACA is unconstitutional in its entirety because the &#8220;individual mandate&#8221; was repealed by Congress as part of the Tax Act. Additionally, on December&#160;18, 2019, the U.S. Court of Appeals for the 5th Circuit upheld the District Court ruling that the individual mandate was unconstitutional and remanded the case back to the District Court to determine whether the remaining provisions of the ACA are invalid as well. The United States Supreme Court is currently reviewing this case, although it is unclear when or how the Supreme Court will rule. Although the U.S. Supreme Court has yet to rule on the constitutionality of the ACA, President Biden issued an executive order to initiate a special enrollment period from February&#160;15, 2021 through August&#160;15, 2021 for purposes of obtaining health insurance coverage through the ACA marketplace. The executive order also instructs certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare, including among others, reexamining Medicaid demonstration projects and waiver programs that include work requirements, and policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the ACA. It is unclear how the Supreme Court ruling, other such litigation, and the healthcare reform measures of the Biden administration will impact the ACA and our business.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Other legislative changes have been proposed and adopted since the ACA was enacted. In August&#160;2011, President Obama signed into law the Budget Control Act of 2011, which, among other things, included aggregate reductions to Medicare payments to providers of up to 2% per fiscal year, which went into effect beginning on April&#160;1, 2013. Additionally, due to subsequent legislative amendments to the statute, including the BBA, the reductions will stay in effect through 2030, other than a temporary suspension from May&#160;1, 2020 through December&#160;31, 2021 due to the ongoing COVID-19 pandemic, unless additional Congressional action is taken. In January&#160;2013, the American Taxpayer Relief Act of 2012 was signed into law, which, among other things, reduced Medicare payments to several providers, including hospitals, and increased the statute of limitations period for the government to recover overpayments to providers from three to five&#160;years.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Further, there has been increasing legislative and enforcement interest in the United States with respect to specialty drug pricing practices. Specifically, there have been several recent U.S. Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drugs. However, it is unclear whether the Biden administration will work to reverse these measures or pursue similar policy initiatives. Further, at the states level, legislatures have increasingly passed legislation and implemented regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures. Further, it is possible that additional governmental action is taken in response to the ongoing COVID-19 pandemic.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">The Foreign Corrupt Practices Act<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The Foreign Corrupt Practices Act, or the FCPA, prohibits any U.S. individual or business from paying, offering, or authorizing payment or offering of anything of value, directly or indirectly, to any foreign official, political party or candidate for the purpose of influencing any act or decision of the foreign entity in order to assist the individual or business in obtaining or retaining business. The FCPA also obligates companies whose securities are listed in the United States to comply with accounting provisions requiring us to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise and maintain an adequate system of internal accounting controls for international operations.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">129</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Environmental Regulation<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In addition to the foregoing, state and federal laws regarding environmental protection and hazardous substances, including the Occupational Safety and Health Act, the Resource Conservancy and Recovery Act and the Toxic Substances Control Act, affect our business. These and other laws govern our use, handling and disposal of various biological, chemical and radioactive substances used in, and wastes generated by, our operations. If our operations result in contamination of the environment or expose individuals to hazardous substances, we could be liable for damages and governmental fines. We believe that we are in material compliance with applicable environmental laws and that continued compliance therewith will not have a material adverse effect on our business. We cannot predict, however, how changes in these laws may affect our future operations.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Other Regulations<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We are also subject to numerous federal, state and local laws relating to such matters as safe working conditions, manufacturing practices, environmental protection, fire hazard control, and disposal of hazardous or potentially hazardous substances. We may incur significant costs to comply with such laws and regulations now or in the future.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Legal Proceedings</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">From time to time, we may become, involved in various legal proceedings arising in the ordinary course of our business. We are not currently a party to any material legal proceedings, and we are not aware of any pending or threatened legal proceeding against us that we believe could have a material adverse effect on our business, operating results or financial condition.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Facilities</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We lease approximately 600 square feet of office space for our principal executive offices, which are located at 79 Madison Avenue, New York, New York 10016, under an operating lease that expires on August&#160;31, 2021, with the option to renew for an additional period upon the expiration of this lease. We also lease approximately 2,500 square feet of laboratory and office space, which is located at 1500 First Avenue North, Birmingham, Alabama 35203, under an operating lease that currently expires on September&#160;1, 2021, which automatically renews for a period of an additional 12&#160;months upon the expiration of the initial term, but which can be terminated by us upon 60 days notice. We have also leased approximately 9,000 square feet of space located in the Martin Biscuit Building in Pepper Place, 2901 2nd Avenue South, Birmingham, Alabama. We are developing approximately 5,250 square feet of laboratory space, as well as approximately 3,700 square feet of office, conference and potentially modular GMP manufacturing space. The lease is a 63-month term, expiring on February 17, 2026 and has an option for a five-year extension. Our Birmingham facilities are both located within Qualified Opportunity Zones as defined in Section 1400Z-2 of the Internal Revenue Code. We will seek to use commercially reasonable efforts to expand our facilities within Qualified Opportunity Zones as long as it remains consistent with the best interests of the Company. We believe that our facilities are adequate to meet our current needs and that additional space can be obtained on commercially reasonable terms as needed.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Employees and Human Capital Resources</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">As of June 30, 2021, we had 13 full-time employees, of whom eight were primarily engaged in research and development activities. A total of five employees have an M.D. or Ph.D. degree. None of our employees are represented by a labor union and we consider our employee relations to be good.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Our human capital resources objectives include, as applicable, identifying, recruiting, retaining, incentivizing and integrating our existing and new employees, advisors and consultants. The principal purposes of our equity and cash incentive plans are to attract, retain and reward personnel through the granting of stock-based and cash-based compensation awards, in order to increase stockholder value and the success of our company by motivating such individuals to perform to the best of their abilities and achieve our objectives.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">130</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tMAN">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">MANAGEMENT</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:18pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The following table sets forth information regarding our executive officers, key employee and directors, including their ages as of July, 2021:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:185.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:0pt 0pt 2.5pt 0pt; width:138.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-right:1pt;letter-spacing:-0.089pt;">NAME </font>
              </div>
            </td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;letter-spacing:-0.089pt;">AGE </font>
              </div>
            </td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt; width:231.4pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:91pt;padding-right:91pt;letter-spacing:-0.089pt;">POSITION(S) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:138.01pt;white-space:normal;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:-0.111pt;">Executive Officers and Key Employee</font>
              </div>
            </td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.88pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:231.4pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:138.01pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">William Ho </font>
              </div>
            </td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.88pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">45</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:231.4pt;">
              <font style="letter-spacing:-0.025pt;">President, Chief Executive Officer and Director </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:138.01pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Lawrence Lamb, Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.88pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">67</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:231.4pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Executive Vice President and Chief Scientific Officer </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:138.01pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Patrick McCall </font>
              </div>
            </td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.88pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">38</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:231.4pt;">
              <font style="letter-spacing:-0.025pt;">Chief Financial Officer </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:138.01pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Kate Rochlin, Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.88pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">40</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:231.4pt;">
              <font style="letter-spacing:-0.025pt;">Vice President, Operations and Innovation </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:138.01pt;">
              <font style="letter-spacing:-0.111pt;">Non-Employee Directors</font>
            </td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.88pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:231.4pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:138.01pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Alan S. Roemer</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">(1)(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.88pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">51</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:231.4pt;">
              <font style="letter-spacing:-0.025pt;">Chairman </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:138.01pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Peter Brandt</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">(1)(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.88pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">64</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:231.4pt;">
              <font style="letter-spacing:-0.025pt;">Director </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:138.01pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Emily T. Fairbairn</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.88pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">59</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:231.4pt;">
              <font style="letter-spacing:-0.025pt;">Director </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:138.01pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Luba Greenwood</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">(1)(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.88pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">42</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:231.4pt;">
              <font style="letter-spacing:-0.025pt;">Director</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:138.01pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Travis Whitfill</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">(2)(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.88pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:center;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; white-space:nowrap;text-align:center;">31</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:0pt; width:17.4pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:231.4pt;">
              <font style="letter-spacing:-0.025pt;">Director</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.01pt; width:456pt;">
          <div style="margin-left: 0pt; width: 120pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:-0.02pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.5pt; margin-bottom:0pt; line-height:8pt; text-align:left; margin-left:20pt;font-size:8pt;">
          <font style="letter-spacing:-0.02pt;">Member of the Audit Committee</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:8pt; margin-top:3.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:-0.02pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.5pt; margin-bottom:0pt; line-height:8pt; text-align:left; margin-left:20pt;font-size:8pt;">
          <font style="letter-spacing:-0.02pt;">Member of the Compensation Committee</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:8pt; margin-top:3.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:-0.02pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:3.5pt; margin-bottom:0pt; line-height:8pt; text-align:left; margin-left:20pt;font-size:8pt;">
          <font style="letter-spacing:-0.02pt;">Member of the Nominating and Corporate Governance Committee</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:11.51pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Executive Officers</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;">William Ho</font><font style="letter-spacing:-0.025pt;"> is our co-founder, and has served as our President, Chief Executive Officer and director since our inception in November&#160;2015 and also served as our Chief Financial Officer from October 2020 to January 2021. Prior to this, from April&#160;2014 to November&#160;2017, Mr.&#160;Ho was the founder and Managing Partner at AlephPoint Capital, a private healthcare fund. Prior to AlephPoint, Mr.&#160;Ho launched the public investments and cross-over portfolio at New Leaf Venture Partners, a leading healthcare venture capital firm, and served as its Public Investment Director from 2010 to 2014. Previously, Mr.&#160;Ho also served as a Senior Equity Research Analyst at Bank of America from 2006 to 2009 and an Equity Research Analyst at Piper Jaffray &amp; Co. from 2003 to 2006, covering the biotechnology and life-science tools sectors. Earlier in his career, Mr. Ho was responsible for FP&amp;A and operational analysis at CuraGen Corporation and worked as an Associate on the Healthcare Investment Banking team at Cowen. Mr. Ho was an inductee into the McMaster University Alumni Gallery in 2020 and currently serves as a member of their Dean&#8217;s Advisory Board for the Faculty of Science. Mr.&#160;Ho received an MBA from the University of Notre Dame and a B.S. in Biochemistry from McMaster University. We believe that Mr.&#160;Ho&#8217;s extensive knowledge of our company as founder, President and Chief Executive Officer and his experience in the healthcare industry qualifies him to serve on our board of directors.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;">Lawrence Lamb, Ph.D.</font><font style="letter-spacing:-0.025pt;"> is our co-founder and has served as our Executive Vice President and Chief Scientific Officer since November 2018 and as the Chair of our Scientific Advisory Board since December 2017. From April&#160;2004 to December&#160;2018, Dr.&#160;Lamb was a Professor of Medicine at the University of Alabama at Birmingham, or UAB, specializing in transplantation immunology, and also served as the Director of the UAB Cell Therapy Laboratory in the Bone Marrow Transplant and Cellular Therapy department. Prior to that, from 1995 to 2004, he served as a Professor of Medicine at the University of South Carolina School of Medicine. Dr.&#160;Lamb currently serves on several national and international committees related to cell and gene therapy. Dr.&#160;Lamb received two postdoctoral fellowships, one from University of South Carolina-Columbia and another from South Carolina Cancer Center. He also received a Ph.D. and an M.S. from University of South Carolina-Columbia and a B.S. from Medical College of Georgia.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;">Patrick McCall</font><font style="letter-spacing:-0.025pt;"> has served as our Chief Financial Officer since February&#160;2021. Prior to joining IN8bio, Mr.&#160;McCall served as Vice President of Finance at Turnstone Biologics Corp., an international </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">131</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">clinical-stage biotechnology company focused on cancer immunotherapies, from November&#160;2018 to January&#160;2021. From January&#160;2018 until November&#160;2018, Mr.&#160;McCall was the Corporate Controller at Catalyst Biosciences, a publicly traded, clinical-stage biopharmaceutical company focused on developing hemophilia treatments. Previously, he served as Catalyst&#8217;s Director of Accounting and Finance from October&#160;2015 to January&#160;2018. Prior to that, Mr.&#160;McCall served as a Senior Manager of Technical Accounting at LendingClub Corp., as a Corporate Financial Reporting Manager at Apple Inc. and as a Manager of Financial Reporting at Chubb Limited. Mr.&#160;McCall is an active Certified Public Accountant (CPA) and holds an MBA from Cornell University and a B.S. in Accounting from Drexel University.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;">Kate Rochlin, Ph.D.</font><font style="letter-spacing:-0.025pt;"> has served as our Vice President of Operations and Innovation since December&#160;2020, and previously served as our Associate Vice President of Operations and Innovation from August&#160;2020 until December&#160;2020. Since February&#160;2013, Dr.&#160;Rochlin has served as a Project Principle of the Solution Lab, Inc., a nonprofit organization that provides Ph.D. and MBA students real-world consulting experiences, and since October&#160;2019 she has also served on the Solution Lab&#8217;s board of directors. From March&#160;2020 until August&#160;2020, Dr.&#160;Rochlin served as the Chief Business Officer of Curadigm SAS, a private nanotechnology company. Previously she served as Curadigm&#8217;s Director of Business Development from March&#160;2019 to August&#160;2020. Prior to that, Dr.&#160;Rochlin Served as Director of Scientific Affairs for Filament BioSolutions Inc., a private biotechnology company, from March&#160;2016 until March&#160;2019. From September&#160;2012 to January&#160;2017, she was a Co-founder and the Chief Scientific Officer of Immunovent, LLC, a biotechnology company focused on commercialization of technologies for diagnosing allergies, and then served as a Scientific and Business Advisor to Immunovent, LLC from January&#160;2017 until March&#160;2019. Dr.&#160;Rochlin received a Ph.D. in Cell and Developmental Biology from Weill Cornell University, and a B.A. with double majors in Molecular Biology and History and Sociology of Science (HSSC) from the University of Pennsylvania.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Non-Employee Directors</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;">Alan S. Roemer, MBA, MPH </font><font style="letter-spacing:-0.025pt;">has served as chairman and a member of our board of directors since September&#160;2020. Mr.&#160;Roemer has served on the board of directors and as the chair of the audit committee of board of NexImmune, Inc., a public biotechnology company, since February&#160;2017. He has served as chairman of the board of UTILITY therapeutics Ltd., a private biotechnology company, since March&#160;2020. Mr.&#160;Roemer was a founding leadership team member and senior vice president of Roivant Sciences, Inc., a private biopharmaceutical company, from the company&#8217;s inception May&#160;2014 to August&#160;2019, where he held various senior management roles responsible for finance, operations and corporate development. From March&#160;2015 to August&#160;2015, he also served as principal financial and accounting officer of Axovant Sciences Ltd., a public biopharmaceutical company, and a founding leadership team member and chief financial officer of its wholly owned subsidiary, Axovant Sciences, Inc. Mr.&#160;Roemer also served as a member of the board of directors of SomPharmaceuticals SA, a private biopharmaceutical company, from August&#160;2012 to May&#160;2016, until its acquisition by Amryt Pharma plc. Prior to Roivant and Axovant, Mr.&#160;Roemer served in various executive roles, including managing director of the Trout Group LLC and Trout Capital LLC from 2009 to 2014, chief financial officer and treasurer of Zelos Therapeutics, Inc. from 2008 to 2009, and vice president of Pharmasset, Inc. 1999 to 2008, which was subsequently acquired by Gilead Sciences, Inc., where he was the first full-time management team member. Mr.&#160;Roemer has also served as a member of the business advisory board of Envisagenics, Inc., a private artificial intelligence company, since March&#160;2020, and a member of the board of trustees of the Helene Fuld College of Nursing since June&#160;2014. Mr.&#160;Roemer received a B.S. in Business Administration from Georgetown University and his MBA and MPH degrees from Emory University&#8217;s Goizueta Business School and Rollins School of Public Health. We believe that Mr.&#160;Roemer&#8217;s significant executive and board leadership experience in the biopharmaceutical industry qualifies him to serve on our board of directors.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;">Peter Brandt</font><font style="letter-spacing:-0.025pt;"> has served as a member of our board of directors since July&#160;2019. Since June&#160;2015, Mr.&#160;Brandt has served as the Chairman Rexahn Pharmaceuticals, Inc., a public biotechnology company, and as a member of Rexahn&#8217;s board of directors since September&#160;2010. From 2011 to 2013, Mr.&#160;Brandt served on the board of directors, and as Chairman from December&#160;2012, of ePocrates, Inc., a point of care medical applications company (until its acquisition by athenahealth, Inc.). From 2011 to 2012, Mr.&#160;Brandt also served as interim Chief Executive Officer and President of ePocrates, Inc. Prior to that, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">132</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">from 2008 to 2009, Mr.&#160;Brandt served as President, Chief Executive Officer, and as a member of the board of directors of Noven Pharmaceuticals, Inc., a specialty pharmaceutical company (until its acquisition by Hisamitsu Pharmaceutical Co., Inc.). Prior to leading Noven, Mr.&#160;Brandt spent 28&#160;years at Pfizer Inc. where he served various roles, including as Pfizer&#8217;s President&#8212;U.S. Pharmaceuticals Operations, where he helped deliver revenue and earnings growth while engineering major change within Pfizer&#8217;s U.S. pharmaceuticals organization. Prior to running U.S. operations, he led Pfizer&#8217;s Latin American pharmaceuticals operations, as well as the following Pfizer Worldwide Pharmaceuticals functions: finance, information technology, planning and business development. He also oversaw the operations of Pfizer&#8217;s care management subsidiary, Pfizer Healthcare Solutions. Mr.&#160;Brandt also served as a director of Auxilium Pharmaceuticals, Inc. from December&#160;2010 to January&#160;2015 (until its acquisition by Endo International PLC). Mr.&#160;Brandt received a B.A. from the University of Connecticut and an MBA from the Columbia School of Business. We believe that Mr.&#160;Brandt&#8217;s broad operational management experience in the life sciences industry and experience serving on numerous boards of directors of life sciences companies qualifies him to serve on our board of directors.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;">Emily T. Fairbairn</font><font style="letter-spacing:-0.025pt;"> has served as a member of our board of directors since July 2021. Since March 2018, Ms. Fairbairn has served a member and chair of the board of directors of Movano Inc., a health-focused technology company. Ms. Fairbairn is currently a principal of Transcend Partners and from 1999 to 2018, Ms. Fairbairn was the co-founder and CEO of Ascend Capital, a multi-billion hedge fund focused on managing assets for institutional clients such as pensions, endowments and public companies. Prior to founding Ascend Capital, Ms. Fairbairn managed equity portfolios for high net worth clients for Merrill Lynch Ms. Fairbairn is an active philanthropist with a history of supporting education, athletics, and medical research. She also serves on the funding board of MIT Sandbox Innovation Fund to actively mentor entrepreneurs. Ms. Fairbairn received her B.S. in Chemical Engineering from California State Polytechnic University Pomona. We believe that Ms. Fairbairn&#39;s expertise in investment and finance matters and her extensive executive leadership and management experience qualify her to serve on our board of directors.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;">Luba Greenwood</font><font style="letter-spacing:-0.025pt;"> has served as a member of our board of directors since July 2021. Since December 2020, Ms. Greenwood has served as Managing Partner of Binney Street Capital, LLC, a venture capital fund established by the Dana-Farber Cancer Institute, and since 2019 she has served as CEO of LUCA Biologics, Inc., a women&#39;s health and microbiome company. From April 2019 to December 2020, Ms. Greenwood served as senior advisor to the CEO of the Dana-Farber Cancer Institute. From October 2018 to February 2021, Ms. Greenwood served as a consultant to Brooklyn ImmunoTherapeutics, Inc. and joined its board of directors in March 2021. From February 2018 to July 2019, Ms. Greenwood was the head of strategic business development and corporate ventures for Verily Life Sciences LLC, a research subsidiary of Alphabet Inc. focused on life sciences and healthcare. From 2015 to February 2018, Ms. Greenwood was the vice president of global business development and mergers and acquisitions at F. Hoffmann-La Roche Ltd., a multinational healthcare company, as well as the head of the Roche Diagnostics Innovation Center, East Coast. Beginning in 2021, Ms.&#160;Greenwood has also served on the board of directors of OS Acquisition Corp., a blank check company. Ms. Greenwood received a B.A. in Biology from Brandeis University and a J.D. from Northeastern University Law School. We believe that Ms. Greenwood&#39;s extensive experience in the pharmaceutical, biotechnology and digital health industries qualifies her to serve on our board of directors.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;">Travis Whitfill</font><font style="letter-spacing:-0.025pt;"> has served as a member of our board of directors since May&#160;2018. Mr.&#160;Whitfill has served as a partner at Bios Equity Partners, LP, a biotechnology-focused venture capital firm, since October&#160;2015 and a Senior Analyst at Bios Research since September&#160;2014. He is also the founder and has served in various roles at Azitra Inc., including Chief Scientific Officer from January&#160;2014 to September&#160;2019 and currently serves as the Executive Director of Advanced Technology since September&#160;2019. He has also served as an associate research scientist with appointments in the Departments of Pediatrics and Emergency Medicine at Yale University since July&#160;2016. Mr.&#160;Whitfill has led numerous grant-funded projects, holds several patents and has co-authored over 50 publications. Mr.&#160;Whitfill received a B.S. from Dallas Baptist University, a MPhil from UCL in the United Kingdom, and an MPH from Yale University. We believe that Mr.&#160;Whitfill&#8217;s strong background in entrepreneurship and in the biotech and healthcare industries qualifies him to serve on our board of directors.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">133</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Family Relationships and Other Arrangements</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">There are no family relationships among our directors and executive officers. Travis Whitfill was designated as a director to our board of directors by the majority of the holders of preferred stock pursuant to our voting agreement, which will terminate upon the completion of this offering.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Board Composition</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our board of directors currently consists of six members. In accordance with our amended and restated certificate of incorporation, which will be effective immediately after the completion of this offering, our board of directors will be divided into three classes with staggered three-year terms. At each annual general meeting of stockholders, the successors to directors whose terms then expire will be elected to serve from the time of election and qualification until the third annual meeting following election. Our directors will be divided among the three classes as follows:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the Class&#160;I directors will be Emily T. Fairbairn and Luba Greenwood and their terms will expire at the annual meeting of stockholders to be held in 2022;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the Class&#160;II directors will be Peter Brandt and Travis Whitfill, and their terms will expire at the annual meeting of stockholders to be held in 2023; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the Class&#160;III directors will be William Ho and Alan S. Roemer, and their terms will expire at the annual meeting of stockholders to be held in 2024.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We expect that any additional directorships resulting from an increase in the number of directors will be distributed among the three classes so that, as nearly as possible, each class will consist of one-third of the directors. The division of our board of directors into three classes with staggered three-year terms may delay or prevent a change of our management or a change in control.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Director Independence<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Under The Nasdaq Stock Market LLC, or Nasdaq, Marketplace Rules, or the Nasdaq Listing Rules, independent directors must comprise a majority of our board of directors as a public company within one year of listing.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our board of directors has undertaken a review of its composition, the composition of its committees and the independence of each director. Based upon information requested from and provided by each director concerning his or her background, employment and affiliations, including family relationships, our board of directors has determined that none of our directors, except William Ho, have any relationships that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director and that each of these directors is &#8220;independent&#8221; as that term is defined under the applicable rules and regulations of the SEC and the listing requirements of the Nasdaq Listing Rules. Our board of directors has determined that Mr.&#160;Ho, by virtue of his position as our President and Chief Executive Officer, is not independent under applicable rules and regulations of the SEC and the Nasdaq Listing Rules. In making this determination, our board of directors considered the current and prior relationships that each non-employee director has with our company and all other facts and circumstances our board of directors deemed relevant in determining their independence, including the beneficial ownership of our capital stock by each non-employee director.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Board Committees</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our board of directors has established an audit committee, a compensation committee and a nominating and corporate governance committee. Our board of directors may establish other committees to facilitate the management of our business. The composition and functions of each committee are described below. Members serve on these committees until their resignation or until otherwise determined by our board of directors. Each committee has adopted a written charter that satisfies the applicable rules and regulations of the SEC and Nasdaq Listing Rules, which we will post on our website at www.in8bio.com upon the completion of this offering.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Audit Committee<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The audit committee is responsible for assisting our board of directors in its oversight of the integrity of our financial statements, the qualifications and independence of our independent auditors and our internal financial and accounting controls. The audit committee has direct responsibility for the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">134</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">appointment, compensation, retention (including termination) and oversight of our independent auditors, and our independent auditors report directly to the audit committee. The audit committee also prepares the audit committee report that the SEC requires to be included in our annual proxy statement.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our audit committee consists of Peter Brandt, Luba Greenwood and Alan S. Roemer. Our board of directors has determined that all members are independent under the Nasdaq Listing Rules and Rule&#160;10A-3(b)(1) of the Securities Exchange Act of 1934, as amended, or the Exchange Act. The chair of our audit committee is Peter Brandt. Our board of directors has determined that Peter Brandt is an &#8220;audit committee financial expert&#8221; as such term is currently defined in Item&#160;407(d)(5) of Regulation&#160;S-K. Our board of directors has also determined that each member of our audit committee can read and understand fundamental financial statements, in accordance with applicable requirements. In arriving at these determinations, the board of directors has examined each audit committee member&#8217;s scope of experience and the nature of their employment in the corporate finance sector.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Compensation Committee<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The compensation committee approves the compensation objectives for the company, the compensation of the chief executive officer and approves, or recommends to our board of directors for approval, the compensation for other executives. The compensation committee reviews all compensation components, including base salary, bonus, benefits and other perquisites.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our compensation committee consists of Luba Greenwood, Alan S. Roemer and Travis Whitfill. Our board of directors has determined that all members are independent under the Nasdaq Listing Rules and are &#8220;non-employee directors&#8221; as defined in Rule&#160;16b-3 promulgated under the Exchange Act. The chair of our compensation committee is Alan S. Roemer.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Nominating and Corporate Governance Committee<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The nominating and corporate governance committee makes recommendations regarding corporate governance, the composition of our board of directors, identification, evaluation and nomination of director candidates and the structure and composition of committees of our board of directors. In addition, the nominating and corporate governance committee is responsible for developing and recommending corporate governance guidelines to our board of directors, as applicable to the company.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Our nominating and corporate governance committee consists of Peter Brandt, Emily T. Fairbairn and Travis Whitfill. The chair of our nominating and corporate governance committee is Travis&#160;Whitfill. Each member of the nominating and corporate governance committee is a non-employee director within the meaning of Rule&#160;16b-3 of the rules promulgated under the Exchange Act, an independent director as defined by the Nasdaq Listing Rules and is free from any relationship that would interfere with the exercise of his or her independent judgment, as determined by the board of directors in accordance with the applicable Nasdaq Listing Rules.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Compensation Committee Interlocks and Insider Participation</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">None of the members of the compensation committee is currently, or has been at any time, one of our executive officers or employees. None of our executive officers currently serves, or has served during the last year, as a member of the board of directors or compensation committee of any entity that has one or more executive officers serving as a member of our board of directors or on our compensation committee.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Code of Business Conduct and Ethics</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We have adopted a written code of business conduct and ethics that applies to all of our directors, officers and employees, including our principal executive officer, principal financial officer and principal accounting officer or controller, or persons performing similar functions, and agents and representatives. The full text of our code of business conduct and ethics will be posted on our website at www.in8bio.com. The nominating and corporate governance committee of our board of directors will be responsible for overseeing our code of business conduct and ethics and any waivers applicable to any director, executive officer or employee. We intend to disclose future amendments to certain provisions of our code </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">135</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:108pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">of business conduct and ethics, or waivers of such provisions applicable to our directors, officers and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, and agents and representatives, on our website identified above.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Limitation on Liability and Indemnification Matters</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Our amended and restated certificate of incorporation, which will become effective immediately after the completion of this offering, and our amended and restated bylaws, which will become effective immediately prior to the completion of this offering, limits our directors&#8217; liability, and may indemnify our directors and officers to the fullest extent permitted under Delaware General Corporation Law, or the DGCL. The DGCL provides that directors of a corporation will not be personally liable for monetary damages for breach of their fiduciary duties as directors, except for liability for any:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">transaction from which the director derives an improper personal benefit;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">unlawful payment of dividends or redemption of shares; or</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">breach of a director&#8217;s duty of loyalty to the corporation or its stockholders.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">These limitations of liability do not apply to liabilities arising under federal securities laws and do not affect the availability of equitable remedies such as injunctive relief or recession.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The DGCL and our amended and restated bylaws provide that we will, in certain situations, indemnify our directors and officers and may indemnify other employees and other agents, to the fullest extent permitted by law. Any indemnified person is also entitled, subject to certain limitations, to advancement, direct payment or reimbursement of reasonable expenses, including attorneys&#8217; fees and disbursements, in advance of the final disposition of the proceeding.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In addition, we have entered, and intend to continue to enter, into separate indemnification agreements with some of our directors and officers. These indemnification agreements, among other things, require us to indemnify our directors and officers for certain expenses, including attorneys&#8217; fees, judgments, fines and settlement amounts incurred by a director or officer in any action or proceeding arising out of their services as a director or officer, or any other company or enterprise to which the person provides services at our request.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We maintain a directors&#8217; and officers&#8217; insurance policy pursuant to which our directors and officers are insured against liability for actions taken in their capacities as directors and officers. We believe that these provisions in our amended and restated certificate of incorporation and amended and restated bylaws and these indemnification agreements are necessary to attract and retain qualified persons as directors and officers.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Insofar as indemnification for liabilities arising under the Securities Act of 1933, as amended, or the Securities Act, may be permitted to directors, officers or control persons, in the opinion of the SEC, such indemnification is against public policy, as expressed in the Securities Act and is therefore unenforceable. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">136</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tEADC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">EXECUTIVE AND DIRECTOR COMPENSATION</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:18pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our named executive officers for the year ended December&#160;31, 2020, which consist of our principal executive officer and our two most highly compensated executive officers, are:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">William Ho, our President, Chief Executive Officer and former Chief Financial Officer;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">Lawrence Lamb, Ph.D., our Executive Vice President and Chief Scientific Officer; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">Melissa Beelen, our Vice President of Clinical Operations.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Summary Compensation Table</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The following table provides information regarding the compensation earned by our named executive officers for the years ended December&#160;31, 2020 and 2019.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:185.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:144.95pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.089pt;">Name and Principal Position </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Year </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Salary</font>
                <br >
                <font style="letter-spacing:-0.089pt;">($)</font><font style=" position:relative; bottom:3.25pt;font-size:6pt;letter-spacing:-0.067pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Bonus</font>
                <br >
                <font style="letter-spacing:-0.089pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Awards</font>
                <br >
                <font style="letter-spacing:-0.089pt;">($)</font><font style=" position:relative; bottom:3.25pt;font-size:6pt;letter-spacing:-0.067pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Non-Equity </font>
                <br >
                <font style="letter-spacing:-0.089pt;">Incentive Plan </font>
                <br >
                <font style="letter-spacing:-0.089pt;">Compensation</font>
                <br >
                <font style="letter-spacing:-0.089pt;">($)</font><font style=" position:relative; bottom:3.25pt;font-size:6pt;letter-spacing:-0.067pt;">(4)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Total</font>
                <br >
                <font style="letter-spacing:-0.089pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:144.95pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">William Ho </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">2020</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">279,167</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">150,000<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(2)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">874,540</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">144,000</td>
            <td style="padding:0pt;padding-left:9.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">1,447,707</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:144.95pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt;font-style:italic;">President, Chief Executive Officer and former</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">2019</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">213,505</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.775pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">213,505</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:top;font-style:italic;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:0.5pt 0pt 1.5pt 0pt; width:144.95pt;">
              <div style="margin-left:10pt;">Chief Financial Officer</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="6">&#8203;</td>
            <td colspan="6">&#8203;</td>
            <td colspan="6">&#8203;</td>
            <td colspan="6">&#8203;</td>
            <td colspan="6">&#8203;</td>
            <td colspan="6">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:144.95pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Lawrence Lamb, Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">2020</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">245,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">1,311,810</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">120,000</td>
            <td style="padding:0pt;padding-left:9.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">1,676,810</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:144.95pt;text-align:left;">
              <div style="margin-left:10pt;font-style:italic;">Executive Vice President and <br >Chief Scientific</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">2019</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">240,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">112,935</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.775pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">352,935</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:italic;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:0.5pt 0pt 1.5pt 0pt; width:144.95pt;">
              <div style="margin-left:10pt;">Officer</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="6">&#8203;</td>
            <td colspan="6">&#8203;</td>
            <td colspan="6">&#8203;</td>
            <td colspan="6">&#8203;</td>
            <td colspan="6">&#8203;</td>
            <td colspan="6">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:144.95pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Melissa Beelen</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">(5)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">2020</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">212,333</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">297,725</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">65,000</td>
            <td style="padding:0pt;padding-left:9.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">570,058</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:144.95pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt;font-style:italic;">Vice President of Clinical Operations</div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">2019</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">156,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">30,359</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.775pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">41,600</td>
            <td style="padding:0pt;padding-left:9.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">227,659</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.2pt; width:456pt;">
          <div style="margin-left: 0pt; width: 120pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:-0.025pt;">Salary amounts represent actual amounts earned during the applicable year. See &#8220;&#8212;Narrative to the Summary Compensation Table&#8212;Annual Base Salary&#8221; below.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:-0.025pt;">Amount represents a cash bonus earned by Mr. Ho. See &#8220;&#8212;Employment Arrangements&#8212;William Ho&#8221; below.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:3.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:-0.025pt;">In accordance with SEC rules, this column reflects the aggregate grant date fair value of the option awards granted during the years presented, computed in accordance with ASC 718 for stock-based compensation transactions. Assumptions used in the calculation of these amounts are included in the notes to our audited financial statements included elsewhere in this prospectus. These amounts do not reflect the actual economic value that will be realized by the named executive officer upon the vesting of the stock options, the exercise of the stock options, or the sale of the common stock underlying such stock options.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:3.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:-0.025pt;">See &#8220;&#8212;Narrative to Summary Compensation Table&#8212;Non-Equity Incentive Plan Compensation&#8221; below for a description of the material terms of the program pursuant to which this compensation was awarded.&#8221;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:3.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:-0.025pt;">Ms. Beelen has resigned as our Vice President of Clinical Operations, effective as of mid-August 2021, due to personal reasons.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Narrative to the Summary Compensation Table</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Annual Base Salary<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our named executive officers receive a base salary to compensate them for services rendered to us. The base salary payable to each named executive officer is intended to provide a fixed component of compensation reflecting the executive&#8217;s skill set, experience, role and responsibilities. None of our named executive officers is currently party to an employment agreement or other agreement or arrangement that provides for automatic or scheduled increases in base salary. During 2020, Dr. Lamb&#8217;s </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">137</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:132.61pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">base salary was $240,000 through November 2020 when it was increased to $300,000, and Ms.&#160;Beelen&#39;s base salary was $208,000 through November 2020 when it was increased to $260,000. During 2020, Mr. Ho&#8217;s base salary was $250,000 through November 2020 when it was increased to $400,000.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Equity-Based Incentive Awards<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">Our equity-based incentive awards are designed to align our interests and those of our stockholders with those of our employees and consultants, including our named executive officers. We have historically used stock options as an incentive for long-term compensation to our named executive officers because they are able to profit from stock options only if our stock price increases relative to the stock option&#8217;s exercise price, which exercise price is set at the fair market value of our common stock on the date of grant. We may grant equity awards at such times as our board of directors determines appropriate. Additional grants may occur periodically in order to specifically incentivize executives with respect to achieving certain corporate goals or to reward executives for exceptional performance.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">Prior to this offering, all of the stock options we have granted were made pursuant to our 2018 Equity Incentive Plan, as amended, or the 2018 Plan. Following this offering, we will grant equity incentive awards under the terms of our 2020 Equity Incentive Plan, or the 2020 Plan. The terms of our equity plans are described below under &#8220;&#8212;Equity Incentive Plans.&#8221;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">We have historically awarded stock options with exercise prices that are equal to the fair market value of our common stock on the date of grant as determined by our board of directors. Our stock option awards generally vest over a four-year period, and may be subject to acceleration of vesting and exercisability under certain termination and change in control events. See &#8220;&#8212;Outstanding Equity Awards at Fiscal Year-End&#8221; below for additional information.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Non-Equity Incentive Plan Compensation</div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">We develop a performance-based bonus program annually. Under the 2020 annual performance bonus program, each named executive officer was eligible to be considered for an annual performance bonus based on (1)&#160;the individual&#8217;s target bonus, as a percentage of base salary, and (2)&#160;the percentage attainment of our corporate goals established by our board of directors in its sole discretion and communicated to each officer. Each named executive officer is assigned a target bonus expressed as a percentage of his or her base salary, which for 2020 was 40% for Mr.&#160;Ho, 40% for Dr.&#160;Lamb and 25% for Ms.&#160;Beelen. For 2020, our board of directors determined that our percentage attainment level was 100% for Dr.&#160;Lamb and Ms.&#160;Beelen and 90% for Mr.&#160;Ho. Accordingly, our board of directors approved performance bonuses for each of the named executive officers as reflected in the column of the Summary Compensation Table above entitled &#8220;Non-Equity Incentive Plan Compensation.&#8221;</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Outstanding Equity Awards at Fiscal Year-End</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">The following table provides information regarding the outstanding equity awards held by our named executive officers as of December&#160;31, 2020. All awards were granted pursuant to the 2018 Plan. See &#8220;&#8212;Equity Incentive Plans&#8212;2018 Equity Incentive Plan&#8221; below for additional information.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">138</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:236pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:92.27pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="28">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Option Awards </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:92.27pt;text-align:left;">
              <font style="letter-spacing:-0.089pt;">Name and Principal </font>
              <br >
              <font style="letter-spacing:-0.089pt;">Position </font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:69.82pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Grant Date </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Securities</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Underlying</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Unexercised</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Options (#)</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Exercisable </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Securities</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Underlying</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Unexercised</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Options (#)</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Unexercisable </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Equity</font>
                <br >
                <font style="letter-spacing:-0.089pt;">incentive</font>
                <br >
                <font style="letter-spacing:-0.089pt;">plan awards:</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.089pt;">securities</font>
                <br >
                <font style="letter-spacing:-0.089pt;">underlying</font>
                <br >
                <font style="letter-spacing:-0.089pt;">unexercised</font>
                <br >
                <font style="letter-spacing:-0.089pt;">unearned</font>
                <br >
                <font style="letter-spacing:-0.089pt;">options</font>
                <br >
                <font style="letter-spacing:-0.089pt;">(#) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Exercise</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Price</font>
                <br >
                <font style="letter-spacing:-0.089pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:69.82pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Expiration</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Date </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:92.27pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.089pt;">William Ho </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:69.82pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.02pt;">October&#160;5, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.275pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">&#8212; </div>
            </td>
            <td style="padding:0pt;padding-left:11.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">182,500<font style="position:absolute;"><font style=" position:relative; bottom:2.75pt;font-size:6pt;">(1)</font> </font></td>
            <td style="padding:0pt;padding-left:12.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">&#8212; </div>
            </td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">6.74</td>
            <td style="padding:0pt;padding-left:6.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:69.82pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.02pt;">October&#160;4, 2030 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:italic;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:0.5pt 0pt 1.5pt 0pt; width:92.27pt;text-align:left;">
              <div style="margin-left:16pt; text-indent:-8pt;">President, Chief <br >Executive Officer and <br >former Chief <br >Financial Officer </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:69.82pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:69.82pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:92.27pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.02pt;">Lawrence Lamb, Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:69.82pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.02pt;">November&#160;12, 2018 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.275pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">48,665</td>
            <td style="padding:0pt;padding-left:11.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">6,085<font style="position:absolute;"><font style=" position:relative; bottom:2.75pt;font-size:6pt;">(2)</font> </font></td>
            <td style="padding:0pt;padding-left:12.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">&#8212; </div>
            </td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">1.07</td>
            <td style="padding:0pt;padding-left:6.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:69.82pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.02pt;">November&#160;11, 2028 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:2pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:0.5pt 0pt 1.5pt 0pt; width:92.27pt;text-align:left;" rowspan="3">
              <div style="margin-left:16pt; text-indent:-8pt; line-height:8pt; padding-bottom:0pt;font-style:italic;">Executive Vice <br >President and Chief <br >Scientific Officer </div>
            </td>
            <td style="padding:0pt; width:3.5pt;" rowspan="3">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; width:69.82pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.02pt;">March&#160;12, 2019 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; line-height:8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; line-height:8pt; min-width:16.5pt; text-align:right; white-space:nowrap;">28,216</td>
            <td style="padding:0pt;padding-left:11.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; line-height:8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; line-height:8pt; min-width:19.5pt; text-align:right; white-space:nowrap;">30,671<font style="position:absolute;"><font style=" position:relative; bottom:2.75pt;font-size:6pt;">(3)</font> </font></td>
            <td style="padding:0pt;padding-left:12.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; line-height:8pt; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; line-height:8pt; min-width:16.5pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">&#8212; </div>
            </td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; line-height:8pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; line-height:8pt; min-width:10.5pt; text-align:right; white-space:nowrap;">1.07</td>
            <td style="padding:0pt;padding-left:6.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; width:69.82pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.02pt;">March&#160;11, 2029 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; width:69.82pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.02pt;">March&#160;12, 2019 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">22,082<font style="position:absolute;"><font style=" position:relative; bottom:2.75pt;font-size:6pt;">(4)</font> </font></td>
            <td style="padding:0pt;padding-left:12.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">66,248<font style="position:absolute;"><font style=" position:relative; bottom:2.75pt;font-size:6pt;">(4)</font> </font></td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">1.07</td>
            <td style="padding:0pt;padding-left:6.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; width:69.82pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.02pt;">March&#160;11, 2029 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; width:69.82pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.02pt;">October&#160;5, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">273,750<font style="position:absolute;"><font style=" position:relative; bottom:2.75pt;font-size:6pt;">(5)</font> </font></td>
            <td style="padding:0pt;padding-left:12.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">6.74</td>
            <td style="padding:0pt;padding-left:6.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; width:69.82pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.02pt;">October&#160;4, 2030 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:92.27pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.02pt;">Melissa Beelen </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:69.82pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.02pt;">April&#160;17, 2019 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.275pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">16,326</td>
            <td style="padding:0pt;padding-left:11.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">22,858<font style="position:absolute;"><font style=" position:relative; bottom:2.75pt;font-size:6pt;">(6)</font> </font></td>
            <td style="padding:0pt;padding-left:12.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.3pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">1.07</td>
            <td style="padding:0pt;padding-left:6.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:69.82pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.02pt;">April&#160;16, 2029 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:2pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:0.5pt 0pt 0.5pt 0pt; width:92.27pt;white-space:normal;text-align:left;" rowspan="3">
              <div style="margin-left:16pt; text-indent:-8pt; line-height:8pt; padding-bottom:0pt;font-style:italic;">Vice President of Clinical Operations </div>
            </td>
            <td style="padding:0pt; width:3.5pt;" rowspan="3">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; width:69.82pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.02pt;">May&#160;5, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; line-height:8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; line-height:8pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; line-height:8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; line-height:8pt; min-width:19.5pt; text-align:right; white-space:nowrap;">13,140<font style="position:absolute;"><font style=" position:relative; bottom:2.75pt;font-size:6pt;">(7)</font> </font></td>
            <td style="padding:0pt;padding-left:12.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; line-height:8pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; line-height:8pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; line-height:8pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; line-height:8pt; min-width:10.5pt; text-align:right; white-space:nowrap;">1.23</td>
            <td style="padding:0pt;padding-left:6.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; width:69.82pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.02pt;">May&#160;4, 2030 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; width:69.82pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.02pt;">May&#160;5, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">5,110<font style="position:absolute;"><font style=" position:relative; bottom:2.75pt;font-size:6pt;">(8)</font> </font></td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">1.23</td>
            <td style="padding:0pt;padding-left:6.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 1.5pt 0pt; width:69.82pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.02pt;">May&#160;4, 2030 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:14pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; width:69.82pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.02pt;">October&#160;5, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.275pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">57,434<font style="position:absolute;"><font style=" position:relative; bottom:2.75pt;font-size:6pt;">(9)</font> </font></td>
            <td style="padding:0pt;padding-left:12.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:16.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">6.74</td>
            <td style="padding:0pt;padding-left:6.3pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; width:69.82pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.02pt;">October&#160;4, 2030</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.2pt; width:456pt;">
          <div style="margin-left: 0pt; width: 120pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">Of the shares underlying this option, 25% vest on October&#160;5, 2021 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the executive officer&#8217;s continuous service.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">The shares underlying this option vest in 36 equal monthly installments, subject to the executive officer&#8217;s continuous service.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">Of the shares underlying this option, 25% vested on January&#160;1, 2020 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the executive officer&#8217;s continuous service. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">Of the shares underlying this option, 22,082 options will vest six&#160;months after completion of this offering and 66,248 will vest upon achievement of certain milestone events, subject to the executive officer&#8217;s continuous service.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">Of the shares underlying this option, 25% vest on October&#160;1, 2021 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the executive officer&#8217;s continuous service.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">(6)</font>
          <br >
        </div>
        <div style=" margin-top:3.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">Of the shares underlying this option, 25% vested on April&#160;1, 2020 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the executive officer&#8217;s continuous service.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">(7)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">Of the shares underlying this option, 25% vest on May&#160;5, 2021 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the executive officer&#8217;s continuous service.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">(8)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">The shares underlying this option vest upon the achievement of certain milestone events, subject to the executive officer&#39;s continuous service.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">(9)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">Of the shares underlying this option, 25% vest on October&#160;5, 2021 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the executive officer&#8217;s continuous service.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.111pt;">Employment Arrangements</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">We have entered into employment agreements and offer letter agreements setting forth the terms and conditions of employment for each of our named executive officers. The material terms of each of these agreements are described below. The employment of each of our named executive officers is &#8220;at will&#8221; and may be terminated at any time. In addition, each of our named executive officers has executed our standard employee confidential information and invention assignment agreement, which includes, among other things, non-solicitation and non-competition provisions.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;font-size:10pt;">William Ho<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">In December 2020, we entered into an amended and restated employment agreement with William Ho, our President and Chief Executive Officer. The amended employment agreement reflects Mr.&#160;Ho&#8217;s current annual base salary of $400,000, which will be increased to $500,000 following the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">139</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">completion of this offering, and provides that Mr.&#160;Ho&#8217;s target annual performance bonus is equal to 40% of his annual base salary, which will be increased to 50% following the completion of this offering. In addition, pursuant to the terms of Mr.&#160;Ho&#8217;s prior employment agreement with us, as amended, Mr.&#160;Ho received a cash bonus of $150,000 upon the closing of our Series&#160;A financing in August 2020.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">If we terminate Mr.&#160;Ho&#8217;s employment with us without cause (as defined in his amended employment agreement), he will receive the following severance payments and benefits if he timely executes and does not revoke a release of claims in our favor and complies with certain restrictive covenants and continuing obligations: (i)&#160;continued payments of his then-current annual base salary for 18&#160;months and (ii)&#160;accelerated vesting of the then-unvested portion of each of his outstanding time-based equity awards that would have become vested had he remained employed by us for an additional 18&#160;months following his termination.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Lawrence Lamb, Ph.D.<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In December 2020, we entered into an amended and restated employment agreement with Dr.&#160;Lawrence Lamb, our Executive Vice President and Chief Scientific Officer. The amended employment agreement reflects Dr.&#160;Lamb&#8217;s current annual base salary of $300,000, which will be increased to $350,000 following the completion of this offering, and provides that Dr.&#160;Lamb&#8217;s target annual performance bonus is equal to 40% of his annual base salary. In connection with the commencement of his employment with us, our board of directors granted Dr.&#160;Lamb an option to purchase 147,218 shares of our common stock at a per share exercise price equal to $1.07 on March&#160;12, 2019.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">If we terminate Dr.&#160;Lamb&#8217;s employment with us without cause (as defined in his employment agreement), he will receive continued payments of his then-current annual base salary for nine&#160;months and, to the extent Dr.&#160;Lamb achieved any of the performance goals for such calendar year, a prorated bonus, subject to his timely execution and non-revocation of a release of claims in our favor and compliance with certain restrictive covenants and continuing obligations.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Melissa Beelen<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In December 2020, we entered into an amended and restated offer letter agreement with Melissa Beelen, our Vice President, Clinical Operations. The amended offer letter agreement reflects Ms.&#160;Beelen&#8217;s current annual base salary of $260,000, which will be increased to $300,000 following the completion of this offering, and provides that Ms.&#160;Beelen&#8217;s target annual performance bonus is equal to 30% of her annual base salary. In connection with the commencement of her employment with us, and pursuant to the terms of her initial offer letter agreement, our board of directors granted Ms.&#160;Beelen an option to purchase 39,184 shares of our common stock at a per share exercise price equal to $1.07 on April&#160;17, 2019. Ms. Beelen has resigned as our Vice President, Clinical Operation, effective mid-August 2021, due to personal reasons.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Potential Payments and Benefits upon Termination or Change in Control</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Mr.&#160;Ho&#8217;s and Dr.&#160;Lamb&#8217;s employment agreements provide for severance benefits as described above under &#8220;&#8212;Employment Arrangements.&#8221;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Health and Welfare and Retirement Benefits; Perquisites</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">All of our current named executive officers are eligible to participate in our employee benefit plans, including our medical, dental, vision, disability and life insurance plans, in each case on the same basis as all of our other employees. We generally do not provide perquisites or personal benefits to our named executive officers, except in limited circumstances.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">401(k) Plan<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Our named executive officers are eligible to participate in a defined contribution retirement plan that provides eligible U.S. employees with an opportunity to save for retirement on a tax advantaged basis. Eligible employees may defer eligible compensation on a pre-tax or after-tax (Roth) basis, up to the statutorily prescribed annual limits on contributions under the Code. Contributions are allocated to each participant&#8217;s individual account and are then invested in selected investment alternatives according to the participants&#8217; directions. We do not match contributions made by participants to the 401(k) plan. The 401(k) plan is intended to be qualified under Section&#160;401(a) of the Code with the 401(k) </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">140</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">plan&#8217;s related trust intended to be tax exempt under Section&#160;501(a) of the Code. As a tax-qualified retirement plan, contributions to the 401(k) plan (except for Roth contributions) and earnings on those contributions are not taxable to the employees until distributed from the 401(k) plan. Our board of directors may elect to adopt qualified or nonqualified benefit plans in the future, if it determines that doing so is in our best interests.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">IPO Grants</font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">At the time of effectiveness of the 2020 Plan, our board of directors granted options to purchase shares of our common stock to certain of our named executive officers, with an exercise price equal to the initial public offering price per share. On such date, Mr. Ho and Dr. Lamb were granted 220,500 and 61,500 options to purchase shares of our common stock, respectively.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Equity Benefit Plans</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">2020 Equity Incentive Plan<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Our board of directors adopted, and our stockholders approved, our 2020 Plan. Our 2020 Plan became effective on the date of the underwriting agreement related to this offering. Our 2020 Plan will come into existence upon its adoption by our board of directors. No further grants will be made under our Prior Plan.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;">Awards</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;Our 2020 Plan provides for the grant of incentive stock options, or ISOs, within the meaning of Section&#160;422 of the Code, to our employees and our parent and subsidiary corporations&#8217; employees, and for the grant of nonstatutory stock options, or NSOs, stock appreciation rights, restricted stock awards, restricted stock unit awards, performance awards and other forms of awards to our employees, directors and consultants and any of our affiliates&#8217; employees and consultants.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;">Authorized Shares</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;Initially, the maximum number of shares of our common stock that may be issued under our 2020 Plan will not exceed 4,200,000 shares of our common stock, which is the sum of (i)&#160;2,626,710 new shares, plus (ii)&#160;an additional number of shares consisting of shares subject to outstanding stock options or other stock awards granted under our Prior Plan that, on or after our 2020 Plan becomes effective, terminate or expire prior to exercise or settlement; are not issued because the award is settled in cash; are forfeited because of the failure to vest; or are reacquired or withheld (or not issued) to satisfy a tax withholding obligation or the purchase or exercise price. In addition, the number of shares of our common stock reserved for issuance under our 2020 Plan will automatically increase on January&#160;1 of each year for a period of 10&#160;years, beginning on January&#160;1, 2022 and continuing through January&#160;1, 2031, in an amount equal to (1)&#160;5% of the total number of shares of our common stock outstanding on the last day of the immediately preceding year, or (2)&#160;a lesser number of shares determined by our board of directors no later than the last day of the immediately preceding year. The maximum number of shares of our common stock that may be issued on the exercise of ISOs under our 2020 Plan will be 13,000,000 shares.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Shares subject to stock awards granted under our 2020 Plan that expire or terminate without being exercised in full or that are paid out in cash rather than in shares will not reduce the number of shares available for issuance under our 2020 Plan. Shares withheld under a stock award to satisfy the exercise, strike or purchase price of a stock award or to satisfy a tax withholding obligation will not reduce the number of shares available for issuance under our 2020 Plan. If any shares of our common stock issued pursuant to a stock award are forfeited back to or repurchased or reacquired by us (i)&#160;because of a failure to meet a contingency or condition required for the vesting of such shares; (ii)&#160;to satisfy the exercise, strike or purchase price of a stock award; or (iii)&#160;to satisfy a tax withholding obligation in connection with a stock award, the shares that are forfeited or repurchased or reacquired will revert to and again become available for issuance under our 2020 Plan.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;">Plan&#160;Administration</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;Our board of directors, or a duly authorized committee of our board of directors, will administer our 2020 Plan. Our board of directors may delegate to one or more of our officers the authority to (i)&#160;designate employees (other than officers) to receive specified stock awards; and (ii)&#160;determine the number of shares subject to such stock awards. Under our 2020 Plan, our board of directors will have the authority to determine stock award recipients, the types of stock awards </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">141</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">to be granted, grant dates, the number of shares subject to each stock award, the fair market value of our common stock, and the provisions of each stock award, including the period of exercisability and the vesting schedule applicable to a stock award.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Under our 2020 Plan, our board of directors also generally will have the authority to effect, with the consent of any materially adversely affected participant, (i)&#160;the reduction of the exercise, purchase, or strike price of any outstanding option or stock appreciation right; (ii)&#160;the cancellation of any outstanding option or stock appreciation right and the grant in substitution therefore of other awards, cash, or other consideration; or (iii)&#160;any other action that is treated as a repricing under generally accepted accounting principles.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;">Stock Options</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;ISOs and NSOs are granted under stock option agreements adopted by the administrator. The administrator will determine the exercise price for stock options, within the terms and conditions of our 2020 Plan, except the exercise price of a stock option generally will not be less than 100% of the fair market value of our common stock on the date of grant. Options granted under our 2020 Plan will vest at the rate specified in the stock option agreement as will be determined by the administrator.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The administrator will determine the term of stock options granted under our 2020 Plan, up to a maximum of 10&#160;years. Unless the terms of an optionholder&#8217;s stock option agreement, or other written agreement between us and the recipient, provide otherwise, if an optionholder&#8217;s service relationship with us or any of our affiliates ceases for any reason other than disability, death, or cause, the optionholder may generally exercise any vested options for a period of three&#160;months following the cessation of service. This period may be extended in the event that exercise of the option is prohibited by applicable securities laws. If an optionholder&#8217;s service relationship with us or any of our affiliates ceases due to death, or an optionholder dies within a certain period following cessation of service, the optionholder or a beneficiary may generally exercise any vested options for a period of 18&#160;months following the date of death. If an optionholder&#8217;s service relationship with us or any of our affiliates ceases due to disability, the optionholder may generally exercise any vested options for a period of 12&#160;months following the cessation of service. In the event of a termination for cause, options generally terminate upon the termination date. In no event may an option be exercised beyond the expiration of its term.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Acceptable consideration for the purchase of common stock issued upon the exercise of a stock option will be determined by the administrator and may include (i)&#160;cash, check, bank draft or money order; (ii)&#160;a broker-assisted cashless exercise; (iii)&#160;the tender of shares of our common stock previously owned by the optionholder; (iv)&#160;a net exercise of the option if it is an NSO; or (v)&#160;other legal consideration approved by the administrator.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Unless the administrator provides otherwise, options or stock appreciation rights generally are not transferable except by will or the laws of descent and distribution. Subject to approval of the administrator or a duly authorized officer, an option may be transferred pursuant to a domestic relations order, official marital settlement agreement, or other divorce or separation instrument.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;">Tax Limitations on ISOs</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;The aggregate fair market value, determined at the time of grant, of our common stock with respect to ISOs that are exercisable for the first time by an award holder during any calendar year under all of our stock plans may not exceed $100,000. Options or portions thereof that exceed such limit will generally be treated as NSOs. No ISO may be granted to any person who, at the time of the grant, owns or is deemed to own stock possessing more than 10% of our total combined voting power or that of any of our parent or subsidiary corporations unless (i)&#160;the option exercise price is at least 110% of the fair market value of the stock subject to the option on the date of grant; and (ii)&#160;the term of the ISO does not exceed five&#160;years from the date of grant.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;">Restricted Stock Unit Awards</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;Restricted stock unit awards are granted under restricted stock unit award agreements adopted by the administrator. Restricted stock unit awards may be granted in consideration for any form of legal consideration that may be acceptable to our board of directors and permissible under applicable law. A restricted stock unit award may be settled by cash, delivery of stock, a combination of cash and stock as deemed appropriate by the administrator, or in any other form of consideration set forth in the restricted stock unit award agreement. Additionally, dividend equivalents </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">142</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">may be credited in respect of shares covered by a restricted stock unit award. Except as otherwise provided in the applicable award agreement, or other written agreement between us and the recipient, restricted stock unit awards that have not vested will be forfeited once the participant&#8217;s continuous service ends for any reason.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;">Restricted Stock Awards</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;Restricted stock awards are granted under restricted stock award agreements adopted by the administrator. A restricted stock award may be awarded in consideration for cash, check, bank draft or money order, past or future services to us, or any other form of legal consideration that may be acceptable to our board of directors and permissible under applicable law. The administrator will determine the terms and conditions of restricted stock awards, including vesting and forfeiture terms. If a participant&#8217;s service relationship with us ends for any reason, we may receive any or all of the shares of common stock held by the participant that have not vested as of the date the participant terminates service with us through a forfeiture condition or a repurchase right.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;">Stock Appreciation Rights</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;Stock appreciation rights are granted under stock appreciation right agreements adopted by the administrator. The administrator will determine the purchase price or strike price for a stock appreciation right, which generally will not be less than 100% of the fair market value of our common stock on the date of grant. A stock appreciation right granted under our 2020 Plan will vest at the rate specified in the stock appreciation right agreement as will be determined by the administrator. Stock appreciation rights may be settled in cash or shares of our common stock or in any other form of payment as determined by our board of directors and specified in the stock appreciation right agreement.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The administrator will determine the term of stock appreciation rights granted under our 2020 Plan, up to a maximum of 10&#160;years. If a participant&#8217;s service relationship with us or any of our affiliates ceases for any reason other than cause, disability, or death, the participant may generally exercise any vested stock appreciation right for a period of three&#160;months following the cessation of service. This period may be further extended in the event that exercise of the stock appreciation right following such a termination of service is prohibited by applicable securities laws. If a participant&#8217;s service relationship with us, or any of our affiliates, ceases due to disability or death, or a participant dies within a certain period following cessation of service, the participant or a beneficiary may generally exercise any vested stock appreciation right for a period of 12&#160;months in the event of disability and 18&#160;months in the event of death. In the event of a termination for cause, stock appreciation rights generally terminate upon the termination date. In no event may a stock appreciation right be exercised beyond the expiration of its term.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;">Performance Awards</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;Our 2020 Plan will permit the grant of performance awards that may be settled in stock, cash or other property. Performance awards may be structured so that the stock or cash will be issued or paid only following the achievement of certain pre-established performance goals during a designated performance period. Performance awards that are settled in cash or other property are not required to be valued in whole or in part by reference to, or otherwise based on, our common stock.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The performance goals may be based on any measure of performance selected by our board of directors. The performance goals may be based on company-wide performance or performance of one or more business&#160;units, divisions, affiliates, or business segments, and may be either absolute or relative to the performance of one or more comparable companies or the performance of one or more relevant indices. Unless specified otherwise by our board of directors at the time the performance award is granted, our board will appropriately make adjustments in the method of calculating the attainment of performance goals as follows: (i)&#160;to exclude restructuring or other nonrecurring charges; (ii)&#160;to exclude exchange rate effects; (iii)&#160;to exclude the effects of changes to generally accepted accounting principles; (iv)&#160;to exclude the effects of any statutory adjustments to corporate tax rates; (v)&#160;to exclude the effects of items that are &#8220;unusual&#8221; in nature or occur &#8220;infrequently&#8221; as determined under generally accepted accounting principles; (vi)&#160;to exclude the dilutive effects of acquisitions or joint ventures; (vii)&#160;to assume that any business divested by us achieved performance objectives at targeted levels during the balance of a performance period following such divestiture; (viii)&#160;to exclude the effect of any change in the outstanding shares of our common stock by reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, spin-off, combination or exchange </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">143</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">of shares or other similar corporate change, or any distributions to common stockholders other than regular cash dividends; (ix)&#160;to exclude the effects of stock based compensation and the award of bonuses under our bonus plans; (x)&#160;to exclude costs incurred in connection with potential acquisitions or divestitures that are required to be expensed under generally accepted accounting principles; and (xi)&#160;to exclude the goodwill and intangible asset impairment charges that are required to be recorded under generally accepted accounting principles.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;">Other Stock Awards</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;The administrator will be permitted to grant other awards based in whole or in part by reference to our common stock. The administrator will set the number of shares under the stock award (or cash equivalent) and all other terms and conditions of such awards.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;">Non-Employee Director Compensation Limit</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;The aggregate value of all compensation granted or paid to any non-employee director with respect to any calendar year, including awards granted and cash fees paid by us to such non-employee director, will not exceed $700,000 in total value, except such amount will increase to $1,000,000 for the first year for newly appointed or elected non-employee directors.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;">Changes to Capital Structure</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;In the event there is a specified type of change in our capital structure, such as a stock split, reverse stock split, or recapitalization, appropriate adjustments will be made to (i)&#160;the class and maximum number of shares reserved for issuance under our 2020 Plan, (ii)&#160;the class and maximum number of shares by which the share reserve may increase automatically each year, (iii)&#160;the class and maximum number of shares that may be issued on the exercise of ISOs, and (iv)&#160;the class and number of shares and exercise price, strike price, or purchase price, if applicable, of all outstanding stock awards.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;">Corporate Transactions</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;In the event of a corporate transaction (as defined below), unless otherwise provided in a participant&#8217;s stock award agreement or other written agreement with us or one of our affiliates or unless otherwise expressly provided by the administrator at the time of grant, any stock awards outstanding under our 2020 Plan may be assumed, continued or substituted for by any surviving or acquiring corporation (or its parent company), and any reacquisition or repurchase rights held by us with respect to the stock award may be assigned to the successor (or its parent company). If the surviving or acquiring corporation (or its parent company) does not assume, continue or substitute for such stock awards, then (i)&#160;with respect to any such stock awards that are held by participants whose continuous service has not terminated prior to the effective time of the corporate transaction, or current participants, the vesting (and exercisability, if applicable) of such stock awards will be accelerated in full (or, in the case of performance awards with multiple vesting levels depending on the level of performance, vesting will accelerate at 100% of the target level) to a date prior to the effective time of the corporate transaction (contingent upon the effectiveness of the corporate transaction), and such stock awards will terminate if not exercised (if applicable) at or prior to the effective time of the corporate transaction, and any reacquisition or repurchase rights held by us with respect to such stock awards will lapse (contingent upon the effectiveness of the corporate transaction); and (ii)&#160;any such stock awards that are held by persons other than current participants will terminate if not exercised (if applicable) prior to the effective time of the corporate transaction, except that any reacquisition or repurchase rights held by us with respect to such stock awards will not terminate and may continue to be exercised notwithstanding the corporate transaction.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In the event a stock award will terminate if not exercised prior to the effective time of a corporate transaction, the administrator may provide, in its sole discretion, that the holder of such stock award may not exercise such stock award but instead will receive a payment equal in value to the excess (if any) of (i)&#160;the value of the property the participant would have received upon the exercise of the stock award, over (ii)&#160;any per share exercise price payable by such holder, if applicable. In addition, any escrow, holdback, earn out or similar provisions in the definitive agreement for the corporate transaction may apply to such payment to the same extent and in the same manner as such provisions apply to the holders of our common stock.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Under our 2020 Plan, a &#8220;corporate transaction&#8221; is generally the consummation of (i)&#160;a sale or other disposition of all or substantially all of our consolidated assets; (ii)&#160;a sale or other disposition of at least 50% of our outstanding securities; (iii)&#160;a merger, consolidation or similar transaction following which </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">144</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">we are not the surviving corporation; or (iv)&#160;a merger, consolidation or similar transaction following which we are the surviving corporation but the shares of our common stock outstanding immediately prior to such transaction are converted or exchanged into other property by virtue of the transaction.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;">Change in Control</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;Stock awards granted under our 2020 Plan may be subject to acceleration of vesting and exercisability upon or after a change in control (as defined below) as may be provided in the applicable stock award agreement or in any other written agreement between us or any affiliate and the participant, but in the absence of such provision, no such acceleration will automatically occur.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Under our 2020 Plan, a &#8220;change in control&#8221; is generally (i)&#160;the acquisition by any person or company of more than 50% of the combined voting power of our then outstanding stock; (ii)&#160;a merger, consolidation or similar transaction in which our stockholders immediately before the transaction do not own, directly or indirectly, more than 50% of the combined voting power of the surviving entity (or the parent of the surviving entity) in substantially the same proportions as their ownership immediately prior to such transaction; (iii)&#160;stockholder approval of a complete dissolution or liquidation; (iv)&#160;a sale, lease, exclusive license or other disposition of all or substantially all of our assets other than to an entity more than 50% of the combined voting power of which is owned by our stockholders in substantially the same proportions as their ownership of our outstanding voting securities immediately prior to such transaction; or (v)&#160;when a majority of our board of directors becomes comprised of individuals who were not serving on our board of directors on the date of the underwriting agreement related to this offering, or the incumbent board, or whose nomination, appointment, or election was not approved by a majority of the incumbent board still in office.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;">Plan&#160;Amendment or Termination</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;Our board of directors has the authority to amend, suspend, or terminate our 2020 Plan at any time, provided that such action does not materially impair the existing rights of any participant without such participant&#8217;s written consent. Certain material amendments also require the approval of our stockholders. No ISOs may be granted after the tenth anniversary of the date our board of directors adopts our 2020 Plan. No stock awards may be granted under our 2020 Plan while it is suspended or after it is terminated.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">2020 Employee Stock Purchase Plan<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Our board of directors adopted, and our stockholders approved, our ESPP. Our ESPP became effective upon the date of the underwriting agreement related to this offering. The purpose of our ESPP will be to secure the services of new employees, to retain the services of existing employees, and to provide incentives for such individuals to exert maximum efforts toward our success and that of our affiliates. Our ESPP will include two components. One component will be designed to allow eligible U.S. employees to purchase our common stock in a manner that may qualify for favorable tax treatment under Section&#160;423 of the Code. The other component will permit the grant of purchase rights that do not qualify for such favorable tax treatment in order to allow deviations necessary to permit participation by eligible employees who are foreign nationals or employed outside of the U.S. while complying with applicable foreign laws.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;">Share Reserve</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;Following this offering, our ESPP will authorize the issuance of 200,000 shares of our common stock under purchase rights granted to our employees or to employees of any of our designated affiliates. The number of shares of our common stock reserved for issuance will automatically increase on January&#160;1 of each year for a period of 10&#160;years, beginning on January&#160;1, 2021 and continuing through January&#160;1, 2031, by the lesser of (i)&#160;1% of the total number of shares of our common stock outstanding on the last day of the immediately preceding year; and (ii)&#160;400,000 shares, except before the date of any such increase, our board of directors may determine that such increase will be less than the amount set forth in clauses (i)&#160;and (ii).</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;">Administration</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;Our board of directors will administer our ESPP and may delegate its authority to administer our ESPP to our compensation committee. Our ESPP will be implemented through a series of offerings under which eligible employees are granted purchase rights to purchase shares of our common stock on specified dates during such offerings. Under our ESPP, our board of directors will be permitted to specify offerings with durations of not more than 27&#160;months and to specify shorter purchase periods within each offering. Each offering will have one or more purchase dates on which </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">145</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">shares of our common stock will be purchased for employees participating in the offering. Our ESPP will provide that an offering may be terminated under certain circumstances.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;">Payroll Deductions</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;Generally, all regular employees, including executive officers, employed by us or by any of our designated affiliates, will be eligible to participate in our ESPP and to contribute, normally through payroll deductions, up to 15% of their earnings (as defined in our ESPP) for the purchase of our common stock under our ESPP. Unless otherwise determined by our board of directors, common stock will be purchased for the accounts of employees participating in our ESPP at a price per share that is at least equal to the lesser of (i)&#160;85% of the fair market value of a share of our common stock on the first day of an offering, or (ii)&#160;85% of the fair market value of a share of our common stock on the date of purchase.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;">Limitations</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;Employees may have to satisfy one or more of the following service requirements before participating in our ESPP, as determined by our board of directors: (i)&#160;being customarily employed for more than 20 hours per week; (ii)&#160;being customarily employed for more than five&#160;months per calendar year; or (iii)&#160;continuous employment with us or one of our affiliates for a period of time (not to exceed two&#160;years). No employee will be permitted to purchase shares under our ESPP at a rate in excess of $25,000 worth of our common stock (based on the fair market value per share of our common stock at the beginning of an offering) for each calendar year such a purchase right is outstanding. Finally, no employee will be eligible for the grant of any purchase rights under our ESPP if immediately after such rights are granted, such employee has voting power over 5% or more of our outstanding capital stock measured by vote or value under Section&#160;424(d) of the Code.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;">Changes to Capital Structure</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;Our ESPP will provide that in the event there occurs a change in our capital structure through such actions as a stock split, merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, large nonrecurring cash dividend, liquidating dividend, combination of shares, exchange of shares, change in corporate structure, or similar transaction, our board of directors will make appropriate adjustments to: (i)&#160;the class(es) and maximum number of shares reserved under our ESPP; (ii)&#160;the class(es) and maximum number of shares by which the share reserve may increase automatically each year; (iii)&#160;the class(es) and number of shares subject to, and purchase price applicable to, outstanding offerings and purchase rights; and (iv)&#160;the class(es) and number of shares that are subject to purchase limits under ongoing offerings.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;">Corporate Transactions</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;Our ESPP will provide that in the event of a corporate transaction (as defined below), any then-outstanding rights to purchase our stock under our ESPP may be assumed, continued, or substituted for by any surviving or acquiring entity (or its parent company). If the surviving or acquiring entity (or its parent company) elects not to assume, continue, or substitute for such purchase rights, then the participants&#8217; accumulated payroll contributions will be used to purchase shares of our common stock within 10 business days before such corporate transaction, and such purchase rights will terminate immediately after such purchase.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Under our ESPP, a &#8220;corporate transaction&#8221; is generally the consummation of (i)&#160;a sale or other disposition of all or substantially all of our consolidated assets; (ii)&#160;a sale or other disposition of at least 50% of our outstanding securities; (iii)&#160;a merger, consolidation or similar transaction following which we are not the surviving corporation; or (iv)&#160;a merger, consolidation or similar transaction following which we are the surviving corporation but the shares of our common stock outstanding immediately prior to such transaction are converted or exchanged into other property by virtue of the transaction.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;">Amendment or Termination</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;Our board of directors will have the authority to amend or terminate our ESPP, except in certain circumstances such amendment or termination may not materially impair any outstanding purchase rights without the holder&#8217;s consent. We will obtain stockholder approval of any amendment to our ESPP as required by applicable law or listing requirements.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">2018 Equity Incentive Plan<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our board of directors adopted, and our stockholders approved, our Prior Plan on May&#160;7, 2018. Our Prior Plan was most recently amended on August&#160;21, 2020. No further stock awards will be granted under our Prior Plan on or after the effectiveness of our 2020 Plan; however, awards outstanding under our Prior Plan will continue to be governed by their existing terms.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">146</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;">Stock Awards</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;Our Prior Plan provides for the grant of ISOs to our employees and our parent and subsidiary corporations&#8217; employees, and for the grant of NSOs, stock appreciation rights, restricted stock awards, restricted stock unit awards, and other forms of stock awards to our employees, directors and consultants and any of our affiliates&#8217; employees and consultants.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;">Authorized Shares</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;As of December 31, 2020, we had reserved 2,101,478 shares of our common stock for issuance under our Prior Plan. As of December 31, 2020, 1,247,158 stock options to purchase shares of our common stock remained outstanding under our Prior Plan.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;">Plan&#160;Administration</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;Our board of directors, or a duly authorized committee of our board of directors, administers our Prior Plan. The administrator has the authority to construe and interpret our Prior Plan and stock awards granted under our Prior Plan and to make all other determinations necessary or expedient for the administration of our Prior Plan. Under our Prior Plan, the administrator also has the authority to effect, with the consent of any adversely affected participant, (i)&#160;the reduction of the exercise, purchase, or strike price of any outstanding stock award; (ii)&#160;the cancellation of any outstanding stock award and the grant in substitution therefore of other awards, cash, or other consideration; or (iii)&#160;any other action that is treated as a repricing under generally accepted accounting principles.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;">Stock Options</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;Stock options granted under our Prior Plan are subject to terms similar to those described above with respect to stock options that may be granted under our 2020 Plan on and after it becomes effective.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;">Changes to Capital Structure.</font><font style="letter-spacing:-0.025pt;">&nbsp;&nbsp;&nbsp;In the event there is a specified type of change in our capital structure, such as a stock split, reverse stock split, or recapitalization, appropriate adjustments will be made to (i)&#160;the class(es) and maximum number of shares reserved for issuance under our Prior Plan, (ii)&#160;the class(es) and maximum number of shares that may be issued on the exercise of ISOs and (iii)&#160;the class(es) and number of shares and price per share, if applicable, of stock subject to outstanding stock awards.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;">Corporate Transaction</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;Our Prior Plan provides that in the event of a corporate transaction (as defined below), unless otherwise provided in an award agreement or other written agreement between us and the participant, our board of directors may take one or more of the following actions with respect to outstanding stock awards:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">arrange for the assumption, continuation, or substitution of a stock award by the surviving or acquiring corporation or parent company;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">arrange for the assignment of any reacquisition or repurchase rights held by us to the surviving or acquiring corporation or parent company;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">accelerate the vesting, in whole or in part, of the stock award and, if applicable, the time at which the stock award may be exercised, to a date prior to the effective time of the corporate transaction and provide for its termination if not exercised (if applicable) at or prior to the effective time of the corporate transaction;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">arrange for the lapse, in whole or in part, of any reacquisition or repurchase rights held by us;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">cancel the stock award, to the extent not vested or not exercised prior to the effective time of the corporate transaction, in exchange for such cash consideration, if any, as our board of directors deems appropriate; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">make a payment, in such form as determined by our board of directors, equal to the excess, if any, of the value of the property the participant would have received upon the exercise of the stock award immediately prior to the effective time of the corporate transaction over any exercise price payable by the holder in connection with such exercise.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Our board of directors is not obligated to treat all stock awards or portions of stock awards in the same manner and is not obligated to treat all participants in the same manner.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Under our Prior Plan, a &#8220;corporate transaction&#8221; is generally the consummation of (i)&#160;a sale or other disposition of all or substantially all of our consolidated assets; (ii)&#160;a sale or other disposition of more than 50% of our outstanding securities; (iii)&#160;a merger, consolidation or similar transaction following which we are not the surviving corporation; or (iv)&#160;a merger, consolidation or similar transaction following </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">147</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">which we are the surviving corporation but the shares of our common stock outstanding immediately prior to such transaction are converted or exchanged into other property by virtue of the transaction.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;">Change in Control</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;A stock award under our Prior Plan may be subject to additional acceleration of vesting and exercisability upon or after a change in control (as defined below) as may be provided in the award agreement or any other written agreement between us and the participant, but in the absence of such provision, no such acceleration will occur. Under our Prior Plan, a &#8220;change in control&#8221; is generally (i)&#160;the acquisition by any person or entity of more than 50% of the combined voting power of our then outstanding securities other than by merger, consolidation, or similar transaction; (ii)&#160;a merger, consolidation or similar transaction in which our stockholders immediately before the transaction do not own, directly or indirectly, more than 50% of the combined voting power of the surviving entity (or the parent of the surviving entity) in substantially the same proportions as their ownership immediately prior to such transaction; or (iii)&#160;a sale, lease, exclusive license or other disposition of all or substantially all of our consolidated assets other than to an entity more than 50% of the combined voting power of which is owned by our stockholders in substantially the same proportions as their ownership of our outstanding voting securities immediately prior to such transaction.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;">Plan&#160;Amendment and Termination</font><font style="letter-spacing:-0.025pt;">.&nbsp;&nbsp;&nbsp;Our board of directors may amend, suspend, or terminate our Prior Plan at any time, provided that such action does not materially impair the existing rights of any participant without such participant&#8217;s written consent. Certain material amendments of our Prior Plan also require the approval of our stockholders. As noted above, no further awards will be granted under our Prior Plan on or after the effectiveness of our 2020 Plan; however, awards outstanding under our Prior Plan will continue to be governed by their existing terms.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Non-Employee Director Compensation</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We have not historically had a formal compensation policy with respect to service on our board of directors, but we have reimbursed our non-employee directors for direct expenses incurred in connection with attending meetings of our board of directors or its committees, and occasionally granted stock options.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In November&#160;2020, our board of directors approved a non-employee director compensation policy that will be effective upon the effectiveness of the registration statement of which this prospectus is a part. This policy is intended to provide a total compensation package that enables us to attract and retain qualified and experienced individuals to serve as directors and to align our directors&#8217; interests with those of our stockholders. Under this policy, we will pay each of our non-employee directors a cash retainer for service on the board of directors and for service on each committee on which the director is a member. The chairperson of each committee will receive a higher retainer for such service. These retainers are payable in arrears in four equal quarterly installments on the last day of each quarter, provided that the amount of such payment will be prorated for any portion of such quarter that the director is not serving on our board of directors or the applicable committee. The retainers to be paid to non-employee directors for service on the board of directors and for service on each committee of the board of directors on which the director is a member are as follows:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:416pt;height:74.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:0pt 0pt 0.667pt 0pt; width:318.77pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="border-bottom:1px solid #000000;padding-right:1pt;letter-spacing:-0.089pt;">Position </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Annual</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Service</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-left:2pt;padding-right:2pt;letter-spacing:-0.089pt;">Retainer </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Chairperson</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Additional</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-left:8pt;padding-right:8pt;letter-spacing:-0.089pt;">Retainer </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:1.75pt 0pt 0.5pt 0pt; width:318.77pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Board of Directors </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">35,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.99pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">65,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:318.77pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Audit Committee </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">7,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.99pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">15,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:318.77pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Compensation Committee </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">5,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.99pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">10,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:318.77pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Nominating and Corporate Governance Committee </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">4,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.99pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">8,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In addition, under our non-employee director compensation policy, each non-employee director elected to our board of directors after the completion of this offering will receive an option to purchase 21,000 shares of our common stock. The shares subject to this initial option grant will vest monthly over a three-year period, subject to the director&#8217;s continued service as a director. Further, on the date of each annual meeting of stockholders held after the completion of this offering, each non-employee director that continues to serve as a non-employee director will receive an option to purchase 10,500 shares of our common stock. The shares subject to each annual option grant will vest in equal monthly </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">148</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">installments over the 12&#160;months following the date of grant and, notwithstanding the foregoing, will be fully vested on the date of Company&#8217;s next annual stockholder meeting, subject to the director&#8217;s continued service as a director. The exercise price per share of these options will equal the fair market value of our common stock on the date of grant. All options granted under this policy will vest in full upon the occurrence of a change in control (as defined in the 2020 Plan) prior to the termination of the director&#8217;s continuous service.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:9pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">IPO Grants</div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">At the time of effectiveness of the 2020 Plan, our board of directors granted options to purchase shares of our common stock to our non-employee directors, with an exercise price equal to the initial public offering price per share. On such date, each of Messrs. Brandt, Roemer and Whitfill received 10,500 options to purchase shares of our common stock, and Ms. Fairbairn and Ms. Greenwood each received 21,000 options to purchase shares of our common stock.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:9pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">2020 Director Compensation Table<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The following table sets forth information regarding the compensation earned for service on our board of directors by our non-employee directors during the year ended December&#160;31, 2020. Other than as set forth below for Mr. Roemer, no directors received any cash compensation for their service on our board of directors during 2020. Mr.&#160;Ho is a member of our board of directors, but he did not receive any additional compensation for service as a director. Mr.&#160;Ho&#8217;s compensation as a named executive officer is set forth above under &#8220;&#8212;Summary Compensation Table.&#8221;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:416pt;height:74.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:0pt 0pt 0.667pt 0pt; width:243.45pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="border-bottom:1px solid #000000;padding-right:1pt;letter-spacing:-0.089pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Fees Earned or</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Paid in Cash</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-left:24pt;padding-right:24pt;letter-spacing:-0.089pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Option</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Awards</font><font style=" position:relative; bottom:3.25pt;font-size:6pt;letter-spacing:-0.067pt;">(1)(4)</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-left:17pt;padding-right:17pt;letter-spacing:-0.089pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Total</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-left:17pt;padding-right:17pt;letter-spacing:-0.089pt;">($) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:1.75pt 0pt 0.5pt 0pt; width:243.45pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Peter Brandt </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.08pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">203,848</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">203,848</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:243.45pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Thomas Cirrito, Ph.D.</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">(5)</font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.08pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">218,544</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">218,544</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:243.45pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Alan S. Roemer </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.08pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">30,769<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(2)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">1,081,960<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(3)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">1,112,729</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:243.45pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Travis Whitfill </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.08pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">10,815</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:36.75pt; text-align:right; white-space:nowrap;">10,815</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 120pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:-0.025pt;">In accordance with SEC rules, this column reflects the aggregate grant date fair value of the option awards granted during fiscal year 2020 computed in accordance with ASC 718. Assumptions used in the calculation of these amounts are included in the notes to our audited financial statements included elsewhere in this prospectus. These amounts do not reflect the actual economic value that will be realized by our non-employee directors upon the vesting of the stock options, the exercise of the stock options or the sale of the common stock underlying such stock options.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:-0.025pt;">Amount represents the annual compensation of $100,000 earned by Mr.&#160;Roemer as Chairman of the board of directors, prorated for the portion of the year during which Mr.&#160;Roemer served in such position.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:-0.025pt;">Reflects an option to purchase 225,879 shares of our common stock, which Mr.&#160;Roemer received upon his appointment to our board of directors in September 2020.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:-0.025pt;">The following table provides information regarding the number of shares of common stock underlying stock options granted to our non-employee directors that were outstanding as of December&#160;31, 2020:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:416pt;height:69.58pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:7pt;">
          <tr style="line-height:7.87pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:7pt;">
            <td style="padding:0pt 0pt 1.66pt 0pt; width:372.79pt;">
              <div style="white-space:nowrap;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-right:1pt;letter-spacing:-0.078pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1.66pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.078pt;">Outstanding </font>
                <br >
                <font style="letter-spacing:-0.078pt;">Option </font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:8pt;padding-right:8pt;letter-spacing:-0.078pt;">Awards </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:2.263pt 0pt 1.097pt 0pt; width:372.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.02pt;">Peter Brandt </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.31pt;width:0pt;">&#8203;</td>
            <td style="padding:2.263pt 0pt 1.097pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.263pt 0pt 1.097pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">72,221</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:2.513pt 0pt 1.097pt 0pt; width:372.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.02pt;">Thomas Cirrito, Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.31pt;width:0pt;">&#8203;</td>
            <td style="padding:2.513pt 0pt 1.097pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.513pt 0pt 1.097pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">76,650</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:2.503pt 0pt 1.107pt 0pt; width:372.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.02pt;">Travis Whitfill </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.31pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">12,775</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:2.503pt 0pt 1.107pt 0pt; width:372.79pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.02pt;">Alan S. Roemer </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.31pt;width:0pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">225,879</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:-0.025pt;">Effective July&#160;19, 2021, Dr. Cirrito is no longer a member of our board of directors.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">149</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tCRAR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:18pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Other than compensation arrangements for our directors and executive officers, which are described elsewhere in this prospectus, the following includes a summary of transactions since January&#160;1, 2018 and any currently proposed transactions, to which we were or are to be a participant, in which</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the amount involved exceeded or will exceed the lesser of (1)&#160;$120,000 or (2)&#160;1% of the average of our total assets for the last two completed fiscal&#160;years, and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">any of our directors, executive officers or holders of more than 5% of our capital stock, or member of the immediate family of, or person sharing the household with, the foregoing persons, had or will have a direct or indirect material interest.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Corporate Reorganization</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We were incorporated under the laws of the State of Delaware on May&#160;7, 2018. We were formed by the domestication of Incysus, Ltd., a Bermuda entity formed in February&#160;2016, into the State of Delaware under the name Incysus Therapeutics, Inc. In August&#160;2020, we amended our charter to change our name to IN8bio, Inc. Upon completion of the domestication, all outstanding Class&#160;A shares of Incysus, Ltd., including Class&#160;A shares held by certain of our directors and executive officers, were automatically converted into an equivalent amount of shares of our common stock and each Class&#160;B share of Incysus, Ltd. was automatically cancelled and did not convert into any shares of any class of our capital stock.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Promissory Note with Our Executive Officer</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In August&#160;2017, we issued a promissory note to our President and Chief Executive Officer, William Ho, which entitled us to borrow up to $100,000 through December&#160;31, 2017. We entered into an amendment to the promissory note in March&#160;2018, which permitted us to borrow up to an aggregate of $150,000 through April&#160;30, 2018, with any amounts outstanding to be repaid on April&#160;30, 2018. All amounts outstanding under the promissory note accrued interest at a rate of 5% per annum. We repaid the then-outstanding balance of $122,730 on May&#160;9, 2018, which included $2,730 in accrued interest.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Preferred Stock, Warrant and Convertible Note Financings</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Convertible Note Financing<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In April&#160;2018, our predecessor entity issued an aggregate principal amount of $2.5&#160;million of convertible notes, or the 2018A Notes, shortly prior to our domestication to a Delaware corporation. See &#8220;&#8212;Corporate Reorganization&#8221; above. The 2018A Notes accrued interest at a rate equal to the annual short-term Applicable Federal Rate as published by the U.S. Internal Revenue Service for the month in which the 2018A Notes were outstanding. In May&#160;2018, we closed on a portion of the Series&#160;A preferred stock financing described below in connection with our domestication, at which time all 2018A Notes and the then-accrued interest totaling $2.5&#160;million were converted into 694,212 shares of our Series&#160;A preferred stock.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Series&#160;A Preferred Stock Financing and Warrants<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Between May&#160;2018 and August&#160;2020, we issued an aggregate of 9,762,331 shares of our Series&#160;A preferred stock at an original price per share of $3.58330 for total gross proceeds of $32.5&#160;million, excluding proceeds from the sale of the 2018A Notes.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Concurrently with the conversion of the 2018A Notes, we sold an additional 627,927 shares of our Series&#160;A preferred stock in the initial closing of our Series&#160;A preferred stock financing on May&#160;7, 2018, or the initial closing. In connection with the initial closing of the Series&#160;A preferred stock financing, certain Series&#160;A investors, including entities affiliated with Bios Partners and entities affiliated with Emily T. Fairbairn, were issued five-year warrants, or the Series&#160;A warrants, entitling such individuals to purchase up to an aggregate of 231,396 shares of our Series&#160;A preferred stock at an exercise price of $0.0003 per share. In October 2020, certain of these individuals, including entities affiliated with Bios Equity Partners, L.P. and entities affiliated with Emily T. Fairbairn, exercised their respective Series A warrants for an aggregate of 231,396 shares of Series&#160;A preferred stock, for aggregate proceeds to us of $64. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">150</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">See the section titled &#8220;Description of Capital Stock&#8212;Series&#160;A Warrants&#8221; elsewhere in this prospectus for more information on the Series&#160;A warrants.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Between May and July&#160;2018, we issued an aggregate of 1,712,250 shares of our Series&#160;A preferred stock for aggregate gross proceeds of $6.1&#160;million (excluding the shares issued upon the conversion of the 2018A Notes). In August&#160;2018, we issued an additional 52,810 shares of our Series&#160;A preferred stock for aggregate gross proceeds of $0.2&#160;million. Between October and December&#160;2018, we issued an additional 539,877 shares of our Series&#160;A preferred stock for aggregate gross proceeds of $0.9&#160;million.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Between January and February&#160;2020, we issued an additional 1,533,947 shares of our Series&#160;A preferred stock for aggregate gross proceeds of $5.5&#160;million. In August&#160;2020, we issued an additional 5,514,404 shares of our Series&#160;A preferred stock for aggregate gross proceeds of $19.8&#160;million.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The table below sets forth the aggregate number of shares of our Series&#160;A preferred stock and warrants purchased by the holders of more than 5% of our capital stock and affiliates, including shares issued upon conversion of the 2018A Notes purchased by such investors. Each share of Series&#160;A preferred stock in the table below will automatically convert into 1.09970 shares of our common stock upon the completion of this offering. For a description of the material rights and privileges of the Series&#160;A preferred stock, see Note 6 to our financial statements included elsewhere in this prospectus.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:107.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:0pt 0pt 2.167pt 0pt; width:159.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="border-bottom:1px solid #000000;padding-bottom:2.16666666666667pt;padding-right:1pt;letter-spacing:-0.089pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Series&#160;A </font>
                <br >
                <font style="letter-spacing:-0.089pt;">Preferred </font>
                <br >
                <font style="letter-spacing:-0.089pt;">Stock (#) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Warrants to </font>
                <br >
                <font style="letter-spacing:-0.089pt;">Purchase </font>
                <br >
                <font style="letter-spacing:-0.089pt;">Series&#160;A </font>
                <br >
                <font style="letter-spacing:-0.089pt;">Preferred </font>
                <br >
                <font style="letter-spacing:-0.089pt;">Stock (#)</font><font style=" position:relative; bottom:3.25pt;font-size:6pt;letter-spacing:-0.067pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Cancellation of</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Indebtedness</font>
                <br >
                <font style="letter-spacing:-0.089pt;">(2018 Note </font>
                <br >
                <font style="letter-spacing:-0.089pt;">Conversion($) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Cash </font>
                <br >
                <font style="letter-spacing:-0.089pt;">Purchase </font>
                <br >
                <font style="letter-spacing:-0.089pt;">Price of </font>
                <br >
                <font style="letter-spacing:-0.089pt;">Series&#160;A </font>
                <br >
                <font style="letter-spacing:-0.089pt;">Preferred </font>
                <br >
                <font style="letter-spacing:-0.089pt;">Stock ($) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Aggregate</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Purchase </font>
                <br >
                <font style="letter-spacing:-0.089pt;">Price ($) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:159.59pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:-0.025pt;">Entities affiliated with Bios Equity Partners, L.P.</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">&#65279;(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">5,861,427</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.36pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">163,049</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.01pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">1,752,744</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:42pt; text-align:right; white-space:nowrap;">19,250,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:42pt; text-align:right; white-space:nowrap;">21,002,744</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:159.59pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:-0.025pt;">Entities affiliated with Emily&#160;T.&#160;Fairbairn</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">&#65279;(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">3,005,920</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.36pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">25,195</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.01pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">270,850</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:42pt; text-align:right; white-space:nowrap;">10,500,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:42pt; text-align:right; white-space:nowrap;">10,770,850</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 120pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:-0.02pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.1pt; margin-bottom:0pt; line-height:8pt; text-align:left; margin-left:20pt;font-size:8pt;">
          <font style="letter-spacing:-0.02pt;">Travis Whitfill, a member of our board of directors, is a partner at Bios Equity Partners, L.P.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:8pt; margin-top:3.11pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:-0.02pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.11pt; margin-bottom:0pt; line-height:8pt; text-align:left; margin-left:20pt;font-size:8pt;">
          <font style="letter-spacing:-0.02pt;">Emily T. Fairbairn is the sole managing member of Transcend Partners Opportunity Fund&#160;LLC, the sole managing partner of Valley High Limited Partnership and exercises control over the Emily&#160;T. Fairbairn Roth IRA.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:8pt; margin-top:3.11pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:-0.02pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:3.11pt; margin-bottom:0pt; line-height:8pt; text-align:left; margin-left:20pt;font-size:8pt;">
          <font style="letter-spacing:-0.02pt;">These warrants were exercised in full in October 2020.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.16pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:9.61pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Common Stock Issuance</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In March&#160;2020, we entered into a common stock purchase agreement with Peter Brandt, a member of our board of directors, to issue and sell 182,500 shares of our common stock for a total purchase price of $0.2&#160;million.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In October 2020, we entered into a common stock purchase agreement with Alan&#160;S. Roemer, a member of our board of directors, to issue and sell 29,674 shares of our common stock for a total purchase price of $0.2 million.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Settlement Agreement</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In July&#160;2020, we entered into a settlement agreement with a former employee, pursuant to which we paid $0.3&#160;million in cash and issued 200,750 shares of our common stock.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Director Antidilution Rights</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In connection with Peter Brandt&#8217;s appointment to our board of directors in 2019, he was granted the right to receive an option to purchase shares of our common stock, at an exercise price equal to the fair market value of the shares on the date of grant, that, combined with his outstanding stock options, represented 0.5% of our fully diluted capitalization (excluding shares issuable upon exercise of warrants or under our equity incentive plans) upon the closing of a sale of our capital stock generating gross proceeds to us of at least $25.0&#160;million, or a Qualified Financing. Upon the closing of the Series&#160;A preferred stock financing in August&#160;2020, Mr.&#160;Brandt was entitled to receive an option to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">151</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">purchase 42,557 shares of our common stock. This option was granted to Mr. Brandt on October 5, 2020 at a price per share of $6.74, which satisfied Mr. Brandt&#8217;s antidilution rights in full.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In connection with Alan S. Roemer&#8217;s appointment to our board of directors in 2020, he was granted the right to receive an option to purchase shares of our common stock, at an exercise price equal to the fair market value of the shares on the date of grant, that, combined with his existing stock option grant, represents 1.5% of our fully diluted capitalization (including shares issuable upon exercise of warrants or warrants or reserved for issuance under our equity incentive plans) upon the closing of a Qualified Financing. Upon the completion of this offering and in satisfaction of the antidilution right, Mr.&#160;Roemer will receive an option to purchase 86,258 shares of our common stock, assuming the sale in this offering of the number of shares set forth on the cover page of this prospectus at the public offering price of $10.00 per share. The final number of shares subject to such option will be determined upon completion of this offering.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Investors&#8217; Rights Agreement</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We are party to an investors&#8217; rights agreement, or the Rights Agreement, dated May&#160;7, 2018, with the holders of our Series&#160;A preferred stock, including all holders of more than 5% of our capital stock, as well as with William Ho and Peter Brandt. The Rights Agreement provides that these holders are entitled to certain registration rights, including the right to demand that we file a registration statement or request that their shares be covered by a registration statement that we otherwise file. In addition to the registration rights, the Rights Agreement provides for certain information rights and rights of first offer in favor of certain holders of our outstanding preferred stock with regard to certain issuances of our capital stock. The information rights and rights of first offer will terminate immediately prior to the consummation of this offering. The registration rights will terminate upon the earliest of (i)&#160;the closing of a deemed liquidation event, (ii)&#160;with respect to each stockholder, the date when such stockholder can sell all of its registrable shares without limitation during a three-month period without registration pursuant to Rule&#160;144 of the Securities Act or another similar exemption under the Securities Act and (iii)&#160;three&#160;years after the completion this offering. For a detailed description of the registration rights, see the section titled &#8220;Description of Capital Stock&#8212;Registration Rights.&#8221;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Indemnification Agreements</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We have entered or intend to enter, and intend to continue to enter, into separate indemnification agreements with some of our directors and executive officers, in addition to the indemnification provided for in our bylaws. These indemnification agreements provide our directors and executive officers with contractual rights to indemnification and, in some cases, expense advancement in any action or proceeding arising out of their services as one of our directors or executive officers or as a director or executive officer of any other company or enterprise to which the person provides services at our request. For more information regarding these indemnification agreements, see the section titled &#8220;Management&#8212;</font>&#8203;<font style="letter-spacing:-0.025pt;">Limitation on Liability and Indemnification Matters.&#8221;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Related Party Transaction Policy</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Prior to the completion of this offering, we intend to adopt a policy that sets forth our procedures for the identification, review, consideration and approval or ratification of related party transactions. For purposes of this policy only, a &#8220;related person transaction&#8221; is a transaction, arrangement or relationship (or any series of similar transactions, arrangements or relationships) in which we and any related person are participants involving an amount that exceeds or will exceed the lesser of (1)&#160;$120,000 or (2)&#160;1% of the average of our total assets for the last two completed fiscal&#160;years. Transactions involving compensation for services provided to us as an employee, consultant or director are not considered related-person transactions under this policy. A &#8220;related person&#8221; is any executive officer, director, nominee to become a director or a holder of more than 5% of our capital stock, or any member of the immediate family of the foregoing.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Under the policy, where a transaction has been identified as a related-person transaction, management must present information regarding the proposed related-person transaction to our audit committee or, where review by our audit committee would be inappropriate due to a conflict of interest, to another independent body of our board of directors, for review. In approving or rejecting any such </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">152</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:568pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">proposal, our board of directors or our audit committee is to consider the material facts of the transaction, including whether the transaction is on terms no less favorable than terms generally available to an unaffiliated third party under the same or similar circumstances and the extent of the related person&#8217;s interest in the transaction. All of the transactions described in this section were entered into prior to the adoption of this policy. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">153</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPRST">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">PRINCIPAL STOCKHOLDERS</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:18pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The following table sets forth information regarding beneficial ownership of our capital stock as of June 30, 2021 by:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">each person, or group of affiliated persons, known by us to beneficially own more than 5% of our common stock;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">each of our directors;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">each of our named executive officers; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">all of our current executive officers and directors as a group.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The&#160;percentage ownership information under the column titled &#8220;Before Offering&#8221; is based on 14,754,553 shares of common stock outstanding as of June 30, 2021, assuming the automatic conversion of all of our outstanding shares of preferred stock into an aggregate of 10,990,065 shares of common stock upon the completion of this offering. The information relating to the number and&#160;percentage of shares beneficially owned under the column titled &#8220;After Offering&#8221; is based on the sale of 4,000,000 shares of common stock in this offering. The&#160;percentage ownership information assumes no exercise of the underwriters&#8217; option to purchase additional shares to cover over-allotments. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Information with respect to beneficial ownership has been furnished by each director, officer or beneficial owner of more than 5% of our capital stock. We have determined beneficial ownership in accordance with the rules of the SEC. These rules generally attribute beneficial ownership of securities to persons who possess sole or shared voting power or investment power with respect to those securities. In addition, the rules include shares of our common stock issuable pursuant to the exercise of stock options or warrants that are either immediately exercisable or exercisable within 60&#160;days of June&#160;30, 2021. These shares are deemed to be outstanding and beneficially owned by the person holding those options or warrants for the purpose of computing the&#160;percentage ownership of that person, but they are not treated as outstanding for the purpose of computing the&#160;percentage ownership of any other person.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Unless otherwise indicated, the persons or entities identified in this table have sole voting and investment power with respect to all shares shown as beneficially owned by them. Except as otherwise noted below, the address for each person or entity listed in the table is c/o&#160;IN8bio, Inc., 79 Madison Avenue, New York, New York 10016.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:256pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;height:27.25pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:323.1pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0.333333333333333pt;">
                <font style="letter-spacing:-0.089pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Shares</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Beneficially</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Owned</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Percentage of</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Shares Beneficially</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Owned </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;height:22.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:323.1pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:31.22pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Before</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Offering </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:31.22pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">After</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Offering </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:323.1pt;text-align:left;">
              <font style="letter-spacing:-0.111pt;">Greater than 5% Stockholders:</font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:31.22pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:31.22pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:323.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Entities affiliated with Bios Equity Partners, L.P.</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">6,625,102</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:31.22pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">44.9%</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:31.22pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">35.3%</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:323.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Transcend Partners Opportunity Fund LLC</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">3,222,485</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:31.22pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">21.8%</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:31.22pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">17.2%</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:323.1pt;text-align:left;">
              <font style="letter-spacing:-0.111pt;">Directors and Named Executive Officers:</font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:31.22pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:31.22pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:323.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">William Ho</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">2,544,929</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:31.22pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">17.2%</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:31.22pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">13.6%</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:323.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Lawrence Lamb, Ph.D.</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">(4)</font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">186,637</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:31.22pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">1.3%</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:31.22pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">1.0%</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:323.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Melissa Beelen</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">(5)</font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">26,689</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:31.22pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">*</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:31.22pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">*</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:323.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Peter Brandt</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">(6)</font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">207,971</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:31.22pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">1.4%</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:31.22pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">1.1%</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:323.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Alan S. Roemer</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">(7)</font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">86,143</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:31.22pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">*</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:31.22pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">*</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:323.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Emily T. Fairbairn</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">(8)</font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">3,341,527</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:31.22pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">22.6% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:31.22pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">17.8%</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:323.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Luba Greenwood </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">7,300</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:31.22pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">* </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:31.22pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">*</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:323.1pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Travis Whitfill</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.019pt;">(9)</font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">12,775</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:31.22pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">*</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:31.22pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">*</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:323.1pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">All current executive officers and directors as a group (9&#160;persons)</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:-0.083pt;">&#65279;(10)</font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">6,413,971</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:31.22pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">42.8%</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:31.22pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">33.8%</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">154</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt;">
          <div style="margin-left: 0pt; width: 120pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:-0.025pt;">Represents beneficial ownership of less than 1%.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:-0.025pt;">Includes (a) 251,211 shares issuable upon the conversion of Series A preferred stock held by Bios Fund II NT, LP (&#8220;Fund II NT&#8221;), (b) 1,876,624 shares issuable upon the conversion of Series A preferred stock held by Bios Fund II QP, LP (&#8220;Fund II QP&#8221;), (c) 574,432 shares issuable upon the conversion of Series A preferred stock held by Bios Fund II, L.P. (&#8220;Bios Fund II&#8221;), (d) 340,712 shares issuable upon the conversion of Series A preferred stock held by Bios Fund III, L.P. (&#8220;Fund III&#8221;), (e) 359,374 shares issuable upon the conversion of Series A preferred stock held by Bios Fund III NT, L.P. (&#8220;Fund III NT&#8221;), (f) 2,225,316 shares issuable upon the conversion of Series A preferred stock held by Bios Fund III QP, L.P. (&#8220;Fund&#160;III QP&#8221;), and (g) 997,433 shares held by Bios Incysus Co-Invest I, LP. Bios Equity Partners II, LP (&#8220;Equity II&#8221;) is the general partner of Fund&#160;II NT, Fund&#160;II QP, Bios Fund&#160;II and Co-Invest. Bios Equity Partners&#160;III, LP (&#8220;Equity&#160;III&#8221;) is the general partner of Fund, III NT, Fund&#160;III QP and Fund&#160;III. Cavu Management, LP and Bios Capital Management, LP are the general partners of Equity II and Equity III. Cavu Advisors LLC (&#8220;Cavu Advisors&#8221;) is the general partner of Cavu Management LP. Bios Advisors GP, LLC (&#8220;Bio Advisors&#8221;) is the general partner of Bios Capital Management, LP. Leslie Kreis, Jr. is a managing partner of Equity II, Equity III, and a manager of Cavu Advisors. Aaron Fletcher is a managing partner of Equity II, Equity III, and a manager of Bios Advisors. Mr. Kreis and Mr. Fletcher have shared voting and investment power over the shares described in this footnote 1. Travis Whitfill, a director of the Company, is a partner at Bios Equity Partners, LP. but does not have voting or investment power over the shares described in this footnote 1. The address of Bios Equity Partners, LP is 1751 River Run, Suite 400, Fort Worth, Texas 76107.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:-0.025pt;">Emily T. Fairbairn is the sole managing member of Transcend Partners Opportunity Fund LLC (&quot;Transcend&quot;), and as such, has voting and investment power over the shares held by Transcend.The address of Transcend is 10 Orinda View Road, Orinda, CA 94563. Excludes 100,000 shares of our common stock that Transcend has agreed to purchase in this offering at the initial public offering price.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:-0.025pt;">Includes (a)&#160;182,499 shares held by Mr.&#160;Ho&#8217;s children and (b)&#160;73,000 shares held by other relatives of Mr.&#160;Ho over which Mr.&#160;Ho has voting power pursuant to a voting proxy.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:-0.025pt;">Includes 113,637 shares underlying outstanding options that are immediately exercisable or will be immediately exercisable within 60 days of June 30, 2021.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:-0.025pt;">Consists of 26,689 shares underlying outstanding options that are immediately exercisable or will be immediately exercisable within 60 days of June 30, 2021.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">(6)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:-0.025pt;">Includes (a) 182,500 shares held by The Peter C. Brandt 2020-4 GRAT (the &#8220;GRAT&#8221;) and (b) 25,471 shares underlying outstanding options that are immediately exercisable or will be immediately exercisable within 60&#160;days of June 30, 2021. Mr.&#160;Brandt is the trustee of the GRAT and, as such, has voting and investment power over the shares held by the GRAT.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">(7)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:-0.025pt;">Includes of 56,469 shares underlying outstanding options that are immediately exercisable or will be immediately exercisable within 60 days of June 30, 2021.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">(8)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:-0.025pt;">Consists of (a) the shares described in footnote 2, (b) 27,706 shares issuable upon the conversion of Series A preferred stock held by Emily T. Fairbairn (&#8220;Roth IRA&#8221;) and (c) 8,212 shares and 83,124 shares issuable upon the conversion of Series A preferred stock held by Valley High Limited Partnership (&#8220;Valley High&#8221;). Emily T. Fairbairn is the sole managing member of Transcend and the sole managing partner of Valley High, and exercises control over the Roth IRA, and as such, has voting and investment power over the shares held by Transcend, Valley High and Roth IRA.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">(9)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:-0.025pt;">Consists of 12,775 shares underlying outstanding options that are immediately exercisable or will be immediately exercisable within 60 days of June 30, 2021.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">(10)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:-0.025pt;">Includes 235,041 shares underlying outstanding options that are immediately exercisable or will be immediately exercisable within 60 days of June 30, 2021. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">155</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDOCS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">DESCRIPTION OF CAPITAL STOCK</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:18pt; width:456pt; line-height:12pt;font-style:italic;">The following description of our capital stock and provisions of our amended and restated certificate of incorporation and amended and restated bylaws are summaries. You should also refer to the amended and restated certificate of incorporation, the amended and restated bylaws and the amended and restated investors&#8217; rights agreement, which are filed as exhibits to the registration statement of which this prospectus is a part.<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">General</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Upon the completion of this offering and the filing of our amended and restated certificate of incorporation, our authorized capital stock will consist of 490,000,000 shares of common stock, par value $0.0001 per share, and 10,000,000 shares of preferred stock, par value $0.0001 per share.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Common Stock</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Outstanding Shares<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">As of March 31, 2021, we had 14,754,553 shares of common stock outstanding, which assumes the automatic conversion of all of our outstanding shares of preferred stock into 10,990,065 shares of common stock upon the completion of this offering. Our common stock was held by 25&#160;stockholders of record as of March 31, 2021.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Voting Rights<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Each holder of common stock is entitled to one vote for each share on all matters submitted to a vote of the stockholders. The affirmative vote of holders of at least 66</font><font style=" position:relative; bottom:2.66pt;font-size:7pt;letter-spacing:-0.018pt;">2</font><font style="letter-spacing:-0.025pt;">&#8725;</font><font style="font-size:7pt;letter-spacing:-0.018pt;">3</font><font style="letter-spacing:-0.025pt;">% of the voting power of all of the then-outstanding shares of capital stock, voting as a single class, will be required to amend certain provisions of our amended and restated certificate of incorporation, including provisions relating to amending our amended and restated bylaws, the classified board, the size of our board, removal of directors, director liability, vacancies on our board, special meetings, stockholder notices, actions by written consent and exclusive jurisdiction.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Dividends<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Subject to preferences that may apply to any outstanding preferred stock, holders of our common stock are entitled to receive ratably any dividends that our board of directors may declare out of funds legally available for that purpose on a non-cumulative basis.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Liquidation<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In the event of our liquidation, dissolution or winding up, holders of our common stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all of our debts and other liabilities, subject to the satisfaction of any liquidation preference granted to the holders of any outstanding shares of preferred stock.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Rights and Preferences<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Holders of our common stock have no preemptive, conversion or subscription rights, and there are no redemption or sinking fund provisions applicable to our common stock. The rights, preferences and privileges of the holders of our common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of our preferred stock that we may designate and issue in the future.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Preferred Stock</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We will not have any preferred shares outstanding following the completion of this offering. Immediately after the completion of this offering, our certificate of incorporation will be amended and restated to delete all references to such shares of preferred stock. Under the amended and restated certificate of incorporation, our board of directors will have the authority, without further action by the stockholders, to issue up to 10,000,000 shares of preferred stock in one or more series, to establish from time to time the number of shares to be included in each such series, to fix the rights, preferences and privileges of the shares of each wholly unissued series and any qualifications, limitations or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">156</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">restrictions thereon and to increase or decrease the number of shares of any such series, but not below the number of shares of such series then outstanding.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Our board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of the common stock. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in our control that may otherwise benefit holders of our common stock and may adversely affect the market price of the common stock and the voting and other rights of the holders of common stock. We have no current plans to issue any shares of preferred stock.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Stock Options</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">As of March 31, 2021, 1,552,290 shares of common stock were issuable upon the exercise of outstanding stock options under the 2018 Plan, at a weighted-average exercise price of $5.20 per share. For additional information regarding terms of our equity incentive plans, see the section titled &#8220;Executive and Director Compensation&#8212;Equity Incentive Plans.&#8221;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Series&#160;A Warrants</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In connection with the Series&#160;A preferred stock financing in May&#160;2018, we issued Series&#160;A warrants to certain investors to purchase an aggregate of 231,396 shares of our Series&#160;A preferred stock at an exercise price of $0.0003 per share. In October 2020, the Series&#160;A warrants were exercised and 231,396 shares of Series A preferred stock were issued to such investors.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Registration Rights</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Upon the completion of this offering, certain holders of shares of our common stock, including those shares of our common stock that will be issued upon the conversion of our preferred stock in connection with this offering, will initially be entitled to certain rights with respect to registration of such shares under the Securities Act. These shares are referred to as registrable securities. The holders of these registrable securities possess registration rights pursuant to the terms of our investors&#8217; rights agreement and are described in additional detail below. The registration of shares of our common stock pursuant to the exercise of the registration rights described below would enable the holders to trade these shares without restriction under the Securities Act when the applicable registration statement is declared effective. We will pay the registration expenses, other than underwriting discounts, selling commissions and stock transfer taxes, of the shares registered pursuant to the demand, piggyback and Form S-3 registrations described below.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Generally, in an underwritten offering, the managing underwriter, if any, has the right, subject to specified conditions and limitations, to limit the number of shares the holders may include. The demand, piggyback and Form S-3 registration rights described below will expire no later than three&#160;years after the completion of this offering, or with respect to any particular holder, at such time that such holder can sell its shares under Rule&#160;144, or other similar exemption, of the Securities Act during any three-month period.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Demand Registration Rights<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Upon the completion of this offering, holders of 13,684,805 shares of our common stock, including all shares of common stock issuable upon conversion of outstanding Preferred Stock, will be entitled to certain demand registration rights. At any time beginning on the earlier of the fifth anniversary of the date of our investors&#8217; rights agreement or 180&#160;days following the effectiveness of this registration statement, the holders of a majority of registrable securities may request that we register all or a portion of their shares, subject to certain specified exceptions.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Piggyback Registration Rights<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In connection with this offering, holders of 13,684,805 shares of our common stock, including all shares of common stock issuable upon conversion of outstanding preferred stock are entitled to rights to notice of this offering and to include their shares of registrable securities in this offering, which the requisite&#160;percentage of holders have waived. In the event that we propose to register any of our securities under the Securities Act in another offering, either for our own account or for the account of other </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">157</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">security holders, the holders of registrable securities will be entitled to certain &#8220;piggyback&#8221; registration rights allowing them to include their shares in such registration, subject to specified conditions and limitations.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">S-3 Registration Rights<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Upon the completion of this offering, the holders of 13,684,805 shares of our common stock, including all shares of common stock issuable upon conversion of outstanding preferred stock will initially be entitled to certain Form S-3 registration rights. The holders of at least 25% of registrable securities may, request that we register all or a portion of their shares on Form S-3 if we are qualified to file a registration statement on Form S-3, subject to specified exceptions. Such request for registration on Form S-3 must cover securities with an aggregate offering price which equals or exceeds $1.0&#160;million, net of selling expenses. The right to have such shares registered on Form S-3 is further subject to other specified conditions and limitations.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Anti-takeover provisions</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Certificate of Incorporation and Bylaws<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Among other things, our amended and restated certificate of incorporation and amended and restated bylaws will:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">permit our board of directors to issue up to 10,000,000 shares of preferred stock, with any rights, preferences and privileges as they may designate, including the right to approve an acquisition or other change in control;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">provide that the authorized number of directors may be changed only by resolution of our board of directors;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">provide that our board of directors will be classified into three classes of directors;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">provide that, subject to the rights of any series of preferred stock to elect directors, directors may only be removed for cause, which removal may be effected, subject to any limitation imposed by law, by the holders of at least 66</font><font style=" position:relative; bottom:2.66pt;font-size:7pt;letter-spacing:-0.018pt;">2</font><font style="letter-spacing:-0.025pt;">&#8725;</font><font style="font-size:7pt;letter-spacing:-0.018pt;">3</font><font style="letter-spacing:-0.025pt;">% of the voting power of all of our then-outstanding shares of the capital stock entitled to vote generally at an election of directors;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">provide that all vacancies, including newly created directorships, may, except as otherwise required by law, be filled by the affirmative vote of a majority of directors then in office, even if less than a quorum;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">require that any action to be taken by our stockholders must be effected at a duly called annual or special meeting of stockholders and not be taken by written consent or electronic transmission;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">provide that stockholders seeking to present proposals before a meeting of stockholders or to nominate candidates for election as directors at a meeting of stockholders must provide advance notice in writing, and also specify requirements as to the form and content of a stockholder&#8217;s notice;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">provide that special meetings of our stockholders may be called only by the chairman of our board of directors, our chief executive officer or president or by our board of directors pursuant to a resolution adopted by a majority of the total number of authorized directors; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">not provide for cumulative voting rights, therefore allowing the holders of a majority of the shares of common stock entitled to vote in any election of directors to elect all of the directors standing for election, if they should so choose.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The amendment of any of these provisions would require approval by the holders of at least 66</font><font style=" position:relative; bottom:2.66pt;font-size:7pt;letter-spacing:-0.018pt;">2</font><font style="letter-spacing:-0.025pt;">&#8725;</font><font style="font-size:7pt;letter-spacing:-0.018pt;">3</font><font style="letter-spacing:-0.025pt;">% of the voting power of all of our then-outstanding common stock entitled to vote generally in the election of directors, voting together as a single class.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The combination of these provisions will make it more difficult for our existing stockholders to replace our board of directors as well as for another party to obtain control of us by replacing our board of directors. Because our board of directors has the power to retain and discharge our officers, these provisions could also make it more difficult for existing stockholders or another party to effect a change in management. In addition, the authorization of undesignated preferred stock makes it </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">158</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">possible for our board of directors to issue preferred stock with voting or other rights or preferences that could impede the success of any attempt to change our control.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">These provisions are intended to enhance the likelihood of continued stability in the composition of our board of directors and its policies and to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to reduce our vulnerability to hostile takeovers and to discourage certain tactics that may be used in proxy fights. However, such provisions could have the effect of discouraging others from making tender offers for our shares and may have the effect of delaying changes in our control or management. As a consequence, these provisions may also inhibit fluctuations in the market price of our stock that could result from actual or rumored takeover attempts. We believe that the benefits of these provisions, including increased protection of our potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure our company, outweigh the disadvantages of discouraging takeover proposals, because negotiation of takeover proposals could result in an improvement of their terms.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Section&#160;203 of the Delaware General Corporation Law<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We are subject to Section&#160;203 of the DGCL, which prohibits a Delaware corporation from engaging in any business combination with any interested stockholder for a period of three&#160;years after the date that such stockholder became an interested stockholder, with the following exceptions:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">before such date, the board of directors of the corporation approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction began, excluding for purposes of determining the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder) those shares owned (i)&#160;by persons who are directors and also officers and (ii)&#160;employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">on or after such date, the business combination is approved by the board of directors and authorized at an annual or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least 66</font><font style=" position:relative; bottom:2.66pt;font-size:7pt;letter-spacing:-0.018pt;">2</font><font style="letter-spacing:-0.025pt;">&#8725;</font><font style="font-size:7pt;letter-spacing:-0.018pt;">3</font><font style="letter-spacing:-0.025pt;">% of the outstanding voting stock that is not owned by the interested stockholder.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In general, Section&#160;203 defines a &#8220;business combination&#8221; to include the following:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">any merger or consolidation involving the corporation and the interested stockholder;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">any sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the interested stockholder;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">any transaction involving the corporation that has the effect of increasing the proportionate share of the stock or any class or series of the corporation beneficially owned by the interested stockholder; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits by or through the corporation.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In general, Section&#160;203 defines an &#8220;interested stockholder&#8221; as an entity or person who, together with the person&#8217;s affiliates and associates, beneficially owns, or within three&#160;years prior to the time of determination of interested stockholder status did own, 15% or more of the outstanding voting stock of the corporation.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The statute could prohibit or delay mergers or other takeover or change in control attempts and, accordingly, may discourage attempts to acquire us even though such a transaction may offer our stockholders the opportunity to sell their stock at a price above the prevailing market price.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">159</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:28pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">A Delaware corporation may &#8220;opt out&#8221; of these provisions with an express provision in its certificate of incorporation. We have not opted out of these provisions, which may as a result, discourage or prevent mergers or other takeover or change of control attempts of us.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Choice of Forum<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Our amended and restated certificate of incorporation to be effective on the completion of this offering will provide that the Court of Chancery of the State of Delaware (or, if and only if, the Court of Chancery of the State of Delaware lacks subject matter jurisdiction, any state court located within the State of Delaware or, if and only if, all such state courts lack subject matter jurisdiction, the federal district court for the District of Delaware) and any appellate court therefrom shall be the sole and exclusive forum for the following claims or causes of action brought under Delaware statutory or common law: (1)&#160;any derivative claim or action brought on our behalf; (2)&#160;any claim or cause of action asserting a breach of fiduciary duty by any of our current or former director, officer or other employee; (3)&#160;any claim or cause of action asserting a claim against us arising out of, or pursuant to, the DGCL, our amended and restated certificate of incorporation or our amended and restated bylaws; (4)&#160;any claim or cause of action seeking to interpret, apply, enforce or determine the validity of our amended and restated certificate of incorporation or our amended and restated bylaws (including any right, obligation, or remedy thereunder); (5)&#160;any claim or cause of action as to which the DGCL confers jurisdiction to the Court of Chancery of the State of Delaware; or (6)&#160;any claim or cause of action asserting a claim against us or any of our directors, officers or other employees, that is governed by the internal affairs doctrine, in all cases to the fullest extent permitted by law and subject to the court having personal jurisdiction over the indispensable parties named as defendants. The aforementioned provision will not apply to claims or causes of action brought to enforce a duty or liability created by the Securities Act, the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In addition, our amended and restated certificate of incorporation will further provide that, unless we consent writing to the selection of an alternative forum, the federal district courts of the United States of America will be the exclusive forum, to the fullest extent permitted by law, for resolving any complaint asserting a cause or causes of action arising under the Securities Act, including all causes of action asserted against any defendant to such complaint. For the avoidance of doubt, this provision is intended to benefit and may be enforced by us, our officers and directors, the underwriters to any offering giving rise to such complaint, and any other professional entity whose profession gives authority to a statement made by that person or entity and who has prepared or certified any part of the documents underlying the offering.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The enforceability of similar choice of forum provisions in other companies&#8217; certificates of incorporation has been challenged in legal proceedings, and it is possible that, in connection with one or more actions or proceedings described above, a court could find the choice of forum provisions contained in our amended and restated certificate of incorporation to be inapplicable or unenforceable. </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Limitations of Liability and Indemnification<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">See the section titled &#8220;Executive and Director Compensation&#8212;Limitations on Liability and Indemnification Matters.&#8221;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Listing</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Our common stock is currently not listed on any securities exchange. Our common stock has been approved for listing on The Nasdaq Global Market under the trading symbol &#8220;INAB.&#8221;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Transfer Agent and Registrar</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The transfer agent and registrar for our common stock is Computershare Trust Company, N.A. The transfer agent&#8217;s address is 150&#160;Royall Street, Canton, Massachusetts 02021. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">160</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSEFF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">SHARES ELIGIBLE FOR FUTURE SALE</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:18pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">Prior to this offering, there has been no public market for our common stock. Future sales of substantial amounts of our common stock, including shares issued on the exercise of outstanding options, in the public market after this offering, or the possibility of these sales or issuances occurring, could adversely affect the prevailing market price for our common stock or impair our ability to raise equity capital.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">Based on our shares outstanding as of March 31, 2021, upon the completion of this offering, a total of 18,754,553 shares of common stock will be outstanding. Of these shares, all of the common stock sold in this offering by us will be freely tradable in the public market without restriction or further registration under the Securities Act, unless these shares are held by &#8220;affiliates,&#8221; as that term is defined in Rule&#160;144 under the Securities Act, or Rule&#160;144.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">The remaining shares of common stock, including the 1,552,290 shares of common stock subject to stock options outstanding as of December 31, 2020, will be on issuance, &#8220;restricted securities,&#8221; as that term is defined in Rule&#160;144. These restricted securities are eligible for public sale only if they are registered under the Securities Act or if they qualify for an exemption from registration under Rule&#160;144 or Rule&#160;701 under the Securities Act, or Rule&#160;701, which are summarized below. Restricted securities may also be sold outside of the United States to non-U.S. persons in accordance with Rule&#160;904 of Regulation&#160;S under the Securities Act.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">Subject to the lock-up agreements described below and in the section titled &#8220;Underwriting,&#8221; and the provisions of Rule&#160;144, Rule&#160;701 or Regulation&#160;S under the Securities Act, as well as our insider trading policy, these restricted securities will be available for sale in the public market after the date of this prospectus.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Rule&#160;144</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">In general, under Rule&#160;144 as currently in effect, once we have been subject to public company reporting requirements of Section&#160;13 or 15(d) of the Exchange Act for at least 90&#160;days, an eligible stockholder is entitled to sell such shares without complying with the manner of sale, volume limitation or notice provisions of Rule&#160;144, subject to compliance with the public information requirements of Rule&#160;144. To be an eligible stockholder under Rule&#160;144, such stockholder must not be deemed to have been one of our affiliates for purposes of the Securities Act at any time during the 90&#160;days preceding a sale and must have beneficially owned the shares proposed to be sold for at least six&#160;months, including the holding period of any prior owner other than our affiliates. If such a person has beneficially owned the shares proposed to be sold for at least one year, including the holding period of any prior owner other than our affiliates, then such person is entitled to sell such shares without complying with any of the requirements of Rule&#160;144, subject to the expiration of the lock-up agreements described below.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">In general, under Rule&#160;144, as currently in effect, our affiliates or persons selling shares on behalf of our affiliates are entitled to sell shares on expiration of the lock-up agreements described below, subject, in the case of restricted securities, to such shares having been beneficially owned for at least six&#160;months. Beginning 90&#160;days after the date of this prospectus, within any three-month period, such stockholders may sell a number of shares that does not exceed the greater of:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">1% of the number of our common stock then outstanding, which will equal 187,545&#160;shares of common stock immediately upon the completion of this offering; or</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the average weekly trading volume of our common stock on Nasdaq during the four calendar weeks preceding the filing of a notice on Form 144 with respect to such sale.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">Sales under Rule&#160;144 by our affiliates or persons selling shares on behalf of our affiliates are also subject to certain manner of sale provisions and notice requirements and to the availability of current public information about us.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">161</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Rule&#160;701</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Rule&#160;701 generally allows a stockholder who was issued shares under a written compensatory plan or contract and who is not deemed to have been an affiliate of our company during the immediately preceding 90&#160;days, to sell these shares in reliance on Rule&#160;144, but without being required to comply with the public information, holding period, volume limitation or notice provisions of Rule&#160;144. Rule&#160;701 also permits affiliates of our company to sell their Rule&#160;701 shares under Rule&#160;144 without complying with the holding period requirements of Rule&#160;144. All holders of Rule&#160;701 shares, however, are required by that rule to wait until 90&#160;days after the date of this prospectus before selling those shares under Rule&#160;701, subject to the expiration of the lock-up agreements described below.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Lock-up Agreements</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In connection with this offering, we, our officers and directors, and holders of substantially all of our outstanding shares of common stock or securities convertible into or exchangeable for shares of our common stock outstanding upon the completion of this offering, have agreed with the underwriters, subject to certain exceptions, not to directly or indirectly offer, sell, contract to sell, pledge, grant any option to purchase, make any short sale or otherwise dispose of or hedge any shares of our common stock or any options to purchase shares of our common stock, or any securities convertible into or exchangeable for shares of common stock during the period from the date of the lock-up agreement continuing through the date that is 180&#160;days after the date of this prospectus, except with the prior written consent of the representative, and certain other exceptions. These agreements are further described in the section titled &#8220;Underwriting.&#8221;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Following the expiration of the lock-up agreements and assuming that no parties are released from the lock-up agreements, all shares of our common stock that are restricted securities or held by our affiliates as of the date of this prospectus will be eligible for sale in the public market in compliance with Rule&#160;144.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In addition to the restrictions contained in these lock-up agreements, we have entered into agreements with certain security holders, including the investors&#8217; rights agreement and our standard form of option agreement, that contain market stand-off provisions imposing restrictions on the ability of such security holders to offer, sell or transfer our equity securities for a period of 180&#160;days following the date of this prospectus.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Registration Rights</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Upon the completion of this offering, the holders of 13,684,805 shares of our common stock, including all shares of common stock issued on conversion of our preferred stock, will be entitled to rights with respect to the registration of their shares under the Securities Act, subject to the lock-up agreements described above and in the section titled &#8220;Underwriting&#8221; herein. Registration of these shares under the Securities Act would result in the shares becoming freely tradable without restriction under the Securities Act, except for shares purchased by affiliates, immediately upon the effectiveness of the registration statement of which this prospectus is a part. Any sales of securities by these stockholders could have a material adverse effect on the trading price of our common stock. See the section titled &#8220;Description of Capital Stock&#8212;Registration Rights.&#8221;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Form S-8 Registration Statements</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We intend to file one or more registration statements on Form S-8 under the Securities Act with the SEC to register the offer and sale of shares of our common stock to be issued under our 2018 Plan, 2020 Plan and ESPP. These registration statements will become effective immediately on filing. Shares covered by these registration statements will then be eligible for sale in the public markets, subject to Rule&#160;144 volume limitations and the lock-up agreements described above, if applicable.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Rule&#160;10b5-1 Plans</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Certain of our employees, executive officers and directors may enter into written trading plans that are intended to comply with Rule&#160;10b5-1 under the Exchange Act. Sales under these trading plans would not be permitted until the expiration of the lock-up agreements described above.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">162</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tMUFI">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:18pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The following is a discussion of the material U.S. federal income tax consequences applicable to non-U.S. holders (as defined below) with respect to their purchase, ownership and disposition of shares of our common stock issued pursuant to this offering, but does not purport to be a complete analysis of all potential tax effects. All prospective non-U.S. holders of our common stock should consult their tax advisors with respect to the U.S. federal income tax consequences of the purchase, ownership and disposition of our common stock, as well as any consequences arising under the laws of any other taxing jurisdiction, including any state, local and non-U.S. tax consequences and any U.S. federal non-income tax consequences. In general, a non-U.S. holder means a beneficial owner of our common stock (other than a partnership or an entity or arrangement treated as a partnership for U.S. federal income tax purposes) that is not a U.S. holder. A U.S. holder is, for U.S. federal income tax purposes:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">an individual who is a citizen or resident of the United States;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">a corporation, or an entity treated as a corporation for U.S. federal income tax purposes, created or organized in the United States or under the laws of the United States or of any state thereof or the District of Columbia;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">an estate, the income of which is subject to U.S. federal income tax regardless of its source; or</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">a trust if (1)&#160;a U.S. court can exercise primary supervision over the trust&#8217;s administration and one or more U.S. persons have the authority to control all of the trust&#8217;s substantial decisions or (2)&#160;the trust has a valid election in effect under applicable U.S. Treasury Regulations to be treated as a U.S. person.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">This discussion is based on current provisions of the U.S. Internal Revenue Code of 1986, as amended, which we refer to as the Code, existing U.S. Treasury Regulations promulgated thereunder, published administrative rulings and judicial decisions, all as in effect as of the date of this prospectus supplement. These laws are subject to change and to differing interpretation, possibly with retroactive effect. Any change or differing interpretation could alter the tax consequences to non-U.S. holders described in this prospectus supplement.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">This discussion is limited to non-U.S. holders that hold shares of our common stock as a capital asset within the meaning of Section&#160;1221 of the Code (generally, for investment). This discussion does not address all aspects of U.S. federal income taxation that may be relevant to a particular non-U.S. holder in light of that non-U.S. holder&#8217;s individual circumstances, nor does it address the effect of the alternative minimum tax or Medicare contribution tax or the impact of special tax accounting rules under Section&#160;451(b) of the Code, any aspects of U.S. estate or gift tax, or any state, local or non-U.S. taxes. This discussion also does not address all special tax rules applicable to particular non-U.S. holders, such as holders that own, or are deemed to own, more than 5% of our capital stock (except to the extent specifically set forth below), corporations that accumulate earnings to avoid U.S. federal income tax, tax-exempt organizations, banks, financial institutions, insurance companies, brokers, dealers or traders in securities, commodities or currencies, tax-qualified retirement plans, holders who hold or receive our common stock pursuant to the exercise of employee stock options or otherwise as compensation, holders holding our common stock as part of a hedge, straddle or other risk reduction strategy, conversion transaction or other integrated investment, holders deemed to sell our common stock under the constructive sale provisions of the Code, &#8220;qualified foreign pension funds&#8221; as defined in Section&#160;897(l)(2) of the Code and entities all of the interests of which are held by qualified foreign pension funds, controlled foreign corporations, passive foreign investment companies and certain former citizens or long-term residents of the United States.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In addition, this discussion does not address the tax treatment of partnerships (or entities or arrangements that are treated as partnerships for U.S. federal income tax purposes) or persons that hold our common stock through such partnerships or such entities or arrangements. If a partnership, including any entity or arrangement treated as a partnership for U.S. federal income tax purposes, holds shares of our common stock, the U.S. federal income tax treatment of a partner in such partnership will generally depend upon the status of the partner, the activities of the partnership and certain </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">163</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">determinations made at the partner level. Such partners and partnerships should consult their tax advisors regarding the tax consequences of the purchase, ownership and disposition of our common stock.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">There can be no assurance that the U.S. Internal Revenue Service, which we refer to as the IRS, will not challenge one or more of the tax consequences described herein, and we have not obtained, nor do we intend to obtain, a ruling with respect to the U.S. federal income tax consequences with respect to the matters discussed below.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Distributions on Our Common Stock</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">As described in the section entitled &#8220;Dividend Policy,&#8221; we do not anticipate declaring or paying dividends to holders of our common stock in the foreseeable future. However, distributions, if any, on our common stock generally will constitute dividends for U.S. federal income tax purposes to the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. If a distribution exceeds our current and accumulated earnings and profits, the excess will be treated as a tax-free return of the non-U.S. holder&#8217;s investment, up to such holder&#8217;s adjusted tax basis in the common stock. Any remaining excess will be treated as capital gain from the sale or exchange of such common stock, subject to the tax treatment described below in &#8220;Gain on Sale, Exchange or Other Disposition of Our Common Stock.&#8221;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Subject to the discussions below regarding effectively connected income, dividends paid to a non-U.S. holder will generally be subject to withholding of U.S. federal income tax at a 30% rate, or such lower rate as may be specified by an applicable income tax treaty. A non-U.S. holder that is eligible for a reduced rate of U.S. withholding tax under an income tax treaty may obtain a refund or credit of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS. A non-U.S. holder of our common stock who claims the benefit of an applicable income tax treaty generally will be required to provide a properly executed IRS Form W-8BEN or W-8BEN-E (or successor form) and satisfy relevant certification and other requirements. Non-U.S. holders are urged to consult their tax advisors regarding their entitlement to benefits under a relevant income tax treaty.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Dividends that are treated as effectively connected with a trade or business conducted by a non-U.S. holder within the United States and, if an applicable income tax treaty so provides, that are attributable to a permanent establishment or a fixed base maintained by the non-U.S. holder within the United States, are generally exempt from the 30% withholding tax if the non-U.S. holder satisfies applicable certification requirements. To claim the exemption, the non-U.S. holder must furnish to us or the applicable withholding agent a valid IRS Form W-8ECI (or applicable successor form), certifying that the dividends are effectively connected with the non-U.S. holder&#8217;s conduct of a trade or business within the United States. However, such U.S. effectively connected income, net of specified deductions and credits, is taxed at the same U.S. federal income tax rates applicable to a &#8220;United States person&#8221; &#8203;(as defined in the Code), which we refer to as a United States person, unless a specific treaty exemption applies. Any U.S. effectively connected income received by a non-U.S. holder that is a corporation may also, under certain circumstances, be subject to an additional &#8220;branch profits tax&#8221; at a 30% rate or such lower rate as may be specified by an applicable income tax treaty.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Gain on Sale, Exchange or Other Disposition of Our Common Stock</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Subject to the discussions below regarding backup withholding and foreign accounts, in general, a non-U.S. holder will not be subject to any U.S. federal income tax on any gain realized upon such holder&#8217;s sale, exchange or other disposition of shares of our common stock unless:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the gain is effectively connected with a U.S. trade or business of the non-U.S. holder and, if an applicable income tax treaty so provides, is attributable to a permanent establishment or a fixed base maintained in the United States by such non-U.S. holder, in which case the non-U.S. holder generally will be taxed at the U.S. federal income tax rates applicable to United States persons and, if the non-U.S. holder is a foreign corporation, the branch profits tax described above in &#8220;Distributions on Our Common Stock&#8221; may also apply;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the non-U.S. holder is a nonresident alien individual who is present in the United States for 183&#160;days or more in the taxable year of the disposition and certain other conditions are met, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">164</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">in which case the non-U.S. holder will be subject to a 30% tax (or such lower rate as may be specified by an applicable income tax treaty) on the net gain derived from the disposition, which may be offset by certain U.S. source capital losses of the non-U.S. holder, if any (even though the individual is not considered a resident of the United States), provided the non-U.S. holder has timely filed U.S. federal income tax returns with respect to such losses; or</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our common stock constitutes a U.S. real property interest because we are, or have been, at any time during the five-year period preceding such disposition (or the non-U.S. holder&#8217;s holding period, if shorter) a &#8220;U.S. real property holding corporation.&#8221; Even if we are or become a U.S. real property holding corporation, provided that our common stock is &#8220;regularly traded&#8221; &#8203;(as defined by U.S. Treasury Regulations) on an established securities market, our common stock will be treated as a U.S. real property interest only with respect to a non-U.S. holder that holds more than 5% of our outstanding common stock, directly or indirectly, actually or constructively, during the shorter of the five-year period ending on the date of the disposition or the period that the non-U.S. holder held our common stock. In such case, such non-U.S. holder generally will be taxed on its net gain derived from the disposition at the U.S. federal income tax rates applicable to United States persons. Generally, a corporation is a U.S. real property holding corporation only if the fair market value of its U.S. real property interests equals or exceeds 50% of the sum of the fair market value of its worldwide real property interests plus its other assets used or held for use in a trade or business. Although there can be no assurance, we do not believe that we are, or have been, a U.S. real property holding corporation, or that we are likely to become one in the future. No assurance can be provided that our common stock will be regularly traded on an established securities market for purposes of the rules described above.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Backup Withholding and Information Reporting</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We must report annually to the IRS and to each non-U.S. holder the gross amount of distributions on our common stock paid to such holder, regardless of whether such distributions constitute dividends or whether any tax was actually withheld. Non-U.S. holders will have to comply with specific certification procedures to establish that the holder is not a United States person in order to avoid backup withholding at the applicable rate with respect to dividends on our common stock. U.S. backup withholding generally will not apply to a non-U.S. holder who provides a properly executed IRS Form W-8BEN or W-8BEN-E (or successor form) or otherwise establishes an exemption.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Information reporting and backup withholding will generally apply to the proceeds of a disposition of our common stock by a non-U.S. holder effected by or through the U.S. office of any broker, U.S. or foreign, unless the holder certifies its status as a non-U.S. holder and satisfies certain other requirements, or otherwise establishes an exemption. Generally, information reporting and backup withholding will not apply to a payment of disposition proceeds to a non-U.S. holder where the transaction is effected outside the United States through a non-U.S. office of a broker. However, for information reporting purposes, dispositions effected through a non-U.S. office of a broker with substantial U.S. ownership or operations generally will be treated in a manner similar to dispositions effected through a U.S. office of a broker.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Non-U.S. holders should consult their tax advisors regarding the application of the information reporting and backup withholding rules to them.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Copies of information returns may be made available to the tax authorities of the country in which the non-U.S. holder resides or is incorporated under the provisions of a specific treaty or agreement.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules from a payment to a non-U.S. holder may be allowed as a credit against the non-U.S. holder&#8217;s U.S. federal income tax liability, if any, and may entitle such holder to a refund, provided that the required information is timely furnished to the IRS.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Foreign Accounts</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Sections&#160;1471 through 1474 of the Code (commonly referred to as FATCA) generally impose a U.S. federal withholding tax of 30% on certain payments made to a &#8220;foreign financial institution&#8221; &#8203;(as </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">165</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:324pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">specifically defined for this purpose), unless such institution enters into an agreement with the U.S. government to, among other things, withhold on certain payments and to collect and provide to the U.S. tax authorities substantial information regarding U.S. account holders of such institution (which may include certain equity and debt holders of such institution, as well as certain account holders that are foreign entities with U.S. owners). Foreign financial institutions located in jurisdictions that have an intergovernmental agreement with the United States governing these withholding and reporting requirements may be subject to different rules. FATCA also generally imposes a 30% withholding tax on certain payments made to a non-financial foreign entity, unless such entity provides the withholding agent with either a certification that it does not have any substantial direct or indirect U.S. owners or information regarding substantial direct and indirect U.S. owners of the entity. The withholding tax under FATCA described above will not apply if the foreign financial institution or non-financial foreign entity otherwise qualifies for an exemption from the rules. The FATCA withholding provisions described above currently apply to dividends on our common stock. The FATCA withholding provisions also would apply to the gross proceeds of a disposition of our common stock, except that the U.S. Treasury Department has released proposed regulations which, if finalized in their present form, would eliminate such withholding. In its preamble to such proposed regulations, the U.S. Treasury Department stated that taxpayers generally may rely on the proposed regulations until final regulations are issued.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Under certain circumstances, a non-U.S. holder might be eligible for refunds or credits of such taxes. Non-U.S. holders are encouraged to consult with their tax advisors regarding the possible implications of FATCA on their investment in our common stock.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">EACH PROSPECTIVE INVESTOR SHOULD CONSULT ITS TAX ADVISORS REGARDING THE TAX CONSEQUENCES OF PURCHASING, HOLDING AND DISPOSING OF OUR COMMON STOCK, AS WELL AS TAX CONSEQUENCES ARISING UNDER ANY STATE, LOCAL, NON-U.S. OR U.S. FEDERAL NON-INCOME TAX LAWS. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">166</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tUND">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">UNDERWRITING</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:18pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">B. Riley Securities, Inc. is acting as representative of the several underwriters in this offering. Under the terms of an underwriting agreement, which has been filed as an exhibit to the registration statement, with respect to the shares being offered, each of the underwriters named below has severally agreed to purchase from us the respective number of shares of common stock shown opposite its name below:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:39pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:0pt 0pt 2.5pt 0pt; width:384.61pt;">
              <div style="white-space:nowrap;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-right:1pt;letter-spacing:-0.089pt;">Underwriters </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;letter-spacing:-0.089pt;">Number of Shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:384.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">B. Riley Securities, Inc. </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.94pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">4,000,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:384.61pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.94pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">4,000,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.81pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The underwriting agreement provides that the underwriters&#8217; obligation to purchase shares of common stock depends on the satisfaction of the certain conditions contained in the underwriting agreement including:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the obligation to purchase all of the shares of common stock offered hereby (other than those shares of common stock covered by their option to purchase additional shares as described below), if any of the shares are purchased;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the representations and warranties made by us to the underwriters are true;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">there is no material change in our business or the financial markets; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:1.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:1.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">we deliver customary closing documents to the underwriters.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Commissions and Expenses</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The following table summarizes the underwriting discounts and commissions we will pay to the underwriters. These amounts are shown assuming both no exercise and full exercise of the underwriters&#8217; option to purchase additional shares. The underwriting fee is the difference between the initial price to the public and the amount the underwriters pay to us for the shares.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:38.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:341.98pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">No Exercise </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Full Exercise </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:341.98pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Per Share </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:42pt; text-align:right; white-space:nowrap;">0.70 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">0.70 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.98pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:42pt; text-align:right; white-space:nowrap;">2,800,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">3,220,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The representative has advised us that the underwriters propose to offer the shares of common stock directly to the public at the offering price on the cover of this prospectus and to selected dealers, which may include the underwriters, at such offering price less a selling concession not in excess of $0.42 per share. If all the shares are not sold at the initial offering price following the initial offering, the representative may change the offering price and other selling terms.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The expenses of the offering that are payable by us are estimated to be approximately $4,650,000 (excluding underwriting discounts and commissions), including reimbursement to the underwriters for certain of their expenses in an amount up to $850,000.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Option to Purchase Additional Shares</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We have granted the underwriters an option exercisable for 30&#160;days after the date of this prospectus to purchase, from time to time, in whole or in part, up to an aggregate of 600,000 shares from us at the offering price less underwriting discounts and commissions, to cover over-allotments, if any. To the extent that this option is exercised, each underwriter will be obligated, subject to certain conditions, to purchase its pro&#160;rata portion of these additional shares based on the underwriter&#8217;s&#160;percentage underwriting commitment in this offering as indicated in the above table.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Lock-Up Agreements</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">We, all of our directors and executive officers, and holders of substantially all of our outstanding stock have agreed that, for a period of 180&#160;days after the date of this prospectus subject to certain limited exceptions, we and they will not directly or indirectly, without the prior written consent of the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">167</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">representative (1)&#160;offer for sale, sell, pledge, or otherwise dispose of (or enter into any transaction or device that is designed to, or could be expected to, result in the disposition by any person at any time in the future of) any shares of common stock (including, without limitation, shares of common stock that may be deemed to be beneficially owned by us or them in accordance with the rules and regulations of the SEC and shares of common stock that may be issued upon exercise of any options or warrants) or securities convertible into or exercisable or exchangeable for common stock (other than the stock and shares issued pursuant to employee benefit plans, qualified stock option plans, or other employee compensation plans existing on the date of this prospectus or pursuant to currently outstanding options, warrants or rights not issued under one of these plans), or sell or grant options, rights or warrants with respect to any shares of common stock or securities convertible into or exchangeable for common stock (other than the grant of options pursuant to option plans existing on the date of this prospectus), (2)&#160;enter into any swap or other derivatives transaction that transfers to another, in whole or in part, any of the economic benefits or risks of ownership of shares of common stock, whether any such transaction described in clause (1)&#160;or (2)&#160;above is to be settled by delivery of common stock or other securities, in cash or otherwise, (3)&#160;make any demand for or exercise any right or confidentially submit or file or cause a registration statement to be filed or confidentially submitted, including any amendments thereto, with respect to the registration of any shares of common stock or securities convertible, exercisable or exchangeable into common stock or any of our other securities, or (4)&#160;publicly disclose the intention to do any of the foregoing.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The representative, in its sole discretion, may release the common stock and other securities subject to the lock-up agreements described above in whole or in part at any time. When determining whether or not to release common stock and other securities from lock-up agreements, the representative will consider, among other factors, the holder&#8217;s reasons for requesting the release, the number of shares of common stock and other securities for which the release is being requested and market conditions at the time. At least three business days before the effectiveness of any release or waiver of any of the restrictions with respect to an officer or director of the Company, the representative will notify us of the impending release or waiver and we have agreed to announce the impending release or waiver in accordance with any method permitted by applicable law or regulation (which may include a press release), except where the release or waiver is effected solely to permit a transfer of common stock that is not for consideration and where the transferee has agreed in writing to be bound by the same terms as the lock-up agreements described above to the extent and for the duration that such terms remain in effect at the time of transfer.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Offering Price Determination</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Prior to this offering, there has been no public market for our common stock. The initial offering price was negotiated between the representative and us. In determining the initial offering price of our common stock, the representative considered:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the history and prospects for the industry in which we compete;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">our financial information;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the ability of our management and our business potential and earning prospects;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the prevailing securities markets at the time of this offering; and</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">the recent market prices of, and the demand for, publicly traded shares of generally comparable companies.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Indemnification</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We have agreed to indemnify the underwriters against certain liabilities, including liabilities under the Securities Act, and to contribute to payments that the underwriters may be required to make for these liabilities.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Stabilization, Short Positions and Penalty Bids</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The representative may engage in stabilizing transactions, short sales and purchases to cover positions created by short sales, and penalty bids or purchases for the purpose of pegging, fixing or maintaining the price of the common stock, in accordance with Regulation&#160;M under the Exchange Act:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">168</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">Stabilizing transactions permit bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">A short position involves a sale by the underwriters of shares in excess of the number of shares the underwriters are obligated to purchase in the offering, which creates the syndicate short position. This short position may be either a covered short position or a naked short position. In a covered short position, the number of shares involved in the sales made by the underwriters in excess of the number of shares they are obligated to purchase is not greater than the number of shares that they may purchase by exercising their option to purchase additional shares. In a naked short position, the number of shares involved is greater than the number of shares in their option to purchase additional shares. The underwriters may close out any short position by either exercising their option to purchase additional shares and/or purchasing shares in the open market. In determining the source of shares to close out the short position, the underwriters will consider, among other things, the price of shares available for purchase in the open market as compared to the price at which they may purchase shares through their option to purchase additional shares. A naked short position is more likely to be created if the underwriters are concerned that there could be downward pressure on the price of the shares in the open market after pricing that could adversely affect investors who purchase in the offering.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">Syndicate covering transactions involve purchases of the common stock in the open market after the distribution has been completed in order to cover syndicate short positions.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:2.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:2.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:-0.025pt;">Penalty bids permit the representative to reclaim a selling concession from a syndicate member when the common stock originally sold by the syndicate member is purchased in a stabilizing or syndicate covering transaction to cover syndicate short positions.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">These stabilizing transactions, syndicate covering transactions and penalty bids may have the effect of raising or maintaining the market price of our common stock or preventing or retarding a decline in the market price of the common stock. As a result, the price of the common stock may be higher than the price that might otherwise exist in the open market. These transactions may be effected on The Nasdaq Global Market or otherwise and, if commenced, may be discontinued at any time.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Neither we nor any of the underwriters make any representation or prediction as to the direction or magnitude of any effect that the transactions described above may have on the price of the common stock. In addition, neither we nor any of the underwriters make any representation that the representative will engage in these stabilizing transactions or that any transaction, once commenced, will not be discontinued without notice.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Electronic Distribution</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">A prospectus in electronic format may be made available on the Internet sites or through other online services maintained by one or more of the underwriters and/or selling group members participating in this offering, or by their affiliates. In those cases, prospective investors may view offering terms online and, depending upon the particular underwriter or selling group member, prospective investors may be allowed to place orders online. The underwriters may agree with us to allocate a specific number of shares for sale to online brokerage account holders. Any such allocation for online distributions will be made by the representative on the same basis as other allocations.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Other than the prospectus in electronic format, the information on any underwriter&#8217;s or selling group member&#8217;s web site and any information contained in any other web site maintained by an underwriter or selling group member is not part of the prospectus or the registration statement of which this prospectus forms a part, has not been approved and/or endorsed by us or any underwriter or selling group member in its capacity as underwriter or selling group member and should not be relied upon by investors.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Listing on the Nasdaq Global Market</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Our common stock has been approved for listing on the Nasdaq Global Market under the symbol &#8220;INAB.&#8221;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">169</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Stamp Taxes</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">If you purchase shares of common stock offered in this prospectus, you may be required to pay stamp taxes and other charges under the laws and practices of the country of purchase, in addition to the offering price listed on the cover page of this prospectus.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Other Relationships</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The underwriters and certain of their affiliates are full service financial institutions engaged in various activities, which may include securities trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing and brokerage activities. The underwriters and certain of their affiliates have, from time to time, performed, and may in the future perform, various commercial and investment banking and financial advisory services for the issuer and its affiliates, for which they received or may in the future receive customary fees and expenses.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In the ordinary course of their various business activities, the underwriters and certain of their affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers, and such investment and securities activities may involve securities and/or instruments of the issuer or its affiliates. If the underwriters or their affiliates have a lending relationship with us, certain of those underwriters or their affiliates routinely hedge, and certain other of those underwriters or their affiliates may hedge, their credit exposure to us consistent with their customary risk management policies. Typically, the underwriters and their affiliates would hedge such exposure by entering into transactions which consist of either the purchase of credit default swaps or the creation of short positions in our securities or the securities of our affiliates, including potentially the shares of common stock offered hereby. Any such credit default swaps or short positions could adversely affect future trading prices of the shares of common stock offered hereby. The underwriters and certain of their affiliates may also communicate independent investment recommendations, market color or trading ideas and/or publish or express independent research views in respect of such securities or instruments and may at any time hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Selling Restrictions</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">General<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Other than in the United States, no action has been taken by us or the underwriters that would permit a public offering of the securities offered by this prospectus in any jurisdiction where action for that purpose is required. The securities offered by this prospectus may not be offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in connection with the offer and sale of any such securities be distributed or published in any jurisdiction, except under circumstances that will result in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus comes are advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus. This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any securities offered by this prospectus in any jurisdiction in which such an offer or a solicitation is unlawful.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">European Economic Area<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In relation to each Member State of the European Economic Area, each an EEA State, no shares have been offered or will be offered pursuant to the offering to the public in that EEA State prior to the publication of a prospectus in relation to the shares which has been approved by the competent authority in that EEA State or, where appropriate, approved in another EEA State and notified to the competent authority in that EEA State, all in accordance with the EU Prospectus Regulation, except that it may make an offer to the public in that EEA State of any shares at any time under the following exemptions under the EU Prospectus Regulation:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:-0.025pt;">to any legal entity which is a qualified investor as defined under the EU Prospectus Regulation;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.01pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:7.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:-0.025pt;">to fewer than 150 natural or legal persons (other than qualified investors as defined under the EU Prospectus Regulation), subject to obtaining the prior consent of underwriters for any such offer; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">170</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">(c)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:-0.025pt;">in any other circumstances falling within Article&#160;1(4) of the EU Prospectus Regulation, provided that no such offer of the shares shall require the Issuer or any Manager to publish a prospectus pursuant to Article&#160;3 of the EU Prospectus Regulation or supplement a prospectus pursuant to Article&#160;23 of the EU Prospectus Regulation.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">For the purposes of this provision, the expression an &#8220;offer to the public&#8221; in relation to the shares in any EEA State means the communication in any form and by any means of sufficient information on the terms of the offer and any shares to be offered so as to enable an investor to decide to purchase or subscribe for any shares, and the expression &#8220;EU Prospectus Regulation&#8221; means Regulation (EU) 2017/</font>&#8203;<font style="letter-spacing:-0.025pt;">1129.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">United Kingdom<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In relation to the United Kingdom, no shares have been offered or will be offered pursuant to the offering to the public in the United Kingdom prior to the publication of a prospectus in relation to the shares which has been approved by the Financial Conduct Authority in accordance with the UK Prospectus Regulation, except that it may make an offer to the public in the United Kingdom of any shares at any time under the following exemptions under the UK Prospectus Regulation:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:-0.025pt;">to any legal entity which is a qualified investor as defined under the UK Prospectus Regulation;</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:-0.025pt;">to fewer than 150 natural or legal persons (other than qualified investors as defined under the UK Prospectus Regulation), subject to obtaining the prior consent of the representative for any such offer; or</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:-0.025pt;">in any other circumstances falling within Article&#160;1(4) of the UK Prospectus Regulation, provided that no such offer of the shares shall require the Issuer or any Manager to publish a prospectus pursuant to Article&#160;3 of the UK Prospectus Regulation or supplement a prospectus pursuant to Article&#160;23 of the UK Prospectus Regulation.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In the United Kingdom, the offering is only addressed to, and is directed only at, &#8220;qualified investors&#8221; within the meaning of Article&#160;2(e) of the UK Prospectus Regulation, who are also (i)&#160;persons having professional experience in matters relating to investments who fall within the definition of &#8220;investment professionals&#8221; in Article&#160;19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, or the Order; (ii)&#160;high net worth bodies corporate, unincorporated associations and partnerships and trustees of high value trusts as described in Article&#160;49(2) of the Order; or (iii)&#160;persons to whom it may otherwise lawfully be communicated (all such persons being referred to as &#8220;relevant persons&#8221;). This document must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this document relates is available only to relevant persons and will be engaged in only with relevant persons.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">For the purposes of this provision, the expression an &#8220;offer to the public&#8221; in relation to the shares in the United Kingdom means the communication in any form and by any means of sufficient information on the terms of the offering and any shares to be offered so as to enable an investor to decide to purchase or subscribe for any shares, and the expression &#8220;UK Prospectus Regulation&#8221; means the UK version of Regulation (EU) No 2017/1129 as amended by The Prospectus (Amendment etc.) (EU Exit) Regulations&#160;2019, which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Canada<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The shares may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National Instrument 45-106 Prospectus Exemptions or subsection&#160;73.3(1) of the Securities Act (Ontario), and are permitted clients, as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the shares must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or damages if this prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser&#8217;s province or territory. The </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">171</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#8217;s province or territory for particulars of these rights or consult with a legal advisor.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Pursuant to section 3A.3 of National Instrument 33-105 Underwriting Conflicts (&#8220;NI 33-105&#8221;), the underwriters are not required to comply with the disclosure requirements of NI 33-105 regarding underwriter conflicts of interest in connection with this offering.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Hong Kong<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The shares may not be offered or sold in Hong Kong by means of any document other than (i)&#160;in circumstances which do not constitute an offer to the public within the meaning of the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32 of the Laws of Hong Kong), or Companies (Winding Up and Miscellaneous Provisions) Ordinance, or which do not constitute an invitation to the public within the meaning of the Securities and Futures Ordinance (Cap. 571 of the Laws of Hong Kong), or Securities and Futures Ordinance, or (ii)&#160;to &#8220;professional investors&#8221; as defined in the Securities and Futures Ordinance and any rules made thereunder, or (iii)&#160;in other circumstances which do not result in the document being a &#8220;prospectus&#8221; as defined in the Companies (Winding Up and Miscellaneous Provisions) Ordinance, and no advertisement, invitation or document relating to the shares may be issued or may be in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere), which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than with respect to the shares which are or are intended to be disposed of only to persons outside Hong Kong or only to &#8220;professional investors&#8221; in Hong Kong as defined in the Securities and Futures Ordinance and any rules made thereunder.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Singapore<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this prospectus and any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the shares may not be circulated or distributed, nor may the shares be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i)&#160;to an institutional investor under Section&#160;274 of the Securities and Futures Act, Chapter 289 of Singapore (the &#8220;SFA&#8221;) (ii)&#160;to a relevant person S-23 pursuant to Section&#160;275(1), or any person pursuant to Section&#160;275(1A), and in accordance with the conditions specified in Section&#160;275, of the SFA, or (iii)&#160;otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Where the shares are subscribed or purchased under Section&#160;275 of the SFA by a relevant person which is a corporation (which is not an accredited investor (as defined in Section&#160;4A of the SFA)) the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor, the securities (as defined in Section&#160;239(1) of the SFA) of that corporation shall not be transferable for 6&#160;months after that corporation has acquired the shares under Section&#160;275 of the SFA except: (1)&#160;to an institutional investor under Section&#160;274 of the SFA or to a relevant person (as defined in Section&#160;275(2) of the SFA), (2)&#160;where such transfer arises from an offer in that corporation&#8217;s securities pursuant to Section&#160;275(1A) of the SFA, (3)&#160;where no consideration is or will be given for the transfer, (4)&#160;where the transfer is by operation of law, (5)&#160;as specified in Section&#160;276(7) of the SFA, or (6)&#160;as specified in Regulation&#160;32 of the Securities and Futures (Offers of Investments) (Shares and Debentures) Regulations&#160;2005 of Singapore, or Regulation&#160;32.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Where the shares are subscribed or purchased under Section&#160;275 of the SFA by a relevant person which is a trust (where the trustee is not an accredited investor (as defined in Section&#160;4A of the SFA)) whose sole purpose is to hold investments and each beneficiary of the trust is an accredited investor, the beneficiaries&#8217; rights and interest (howsoever described) in that trust shall not be transferable for 6&#160;months after that trust has acquired the or under Section&#160;275 of the SFA except: (1)&#160;to an institutional investor under Section&#160;274 of the SFA or to a relevant person (as defined in Section&#160;275(2) of the SFA), (2)&#160;where such transfer arises from an offer that is made on terms that such rights or interest are acquired at a consideration of not less than $200,000 (or its equivalent in a foreign currency) for each transaction (whether such amount is to be paid for in cash or by exchange of securities or other assets), </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">172</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">(3)&#160;where no consideration is or will be given for the transfer, (4)&#160;where the transfer is by operation of law, (5)&#160;as specified in Section&#160;276(7) of the SFA, or (6)&#160;as specified in Regulation&#160;32.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Switzerland<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The shares may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange (&#8220;SIX&#8221;), or on any other stock exchange or regulated trading facility in Switzerland. This document has been prepared without regard to the disclosure standards for issuance prospectuses under Article&#160;652a or Article&#160;1156 of the Swiss Code of Obligations or the disclosure standards for listing prospectuses under Article&#160;27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this document nor any other offering or marketing material relating to the shares or the offering may be publicly distributed or otherwise made publicly available in Switzerland.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Neither this document nor any other offering or marketing material relating to the shares or the offering may be publicly distributed or otherwise made publicly available in Switzerland. Neither this document nor any other offering or marketing material relating to the offering, the Company, the shares have been or will be filed with or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and the offer of shares will not be supervised by, the Swiss Financial Market Supervisory Authority and the offer of shares has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes (&#8220;CISA&#8221;). The investor protection afforded to acquirers of interests in collective investment schemes under the CISA does not extend to acquirers of shares.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Japan<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">No registration pursuant to Article&#160;4, paragraph 1 of the Financial Instruments and Exchange Law of Japan (Law No. 25 of 1948, as amended) (the &#8220;FIEL&#8221;) has been made or will be made with respect to the solicitation of the application for the acquisition of the shares.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Accordingly, the shares have not been, directly or indirectly, offered or sold and will not be, directly or indirectly, offered or sold in Japan or to, or for the benefit of, any resident of Japan (which term as used herein means any person resident in Japan, including any corporation or other entity organized under the laws of Japan) or to others for re-offering or re-sale, directly or indirectly, in Japan or to, or for the benefit of, any resident of Japan except pursuant to an exemption from the registration requirements, and otherwise in compliance with, the FIEL and the other applicable laws and regulations of Japan.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Australia<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">No placement document, prospectus, product disclosure statement or other disclosure document has been lodged with the Australian Securities and Investments Commission in relation to the offering. This prospectus does not constitute a prospectus, product disclosure statement or other disclosure document under the Corporations Act 2001, or the Corporations Act, and does not purport to include the information required for a prospectus, product disclosure statement or other disclosure document under the Corporations Act.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Any offer in Australia of the shares may only be made to persons, which we refer to as Exempt Investors, who are &#8220;sophisticated investors&#8221; &#8203;(within the meaning of Section&#160;708(8) of the Corporations Act), &#8220;professional investors&#8221; &#8203;(within the meaning of Section&#160;708(11) of the Corporations Act) or otherwise pursuant to one or more exemptions contained in Section&#160;708 of the Corporations Act so that it is lawful to offer the shares without disclosure to investors under Chapter 6D of the Corporations Act.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The shares applied for by Exempt Investors in Australia must not be offered for sale in Australia in the period of 12&#160;months after the date of allotment under the offering, except in circumstances where disclosure to investors under Chapter 6D of the Corporations Act would not be required pursuant to an exemption under Section&#160;708 of the Corporations Act or otherwise or where the offer is pursuant to a disclosure document which complies with Chapter 6D of the Corporations Act. Any person acquiring shares must observe such Australian on-sale restrictions.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">This prospectus contains general information only and does not take account of the investment objectives, financial situation or particular needs of any particular person. It does not contain any </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">173</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:418pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">securities recommendations or financial product advice. Before making an investment decision, investors need to consider whether the information in this prospectus is appropriate to their needs, objectives and circumstances and, if necessary, seek expert advice on those matters.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Israel<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">This document does not constitute a prospectus under the Israeli Securities Law, 5728-1968, or the Securities Law, and has not been filed with or approved by the Israel Securities Authority. In the State of Israel, this document is being distributed only to, and is directed only at, and any offer of the securities offered hereby is directed only at, (i)&#160;a limited number of persons in accordance with the Securities Law and (ii)&#160;investors listed in the first addendum, or the Addendum, to the Israeli Securities Law, consisting primarily of joint investment in trust funds, provident funds, insurance companies, banks, portfolio managers, investment advisors, members of the Tel Aviv Stock Exchange, underwriters, venture capital funds, entities with equity in excess of NIS 50&#160;million and &#8220;qualified individuals,&#8221; each as defined in the Addendum (as it may be amended from time to time), collectively referred to as qualified investors (in each case purchasing for their own account or, where permitted under the Addendum, for the accounts of their clients who are investors listed in the Addendum). Qualified investors will be required to submit written confirmation that they fall within the scope of the Addendum, are aware of the meaning of same and agree to it. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">174</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tLEMA">&#8203;</a><a name="tEXP">&#8203;</a><a name="tWYCF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:146pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">LEGAL MATTERS</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:18pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The validity of the issuance of our common stock offered in this prospectus will be passed upon for us by Cooley LLP, New York, New York. Certain legal matters in connection with this offering will be passed upon for the underwriters by Latham &amp; Watkins LLP, New York, New York. As of the date of this prospectus, partners of Cooley LLP and GC&amp;H Investments, LLC, an entity that is comprised of partners and associates of Cooley LLP, beneficially own an aggregate of 158,171 shares of our Series&#160;A preferred stock, which shares of Series&#160;A preferred stock will be converted into 173,937 shares of our common stock upon the completion of this offering.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">EXPERTS</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:18pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Our financial statements as of December&#160;31, 2019 and 2020, and for the&#160;years then ended, appearing in this prospectus and registration statement have been audited by CohnReznick LLP, independent registered public accounting firm, as set forth in their report thereon appearing elsewhere herein, and are included in reliance upon such report given on the authority of such firm as experts in accounting and auditing.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">WHERE YOU CAN FIND ADDITIONAL INFORMATION</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:18pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We have filed with the SEC a registration statement on Form S-1, including exhibits and schedules, under the Securities Act, with respect to the shares of common stock being offered by this prospectus. This prospectus, which constitutes part of the registration statement, does not contain all of the information in the registration statement and its exhibits. For further information with respect to us and the common stock offered by this prospectus, we refer you to the registration statement and its exhibits. Statements contained in this prospectus as to the contents of any contract or any other document referred to are not necessarily complete, and in each instance, we refer you to the copy of the contract or other document filed as an exhibit to the registration statement. Each of these statements is qualified in all respects by this reference.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">You may read our SEC filings, including this registration statement, over the Internet at the SEC&#8217;s website at www.sec.gov. Upon the completion of this offering, we will be subject to the information reporting requirements of the Exchange Act and we will file reports, proxy statements and other information with the SEC. These reports, proxy statements and other information will be available for review on the web site of the SEC referred to above. We also maintain a website at www.in8bio.com, at which, following the completion of this offering, you may access these materials free of charge as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC. Information contained on or accessible through our website is not a part of this prospectus, and the inclusion of our website address in this prospectus is an inactive textual reference only.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">175</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="TOC2">&#8203;</a><a name="tITFS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:339.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">IN8BIO, INC.</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">INDEX TO FINANCIAL STATEMENTS</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:217.5pt;margin-top:20pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:431.18pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.111pt;">Page</font><font style="font-size:8pt;">&#8203;</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:431.18pt;text-align:left;">
              <font style="letter-spacing:-0.111pt;">Audited Financial Statements</font>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.635pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.635pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:431.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#fRIP"><font style="letter-spacing:-0.025pt;">Report of Independent Registered Public Accounting Firm </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.635pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#fRIP">F-2</a></font> <a href="#fRIP"></a></td>
            <td style="padding:0pt;padding-left:1.635pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:431.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#fBSH"><font style="letter-spacing:-0.025pt;">Balance Sheets </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.635pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#fBSH">F-3</a></font> <a href="#fBSH"></a></td>
            <td style="padding:0pt;padding-left:1.635pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:431.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#fSOP"><font style="letter-spacing:-0.025pt;">Statements of Operations </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.635pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#fSOP">F-4</a></font> <a href="#fSOP"></a></td>
            <td style="padding:0pt;padding-left:1.635pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:431.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#fSCC"><font style="letter-spacing:-0.025pt;">Statements of Changes in Convertible Preferred Stock and Stockholders&#8217; Deficit </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.635pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#fSCC">F-5</a></font> <a href="#fSCC"></a></td>
            <td style="padding:0pt;padding-left:1.635pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:431.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#fSCF"><font style="letter-spacing:-0.025pt;">Statements of Cash Flows </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.635pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#fSCF">F-6</a></font> <a href="#fSCF"></a></td>
            <td style="padding:0pt;padding-left:1.635pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:431.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#fNFS"><font style="letter-spacing:-0.025pt;">Notes to Financial Statements </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.635pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#fNFS">F-7</a></font> <a href="#fNFS"></a></td>
            <td style="padding:0pt;padding-left:1.635pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:431.18pt;text-align:left;">
              <font style="letter-spacing:-0.111pt;">Unaudited Condensed Interim Financial Statements</font>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.635pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.635pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:431.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCIBS"><font style="letter-spacing:-0.025pt;">Condensed Interim Balance Sheets </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.635pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#tCIBS">F-24</a></font>
            </td>
            <td style="padding:0pt;padding-left:1.635pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:431.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCISO"><font style="letter-spacing:-0.025pt;">Condensed Interim Statements of Operations </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.635pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#tCISO">F-25</a></font>
            </td>
            <td style="padding:0pt;padding-left:1.635pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:431.18pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tCISO1"><font style="letter-spacing:-0.025pt;">Condensed Interim Statements of Changes in Convertible Preferred Stock and Stockholders&#8217; Deficit</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.635pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#tCISO1">F-26</a></font>
            </td>
            <td style="padding:0pt;padding-left:1.635pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:431.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCISO2"><font style="letter-spacing:-0.025pt;">Condensed Interim Statements of Cash Flows </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.635pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#tCISO2">F-27</a></font>
            </td>
            <td style="padding:0pt;padding-left:1.635pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:431.18pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tNTCI"><font style="letter-spacing:-0.025pt;">Notes to Condensed Interim Financial Statements </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.635pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:-0.025pt;"><a href="#tNTCI">F-28</a></font>
            </td>
            <td style="padding:0pt;padding-left:1.635pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="fRIP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:122pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Report of Independent Registered Public Accounting Firm</font><font style="font-weight:normal;text-transform:uppercase;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:18pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">To the Board of Directors and Stockholders </font> <br ><font style="letter-spacing:-0.025pt;">IN8bio, Inc.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Opinion on the Financial Statements</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We have audited the accompanying balance sheets of IN8bio, Inc. (the &#8220;Company&#8221;) as of December&#160;31, 2019 and 2020, and the related statements of operations, changes in convertible preferred stock and stockholders&#8217; deficit and cash flows for the&#160;years then ended, and the related notes (collectively referred to as &#8220;the financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December&#160;31, 2019 and 2020, and the results of its operations and its cash flows for the&#160;years then ended, in conformity with accounting principles generally accepted in the United States of America.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">Basis for Opinion</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">/s/ CohnReznick LLP </font> <br ><font style="letter-spacing:-0.025pt;">We have served as the Company&#8217;s auditor since January&#160;2017.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Tysons, Virginia </font> <br ><font style="letter-spacing:-0.025pt;">March 31, 2021</font></div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="fBSH">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:17.51pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">IN8BIO, INC. </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">BALANCE SHEETS</font>
          <br >
          <font style="font-style:italic;font-weight:normal;text-transform:lowercase;">(in thousands except for per share data)</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;margin-bottom:7pt;margin-top:20pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:353.41pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Year ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:353.41pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <font style="letter-spacing:-0.111pt;">Assets</font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <font style="letter-spacing:-0.025pt;">Current assets </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Cash </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">610</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">17,994</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Prepaid expenses and other current assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">153</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">150</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:10pt;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Total Current Assets</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">763</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">18,144</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <font style="letter-spacing:-0.025pt;">Non-current assets </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Property and equipment, net </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">274</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">186</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Deferred offering costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">2,439</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Other non-current assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">93</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">141</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:10pt;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Total Non-Current Assets</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">367</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">2,766</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:10pt;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Total Assets</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">1,130</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">20,910</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <font style="letter-spacing:-0.111pt;">Liabilities, Convertible Preferred Stock and Stockholders&#8217; Deficit</font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <font style="letter-spacing:-0.111pt;">Liabilities</font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <font style="letter-spacing:-0.025pt;">Current liabilities </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">560</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">620</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Accrued expenses and other current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">87</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">1,778</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Loan payable </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">174</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:10pt;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Total Current Liabilities</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">647</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">2,572</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Deferred rent </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">17</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Warrant liability </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">829</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:10pt;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Total Liabilities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">1,476</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">2,589</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <font style="letter-spacing:-0.111pt;">Commitments and Contingencies</font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:-0.025pt;">Convertible preferred stock, par value $0.0001 per share; 7,435,616 and </font>
                <br >
                <font style="letter-spacing:-0.025pt;">27,564,260 shares authorized at December&#160;31, 2019 and 2020, respectively; </font>
                <br >
                <font style="letter-spacing:-0.025pt;">2,713,980 shares and 9,993,727 shares, issued and outstanding at </font>
                <br >
                <font style="letter-spacing:-0.025pt;">December&#160;31, 2019 and 2020, and a liquidation preference of $10,931 and </font>
                <br >
                <font style="letter-spacing:-0.025pt;">$37,969 at December&#160;31, 2019 and 2020, respectively </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">8,896</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">34,900</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <font style="letter-spacing:-0.111pt;">Stockholders&#8217; Deficit</font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:353.41pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:-0.025pt;">Common stock, par value $0.0001 per share; 27,000,000 and 50,700,000 shares authorized at December&#160;31, 2019 and 2020, respectively; 3,235,671 and 3,764,488 shares issued and outstanding at December&#160;31, 2019 and 2020, respectively </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Additional paid-in capital </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">238</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">1,458</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Accumulated deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(9,481<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">(18,038<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:10pt;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Total Stockholders&#8217; Deficit</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(9,242<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">(16,579<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:10pt;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Total Liabilities, Convertible Preferred Stock and Stockholders&#8217; Deficit</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.63pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">1,130</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.62pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">20,910</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The accompanying notes are an integral part of these financial statements. </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="fSOP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:369.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">IN8BIO, INC. </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">STATEMENTS OF OPERATIONS</font>
          <br >
          <font style="font-style:italic;font-weight:normal;">(in thousands except for share and per share data)</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:179.5pt;margin-top:20pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:343.98pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Year ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:343.98pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:343.98pt;text-align:left;">
              <font style="letter-spacing:-0.111pt;">Operating expenses</font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:343.98pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">2,358</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">5,378</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:343.98pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">2,708</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">3,179</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:343.98pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Loss on disposal of property and equipment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">68</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:343.98pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Total operating expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">5,134</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">8,557</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:343.98pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Loss from operations </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(5,134<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(8,557<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:343.98pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Net loss</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(5,134<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(8,557<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:343.98pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Net loss attributable to common stockholders&#8201;&#8211;&#8201;basic and diluted (Note 12)</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(5,912<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(10,340<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:343.98pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Net loss per share attributable to common stockholders&#8201;&#8211;&#8201;basic and diluted</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(1.85<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(3.02<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:343.98pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Weighted-average shares of common stock&#8201;&#8211;&#8201;basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">3,188,165</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">3,419,075</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:10pt; margin-top:5pt; text-align:center; width:446pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;"> </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The accompanying notes are an integral part of these financial statements. </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8.5pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="fSCC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:188.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">IN8BIO, INC. </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.111pt;">STATEMENT OF CHANGES IN CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; DEFICIT</font>
          <br >
          <font style="font-style:italic;font-weight:normal;">(in thousands, except share data)</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:350pt;margin-top:20pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:8pt;height:9.25pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:123.19pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Convertible Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Common Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="3">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="3">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.089pt;">Additional </font>
                <br >
                <font style="letter-spacing:-0.089pt;">Paid-</font>
                <br >
                <font style="letter-spacing:-0.089pt;">in-Capital </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="3">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="3">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="3">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.089pt;">Accumulated </font>
                <br >
                <font style="letter-spacing:-0.089pt;">Deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="3">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="3">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="3">
              <div style="white-space:nowrap; text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.089pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;" rowspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:123.19pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Series&#160;A </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Class&#160;A </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:123.19pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8.5pt;">
            <td style="padding:3.25pt 0pt 2pt 0pt; width:123.19pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.094pt;">Balance at January&#160;1, 2019</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2,713,980</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">8,896</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">3,174,751</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">97</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(4,347<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(4,249<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8.5pt;">
            <td style="padding:3.167pt 0pt 1.833pt 0pt; width:123.19pt;white-space:normal;text-align:left;">
              <div style="margin-left:8.5pt; text-indent:-8.5pt;">
                <font style="letter-spacing:-0.021pt;">Exercise of common stock&#8201;&#8211;&#8201;Class&#160;A </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">60,920</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">65</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">65</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8.5pt;">
            <td style="padding:3.167pt 0pt 1.833pt 0pt; width:123.19pt;white-space:normal;text-align:left;">
              <div style="margin-left:8.5pt; text-indent:-8.5pt;">
                <font style="letter-spacing:-0.021pt;">Stock-based compensation expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">76</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">76</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8.5pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.75pt 0pt; width:123.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.021pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.98pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.27pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.81pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(5,134<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(5,134<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8.5pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.75pt 0pt; width:123.19pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.094pt;">Balance at December&#160;31, 2019</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">2,713,980</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">8,896</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">3,235,671</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.98pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:6.75pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.27pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">238</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.81pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(9,481<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(9,242<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8.5pt;">
            <td style="padding:2.917pt 0pt 1.833pt 0pt; width:123.19pt;white-space:normal;text-align:left;">
              <div style="margin-left:8.5pt; text-indent:-8.5pt;">
                <font style="letter-spacing:-0.021pt;">Issuance of common stock&#8201;&#8211;&#8201;Class&#160;A </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;">&#8203;</td>
            <td style="padding:2.917pt 0pt 1.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.917pt 0pt 1.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;">&#8203;</td>
            <td style="padding:2.917pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.917pt 0pt 1.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.917pt 0pt 1.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.917pt 0pt 1.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">227,010</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.98pt;width:0pt;">&#8203;</td>
            <td style="padding:2.917pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.917pt 0pt 1.833pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.27pt;width:0pt;">&#8203;</td>
            <td style="padding:2.917pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.917pt 0pt 1.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">499</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.81pt;width:0pt;">&#8203;</td>
            <td style="padding:2.917pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.917pt 0pt 1.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.917pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.917pt 0pt 1.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">499</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8.5pt;">
            <td style="padding:3.167pt 0pt 1.833pt 0pt; width:123.19pt;white-space:normal;text-align:left;">
              <div style="margin-left:8.5pt; text-indent:-8.5pt;">
                <font style="letter-spacing:-0.021pt;">Issuance of common stock&#8201;&#8211;&#8201;Class&#160;A in relation to license agreement </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">89,629</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">103</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">103</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8.5pt;">
            <td style="padding:3.167pt 0pt 1.833pt 0pt; width:123.19pt;white-space:normal;text-align:left;">
              <div style="margin-left:8.5pt; text-indent:-8.5pt;">
                <font style="letter-spacing:-0.021pt;">Issuance of common stock&#8201;&#8211;&#8201;Class&#160;A in relation to legal settlement </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">200,750</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">248</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">248</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8.5pt;">
            <td style="padding:3.167pt 0pt 1.833pt 0pt; width:123.19pt;white-space:normal;text-align:left;">
              <div style="margin-left:8.5pt; text-indent:-8.5pt;">
                <font style="letter-spacing:-0.021pt;">Exercise of common stock option&#8201;&#8211;&#8201;Class&#160;A </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">11,428</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">13</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">13</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8.5pt;">
            <td style="padding:3.167pt 0pt 1.833pt 0pt; width:123.19pt;white-space:normal;text-align:left;">
              <div style="margin-left:8.5pt; text-indent:-8.5pt;">
                <font style="letter-spacing:-0.021pt;">Issuance of convertible preferred stock&#8201;&#8211;&#8201;Series&#160;A, net of $81 issuance cost </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">7,048,351</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">25,175</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8.5pt;">
            <td style="padding:3.167pt 0pt 1.833pt 0pt; width:123.19pt;white-space:normal;text-align:left;">
              <div style="margin-left:8.5pt; text-indent:-8.5pt;">
                <font style="letter-spacing:-0.021pt;">Exercise of warrants into convertible preferred stock&#8201;&#8211;&#8201;Series&#160;A </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">231,396</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">829</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8.5pt;">
            <td style="padding:3.167pt 0pt 1.833pt 0pt; width:123.19pt;white-space:normal;text-align:left;">
              <div style="margin-left:8.5pt; text-indent:-8.5pt;">
                <font style="letter-spacing:-0.021pt;">Stock-based compensation expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">357</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.81pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.167pt 0pt 1.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">357</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.5pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8.5pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.75pt 0pt; width:123.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.021pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.98pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:6.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.27pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.81pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(8,557<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.75pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(8,557<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8.5pt;">
            <td style="padding:3.25pt 0pt 3.5pt 0pt; width:123.19pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.094pt;">Balance at December&#160;31, 2020</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">9,993,727</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.58pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">34,900</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">3,764,488</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.98pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:6.75pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.27pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,458</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.81pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(18,038<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.75pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(16,579<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:8.5pt; margin-top:6.5pt; text-align:center; width:447.5pt; line-height:9pt;">
          <font style="letter-spacing:-0.021pt;"> </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">The accompanying notes are an integral part of these financial statements. </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:-0.025pt;">F-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="fSCF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:16.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">IN8BIO, INC. </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">STATEMENTS OF CASH FLOWS</font>
          <br >
          <font style="font-style:italic;font-weight:normal;">(in thousands)</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:534.5pt;margin-top:20pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:353.41pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Year ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:353.41pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <font style="letter-spacing:-0.111pt;">Cash flows from operating activities</font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(5,134<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">(8,557<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Adjustments to reconcile net loss to net cash used in operating activities: </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Depreciation </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">96</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">88</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Loss on disposal of property and equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">68</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Non-cash stock-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">76</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">357</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Non-cash stock issuance related to license agreement </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">103</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Non-cash stock issuance related to legal settlement </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">248</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Deferred rent </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">17</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Changes in operating assets and liabilities: </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Prepaid expenses and other current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(100<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">3</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Other non-current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(65<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">(48<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Other receivable </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">30</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">141</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">(160<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Accrued expenses and other current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">87</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">816</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Net cash used in operating activities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(4,801<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">(7,133<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <font style="letter-spacing:-0.111pt;">Cash flows from investing activities</font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Purchase of property and equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(330<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Proceeds from disposal of property and equipment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">686</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Net cash provided by investing activities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">356</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <font style="letter-spacing:-0.111pt;">Cash flows from financing activities</font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Proceeds from exercise of common stock options</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">65</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">13</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Proceeds from issuance of common stock</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">499</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Proceeds from issuance of loan </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">174</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Proceeds from issuance of preferred stock, net of $81 of issuance costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">25,175</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Payment of deferred offering costs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">(1,344<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Net cash provided by financing activities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">65</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">24,517</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Net (decrease) increase in cash and restricted cash</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(4,380<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">17,384</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:353.41pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Cash and restricted cash, beginning of year</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">4,990</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">610</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:353.41pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Cash and restricted cash, end of year</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">610</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">17,994</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:353.41pt;text-align:left;">
              <font style="letter-spacing:-0.111pt;">Supplemental disclosure of noncash financing activities</font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:353.41pt;white-space:normal;text-align:left;">
              <div style="margin-left:30pt; text-indent:-10pt;">
                <font style="letter-spacing:-0.025pt;">Deferred offering costs included in accounts payable and accrued expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">1,095</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.833pt 0pt; width:353.41pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Exercise of convertible preferred stock warrants</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.29pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.833pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">829</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The accompanying notes are an integral part of these financial statements. </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="fNFS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">IN8BIO, INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">NOTES TO FINANCIAL STATEMENTS</font><font style="font-weight:normal;text-transform:uppercase;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">1. Organization and Nature of Operations</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Organization and Business<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Incysus, Inc. (&#8220;Incysus&#8221;) was a corporation formed in the State of Delaware on November 23, 2015 and Incysus, Ltd. was incorporated in Bermuda on February 8, 2016. Incysus was the wholly owned United States subsidiary of Incysus, Ltd. On May 7, 2018, Incysus, Ltd. reincorporated in the United States in a domestication transaction (the &#8220;Domestication&#8221;) in which Incysus, Ltd. converted into a newly formed Delaware corporation, Incysus Therapeutics, Inc. (&#8220;Incysus Therapeutics&#8221;). On July 24, 2019, Incysus Therapeutics merged with Incysus. Incysus Therapeutics subsequently changed its name to IN8bio, Inc. (the &#8220;Company&#8221;) in August 2020. Following the Domestication in May 2018 and the merging of Incysus Therapeutics and Incysus in July 2019, the Company did not have any subsidiaries to consolidate as of December 31, 2020. The Company is headquartered in New York, New York.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The Company is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell therapies for the treatment of cancer. The Company&#39;s lead product candidates are currently in Phase&#160;1 clinical trials: INB-200, for the treatment of newly diagnosed glioblastoma (&#8220;GBM&#8221;), and INB-100, for the treatment of patients with leukemia that are undergoing hematopoietic stem cell transplantation (&#8220;HSCT&#8221;). In addition, the Company&#39;s DeltEx platform has yielded a broad portfolio of preclinical programs, including INB-400 and INB-300, focused on addressing other solid tumor types.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">COVID-19</div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In December 2019, a novel strain of coronavirus, which causes the disease known as COVID-19, has spread worldwide. In March 2020, the World Health Organization declared the COVID-19 outbreak a pandemic and the U.S. government imposed travel restrictions on travel between the United States, Europe and certain other countries. The outbreak and government measures taken in response have had a significant impact, both direct and indirect, on businesses and commerce, as certain worker shortages have occurred, supply chains have been disrupted, and facilities and production have been suspended. The future progression of the pandemic and its effects on the Company&#39;s business and operations are uncertain.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The COVID-19 pandemic has impacted and may continue to impact the clinical sites and startup activities for the Company&#39;s Phase 1/2 clinical trial, including third-party manufacturing and logistics providers, which would disrupt its clinical supply chain or the availability or cost of materials, and it may affect the Company&#39;s ability to timely complete its clinical trials and delay the initiation and/or enrollment of any future clinical trials, disrupt regulatory activities or have other adverse effects on its business and operations.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The Company is monitoring the potential impact of COVID-19 on its business and financial statements and cannot be certain what the overall impact of the COVID-19 pandemic will be. The extent to which the COVID-19 pandemic will directly or indirectly impact its business, results of operations, financial condition and liquidity, including planned and future clinical trials and research and development costs, will depend on future developments that are highly uncertain, including as a result of new information that may emerge concerning COVID-19, the actions taken to contain or treat it, and the duration and intensity of the related effects.</font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Liquidity<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Through December&#160;31, 2020, the Company has funded its operations primarily with proceeds from the initial closing and additional closings of our Series&#160;A convertible preferred stock financing (&#8220;Series&#160;A Financing&#8221;) and through its license agreements. The Company has incurred recurring losses and negative operating cash flows from operations since its inception, including net losses of $5.1&#160;million and $8.6&#160;million for the&#160;years ended December&#160;31, 2019 and 2020, respectively. As of December&#160;31, 2020, the Company had an accumulated deficit of $18.0&#160;million. The Company expects to continue to generate operating losses for the foreseeable future.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">IN8BIO, INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">NOTES TO FINANCIAL STATEMENTS</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">1. Organization and Nature of Operations&#8201;(Continued)</font>
        </div>
        <div style="text-indent:20pt; margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">As of March&#160;31, 2021, the issuance date of these financial statements for the year ended December&#160;31, 2020, the Company expects that its cash will be sufficient to fund its operating expenses and capital expenditure requirements through at least 12&#160;months from the issuance of the financial statements. The future viability of the Company beyond that point is dependent on its ability to raise additional capital to finance its operations.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Reverse Stock Split<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">On November&#160;5, 2020, the Company effected a 0.365-for-1 reverse stock split of the Company&#8217;s common stock and preferred stock, and the conversion price for the preferred stock was adjusted. All shares, stock options, warrants and per share information presented in the financial statements have been adjusted to reflect the reverse stock split on a retroactive basis for all periods presented. There was no change in the par value and authorized number of shares of the Company&#8217;s common stock and preferred stock.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">2. Summary of Significant Accounting Policies</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Basis of Presentation<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;).</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Use of Estimates<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant items subject to such estimates and assumptions include the useful lives of property and equipment, deferred tax assets and liabilities and related valuation allowance, fair value of common stock and stock-based compensation, warrant liability and accrued research and development costs. Management bases its estimates on historical experience and on various other market-specific relevant assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Concentration of Credit Risk<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash. The Company&#8217;s cash is maintained with a high quality, accredited financial institution. These amounts, at times, may exceed federally insured limits. The Company has not experienced any credit losses in such accounts and does not believe it is exposed to significant risk on these funds. The Company has no off-balance sheet concentrations of credit risk, such as foreign currency exchange contracts, option contracts or other hedging arrangements. Management deems there to be minimal credit risk associated with the Company&#8217;s cash.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Cash and Restricted Cash<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Cash consists of standard checking accounts. The Company has restricted cash of $0.1&#160;million in the form of a security deposit related to its agreement with an equipment rental company for the&#160;years ended December&#160;31, 2019 and 2020, respectively. These amounts have been classified as non-current assets on the Company&#8217;s balance sheets.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Property and Equipment<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Property and equipment are stated at cost, less accumulated depreciation. Depreciation of property and equipment is calculated using the straight-line method over the estimated useful lives of the assets. Significant replacements and improvements are capitalized, while maintenance and repairs, which do not improve or extend the life of the respective assets, are charged to expense as incurred. The estimated useful lives of the Company&#8217;s respective assets are as follows:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="GoBack">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">IN8BIO, INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">NOTES TO FINANCIAL STATEMENTS</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">2. Summary of Significant Accounting Policies&#8201;(Continued)</font>
        </div>
        <table style="width:456pt;height:38.5pt;margin-top:12pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:372.62pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:81.38pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Estimated Useful Life </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:372.62pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Computer equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:81.38pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">3&#160;years </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:372.62pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Laboratory equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:81.38pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">3-5&#160;years</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Costs for capital assets not yet placed into service are capitalized as construction-in-progress and depreciated in accordance with the above guidelines once placed into service. Upon retirement or disposal of property and equipment, the cost and related accumulated depreciation are removed from the balance sheet and any gain or loss is reflected in the statement of operations.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Impairment of Long-Lived Assets<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Long-lived assets, such as property and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted cash flows expected to be generated by the asset. Impairment losses are then measured by comparing the fair value of assets to their carrying amounts. There were no impairments recorded for the&#160;years ended December&#160;31, 2019 and 2020.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Research and Development Costs<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Research and development costs are generally expensed as incurred and consist primarily of salaries and benefits, stock-based compensation expense, lab supplies and facility costs, as well as fees paid to nonemployees and entities that conduct certain research and development activities on the Company&#8217;s behalf and expenses incurred in connection with license agreements. Non-refundable advance payments for goods or services that will be used for rendered or future research and development activities are deferred and amortized over the period that the goods are delivered, or the related services are performed, subject to an assessment of recoverability.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The Company analyzes the progress of clinical trials, invoices received and contracted costs when evaluating the adequacy of the amount expensed and the related prepaid asset and accrued liability. The Company makes significant judgments and estimates in determining the accrued balance and expense in each accounting period. As actual costs become known, the Company adjusts the accrued estimates. Although the Company does not expect the estimates to be materially different from amounts actually incurred, the status and timing of services performed, the number of patients enrolled and the rate of patient enrollment may vary from the Company&#8217;s estimates and could result in the Company reporting amounts that are too high or too low in any particular period. The Company&#8217;s accrued expenses are dependent, in part, upon the receipt of timely and accurate reporting from clinical research organizations and other third-party service providers.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Leases<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The payments on operating lease agreements are recognized as an expense on a straight-line basis over the lease term. Associated costs, such as maintenance and insurance, are expensed as incurred.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The Company records the difference between cash rent payments and the recognition of rent expense as a deferred rent liability for its operating leases.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Fair Value of Financial Instruments<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The Company applies fair value accounting for all financial assets and liabilities and nonfinancial assets and liabilities that are required to be disclosed at fair value in the financial statements, Fair value is the price at which an asset could be exchanged, or a liability transferred (an exit price) in an orderly transaction between knowledgeable, willing parties in the principal or most advantageous market for the asset or liability. Where available, fair value is based on observable market prices or parameters or derived from such prices or parameters. Where observable prices or inputs are not available, valuation models are applied.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">IN8BIO, INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">NOTES TO FINANCIAL STATEMENTS</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">2. Summary of Significant Accounting Policies&#8201;(Continued)</font>
        </div>
        <div style="text-indent:20pt; margin-top:12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.71pt; margin-bottom:0pt; text-align:left; width:52pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">Level&#160;1&#8201;&#8212;&#8201;</font>
          <br >
        </div>
        <div style=" margin-top:7.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:72pt;">
          <font style="letter-spacing:-0.025pt;">Inputs are unadjusted, quoted prices in active markets for identical assets at the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:52pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">Level&#160;2&#8201;&#8212;&#8201;</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:72pt;">
          <font style="letter-spacing:-0.025pt;">Inputs are other than quoted prices included in Level&#160;1, which are either directly or indirectly observable for the asset or liability through correlation with market data at the reporting date and for the duration of the instrument&#8217;s anticipated life.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:52pt;white-space:nowrap;">
          <font style="letter-spacing:-0.025pt;">Level&#160;3&#8201;&#8212;&#8201;</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:72pt;">
          <font style="letter-spacing:-0.025pt;">Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities and which reflect management&#8217;s best estimate of what market participants would use in pricing the asset or liability at the reporting date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The Company&#8217;s financial instruments include cash and restricted cash, accounts payable, and warrant liability. The Company&#8217;s warrant liability was carried at fair value, determined according to the fair value hierarchy described above (see Note 3). The carrying amounts of cash, restricted cash, and accounts payable approximate fair value due to the short-term nature of these instruments.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Income Taxes<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The Company utilizes the asset and liability method of accounting for income taxes. This method requires recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates in effect for the year in which those temporary differences are expected to be recovered or settled. The Company evaluates its ability to benefit from all deferred tax assets and establishes valuation allowances for amounts it believes may not be realizable.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The Company recognizes the financial statement benefit of an income tax position only after determining that the relevant taxing authority would more-likely-than-not sustain the position following audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the relevant taxing authority. The Company recognizes interest accrued related to unrecognized tax benefits and penalties in the provision for income taxes.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Tax regulations within each jurisdiction are subject to the interpretation of the related tax laws and regulations and require application of significant judgment. The Company is subject to U.S. federal and various state and local jurisdictions. Due to the Company&#8217;s net operating loss carryforwards, the Company may be subject to examination by authorities for all previously filed income tax returns.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">On March&#160;27, 2020, the Coronavirus Aid, Relief and Economic Security Act (the &#8220;CARES Act&#8221;) was signed into law in response to the COVID-19 pandemic. The CARES Act provides numerous tax provisions and stimulus measures, including temporary changes regarding the prior and future utilization of net operating losses, temporary changes to the prior and future limitations on interest deductions, and technical corrections from prior tax legislation for tax depreciation of certain qualified improvement property. The Company has evaluated the provisions of the CARES Act relating to income taxes which will result in adjustments to certain deferred tax assets and liabilities. Due to the Company&#8217;s U.S. valuation allowance, the Company noted the provisions of the CARES Act did not have a material impact on its financial statements.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">IN8BIO, INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">NOTES TO FINANCIAL STATEMENTS</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">2. Summary of Significant Accounting Policies&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Stock-Based Compensation<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The Company measures all stock-based awards granted to employees, nonemployees and directors based on the fair value on the date of the grant and recognizes compensation expense for those awards over the requisite service period, which is generally the vesting period of the respective award. The stock-based compensation expense is accounted for in the statements of operations based on the awards&#8217; grant date fair values. The Company accounts for forfeitures as they occur by reversing any expense recognized for unvested awards.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The Company estimates the fair value of options granted using the Black-Scholes option pricing model. The Black-Scholes option pricing model requires inputs based on certain subjective assumptions, including (a)&#160;the expected stock price volatility, (b)&#160;the calculation of expected term of the award, (c)&#160;the risk-free interest rate and (d)&#160;expected dividends. Due to the lack of a public market for the Company&#8217;s common stock and a lack of company-specific historical and implied volatility data, the Company has based its estimate of expected volatility on the historical volatility of a group of similar companies that are publicly traded. The historical volatility is calculated based on a period of time commensurate with the expected term assumption. The computation of expected volatility is based on the historical volatility of a representative group of companies with similar characteristics to the Company, including stage of product development and life science industry focus. The Company uses the simplified method as allowed by the Securities and Exchange Commission (&#8220;SEC&#8221;) Staff Accounting Bulletin (&#8220;SAB&#8221;) No. 107, </font><font style="font-style:italic;">Share-Based Payment</font><font style="letter-spacing:-0.025pt;">, to calculate the expected term for options granted to employees as it does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected term of the stock options. The expected dividend yield is assumed to be zero as the Company has never paid dividends and has no current plans to pay any dividends on its common stock.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Warrants<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The Company accounts for warrants on capital stock based on guidelines provided in ASC Topic 815, </font><font style="font-style:italic;">Derivatives and Hedging&#8201;&#8212;&#8201;Contracts in Entity&#8217;s Own Equity</font><font style="letter-spacing:-0.025pt;"> (&#8220;ASC 815&#8221;), which provides guidance on contracts that are settled in the Company&#8217;s own shares as either a liability or as an equity instrument depending on the warrant agreement. The Company uses the Black-Scholes pricing model, depending on the applicable terms of the warrant agreement, to value the warrants.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Deferred Offering Costs<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The Company capitalizes certain legal, professional accounting and other third-party fees that are directly associated with in-process preferred stock or common stock financings as deferred offering costs until such financings are consummated. After consummation of the equity financing, these costs are recorded as a reduction to the carrying value of convertible preferred stock or in stockholders&#8217; equity (deficit) as a reduction of additional paid-in capital generated as a result of the offering. Should a planned equity financing be abandoned, the deferred offering costs will be expensed immediately as a charge to operating expenses in the statements of operations. As of December&#160;31, 2019 and 2020, the Company had deferred offering costs of $0 and $2.4&#160;million, respectively.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Accounting Pronouncements Recently Adopted<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In June&#160;2018, the FASB issued ASU 2018-07, </font><font style="font-style:italic;">Compensation&#8201;&#8212;&#8201;Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting</font><font style="letter-spacing:-0.025pt;"> (&#8220;ASU 2018-07&#8221;). These amendments expand the scope of Topic 718, Compensation&#8201;&#8212;&#8201;Stock Compensation, which currently only includes share-based payments to employees, to include share-based payments issued to nonemployees for goods or services. Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned. This ASU supersedes Subtopic 505-50, </font><font style="font-style:italic;">Equity&#8201;&#8212;&#8201;Equity-Based Payments to Non-Employees</font><font style="letter-spacing:-0.025pt;">. This standard is effective for public companies for annual periods beginning after December&#160;15, 2018, including interim periods within those fiscal&#160;years, with early </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:34pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">IN8BIO, INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">NOTES TO FINANCIAL STATEMENTS</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">2. Summary of Significant Accounting Policies&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">adoption permitted as long as ASU 2014-09 has been adopted by the Company. The Company adopted ASU 2018-07 as of January&#160;1, 2019, which did not have a material impact on the Company&#8217;s financial statements.</font><font style="font-weight:bold;letter-spacing:-0.111pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In August&#160;2018, the FASB issued ASU 2018-13, </font><font style="font-style:italic;">Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement</font><font style="letter-spacing:-0.025pt;"> (&#8220;ASU 2018-13&#8221;), which modifies the disclosure requirements on fair value measurements. The amendment of ASU 2018-13 removes disclosure requirements from Topic 820 in the areas of (1)&#160;the amount of and reasons for transfers between Level&#160;1 and Level&#160;2 of the fair value hierarchy; (2)&#160;the policy for timing of transfers between levels, and (3)&#160;the valuation processes for Level&#160;3 fair value measurements. This guidance is effective for fiscal&#160;years, and interim periods within those fiscal&#160;years, beginning after December&#160;15, 2019. Early adoption is permitted. The guidance was adopted on January&#160;1, 2020 and did not have a material impact on the Company&#8217;s financial statements.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Accounting Pronouncements Not Yet Adopted<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In February&#160;2016, the FASB issued ASU 2016-02, </font><font style="font-style:italic;">Leases (Topic 842)</font><font style="letter-spacing:-0.025pt;"> (&#8220;ASC 842&#8221;), which amends the existing accounting standards for leases. The guidance requires lessees to recognize assets and liabilities related to long-term leases on the balance sheet and expands disclosure requirements regarding leasing arrangements. In July&#160;2018, the FASB issued additional guidance, which offers a transition option to entities adopting the new lease standard. Under the transition option, entities can elect to apply the new guidance using a modified retrospective approach at the beginning of the year in which the new lease standard is adopted, rather than to the earliest comparative period presented in their financial statement and provides for certain practical expedients. The guidance is effective for reporting periods beginning after December&#160;15, 2020 for private companies with early adoption permitted. The Company adopted this standard on January&#160;1, 2021.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The Company has completed its assessment of the impact ASU 2016-02 will have on its financial position, results of operations, and related footnotes. The Company elected to utilize the available package of practical expedients permitted under the transition guidance within the new standard, which does not require the reassessment of the following: i) whether existing or expired arrangements are or contain a lease, ii) the lease classification of existing or expired leases, and iii) whether previous initial direct costs would qualify for capitalization under the new lease standard. Additionally, the Company made an accounting policy election to keep leases with an initial term of 12&#160;months or less off of its balance sheet. The Company&#8217;s assessment included identifying the Company&#8217;s lease population, assessing significant leases under the new guidance and identifying changes to processes and controls. The adoption of the new standard will result in the recognition of right-of-use assets and lease liabilities of approximately $1.7&#160;million and $1.8&#160;million, as of December 31, 2019 and 2020, respectively, on the Company&#8217;s balance sheet. The adoption of the new standard will not have a material impact on the Company&#8217;s statement of operations or its liquidity.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In December&#160;2019, the FASB issued ASU 2019-12, </font><font style="font-style:italic;">Simplifications for Income Taxes</font><font style="letter-spacing:-0.025pt;"> (&#8220;ASU 2019-12&#8221;) guidance simplifying the accounting for income taxes, specifically with respect to intra-period tax allocation, income tax provisions provided for in interim financial statements, and franchise and other taxes partially based on income. The guidance is effective for reporting periods beginning after December&#160;15, 2021. The Company is currently evaluating the impact, if any, that the adoption of this guidance will have on the financial statements.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:82pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">IN8BIO, INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">NOTES TO FINANCIAL STATEMENTS</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">3. Fair Value of Assets and Liabilities</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The following table presents information about the Company&#8217;s financial assets and liabilities measured at fair value on a recurring basis and indicates the level of the fair value hierarchy utilized to determine such fair values as of December&#160;31, 2019 (in thousands):</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:81pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:0pt 0pt 2.167pt 0pt; width:180.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-right:1pt;letter-spacing:-0.089pt;">Description </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">December&#160;31,</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:17pt;padding-right:17pt;letter-spacing:-0.089pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Quoted prices</font>
                <br >
                <font style="letter-spacing:-0.089pt;">active markets</font>
                <br >
                <font style="letter-spacing:-0.089pt;">for identical</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;letter-spacing:-0.089pt;">assets (Level&#160;1) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Significant other</font>
                <br >
                <font style="letter-spacing:-0.089pt;">observable</font>
                <br >
                <font style="letter-spacing:-0.089pt;">inputs</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:15pt;padding-right:15pt;letter-spacing:-0.089pt;">(Level&#160;2) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Significant other</font>
                <br >
                <font style="letter-spacing:-0.089pt;">observable</font>
                <br >
                <font style="letter-spacing:-0.089pt;">inputs</font>
                <br >
                <font style="border-bottom:1px solid #000000;padding-bottom:1pt;padding-left:15pt;padding-right:15pt;letter-spacing:-0.089pt;">(Level&#160;3) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:italic;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:180.81pt;text-align:left;">Liability </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:29.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:43.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:47.46pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:40.79pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:180.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Warrant liability </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:29.78pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:15pt; text-align:right; white-space:nowrap;">829</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:43.59pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:47.46pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:40.79pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:15pt; text-align:right; white-space:nowrap;">829</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:180.81pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Total financial liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:29.78pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:15pt; text-align:right; white-space:nowrap;">829</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:43.59pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:47.46pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:40.79pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:15pt; text-align:right; white-space:nowrap;">829</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The fair value of the Series&#160;A convertible preferred stock (&#8220;Series A Preferred Stock&#8221;) warrants upon issuance was $0.8&#160;million, which was determined using the intrinsic value because the exercise price was only $0.0003 per share. The intrinsic value was calculated by taking the fair value of the underlying Series&#160;A Preferred Stock of $3.5833 per share less the exercise price of $0.0003 per share. The fair value of the Series&#160;A Preferred Stock was based on the price paid by investors and has not changed since issuance. Accordingly, there have been no changes in the fair value of the warrant liability for the year ended December&#160;31, 2019. In October&#160;2020, the warrants were exercised at the price of $0.0003 per share and the warrant liability was settled for its fair value of $0.8&#160;million. As of December&#160;31, 2020, there were no remaining warrants outstanding.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">During the&#160;years ended December&#160;31, 2019 and 2020, the Company had one additional Level&#160;3 financial instrument remeasured on a recurring basis, which consisted of an antidilution liability related to an antidilution provision in the license agreement with UAB Research Foundation (&#8220;UABRF&#8221;) (see Note 10). Both instruments were deemed immaterial, based on the remote probability of the occurrence of underlying events. The antidilution liability was settled in connection with the Company&#8217;s Series&#160;A Preferred Stock issuances during the year ended December&#160;31, 2020. There were no transfers between fair value hierarchy levels during the&#160;years ended December&#160;31, 2019 and 2020.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">4. Property and Equipment</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:4pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Property and equipment, net, consists of the following (in thousands):</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:63pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:337.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:337.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Machinery and equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:26.45pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">443</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:26.45pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">443</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:337.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Less accumulated depreciation </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:26.45pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(169<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:26.45pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(257<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:337.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Property and equipment, net </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:26.45pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">274</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:26.45pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">186</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Depreciation expense for property and equipment totaled $0.1&#160;million for each of the&#160;years ended December&#160;31, 2019 and 2020.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">IN8BIO, INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">NOTES TO FINANCIAL STATEMENTS</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">5. Accrued Expenses and Other Current Liabilities</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:4pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Accrued expenses and other current liabilities consist of the following (in thousands):</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:93pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:337.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:337.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Accrued offering costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.34pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.45pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">876</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:337.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Accrued clinical trials </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.34pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.45pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">376</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:337.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Accrued compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.34pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">87</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.45pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">400</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:337.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Accrued other </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.34pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.45pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">126</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:337.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Total accrued expenses and other current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.34pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">87</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.45pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">1,778</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.7pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">6. Loan Payable</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In April&#160;2020, the Company was granted a loan (the &#8220;Loan&#8221;) in an amount of $0.2&#160;million, pursuant to the Paycheck Protection Program (the &#8220;PPP&#8221;) under Division A, Title I of the CARES Act, which was enacted on March&#160;27, 2020. The Loan, which was in the form of a Note dated April&#160;16, 2020, matures on April&#160;16, 2022 and bears interest at a rate of 1.0% per annum, payable monthly commencing on November&#160;16, 2020. The Note may be prepaid by the Company at any time prior to maturity with no prepayment penalties.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Funds from the Loan may only be used for payroll costs, costs used to continue group healthcare benefits, mortgage payments, rent, utilities, and interest on other debt obligations incurred before February&#160;15, 2020. The Company used the entire Loan amount for qualifying expenses. Under the terms of the PPP, certain amounts of the Loan may be forgiven if they are used for qualifying expenses as described in the CARES Act. The Company plans to pay back the full amount of the Loan in 2021.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Loan payable consists of the following (in thousands except year and percentage):</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:48pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:322.87pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Year of</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Maturity </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Interest</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Rate </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Outstanding</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Principal </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:322.87pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Loan payable </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">2022</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.35pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1.00<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.87pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:15pt; text-align:right; white-space:nowrap;">174</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:322.87pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Total loan payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.87pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:15pt; text-align:right; white-space:nowrap;">174</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:16.8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">7. Convertible Preferred Stock</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Convertible Series&#160;A Preferred Stock<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">From January through August&#160;2020, the Company issued 7,048,351 shares of Series&#160;A Preferred Stock at $3.5833 per share for $25.3&#160;million in gross proceeds related to the Series&#160;A Preferred Stock issuance from 2018.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">At December&#160;31, 2020, a total of $35.0&#160;million, at $3.5833 per share, had been raised by the Company through the Series&#160;A preferred financing and/or the Company issued Note Series&#160;2018A convertible promissory note conversion that converted into Series&#160;A Preferred Stock on May&#160;7, 2018 following the Domestication. The Series&#160;A Preferred Stock includes 2,713,980 and 9,993,727 shares issued and outstanding on December&#160;31, 2019 and 2020, respectively.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In August 2020, the Company increased the authorized shares of Series&#160;A Preferred Stock, par value $0.0001 per share, to 27,564,260 shares.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Dividends<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Dividends at the rate per annum of $0.2866 per share shall accrue on the Series&#160;A Preferred Stock, subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Series&#160;A Preferred Stock. Accruing dividends accrue from day to day, whether or not declared, and are cumulative; provided that such accruing dividends </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">IN8BIO, INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">NOTES TO FINANCIAL STATEMENTS</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">7. Convertible Preferred Stock&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">are payable only when, as and if declared by the Board of Directors and the Company is under no obligation to pay such accruing dividends.</font><font style="font-weight:bold;letter-spacing:-0.111pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Liquidation<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The Series&#160;A Preferred Stock has a liquidation preference to the holders of common stock. The Series&#160;A Preferred Stock has a liquidation preference of $3.5833 per share plus any accrued but unpaid dividends.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company or a deemed liquidation event, the holders of the shares of Series&#160;A Preferred Stock then outstanding are entitled to be paid out of the assets of the Company available for distribution to its stockholders before any payments are made to the holders of common stock by reason of their ownership thereof, an amount per share equal to one times the Series&#160;A original issue price, plus any accruing dividends accrued but unpaid thereon, whether or not declared.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company or a deemed liquidation event, after payment in full of all Series&#160;A liquidation amounts required to be paid to the holders of shares of Series&#160;A Preferred Stock, the remaining assets of the Company available for distribution to its stockholders are required to be distributed among the holders of the shares of Series&#160;A Preferred Stock and common stock, pro-rata based on the number of shares held by each such holder, treating for this purpose all such securities as if they had been converted to common stock, provided, that if the aggregate amount which the holders of Series&#160;A Preferred Stock are entitled to receive exceeds $3.92361 per share (the &#8220;Maximum Participation Amount&#8221;), each holder of Series&#160;A Preferred Stock is entitled to receive upon such liquidation, dissolution or winding up of the Company, the greater of (i)&#160;the Maximum Participation Amount and (ii)&#160;the amount such holder would have received if all shares of Series&#160;A Preferred Stock had been converted into common stock immediately prior to such liquidation, dissolution or winding up of the Company.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Voting Rights<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Each holder of outstanding shares of Series&#160;A Preferred Stock is entitled to cast the number of votes equal to the number of whole shares of common stock into which the shares of the Series&#160;A Preferred Stock held by such holder are convertible as of the record date for determining stockholders entitled to vote on such matter.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Protective Provisions<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">At any time when at least 131,400 shares of Series&#160;A Preferred Stock remain outstanding (subject to appropriate adjustments), the Company shall not take any of the following actions without (1)&#160;the vote or written consent of the holders of at least 60% of the then outstanding shares of Series&#160;A Preferred Stock separately as a class and (2)&#160;prior approval of at least 60% of the members of the Company&#8217;s Board of Directors then in office: (i)&#160;liquidate, dissolve or wind-up the business and affairs of the Company, effect any merger or consolidation or any other Deemed Liquidation Event, or consent to any of the foregoing; (ii)&#160;amend, alter or repeal any provision of the Company&#8217;s certificate of incorporation or bylaws in a manner that adversely affects the powers, preferences or rights of the Series&#160;A Preferred Stock; (iii)&#160;create, or authorize the creation of, or issue shares of, or obligate itself to issue shares of, any additional class or series of capital stock unless the same ranks junior to the Series&#160;A Preferred Stock with respect to the distribution of assets on the liquidation, dissolution or winding up of the Company, the payment of dividends and rights of redemption; (iv)&#160;increase or decrease the authorized number of shares of Preferred Stock or of Series&#160;A Preferred Stock, or increase or decrease the authorized number of shares of any additional class or series of capital stock of the Company; (v)&#160;(a)&#160;reclassify, alter or amend any existing security of the Company that is pari&#160;passu with the Series&#160;A Preferred Stock in respect of the distribution of assets on the liquidation, dissolution or winding up of the Company, the payment of dividends or rights of redemption, if such reclassification, alteration or amendment would render such other security senior to the Series&#160;A Preferred Stock in respect of any </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">IN8BIO, INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">NOTES TO FINANCIAL STATEMENTS</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">7. Convertible Preferred Stock&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">such right, preference, or privilege or (b)&#160;reclassify, alter or amend any existing security of the Company that is junior to the Series&#160;A Preferred Stock in respect of the distribution of assets on the liquidation, dissolution or winding up of the Company, the payment of dividends or rights of redemption, if such reclassification, alteration or amendment would render such other security senior to or pari&#160;passu with the Series&#160;A Preferred Stock in respect of any such right, preference or privilege; (vi)&#160;purchase or redeem (or permit any subsidiary to purchase or redeem) or pay or declare any dividend or make any distribution on, any shares of capital stock of the Company other than (a)&#160;redemptions of or dividends or distributions on the Series&#160;A Preferred Stock as expressly authorized in the Certificate of Incorporation, (b)&#160;dividends or other distributions payable on the Common Stock solely in the form of additional shares of Common Stock and (c)&#160;repurchases of stock from former employees, officers, directors, consultants or other persons who performed services for the Company or any subsidiary in connection with the cessation of such employment or service at the lower of the original purchase price or the then current fair market value thereof; (vii)&#160;create, or authorize the creation of, or issue, or authorize the issuance of any debt security or permit any subsidiary to take any such action with respect to any debt security, if the aggregate indebtedness of the Company and its subsidiaries for borrowed money following such action would exceed $2,000,000 (other than equipment leases or bank lines of credit); (viii)&#160;create, or hold capital stock in, any subsidiary that is not wholly owned (either directly or through one or more other subsidiaries) by the Company, or permit any subsidiary to create, or authorize the creation of, or issue or obligate itself to issue, any shares of any class or series of capital stock, or sell, transfer or otherwise dispose of any capital stock of any direct or indirect subsidiary of the Company, or permit any direct or indirect subsidiary to sell, lease, transfer, exclusively license or otherwise dispose (in a single transaction or series of related transactions) of all or substantially all of the assets of such subsidiary; or (ix)&#160;increase or decrease the authorized number of directors constituting the Board.</font><font style="font-weight:bold;letter-spacing:-0.111pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Optional and Mandatory Conversion Rights<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Each share of Series&#160;A Preferred Stock is convertible, at the option of the holder thereof, at any time and from time to time, and without the payment of additional consideration by the holder thereof, into such number of fully paid and non-assessable shares of common stock as is determined by dividing the Series&#160;A original issue price by the Series&#160;A conversion price in effect at the time of conversion. The Series&#160;A conversion price is initially equal to $3.5833. Such initial Series&#160;A conversion price, and the rate at which shares of Series&#160;A Preferred Stock may be converted into shares of common stock, is subject to adjustment.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In connection with the Series&#160;A Preferred Stock issuance in August&#160;2020, the Series&#160;A conversion price was adjusted to $3.2583.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The Series&#160;A Preferred Stock automatically converts to common stock, at the then effective conversion rate, upon (i)&#160;the written request of a majority of the outstanding shares of the Series&#160;A Preferred Stock voting as a single class or (ii)&#160;an initial public offering resulting in gross proceeds to the Company of at least $25.0&#160;million. At the time of issuance, no beneficial conversion charge was recorded as the fair value of the Series&#160;A Preferred Stock was determined by management to be less than the stated conversion value. When the triggering event that forces conversion where both price and shares are known, the beneficial conversion charge will be recorded.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Redemption<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The Series&#160;A Preferred Stock is redeemable upon the occurrence of a deemed liquidation event, which is not solely in control of the Company. Therefore, the Series&#160;A Preferred Stock has been classified as temporary equity.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Series&#160;A Preferred Stock Warrants<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">On May&#160;7, 2018, in connection with the sale and issuance of the Series&#160;A Preferred Stock, the Company issued liability-classified warrants to purchase an aggregate of 231,396 shares of Series&#160;A </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">IN8BIO, INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">NOTES TO FINANCIAL STATEMENTS</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">7. Convertible Preferred Stock&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Preferred Stock (the &#8220;2018 Warrants&#8221;), with an exercise price of $0.0003 per share of Series&#160;A Preferred Stock, subject to adjustment per the terms of the 2018 Warrants. The 2018 Warrants were exercisable immediately on date of issuance and expire five&#160;years from issuance, in May&#160;2023. These warrants are subject to an earlier expiration upon the closing of the Company&#8217;s qualifying initial public offering of common stock. As of December&#160;31, 2019, the Company had 231,396 warrants outstanding, with a fair value of $0.8&#160;million. In October&#160;2020, the warrants were exercised at the price of $0.0003 per share and the warrant liability was settled for its fair value of $0.8&#160;million (see Note 3).</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">8. Common Stock</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The Company has 27,000,000 and 50,700,000 authorized shares of common stock, par value $0.0001 per share, of which 3,235,671 and 3,764,488 shares were issued and outstanding as of December&#160;31, 2019 and 2020, respectively.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In March&#160;2020, the Company entered into a common stock purchase agreement with a director of the Company to issue and sell 182,500 shares of its common stock for a total purchase price of $0.2&#160;million.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In August 2020, the Company increased the authorized shares of common stock, par value $0.0001 per share, to 50,700,000 shares.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In October 2020, the Company entered into a common stock purchase agreement with a director of the Company to issue and sell 29,674 shares of its common stock for a total purchase price of $0.2 million.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">9. Stock-Based Compensation</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">2018 Equity Incentive Plan<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">On May&#160;7, 2018, the Company established and adopted the 2018 Equity Incentive Plan (the &#8220;2018 Plan&#8221;) providing for the granting of stock awards for employees, directors and consultants to purchase shares of the Company&#8217;s Common Stock. A total of 817,126 and 2,101,478 shares were authorized under the 2018 Plan and 393,593 and 854,320 shares are available for granting of stock awards as of December&#160;31, 2019 and 2020, respectively. The Plan provides for the granting of the following types of stock awards: (i)&#160;incentive stock options, (ii)&#160;non-statutory stock options, (iii)&#160;stock appreciation rights, (iv)&#160;restricted stock awards, (v)&#160;restricted stock unit awards and (vi)&#160;other stock awards. Incentive stock options may be granted only to employees of the Company. Stock awards other than incentive stock options may be granted to employees, directors and consultants who are providing continuous service to the Company.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The following is a summary of the Company&#8217;s stock option activity for the&#160;years ended December&#160;31, 2019 and 2020 (in thousands, except years, share and per share data):</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:126pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:211.32pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Weighted-</font>
                <br >
                <font style="letter-spacing:-0.089pt;">average</font>
                <br >
                <font style="letter-spacing:-0.089pt;">exercise price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Weighted-</font>
                <br >
                <font style="letter-spacing:-0.089pt;">average</font>
                <br >
                <font style="letter-spacing:-0.089pt;">contractual</font>
                <br >
                <font style="letter-spacing:-0.089pt;">term (in&#160;years) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Aggregate</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Intrinsic Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:211.32pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Outstanding as of January&#160;1, 2019 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">237,773</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.78pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.07</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.57pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">9.86</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:211.32pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">287,788</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.78pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.08</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.57pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">9.32</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:211.32pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Exercised </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">(60,921<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.78pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.08</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.57pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.91</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:211.32pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Cancelled </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:33pt; text-align:right; white-space:nowrap;">(102,029<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.78pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1.08</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.57pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">9.33</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.85pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:9pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:211.32pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Outstanding as of December&#160;31, 2019 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">362,611</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.78pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.08</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.57pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">9.22</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">5</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:211.32pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:33pt; text-align:right; white-space:nowrap;">929,806</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.78pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">6.56</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.57pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">9.74</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">IN8BIO, INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">NOTES TO FINANCIAL STATEMENTS</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">9. Stock-Based Compensation&#8201;(Continued)</font>
        </div>
        <table style="width:456pt;height:115pt;margin-top:12pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:211.32pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Weighted-</font>
                <br >
                <font style="letter-spacing:-0.089pt;">average</font>
                <br >
                <font style="letter-spacing:-0.089pt;">exercise price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Weighted-</font>
                <br >
                <font style="letter-spacing:-0.089pt;">average</font>
                <br >
                <font style="letter-spacing:-0.089pt;">contractual</font>
                <br >
                <font style="letter-spacing:-0.089pt;">term (in&#160;years) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Aggregate</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Intrinsic Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:211.32pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Exercised </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">(11,428<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.78pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.09</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.57pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">8.78</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:211.32pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Cancelled </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(33,831<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.78pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1.08</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.57pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">9.02</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.85pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:211.32pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Outstanding as of December&#160;31, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">1,247,158</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.78pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">5.16</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.57pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">9.34</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.85pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">1,486</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:211.32pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Exercisable at December&#160;31, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">149,686</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.78pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1.78</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.57pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">8.28</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.85pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">562</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:211.32pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Nonvested at December&#160;31, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">1,097,472</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.78pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">5.63</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.57pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">9.49</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.85pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">924</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="height:4pt;line-height:4pt;">
            <td style="padding:0pt;font-size:0pt;line-height:0pt;" colspan="26">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Generally, options are granted with an exercise price at, or in excess of, the fair value of common stock at the date of issuance. Options typically vest over a one to four-year period in equal increments. The original term of all options is 10&#160;years.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The weighted-average grant date fair value of options granted during the&#160;years ended December&#160;31, 2019 and 2020 was $0.77 and $4.67, respectively. The aggregate intrinsic value is calculated as the difference between the exercise price and the estimated fair value of the Company&#8217;s common stock at the end of the reporting period. The aggregate intrinsic value of stock options exercised in the years ended December&#160;31, 2019 and 2020 was $1,919 and $48,741 respectively.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The total fair value of options vested during the years ended December&#160;31, 2019 and 2020 was $49,283 and $0.2&#160;million, respectively.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Stock-Based Compensation Expense<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">A summary of the assumptions used in determining the fair value of stock options granted in the period is as follows for the&#160;years ended December&#160;31, 2019 and 2020:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:77.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:306.43pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:67.78pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:67.78pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:306.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Expected dividend yield </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:67.78pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:67.78pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:306.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Expected volatility </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:67.78pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">81.9%&#8201;&#8211;&#8201;90.1% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:67.78pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">83.3%&#8201;&#8211;&#8201;90.9% </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:306.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Risk-free interest rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:67.78pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">1.6%&#8201;&#8211;&#8201;2.5% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:67.78pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">0.3%&#8201;&#8211;&#8201;1.4% </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:306.43pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Expected average life (in&#160;years) </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:67.78pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">5.98&#8201;&#8211;&#8201;8.97 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:67.78pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">4.25&#8201;&#8211;&#8201;9.34</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:7.31pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The Company recorded stock-based compensation as follows (in thousands):</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:63pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:337.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:337.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.34pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:33pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">50</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:29.78pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">192</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:337.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.34pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:33pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">26</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:29.78pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:15pt; text-align:right; white-space:nowrap;">165</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:337.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.34pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:33pt; text-align:right; ">&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">76</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:29.78pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:15pt; text-align:right; white-space:nowrap;">357</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.3pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">No related tax benefits from stock-based compensation expense were recognized for the&#160;years ended December&#160;31, 2019 and 2020. As of December&#160;31, 2020, there was $4.2&#160;million in unrecognized stock-based compensation cost, which is expected to be recognized over a weighted-average period of 3.30 years.</font>
        </div>
        <div style="margin-top:9.62pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">10. License Agreements</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Emory University, Children&#8217;s Healthcare of Atlanta, Inc. and UAB Research Foundation<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In June&#160;2016, the Company entered into an exclusive license agreement with the Emory University, Children&#8217;s Healthcare of Atlanta, Inc. and UAB, as amended from time to time (the &#8220;Emory License </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-18</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">IN8BIO, INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">NOTES TO FINANCIAL STATEMENTS</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">10. License Agreements&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Agreement&#8221;). The Emory License Agreement was amended in October&#160;2017 and July&#160;2020. Under the Emory License Agreement, the Company obtained an exclusive worldwide license under certain immunotherapy related patents and know-how related to gamma-delta T cells developed by the Emory University, Children&#8217;s Healthcare of Atlanta, Inc. and UABRF&#8217;s affiliate, the University of Alabama at Birmingham, to develop, make, have made, use, sell, import and otherwise commercialize products that are covered by such patents or otherwise incorporate or use the licensed technology. Such exclusive license is subject to certain rights retained by these institutions and also the U.S. government.</font><font style="font-weight:bold;letter-spacing:-0.111pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In consideration of the license granted under the Emory License Agreement, the Company paid Emory University a nominal upfront payment. In addition, the Company is required to pay Emory University development milestones totaling up to an aggregate of $1.4&#160;million, low-single-digit to mid-single-digit tiered running royalties on the net sales of the licensed products, including an annual minimum royalty beginning on a specified period after the first sale of a licensed product, and a share of certain payments that the Company may receive from sublicenses. In addition, in the event no milestone payments have been paid in certain&#160;years, the Company will be required to pay an annual license maintenance fee. The Emory License Agreement also requires the Company to reimburse Emory University for the cost of the prosecution and maintenance of the licensed patents. Pursuant to the Emory License Agreement, the Company is required to use its best efforts to develop, manufacture and commercialize the licensed product, and is obligated to meet certain specified deadlines in the development of the licensed products.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The term of the Emory License Agreement will continue until 15&#160;years after the first commercial sale of the licensed product, or the expiration of the relevant licensed patents, whichever is later. The Company may terminate the Emory License Agreement at will at any time upon prior written notice to Emory University. Emory University has the right to terminate the Emory License Agreement if the Company materially breaches the agreement (including failure to meet diligence obligations) and fails to cure such breach within a specified cure period, if the Company becomes bankrupt or insolvent or decides to cease development and commercialization of the licensed product, or if the Company challenges the validity or enforceability of any licensed patents.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Exclusive License Agreement with UABRF<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In March&#160;2016, the Company entered into an exclusive license agreement with UABRF, as amended from time to time (the &#8220;UABRF License Agreement&#8221;). The Company amended the UABRF License Agreement in December&#160;2016, January&#160;2017, June&#160;2017 and November&#160;2018. Under the UABRF License Agreement, the Company obtained an exclusive worldwide license under certain immunotherapy-related patents related to the use of gamma-delta T cells, certain CAR-T cells and combination treatments for cellular therapies developed by the University of Alabama at Birmingham and owned by UABRF to develop, make, have made, use, sell, import and otherwise commercialize products that are covered by such patents. Such exclusive license is subject to certain rights retained by UABRF and also the U.S. government.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In consideration of the license granted under the UABRF License Agreement, the Company paid UABRF a nominal upfront payment and issued 91,250 shares of common stock to UABRF, which were subject to certain anti-dilution rights.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In addition, the Company is required to pay UABRF development milestones totaling up to an aggregate of $1.4&#160;million, lump-sum royalties on cumulative net sales totaling up to an aggregate of $22.5&#160;million, mid-single-digit running royalties on our net sales of the licensed products, low-single-digit running royalties on net sales of the licensed products, and a share of certain non-royalty income that the Company may receive, including from any sublicenses. The UABRF License Agreement also requires the Company to reimburse UABRF for the cost of the prosecution and maintenance of the licensed patents.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-19</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:56.58pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">IN8BIO, INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">NOTES TO FINANCIAL STATEMENTS</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">10. License Agreements&#8201;(Continued)</font>
        </div>
        <div style="text-indent:20pt; margin-top:12pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">Pursuant to the UABRF License Agreement, the Company is required to use good faith reasonable commercial efforts to develop, manufacture and commercialize the licensed product.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">The term of the UABRF License Agreement will continue until the expiration of the licensed patents. The Company may terminate the UABRF License Agreement at will at any time upon prior written notice to UABRF. UABRF has the right to terminate the UABRF License Agreement if the Company materially breaches the agreement and fails to cure such breach within a specified cure period, if the Company fails to diligently undertake development and commercialization activities as set forth in the development and commercialization plan, if the Company underreports its payment obligations or underpays by more than a specified threshold, if the Company challenges the validity or enforceability of any licensed patents, or if the Company becomes bankrupt or insolvent.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Antidilution Provision<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">The antidilution provision required the Company to issue additional shares of common stock such that UABRF maintains a 2.5% ownership interest in the Company until it has raised at least $20.0&#160;million through one or more rounds of investment. During the&#160;years ended December&#160;31, 2019 and 2020, the Company issued 0 and 89,629 shares of common stock, respectively, for a total of 151,382 shares of common stock issued in satisfaction of this antidilution provision.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">The Company assessed the antidilution right and determined that the right (i)&#160;meets the definition of a freestanding financial instrument that was not indexed to the Company&#8217;s own stock and (ii)&#160;meets the definition of a derivative and did not qualify for equity classification. The initial fair value of the antidilution liability, and the value as of December&#160;31, 2019 and 2020, was determined to be immaterial based on the remote probability of an additional financing and the immaterial value of the total number of shares that could be issued pursuant to the provision.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">11. Income Taxes</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">For the&#160;years ended December&#160;31, 2019 and 2020, the tax provision (benefit) consisted of (in thousands):</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:145pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:337.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:337.99pt;text-align:left;">
              <font style="letter-spacing:-0.025pt;">Current provision (benefit): </font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:337.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Federal </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.25pt 0pt 1.25pt 0pt; width:337.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">State </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.25pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.25pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.25pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.25pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2pt 0pt 1.25pt 0pt; width:337.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2pt 0pt 1.25pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1.25pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2pt 0pt 1.25pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1.25pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:337.99pt;text-align:left;">
              <font style="letter-spacing:-0.025pt;">Deferred provision (benefit): </font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:337.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Federal </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(845<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(1,569<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.25pt 0pt 1.25pt 0pt; width:337.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">State </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.25pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.25pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(600<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.25pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.25pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(1,116<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2pt 0pt 1.25pt 0pt; width:337.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2pt 0pt 1.25pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1.25pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(1,445<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2pt 0pt 1.25pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1.25pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(2,685<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2pt 0pt 1.25pt 0pt; width:337.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Change in valuation allowance </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2pt 0pt 1.25pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1.25pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">1,445</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2pt 0pt 1.25pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1.25pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">2,685</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2pt 0pt 2pt 0pt; width:337.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Income tax provision (benefit) </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2pt 0pt 1.25pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2pt 0pt 1.25pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2pt 0pt 1.25pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2pt 0pt 1.25pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-20</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">IN8BIO, INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">NOTES TO FINANCIAL STATEMENTS</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">11. Income Taxes&#8201;(Continued)</font>
        </div>
        <div style="text-indent:20pt; margin-top:12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The items accounting for the difference between income taxes computed at the federal statutory rate and the Company&#8217;s effective tax rate for 2019 and 2020 were as follows:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:80.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:337.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:337.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">U.S Federal statutory rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:37.57pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:12.75pt; text-align:right; white-space:nowrap;">21<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:37.57pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:12.75pt; text-align:right; white-space:nowrap;">21<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:337.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">State taxes, net of Federal Benefit </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:37.57pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:12.75pt; text-align:right; white-space:nowrap;">10<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:37.57pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:12.75pt; text-align:right; white-space:nowrap;">10<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:337.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Non-deductible expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:37.57pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:12.75pt; text-align:right; white-space:nowrap;">(1<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:37.57pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:12.75pt; text-align:right; white-space:nowrap;">0<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.25pt 0pt 1.25pt 0pt; width:337.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Change in valuation allowance </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:37.57pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.25pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.25pt 0pt;border-bottom:1px solid #000000; min-width:12.75pt; text-align:right; white-space:nowrap;">(30<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:37.57pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.25pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.25pt 0pt;border-bottom:1px solid #000000; min-width:12.75pt; text-align:right; white-space:nowrap;">(31<font style="position:absolute;">)%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2pt 0pt 2pt 0pt; width:337.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Effective rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:37.57pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2pt 0pt 1.25pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1.25pt 0pt;border-bottom:3pt double #000000; min-width:12.75pt; text-align:right; white-space:nowrap;">0<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:37.57pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2pt 0pt 1.25pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1.25pt 0pt;border-bottom:3pt double #000000; min-width:12.75pt; text-align:right; white-space:nowrap;">0<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.9pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial statement purposes and the amounts used for income tax purposes.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Components of the Company&#8217;s net deferred tax assets (liabilities) balance are as follows at December&#160;31, 2018 and 2019 (in thousands):</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:155pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:337.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:337.99pt;text-align:left;">
              <font style="letter-spacing:-0.025pt;">Deferred tax assets: </font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:337.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Stock-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">14</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">155</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:337.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Net operating loss carryforwards and alternative minimum tax credits </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">2,089</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">4,667</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:337.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Total deferred tax assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">2,103</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">4,822</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:337.99pt;text-align:left;">
              <font style="letter-spacing:-0.025pt;">Deferred tax liabilities: </font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:337.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Property and equipment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(5<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(38<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:337.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Total deferred tax liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(5<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(38<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:337.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Valuation allowance </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(2,098<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(4,784<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:337.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Deferred tax assets (liabilities), net </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.12pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The CARES Act, among other things, permits net operating loss (&#8220;NOL&#8221;) carryovers and carrybacks to offset 100% of taxable income for taxable&#160;years beginning before 2021. In addition, the CARES Act allows NOLs incurred in 2018, 2019, and 2020 to be carried back to each of the five preceding taxable&#160;years to generate a refund of previously paid income taxes. The Company is currently evaluating the impact of the CARES Act, but at present, does not expect to benefit from the NOL carryback provisions.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">As of December&#160;31, 2020, the Company had federal NOL carryforwards of approximately $14.9&#160;million, New York State NOL carryforwards of approximately $14.9&#160;million, and New York City NOL carryforwards of approximately $14.9&#160;million. However, the Company&#8217;s ability to utilize these NOLs will be dependent on the Company&#8217;s ability to generate future taxable income. Furthermore, the utilization of these NOLs may also be limited in the future.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">12. Net Loss Per Share</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Basic net loss per share is calculated by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is the same as basic net loss per share for the periods presented since the effects of potentially dilutive securities are antidilutive given the net loss of the Company. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-21</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">IN8BIO, INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">NOTES TO FINANCIAL STATEMENTS</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">12. Net Loss Per Share&#8201;(Continued)</font>
        </div>
        <div style="text-indent:20pt; margin-top:12pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The Company has calculated basic and diluted loss per share for the&#160;years ended December&#160;31, 2019 and 2020 as follows (in thousands, except share and per share data):</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:139pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:337.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.99999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:337.99pt;text-align:left;">
              <font style="letter-spacing:-0.025pt;">Numerator: </font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:337.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">(5,134<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">(8,557<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:337.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Less: Accruals of dividends of preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(778<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(1,783<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:337.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Net loss attributable to common stockholders&#8201;&#8211;&#8201;basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(5,912<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(10,340<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:337.99pt;text-align:left;">
              <font style="letter-spacing:-0.025pt;">Denominator: </font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:337.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Weighted-average common stock outstanding </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">3,188,165</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">3,419,075</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:1.417pt 0pt 2.583pt 0pt; width:337.99pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:-0.025pt;">Net loss per share attributable to common stockholders&#8201;&#8211;&#8201;basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(1.85<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(3.02<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.7pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The following potentially dilutive securities were excluded from the computation of the diluted net loss per share for the periods presented because their effect would have been antidilutive:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:62.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:337.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2019 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:337.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Convertible preferred stock on an if converted basis </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.56pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">2,999,149</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.56pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">9,993,727</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:337.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Stock options to purchase common stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.56pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">362,611</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.56pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">1,247,158</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:337.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Warrants to purchase preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.56pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">231,396</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.56pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.7pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">13. Commitments and Contingencies</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Intellectual Property<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The Company has existing commitments to the licensors of the intellectual property which the Company has licensed. These commitments are based upon certain clinical research, regulatory, financial and sales milestones being achieved. Additionally, the Company is obligated to pay a single-digit royalty on commercial sales on a global basis. The royalty term is the later of 10&#160;years from first commercial sale or expiration of the last-to-expire component of the licensed intellectual property.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Litigation Disclosure<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Incyte Corporation<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In April&#160;2019, Incyte Corporation (&#8220;Incyte&#8221;) filed an opposition to the Company&#8217;s pending application at the United States Patent and Trademark Office to register the mark INCYSUS alleging that the INCYSUS mark was likely to give rise to confusion in the marketplace with Incyte and, consequently, the mark should not proceed to registration. On April&#160;24, 2019, Incyte also filed an opposition on similar grounds to the Company&#8217;s pending application to register INCYSUS in the European Union. The parties settled this matter out of court on November&#160;26, 2019 pursuant to which both parties dismissed the above noted actions and the Company agreed to cease use of the INCYSUS mark by August&#160;26, 2020. </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Other Settlement<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In July&#160;2020, the Company entered into a settlement agreement with a former employee for $0.3&#160;million in cash and 200,750 shares of common stock.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Lease Commitment Disclosure<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Equipment Leases<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The Company entered into an agreement with an equipment leasing company in the fall of 2018, which provided up to $1.4&#160;million for equipment purchases in the form of sale and leasebacks or direct </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-22</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:61pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">IN8BIO, INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">NOTES TO FINANCIAL STATEMENTS</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">13. Commitments and Contingencies&#8201;(Continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">leases. As of December&#160;31, 2020, the Company had completed the sale and leaseback for four pieces of equipment and is leasing two other items directly from the leasing company. The terms of the leases are three&#160;years and afterwards provide for either annual extensions or an outright purchase of the equipment.</font><font style="font-weight:bold;letter-spacing:-0.111pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The equipment leases require two advance rental payments to be held as security deposits. The security deposits held amounted to approximately $0.1&#160;million for each of the&#160;years ended December&#160;31, 2019 and 2020. They are included in other non-current assets on the balance sheets.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Operating Leases<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In December&#160;2020, the Company entered into an operating lease for office space in Birmingham, Alabama, for a 63-month term, ending in March&#160;2026, with an option to extend five&#160;years. Throughout the term of the lease, the Company is responsible for paying certain costs and expenses, in addition to the rent, as specified in the lease, including a proportionate share of applicable taxes, operating expenses and utilities.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In December&#160;2020, the Company entered into an operating lease for laboratory space in Birmingham, Alabama, for a 63-month term, ending in March&#160;2026, with an option to extend five&#160;years. Throughout the term of the lease, the Company is responsible for paying certain costs and expenses, in addition to the rent, as specified in the lease, including a proportionate share of applicable taxes, operating expenses and utilities.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The operating leases required security deposits at the inception of the lease. The security deposits amounted to approximately $17,000 for the year ended December&#160;31, 2020, which are included in non-current assets on the balance sheets.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The following table summarizes the approximate future minimum rentals under the equipment and operating leases in effect at December&#160;31, 2020 (in thousands):</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:114pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:419.35pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Amounts </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:419.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">832</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">562</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">365</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">230</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.09pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">236</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:419.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Thereafter </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.09pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">41</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:419.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Total minimum payments </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.09pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">2,266</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">14. Subsequent Events</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The Company has evaluated subsequent events from the balance sheet date through March&#160;31, 2021, the date at which the financial statements were available to be issued, and has not identified any requiring disclosure.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-23</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCIBS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">IN8BIO, INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">CONDENSED INTERIM BALANCE SHEETS </font>
        </div>
        <div style="margin-top:2pt; text-align:center; width:456pt; line-height:12pt;font-style:italic;">(in thousands except for share and per share data)<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <table style="width:456pt;height:567pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:346.46pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">As of </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:346.46pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.583pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">December&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.089pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.583pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">March&#160;31, </font>
                <br >
                <font style="letter-spacing:-0.089pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:346.46pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.28pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.28pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">(unaudited) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:346.46pt;text-align:left;">
              <font style="letter-spacing:-0.111pt;">Assets</font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:346.46pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:346.46pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Cash </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">17,994</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">15,052</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:346.46pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Prepaid expenses and other current assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">150</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">320</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.25pt 0pt 1.5pt 0pt; width:346.46pt;text-align:left;">
              <div style="margin-left:10pt;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Total Current Assets</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">18,144</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">15,372</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:346.46pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Non-current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:346.46pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Property and equipment, net </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">186</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">164</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:346.46pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Deferred offering costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">2,439</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">3,134</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:346.46pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Right of use assets&#8201;&#8211;&#8201;financing leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">819</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:346.46pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Right of use assets&#8201;&#8211;&#8201;operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">793</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:346.46pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Other non-current assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">141</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">141</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.25pt 0pt 1.5pt 0pt; width:346.46pt;text-align:left;">
              <div style="margin-left:10pt;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Total Non-Current Assets</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">2,766</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">5,051</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:346.46pt;text-align:left;">
              <div style="margin-left:10pt;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Total Assets</font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">20,910</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">20,423</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:7.75pt 0pt 0.5pt 0pt; width:346.46pt;text-align:left;">
              <font style="letter-spacing:-0.111pt;">Liabilities, Convertible Preferred Stock and Stockholders&#8217; Deficit</font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:346.46pt;text-align:left;">
              <font style="letter-spacing:-0.111pt;">Liabilities</font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:346.46pt;text-align:left;">
              <font style="letter-spacing:-0.025pt;">Current liabilities </font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:346.46pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">620</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">660</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:346.46pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Accrued expenses and other current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">1,778</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">1,632</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:346.46pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Short-term financing lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">466</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:346.46pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Short-term operating lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">130</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:346.46pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Loan payable, current </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">174</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">174</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:346.46pt;text-align:left;">
              <div style="margin-left:10pt;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Total Current Liabilities</font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">2,572</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">3,062</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:346.46pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Deferred rent </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">17</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:346.46pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Long-term financing lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">309</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:346.46pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Long-term operating lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">733</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.25pt 0pt 1.5pt 0pt; width:346.46pt;text-align:left;">
              <div style="margin-left:10pt;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Total Liabilities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">2,589</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">4,104</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:346.46pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.111pt;">Commitments and Contingencies</font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:0.5pt 0pt 0.5pt 0pt; width:346.46pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:-0.025pt;">Convertible preferred stock, par value $0.0001 per share; 27,564,260 shares authorized, 9,993,727 shares, issued and outstanding at December&#160;31, 2020 and March&#160;31, 2021, and a liquidation preference of $37,969 and $38,676 at December&#160;31, 2020 and March&#160;31, 2021, respectively </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">34,900</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">34,900</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:346.46pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.111pt;">Stockholders&#8217; Deficit</font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:0.5pt 0pt 0.5pt 0pt; width:346.46pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:-0.025pt;">Common stock, par value $0.0001 per share; 50,700,000 shares authorized, 3,764,488 shares issued and outstanding at December&#160;31, 2020 and March&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:346.46pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Additional paid-in capital </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">1,458</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">1,819</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:346.46pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Accumulated deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">(18,038<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">(20,401<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.25pt 0pt 1.5pt 0pt; width:346.46pt;text-align:left;">
              <div style="margin-left:10pt;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Total Stockholders&#8217; Deficit</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">(16,579<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">(18,581<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:0.917pt 0pt 1.583pt 0pt; width:346.46pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Total Liabilities, Convertible Preferred Stock and Stockholders&#8217; </font>
                <br >
                <font style="letter-spacing:-0.111pt;">Deficit</font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.56pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0.917pt 0pt 0.333pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:0.917pt 0pt 0.333pt 0pt;border-bottom:3pt double #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">20,910</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0.917pt 0pt 0.333pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:0.917pt 0pt 0.333pt 0pt;border-bottom:3pt double #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">20,423</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The accompanying notes are an integral part of these unaudited condensed interim financial statements. </font>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-24</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCISO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:357.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">IN8BIO, INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">CONDENSED INTERIM STATEMENTS OF OPERATIONS </font>
        </div>
        <div style="margin-top:2pt; text-align:center; width:456pt; line-height:12pt;font-style:italic;">(in thousands except for share and per share data)<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <table style="width:456pt;height:201.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:336.07pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Three Months Ended March&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:336.07pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:336.07pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">(unaudited) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:336.07pt;text-align:left;">
              <font style="letter-spacing:-0.111pt;">Operating expenses</font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.07pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">1,052</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">1,245</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.07pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">639</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">1,118</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:336.07pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Total operating expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.96pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">1,691</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.96pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">2,363</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:336.07pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Loss from operations </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.96pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(1,691<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.96pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(2,363<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:336.07pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Net loss</font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.96pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(1,691<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.96pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(2,363<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:1.417pt 0pt 2.583pt 0pt; width:336.07pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:-0.025pt;">Net loss attributable to common stockholders&#8201;&#8211;&#8201;basic and diluted </font>
                <br >
                <font style="letter-spacing:-0.025pt;">(Note 10) </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.96pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(1,951<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.96pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(3,069<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:1.417pt 0pt 2.583pt 0pt; width:336.07pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:-0.025pt;">Net loss per share attributable to common stockholders&#8201;&#8211;&#8201;basic and </font>
                <br >
                <font style="letter-spacing:-0.025pt;">diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.96pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(0.59<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.96pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:1.417pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(0.82<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:336.07pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Weighted-average shares of common stock&#8201;&#8211;&#8201;basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.96pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">3,305,367</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.96pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">3,764,488</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The accompanying notes are an integral part of these unaudited condensed interim financial statements. </font>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-25</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCISO1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:12pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">IN8BIO, INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">CONDENSED INTERIM STATEMENTS OF CHANGES IN CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#8217; DEFICIT </font>
        </div>
        <div style="margin-top:2pt; text-align:center; width:456pt; line-height:12pt;font-style:italic;">(in thousands, except share data)<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
      </div>
      <div style="margin-top:12pt;margin-bottom:316.5pt;margin-left:27.16pt;width:541pt;">
        <table style="width:541pt;height:248.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:8pt;height:9.25pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:189.62pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Convertible Preferred Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Common Stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="3">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="3">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.089pt;">Additional </font>
                <br >
                <font style="letter-spacing:-0.089pt;">Paid-in-</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Capital </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="3">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="3">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="3">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.089pt;">Accumulated </font>
                <br >
                <font style="letter-spacing:-0.089pt;">Deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="3">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="3">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4" rowspan="3">
              <div style="white-space:nowrap; text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.089pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:189.62pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Series&#160;A </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Class&#160;A </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:189.62pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:189.62pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Balance at January&#160;1, 2020</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.55pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">2,713,980</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.54pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">8,896</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">3,235,671</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.64pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">238</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.9pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">(9,481<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">(9,242<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:189.62pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:-0.025pt;">Issuance of common stock&#8201;&#8211;&#8201;Class&#160;A in relation to license agreement </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.55pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.54pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">44,011</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.64pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.7pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.9pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:189.62pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Issuance of common stock&#8201;&#8211;&#8201;Class&#160;A </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.55pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.54pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">182,500</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.64pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">200</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.9pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">200</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:189.62pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:-0.025pt;">Issuance of convertible preferred stock &#8211; Series&#160;A, net of $16 issuance cost </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.55pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">1,533,947</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.54pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">5,480</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.64pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.7pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.9pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:189.62pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Stock-based compensation expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.55pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.54pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.64pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">18</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.9pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">18</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:189.62pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.55pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.54pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.64pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.7pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.9pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">(1,691<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">(1,691<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:1.917pt 0pt 2.583pt 0pt; width:189.62pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Balance at March&#160;31, 2020</font>
                <br >
                <font style="letter-spacing:-0.111pt;">(unaudited)</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.55pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">4,247,927</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.54pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">14,376</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">3,462,182</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.64pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:9pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.7pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">456</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.9pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">(11,172<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">(10,715<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:11.75pt 0pt 0.5pt 0pt; width:189.62pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Balance at January&#160;1, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.55pt;width:0pt;">&#8203;</td>
            <td style="padding:11.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:11.75pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">9,993,727</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.54pt;width:0pt;">&#8203;</td>
            <td style="padding:11.75pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:11.75pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">34,900</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:11.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:11.75pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">3,764,488</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.64pt;width:0pt;">&#8203;</td>
            <td style="padding:11.75pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:11.75pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.7pt;width:0pt;">&#8203;</td>
            <td style="padding:11.75pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:11.75pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">1,458</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.9pt;width:0pt;">&#8203;</td>
            <td style="padding:11.75pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:11.75pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">(18,038<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:11.75pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:11.75pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">(16,579<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:189.62pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Stock-based compensation expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.55pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.54pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.64pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.7pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">361</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.9pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:28.5pt; text-align:right; white-space:nowrap;">361</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:189.62pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.55pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.54pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.64pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.7pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.9pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">(2,363<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">(2,363<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:189.62pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Balance at March&#160;31, 2021 (unaudited)</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.55pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">9,993,727</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.54pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">34,900</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">3,764,488</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.64pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:9pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.7pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">1,819</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.9pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">(20,401<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:28.5pt; text-align:right; white-space:nowrap;">(18,581<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The accompanying notes are an integral part of these unaudited condensed interim financial statements. </font>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-26</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCISO2">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:80pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;">
          <font style="text-transform:uppercase;letter-spacing:-0.2pt;">IN8BIO, INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;">
          <font style="text-transform:uppercase;letter-spacing:-0.2pt;">CONDENSED INTERIM STATEMENTS OF CASH FLOWS </font>
        </div>
        <div style="margin-top:2pt; text-align:center; width:456pt; line-height:12pt;font-style:italic;">(in thousands)<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <table style="width:456pt;height:481pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:336.07pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Three Months Ended March&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:336.07pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:336.07pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">(unaudited) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:336.07pt;text-align:left;">
              <font style="letter-spacing:-0.111pt;">Cash flows from operating activities</font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.07pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(1,691<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">(2,363<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.07pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Adjustments to reconcile net loss to net cash used in operating activities: </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.07pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Depreciation </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">22</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">22</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.07pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Non-cash stock-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">18</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">361</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.07pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Amortization of financing lease right-of-use assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">113</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.07pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Amortization of operating lease right-of-use assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">30</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.07pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Changes in operating assets and liabilities: </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.07pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Prepaid expenses and other current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">65</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">(162<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.07pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Other non-current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(48<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">(52<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.07pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(60<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">(180<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.07pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Accrued expenses and other current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">71</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">(298<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.07pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Short-term operating lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">57</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:336.07pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Long-term operating lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">(35<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:336.07pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Net cash used in operating activities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(1,623<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">(2,507<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:336.07pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.111pt;">Cash flows from financing activities</font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.07pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Proceeds from exercise of common stock options&#8201;&#8211;&#8201;Class&#160;A </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">200</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:336.07pt;white-space:normal;text-align:left;">
              <div style="margin-left:30pt; text-indent:-10pt;">
                <font style="letter-spacing:-0.025pt;">Proceeds from issuance of preferred stock&#8201;&#8211;&#8201;Series&#160;A, net of $16 of issuance costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">5,480</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.07pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Payments of financing lease obligations </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">(112<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:336.07pt;text-align:left;">
              <div style="margin-left:20pt;">
                <font style="letter-spacing:-0.025pt;">Payment of deferred offering costs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">(323<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:336.07pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Net cash provided by (used in) financing activities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">5,680</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">(435<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:336.07pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Net increase (decrease) in cash and restricted cash</font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">4,057</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">(2,942<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:336.07pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Cash and restricted cash, beginning of period</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">610</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">17,994</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:336.07pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.111pt;">Cash and restricted cash, end of period</font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">4,667</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:26.25pt; text-align:right; white-space:nowrap;">15,052</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:336.07pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.111pt;">Supplemental disclosure of noncash financing activities</font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:336.07pt;white-space:normal;text-align:left;">
              <div style="margin-left:30pt; text-indent:-10pt;">
                <font style="letter-spacing:-0.025pt;">Deferred offering costs included in accounts payable and accrued expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">1,238</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:336.07pt;text-align:left;">
              <div style="margin-left:30pt; text-indent:-10pt;">
                <font style="letter-spacing:-0.025pt;">Initial measurement of operating lease right-of-use assets and </font>
                <br >
                <font style="letter-spacing:-0.025pt;">liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.96pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:26.25pt; text-align:right; white-space:nowrap;">3,483</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The accompanying notes are an integral part of these unaudited condensed interim financial statements. </font>
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-27</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tNTCI">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">IN8BIO, INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="text-transform:uppercase;letter-spacing:-0.111pt;">NOTES TO CONDENSED INTERIM FINANCIAL STATEMENTS (UNAUDITED)</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">1. Organization and Nature of Operations</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Organization and Business<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Incysus, Inc. (&#8220;Incysus&#8221;) was a corporation formed in the State of Delaware on November&#160;23, 2015 and Incysus, Ltd. was incorporated in Bermuda on February&#160;8, 2016. Incysus was the wholly owned United States subsidiary of Incysus, Ltd. On May&#160;7, 2018, Incysus, Ltd. reincorporated in the United States in a domestication transaction (the &#8220;Domestication&#8221;) in which Incysus, Ltd. converted into a newly formed Delaware corporation, Incysus Therapeutics, Inc. (&#8220;Incysus Therapeutics&#8221;). On July&#160;24, 2019, Incysus Therapeutics merged with Incysus. Incysus Therapeutics subsequently changed its name to IN8bio, Inc. (the &#8220;Company&#8221;) in August&#160;2020. Following the Domestication in May&#160;2018 and the merging of Incysus Therapeutics and Incysus in July&#160;2019, the Company did not have any subsidiaries to consolidate as of December&#160;31, 2020. The Company is headquartered in New York, New York.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The Company is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell therapies for the treatment of cancer. The Company&#8217;s lead product candidates are currently in Phase&#160;1 clinical trials: INB-200, for the treatment of newly diagnosed glioblastoma (&#8220;GBM&#8221;), and INB-100, for the treatment of patients with leukemia that are undergoing hematopoietic stem cell transplantation (&#8220;HSCT&#8221;). In addition, the Company&#8217;s DeltEx platform has yielded a broad portfolio of preclinical programs, including INB-400 and INB-300, focused on addressing other solid tumor types.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">COVID-19<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In December&#160;2019, a novel strain of coronavirus, which causes the disease known as COVID-19, has spread worldwide. In March&#160;2020, the World Health Organization declared the COVID-19 outbreak a pandemic and the U.S. government imposed travel restrictions on travel between the United States, Europe and certain other countries. The outbreak and government measures taken in response have had a significant impact, both direct and indirect, on businesses and commerce, as certain worker shortages have occurred, supply chains have been disrupted, and facilities and production have been suspended. The future progression of the pandemic and its effects on the Company&#8217;s business and operations are uncertain.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The COVID-19 pandemic has impacted and may continue to impact the clinical sites and startup activities for the Company&#8217;s Phase&#160;1/2 clinical trial, including third-party manufacturing and logistics providers, which would disrupt its clinical supply chain or the availability or cost of materials, and it may affect the Company&#8217;s ability to timely complete its clinical trials and delay the initiation and/or enrollment of any future clinical trials, disrupt regulatory activities or have other adverse effects on its business and operations.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The Company is monitoring the potential impact of COVID-19 on its business and financial statements and cannot be certain what the overall impact of the COVID-19 pandemic will be. The extent to which the COVID-19 pandemic will directly or indirectly impact its business, results of operations, financial condition and liquidity, including planned and future clinical trials and research and development costs, will depend on future developments that are highly uncertain, including as a result of new information that may emerge concerning COVID-19, the actions taken to contain or treat it, and the duration and intensity of the related effects.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Liquidity<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Through March&#160;31, 2021, the Company has funded its operations primarily with proceeds from the initial closing and additional closings of our Series&#160;A convertible preferred stock financing (&#8220;Series&#160;A Financing&#8221;) and through its license agreements. The Company has incurred recurring losses and negative operating cash flows from operations since its inception, including net losses of $1.7&#160;million and $2.4&#160;million for the three&#160;months ended March&#160;31, 2020 and 2021, respectively. As of March&#160;31, 2021, the Company had an accumulated deficit of $20.4&#160;million. The Company expects to continue to generate operating losses for the foreseeable future.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-28</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">As of the issuance date of these financial statements, the Company expects that its cash will be sufficient to fund its operating expenses and capital expenditure requirements through at least 12&#160;months from the issuance of the financial statements. The future viability of the Company beyond that point is dependent on its ability to raise additional capital to finance its operations.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Reverse Stock Split<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">On November&#160;5, 2020, the Company effected a 0.365-for-1 reverse stock split of the Company&#8217;s common stock and preferred stock, and the conversion price for the preferred stock was adjusted. All shares, stock options, warrants and per share information presented in the financial statements have been adjusted to reflect the reverse stock split on a retroactive basis for all periods presented. There was no change in the par value and authorized number of shares of the Company&#8217;s common stock and preferred stock.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">2. Summary of Significant Accounting Policies</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Basis of Presentation<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The accompanying unaudited condensed interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). In management&#8217;s opinion, the accompanying unaudited condensed interim financial statements include all adjustments, consisting of normal recurring adjustments, which are necessary to present fairly the Company&#8217;s financial position, results of operations, and cash flows. The unaudited interim condensed results of operations are not necessarily indicative of the results that may occur for the full fiscal year. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been omitted pursuant to instructions, rules, and regulations prescribed by the United States Securities and Exchange Commission (&#8220;SEC&#8221;). Management believes that the disclosures provided herein are adequate to make the information presented not misleading when these unaudited condensed interim financial statements are read in conjunction with the audited financial statements and notes thereto as of and for the year ended December&#160;31, 2020.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Significant Accounting Policies<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The Company&#8217;s significant accounting policies are disclosed in the audited financial statements for the year ended December&#160;31, 2020, included elsewhere in this prospectus. Since the date of those financial statements, there have been no changes to its significant accounting policies except as noted below.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Leases<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Effective January&#160;1, 2021, the Company early adopted Accounting Standards Update (&#8220;ASU&#8221;) No. 2016-02, </font><font style="font-style:italic;">Leases</font><font style="letter-spacing:-0.025pt;"> (Topic 842) (&#8220;ASU 2016-02&#8221; or &#8220;ASC 842&#8221;), using the modified retrospective method and utilized the effective date as its date of initial application, with prior periods presented in accordance with previous guidance under ASC 840, </font><font style="font-style:italic;">Leases</font><font style="letter-spacing:-0.025pt;">. At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease based on the unique facts and circumstances present in the arrangement. Leases with a term greater than one year are recognized on the balance sheet as right-of-use assets and current and non-current lease liabilities, as applicable.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Operating lease liabilities and their corresponding right-of-use assets are initially recorded based on the present value of lease payments over the expected remaining lease term. The interest rate implicit in lease contracts is typically not readily determinable. As a result, the Company utilizes its incremental borrowing rate to discount lease payments, which reflects the fixed rate at which the Company could borrow on a collateralized basis the amount of the lease payments in the same currency, for a similar term, in a similar economic environment. Prospectively, the Company will adjust the right-of-use assets for straight-line rent expense and remeasure the lease liability at the net present value using the same incremental borrowing rate that was in effect as of the lease commencement or transition date.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The Company elected the following practical expedients, which must be elected as a package and applied consistently to all of its leases at the transition date (including those for which the entity is a lessee or a lessor): i) the Company did not reassess whether any expired or existing contracts are or contain leases; ii) the Company did not reassess the lease classification for any expired or existing leases (that is, all existing leases that were classified as operating leases in accordance with ASC 840 are </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-29</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">classified as operating leases, and all existing leases that were classified as capital leases in accordance with ASC 840 are classified as finance leases); and iii) the Company did not reassess initial direct costs for any existing leases.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">For leases that existed prior to the date of initial application of ASC 842 (which were previously classified as operating leases), a lessee may elect to use either the total lease term measured at lease inception under ASC 840 or the remaining lease term as of the date of initial application of ASC 842 in determining the period for which to measure its incremental borrowing rate. In transition to ASC 842, the Company utilized the remaining lease term of its leases in determining the appropriate incremental borrowing rates.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In accordance with ASC 842, components of a lease should be split into three categories: lease components, non-lease components, and non-components. The fixed and in-substance fixed contract consideration (including any consideration related to non-components) must be allocated based on the respective relative fair values to the lease components and non-lease components.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Entities may elect not to separate lease and non-lease components. The Company has elected to account for lease and non-lease components together as a single lease component for all underlying assets and allocate all of the contract consideration to the lease component only. On the adoption date, $1.7&#160;million was recognized as total lease liabilities and $1.8&#160;million was recognized as total right-of-use assets on the Company&#8217;s balance sheet.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Deferred Offering Costs<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The Company capitalizes certain legal, professional accounting and other third-party fees that are directly associated with in-process preferred stock or common stock financings as deferred offering costs until such financings are consummated. After consummation of the equity financing, these costs are recorded as a reduction to the carrying value of convertible preferred stock or in stockholders&#8217; equity (deficit) as a reduction of additional paid-in capital generated as a result of the offering. Should a planned equity financing be abandoned, the deferred offering costs will be expensed immediately as a charge to operating expenses in the statements of operations. As of December&#160;31, 2020 and March&#160;31, 2021, the Company had deferred offering costs of $2.4&#160;million and $3.1&#160;million, respectively.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">3. Property and Equipment</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:4pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Property and equipment, net, consists of the following (in thousands):</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:63pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:353.3pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">March&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:353.3pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Machinery and equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:26.45pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">443</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.13pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">443</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:353.3pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Less accumulated depreciation </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:26.45pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(257<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.13pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(279<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:353.3pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Property and equipment, net </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:26.45pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">186</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.13pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">164</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13.2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Depreciation expense for property and equipment totaled $22,000 for the three&#160;months ended March&#160;31, 2020 and 2021.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">4. Accrued Expenses and Other Current Liabilities</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:4pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Accrued expenses and other current liabilities consist of the following (in thousands):</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:93pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:353.3pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">March&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:353.3pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Accrued offering costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.45pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">876</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.13pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">1,028</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:353.3pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Accrued clinical trials </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.45pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">376</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.13pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">415</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:353.3pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Accrued compensation </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.45pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">400</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.13pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">170</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:353.3pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Accrued other </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.45pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">126</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.13pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">19</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:353.3pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Total accrued expenses and other current liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:21.45pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">1,778</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.13pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">1,632</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-30</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">5. Loan Payable</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In April&#160;2020, the Company was granted a loan (the &#8220;Loan&#8221;) in an amount of $0.2&#160;million, pursuant to the Paycheck Protection Program (the &#8220;PPP&#8221;) under Division A, Title I of the CARES Act, which was enacted on March&#160;27, 2020. The Loan, which was in the form of a Note dated April&#160;16, 2020, matures on April&#160;16, 2022 and bears interest at a rate of 1.0% per annum, payable monthly commencing on November&#160;16, 2020. The Note may be prepaid by the Company at any time prior to maturity with no prepayment penalties.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Funds from the Loan may only be used for payroll costs, costs used to continue group healthcare benefits, mortgage payments, rent, utilities, and interest on other debt obligations incurred before February&#160;15, 2020. The Company used the entire Loan amount for qualifying expenses. Under the terms of the PPP, certain amounts of the Loan may be forgiven if they are used for qualifying expenses as described in the CARES Act. The Company plans to pay back the full amount of the Loan in 2021.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Loan payable at December&#160;31, 2020 and March&#160;31, 2021 consists of the following (in thousands except&#160;years and&#160;percentage):</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:48pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:322.87pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:31.23pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Year of</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Maturity </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Interest</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Rate </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Outstanding</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Principal </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:322.87pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Loan payable </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:31.23pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.025pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.35pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1.00<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.87pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:15pt; text-align:right; white-space:nowrap;">174</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:322.87pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Total loan payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt; width:31.23pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;padding-bottom:1.75pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:24.87pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:15pt; text-align:right; white-space:nowrap;">174</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">6. Convertible Preferred Stock</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Convertible Series&#160;A Preferred Stock<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">From January through August&#160;2020, the Company issued 7,048,351 shares of Series&#160;A convertible preferred stock (&#8220;Series&#160;A Preferred Stock&#8221;) at $3.5833 per share for $25.3&#160;million in gross proceeds related to the Series&#160;A Preferred Stock agreement from 2018.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">At March&#160;31, 2021, a total of $35.0&#160;million, at $3.5833 per share, had been raised by the Company through the Series&#160;A preferred financing and/or the Company issued Note Series&#160;2018A convertible promissory note conversion that converted into Series&#160;A Preferred Stock on May&#160;7, 2018 following the Domestication. The Series&#160;A Preferred Stock includes 9,993,727 shares issued and outstanding on December&#160;31, 2020 and March&#160;31, 2021. In connection with the issuance of Series&#160;A Preferred Stock in 2018, the Company issued 231,396 warrants to purchase Series&#160;A Preferred Stock, accounted for as issuance costs and classified as a liability. In October&#160;2020, the warrants were exercised and converted into Series&#160;A Preferred Stock.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In August, 2020, the Company increased the authorized shares of Series&#160;A Preferred Stock, par value $0.0001 per share, to 27,564,260 shares.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Dividends<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Dividends at the rate per annum of $0.2866 per share shall accrue on the Series&#160;A Preferred Stock, subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Series&#160;A Preferred Stock. Accruing dividends accrue from day to day, whether or not declared, and are cumulative; provided that such accruing dividends are payable only when, as and if declared by the Board of Directors and the Company is under no obligation to pay such accruing dividends.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Liquidation<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The Series&#160;A Preferred Stock has a liquidation preference to the holders of common stock. The Series&#160;A Preferred Stock has a liquidation preference of $3.5833 per share plus any accrued but unpaid dividends.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company or a deemed liquidation event, the holders of the shares of Series&#160;A Preferred Stock then outstanding are entitled to be paid out of the assets of the Company available for distribution to its stockholders before any payments are made to the holders of common stock by reason of their ownership thereof, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-31</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">an amount per share equal to one times the Series&#160;A original issue price, plus any accruing dividends accrued but unpaid thereon, whether or not declared.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company or a deemed liquidation event, after payment in full of all Series&#160;A liquidation amounts required to be paid to the holders of shares of Series&#160;A Preferred Stock, the remaining assets of the Company available for distribution to its stockholders are required to be distributed among the holders of the shares of Series&#160;A Preferred Stock and common stock, pro-rata based on the number of shares held by each such holder, treating for this purpose all such securities as if they had been converted to common stock, provided, that if the aggregate amount which the holders of Series&#160;A Preferred Stock are entitled to receive exceeds $3.92361 per share (the &#8220;Maximum Participation Amount&#8221;), each holder of Series&#160;A Preferred Stock is entitled to receive upon such liquidation, dissolution or winding up of the Company, the greater of (i)&#160;the Maximum Participation Amount and (ii)&#160;the amount such holder would have received if all shares of Series&#160;A Preferred Stock had been converted into common stock immediately prior to such liquidation, dissolution or winding up of the Company.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Voting Rights<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Each holder of outstanding shares of Series&#160;A Preferred Stock is entitled to cast the number of votes equal to the number of whole shares of common stock into which the shares of the Series&#160;A Preferred Stock held by such holder are convertible as of the record date for determining stockholders entitled to vote on such matter.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Protective Provisions<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">At any time when at least 131,400 shares of Series&#160;A Preferred Stock remain outstanding (subject to appropriate adjustments), the Company shall not take any of the following actions without (1)&#160;the vote or written consent of the holders of at least 60% of the then outstanding shares of Series&#160;A Preferred Stock separately as a class and (2)&#160;prior approval of at least 60% of the members of the Company&#8217;s board of directors then in office: (i)&#160;liquidate, dissolve or wind-up the business and affairs of the Company, effect any merger or consolidation or any other Deemed Liquidation Event, or consent to any of the foregoing; (ii)&#160;amend, alter or repeal any provision of the Company&#8217;s certificate of incorporation or bylaws in a manner that adversely affects the powers, preferences or rights of the Series&#160;A Preferred Stock; (iii)&#160;create, or authorize the creation of, or issue shares of, or obligate itself to issue shares of, any additional class or series of capital stock unless the same ranks junior to the Series&#160;A Preferred Stock with respect to the distribution of assets on the liquidation, dissolution or winding up of the Company, the payment of dividends and rights of redemption; (iv)&#160;increase or decrease the authorized number of shares of Preferred Stock or of Series&#160;A Preferred Stock, or increase or decrease the authorized number of shares of any additional class or series of capital stock of the Company; (v)&#160;(a)&#160;reclassify, alter or amend any existing security of the Company that is pari&#160;passu with the Series&#160;A Preferred Stock in respect of the distribution of assets on the liquidation, dissolution or winding up of the Company, the payment of dividends or rights of redemption, if such reclassification, alteration or amendment would render such other security senior to the Series&#160;A Preferred Stock in respect of any such right, preference, or privilege or (b)&#160;reclassify, alter or amend any existing security of the Company that is junior to the Series&#160;A Preferred Stock in respect of the distribution of assets on the liquidation, dissolution or winding up of the Company, the payment of dividends or rights of redemption, if such reclassification, alteration or amendment would render such other security senior to or pari&#160;passu with the Series&#160;A Preferred Stock in respect of any such right, preference or privilege; (vi)&#160;purchase or redeem (or permit any subsidiary to purchase or redeem) or pay or declare any dividend or make any distribution on, any shares of capital stock of the Company other than (a)&#160;redemptions of or dividends or distributions on the Series&#160;A Preferred Stock as expressly authorized in the Certificate of Incorporation, (b)&#160;dividends or other distributions payable on the common stock solely in the form of additional shares of common stock and (c)&#160;repurchases of stock from former employees, officers, directors, consultants or other persons who performed services for the Company or any subsidiary in connection with the cessation of such employment or service at the lower of the original purchase price or the then current fair market value thereof; (vii)&#160;create, or authorize the creation of, or issue, or authorize the issuance of any debt security or permit any subsidiary to take any such action with respect to any debt security, if the aggregate indebtedness of the Company and its subsidiaries for borrowed money following such action would exceed $2,000,000 (other than equipment leases or bank lines of credit); </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-32</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">(viii)&#160;create, or hold capital stock in, any subsidiary that is not wholly owned (either directly or through one or more other subsidiaries) by the Company, or permit any subsidiary to create, or authorize the creation of, or issue or obligate itself to issue, any shares of any class or series of capital stock, or sell, transfer or otherwise dispose of any capital stock of any direct or indirect subsidiary of the Company, or permit any direct or indirect subsidiary to sell, lease, transfer, exclusively license or otherwise dispose (in a single transaction or series of related transactions) of all or substantially all of the assets of such subsidiary; or (ix)&#160;increase or decrease the authorized number of directors constituting the board of directors.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Optional and Mandatory Conversion Rights<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Each share of Series&#160;A Preferred Stock is convertible, at the option of the holder thereof, at any time and from time to time, and without the payment of additional consideration by the holder thereof, into such number of fully paid and non-assessable shares of common stock as is determined by dividing the Series&#160;A original issue price by the Series&#160;A conversion price in effect at the time of conversion. The Series&#160;A conversion price is initially equal to $3.5833. Such initial Series&#160;A conversion price, and the rate at which shares of Series&#160;A Preferred Stock may be converted into shares of common stock, is subject to adjustment.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In connection with the Series&#160;A Preferred Stock issuance in August&#160;2020, the Series&#160;A conversion price was adjusted to $3.2583.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The Series&#160;A Preferred Stock automatically converts to common stock, at the then effective conversion rate, upon (i)&#160;the written request of a majority of the outstanding shares of the Series&#160;A Preferred Stock voting as a single class or (ii)&#160;an initial public offering resulting in gross proceeds to the Company of at least $25.0&#160;million. At the time of issuance, no beneficial conversion charge was recorded as the fair value of the Series&#160;A Preferred Stock was determined by management to be less than the stated conversion value. When the triggering event that forces conversion where both price and shares are known, the beneficial conversion charge will be recorded.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Redemption<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The Series&#160;A Preferred Stock is redeemable upon the occurrence of a deemed liquidation event, which is not solely in control of the Company. Therefore, the Series&#160;A Preferred Stock has been classified as temporary equity.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Series&#160;A Preferred Stock Warrants<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">On May&#160;7, 2018, in connection with the sale and issuance of the Series&#160;A Preferred Stock, the Company issued liability-classified warrants to purchase an aggregate of 231,396 shares of Series&#160;A Preferred Stock (the &#8220;2018 Warrants&#8221;), with an exercise price of $0.0003 per share of Series&#160;A Preferred Stock, subject to adjustment per the terms of the 2018 Warrants. The 2018 Warrants were exercisable immediately on date of issuance and expire five&#160;years from issuance, in May&#160;2023. These warrants were subject to an earlier expiration upon the closing of the Company&#8217;s qualifying initial public offering of common stock. In October&#160;2020, the warrants were exercised at the price of $0.0003 per share and the warrant liability was settled for its fair value of $0.8&#160;million.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">7. Common Stock</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The Company has 50,700,000 authorized shares of common stock, par value $0.0001 per share, of which 3,764,488 shares were issued and outstanding as of December&#160;31, 2020 and March&#160;31, 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In March&#160;2020, the Company entered into a common stock purchase agreement with a director of the Company to issue and sell 182,500 shares of its common stock for a total purchase price of $0.2&#160;million.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In August&#160;2020, the Company increased the authorized shares of common stock, par value $0.0001 per share, to 50,700,000 shares.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In October&#160;2020, the Company entered into a common stock purchase agreement with a director of the Company to issue and sell 29,674 shares of its common stock for a total purchase price of $0.2&#160;million.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-33</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:44pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">8. Stock-Based Compensation</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">2018 Equity Incentive Plan<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">On May&#160;7, 2018, the Company established and adopted the 2018 Equity Incentive Plan (the &#8220;2018 Plan&#8221;) providing for the granting of stock awards for employees, directors and consultants to purchase shares of the Company&#8217;s common stock. A total of 2,101,478 shares were authorized under the 2018 Plan and 854,320 and 549,188 shares are available for granting of stock awards as of December&#160;31, 2020 and March&#160;31, 2021, respectively. The 2018 Plan provides for the granting of the following types of stock awards: (i)&#160;incentive stock options, (ii)&#160;non-statutory stock options, (iii)&#160;stock appreciation rights, (iv)&#160;restricted stock awards, (v)&#160;restricted stock unit awards and (vi)&#160;other stock awards. Incentive stock options may be granted only to employees of the Company. Stock awards other than incentive stock options may be granted to employees, directors and consultants who are providing continuous service to the Company.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The following is a summary of the Company&#8217;s stock option activity for the three&#160;months ended March&#160;31, 2020 and 2021 (in thousands, except share and per share data):</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:255pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:211.32pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Weighted-</font>
                <br >
                <font style="letter-spacing:-0.089pt;">average</font>
                <br >
                <font style="letter-spacing:-0.089pt;">exercise price </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Weighted-</font>
                <br >
                <font style="letter-spacing:-0.089pt;">average</font>
                <br >
                <font style="letter-spacing:-0.089pt;">contractual</font>
                <br >
                <font style="letter-spacing:-0.089pt;">term (in&#160;years) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">Aggregate</font>
                <br >
                <font style="letter-spacing:-0.089pt;">Intrinsic Value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:211.32pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Outstanding as of January&#160;1, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">362,611</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.78pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.08</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.57pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">9.22</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">5</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:211.32pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">1,825</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.78pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.10</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.57pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">9.85</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:211.32pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Exercised </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.78pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.57pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:211.32pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Cancelled </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.78pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.57pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.85pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:211.32pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Outstanding as of March&#160;31, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">364,436</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.78pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1.08</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.57pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">8.98</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.85pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">8</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.75pt 0pt 2.5pt 0pt; width:211.32pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Exercisable at March&#160;31, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">114,587</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.78pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1.08</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.57pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">8.83</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.85pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">2</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:211.32pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Nonvested at March&#160;31, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">249,849</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.78pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1.08</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.57pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">8.96</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.85pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">6</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:211.32pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Outstanding as of January&#160;1, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">1,247,158</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5.16</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.57pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">9.34</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.85pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">1,486</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:211.32pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">305,152</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.78pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5.36</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.57pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">9.84</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:211.32pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Exercised </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.78pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.57pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:211.32pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Cancelled </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.78pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.57pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.85pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:211.32pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Outstanding as of March&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">1,552,290</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.78pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">5.20</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.57pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">9.24</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.85pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">1,486</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:211.32pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Exercisable at March&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">195,024</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.78pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">2.38</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.57pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">8.24</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.85pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">643</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:211.32pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Nonvested at March&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">1,357,266</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.78pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">5.61</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:35.57pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">9.39</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.85pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">843</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">Generally, options are granted with an exercise price at, or in excess of, the fair value of common stock at the date of issuance. Options typically vest over a one to four-year period in equal increments. The original term of all options is 10&#160;years.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The weighted-average grant date fair value of options granted during the three&#160;months ended March&#160;31, 2020 and 2021 is $0.96 and $4.02, respectively. The aggregate intrinsic value is calculated as the difference between the exercise price and the estimated fair value of the Company&#8217;s common stock at the end of the reporting period.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The total fair value of options vested during the three&#160;months ended March&#160;31, 2021 was $0.2&#160;million. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-34</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Stock-Based Compensation Expense<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">A summary of the assumptions used in determining the fair value of stock options granted in the period is as follows for the three&#160;months ended March&#160;31, 2020 and 2021:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:77.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:362.61pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">March&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:9pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">March&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:362.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Expected dividend yield </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.24pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:362.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Expected volatility </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.24pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">83.3<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">88.78<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:362.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Risk-free interest rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.24pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.40<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">0.67<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:362.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Expected average life (in&#160;years) </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.24pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">6.08</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt; width:9pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">6.08</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:8.1pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The Company recorded stock-based compensation as follows (in thousands):</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:63pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:368.61pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">March&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">March&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:368.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Research and development </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:20.02pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">16</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.46pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">168</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:368.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">General and administrative </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:20.02pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">2</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.46pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:15pt; text-align:right; white-space:nowrap;">193</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:368.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:20.02pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">18</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.46pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:15pt; text-align:right; white-space:nowrap;">361</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13.1pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">No related tax benefits from stock-based compensation expense were recognized for the three&#160;months ended March&#160;31, 2020 and 2021. As of March&#160;31, 2021, there was $5.1&#160;million in unrecognized stock-based compensation cost, which is expected to be recognized over a weighted average period of 3.24&#160;years.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">9. License Agreements</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Emory University, Children&#8217;s Healthcare of Atlanta, Inc. and UAB Research Foundation<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In June&#160;2016, the Company entered into an exclusive license agreement with the Emory University, Children&#8217;s Healthcare of Atlanta, Inc. and UAB, as amended from time to time (the &#8220;Emory License Agreement&#8221;). The Emory License Agreement was amended in October&#160;2017 and July&#160;2020. Under the Emory License Agreement, the Company obtained an exclusive worldwide license under certain immunotherapy related patents and know-how related to gamma-delta T cells developed by the Emory University, Children&#8217;s Healthcare of Atlanta, Inc. and UABRF&#8217;s affiliate, the University of Alabama at Birmingham, to develop, make, have made, use, sell, import and otherwise commercialize products that are covered by such patents or otherwise incorporate or use the licensed technology. Such exclusive license is subject to certain rights retained by these institutions and also the U.S. government.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In consideration of the license granted under the Emory License Agreement, the Company paid Emory University a nominal upfront payment. In addition, the Company is required to pay Emory University development milestones totaling up to an aggregate of $1.4&#160;million, low-single-digit to mid-single-digit tiered running royalties on the net sales of the licensed products, including an annual minimum royalty beginning on a specified period after the first sale of a licensed product, and a share of certain payments that the Company may receive from sublicenses. In addition, in the event no milestone payments have been paid in certain&#160;years, the Company will be required to pay an annual license maintenance fee. The Emory License Agreement also requires the Company to reimburse Emory University for the cost of the prosecution and maintenance of the licensed patents. Pursuant to the Emory License Agreement, the Company is required to use its best efforts to develop, manufacture and commercialize the licensed product, and is obligated to meet certain specified deadlines in the development of the licensed products.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The term of the Emory License Agreement will continue until 15&#160;years after the first commercial sale of the licensed product, or the expiration of the relevant licensed patents, whichever is later. The Company may terminate the Emory License Agreement at will at any time upon prior written notice to Emory University. Emory University has the right to terminate the Emory License Agreement if the Company materially breaches the agreement (including failure to meet diligence obligations) and fails to cure such breach within a specified cure period, if the Company becomes bankrupt or insolvent or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-35</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">decides to cease development and commercialization of the licensed product, or if the Company challenges the validity or enforceability of any licensed patents.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Exclusive License Agreement with UABRF<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In March&#160;2016, the Company entered into an exclusive license agreement with UABRF, as amended from time to time (the &#8220;UABRF License Agreement&#8221;). The Company amended the UABRF License Agreement in December&#160;2016, January&#160;2017, June&#160;2017 and November&#160;2018. Under the UABRF License Agreement, the Company obtained an exclusive worldwide license under certain immunotherapy-related patents related to the use of gamma-delta T cells, certain CAR-T cells and combination treatments for cellular therapies developed by the University of Alabama at Birmingham and owned by UABRF to develop, make, have made, use, sell, import and otherwise commercialize products that are covered by such patents. Such exclusive license is subject to certain rights retained by UABRF and also the U.S. government.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In consideration of the license granted under the UABRF License Agreement, the Company paid UABRF a nominal upfront payment and issued 91,250 shares of common stock to UABRF, which were subject to certain anti-dilution rights.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">In addition, the Company is required to pay UABRF development milestones totaling up to an aggregate of $1.4&#160;million, lump-sum royalties on cumulative net sales totaling up to an aggregate of $22.5&#160;million, mid-single-digit running royalties on our net sales of the licensed products, low-single-digit running royalties on net sales of the licensed products, and a share of certain non-royalty income that the Company may receive, including from any sublicenses. The UABRF License Agreement also requires the Company to reimburse UABRF for the cost of the prosecution and maintenance of the licensed patents.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Pursuant to the UABRF License Agreement, the Company is required to use good faith reasonable commercial efforts to develop, manufacture and commercialize the licensed product.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The term of the UABRF License Agreement will continue until the expiration of the licensed patents. The Company may terminate the UABRF License Agreement at will at any time upon prior written notice to UABRF. UABRF has the right to terminate the UABRF License Agreement if the Company materially breaches the agreement and fails to cure such breach within a specified cure period, if the Company fails to diligently undertake development and commercialization activities as set forth in the development and commercialization plan, if the Company underreports its payment obligations or underpays by more than a specified threshold, if the Company challenges the validity or enforceability of any licensed patents, or if the Company becomes bankrupt or insolvent.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Antidilution Provision<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The antidilution provision required the Company to issue additional shares of common stock such that UABRF maintains a 2.5% ownership interest in the Company until it has raised at least $20.0&#160;million through one or more rounds of investment. During the three&#160;months ended March&#160;31, 2020 and 2021, the Company did not issue any additional shares common stock in connection with the antidilution provision. As of March&#160;31, 2021, the Company had a total of 151,382 shares of common stock issued in satisfaction of this antidilution provision.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">The Company assessed the antidilution right and determined that the right (i)&#160;meets the definition of a freestanding financial instrument that was not indexed to the Company&#8217;s own stock and (ii)&#160;meets the definition of a derivative and did not qualify for equity classification. The initial fair value of the antidilution liability, and the value at March&#160;31, 2020, was determined to be immaterial based on the remote probability of an additional financing and the immaterial value of the total number of shares that could be issued pursuant to the provision. The antidilution provision was settled in August 2020 when the Company raised an additional $19.8&#160;million in gross proceeds through the issuance and sale of Series A Preferred Stock for a total of $35.0&#160;million in gross proceeds related to the issuance and sale of Series A Preferred Stock.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">10. Net Loss Per Share</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:-0.025pt;">Basic net loss per share is calculated by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period, without </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-36</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">consideration for potentially dilutive securities. Diluted net loss per share is the same as basic net loss per share for the periods presented since the effects of potentially dilutive securities are antidilutive given the net loss of the Company.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The Company has calculated basic and diluted loss per share for the three&#160;months ended March&#160;31, 2020 and 2021 as follows (in thousands, except share and per share data):</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:127pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:341.98pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">March&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">March&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:341.98pt;text-align:left;">
              <font style="letter-spacing:-0.025pt;">Numerator: </font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:341.98pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Net loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">(1,691<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">(2,363<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:341.98pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Less: Accruals of dividends of preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(260<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(706<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:341.98pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Net loss attributable to common stockholders &#8211; basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(1,951<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(3,069<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:341.98pt;text-align:left;">
              <font style="letter-spacing:-0.025pt;">Denominator: </font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:341.98pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Weighted-average common stock outstanding </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">3,305,367</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">3,764,488</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:341.98pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.025pt;">Net loss per share attributable to common stockholders &#8211; basic and diluted </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(0.59<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:37.5pt; text-align:right; white-space:nowrap;">(0.82<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The following potentially dilutive securities were excluded from the computation of the diluted net loss per share for the periods presented because their effect would have been antidilutive:</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:62.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:353.09pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">March&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.089pt;">March&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.089pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:353.09pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Convertible preferred stock on an if converted basis </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">4,247,927</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">9,993,727</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.09pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Stock options to purchase common stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">364,436</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">1,552,290</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.09pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Warrants to purchase preferred stock </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">231,396</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">11. Commitments and Contingencies</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Intellectual Property<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The Company has existing commitments to the licensors of the intellectual property which the Company has licensed. These commitments are based upon certain clinical research, regulatory, financial and sales milestones being achieved. Additionally, the Company is obligated to pay a single-digit royalty on commercial sales on a global basis. The royalty term is the later of 10&#160;years from first commercial sale or expiration of the last-to-expire component of the licensed intellectual property.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Litigation Disclosure<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Incyte Corporation<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In April&#160;2019, Incyte Corporation (&#8220;Incyte&#8221;) filed an opposition to the Company&#8217;s pending application at the United States Patent and Trademark Office to register the mark INCYSUS alleging that the INCYSUS mark was likely to give rise to confusion in the marketplace with Incyte and, consequently, the mark should not proceed to registration. On April&#160;24, 2019, Incyte also filed an opposition on similar grounds to the Company&#8217;s pending application to register INCYSUS in the European Union. The parties settled this matter out of court on November&#160;26, 2019 pursuant to which both parties dismissed the above noted actions and the Company agreed to cease use of the INCYSUS mark by August&#160;26, 2020. </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Other Settlement<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">In July&#160;2020, the Company entered into a settlement agreement with a former employee for $0.3&#160;million in cash and 200,750 shares of common stock.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">Lease Commitment Disclosure<font style="font-style:normal;font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The Company has historically entered into lease arrangements for its facilities. As of December&#160;31, 2020, the Company had three operating leases with required future minimum payments. In applying the transition guidance under ASC 842, the Company determined the classification of these leases to be operating leases and recorded right-of-use assets and lease liabilities as of the effective dates. The Company&#8217;s leases generally do not include termination or purchase options. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-37</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;">Equipment Leases<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">The Company entered into an agreement with an equipment leasing company in the fall of 2018, which provided up to $1.4&#160;million for equipment purchases in the form of sale and leasebacks or direct leases. As of March&#160;31, 2021, the Company had completed the sale and leaseback for four pieces of equipment and is leasing two other items directly from the leasing company. The terms of the leases are three&#160;years and afterwards provide for either annual extensions or an outright purchase of the equipment.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">The equipment leases require two advance rental payments to be held as security deposits. The security deposits held amounted to approximately $0.1&#160;million as of December&#160;31, 2020 and March&#160;31, 2021. They are included in other non-current assets on the balance sheets.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:4pt; width:456pt; line-height:12pt;font-style:italic;">Operating Leases<font style="font-style:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font></div>
        <div style="text-indent:20pt; margin-top:2pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">In December&#160;2020, the Company entered into an operating lease for office space in Birmingham, Alabama, for a 63-month term, ending in March&#160;2026, with an option to extend five&#160;years. Throughout the term of the lease, the Company is responsible for paying certain costs and expenses, in addition to the rent, as specified in the lease, including a proportionate share of applicable taxes, operating expenses and utilities.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">In December&#160;2020, the Company entered into an operating lease for laboratory space in Birmingham, Alabama, for a 63-month term, ending in March&#160;2026, with an option to extend five&#160;years. Throughout the term of the lease, the Company is responsible for paying certain costs and expenses, in addition to the rent, as specified in the lease, including a proportionate share of applicable taxes, operating expenses and utilities.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">The operating leases required security deposits at the inception of the lease. The security deposits amounted to approximately $17,000 for the three&#160;months ended March&#160;31, 2021. They are included in non-current assets on the balance sheet.</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:-0.025pt;">The following table contains a summary of the lease costs recognized under ASC 842 and other information pertaining to the Company&#8217;s finance and operating leases for the three&#160;months ended March&#160;31, 2021 (in thousands):</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:129pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:419.35pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Amounts </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:419.35pt;text-align:left;">
              <font style="letter-spacing:-0.111pt;">Lease Cost</font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.35pt;text-align:left;">
              <font style="letter-spacing:-0.025pt;">Financing lease costs: </font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Amortization of finance right-of-use assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">113</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Interest on finance lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">21</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Operating lease costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">52</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:419.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Short-term lease costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">115</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:419.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Variable lease costs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:419.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Total minimum payments </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.42pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:15pt; text-align:right; white-space:nowrap;">301</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:456pt;height:100pt;margin-top:15pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:428.99pt;">
              <font style="letter-spacing:-0.111pt;">Other Lease Information </font>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td colspan="6">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:428.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Cash paid for amounts included in the measurement of lease liability&#8201;&#8211;&#8201;finance leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">21</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:428.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Cash paid for amounts included in the measurement of lease liability&#8201;&#8211;&#8201;operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">133</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:428.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Weighted-average remaining lease term&#8201;&#8211;&#8201;finance leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.86</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:428.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Weighted-average remaining lease term&#8201;&#8211;&#8201;operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">4.92</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:428.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Weighted-average discount rate&#8201;&#8211;&#8201;finance leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">10.2<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:428.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Weighted-average discount rate&#8201;&#8211;&#8201;operating leases </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">10.4<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-38</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:404.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The following table reconciles the undiscounted cash flows to the operating and financing lease liabilities at March&#160;31, 2021 (in thousands):</font><font style="font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:144.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:366.4pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Financing </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.089pt;">Operating </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:366.4pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.54pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">400</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">158</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.4pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.54pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">315</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">216</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.4pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.54pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">132</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">223</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.4pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.54pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">230</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.4pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.54pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">236</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:366.4pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Thereafter </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.54pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:15pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.27pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">41</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:366.4pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Total lease payments </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.54pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:15pt; text-align:right; white-space:nowrap;">847</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21.75pt; text-align:right; white-space:nowrap;">1,104</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:366.4pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Less: interest </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.54pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:15pt; text-align:right; white-space:nowrap;">(72<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.27pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:6pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">(241<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:366.4pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.025pt;">Total lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt; width:1pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.54pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:15pt; text-align:right; white-space:nowrap;">775</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.27pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:6pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21.75pt; text-align:right; white-space:nowrap;">863</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.111pt;">12. Subsequent Events</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">The Company has evaluated subsequent events and has not identified any requiring disclosures.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:-0.025pt;">F-39</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style=" width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 0pt; font-size: 3pt; line-height: 0pt; border-bottom: 3pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:74pt; text-align:center; width:456pt; line-height:16pt;font-weight:bold;font-family:Arial, Helvetica, sans-serif;font-size:14pt;">
          <font style="letter-spacing:-0.155pt;">4,000,000 Shares</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="position:relative;margin-top:26pt; text-align:center; width:456pt;">
          <img src="lg_in8bio-4c.jpg" alt="[MISSING IMAGE: lg_in8bio-4c.jpg]" height="66" width="173" >
        </div>
        <div style="margin-top:29pt; text-align:center; width:456pt; line-height:16pt;font-weight:bold;font-family:Arial, Helvetica, sans-serif;font-size:14pt;">
          <font style="letter-spacing:-0.155pt;">Common Stock</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="margin-top:99.167pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #63D05A; ">&#8203;</div>
        </div>
        <div style="margin-top:14pt; text-align:center; width:456pt; line-height:14pt;font-weight:bold;font-family:Arial, Helvetica, sans-serif;font-size:12pt;">
          <font style="letter-spacing:-0.133pt;">Prospectus</font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Arial, Helvetica, sans-serif;font-size:10pt;">
          <font style="letter-spacing:-0.111pt;">July 29, 2021</font><font style="font-weight:normal;font-family:Times New Roman, Times, serif ;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:20.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #63D05A; ">&#8203;</div>
        </div>
        <div style="margin-top:135.5pt; text-align:center; width:456pt;">
          <div style="margin-left: 36.842%; margin-right: 36.842%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <table style="width:456pt;margin-top:55.5pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:16pt;">
          <tr style="line-height:16pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Arial, Helvetica, sans-serif;font-size:16pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:144pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:144pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.178pt;">B. Riley Securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0.5pt 0.5pt 0pt; width:144pt;text-align:right;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:105.65pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 0pt; font-size: 3pt; line-height: 0pt; border-bottom: 3pt solid #000000; ">&#8203;</div>
        </div>
      </div>
      <hr >
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>lg_in8bio-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_in8bio-4c.jpg
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M[0!(4&AO=&]S:&]P(#,N,  X0DE-! 0       \< 5H  QLE1QP"   "  (
M.$))300E       0_.$?B<BWR7@O-&(T!UAWZ__N  Y!9&]B90!DP     '_
MVP"$  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$" @(" @(" @(" @,# P,# P,# P,! 0$! 0$! @$! @(" 0(" P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# __
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M  P# 0 "$0,1 #\ S^
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M>_&YR>DU9B8YOJ++[,D=6.8NM]TU<@)
M
M
M
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MHOK/RIB8FD\W+%E]F2V+\<Q=9/K$UC\8;YA(
M
M
M
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M?6?)W6W63TWQ,7>R>#MA@U&GU6.,VER69<,\KK+HNMG[)B9A] BN
M
M
M
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MU4]*'SSL-$Q=$76S6V6L,@
M
M
M
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MRW9<\S7C,TCW4K1SM57M55]U555^NI-K?8&
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MM\33B]3.WNY=C[JVW'NVPZG%J=%ELBZ)LNB9I/+JB)F;9]TO02A^Z
M
M
M
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M/-?9OEW:+=;L6>R-RLMCYV"9B+[+IBM(BM;HX\X7EGX[F$
M
M
M
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M=UXK(^;AF8_/$?E^99,SQZYB9I'))^?,NS
M
M
M
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M9RN3T'U&'#9AMZ;>?K+I'W+W)N'=>X3K-;=-NEMF?EXZ\(CC[Z35V<N?B!@
M                                  =@VENS<^P-SXC>NRLO:P6Y\%;B
MN4+]2:6'F=%(V58IFPOC[V-_)HJ.70T=PV_!N&"[#FMB8F*/JNSN\M]['WO#
MONPY[\.LP7Q=;-LS'&.5:3%;>/&&71Y=WF(;9\4>V*NRMZ6ZV$ZPX*I%!D*%
MF:*+\>LBC:CLA662PYSY97+]RB:K[YP)W'VYGV;/-UL3.EF>$^SW?<]R?IT^
MHO8_,.R6:+67V8>[<-D1DQS,1\R(X?,MK-9ZIB9I"5(^7=H0
M
M
M
M                        %BGCX\<O3CP/]&<UOG=%VK<W?=HVZVR-I,LP
MMOYO,+$J0_N2S1RQUX'.YU=_E<NB>Y^KM.U:C=M5&##$]'[4^D0^-[X[TVKL
M?8\N[[E?;%UL?DLK%;KIY1$5K2K\^#K?UHZL^+3K)FNHV_\ *7MP;LW5DII*
M=226P^IA<<ZS*ZM7@KNEG@@[BM/RJK=-=#G/:MJPZ#!;IL%OI^/O>4/D[R9J
MNZ=PU'<>^YIMT-DSTVS/"(XS;;;%?3EP>_[#V/C]A8>.K"UDV7M1L?D;BM:K
MU<K6.1C5Y4<WD5-.!])AQ1BCWNCW=?=&K[LW&<^69MV^R9C'9Z>L5Y\:NXES
MYP,                                  %/^FOH VW31M7EYN95]#/AK
M[VC=5U(W9++>-TK;,&7)-++9F946>-%1KN>-5[$E8Z/[_0C;FQW_  RGDTFI
MP\,EDQ+M>RM[;KZ;[LPN_-B9BQA=S[?MQ7*5RG-(Q)$BD;(^"=L+V)+'*UO*
MJ.73B:FX[=I]RT]V#-;%T3%/_P >]]/V3WKOO8>_8-^V+/?@UN#)%ULQ,QQC
MVQ6*V\>,,R+R]_'/M?Q>].(X+T]?%]5-J5:U;=^W9)F).]48R*+)U^>=\EAE
MQR*YW*GP57B=?^X=@U&RZFDQ,Z6Z?RW?IF)]E*O=[Z?//6Q>:.V[;K;K<7=.
MELC]XP5XT^&W+;6:W1DFV9FG*>$I$SYUV'
M
M
M
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MR_%EMI?;$QU69+:1?;=;69BEW"*\UPYH/O0
M
M
M
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M9%L
M
M
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M;HC<-#CB=/DNOK=FLF9B;*3-:XXB.4<I3X'P#OX
M
M
M
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MI,7Q%+[9CTF+JQQ>UFD^S
M
M
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MEU*?ST?8P^?QVX(4FQ,&6G56HYT2XFZQS-41=%UB5>"KH?28MTT&HMZL5]7
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M]#?E?5[9K+O&O<^3-%NKF)T-DV7=-M_&<EO5RB)B*\?5D_'%KU'
M
M
M
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M:#38M7B^&ZVRVV8^R8B)>YHB(B(G8B(B>\G U'UJH
M
M
M
M        A"\]'Q'V^COA8M;#PEME;/\ 5.27%5GQV&LM-J5F/?:1K&S1R\CT
M5..BHNFA]UV!M<:_>;<V2*XL7&?M]'!?U!]X3VIX_P!1^[WQ9KM1^2WCQI-8
MNFE8F:0PA=NXB3-9[&XUK%?\IL?*+/I^'WC99%=P7BYR^D[$74LQS=Z4>/\
MONZ_N6W:G<LUW]9$32?;6J]U(HZT,%6%J-AKPQ,:U--$5(VM=V:>E#\V/6?:
MZO3DOSY+\^6:Y+[IF?QX!ED           &B1[(F+)(JHU."(B:N<Y>#6M:G
M%5<O#@8NNMLCJNY)667Y;XQXXK=*8?RXO+,S7B(O8OK)ULQMK#=(:5B*S@=N
MV8Y(+.]5AETD21DL*35*4#TUYEX2=B<#C?NWNZW16SHM',3K)]8Y6<IB??=/
M'AZ/0+Z5OI0U'?6?%WIWOBNQ]G8[JV8[HF+M9,3?;?;[;<=LQ;/5^WRC@RL]
MJ;2VYLC!8[;6UL11PN&Q=6"G3I4:T->-D->-L4?.D+&)))R-35R\5.&LF2_+
M?.3),S?,UF9>P>W;;H=IT>/;]NQ68='BLMMMMLMBV(BV(B.$1'I'/U=C(-T
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MVZLQ[.7)_01X1\@7>3O&VW]VY;.C4YK)LR6__,QTMN]9YSQ^]=T<=N60
M
M
M
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M#KL"
M
M
M                               #H'5/=]#873S>.[<G(V.IA=O9:Z]S
MG(Q.:&C8D8WF<YJ)S.;IVH;&DPW:C4V8;.-UU\1^,M77:G'H]%FU66:8\>*Z
MZ?\ W;9G^9^:MU\WW/U,ZQ]1=^RSOLNSNYLMW<LCG.<Z%F1M,@35SWKHD:II
MQ.VVT:.=#M^'23%.BR*O%[RCW%C[I[WUVZ8[INQ9,UUT3[HY?HAZKTTQ28G:
M-153EENHKY$5..B<JIQT12C571?J)B.5KI]WKKYW#N')2:V8N$?I=Y*7RX
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MU$:UK6HB(B>@ZNWWW7W3??,S=,UF9]KO)99;CMBRR(BR(I$1RB(;Q%(
M
M:7O9&G-(]K&_LGN1J?7540#ANR>-9KSY"BS3MYK<#=/?UD0#0S+XF5$6/)XZ
M1%X(K+M9Z*OJ16RJ@I(YD<\,O[U-%+_!R,?]ZJ@;H
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M8YZ[9X3-L32RZ8GUNMI=]Z\ XX<M@
M                                 #Y&;SV'VYCK.5S>1J8VA4B?--8M
MSQPL:QB*YVBR.;S.T3L3B9B)GA#$S3C*.CK#YBVRMM6;F#Z9XUV],FQCX?EK
M9$KU:]A.=CG-UD3O48]O#CQU+;<58K*N[)%:0L#WAXP/$-OE9T=N9VW*$CG=
MWCZ\/%C7<R:=Y%-Q5&NTU]PMBRV.7-";[I^QXG:WSU.R#WR9#?N7L/>JJY6V
MKL2*BJJJFC9]/22BV(1K+CP;KZ@4]/D.]<Q71J\S$6[>DY7:ZZ\9^/PN)FD>
MI67J&T_$MX@MDO9)C=^3WHXN76K9A?*DS$Y=6+WLZIHJ,T(]$3PEGJNJO2Z5
M^9+8K2U<7U:VT^G%++%&_<%>1JM:U58Q[WUVRKP7B[T%5V*O+FG&2?5)_L'J
M;LCJ;B8LULS/TLQ2E1JIW,T:6&<S4?I)7YUE8J([CJFA3=;-LTGFMB8GD[Z8
M9                                                       \HZQ
M=8MG=%-GW]W;OR$56O6B?\EJ\[/E-VSR.6*"&%7MD<CWIHJHBZ&8B9FC$S$<
MT#G6SQ0]5.O>2M=_?L[3V(V:9<=MVI-)')8A<KVI+)9@GY]985:O$VK+(MC_
M #E$W3/#T6]P4*M;F[MKY%=Q<^S(ZR]57BJ\\O,[BI8BY:(U.#6M;^U:C?M(
M@%0     HO8OO+]H"2ORR?RYU(_F?\04YN4+<?JF(-9:     !151J*YRHUK
M457.541$1$U555>"(B 1U^*CQQ8?IA+>V#TW2'<F_G1O@LS5Y8WUL#([O$9,
MY[)>2:1JL[/06V8^KC/)7=?$<(YH=-U;DWAU#S$^X=_[CR&=R-F1\R1_*;,%
M>LKWN<D:5TF6)48CU3LXFS$1$4A3S?);%$Q$1L<::)HBHQNOU]-=3(W
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M$S$16>3;ALU[&JU[$,Z-^Z[F5DO+[_(YVAFZR^SXHF/MABV^V_X9B?L;Q%(
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M)&QQHZ:LKI5=-WKW*NC470UK[.GER76WQ=]J[HK3
M                                #Y^5R=3#8V]E;TS(*F/JSVYY9'M8
MUL<$3I7_  GJUNO*W@(BO"!CC^)'K7ENO_4[(Y*>U,FR-N6YJFVL7WC_ ).]
MT$TT%B21K9'Q2J]W'BAMV64BC7NFLU>+*ON(B(B(B)P1$1-$1$[.Q"Q%0
M    "B]B^\OV@)*_+)_+G4C^9_Q!3FY0MQ^J8@UEH     $=WC@\4\O2["MZ
M=;$M-?O[<L4U=]F![7NPE62&1KWRM;(US9)F:HFO878[*\9Y*[[J<(YH5:U9
MT+I[5J>6]E+TLEG(9"Q(^:>>>=ZRR?NDJN>C6O>OI-E2Y(         !QKE9
M+4'*CG130R1V:\S%5'QSUW)-%RN;\)-9&IV#TIZ"<?P(]?7=4^G;=I[AM(_>
MFRXHJF12:5$FLUN6-M:1C'R.D>K&*B+H:N6V(FL<EV.9F./-?H5+
M              ")_P SS\E]/OX:Y]J4V<'*563T16-^Y9^T9]ZA<J5
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MJQ[XX<JE:*#.XWO&NFI7HVM9*KVH][D9,Y.9%7UFI?9-DT]&Q;-8J]^()
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MF$MQ7<=E:<%J">%S7L7O(VO<W5KG(CF*[14U-28F)I/-L1QAV(PR
M             B?\SS\E]/OX:Y]J4V<'*563T16-^Y9^T9]ZA<J5
M  +S/+\^GB[[/+\3"4Y.4IV?%">8UEX     &$1Y\=ADOB^="QVKJ^+H]XG-
MJC>:";3AJJ-4[)>*[*;#=,\IO>;GUDY+)[CT=G[48;OY4572"JU;V2MJB<[$
M8B+[Z-/N=XG^KMM])>;_ )$SW?NN'3Q\,U>Y+VK[ZGXL<G%L<@,@
M#2_[A_[1_P!ZHGE/V,V_%'VPRL_)*VFF)\.N0W+W2,?N7)O5S^5$=)\D5C$U
M7E15TU]:G /?&;KW><?^3;'Z7N-]$.T8]%XDQ[C9$=6HS7UGV],T34GQCN:
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MC<K*^.*'<2L;$CG:/EY8I4U7W7+[I1DQ4_-;R767UX3S25%"P
M                           (BO,<ZT6Y'X?HK@;CX69)SI]T+!(J.;&U
MDCZL3UCD1S47EXZIQU+\5O[2K)=Z0C 9&R)C(F-1K6-1NB=BN1$1SO?<J&PJ
M:@        #W^*>E/6GI3ZJ 7.^#?J]:Z0]9J.)LW'0[2WY)\FR,#GJE>K.S
MN(JSFM<]D;'+)HO!.)5EMZH]Z=DTFGHR$HI&31QRQJCF2L9(QR<45CVHYJHJ
M<%144U5[6
MA#\R#=D^5ZH;-VJLBK6PT4TCHT7X*+8CG=JY$=HJKKZ4-G%%(^U3DYK"2Y6
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MOA?!U75=33OBEU&Q;-;7M)%(
M              Q[?&WD?QGXC,TU7JYM&KC^5-/N>>!^NG'U*;>./RPU[Z3=
M5:^6(@        "B]B^\OV@)*_+)_+G4C^9_Q!3FY0MQ^J8@UEH    (%_,&
MRK\EUYQN-=(JLPE:-6LU54:MF*5>S54377W#9Q1-%%\_F6:ER
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MXG+W;5<UK7*[AP34HRQPX<H3LFER= UUX
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MQQVW[SGMK;%T1/R[9](B8YSSKZ/('ZQOJ*WG>]_U'CS8,DX>W=)DZ;KL=_\
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MT+$151S=44A='Y9HS$S$UCFR8ZK^\K5Y.WO((GZ^OFC:[_":;9;X
M                           '@OB:@DL]$M]Q1(KGKB9E1$[=&L>J]GN(
M3L^*$;_A8V&#7FH.5/1=O-7W%2R]/\!MM=]<R          !MS+I#/[L,J?_
M ('?X0)A/++JRP=*LK*]JM9-=3NU771=.770ULTS6*K<?"J3(I6@
M                                         &.IXP?TC=U^R8OYN\V\
M?P->[FMX+$0        !1>Q?>7[0$E?ED_ESJ1_,_P"(*<W*%N/U3$&LM
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MOP9$]*G7F^V;+ILNYQ-/P?T!Z34XM;I<>LP37#EQVWVS[;;HBZ/T2^H1;
M 8P/G@]"G[?WYLGK=AZ2OJ[CBGH[HM10HUD$])CV4^_>R-$=WK'=KG:ZG<'Z
M<M]LU>CU&P:B^F7%,3CM]L3\5/LEY9_7[X\S?O6B[SV[3]6#+9=9J,D1'Y;X
MF.BO#C6*\9GT0/ZJJ)HKVHJ:IR/<W5%37BK=-4T.U7[E$\XXO+VS+EPS,X[I
MB>4T;].E8RN2Q6'IQ/FN9;*8_'PQ1M<Y[UN6XJRHUK45RJO>>H9\-FGTV3/?
M2+<=EUU?LBK]/8M#?N6ZX-);;-WS,MMM(K,S-UT1'M]K.T\&G1FIT'\.W3OI
M]7JLK34L/!?O<J-YWW,G#%:G=*Y(XW.<CGZ<4U30\QN_NX,G<O=6KW2^:Q=D
MFV/LMF8A_1=X?[(T/CWQ[MW;6@MZ<>/#%]WMZ\D1??,\OVI>[[ZVIC=\;0W#
MM3+5X[5+.8F_CY(941S%=9JRPQOT<CDU8]Z*G#T'S6VZW+MVNQ:W#,Q?CR6W
M?A,2^[WC;L6[[7J-LSQ$X\^&^SCQ^*V8K]U6!SXD>B>X?#KUNWOTLW)%*V3&
MY.>[B[CX9(X+]'(V)[$$E>1\<<<K4A5$7EU1%/4_L/?-'WAVSIM\T5(LOLI=
M;6)FVZV(B8GG3[W\\/F[QON/C/OO6=NZ^Z<M^+),QDZ9MB^R[C;='"*\Z3,<
M*N]>$#Q8;R\(75>COS ,GRVUKTL<.\]K-G?##EZ6K6([5)(V,EK-3F:NG'30
MTO(?C/;^_P#8[]MU-,>OMBN'+2LV7?ARGD^@\!>==]\+]S6;CI.K-M&28C4:
M?JI&:R(FD1/I=$S$Q/+A268;T&\9?07Q!;;QN=V;OG#,LVJL4EW%Y*]4Q]JC
M<[N);-1S+-AJO6":3EU3MT/.SNOQOW;VAK;])NFDR]-MTTNMMFZ+K?2ZL1ZQ
MQ>X?8?EWL+R)L^+=]@W#!-E]L=5E]]ME]M\1'79-MTQ-;;II[Z/2^H'7SI#T
MQPEG<&\=^[<QV.JQ232.CRU"S,K(V/>[D@ALND>JHQ=.':?B[1VGW%OFJMT>
MVZ3/?FNF(C\ET1QX<YBCZ7>^].U>WM#?N.[:_2XM-9;,S_6V3-(BLTMZJSPA
MBK>9%YB=SQ5YG_EMTU=9QO2#!6YF6KR2O;_7&1KW=Q:EA29S8HHD71&JG$[^
M>$_"F+L731OF_1%_<66V*6T_U,>ML33C,O(KZJ_JFO\ ).HO[0[0NNL[/PWS
M$WUXZN8I-N28K^6VWC$1Z\_MBYP>W\QNO/83:6W:<^1S>?R%/'4:56-\LTG?
MSQP/=R1,>]$8U^JKHNB'/VNU>DVO0Y=PUEUMFFQ63=,SPCA%><NF/:?;^O[H
MWW!M.WX[LNIS98MBV.,S,SZ<_O\ 9#.B\%G0:#PY^'G873?NF-R5'&QW<Q,C
M6I)+D;\<=BPDCDCC<JQ.7EXIZ#RA\F=V7]Y]X:O>_P#X-]_39'I%MM8BG-_0
MYX<[#P>-O'FW]JX/BQ8^N^?6<F2(NOKPCUX+K3X%R>  -N:)D\4L$J<T<T;X
MI&_LF2-5CT^JU1$TXQS8NMBZV;;N4Q1'1B/+,\/^%\1S_$74QLK<[\M?DX,;
MS_N$.2DU=)91_=\R\TBZ]NNGI.2]'Y3[FT/:F7M/#D_V+-;TW3/&>F)Y."-+
M]/78.D\@?\PL6&[^*QE^;$=7Y8R3%.NGMIP]M/5>[U-N6,3TXWI;H(Y+%3:F
M<=75J*KF.CQ5KD<B)Q^ K4./]%2_78NOE.6VO]**N8=_ONP;!KLN/A?9HLTQ
M[IC'=2?N?GZ9ZQ/=W1NJ[:E?/:M;CS<L\TCE>][WY.TY55SE5VFJ^E3T3[?W
M*RW38L>.D619;$1'NB'\T7<^JSZO>]3GU-TWYKL^2Z9F9FLS=,SS?*7U?]/1
M[IRQL^OF9CB_!CVM!]G$Q=$71RE-V/9&6OX'?VR,QBWRQY"CN;"/KNA5Z2KK
ME*G.QJQJC_AMX</6?G;QI<&MVC5:74Q$X;\%\37E\,\7U_8V[Z[8^Y=)N.WW
M76ZC'J<=T=-:S2Z.'#VQP9I'C!\/F=\57A$?L+"W'XW=.2VSMW+X]7.=RSW8
M,9#9=2E;ROU^4R/Y554X'DWLF]SVMWA=N.'CBQ9\EO#V=<Q6/LCB][O+WC[6
M>6?$%W;.DS?)W+/I\&:VZ?6^RR+^B?\ OS^66/GX8?*P\4N1ZZ;4GZA[/?LC
M:>SLU!;RN?=;:KI?D5N&:NE9C8$?(EAD2JNFBHAW)WGS[VGA["S:7!GC4[QE
MQ39;CI[8I,S->%'G7X8^D3RCH?(&FU?=.DOT.T:?-;DORS?'.V8F(LI69B?;
MPFGVLO?'U?D-"E2YN?Y)4K5>=>U_R>%D7,O[;DU.@V;)\W+=EY=5TS^,U>P6
M''&'#9AB:Q;;$?A%'+*UCRI>B73%W4=O5I=IXQ>H+8NY3<GR>/Y>D?=]UR]]
MR<_[WP[>P_5Q[WNN+;;MHLSY(VZ^:SCK/3/&O+D^=GM/MZ=\_P 2?NN'^-Q%
M/G=,=?*GQ4KRX<^3U4_*?1        '&N?R.U[-/\4XS',8R?6?Z;NH?MZ_.
M)S<M^&&M/-T(DP         /N['>Z+J5L66-='MR]1$7U(MV#7[!B9X$3289
M0^,77&X]5[5HU%7_ %$9HMIS@
M.D]1L"W<VR-S8541RW,/?8QJ_P"5(E656-[%[7<"5LTFK$\F+ZZD[%9/-X>5
MBQS8_,9-DD:IHK$6],C>"HBZ+H;K6AO           #B7I6PU97O[%3N_P#R
MI/@-^NJCGP)3U> W:;]M] -M69XUCM9=9[3VJFCEC56=TJZM1>*(IJ9:]5%V
M.(BU>F5K                                                  #'
M4\8/Z1NZ_9,7\W>;>/X&O=S6\%B(         HO8OO+]H"2ORR?RYU(_F?\
M$%.;E"W'ZIB#66@    Q]/'1^DOF_9,?\0\VL7PJ+_B6L%J
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M'[>OSB<W+?AAK3S="),         #[>ROI'V-^>*?SZ C=R8]891.,_)N/\
M8:GS>,TYYMMSC                                    VY8VS121.^Y
MEC?&[]J]JM7["@8ZOBYZ<OZ8=>L\R.N^+"[N?';Q4O=JR%TG[M-.UKN1D>K7
M*J+HJFUCFL->Z*3[EO9:B          '.P&W+V]MW[8V5C:\EBYG,I37EC:Y
MRM@KVX5G5R-:]43NU7M0C=-(J4F9X,G;8>UZ6S=H8#;=!B1U\7C:E=&HB(G>
M-@C25=$1NG,]%7L-.Z:S66S'"';C#(
M                   !CJ>,'](W=?LF+^;O-O'\#7NYK>"Q$         47
ML7WE^T!)7Y9/Y<ZD?S/^(*<W*%N/U3$&LM    !CZ>.C])?-^R8_XAYM8OA4
M7_$M8+4                !HFB9/#)!(U'-D3@B^A^GP'(OH5KN($JOEV]>
MG6*=OHCNO(ZY##(LFUY+,FLEZNK8WSPL?+*KG)%S<$1/0:^6RGYEN.8C\J6
MH6@                !$_YGGY+Z??PUS[4ILX.4JLGHBL;]RS]HS[U"Y4J
M         7F>7Y]/%WV>7XF$IR<I3L^*$\QK+P     +&/,8Z6UNJWA/ZHX%
M:/RV_!A9[^/1&<[XY:D,TKW-1&2*O[GKZ#ZGLW7W;?W#I\\74MZXB?OE\-Y'
MV7'O_9FOV[);U]6GOF(]\6S]K\^6TR;&Y6RV5CHYL;EK%5S7(K'-=6N.A>U4
M7E5NBLT.YO1&7%-L<8NMK^,/"_=='.'5ZC09(Z;HNOB8GTF*Q1<_1L)<QU*V
MBZ]["Q%777BUC4]TX\RV3BU%^*?277G589TVLRZ>?V;I_3,N015     &:5
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MHV-M3M;-%S-1%3@J+QU*,M]/R+,=O[288UUP
M                           QU/&#^D;NOV3%_-WFWC^!KW<UO!8B
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MN)^<_5       <:Y_([7LT_Q3C,<QC)]9_INZA^WK\XG-RWX8:T\W0B3
M      ^WLKZ1]C?GBG\^@(W<F/6&43C/R;C_ &&I\WC-.>;;<XP
M                           &E[&2,?'(UKV2-<Q['(CFN:Y%1S7(NJ*B
MHH$-/C7\(N3VYD\CUHZ5X]UG'V-;&[]MU(M.1D:.>Z[!'##JJ/DD551..O:;
M&.^O"5%]DQQMY(W*EN"]"DT#G<%5DD4C%BFBE8O++&^%^DC>1_#BG$N0<DR
M     4<]D;'22O;'&QJN<YRHG!.*Z:JFJ\#'(7$>&7PV;C\1FZ*V0OU+.+Z6
MX6W%-?OS121?CJ:)\=B&")LL2ZM<K%35%TT(7WQ;]J5MO5/N9"&W=O8G:N%Q
MVW\'3AHXS&5HJM6O"QD;&1Q,:Q%5&-:U7JC>*Z<35F9F:SS;')]LP
M                                            #'4\8/Z1NZ_9,7\W
M>;>/X&O=S6\%B(         HO8OO+]H"2ORR?RYU(_F?\04YN4+<?JF(-9:
M   #'T\='Z2^;]DQ_P 0\VL7PJ+_ (EK!:@                 #@J*U?N7
M(K7)IKJUR:+]@"\_P*]<O^5/49_3O/W%CVCO:5%Q<L\JI6Q=R%(V,:U'RMC9
M\HD<J<$*<EDS'#T3LNF)I/)/"Q[9&,D8Y',D:U['(NJ.:Y$<UR*G!45%-9>U
M                (G_,\_)?3[^&N?:E-G!RE5D]$5C?N6?M&?>H7*E0
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MBVZ8CTF8X_B][/I W76[KX-VS)K[[LF?'DRV1=/^3;=^6/NC@D\."W9X
M  !QKG\CM>S3_%.,QS&,GUG^F[J'[>OSB<W+?AAK3S="),         #[>RO
MI'V-^>*?SZ C=R8]891.,_)N/]AJ?-XS3GFVW.,
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M3@Z&W-LXVMB\3C8&5ZU:M%'&B,C31'2*QK.\D5.UR\37F9GC*V(B.$.QF&0
M                                                   QU/&#^D;N
MOV3%_-WFWC^!KW<UO!8B         *+V+[R_: DK\LG\N=2/YG_$%.;E"W'Z
MIB#66@    Q]/'1^DOF_9,?\0\VL7PJ+_B6L%J                   ./8
MCF5(K%25U>]2G@NU;,:JV2.2K(V=K6.;HY.=S$3@I@3\>#/KU%UHZ8T8LG89
M_6[;,,&.SM9SVI,B1QL96F5BR/D=WD:<5]9JY+>F?<OLNK''FO"*TP
M        ")_S//R7T^_AKGVI39P<I59/1%8W[EG[1GWJ%RI4          O,
M\OSZ>+OL\OQ,)3DY2G9\4)YC67@      +1?'!T#I>(KPZ=0.G\E"&YE+.'M
M6L,^1C%D@O5*\TL:Q.='(YKI$U;P35=3Z/M7>+]DWO!K;;IBR+XB[[)E\CWU
MVUIN[>U=9L>IMBZW+ANI$Q^U%L]/I/J_/;W5M_,;$W?F=OY>M)2R^W,U=H2U
MY&N9(QM2]+"CE1R,<B.9%PX(=U=/EP:[2VY,<]6GRV1,??#PP[N[<U6P;UK.
MW]QLFS-CR7VW1/WT_'F]WQ5]F5QE.^Q47O8VM?HJ+RJQJ(NNBKIJI\%GT\Z7
M4WZ>[TGA][KCK])=H-=DTEW[,\/OESB,1Z0U#5"46RS26G5?1P^R3BSU9I"A
M/HAD)4@5)4E@)=(&8CV"I+I#0G%K"I+I S$>P:)&->B(JN8YKD?')&YS)(Y&
M+S,?&]JHYCFNT75%,7XHR6]%T5ME;@SYM-EC-@NFW);-8F."</RW?-"N])Y\
M-T-\0.5GN[%FE@H;4WK<DDFDV\CW1PP4;KY9WRSUYYY>+E^X[?6</]Y]A79I
MNW':X_K^=UL?M>V8]\/3#Z6_J\MV?'A[(\AYKIVNL68=1=69Q<HMLOK-9MF9
MY^G-E#XC,8O/XVGE\-?JY+&WZ\-JI=I3Q6:\\,\;98WLEA<]BZL>B]O X3OL
MOQ7SCR1,7Q/&)X/5C2ZK3:[3V:O1WV9--DMB;;K9BZV8F*Q,3%8E]+M(-AQE
MI4U556I655[56"+5??7D)_,R?Y5WXRAT6<Z17[&N.O7A55B@AB5>U8XF,5??
M5K4U,3??=\4S/WLQ;;;RB(;Q%(         ;?>Q?Z2/U?=M]'U0++_%+X%^@
M?BLII9WUMZI!NVG6?!B-U4%BK7JCGJJJZSW3$^6MU=KH_5=43B?7=L=Z;WVK
MD_\ M^3_ &:ZZ)NLGC$T]GL^YPWY1\%>/_+,6:CN;21.[8<=UF+-9/1?;U36
M>JD?GBO^57E"*VYY#.!ER_?4^MMBO@^]5ZTW8J-UAL?-JD37]TK=$8NFO-Z#
MGK;/J7U6@TT8[]OMOU$1PNZ^%?L=0M5_Z>NRY=W_ 'S3[U?9MO76<7RXF:5Y
M=5/N2+>%/RWO#_X7K46Y\3BH-S;ZAB=&NZ<HR&=8F.8Q'N@K21.C@?SLYD<B
MZHO8<<=^^:>[N^L4Z#4Y9P[36ORK:Q^,UXNTGBOZ=/'?BR^-?M6FC-O?1TSF
MR4NFD?Y,3'Y>-9X(4?.5\3F0ZB=8(.@^!R,L>U.GJH[<$-6=R5\GDK4;W(V9
M(IG1R)5^YT5IS1X![7P[9MD]QZFV)U>I^"9YVVQPX?:Z&_75YBS[AW%_RZVK
M+-FCT'#/;$\+\LTNBO&D],3[/5#!HB(B)HB-1$1$X(B)HB<$]9VGTFKY<7FY
MSXSSEH7_ .[['NGT^DU474MNY)*'Z?\ (RH8%'-1S7-<B*CD5%1>/:BIK[Z:
MF8FG&&8F;9BZ.<)S/*#ZY.W+5ZE>#W?F3?D,%O; 9%VP:EV57-H68L=,MR&!
M9I':I++*QS6M;P5OJ.GWU.]D8[=-I^^]KQQ9JL%\1GNMCXHK'3,TCTI->/J]
M.OHG\EY]^T&X^)^X=7-^DU>DO_=,5_'HOF+_ )D6S,\IB;9B*<.GV(A>LO33
M</1OJUOOIGNJE+1R^W\_D41DK'QMGK6+L\E66%7LB25KX-%U:FA^?V1O^+=M
MOQ:G!/Y+K8G_ +'0SRYV/NW8'>VNV#=K9C4X-1=;,TF(F*UBZ.$5B8F.,<'F
MB_6_Z(<Y;-J9I$RXSAM*FB^^<H;=DG)BI,IPU14[62NX[$4*\]O(Y:_3H4ZE
M:*2>Q-):L,KZ1PQ-?(]463T(IMY<V/3X;]1EF+<5EDW3,S$1%(KSE^KLVAR[
MEN&/38K;KNJZ(I;$S-9](B*S,^R(XLZ'P-=&;'A_\-'3GIUEXXJN9I8Q+^58
MY[$D^5Y)&6'I(BMC<CV:HU45-45#R=\J=S8^[^^-;O6">K!??TV_]VWA%']$
M/@_L>/'7C+;>V)X9,>+YE]>?7EI==7A'&O!=\<=N6@      '&N?R.U[-/\
M%.,QS&,GUG^F[J'[>OSB<W+?AAK3S="),         #[>ROI'V-^>*?SZ C=
MR8]891.,_)N/]AJ?-XS3GFVW.,
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M>2QJK7+R^C30KNNNNYI1;$<GM#6M:B-:B-:U-$:U$1$1.Q$1."(A%)4
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M              ")_P SS\E]/OX:Y]J4V<'*563T16-^Y9^T9]ZA<J5
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MGB=]ZY3#+D(J*FJ*BHOI3B@%0
M                     **J(FJJB(GI7@@&P^W5CU[RS7CT[>>:-NGO\SD
MX<V<PM=O-8R^,A;QXRWZL:<.W[J5-126)F(?#GZ@;*KJB2[GP;57737)TO1P
M7_SYGIDZH?)EZM=.8)%ADW=A&R)VI^,*J_9254'3)U0V_P#F_P!-N9K/ZW87
MF<NB?[?6]/#_ $HZ98ZK7UH^HFQYG-9'NG!N<[16I^,Z?'5-?]-ZATRS6)?:
MK[CV_;1%K9O$SZ]B1Y&H]5^HV95%)*P^@R]2D^XN57_M+$3OM/4PRY+7-=Q:
MY')ZVJB_: J                 8ZGC!_2-W7[)B_F[S;Q_ U[N:W@L1
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MPO<_+=0LC,KE55[I]J!%U55TT9.G!-2<6Q1&9KQ=/L9+<5W^7[DS-GF^[_\
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MX_@:]W-;P6(@        "B]B^\OV@)*_+)_+G4C^9_Q!3FY0MQ^J8@UEH
M ,?3QT?I+YOV3'_$/-K%\*B_XEK!:@                     ^KMG=F;Z<
M[PV[U#VU-)!E=OWH%D9&YS4LU);$7RI)$:YB/1(&KVJ8NB)BD\CUK#)4Z2=2
M,+U7V'@=ZX.=DU7*4XG2M:YKG0VFQL^41/1KWJU6R*O;Q-*Z*31LVS6*O23#
M(            $3_ )GGY+Z??PUS[4ILX.4JLGHBL;]RS]HS[U"Y4J
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M+IKXB8NLNBZV8F*\)B9A]4@V0 !151J*YRHUK457.541$1$U555>"(B 1O\
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MD$4P      '&N?R.U[-/\4XS',8R?6?Z;NH?MZ_.)S<M^&&M/-T(DP
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M0            1/^9Y^2^GW\-<^U*;.#E*K)Z(K&_<L_:,^]0N5*@
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MS$.>Z?;CO8*[!*R5U=9[$]:SRO:[NTKK*V)J.Y$3L(S;$Q22)FV:PEC\.WF
M8'=DM'9_5R!NUMSN2.M7RDCVK4RL[G11M>]>]5M=7O>I1=BI\*VR^O">:2ZO
M9KW(8[-6>&S7E:U\4T$C)8I&.1'-<R2-SF.1477@I2M;X           X>1_
M)][V.U\0\,3R8OW4/Z4M^_G6Q\]L&]')KSS=:,L        '(Q&;S>R]Q8C>
M^TK4N/W#@[4,[)8'OC;/6;,R2S',R-S&R(Z%FGPNPC=%2.'%D>>'SJ_C.M?3
M+;V\Z3F-M6:D<.3K(]KI(+T#&1SJ]$>]S>\?\)-?6:E]O3=1L6S6'MQ%(
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M5->[',<8Y+K;Z\)YKWHY&2L;)$]DD;T1S'QN1['M7L<US55KD7UH5IM8
M   &.IXP?TC=U^R8OYN\V\?P->[FMX+$0        !1>Q?>7[0$E?ED_ESJ1
M_,_X@IS<H6X_5,0:RT    &/IXZ/TE\W[)C_ (AYM8OA47_$M8+4
M  [$55[$157W$1-57ZP&^^ED(Z$>8=5E_$LRJV/)(QZP<Z+RJU\B)W;./K4Q
M6(YC8_PHB_45-4^P9         !Q[/RN-U7(8Z9];*8JS!>HV8G.9)&ZM*V=
MS6N9H[X:QHG;Q R#/"'UXJ=;^EV,NV[$:;KPD,6/W#156I-#)%&QD,SF]X]Z
MI.U-=5])IY+:3PY2OLFL<>:ZX@F           ")_P SS\E]/OX:Y]J4V<'*
M563T16-^Y9^T9]ZA<J5          +S/+\^GB[[/+\3"4Y.4IV?%">8UEX
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M@%6K#3B[N+F<Y7*^6:5ZRSRR.7F>]\K]9%YG<>*J7*W(
M   #CVJE>['W5AKM$5',EB<L4\;VKS,>R9FDB*UW'@H%XGAL\9.\.B5VAM3?
MMNSN;IW-+'7@OS/>^QM]DLD,37*^299)VHB>G@B%-V/JXQPE.V^8^Q.EM/=N
MW]\8''[DVSDJ^4Q&2@98K6:\D;_@2)JC96L>_NI$]+5XFO,3$TE?S=D,
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M3T16-^Y9^T9]ZA<J5          +S/+\^GB[[/+\3"4Y.4IV?%">8UEX
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M-U]>7)'-5IPTV.;&KY)9'.DL69GNFGGF>[GDD=+)K(O,]57M+U;D@
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M]RS]HS[U"Y4J          7F>7Y]/%WV>7XF$IR<I3L^*$\QK+P
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MT9"5)%3,6L!/I%25( E26 STBIF(]@$ND4U3M]"(JJJ\$1$XDXL]I2?O7U>
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M+G"=EU)IZ)\JEJO>K5[E2:.>M:ACG@FB<U\<D4K$>Q[7-56JCFN]"FJO<@
M     #AY'\GWO8[7Q#PQ/)B_=0_I2W[^=;'SVP;T<FO/-UHRP         .\
M](+,E/K/T]GC3F=^,&-1.S@ZS U>/O$;N568I6K)OI*JTJBKVK5KJOOK$Q32
MGFV7*         4<YK&N>]R-:U%<YSE1&M:U-5<Y5X(B(G%0(>?&_P"+6WE+
M][HGTQR"LC1'0;QS].75(8GH]OR2&6"9.'>,T54X\>)?CLX=7JJOOGE')&;6
MK0U(DAA1>757O>]5?))(]>:1\DCOAO5SU5>*^DV%3?
M            4<UKFJUS4<UR*BM<B*BHJ*G8O#T@7&^&#Q(9OP[[MK4,C9L7
M>F6X+<463IR2R2MP\[WQUX;$/>2HUC45RKHB:%5^.+H]Z5MTV\F0=@,]BMSX
M>AG<)<AO8S)5HK56S!(R1CXY6->U%=&YS4<B.XIKP-:8I-%\3$Q6'V##(
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M,,@        ")_S//R7T^_AKGVI39P<I59/1%8W[EG[1GWJ%RI4
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M<$.DCG*VK%58L438F.<]L?P%T^#H+8Z8H3,S-9==)
M       -FS6CN0.KR]BJDD;D71T<T?PX7L<G%JMD1%X&.9]B7#R_O$?-G\;)
MT9WOD>;<&WXT9MZW:DUER]-K6.=$QTDKG.6NUW!-.)KY+/VOQ78Y]$I!2L
M     </(_D^][':^(>&)Y,7[J']*6_?SK8^>V#>CDUYYNM&6         !W+
MI5],/3W\Y1_.H2-WPRS'-D[4?Y%3]EK_ !+#2;$<G*#(       !8/XX/$N[
MI)M'^I>T;3';_P!WP3TZ2PR-=)C*SF/;/-*QLC7L>^/5$U0MQV5FL\E>2ZG!
M!Y5@? DTUB:2W?NRRV;UR9SI)II[$BS2(Y\BJ]4:]RZ:KP-E2Y)D
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MW[EG[1GWJ%RI4          O,\OSZ>+OL\OQ,)3DY2G9\4)YC67@
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MLDMS+7)F4*TCG+'1IP3RMK=RQ7/9&CX')]R;EL4BGHUIGJFKKQ(
M                         XUJ&:5L,U29]:]1FBN4[43G,EBEK2-G:UCV
M:/1'OC1%T5-1/'@)Z_!7X@$ZT=-ZV/S5AG]==J008_.P.>U)7L8QC*T_*LCW
MNYX]-5T-3)9TS7TE?9=U1]B] K3  &.IXP?TC=U^R8OYN\V\?P->[FMX+$0
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MG[1GWJ%RI4          O,\OSZ>+OL\OQ,)3DY2G9\4)YC67@
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M&,GUG^F[J'[>OSB<W+?AAK3S="),
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M_:,^]0N5*@         %YGE^?3Q=]GE^)A*<G*4[/BA/,:R\
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MS,S/K[/9#V!V'8-H[9VO%LVR8+,&WX;(MMMMB(X1[:1%9]\N]&B_9
M        .-<_D=KV:?XIQF.8QD^L_P!-W4/V]?G$YN6_##6GFZ$28
M        '_37T)[Z^@#AV;]:JJ(]SY7*J(C*L;K+U55TTY(4<[77W#%8@KZ.
MY;9Z>=3][2QLVEL?)Y&&16HEB>"W4:G,J<J_ND&BI\)#$W1',HN"PO@:\1>=
MC;)9Q46WV/1'(LMF-[M'(BHO(^)%X(OV"'S+?:G%ESO%7RY^LDD2.M;IABE7
MM8C(G>KAKW/H'S;6?ERWI/+FZP-8YT>[(72(GP6K'%Q7_4#YMI\N74,IX"?$
M-B8WR4V09WDU5(VSQ1O?[B(D6J\$^R(RV_>CT7/"-U=%^M6R)96[CZ?WXJ]?
M]^L5VV+/*B<VKD;% NO!I/JM]&)B8YO,67X5F?6FCLU+$:\LD=RK-5Y7(NBI
MK.UFNBF8FK#G</0J.3AQ:J*G%->U.!D              :ZF8O;9S6#W9BY9
M(LE@<C3EA=$YS']PMJ)]A.9BM=IW;%UXD9Y%:,F3I!ORCU*Z=[8W?CW-=#D\
M;65^CVOTL11,CG15:YVB]ZB\%74U+HI=1LQ-8J]+(L@    X>1_)][V.U\0\
M,3R8OW4/Z4M^_G6Q\]L&]')KSS=:,L         #N72KZ8>GOYRC^=0D;OAE
MF.;)VH_R*G[+7^)8:38CDY09      \NZS=0J'2_IONC>60>UL6,QMCNN9[6
M*MF:)\=?EYGLU5)51=$74E;;U31&Z:15C/6<QD=SYK.;MS,LD^4S^0N332RN
M<]_<?*I7UDU>KET2)Z:<3<B*11KAD            ^UZ_0GOKZ .(^VWOV5*
MT-B]<D7EB@I5YK2N<JZ-15KM?RZJ8K$321[EL/PS=?.I3&SX;9L^,Q[^14R%
MR1]?1C^54>L=B%./*Y%T(W7VQPF4HMNGE"Z+;'EL;_OQ,?N7?<>.D=R+)$RL
MR5$UY5<S5L*IP153ZA7.6*LQCFO%ZQ4\L3:R-3\8;XN67JB<_)4:UJN]*HO*
MBZ:^X1^=[(2^5[VY/Y8NSU9_LF]+L$J:_#6HQR*O'EX*G#11\Z?8?*][SO<7
MEG;FJ1R2;<ZAI9<B+W4#ZC6+P1VB*YT'O(9^;$^C'RY6T[U\'?B%V%!-:7;O
M]9J$/,JW:TR*[D3F55[F*%7:\K-=/=+(R6SRYHS;='-;;8?:QMQV,S>/O8C)
ML<K'U[=2S!&U[55'(DT\<;535%)UX51;_#M14<GK:J.;Z^"IP,@
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M&?>H7*E0         "\SR_/IXN^SR_$PE.3E*=GQ0GF-9>
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M7SDRW3=DF>,S-9G[Y>B>#!@TV*W!IK+<>&V*1;;$6VQ'LB(I$.:06@
M         #C7/Y':]FG^*<9CF,9/K/\ 3=U#]O7YQ.;EOPPUIYNA$F
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M->Q[4<Q['(YCVN35KFN:JHYJHO!4/S)B8FD\W[\3$Q6.,2U&&0
M     !QKG\CM>S3_ !3C,<QC)]9_INZA^WK\XG-RWX8:T\W0B3
M   &Q9LQU(DD>U\CWO9%7@B8LDL\TCN2.-D;-7NYGJB<$4Q6@DF\(O@GEW3^
M+^J/6?'O2D]&6MO;2L(YJ-8Y&R06K'/$BJQ'MUY5[>PIR7TX6K+;*\93#8_&
MT,34@H8VI7I5*\4<,->M#'!$QD;$8Q$9&UK>#6IZ#7YK8B(X0YH9
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M_4[K9O?=,\BRU(K:4<9QYHXV4I9ZSDC^$]J:(GH-RV)MBGHUIGJFKS(FP
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MB.<O,J(B\>/$T[XI=2&Q9-;7N9%)CJ>,'](W=?LF+^;O-O'\#7NYK>"Q$
M      47L7WE^T!)7Y9/Y<ZD?S/^(*<W*%N/U3$&LM    !CZ>.C])?-^R8_
MXAYM8OA47_$M8+4         !HD_>I?X*7[QP$O'ED?1SN+VV'[UIKY^:W%R
ME)Z4+0   C8\P3P_KO+:4'53:]/7=6S$?-:CK1:S9*B]KT=WG=Q.>[Y.BJO%
M?278KYC\JO)'"J&ZM89;@9/'V*KHY$5-%;-$O)*U6KQ14>BH;$352WC(
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M:>$QVWL'3AHXS&58JM:O!&R-J,B8UB.<D;6M5[N7BNG$U9FLUE?$4BC[IAD
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MK'O8]<"7(GV\=DH'U<KBK-BE=JRM<R2-:TSZ[7*UZ-=H_NU5.":FW50WS(
M      /?XIV*GK1>"I]5 +F?!_UPFZ(]6:V,REMT.Q]]3QU<BCW*M?'V46"&
MJ]C72,CC5TJ^A"N^SJCAS2LGIN]S(3KSQ6H(;$#VR0SQLEBD8Y'->R1J/8YK
MFJK516KZ#4;#>    $3_ )GGY+Z??PUS[4ILX.4JLGHBL;]RS]HS[U"Y4J
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MUZW"_='7?J)DW2+*WY:V%KE7F1.YFFCX*JJ;MD=-L0UIXS5YB28
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M$U',:^=D+HU55:Y->=?6A5EX6IV?$G[1$1$1$T1$T1$]")V(:J]4
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MO1#9.&; D+TQS+4R<J-<Z2TQDG,[X+5^Y5#2O^*6Q9%+:+A"*0
M    !XEXB=K)O'H]O7!K&DJSXJQ,Q%;S:.K1/F1R)RNXIR^HE9-+JHW\;98U
M6-;)'!/#*J]Y7OWZZHNJ*U(;+XVIHNBHFC3=:[Z          !L6FH^O,UR:
MHC'.T]UB*J+]13$\8$Z_E_[C7,] <%2D?SRXN:Q$[X7,J(Y8]$[55$X&MEC\
MWN7XY_*BV\8/Z1NZ_9,7\W>78_@57<UO!8B         *+V+[R_: DK\LG\N
M=2/YG_$%.;E"W'ZIB#66@    Q]/'1^DOF_9,?\ $/-K%\*B_P"):P6H
M     #1)^]2_P4OWC@)>/+(^CG<7ML/WK37S\UN+E*3TH6@      (P/,+Z!
M/W!@*_6#:M!'9[:K7/S,5:/67)4WH]C9)$CC<]ZP([TJ78KJ<)59(GG')$/!
M.RU"RQ']R[X+O6DK.$K53T*UZ*ALJFZ         TOC9*Q\3VHYKVJW1>Q'*
MBHUWOM50),O+PZ]2XVY:Z&;IO*K&.=/LZ6Q)^^L1K'68&OED37BJ:(B>@U\M
MG[4+<<^DI@BA:  (G_,\_)?3[^&N?:E-G!RE5D]$5C?N6?M&?>H7*E0
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M)HUJ(B=FB>CWC\V+9F>J[C=+CN9NONG)DFM\A.(]@&>D5)4A@)4D#/2*DHM
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MK')4,@        #C7/Y':]FG^*<9CF,9/K/]-W4/V]?G$YN6_##6GFZ$28
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M6LS2RMTU1>62%R+]R[L4A?/Y99CFR386=W#$S]A&QG^:U$_P&FV6X
M         VY6\\4C%_RXWM_SFJG^$#&Z\36'7 ^(;J'56/NXYYX)(D1-$U<^
M=SN&B&W9\,2U[OBF'BQ8B         *+Q14]:*GUTT,"3/RR,HL65ZE8ASO@
M_P"Q.C;KIQT@7@FO'1/<*,O*)CDMQ4XK5/&#^D;NOV3%_-WEF/X$+N:W@L1
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MK&_<L_:,^]0N5*@         %YGE^?3Q=]GE^)A*<G*4[/BA/,:R\
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M;X%*'R_Q'XNPYB.9C:]Q^NB?!>L,:L7L7_**LG"W@E9\;(%-5L
M       !C\^.JJE/Q'Y61K.5EV"G)JG^4_NI7.7L]"FUCG\L0U[_ (EJ9:B
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MK)Z(K&_<L_:,^]0N5*@         %YGE^?3Q=]GE^)A*<G*4[/BA/,:R\
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M&_LJMAOUX7H!C#=4J*X_K#U"K:<K4R4CVM[$3GM3N7W.)NVTHUII7AR=0),
M        #YV5U^1KIVI8K+]:5%U^IH8GD,C+PDR)+T#V$Y']Y_\ #E17>ZBH
M:F3XFQ9\,+D2"0  X>1_)][V.U\0\,3R8OW4/Z4M^_G6Q\]L&]')KSS=:,L
M        #N72KZ8>GOYRC^=0D;OAEF.;)VH_R*G[+7^)8:38CDY09   "/;S
M&[;8.B<T*L5RSVHT1==$:B*[T>DMQ5ZJJ\G)"C!^\0_P4?WJ&TI;H
M  !>GY>4+9>N6<D=VUZZ\G#7[N&'7CZ.)5E^!.SFG?-5>
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M!"<6>UFGM-%7M)Q%"L1R5Y41./\ A,T8K,\E>;U<246S)1352460S2%"<1[
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MO#O,S0=K^UOUUTT]TC=R/6C*/Q+49BL8Q.QN/IM3WFUHT3[1I3S;3Z
M             V;":UYT]<,J?78Y ,:CQ!5VU>O?42)BZM2VQ==-/NIIE[/J
MFY9\,2UIYO*B;          X&3_D;_X6#XQ ,B'P<)IX>]A^QR_?--.^:W2O
ML^%= 03  '#R/Y/O>QVOB'AB>3%^ZA_2EOW\ZV/GM@WHY->>;K1E@
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M8+4         !HD_>I?X*7[QP$O'ED?1SN+VV'[UIKY^:W%RE)Z4+0
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M^%<^13  '#R/Y/O>QVOB'AB>3%^ZA_2EOW\ZV/GM@WHY->>;K1E@
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M/^(*<W*%N/U3$&LM    !CZ>.C])?-^R8_XAYM8OA47_ !+6"U
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MIY[8\,[);TVV:KNK-9_7:FZV*TKU6X[(F)Z8QS,Q$QQGG/-(L<6.Q0
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M)X\5_)Q0YU      XUS^1VO9I_BG&8YC&3ZS_3=U#]O7YQ.;EOPPUIYNA$F
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MD_ESJ1_,_P"(*<W*%N/U3$&LM    !CZ>.C])?-^R8_XAYM8OA47_$M8+4
M       !HD_>I?X*7[QP$O'ED?1SN+VV'[UIKY^:W%RE)Z4+0
M66^-?H&WK'TULY/#UVKO':4$^0PDT;$[Y[&,>^U#S-C>]W-&BJB:EF.^;9IZ
M2A?;6*^Q M5GDFC?'88Z&Y4FFIVH'M5DD<E618'J]COA-YGL7M-M0Y(
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M;^/&7NYX6\+=M^'>V[-LVRRS)N^2VV=1GF(ZLE\1Z<*Q;'L7K''SF@
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M;;I]?LEZ.?07Y+T^S=S9^R-PRW5W.(^3;-9B,ED3=-.-(K;'LXT989Y^/70
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MKV(!CS>-7(QY7Q);F5CN=*#:L/,G'1&ME:U."KZ&FUCC\L2U[^-RV8M1
M      "^'RYJ22]9-U7%156&"-$7CHG-%#K[A3EITK+.;R7Q@_I&[K]DQ?S=
MY+'\"-W-;P6(@        "B]B^\OV@)*_+)_+G4C^9_Q!3FY0MQ^J8@UEH
M  ,?3QT?I+YOV3'_ !#S:Q?"HO\ B6L%J          T2?O4O\%+]XX"7CRR
M/HYW%[;#]ZTU\_-;BY2D]*%H           -$D;)8WQ2-1\<K'1R,<FK7,>U
M6N:Y%X*CFKHH$!WC?Z'+T@ZF?UXPM-8MF;YG>ZPR")?D^*N1)++*CN2-K&=^
M]W#5?2;6._JCCZ*+[:37T6@^I?0J(Y%]:*FJ+]8M0
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M+INI6DT43JM+;=-EV3'%\<XZHK^%6G\>87_OC%_TA4_##IN]DL?O>E_M<?\
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MB.3*AD /1>CW4'(]*.K&PNH6+>^.UM_/XY=8WNC<L-F]7CG3G:YBIK$J^D_
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MJRJURZ+_ );8$^ZT*,O**K,41Z\UN/C!_2-W7[)B_F[R>/X$;N:W@L1
M    %%[%]Y?M 25^63^7.I'\S_B"G-RA;C]4Q!K+0    8^GCH_27S?LF/\
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M:*_731?43QTZHJC=\+&]P[E=275-%;;N,5%_ZD[F?X#;B:PUWU#(
M .P;$RJ[?ZE[&SG-R-IY:M&Y^O+RI8N0,7X6J::I[I&>,4]68FDLH+$SLLXO
M&V(W(]D]"G,UR+JCFRUXWHO:O:CC2GFV7T                '7]UY*'$;:
MSN1G<C8ZN)R$JJJHB:LJ3.:FJJG:J&8BLC%UR]]<QNG=&:5ZR)?S.1Y7*JKP
MCO3\-55==-3=B(B.#5<<R         #2[@QZ^ICU^LU5 E8\L/')^)=_YE4^
M%<L4H4=IVHC6*NCO3IR>LULW.%N.G'VK,/&#^D;NOV3%_-WEN/X$+N:W@L1
M        %%[%]Y?M 25^63^7.I'\S_B"G-RA;C]4Q!K+0    8^GCH_27S?L
MF/\ B'FUB^%1?\2U@M0         &B3]ZE_@I?O' 2\>61]'.XO;8?O6FOGY
MK<7*4GI0M              1&^8GT%?%\DZY[5H:SX_EAW=%6C^';AY)&5IG
M,BBU7DUXJJE^*[]E5DCUA%Y'*R>-DT;D<V1J+P]#M$YFKQ7BU5T+XXJFLR
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MCCC:C&,8UJ(C6M:B(B(=#;KINNFZZ:W3-9>QMMMMEL66Q2V(B(CV1'*&Z89
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MQ,3PF:UB8J[YHB<>U%XI[R\?1[Y]Q-D_<^)K/WG,2BPHHO$ETPRH9
M  O%%3UHJ?730$<ZLBGR(>HSECZM=-KTWP:C\9D,2QS^#4<V-L\3&*_T\W,N
MB'2?ZLMDMLR;?O6*/S7]5M_#V<IJ]:O_ $^N[-5K]KW;MO53_L^GC'DQ>_JF
MET4K[JLCDZ7/24    %')S-<GK14^NF@&.EXNL>[%^(_?;',Y&VY*SHDU]:S
M*NG!.TV\?PPU[OB6]EB(         TO3FCD;^RCD3Z['(!+GY9NZ$M[%W+M*
M2727;]J%[('/U<UEA&*Y4:KM>"JGH0U\T<:K<7JE!*%H
M 1O^9-N^3$=)J.UX)=+&Y[BM9$C]'2-JHYSN".151-?4I=ACC57DGA1#5$WE
MBB:O:D;->&G'D37A[YLJ6L          [7TSQBYOJUT_Q+6J]UC*0R(W151>
MXMPOXIHO9H1NY,Q%99/F/9W5"E'IIW=2LS3U<D+&Z?8-)LN6   </(_D^]['
M:^(>&)Y,7[J']*6_?SK8^>V#>CDUYYNM&6         !W+I5],/3W\Y1_.H2
M-WPRS'-D[4?Y%3]EK_$L-)L1R<H,@  !Y_U3Q'X]Z?;KQO+S=]A<@[33758Z
MDS^S1VJ\"5O"6)BL48PD,"U+.4J.3E?!E\FQS5145NEV9J<%]XW(Y-9R3(
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MV/;%:KVY9;"LC>YD;52&/1.&O8;=DQ,5AK71,2\\)L
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M           "6KR9MTKAO%4NW^]Y&;EQUM7,YM$D6I#$Y$5.9-51>S@IUO\
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MZK3T=V74?*U<6U_J\D0\*]^T<V1?;^WCF?Y7=E313Z^>$ODH4,,@
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M)JC77   !P\C^3[WL=KXAX8GDQ?NH?TI;]_.MCY[8-Z.37GFZT98
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M:P6H         #1)^]2_P4OWC@)>/+(^CG<7ML/WK37S\UN+E*3TH6@
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M=W598UM34HJV1@:]KI8;=:-D4BRL1[W-614YN/K-.^WIFGHV+9K'O>Z$4@
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M\SP/\^6VV>3-TMMX6_/N?!A55@BU_8)]I#F/'_J;?L=:,D4RW?:UF40
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MDW*J-<Y.&FI9CFEWN5Y(K"""I.EFO'(G^3K"Y/4Z']S=_P#B0VH4N09
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M3^7.I'\S_B"G-RA;C]4Q!K+0    8^GCH_27S?LF/^(>;6+X5%_Q+6"U
M      :)/WJ7^"E^\<!+QY9'T<[B]MA^]::^?FMQ<I2>E"T
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M'_L9M3_P[B/^#'\7W:/_ -*U']Y?_I'\ V+_ '+2?W./_1/ZA['_ +&;4_\
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M 'F;<+-Q[^W/58YK;.HO_1,PVF\(XV^IC?M(<K6QTV6QZ4=?;N-\S[P,
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M.=P-^OD<9D:\=FM9KRQRM='*U'M1W=N>C'HB\45=4-68F)I/-?$UBK[1AD
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MNOO'77ZF-;&#Q_=I:TG+?;]])EWW^@_98UGD:=SF*_NV&>-.75P9A1YP/9@
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M:WUBM69.QS7M:]BHYKVHYKD[%:Y$5%3W%13S=F)B:3S>UT3$Q6.348
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MEC>B<ZIV%D6Q'+DKF9GC/-U*.-D3$CB8UC&\$1$1%7L^Z5$3F7AZ28U@
M       !1SD8USUX(QKGKKIV-37TZ=H$D_EN=)ER>4W#UCRL#^[5\=7;3I8E
M1$:Z-C;<D3GQ\$16Z?!=Z2C+=PZ5F.*_F3&&NN ,=3Q@_I&[K]DQ?S=YMX_@
M:]W-;P6(@        "B]B^\OV@)*_+)_+G4C^9_Q!3FY0MQ^J8@UEH    ,?
M3QT?I+YOV3'_ !#S:Q?"HO\ B6L%J          T2?O4O\%+]XX"7CRR/HYW
M%[;#]ZTU\_-;BY2D]*%H                  -FQ!%:@FK3L;)#/%)#(Q[4
M>US)&JQS7-<BM5%:OI QZ?%WT2GZ(=6+-W'U71;+WQ-);Q3V-7Y/1G5TT]MC
MG-C9&Q72+IIJ;>.[JCWM>^)B?<MI][BGH7UIZ%^JA8B               7F
M>7Y]/%WV>7XF$IR<I3L^*$\QK+P     ++/'UL3^O?AKW[28WGFJ8R>U&Q(^
M\>_DKV$5&KR/<WBY.PY \9;E&V=WZ7-,TMG)$3^,./?*>TQO/8VX:*E;IT]\
MQ%*\8LNHP2LI3GQ.>R-&RSNIJ.0LPR,7_)5MA[53L3TH>H>DRX]1IK,V*:X[
MK8F/PA_/?OVWZG;]?J-%K+)LU-N2^)M]DQ,NT<_,UKD_RFM77ZB&[%L3#X'I
MI=,>R5.*]I*+:G()](&:4%3(&>D.PE%OXBFI.+)]2BBKJ3BV(^U*AHJF6*PU
M<J)Q5>!FC%:\GV-N;DR>S=R[?W;A;$E3)[?RU"]7L1*YKV,@MQ33(BM<UVCF
M1JB\35W';M/N>WYMOU=L78,N.ZV8GWQ1]/V?W!K^V=_TV[[=EG#JL.6VZ+XY
MQ,3#.^\*?6[">(/H7L/J5A)F21Y3$5JMUB2-=)%D<?!%6NI*U))',<Z9JNT5
M=>)Y,]_=KZOL_NK5[)JXI=CR3-OLFVZ9FVGW/Z*/%W?&U^1.Q]#W1M-\WX,V
M*+;IGA/S,<1;DB8]/SQ/-<4?&N00    6(]7?,>\*W1+?>2Z<;ZWU)2W5AE8
MF4I5J#[3*JR<W(UTL<J-YEY%X'[NA[;WC<<$:C28JXKN4S-' O>OU+>(/'N_
M9>VNZ=PR8MWPTZ[+,5V3IK[9CU]SSC];EX*/[P[G]$2_AC<_P7W%_8V_TH?)
M?]9_T^?\5U'_ .K7_K/UN7@H_O#N?T1+^&'^"^X?[&W^E!_UG_3Y_P 5U'_Z
MMD_6?K<O!1_>'<_H>7\,/\%]P_V5O]*#_K/^GS_BNH__ %:_]9^MR\%/]X5W
M^AIOPIG_  5W%Z8K/Z<'_6A]/?\ Q;4?_JU_ZS];EX*?[P[O]#S?A1_@KN/^
MRL_IP?\ 6?\ 3Y_Q74?_ *M?^MOU?-K\%%F9L7_,>Q%S?Y<N*DC9[RN=,B(8
MN[,[AMBMV&VGNNB5N#ZR?I_U&2,5F[Y;;IY3?@NMC\9EV7!^:+X,=P9_$[;H
M=48?QEFK45.@DU)S()+,\K888GSI*YL:R2/1$U*,O:N^8<-V?)AICMBL\>/X
M/VML^JGPAN^[8-ET.[VW:[47Q;96R8MZIY1-U:1,^E>:02">*U!#9@>DD%B*
M.>&1JZM?%*Q)(WM5."HYCD5#YZ8F)I/-V&LOMR61?9-;+HB8GVQ/)NF$@
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M?7\-BZL:;''W=7%[C_1-L./;_$.'=[+>F[5YLE>%)GHNI7ER]D^J9@ZU.XP
M     #1)&R:.2*1$='*QT;VKQ1S'M5KD5%X:*B@8^GC/Z.R](>L=K.TJJP;3
MW[(ZQ2<QFE>I/&LTMAKE;&R-CG2>M>)M8YK"B^*2M;^UP5%]:+Q1?JH6H
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MP&:KR5,UA+=BG=K2M<R1K()GP0O5KT:Y4D;'KV&Y$U44F&LR
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MW(;?S=:2GF\):GIW:TS7,D:V"9\$3^5Z-<J2-CU3@;<3$PUVHR
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M25970*Y[':/3G<Q535$-N)JHXQSYN09
M     -$DC(8Y)I'(UD;5=JNB(KM/@MXJG%R\ )./+NZ#6+EFWUSW31<Q++EA
MV=%9B5'0Q*R-EJ=K)8M4153@J+Z>!1EOBG3"S';^TE]-=<  ,=3Q@_I&[K]D
MQ?S=YMX_@:]W-;P6(@        "B]B^\OV@)*_+)_+G4C^9_Q!3FY0MQ^J8@
MUEH    ,?3QT?I+YOV3'_$/-K%\*B_XEK!:@         -$G[U+_  4OWC@)
M>/+(^CG<7ML/WK37S\UN+E*3TH6@                   %37@O%%X*B^D"
M%OS"NA#]K;CK=;MLTG+C<G(D6\HJ\/+'$]C9$K3JV*)&Z/>[BJJ7XKHI3U4Y
M+9B:QR1X-<Q[621N1S'M:Y%1=?ND1=-4]*:FPK5             !>9Y?GT\
M7?9Y?B82G)RE.SXH3S&LO      HYJ.:K7)JCD5JIZT5-%3ZP&)#YT?13^J/
M5V#?V/J+#C\ZG.YS8E2-TKW67N^&D36_!<NG:IWN^F_N2-9LMVT99KFQSPX^
MD4][RZ^N?L;)CW#2]UZ>.G3S$VW\.<W3,Q-:>ZG/U0Q86;7O(%7T-5/=[%7T
MG:C%Q_++S(W/'3IRP^VJZ%\62_+HIJI*+89H:*I(K#5RHG%5X&:,5KR-43L)
M1;)29YJ*NOO$XMB"BA)D    &]6M7<?=H93&VIJ62Q5NO>HVZ\DD,T,U29MA
MG))$YLC>9\:=BH5YL.+48;]/FB+L5]LVS$Q$Q,3%.4OT-KW#-M>MQZS!==;?
M9?$\)F)K$\)B8XQ,>V&8WY:7CDQ'BDZ8U=L;FR%>OU8V30JTMP4)Y8HI\E!&
MQD-:_7CDG=+8?(Q$Y^5%]:GF?YN\5ZKL+?+M=H[)GM_57S=CNB)F+9GC-L\*
M13T>\?TT^=MH\M=J8]'GRVV]U:+%;;FQS,1-UL?EMOMK-;NJDS-(X>J4$X*=
MG    ZSE=E[0SDZV<QM?;V3LKVV;^&QUNP[]M-/6DD<B:^E3>P;IN6EL^7IM
M1FQV>RV^Z(_")HT,^T[3JLDY=7I=-ERSZWXK+Y_&ZV9?&FZ5]-K#$9+L3:3F
MM[$_J]B4^U40V;-_WRR:VZO4U_\ ,O\ UM>[M[MZ^*7;?H?[C%_H./\ \H.E
M_P#8':7] 8O_ (4G_B/?O]\U/]Y?^M7_ (9[;_X?H?[C%_HG_*#I?_8':7]
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M/.$8-:Q%;@CLP.YXWZHO#1S)&\)&.;VM5K^'$O5-X
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M/5Z+#FO9(QDD;D<R1K7-5%1?ND1>75%7BW7B7(*@
M            !ZKT'Z-Y?Q =3,;M.C',S:F)M06MV91L;UAAC@F@GBA1Z,?&
M]9D14[2NZ_IBJ5MO5+) VSMS%;2P6-V]A*D5+&XNK#5K00L:QC6Q1M9S*C&M
M17/Y=573BIJS,S-97Q%(H^Z89  &.IXP?TC=U^R8OYN\V\?P->[FMX+$0
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M/!_G/MKS)V[9K='?9AW_ !6Q&HT\W1U673ZVUFMUMW.)CERE?.<5N=
M          !YGU:ZM['Z+;+S&^M^YREA<+B*DUE[[,\,<L[XXI)&0UXI)(W2
MOD6/1$0_0VK:MPWO7X]LVO%=EUF6Z(BV(F>?K/LB'Y.][YM7;FV9=XWK-9@V
M_#;-UUUTQ'"(K2*\YGTAA>>/CQV;R\8G4"U1Q5BWC.F&%MSP8/$13S-BO1QR
MS,;;G1D[XWH]C]=%0]#/$/B32]B;?;J=7;&7N/-;$WW3$?DK$?ECAPH\</J9
M^I+5^2]SOV?9<EV'M+3W3%D1,Q\VG*^ZDTF)X\%D%"C'2B3@BS.1.=VB<."=
MG ["Z;3QI[>/')+H]J]5?JLG_P N.3F&PU@           %71%7U(J_615_P
M!F(K,1[99&?D:=">[H;[ZYYS'ZKEGUL=M2Q+$J=VR+D^72P2OB37F5.5>5VA
MTC^JONV,FHTO:VENI\NMV6*\Z_#$Q7[^3UU^@?QUDVO8];WKK;;;L>JBW'@F
MGP]%U;YB:>O".?HR+SID]&0          X>0Q]/*T;6.OUXK5.[!+6LP3,9)
M'+#,QT<C7,>US5U:Y>U (!O%QX8<IT$W1=WGM6E8N=,,_:DFF@KQ22_U<GF?
M+-(BI%"G,V21?>1#:QWQ-(GFHOMZ>/HM08]DL;)8W(^.1J.:Y%1>U-=%T5=%
M3U%J#4                                -#&9"]D*&#P5*;*[@RT\=7
M'8^M&^5[GS/2+O).Z1ZQ-C5Z+Q0Q,T8F4X_@X\*%7HQ@6;MWC!%>ZD9Z&.>_
M-,QDBXEKF-_V6%71(K)$1$U5#6R7]7".2^RRG&5]Q4L        .'D?R?>]C
MM?$/#$\F+]U#^E+?OYUL?/;!O1R:\\W6C+          [ETJ^F'I[^<H_G4)
M&[X99CFR=J/\BI^RU_B6&DV(Y.4&0       #K>[MIX/>^WLGMG<5&'(8G*U
MI*UFO,QCVJV1BM1[>=KD:]FNJ+H9B9MFL$Q7A+'2\070K/\ ASWY:PEV*Q:V
M)FK4]G:V;6)ZQ,;++-+)7F>V-L</=<&\5]' V[;XNCWM>Z.F?<\?5--.**BH
MBHJ=BHJ:HOU4)HJ                               'T-O;<W'O[=&*V
M#LNC-D=Q9NPR!5A8]S*5=9&,L2S2,:]D?+%)JG-VZ$;IIQGDS$5FC(=\.'0/
M;O0/8&.VYC8HY\U/7BGS^7=&Q+%Z\]B.D1S^1K^[B<O*B+VZ:FI==-T\5]MO
M3'O7"D4@   QU/&#^D;NOV3%_-WFWC^!KW<UO!8B         *+V+[R_: DK
M\LG\N=2/YG_$%.;E"W'ZIB#66@    Q]/'1^DOF_9,?\0\VL7PJ+_B6L%J
M        T2?O4O\ !2_>. EX\LCZ.=Q>VP_>M-?/S6XN4I/2A:
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M/51=;TK48)HK,39H'\\;OJ/:J:<R/9]TQ47UER#=
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MRYU(_F?\04YN4+<?JF(-9:    #'T\='Z2^;]DQ_Q#S:Q?"HO^):P6H
M    #1)^]2_P4OWC@)>/+(^CG<7ML/WK37S\UN+E*3TH6@
M       '%O4Z^0IVJ%J-DU:Y7FK3Q/:US'Q3QNCD:K7(J*BM<OH QU/%/T7L
M]">KEVI6K2,V5O&>2[MZ?E<D%>9[YK%R)7)&R-JI+P3UFY9=$Q7U:]UM)]SP
M-4T_P>ZGK)HJ           "\SR_/IXN^SR_$PE.3E*=GQ0GF-9>
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MB2S0VI\;DJD^*RM1[HK=*[#+6=%(QRL<C%G;&LB*YJ\40OB8GDK;_P#]YD
M                       !I>^.)KGRO;&QJ<RJYR(JM]/*BJG,NB>@#T/I
M3T<ZD==LS#BMB8BY!A>]:W)[HLP35X:<"O8V1\;9HECF1(WZ\-2,W1;S9B)G
MDG.\//A5V%T#Q+%HUH,SNNPQ/QIN2S#&Z:S(K8]5@:^+F@1',X*FBFK??-WV
M+[;8C[5T9!(          .'D?R?>]CM?$/#$\F+]U#^E+?OYUL?/;!O1R:\\
MW6C+          [ETJ^F'I[^<H_G4)&[X99CFR=J/\BI^RU_B6&DV(Y.4&0
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M:4F9K%:1'O6[TK'RFNURK\-B(CD]/HT4Y7LNZK./Q0ZIZG#\C-,?LSR<DRH
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M(*S497B;&U/4U.9>SM=IJJ\#ZRV+;(I9%'%.3+ES7=66Z9ENF:U04,
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MP.U\33Q.,HPMA@AJP11KR-1$19'L8UTKU1$U5=5X%,S,S65L1$<G9C#(
M       .'D?R?>]CM?$/#$\F+]U#^E+?OYUL?/;!O1R:\\W6C+
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M2*W7370U[KINFLKXB(Y/3R+(
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M:>8^3?313/K?%;;[^F8](F8B?OADXHB(FB<$3@B)V(AT9>H0
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M.)C8XVHG!$:QB(UJ)[A6FW
M                                                       ''MU:
M]ZK8IVHF35K4,M>>*1K7LDBF8Z.1CFN16N1S7*G%"5E]V.^+[)I=$UC[F+K;
M;[9LNBMLQ28]S$7\V?P/6.C6][/6'9&)E_J9N:X^>_'3@>^*E;FDGED5[8*S
M61HU=-=5TT._7T_>4+=^T%O;&ZY(_?\ #;2R9GC-L4]L\7E9]9'@C'LNJO\
M(O;V&;=%GO\ ]HBV*Q%]TTBZD1PY16?Q0[XFXDK/D[W<4^X5?3V:_6.U.*_A
MT7?<\U-PTTX[_FVQ]KZ_86/SU
M       5 N>\(7ABW5XK^L^WM@86&>MMJGD*MW>.>;!)+5QV/K316'1/>D4D
M:NM1HK$1?6<>^2^_=!X^[9S;KJ)B[7763;AQUI-UTQ3V^G-V#^GOPMO7ESO+
M3Z'31./:<>2V[/FFV9MQXZ\?2:W73%(CWU9QG3GI_MKI=LO ;&VCC:^*P6W\
M?7HU*M:-D;$[J)C))7(QK$=)*]O,JZ<54\K-YW?6[[N>;==POG)JLU\W3,S7
MG/+[GOKL.R:#MS:,&R[99;CT6GQVV6Q;$1'"(BM(IQGG+NY^6_7
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M35S->PA.2Z4HLM>^UJ-*FU&4ZE6JQJ(UK*U>*!K6HB(B(V)C41$1"%9E-R@
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M==S619;#WF***%B1PQQQ,3L9$QL;$]YK41$(I-P
M
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ML]4?YSJIJ,$Z?)T_L3R<@*0
M   .Q[-V=NCJ-NW![#V5B[&8W-N.[#2HU*T<DBM265L4LTJQLD[N.)K^955-
M.!^=N^[;?L6VY=VW3);CT6&V;IF?=Z?;+Z[LKLS>N^=^P;%L>&_-K<U\6VVQ
M$\Y]9]D1ZRS4? +X.=O>$;H]CL$L5:_O[/Q09/>6X>X8RS:MRQ,?'115ACDC
MBH(Y6:?Y2IJIY>^6_).L\B]R7ZRMUFTXIFW#CK6(B.'5SXS=S>]W@/PUMWAS
MLO%L]LV9M[S?GU&:+:3-UW&,?*M,=>GWTJON.*7.8
M       %%1')HJ(J>I4U3ZR@<=]*G+^^5*TG[>")_P!\Q0/D7=J;9R"*ES 8
M>?5%1728ZFYRHO#BY855>TS688F(EU*WT<Z:7E5;&S\*Y5UUTH5F]NNO9%[I
MGJDZ8==L^'/HW;9R3[(Q+FIJNB01M[?=:Q#/7<QTPX7_ ,L71+^PV+_U;?\
MLF.NYGI@_P#ECZ):HO\ 4;%\%1?WMO:BZI_D^L==S'3#[-;H#TDJ.:Z#9>':
MK=--:L+NS33MC7U#KN]ITQ#M%+IEL+'JU:NU,)&K=$1?Q;35>'OP^X8ZI9Z8
M=IAPV(KL:ROBL="QB:-;%2K1HU$]2-B1$,5EFCG,AAC_ 'N*./3LY&-;]ZB
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M-TT2&A58O!$1-7-B1RZ(ABLLQ$1R?>9''&G+&QD;?4QJ-3ZS41##+6
M
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M]SHT4S+#&R1^E/A(G'0^UB>NWJAP7DQ78;ILO:S"(
M                   :XHK5JS5Q^/J6,AD\A/%4H4*L,D]BQ8GD2*)K(HFO
MD<JR/3L12-^3'BQW9LUUMF&R)F;IFD1$>^>#<T&@U.Y:FW3:6RZ_)=-(BV)F
M9GV1$<9F?9#*_P#*S\O2+H)M2MUCZN8>&7J]NF".U0Q]N.*==HXR>)O=11N=
M"B_*[D*M>[CK&JZ=O9YX>>_,-W=VY7=N]OY9_P /8)I==%8^=?'.>?*V:Q[^
M;VO^DOZ>K?&W;UO<_=&FML[MU45MLNI=.#'6>CC3A=?;2Z8K^69HF@.L[NH
M
M
M
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M-[)XTEC5'-5-51--471%7TKZSZVMMT5M<.7VW8K^B_A*IA@
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MHC6M:U-$:U$T1$1$X(=0YF9FL\WH'$1$4CDJ8
M
M
M
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M5:BIJFJ(OK]9]S$Q?'5:X%R8[\-TV7^C4$0
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M0
M
M
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MB(B:(B)P1$1."(B'7_F[5\N$*@
M
M
M
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M?2)R99B)R7WT_-=U4K'5/&E5TI\(Y*
M
M
M
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MT6&W3Z3'9BP6Q2+;+8MMC[HB(?5*&P
M
M
M
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MVP=J;?CVS8=+AT^DQ6Q;;%MML32(B.-T16>7J]./PWT
M
M
M
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MK,W73/\ ++M5MNT;7M&"W3;9I\.##;;2(LLMMX1[:1%7;#\]^D
M
M
M
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M(B<$0_,F9F:SS?JJ@
M
M
M
M                         #Y%SM7\D?SSM]/:7X__ '_N0R_^[_[SX,W;
M_P#F5_Z[M])MV_\ \S]S2O\ _P"7^]\IWW2_1KV_Y7W7U?=-B.7_ .FM*>?_
M .@N1']RWZ/?_5_<_P#DD)YS_P#6+;?A_P#T/[N3[-;M3_\ E;T?R;M^I_@-
M:_E_\?[VYCY__!^YV2'[A/WK_P!3]Q]0T[N?K][<]&Z1
M
M
,            #__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm2030088d23-fc_overv4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d23-fc_overv4c.jpg
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MR#70MZCI;+'%=JV2_LR*FS-@
M     '6_3X5G=<<     !CXX2X],LI]CO"G',..?DH9?S[+^#LTM8     !<
MMERWVFH
M  ""0            #3XQA-7<)K\N2BTG%+8=:8$+FE07-YO]=( &EDN$SK5
MSNF.5N1W";K6  #7V76RLER8\7;NS4*6HF8EHQ:DQ?7IT@ UQ,,35!B@R<N'
MI,X5<6G;^@!YL35D5.E7J381+[9E$ &$C16:LLKC1,N'6&_]TR 8]/.J:LFE
M ,M'2GH1=,@ U=-=9JO"7DP^O:IK>NP=E"BIF8UM*8"6F2[#ZM./I;J?0[).
MX7<"Z;N 4[><5\-6@ 0202 0"0  "D$EV        ( )   !!((!(
M()!!(  !!)!(  !!)!) *474D  @$E=.0=R2#E:/KH]WK$59W7'B 203$5,*
M@ DW3Z3EG,7#=G                                   KY8
M     >/&9/+5'WW#B*F4@ 2Q8)!!Z98Q]!['=;[T
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MFX7M68.'[.            *E+;;*F<4Z<KQWA\"3G'<&%I;P<JRUG$.L/T<
MRR 2  >/&9/+5&WW#RI"D @$A0B-4],L8>@]CNM]Z
M                J4MMLQ7&$UIAVYW:YONG$DN$JVAC#:U8S2EUJDQPJQO&
MQAF>P   >/&8_+5'W_#B*F()(H3!820#TQQCZ#V.ZWWH
M                  "I2VVP            >/&9/+5&WW#R"*F !%!$D5,>
MF.,?0>QW6^]                                   5*6VV
M   #QXS)Y:H^^XB$D @4@"002>F.,?0>QW6^]
M            5*6VV            #QXS'Y:H^_X<"#// =W[+Y??I?MM;+M
MN1YFC[X&Y_HU7W?& #TQQCZ#V.ZWWH=<=!+SDZ!<@64.7BE\L^Y]
M :R=GZ!IWW/%8'8_+<>BV.,ZWC8\L                 *E+;;
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M=L?HR79(        -.>Y8NT&R!A,#D:?IZ4XSS]L=UOO8
M  J4MML            'CQF3RU1M]P\D4B2"002!*L@],L8^@]CNM]Z
M         Z;[;7H-QL0.9H^ULVG)                  5*6VV
M   #QXS)Y:HV^X>5( !%3*2*1(/3'&/H/8[K?>@
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M=VG7DXR!9W9AR7M[+>=^F<[ -.>Y8NT&R!A2$D*3T%QYG#;KJ&30
M        *E#9_'7#>??3<R<MI+FTZL->WR8O779IW.-SK       /'C,?EJC
M;_AY( ) "D!829?3'&7H/8[K?>1@B7'*]K=-MEY:=2U8VE[BSO39JZ0  .M/
MG'TKG'5QR:_ .R -.>Y8NT%R!A.5!,R<-VST_P 6^AN\^&[
M    J4MMLZ8DX<OVL[,X1]23@G8G/       /'C,GEJC[[ARPBD"2*F!!)!)
MZ8XQ]!['=;[T! ) ( )        !@/G^F:Q]HQX!V?RW.]G0\Q]S\=T
M            *E+;;            !X\9D\M4??</%(D*0""5A)6+$>F6,?0
M>QW6^]                                   5*6VV            #S
M!S#C&H[[:3$5,"*  $Q%3&^>-._9SZYS8
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M+!U!SK."=X7P &B.2ND^;&6\;@ "$E825*0"$S)P'->S6 ,P=Q\/J
M    *E+;;-;)<;V<279PQX=$?4Z<LQR:TQC:M?DGW.WJQ10BBKO9=,@  \+/
M2&$<>\KQ\)*PF4^&Y?NMO]N;\_I0N2XZ_<9R6(>=X7H]S\ !ZU8/ROM7TKLX
M%)EQ:6\^9W!CXO1DRP   #7J:OTGR6U)\#@&=+ !HEDKI/FOEO&\)*@ 0@$K
M" 2OH-B[('H?BOOP           %2EMME>**=87,K):BO'<'5ER.O*N=7')J
M^'Y.E*8N>$   \+/2&$,>\KL !" 2HA)4A83UKP?EC:OI79P
M -3>[]6TAR+TD     I!LMU#LV_.,N\R            5([';_.D??ZZ[F1S
M]G=G'LKD7->2E!KL);=979<?)]&KN$R:E/7A%?.>;662 >%GI'"&/>4V (40
MDJ !"2H]:L'Y7VKZ5V<                                  "I2VE,:
M51SF'?'(.B.N.XEX2='5EENB8V7&!D8ZLRP5,JY]C[FQ]D@'F7DK&M4W>T@
M!)40$* -Z>B][S;PG-  202D*   )(    !*0LD    !"@     "2     20
M 2054M0 )2%D@      D@ 'Z/$W&/E6@;3AT   !2 %>K/?/1&T'.]Z
M                              J4MML            'B+C'RK0-GPZD
M *" I  ]6>^^B-H.=[T             !@_BNK:Y\/T> <B_3=[M&5>W^FX
M                %2EMM@            \1<8^5:!M.' 0H  (4A7JSWST1
MM!SO>A!)  )( )  !   )  -(.K8M\Y>G8/ &?.6[EZP=^]#=[]MT
M         !4I;;9 ! )  ())      /$7&/E6@;/AU(&T'-Y$YNO5UGRTW/=
M<E8_KR.H7 8NIFVXE2!ZL]]]$;0<[WH:K35^RI)?U[5,535L#=.NRW8SXEJL
M  ^1JG-7'*TO?)4S(JV!.O-E[I T@ZMBWSEZ=@]01^K?4;O/H#;'L&00
M            *D=S\=."?KKZDX5:RRV0[DRLGR7#QWYU-ETC=VP     #Q%Q
MCY5H&SX=2 I    'JSWWT1M!SO>A  !) !(  !    ) -(.K8M\Y>GX/$'Z7
MTJ[IG7<[LN3                 !4I;;8()(   !(      /$7&/E6@;/AP
M%!   4A7JSWST1M!SO>@             *IM]A2=KQ@'8:_ME'?\X
M          !4I;;8            /%_&OF*A[3B0  !(J(D@'J+WG/NR_.=V
M                                   J);@            :,X+XNO<=
MI(I*0 H( 59MAEKD,I=J^X                                  %3+8
M            2>:'F3A:IQ/S      &]^>>4S?WC=              =7M=/
M3[/2!R?I;'R6L                 "I2VVP            >9GF3A:IQ/S
M     &]^>>5S?WC<XGE[@ZHMIS+,<2Y!LXTO3G<V<X[P  P[+<;/A+W2<"D5
M9?L6=.SKM@:R8QV6GF'.. _>IO#G+E,]=]W0                 J4MML
M          'F9YDX6J<3\P!ESM^X^FJ\3Y3O^1U\GZ7$'3MMT/'Z !O?GGE,
MW]XW6$IJQ07(^Z70QK-5DLL"8Y6Q%R3)-GV !JO+VY\3NUX98;.9'',=&;B]
M6#63&.RT\PYQP ^FIO1G;E,Y=YW0                %2EMM@
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M//*9O[QN@                                  *E+;;
M!I_A[CNDV6E      &RN3-[D;L?V
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M#4# :@8#4# :@8#4# :@8#4# :@8#4# :@8#4# :@8#4# :@8#4# :@8#4#
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M::?#33X::?#33X::?#33X::?#33X::?#33X::?#33X1;11DU^1?_V@ ( 0,
M 04"_P##ZBJ:1<P8#,& S!@,P8#,& S!@,P8#,& S!@,P8#,& S!@,P8#,&
MS!@,Q8#,& S!@,P8#,& S!@,P8#,& S!@,P8#,& S%@,P8#,& S!@,P8#,&
MS!@,P8#,& S!@,P8#,& S!@,P8#,& LML-9_Y^,\2*;'(C'(C'(C'(C'(C'(
MC'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(
MC'(C'(C'(C'(C'(C'(C&HC'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(
MC'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(
MC'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(
MC'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C'(C&HC'(
MC'(C'(C'(C'(C'(C'(@CM(YG<^_1=:CDAJ.2&HY(:CDAJ.2&HY(:CDAJ.2&H
MY(:CDAJ.2&HY(:CDAJ.2$0Z5>LOD4AS^VIWIGR*0Y_;4[TSX19>WJ0Y_;4[T
MS?7\BC'$U.P&IV U.P&IV U.P&IV U.P&IV U.P&IV U.P&IV U.P&IV 8R3
M:0+[K(<_MJ=Z9OM4<MMD'"S92,DTI%+W20Y_;4[TS?:HY;;LS."N4?MM2]SD
M.?VU.],WVJ.7VR::BIXJ))'DWHM[>I#G]M3O3-]D8XDB32S8:6;C2S8:6;C2
MS<:6;#2S<:6;C2[<:6;C2S8:7;C2S8:6;B/BF\=[M(<_MJ=Z9\BD.?VU.],^
M12'/[:G>F?(I#G]M3O3/D4AS_HCF39PFG&$(O(1WUJH1\<[3R]A]+QOA77HI
MWIF^S[MPT1SN4&=R@SN4"4[)$49O$7R'O\AS_H1>KH$3D'*8=/7#P'F7QRYP
M_P#M,8QS>BG>F;[5'+>AB^68+,GJ+Y'WZ0Y_;4[TST\-QX^NJ.6]!2F.:%B[
M6"?LEA2EWJ0Y_;4[TS?:IY;^D*8YHB(*Q+[_ "'/[:G>F;ZJ@BO9E[ 9>P&7
ML 1FS3-\ D.?VU.],^12'/[:G>F?(I#G]M3O3-]=OF[$NH(L:@BQJ"+!)V,4
M/\ D.?VU.],]'#>:HY;T0LWQ^ 2'/[:G>F;[5'+^FG';E9+V0M_>I#G]M3O3
M-]JCEO1%Q2LBH@@DV2]^D.?VU.],WV9CUI%+3#\:8?C3#\)4PZ^Q%%)NE[_(
M<_MJ=Z9\B7D3D7S,XS,XS,XS,XS,XS,XS,XS-09F<9F<9FH,S.,S.,S.(]6U
M=M\B=<UMHCD]]M,4H^Q,?8F/L3'V)C[$Q]B8^Q,?8F/L3'V)C[$Q]B8^Q,?8
MF++;+?=G7-;:(Y/?9O\ QVS-XHT.BLFN3>K"E+O3KFO0W9_?85F:^Y;X<8(_
M'+[+JJ5J*GHB.3WV;_QV[-X=HH0UAR>YNN:]"+NU$N..#2*X3<&2&/\ _JJH
M993T1')[[-_X[>-C?=7?-;:(Y/?91NLX3RM\,K?#*WPRM\,K?#*WPRM\,K?#
M*WPRM\,K?#*WPRM\,K?!A&6IFWNPQ3;TZYK;1')_(EV"9U\N2&7)#+DAER0R
MY(9<D,N2&7)#+DAER0RY(9<D,N2&7)!@E8BW^12'4-M3O2_D4AS^VIWI>^RD
MEEB6JQJP:L!:K+:9)5-8GO\ (<_MJ=Z7OM5<KZ(F64CE$5DW"7OTAU#T13I%
M!%-9G>D56![&[N(3;XQ#ZWRB*SST4[TO?:IY7T<.(@8]PS1]D_\ G>I#G]M3
MO2]]JGE?[_[$+"V-K/?Y#J&VIWI>^KMD'-F4QHRF-&4QH)&L$S_ '[9Q:^PK
MD85R,*Z&%<C"NAA70PKD85T,*Y&%<C"N1A7(PKH85R*?(8D;\B,H?C]AQ]AQ
M]AQ]AQ]AQ]AQ]AQ]AQ]AQ]AQ]AQ]AQ]AQ]APG;;:7Y$;_K;)?\;[QLL%XHO%
M%XHO%^ F_P"MLE_QOJW_ *]"9[WP W_7H*6RT6$_^3$%PMHND%MG"WT)?\>K
MC_>.TX[!;_UZ4SWO?S?]>BPUM@O6B]:+YA?M'_OTI?\ &[</6M_Z]!2VFM*6
MPMGOQO\ K;)?\;ZJ6TUGUG'UG'UG'UG!2W;/?S?];9+_ (^16I&MM^DP^DP^
MDP^DP^DP^DP^DP^DP^DP^DP^DP^DP^DP^DP(6[9\B__:  @! @(&/P+_ &?U
M4$9F+M<QB[7,8NUS&+M<QB[7,8NUS&+M<QB[7,8NUS&+M<QB[7,8NUS&+M<Q
MB[7,8NUS&+M<QB[7,8NUS&+M<QB[7,8NUS&+M<QB[7,8NUS&+M<QB[7,8NUS
M&+M<QB[7,8NUS&+M<QB[7,8NUS&+M<QB[7,8NUS&+M<QB[7,8NUS&+M<QB[7
M,8D./^_\OZ*Z:1%%=%(BBNBD11712(HKHI$45T4B**Z*1%%=%(BBNBD11712
M(HKHI$45T4B**Z*1%%=%(BBNBD11712(HKHI$45T4B**Z*1%%=%(BBNBD117
M12(HKHI$45T4B**Z*1%%=%(BBNBD11712(HKHI$45T4B**Z*1%%=%(BBNBD1
M1712(HKHI$45T4B**Z*1%%=%(BBNBD11712(HKHI$45T4B**Z*1%%=%(BBNB
MD11712(HKHI$45T4B**Z*1%%=%(BBNBD11712(HKHI$45T4B**Z*1%%=%(BB
MNBD11712(HKHI$45T4B**Z*1%%=%(BBNBD11712(HKHI$45T4B**Z*1%%=%(
MBBNBD11712(HKHI$45T4B**Z*1%%=%(BBNBD11712(HKHI$45T4B**Z*1%%=
M%(BBNBD11712(HKHI$45T4B**Z*1%%=%(BBNBD11712(HKHI$45T4B**Z*1%
M%=%(BBNBT(HKHI$45T4B**Z*1%%=%(BBNBD11712(HKHI$45T4B**Z*1%%=%
M(BBNBD11712(HKHI$45T4B**Z*1%%=%(BBNBD11712(HKHI$45T4B4]2LFD(
M6J64TEG]PSSC/.,\XSSC/.,\XSSC/.,\XSSC/.,\XSSC/./+;V9.<;>X7=A^
MPN<;>X7=A^PN9*O,(B*7)EB73C3>XGNP_86/&EN3)TB*-- BC30(HTT"*--
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MX;$*_>-E=U[6;G!'L20!5$>4:,1C PW,)%;'GF,-_*=($B=0UJ*S+BJ[S_\
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M78JD'Z$C3(E13U99K)MDKD;5RTD<F5$+!/6WU<YZ<U@B@C$&9>!.&:[7O!E
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MOI5*JQ;'7)]818!;%'%:]OPN8!<&M7%=<2+$%2VQ*4(XT\J#,-X=+RJ3AI0
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MU2_5-=\S#_)66,D',F4Y)1:XW-,SIWS8KX4E>6PC1%YD8BM[:.R\*<<#=7U
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MQDYLQB21C3F-1^AZ\53/CBNG>A LD50(<6$H9$V.)H*\G-ACD1@21QIJ!?\
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MJ_\ RF/I/_DJ_P#RF/I/_DJ__*8^D_\ DJ__ "F/I/\ Y*O_ ,ICZ3_Y*O\
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M.1=2(\F1!AT(/2@6K6NO5@X$DU(U>GQOC6C8XI[8G\)IIL&UQY**#<;-X$M
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M^#NM:!AL;) >NK@/"6Z/@'7-Q0[HGPK=.33([FR]#Q"H@X]9 )05$2C8&C!
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MWXG5W?B=7=^)U=WXC6M?N/\ _]H # ,!  (1 Q$  !
M           "?+M[::8\
M  :2222:26$FVFVP&6.22228
M                    0              ,D*T=8  =;]8  !!^=I^  5J#
MW@ %:X  6QK  &^10 "5O/1_>\K7T !@ <P@R&26&@$*R1MH" :X.2-.$2R4
MD$F2RB8#&2-NBR2PCBF0X( :&F2: 2"*(20
M           $             %P-MK\OT
M        ( "2"   220 0 =C]]OQET
M     'FKE)3&9@U3/8!-/QQ^?OD              6262RV26@
M  ("]:^TGTK:]FT!MO\ ???_ /0 1R;0   /!!)  VV''^W'V
M  A8T4U]2P/$   ,VX7)PT 0!A](P  !$#+" !06>W"Y"S8           !@
M9;8  )#+0!   VP7'&X(0             !7!Q&'X^8             =G!V
M:%'"%*%@  ".# Q^'0             !)-)A))!*             @;:22=K
M;39(  !PP6?R X0                                  !@_]BPT,'.@
M   &S'W(1V70                                   @
M!VXVW)W#0                                   @             .V
M_/\ E\T                                   (            !-GE*
M#EMT 9^=R         $VT@                 (            !_LD)7_A
MD"5ZZX    M4C$ -QO<                 $(9:/I         3Q@</OD &
M!>,   "17/H 4O\ R                 !F36OVP       #C'?9?[! '>3
M^@        &25(                 "             ',[[?;1Y
M        )(                  "             '#;9@,[9
M                         "             #?9<G\_\ 0
M                       !@            !(87PX>80             !
MR0                  !@             XV&SVW&0 _%PX   (     GVZ
MP                 A( (         $&_WVF>/0,^Z4X  !=H%!P!1V&0
M               T^AXAN       %W_VV&QU $:V/:   +R'20 ^ 1
M            A;K332        QY^XWWV0!( !(         _MD
M         @             9R"WQQ.0
M      @            #'&Y)+''I))))))))))))))))))))))))))))))))
M))(9))))))))))))&UD]VVNE0             !++;;;+)2
MAEM>S^G-JETMB*DDEW^DE0              UTDFETNLP            I-W
MDGKYOOF-MF*EUK1S^U0!U_20    D[: !*FTNNHTOL            AI]E\P
MUV<C   ,NO!/TDK0 M^D@    F-^  %D4E_S_P!0            ( $F$&&N
MVF   #I)_P#:[;]              #)1-)!, 6            !.[^/W*':S
M6+@ I;:Z:2Z=                                   &A-I)7*>VR6^
M QDEX,LDBDD@ADDDD$DDDDA@DDDDEDDDDDDD$DDDD@D@ADD,$DDDDDD$D@1;
M3;;#;5                                   "             ##9 ;
M#3=              '?WH                 "             ()9-%#+$
M @$D $    DD  &*3R                 "$ D$$$@      ++>:-++= I1
M_<F   B!D$ %8#-                 !3,ION$P      +"8;;;;= DD@D@
M   DDDD '(@H                 & @DDDD       +;!+;:+$
M     %MI                  "             -MNOY&/O
M                       %             N]W_P!O_KI)))))))))))))
M)))))-))))))))))))))))9))))))I))))),      @P             !23
M@                  @            ,  $ $  @U\6=B0  JG6FR  50
M               !@            ,@ P)H  0-GM/80 !M0!DT   'P
M             @            ( IF40  @ ,_J   !:>PMP @ '@
M          @            ,$H( @@$P (((    +:/*  (-.
M       @            ,   $   P
M   !@            .6FVVVVW@
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M< ?.8MRGI*8POHA4&$O8A*6"8B539106UX$<[3!'ZAM4"(7JJ3JH3FH&>_!
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MM%VUYHZ$I=+X:W0'$ZP=JP04W\GB8A B89F6"7B)\W3X>K,V^$.\M=,!=8V
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M\3,N8 ,SF\=G^:Q-5*%![ZRG41)67+W!!3>):;/XXXT%L?1?%EC"6%<ADWS
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M'8N41SD'"CC6+)O:CD&0A#2N.P+I2[]A$F#VOYZ2YUGXESA*E3\2]^'8TV$
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MNG[3<OVFZ?M-T_:;Y^TW3]IN'[3?/VFY?M-T_:7BG*8:""Q3J4"M 'BM3SV
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MDU7QEKN/+K!C>)9PZ7?A-R\^RS8BD1M1@=5 =6/4#"D*Q!0,:VZI^BM3S\:
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MJX2W2\2C1BKKX$!4=*[=S.R]AS\?2H=((1>1:V\0*XS%6VI89<SD-TG*)G$
M6PI;(&4V,VJMJ%04**K]%U//Q@AK:5QC7"8OI'I#KL+<;*:O[+IU//Q8:4HB
M(2EJK5%N:)R97FRO(V5:\G;6JUR4RKP96DE>1LJU1=E2HBFKNF6)R>.<_9&I
MY^,PXG&)4#%SA<X37$98'67QFNFPKC+/'O  =THM^TF\GO-Y/>;Z>\WT]YNM
M[S>3WFZWO-Y/>;K>\WD]YO)[S>3WF\GO-Y/>9UW5H2^5GB]3SBZ,54TZ/)Y,
M"YAKR/[ORCYM]^4LZ0+:@E1K!.DM5\)2RQ,U5F5S@OQ"ZAQO_D&T\& NDH+J
M66N>_M!N_P"8KAI5RQIF:I:ZXQ$UV.IC<SJ14V76&.N)3<1E5,WC6:MFD=2.
MN(E9\>]O;GE<]9K@CR)<OCPA9+;C+)GA"XC"#1G2,3$EW <4:(T-(&HD!U^V
MN(:@XCT2Q%\3J><;"NOB4*^=?NW5509=8JUWW_/O+T<+Y?\ =_U2JKT-^<*>
M=[[^D4X:U[_Y^XI59X?PJ99=0WWW!"O,8<1KN^OS+.%[_F.8@_8Q!%O! !^O
M:*K\I8ZWOOR_X4TWW_$";]*YRS<_[\RS._/_ &(X:?[?^Q11X$<J]=M%0A6L
M"5#R+.B9!M,)HQ7$Z0$982.H(T$)5X2Z$0=*P)2VI-D;6T%Q %@'5-F!BHW6
M,JX3I-HDZFP&6AJK6FW2DC8UHG&A272#2#9%N&6Y82JZ]EX"K8O4TFJO+^QY
M+OJ5+6<3$!Z2GNE"Y)BO@Q8AQE-7PB(TQ$[.YN><:@EQ>,\R*:3A4"9:3\0=
MEW*'RF!N::1B<*;@<!>#6'%Y2)HUBR!  @FB7DY^)U//88+Z_P"P;UQ"B7Q8
M6\I36]\_Y*,WPW]7SA=J\RAL;Z0MI&J&(:OIRWW_ &VPWU_R%YZ^D OZ]8!<
M]8+,:^7G QU+[AE4%"YK@B\I< UK52V\>0PYN(P%BP";A ("X!FRX0HILU@9
M4P<%,#4R 1[(G0LP!HCEI1+4TUAHC77<\<3#C% %=!1?(#0"@X\U;959F-8U
MJQ[+R#"62UJ&DYW7'\E&A3.0S[Q\Q%$I,]TERFNL*\,1*W41P,1LM.7\@M [
M)O=LX6D==CI,0YND6#STF;ZS7SF9KYS)^9::88C5"IIY@9SHW":BZ#Q.IY[.
MD,9(IU=]_P!2W7C+2V6)>*X2V7<N6W_/^LM+04T@UD@II!&G<:.#1K+YZ2JS
M,3)B&-9HW+:CPE+%2>4K$JM?'O6XA#'%%V1SRMBS!QU!X<&Z#5I!L,P3RD+5
M4&^#^9" 0<G)L.(4&TI;:BKXY;6D@NU #Q6IYP ^#N !1\K/SC48!UUB:C,H
MVZRG?R@6RLT2M]_F6@7ISJ!?'???)!NFLINIG@36!Z7OO_(UP<Z]Y;?^[\X&
MV%M^EP3IV7@V*5I*YLP8B8CGRB8AG6,NL1>$"&O2-/V2]J><H-.,&I?0J6WT
MEWK+F#3?C%O^?R"/.#6G.X-K((*,>46X&5H:Q>7*OY46Z[XJ6NS7=V+U4M^8
M,TYW_*F&_+LM"EDJ@3@C3I2:;)5>DDOW$H3)%*=<F7/V"Y>8;$.513:+:ZL4
MLXY^R%EY^+TL:MCI-=N9UVM<=G2#<WMS_9&IY^+SV?<8RMFDUV.D(STV[VY_
M'$EGN4'DSZ55'.Y6>DM)6*\!K#D,T&=5S);0 ]H]DT526 1/HNIY^,[<9B7L
MQ,.CL<9EYKC,SIMS-[<_T TXF;Z; "M4*5%9ZH49 %-) ?XZLEFB(Y$$'($<
MGT34\_%_B[.TF-A0V@:.$Z(<\(4BB,IN2I$EL/%1;X-)4DTA<A@+0Q3^HJIY
M1+$LB*5AQ,\()0R!DW<&_"I2VJE"CLH$P0<;*V=)O;GVKI3C=I#08O'_ &9N
M]&N"'&-5FORO?]1:M]_Q"A3C_LHU6O&M.DLBV.5[Z0LZN$U>$U*TOMWS<5S]
MM^;+SPTQRT+C6&*-_G^16I#0BE:/YO\ N8PN&-]\2QUK)_<RP- ]JUF-W"X7
M!0 !:K@ XJZ$(F9'PFPVZ#F!50/HC4\X2V!H4HHPMK7;>-=(S5I!*SD^?]F#
MPC6BJKGR?7666N+X1KA5M;\?[PN&K>^24+X::^<K'#0]-]/[*57&G^U#;C33
M??\ ,1"AQKZ> _.UV5W&YN?Q]BR7%( &K<!JO*$$&2"!;-2V5^:<;]%:GGXR
MM<UCRE[<\)G;@QM\YO;G\=BVL 0JPYUB?&I\:GQJ5)Q*X-!=EFHZC24@_1M3
MS\6F[8-" 2J)D3"9-NE#Y3V3IDR=)M$Z4.6]@=+LDH0ZEDB%(H"69,9/LC4\
M_%TO4AC0+7";\_Q-Z?XF]/\ $WY_B;T_Q-Z?XF]/\3?G^)OS_$WY_B;T_P 3
M>G^)OS_$WY_B UN[G'M]D:GGXO<'-[_0\WKXXBP'FAZSX!_L^ ?[/@'^RQ.N
M %]?HVIY^+W!S>_T/-LK1G+A!/E.I1$Y9)2Z2]U*=:G08DUK*935\.T'%F I
M8-2U8O\ 3+:4W.@RU7PAS-3]TMR8B:[?ZWIV!1LU((-'_?\ O/>OHFIY^+W!
MS>R\)*#Y%7]@!UO1:L&CSO6)<.1*NLUJ8?;\DX2&*UF]<?Q>LQ1P@7F]2^7&
M9YNVO9T/-Z[-!S2O*!&UQ;XN$15+J%#K "IK AUQ?XETZQ"W628*ST_4IZ?P
M[5.6X02F.*"Z,?5<L4S?_8)NWZ2S#C7O$M<S29#;_6].R*-F$B/2->9_NYT^
MAZGGXO>'-[(JBA7]V?R!U:0H7R%(\\2N%4(& O+ISBIBEBVBVM+:S4R^B*,W
M@YWFXX>UV=#S=DVYX9AP4Q_G2:6X5YP5N]):Z]R9:E:#TSOOR@UM125S+J#D
MXU_V 49HB"%RM><( 67?8_K>G9T!G%X$%%YO%ZN^/HFIY^+W!S>_T/-Z]JVJ
MX=[;+9;IPV6-%V6R^P$-IT<NL>>_9_LZO]G^SKOV?[#-@=;,?V%_WM;Y_1=3
MS\7N#F]_H>;U^R-3S\79(AU>+?*?,,?,,?,,?,,?,,?,,?,,?,,?,,?,,?,,
6?,,?,,?,,!ZVRXTS^#[(6U?%_P#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tm2030088d18-fc_rise4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d18-fc_rise4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!Y@.0 P$1  (1 0,1 ?_$ .P   (!!0$! 0
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M P$  A$#$0 _ /W\4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4
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M0.=!\'!T_3<CZ:PXM%/8""+@@CQ!N*R!T 4 4 4 4 4 4 4 4 4 4 4 4 4
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MY/\ &D&SC9_NN-J 6A7O&M>1=LW++Y;BH>U:OVKZYK;JBX5Q'*% % % % %
M% % % % % % % % % % % % % % % % % % % % % % (D $D@ <238#WF@+
M/*RJ$W1&LXK4*</[B?\ #PZS]%<JMO.1&TBQN...JZG%E:O$F_ROPKDHED<;
M=<R(%#26\8!/"IF7(F#;2UC\_H(K:1&JXD@2>7W?55;2)RDQY"WN\>=8;J:6
M!()\:E:$;W$[5'B9"BBWV #IRO\ =7(HI#M'6B!RK+>XNP+:7N/=?7Y5*NH
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M:B#8FY2024J2>8-P:Q.W"XG&='%FH3G;ES6W27 V9@]\-/\ 3'R_2P[HE,Q
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M)T4."T*!(4#H02#QKPM7IE%-H]_3WK>I@[-Y<UJ:HUY;=QTWL#<J,I&Q>62
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M._I[EB7+/+8]C/?T^IMZB/-!X[MJ\M^TNU<!V H H H H H H H H H H H
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M:^-Y*%S"[ZG]?#T&9UT#T0H H H H H H H H H H H H H H H H H H H
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MG:3BQ>UZCX%#AS^(I0#Y??Q/D/*F0%6@.Y^V_C[7J4)08(',7.M[7M\?&IV
MC[7JE'?4$WXZWH@!5Y >[2],$ L>/#S\Z8><#ZB+6/#6^MP;WN-0;BU0E#96
MVMXVZ(.7=40.E#$U6MAPZ)1T',67\_&O)U>A_P!I87:O=[CV-'KZ?LM0^Q^_
MW^G>;.!"@"#<$7!\1R(\C7D'M+'$= % % % % % % % % % % % % % % %
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MA*4)2"I2E%1 2$I!))T %.T=A(%)2%)*5A8"DJ2H$%) 4E0(N"% Z5:)X@*
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M="+%5O DCRKTM)X5Z=8:G?YKLMSPCZ%GV-M<#@N=1OW%2%(+AGZ7]%"]=(0
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ME$'X"N6W':\C,GL1C?QO?G]^E<U?2<9("M11O(J#A[ZDGC381DQX_16 EM)
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M'1=0YJ5.GNR'<65N_&R]MYYTO[DVZPVX)KJNIW,XA3GH-RGN:YL%TH:?7J7
MMM9NLK->[TK6O4VW8O.M^"S_ "EO[5D]^#S;/@/%G1+?3+\=?HTEH;S:Y5E"
M>=%NC)5<5LHTL$D=(;7RBL9D1$=4?R>06EM0)%FI)(2R\.K0=1LA7"X()_=%
M>QI[CMW.5_))^L^)UEE7['.OWD%7M6U?2O/O-L6->FG4\&H7X7MI;3QID41Y
MTR #WV^?V5%Q P0.5ZI&!-S>E"BXTX($M021;3PT!'E3@0"/XKC7E[<:FVA2
M)Y?3\S5 ]+<[\J +:7\[5-H&-!PO>Y]OE3:1JI&JU4HP-"?"WTFJ!5*@./QY
M4RQ!+AU#CJ-?=1 6G[* "1X:GZ/[:RTR*HJTLBA2H&+<+7/MRHP L#KK0!<7
MX<^1IB@!',:CVT^FE2 #_90&>[)S?Y22<6^O_=Y:[L%2K!J3:UA?@F0!;R4!
MXUYO4-/SP[Z*^*.?9]1Z?3=3W<^YG\LLN#^LV[7AGOA0!0!0!0!0!0'AR$K\
MK'4H'^8O\+8XZGBKW)%:A'F? C=$8;<WO>Y/$GB;C7XFNQQ./L%0$Q6H+::6
M14 I)[",F*P(DTCG[>PJQ574K>PFDWXBXU]W#RJMX<1RXE1(U]WL*P5Y%2HE
M4P/A7+L >?MY5EX@*@6952+ZGX'SUHL2R>XG[>%#(P+W\?VT*DVZ(J(3_$?W
M1]/Q\K5/:;Q6&PH3\?!R<=<7(169D=8U:>0'!>QLI%_Q(6D\%)((JQE*#YH.
MD@FUBG1F@=W;<E[%E,9?;T^5%A3'2QT)>5ZL=[I+J67%$%,F,M )3U@E/20;
M\:]2Q>CJ5W=Y)R7K]S.Q"2N*DEB8HYOC=SPLO.S1;AZ?I,GXJ9;0?IKG^[:=
M?95#E5J"Q:52PRI<N<\J1-DORY"[=3TAU;KA X#J620D<@-!7)&*6$4E$O!&
M-3<\U%4I$:(]/4VKI=<:4AN.@@:MAY=PZZGF$@A)T40=*W%.;I;6&_)>GR1*
MESV]NT-SFY&,DOX_*,!2D-OI;0[TJ24K]/5V/);*5:A)41_$!6;D%-=W>C2N
MS?V-?Z0Z-<K1GF$RL.3EE9'=TJ7DVX<1Z1%C/K>?_.34NM_EX7!2&FEE:E$&
MR"4B^FAX;L)1AR:=*+;HWN6\.#Y:0HDV=*;6R$W-8B//FXQ6'<<4XE$91*@I
MA-O1>;"DMN(;<3P"D@Z7 L17B7X1M7'",N9;_H.M<Y82I%U,F"4C6P%N=<.)
MQ59*H0= % (\#;C5 :Z<^-_LH!U *@"@'0".E >&=D<;C652,C.AP(XOU/S9
M3,5D <27I#C;8 ]];C"=Q\L$V^"J/EQ>",5A[_V%DI0@XS>^T9\Q1LF'#W)A
MI,I1%P0EEF8MQ1%N0KL2T>KA'GG:N*.]Q:7L+WD'A55[3+=#P(.E]/#B#YZ5
MUJFVA52!04VB-CH:##(ATZ&]O(V"1;30UJHS(5H!K;^S^VIM(0*>8^-5FHT6
M!I/NUNR;C6L7MO!MMR,QGYK,1MM:K(0IQQ"6 Y^)(*2XX"0=!<$Z7!^%\?>+
M]?X2Z=IH]'M0N^(.H:E6-,IXPBW3GN-55>7FC&*;2K/FE51<7])X5\.:/Q'K
MKZZC<E;Z-H[#O7W#YVE7E@G1TK24FZ5I&BHY56'H[>[[*4J<WEC&W" 5H;PZ
M7&T*(U2A:@@K2D\"4B]?)JY^+<XJ5SKVEC-XM+26VD]R;@FTMCHNP]EQ_#>+
MY8='U$H+)O4W$WQ:YFD_.R7_  ]WQ_[:X_\ ]"(^^KS?BQ_S_3_U2U^J2GX<
M?\FO?UFY[Q_\/=[\]ZX__P!"(IS_ (L[.OZ?^J6OU24_#C_DU[^LW/UA_P##
MW>__ +:P/_0B*G-^+/\ U!I_ZI:_5+3\.?\ D][^LW/UB'_#K>W_ +:X_P#]
M"(^^KS_BS_U!8_JEK]4K_P .7GT:]_6;GZP?\.][?^VF/_\ 0J/N%.?\6?\
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M(47/4ZND("!^(N=6@'&^G&N]*\J<S>&\SR[-ITMM/N!W:[3N0L?FX^0FX12
MMG"[D2^%B,.GJ_IF1="I$4M@VZ+N-H.A;!KP;VFZ7U12N::4>]3HY0:>/%+R
M>\[$+ERU@\MQU]LCN[M'?)1$BREXS-*2E1P^4]-B0Z;?C$%U*U1Y_0>(;47
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MP;5KAAZ3@O<Z55A%&_6(D6*D)C1H\=(T"6&6V4@>%FTI%J\IRE+YFV=:K*I
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M2E9_EMLK4 I5B;VM?IN#X^FT.ET5V6KG)OEJZ-?+OXM[O>;:;RR-3;V[=Y#
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MLRN!8?LJ&GB.J0DGCY_1\:C!YIV1Q^)8,C(S(\)@?]))=0T%'CTMI40MU?\
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MNKCMAH*1U!93T)LVD%8N>D"]JY)W;DURSDVEO-.4G@V7BN,R% % % % % %
M<C?JC[=(RN+A;_QD:^2V^$P\SZ+=UR<$ZM2FI"^D%1.*EN$WY-/.$Z)%?1]
MUO=W'H[C^">,>$MWG7K2WG5U-NJ4UFL^PP+].@PKT_*"8(ZLRB/%5B0_T%Q+
M05(_/JAA8MZR;M]13^(()MIU5Q^*GJ8V;?=\WW=R?-3S<M>&?G\QP6]N\V]W
M4Q6!RL%O&Y!ME;^42[&E);Z427(*V57=41974R^$*:6J_2L7'"O+\/W-3"<I
MQKW,555R4J[/-6M#;I)49S9AX.7[=2NB<E3^,#@$++M()C/-ZA"9%B?RDGQ0
MNP)!Z2H:U]?<E;UD:QPN4Q7EFNSU'&JP=-ALK-]UFY6+_+N2DE*6B+=?#\)'
MC71M=.Y;G,LZG([M51G)\U$_?V[\;B<.AQX_GH\B9);"E-0(+3[9?FR'/W6D
M,HU238J59(NH@'Z"+CI=/*Y<I2E%Q>Q(X,9RHLO+R[3Z,8P8M_:LUR6(ZF%M
MY Y%3@;/2$+=LIWJ_=4AD(*;ZBXM7YGKI:F'58QAS<U8\GH67GK4['L.(\_E
M)K4.1";F2VX4A07(B(DNHBO.=( 4['2H,N+_  C4@G3QK] M6K<KBNN,7<63
MHJKL>9PRX9&BLC"F9?(1,7C8ZY>1R4N/CX$5L7<D3)KZ(\=AOEU./.)'E>O5
MA*-N#G-TA%-M[DL6<5*NBVGV=VM@F=L[;P&W8YZVL)A\=BD+X>I^1B-1RY;D
M7%-E7QK\SOW7?OSO2SE)OTL]6,>2--QJG>&0_/YR2$JNS"(AM6.G\HDO$#S>
M4H>8 KV]%;=K3JOS2Q].7J/G===[W42I\L</1]9C-C7<3H=*J,3S!_\ QN[=
M7L/_ ,9HX]_^]XVOP+\9_P#W%X4_O.7Z>F/V+\+O^"^(J?\ V$?T;YT;7N'C
M!0!0!0"Y@CB#<4*:,_3Q^GO8?Z9.WC_;/MR]GW]N/[TWUOM:]R9%C*9(9ON%
MNC([MSR$RH\* V(*,KE'1';]/J;:LDJ41>N2[=E>ESRSHEZ,#$(J$>5;S7/?
M[]&VP._&[\!W.9WQW=[*]X=M;>E[.Q_=OL1ON5L#>LW9,Z>UE7]E;D<3%R6'
MW1M=.5:$MF+.B/"-*_FM%"B;\EK42MIP:4K;V/%5).W&;YDW&6]&&0/^SP[
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MN("O2=<CO-K:>0V\R\P^RI"T+2%(6D@BXKH24H-QDJ21IX%TJ9 * * ?#3Q
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MS]]>70V+7ASXCSO;A3$ ;W/T_&KA4!I8::^-_,TKB /A?AX<* 6O#XTR8"E
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M4 7TMR\*.F8#33Z:;0.U^'RO1DJ(W&AJ;*ES _95R(._WVY7H@ %]*%%:_\
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M=K5VE.W\VU;5]6YEF^WAY^[QKI'*;=E=LR<3"D8]]?\ 51%:=F19*TAIYUQ
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M\DO6<-U\MN<MT6_0CFXI'C7U-3Y*H<O=Y4VA?-4\RKZ$^'M\:WV&WF8EF/\
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M[=> W-'N?_MF-K\"_&?_ -Q>%/[SG^GIC]A_"W_@WB+^[X_HWSHZO<>9XH4
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MV1U^^O\ R]W/FW<LJ^BE38.V.P'>ON1)CG)X=_9&"=6#(RFYD&),0T397Y;
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M^*3]#/V'\+*RZ1XAM1QN2Z>J)9ND;U:;\UZ4=($6)'A[_M KW3Q0H!4 Z 5
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M!GK^Y7_G=/\ !KK^SQ3U'^27\^/\3^C_ /3VB_E'_-"./W8"0-_Y[WCJ]_\
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M2=(HR\JO(UCVL[[=MN\:9R=EYI;V0QH*YN&R<=6.S#,8+2VF<F$ZM2GX"UK
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M?:;>,?O=@M\;72&]I8A_*'<,I\K989AY'%3HSN*:_ IN>\Z^^A32 ;ME*5J
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MGV&[:;ZW/D-X9_%3%9S,;&SG;K*2,?D'8#>1VSG6%Q934QME'4Y.CQW%(CR
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MH(2E]J%"86I]20$>JLD_B7:O.:N:BYWLE2#DDO<NPX/BF^;[+:1]2 E* $I
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MO-H.OR'W%O/O.N8*"I;KSKA4MQQQ9)*B22=37-#Y5V&:4>!M:M 9%OD/I%Z
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M*XMD/B?GI@O.T?4]-\%^(NI15RUIY6[+RE<:MI\4I?$UQ2:-;N?JSV&EPAO
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M.I(3%6VT3927+$J_6Y>".@VI0Z7KM1J7U><5\<7'DBZ9*#BVXK+YTWL<<E]
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M:M+.7L^OZ#T^F6>>X[S^6.7;]2]IMRO$/?"@"@"@/+-CB5'6W_%;J0?!8X?
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M<Q[ZV6,IF,QT$@NXG"3%L&W-+LW\BEQ/FFXKS)]<Z?%TBY2[$_IH?56/P_\
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M4RS';D5% D@CES]_E6$U3$KK6J(&Y43<?A.@]KZZ5I8+M(TVRV9''M3D_B_
MZD'TW0+VOQ2H<5(/T5Y'5NBZ?JUI<WPZF*^&7T/?'UK9Q[^EUDM+*BQMO-?2
MMS]IJ#N!L"#O/;F2VKN(36L=D#&6J7C'FVGVGHDAF3'=8=>8D,E2%L)!#C:@
M1<6K\SU_2];TZ?+J(4ALDL8OL?T.CX'U_2.L/2ZF.MT3B[L:_#+<ZIIJJ]*?
MG([/VMBMD[;Q6U\092\?B65LQW)CR7I;Q>?=DO/2'&VV6BXZ^\I1"4(2 ;
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M@]M*;2BX?'0U: *H&201< >0TK+8S'Q-S>W,_P!O&J3(B;7TX?3422[2A5R
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M]A1$WH Y52!XZ?LK+>-&49O8> ^O7Z;5:8D#AYW!H! V^(M6:/,H<]*UC7@
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MD:)5QD6#) VU%,4;S*HL-1S^CW5M8F,<B=[BXY:<^.OQK+6/ TMSS.49'?\
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M#Z_HK.T#]WL*K <KU*UP8 W!'#ARIC4"I79L!-"%N+2A"5+6I02A" 5*4HZ
M)2-2HGAXU6TE5Y#%NBS-S;6VTG%-B9+0#D7D#0V4(K9&K2#K=Q5_Q*^ TO?P
M-9J^^ER0_=+U\3Z#0Z/N(]Y<7[9KT</+_3F5= ]$* * * * * * * * * *
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MZH*$D\"=-?;Y5'6O 5V$*UP*/CJ3P^=JG8056A0Y4H@.]N'/CI_;4P0H*KM
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M\^@TNCAIU7.X\W[C)JZAW0H H H H H H H H H H H H H H H H H H H
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M3,!4>% ,BWQ]_P!HJYY !;G?X4 JH&#R-[4 PH)X"_@?;E4XD[1<?;P%4HJ
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MW+5RS+EN)I^6W)GCM;EQMKX<#X&U;K18''B(\>7PX<*/?0!?C?GK[O=Y42P
MO:]6@&231^L"UTY\!^RHJ[0.YUTTM8\?G[ZH"Y!X?10@ VOI[O*E"@1I[_E0
M@>\&WR^PT**F?: H H!\K6]O.E$0#X?$^_Q^(I1%%1JH <];?;2@"E 2OH+D
M^X4Q)B(VY?VT $?18?&W[* 7W\:,H4 5*TS!+0:C7Z*I,2-.!0HT J@9M;ST
M]N%9Q(A V]OE0H[Z6MPY^PHJH%[Q6WLGER#&84ABXO*?"FXX\>E725ND>" K
MSM7!?U5FQ\S^/<L_J\YV+&EO:A_ O@WO!?7YC9^(V;C<<4O2+SY( /4\D!E"
MA;5MFZA<6XJ*C7CW]?=N_#'X8<,SV;'3K-JDI_%/CEYE[S,.'"NB>@% % %
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MF#+Q&18VILPS N7M\*+B H@%-H#P]O&G:!B_*CHB/B&M^'S]U,*!BTY?&G:
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- H H H H H H H#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tm2030088d18-ph_target4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d18-ph_target4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!U ,4 P$1  (1 0,1 ?_$ .@  0 !!0 # 0$
M       '! 4&" D! PH""P$!  (" P$!              4&! <! @,("1
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M=200L:8LVV'+^TFJ1'Q2(VK)J+F.M'E &BQC")TQ$1KD;SZA>CA74Y% * 4
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M/KUC_3V_P\ ]$NO]W>_C'_SJ/1LW_6W_ '?\0^O6?_!;]SWAZ)=?[N]_&/\
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MXVGPE_W;BXY/I;EM7B6P]M0O.[DR7Y$7PI=WOLNE2YA"@% * 4 H!0"@% *
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M:_9Q^:C'O_33^,_*5%9)Y"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MXGM]PNE>)E"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M\,U*H(J%;F<<PD PB8"Z:\:IL>+A7%Z5-O>?0FWIWE?7(% * 4 H!0"@% *
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M^/:4"@)_UULKF$!$!!:2%/AKTJA'BF'1V\:S_P#^IO:/P\7W1E4[H^3B(O\
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M.0OJT8J\;;Q_(SK)I>=X1-R3MLV\J8X/YB(M!2$2N:0:% @IF;PRER,06$3
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M86GFG*3&PYZ4;1#J.9R%OW<^2>DGY!U$PJ#:0AK?DHY1_)R3)1%%L"WG"B@
M $\HNH)-[BTW)ONVHVG%6?+S>6V**=^VY+7E;$6QMJ]9FZ'EF04BO$3-Y/;-
MA;;D+M@K0C)-LH@M*/V35@FHF8!5X#0<+/-Y;\-H]A_4<;AS?:QD\E6$PRE8
M;BWF\[>;2ZL<RBP-XV]8AY9T3/-'%MOUC 5%US@DH(ARB.H4'"S83'F1;%RU
M9=N9&QG=<'?%B7=&(3%LW9;4BVE8.;C7 G*FZ8/FIU$5B HF8APU R:A3$,
M&*8 ''8S-* 4 H!0'K5^:4_-G_)&O.]]%+XK\AWM^G'O1B/#ZL?I?WNJ7_Q/
MLXOWA/?[S\G]$S*KP5X4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!@-UW8$
M>!XZ..4STP<JZX<0: /24O4+@0_$\=26'A^L_6W?H^A=?]GE('5=5]17'QW^
MNZ7\'^WR=Y$!C&.8QSF$QC")C&,(F,8QAU,8PCJ(B(CQ&IKLZ"I-MNKWL\4
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MMEQ;G^)DGIVI7,*?"]N.WM75VKM\I-[9R@[02<ME2K(+$ Z:A!U Q1]\! >
M@/$!X#5?G"5N3A-4DBZV[D+T%<MM.#54SWUU.XH!0"@% * 4 H!0"@% * 4
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MSW]AO=0ZB@% * ]:OS2GYL_Y(UYW?HI?%?D.]OTUWHQ+^6?TO[W5,_XI\O\
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MXWO^^6;1,^O^2NO;^1^./XUX5U$F5$EE% * 4 H!0"@% * 4 H!0"@% * 4
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M3DIJQ=B[:MPM\=?6R5R;G;7!&,7-RM_1T4H$*4I0 I2@!2E*     :   '
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MLAWOR,K&GZJV_9T?HRUG8?V2U^SC\U&/?^FG\9^4J*R3R% * \: /2 #0#0
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M389_'P(:!Y'9U5#7LSJ++C:;NJC,6D$&@?)^SIXU&7<S;M9.V--;V4+^C \
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MOG(S=.^V0[WY&5C3]5;?LZ/T9:SL/[):_9Q^:C'O_33^,_*5%9)Y"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@/6K\TI^;/\
MDC7G>^BE\5^0[V_37>C$?Y9_2_O54RJ_E.OY_P"\)W_>?D_HF95=ROB@% *
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M\Q3" \E>.'CSQ[7#=BXW6]J:HUU)KW?"536LGU^9P1=86U3P[V_(O 8W661
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MLZ/T9:SL/[):_9Q^:C'O_33^,_*5%9)Y"@% * 4 H!0"@% * 4 H!0"@% *
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M*TYO)UZ=>'54_BY)3\_!K7811-QH:&\G0>/5XZLF)D4H^@H^H8F]-;2'9Z-
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M<HU[:G[;>S#FV//7(&E<T-J61DXD?745%Z^W6U?26RB]="?#L7FT?23=[O\
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MQYA^VD;0QK:<3:, DL=THSBT3]\^?*E(1:2EY%RHO)34LX(F4%';M99PH!0
MQQ  TBLW/S-1O?6,VY*Y=I2KZ%U)*BBNQ)+L/6%N%N/#!41(%8AW,/OAUYO
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MJ1>MCFXZ>0"Q.</;+K7G>CQVI1ZXOR'OBW/59-NYU33]W:;'55S8@H!0"@%
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M=]1IUS#N\=W_ ,48Q<O6_P#^-KCIN?#1E@Y4S\[2^9<'.TVWZ[.MY5O@M_\
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M% * A>_BZ3I!^,P;F#Q=XX)]DE3NG/\ R_RG^(INNJF=WP7E9A-9Y#"@% *
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M37>C$M/_ *9T_P#5_>JIG_%/E?O"=_WCY/Z)F-7<KXH!0"@% * 4 H!0"@%
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M5V,4I.*HJ=2JDDVDFTDFVD8]O PK62\RW:@LEJCDEMH3%4Z98H!0"@% * 4
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M^\_)_1,RJ[E>% * 4 H!0"@% * 4 H!0"@% * 4!8[D9B^A)%N  )^X%9/\
M#;&*X* >$PIZ>W61B3]7D1D]U:>/886HV?7X5R"W\-?%M_$:^59"@GF@% *
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M[QP;41 >TJ:0A_S5&ZG.EJ-OI;KXO_4G^7[/%?G?>Z,:>%_V+W27*A2V"@%
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M(B';HF8 'P@-6>Q<];9C/I:V]_2:^S;'U;*G9Z%+9W/:O<+57J8H]GLZZ 4
MH#$K[LBV\DV;<MA7>P))VU=D.\A)=F8>0YVKQ,2=ZW6T$S9ZT5Y5FZQ=#HKI
MD4*(&* U):/JV=H6J6-8TV;MYV-=C.$NV+W-=,6JJ47LE%M/8R&Y@T'3.:-$
MRN7M9MJ[IF99E:N1Z>&2WQ?Y,HNDH26V,TI+:D?(QG["5U;=<JW#C:Z"'4]'
M+^=V_- D)&ER6V[.<T3-M!#4FCA O(LF B*#DBB0\2#7Z3<E\V:=SKR]9US
M=/6*ER'3:NKTX2[GMB_RHN,EO/QA]IWL^U?V<<UY/+6JQJ[4N*U<I2-ZS)OU
M=V/QELE'\B:E![8LP.->]'E<>&G9IV5.W[73T&O(NNQ[S/(N2%,2:&TTT]G7
MQJ,O6N)4,JQ>E:DFNLEF!N'DY2F/Y.@=?$!]WJJ S,*OG16TNVDZQ1*$WL);
MBYL-"B50!X!T=7N57;^+O31>\34*I-.J,_CYW0 \L.'5K41?P]NPLF+J/6S,
M&DZ'#R_;U]KMJ,NX?83MC4NI["_HSW1\IU=H_=Z:PIX76B2MZHZ;RL"?'3YP
M/;U^UPKR^I(R/O39O*96>'CJK[_LT"O2&$NA'E<U1]98W4Z''Y373PCK]FLR
MWB=A&W]2;WLQ)_.@(&\L/=Z?&.OAJ2LX?80>3J2H]I@4I-Z\PBH  &O7X_"/
M&I>QC4V(KN7GUJZ[")YZX0T,0APX@/'7M\(#QJ?Q,-MUDBDZKJZ2<(,B*6E#
M*&,/-KKJ/W1'PU8K%E12*%E9,K\FY/88!(O= -H;CQJ4LVJLPF^%5Z3\6195
MT93O>V[ LV.6EKENJ40BHMFD41#O%>8Z[MR<H&\WCX]JFHX<K&T(B@D=0P@4
MHC7GK.KZ?R_I5_6-3FK>!CVW.;?4MR77*3I&*6V4FDMK)_E7EO5>:]<QN7]&
MM.]JF7=5NW%=;VN4GT0A%.<Y/9&$92>Q,^N+;WA2W=ON)K5QC;A$SA#M/.9V
M5!,A'%P7._ J\Y-NCE(0ZAG3KR$0/S&1:)(H@/*F73\VN=.:LWG/F/(U[-;7
MK94MPKLMVH[+<%U46V5/2FY2WR9^T'LWY%TWV<\GXG*NFI/U,.*[<HD[U^>V
M[=EL3?%+9&NV-N,(5I%$U552]"@% 3I9L?YA!MS&*)57IC/% 'IT5T*B =@>
M;D*/C$:K^?<]9D-+T8[/?]TNVCX_J,*+?IS?$_#N]RAE589*B@% * 4 H!0"
M@% * 4 H!0"@% * 4 H"U3?",=#V%)](2HC7?X5=[E\Y&;IWVR'>_(RM:?JK
M;]G1^C+6=A_9+7[./S48]_Z:?QGY2HK)/(4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4!ZU?FE/S9_R1KSN_12^*_(=X>FN]&(
M_P L_I?WJJ;_ ,4^7^\)W_>?D_HF95=BOB@% * 4 H!0"@% * 4 H!0"@% *
M 4!&F08SF3:RR1>*?^D<B&HCR&$QVYNC@!3B8!'M,%2VFWMKLOIVK\96]?QJ
MQCE1WKS9=W1[M?&B+*EBL"@% * 4!IUO,VGP>Z/'7H] S2(R1:Q';^P;E73^
M3*Z53 SBW)=5,HK>@9PZ*95#% YFRQ2+E*?D,DIL[V7^T7+]G^M^NGQ7-#R&
MHY%I;Z+==@MWK+=71.BE%N#:JI1TI[;_ &0:?[6.6OJ\."SS-B*4L2\ULJUY
MUFXUM]5=:2;57;DHS2=)1E\M-PV]<=B7+,6C=L0]@+DMY^M&S$1(I&0=LGB(
MAS$4(.H'(H0P'34()DU4S%.0QB&*(_H/@9^#J^#:U'3KD+V#>@I0G%U4D_>W
M-/:G5-)IH_(;7=#U/E_4[^DZK9N8^IX]QPN6YJDH26]->)IJJDFI1;33=>PD
M-= UT'@ \0XUQ=LTVK<12E7XQF<?*&)RB!O?TJ/NV5+8>]N].TZI["08FXCI
M<H"?AH' 1T"HC)PE+<673]9G;V29)$;<Z9@+J<"CH'WW;X= J%O8,ET51<</
M6;<EOHS,FEP!P$% ZOONWKXCKU5&W,7HH3MG4*JJ:+XE<(@ >7[_ %>]6++#
M742,-3:6\J@N'0/AB'C,(?9ZJ\_J78>OWHZ;RG4N'77RNCM'0 ]^NZPTMZ/*
M>IM[F69U< <=5-.S4VGN<:RK>+3<C!O:CUOQLQ&1N9),#?*\P\>@VG;IT:U(
M6<*4GNH0F7J]JVFW*K(ZEKE,IS !^'$. ]7O<*F<?!4=K14,_6Y7$U%D=2,L
M*@F$3ZCQXZAV5,6K"BJ4*M?R)WI5;,+?2 !KY7B_M&I"U:;9BN22V[S%?]9)
MO&S!@W<OGSYR@S9,FB*CEV\>.52H-FK5LB4ZSARNL<I$R$ 3&,(  "(@%9DI
M6L:U*[=E&%J$6Y2;244E5MM[$DMK;W'KB8M_,R(6K,)3OW)*,8Q3<I2DZ*,8
MJK;;V))5;V(^DKU?FS+_ +?+:5R'D!DB?+]Y1J:*K8PE6^H]NKF2=?5Y$Y=4
MQF'RJ::D@J41 IDR(D'E(H97X6]LWM1_G/.6BZ-)_P M8UQM/=Z^XJKUC_,B
MJJVGOJYM5:4?U4_IR]A__P#6^E/F3F*W'^<LVTDX[_JMETEZI/=ZV;2=Z2K2
MBMQ=%)RZ2UHL^H!0"@+M!QII:3:LP >[.?G7, :\B"?E*B/$--0#E#PB%>5^
MZK-F5SIIL[S*PL=Y63&S^2WM[EO]XV&(0I"E(0 *0A0*4H= %*   !X  *K+
M;;J]YL!)17"MR/U7!R* 4 H!0"@% * 4 H!0"@% * 4 H!0"@+5-?PQU^"3Z
M0E1&N_PJ[W+YR,W3OMD.]^1E:T_56W[.C]&6L[#^R6OV<?FHQ[WTT_C/RE16
M2>0H!0"@% * 4 H!0%G87# RC^4BHR;B9&3A%4D9J.8R+1V^B%E@,9%*4:-U
ME%V"JI2")2JE()@ =*48+Q0&/0=VVM<R\LVMRXX.><P+T8Z;0AY1E(K1#\HG
M*+*23:+*G9.@,D<.10"FU(8--2CIRTUO%4]QD-< 4 H!0"@% * 4 H!0"@%
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MV*^* 4 H!0"@% * 4 H!0"@% * 4 H#\G.5,ICG,!2E 3&,80 "E#B)A$1
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M7ABCYVUWV7\^\N*4M;T;4L:U'?.>/=]7X+JB[;\$F1$#XY1$HF$#%'00'4!
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M\[WT4OBOR'>WZ<>]&(_RS^E_>JIE/_J=/SOWA/?[S\G]$S*KN5X4 H!0"@%
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M'H*4O6(Z  5UG.-N+G-TBCTM6KEZ:MVDY3?0B:;;M="%3!PORKR*A=#J]*:
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M@L4NA@[P ,IB:MI,;$?K.-]%TKJ[5V=:Z.[=TO6>%<<-QN#5>,44 H!0"@%
M* 4 H!0"@% * 4 H"US7\,=?@D^D)41KO\*N]R^<C-T[[9#O?D96-/U5M^SH
M_1EK.P_LEK]G'YJ,>_\ 33^,_*5%9)Y"@% ?DYR)D,HH8I"$*)SG.8"D(4H"
M)C&,(@!2E -1$> !3>#"+?R985U2*L3;UU1,I))%4.+-NN(*J$2^=4; H1,'
M::8<1,D)R@''72LJ[A9=B'K+MN48=?X;O"=Y6YQ59*B,YK%.@H!0"@% * 4
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M6W*+4DJ.JVKO-Z:KAA'B@/- :*;(16N>4W1Y %!0R]T;B[KBR<A#&$S*V63
MK$H !1-RIDF# '4'$.H:LG,5+,,/&;2C#%B_#)NOD,O(C+]7;BFVH+<=!&UO
M3;OYF,=Z#T&53%N0?"!W'=%$/$-56>38M^E./@V^06L#-O>A:GX53RT,E98_
MDUA*9XX;,R#\(I!,Y6 .SE)R(Z_\XUBSU*S'T$Y/Q+W_ '"2LZ!E3VWI1@O&
M_<V>Z9E'V5"LN4RJ9WZH &IG0@9/4.Q H GIKU&YJP+N??N;(OA79[Y+V-%P
MK.V:<Y?G;O%N\=3*R$(D0J:9"ID*&A2$*!2E .HI2@  %8;;;J]K):,8Q7#%
M)174?NN#D4 H!0"@% * 4! VXC;ICG<SC]Y8&1&!SH]X+V!GV/=)3MK3)4C)
M(R\,Z525*10"FY%DC@9%PD(D.40T$)32-7S-%RUEX;V[I1?HR74_Q/>GN/*]
M9A>AP3_]#@BYV2[C-C.38K/36&B\NXLQS*'DKF=VF]21E).P)#O82XV,U:<H
M47S<7EOR"P.>X+(-&I3"J=7NTS'+M6/,VC\SX4M*E*6/G7HTBIK8IK;%QFMF
MR25*\+>Y*KH1GU>_BW5?2K&/2NK\.\Z_6W'6CDK!D]D+;_D&XGMBW/:L]+,;
M+15:+H%G$&#A5:WER.VZTA!O$WR)4'3;453<=#B4Y#5KC/NYFG9KQ]1LP^OV
MG3B==JZ'L=))[T_QU)N&4KL%=BDY=#]\U"Q%OAN5M;<EC*]0C(9H_MN1@+.O
MF":FC'-I2[B.<M(I[+MT#J).6"+Y1-0[E$A'"!@,H8%=?)B;R=VX[TG6;=7V
MF.[LI5<M[(JPGN^RKB&Y$V]RS$W?%HBY.WF[<N"4<R#UH7O#%6<P4B_5<*L'
MR"HB;NA,+=;02F HF!0O2<%*VW;2<J;.A-]%6D]G;1G6,G&:C.M*[>OQ=?8=
M2$\[2MUQC*8MI:/;0\JU2>,'+9(SA=1NN0#D$ZKH-"*AKH8O=$,0P" @ A6F
M]4YQUV&1<Q."&-.$G%I+BDFM_G/8^QJ*5-QLW3^6=(G8AD<4K\9)-.O"FGV+
M:NU-[S'7-XW4ZU[ZX)80-\(B;U=%,?&F@=,GO56KNN:Q?^DRK].I3:7B32)R
MWI&F6O0L6J]L4_==2V>EY7749.0YOC>>.!-[O>:UA_7<RO%ZZ[7X\O?,KZIB
MTX?5VZ?%7O%R;WA=+30$+@EP*730AWRZR8:=0)K'43T]JLNUK>L6?H\J^EU.
M;:\3;1C7-)TR[Z=BUX(I/QJC,SB\OW,R$A7Q&<JB' _>I>;.1#CIRKM^5,H^
M$R9JG\/GC6,=I9"MWK?35<,O X[/'%D/E<J:;>3=ASM3Z*.J\*>WW42W 90M
MJ:$B#A4T.\/R@"+\2E;G,(<02>E^1$ 'A\IW9AZ@J[:9SCI.>U;NMV,A]$]S
M?9+=_>X6^A%5S^6M1PZS@E>LKICO7?'?XJ]Y(Y3 8 ,40,4P )3 .H" AJ @
M(<! 0JUIIJJVHK[33H]YYKDX% * 4 H!0%JF^,8Z_!)](2HC7?X5=[E\Y&;I
MWVR'>_(RM:?JK;]G1^C+6=A_9+7[./S48]_Z:?QGY2HK)/(4 H#EEZW^)D)'
M:8V>LTS';0.5+.E98Q1$"HL%X^XX-)4X!P$HRDPW(&O6<*O/L]G"&ON,O2G8
MFEWUC+R)F#GI^HKT*2.8'JV8N274OIV7G+%.<@88BC$$/DW,D<U^JI"3AH8[
M-L<P&^*#@O;5VYSN02M+_N*U>?<O,\OXCG1M]V71PG2[/C=9OEZ]"+%,!E7S
M-PF)@'RT7$4P51,7XQ>0X!PZ!#2J7I4HRT^WP]3\K)ZS]&CI]:39PSM6V6CH
MAB.FMOPS9R0W Q'"$<V26*8/C H4=:I.0U*_.4?1<VUXS G1R;6ZID%>1U%
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MBX>7S)W-I<_*X,W32.92-B7 D "H@H<ZI-15.8# FGO;"GE7;$;V9%0NS2?
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M/)?TJL'$F2L@XIRVWN)[<.8(:*N&Z['N_%\R@5C;CB;2F"-RK1B[MN?O@'/
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MX8S7=P.34>K8<RN2GCVKS]-37AWKW3NB'  #P!6KR3/- * 4 H!0"@% * 4
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M?X5=[E\Y&;IWVR'>_(RL:?JK;]G1^C+6=A_9+7[./S48]_Z:?QGY2HK)/(4
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M+)Q-JH8PD<<KXYB[!80%ANQC&D5$LR1:\,P,LJY.J[\]#BJMO89*R]59BRV
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M;D2RLJ3GD7).4I/>Y-U;?A/I*[*SAV(XV-%0L6XJ,8K8DDJ)+P$IPT* @7R
M]S[7"K;@8%4MFPK&9FTV)DGQ< )^4 3UZ.K[-6_$TRJ6S85K)SJ/>9NUM43%
M#5/W"_V:=%3UG2E\$B+FH[=K*M2U!Y1\CC^"->T]*V>C[AY1U&OY1C,C;9B
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M;=%P6W^5YJ4>)5W5JFJ&19LW)\*FN&S#:D][?6_>.QM:[) 4 H!0"@% * 4
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MK<F"-G*@A%2ATT'0".I&ZXCR-W@:_! AC<JFG20=1UY0TM/*FM2TK4%:NO\
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M^=.Y2:7N(V)I4/5Z;CP_]F'C<4W[ICU1AGG._<M=*MPY%2MI(YACK09I-Q3
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MOVZLO*%?YBQZ?G__ (YD%S+3[EO5_,^?$VZK=YJD4 H!0"@% * 4 H!0"@%
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MG#M^R/MUKW4L>C9==/R*TVDM;6+J/&79-68X4_TD^S-),"#J/+*10"*Y4PU
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MI_&?E*BLD\A0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0'K5^:4_-G_)&O.[]%+XK\AWM^FN]&(_RQ^E_>ZIE%_*=.CB_>$]_O
M/R?T2V9.M\9RVEUD"<SV)$T@W /A'2(40=HATB/,AJ8 #B8Q"A6;S?ICU'29
M7+:KD6//CVI>FO[NVG2TD<<MY_U+48PFZ6;OFOL;]%^/9V)LU+K2AM,TSW5V
M2H)87(;!$3>:E)!3_( CRMS*J+Q+XQ2E^"FLHJBH<1^_2#H"M(>UW0I?J.9,
M=>@E:O4^#5NW+P-RBWVP70;B]ENM13O<OWW3B;NVN^B4X^%)22[)/I-;("3
MO)Y79V^#A[=:OT_)I0V-GXS=2:8.7TY!YNSV>&KYIV;2CJ4[-Q-Z9,4+<0$
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M913/H'QB"(]M53&U_*M>;?2N0\3\?OKPGG#,N1]/SEXF3+ W;"W"0/,7/(Y
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MN5:KHHOQ'8FAT% >M7YI3\V?\D:\[WT4OBOR'>WZ:[T8CP^K/Z;LZ_.ZIO\
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M0LCZKJMF=F[T5W/MC)5C)=J;-U8>5IFM6/K.F787K79O79*+HT^QI'N:W&(
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M* @!BB&H:T!5-FS9FW1:,VZ#5JV2(BW;-DDT&Z"*90(FDBBD4J:229  "E*
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MB (CIH&G1X_#4UAX=:.AFVK21,4/;',!=4^SJX>YQJQXV#7HV&;"WU$BL+3
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MPJ[W+YR,W3OMD.]^1E:T_56W[.C]&6L[#^R6OV<?FHQ[_P!-/XS\I45DGD*
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MMB) PIZEZ-.KK&JA@XZ=-A&V(&PUM08&Y-2=G5V^U5QPL:M-A)VX(GF MOG
MGR>O1PT_L'2K7B8>ZBVF?:MU)@B[2YBEU3X<.@!JP8^GUIL,V%G892%G%Y/F
MAZ->OV:<*S_NW9N/;U)CTG:.A3:)Z=/#00^T%8=_3Z+=M/.=GI(EG[;Y /\
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MJP%NYPW;1&2\6R)Y6#D"W59+;;9@6PEYPC:)DW[R(*2[;-DVGF\@FT=B+;O
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MRAIF+#@MJ6]UIQ2?;*B\N]M'%BU*WQ3N;;LG5^\;BU73(% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * ]:OS2GYL_Y(UYWOHI?%?D.]OTX]
MZ,1_EC]+^]U3*_\ U.OYW[PGO]Y^3^B9E5W*\* 4 H#$K4L.R[%&YC69:T';
M!KSNR7ON[!A(YM'#<5YSX-@F[HF/-DR>?3<J#-+OW"FJBG=EYA'0* RV@% *
M 4 H!0"@% * 4 H!0"@% * 4 H"#<P(""\*XT\DR+Q$1ZN8IT#A[8@:JIS'%
M^LM3[)+R$?G+T60SR\!$:K->A$>1/GB06CL*98?(>2LWQ[=ITS .@@(PCPG3
MH/4:H#FFY*QRUGW8/SEB7?F,P]1DX8%Z4=ZM2\C/G@M8@:)Z_P!W[ #7Q]@K
M:C5]C?0V<M-,OR7B)U5>-/2V$Q953:*T$B_)CU:%ZO#H-7K3X[D2EC:S:VSD
M""*(:!P#7L^^_LJ]Z;!;&2]E&TEHL4E11*8 XZ:^'H$:ONG6HO>3%B*=#8%"
M :"QYM"AY/1T=("/1TU;(8=MV>+IH2JM1X:LA*\(]%$52@ !TCH''K'[E5G4
M;44F1N1%(U;O%N3Y3@'$#!U=0U1-1@E4AKR6TU1O!(H=[T??]?AJAY\=Y$W]
MYJ[=Q"@*O4&IZHNH+>1=[<S6*ZB@ J]0:G\775&STJOKH0]];SN/LT<'<[9\
M6J*&U,G'SK8..NJ;2[)]LEX@!)(H:>"OJ/V;SE/DK <NB$UXKMQ+R&P]";>D
MV6^I_.D;/"(CY0!IU=M7>BW$L31B!(17G7'WI$F*/MG.Y/T^ $ZLW+<7QW9]
MD5XZ^\2&"O2?<3A5K) 4 H!0"@% * 4 H#D]=^1]U.ZW=SGO;KMWS<VVNX<V
MFLL:0.6,JQ>,;.R7E;(F9\H6@CDMM9=D(Y$--6):ED67CR:AG$@^=0SU^]D)
M$R"()I)"L([[%&K56R=\'WIN:PE8.X9SOJN*PKDL_!;F5NRR]R]K1D=9J.3L
M)1=F%NN:N&_<:QLK+$LJ^+$<,GS23\U!"-D")IKLT2%Y]1PZ.G":K^JNWJ;B
M]PLID_'.[UA;-MY:E+'Q1NYPW;\'$?5Y=MM:W'QLBK9%LR$8ISKO[BQ7<ELO
M8N8>J*'6,L[;E6T/Q,.912W&HV,MW.ZB^MG5U;L)WUFFW_&EZ09MP$NTPA>^
M$\//(9M_27)N1;3M>U9M9M?=KY"<$NR+LYH J-Q1?<[X#(@J/(50<N*4J4V'
M=K;KD*\,P;<<&Y1OBW!QYD'*&%L;7[=UGBV=$-9%WWK9$/<$Y;GF<H8SXGU<
MF))5L"3H>_ $>57R^:AT=$Z+<<JIQ7UAL3OKQOM$3W]L%H.^MK.7-PCB\S[3
ML1EE8^4QME/$&/FEMH19986BS"4:9,6<J+F4!1-1H0H%$#F$!V\WAK3I.J60
M<KVQMAP(]R=GZ_Q?Q.-;3@POF^T[;%F]NN?.>,M]%>(LRW$WY_3][W2^1;Q\
M0P(L91Z]2;( 83%H=4JNB-88OUFNWYK%Y8=Y<MK,VV^=P[8EL90N.QL[8[5M
MZ]IO'M[3SNT;/N>QHBU)2]4+R)<-YLS0R4>R74ET94Z39PT1461 XYX7T;2'
MMP/K*$F.V+>7+6+8^7-ONYK!^TC*NXRP+#W%XU8V_+S,#:]M3)H*_P"#9-9F
MZ+4NJW8^ZVB#609>?>?L55$TWK5 %DQ.9V4-JZ54V)VVYUR+DG<YN[Q?=<A'
MN[2P];VU60LELUBFK)VT=98Q1*7=>1WSU$ 7D"NIEJ0R(*#H@0!*7@-$=6DD
MC>JAU% * 4 H"US7\,=?@D^D)41KW\*N]R^<C-T[[9#O?D96-/U5M^SH_1EK
M.P_LEK]G'YJ,>_\ 33^,_*5%9)Y"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@/6K\TI^;/^2->=WZ*7Q7Y#O;]-=Z,2_EG]+^
M]U3/^*?+_>$[_O/R?T3,:NY7Q0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% 1?E=D+BWV[LH:F8ODQ-P_Z;@ID3>+Y3DJ!Y@M<6)&[TPG[CV>6AB9D:VJ
M]3-=]1T$!X\>GL]FE4RBK4BC!,GPHW#C>_H$"&.>7LRYF"9"AJ8ZSJ&>)(%
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M*W):[ZTW.;[XN]Y$'Q_F2S8)P6/ACH&=-'[K5,_( E''%6+BR+<*^J<QM_\
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M!0"@% * 4!ZU?FE/S9_R1KSO?12^*_(=[?IKO1B/\L_I?WJJ9_Q3Y?[PGO\
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MM+'L0Q<:WBVMENW",5W122]Q&UX0C;A&W'T8I)>#87,A3J'*1,ICG4.!"$*
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M37ZJWM^5T>+?_P"IEXEMSN<?Y,?*;(5=R5% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@+5-_PQU^"3Z0E1&N_PJ[W+YR,W3OMD.]^1E:T_56W[
M.C]&6L[#^R6OV<?FHQ[_ --/XS\I45DGD* 4 H!0"@% * 4 H!0%.5VU.Y69
M$<MSNVZ*#APU*LF9P@@Y,N1LLL@!A522<';*@F8P !Q3, "/*.@'Y;O6;L7!
M6KINY%HX.T= @LFJ+9TF5,ZC9?NS&[EPF14HB0VA@ P#IQ"@*J@*9!ZS<JO$
M&[INNO'N"-7Z**Z2JK)RHV;O4V[M,AC';+J,WB2Q2' IA25(8 Y3 (@>73MJ
MQ;.'KUP@T9M$57+ITY530;-FZ!#*+.'"ZIB)(HHIE$QC&$"E* B(Z4![RF*8
MH&*(&*8 $I@$! 0'B @(<! 0H#S0%,B]:.%7:#=TW778*D0?(HK)J*LUU&Z+
MM-%TF0QCMU3M7":H%. "*:A3!P, T!Z(Z5C)=%1Q%2+&202<NF2J[!V@\13>
M,EC-GK115LHHF1TT<)F353$0.F<HE, "% 7#6@% -: :AVT H!0"@% 4RCQH
MBX;-%7+=)T\[[S1NHLD1=UYN0%%_-T3&!1?N$QYC\H#REXCH% 5.M * 4!ZU
M?FE/S9_R1KSO?12^*_(=[?IQ[T8C_+/Z7]ZJF_\ %/E_O"=_WGY/Z)F578KX
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% 66X(1K<$6XC7/D]X'.@L
M :F;.2 /=+D#AKRB.@AJ',41#KK%S,6&98E8GT[GU/H?O]AYW;:NP<6:G2$<
M[BGSB/>)]VY;'$BA1UY3!TE.0=/*(H40$H]8#6O;]F>/<=FZJ3B_P\#(6<)0
MDXRWEI>LF4HR>1LDU0>L'[9=F^9NDR+-G;1RD9!PW<)* )%4ED3F*8H@("4=
M!K&O6K=ZW*S=BI69Q<9)JJ:>QIKI36QHZ2C&<7"2K%JC76CA%N>VW2V KG/.
M6^@[?8MG78FA9 PG74MYXX,H<;;EE>)]4=!\U<'X+I  &,*I3Z_*_//)F1RG
MG/*Q%*>A79>9+?ZMO_MS?9^1)^DMGI)FN=8TF>FWO6VDWAR>Q]7YK_$^GO(4
M@[B$G+Y8"'#4->'C#6JSBYM*;3 M7B68BYP "Z*<=.CFX^/AK5@Q\XSX749\
MSNP2@7Y0>SIJ6M:A1;SW5W9L+S];_)U[WLX<W$:R?O'9O._K2U.[MU ?E>KX
MU>%S4'UG65WMV&#2UT<#"*N@\>'-Q'P &E161GI[V>$KJ(IF[C$X'#GT#CU]
M/C]NJ_EYO%TF#=O=!F&!,%W-N&O1.-; ZCK+BUTEKON<A"\C)I\YZ-C3+ *3
MB;D2AR(DT."(&%4Y1(7E-)<I\JYO-^I*S#BAIEMIWKO4O@QZYRW+?P^D]BV^
MVF:;>U3(X558Z?G2ZEU+\Y]'5O._-KVU!V;;T1:UN1Z47!03%".C6*7,)46R
M!>4NISB9194YM3**'$3J',)C"(B(U]8X6#C:;B6\#"BH8MJ*C&*Z$O*WO;>U
MNK9LJU:MV+4;-I<-N*HD95'1[J5?-V+%(RKAP<")E !  #[Y0X]!4R%XB(]
M!4A8LW,BXK-I5G)GM"#G)1CO9M?;T(WM^*;QJ'E"F G76$  SAPIH*JQ@ZM3
M<"AQY2  :CI6P\/$MX=B-B'1O?6^E_AT4)JU;5J"BB]UE'H* 4 H!0"@% *
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MCP  U'A4G;M3O35NTF[CW)&1&,I/ACM;-E[+LY"V6HK+<BTLY( .5P#4$4^
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MO_U.OY_[PGO]Y^3^B9E5W*\* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M<W:5J0.00\!Q/4WC:'AV/.N5N3_.W>+WZF7#$M0VO:_PZ"02$(F4I"%*0A0
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MN.O_ /JG'?$/_P#$(>N3R>\E:AP* 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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MYC[UR^N/B'U?C?B*_P"*/W*X_EG2_@S_ +S'WKE]<?$>/J]&_$5_Q1^Y7/\
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M^]<OKCXA]7HWXBO^*/W*?RUI?P9_WF/O7+ZX^(?5Z-^(K_BF^Y3^6M+^#/\
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M_?\ GKCTCYMZ,_T7>^D>][[EX]_S\WE\U 8!E?\ H-RVU_7#^D_=^F$_J?\
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8 * 4 H!0"@% * 4 H!0"@% * 4 H#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm2030088d18-ph_targ4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d18-ph_targ4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!0@+^ P$1  (1 0,1 ?_$ 0   0 !! ,! 0
M       & 04'" ($"0,* 0$  04! 0$!             0(#! 4&!P@)"A
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MRN/F*>(W;D$[VCTYP2, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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MU].P TWTIL^F/^K_ .C/(-BM=EO]B_37Z4_/W*PJ"^]C^;OFXG'A\WVKM\H
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M=!*J$S\^R/S[](@3]KX]E9^R?Y+E;_*9!5OJ;7X P!@# & , 8 P!@# & ,
M8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@
M# & , 8 P!@ 0YP"W)1$4@\7D4(UBC(.BE(Y?I-4$WC@A.1(1=T4@+JE)R/
M&,(!SV8!<< 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@
M# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!
M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P
M!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M7_ & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M.77DDH)5'3>R];W2Q$;K,XQX_,I(1M.<)LO$W*!UU$P4%,HF,6%@2]AJ5?\
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MJ&5U&SWV6E6-:-/!I]#7W)[C79G*WLI<[N\J/=T-=1V\S3'& , 8 P!@# &
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MKS%.S:PMWK/$UNJF\?0_.S*S3[[2XSG[UNY1/J:_Z/,2O.Q-", 8 P!@# &
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MJ5]/<'Q]F0 /8&"-H#D>WN^#OP3\)0>>>SU9*V!4IB5'L'GZG]G(070=)O\
M]($O^+S_ +XIFLL?_<T/_1G\,C)N_P#A,OXR^!$JSL#0C & , 8 P!@# & ,
M 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!
M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@$!M'_2[6W_',_\
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M, 8 P!@# & , 8 P!@# & , 8!:7T[$QPB5T]1(H'>B0156#U<I) <Y>?A
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M*9*V#>3_ " , 8 P!@# & , 8 R'L!#(7^"'_C"OYQ<X?0/Y!_Q9?$=)J?\
M,+\A?&78..T/S?F#-YB8&('ZX\=WU<? %Z!W 'QXVC:6"TSGT:K-BL?L+F3"
MOP4M-_-K(OB>2'S6P7?>Q-"B @+EUY'@)R'W1@RN$..2C6E70IF^"+EO2-=>
MG/JCK^_#S42,,I5[3#(E?FAU7J;]"0B%%_9_;X]T"+50XM%CID<$,F7P&5()
M1,!A\.3F<K++I.M8,LV,S&]ALDC:GCZGQ?HYAU+YJHYZ*NG)VRU(R=40ZXZ,
MW).;ZU>^//3XRM9V19K1.7*P2*<H$B#]]#RUBL*[A>+<**QQQ(@ H\-T 3NJ
M]-5==JH4.U!T70ZG<A>CGI^KT;IF,B::X:M]!MKA&:X5^D-@6>,Z]L!L\:W>
MI3[M>256N%/M)'8'>1<J+MDJNV;*^6"C=$Y'>S;?2R%:C@EN,=H>[NZ9D!:$
M".V@LS@HJT0-$B7N\]Q/X;54!<JI.4FPP>I8EY=EX_6T6ZKM@6023B4VOLI4
M6P("F5HV*E/?SZO,L>T=S!?]++>7W<?3B2DU77@R&^U:O0K33KEKUFOU,[Z6
M=:ZGZ'!6*M59SKZ24V :0I2$;"6EVW\B-4;(J$%/QE'R4O#*OW*MX8UW(=S!
MJCK1=;-DM-:'UIH2#EX37,1(M1LDXXM%LL%CLECN]TN5D=(HMEIZX7>XRLY:
M[-*>QMDD"*O':PHMTB))^%,A2A;G<E-XE<8QAA'>9@[/1W>GLRDJ[=IUW3MJ
MS2%=TX0;I%[U%U")EY]  )Q#DP^H.W*)SA;CQ7&HQZV42G"VJW&HKK(2_P!B
M0K;DC--P_. =AR$\A'D.SCQK "OUB"&:Z[JV7CA;3F_,O3CZ#77=5R\'2%9/
MS+[O(1%WLB85Y*U;,V@>@WA.X5 /5XCG*G_X&8$]7S$OV:C%>=^G#T&%<U:^
M\(J,?3]WF+$M<;(N/)I5<G/H0(B@ ?%Y21!S%GG\Y)^^UV47P&,\_FY8N;\E
M$=(+#. MYX2T@"P%$@* [6 X%'D?"!@/R!>1[LL]_?5WZ0IR[]*G%7&G17;3
MJ*7GLVX]U*Y/@K6E72O9L.TG;K,D/R9N1'C]L<&6#OY[05\89D+4]0BJJ]<K
MUNOPU+:S%ZM.)EZ:[(M#<Q?,<MWA0'[ERU2#D/4)VX-SC]?G,NWKVHVU64HS
M77%?%1ER.<O)TP?;]XEC#;)!$"R<4)0[/OK%7Q?']Y7$O^'FRL<RIK_F+?EB
M_B?K+\<\JTFO,9!B;; 3(E(RD$O:#< #5QRW<"80Y\)$U?""HA_<"8,W>6U/
M)9K"U-<;W/!^9[?)4RK=^U<PB\>@D>9Y>& , 8 P!@# & , 8 P!@# & , 8
M P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M & 1B8M<9$^)(#>UNPY#V= 0$"#ZEENTB?;W@'B,'JS/RNG7\S[7NV^E_$ON
M1JL[JV6RGLKV[W0MW:]WI?48QD[7+20F**YFS<W(>SM3&2 0$>XZ@"*BG9W\
MCP/JS?6-.R]C%+BGTO'_ *#F<UJN;S54Y.-OHCAYWM9'P'Y'(\CVCSZ1]/?F
M8U[1KEL.  4  1Y[?5\?&58[$**E6."#V!XN1[N?7C$46[:4^Y'X0[![>>?B
M[ QM1&Q]97M 0'TCVCZNWG\X,C:NHG%=H /%R'/RN?J9+=.P;>TX\]G&24GW
M2760,15$YTE"C\E1,XD. AZA*(& >S*)0C.L98Q>XKC.<&IP;4EO3H3.*O+]
MJ)$I OMR'( )^PCDH=W(*<^%7CU&#D?7FKS&DV;B<K/L3]'FW>3S&ZRFN9BS
M2.8_66^G\+S[_+YS)L;+L)9+S&:Y3B  )T3?(72'CN.D/R@X]8<E'T".:&_E
MKV7EPW51=.Y^7[F=/ELYE\W'BLR3>];UY/N1<\L&40"TC_SOUK_QQ/\ _5:5
MR5L(KB3_ ""1@#  ]G;@&M-ZZN]!Z^E'4',W8CZ98J"B\CZ]&R4Z9JL7[M!=
MZP;*1:;A(>PZ8K^80P"!B@(<96K<Y;$4RG&+HV2'6/4GIO;KT8FEVY)S. B=
M<8*39/H:5.DD'B5,V0D6Z"<AY1/E']F.MX"]IN  1R)0E':%.,MFTSKE)4,
M8 R'L!"X;CV0_/I<*]WP>#.(Y?\ Y%_Q9? CI=2_F%^0OC+MV#P';]CT9O#7
M[,2G9V\\]^3B3B<A'C*40E4^2JJ***JS@Z:2"22BJRJQBIHII)E$RAU5#B!2
M)D(')A$>  .W)HZX!X=AX5T';M)U7U1V?8#1M('H*ECN[-LW@4FJZIX>5=O"
M,56K=9RR0,P*L"2Q2>,!*D4H  B !F^N69W<JK?]Y1><TT+L+>8<U[E6>O%
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MY4MNEWY+V^3I79Y4C96K\+NS"702?-B7A@# & , 8 P!@# & , 8 P!@# &
M, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ?-99)
MND=990J2291,=0X@4I2AZ1$<JC&4Y*,%63*9SA;BYS:4%M;,4V"YKNS'9Q9C
M-VP\D,Y[2KKAW#X?2BF(=WZ8?@[LZ')Z7"TE=S'M7.C<O6_0<GJ&LW+S=K*O
MAM=.]^I>D@8\F$>>>?6/=\(\]O/(YMU1(T.UT!O" >'M]?YA]&%5XDNB5"G/
MA^47N'LX'O\ S=F-N#VE/6CB''(#Z $._P!/UN>W)>P+;U'(3?==P^D/M_8R
M*;":E/6/ ]H]G9V?#SD]1&!Q$!#M'T_F[<E- "''IY[.>S"%*%1#L 0[N>[U
M9'5O'6!^5SQSSZ/BX[@^+&SL&TY?=%#^YYY_L?6R-C[2=J[#[-W*S-5-=JJH
MBL0>2J)B('#U=P\" ^D!Y ?3E,X1NQ<+B3B]Q5;N3M35RTW&:WHRO7;BE("1
MG(^!N\'@J:P?)1<F[N!#G[TJ/J^Y,/=QV!G/9W3)65WMBLK>];UZU]W6=9IV
MLQOM6<S2-[<]S]3]#]!-CHI*'24.DF=1$3&1.<A3'2,8HD,9,P@(D,8AA 1#
M@1 >,U!OCZ8 P!@&J_65L>6UIHR>D8%=5E-6&0CZE'2"!Q36CQE@<.'[I$P
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M.P#CC_)#_9R%G<ION1\Y+T_/_NI^8X?1N=[OFQW^!'[65?3LI^\CYR/J[/\
M[J?F.HZBI!D!1=M'#8INPIU4CE(8?4!Q#PB/'HYRY;S%F[^SDI/J99NY7,6/
MVT)176J'2$  "AV<\]OU?@#+JVOH++W(^*ZZ#5%5PY42;MT2"JNX74*D@BF7
M[I114YBD33+Z3"(!E<(SN24()N;P22JV^I%%RY:LP=VZU&W%5;;HDNEMX)=;
M-8;YUK=+>N3KM[%NBIKO6IS)+1M85=W*015+V"BLWJ;68,@H ]@@H)..\> [
M<[O2/"[G[6DIY+2\PK4E52NI68M=*=YPJNRIY7S!XX^%/+4I6]2UO*2OQ='"
MPY9F:?0UEXW*/MI3>:_R?O5.EAD8Q&CC8<T4.Y2/IH(D4XY$/"$M*1BH<\?I
MBAG8V/L_<_W56Y')6GT2O5_R(R1Y[FOM9>%-B3C:>I7UTPR]%_M+D'Z#IL_>
MM]+JZI2KM=G1Y.0 RCJI,%" '9R;PL; [4$OQ%$>S+EW[/G/L(UC+(3ET*[+
M_K6TBQ8^UMX5W)>W#5+<>F67@U_9NR?H,QU#W@?2+=%BM6>W(V =F$H"C<HN
M<J:11,/ %-)34>VAA'D>T0<B >G.9U+P>\1M+B[EW3IWK?39E;NOYL).?]D[
M/1OM$^#VMS5JSK%K+WGNS,+N72_/N05O^V;;0D]!V6/0E:W-Q-@BG'A,A)PD
MBSE&"P"'B 4GC!9=N<.!Y[#9YWFLIF\C>>7SUJY9S$=L9Q<)+M4DGZ#V#(:A
MD-4R\<WIE^SF,I+9.U.-R#[)1;7I+P;L["\=O/B^+X?5WYC+K,U]1PX$! 0]
M/=V9.#(I0Y!V& >0Y'D1^ >/3]7(W$[\3)U4M0G%.+DE?$;L(U=G'D3#W%07
M,//:/Z4P]_</HS0ZCI]$\Q85.E?&OC.GTG56VLKF75_@R^)_$_(9)S1G2C ,
M9;!W+K'5K4SF]7*&@C^ RB4>HX]JF'12@ C['"LBN95UW]Y$3 'I$,E1E+80
MY16UGE9U9=7-.W55$]>4RN31V:%AC9DEDE3HLQ748MWS<$&D,D1RX,"_MP\'
M453,''W \]E^%MQQ98G-25$9ZZ%IV[42A6%AM?QTW7P2$4KKY_=%TJ^#B0F%
M) TQ'0X3"S55=@LL1%9,I2@F*ZJ@D$PG/X:;J3>&W>5VZI>UL-#.J;>$ONS8
MJKE]$+5R*J0/J["P+HQC2+4J+U7YP=2Q3> A)5VX3 %4RE J)$R)\F,43FN0
MBH+M+4Y<3ZCV(Z<=\ZYV]5VL13UGK"5J4/%LI&N3!$DI1JS;-TF#9ZD9%15N
M^9'%$"BHD8? <0 X$$Q0&Q.+BZO8S(C)26!LCE!4, 9#V A<-_!#=G(>T*\_
M5\'YV<1R_P#R#_BR^(Z74OYA?D+XR[#ZP] 9O%T&O70 ](^GX._#)?H*]OV.
M_P!&01@>,'5N2!UQU35VS5E0D8\*G4+I8/8RF*5M.)S;LSER*:!1-XWT<P16
M6(!1%05#&$!\SC-WE.*[E7&6*Q7D-3F>&WF%*.&QL]9Z5LFA;%9?.%*MD)9$
M *4ZJ<<^14>-/&'B KZ/,8C]BIQ^E63(8/5FIN6KEMTFFC90NPFO9:,(=8^P
MPH6B[.1LN5*5N)2TV-*)Q*<4YDAR3"I/"(& R,(1QP("'!S%R]DK7>7U79''
MS%K-3[NTZ;7AYS&_0%KWZ-ZH?W1VB))"_P L== RB8%4"#@5'4:P IA^5Y;A
MZ=TKZC%,4?5EW4+KE=4%LBO26\G;X;?%O?P&<MB=,>E=F$75G:7'Q\JKXA^?
MZT4E?F 5.("9=99@0C614[.SVM%P4/5SEBWFK]K",FUT/$O3R]JYM6/4:%;*
MZ%9^AK%LFKMAF7516 T9'RQE82QH*%[1]CGXHQ&BZI #D3BDS O/'/=E^YK.
M7L0KFE1-TPQKY-IK<S:CE4I\6_#I,7(;@ZFM;R3*)O,9,VQ,ZJ$>Q)9FKF77
M=!XP*1M%6>.444>N%1'@OF*NN!'[@1S$OY+1=5B[]JXHS2Q:=*+KC+8O(C!G
MP9CVI2K*FVOK/56K,Z,ZBDUK [5;29C&%9NHLND5$H\"0J8HIB10 #O'D1Y]
M6<_D+6CSL5SDVKU7O:PW4HBW:AE7&MUOCKUDE^:]6?TC_P#JWOXO,SZ-RY^\
M_M/U%W@R7ROA*?->JQ_]HC_*WOZ*>3]'Y=7]YZ7ZAP9'I^$?-FJP_P#:(_'[
M6]_%X^C<N_O/[3]0X,ET_" B]5_TC_\ JWOXO#RW+N^YZ7ZAP9'<_A,<7G9G
M2[K7RPO.R:[7%U@\2+%].+C)K%Y /&C%($6DE4PY[3%2$H>O-)JFL\@Z)3ZT
MSUFS)[%*X^)]D4G)KKH8F8S>C93#,WHP?0WCYJ5]!C8.JCH='NW+!C_]3?H0
M^:;^NO"E_P#S.U_M/T#%^NN7?WZ\TOT3F'5+T/CW;DA!_P#J?_W/C^NO"K_S
M.U_M/T!]<\N_XA>:7Z(_[4G1!_\ [CA _P#J?_W/C^NO"K_S.U_M?T!]<<NI
M_MUYI?HG >JCH=#OW+!__<__ +GR/Z[\*:U^L[7^T_0'USRY_B%YI?HF2J+L
M_I=V6D8]&V!7[(HF BLS83#_ .<VX!SR9S%+ C)-RCQSR=(H"':'9F]TO7.0
M-:C72\Y:O/>HSEQ+MBZ27E1EY;-Z-FU_RUV,WT)NOFVF1O8M4!__ !7=_P (
ME/V.;CNN6_E.O;,R^'(]/PE/8]4?E0_RB5_8X=KEMX.7IGZ@HY'<_2ROL6J/
MRL?P\K^QR.ZY:^5Z9BF2Z?2R:1=HJ2";6+93 * !BMVQ7!W:A_EFX32%PY3Y
M\("/A+XC< ' =V;;+:CIL(QR]J[7&BKQ/L56OA9D0O6$E",O/]\F>;8R",3R
M5=460^>E/ J"0^2'C<EY3\8\C]X#C[KU]N7(<=/9*)<-:R+%[-1/V\/PS_[6
M55NTZBG]7]U2<L?9@9M@9F\34J*96X\F'E(I0*3M/\L?DAZ>W+3K7':7%2F&
MPQ];"5\@G!'@LGS\HC/P@ER/>+H #RP,']SP?GOR];X]^PM3X=VTQA*R\3 Q
M[F6G92.A8IF3S7DI+OFL;'-$N0+YCIZ\51;-T_$/')S '.7=FW84'*,E(N;8
M-I2&DF$O%O$P69R46\;2#!VD(B4%6KQHHLW<)B8!#Q$,(=F,&NH@[_ ^@.<,
M%,*H*\#ZA^M^;UY*> *9 .M[:R]L^;O;&OSA[-[9[![0E[;['YH(^U^R^/S_
M &;SA\'F>'P>/LYYR"0[>LF"::K]XU9)*N&[1)1XX1;)J.W:I4&K5,ZQR%.Y
M<KG B9 $3'.( 4!$<D@[7''?DJ@&%@#(5!^[DO[QK_A+Y8N[BY;VLR1EDO#
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MY2?!<OWU2S;<HJ:4()J5V2C*+;DX13W31XI;+W5O#>;M5SL[8EELC55Q[2G
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M HG3$#!R \X[-P*2,G&P[-:1EY!C%1[<"BX?23MNQ9H <Y2$%9TZ4202 QS
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MI*D,0X 8! +RH^PI,DT_^?6W[DY_>#Y1<]QE4/>1X6=6T6"_4_MY;P<F4L#
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M[(9%M*3YV,Q*&23EFB#,2IJY$7:BJ5QKM,9JXW6F%##VN?=];JF73ZN;6U-
M#JR'>]8<C0Z9/6'5J\# H[CU-TVQNKXV/I.MV<+0ZX>(V30;'(&0CHY!E&2:
MQ7R1E%U"O5*Y78I5B_:P^,B-N5:27LX_$3J#]WOLMI):ABGU%K!Z.YBNAV8Z
M@(8]FCG#"][#UA#[;C>H>PW!@9T8MZE[0E98M&4>.P<'LR F3<&<IE.4:>^6
M...-/10J[IU71A7XS$%NZ%MS:XH<"RH&N*6-R?4;JFHEZCU+H6/"UT&X=2^N
M[%I2H2,FPGHI688U71D%)-8!@\=A$1!BIQK@J;%=PB?6:AG,O%PMW9->U&6"
MK2D9*N_\*G7O6*1K\[*,.&#P=6_)C0RGTK=/?4%0ZW8Z_)V^P:+KS'>]AO5<
MJ$!%:&LT3:-=6*M:W!*H.(V J*E>UVUBY^OS/F-JZVBR>;*K+$.N<2N!T&<S
M.6N24DE<EW:3;XU22<L<75X-;6]GD-;=G%M/!NG7]S,74OI]ZH9C6&E] 3FO
M(36$3J'=,[MY7<ZFPZY9UWJL=>=A7*I,*K38))S)(/I-U:VJ3M5\NW31:)."
M>%450*%VYF<I&[/,1DYN=M1X>%K<DZM]FXES@FY;6U2ACK4O1%ON"C*FWL4
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M]%RZ_56>-_DU],B 6OWF4G%-08:YT[!0Z")1(@>?EUG+=,I0\)/!$P;*'33
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M-S;)28C[%)6AQK:FK6*1L$2^1DXJ=?3:D*:2=S$9)-TW#=THJ99%<A5"&*<
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M"/VU?%A3[JYI/+;GMPOM*G:\ZUZ2)PWO)NH^;>)(,-0Z?DS&72!1!G< 274
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MSW"PNYMQ@L>&*7F.IX%PI5V$>^@S?^E@_DQ?_6\O]Y+H(X%TDU0CVY8YO'K
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M3T625MQ*PV(\LAJVP%T#J;+ -%2JO!;%4]F3,!E/" \Y%54DEW'P8^ #@?2
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M_P#/K;]R<_O!\IN.L&50]Y'F7ODP!OK8X?\ \X9_Z%B\^BN55_\ 262_A/\
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M]/I[>_.IR5IX')YZ[M=<# ]A<A]\[0'OX[?T/B#.RR=O!'!:A>6)@*TN0^4
MCW ;T]WB]?J[LZ[)0P1YOK-U5:-<;8Y#PG#GU]WJ'^UG:Z7;]I'BG-F82MN)
MOG[I&J'E-W[-NYB&]FJVO4H(%! ?+![;9YBX1*!@[/,!I6%_AX'X<\L^T7J"
MR_*V0TI/]9F,X[GYMJW)/TW8GI_V0=*EG.>]4UUK]5E-.5JOXU^[!K^S9F?H
M' P< ' =HCR'J[?K9\=49^A]>HGE2@XJ=CI^.G(R/F(B0018/HN59-Y".?-E
M?..LW=L7:2K9RB8..2G*8H^K-1J.;S&4O6;^5N3M9F#<HRA)QE%JE&I)II]:
M9O=(R&4U#+9C+9^U;O9.Y%0G"Y%3A.+JVI1DG&2V8--$UJE*IU#B2P-(JM<I
M\(191R6(K$+&P4:#A;P@LX]ABVS5L*ZH$*!C^'Q&  Y'L#-5J.J:EJ^8^EZK
MF+V9S5$N.[.5R5%L7%)MT6Y5H;O2-$T;E_*?5^A93+9/(\3?=V+4+4*O:^&$
M8QJZ*KI5T1$Y31VE)Q\\DYK3^KI>2D%5%W\C)Z_J;]\]75$157=NW42JX<K*
M"/RC',8P^D<V.7YKYHREJ-C*ZEG[=B"2C&.8O1C%+8DE-))="1J,UR'R/GK\
M\UG=&TJ]F;C;G.>4R\Y2;VN4I6VY-[VVVSYP.B-(U:793]9T]J^O3L:H96.F
M82A5:+E6"ITSHG59R#&*0=M5#(JF*)B'*(E,(=PCE6<YMYJU#+2R>?U+/WLI
M-4E">8NSA)5K2493::JD\5M*-/Y Y%TC.0U'2M%TK+9^TZPNVLI8MW(.C58S
MC;4HNC:JFL&T96SGCKCI27\W/_XDZ_>%, C.N?\ 9_2/]4J]_HEI@E[29Y#V
M$$#8M6[Z+=,GC=%VT=B[;.FKE(B[=RV<)@DNW<(J@9-9!9(PE.0P"4Q1$!#C
M.,Y:N7+.4[ZU)QNQO-IIT::HTTUBFGBFMAT.L6;68E*Q?C&=B=KAE&23C*+J
MFFG@TU@T\&CROW![G;ISV%/.K!1IRU:B5?N%G3Z%@"LINL@LNH*B@QL5+>%Q
M$I>(P^%%%R#=,."IID* %SZOY7^U'SSHF3CDM8LY;4XPBE&Y<XK=VBP7%.&$
MWURAQ/;*3;J?%'.OV)O#/F349ZEH&8S>C2NR<I6K7#=L5;J^"W<]JVNB,9\$
M=D8Q2H9&Z</=<=/'3_/L+H_"6VI=XEP5Y"R]S39EB(-XD8#MWT76F9/FX)%L
MH &27<F<J(' #I"0X ;-%SW]HCGCG7)STJSW6G:1=CPW(6.+CN1>V,[LO:X6
ML'&*BI*JE5.ATWAA]DKPT\.=1MZYF>^U?7;,E*W<S*CW=J2V3MV(K@XXO&,I
MN;BZ./#)5/2<!#^S^AG@KJ?4U"H^L._GX<+H(70._MX[N[ V'+X_[600:PS+
M?V66DF_'!47SHA0_N/./X.SX2"&<;F(<%^<%M4G\)R&8AP7Y1>Q2?PELRSM>
M!9P6TKD53VDXK8.1R:K<1CY#1OKDVAN/4T'K6]:RV':*BFWL,I79=K&OU#QD
MB>48)2<6,A%.BN8MT#4L$Z OFI&$/-'CTYY=XHZ_S+R[E,EJNAYR_ETKTK<U
M&7LRXH\4>*+K%TX)4JGM.>YASF>R4+.9R=V<%Q.+2>#JJJJ>#IPO=O,&:Z]Z
M/U!1 I)7!E3K\W#@%#NXGZ/22G !V@[@#-F)#"'I]D,'P9RNC^/G.65HM1AE
M<Y;W\4.[E\ZW2/\ 8,3(\W:DJ+,<%Q=E'Z*+T&UD;UZ].VU$$&^Y=$&(Y5$J
M9WB<=6[HV0 > %8'D@G!3#8A1Y[$DU#AQR'(YZ%E_%WDSF&*AS+I-+KWJ-N^
MEU\4E;FO(FSH(:[I^:7_ #ECVNQ2]+HR<QE Z$-F%.O2[PA2I%S\HK52?D:^
M)%C]OE)1EX3]G5\)AX\#8? /'R1X[<W-C2/"?7/:TO-+*WI;G.5O'\F^J>2+
MIT&3&QHF9_8SX)=K7HE\1(G/14^213>4C843-M% \2(2[,[1,Y.!$!)(Q2LH
MBMZ.Y$@#WYDS\+[T4KNE9RW=MO9QIK^U!S3\Q>^J9+VK-Q277AZ54L)M'[8J
M1C>U5E:2;$'L=0+A"6(?CL\1&C<_SF !_=(%YY^/,6?*G,.0QG8<XK?;:G7R
M+VO/$MO)YF&V-:=&/P8^@O#%T^C%"MY%H\CG)>.4'K99HL''K27(F?[&7+-R
M[EY<%Z,H3Z))I^9B+E%\,ZIDZ9V'PE#[YQV>D0^WFYM9^D=I<4N@/+#XR"'F
M<]GK#\PY%W/U6T.728XG)HH@?Y?(]O/UOS\T6;S6%2S.>Y&"K+*@H*@>(. Y
MY[>\?7G,9N_@V]K,>3PZS"$\\+PI\KU^GZV<MF[E6S"NR,'V!T B?@?6'?\
M7SF<Y<,"3P,-3BX<'[>/C_-\.<EG[B=48%UX,Q#,K (G[?3Q^CG,W9;6:+-2
MJ>IWNUJZLTI>RK6HD8B4_98B(;*F#@%DZY'NG"@E-W&*5:?$OQ@.>_>"F3E;
MTO.Y^2HKU^$$^GNXM_#,ZCE.TU8O7WLE-+YJ?Z1[86;_ *-P7]ZS_P#0!S[
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M+E143'72$2'$Q1$,JH#A(:YUY+N6[V6H-*E'C2%7KC5W(U6">NFM==-SM',
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MFZ1BHU%U'L1BV#E)BU3<,8P13$8YFL1(JC9@(HD'R2"5/Y(=G8&*K<025C_
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M?%Z_3^;T9U&1RS5'0Y+4,WNJ87GI OWP1'@ \7I^SG59.SL.(U',T3,!660
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MJ^26U>1H[#3.8,]D)*>2OSMOJDZ>6.Q^5,VRJ/6I:F2:;2XP\3:F?A%-9RB
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MFP+(1,S:&,(B8S9 1$1Y$1%(@B(CZ1$<Q7M,A;$=G()& , 8 P!@# & , 8
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M\5^.IP?FE!'G^9\%_&C)3=N>AYN;6^V[=Q>1PN2J=-MT==7SU4J!-%7=(QA
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M+>%&3W&;4$O)011Y\7E))I>+NY\L@%YX]'/&8KVF0L%0^N , 8 P!@# & ,
M8 P!@# & , 8 P!@# & , 8 P!@# & , H( (" @ @(<" ]H" ]X"'I <#:0
MF9I3-[XUXX2LG ]HI<?YHH/]Z4!,B(^LO(?!FVRVJW;7L7_;AT[_ +_E\YHL
MYH=F]6>6I;N='X+]7D\QC5_#R<4;PO&IR$#L*L4/&B;M'CPJD$2=O'</!O@S
M>6<SE\PJVY)OHW^8YO,9/,Y1TO0:CT[5Y]GQEJ#M'DO''' @/]CX,R'@J,Q%
M6N  ! 3@'J]?/H^IAO8QO9Q\0]@#^E[N/T?@R:"NX%-P;D?3W\?5_1PU5$)X
MCQ#XN0#M[>.SX^_ZF*84%<:E Y ?%V=_I_/XQU#%8G/T^$0X .WY/KRG=7>5
M=3V%/")S?)]/=ZQ]'''IR:\*Q(HY/ DT54962\)S)"S;CVBNY 2<AS_O:/\
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M>?+2*!0$P\ )SC]T<X\=IA$1'.GL6+.7AW=F*C#J,^,8P7#%41W,O%0P!@#
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M/0E0R$E%46"/ME9(P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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MN]77;BA(,9>O-VYCB MG*_"A4X)3J;9&_P!J2/\ J"Y_ZPM<%6XG^"!@# &
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MJQK&U:):M>V%[!+M6TTTAK?"O8*2<1+A\SD6:$BBT?',B=5!9,J@ )B&#D!
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M=:?7=?2-TV2EK>/?(4RKR+^6BXDC'5^O-=1,F]/)R2JSB1D$'LBN/A**X)E
MF"*;S:L85H,Z6P^)?VXL2>& GC)[/[(=XF],;P>7YGG><F <^/P^'T<]N"2[
MX P!@# .E)?S<_\ XDZ_>%, C.N?]G](_P!4J]_HEI@E[29X(& , 8 P!@#
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MJEW@T++2;+ 7*ONA6*SFZK-1E@B'AVYS)K)M9.*=NF"YTE"B4P%4'PF[!X'
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MT/:S'=F7$#)2H9CA-6;";^\QO>YUZN^2U=*]'%2UU'W$RS'YN=76.VU)6!Y
M)H Z-) Z0AUB+B<R (B4> .)NS(&-34O53SK$Z2-!S_1QKKI;M^P=H5^V[&9
MZ(WRBO1WO3A.5;8.P)NYP]YVP_?7B$NE7D:BVM2Z4Q$%C'+E^X9 +-54K@3(
MR0JK I7^A';6RNH?W@ELV/L3>NI&6UDM!L*59=)["3U_4]E/8/I>I](NDZG
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MZNA]C5BOTR_1>K*S&VVH5)TN^K5:GV=;:MI&"@G+AR^76C8QPF**7*Z_!2<
MJH  <T%9D'7A#IT*E)J%,0Y*I7R'(<HE.0Q8IJ!BF*8 $IBB' @/=@/:3' &
M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P#2SK\_[M]C_[K/\ /4!_
MWPO]CO\ #![_ /YQ_HC_ (3@A[#GT#_]W&N?]UO^=YW_ +G_ /L?_AGZ7_YN
M_I7_ (1DL+8;H9!(P!@ >X?T>[ZN <2?<AW=WH[OJ8!RP!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
? P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tm2030088d18-ph_activa4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d18-ph_activa4c.jpg
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M$" P$P<Q,A1 (3-0%19@02(7(Y T-@B -3=P)A$  0," P,%"0H(" D)"0$
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M)FG1R.I4WI##)DB(@;*(R;?/R^-_FRC6T+"6RCH,_,T[&-4$0.G#4A@#M0
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MF4$0( C=Z=O'&B-M)TX;@)4;+
M
M
M                                         !CN7;MZ^X
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M"?.G+*=>B     +<UR2\CQ\CT2P^10PY\3*&N29EZ8HE1ER$GT) 9,
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MZ^,9[K_1?PS;_N?(#%[ZL7Z'*L-U=!,T/>*DA02HBL3D]%F34>GDM%H
M    0_E5X7RJ_F"584$$@$F*F45QFDJESGE-NET,SOL4F?&,\6_!OLNLO)^D
MZH^P?+]]?1_"512)"0%84*3-8@4F:Q'G"?&K+*=>D    -7^/]/P?^</NWSC
M+NK]'?");]#^?X*W1H!,(D5!2584*3%4@C.U+\LYW7]1(       ^6,:_P"'
M5CU+2F40E2%0D)A$BI00K*@15,KOW97>N_/#+DWXS]6P'-O])_5?G&PO3>?0
M2K"@E6%)("I020\X3XU993KT@    (/YWN<A?&_J'0?Z ^%R?T?!K"@$Q6)%
M#U!,^9@A$TD*B&0U;YCS.S=:]P      \1&MN!4PM/ A),5B:02I#5O#I:E\
M_2A/*KXS3C?[)F?4L;<]!>VMWKON5) 3'HWI-<N4*B%)FJ!'[O-Q=BM-.3VZ
ME) 435 0\X9>-4Y3KT@    +;/5!NMPK79J]1/F8J5B2*IUMV_-\T>Y^8::]
M/XN&]/BV^>N5<_J[.X/J.@O'?1>@?'?0J@J7&&R=<CO7.&T     ""<6K%.=
MIK"D@036&E?-<_DCY]Q(AS--QGG]IR])\GRC"WQQD-W/JKWW9Z$]=U* J3WJ
M]/,6+%8BDS6('.'O/F/Y.?I/\=?H]\)_3W:GR?[J3Q%OT;@B9+AE0O(FZ3L+
M'+SKGSJG*=>D!0X+^N? =@<?T74W@/JM_JW@>)Q@O6X-ANTD 5B:D'ZW"_/S
M[#^>=%^L\+DJ_0O]%ZXUV*I^.>FSVT\=8H3KE=GN[Y+]\W_X[Z$DA?ZMTZY'
M?])     Q%77K/SU3YSCZB: 3&#J8<;_ #?@Z5\Q1R.>V]V[KO//[YY>LLJ1
M'PPQM->NRUZK#7JV[Z2YV9])[LBM[TQ<9Y;&Z_6N<LDD/EGA^)7ZU_!T'Z_!
M_;?\E?O"=\7T0_/FQIRLM$98S*)W#CEAD=WZ-WC7/C5EE.O2 YD]U\Q_(?\
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MG.>GT<CNW<R6ZUI+J:E92_+&U7M4_)%W#<:=9S%H3 _1:K8\ZY\:LLIUZ0
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M$S&Z<<@-)98ZLRC5F6.[<,N@]]3$W.?CMU<  4*E#(Z;$CI=++5K=4@
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M\:_]K.OU,#S,U0A\)C&91FL,DJ)K$)(4F:Q J4$JPH!+SKR\:IRG7I
M                         6'.M6M7?=7-       )I*L14%  6E&Q?7ZM
MY>K@                              "TI;_CIV           ???KNKF
M@
M
M                                                         #YG
MD]%N79:%X                                         4/R!1NM-F2
MT@B-K':2?L                                        "V.,349MPN
M3!HMD]VGV
M                                        +$NSV
M                  <^D"-?(GJ;XC!VV168PP     !K;+'0F6/9^O9.8GG
M!&23OPJ                              #C$^YSRC?*=;&C$?L>G2V6,
M!R@A$I@()  D@F&3CHZ8ZNPSZ>PS_.A'.,OVDB:@
M          \ED?<^QY+0OBH      -<3C;IV=$U,&<&GZ&E0
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M+9U?CW#Z6YJ_%>!4UOD_CK#\P?H<$Q/%Y<N'%L(T'PSXVKK&5XXPN90UWB/
M*J;!PS&ZR@DX7C4O&HM%50I]1BE!1!SQKA+N.UGB; :>4)OACQK82Z#%L>Q:
M(OP[XX<LG\6HI-Y(\>X;*NVO"?C-E--3U]!66='5W#@NZ"FR2!CWBG L7L,F
M\<X=E\@\!Q \:_B= 5O^@8Q@]9BMG+\&X_(6CQO3HFEAE<6:.^+\;ERXGA:I
M*0SAM<QF8LO"U*[98MX\QG$JAKPC3-#^ U7\EQ#%X6&X_P#_ "*7(0D?*,?*
M,?*,?*,?*,?*,?*,?*,?*,?*,?*,?*,?*,?*,?*,?*,?*,?*,?*,?*,?*,?*
M,?*,(D(4?] 2%[4-H))?3N()26%;V^I8S45M?&\V1GZRJMJ^[K=Q W4$F9Y4
MQUC$R41C-,\C8;(K/*4*1=[BU-1)&I$-Q&-R3&/934Y0UO28W$+.RA4]?B^9
MU.68ZCS#7IK<;ORR2N^NE>WB]*BQ@TZT^GA9V<.HA1_*6#2W3\C8>4JGRC'\
M@@XYEN.Y;'7G>)MU[3K;[72/VQ?9U,K_ /%_&.=833>*VCOZG#RM6ZZ!A[58
M]GD>'3H\+0<;K\.\L^8$V*\NOFLHC>1IMS>3)!1\?RK+LFL7R@1)D^/2+K,8
MI\\H]F/81,@XGC$_P7C,6309\Y<3LEQ#)38\2Y+08ZK.O$5W;VU9]=+]O#+\
MND1WUK6ZK G'DWO'Q)_Y/@<G.&,@K)SL;Q_A=S QWR78?_G5.1_M'2/TB^SJ
M.M-OML85A\5VPJZZVBHQ3&6ZN'B.+U[Q8EBY!4"$Y+DUM?,?F5E=8*=QR@?L
M[7&,=O79U+4V<*YPV"_CU7C./4KS-#21IM;B>,TTF#7P:R.$8W0M*M\>HK]$
M2'%@1_KI7MX9)B-M^Y0\-R"6O'L:BT#7&AQ.JQR;C^*56-2$>,\;1=9-B=3E
M:7/&&,.5%9X<QJIG](_2+^/]9-UM(^0P/D, E)5QE^WEG990P%0LRH9SOT*O
M2+[.E&FL2E=/4OKWI;# <M5F%RY*P:E*Y2<<(-SI+858]U+;K;A<?(4Q]BN$
M2)(G2(4=46'PR'.ELO%EF1;L2RMZY<Z9^D7\?1>OZB,JWR!U[(,:RB->L\KD
MEEL+GF85(?4.XLQJ?#4QO603*?2$3U!N4RY]0_*9CA^P>=ZA&9!BP4D(6APA
M8UD.VC)\>4A+KJBMJ4<;K&+2KD1JBSF+Q+%ETO4/TB^SHY3C#=\Q)C/PWV'W
MHKV*9.B]9X/2D-!V2Z[U&I3K8:E-N_2S+#:9GJ?6;=6TJ/+0_P 5*)*;O-[&
M:ZBZMVUX9DDJW/K'Z1?Q]+),9C7S$V%)KI,27)@R,;RJ+=L/S35] Q,4@$9&
M7T"UI0F3/<>^B(1)IJ4%H2XBT\>RD.1O']VZJAQN%0HZQ^D7V=.ZQ^OO6E89
M9-VE;3P:I'T+,AQH-.I=3UC,DE,EJD*YST24_,\>KQ)\F!WR%D+@_G>4:M^0
M<C0(GDMTA S;'IX2I*T\D*7NZ$^VK*M$#(J&T7T3](OLZ;KB6D.NJ>5S?<6^
M6X]1"T\P&92?(^92@YE&4O!&1Y,V<?/LRBG!\NW3)U'DS&;-7V47%IU32FG4
MNIZMC)-2N>\SBLJ3M\@M;Q9(!-CMCMCM@VP:!77%K3KQ_/(UBODB2>\CE\BY
MM_$Z^7,E3Y'BC"X<6NX7&3>0IWD.ON+G&::ESG$LBCX]G6)94_F=O*H,4Q*S
MDW>+@_2+[.3*/,AP+6B\PXU9B-*C3&>)F22D/&\OFR#(JW&X5_Y%O[PTM&9I
M8!1Q\<?'!QPI@*9%)E5_CBL8\AU&0&?%AXV5D>I=.7)*,V9F9\ME90ZF+D&;
MS;=*6PEL$T":'9'9'9!M V@IH*;&/YG/I2J[6%<1>#3AM+:<)U'%:TMHR[('
M,FOHD.7/D8Q$DP,>X3\ CY5Y=SK'48AC59#N[7+,#1ELV]NL6S:-A^(Y]*I\
M>!^D7V<?*N2+H<;X4N1W>/.U/G&4VBC\G8E=FE25E,?W<^5^1X-$[/G6%S+;
MCA$<(C@HX^./C@XX5'"XX<CA;(Q3R7+JR;<;>;X0Y'4EO]][ED2&8K&2WKF0
M6*4!* AL):!- FAVAV@;04V%MA;84@4]Q,HIE5:1;B%PKWMK@UT+(_)N-4*9
M^79UG1M5.)TX=\AS(D?"O($_&K*+GN'2F$+2XCG/TB_CX^=7%_/X8?XWEY?4
M7F"Y1CW#'\VR/&1A.;)S%KE\AYP=2EMLU!ED-M!#(0P"9'9'9!LA3 6R%M!U
MD.M# <W71/\ KP(S(V7"=;Z-B]VV.;.,D.RDH2$("&PAL);"6@3([(-D*:"F
MPML+;"T!:!AEU^SVW!"MB\G\OP:E^XR3+<F2TY40E0\/\@9<B1X/6F!<XED5
M"M*5+5@'C";,E= _2+[..3X=29:U=^$[>,%XEDS<_/;"RPFF\<YQ>1LAO?'>
M*WXR'P[=0',"Q)S$ZGDS/)"QFEU=D/,M!IH-,A#00T"9'9'9!M!306T'&0XT
M'F@ZV/%^6');X07=%]&Q=[DCES.^*GK4)#: VV$-AMH(9"603([(-D*9"V0M
MH.-AQL+0'$C![\K2OX9OBMY+O:?PS;35T6#8SCI\/4-PH3*^B?I%_'S9]@*,
MR:PCQ.>/V2C)*5K-:^7R'D:;^Z9:#388:#;00T$,A+ [ [ -@+9"V@XT'6@Z
MV'V@R_(KY>/W<;(*D)5M4E1*3SK5L09ZGRY):?O%TVD-)#:0V@--A#82T$LC
ML!3(6T%MAQL.MAQ(<2'$BCLE4]OJ1\(*]LCKGZ1?9T)JMK/+G=R=)C4= 80&
M4!E ;;#;8;:"603 [ 4R%M!QH.-AU ?;#R ^@>)[@XEOP@JU:YYZML7ERB>=
M;0H(-D&DAM(:0&D!ML-LA#([ 4P'60XV'$!Y =2'4AT@X0PZ?^X8\&U;%\7L
MCHX\@C(RZ1^V+^/C89!Y+GY4WDZL9HHF8XO.IL>RS',K;%@K_+E\OV/=L8R?
MNRD,(#*0T@--AEH-L@F ; 6R'&@ZV'D!U(>2'DB0D5\U=5:;B,A 5_GSVI_\
M/+Y+E;(+9!L@T0:2&4AI(9;#380T.R%-!YL/-AU(>2'4AP@Z0<'C.3JU%8[[
MOQ(YIN\EKZ J/)(%\4PGCAJ)1'B29*<>Z1^D7V<4X+3Y?Y SIRMQ;(Z^3CMA
M1^+[1R7D8F'K(Y<YE?-S"*09(,I#)!E(90&&PTT$L@V0XR'6P\@/)#R0\0?(
M2"#Y"E=^13"&>C_/;<WDIPSM6PT&@R09(,$&$AI(8:W#XWV>9T#R0^D/)#Q!
MX@Z'@X/'3FR^KW"2Z,TQNPF3<)QRP@RPJ'#6OA*\P^.X4NIN*N^@#(,DI,6@
M0ID>QAB+?U4VWX'Z1?Q\=I$;K#+Y%'8(V6&(Y"3^?D+UFK-VSBAD,A@,D&"$
M=(90&F-0MC[/-Z!](?(/$'B#P?#Y!\8.[WL3,1_L]SVW-Y'U_?&PT&0R&A']
M6 R(F@_QVR= ^'P_ZO!X.AX.#Q]_Y&/D/[8G_;#-\BL(4O"LCL94[A@-QE-=
M//\ E'C/&9^>9I5XAY Q?*(HC_RC-LI_E^;9-+MLARK'2>FYCCUB#](OLZ$C
M\W*X6V9&# 9# 9# C!@PPH@ZHML@P^) >#P>$@/A\8"7_P#CPQ^7GMB_QY?)
M3>EFV&@R&3#)A@PPH-*##N@^3]GGM0\L/J#QAXP\8=#P<'CEO=>1(_?6J#&,
MFT=ML9'BK%^>.8DQ1.<,5P^#B:\MQ&ORZ$]XEK)E#DN)PLH.\\=)GW<7QU2P
M;&W\95%P_9X/7VC0/TB_CZ$HO^?D+UN6/B7T4PR89,,&&3#"A'6&7 V_H%2/
MLZZ'EA]0>,/&'C#YA\P^,19[&+B-]W^>R3K&Y?),/N5K9AHPT8:4&5!E89=#
M3P0\.^%/AUX/.AU8>4'5!PPZ8<,>-(ND:M<(N'EK-\OQ2<SYFS]I6'>;XUE(
MZA^D7\?0G)T>Y?)4#X&71E!E084&5!E8:<##P;?T"9 .2''PZ\'G \L.J#R@
M\H2%!XS,08_Q(0A%J]SOH[C/+D-?^YTJ##9AI0;4&EAI8;<#;P0^.^%/AUX.
M.!Q8>6'%!U0=,+,8M7G6T)&:3C2)#SUE5U]S#O/ =<^J)_Z_VRGXS"8T?IGZ
M1?9T)Z?MR^7:HWJZ.H,K#"PRH-+#3@:="'@3X-\+?#CH=<#K@=6'E_9Y0D+&
M&U?[UE'" GHRF^U(Y<MJOVB\;,-*#:PVL-.!#@2Z$O#OA3P6Z%N!QP.K#B@X
MH.*&-59W-U$C]]SL,[6(G8>X9;Y,QK$)#'GO%G',?S;&<HZ9^D7V="2C>SRV
M]:S<5CD=^!+86&5AEP-N!MP-O!+P[P[P4\%O!QT..!Q8><#RP\L>)J,XM?PB
MHV,]"T8U+ERW'_WVO3JDVUAMP(<#;H0\$O GQW@;P4\%O!;H<<#C@<6%JU&&
MX\JD@0'T-J&9^8[?',A@?^P*#&,Y;19;$\A>)D9=867B#.Z]5-XU\A_N1:Z=
M$_2+^/HR&^TYR^5\>)EUEP,NAEX-NA#H0\$OCOCO@WPIX+>#CH=>#KH>=&,X
M[)RJUCQF(<<,M]USHN()Q#B%-+Y<\QLV7$*"%A#@0X$N G03P[P-X*="G IP
M+<"UA:A@M*JPLN$/>M[-O'U/FS%[XDS2E7XRI,M@9IU3](OX^C/;U+EFPH]C
M#R7'I>+6C3H9=#;P0^$.@GAWAW@;H4Z%O!QX..AYX,1Y-C*Q+&H^+U7""UM1
MTK./J7*I"5IRW'544Y*PE80X$N G 3H[H[H-P*<"G M84L8]CTK(94*%&KXO
M"&QV6^3*[YK%\<@X]FEMCMMY,K\:3(\JQVWI/EG&68D+R; L*5GS50O1[+-*
MBNF'YJH4"D\EU%F_5>5JFQG@_2+[.BI)+3,<:@)BS(LYKDR"@@Y)77E%98U/
M:>#;P0\$/ GQWQ\@&^%/A;P6\'7A_P C[F$82QC+'!EHW7"+0ND9$92F#8=Y
M9,:/,8OL%GP'=5(4EP$Z"=!.CNCN@W0;H4X#49BCP:RL78<.-7Q^$!DG5<N5
MT+648V['R2;A^-8AD42\R.NRZ;E&%XAE45Q<3R%C</"JJ&QCOANMM+>SL,5R
M%W&\MP2_R/+Z_#[.S4#](OX^EY&LVUNXE!7"JN6XI:Z]A9)@-SCRVWPB0$R"
M!2"'?(=\&^05((+D!;XJZ*[OE8?@$+'"XQF>TCJ2&$R&W6EM+YKK%ZJ\*YPV
MXJ#W@G!W!W!W ;@-8J\3O+84&'5U(KB[&G/Q*>]L,=L(,Z-91>E8UT*VA5=5
M74L+D/TB^SHR9#<6/ 9=R;(Y44B*3*C0VHDR--:Y<A\<45V=OX^RBG'<4VHG
MQWQ\@&^%/BKH+V\50^)X$4V&&(S7&'&Z\J*B2AUM;*N>?14]F)7CBH=#OC.6
M0_UM<!OQG.,0_&U8T<"@IJSEC1SD+2DD)RG%F[IN@N96.6;+[4EGKGZ1?Q]'
M+8DZ=1XVW&Q)JT\BRW1'K;[(EHDQ\,9BR6YD;EU%C2U%NB5XLQ1\+\.U9F7A
MROUC>)L99$##L7K#^Q%R18N[Z%^.W(3(CKCK^@C2(4B>A"6TB]O8M%%5^Z9)
M8XSDSU$\P^U):ZQ^D7V=!:TMIR;*9-M/L<0DWT>KPJDK@>Q")KCF0Y RTAAH
M^KIQCP]/HU)2LI%8%(4V?4:9<>-N RE&3XR_1OX=E*[ 9/DS-&S65MGE%C65
M<*IC91BK-NU2WMACDR-Y'4<AA]J2SU#](OLYY$AF(SD>2S,AE8CC!4L;AGEB
MJ#2>.:O4Y28W;LLOJX3D60W,C=1J.XZ&H[;7TSC3;I/59AQAUKHE'>,FJ]"0
ME*4D'6FWV\EQU_'I59!DY';5M;$J8O#+5K=R-6"TSU96P&ZR!U#](OLY[^I_
M>ZS&</8HSXY?5,W:I65_QUG3(\H>J/'24C]MCMMKBO-])N*\X&H;2/JUQ([@
M55LF#J5 ZIX?M3H*I":N.0;89:$KV\DV%&L8UW23L:G8ME+=RWPRC$/WIZH@
MJK*WJGZ1?9T\DR2-0QL>@3\GO'L7HI,UMMMI/%;3;@5 ;,'7J'P7B'PGP4%X
M%7K"8+1!+3:/T65[>69"BV$?*J)O')3&39E*:PZ_F7D;KGZ1?Q]+,\EDT:*#
M'9F428%=#JX_ZE*]O-Y&A/+;\?S67ZIIEEA/7/TB^SI3JR!9)0A#:/U.7[>9
MUII]N%70:U'T!^D7V?K\A&]#;A*+Z=QPB)A&QO\ H!3+:A\9L?&;'QFQ\9L?
M&;'Q6Q\9L?&;'QFQ\9L?&;'QFQ\9L?&;'QFQ\9L?&;'QFQ\9L?&;'QFQ\9L?
M&;"66T__ !DWI(U.(0"4E1.2&&>")$=Q?]*959V$S)O*$>MR;,LAQ^)XLR?'
M<$QS/4Y1!R/",4L/"V/QHR-VS^DGNYVJGPGB7\>+QQY*BPH^%YODV1G2>2L7
MGH\/..X9:XQY2S:,VA+:/_YO(DL1&B,E%_0?D',I&)PHTGRQ16E-DOE7*YM!
MY0F2J7 ?(LO)L9H<M\C2Y@G7E36N_P LQP?RS'!_+,<'\LQP?RS'!_+,<'\L
MQP?RS'!_+,<'\LQP?RS'!_+,<'\LQP9;D%+.H:/*[.D.DR"!>LA65V2?*+/E
M' )$S]?\MUMBW(_VQ6Y!:X+Y"QC"['Q/!LI5CXZ@R)V"0?XE)6,BP\K^;_K-
M(_UFD?ZS2/\ 6:1_K-(_UFD?ZS2/]9I'^LTC_6:1_K-(_P!9I'^LTB^PE-)6
ML,/27<8PA^(Z,O@6%EY4E7-/*Q_]?,-_'U_X^!;0CX_<Z^5-0'ZC&RQM,?A/
M*.<*-0441_ZS_]H " $"  $% O\ I(+E(2?S#'S#'S#'S#'S#'S#'RS'S#'S
M#'S#'S#'S#'S#'S#'S#'S#'S#'S#'S#'S#'S#'RS'S##<E"S_H"4LTMM-DA/
MT[S9*3'7O;_7YGL+TX./,M!*T.%QVF-HT&F@VGU%>V'^/]?F>PN%W=.-.*,U
MGCBEE8\5 ^']@?35[8?X_P!?F>PO06M),^4Q163QUE4S6IXF>H,]1N!'H-PW
M=-7MA_C_ %G<DAO0-Z!J1\9GL+TY)%S71C8O:V0OZ%7MA_CZ3,AMX_TI3J$!
M4DP;BS&I\NID$NN$'G#=2DR,N.3/.-Q0RRY(<8;[+'"SR)2%_O-IK2W*YRNF
MKVP_Q]%=G!:.=9K<LZFX:L4<I(48)D;$C0N30@:$ V2!MJ+ZA;B4!;ZE=5+I
M@C(^$J*Q,:+&8&L:%%AEQGU,R&XU#EOG2U"H'45[8?X^C<5"+)MUIQAQMQ;*
MZ:W*Q;X);-02A*>H;:3"D&GZ5U_Z C-(2X2N)F1%/R"5(6F=-2=#:O3>NKVP
M_P ?2M:EJR;?8>BNLO.QW:BV;LT):T^@4V1_1&9$3CQJ^C0YP,B44O&7DJ:Q
MJP6==5L5Q=97MA_CZ<^LBV*&L;FN3Z^KAUJ/H5()04DT]?T#KF\^@[91&@N[
M"KB68_=9P*XED&[LPU9Q'1ZER-KUZ#,:1(-Z#,CET5>V'^/II3N-*227/&KI
MDL,8V$4E:V"@5Z0<*"8745BP[CD90DT<YCE41*)2=I]5]S4^>59LL"1+?E'H
M-.30:!F2_'.):H>/D;7N+EHJG]R>;;;91DELZX_P(BTT&TP9&"]3X*]L/\?)
M QGO1Y>-SF M"VU<B$[2YH<-^:[#I8D4;@:QW!W!O'<!. EB57Q)I3Z:3#Y%
M)W%U'7-A<SSS;")=HX^-!H-!M&T;!M&T:#0:")9NQ@P^W(1P(]ID9*+B1&HZ
MV$4"&XZVRBP<0].X:Z)(]>)&#3P5[8?X^./PBES>$F%%F)D8JV9RJ*QBCT#:
M-.>OI'99--,Q6U. U@UC>-PW#<-X)82X"4+"C;?"B-)\'4=1Q>]7*M:6TS91
MRW= 1 D@DC:-HVC:-H-(-(,N$:2Y%<8?1(;X-*T/A!Q^?,-FLIZ<*DV4D)I&
MG%VM*S/8<IK1M9D:3YU>V'^/CB9%V>%E=MUTF+;0)G"95PIPM*LZT^6FJOD
MST"U@U U U#<-PW#<"4"4"4$J"5"WJREIXJ+:?1?5M1S6DWO+($0)()(T&T;
M1M&T&D&0-(4D&7"MD_'D<"/0ZW&79;<:!6UX44ITG;2EK#1EQ&]%LX,PC^Q7
M60---]!7MA_CXP+*57*BY1&6"L8)M5#+%I)NJJ*N'$N;"&(>21G2M[$K"1R5
MD+YTK_%"5J"E U U U#<-PW#<-P)0)0(PE02H7U?VSX.I^W1?5N7RV4OX[)
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MMT3L'EM@Z:U3(R%^31P<;O9S=C/QVIL!889-8505"JB)R75G^UP?\W5LM!M
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M.W<-C<TM=GN:WB/VV/&6>T+>Z--&39N(FE,]F/95_P"G#_\ W&;_ (!]L?\
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MK&S(<EL0R>E$4>4Z1D;[$DGUE-.*KB[#V+39BW3K?8@8FVJ4LR+,[7-.3OU
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MTF%)M!<0N.=EM-INC,;6ZI.HK>BG+BZ<)LPV+)8KQP?)69P];>,G;ZT]/8E
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MEQWDA$V\9D5JBD9O*J"@*B9K7%L8>X[D<'N6W@X;7;K;"I:)*V\9.I7H=\F
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MI5JN'9EIL%GMTI]"%V1"MT6.\8EZ0;QIL20"Y4V+@(=NB1H,1M25N-$8:C,
MIDIFHM,B (IF2JN6WN0":L]M:6UR)$JW;J$PVD*3+JDF1&$ 06GGZ]8DS7#;
M5[M%NNH,KJ:2?#8E;I5I56M\!*WJIG3;AJ)"C,1(K Z&8T9H&&&@3U6VFT$
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M1%QJ5^XD/ZM7F43H4ACH=/+A0@16V-7IGF3KE/CNG4R_!WCO[,[)BJ9$U*8
MG14%6H[U!J33B)MKA C6^6ZJ\S!H"=+A(@"G2N')DU16<\WNT;!=01FE5"(=
M>PW35$K3)*>$7H7"_.^!/!"XT2-7".)(PXOH.#MW#OR5+8OJKAR-):)E]DM+
MC9[47\"BO(NQ<-R([A,O-$AMN M"$DP3+Z(U<8X(KPIZ#X>COVN;/TA]55[M
M/2/XJ<GSEY,9K1/BCL_+X2E=:?%+\>U,4]$OBK\'/[E5MBE?6<VT\0X55555
M=JKGX?4"TY^9>E.7&E>HY\7D7YJ]TB):"**1+S"*55?(F'&K<X4&$BJ($WU9
M3P_K#=])K5S#3&L+G/$N?M;ZUZ44U1</P9]')$=I'@DHB"KK6M&R%T11!UBI
M)FFWPZ]"X7YWP)X.N3,]H5[/)IM_FGZ)4VE7RCR8<B2VE:?:6A"NQ4Y# MA@
M2;%PW*B.DR^TNH#'WQ)-A 2;47;A1=TQY[(5D,>J0[-\Q7,FU7DVBN-+?5'G
M]9?Q>X$%SK#S^L/XTQ5,T]PJ1K04S5<* =1K9\HD\:\E?<5<(V\J9^B:Y9\Q
M=/<-LTJ#@D!)SB::23RHN".TOMO,+F+$DMV^'R4<INW$3QZ<4?*)%#E(GM\7
MD!I%KYTP:L$X])>$1?D.>L@YZ6P3)MO5TKX_#KT+A?G? GA$"6VJ.MHNYDMK
MI>:KR5V&%?57+"P'>K'3ZSMZ)]4;&JE03]>OQ.3HPHQ6NL7VCSG7>.G.65$\
M243W%DM1Y179Y.;&H?*G*B^'4B6B)FJ^+%$R:'T4Y_E+X!2)4$12I$2HB(G.
MJKDB845F=K=3]%!'M'_.U%A/XV%2#:>@Y<C_ .4P*?Y>/JT@1_F15-?^><<3
MWL5[:ST=@A4Z/L*XZZP7O$<33_T)M8I<+6V2?'AO$"_ZM[>(O\9,(/:UA.K^
MCG!N?^>138^E@3 A,"2HD"H0DGR2&J*G>HRZO6]0N?Y*^/P&\N5PAP07T5E2
M&F=7S4,D4O)C=6^\6Z8[^J8ELF[_ *O5K][P2]"X7YWP)X12+S<Z\V%(O(G(
MB>+P!#<+DRCZ?[I'K)E]"LM:E;_AZ<$%DM.=<I-R<Y.?LL=>7^DQE<FXB?%A
MPXS=.@S!USZ6/K+_ ';/XDQUKWFE!$Q4;_>*^.X2C3S&X282EY=>3XLIB-(3
M_G&5+W\(ERML&:'K$PKL)ZGG?:K_  4P+3[KUID&J(@3Q1&55>1)32FRG\+1
MA"%4422HDBU0D7E14R5.\UCY4YTYEQJ'RIS+S>&5@?1'T_E%S= ^ -B-2XS1
MJB@T=([)<SSZ5151?5"J]&*S7_JD]"*S5J,'^CJNLO&55\!KM\QUE/69KKCG
M\]@ZMKYJX"'= ;@RBR&0ATAO'\5=:ZHYER5517G[VA?:#M^4GQN^!B$H%>;@
MA)$0D0DC,CDY,<%<BTKD"+Z1>)%PY+FR'I<ETE)Q]\U<<)56OI%L3Q;$Q&XG
MG,@_<9J$[ W@HJ08M5 '&D79(D(E=6U 6B<O=O'!_";_  U%CVJSVZZ*Y>HD
MMTC[6@"X*.1G,U1P\LMF)US]IMYX;C@W) 8TJUMRH\=&C!$1@@?UO/RC=KI$
M$553$^5:+Y$D,VH-[<E<WT,X3.DCW\EJ:U'=:8T"JZU33EMQ(BV"]QKA)B@C
MKT=!D1W]RJZ4?!J4RP;L=57TQJ.>W'$%Z@HTLRV6N5,C(^"FSO60J&\!"%2&
MOCQP_>)F[25<[/;YTC<CH:WTF,VZYNP5241U%S]Q>A<+\[X$[WL5@BQ9T6(Z
MH3)4A7-$HQZIM0U:5-  7Z1=6I=B4VBU<M[9)*T3]I^NAJOR9;0]5/GB& D1
M)#,EAS,'F' =:+YI@JBO>*JY(F:XKZJ>BGBY^E>_[9<7%S73'C-Z5DRG/BL@
MI#DGK$O5%,&S&<6T6\JHC$0U20X'_:)G5<*J;4#0.%5<U7-57-55>5<;._3L
M$PBC(O6@R:OPS_T:K5I?&"BN BR*6NZ%04C/&BL2"_[)(6B$J_$*A=/>:O5]
M9.=/QIBJ;%S\)SF54!/\Y?$F%55JJYU\:]\<R<ZC3(9)RN.GR-,AM-PO_CE@
MHL$3M\%<G*'^TR$YG'!^S;5/4'RJOA$C2D*? 3(6R.C\?^@=*M03XA9<U,#,
M@NZVUR,%R>9<Y6W@JN@T\R\G=$QVI[Z<J>7"&.Q>3F7E1>\-PUT@V)&9+L$1
M342^1$Q.NJZD9</=0FR_0PF>JP/B4DZZ_*)<-Q84=Z7)=5!!EALG'"55IL%,
MDSV[$Q98,QH6)<2W18\AH2$T!UII!)-0*HKLY.[Q)(O]KN963^[=G[%.9?GV
M^,[-;W3;K02XCC.^( K4*K3%CA<+<..7*%%XF"XR94B)+XLFV$B!?^*P[5)E
MBY.=%<J*>@.;/+BIZ[67BN\Q.)?9]*MT1Z=9&.%CN)L/M.JP/9P?C6HU!DD8
M[15PBI5*$F$C-1YQPX_#4RVM\5\1\%QK%?.&9&XW4&%%D;Q1O^X=IJ%10"TU
MQQHQ=.,)?&ASN'946!;0X?@V]T):YZVNPD;L@W ZNC'#EBE>S_VA+)M]LMML
M?>"P!V;>LLM1S<0SF@>Y0DK513+N+T+A?G? G>$Q&)1FWDB@,F*T5EG1JF/)
MRUW743F4Z]W>V>XOP]2HKC0JAQW:?K8[B$R?32N!;O=G;DDFV3;WNSDJ?*C/
M"X"ET&*8%I)RVV25*1KH(Q555Y ?UG%-?X=<(0JA"250A6J*B[%14R5,;H=B
M+UEYUYNA._>MUN:2XW0!43+5^Q0W?BO$E2?=#E :>,L'.N4ER5(<VD?H@/(V
MT'HM-#R"F7@^C#5NOR.3X2*#;4W569%"J#];J_VID$\>M$Y]F >9<!UET$<:
M<;)#;< DJ) 29*))W49+^ O^;X0C]5.J'S4_'WSLF0X++# *XZX?HB(_A7F3
M:JX)]-80VOJX;!+Z+?*Z0[$=>7-?(G)X89<0LO1?8+[*2U7-MQ/P+M%<-3H9
M5;/(P7[1AU/39=3D,/?3/N[M?1<V>(D3X4[BJN2)FJKDB)SKAUMJ2-VN (J#
M#@FA@A\TB6B$PRB<OI%XL.QH#;D6W9B^U _9H@-KM^\+H\0)IIMJ8BOQ<:[_
M '@[Q*'_ /R>'.NSJ^)(O#NAFG/ND7IP<'A:V6_A>(::2.&':+DZFRKT]]%(
MB\=*ISX=<FN2;C;IYBMP;==)Z0A[$F,&Z:U?%-J*M#3R820'$-M;%1U:)4@8
MCX\M"9D;MS4G1@' 6H.")@O.))J%<\\T7P"]"X7YWP)WG#S->HD.>[3DUD]&
M%5\P]V;<V9PP29E=FB _'4V)2@V)NJKP.;P$%30<@+/!%.MCIQD_WV'^UQ:<
MY&TFIE/GB/<0+;/+LNJI09*=HAET-GUF:_S9"N)XNP!@3K<+#KNY<5R-(;?(
MPU AIK:-#'T:KT]\5CM#O_%'0_;)0+^[VC3)MM?^N.BO^C'Q[*KFJYJJYJJK
MM55Y57N[.YLQLQL[NSO M%T=4K.^=&G355^[7C7TQ_[(X2]=/5]+GJBHJ*BI
M5%1:HJ+L5%Y47N9;47+IP)^?IY?!**>D[U$Z/6][OUM4,_V"(Y]>0+E*E#DN
M:;66%R3G7/F]P"V^ZH09WU$BOV8._P"[OKS:#ZJK\4E[HFFT514\F)%OM=O>
MF3HSAL/.3*Q8C+K:Z233_M#]%3Y"+SX4[M<NPVT\T9(_N^WJ/,W&"LF?YGEP
M/9X[MZF;&UE-[BW(ZN2:8(*<F=1=FLVT7E!=F&NU"Y MJ4W03Z6V"T/_ &:U
M1VQIY&D1>?%8M\1VZ)GI?C;F YE]FB@3K[2U];K?-P27*U2FVQ_WIH%D0R3G
M22SK:3RT7" "*9DM!$$4B)5V(@I555<1KQQ%&*);F"!]BWOCIDSG!74WOVEZ
MS$5%S5"ZQ[*4\"O0N%^=\"=XT%U:<WL=#2++CN;J3'WFG6@K0FS$E%,B$DP3
MECGQ[DUR1Y7['+Z$/K1G5Z5;PW;'+)<0F/."VV"QG%;526FKM H4?=)REJTH
MF.&N$K/,<A#]W./7"5%7=/27E<H>AX:.- ;ZN$M**M4Q;[9-GR[C;KI(&&XS
M,>=E$RZ_U67V7'5-P:.40DKI4<&<BW!%E'5>VV^D21J^,>A-R\OSP+"E87V[
MTQRL$342>US(HN."P^GC0D7Q8?2:K:W:Z&VY,%LD,8K#*%N(N\3(S134C5,J
MKXN]<EMHA3I)=D@ J5'M!B1;XTY6XX#J\:T3EPY(?,G7GG"===-:FXX:ZC,E
MY2)5[[9X+^[5P<K(C I6MT]KL5M*G$55VG'3,/D?-[JMKL/9TI^-/!**+U6N
MKY?6]_OB88<I<)PJTPB>DTRO5>D^+2G5'Y2^+OMG<V8V8V> 2#(<K/MXH"ZE
MZ[\5*"T]\I0KH+R<_=&9P[:NU%.8 I4AH&R<9DL_4]9V2>XC;QI!HJ:56BYX
M[3Q)<AAZ\S9C%VV<?B<DG^SMKT;S .0+<V4L/]^E?M,NO*0N.9,JOR$'NYXW
MC42*TY^L;CM ?\810O!+T+A?G? G?Q'69:0KC!1T&7' WC#S3J@2LOH-#&A!
M422M*KDN&KQ>)K$R5%U+#C1!<[.TZJ*._<==$#=,1+JII%$7//"DNQ$KA2Y5
M6O?)&B.(=MM.MA@Q]%^0:CVM].<=0( ^(:\O>[.YLQL[FS&S&SO8\V*:M28C
MP/LFGJN-EJ3I1>7G3$6YQE'ZT=,AI%JL:4*)OV"Y:@2Y<XJB]Q"3:BU3"$FQ
M4KX C7U14O,E<*J[5557I7OIDI"56!/L\7F2.Q405.;>+4^DO ;,;,;/ 0YR
M+]6#FB0GQHSO4?3R M4\:8JBU%<T5-BHN:*G2G<%/CHH_"GOI[@7H7"_.^!/
M T^.J)Y-J]].?:/3*E(EOAJFU'I2$A&/RFF$(NE/<<JRN%]3<VE?815R&;%%
M26G]+&K_ !$[NGXI+YES3P#GRJ#YUS][OKC(%:.DSV9E?YV2NY14\8(:EY/<
MD R6KD82A.\^J,ND*]+.GN"7Q21?,O>+$>N48'T+20ZE5 +XIN(*M@O2N$5%
M147-%3-%1=BI3:B^#7H7"_.^!.\XGM'"4;A);?P\]:F%<O17()3AW"TQK@N<
M4B;(1)U4V)B--]I%RX?L]P=?>:583S_8G>NJLA%&1JE/.;JFJB+3#W$,6^VU
MVRQ]7:+EVH!C1R"B$#Y'I5EVI)U21"6J<Z8DN\/7>)=0AF#<GLQJJL&X*DWO
M ,0-$<%%TK2BTR[@#S(J^?\ ^'?6JT@75BQSFO#R;V46[:K\H6F%_C>"V=\O
M=@7)M:%"EL2,N46W$5P>@VZIA"',22J+XEV=PQYQKYE_+X!L>=ROF1?Q]];8
M:+]O*<?+HC-H(^34_P"][DNT)5]!R-*!/Z039<_Z,<47T$S/HYO+C3NA]^O\
M;;AIM]''Y#@:FX[.G5NT73O'")4$!54Z5PXD='&9#2:G(SVG6@5IO (543"O
MFQ+2-E(6,^C'],K1;KZ>"0ZH:*J&A^DA(O60JYZJXMR2M2'NW%!#])&%=-6*
MUSINJ4\7@UZ%PO3\"=Y[1WKI(O3!0IO#+37W7>)ML A<X:A$6]"*X NDBCM7
M9C@.Q MIM+4&TW-8'&?& SKVW"H2"<%D7)<>,[<'QSWCQ*J)2F/:S%O%TGSX
MKO$]BNB7*PVMAA\6AH#7$'W(1,M#:4DZ=?.*HNU:XO43[VL'%[0V2V/?WML5
MM:MAC27+;CV6ZMQ_V=R4@*3P:<Q&M=J4P7B04][\O?7HZU%F4D,?$D-L(ZI_
M'!>ZG?[._7"X7%HD5KOK9 =KSJ<5HE]]>X'CJGO> 8_TG^9WUO:Y M^ORN27
M17WFD\%L[U>]?;KD[;GDIXP>8<3S(F%!?TB9?.3D\O<2Z6]HI@.--MO--JBN
MMFUU4( KUP(>;8N'+G/:**FX-AA@Z(Z>\4=1F'J"*#RYKW-Z<2,;NW>$PT3G
M\=14N[*@R>($"3"DO1)+?W==31J0P:MN@KC<(FUT$G(N&+I9YT>XP)"+N948
M];9:5H0\X&"Y**T5.Y]YWZ>U;X>^".+ABZX3C[NI09:98!QYUPD%<A1<DQ%G
MPW-[%FQVI49S28;QA\$<;/0X(N!J MBHBIW+G8HTK>72SMQ';C&W3X]G":&\
MC+O3;1ES6'Q26G+W5Z%POSO@3O%5$1%+TEIMIDE>>B8TOM-O"BU076P<1%YT
M0T5*X(D:;0C% ,MV&HP3)!):5(43DPHL,M,BJU5&FQ;15YU0$2J]QSYW>IBX
M.EF3DZ6:KSJ4AQ>XG@U[U<+BPDO)!%K_ %#CC*>\'<:^>G@&/])_F=]%_P##
M&J?VF5X!._7O4_\ H9?X [FG>G3I_P"2X:^;\*]QJVP'BBIN!??>;R=-7")!
M;$Z5$!0.3;C[LG/'+!UIQQEUW-UHVDU**GM-L@KMV+W?:.S8."?[TLO<<W@G
M9"WNVVP([^0)'-F:).."H4)23+/%KLCKA6J\<?<97.=*6Q0SO1\.6XVV'),6
MSQ&6G!DW!0TH.E"%,Z;*XXT 9/$1)99EB>X<XFOEBD6BX3(,Z:TU*@31E1&6
MGGXY=76@ZB!:\V.!7[UQS=;C,O''%G;5IN+!8@V2:_'D%O[2WNB+]D5*-ZZB
MJ9JE<<4V1CC"[<.VO@G[MM#9VQJ(-QN]T>B;QZYW%UUDA5I2#[,$$%_#[-;5
M;+XMDD\0P.)(-ZF-QF7@)ZR2#BOW6,PZ&GM+@1")I,@ W/%CVNV\.(YTU[A3
MACA0[;<I#41)?:I M))EFHLT)U_6M:U3'LRO4GB^?=@XSN5NM]XL\B/$;M33
M5QAMO!]WLM,HXP4;5Z2DI&N:\W<7H7"_.^!/ N?/7OI0_%DOIYG23N)A.]3"
M=XO>KW+'7+]G>7SRY"IY^XU\\? ,K\HD\Z)^+OK<]R.0";_U4@R7_IO#+WTE
MSD9MSOG<?8!$\J5QG]F/I+S\R)BB!I^4A%7WU7 !6NE$2O/W&GT?6++9#=H[
MHWC;C=5) <"HKU25:*G/@Y3C_:YAANT/1NVV0+TT;'42DI4V\W=O[D*3*D+Q
M#>I-\E=IW7U,B2B(33&[ /J4IRU7$:-+?F09=OF-7&TW6W.HS/MD]BN[DQG%
M$AV+0A5*$GDQ?+1<KW>[C-XDE09=WOLEU@ISQVYP3BLLL[KLD6*T@T0!'EZ*
M</K,D26/[O7R'?HO9]W]=(A@X -/ZP+ZDD<SI1<2N(K'Q'>N$KI<HS<6\.6C
MLQLW-MA-##CT>4TX 2V0R%T:+^''"%PANRF?[FV^;;X$=%:5N4-P:5N3(FDK
M>LY+ADKBDBI4U7'&TA^=<6RXX@6RWW!&E8I$:M:#N3AZFBZ[FCK:JXX.:>E3
M&TX,G0)\!6]S62Y;XXQVQEZFUZAB-5TT[B]"X7YWP)X%SIKYT3O4Q>(R_H;I
M.#R))<I[W<3">"7O[ WL7[JB.+TO-H]_\SN-_._ G@%7XA"OGZOP]]!G(F<6
M63)?T<H*U7H<93S^Y+G/5,W7F8@+\ED%=<^D\F#;Y5ZP^.B9IY.Y;FK,C$6V
MRXJEV\HC<HW)HNFCL;4^+C#>[9T$B::KJPA'<XLA$_1O6N @%XE5AEARG0J8
M9MW$\5BVO/$+;5RBJYV!7"6@C)9=)QV*A+Z^HAYZ)X5>A<+\[X$\#7XPHOFR
M[Z4XB4;N3,>>',I&.Y>I_IF%\_<3W#1,U7)$YUY$\^(47_JT2-'_ -2R#:?Y
M/<K\457X/A\ X'."TZ:9>_WUQAHE7#CD;*?S['US2)\X@IY?<EOCD.ETVNU/
MIR[V3]:J+XP!4'R8146BIL7EPV"N+IK5=B9#GFJ)7#L"Z1&9L-Y*&P^.H?$0
MKZ3;@\A#0DP;O#]W>@5S2)/;[9'1:[ D K<AL$^4CBX'[POUN;BZNNL-F2](
M(.70+PL-B2ISJM,,1@4E".RTP"FNHU%D$;%27E*@Y^$7HPOSO@3P('S*J>?-
M.^MUX;&JP'RBR%_F)=%;)?$#[=/X?N!>[:XJI5EI[MLKFW$/ZY47Q..((?PN
MZX?0/P^!<#DU53H+-/P]]) 1TQI2]LB_%T/*JFVG]$[5.CP6WP$2,J58 NTR
MUY$CL*A$*_TI4#^%A=7H!FOCYA\6-.Z"GS4_#MPX2>BHH@<Z5])/)3N]AFE*
MEW'=BZ4&"T+CC0.9MJ^XZXTTUO!S1*ZJ9TP@O6R]QP7:[NHCR#T@$K7YL:;/
M=6'Y")J*&YJCS13E7LSR X8CRJ.I/!KT+A?G? G@33E1-2>3/OIUL?\ LYL9
MQC5^K-4JTZGC:=1"\F),*4"MR(CQQW@7D<:)17R+3+G3O]O<V^!E7V0%';FO
M9X=4S2$P2ZS\2/R$\P=T.=>LOE_)X$7T]7JGT+Z*^1>^3<T2?#4W8JK^D11^
MMC*O)O:)3Y284211(55"%<E146BHJ<BHON"B;>3QK@GI*?M\_=N/)3..TB5;
MC5^,BK4_'ER8(#RWE*%R52N2]->Y/LD:PQ=,$Q#?3GGU.4!@+C<AL&=T+;+@
MEEF7P8$;KPX0_'=M\Y"R^3&DLA7_ %N%E6:6CNBG:(CJ;J;%5>21'555$7D)
M*@O(N/OJV3V[?<S:!J4W);,XDO<CH9<4VZNL.@VB"O5-%1$R3E71:V[DWR.V
MV6PZA?Z)\H\A/*&(;L:S2K8\Q(:>;G27F(S<8@,51W4CRN+HIL%"5>;"5]*B
M5ILKRTVY>"7H7"_.^!/!*/)M'H7OF>)8PJB/DW$N2".6]0:1I2\V\$=V7C0>
M?W",%E=U';3?3I5*HQ'K3+D5YU<@3G\288B1@1J/&:!AEL=@--"@@GD1.X(^
M5?FIX(@+824P39;16GXE\J=\5]A!]2ZJ?>+8I]DZN22D3XCOK\Q9\ON!+B^U
MJ@V]=2*:=1V9^A!/C;FNM>943G[HCJ+0'65*KIRV9=.!636'<XX*,2Z,"BN@
M.W<R&UTI)CU]5514Y%3/!*W;EO$5%ZLFT_M"J/)JB92P7^"J>/%HD-VB[1&
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M1''[HGG55>A@/9W2YWX?5;557E#073@S&)]YQ1S[1;JO+IYSC422/\54\>%
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M8F7E-6F;,?T$(PR3&%^H7TA!PDS[!GM*8!KT:)*^D8S>O&-.O9L@#80,$:
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M!_ZGE.J&AV/'?QU65E$"4)M6M4U$M%I;C;Z]_M>><,^<_P#@!%I:5.3(/9@
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M=2E-CK+*&ZY7</Y]I6;SJ#KFEVQWA)8;WY5/M<1<5R8.@+H ZV_#C5=R_L?
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MQK]?TDOT*0/!I\?3XVJ#"E^+H\33X'P F.K5/B>#"TP#P)3%S'HE+@F8T2B
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M/-^1P0U ;U4"ZJW:>NJV\M? 8PYCON2=ZX7G -EF\M]5ZG>K^D 8I2Z7%MZ
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MTZ5(K4D=DCT9TSWG9ALD'N9I4?\ B_&F_P!*#K+-D-:+J_X#1/Q_;50+R_\
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M""$  >BP"8 @               8A"R4 @
M
M
M                                                   @"0 002
M  !                                =$50NQ41NH ?-$      200#@
M20B                 +9 +A>3R?];]=L     #.$JN2#5362
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MY-(0B^0K=L>@   *9NY65&7+MI'U2P2DD[[\&<    8D% *7O*.%FA?H
M#7=;13^B-><77TS?6WX'XG\    ,'Y=2AI.,"Q$,8     RF[1ILGXRLD+Y?
MJ,ZX/SA\    #VJ,%2Y.W?J18      %Y)FNN?-.C)CWSG<P>S0A<    ;T7
MH>71_!64F$      "1R8;GO^Q)J[2P&^=+A/_<    /RI$R( ;[AZ1T
M  >H82P]CNG^#NS!?0M?X]\   "<C_J8%S59!J*        #L)L=JSLX@$_G
MD\F<PDG4   0 !.B:RS8EE:@         #E1\'!R4B%(XT\D?_HE\    @!P
M>G4B#S84           #:5\';'@[WE$\D=%>AH     8* !;GB[@
M         )KKYB__ ..Z_P!OWP    $6                        !JOO
MCNBN.1_^?=P    &                         !LE#D\9SI^L5_5P
M                          !EZ_(W7?2I &Y4
M            %MM'G'L\GHEDD
M
M
M                      !(
M      !+8/8                                         (@*@
M
M                           !
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MQ4MKLVP_S413CIYQ$K(V_P!P3 R-VZ@]\K*2P_$<&KG2^)3K\-/C2!GEB_\
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MG:+[+2:^H;\#J">L*%ZFZST/IK!+POD:EZX>L:0+IFZURM5LQ6(X.F]FMQ-
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M\SRKG]RRAOJWV'"6"[+(26RRW@5'W$NJ&>Y6.^Q%*&F@@#_TN96&??G88WT
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MI;RBI09VL2PEV K0PZ=!4W(18P+1UNH3#<VNZM6FRE].4HY./[A<HO!@]_\
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M9B$*Z>-55HA;17AGP)GPJY7T:>'D7#/GON!)C;V5M>2_*;N*<C6G6(> 3>=
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M?S*;ZP]T&\.WG_)8VVY4J*MJ:P7B"9Q&*$KWBE$M5O*>(!6C"Z\/,N&?.?9
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MEY?=O=FD7*L,#*,3.J).L4M%W+$FY:N030X)"K4RJ0LUU:XLO#9-5RE[0<U
M%N)GKT.^_!!] #1H&VFTWV1C-)?CI+O$Z0Q%=-8^>KP)I.L?DMF?-?: 5HC5
M9M*:7?+]?Q,QAU,L$)S.4-<Q^($T685D!&C&,@ T$M@(3CL83?&JZ6CPE<RM
M B/43#"73$0[0LT@&A!V&,BXL K;%V6@H%ZI+4+C(SU+?0V$OJD64[J*Q>=8
M%R[:F)?N/Q_/M]_3X.X?US[F8^"A[/4\_,LJX),Z[>"XEML+&I?K#S'[BSM'
MC\!%\HA@.N1_VH,'/+[Y!,0-L#U,M.R3"A[S\>>B0MRS?,3-[1^9JL#5KX[L
M.A1T(K_Q3$*O9FX":R_HKZ=<>.GAYUPSYK[0A!JK1 U7,(*.-OGVA?-T[!Y\
MU!6H+_W\36V:$T7-2)3<^$MV>'OW=OU4K!3@7N_<VP;/5_K?M'X?J8]@)8'0
MP.MQ&Z4!%.$2G1N*ME>JY7WF36)NZQTS VVA!7@O';K^)K_P5UPT&H_QR;RK
M-FPT'G4VCI?@M-2DS+N8VAH33.T0K$O/6)*BKTUF@\PP7!Q<NZY-WL<==.\
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MJ;7=0HTE)S$OM"C./+W.?YFLI8==9F;Q2# @8 IA$B-;(T6\P6NJM"Z!7"+
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M@)H]OY?HKV,MT!DRBBW0MB!G.3"@: L&\M:KO#G5"]T CH78,A5J)GF-X!8
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M6[,(2NM^;C89>',J2I8!X5,6$-YCUC)B6S$S4EJK*!EURM4RO"J@95: <KB
M7HOV%UZ18ZPCV(_K]_8YH29ZRI>H3-UL0.D<+6Z[F?D2S,QD35S>B1\8&$=\
M86IN>$[[S!"UA>LW]HZREZC)/2Z@H*KY1^#:W33V@I4X?/GOVXA=3Y^?Y@:-
MYI]!1'F:S,[1A/D'YFCV_E^RZ393WR?AF*N,HA:9UE2R8E>*>Y_1%V-JFA#)
M-<0!%<,/&9>Z3<&$_0"PZS6G6Q-8-)U,P!9F)5AJU.BD#5Y1$;"0WZ;B7F"E
M-G0?E_7V479<[0JE=&"O:88<1!BO;-1Z-^E2MS,4JBTE<]N%X136/B4V+NZS
M:\.\K>(V8/I*QZM$Z4,_Q' ^D\L$':5^Y7$:ANB!OS_<[U-KGX^C/AGP[SY!
M^9I]OY?LT5H+/3/XQ"CI,7B8OM')<'::P#W=C'Q3/4(X7(@5>)86JO$(##*0
M+YQ#L2"H;P\-RK"XF\> %5<34PX99O,=34@EYEEYA,#B7E-9FNG,&Q%U2S@*
M"L,IOI+*Z2^M"WK_ %7V;:/9F#,QKO!":2N92:+GJQGU?D(VH1'([=/#-)GZ
M0($/@D]4Z]? 5"#O!KK*>\';2+AFXRCIO0V]&;Z]B+<93/#+$PP;7G\1=]/3
M^IIFLO6:^?/\Q'3/GK1"VTJNWZ8!1V\:G?2?CP/"L3-NC\S0[?R_92\.D;O
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M,FD7 L'"L0G1A5K <Q/,'G,.KN #F,WF"*<Q$0XJ&IOE%+]@%A9 !CE# >^
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MT3,(H6$878=.1,HDM.5,-*\:)E4:U$$I00XH  !T(?$6B51<NH>Q\O3W^_T
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm2030088d18-lc_overallbw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d18-lc_overallbw.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!J@)> P$1  (1 0,1 ?_$ ,<  0 !! ,! 0$
M       )!08'" $$"@(#"P$! 0$!                  $" Q    8" 0$"
M! X. PH("@@'  (#! 4& 0<($1()(1,4%3'3E%755E>7UY@960H:02*T=946
M-G>W&+@Y>3I1(Q=A<8&1L3(S--0X8M(D5&0E-;6AP4)CLW1VEM9'\/%24W.3
MP[9%I<4F)S=X$0$!  $$ @$$ @,!  ,      1$Q05$"(1)A<3(#$X&1H2)"
ML?#!0__:  P# 0 "$0,1 #\ ]_
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MV1["*>3FR4N.N1>^WT2;I'AAH
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MV<943P>_\7QA/^F^'=J_Z]SQ_P#^^-T?]Q449[[?1>NZ3H8:
M
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M;'QQ;1FS[KK27VG ZA+.:_JWX^+KV,L?9IPZSK[=$B+".>K=K.4.P<);
M>:?Z6GGIW+>YNG@__P N<?OTF1 (]'U;_)V!^\L7]PH"W55:$
M
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MGG/G^_ZLJU90RQCFYU.PJ](HKV>RG@Y\X+G"O=36_P G8'[RQ?W"@+=55H0
M !3Y:48P<5)S4HOY-&0\>\E)%SXI9;R=C'ME';M?Q+=-5=7Q3=$QNR0ICFZ=
M,8SGI@!HS\ISPB]V=3WN=J__  0-_K[\,^W4QWG/"+/_ ,YE/>YVK_\  XOZ
MN_![]6Z]4M$'=JO7+E67N9*N6V!A[- 2&6SMGE_"3T<VE8IYEH_0;/FN73!V
MF?Q:R2:I.UV3E*;&<8YV8N+JTKX
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M&72KN*[<4^65-Y*MD_C7C)0Q39-DQBYQG/3.<XQ>V9VJ=<6+$Y>:\H$?Q<Y
MOF%'I[%ZTU)>7#5XSK,*V=-G"4 ].FNW<(LB+(K)GQU*8N<&QGPXR+TM]I]3
MM]M9,XL?[L?'/\Q.H_\ ]@5\3O\ =?JO7[9]&>!E0
M
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M:$]>W%7,8MU-S/T-M2$GIG-XJU%\QW&?J/FZ\7.FP\C)^8CMR>?XU#S\KY1
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MBN^
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M"[_=-X\_FGIW_=* GY/OK4T;.#"@
M                          A-6_F+4/X,[/\ ;3L0NR;ILA%  !YI_I:G
M[EO<WYW./WZ3(@$>CZM_D[ _>6+^X4!;JJM"    #4F['B*=RDUG8'+1NR2O
M%8G*\YD\FS@SN90*B@Q*J1,JRJBN"Y:-B=<$)T5QGK]KD=)F_CLX8OCM*VV'
M-L                      &K7-S_=(Y!_FPLGW*-=/OB=M':X7?[IW'G\T
M]._[I0%[_?2:-FQA0
M               0FK?S%J'\&=G^VG8A=DW39"*  #S3_2U/W+>YOSN<?OTF
M1 (]'U;_ "=@?O+%_<* MU56A    !K/R=:-S0&N),W]6[B]O4D[5T3)2*I%
M<+/4%R>.Z>,*D<AL9-C&<8R8I<Y]# WTW^C/;_[;,##0
M      -6N;G^Z1R$_-A9/N4:Z??/JG;1U^&<S$(\4N/B2TK')*IZHIQ%$E7S
M9-0ARQ*&,E.0ZN#%-C/V,X%[S_:_5.NC9CS[!^O,5^$6GIPSBKF&)V$SGIB8
MBLYSX,8Q(-.N<_\ YP8JYBJ^CX<"
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M6&.>J/5UG#U-5M/R64D'1W"BBY3HM5$\%*;.,E3[.,8QCH-?D^ZIU^UL4,-
M                        #1'O*/\ <_V'_P"T6JOTK4P=/Q_<SVT;R,?]
M19_^JM__ $)!S:FCM
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M"*.$D>ICYQGQ7:Q@N39P-][F2_#'76SY;,C#8
M  T1[RC_ '/]A_\ M%JK]*U,'3\?W,]M&[#%^PPQ9_\ +6G@:M\?ZRC]A$G_
M  QS7/AV_.##_GK3U2C_ ,<%/.##_GK3U2C_ ,<#)YP8?\]:>J4?^.!F./.#
M#_GS/U2C_P <!V4U$U28424(H3/7H=,Q3DSTSG&>ABYSC/3..G]\!]@
M          Q!M?:+^@)1D55Z@KL'8%CC[)(U*BHV2!J+BT%J3)K(3$=&S=E<
M-XKSR=L\3\F;F-CQF<F44,DV1<.$;)D5K4E\D]GZVIU^F==7G4DM:(9"3DM:
M[+:PS*]TQZ<ZB3B$LK>NS5B@\/VRB6<]IJ^<HJ)F*<I\X-TQ!D4 Z@
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M31B1?$=Y6DDT9+&<.<+*=A0QTTD?ML=G.,]KUSTG,<YVGMOY2.#BZ
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M#'][_P"GH> <VW(                               *!:_R6LOW@F/\
MNYR+-2Z-,>[/_P!R+2/_ .%L+]*UZ&OR??6>OVM[1AH             1[\/
M=JQG)S:7++<D=6Y>+I>L>2-ZXUZS?RQD\L+D_P!*P56HFW-H0K3"./%%>[,C
MI6KME\J*9RQKN3)^*\J<IFU=)$FN5LUG@!*U.-Y>ZEAMIEC^/?,C=&R-Y7V,
MCH-Y'[8@);=Q(1+=E#K=U2F313:JWS$<[RC(88$F(=.5<$:JX5(U<MYF?R82
M%4VGUC7M2K-$I4'&UBG4R!B:O5:Y#-4V43!5Z"8H1D/$1S1+&$V[*/8-DTDR
M8\!2%Q@16M$MQ?=2?.FF<R,7%!%I4^,%TX[9H7F4YW#U>W;,JNPOQIQ8/.)4
MT$62=:\E\D\D-D^5>WXTO9[.;GQA,><L$;5[OA]LG;O/S9Y-H-(E+FSPJ@.)
M#6'/55G9]>N82 VW"_CNX>EG&Y;$@XSM#"GD)4V9BX9YQX[/C.I&?&##1_>N
MNV7$'D9Q.D(/=&Y^.-Q9<%(?C=>>3\+QO+OCCGMBMZ,L-7S4]8WJNM32\IK;
M<+*0LLQ-U%^N<C1PS?R#+M/5,8;YNN?J:*%P'X+[%VWPAU@G>)Z]:^>L.]AV
MQW@%==;=HCZ*V3?M<,.3^QKO1E[E4WB50D*?9-K5A\VE3979(9:D>%-Y'@IL
M$PMF3"7N XRN87G#LSF":WHN&NP>,NI./1*)B&.FXC%M8;)VQ?SV@T_F0.FZ
M2F"[-PVPTPU)E'+/)_&G\9V23/C"J[R9T')<@V&EX1"UM:Y ZZY$:IW5<8QU
M$&ETKW :OD7UA;4@V,/6A&!9&SIQSHS@^%R8*RR3*1L'ZX2X_H6YR<X\7?:L
M_I[;&FMAQ>L=XZ)F+6XI4[9JXYM]*FZOL.%:P-_I-PK;27A'3N*G6\8P<I+H
MN"+M'D>B=/P]<X2X\71+/[6_I;C1M;3-48DC=S14OLC8/(E]OCDY<G]$1,PV
M6VGX16%G*/280TLKF@1K%C$P+2,<87=JMVL4;M%,=R?);;GZ8&O%G[O3:T[#
M7_C^UWY7F7#;:6V9S:=MH2NM,.-OM6EJV!_:C;-<P&Q2V-&';5B9N!E,IOEX
MM:4:-%C)%.?)2F%G::[F/Z;J;HTI*[FO>C334TQ2U)J^YK;4M=/P5_YPOFP*
ML@AG4;5^9$R3 U2I]B<K3Z[=;*F5Y>-C<]C)$CY&9<2\C7;CAPPN^FMN5VU6
M6^52>HFIJOO^H:BC8&N2D5;W\;R'W!";=LCS9DJZDW,9(OJT[@4F++#)$A'.
M%5'*V2JY[.;>TL)$BPRH              (35OYBU#^#.S_;3L0NR;ILA%
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M=71>O#*&R;)8ETGC.?1P1.6D")E_O%(7&,?W,#7?[JSU^UG89:
M
M            !":M_,6H?P9V?[:=B%V3=-D(H  /-/\ 2U/W+>YOSN<?OTF1
M (]'U;_)V!^\L7]PH"W55:$     !^:J95DE$3]>PJF=,_3/3/9.7)3=,_8S
MTR U.XV&5I]BVUIQPHN9"G6<TM6R.#N5CIUF9QC#)(KAWE,ZI$D$T<Y["14_
M&'.;!C=O&1T[^9.W+'7Q;&VHYM@
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M?&8-E15=;R&-:H8+C"9<^.)GKG)<XSTGG\>.&=.WU;5#FT
M
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M(YO6Y-&ZUUFWDV:<)*&(X42+GL."E[!L=,B>![Q*W^3L#]Y8O[A0"ZJK0@
M    #5/E Y1@%-,W=8ZR*-7VO!&?N&Y3942AWA%59/'1(N%CX6288)V,'*4^
M#9+G!NUCIT_'YS/AGM<8ORVL'-H
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M#G7C6*QS%QC!3&5:I',;&,>#IG)OL> 8NK45,
M                                                           0
MFK?S%J'\&=G^VG8A=DW39"*  #S3_2U/W+>YOSN<?OTF1 (]'U;_ "=@?O+%
M_<* MU56A       &,]RU]*T:KOD*J;),.*W(N4S%*F?/E$8EYT:XZ*]28[3
MED3'7/A+UZX\.,#76X[1.TS%M<=+HSNVIJLY2E%)62AV#:"GU5B.BK(R[)LB
M=1!51RBB5<^&RR1NTGDZ?VW3!LYQGI>\QV.MS&<1A0
M
M  !":M_,6H?P9V?[:=B%V3=-D(H  /-/]+4_<M[F_.YQ^_29$ CT?5O\G8'[
MRQ?W"@+=55H0      !QG&#8R4V,9QG&<9QG'7&<9\&<9QGP9QG #6?1R#F'
MV3R)KAO)_(FUZB[(TPA@_4A[<P>O%DC9-@A<%309(8P4I<8*;M=,FQTZ;[8O
M67X9ZZV-F1AH
M                                 0FK?S%J'\&=G^VG8A=DW39"*  #
MS3_2U/W+>YOSN<?OTF1 (]'U;_)V!^\L7]PH"W55:$        &F]PS,:@W[
M7[?F?/BD[?F"Q=K8*MF+=FRD8N#\V5[!WBA7;]?)5G:B^/%%0+G)>P;.<9QT
MZ3_;IC>,7,[9VK<@<VP
M                                       !":M_,6H?P9V?[:=B%V3=
M-D(H  /-/]+4_<M[F_.YQ^_29$ CT?5O\G8'[RQ?W"@+=55H0        8BW
M?KE?9U!D*_'+E9SJ#AI*UYZ9?+0C678J=MN=5VFV=.4$.AL]K*1<'ZXQTS@:
MZ=O6YV2S,6?K"^;"Q?W^IMC,JR23A:/&V-C)5U:9>><6^'B$4JJ^>2IRY4<F
M.;!CYPGCM'SG/7/3(O:=<>W7E);G%;&C#0
M                                                     "$U;^8M
M0_@SL_VT[$+LFZ;(10  >:?Z6I^Y;W-^=SC]^DR(!'H^K?Y.P/WEB_N% 6ZJ
MK0@         -9G[]&+Y:PQ'F2HXL6E5HB+.HHFGAR_96Q[+N&Z)3FP999-D
MV,?)2XR;LXSGT,9Z;_\ S_EG_K^&S(PT
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MEU2EP9-0_:]''@ZY$[=+U^A.TOU9L&6@
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M3-T\&2YSC(YMNR
M                                (35OYBU#^#.R_;3L0NR;ILNF/Z!%
M.F,>A@!QTQZ/3'4!YJ/I:G[EO<WYW./WZ3(@$>CZM_D[ _>6+^X4!;JJM"
M         +6N%.KUXA5X2R1;&49GPHJ@1^U3=D:/?$+((OD4E<9+APVPMG)<
M^CX19;-$LEU:LZ=L%IU)>&^A[NFX<Q<FO,N-<V%[),%5',!&9,WC6*49&%=>
M1Y>$:*K=E=1,Z><YQDOH=>G:3M/>:[LRXOK6YXY-@
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M1AH
M                  !":M_,6H?P9V?[:=B%V3=-D(H  /-/]+4_<M[F_.YQ
M^_29$ CT?5O\G8'[RQ?W"@+=55H0             &A_*JG/*T_@MDZXIKI*
MULY&2MEEO<>3+[$4C L&J3?,DQ?D=QWBEB+95P;),8QAKG&2F[6<XZ_CN?\
M6WQPY]Y9YFJ]-7<E59%_7JILROFI,@_ID1.L;/.S#1)&VJ.C-&"#YE')Q4<B
MVQ.N<JK(D3,8I<$,7&.F!.W3?KRL[9\5MX.;8
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MC+;XIL&QC./0SCKC^]D<VW(
M     ^2F*?&#$,4Q<^ADN<&QG^]G'7 #Z
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M%SDW9S@^,XSCP#/;K>NK4N62!E0
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M-/\ 2U/W+>YOSN<?OTF1 (]'U;_)V!^\L7]PH"W55:$
M   #IX.G_P!7^(!K5*Z-LL?L2?V!K.\QU&<V=BFA-M'-5)9/+7IGJCYZ_P J
MR$J1-$[M<Q<Y*1,N"]GP>#(W[S&.TRSZ^<Q4_P 1^0?NZ0?O70_LF&>G'^3'
M;EQ^(_(3W=(/WK8?V4#/7C_)CMRHMDK?(^$K\U+QVW8R??QD6^?,H-GK")([
MEW35LHLA'-CE?.#$6>*$P0N<)GZ9-Z&?0"7I;YG^2^W*V9/?^P(G7SQ21T_M
M)E9V-0=&=V=>LM"P;.>:PJAEYUTCXWL(0[>0)E<^#IX*5$N<9+]@7TZV^+,)
M[7&ER[.HN2[:=:56$V$PD:Y,2E?=2V;A8BQ5>J\[Y(X\4=:)55<-R*D4RI@A
M>P3&.T0V/1#MTQYA.V?%94HV^-=W:)7E//\ #5TR,D_CO-T_/P;.04*Q5*EY
M<1#R_.<LW.3=4C_^5@9O2Q9VE7I_:-KWV]TW_P!Z(3_;A,5?:<Q<D;*1DRT3
M?Q$BQE&*IE"I/8YV@]:*&2.9)4J;ELHJB?*:A<E-T-GH;&<9\(FBO@\Q$IOT
MXM23CTY-7':2C3O&Y'ZI<E,?M)LS*8<'+V"&SUP7..A<Y^QD!40
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MB;9VQ-;)TS,Q=+@H6^,9%Y&5R^QLI-NTW$_4HB-*2/CT3*FP9?!LEQ]KC.?
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MC[:M/C[C 4E9_@\G8V$C(LWB*K%2);HQB9E%TWSWRTN6ZZF"_P!67!#=K^G
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M
M                                "$U;^8M0_@SL_P!M.Q"[)NFR$4
M'FG^EJ?N6]S?G<X_?I,B 1Z/JW^3L#]Y8O[A0%NJJT(
M
M               (35OYBU#^#.S_ &T[$+LFZ;(10  >:?Z6I^Y;W-^=SC]^
MDR(!'H^K?Y.P/WEB_N% 6ZJK0@
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MI,B 1Z/JW^3L#]Y8O[A0%NJJT(
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M!;JJM"
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M55:$
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M^\L7]PH!=55H0
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M]6_R=@?O+%_<* MU56A
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M@_>*F/9@,3D/K>G<W^W#D'[Q4Q[,!B<CG'TO3N;\^#%PY!YSGP8QC1,QX?\
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MV#JO9]7:Q4C+5"T-8J1F85PJI"3\=),GC%X[9/HV0;KHJF*ITPLPK9T0
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MF%.RV5R1NCUS1C==I&Q[5RMEPY;,6C=PX-_G+KHH)IJK9_NJJ%R;_",-.\
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M49)-4'T?(,729D73)\R=)JMG;1RB?)%$SE,0Y<YQG&<9 8^I^D]-:]I#K65
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MWLB&AG.#%<1$3>7$4I9XZ,<%/G!VZ+HB1\9SU+D,T9+
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M[#1+;6;K K*J()3=3GHJQQ"BR.<8613DH=V]9'52SG':+@^<EZ^$!<X
M
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MO%K><E+T.T>;(V&H$M9+75*-LW6T*P11L!89^],\1DF)GBYU$DL8ET$YXRH
M
M                                ^%?]$I_F?YA_]+_HO\W/^D_X']/]
MP!9E%_)K'Y$_ZU(_D+^37^G/Z'_2O^<?^<ZBCO4__L-'\E_]:D?R/_[#_P!>
M<?Z'_I7_ #C_ ,_VQ!7)#_4'W^I_ZJX_[0_U#_0F_P!>_P"B_P#WG_ Z@+<H
MGY+QGY(?YBGY"?DO_I#?]F?\#_[7_"Z@+O
0                 !__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>tm2030088d18-bc_pancan4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d18-bc_pancan4clr.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@"?@-2 P$1  (1 0,1 ?_$ 1H  0  !@,! 0
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M"!CA,D*BTU7PP6)R(S-#<QF"LN*C)#1$E#5%"6.S\8-T)396PF2D1C<G_]H
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MX93-0T- - - - - - - - - - - - - - - - - - - - - - - - - - -
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M-C#DTES-YF4YX=:AV%KA"K962B<(D6J4+ -D*ZZJ"L$Y6"O3#J, TBE[T3*
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M=#W94O<I>Z+^2E[LGNR[#N&Q-NT-A]-O32(@2B@@42F%$@G#<"&$@&$O01
M,(")0]@?/I:&D?&I$13E=N]<1[)PZ;=WPKM=LFLY; I^6#9PJ4RR)5-^O:8
M'VZ19%#J'U*)-D]EC($W3#<# F03$V_A%,(;E$/EW#0MA\3Z%AYDB7VK%L),
MJ2GO4"R3-%X")P'<#I$=E6!(X"'J4 TR"$3LDT4DOZ6F4F_\R  '3H&P!L
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M+Y.Y3Y.XNR!9:5 L$8S[M!C.BISV03-8UN8R$(TBX>3(LJV3,8B!0*F7T[0
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M'IH,Q=GA'QH6CE3Q.X!Y.;<W^:'&L]=X8\::R[QGA+)*E.I;]Q7Z#$.5G\S
M*-SF4E'_ ,1\.N)Q*;W212B'R'ND6X658HYR<=?'QYH/*&ORHE+93:GD2#X\
MP53S.]Q_<;1$/Y2JX\9B]K4A)U"OS;O[6GDOZI WN0077:F$3 (;"?7!C\SI
MC"YY#X(\K^4CC'ME@,7<W?+SQNR;AZF3D [;2K[%E=M[ZO*7>2K!""\BVMM,
MX,X%-=(AQ2(!SE IN[4#,SGFBSE>\0Y0X$460R[9>)'%>UIWLF5N66.<8LK]
M?<>34768Q&L4BMN#5BVO*.QM!0%%9TU:=YB]I1^H0-4&)KA-<\20ODUYL/J7
MEODMFBE9_P#&5E6NX9SAR4C[6_GL[6*!.UEIM:E/'M.@U&%18M(AR5BFY19D
M.=%0$B"(EW*P92L/CJICEUE;]G--.5MR<*UPKSP^5^THMZ 0DPA)Q1(]=;WB
M)BQS\H+""0J F/UC>W0&9C"L6\;^>GFO)DBG32.?<+N,*8R(-#HLGKY"S94]
M^4'A2?#.'38IR=X"?WA04+TV'I"GC?":S<6/-OEVS-&*&&C9#\BF0X*J=A>Q
MD^5QQ6:_5K)+,2>AB#.MU6IU V]X9'<-PV'5>0++$V!-9-#0#0#0#0#0#0#0
M#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0#0
M$! ! 0'T'0%A'*'A)&YUSUQ9Y,5>VN<>Y;XQW=[+LIAG&A(-[Q0;''J15MQM
M9$R*(K_8TLD9-<BA3"**Z)1 -A-O49>4OK)'L@3*06;;;M !*+=$ VV_)$@$
M[=@^3TTCN%@?-(P4-+L5HR4BV$A'."F(NQ>-47+14IMP,51NL0Z1@$!'U#2(
M@<<'7("LL48RNPT;!QS?N%%A%,T&#-(3B83"FV;$31*)A,.X@&^IO"!VJB*2
MNPJ$*?M$#%[@W[3!OL)?D$-_700(?#I=Y5.P/>% 2E4_AE*8=S% WJ!3"'4/
M0=6(@<"D<R5(JFHV1.FN0Y%R&3()5B*%*10JI1+LH4Y" 4V^^X!L/32(@=6U
MJ=98L6\8R@HII'-%RNFC)LQ;)-6S@I_>%7;H$3!-%4JGU@,4 'NZ^ND1!';_
M  3;L$@HD,41[A*8 ,!C]QC]X@;<!4[SB/</41'<>ND1 PX<E/']S+M7(.]Y
MMXL\Z)#$D)E&%K\=:,393QJRS'C^KRU;*=-G;,;,)*6CS5>:5 WO% (44S*]
M=A]="6ET_C\X-57@C@E3$T7;)S)-IM%WM.5\KY-M#9NVG,B96O+Y.3M=L>,F
MH?",BO'?1!%/ZJ")2D#?M$1!+,R^P[= YR*&2(*A $"*=H=Y0'U*!]NX"C[0
M]!TB6".H+6:^21<2Z<1'IRKM C5U(IM$"/739(3F30<.2I@LND05#;%,(AU'
MY=(C11]C.(C(]-)%DQ:M44 ,"*3=%-%)$#_E DFD4A$P,/40  #<=](L0/I%
MH@*@K"F J#W;GV#<0,!0$#=/K%V*'0>@;:1$$=6VK4 SDGLRTAXYM+2)$4Y"
M20:()OGQ&X""!7;HJ8+N 2 1[>\P[:1$#M2-D2=^Q _C#=QQ  #N'8 #?M
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MF4$^WM]V %[.T0,42[" ]!*80_#I$0.5-%)(@)IIE(0.T *4-@ "@4I0 /8
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MY8.,,X*<INA3 .WKL._][UU0Y9EE1-H0: : : : : : : : : : : : : :
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M#[="93+*ZYJ<2V&4PP>^Y(80:9@%PFT_-FXRC2T;L#E13W14!K:LR24!83]
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M)4HV1W-\Z)>\#M6EM])U(<"Y")O)MSM-M_YQ$V3;TVJE '?\"E6, ;:U[/\
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MN2$$U.]<N"^Z0 JSTW\<?ZA>JGIJ&D8D.90$#]HB\3X[$_X,_*\#>GK[AH(
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M\VV@&P?('XM -@Z] ZCN/3U'Y1^?IH!VE^0/Q!\W\K0#M+Z;!M] : ;!\@:
M" #Z@ [" AN&^P@.X#]("&@   >@ 'IZ!MZ  !^( T    1$  !'U$ ZC]/R
MZ   !T   /D -M 1T T T T! 0 P;" #]( /[^@,3//OC)S#O+RY9JP-Y#,N
M\9JM1L12LA^:NF8WQ':8*6L%29V6?6FW,M<JY)31'$PD=%%8A%2ID(@ E+N8
M=:B9@S%_XMF?D!SKQ%PEY"LX>33/5JJP,[7>;[@:+Q#AI_$V>%H]@L$4\K+-
M>.I3:RN5)EE"@8 ;KI. 5/\ 5-[-"0C:8UWWERY:VKASY*>74+R2SK5K5C;D
MSC"DXPJLQB6J5K%N)</K\F8ZI+M8J1>P#\\Q>):F**-YE%[\2Z:=H@!RB8.T
M(61-D/CIYLN&V>,L8VP7'NLO5:SY79 AB&^9'Q?(4O%^;Y&-:)*2OYL+6[>*
MC.")Q$R8*-6H*E,42=#!J%C:95\BY"IF**1:<CY#LD74*12H.0LEHLTTX*TB
MH6%BD1</I!\N;H1N@D41';<P^@ (B :(K,3F%O.UP)S=F2A8<A)_*=3<9?D$
MX;"V0,BXNF:=B[,4RZ?!'L(S'EO>.UOM9U*+B'PH*-VY5P$!*;J4!< /2\B/
M-7PNXYY2N^))A7+V3+)B<S#\\\CA7%LOD6KX:)*)G49!D:=9O&+:'7,FF)SI
MI X4(0IA$H" Z.P=@HSR7YSVJ?YE^&5CQGS$1]QSYDV/.CRZ?83.)?1.2:I#
M8IC;)43JOI)BYDXLL=)N3*$!LJV6!7<BG0-7(B%,>!OE0:T/@ED3DISHRO-V
M)VCR\R]A*A%CJTP?W"VR3.QOV]!QG1ZS6XZ/^WK \:,%4FB)@*HI[LPG/L&X
M3+:#(=Q(\GW&OF+D&T8>IB63L:9II\ UMDUAC.5 >XWR.2IO%DT&]H9Q#A[)
M-Y&#,LJ0@K(K#VF, & -(I&I7:4M\Z1DU/$ESI((@8!PN_WZ>@#/0?RAT$=]
MM<]ST7>$JMDKR'08KTDMQJJFK5+%[RBHFH#$99RG]F1H)Y3R64"L&A0(2Z6<
MI2=K9/ZI "5  *7;IL'IKZOP_"\*\@H)W>DWT,ENC);VJM/Q>UEUTUMEUBO\
MM+$[Y+3\MKP2K54DNEF@DE-8DK$ED1V(9;RL B'YT\FF^F[6H-OFV"6V'7<%
M@N$0[>[44_S9#L4VNVN&7TI??'U><2!ES+ _E92R<8OR??>S 'S>DF ZVL$P
M1V>3T>]D,O7;7'[SOOCZO.)PRUE4 V#)^3"[^F]XM77TZ@(2VGH/!O-Z/>R#
MUUUP^\[[X^KSCC#+F5]]AREDT0V_U<VD?WI,-_QZ>@L'?^'H][(7UTUQR>D[
M[X^KS@;+F5Q-TRADX0Z?DWFTA]/3[6#4>"8++8[O1C^;(3UUUQSXG??'U><<
MGYW,J= '*.31W].R[VD3?\=+!\FIZ%P7S>CWL@]==</O.^^/J\X?G;RI_NGY
M/ -MNMWM "'R#L$MMTU5@N"^;T8_FR#UVUPS8G??'U.<0_.SE$=]\J9-,&WI
M]][44.GMW+*[[:/!L'5ODU'O9#D]=]<_O2^^/J\X\JMFK,GWI)&HY7R8+$8L
M%DTBWFS@J*WQ"8*")CRQ?J GOMN.NV76XX=)B]22I=*?DRT8/1D:MEER*,<K
M>8\ZJXUKE/J-1QVGBE\<BJS23M5JL5-TDT$WG;6BXIM0<,MB]8&6<HE !+E3
M* F,'4I;Q9C"  (@(])?UW#7>*N%856JM.ZT5*LG:R(\#]=-<$O]4OW5KU><
M3DRYE4#D$<HY-[ ,41[KQ9P'8#!OW?UTZ=/GUB7 L(;4*%&6:.71ELW[%&PC
MUUUQA#TG??'U><;8'A,L=ELG$M_)6F?FIU\GDBSLOBYR4>R[XB2*,9[M 7;Y
M=RJ*20'^J4#B!=QVU\[;2:%&YXNJ=WE36CF4,[X#],?=6Q;$,8U!J7W$[U/>
M:LMY<L9YIYG+^CIO1;FRY8V-JTS)%'<H#U#</:  /X@Z:]>GT[UB;0#0#0#0
M#0#0#0#0#0#0#0#0%-<R9.KV%<39(R];%%$JSC.DV6\3HI"4%CQE:B74L[1;
MB<0+\2NDU$B>_3O,&JB,UKN'N,_)SY6\0L^;N0N?^4.'="RP]E[-QSP+Q_J5
M(;,ZM2F$O)Q-:E\A2EDB9F2M;JQ,8UN^.W4=*(&(X-]4G0@.P9RG;YDY&>53
MB[XL_(1(\EIS[+Y!<:9-RTX_\K*U U-FSS!CY5:ODB;HO5@2?0[&Q,UW#ENZ
M(>/;HJ>H)@8.X;V"YCV)^*_E^BN,59Y*86\K=[R/DA7#L!F!'$F9,)X6-C^U
MN7=-:75Q25W]6J3"?9)R*BPLDG"2Z:A2F >X@@ ZD1!HOGX@^4_%V9O&M"\_
M,X/&&)H>KP%A;YI;F]Z9G7;I1YAW5[-&1*2KDR[C[1GF9B1Z(G%10RR9=P]0
M#-OEI7AJY^\O^:/)WGM$\FX?\WM5HKG#5GP?A]>&BV,I0,=Y,JZ]DK/V](M"
M&D'\]8JPLR?O4G2ROPSI<Q" F4 (#L#.99^9G-SC_P "<5Q>:.2=FD*CCN4N
M<#0RSC")<3/P<[8R/56!GK9J;WQ&)48]4RBA0.(=NP%'?0IC@9?M#?CZ7E)>
MOR:V>ZU9S0L;8L9U:Q87FXVR<@(2:F#0T-)X-AQ<K.K<WEW0 +85RLMTA$Y^
MTI3"42)=UQ[\J?#SD1A3+^<H6\S./:YQ\=237/%?R[77%&NV('<693XAI>*\
MJX?#'+'! WN@365]X(;!];ZNG8*49P3YP>#^><L4'$D2\R_09'+[IRRPK;<L
MXKEJ)C[,CU #"#/'=H>O72<L[<BF8$$EDFQUC  $ 1,7<2)Y3,OGLX)8:R%E
M_%3T^<;YD# ]ID:UEBM8PQ))6YU2FL.T9.Y.VS#DCQDP0J38KXI3NA6!3O(<
M"ICVB.K 1/CA?V@;QT6"V4.+A;GDR3QUD"=KM0BN02.+YL,"Q]\LZ+=:+H4U
M?E5FYV%I$SU%)5$&2J2"R@$.J [[0%S'+?RG\6^'EVK>*[HMD?).9;37C6^)
MPU@RB/,E9'/4DS+$/9WL(T>L&\;!BJ@8I%EG!.\P?5 0'?0L=S*=7'^7;A#)
M\0[5S7;9)DCX6H-@B*CD3WM==,[ICVUS%HCJ>E6[G4W2Z3R$EV<U*H@N4QQ(
M"(BH0QRAOH2)X+CIYK^$/*#.M/P'C&=R.%DR6:X?FKLULQ[(U:AY22H<8TE[
M.ZH,_(NB*S39@R?);&,@D"AC ).X!WTL$2\"K\Q<)7GE/D/A[5I6:FLRXLQ_
M 9&OZ#6(.:N56'LTDM$PS*1G2N2^YGG*P@?X0$NXJ(@IWATTW@6\<ZN,W+7*
MCQ?).!>?F5^*\#2<>S2CZ@T/'N+;=&6>9BDWTNG-OW]Z@)=\V650*#<R:)BD
M[2@.V^D1 Q#>'.J>2'G#QZQSRVR9Y2<U$9M\QY%K4_B9+%6#SURR0^+LAR58
M,R=RX4<DPW2L#*) RQDS@=,RA@((;[@B(,V9LNY=QS@'&5KR[F"X0U$QQ0XL
M\Q;;=/N1;Q<3'IJIMRK+J=IC"=RX6(DFF0!,=50I"@(B&F5C(C&9QQ\WG"3D
MQF>FX-JKK+]%MV363J1Q$^RYB^3H57R\P9I*++.<?3#MR]^U@%%(QB%5*V,<
M Z!N(!I 19T.0_/)P"QUD.U4EU8<J6BKX\N9L?Y0SC2<73%CP3C*Y-Y,L3(0
M%SR&DZ;(1Z\6_,!')T6[E)'?<3[:6%BSCOO*[)DGY;>-.%L>9-%[QQRGP,R)
MF]2 C&T,ZA;'8V=ND&E;MK:7%H:6$ B$TO=E3<D;G*(")-Q$1(CM+6> ?EWB
M:%XS.-.=N:M^ON5LV9QON4Z31*W1J0VLF5<KS-7OUF;)0]7IU;;P[*04A*ZT
M0]^M_$%(0H"<QA$1U>$9#+-PX\@_'KF\-^B\3/KA!7W%#N,890Q/D^HOZ)DZ
M@N9HKA2&&RUI^HX!NA+(-3G04364(< $.AMRA"E=:_R)Q):,Y7KCC"6DKW+^
M-Z=6[]<*J5@_3/$U6VO7L? 21I!1N2.< ^=QRQ 334,H3LW, !UT@(E2;6K_
M &-6,I1,.T!,=0Z#W Q7]!Z==M]8G4).VL[;K!)M_DM-=4_-[XWY\SI3*=:*
MY3<S94JM>894RG\!!UO(EQ@8AF*]XFU5_AHV*DV[)$5%C"8W:0NYA$1WU])Z
ME8'A=^P&E5K4I9YTMR5P[Z'6/RS]X/7C7#"=H]ZPS#,1OUSNM*':T:]6FG%)
MQ:ISRIO?9<('*3D\([!R(SIOUVVR]D3T]O3[:VUY=+JK@L>VN\D/S:?*>C_:
M1M 5OIS%O\W>/M"(\HN4  '_ )PV<Q#?J(Y>R)TZ"/MF-_9K?JK@'@).]I\I
M/:5M ^^\6_S=X^T)!Y/\DNH_I!9[W'<=PRU?=A'Y _K_ /BU?57!LU"A#\V4
M>TG7_P"]\1C_ .HK<XG2Y/\ )T2 "'(3.H$]1!7+]_(;?V[E"=-T$/;K,VJ^
M!)]O0IQWI)($]I.O^;&L4E_-O5=+B51'.;E!R@VZ\B<WE^?\\&0A$/7Y)DX_
MN:+5G $_U$K?YDG*@MI.O[RXWBS6_>[Q^.HS@-R>Y0B._P"D7G#I\F7<B>SU
M_P M=:]6< C;=Y.]I\I?:1K[]]8I_FJ_/(_I0\GO3](C.OH/0,OY#].O_5O7
M-ZKZO^!I][(3VE[0?OO%O\W7^T/F<\H>2Z"*ZZO(;//>0GO$Q#+M\$OU V'8
M33P&#K\H:Z&_ZOX33IR^3W>E-)*^V[62.Z=1<]H6T&\WRE1DQG$IJD\ZE[:\
MUG:[%'MGG.L@.5W)V18E>?I!9R!=;?N..7;]W>[346+MWEFQ-MOMT'IOK5#
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MK54R/X/TZY#QD*C!\S:'!0H,FZ#(8^'+CKW98YFJDD@9)LHFW3 Y"E*!_=E
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MI\AWBQQ\LI<S_=#PUV>$3#)3%K#7Y%HWM+\&:5OB&S^10CYQ-IV@NF5P<"&
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M H   &K$S J4[I]3D*X-0D*Q7GU4,U28GK+N%C7-?.R1[029FAEFQXT6J92
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M<)4ZK5\YFXM,SA 54SB7W D* ]-Q0!>[SQ\+''O 7&[)7);@E*9)XQ\D>/\
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MY(G[97>6HJ"FJ97#^:CL]8.4: : : : : : : : : : : : : : : : : :
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MS[)^S]/]7)^8C[-<9L: : : : : : : : : : : : : : : : : : : : :
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M+S>GW_R$0\0G.8WUC8\KP#\@6^,$.GI_!+MI[1M7U9+4LZG*3X6]J7FU/O\
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M=C3,>+,RTN,R+B:_57(U$F43+QEMILRQGH!XD0"B<R<DP66;%]V"A>\#&*)
M, FV#<00$44CJO-;A]<\DN\1T[DGA.QY1:+J-'-%@\AU=_93/$UOASMBQK20
M.NY>@X#L!(@&4$X[ 7?3*+,Q6O(N3:%B2BVG)N2K3$4N@4F(<SMKMD\[38PL
M%$,^SXE_(NU1 C=NA[PO<8VVVX:0+&)CD#SA>)3?;]/OC=Z ;ID.('ZH]W4
M*J)A .T=]@';VZ0)%%\?'_DO@7E112Y,X[Y3I^7J$>4>0Q;5299"8AQE& @#
MQE\4W$2>_0W^L7U#2 B5Q,4AMA,4#=O4!$H&$H_*&X"(#J%(B " @( ("&P@
M( ("'R" ]- =!9+)7Z16YVUV:2:0=:K,3(ST[+/3 @QBHB*:JO9%^Z4V J39
MJU1,<YO0 #5RDR%!:?S+XMW^2P]#TS.% LDER K\]:\+M(N;0<*9)KU6.HG8
MI:J]OU91I#J(G!<Q!^H)1T@(ERW8F8X*=A!/L&RG:43;#\AMM^GTZA3SUK7
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M^X]E6JV>ZW701&-N-IR;+S<<2.);A!5-J:,<M4B*@4PD,00WAK.9W\W<\(3
M'$NR9+RQ=,'8XY)Q''2>RBTQ%8<@0[J+=7R.IKR79P<6B6;C9NRUYS8FX-DE
M6JP*N4QV3/WCW:6$M.ZX&<[L9\N< X#LSW*>')'.>2,152]73'%"MD2Y?PLY
M(0K.0L35K6#3DM/L&48Y<" IKG450*(%4,(@(ZDRLB+2BGG1( ^)3G3W!U'"
MKX-A#U 9V##;J'R".N6@M*\4X;YPXBX7.\O=I<AID0P$"/8]SU<H_!-NXO\
M&B(#[@@" ].NXCK[+P.:_2X=1_1T]'H9(1T>Y1^%^LZCK%?XI)^65_\ N3'9
M%.0F_P#5RX[B([@"H?\ WNNO<E]J3-N2EQRG8VF\B4![TG^/7'R[_P ;\_S:
MG07SN*/'*(3[G9(^^)_CU<?H]Z'T>SUVTZ"^=Q1XY2:+>9$.](?^?7 _-_'#
M\GS:=!?>XH\<I>WA_P")'WI0Z?%N-OD$J@]?Z'Y=.@OG<4>.4=OD@0,HF("
MO%PW#V^\+^\ ;]-<=2E?I8-24F]+=EWQVRRJ-I[+'?;^<+'!?C%U/[.:@8 $
M5@W'[?8 !=QV^J.^VWIKM^+N_.[5GT=-+HIXPT<FBSOFJ\?6.YIR)KRJE_W)
M3]$2K[# Q =.D<R]O7<$$O7VB(:^/+S^N;WS]S;A_<:>[HHQZN%5!\M;%J*J
MOPIN"DBM\.*A_<"O^>EB7WWNM_=^^ H[=VW< =-<*.JFRF2S4*- - - - -
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M9-QBQC7%O0MYYL7XK?$_&?$MP1!+W?;V=>[?7%+8H'-#B+B]4HT T T T T
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M3UUZ^VD*I)JY(YI)DO*95%_NZA]/>Z9)+5VI3Z32AAE5_P!==U^,W24@,!0
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M.6 P9R\MO#_"'#')*O'C&S;%\;$C.Y'S=!1#:SS\_DAY.(R:[JD"::8M!9M
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M]VH$.NV^P;+!N(!JR[8[U-'1I2.&_$/W*,)2CZ4O'>T^0F'P 5+_ '>[>/\
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M.PJO8,G\3V$BS12YA!$$MQ5+OW;:I&["]#4*- - - - - - - - - - - -
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MDKQ0\H262C*/,EUJZP:1/M@M/E9)0QV** I':$ I V#?:"#*LXDX#^0"^O\
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MF$6WM4>E&S17-9L,G6WX.&:+AR1(AWT4H9,1/U3$!$ WU G$NK*H4X=-]_:
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MQ@Q?-7WM^TTQ;%2;7-O40A APC 7]\8RWO?B >=O:':*/\(=9C)<YK)H: :
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M58)I4O\ 4_M#8WKUU5 RT5IU#0T T T T T T T T T T T T T T T T T
MT T T T T T T T T T T T T T T T!P.3*%1.9+;O* B&^X@'0>H@ AW &
M_7YOGU41FL!QA\FWFKYFXIE,_<=>#_#.SXL:W>[T^/:S_(&\U>X2CFCS*\/(
M(IQ+JMKM4UEE$0]T8S@I#F$=]BZ$MS%^W$/R^8[SAQ[Y/9+S[0);C/EOA"K9
MV'*C"]FD&DE,4IQ5*XO8E)> >$5;FF*W9TF3A"+7,5/W[A$2;F'KH(EF..?(
M%YL>7M*4Y-\3^#G'NI\:9 7<QBRN<@,I6&O9BS#3$C?$Q=@1C8B)=1E?3GV*
MB8M2G.F!C[@)Q+]<1+7:9,^"_D@Q_P K>+:W(G*4$KQ7?TF9F*;FNH9KDFE+
M:8SNM?=&;R#5U9+.>'C5X-VD*:[5V<4BJ$5 H[G*8=#2ZQ>1B?D1@+/+-](8
M/S;B;,3&,.5.2>8NR'4K\VCCJ&4(F5\M5I:53:"H=(P%]X)>X2CMOJ"**QZ%
M/)VT-Z[83;B/9"30 4-MQ,+-</01* [%W'1RJ9J5V)Y203J*HWVJ4.JED-%K
M@KY4^1W&_![W#]&C:"XK58RMET6"LO"OGDB<9#($Z^7^(63D&Z0]JRPE#8H;
M &O=6J^SRX8QAJO=:9*VS+:NH?"&V#WDM<]1M=[SJ]A,LGDU)KYZ3RI.RS(7
ME?KQN7H>D)BW?Y?N](;C[?3[7 -Q^G7D?LHPG)TDOUCU=\86T?N:$/S5R$H^
M<?E\/^4V, ^BMOQ]!_GIL/EU?9/A/=R_6)\8.T;N:'>KFD?UXG,+_,3%FWLW
MKC_<?;U_KUT';4]E&#]W+]8?&#M)W*'>KD.%;SA<Q#$.?[%Q60B)04[@A9E$
MZ@AN/8)49<Q1*&WR^W4O&S#!:%U;I3*:]6V=MDS97#=.23WNMH->>G)5DIOM
M[8*5669%HY>KU#;2QG8'=JHE2LKXI"O9RO14D]*B42(%=.V:3E;W1!,82D%1
M80 /YD U\_8A=U=K[/1D^9*V?I3@>(5,4P>[WZI\^I34SZJ3/>:Z0[J- ?%)
M-F3R.?-)$$ACW+-R@^!8_NT1:*HG(Y!53N)V)BB8>X>X-@]H: \-B>I8]HU!
MK]6Q4A&-J#%(O"5]&&DOM>-(DZDGCUX#>0%T^%P'VBX6W'WI^T1$O3MV"LB*
MC:A1H!H!H!H!H!H!H!H!H!H!H!H!H!H#R-^AT+#2K5 .9Z2JZ$U7YB*5L</(
MFB)2"3?1SENI+Q\H51$T>[C4U!636 Q13,0#;AMJHC-;^W>)7&)ZQ8#Q'F?Y
MK5F1(Q>K,YEQS/?23&*<I(G5*Z6CG-Q,DX:I&#ZR1>T1+[0'0EI=C^S]Y2L>
M3O'G5 M^1+GEVST3*>;L<3.5[M:)JX/<DN*ADR?CD+C%3TZZ=O7,'+,"HG;)
M <Y&I!]T4PE -,P64S>ZAH: : : : : : : : : : : : : : : : : : :
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MEF246V\AZV%\7/"*#FXN<B,.L&DE#/FDE'J!.VW9)^P<$=-7(E=S2@*"BLF
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M4-'F+2!35RPD!,H">%F0[MMNHLW =3!U#O'U^74<[E@TLC-2I*HI/HS?C_\
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MC#H4!_0.DMS 0H'$!S7'?5%3;O[0$/3?5)!&3#4*- - - - - - - - - -
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M!64+1QDSYC[**9FI73^!AYMHC<H BAB%(C9*>[62L< Y()P[DW39(X (&$
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MYJ,#QT>$-;I*6KD :\U:5,SN&0XA1TJNH*)'21&CD@>_ 2=H4J-I81 -M_E
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M+V1"TG4-%BU%7[4&22 /?@MM[L>WM]NJ9*WZAH: : : : : : : : : : :
M: : : : : : : : : : : : : : : : : : : : : : UWOVG';]7'4MP*/_
M )X_%;H;L #?[()1$@&4.0H&. ;;".PAO].JB,PP9LL-OQ%DWF+X,ZRK*Q'Z
M<'+'"]AP$"4?(EB(7COGU9O+\@@3=-"B@RCH5Q'NP70(B=(K1?M$I_K:&=X]
M*TXV2=IPG^TS<?\ $$8Z.ZIMUKD-3J[ &$'+Z-Q9A:#=MZ\T31;IF<F>15?4
M1%$"A[T% +M[-4&Q9X[/(;Q*REX\\/9?9YCQ=2H?'>'*M$90@IVU5ZN2.+[#
M3JO&,+'!VJ'?R35U#NHYV@)?XTI2J"("41WU,K*LAA@Y9\L:;Y7>'6'+U;;$
MTX>LY_GI#H<&[IE.HSE@Q%G">Q>H]=5]WF*"5:NHYK5K6Y*9!D9RLBBJY 2D
M$0]X 4'!A3(?."K\^+;@=SA;QUUGR%77CHWFZ!RDP.VN$KAZ7QU 7*)^WH'.
M5#A7\'+Q4PM'E*6'46:]Q5@_BE#I"81;RRDX3*A]S?VA7M#;,_C0ZE'N*.+L
MV[@':/0O]D>W?W;;>S4-&4J@H9598/BFF<I&HRN7DJ"N7(<E064E'TM[;"1*
MQ)ES664LJM(M891X)A036.90I?41]=1)MI9VUV2RMRRJG/\ K%,YOY+BUU8,
M_-XPL(!#7/<!, Y5R?Z )@_TYS!O9O\ S8:^I]1+Q0I8#3IU)Y5.LMJ/R,]Y
MJG4FVKWZJI6Z<VC![L)4BLR?UCB4 $H&*8 ,;ZI0V3-T,<VP!OKR^M>KO-)"
M6>5O2E>59IDSY]Z.IW+XC8P\ *I"/>0Z8CN8Y::F78.X.XI9@X[B'0 V$.OI
MOTUZ8VN32SNE7E:=-;^XMP^^?<NDJ4:F*RU)9ETDDJEBFHY$;-1/R"_X$O[P
M:]()Q43[[2:4'E1-H4: : : Z*SQBLU6Y^'0,0B\K#24<D=3?W9%'C-9N0ZG
M:!C=A3* ([ ([:J(RB?%#$4U@C ./L4V)_'RDQ4VLTB\?Q97!6+@TE9)B82]
MR5TFBN'ND)$I#;E#ZQ1VZ:,(N)U"C0#0#0#0#0#0#0#0#0#0#0#0#0#0'@\H
MFG2XXO1JQ88VIV(M2L1X2T3*::L3790D0\.QFY)-5)9,[&*<E*X6 Q3![M,P
MB AT$1FBVSR+P*R;=Y>=\BW/?GMY"(.ORCZ'NH8VI&1*YP<K+]@Z T@U3:X_
MCXH\]#0IA5!8ZBIF9T##_$ /76K.J9-A3&?C0\?.7Y/A+S"X"ML?89KV'+4R
MNT%<N/L/&Q3?,N,RQLI'2>*[B]:E35?P2\P[]ZZ2>>]63=->PX?E!H4SDIE$
MI"E'U .OMV^;?Y _!K)HGT T T T T!1#+/&KC_GALQ:9HPUC;*2,6L=>,^_
M=.@;,K&**& ZHQSB68NEV)5C%**@)&("G:'=OL&K%D@CV-0Q7C?'U72I-$HM
M3IM.104;)U>L5Z)@X'W*R(-ERGBHUHW9JBX;@!%!.0PJ$#8PB&D6((IPAQ(X
MJM7";QKQHP V>I*E72?-\.8[1>I+D-WD62=DKA5TU2&#<# 8!*(=-M(E*],V
M+./03;,6R+1LBF1%%NW3*BBBBF4")HHI$ I$DDRAL4I0 "AZ!I$D#H'-%I;V
MUQU[>5.MN[M#Q[J)B;>Y@XQ>SQ<4^$!>Q<=/JM3RS&.>&#=5!)8B2@]3%'2(
M@=C8*] VN&DZY9X:*L5>FF+B-F(*<CV<M#RT>[(*3IC)1K]%PS?-'"0B4Z2I
M#$.41 0$-0IT<IC?'\[78VHS=)J<S589>*=1%:E:Y#2,!%N((4S0JT?#O&2T
M>S5B#I%,V,FF4R!B@)!*( ("0/"V[C1QYO\ ;HJ_WG"&*;C>8,I20]OL]!J\
MY9(TA$Q21(TF9&+</TB-R#LD'?LE_ VZ:1$$?>WX^X+:JRRS?#V,4U)VU,KU
M-&"B5;^NUVCD!:L+A([Q0_&V=DV$2)/U.YTF41 IP 1W""/7V''M$MK^"EK7
M3JM9I2K/2R=9D;!7H>8?5R1()1+(0+N09.'$.]#W9?XUN9-3Z@=>F@@==?,9
MXSRO77=.R72:KD*K2!P.\KET@8ZRPKE1/^EJ*1LRU=LS*("4!3-V=R8AN40'
M5M$%D/DQEA[$N%(,:OB3'E*QI7Q7.\4A*17(BL1RSI1,B1W;AI#M&B+AR9-,
MH"H<#'V#UTMAO"Q%2Q,4  1'8!].OKOH4\O6:33::$L%.JU=JQ)V5<3DX2MP
MD7"$F9MWU=R\H$8T;?'R;KI[Q=7N5/L&YM"6'H72+9RD=NZ(FJBJFHF=-4I3
MD.FJF=)4ABG 2B4Z1S%$/: B'H.@L*,4CC7QXQI9IB[X\PEBJCVZ?4<+3-IJ
M5#K$!.R)W2H+N_B96*C&KPY7*X=ZA>_8YNH@.D62S*?!D#BWQKRW8XRV90P;
MBC(EIAP (RP7.A5BQS#1,G:)$22,I%N79T$C% 2$.<Q2"'U0#1Q"AF*FN\>4
M1_(5J7?TZL/I:EF<&ILJ\@8IU)5$7;=)F\^[#]=H=U ?&,D$T5?A3I>]1(4A
MMR@ :A8'0.<)8>>5&6H#G%N/5:-/*O7$W3AIE;"L2[F2*H$@ZDX$L8$6^=/1
M5,9515(QSF'N$1'8=6(@CY,78%PE@YB\88<Q+CO%S.05!:00H=/@:L5^KW"8
M%'HP[%H9V8HG'85!-V[[!L&LS."B((QY^=,I5/$ISB P )38;=%$I@*)1*>>
M@R& Q3 (" E-Z#K4M5T5IK<,U+OY3+T1>MA?!N&J5 TZT5#'E,J]B<TN%36E
M8*O0\7(F3D(>/,^3%VT9)N.QT9,!4 3#WB&X[CKJJN.WV^7=4JT\TU&"LCF6
M1=0[-AVJ6"X1B#Q2X76E)?HS1G4J3;=DS;2C;G+B&YD2E,0BA! I@+MW@(@/
M84=A'IUUTB<5$[].JBFTJB@YK?Q'U:&1H!H!H!H!H!H#'&O-S7ZUIE6_MF6"
MO&X0/YDT"$B\^Q1EBYC8M E!B???9YI &H^[]\*?O0)]7NVT) R.:%&@&@&@
M&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@
M*-YRX^X8Y*TUKCW.V.ZWDZDL[)!W!O6K4Q)(Q2=FK*YW=>F0;'$"_&P[T_OD
M#?P%2@/7;;0'0V+BKQUMN:*1R)LF(*3,9PQK#O*]1,G/8A)6VU:$?D63=QD5
M)B('0:K).3E$H@(@0X@ @&K%DL.ZH''?"N*[=E6^X[QU6ZA<<WV1&X9:L,,R
M*A)7VSMV01J,W8G!A.9[($8$*B!QVV3* !MI$0+(LA^%KQ=Y4R8^R[>>&>')
M>\RT@:7FY!. ^S6,]*J+&<+24U"Q:S.'DGCE4VZIU$!%78.[?;2+$$7=90XD
M<:<SX:+QYR?A3'MOPDBW8M6>,I*N1Y*C&)QB@*QQXB):(MV\2NQ6#O24;@F<
MAQ$0'<1T$$4\XN>/3AEPN=3\EQFP!0\535I11:V&PP<>=:QRS)L(&;,'<](J
MO)0[!N)0[405!/< $0$0 =(B!>=J%/-VLB?W;L1AZ?UBEP$=OE9K;]=OEUG1
MFJ3)2.V(<\M-]+-D1@)\+'&'CUD7@K6;=>,0T6T6.4RIG#X^7F*Y'OW[CW&4
M;*FC[QPNB=0P$2 "@ CT  UWBEBN*W&14:56:67A/!<1V<:F8[>Y\3QC#Z-Z
MO%5Q4TTJ;2AD,L7Z$_$P_P!4< XQ)OZF"I1!3!MN/Y1FQ@ 1^C7,M8\:C96F
MXSHO9%LVEM6$7>3?T%9^&0JMC7!&'\/#(JXSH-9I1I<$@DQK\2PC1? W*H"'
MQ(M&Z(J^Z]Z;MW]!'727_$L0Q*3H[U.YEOGDF"ZK:OZMMS8-0IT4\NBDHE80
M] ^C7;4H*!Y'EM(ZH&@&@&@//VV0<Q-6L<HS[ =QT%*OFHJ% Z8.&K%==$3D
M'H8H*$#<!Z"&@+?^&>3[9F;C9C3)=X5:+VFT,YM>568MRM6ISL;-,Q;?W2!1
M$" 5HR3#U'<0U61%T&H4: : : : : : : : : : : : : : Q ^4SEI:,0T*
M;P%7N*?*C/ YXQ%D&%"\<=Z8XM+2A.)-BM66Y)A9L/\ $2)COO?ID!4@F3(8
M0Z^FK3)A>X%>17.G%7@Q1N,5W\*W-&=M.,*<^IR9JUA\B=3R:"8NRLYZ:2DH
M<[EF_F4UBB](X(Z,"G<(*' 0U!9 RU> /%F1,7>/J #*./;=AVW7S+V;LDO<
M.6V!?5M;%S>X9$FI1A5(J+DR(O"0[5DL0R)_=()J@83D3* AN",VNH:&@&@&
M@&@&@&@&@&@&@&@&@&@&@&@&@-+KDGSAY,\<_P!HO0.^RK=S\,:\XP1C/*..
MG4ZY/0:N;/=8E*S6[6>&.59BU<??PK)(BVQ#?$." )@((ZU$QG*Q?M._,KD5
MBRH8GPGQ.R5:L=WF'@)3DCF>ST:;5A9>-Q#!3L51HINY=M=E6[>7MTV.Q!,!
M5@2'ZH]HCH5Y+<I=MY&^6/D2PKXV:K?>)F'X?((N>()+[ESD79<F1<)/X;58
M46&E7]GB*E(QSI6ZV%9FLY=)#[U-,BR8"(&W -!FWS*1XT;W<,F\ ^(N0L@S
MS^TW:Y8(Q_8;/8I10JLC-3$E"H+O)%ZJ"3<%7#E0>XQNT-Q'?KON,948L?VE
M2^\D:AQ*P1!\5\EW#%V6,G\J<7XRAYFFSJT!(/U+<:0BFL4\>ME4SGCG,BY1
M Z8F AQV W33(B.W(52Q%Y,4Y?P=NN:EDDSERS2, 6>BV5FZ6$DN]Y.TV)<X
M^0@')2MP.WF[5DINV.1/W>X?&D';8=49H&([P_\ D\OW$#@AS>SKY'LKY(RG
M;,7\FZG0Z_7)F5?V>Z/[3=:A#/V.,JDV=@HJB^%X^/[U$" F@"*IMP*0="9+
M6>KLO/KR^RGE'PCB2#@+W4<<Y;XW6#DJQX=R-KXQ+W!_'1#FP+$@ARDXQ3(N
MH!9=FW0(,:L\7< H42"X VYM!;$RRU'SL\5;'Q3<<BEJ]DMI>VN7X[C:[XQ(
MP"C_ #:3D9- _3@<1HPS,@ME9F;7CE ;N2J?#F#J82]-1ER%?^'7D^HW*7+M
MFXY7+".;>+?(JM5)'(1</9WK@1,W8* =R@R6ME:F8]1] S3%B]=HI.4T5Q5;
MG5*!R@/< +"IP<<QXCSP=?$GSA. ] PV^-T^:6AQ#;J @8#[" AU 0UTM\35
M)I;J[)U5P3GQ&Z:&5UE^,TCXKF1RJ1CF#=#D+EXB+=BT2133NDLF1-%)ND1(
MB9/>CVD*0   Z=-?.-^QN]4KY6DEFF4JJS+*\TS1^\NJ.QS9K>]7[E>KW@TE
M2\U+I2GGFT4]*::G*YG\S.VWU3T4)S'Y5KS,2F?D1ETQ1E8X#IJ7.7,50AG:
M('(</B"[D.3<-=*L>OCJR)3S0TE])[J.?&-C>RN[X?>ZTN'4Z%>6[3Z*<DCR
M)P:C*N"S</T=<,NGLAB[&TA(.%7;I[1:J[<.5SF47<NUX%@99PJH;J=13<1,
M(]1,(B.OI7#ZLU7#Z$\V5TY8\1^%.M=WIW/6O$[K=DE=9+Y54JWE4:7615/7
M6'8!H!H!H!H!H"UQ;CRY/S#;<H_O*G\*C@-SA4*C]G#[X5G%W;7$9X97WNP)
M 5M[CW DZB;N[O9JD+H]0HT T T T T T T T T T T T T T T T T T T
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ML56S7^N;J(>@LD;L]X+91/WAC&ZA,QI&;S4*- - - - - - - - - - - -
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M;:,>36'<:25$NL])VNW5!U2X(]?LEHF7 NI6P3,9\(#1],2"X%45='(+DZA
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MLXY>R!#B5(Y72J9A/W"!3:H,Y?00^;J'\CV:R:/ 2V+,>SMWK^29FEU:4O\
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MKUJ&AH"&P;[[=1_]7]\= 1T T T T T T T T T T T T T T T T T T T
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MFT9EW+:1KS>&OEYQ6Q?P=KM)R9G#&53M\7E3.)Y" L4]',92/3=Y3LCI#XA
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MVFAD: : : : QG+B(>7-D.WU X(/R]W7;N'-;#IZ=N_7Y=]4C,F.H4: : :
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MA?;_ &E%+XO;WP[^ZW^MK1DK)K)H: : : : : : : : : : : : : : : :
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M^J1F3#4*- - - - - - - - - - - - - - - - - - - - - - - - - -
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M5Y-<L<9(O'&2^!W'3ASR?@FT>"OOI&HUFY.&&38I5-$#]Z*E+DG;@XF(8!!
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MCT\QO]X4XR_Q$/C+EUB;(3*19-'$99,9Q48V=*U%VW<#[Q=X#55JY#W0IF,
MB%&8N]\[)C?JC><9M^HX7D-QZ>@S,,;_ )(H:Z6M*G1GF:[99.,[C@]:K3Q2
MZ.29K2J).&=-.*/S]&"@@R:!W=09M_781W]REU'?KOU]?77RM?95-?:TTUK=
M6:/?,_HGU'ITYM6,/4R32N-"&\NBE@?290=B[&]GLV^40WUQ4Z<CC%9SRBG)
M3[9064E]X/\ -?O?)K?1T]PYTI)7%0B0$V^PCMN'3T#54DBS&XH]5353'M=7
M;F/W)'L<(!DS;&*/]<FP;" [AKCHRJ2\4ZDJA/I9>J=CUIO=YEU:OMWEG?0]
M%-9F^:S]36LB(P$0(CN(Q[01$?:(MTQ$?QCKZSI2J6C(EDT5V#^<#$[,3O*6
M15Y_YS.]ULZ(: : HVIC?&0YR3RV9!I^=\F.E*"FZ^U#?&EH1[ C.*MQAOB@
M)\.::( _$"E^4($WWUJ!EYRLFLFAH!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!
MH!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H"W/F !?T3^3 F ![<"9=,&X .PA
M09_J&X#UU41Y#&UX-*54;]X6^%E4N]:A+97)K#,M'RL%8HYK+1<@S<W"W(+M
MW3)ZDNBJFHD<2CN41V'59%G-7VU2DWB#@7Y2^&6-9*5B^.H>8JF8#8R\2]%!
MG3<29<L]%/D"J1[@IS'0AR@)6BA04*0A' E'83=3)G-XJE\9, 5[BE#\8F5#
MJ 8)2Q@RI#FGI,&*-=D:P:(1:NG2[<R1FRAGP"+@[@X&,9404$PFV'1]8JW3
M7;YCY-1\>W$'A/@C@-G/)%*X+/\ )>0ZOF3EGABJCROM6%*Q%?&61E"QA8HD
MVDQ;RUN>KM%':_O?A4NXI$S F8-. A=_XS^:Y(.D\C+WGCR4<=N57$S'A*/+
MX]S[+3E8H^7::$\+Z.LE?SS4XQNPBZS[N=03)&.%S%5=]Q@*0"@ :A>P=)C?
MSK<4)7R#\@L;V[F]QM;<4J[@_%<[B:RJW.F,X>4R;+S<VC>8YC<BK@K-NF<4
MDT.=J*A@0[M^T-]6 COF>56Q5ZYX^>66M2;*>KD]5',U"3$>NFZCI6,DHE1X
MQD6+E(QDEVCM!4JB9RB)3%, ATU'&2:"LC*^N9G2<LR>9)KAW3\J6N#M(W\
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MNVZ;[:L3)DMU#0T T T T T T T T T T T T T T T T T T T T T T T
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M QR' 0#U$! 0]="Q)"OD'3=1>.70?@D<R8@U725 54]O>("=,Q@(L0!ZE'J
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MIN.^H+"05D.@BHGU 1+N8O4 *)A$-_7ZI1'Z '5M%A'WJ.QA]XGL&PF'N+L
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M+/&O+RT2$X\NF,L+W+!3"J&-&*4R=I]\?B_GU9Q@X9*O%G:AC"D!2+@F9(1
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M'HR+)\0T6Z4<B"Q2%(IL ;&T0:B7I,FP-&K9L F,5NW1;@)C=QA*@0$R"(@
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M.'C1GO5PG?O MD)E;"NO=>X%J,9\ @8N_O /[P?DU26EXFH4: : : : : :
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MZ8+& C_YJ4+[>@Y16';\=3U/:;?/!4OKF?X?"?\ NTW'1Y2(?M+MA-U'BG"
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MO#AI-9OE/SZUKP>A@&L%YP>A---+0GT8S0C9NPLXB[?7<CQX: : : : : :
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M^*CD=CR7EX9]><S1]0QOBFFMW35U9+3>9N[UP\6UK\0@HI(O'+1%JLN(I)F
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MM$ UKHJ7A)>,:5Q[E>-7.("<H^G[AP_D#KCFHTXQTU#A&G<>Y7C5SC(KXG!
MGD&XU#L( %V-N.^X[#%OP -@'Y1UY'JE1_\ >Z3DF4T&L^;2EM/GGWHW=IMC
M>)JDI5/H3?M%-^QJYHL_10W X$4)O_% !0#T^L!B)F#;YM]?2:<$IOHN7LP9
M^%$NBX339)6T^'(=AH4L*6QE>Q\E#7,1:T^'&R?$)WCX]KV($>%O5RFUG20N
MXF[_ (G[*1,KZ;=OMZZJ,O(7ZZAH: : : : : : : : : : : : : : : :
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MDG:SV,9-"H/1,N(%<$,4H  !JYBJ)>UK)H: : : : : : : : : : : : :
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M[LTDZ>E8_P"4_E/4&O\ K%AVAC&$-.;%U@=XC-,XMQI33+(E]%KJ'ZB,&(_
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M'WJ?D&_ 'XQ#52BRQ2M>0Q&^=1L)O$OS?2$0!)3#;U-8 .*8BE]M0I1*0Q0
M0.8^P!U#;UUFI+-5E<LN7?(JU2[U*$U/Z-5-\&=+J%)Z?X)O'])U.L2+C']I
M^(?UV%>KF+D2U_67=1K9=4W;]H%*7N4./0.@:\2J:B8!6G=:M+.ZLS;=MD7:
M^I$^G;C[V^U_"Z$EPN5XI*Z4953D34T5)(M&5/?T4HGHP\#/CX#??'UIZ^N^
M0K2(C^$SY3;;Z=<3V?:N.U2U.-'--[X.VB-MXH1_-FY42AX%_'OOO^;^U_+_
M +8EN_D/PUGV=ZN[D_6)\8FV;SBCQ3$#>!?Q[F'_ &OK7_OB6[_1#3V=ZN[D
M_6'QB;9O.*,>";E)A\#'CV$-OS?VKV>F1;A[/^R6GL[U=W)^L/C#VS9[Q1XI
MCZ$? WX\2)['Q[;>[<1Z9#M0AM[.IWIS?NZXIMG. .;M=-+J'+)[Y>VZFM&E
M?*4LNYHS/\:(+^!OQXG* )X^MO=W;COD.UATV'VIOB&WW'Y=639S@"?;Z;4-
MX3^^5MMJ*%:^4IY8Y-&96[N5G '@8\>X!M^;ZU_[XEO_ 'QD1$=<GL[U=ADG
MZQP_&)MFS7BCQ3 ? QX]QV#\WUJ_WP[</_= -<?LYU>S:?&C7QA;9\]XH\4Q
M:%#^*#B%5_(U6<-Q--FT*5$<<D,XLFRMKG7#@E]A<LQ4*R>J/%G)W"C0K(I2
M>X[P2,;J(#KKZ6J&'7;H:=!?H:+>7+:YINRSPS$/>%VCXGK!/CU[JTW5KW*>
MC4AI6Z4KD5D,FA"V.7,;+31/X=%%/LV[4R)% H]P%*GN!"]P[";IUWUY/,J=
M.;M<]AZ2FJ3U7TE2'23-MPW6^!'W:U&!D:H&@&@&@&@&@&@&@&@&@&@&@&@&
M@&@&@&@&@&@&@&@/F=MDW;=9JL0JB*Z2J*I3".PD6(*1P$ $.X/=G-[?Y>JB
M,LT3\>'#8O'&T\1S8%IA^.EUFI2Q6;%QU)U6#E)R<FDK#+2:KE:84F47;R91
M*X$R+I/8X;% I>FE@ANGL)_AIQOMJ_'IU9L2U:27XHN"NN._UY=!/%:P0;6M
M"->3:R+=-0!@6*#;9V5T D3 ?RA$PH[A(%M'(KPZ>.GEAE4^:L\\9Z;=,D//
M@PF[$21M5?5LA(XJ*;$EC:UN?B6,R""3<A=UDQ,)0[3"(;AI$0+JWG$GCR^L
MV"KBMBJJIV/C*Q>1F!9!F@ZCRXPCY" 4JKQG76#!RUC"MUZXL=IVKHK 5,X]
MNQOK:1&B=K6^-6&J;F3('(6L4*%B\T93K,#3;_?$%) 96S5JKNG;VOQ#U)9X
MI&IM(QR^5,3W2"9Q[_K&,'32(@RFI^ _$E7".0..+G!=)>X1RG9K/<[[CI\G
M*/H6QVNXV)2V6*><J/9)R_;2<C8%3.@4062%!4VZ78!2E"Q$&>.XG^,WA+P@
M-9W/&+ %.Q?*W=HC'VV;8+3<S.2\>W,[%O''E[')2[Y"/;D>'*5% R1!*!0,
M @4-D1 ][$8;K7#KCSD"M\/<'09WD.VO60*=B"+G'<+&7'(TV1>579*3\\\?
MA$GLTN!4U'"B@)H]^_U2^@.)C\\1_"+*F(+IRUYI\HL=57%W*/F=E-:QV/'E
M0E&4S$XYQS746S&G50):*4-%R<@\435D7JR0#W.5Q^L8/2!;J,Q&0:#4,ITN
MT8YOT*TLM+ND,^KMHK[\[@C.7AI%$S=]'KG:+-G2:;A$X@84U"&#V"&A3%+%
M_L_GAVA7[*3C."&)47K!=)RW47E,A/T2*('$Y!^$D;HZ:*?7'<0.F8H^@@(#
MMI$FBC+=6*O7Z77HFJU2%BJ[7H%@A&0\+"L6\;%1K%L3W:#1DQ:D(@V;I%#8
M"%#8-&XE@6%<JO%'P'YKWR#R9R8XXTO)EY@6#>&;V5Z[L,+)OH%HLLX;PTPM
M6Y>'&6CTE7!Q!-?N$I3"4I@*.VD1 JEEG@9Q*S?@*$XO9.P;1;+@FL,(R.K&
M/U(YQ'1=:0A&J;*(/7W$4Y9R48\9-42D*JDN"IBA]<3"(CJY20/#\</&/PBX
MFT7)..L#8$JU*K688M2%RF!'M@EI>\12K)Y&'C)R?F)A_-*1Y6+]4@(IN$R
M)A, %./=J1$#W-&X%\3<:R6#9BCX3JM>D>--4LE'P8Y9N)Q0V.ZK<#K'LT-#
M)NI1=!9K+&<*"H+HCA3ZWU3%TBA!EL$WX0O&!8LU.<_2_$G'CW(KZSDN\@X.
M[M"5=?7%)T1X2Q.J>C.DJZKXSA,#F+\(#<QMQ,D;N-NB(&36RLVR52FFB*1$
M$D("22121(1-)(B4>NF0B28;$(0A0V*4-M@#;44SDJ*?Z.<UHZ<TJ>50:-6C
MQ0^*'AOR:XB1N8,JT>9E[Q9,KYK),2#>U3T<@N,?DRQLVW8S:/$4D>UJB0!
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MA/DEQILV96SAW@J6Y"XY&D5S,96_NE/@:?(B^>"$TNW6!5)DZ31<*$*80#H
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MM;C)] - - - - - - - - - - - - - - - - - - - - - - - - - - -
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MYJ/(8 ;_ )\E/];T;_\ !ZDVO&LK5LT.J8^$+8@OV/U$0+YI_(:(?[>:@_\
M@]&_X37'Z[ZR=WUPO=#V(>!^HB;]='Y"P_\ +F</_!Z._P )KF]==9>ZZYU/
MP>[$W^Q7>(^.0\ROD$D&+IDZS9[]H^;.&;E,U>C?XQ!PB=!5,1]WN '34$-1
MZ\:R?-<W7.GO'N<[(]'I+K2D4JW95U\IY#&GE=YQXJID)0Z3E\L/6*^DY0BX
M]."CUA;D>/7$BX 3G3 1]X[<G,(_/K$VO&L*6C+/9P_*<E+W/]C\]-5;W3DF
M3LLDER]2&^>['S0^0LP]HYT4 P].E>C0]?3;ZGKUUQO7?6&#TIXRY[3D7N?[
M$5:Z/U$;%?@ZYBY^Y8TW-<EG*XEN#ZIVJ&C(-P,>UCQ:M74,T742[6Q0[P%=
M43;FWVWU[4U)QNIBUU?3QTDX'P'[W6RS5+9ABURNVJLFC2KT])V0RN9?B,^1
M#@<A3!Z"'T>G0?W0UYP?'33E<'E)]"#0#0#0#0#0#0#0#0#0#0#0'266NPMN
MKTW5K'&M)B L43(0DU%/DBKLY&+E&BS%\R=(G 2*H.6RYB& ?4!T#-:BY?LX
ML-$Y#A+S@?R%<S^/M(H+2[,\<XTIMJAY%GB2J7P07N-/Q'/2#4DC3(.5%(.Q
M(I5P2'<0WZ:T9S&0KPH3F YO@+CM'C71KC0L7U6YY?HK=AD&6BI^[SUEIN3[
M/7[==+/.0S9FRE9>XV*/<2*BPIE5'X@ /U =3,)8&6C4-#0#0#0#0#0#0#0&
M 3]H$9N'^*_'^FU:N'AD/)YQJ5<)-T#K"FU+6LJBLX5$I3 FW2,)"G,/0/>%
MU499AGN&'LJ5KR?27A]C:K*O>+G(#F/C3R$N9\J*B5=98MJ\7*Y1R5CQ9DH4
M8\8YYD>NLQ!$R/:L8%P.!A4 =6Q H)E+!N5<I\1/-(QQE#W),<>^9B)RS9HR
MC1QU;*&-*-<'*EDEJS%G070E%JTT$7R:(I+H*"U PE$"#H3=_#<+B*5(<>^5
M7+WQ[5_%'/\ YX>1&X4#D'0,U?=9XUHT+3^/,93Y!HXD[GEAS*8MAW+6*035
M*R<1[-<CA4%1 @[EZ.R5%T'!"KMVOC:\[[\8,J,Y8^0/.4'#E1B8KR8:-,6L
MFK$P[D!9T@@03E0 -TP$NY0WU%D#1X/,U91;_L^_A]3:0HI2;6[^/>0.DUCQ
M(]9NG=BKKB5>@5%N"R#QR8QA<*#VG-W&$V^KO$S%Q%-Y-XA\87E<\C<US<=.
M<;5+EPMB#+6!,[R];F9B#M-=J.-*[1YS&"4Q"QDBJQD8.<A55DF1Q3(<3$.
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MOP%+OIN<9>W7:\K/3V(\4GV9(;QH<! _)XQXN >GY,._WVW_ .B_33U7U?\
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MZF@)A]V510Q4_P"" :19((N(#;8-O3V:A3SED*G]W+&H)M_ZRS)3CU#H#)P
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M0.Y0'P*^[ 3=@=-W 4SRR,HA8,?R$O%>]19RM6<234'B"J#CX1_$'>I NV6
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MD(?=[ ?^,<8_BJW]_K@\CU=7T:7'+RF_3.NOG&*?UG(/N[@+_&&,>OREJ_\
M(VVU9;GJ\IDY9:.E'NE#LD]-:Z^<8I_6<A.-;P /^5^+/Z"KB'[P:[GT-S\'
M=.MRG'Z:UT\YQ;^LY"R8]JHY/(0TP\!,9_FE5XKN\A+1YXJH%:#>D\F,:^D^
M),"W%8K@(4XI^X!4 $OUMM=+4N6!.=U*_0J\/*EHZ.10ZIU$NLFOD]-72G6Q
M-RRN,7TL=V%BW\G5WR]A2M<??RB1^+-Q]>T:NH/S;@<5  /G#;7%/1U?G6@U
M2LWY>43XSK\DI:UXQ129H=+^-'&-;P$(" ,,8=0$.H54"!Z^H 4/J]>OIK$M
MRU>F:25)3-Y8R\OXCB]-:\*VG>,4<^;];ES9MT]Q'V3'L0U;,XZR4]JR9(E2
M;,VDU#((-TR"/8D@@W=)ID(4/0 #8-=THU;C=UY/1JR*7\Z4[/><-QJ]3N^7
MR[WNK>G:VY)VWPO1BSTT1.QDXFLK&2,9($3. '-'OVST";@(@"P-U#^Z..W0
M!'J'77525;O5F=.E,III7!Y'V#M\]WOE'^^4:E*5Y-*6:5_62.Y1 _>J)CF$
M![.TIB@ D_*WZ@ =V^N2,7"!T^A-*[9HRO)O'T:%&@&@&@&@&@&@&@&@&@&@
M&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@)>T!'NZ[] ]GH [[;[;^N@(=@#ON(F
MW 0V';;8?7H   [_ #Z$@1[?7;H!@ZAU^3;IUV#\ :I8'"DU00,H=))-,RH]
MRAB$(4QS>G<8Q2@8P[?*(Z-Q) YQ#<!#Y0$.OSZA3@7.BW24<N%2HHH$.JNL
MJ<J:2210[U5553; DDF4!,81$"@ "(]-4A2P<\8+(8W=FC$Y3%.)3%-D6G%,
M"@?5$AOZ[@/>7;;8>ORZ"P]Q7;55[DR&4J=C@;-&D6.W&1KTO'S;(K@@%,HA
M\7'.'")5TRG*)BB.X 8-,@/0]H;;#U#Y^OMW_A;AH('%\.E[T%^T/>@':!]B
MB;;Y-]M](E.BM0"-;L!3%_BQA)8IPV  $/@G  (B.P!_>VUF6#^=\TLT.B;7
MS\W"80_"";%'Z!%34LQZ,,R?*F<?B1FS0!I$2%RE92HBN#X2.R@! ^J!P]/F
MUT$]*Y:3T52=OTH1Z[/(Z-\UOFNM)5)KS)34G:J33E6CU+';G,O8&P7T$OYL
M0';IM]UR_3];?Y/GUQ5:6']&^GEH*EG<95P6QW2^5:T>&OG?5.4F V$ ]#XU
M#_ KUDOX]E-=&Z.KSST>^7*57O6=?MKYQSD3%PAZBZQD #\KFL%#K\XJ!^_I
MT6KO_2[Y<XSZ0UE7T[YQU"3MP>/H\QI\GU7M4 /W3#UUU5&GA>A_9Y:+I\*=
MO&58CK/FFO?'4([80#J*F,A^E6JC^'ZH@/[NE6EAFC_:):*IQW4K>,KONLTU
MG27M?RJA'?!WJ*N-B_X%Q6"E^G;WFNFZ'5YYZ/?KE)Y7K0LE6^0X:A.(80VV
M!QC -_YE6JD'Z-_>!N'S:O1ZO.Q]"OY2Y3/E^LJ^G?.^J'FK(_PG#Q,Q+)*8
MX=*QL8\?D:)/:L!ESM&QURHB4!,8OO1+MOU]=<U.3 $K.AZ-9])<IR3XEK;3
MI=(JN)*E^2JC6_"QQ92OC?EC#N;<0T_)\A"8WJCBT-I592!<.:X5Q'_ 3TG$
MD*I[T4U=W*; %=C '0P>S2M3U=G^;T.A^=*GV3$N)ZS5Y%.JV)N.:ITBWLC2
M*ZB.#A'<38Q-Z!W"K5SB/TF%3KKA5'5Y61H]\N4OE>L_A;Y'AJ 1P:/HKC$O
MS@M5D]_PE5ZAJ.CJ\\KH]^N4*]ZSK]K?..H=A&V?%<("K>*L=&C453^\4283
M-?9I&4V*'>)$7!"G4$H!N8=Q^?7<:+PRE270UJ<M-9$II>4Z2\T=8;_#IKO?
M*T,DSDJ3==RNS@.Y#(=" -OOK4=O0/[(8D1#Z1!^.N66_P!RR*M3?\J7E.!X
M)BJ2_L=[C^ZGYH/D.A=IMKK4M]O98(HP_@+\>&^J[_<X6UJ</SI>4R\&Q27M
MIKG>]']W/S0A;Z5)N$&K&X5QT\<'!-!FSL,0LY<*F_(21;)N5EE%#>PH;B.M
M25J$Z_159''?3.&O@^(T9>FO%VO5.@E&,U.9+C<L.N>W1_I27M_BR=?^)#Z-
M<_5B=(M'Z/S<W <F@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&
M@&@&@&@ ^@^W0&@UY!7\[@?SV9PY\UYXY29<,QX=RF2(X@G^$D,0Y?*OB>\'
M?>YW6^#APL;9ZH)2*"=)$Y #<X"&C$+2M'[3G8%>6+]7#M1G7)Z%PYXQQ?-"
M[N(XIE6KRU9-R1$8PQK"R0B8B7NW,,9\[%,.\Z?U#& O=N+.&9(YKA/QZEYS
M$?/+R'9+Q]/\4L3<*,153%&(\G@O]QZ';'U3B7=^NLDR5>+,IZ8G3M&I6J9&
MAU4RE[0[C" @!23POY?Q/@Q3R*<HB3Y>//BIR!G.B#PT>Y2?/Z;5$SB%LB\B
M255B+.9&2@:Q8[09K\"W.@D"AA.)=]AVA3YO/[;<!^0WAYQ+JF%,MU;)>.<I
M>0/"F%)B\8\F$)IG%/[$_3B)=HBY1,5 )6.:6) XD,8!*+A,1]=%D#M.AQSS
MWO-!\"UZQS9G I\H,77&X^*AE&*.' RJN95I1SARB/61DD#&5>,Z@^2D$1 X
M@N+$P@IUW"@Q4\*N460_"YP Y\0N(X6-N&:B<_L;\<:?)6\XN:Y%7>>I$.$_
M:IQLV*M\8T;*-7AVZ'>0ISF3*=3Y64BLR%T]]X398D?/#Q9I%SY+.7N;+MP8
MN67IW+4;B>@-H&/R7&/K7W.6&.BBO7)2/2755136<N%GWNR]XK=P (-X9XE;
M4//?RGIG$3*,;D*.Q/%<D,*\[*QP6R7R DXJ6)A:GLK4G9S'Y 6&K1*3L6\;
M66E?.LX8$=BV.8H "O7L$(P,MOCGY*\XLGY:FJIF&]<<>5_'"6QV2[T3EWQ[
M?U^GMV]G3?Q[17'-GQ*6S6"?04D&<H#IK(E[$ (U,!P[E VD#2RV_A8>Y\[0
MB?Q&\YP-]8!PL_ 0$ VV^UX;U_#KCJP5&HUE48<9UV%S3>D;I+'M9ZB4V^H.
MPT(&%[O ,60!<[6&S-MT"Q3 ;![HFW0'@  ==?+U]Q"^^6UHU)OUL_\ .9_0
MIJ/JGJU/JQAZGN-V<+C07S%X*0^D+Y>-@_LSMF_7_OCF0Z;C[?C.NND=]O;=
MM28\CGU3U:4S2N-VA^8B(7R\>GWSMGKOO]XYCIU^=YK$]YO$\NC//,Y>$SZI
MZM>8W;O$1^_EXW#^S2V==Q_TQ3'S?_'/DUPZ4VZ^-D]4]6E_@;MWB(#?+QL(
MA<[9ON'3[QS'S]?\6;^S32FCE?&QZI:M>8W;O$/OW>/]6EL]H?Z8YGU#_P"6
M;>@ZYI+U>*<NC)/,I>$OJGJSYC=H?F(C]^[Q[;G; ^BQ3 _*&W^+-@UORZ]Y
MJDP]4]6O,;MWB'W\O'^K2V!O_P#G',= #_Y;[=1WV]-0<\T!ZIZM>8W;O$2'
MOE[V#:YVW??_ %1S/7I_T9KI])[KXV3U3U97^!NW>(X/OI;C+)N!L]B+(@0S
M<)$9R3!Z#,3 J+0'7Q/Q -C*E ?=]W8)NNV^N\4<3FDN4MVE;4RC;&VUM_C/
M7+V4857UVO&-.A25QJ.G"306BM&C3D<.%RM\+/J^_MX$!#[Y6OIOU"QS.W7V
M#_5FNAFO%\D>GTDT&>Q_4[56DE+)<+LIH6]HB'W[O !_ITM@?)_9',]=^H>C
MSITU/+;W']9,2;5+5F:6$UQNVBUW"(_?V\C_ -^=LVZ=/O%,?-U_Q9K*O5YE
MFTU/-I[L3CI:G:K4GI4KA=E-^8C;K_9O)>7G,1<CEIF5DY=5K>Z:5!23D';\
MZ!%H&<]Z1([I98Q"G%,NX!TW#7N#9I>*U>G>JE:9S3Z4L&_Y1^7'OX87AV%:
MZ830PZC3HTJUTJ3SJ504TVE(HO?@;+:  "?3TW$/P .O:"MM>4^!Y4DH+(<V
MJ:&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@&@
M&@*1<@!$N!\V&*(E,3$>23%, B E,%,FMC (;" AH#0$\:&5/V?>'XF5AASP
MJLI/<ETKADK[\RIL-\F[N*[4;S*C7P&Q4.G2]:<BE$BD79NLJ8@%$I^NM(S$
MV2@YM<(?'[X\\:Y@\>>''M[JO)/+[/'_ !JPO'-;ACF4RAF*XSBE<6;.T<BP
MQ)NJL4W$.H==9XV33*4A.W\L-0D4LAZ+%ODRYGXAY-8IXW^2SB[CG!!.145;
MW6"<I8>RC^<FJS5II$4E-SV/K&Q+&@]B9A&*<IG2<B;W*ZA@ A>H:0+%Q+;J
M3YF>?F:8R[<BN/W";%V7>*-#R[8<92=0K>;B.>5;^"JMA;5^>OK'&A(0.U%L
M+@7"4:*7Q:J90V'8=]("+C V0'DH,[0Y*3^'=-22-5<O@:/43-WC8'<09?X=
MV@;ZR#E$%>U0@]2F 0]FI,E'1>1RLS-,UI-94E _*SJD].LG-[;,YN8:-TLH
MY*]VW;2CYL@GW7*8.8")(K%3)N8PB.P!N(Z^>M=JU58Q-(IGHRQ26YD/VP]T
MC \&O>QVXWV]7:C4O56+GFFE3<S3F2C'<6X>Q"UVCV66?V]@_;$CZ!\WQ&_M
M^77AZK5I7%33:7"SZ<]7, >6Y7;Q<O(1&V6CV66?]?\ -B0ZAL(^GQ'37(KW
M>O"3<86K>K\?[G=O%R\@"V6C_5)/[]-MIF2#H/S_ !(==/++UX2;C.3T!@B_
MPEWA^[EY"'WKM7MLT_MZ]9B2'\ _U1K$U>M.]*::9S<(] 8(_P#"7?Q<O(!M
MEIV#^R6?#_LQ(_-_\9 -M):U:1QEFFCPDFU>P*90=SNT/W<O(/O7:M^EEL'^
M?,EM\PC_ %3[=;\LO7A)N,QZMX E_<KMXN7D(A:[5O\ Z99\-M_29D/8/S.0
M]NGEMZA^LFXSD] 8'YI=_%R\APN+=:@:K$^\E@$Y@V#^O4G_ #I3!V_$[" [
M?)KK+E?:_3?I)YG3AD>0[+K%JY@-; +W)Y%=W>99.T>A+%.&56$C:SV) %$F
M\_-H(IJJ>Y30E7Z2)$C" B"9$UP(4HF* ] ]?PZX[U?;PZ[T)WT>:T\/V8:J
M89)J[TN)72A/?G4F3FFDECHZ<\%DX.(^C[V6K<0^\M@W]G]>9#_ID=]]=/Y9
M>H?K)H<)[&]6]7_,KMXN7D'WLM1>OWFL'3KUF9(?P_XI^C3RR\OZ<W&/5O5_
MS.[>+EY!][+2(;C99_\ SYD?: ;]?B/;JN^7IK1Z2:'"%JU@$KBKG=TW^1+R
M$/O59_\ 5+8!]/RIF2'YAZBXZ:XU7KRNR9V[Y/5S 7;Y'=^\0"U6?U^\D_M\
MTQ([AMO_ /&?4=6:\WAIISS<8>K.K\_:S7.[N5_D(OD\:=EL3GG7Q@0<V&;7
M15RI E406E7ZR*A>Y;8JB2BYDSEW]@@(:\FU;O5X]-W>AIS=#-/+%1L=J/27
MO':O8'3V/XG>:=TH*O3N\[EF4J37:39#]'0  H 4 V H  !\@ &P!^ -?1B2
ME2E61(_"9N+B\I'5(- - - - - - - - - - - - - - - - - - - - - -
M - - - !]!T!K\7;QDY#S5S8\I=QRG7J]^CWS+XEXUPM0Y8T]'O9(USK*(JG
M=2E;24+)QR$),-D'22BH%*J*0=@B.M&,\> QTX9\-7.^,\6O/S%^;@JUUYQ<
MFCXVQS47+BY5_P"RU\.83#'$-CQN^MA#!&1ZSN,K[U=R@<P&%0I>_N.81T#R
M6Y3V?)+@EY'K]RIP1<[#PKQ#S'X[<:>/N,:9B##F3^3U:Q[0X/+[*NQ*60<B
M3U3^PYT+?)DF(]-&.&03]RBB0PD!0JGU WH&9[CK \DN3E/O^*/(UP+P'B+&
M,,%#=8YIT'E>LYXK%K7:.)XTD5_!,JK7XZN?=,S-B9KNF(*_%& I2@3<PJ**
M>0?QU/KC0>'&/^&>(\<46K8>YXX/Y'Y!JU=-7\>P3:K4RP,']QL#)D5-LUD)
MU2/BT2E12(9=?W90 !V#4S!]8LZR'XB,^VWS'P6<474$GX]G&3ZGS6MU."98
M-WK_ )DT.LHTB%?!5BJ?:ID"-XUI)?&=@M3*E5*8OO% ,%CNDMB50X_^'MOD
MNI>3'#O.&A1CO%_*;F"ZS;B]S6KBU<V%G#M(ILE"6UA)Q"IWE4LT?)-NY)-3
M^-3 VQBB4P@(9X9BQNW>,[RO,?)KB/.=-MV09C"&'L'S?%R"SG-WWC6IG]#'
M4L\L9"V!BP=UXD4^=-V3Y "NWS0TT/Y8B90-M06QWC(YE?QJ9'XB<4Z5C7QK
M5>D7^1B\RM,G\C\8\@EX&<=\S:T]+(!;ZS<\A6Z)E6M?LDP=R3X=^FT &I0[
M2  ;@:ER%O/CH\=>>*WY$WO."<X?8P\:^+F&&[!C>6X]XERK'Y)1S7>+),-G
MQKY9RUB&JU=AB0"#,2(IF9**JF.!@/ZB)921A:9!O.V4">(_G0 FW_V%7^P
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MG /(W@WRR@\STSBQE*R4U.4RM5X%LT;V-A#V*%$T!%.IYL_,++WQ3E]^B;<
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M+NK+8;I^A20W>0A]NWN*4VP^H=P .P^GIOKZ$3BHGXF*U1)M4HT T T T T
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M<OS8$^H4: : : : : : : : : : : : : : : : : : : : : : : : : :
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MQCP/<;A5.;7(R&K5FLN*Z=-SD#%U;(\HVKC&(DI*+<.XYI!)-TP9II&(5N!
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MS:I@: : : : : : : : : : : : : : : : : : : : : : : : : : : :
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MQ"Z4[W<\$O-2Z5)%-)/&AVTDR3EFMGCVR:=JC;:CT_ZV3QV>WE50?H[YO?\
M[2AKBFUJP-?MEUSJ?AGV[Q@\!O/?4.>/UL?CMW#_ ,ZW'W7J'UYO?;Z/L74]
M:\#\,N)CX:-N_P!PWGOJ'/'ZV/QV>WE7CW_FLZ'[T,'RZ>M>">&77"]VG;LO
M]AO/?4.>3?K9/'9[>4^.1^D\V/R?]1M<GK/@/AEQ,S\,^W7[@O/?4>>0_6Q^
M.K^VEQQ_13?^@VGK/@*_;+KCX9]NWW!>>^H\\#Y8O'7[.5&.B?SQ33@"/S#_
M %F'U'69M:<"E45677+\,^W99, O/?4.>/ULGCJ]!Y68]$?:'O9OY?D^Q@UC
MUKP1_M5UR_#1MVSX#>>^H<\C^MA\=!.H\IL<[#[1&:#K\G^0P?)KE]9\#\-+
M'JF?AGVZ_<%Y[ZASSI%/*;XY ES6$G(_%*CXC(L422 )?[5.P4<)N#M0<?91
M3$8D<E[S)F$I1$HCL(CN/)4UFP-7=-UTD\EEG8CE.RS[!=K%+6"E@%3"JLN*
MU*,U1R.>GI0E4S62?17:RQMM.S2\LOCO,<P*\HL9)E -@%,\QN8WKOTC1#M
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M_0TE*VIHRQ:C%.994U8\Q7#74'C8T T T T T T T! 0 ?7Y]A]H;^NP^H:
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M D"&/[C\T&?*1C=O4WTF4PBV295/(3DJR9A[-W#M(3&$I-M3?*3^1R8/R_\
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MXO)[MGH5O&R\I+_$_P RKT_GD_F^4-.CJ=U_.,='=?-Z_C%RG$Y3*+5<X>\
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M5W$C;5<EIH$0DF<N1ZDW8)Q7NA%1-1(XGZ;?+JF<YDO*0J9!V+U !'8 $=Q
M.FQ>HAOMZ!H56(P1AX;RR_'/R=8)LN4XZ24YY\AKMR(I5B:5UZV7PY;)6(JS
M6FN3@+Q8TK+4^?J+=^FJ@*1@4* EV';:F2F]?\&IJKP?X><4X+,S$EFX[\G:
M=R<R1D>3K3QT[RM;(>?).V'N;$>!((.)LZ*22*SE9P=,A  XG$-]!F+]N-O
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MS#,2NF)W97BZ/M&?-NN6J.*:D8Y4P#&$E?J7SH9.NDRX+7<3Q4: : : : :
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M^L^TK!-R>' N4X_@BVN;E+ZW(0#]H3X/;]8S*8#\@55'?V_]40U?:5@NY/\
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M-0EFW;6D^RS\K.N=9'((]"?[*F2?3NZ_V72G4=S>NOGC7267TQ-(VH2V*/\
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M-I61FZNBI1Z:N8_QBJ;4Y70+$ I03 P]H0>8V(D"&(0 /V@;V@4  N^X]0V
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M_P#H"TP(A^,+AMZZY/9OB?=4N_FYH_B#:MQ_TB\\=/F$/U+,)M_]T)X@[_\
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MTE_4J0W_ /4,X>_AMD ;]ZX#MKC]FF*=U1[]\TG\0+53[FO/'3YI-^I5AO\
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MZ>HR4*'KMZ[WH=M_I'Z=/9=6R]-+UR_Q \)^Y*WC)/LP'B'PP;<?UH'$</\
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MSGH]0HT T T T T T T T T T T T T T T T T T T T T T T T T T T
MT!\[@R/NE"K'(1+L-[T5#@F0$_0XF,)B[%VZ"/IJD>X=)68JL046G&U-E"1T
M059=5)G (,FS KARJ=9TJ5%EVH>]65,8YQ -S&W$>NF49,IZ/4*- - - >:C
M8>O-9Z;F&#"'1L$JG'$L$@S;M"2T@FR152B"2[E(/C')&:!E"MP7,()D,)2
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M?<836:Y3AG?[0MD_$E/.Q^_=RQ3D"-:1<\:EM)%1NUDYV(49E5(W$XB<G=L
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M]N]CY%LF[9.T#[ )T7#98IRB(!N4P#J%.ST T T T T T T T T T T T T
MT T T T T T T T T T T T T T T!U4Y-Q-:AY*?G7[2*A8=DXDI63?N$FC
M&.CVB8K/'SQTN=-!LT:H%$ZBAS%*0A1$1  T@1N!Y/&^5,>Y@H\%DK%UQK5^
MH-G9C(5ZX5.;CYZN3+,BJJ*CF.F(U=RP>()*HF*8R:A@*8! ?35@(GP8YS3B
MC+KBYM<89$I=^5QY9G=,O!*C9(NP'JEL8ID5>UV?+&.''V5,-4U %1!82J%
M=Q#KI 1*G]Q?E#\8:A2.X?+H!H"&X!ZB ?AT!3:/R_C65R+/XBC;S47V4:K
M1%JLF/VEACE[?!5NP.'C6#G)6 (H,DRBY9PP6(@N=,$E#I& !W#K8&8E2!'8
M!'Y-_;MZ?./30L2G$+F#&%BR+:L10E^ITME&BQ4/.77'\;8XQ];ZI#6 AE(*
M3L$ W7/)Q+*7('<V4<)ID6+U((Z0$3VTG,Q4*U,]F)..BF15$DC/))\V8-2J
MKJ%203.X=*))%.LJ<"D 1W,80 -Q'2!3L"*$/U(8IBB " E,!@'< -ZAN&W:
M(#Z^W4@2)/H4IODS+^,,-1<1.96OU0QY"3UABJE#RUSL436X^2L\ZO\ #0T
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M$P[B8<1XYW$1'KO4(<>OLUDV5CT T T T T T T T T T T T T T T T T
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MB\I/%NEUC'4/2.2_(PW)/$&5 RV6,5R&REY6)>6'#EPJ;&"-)U1I)LFQT59
M7 IB9,"B3L.!PJ(RB]C\>O/>=LW!S)N%/&)Q+XMU[AGR*QCE.PXUK&<J^ZR?
MF5Y6''N)Z12NK3'3",@JRW;M_>IHNUG;ERL<#E(8A!,,*;%F2^'.):.RR%R
MX[\4<(2/+UO!VFU4&<E&$16W\OE638.A:#-W4K-9=DE(R3HPNW0D$#%$=@$#
M;@LZH,(' 7C)Y;N,68LF<A<Y<!L#\@^4&>[DV6R1R4GN;%?B9"L4,KX[6.J&
M/Z*GB2?0K-<JL N) :M'8*2!T0]X<O< %$@9<\08 RW7?+-RLY)S]9!EBG)?
M%/CMCFK6$CYNL1[<*58KM*V6**V Y7($C&\P@ *"F0IP,&P>NA5&)E0U#0T
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M^EI07LV+V;=NP]NWIM[=M!83Z : : : : : : : : : : : : : : : : :
M: : : : : : : : : : : E-V;AW=N^_U=]M]_F]N@(_5^;V[>GX= 0^KVAM
MMV_5[?D]0[=OP^F@L'U>GY/LV]/P;?ATM)9F)?XOI^1Z=/3T[B_)[.[;0MA'
M^+[1V[>W?KMMMOW>W;V]W[NEI+#SMK^['W=F_O:,2%9^R);[?^V/<_9GV)\
MY^V?M#WW\2#'X#WGO^_<GN]^[5!JL<:F?[+R3EC0%\%2U+6SL?(*X8G8S"7+
MTN)D<A ^?BH;'BN1(XG'TSP[P5@; Q4%'H MQ O;JO(94(FV0G[K8GNO=]O;
M]3L[=NSZN_;M_!]/36;35A/]7?V;_@WT*2C[O<=^W?IO]&X[;_AWU;26$WU>
MOIZ!OZ>GLW^;4M*<1O<?PO=>G7?MVVW';?V;;^F^@.8?0=_3VZ =/[W[N@)
M]W[.WU#TV]=QV_=WTM)81'MWZ]N_3Y-_7ZOS^NA2 >[[0[>WLW';MV[=^N_I
MTU;00'W6P[]FVQM_3;;^%OMTU+00#W.P]ON]MQWVVVW[2[[;?SNWIJVBPG'L
J]O;Z^W;UZ>F_MU 1';V^F@)"^[[A[>WNZ[[;;_E&_#MW;ZMHL.34!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>tm2030088d18-ph_ingbio4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d18-ph_ingbio4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!; -B P$1  (1 0,1 ?_$ /X  0 !! ,! 0$
M       (!08'"0,$"@(!"P$!  $% 0$!              8! P0%!P(("1
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MPF#P$"\?+EL1[CM U^PJX'#B#Q-%D]WW2TUB5=5W)LVZ"!C%4656333+P;H
MH&'\(YC> %#D3#X!R.:V;(6MNPOE<&M'7UK:.QMRRFX:$55(C.Z&O3"\M/(S
M$02G0T80ZSY1Z1!P$NX,8S1HJT7(D=)%RT*99-41!-0H%$HB Y@G.V3HRZ)P
MTXUT5EUG*U^T@UZE:[+OHUM*3+B,CGJ:R+ 3>O? HGZ1$O4!$P%P<2I HJ(@
M)2\B(ASQ[,P_VA@)K4;5>-A(T>=Z1Z%6EN\W6A50*69:%   _6JZ!%(2]72'
M)U"%3(7J'VB/''RY<',5N?1H0K9L96CSA0KOF[N*2/EG&38(HN!#R%S/$!:'
MY\ +ZDHBB4XC[/>$/NB&7V9VT=H[0J@MB/2X*JE[H:F9/S0>MQ)X !RN$SIF
M'V#T'3$Q#AS\H"(9G-O8I&[HS4>!94..=*W<U [H*L;CI=H\C_[H'/W^ XR@
MOHJT64<%<TJ L.W;OVHE/F#Q;M\U*8B)%3=:Q2B '$0#V_*/&9\)$L7:-X56
MFO;9]I<=A)HZE51J[]HAK>>F&$0A*,_/>JBDF0%R"8P\"/ !XC\F>G^:PO(T
M 5NWC[:=L+3YSC19X#NCJHDZO6-RA\G4J0!_W0 <U?TE!6A.JWYP%WP 5N6+
MO"IE>B'TJ[?MB(LT15,)E0XZ0$ $?9[/'+T5VR61K&])5FXP\L$#Y7Z!HJL/
M-OM&M9N"]1)9D/W>IPF !_'X#FP>W::$+0LH\5!"R]6N\6EV&+))-GJ2B1E#
M$ Q% , B4>!Z1 /',2>XCA?M<0-*K:VF.FN8NT8UQ%:<%6OWK:GR >K1Y_XT
MO^Y]_+3;N)W2%D.P]P* -.[PKL5CNGJ=ALCR 1>(BLTCU7IB^843 1-9LESP
M/'ARN'CFR+ (1+T%:69IAE,3O2"O%[W 5IF(@9TEX<_X1,QRYH"\ DE40W<M
M5"\?SQ#QY]JA0]G\(9;,S&A71&]W!8RM'>_K6J6 \'+3+>..G!?%_,?J"W([
M!95JFW+'&4 1DCJ*+^4!$>LXJAT 7J$ '67>6BMY.S/'3RJXR![]1UJV'7?G
M1F]6G;(K(-4484T:"I1<)F $I-E#O&RBH^/2HNWF$S]//N<@'C[1QVYVW+PT
M$5)HJFV>VOB5]1W>%3I-!-9*00#K*0P<* /('*!@^YF7!E(9!6NBI';R2U#.
M(7%,=X](AD3+O)EHD4"^Z4ZH )S"(\%+X@/CQ_<S8V]PR?T!75)[:2!NZ0@*
M\M7]T-0V._\ 0QK]NJKT@;@BI3_* #[/9XCQF4Y@"Q X]*E8FH55,BA?$IR@
M8/X!RR=%<!JOO"JF$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A
M$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F
M$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB
M81,(F$3")A$PB@1W2R3IK(0I$55$P-*1I1Z!$.0,_1#@?$ X$,QY7[7@=9'O
MA;FQ@[6![JG1CB?8!\"\4_VJVW+=#=\&Y(]B_>%;-96,2332%?H*4:S$>'N>
M "'7SDJOHSZV: TV-]Y0J&5H@))&LCNGPE7O]D9MBWS7<^V;R3UVHW5H]W6
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M=U;NJ'=73I[*NL<8R)(ZAX^SIH%M$U+W!$VE565KB)40(J46T@T(L94T9))
M'JFQAZ4UC)<AU)F.0@B0?$ $!R88F\M[N.I-)QQ'6I3C[R[R%8JM:X-U\H\!
M]Q:Y>\K9%H+LMRDQDW7!&#43@4JW0<IS#X@("'2<H 'B(>P1SHF+A+\<'M'F
MEQ]Y<]YJ$D.9[.=U7A@]Y8?T#L&V*[GI!32;TR1'Y@6 Q5/+ !04-TF,8>.0
MY#CIY 1RY>VY%I-IP;XEBX US5OX9%ND-L"7\L2++N>D3#Y9P,)1\3>Z7\(>
M.,YN^'LW QN\XC@NYM<)'%LL?Y,.X^RL(]P%^GBZLNJC5TL"A895)(1,8>DY
MC%+S[0^[\F;G#6[S=0EQ-2_4*/\ ,DS/H^Z;&!M;%0'3[*K3*WVI;V"28R$C
M(%(3GI31.H * (<\" &YY\./[GR9/;ZV)/F@"BXK8O<QI+ZT*W%=L>Q)Z0U#
M%OSN7 "JY=F_&J' P 50>CJY'GPX\?DR!9]CF7^QI'HC1=CY.D8["!Y!]-W0
MLV$M\Z!RJ^M6'J-P)0.?IX,'R<B(<@/&:QDDH>UM*#K4A]3MW R$ESJU 7UV
MYWN;>=Q=Y8'>*G2:TAZH0OF'Y 1EH H")>>/ ##]S.DS1TQ<1ZQQ7&<J6'*R
M-;H \^\I;6RSRI#G#U*H>T X,?V@'L\/#([(2&^!8K#0K$:UMER&Z1=+>T3<
M=1N1+[!]@^'&8$SG%NBS87#=[*AMOZ]RS;?%=;'=<@GV\7"0:@J/48CU&=JQ
M2*-^KQ(N#953Q#WNGGY.<YES7<21W[VM) [-GNARV%FT.8#UN.OM*!U[WI(1
M.EMM0\@[GW,A+M-1.HUK$D!1PDQ3UGIQR_E7B[A0J,?"$D5TFRKH?,$B[I,A
M$U5# F.@@N9W31N!X./$]?!94D;*%WP=IX=/'@I8:E[DF1:<QD;A/,J@Z4LK
MBB>CEYI $G5HC5%&OP^*?. 9%DA?%3*HAPDF<Y5"@)"G'IR5XJ<R;6$_E7.T
M]O54L2R!DKI#2.@/"IU%::+%NT=U7&W6M"/AG+Q1N@V.+=)-13@4TC+"HLIT
MCQR8"\\_(&=8QD,<-J9'&A+NGQ!1F^GGO)FQQU<T [0MA'V6EZL5BMRBK]PL
M8"G! "BH82\%=E ##XB'48 ^Z.;*=@8:!84#R^M5ZR80QCQ;,QO:*).?_8AF
M"[BLX<%5<HJIA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F
M$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB
M81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"
M)A$PB81,(M;?>C)&AFR4H4GFGCEFSXB/7T J+5<JX)B8 $2@<4^!'@>,P;UV
MP"3[D@^UJI'A(C/NA'%S2*UZQ1>=??G>;VBGV5-#M3M[J4I>':A'4I++J++O
M''4B5-)9RX!ARJ8&Z90\?   /N9,[+.W=Q;":../:1I4Z^SYI]]0[*8''V-\
M;6[>_MFGSJ TUZE7^WWNI[5WLK*R>FM#5R*L\?%NF1YQBLL@K'(2:8HJ@7EH
M3K!80#J /;QF%E<]-%!2[C80[04\/_I'OK9X+EJWOKD_1<CZL\YU1_UZE'_N
M'E63*M$M3WRT7=8F6-M:J$$Q%".H]R=5,YBD.10S84SJ)&^XFH<0$#<&#AV<
M:7R$ U -?%7J71<\>S-O&]FQ[8==/2.XZ^XHY;HE&54HB-RC7CUP6+VI4-BL
M7*(I%<^M;L6UE<LXLZ)42N5Y)Q6W#5,XJ>;YKDGO")0#-3;QM<2*:%GN]!]M
M1B=^VA)Z5&+NVUO%;S@;=MG3JCB,L%!MAE=F0+#RA=1XV!J!$[O&-47"*,W7
MK.U9H.RJ <.DY%1Z#&ZCF6W9P7 ;.T.8X:'Q='C7EQ+HZQDBG0H;P$I>JBW:
MQ]56"ZM^D%F[B93>3$(QDU4E"R$PXKTX8!E!:M \M-<\='$2,4H>2L0ZIU+]
MVRS!,TH <.%!0D=6FGNGQKS$Z5WF@U"ZD(M=K*6[1LFD^F9!" F)IN@M5H5*
M,5D:X(3QXIO&MHHK8JCI@@Z010$RBGFF+T#U& ,=HYC6R>8UAZ =17PU\B]L
M8PNH0=.E5BH3*MBC(LR)8:#>PDA&N6;:)<R$._042>,@72=Q[X9N-9-5CD 1
M,@5L?WN? @ES374[H)2]P)83UU"V\-N)6=D/Z1;A.TIQ)UZP+D%R99O+2OP.
M=+^ F_ER%=HGL M/-.DU"1/#J+G(B4B15US% .D  ,C#90&^86'X0!\(.FJO
MLM+JRD9*TD.)XCJTT]U93W6I5$K$_7EXYLLNL#8I#G9)+N3^Z(%*43")E.2@
M/ >P/;GU!@0T88!KJ NZ!7W5 N;)WOSCG3 F0-H58^M6]6/<8A1G$H-G:3I-
M5OTLR)BD E,7J,ISXK"0/'[GLS*R,@CQMQJ'>;TA8.'K-EK>-GFN+QJ"IXF*
M3I,)A HE-X\\'Z@#Q$0+QX>/R9QH7.Z:E&DD<.%%]!26&V O<YXVGC4>=X5C
M_9+=F^J$PV=E3.V5;CYQ3ATIJ% Q1 3>(\AF_P"7 \9:*M#KP)48YJ[,8":E
M6G:*D#CJH"2=0I+H_25E$B8IN0)YH@)A$WCR!N>!X^]G6K@.W;J, ]A<-@?&
M64J5/C34,TAZ&V9M$DT&)553D22-U$)UCSR3JY'IY'.3<X'9EG/: T[0NV\@
ML[;!;'5='VCN&AX!9.!FGY/0F8H'\P#@;CQZ0\ #VASQSFECO29&!X_)U /!
M2;Z%C9#(Z)[O6'<-34#P>'K7QVZ,T6W<5='!"%!5>@2'GCXCUF+/0!2^(CP'
M!?D^_G4KTL=BK<1\"TGWEPK(LEBRLXF],/H?:HI<6E,%#''CY!^[SXA[?O\
M.1"9CMB-.NBQ,X:B!RF$/$0$G/W>>1^3Q\,P7^BK[#3BM?/==4(FU;T@FDH1
MPFM$]N=JFH:19.#LY*&F&-BJ7I)*-=)\BDN1-91,Y3@=%=!11%8BB*BA#<JY
MO<1DY*4U9'[SEN<=K"#]\??"@'=HVQ-.WK?+J*?$F7+;]W<T^>?0(YE)"MO:
M%KR3- 5Y1B:(C8,8Z<FBK-$O(%FFB"R0)D.L*Y-#%M-S&#H-Q]OHKX-/'X5E
MR^@1T;3]M?=R\AWI#:\F:"6AG2\E8F;5@_<HOW4,FQDH*6D7 JME5F",K-3X
M$<+G;F-T(-F;455P9D7/,\)!#]'3W-*R@BAZA6M!U:U.G6>B@&ND>\2QVX_H
MRT>SHM@M6ULRBHM]*RI4BS+^-5(I[WXQLV,B?@B8F .D_!A$WW\Z/!<=L6PM
MKV?:5/7717[.S]6@?<.V]N6:5XT/2%.+[-RHQ]:N*K9BX\Q$56AP./2/XQ10
MQS!U%'CY?9DJR+0R;:&D"@T43LHJ1DEVZI/11>IZ$#B+:!]Q(G_>AFH=Q6<.
M"JN454PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB
M81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"
M)A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,
M(F$4!.\+7$]<81T2*7:I"9 Q0%<1#I-R/C\O/&>OHV2^%&/:WQK/LLS;XQU9
MHR_Q=:\ZVPOLPVVPI^3MEF7A7,F<Q4UE//>D'RR%\I,@ B<I>"E'^//1Q64A
M'9Q7+&M'P>'OJ^<]RS=O+[RU+ICQ=NU7>UK]G),ZE=/5:<[@&J$LW(+]51RN
M;S@3-^)(0ZYA]\O6/@&862QMV^,>N7$5.@:_:7NPYRY:P+W.@AD;(\$&CAPZ
M/"OWN4[']A7#6$VP9M6=G=-8ATHM"QQ50=S3)9LJE(1C!,G!UWHH!UH 004,
MLGTD]XW QR_Y7N9\<^\A?&2P;@*FIIU5T65><]X?,6S"]KXY6/H'$B@:3T]*
MTLU9\66I$?JNS.?2'A0C(QF#Y9--Y$34 LR/59M- YR+"@[&.+YC@A>HR2BX
M?XT!XYK-*Z"4N-16M>C7J/41TA>]HE;1I\W[77XBKHT2+_6-AO);$HFG)P=8
MEXAFQ?'Z:U.491R1)A7;+%-S"#M&HO%TV\>]*50R+!P *"H5L4Q-1D\EVL0;
M'Z?3X^FG4#TCKU"WV%Q<<\WY<_DZ'AQTX'I%1U=55'/;&NJQ)I$VSJ9I'L6-
ME\Q-*=AT43BRD4DR.!J=U3B#"E*-#@?E!=1-0#D4 RI3\IJC;M[R5@]3O'.+
M*UHXDT\75["LWUL&RET;*4Z0* @<#[/2L=:UV_N*E22 2E%LL8JVEF*Z$4Y4
ME;#1)M,KD"(+$8)/%%&T>[*=3\;&+G9K$Y*(E IRDSKH6@ $<X?45IP/BZO;
MU6):VLUQJUE&JYW\5IF%M%@E6C6MTH4W,BNE$%L*\FR."B!)!M\*@"+R$PT9
MM)+J;@VX$_DIIF3Z1+T'T][=3RP"-CJGVE*,/B;M\F\12.'@:3I[RVE_9[&A
M]^[AGF56B9@86O5YI8KG,KMDV,0F*,@R3!&)2,GZ\7LW)/W!TRJE;B#=-4PD
M$? LG[O, [+YL-XP1-WR=5 0*>,DT]M>N;S=8;&Q2W!:R;?2,<75H3KP'FT'
M6:T6Z.D=JNJW$F^LEJ@QGEY.1=),!F.5?0LV_@DFB@8>D@#SQSQR.?45I;0V
M4'80U$0.BXS?W<V4N3>7>LYZ>"J>SNT34KQ@2?J\06MS,<LDZ]5&)^6=1-,X
M=20IE]TY3$Y#CCY<O3PLGB=$ZNUPH:+&@DDM+AMS#3>PU'4L,V/M\N*LVNI3
MFR2T&9JT.U.^=&*N*OD@*_653J$H"<,AEWRO(V[,EFQHA+1TZKH=ISMVM@UF
M1>]T[3I1HI[:LNU=KF[;!!NV#:)BE5ETQ*FDF^*'443![ ,4 YX^_F1B,'=V
M5^VXD#>R;KUZK!SW,MID\2ZU:7>L'V!3PJ-;K[.;N-17(LWIC54RGOG4),-C
M!T=1C   / E$W\/WLF;R\R5Z2N>-[-L>OOT4H*KVP[PAJXT8.:XBV60$2'1!
MXB<P%#@#!P3@/DX#(QS#BY;ZX,[6!PH/!T:J:<LYV/&6XMG.+6U)J-5D6J]N
M^P$IB+/<(=9I7165!^Z3=$$Z*7DJ&(8"D'S! %@+SFAM,#*9V^L1!L(/'WE)
M[_FR!EF18S/==5KJ*>.BI5#U+*:VW5*3+QR+IE:J1-K0YN@Q#E9M;%!$#S.>
M/>,!RB/L\<E^4$;,?%"VOF:>VN9RW+[F[=.XG<]Q/N:K+\Y^,$3<<_=\?N@
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M$D"HJ0.C7Q+S>W\;6]E.VC3'H0=10:'BMI_:AI*:TYM\E6<++R!DV<6\=+]
M%2(\6 1<(E,'@()F+P'/CP.3*^=-</,E#M  U4;LVPVT9CK5Q)/MKT7PQ1+&
MM $.!!(OA_\ F@&:EW%98-55,\JJ81,(F$3")A$PB81,(F$3")A$PB81,(F$
M3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB8
M1,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")
MA$PB81,(F$3")A$PB81,(F$3"**&YI 0D/AJYG!_/ 3$3*8>D$"IG%4P$
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MOB2IWP*)'*(@*9BJ\C]P1S!_\KM7"X<20=*<*=&JTF)DDN'&0[MO1Y5OCBP
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M3EX'@H@7J,8?[HCF/<S%SZOT>0MCC6-9;[1Z()605GZ3=1N*8"<053 I>LH
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ME? 2/>6@'[4>G2+K<T9+PE?L,A$NZG'%0<Q["3M/)V!E"N@6=0K>1(W.510
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M[:U=M?- .0!9L[8@N)0-_P %4G&?0=IWH31EO:M@DC:!IVC03[-%PZZY4@N
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MV/LF7=MBW79S5/.,K'3VI-[[&LJCE('#E=F$Y!K5SH=*@99 A/K+1 .D0 Q
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MM^VT>V-H=7TJ@T'4.E=?6^RW,S3;=8I.8I:RM,/9G,HNPFE&C$8FO"X='=.
M.63,Q73BT14<%,H<I!(80$ X#.*\V<@R0946V*$KHY6@M:]M75ZJ@"OWIH*Z
M*88[+Q2P;Y]NYAH2#4?R'P+7K)_;-Z;BIUY%)5&RRS)HZ.V"<C7J2L:\*0P
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MS;X"MDLUIAF<[ .&LDQDW*[\DT]:/IME-F2+YSTXJE8#Y9"@F(YE,F#75E<
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MZ91<[5+2WEW;8(TRK8/B#4@/7PH%2;/$054553 A3' 0+\R=]N2[I.:.9K+
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M/U$%CF$%%# (F'Z;/?QW87UQ'S#E>7Y7<TQM%'B.!]'-'FD3.>'Z'@XLW-'
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M[(D)C)).'A@.[602.<1(F8XD*8PB  (C@N+M7&J  <%?HB!0$1'@  1$1^0
M]HYY) %3P55AXDY9=E.%TZ;(GK%#;K+M5KNFU0<S=K51.*2Y:*B]3<1S."(?
MDH3+A%P#DQ#>D0,D)'8\Y;E,WSM,^/EN8V/*;'.8Z^#&NGNRTT=ZB'AT;( :
MCUR1D@E(/J\3HRRX6O$LUX2+<[+:OITJ7?S*Z ??$&OP12CEWOJ4UFZZ5)^K
M,KH\Z2E5D;X9:ZO5A*'')E+(I(II%\? B14TRAX%* >&9)[L>1[BC\O819.Y
MH 9+^MZ]U.DFY,@'B:&M'  #1>_HZS=K*P2.ZW^>?_=7W%^_47I+]3NK/V>U
M+YHROU5=U_[MX#]7VGZ%/HW'?-X/B-\B?49I+]3NK/V?5+YHQ]57=?\ NW@/
MU?:?H4^C<=\WA^(WR)]1>DOU.ZL_9[4OFC'U5=U_[MX#]7VGZ%/HW'?-X/B-
M\B?47I+]3NK/V?5+YHQ]57=?^[> _5]I^A3Z-QWS>'XC?(GU&:2_4[JS]GU2
M^:,?55W7_NW@/U?:?H4^C<=\A#\1OD3ZB])?J=U9^SVI?-&/JJ[K_P!V\!^K
M[3]"GT;COF\'Q&^1/J+TE^IW5G[/:E\T8^JKNO\ W;P'ZOM/T*?1N.^;P?$;
MY$^HO27ZG=6?L]J7S1CZJNZ_]V\!^K[3]"GT;COF\'Q&^1/J+TE^IW5G[/:E
M\T8^JKNO_=O ?J^T_0I]&X[YO!\1OD3ZB])?J=U9^SVI?-&/JJ[K_P!V\!^K
M[3]"GT;COF\'Q&^1/J+TE^IW5G[/:E\T8^JKNO\ W;P'ZOM/T*?1N.^;P?$;
MY$^HO27ZG=6?L]J7S1CZJNZ_]V\!^K[3]"GT;COF\'Q&^1/J+TE^IW5G[/JE
M\T8^JKNO_=O ?J^T_0I]&X[YO#\1OD3ZB])?J=U9^SZI?-&/JJ[K_P!V\!^K
M[3]"GT;COF\/Q&^1/J+TE^IW5G[/:E\T8^JKNO\ W;P'ZOM/T*?1N.^;P?$;
MY$^HO27ZG=6?L^J7S1CZJNZ_]V\!^K[3]"GT;COF\/Q&^1/J+TE^IW5G[/:E
M\T8^JKNO_=O ?J^T_0I]&X[YO!\1OD3ZB])?J=U9^SVI?-&/JJ[K_P!V\!^K
M[3]"GT;COF\'Q&^1/J+TE^IW5G[/JE\T8^JKNO\ W;P'ZOM/T*?1N.^;P_$;
MY$^HO27ZG=6?L^J7S1CZJNZ_]V\!^K[3]"GT;COF\/Q&^1/J+TE^IW5G[/:E
M\T8^JKNO_=O ?J^T_0I]&X[YO!\1OD3ZB])?J=U9^SZI?-&/JJ[K_P!V\!^K
M[3]"GT;COF\/Q&^1/J+TE^IW5G[/:E\T8^JKNO\ W;P'ZOM/T*?1N.^;P?$;
MY$^HO27ZG=6?L]J7S1CZJNZ_]V\!^K[3]"GT;COF\'Q&^1/J+TE^IW5G[/JE
M\T8^JKNO_=O ?J^T_0I]&X[YO#\1OD3ZB])?J=U9^SVI?-&/JJ[K_P!V\!^K
M[3]"GT;COF\'Q&^1/J+TE^IW5G[/JE\T8^JKNO\ W;P'ZOM/T*?1N.^;P_$;
MY$^HO27ZG=6?L^J7S1CZJNZ_]V\!^K[3]"GT;COF\/Q&^1/J+TE^IW5G[/JE
M\T8^JKNO_=O ?J^T_0I]&X[YO#\1OD3ZB])?J=U9^SVI?-&/JJ[K_P!V\!^K
M[3]"GT;COF\'Q&^1/J+TE^IW5G[/:E\T8^JKNO\ W;P'ZOM/T*?1N.^;P?$;
MY$^HO27ZG=6?L^J7S1CZJNZ_]V\!^K[3]"GT;COF\/Q&^1=^+U#J>#D&DO":
MPUY#RK!4%V,G%4JMQ\BR7* @"S1ZTC$7+=4 ,(=1# / YEV'=UW?8J\CR.+P
M6&MLA"[<R6*RMHY&.^Z8]D0<T^$$%>F6%C&\/CAB:\<"&-!'B("INZKR6@:U
MMT\VD&K&;;PKPD!YQVXJ&F7)/31QTVS@1!R"#I8JAR])OQ9#"(" 9T3$V7KU
M_% X'L2_SCT #4Z^YXU6\G]7MGR C>&Z>-:'NU?;O>3ONTN+%-=S+V?KLU>Y
MVKJZ[D-<5V#/"0L=,2S)9[!6"H6*L.US(IQZR29W2#D>2$,8H=)O,GD6*QUE
M%)=$#LXRX@%HZ#IJ:^\HU/=33D,I20M'PCK[E%/RRT6;L*<7L[8_;)7HHJY[
M)!6^N-)6)M.SX>.B+I+0U?O06&$=_!I9A8:4P;S2[!L*SYL=X1L8XJH*&-!)
MN7.7<\3%=BET9"X.W.8QQ<&C4M+:$4(JX$.%!04UMWT5PPB0 F':*@5#@>DD
M5(-?Y:K.4#/3L%#IL]:U&&GZG&TF+D(&.7L7P*T'F7JS-=.$F8V29F4BGCJ*
M<K.1,X I_/3Z3^\<>G98_$V&*QUOBV.ECAA9L!<"\[6BC7;B:O)</.<=:DG5
M66/E94PM:\4%/.H:]-=-/MK6EWX]O>S[E2'$'0-/N[?\3V!K.=2KCB3C5XYJ
MU9VV&L=A6>2\L=5L#:",@N<@F*)SF2(5,O(EX_.KO&[J.\C)_P 0^4YPL,?>
MNY?N;679=0@2;G>H]GMVL=O9N>-@W!@ZJU%=I+-!'C(K<R&&02@]-0*DTKX:
MTX^-9\UA4I.4V)7$GD8^3:L)#X@^46:+IHHHQY5'116.H0I" HND4@<CR)C
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ME^IW5G[/:E\T8^JKNO\ W;P'ZOM/T*?1N.^;P?$;Y%\FT7I+I-_]SNK/8/\
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MPE %"$.0QR\<&Y$P\"!N0RX]Y,=.-"O!-'4Z*JIR44W=.7H.2@$='(D*?RE
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M)A%3G;9193DA>0$H!SR4/$.1^4><OQO:UM#Q6+-$Y[J@:45*6C5A#I%-,YC
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M=)1-[2&_[7,:YJ5YH*U\*\;%'^G6LK_+J!#O%(*SI'BII,6ZQR(B1R1=C($
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M%!3H5F.T9VNYY!-?8"BY (2S(J)WS5RX)TD%1L8CKSE% $?-56,1%406./B
M<>'/WLU[K&X>:;3[2V[IH:4KT:>!9M)=',/!K-8%N_:KO@+ZY,R!B<)H&!42
MD6*0Q5#*&'C@I@'D!ZODRGT;-KH=0L42L=H\BE5+WMQ<V%O'VJYKO91@TA6"
MJ95$%G"14ET$$GKHJI X K-9(#$Y$.#&]T!YS(L[:XMWF2/<VC="#JL"[,9
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M6(3JW0K6G8:MN[3$RK'S-=?66J J8IVQ6;LRB" CP)XU\JB!0*! \$C\I^/
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MQKVYQV/M+VS>67$=V""/ZN2H/6"-".!"NS5^SXW847[WE,;"R(4LI%]?@/R
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M_;T !0#Y _A'+?[*6U= -57Z6FZ*KE/]G533J>8+%N*@#P"@D*8>G@?#@2
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MPLOSEOQ#^,GUKV_S)_YP?B)^]''_ *'//SRA\WX_867YRWXA_&3ZU[?YD_\
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MI"R9"\!_[N'B'O\ //,N9.6S9DWUBW_Q#Z31\#PC[W\'Q+NO)7.HR;6XK*N
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MT',XC@;K"!@.#994  3"!1I$2T.:31KVT/MAPKUBK1]K6BMSQEY:]K:R1NW
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MD.8X5!&H(/2"N2R120R.BF:6RM)!!%"".((.H(7!GI>$$0 !$1   !$1$>
M \1$1'P  #"$TU/!:I>X'N*[;8_>^O;G'Q9KI;:#/MFMNL4/#-Y!/X)!L;:G
M&Q<')/Y6-;KR41/V11P"B "B?G@5C= $R=8K"Y>7&2P2'LH9&DL!--7;:EP
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M9/$<8W'I!\Z*<O$24#).XF6:*LI!DJ9%PW5+P(&*/@<AOP5452\&(<HB4Y1
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MW4A6N6&6.BT21;I>O94)@/00A2E.4P@'CX0EPVN+>HE=#8[>P/ZP#[:Q/]H
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MA>*E?GASQ[/O\\X36BB;L_0;2<8_'*]ZETNHND=_&,5#QP2#([-PU2GDBMU
M!W;&15D@56]TCYB4Z:B"RP(F#3Y''-F/;0C\I7S@#Z0I2M.&X>Z*U!.VG3.2
M^=9L9_\ UN1>WU0,I"]S0XQD.#C&7$5[%^NG_P <FQS7,:9=W&;6=!H-/@)I
MU7W!K69L1RXD[ Y7?2#-RF0%G:R+!(Z40@]34.1)#R&B:@ )1#\:'(Y%K86T
M3&2%GY4"NNI!]X>TM5S!SCG+^ZN+2.Y QKGEH;$ UI9P](U>01QJ\@U/1HI+
M:FIKJMQ+N5F6Y4+#8U&[AVW'RCJQ46T34+$09UT2E*J=J#A9PMXJ 1V[6(10
MZ14S9GGBH:!0++&454PB81,(F$5.F/\ 1$I_JY]_DRN$/!0;7:MGS-9D];H/
M&;MLHU=M'2*;AJZ;+I"DNW<MUBG27072.)3D, E,41 0$!R\."QSQ6"_W4>U
MG_\ )H[?/V+ZV_\ Z:RFUO4E2I&0J::*Z:**9$DDFJZ:221"IIIID;'*1-,A
M  I"$*       !E2JMT4O*C_ +)UC^CT+_R:VRRKPX*X<*J81,(K D?[4J=_
M0#97]8M49$;W_GF-_P!HR7^(Q2Q7_P!LC_JI/PHU?^2Y9281,(K2N=,A;Q#+
M1$PCR'!E&;U("@[CW73P5RU4$!X'PX,4>2J%\# .;#&9*YQ=R+BV/\YIX.'4
M?M'B.A:?-X.QSUD;.];X6N'I,=]TT^^.!&A6MRT5]Q5I^3@'3EJ[6C')D#.&
M:Q%D5 #@Q3>X8XHJ](@!TS>^F?DIO$,[/8W;+^T9=L#FM>VM"*$>4=1&A&H7
MS)E<=)B<A+CI7,>^)U*M((/M5H>MIU::@ZA4#,M:],(NYVRH)A>KNX !!535
M]414-R(]1$.Z_OO.D7I'DH=!G)_8'(]7C[ XX[<S219:\V&E;A_X;E]:<L8V
MRR'+UEZXS?LLX*:N%*Q-KP(ZAQ60]?;\9W.];%J+Z,:PJ5 <6=.1<'?.#O8A
MM6["$"W7M+59@V3AC6QL R4443B#E@0QTQ5*45,DV1Q-S98ZUOHIC(^Y#*-#
M10ES-WF$$[MA\Q_4Z@-."@/)G-6'YLYSR_*;L9V!QDDS=W:RN>!#.(&]NTAH
MC-R/R]L*GM(0YS2X N5^L+M4-BUNCV^B6.*M-9D]E:T*RFH9TF\9+G:;.KC1
MXCYA/%-PT=(G353.!3IJ%$I@ 0XR,Y+UV!K[6[#F2"E6D 'B"/\ JNS97E*/
MEVYDM[RTDM<I#MJU^\.;NH0=KC2CF.J#0@@@@TH5$+7?]G]%_H=6?^166=7Q
M_P#8(/ZEGX(7QIF/\WN_[S+^&Y7CF6M<F$3")A%RHK+-EDG#=51!PW4(L@NB
M<R2R*R1@.FJDH02G343. "4P" @(<AE'-:]I8\ L(H0=00>((ZEZ8]\3Q)&2
MV1I!!!H01J""-00>!4P*E(,M\U5W7+4T53L< BFJULK9J/0!U0\M)<52%*W2
M7<"GPNV$2D7* G( "3E/G>0BEY4OVWM@X&RF.L9/5Q%.) KYKN+3H=#0]FP]
MQ!W@XE^,RS",E;M!;.UNE3H#4: FGG,K1X&YH!;5L3YV)6@9B1AG*S9PO&NE
M&JJS-8CALH9,>.I-5,1*/WP_"(;DI@ P" 3^TF%Y!'<1AP;(T$ BAUZP?LIK
MP7(<A:/QUY+92N8Z2)Y:2T@M-.HCWN(.AU!"H_(C]P1Y\./'V?>\./;GQAS#
MW_Y7F+F6XY1Y??<036_-+;:""SLS/<Y/%VQM[7,,O&W\445DVWNK@[KBW?)(
M;0"6WW$DCJ=AR/:V&/CRE\(Y&28TR/?+*&1V]S('R6IB,+G.F+XV"D;PT=J2
MU]!0*!2R#B4[H-M24@BN?T5+BXFKMG5ECUQ;(PZS+X])1]?253>13)P1T0.5
MDQ,L)S&*<2F H9?==WD\J6N!PF+Y0S&-Q?)-GS0_'10P\LY" 38R_=<?0V)%
M[=1N,=Q'<L?)--&YD0#-KHFAP>>$\Z<N9>][R\[?YRSN;K,/PC)6.DRMK(8[
MBU$'KUX+:)X=V+XG-#(Y&N>XN<X/=7:,BN6YVBPI+"0QN@A^2'*J7I4*!R^\
M03!R #P(?(.?4?)O.&(Y[P+.8L$VZ;CWSS14N();:4/@E="^L4S6/VES=T;Z
M;9(RU["6N!4"SF$O>7\@<;D#$;D,8^L<C)6;9&A[:/82VH!HYO%K@6D A0P[
MW48Q35,,N[!+XDA;V9(@3<>?PNR=A)$2^44SMTRB?Y.2EY^3.K\FF09*1K:]
MD8O.ZN(I]OW5Q+O?;;.Y?MY)*"Y;=>9UT+'%]/!HTGPAO@4[>P6P2=DT)IQS
M+**+.(V07KR"ZHB)UHZ"L[B/C?>'Q,5%DD1(!^XGFDYPB9#D+MK.!CW>RYE3
M[9U7?NX>_N,AR1B7W)J^*=T0/WD<Y:P>)K:,'\U;:M[:NC'\:_O$89K&RC!+
MSY8BJB;9K*MR])/,ZCB1,DH41 ">/*X\$\3B7./\JYV:*9F+GW/@>:,H"2T^
M_MZ_N>/"J^MN?^5+:XMI,]:ED5W&*R D-;(.%==-_"GW?HZNHM66R@K,[9JS
M7A6>#/NK! 0<JD@O,-6RE>DC.Y08I\9$R42LTGW#$C8Q5>H3^9P'B4.)AFYA
M':/=&2)0*'CP/'P+-[EL=E/7VW5W'&< 6331APA<77$(:P.9N!E#H@[=5E W
MI-'&L=+W:-IZQVH%C;4RW66*GS4B&5;PLDX4>5F</(65B[?-JX[.X;L8HS!:
M'2(*!&,25$'"[URB5-,RD)BB;+NVFH$=1J!6AJ=21T5(XU.G2OI(N  (!? Z
MG#H-3K[NO"G25(^4V+&;$HE!V5"L4RVR+L-3"/;N/+0,YC;JY2AGK4KIN#U(
M&,BR<>:84C+)D.B"B8G(!#FR,*^2#(1]EJQ_#R*,<SXVUR'*V1L;UQ9CGV<D
MI('HN@!D8ZA+07-+=-:.K3IJLP0JLNO'I*3K-HPDA4<@LV8N3.VQ$RN5BM3)
MN#D3,H*K4"&-R4O!A$. ]F=';N(\\4<OB3(QX^.[<S&222V0#:.>T,<3M&ZK
M02!1U0-3H!J5L'LVLHR^:]K+@!183\;5HD\?)GX(0R9(MNH9E('\ ,R.(<@8
M>11-R8O@)RFY78YR?$Y>=FK[1\[]S?#N/G-^^_"X'H([GE.5K7F'ERUE\V/(
MQ6D>QYT%.S!VO^]/7Q:=1H2#!!9,R"JJ)A3,9%0Z9C)*$62,9,PE$R:J1C)J
MIB(>Z8HB!@\0'C.JM<'-#A6A'3H?9!X+@#VF-Y8:$M)&AJ-.HC0CJ(XKS'=Q
MEC>6O>^V9AZJ990U[L$8W$WM)'04@K!1* ?<*WC8Y(@?>+G;</"V#%V\;>'9
M-)\;AN/NDE?FSS_D)LISME;V<ESC?2M%>AD;S'&/_2QC0/$I_P +I29INM:A
M!5^2?M2?$Z[9[V2+8,Y"Q.92-YF2*P0RBHQ@D:3:+<GIEFRH'23ZN1$#%/QF
MUQF$BYRS/-,C>TO<JV!I$I!B;ZJPQ14 ;N;YA+J[O-DJYM":CZ3N[CF?ZMN7
M.2+:4PX[#23RO,#/_)<;MXGFH7N[-^V5K6!IC\Z, .W;=KKXI-KM25EGHQW$
M3):W'O:U"^;:YMD^LP3TPBZD'3I,D:DYC_3'CWK%15H#A/TA0$2$ 3&('OF'
M*<NXBUMI;^ZACNKFY;;QB-KMKI92&Q14](/<=Q#BVA;5SB&M+E<Y-QO..=RE
M]:X^QNIL99VIN)73R,[6..-KI)YZC\F6-:8]T8>"UU&QM+W[%G_GGY/[G_6^
M[XYC*04(6H_NHI".L]KL;!5P^$M["DC:6!&0>06+GF3T0>F9>7P"(>K23<E
MO $.L(% "@ !U?EB^=D<88;CSGQG8:]+2-*^Q4>&B^8N\?#,Y>YE;>8[\E%.
M!,S;ILD:[SMO5YP#Q2E"Z@  "]!U<E/C=>@IK@ &7AHR3$"_@@+]D@Z$ ^\
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MB^61]7'5SCQ<1P 'O =)7"+V^YC[T>8(,?80DN]&.)E=K&DC<]SCX@7O=04
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MN;.:X)(/V=P $>(B&USF_P#R4^"T\=E>)K60ZFHXQZR7KG*816)V]J70CO;
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M86+B5'T7&.7C5%RR]+(.WH.%T2E$!<%,(#P42B("%:KS0>RON@0[2'B'-A=
M1)5ZDHHHX5Y$R,<U,<WO'-U'Z#&3,?@/#IZ> STO'$T62&PJF;I'<$ BQTRF
M5*' ^6<Y>HR?/R^6(]//R\8*ITZ+%VVE%F$+&3S8Q07KT[&2Y!. B44HQTC+
MK)CP \>:2,Z ^^(93H7H>%2,(8IR$.0Q3D.4IB'((&*<I@ 2F*8!$#%, \@(
M> AGE7%]81,(F$3")A%T)4 -%R11]@L'@#_ +=0!STP O /"H7B4EL;G#B&G
MWEY^:+MW9;V(?BZN4LX,UM%NC4#K@S54(RB[))L&2 J*-3** W:-R$ QA$P@
M'(B(\CG4+3 8B=KWRQ5(FE&CG#1LC@!0. T  7!\AS;S%;2QQP7%&&V@<:LC
M/G/B8YQJ6DZDD\5>0;1V#^E4A_[TQ_W.&>9G[,X4G^AT_GO_ !EK_P!M^9J?
MVG7^KB_$5JWC<FT(>ISDE&7.59OFS0!0<I)QX*)BJNDB<2B+(0 3)J"']W,.
M_P"7L1!9R2Q0TD:-/.>??<MCB><.8KK(Q6\UQ6)SM1LC'0>D,!6]36*JJ^MM
M>KKJ'567I%46654,)SJ*JP+ YSG,;D3'.8PB(CXB.<XOV,BOIHXQ1C9G@#J
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MHY8NE6;UB"#E!V=@[2<J3[E6+"74KY,E(&.;&?2)#=KJM>06AQWM!&T$<22
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MB!S!^" ]>Y<Y<.0<+R]!%B#H-07G\4=)Z> Z5 >=>=&XAAQF,<#E'#SG:$1
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M$PBL#:_]ENROZ 7'^KLCD1[P/^!YO_:+S_#R+%O?['-_5._!*NJ"_P!"0_\
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MO_9;LK^@%Q_J[(Y$>\#_ ('F_P#:+S_#R+%O?['-_5._!*NJ"_T)#?ZJC_\
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M=F)^#=D;R\4J":S5XNDJGTF WCP$0SV%EP-\+.26*=CX(IF21[]CXYHVR1N
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M0C9$SQ))P4R:)]#@N[,9S V>6BO'1W%U<,8YKH0&1L?<FW#M[I6&0U ($;'
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M^>>1^H\W=M;1@:T=ON;_ -LX3^C"'_*LKF1R1_EDO]>?P&*SWI?YY!_=!_\
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MPBJC';VIY,;@$;LW7T@.O#*DOX,KE770T8Z)53K$N (2*GT9,D1 XF![Y E
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MCUBE'@DU*#))D\6.JD5/I!-4PF+P81'/3[^^D+C)-*XO)+JO<=Q<*$NUUJ
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M**85Z0>N5W!I*R(&6!3R02.5? L*O.^S;K36KNUQ.W]6VR5D=/U;8VQEF-,
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MLG87LN4DZ[4&U:%VRWK8MXL[1KURT:RR_K:;%2NG&+QH"ZAWBGJ%4G2SA,"
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MPN&T9[6;VH.*VO%J3X1KV3E@2>S3:#?%:DD&D.\BXXKN/DVXF<(JL'4@!$@
M5?+ 0')YRKWNCF/GN[Y(N<<^REMS<=F^6:CYFP2!@D9"^*,/CE;61CH);@!H
M!DV U69;93M[U]F]A86[J$G4T/&A J#Q!:7>&BQ*;N,OD:_G'-FA6S-A7-G;
M*KR,?!R$>L$Q&4G7=AMAH:3</H=PX1.@K%HB5XV%$RQU@ 2 1,Q5.>N[Y^;+
M*[NI\W:LCL[+.Y*W;'!)&>VBLL=<79AE<^%SFEIB92:,L+W/U:&L<U^%]*W+
M7.,S0&LFD;0$:AD;G4-1X!J*5\0UK).Z^:;+@:;U*YC(MLOK928D4KK&2"D;
M$;5*;Z*R"3%*(24?.#*-U@<-P,3R03 >LW4 !LV_Q 9*&4')\O206#'XTS2"
M]BD,4.5_LD@8V$&1Q+7]I&"W8&@[B74'L9N4'\I 6L'9U.\&@D]$TIKTU'1U
MKN4/NL<['=NFE6U=-O#K,1EZZ=Q,HQC:6BT)Y&'?F?2,Q$QT/%R#5JN#LJ"3
MIZ59,!3!0%0Z,R.4^_Z?G6>2WP.!NI'NA[:W+IA$V6)L[89"^2:*.&*1K7=L
M&,EF#VU8'B0%J]6V:==N+887&HJW6E1NH:D@ 'II4]5:KI=R^W]E:UFB'J[A
M:,@XJC+6Q-9*E+VQG9+"UGR-G-9L,@D;BJPA8(AEO5@9N<3G$"JB)0(.+WW]
MXO.W).3#L$]T&*M\4;L$63KMES<,N UUM<2 _P#BP=@"_M:QDN)VR$M#3YR]
M_>6DE821&V/=Z&X.=7T7'X(VZUT\?0KMV%O&1=ZUV/-:E!J-KUY&.'=G);H2
MS136$;HQ\TH[7A3OX5O'V>3:/(DQ42IJ'9FXZU#B02%4D7.'>G>7').:R7=[
MV?[08>!S[H7<%S$V!K8YR]T)DA;'<RL?$0P-<83Z3W;2UK[]UDGNM)I+&G;1
M-)=N#@!H:TJVCB"-*:=9Z\>W;N><PE[U326DU"QA3O* ML]_*))$=N4;C$B_
M2CH5JHD*:;5!MTN'KI, \DSELDF8!%4H0_FCOSGQ?-F Y8MKJU@:9<>[)R2@
M;W-O(NT$<+"*!C6TDGE:/,,D#&$$R 8MQF'1W,%NUS1JSM">/GBM!X.DGHJ
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M3H#NXTJ1H>I2E111;(HMVZ::#=!)-%!%(A4TD44B@FDDDF0 (1-,@ !0 .
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M)[+=CRZS(/91.+@74%:T>X'S2XTC9$3NW.6AP^(OH9<C;77:-=,YH;<@CM)
M&D"NE/-:0=P \]\@&W:U8[U!6MNV??%CU=;^Y';1%.W&1K$B2.)$'AH[:M>G
MT6\P@M*2QYAZO,,&1DRMED7:DLY!!RF<[XRBJC9ILLY=X2UY=BRUCB[*F4;(
MW=NW.MWL):0UH: TGTFN:(FU:0(Z /DPL5;Y2?,/Q]W?7-;!S#3:6B9K@'5+
MBXD@>B0XR&C@>TJ2QFT7.2+H*C)=.Z[5VO\ ;SG4MJ?&C5X_7TI>9.P@JF\:
M,W4=&S-E+420L>#NR/K$[I-6EIDA$&JA1:L>@!%9=!-0E59RG>[J\J$UY,'?
MU)**V;7];%AEM?WYB_(>PVND4YI8K.5]4VY==1*LS=.AL%A^&GD!8K@U\WI$
M0(LE7#NBTI0[N^US9[/+,[FQ;L7 P;.A[#FUY 9-Y58]@S@5X*IR3*R2KE[=
MHM,K*/5=.P,Z#E,.A3H(L63'?5J)B\D6T?'W230BG$$DN\4I=RC"OR3E==V4
MR4"S>5L)&4FX1FP62D(H449)L[1.V%$7)?)$BOHW>'V\H@Y.]O;B+0C#O$+$
M[FJ5L&$84QXR>66.-&[ ?R]49,M>RSQ_47Z+-I-J,'+]1(@-DU170\TB_*EW
M:ZDM<O:(7U=C@'U?L[:ML&-FI-ZKTS8O41FDUQD6%<FZO'6!LBE-[\K\>*:[
M8BIC.TW %%JH57":*3F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3
M")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81
M,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A
M%\'YZ#<>WCP_A_C#"+17-2<\A+2-@N"T3$W:JNK6_NL\]L=@B-D-+@P"SSD(
MRK]>BK$K)GKK5-\!SIQTJ<5(U9P@FLBG^(;;Z-F/]2=NV=K1Q+B]PD:026-C
MBVD2-(V\7M!!<"TD$*,74N39DJ,=(!O 8T-!C<W2I<[<"TC7X#CPU 6S+8T=
M>;UVK^2_C7+ZZR5*J,M9(5(S5B\E7+(\++V6.2],QGTFCA^BV7#R6J2ZW)O)
M;G*J*:I=**"6GP:\ ::=(KX>%5(Y0]T3@PTD+30]14'](-)Z1VO2G,4^1(O4
M[2]LLRLVI+^NMZ3K^48S[.7JUQGG4C6$WBJZ;5-,K?TTDC'.V[?J)TG163W6
M3N+.=C1:ZD'Y/L]K2TC8=:.(=MX#@VI%2%'\/:WT,[C.TLCVT=5VX.=44<--
M.GKXTZ%.R<T/HG84G(7@XJ2+5=XM,69M6K*Z/7+$^(6"=K+S\=$N%DI!46L
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M$PB81:%OMJ]G7BF/.WZ!JUALD)&RK38DC,)5V;DX07;ELZI:$:=ZI'*$*Y!
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MV_V]6YB:!K=WVJ9.N,:BQB$&@7!B^).13EVE#R#QQZM@JX8$4*J1+@S@JXE
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MT&G30D&G32BU.R=UEIEVJ_EI!U(O5A$RCEXY575-R(FXZU!,)2 (^!0X*4/
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M21O !+'M/ T((():0?-<5\\<V<GYSDK*?1.=C#+@MW-<T[F/;4C<UVG2"""
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MH#6"FG @>%69Z=7Q\!\?OCQ_%G15S*A6X+1("74-!*/M"!2 ?_?U\^9>;_\
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MJ'@ YRYR,UK,'M: &B9V@\35C_Q*X^PQO>,VUQL$-O;#'0G9$QL;02^6IVL
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M^.3< !2@4A0*0I2A]-\I\J87DK!Q<OX"+LL?%4ZG<Y[G&KGO=Q<]QXG@!1H
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MUMVPUQ&.H%8FJQOJ]N]OU37;>15EY>SRAF\C 2UHN#I\NNY08 X<L&W0W:I
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MT*N3'[L/U3[7\KZ$_5I]#(WZQ_@7PWX5]'_H#%?1KU77_FOUOT$^&^@Z_?\
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<81,(F$3")A$PB81,(F$3")A$PB81,(F$3"+_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>tm2030088d18-bc_inb4004c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d18-bc_inb4004c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@"! .2 P$1  (1 0,1 ?_$ 08  0 " @(# 0$
M       '" 8) 04" P0*"P$!  $% 0$!              $" P4&!P0("1
M  8" 0($ @4%" @/" D5 0(#! 4&  <1$@@A,1,400E182(5%G&!D3(C\*&Q
MT4(D%QG!4C-3DU>7&.'Q8I+2-"4FUB=G=[?7.(*B0S9V-\>X<K)S1%25M=66
MMD=X.<+B8V0U5H=8F IT986&*&@I$0 " 0,"! (%!0L%"@L( @,  0(1 P0A
M!3%!$@9187&!(A,'D:&Q,A3PP=%"4B/35)05%^%B<C,(@I*R<R0T=+06-O&B
MTD-38[/4-74WPH-$9*0E5963)N*C9O_:  P# 0 "$0,1 #\ _?Q@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M0\O'PR:,&<PO>?V^2:J3>4N#RC+K'(DE_236;-0&*BI_ $DIRSQ,=7EE1'D
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MH)JGIS+8@(#XAXA]6 , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P#@1 /,>/A^?Z,
MQFWVV'I5??V2:55*PCR$$R;5NJ]>NW"ZI&S)A'LFY3KO)"0>+$112( B=0X!
MX!R(0VDJO@"ILKW;R#-V4B=*@V+4XE,1.>N@-)4B1R)F*1XV9PCV/1>D$3@<
MC=T[0#I 2+G WA;=V*(JB5=6=PU;V1*'K:[5*#LI8\\F@U1E&LQ#RK1!=LV>
MFAY=(C1RHO'JO4 51=M&:P^L!D2K)E.<M49J7U>)*U+!=9/[8OT^8!]?\&5@
M=1? .0\?+ /+ & , 8 P!@# & , 8 P!@# & , 8 P!@&K[O#M\I<-S4'3]7
MB%++*5Q$DPQA4%!0%?8MX93$5!NW$B)%T(>*I^MV$^ZF'2I# VCY9,Z::S@R
M"*DKQ#?RE;Y2#L]/L4U1[PUCF=MKWM7#DT0JNI"3L#+ JI VRN&?"61/!R8-
MUVBGKD(=O*L'C?[942+*J?**U/1D 8 P!@# & ?$\;+JBR>1[U6)G8219SU8
MG4"B=U7K)%F.I%3+5,#I^M[=0XD<-S&!)ZS46:K 9!=4AI7@#;EV^[@0W+0&
MLZNU1BK3#/7-8O4"D<ZB<-;8M%NJ^(S44'U5X:5:ND)".6. '6CG:)S 4XF*
M$<Z G/ & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@
M# & , 8 P!@# ,>LMNJU,AGEBMUC@ZO QY0,^FK!*L8>*: 80*3W$A(+MVJ(
MG,8 *!C )A$ #D1P# Z3OW2FQY,82C;3HUHF_25<$AHFQ1SB67:H 45GC:-]
M<KQVS2 X"99,ATP P?:\0P%J2X @/D(#^3 .< 8 P!@# & <"(!YCQ@$.6_<
MT!7[,WU]!(+7/93QNF])3(']JO#1:YQ(C8;K)\&CZ97#"4W0X>&!9YT&(S1=
M+!Z6!])(D ,P9L52=<LUI)0@&72C$5$8UL;QY09BX,H\7(3GQ45, J"'4!$P
M'H 2U34R#! P!@# & , 8 P!@# & 8Y;+*SJ,$]GGR:JR+/VZ9&R H@X=NWS
MMO'Q[)N+E9NW*L]?NTDB"HH0@&. F, <CE48N<E%<61*481<I<$4D=]T6^G4
MI*Q]4T)7'JP35?CX<ETV!-TF/]I+>RCWAWLVQH5R.N^;3;@2D3*Q;E.D)1*)
MP RF>F>-T1<G)4Y>9XX9G7)147J>%D[D.ZJH!;8^R]NVL$)N-H[B>KB=/W19
MKU[VQ2"%E0JD7*,'VH:&DVCI*8KITEG'ODP2*/VA)R4V6[5GWD>KJ2?TER]D
MQLS46F]*^H[%;N&[I)4+?*TSM[U$_JM69FDPD+7OZV56<=QI63IY[E>OH:$G
M08&4!DJ!""Y4$2@!O(P<Q=M>[DHUJRJQ?5Z#G1JAZHONPVDRL#]&^Z4:P%9B
M:;79V:EX6U.)AK%2I)"[GV"FWE9*"@BS,76*[#13M!06C(CLSTY$E53@9-&Y
M]F]GJZEPJ65FP;2<6JOU%Z(Y^UE6#.38.$G3&0;(/63I P'1<M'21%F[A$X"
M)3I+(G Q1 >! <\I[3[< 8 P!@# & , 8 P!@# & , 8 P"'MSWB3I]>B&-;
M!J:XW:R,:?5#/45'+%B\<,I*;G)Y^V36;B[:U>GP4E)@V%5$'RS1-J"J9URG
M+$G15)X:^!7)QJNESH(JW>.5VF_(?W1I#:B_X^ SXQ$RFD&->G$UZ96%3 ER
M",+%QC),QCBD@GUFY\KDV6^IG<,-:T&- OW7KJC1P /V?NRC5EB'@/)?]I1"
M/B7].4D>T>F3U=KJ6 336M*#+ 8P&$9BA5:1^V0W)3\OX9?DQ#>0CSP.*M<-
M!5F$2';YJ9<0<5VM+ZSED0.+6=TM.3NF)9LN9-5,'"QM9R57CYI0J:X@!)-N
M^0$. ,F8   K4Y(GJ?,Z8*=W+T\J9];]S$S.M6J8$;UO=5=A+5[[H.58GWE>
MXR+)/%4%0#$$R3$H^B<2^)BIG)4KKX<B>H^[_.([QZ2=9:XZ%H>R8E(%#"[U
M+89)H\!--,JI3!%33R<LC]42E,02HQ8"900X* > UJXN!-4S,:C\P?2,S)FK
M]T;W#5%E24%)S"WJLOFZR ^J=,%%QC D',>@8"=0*/4&I>D>>? >+G4J5!<2
MK7>GW>-3EZ?:*_:(Q4J9R/H"68RS;A1,BI"G58KKE24$BA1$ANDP<^(8JB3*
M.HH^1@'CS\0\,D#D/I#]. .0^D/TX Y#Z0\?+QP#CJ+_ &P>?'G\?HP#RP!@
M# & , 8 P!@# /6J82$,8./ !$1$!$ #CS\/' ->W;%2'TY<=S]RML>-I2=V
MOL"WQ5 .R4.M%Q&GZW,-:S7U8I59!%912[MJ:Q>N5OU'#9JR]/@I.H]27R%+
M?/FR9MP:1JVX64:I)+NX&V5XS@]6NL.FV&7ARO!1,_BG:+E,[:<JTP9LG[Z-
M< *2PD(JF9!TD@Y1J:\.)"?B:W+Q7K9JF4)#[-B481-RZ]I!W5AZRFO+48QP
M*V*PF%SK&K,VZ 0_W'EE$G0'Y*V6?$+ZYJ:%=:\3X1Y+P!O 1#D.0XY#Z0Y^
M Y31@8 P!@# & 3YVH68M3WJC$JOBMHO:];?0*C$W(%>WBEM75FK3E H&!,K
MA:DHSZ;D_2)E$F#0G( F #+!M<R , 8 P!@# & , 8 P!@# & , 8 P!@# &
M , 8 P!@# & , 8 P!@# & , 8!X"H0!X$P<^7G\0^'Y?# 'J$XYZB\?EP"&
M[QW!Z;H!I-E/;&J 6.,*!1I#"P1,E?I%^N*:4?"0E*:/3V*7GYAVNDW9LT&Y
MUW+A9-,A1,< $# C;KW4]143BNURX-'S\I/N->U[+TW$03$3B8@GOSBOW:WV
M2O%()>L2PT59503$ $@*<D+-/ BI\E9U&L^E2WK<\C%;.V,98KB,,I$BE0]:
MH$*H5&&U;5I1:1^YE$BJF]W.N#JSTLH<?5719D:1[.I1*7([';NKX'8=:=$=
M$&.F8I)>2@+(P20"<J\NV04,SM%:=*I*&B[5 G_G#)VEPIZJ8)'ZT3G)AKP"
MU?F9?V\["D]D:OB):R>T3O$&]EZ3L-JR(*35O>Z9(KU^R+,T#"8Z$9+NV7W@
MQ PB)F#M W(@8!&@KJ3?@# & , 8!ULM,P\!&2$U.RL="P\2T<2$K+2SUM'1
MD8P:)&6=/9!^\51:LVC9$ACJ**'*0A0$1$ # *JRMWV)O-PO&ZP?2&M-2)KJ
MM9#;CB+%"^7I,@B19+3D#/L%64/65RB $MTFW7(\(!C1+%=!1O+%E+P(J2A2
M:)4]?QQHFI0S>+0<N"/91X)W#Z<L,KZ"2"]@M=BD57<[:[*^(B47,C).'3UR
M8.55##E36A37DB58\P")?R#^?P^'U>&4<_(N\8G;X*1@# & , 8 P!@# & ,
M J5WPU%U;NV#;OL;-9JG(T^J/MGQ$M59C[AD2S^JR#L.MI+2B;-T];, L-;:
MJK>U,V<F*ETD73Y$1U3O;)S<+M'=<W;KD[.;:V[(G;G%TE&4;,VFGK1KBJ+B
MD978[./D[SB8^5!7,>>3:4HO@TYQ5'3D^?D:4J/=;\'=[I:$_I+VLZ@IK>KA
ME)UR6VML>;KCZ/:395VK%S7INTR$*HU:G !33%'I()2B4 $I>/ASX0?$?OO=
M?B]C;-N.[9N1M$LNY%VYW.N+71=:3XU5.EU^74^A>_.UNV\/LJYF8>!C6<R-
MI-2C!1DG[Q:UX^KP(^__ '@'9VV=9;*UL.LMQ;AUD6P:#E7DDVUAM.\ZV1=/
M*WOS5T:PE72E$G:Z]?/46%Z?-2G<JKD20<&*F"?JJ^I]G=\;IG[?;M/"O3MU
M4M%35]5M:U\%]+,7\".V=A[AR<G]\XEG)<;D(ISCU43M7G1:JB<DGZM>9,WR
M"=E;3W!V:]TLSMK8NP]L33'=5LJD3-[+N5HV'.IU]KJ2DOF\ A-V^3F9A>,;
MR,PZ.1 RQR$4<'Z0#J'/5VGN6X9_;MS+R;D[F5&5SI;I71:</ U[XT;#L>Q=
MYV\'9<>UC8D\:W.4(1:CU.<T]'*7%4YI>1729N^S'[W5#$^T]O/D[A(Z2@9Z
M*=[@V:YA+&PME4J[:?C96%=VX\(Y:6 SU4KLAT 36]4_7^L;GX#[<^*?Q N?
M$3#VZ]O.=/;IY&/U0=UR@XR]WU)Z*7'J33E7EHJ'3-[[/[3M]K9&5:V[%C>]
MW=<9*W%37LR:?%+2E53@?J=H=0B=?TBH4. ]Z,%2JQ 5*%&2>KR4B,37(II#
M1POY%R)G#][[-D3U5U!$ZI^3&\1'/TRXZGR=IP7 RO & , 8 P!@# & , 8
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MCY_GXX\0'()// & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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MV9.%N%6G370P2<BM@Q,U)1_]-6S'*C!XJ@5T:>F4S*%+XE5,G]_*"4RA3<\
M?PY\Q\\O?N*Q'C)M^@A;I=DE*BU,NBY#?-?IZELB=ZSC]1*72BFT%9HD9EBN
MB*S,RAE9&;E+2#<Z9#*&ZB,3&$" 'D8>*); G%RMW.+YHE;M22C.&E-=3MJG
MWI6]DLJRO=1@9X&3^0BW;RONU()^DZBGSF+?&Z.)B'D$RNV9_3]-)B)R<"8"
M"(E+KMVT[5QVY<GR,S!PN14XK1HMIKG?6MMGN$HV#E5HVQ*@<4ZO9&Y8N:<
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M >(E9MEU%C<>($2$?ADK@'P-\A.>D.?W?N'(!YX P!@# & , 8 P!@# & ,
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M*KP/GF$AHZO@96/#UGZ'V"HKL6:PB BLT;JB(>0BHB0XB'U"(YZBH^O & ,
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M1T!5D+GW :U8K*#Z5*)9=J/&_'4D[3K\4:FQ+1Q]D>@P6*_-7Z/B43'BQXY
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M#(!S@# & , 8 P!@# & , 8!K-W'>=>V'N[TBK)V)#[CI]<WY69Z2C%G3MM
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ME3TUY<_%V=ENUN$L6Y*EN[#U=:?%>E-JG*AC7= E_,&!@'D5:S<4N0\AZ6K
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M2J&>-8!XB)PZ_0MLV\D)E,Q>"JLGC7SZ XE@O;D 8 P!@# & , 8 P!@# &
M, 8 P!@# & , 8 P!@# & , 8 P!@# & =18)R)K,',6.>D6D/!P$8^FIJ6D
M%R-6$7$Q;91])2+URJ()MV;)F@=54YAZ2$*(CX!@%7-.LIBV/Y_?5QB#Q-BV
M<UC$*9"2+0[6>HNF(XAW=+JDTDJ *L[+//)!W8)M 0!1J^DRQZAEBQJ*@UI?
M(42^<I-8 ;:L[Q-E5JQ"M'06^6M3L5,G2"=)1K:4E06BRH/!(8C1X:X-Y5-
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M "MILQO^YS%;I2W"WE/3W5^#KY2K!^KVM?0>BSJY0T]J#7K6OWC."F\.H1Y
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M?0AI%>Q*0=N-LX'(: E=KAZ4Z6\DJA&PV!BFWZ#09S>T$Y>OU!!4 KK0W/X
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M#C*U4H=.1W&20, 8!C;ISZELB& &#^;14G*')X@)CK'3CD!, #P'IIJ*^?\
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M^ROU:_\ MF7^G']6!V2_XII[_+7OW_K0Q_%+OO\ 7;?[)A?]W'\,^ROU:_\
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M_P"CZ\YO_P -/]XW_B9_X4#6.[?_  G_ -]#[Y1Q5PLU35<-TU5G!4C$;H(
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M9^H$7&OR-.&KJ05B'C@OBT!9%4X*VVU6I6DTC%Y[;->UQ5MO[3;G/)Q+M_\
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M*-3=(!RB+4[9#D?/E9-4 -QR AR&;7_![LQO6.3_ /RO\",-_MKOZ7UK/_\
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M-OCJZU(^L:,<G-5N/563;(R=CK3UK8X"*<.51!-NUE)B*1;JJ&\")J"8>>,
MP>C;7IFQ(%M8X%\Y307%1%]'R#%VUEH&6;*BWE:]/L_34&)L,(]*=N\9JF*N
M@LF8IBAX"-RI;:\#&+EW":JI+PD3*V^ 2G5@$6D&O+,V\T[, B %8UXRA[1+
M&,)1Z2LF+D3B' >..H4(_0VDGL-F]>0TFN_8LI%6(?Q"#*2KSJ+E$6K&0/&S
MD)96D+/1SXL?)M7)2/D$U%6SE%9(ADE4S&H=23OJ;3U+1)*+6$&ZL!&@"AH9
MH54S%\Z-P+5O*NE2(*R3;P%11L":*!@*!% 4 P8CQ)J6,.H1,I1.(% 3HHD
M   ZE5"(I$* < ')C@''T9<X%)YX(& 0OMN,&0!% "B(2T++PH#Y?:63,B4!
M$ $> "2'\F4O1E7(D?MW=&?:!T@].'2=WJ+6SDQ1#CI,O3(54P<<CQP)LH*R
M8L 8 P!@# & <&\AR&@:^OE<$*GV4ZZ(F4I"$OW<>0A" !2$(7N:W$!"$*
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M]B&8+J25&9:)N8[>_P#S":1X\OZ(M;<?_0V&#^ ,]B*B8, 8 P!@# & , 8
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M3((<?N_=XAE92>U$.3A]7\.1)E4>)EC$@ '/CP >'Y1X_L9:+LO [#)*1@#
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M<0 !,8>/B/GFJW[?NK\[7'IFU\C:-^QKKOXUN^U1SA&7]\D_OF?Y:+XP!@#
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MF5U!3KL/T.8Y?R_0(Y6E)JJ^?0F-$_P:F(N7\.+\Y(YPF/4'MRQ\;!G9ROK
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ME1-<4_6T<M%TZ&8PC%=RZ=':1[1LQ:$6>N#.W1T6;-)!J@+APH)S]! Y'CX
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M%Y#6*-BMDG1&4]:I&0@(.Q5UO7$;6X;,Z\NW2]^V;.V+?T3)*J(E(B9;ZA[
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MQ*T<5CM6WI,-'QE2Q=AV/$.]7U:4*V.D1TLS=;DLU=DGR*'J%,8S>(6X P
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ME:NW&E&O6^#?\OE4ASA!-U22\"#)WNKI<>9="(A+!*N4P R:LF5O7V2J9N@
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MH[:I*HH*N6Z:S@5 ;HJ+)D57%(@JJ@BF8P'5%-,HF-T@/!0Y'PP#W@("'("
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M/F?H9TQ91NFH-5W$6P,QMNN:19_: 5N0&OW]68N5]N!6:+9H4$?=]( DF1,
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M8B(\\YIMR/1<E!.M&;3"3G!3:HVB5<I*A@# & , 8 P!@# & , 8 P!@# &
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MO]]<C_1L+_4<8Y]\+O\ <K'_ -(S/]=R#8%G/CH(P!@# & , 8 P!@# & ,
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M?F,%5ZUT:Y&E';37T7]246C"-4CU^2<I2*C))NV>(JG@3)OFZ[F07;)H'2*
ME53;^W4#H$I *(<8NZJ-+R/9:_&UYD6F%10G6I]M)$Q#+'*F+M%F8HG$JBB[
M\$('VHFZR H@EP!%PXX !$+/.A==*5/ 1*JHF0@&>' Y$B"3U)=4A%#$;HK,
MSKG:111-U)\IIJK<F+T\&Y#DVH\2*-JJU)0A-/;$L+5-_P#A[[LAE125^][@
M[1@H4Y#D;*$<MDY!2'9* /J" "B1P(A\!. AEB>59@M'5^6I?M6+L_)>>GX2
M>:+VB3UI7325=S]H:\I%7"GP3IK D(<B0 =Q-6!&OQQ6Y1 IO609OB?9$WCU
M<YXKFY:>PB_#"_+EKY%SJ1V0$B_1,M%T^O@7J RCTQ[[8 3'K 3)^Z9)U1,1
M(N<! &@'Z0X$WD.>*]F7;GLUE2G)GHA9MP?LKU\R<FNN-%4UP@E9K.C8Y]50
MZZ;5P\]U)*K((D9J"VBJZFZEF"#<C3H-PHDT2$@@8""(\Q:AEW))64UIRXZ^
M/WRNY.$(_G'2/WCMW((BZ*M5816.A%&+1(D?-RQD@2>MU'95'T3[ ;;TQ\@S
M5;D%%11L**C83%1Y6.8-JVVUF6[362TWI37AQK7YC7\J=B4_S55X^?HXG5/G
M4XV.05&]<8M>K[;QW//SJ<% !,4K,\%&I&$?I]T''T9D->=*GF73RXGVP5>L
MEY4(V@262WB<$RF1UO 2JT>8%C* E[Z=B1G%XI)4HE 53R3%(. ZC !_&Q<R
M+-G^LE%?27[>/>N/V8NGS%Q]6]F5NFU(M78J#*ETM-(JCJJ1D@@YMT@F"_J*
M0[]>-*XA:^R?E4.+ARU?/7JA5#= MEA]8N)R=VK%PQM*Z5^^C(V-M:EU7VJ>
M"-G4;&L(=BSC(MHW81T>U;L6+%HD1!JS9M4B(-FK9!,"IHMVZ*92$(4 *4H
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MY6/_ *1F?Z[D&P+.?'01@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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MX#\?$/TX![, 8 P#@1 H"(^0>> >!52''@H\_1X#P/AS_!@'LP!@# & , 8
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M9O\ 5?H#^/)ZO04]#'LS?ZK]&.KT#H8]D?\ U7Z _CQU>@=#/,K$XCQP/_=
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MIT$8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ..?/QP"@6]OE?\
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MBI*SS_[RMDS.RP ^?*B<$?7]!$!Z4B$( %"2":, 8 P!@# & , 8 P!@# &
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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MVQ%;JD-?0NG[,UN=5C-/R=-1<[&@YQW*15?V3I.U/*]8&(N84'2$--0-?M,
MW7*E(D7,H44A*;-U^ , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P#U+(
MD73.DJ0BB:A#$.FH4#IJ$.'28AR&Y*8A@\! ? 0QSKS0:35'JF17I726MNWR
MA,=::GK;6JTV-D)V4:1+0RBA$WMBFG\])J&66,==0!>R!R)%,800;D31)PFF
M0I<IO6];GW#N$MUWB]*_G3C"+E+C2$5&*\DDO6VV]6S$[)L>T]N[?':MEL6\
M? A*4E""275.3E)Z<6V^+)9S%F6& , 8 P!@# & , 8 P!@# & , 8 P!@#
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MZS2NP</ M'#@[M=K"1C**;+.U"D(HZ5;L44$E'"A$RE,<0$X@4 $? ,$'>8
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8!X'4*0HF$0X* B/(@   >8B(B' !\1^& 4^UCWK:OV5;+]3"Q%
MQJTY1W<H5LUL,,GUW&)BIUQ77,]54HIY)N',<E(H%]45R(>@DL113@H*"F&A
MDLUM*VV%X:.J+%TS5$!]-E'-F,S.'(<!*19^Z5]U!PZ1C#T@;A=L4W BZ\T\
MFGB*^!ZYOMO0O4=!J7&V3K:;A[E0[VU=0"K0RC65HMD8V=@S6E)MC)2DHFX6
M:F;*N!,@H#=0Q4BI (@*I%"T8>'AD$C & , 8 P!@# & , 8 P!@# & , 8
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M_6T0!/6:\75NN6U2:-5A3&456K5(DG[1<[ $S"HVLM[ S24=)E(4#G)%)Q)
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MR^K+Y'Q?]%LB.XNT^C.LW++YRUN6_3UQ7LKSN1MKQ,_C9B*F&B4A$R+*38+
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M^W#<&^N;C:KI&.B7R$ZIHI(D(FDF1--,H$33(4"D(0H 4I"% ."D*4   #R
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M9X-Y]^$9JGLKVI^7LJKU\]"O5D[H7JH&3J-;(W*("'O;"H"JH!SX]$9'.!2
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MW#D5&TXIBFYZ1YZ? ? 0X^KQ ,%)Y8 P!@# & , 8 P!@# & , 8 P!@# &
M, 8 P!@'B8Q2AR(\<8J"/+5=QCWR5<KD6YLUM=(E<)1#97V3*-:*>L1*4LDP
MHFHA"Q1U4C$*/0LY7,4P((JB0W3Z+-GKC[ZY)1QZTKQ;IQ45S:YZI+F]4>+(
MS/=7/L^/%W,RE>E.BBGPE.3^JGK31R='TQ='3KV6OSOY!G8;T]"TSC,[=W',
M%"&3J%9?(IEZ7-<KZAE$1?HJ=1B23X7<D7K.5)9%$_HE2OJ*<,=.%M\_QGZ7
MR]"I'R?$MV\!SN1R-PDKU^.J7_-VW2GL0YOC[<^JYJZ247TKM+ML>I4%F"LV
M_ KU4@F9Q+,GN91YQSXHM0,7H1Y\!54,1$HCXF <]&W;5F[I/HQ(5@N,GI%>
MM_0JOR//O7<&V;#9][N%RDG]6$=9R?'1??=%XLIO<^X*ZV47#6&/^$XE3[)"
M,#@>:53X\G,KY-CF^(-2IF+_ 'PW.=$VWL_ Q4KF76_?7CI!>E<6<:WKXC;M
MN#E:V[_)<1\U_6M?T]5%^B.GB06(B8ZBAS&445.95554QE%EEC\=:RZI^3K*
MG$.3&,(F,/B(YM\(J$5"*2@N2X>I'/[MQW9.Y<DY77Q;;;?I;U9QE9:J^0P0
M, @3>_<-3-"0+>7L)SOG:LE7$0@X\4%Y=ZWD9Y 'C)DR,\;KIOY&I1$^X8.E
M0+&HNXL$W:J?K(D6G$Q,S<\O[%MZB[W3U-R;C&$4Z=4GX>"6O/A5F([F[GV'
MLO9EOO<ER<,!W%;MQMI2NW)R3E2">FBA)MR:C%*C:;C6,-!]Y5%W$B^;RPMJ
MC*0<?'+SPS1D8-FFHI$P";J58HA,V0I:\\LAY;]LN\33BFB#1-TJHLZ34/Z-
MUVK<]FR+5C/49PO:0G#J:E*E>FC5:]-)+Q6IA.S/B1V?W[@9.5M-RYC7\./7
M=M9$K<>FVZ?G%--1<%+V9-O3V:I=2KETAWJ=K$8_/'.-P0RZR1_04<1<#<9J
M, Y3=(B28B:Z^BUTN?'U$UCD$/$#"'CGLM]O[S=BKD+,NEZZN*?R-IG@R?B[
M\.<6]+%N[I8=R.CZ8W9K^^A;E%^IDX4G85!V3&&F*!<*[;XU,Q2+N(&3;O5&
M2AP$2(R+,IBOHQ<X%'A-RDD<>/+,=?L7\6;ADPE"2\5]#X/U&X;3O6S[]CK+
MV7*L96-SE;G&5/*26L7Y-)F8&* !X?2'U_7_  9:\S)^1Z\DI& ,>0 ")3IJ
M$$R:B*A5D54SF3526((&(JBH00.DJF8 $IBB @(<@.4SC&Y!V[B3MODU5?(7
M+=R=JXKMN4HW5P:=&J>#Y$ZTSN NM8]!G+*#;8H@@!PD53%FD4N/U6\KR(NC
M%'Q#W1%CF\O4*&:?N?:&!EUN8B=B_P"5'!^KBO50Z)LGQ%W7 I9W#_*L>G&7
M]8O[O2K],?63W,[WJSZKK2<.\4(J4@D?LW*8-I=FHKR5)DBV,805=.3>!%2"
M=$I0$W5X#QJF/VQG6\Q6<J.G)K52^GY#H67WSM,]LEEX=S@O:3TE'R2XOTJN
MFM2&]4V.PS]CLCQLY9HS;D8(T*602<.XEB8WWTS1:+(-W31<67\Y*50R9RJ=
M1S*<F-X#L'<F#8Q<&U;C&L8QDY/FZ-:KSXTKI30U'LW=<S<MRR+SE%77*'NT
MTW&*:E1-*C:Y.C3UKY.U]7O 2#Y2MV..7K-O00.Z/#N3^Z9R;5$4R+R5:F$T
MDVTY&$44*!N"I.D.HH+H)"8O5SVY8<8>_@U.P^:XKRDN3^9\F]3K.-F^\N?9
M<B+M9B5>ENJDN;MR_'BF]>$HZ=4555D+D!'CZ@'].6#W@0 ?, 'X>(8H@?!&
M1<=#M$V,6P9QK)(RID6;!LBT:HBLJHNJ*3=N1-%/U5E3'-P4.HYA$>1$<JG*
M4Y.<VY3?%MU;^4B,8PBHP245R6B.PRDD8 P!@# & , 8 P!@# & , 8 P!@#
M & , 8 P!@'@<X$*81'C@HCY?0 _FP#6GJ_O5VQLY&Z1;74U?B++#6^8B(\9
M&PNB,(B%CGIXTPV6-*@,NZGF;]$Q%46@D24*(&*<@< )*I%?'B:NOG'4GO(W
M_HVO5+16Y[[-;13OC(EMT!IMY^%27.ASS)U&G 8Z)=)S3U.GV 6;U5*9DS(K
M,E%Q43'TB<1<BIP=N5>EIITXT>FE25)Q:DN*U]9N$T/1M_6W5NLI';U8KFI[
MTXHU4/L6%+(MK@[C[@-?8ELC.OH1+S[B:,&TSZHM57+I]TI@4JC<P@(C\QX?
M]G7'N;K?R=WS'^[YY$Y1A:BNIQ<FUU2FI13==6X2=-%1ZF[/O&];Q(6,>%)Q
MA2KT]>A9*M:7I\%(-IV01>VVRM#^JUL%N<IR[N.6]-5$RT#'E1;P%84416.0
MYHQFS,H0PE.)@SN?;O9?;7:L.C9,2W:NTH[C75<EZ9NLO4J+2B25#6,S<LS.
ME7(FW'P6B^3[F2Z!2E  *   > <?1YYM5$> YP!@# & , 8 P!@# & , 8 P
M!@# & , 8 P!@# & <"/ <C\, JMM&W6W85R?:2UI,NZPPC8YLYW!M"*,@,M
M36<RV]:'H])54*L@TV98F)BNSN5TE2PD4JDZ],5G3,04)U>B,-L&P:3HVF/:
MEK:M1:K"@PDNLLU5EAB8".>,FKV6=,I*=<IR$C/7";?%45>G$'#E9TLHJ\6]
M<QNKQ9.X6\=/H]J:X^7I-N[=[/R]YN6OM#=K%O22C2/5.2;HY*/)<?:E1:.E
M6C$WBLA:I916<D6TXX8+$</'DN"ZU2KJP%*(,:W (+ W/)G(;A,Q#"]*CR9R
M\#@ /X+ER=Z2E<=(5X?=]WB;99Q,?:\91QH.+DZ:**N2H_QI2X1TUT5*M17$
MC2NQ<97F;2#.K./(=.*>R_7(-)E!O)NEWZ3F=D9%9PNNBLT76E#.U"GZ#N3J
M'.J"P>F >*$/=0H^'X>*^6K-GR\B]GY#OQC;A=DU%4<:J*5(PBO))12X:*B/
MN>S#V>DIB)@I/[AJE5]2-MUI3(U_8R3-H#YY7:BHX(HW8.X5F<GWO(J$408$
M5!LV3!Z559C7)N<W&VZ6H\7][^7ARK4L0LK&MVK^3!W,V_&,K5OVOJ2DXJ=U
M)ZJ33=N-(]32FY.VTI_,U4M$O6:Z6H0C.KU-)%R\K,Q<9J7E;++(.F (QUC"
MN.F\J]58+EZ%T0D9!LJHF0G4BF)LLW+LE:48PC&W6J<GKKX4X?W5/,A_8;&5
M>EES=W<&TIQM0A&W"CUAUQZ(OI>CI!T?XSYY$286@8]6/662CT#F%19V@[,Z
M/*J'*0%EI,S@K21<.53)]2G6=1,1Y$#!R(!A,S?+6'%Q<TDN?\I:AMZS;T9V
MU.<Y.B37T??(>EMN03>O2\DBD$S+2$:X;QJIH](\*NH*CUK7?V;A15,D"HNZ
M]X<3*+*>@L<XG/X &*Q>ZL*]?5MMM<7X46K?#33UF5W+8=PP<6=V'L>[HHK\
M9SFXQCZ:2E'R]2=.FJ\'7:_68RLU1-R,<47$T^D(V.K\,27L<N\5E9NR]4BF
M"J;I]+.#.$W"2(. $2G]0Q@*;,Y;W6UER][:EH_F?W:E>)MES"Q/LV:K?6E2
M74FZMZMR4:IU>M?.FA:VE;NE8@\>VO;E23B%_18#8SMF7WW'."G$B#J5&#10
M8R46H)3&441;IKH',*A@.4QO2V;$W6LE#(^J^#H:!OW9..X2R-D5+JJW;;T:
MXMPKJOZ+?&M.1V\U'ONWZ4EMP:R(:1U78),;7NK6K-47<8Q92!EGMBW=JUHW
M!46-B0*X-)V**;=36PM4UG;=(LIUG?9O1JJX',91E;DXR5))T:YESX:6CYZ)
MCIN(?-9.*EV3:2C))DLFX9OX]ZB1RS>-'"0F27;.6ZA3D.41 Q1 0R S6Y\Q
M;3FZ]D3G9W?--:>B]Y+Z%[C76S[EKJ5N=3I#>=JZVH-D4D&OWI<05B5!&:M3
M4PIBBN;@HCT^'(!PU1JQA_E1=VKR6N+E56"U QV%V[=]KQ.NZYD-26^J:]O7
M<EOEOLFA=KK-MLN@V!,* A!+'/)3T%'Q#EH^!8L>_:IJ!Z@)<M2YW9EVC=TV
MHJ=WE@6NUG1%^V[VY=L=*T:\9V=I<X:C;/UCVG_T8NUUC?>MJE%H>A[*(B"2
MCQ5XH^:H <#K@(F,? +1E0I;LW^9 OIZIPE>A-_5V'C;5$&VAJJ:[^[K>]C;
M(M:&CT:O)[<J^TR[)I4Q4J@KMLZDJ->&X(M':X%DSPZ)T_NY:="-?,Q+^K;[
M_$MFSE^=,)AW9GB6^'S[9%=WI5JWL>:L-\^7CVI:&1LD5=B1)7$1;;1MK5]@
M0"1",:>@J4CPQ6:*R:J<$^7W<#=/\N;6W<#JO0\S6.XAF_C; ;:-WE*5&3FP
M[3LJS1NMWZS$];:V6:M.RMOJ1LL9R1TJ,<QL<E&,D5"$;BD4103#7F7YP!@#
M & , 8 P!@# & , 8 P!@# & , 8 P!@'B8> Y\ ^D1\N #D<$JG,B2;LTM:
MI56IT)X5O[14Z%KNR;=)ZRK14SF37AH7W!%HV4O"H\E!%0JK6++RN[(<_MV3
MOU0MV[,%?R-?R8<'+S?A#Y'+@FM6L7>R+^1=^R8#I^7=HFH?S85JI77YIQ@M
M9U?3">9P-:A*A'J(,$_2(90SR1D7KA5W(R;L$4TUI.;EGBBKZ3?J)HE Z[A0
MY^@A2\@4I0"Q<N3OS75J^"2X+R26B]1Z[&/CX=IJTE%<92;JY/\ *G)MN3HO
MK2==$JT16_:'<."!W4!KY1%=8H*(/+28I%FC<X )#$@T3E,D_5+XB#DX&;@(
M!T%5YZB[IL?:4K[CE;HG"SHU#5-^GP3\./B<S[H^(=O&<L#86KF2FU*[QC!\
M'T\FT^>L?"O$J&[=NY!VL^?NG+]\X$#+O7RZCMVX,'@ K.%S'54X#P#D> #P
M#P\,Z39QK./;5FPE"TN$4DE\AQC*R\C,O/(RIRN7WQE)MR?I;XGHR\E0\YQ@
M@8!S@'& 4A[V]$63;U%CWM;F&C9Y6))G*%82Q[.M$K>JC(13PK@[>;EXV$;O
M%)!@)G;:OI(LDFKEW*R";(.MK[=DW6.P[C+.OVYW<2Y;<)]"]I/JK'3BU^*T
MDZ^#-#^*/85[XB]J6MHP+]BQN.+D^_@[T_=V9QZ'&<'.C4)):]<J1T:E)+5:
M3JK64KDM$UNN XE)N?%RV2:I+)MUW[OTRO4(]G"^@[>2[8!CT5TU7*K)  ,8
MQP34((%TGOGOOXJ=D=W96Y9>$LGMF_F86-@XUFV[T+D;MU8\;F1G7[V-9Q+L
MYWI1GC6K&3<MJU;;NRLSJN<?#+X7_"3XE=I8G;NV;@\;O*&%N.1N.5D7E9E"
M>/:ED3LXNW8UG-NYV-:M8T'9RK^3APF[UZF-;O1=;;U+L;=S4*RDI_:4:Q?/
MF$?(IL*S6PLK%JUE&:;Q@)YAU8(0'XKH*@;E%N5 Q1Y254)TG'KT/B"LNQ:R
M+6)?M6IVT^F[)1N1JN#BD_:7A5UY,YE+X$K$O7<3/W2W/(MR:KC1=ZVU3V9Q
MN=<>M-4>D::Z5I4P"UZHW1VGST?LVDVL5&3-\W:DN=;0<-"I>HX(="%OE7<J
MO&YX&762*D9%=5[&N%3$2,H1<Z!!S.+NVT]S6G@YEOIO-?C4]'L/CU?/])K.
M9V]WA\+,Z'<FPY3NX=N23G"M&JUZ,BRZUMS>C3<H5I5ITB]VN@=R16^-4U[8
M<<W1C7[H'$5:X))<7 5VX10IDFHDBAN53,E062>LA4'U3QKQL=0 .8P!SK<,
M*]MF?/ NZ]#JGXP>L7Z=:/DFFN1]I=F=SXG>7;6/W#BIPG=ATW+=:^[OQHKD
M/Z*=90XOW<K3?%DQ9YC9#G]W[OHP!@'& ,$IT=3R'@?'@ 'CSX ?'Z@'@,AQ
M4E1U)<O"E?$F;1KCT+H).>GU&C-;CQ_5:SD2'(\_05R;](YJO=,)2V^O).2^
M9G0.P+G1O$HRYQ@_DE'\)>^Q5:$MC$&,LV%8J*ON6;MNJJRDXM\5)1)*1AI5
MFHC(1$F@18P$<-E4EB 8P ;@P@/*+5VY8EU6W1TU7%->#3T:?---?,=[R,>S
ME0Z+RK35-:2B^%8R6L9:Z--/U&!QUFF*._;5S8$B+^,=JD0KFPEF[=HV>F5.
M"+6#N'M"I,(FR'4$"HNBIMV$F<P$2*BN8K<UZ5NW?A[W'HIKZT/OQ\5Y5;CQ
MU6J\D,B[B75CYTNJVW2%UI*K?XLZ:1EX2HH3T5(RI%R^FH"@"(>7/'[P#_9S
MRF2/9@# & , 8 P!@# & , 8 P#@1 // ..HOT^7]G_3P#RP!@# & , 8 P!
M@%?T.X*O/9R^5=A 6E2P4*XFI#YH^8-H]K(R1JS7[8W?1;T7BXNXMU%V1 4^
ME,SPPE,8&XIBF=2:?(&U]WW?=\AT'W1M*_K^K)J/8N/5#D&;I1S"0J#9?]JF
M4\2D1.9FU2$.4IDWA4BGX'DR!N28TH'4KZ\[,+DQ[@F5NKUJ:):=NJ"[G;\(
MSEYJK6926;QK[]E6#00$_P!R++,-HM5Z15X54/06,)CB<N013Y"]]1U[2:(S
M%C4*M"5] P%]<T8P00<O#E  ]>0?= OI)R<0Y,JX454,/B8PCXX),Q  #P .
M ^K .< 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & 0QO?9KO65"7
M>UZ/0GM@VB3CZ/JZL.#J$1L6PK(95"!:O#(#[E*!B$T5Y6873 3,X6/>.?)$
M<<>!#=%YE8+"YD=%4'^CRD*+V"\OH\UMOVRI!LFI-6"P6245+<;N,<SZ/O.W
M2)&;QRS:B9-O'-$&C9$AT4F[<,?G9D\>/N[*;N_0GI7U4-W[0[:L;O=6;GS2
MV^,^GIYSFE5)NFD6Z)M:\>!TK:MP$C'.6R3SUW#-^;W+5VW.G*MFKA!12/,9
MM*(BY!5-T9!ZJ98@F<O$RKF*8G@GB_=QG%N;UKJO'[GKR-ZEE9>-=45%J,K;
MBG"JC&NC6G\WV5X)N*HFSZVY&,2@XKL&W09GBHU!=@T4(?[M;>\%^5FV4,!C
MBS;BLR$3AX"!3]1"F'D,<(T7 M77?OS]_?EU.<G6O&NFOG)O6OF85L.Q"K"Q
M-=AGR<+9-A62$UXT</4$EI&MELRRI9A^LQ4 Y3.V$*Q=':BIU,UW143"*B1@
MZ[%]I15NKK<DH)^%>?J^DRVS8T?M-S,O1C<Q,.S<R)1X=?NXJ48M\:2DTFUK
M3A1F-[+4;L$Z3I:I0+MS&V=K87$HS*1151W3*N_@CV8+'-J$.1DYV#8+>W_$
M$NZ,+I5JZD3MBK2:S--2,JY&+6';BVFFGQ::BU7J?BW2K].E:)W]GMW+L,KN
M?.O1C<L2MQBZI=-V["ZXRA#\;W%N'3:M1]E-6G)QMPG)?=>K>XHT6#YVW<VV
MTV)P$1"IME1C5YRTND'#E.&:F5%RVJ]6C(IBX>B)1,E&Q,<N?I563+ZVJ=Q;
MS' L2N3?YRNBIHY-5^3Z$1LNT2W7*>/&F/@6%U3E*DE&UJG)N*K.<IN$6^#E
M-/2M52C9MBMCA^?\<VA*2*F1--2 J0.(2K,50 04:2WK=<]9B 81 XJ.DF*H
M&Z5&"7!@SXX^(7Q,O8MR=N[>K&E>F+HOIK7UGT-VML6UQL16V8TH:4]Y=HYR
M_G1HNF*]%5_.=-(=_&+UP:66 _"$*P9R30$Q I4SI3M?BCB*)0*!6Y6LJH!?
M  \PXZ0#.4[)\7;T\B]TW)5]U^5RZNE\^:K4R^]]LVI7MMMW8*DLU]3?.ENY
M."?BW.,>/@B5-<WQV"\8Q!_TLG ]"!EU%GATEF:1OV*1%%BB)7+9,Y^#'*F0
M4OL^)N ^D_A[WZL[HA.=:JNKK]\UGN;MRW:A.^H4O):^?A4NFK&, 90#X#J!
M]\E47;'BG#R,4.Y:&]%1PLTCW945/1,4P"JL!A2\ $0 P=7U!@7E?M1GR:3^
M[UG$W<N>\NVG1.W3EXZ\_26.T=<%6)T->2R_OVRR4FYJK]THF+D")#[U[5%T
M?2(BL1NU47<LQ3 @%9(JI"D4K=,Q]OVW*<O\FFU6CI7Z/N_E.8][[+;CU;YA
M1I&L5=@DZ1D]%/T2=*^;7C0R73H.-0;5F]'])B:WML3)[+TOR(D9U@[>0;-]
MCZI8]0@DC'0DC*MIB%:$_N,<_<H)%*WCR@7)T=*OB<Z3_%+?_7D$G' ?N_=]
M> <X!QP'T?'G\^ . ^C .0  \L 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M8 'R' (BLD](VB:>:^J3A5HNQ19&NUI1,8A*NPDT@52AXI4H_MKS+1R@*HD_
M4C&JJ;U?Q49(//5;A&W!9-Y=477ICPZFM*OGTI_WS3BN$FL=DW+N1>^P8CZ6
ME^<G^1%_BQ_ZR4?[Q-3?XBEF+9"LT*LE0*5C UZOLCFZS\)-F;9/DQE55CB8
MZBRISB)C&$RJJAN1ZCF\;48WLN]TJL[]QTIS=?FI\R+\Y8FW8KE-QMXEJ-6V
M]$ES;\7\K?BRC^V=R/KZJ>(AC/(RI)\@9%3]@\G% ,8/6D2$,)DF EX%-L8>
MH0^TJ &X(3I^P=M0VZ"R<Q*>:]4M&H>7]+S6GAY\,[P[UN[S)X&VRE;VI:-Z
MQE<?BUQ4*<$]7Q:\(- . X_=Q]&;C&J572ISG1))5HD<^>37Q"3>B  (\< /
MCX!X#Y_1C3FT5*$Y-1BFV_O:G'/[N!'@0\P'CR$,BJK2I2DVZ)-OP6KY/5+5
M<5JU37TC^'Z/CE5 TUQ,YA]:7ZQ1S>7@ZTO*1;H#^W>-9*"Z%!15.@L42*RJ
M2R:B*Z9B'(<I3%,40$ ',)D;]M.)?ECY-WINQ=&J2^\O7H;-A]I]P;ABPR\/
M&=S&FJQDI6]>7.::U\4C"UT56RZ[9P0$W#9=9LNF"B2P)K-U#(K$!9 ZJ"I2
MJ%$ ,0YB& .2B(" CEK5R-ZW&[;_ *N237H?#S^4UZ_9GCW96;BI<A)Q:JG2
M471JJJG1\U5/DR%NY)60;]NV]UHKK!\33>R1()"B90C?\'RX22J? "8#I1HK
M'#CQY ./'C/7A)_O"P_'(M_X<37>[;ER':.[3L5]^MJR^FG'J^SW*4IKQU-0
MG8_3X.:?[*FY5$'#J.BZU!1_IN7#1Y'MIYS,O9!VP>L5D'L<^4- -R)+HG35
M3Z3 !@Y$!W+OQ6KWV7'NPC*U#(]ZNJ*=)VI]4))/3JC)]4'RDJIIZGR/\#+4
ML9[IN-N<H9,K?V5N$I1;LWHW%>BI0I)>\C'H=&JJJK1LM0PHKO6<O&*PKU5.
M$:1=>@H=E"PE7K[!V4LTJ[MA[@]6(@$J^3J=>;%0?/WY3B\=KF;E3#J2-POX
MA_$S,[56+C6]KOY5O*S,>'OXW;?N80E[[W\93O7+5K']Q9M]:][*$;DKJ4)3
M=J:C]<?"?X.[=WA]KOSWK'PI86!?E'%=F:O3E;5E8\E;L6+]W+]_>N1A+W:G
M<M1MSETVU>@R8C(5[9-:F()T4K^!L366J\H0JJ2R1T')5XUV9L];'4:K^EU>
MHBX1.8"'*4Y3 <OADNR.]=I[LQ%ONP3Z[=C*=MTG&<5<M:2C&Y;<K-U5=5<M
M7+D'6BG52C'$_$+X=;QV5N'^S/=5ND<O#4XQ:E&4K-^#<7.W<C"]:E3C"]:M
M7(Z/IX-Q3\KXSL^G=B=:GJ-/Z2&BZ:A?!)236IU>))G( > "9F@R$0 /U>GX
M<9U+O-QEN=FXZ*;QH-^N4W]+.:_V<U>M]H9]J3?V>.Z3Z7XMV;2D_FA7Q?'@
M;*\U?TG?"3]34 =@V<6#H5T82+;B^F7"(=)SD,)TF#!!40,";AVZ#K\@_8HJ
M>(")>=:[EWE[1BKW+7VRX_97A'FW]W@;KV7VW#N'/:OJ2P;2K<>JK7ZD8OQK
MJ_),P>=@W]:F92OR@![^'>JLESE#I(N!0*H@[1 ?'T'S90BZ?Q B@ /CX9EM
MOS;6X8MO+L_4G!-_TN$OD>GI->WG;;VT;C>VZ^O;MS='XQ>L7ZUKZ#J/R^7Y
M>/T9[N.G,QBXT(DH^SI&WWS95*D*!.U NOCQ8-I>9E(1R2TM9>R[!A&$G'Q4
M>Y6D8Z+D(VDH2319R4H.6TD4">*)Q-%.B,'*57)/DU1I1K'5*K3D^%=$>S(M
MXD(=-J_:GDQ47.VFNJ"FI.$GK1*72Z)OJ;3TI1N6P'D.0\AR3Q$CZI<BVNK/
M@1#W#"01YY'P% B4F'''TC'9@NXHN6URIRDOG37WS;>R[CAOL$W]:$E_>TG_
M .R3(AN"2UWLNZ04ZH]DZHK8GBJ:0""[Z#^\?1D$UH\IS@==ATNN3M^>0#[2
M7VN4SZA#MN&Z['8S,+V<U0::X*=)-?WWFZ??-_EWE>[?[GRMNW24I[9*[U)K
M5VNM*:IS<:/ZJX<N:+9 I 6Z" Z18^=@IMB8O!DT7C&08.DC$5243.0Z2R2J
M9A(<A@^DI@ >0S29V[EB\X33A>B_6G]W,ZA:N8V;BJY;<+N)=AY.,HOYG7P(
MU9/I+6+QA 3RR[^DR4BSBZK93F.LYK2[Y0K6,JEM4./6=BJZ43:14H(F%8QD
MVKP0<BDX>WFHY*<H*EY)N4?&G&4?.FK7I:TJEY(3GM[5F^ZX<I*-N?.#?"W/
M^;6D;<]6ZJ$]:.<SD5(?]4?H^'U<_6&>6E#)\JGLP!@# & , 8 P!@# .@LM
MDBJG#NYR96.BQ9E3Z_33.LNLLNLFV:M6R! ZUG3MTL1-,@?K','D'(Y=L6+N
M3>C8LJMV3T18R<FQAV)9.3+ILP56RIE@[@;-++)H5]$M7CWH&^[G3V/7=2DD
M0I!,8[)Z]0)7C*D INLK8'Y  O454Q1 V;MA=JXRCU9=Q7+L>,8/1>OB_D.>
M9_>N3<:CM]MV[4N$IQU?HKI\[(OF+?9EFSQ]*6BSOBMVZ[M5,)U^S(8C5%18
MQ4V[!Q'LDS& G <$*7D?'PS-V]IVVS_5VHM)<TI?A-=N;SNN0_SF3<3;_%JO
MHH2):];6FFULMF>W,[WI7CF[]DQD9YLJ0\F[;,$1CY,TJ922%)RY*(@=% 3I
M\F "B $' X&[X.9FQQOLEN,)/V7TIM?TM-3:-PV/<L# ^U_;KC<%[2ZI*+7D
MZUKX5IZC%HN]7>'.!HZWS1"$Z1!O(.OOIJ(% 0 ATYDKU4A!#S!-1,P\> _'
M,U?V/;<A4E:49^*]GYD:]C]R;MC4]W=<H?SO:^5O\)*]5[CP*+,MV8)HQKLQ
MTF]KB6DBWBC>B4PN'*R+XAT%V;4J9C+*,G3HY"@)Q2!(BBA-9W#MAVE*>!<5
MQQ57#3J2]6AMFV=YV[[A;W&W*WUND9I/I;]:+7$,!B@8!Y 0 >?S?#ZLU/T\
M3>3RP!@# & , C-GJBH1VS9K;;%BHVN=AK,;59ITF[7*QD(Z)=G=,73B/Y%L
M>72(8J'NNGU3-4DTA$2)E  )+X#Z _1]& <X P!@# & , 8 P!@# & , 8 P
M!@# & , 8 P!@# & , 8 P#@1X 1XYX#R\/'ZO'@, J.E)*;-[B)V40*1>E]
MO\6ZID<*B8&(^W'=HZ+E+/)L5 $Q 5I.OG3>+*J @(*3[]'^0;)2U(T;U="-
MK&_;66[WI:;CFYH!FLM ($.83&.K3WLG&NCOBF+T"U7F6QER](B(MP*42B;D
M<P63>4LJ=:]*5/N]9US9\2YMVR8BLS2R+C]Y*O!*:32]-&M>5>)TCJ-AV;9L
M+ZF=+0B9'1 /&0L@NR;..EP9=:.;O7DNW 2F!0Z)&XKDY^TD ^&>:4:+J:UI
M]VGW<C)VKER])QM7EUU:2U57KI5T7'G6E=:\S$HA:=3JJ3*!@Y.%*<LQ/*V5
M=HUD'$VSD9*8<UZ-JK!19^]<N2Q*+1L=Q(-B(M0$")D7 A>B$VXQA;3CXR>O
M'\E:^%*M(]UY8ZRY7,FY"Y7HBK2;2A2W'J<Y4HJRKI%R;XU53#-I&?IU<6Z-
MI^^$G,,OLS5UU?H,&SMA=M6II75>JSB<2RC6+AN^:Q2ZB)B()KG9%>)*EZB)
MF-9R5*%E1;K"CN1?/JMZZTTUIJO297MZ<+^X*4;2M_GEBY-J/5*,K.3^:C=M
M]3;5'*,95K'J4)1:ZFC+[F9X78>H9EB1832LWL*ER3<B*O)H*?U],7U=8X$(
M()^QL6K8H!ZN.DBQO#[64Y,O=3@_QI>SQ2^LG)_.J>KT&)VSW<]MS\*<H*=N
M./>6J;K&\K"2YMSA>N/3ZW375(BN_6!A:;)$(5I\A--M>OY.3LLC&G3>Q,;/
MV&.7U]#UI62;F5:??P,K@^>.6Q#F5:-FX>L!/73*?C7Q!OREC-8LNI0C)MK7
M6C2U];]"-T[7PKFVXEUYL7;R,Q0A:@U2;C&:NSN=/%6_S=N*;24I-.-4JJG6
MPDEG$ZY$XGZ5".G8)*<B4#"\ "G$>..HI51 >? ?,,_,WXJWLO[;).O!_2?1
M_:D;4,2.GW4('="^CG+IPW6*B59G(,'0*)E.F=I(-@17(IZA1(/!%>2C_)4
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MTI4X'WAWC<W^Y]CQ=-HA*J7.XUPE/R6M(\.;UX1&///YN/+-LX&BMU.,%)R
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M>:_M6XXR;O69J*XNE5\Q[,;>]IRVHV+]MR?!5H_GH2"FJ50H&(("4WZI@$!
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M JVO$#0<PW?,)F5ND:O4Z;(-7J*C"00/$+,%+3;#/6BIRG K%!B\3$W\^+U
M8WG[>^"G>_=.1'=.Z,FY8@WU5OMSOO6CI%-]*T:]N4)4HU&C2*LSN7;,*/N,
M"$94X4HDN:U6CH]>?@T6+TSJ>/U+3T:VF_-89)63L4Q,V=['-64G-O;!99BP
MC[ST15441BPEQ:-?5566!LB3U%#J"<YOJ_M+MK;^T.W\7MW:U+[%BVE%.6CD
M^<I+3VF^+]&IH.?F7-PS)YMY15Z;UIY*B7H)=  #P   /J\,V0\9S@# & ,
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M"5/(F]>N7YN[>;E=>KE)U;?I>I[0_>^GZ/AQE90HU1W<!6[!:GH1]<AWTPY
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M^;"QB['#%M1E<OK,R)>\2]E*5O'BXQU>GLP:;H_K46B;ER;E&;%+H.=5=VJ
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M.9O]5%T:M1='R^N^/]RM>&J+@0L%#UY@A&0D:SBV#<O[)HR0(@D41XZSF*0
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MPZ8T=1]<M9FPIRL:P>-7[%9H51)1-)PB1I*.B(@L13VX.512Z!4.)A))F ,
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M_M63^F ?*-[$0_\ K57'_+MO4/\ TD8_C1\0OUNU^S8_Z$/X)?#I_P#P=_\
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ME:U IN/CP'V><UGN_P#S7'K^5+Z#IWPNXY=>-8FSS-$.NC & , 8 P!@# &
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MM25%U<8PG*,Y*CI&J3^3LJKM5A-0FLM6M4S.O;Y/O[#;HY[9[A.,:';#G/\
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M_ ,]V,NCMZ,?^LN?X3(F+Y_Q>><TI70VZ+HZ^1$=U$1GUP_M6;  ^GQ0 _\
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M%(43" "!D31RD\;-W:!NM%RBDNB?I,7K26(51,X%.!3E Q3 / @ A\0P#Z,
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M;"6W;=:Q4O:4*R:X.4M?F.(=R;F]YWF]G/\ JW*D/Z"TBO)T3JO,QOC];[7
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M+H6M?9TE!\6_J-)UYIDPYYSWC & , 8 P")=X#TZRLP\@ B$*4/'QY-88DH
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MWN__ #3'?\]_0SI?PP?Y[)2_)_Y!L\S03KXP!@# & , 8 P!@# & , X,(%
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MUUV7NB_;V/M*]9LT458C8AHE3J2AHHI)4CJDDDJ:)))%"2I '@"B(  <!XB
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MNQX237"2MOJ7R_+2O#4E84/'^ZH\CQYG'GD?^YS7U:_G0^4R+E1THSGT./\
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M)IJO.OL_?^8WOX<796-TE82TG&:;7#@I?-TOY4;;,YL=O& , 8 P!@# & ,
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MJC)T1/J:*:)0(F4"E* %*4/ "E*  4I0#P I0#P#RPJ@]N , 8 P!@# & ,
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MB1<FU%4'"*Z*S54#)= *<&$IMDVGN+*L9*6X793Q6J.NK7@S3]^[.VS-PI+
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M(3JEYGJV;W15C1.[)!'8UC(RAY*&A:FS<."&(R5L#=BTFEW7H)G,FR(NDZ6
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MZ4?-7?&W_N[N/(MK^KNM78_^\K6GK3([_=_I?2.;"VE6O)5?H-1H^-']WTG
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M'D ^/F/E@'. , \>LHF$O/V@\PX'R\/$/#Q#Q_3@'E@# & , 8 P!@# & ,
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M1%GVS.V'5\#VWO*_6]70;N=VD[C=L-=K-:JZ7=Q3FLS4X$^R2EGCLT>G(E<
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MBVZDN>I7++<+5!E'W%E+-%)9HIJ[7A/=,#2U=KBBQ6RS4Q%?324(4Y@#KY\
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MH3:&UK)69MJL*H(#1V=-:N8T#'3$ZCI([TBB')#Q5U*M.FIZ+G\R;=VJI7N
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MHU\JU=/"IV^6R\, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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MU(N*:,3G*4!, %,9#D/$<IXNI5P21E6 , 8 P!@# & , 8 P!@# & !'CQ'
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M$G.[+FSM&'@X>W6(XF#;C;QXK1)?._%^;U._RR>H8 P!@# & , 8 P!@# &
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M9=72^FG532O"OGY%0++V_P"QK;,.9V=NE??R#D>D %G*(M63<IC&28Q[<3J
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M5^0>10*M:'^<@QT)K3L8BG>G=24[7KRHTU7O8UYM&11N)M,TF1:&BXRI4%2
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M8%'V5!(6C7MPJUYK3E11%O8*?8(JS0JZR0$%5%*4AG3QD=5(%"]10/U%Y#D
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MRLBYDS^M<FY/UMO[Y]786+#"P[6%;_J[-N,%Z(I+[QW>63TC & , 8 P!@#
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M_P!;^3U16J>F#N[E?N9GV+#A;]Y'(C&=9OV;=%*<Y12JFU3W";?O*2EHHM/
MYSNA9UAW;+2.NDU"LJW/,G3AG.KFL=F>T&^)P[.K)R#.KO(5PS2CKFM(-U"O
MEV2+V1*T,J5=90Q?9C;+/*G;M.Y+KE*-*I4C&Y;K5I354G%)U55%.=:1H8[,
M[J^R6KN6K496X^\5(W'64[5^-OH58..OO7)4DX.<E:^M+3O9_N8L$2ZL"Y:"
M[)"0[FSEC_7F7+RRVII2=M676$\O'P+>-:(1Z+W\."[15,Z=BU1?-CJ(JE6
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M&;A)VU;.FYRJ-W+=%P@J3Q(HDL0JB9RC\2G(8!#Z0'*2L^G /SI]QOS0^YB
MV1W":FI:.FX.6J>P.YK4\'K).GWF2[B:%0]4]J]IW+4^\&<E'5T0IC_6$_;8
M5NU:H# (-!2DVA2OW+HBS8PA/4DK8O>!O_LZ[!>Q:VM;-4;[>-T1L$6_;JWO
M[Z2K<2:P:=N.WV06!W:=UZP;$GYV59M8MNJ^M+-H!$URM&YUC,H\Q:AUIJ0/
M8/G/]R<)?:% (ZEU/,2,O0ZB^M>G(R.GE;Z:[6;LP>=S#9O2+8IM$DE8H"9M
M1F,9'KITA6.,V=>U&3/+$6:H2#";-\Q[NNV)8.W*Y:XW1V[V:4@E>X:R2Y-6
MTK>+32%E5K?8,MW!/=7[:J\Q>DCW"RZ]L9EFK=6&M2A&+Y1LH^;,GB"S!2/,
ME5>B+T[]^9!M*@Z)[1MI1CW0VE"]P?;C:=XV78&]JYL>VZNC;I :TI-S@-%U
MV/H=IK-L4N6PGUJ>*1IBGDGQF$(Z(VC7[LQ$P#P($V!\T[O6IEC[C*S_ $):
MC+_FYQ*%UMMI>4[;I:XVUKNV8T>7MON#EJM:(ZPIM:I5[[;7]Z(=JBX5_!:Y
M4D(@5#@@1#JM"'+U\SCN-JFRUMK5>Z:PW+#Q_;]:J^@XUS$[&@NV%X9+O]UQ
MHP>Y!W4K_;H%P="HT*;=E>/D[8-=4$BAT[ 6,%1TB)UH;O\ L-W_ +![FNVF
MF;>V9!4Z%M$[+72-47UZ_3D*18HRMV^:@(>UUI5&R7%%O'V"-CDUQ0)+RJ2*
MQCE2>.4@(L<%P+C8 P!@# & , 8 P!@# & , X$ 'S\< J!W(:[44$FP(AL)
MO0229V5%!,O(MTP$K.;4 @=1Q:E$$'!A >$ 3,(@1(<WGM#>59D]KR9)6I.L
M&^$9>'E7Z?2<K^(O;;RK?[]Q(5OPC2XEQ<>4_.45H_YJ6NAK$M&]++69RQ1:
MVJ;%(5RMN#-U+*QE9=P=XR3:4SW+]I78VC2KIP@24O31(B;=9RLJU92"Q"G5
M:D:NNJPQ+<H6W&[2_-I]+BJ)/WK=95\+,N7&=M?CU7!,G.R<>Y=ZK$7BVH_6
M]XW*2_,+2W[N2^O?APE7IA=DM8=$NE@NX>ZRDM$-U]32C%K-S-.AFI37 K*0
M9A,3E[K]BEC/9F!AJ_*L&;JH%5B2IO&XRJ#I,1.@=1-,:[NWX\/>.-Y.[;4_
MQ71]'3T)/CJKCY.E'QH>:WN^=.5CKQO8OSLQ25Q*<>MW8W)/10DHN"Z:277I
MK&J.N?\ <7>4J]$/4]5SC*=N%.7L\/%%/8I-:LG>T&.LD$28$:O%,[ ]3F9E
MHUE&"2T>[8G%<B97)4#K9$L*TG<7O%TVW36GM=-V49457^+&J\4UXZ>E9^0K
MEFQ.Q[5Z,FVI.EM1LQFI5<8UE*<DFE1Q=>/2RQ46P82Y*Y:YF"AE;6WAFOH3
M"T,S&9B??,5O?,HZ2=(K2T:W-]YN4S(D6 .A=0IN>L_5Y[D7"4[4)/W'4ZI/
M27W4XGJL_G86\B["/VCW:U:]J/4JZ-JO!\*\V9(82\<"(%$W'3R(!U<CP'3]
M/(CEIW()5DTEYZ%V-JXVE%/7@=RQJ=KE.D8VKV.0(?@2JLX.4<-Q >..7*;4
M6Q?/XG#/'>W;:\?^NR+2EX=2K\AD\?8-\R_\VQ,B:\5"5/E:7S$A1.A]HRG2
M/X?;Q2:@ (*3,NR;#TB ^)D&2DB\)P ^(&2 0^(9A;_=VRVJJ,Y7)+E%/Z=#
M9<7X?=SY"3G9A9B_RYI?-!MDCQG:O-K<??MLBFB?ZQD8J,<R"G5X?J.GSA@0
MG'TBB;Z@S"W^^84ICX[ZOYTM/D539</X6WZUS<N,?\7!U_OI.OR(LS1:6ZI;
M T>K:K)9D1$@I!87#)T#+I*)138J),D7B:!@X_9J+*D)Q]@"AR Z5N&<L^^[
M_NK5J3XJ"HGYODWZCINS[5+:<;[,\G(R$N#NM-I>"=*T7A5F>YX3+'!C 4!,
M/D'GD-T!XE.4_/'PXY_.'.34'G@# & , PC8]C_"E'M$X104G+*(= P.  /$
MHZ)[2*+]H0+^TD7"1?SY[=MQGF;A9QJ54[D4_P"C7VOFJ8O>\Y;9M&3GMTE;
MLR<?Z5*07KDUZC5L0A2$(0O(@0H$ QAZC& /#D3"(B81X\Q\1SNT(="Z5I!)
M)+R2/E*4JUK]9R;K_2=6>SI'CGX?PY555H0HMJO(=(_0.20<<#]&!1F!7*M2
MR_OIZKAZ\L]A8R!L4"+EC'J6J&KTTO::=(5Z<D4EV=0VOJ6WO%YRDS:Q%&;"
M5<.47:?H/1=LM6[AV'][6U=LNF9"-%X->#])O?:'=;[?OO&R*RVZY)-TXQ?B
MJO37F117-CFJL[/;"B-0[$2WE-LFU%9S+:NOX[6,4L\"*B['=3Z=C]@,I]Q+
M63[AC%UX@S)K2D9=D58MG0@U5K*&FWGW#>P[>SW;,Y0MS;3<:MODNI\$M:>E
MKP.F8%GL;;][RN][%]1W7)L=$E[WV4FTY-6^'5/H@IN3:72I1I675*%*J<@R
M6&RV9O[>PK,'D>S:+RXV.58M)B0;S5DF;A9DTF,;:]GWZ;:MWEAD&+*/B4",
MH^)C&Q8Z);N'>Y]N;&MIMN[>]K+FM7X+P.:=Y]V3[AO^YQZQV^$JJO&<ORF_
M7]'A5R'\/CX#QR/E^GZLVBJ5%Q;-#\WP^CTEL.V[7JB[LVP)=L'MT2+,JTFN
MGXK*G_9/9M(#>14T^INB8.0-UJCY= YSCO+>>MK:L>2<8NLVGQYJ/J^\CLWP
MV[=E!/?\R%&TXV:\T]'<\FU6*\F_(N: >?[O#- .NG. , 8 P!@# & , 8 P
M!@# & , 8 P!@# & 1KN&]R.LM97>]P].LVPYFLUV2DX6BTV*>S-FMTTDB)(
MBOQ+&/;NG/K2DB=-(ZWIF3:I&,LIPFF<P>_:L*UN6YV-OO7[6-9O78QE=NOI
MMVXMT<YM\HJK?C2G,Q^[9US;=LOY]FS=R;UJU*4;5M.5RY)*JA!+BY.B7A6O
M(_(-J>8[YZ#W@.M^JZ8W=;-WLYA#8VWZ:RH=N+,3U"OC]]'/8)[! Q<2$;4I
M-C KL*^1<ID&9HAJ5(!!H7C[JWS&^%FX?#I=J6MSVVSLZA*SBW7>M461:C"?
M4I=5)3ZKD7>:HVKDJTZSX$V+,^*^V_$=]VWMKW.]OD[D;V595BZF\6]*5OHE
M'I^KTVY1LUK%.U%:^[J?LL@)4LY"1,RFTD(].6C&$FFPEV#F*EF1'[9-T1I*
MQ;U--Y&R38JH$705*55%4#$, & <^";MMVKLK3E&3C)JL6G%T=*Q:T:\&N*U
M/T'LW%>LPO1C**E%.DDU)55:23U37-/5,[?*"X, 8 P!@# & , 8 P!@# &
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M & >)P 0'GX .&#7_0$P_K)>Y(.!'_\ Q5[:!#D?(?Z0M]%X\_\ 4YONX_\
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MJ;8X&IV+8#K72S&?LR,@XA&1*9M.DWY\1ZE%)JOS"^CZNJW2%,H]*RI#&^R
MX!KKIWRL^Z_:EX[>7'?+W4TC9>F.UUY!3&L]*:DU^O4HN6G*LQ9,:P^MEB<C
M'/''W4C&H$4.9NZ<+(E4225;%<.16$:^)'>C_DM[0U!L[6$,G9^T5UH34&Z4
M=HP-]5[;(&T=W%QJ<+:7-NK&J;9<[RRGZ=#M(U\LFW_$<4DE/H((E%FHT $D
MD9Y:A)H^N.^4/W-4GMGTG0=<[ITHTWAH3O9LW=O39ZTUJYRNM)(LBW7/ 0$X
MQ8JL+)[F.E4FJKD$A]-= JJ13IF,54D$F0.OEP_,.I>]NY';&C>X/M3KD7W$
M;&2V%-Q>P=./K\^:NT&:R*#=J:<AI5&*(1=^Y$Q6YQ!0HDZQ$2@.34B@W7\K
M#O'[G[7!;-W5W2Z_@]C:'TYK>%[5#ZIJDI#52G[[KLM2+C=]KW"$<LVK8(^T
M6NGBV;L8Y$4VL8+$>@5HWI=QZ1J7Z[R.US<7=[V%VSMMG+1KNN[DOD+J@+1:
M&:%B4UP%DI&QJ)>;,ZBF@MOQ&WB9DM4<$9IG(91N9P0IQ,!3',)XT*24;Y7G
M=KLF_=M\AWO=U='V3ISM0E*S8=6Z6U/KQ2JQ<M8:4SCVE2?V^>>>P7>$B21:
M)%/4;O%ET 4234;%<.14FJ&O,SG6/RGD(FM?,:B]K!I>_P YWA;6WY?M1VAW
M2"34UJ-CMH+<X@2.)*P1:T@QFZU*V%%V*D6L0I7*'JI& _ XJ11'':W\M?>F
MFMU=D>U=A[5H-L2[6NV>]Z!LR$2E:EI.SJS5AO3NJ2<$XEFJ2;6+AZ[9&315
M%P/606IBI\DZ1P-?4;K,@D8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@
M# & , 8 P!@'0V.M0MJBG$-.1[=^P<A]I)4O!TSAST+MUB\*MW*1AY(H02F*
M/D.7\;*R,.]'(QI.%V+Y?0_+R/)G8&)N6/+$SH1N6)+5/Z5X-<FM44,V5I&Q
MT<7,I'E//59,RA_>($ZI**; '7S+MDRAUH)AX"Y2 2< )E2I!XCT_9>Z,3/:
ML9=+69XU?3)_0J^#]53A7<W8>=M*GEX*=_;5KHOSEN/\Y?C)<*QJ^;2(.4("
MR)R<\E53.4!#Q 0.00Y 0\P #<_1FW22:<9:)IKYF<]HZ5\4_5IQ?--<5STT
MU-J5 F1L-*JTV8?VDE!QCEP'A]EV=FC[PG@(_P!S=@</S9P7.L/&S+N.^,+D
ME\[I\Q]9;3E_;MKQLSG=L0D_2XIOYS,,\ID!@'@H7J(8/,?A^7(=::<0:C^[
M;L;V-L78&T-L5"6CY6&NNL=BQUFUC%/9VJ.[=/0&I%HW2QY!%M)+PE]LS39:
M2*PKR*D8T:L6S-$$E?35.IWKX?\ Q2VK8-FQ-BS[4K>7B[ACW+.4XPN>ZMSR
M4\U1]E3M0EC5CTP5R4Y2N-M527RO\6/@=O?=?<.X]T[=?A>P\S:\BW=P8RN6
M%>NV<2?[OE*EQV[]V.9T2<[GNK<(6[*Z6XRE+,=CTW2NA.V%I-75MK#7VUK1
M6-0@FYV35G&QR/\ ;]#ID55JX,1KR,=NW5EM4"P(LW:H1)/[H;U%.I/U#&QV
MSY_<?=O?<[.U2S\S8[&1E_YO>6,XXN1>E<N=>1-)6;=R3C*<KC7A&DJ(S>_[
M5VAV'\+K=W?8[;@=R9&'@JN58>7UYN)CPM6W#$@Y2R+MJ*E&$;2:K1RK"K=>
M>PB9UM=_Q_K7=%@K<O=+:AM. K5:V/K-#66WI6H739-]7V-&Q5B;NR-K56)R
M:ZUG<?'*"[@ILL@T/^Q;MSCM_P 7,3>=LEB;SVO9N6MFQOLER[<Q<IY6)"_9
MQL?[/*4)13M7(6^E1N371?L^YFO;E**Y[\ -P[=WB.;L'>>39O=PYDLVU8M9
MN';PL^>/>RLG[5;A<A+IOVIWNJ=RS;?O,:^[]N2]W"W.797'L OE_P!C;F0I
M[=#5E3E=RZRBTI9[-S!8VY]OD%H>MQ$E6!@(.14)<HUOLB&9E58RQV0KE1=@
M5T3U3&4C;_C!MFU[!MT,RNX;A:VS*?0[<7[G<+N=<FKRG<C^;G]EN3Z;EKK2
MDX)P]G2=X_L][QOG<FZRVI0VC:[N]XD?>*Y.F3M%G;+-MX[MVI_GK?VZU#JM
M7W;;C&XU<77KN4JL0M U^#AU_8 I%0T7&*!%LSQT:!X]DBU-]WQZCEZ=BQY2
M_9(BLJ*:?!1,80ZA^;LB[[_)N7UU4G.4O::;]IMZNBJ_%T57J?8N'8>-B6L>
M73U6[<8^RG&/LI+V8MRZ8Z:+J=%I5\3(LM'I'GY^. 8O8*75K0D*<[ 14IR
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M 8 P!@# & , 8 P!@# & , 8 P#@WZIOR#_!@A\"@= _^V3=R/\ ]BKVT_\
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M9?<<''QO:XY@6F^%W$1:"&H"MJ(FK63.&WW$+J=;6))=,[):+(^1=%4(*9S
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M1PST#-4JR0]GI%G2<*1;H#*L)UN*2S^/4 4G[!61CP%$?<MC"4O+8"D.!3^
ME <R>3W3;W+!EA;C9]J25)1?"2X2H_GU,)A=AW]DW*UN.S9.EN24H7(U<K;^
MM'J7EPTXHM601$O(^?Z?@'F/QS3^.ITC@>> , 8 P!@# & , 8 P!@# & ,
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M@# & , 8 P!@# & , 8 P!@# & , <8 P!@# & ..?/QP#@"@'D !Y>0<>6
M<X P!@# & , 8 P!@''24?,H#QY> 8%6N!S@# & , 8 P!@# & , 8 P!@#
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M*366C'( HW<$ JR)PZB&*/C@'?  !X   'T!X8!S@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M>*^4>NA_?DO\(3^/)Z9>#'7#Q7RCUT/[\E_A"?QY'3+P8ZX>*^4>NA_?DO\
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M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M0W-#U.2?Z>9;]9MG-=NKTSC4,C,!7V5S3-$UN13]LYF!! K7J]]U#SZ/3]K
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>tm2030088d23-ph_inppha4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d23-ph_inppha4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!#@-T P$1  (1 0,1 ?_$ 1H  0 !!0$! 0$
M       ' 04&" D$ P(* 0$  04! 0$              0(#! 4&!P@)$
M!@(  @0%"0T.#PP&!0T! @,$!08 !Q$((1(3%#&3%1@)05'451:6UE<9\&%Q
M@;$BE=56MA<W69&AP3+2(U/$186U=H98T3-SLU1TM"5U)C9WESB8\7+#TR0T
M-4:FQB<YX4*RM[AY4I3%9Z<I8D-$A*5FYD=(B*A)$0 ! P("! 0+#A,$!P@#
M  ,!  (#$002!2$Q!@=!41,487'1(I*3TQ46"!B!D;$R4J+24W-4U%56%_"A
MP4)RLN(C,[,T=+3D-765-U<D9)0V8H)#@Z-$1N'"8\/$12='\80E9:4F_]H
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M97H2NQ=+<0@6:=F+)-S;%M&)L&SDLBJ\2[N90#@.8YRN[%X+$8'3$5J'M+:
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MKUS%;YJ_+32H^]3E?5FS6:YPE,:1T=.TFLNWLQ,-)1XV<+/+E8*^65[!M$K
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MYD?ZAJCI^=^'75^*J"IG9\_?)*1HU(;FKT.4Q6R!3%-LJL 8IBI% Q3 ,AQ
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M/WD5(+L>''AQ8<7780<(.D!,<&+%5M>GT*:JTU>:EQVQZ*C8%OD+Q<]V<O\
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M>Z-^U<I'S;+'3")A$PB81,(F$4;:H_R5DP_^CL[>(?\ XW;$']'-7D_Y&_\
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M]4;3B&-A!:T :N+2=?G=#HE47#Q@?R4K2'N+G:36A)(:!3S3JJ=&H+IG"?\
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M0/\ )RW\?Y';G^I[D,?-ENU^5%MVRV[HI\H+?Y3^768=JOO@R?*'>D"_)R;
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MK0BGX6V[JKD.^K?I#*V5N[W,26N!_ 7_  ?_ *RD+Y13G\_)R[ X>M[CMS_
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M"KT-><_GF:.6KM/T>.T3*-7*#E,JE0V]U#*-U2+$*<"T0!$HF)P'@(#PR';
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M,+:':F90<.R6FI"27B*Q7F:ATHV(:&0BHU-0Y6K=$%#]8E%+&$6'7O7].V9
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M5]]5MB5&!N,!(LI"/<QT['HO"E;2K-6/?]S<& KR,<.&:QB=NV427)T"0Y3
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MX@+)-+@)1$P<=)E<WAQ%FHG=R?,'LY/#HPA[-%:UTO<'UI]:!T5L!,WO8Z'
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MKH%;MIE>'3074 3&! YP H];AG+;:6#LRV8O+9LAB:(7/) J2(QRF'6*!V$
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M0''16FE;K(,US"]OC#<R8H^3<:86#2".%K0>/A6Z&WK+*T[6-WM$$JBC,04
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M*44VA#3R\,P19NIUU&-%G*+9[,.$C.%@[54PJ*"(G,/2,J1JTJ7\(F$3C\W
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M)=X]IF%W=0V,;;:]:V>5XC9'(^QN&1$O.AOWQS #361K6RRF5L5ZU[G!G6O
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M^*JD[!NDH"J<C;54"]81#L$B<0$W6,->\'=;E.R&0V6:V5Q<2SW5W!$YK\
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M,9<4P:(("11=9+CP#C=G=QNU^TUNRYL9K%D<D3Y&A[Y2XAES-:$8(H9'C[Y
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MACE<Z>%MY&Z2!TK#&UK0X,<TT>YP</2X2'&Q<9=/;1<K(8_K:M!)<W&"6U%
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MRHQ-N'LD>Y\CL$4<43'2222.H<+&,:YQ(!-!0 F@7F]O;R7,HBCIB()J30
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MK #0*X@ZM -9< 2=9Z6A1U8[))6R?F+/.O$WDS/23N6E'14V[<KA^^6.X<K
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M:1M:V2:6.:20!M")#+$UY>#B)+@ZK7%JOG.+LN#_ +UH)(&!H%7.#B=&FN(
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MK[5'V(ZB)W=O^P(^*)^IQS2T]JC[$=1$[NW_ &!'Q1/U..:6GM4?8CJ(OJ
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M9J,^\;K=AG637.5NL,[!GB<T$PVM&OUL<?[7]:\-=YBOVNV>76]RR?D[CK7
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MV1W:;42;*9Q99C/>QQ1R%\(A+")&X@!CE8ZH&NK=>JJU.8;06V7W)M9(Y'/
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M&T&166?6K7LMKVTAN&-=3$ULT;9&AU"1B < :$BNHD+IK>9MQ;QW#00V1C7
M'6 X @'HZ=*U?N_.30:';K!3I*KW)X_KL@I'.G<>C!BS753(F<QVQG,P@X%,
M04Z.L0H_.SYVVQ\:G8K8K:>]V5S'+\TEO;*8QO=&("QQ !JW%,UU-/"T%:"Z
MVFM;6Y?;.BE+F.H2,-#TJN6*^?MK3[C[\/T4:Z/U9[.9\M'=[\69QV-M\(5C
MPML_:9O6^R3S]=9_<=?OH=C7>'\/8\M'=[\69QV-M\(3PML_:9O6^R5//UUI
MT<*??0$! 0$$:[Q 0]80G@$!QY:.[WXLSCL;?X0H\+;,_P"QF];[):X\OV]]
M1:+D=T.F%4N*Z6SMK3%XC$VK:"*:'K;UHS-%UM<%9LI>,-*N)'LNSZQ.P6('
M'K 8 YC9SQK=W.S\E\^/+<W+;J[=*VC;?K6$#"S\/]:XOI2N@A9UYMQ:70B!
MAFJR,-/I-)X3Z;A%%L?Y^VM/N.OOTT*YP^E_?W.G\M'=[\69QV-O\(6%X6V?
MM,WK?9)Y^VM/4IU]^DC70^I.X\M'=[\69QV-O\(3PML_:9O6^R3S]M9_<=?/
M$5S[>X\M'=[\69QV-O\ "$\+;/VF;UOLE.6E]]UG>'NE]SD//1'N8"(%[Y<3
MC2=X\L^5!;]U\GOGO'LO))^OU^K^F+PX]/#V+=-OIV>WO<_&16MY;'+^1Q\N
M(QBY?E<.'DY'ZN1=BK36*5TTVN69O#FF/DF/9R>&N*FG%750GB6;[-OC/6-%
MGKR_CW,JU@2QQUF#-5%!POY1EX^(3[-98IDR=FK( <W$!XE*(9U^\+;.VW?;
M'7NV%Y#)<6MDV,NC80'.Y2:.$4+M H9 37@!67?W;;&T?=/:7-;30-!TN#?J
MK4'S_*C\7MD^S$7['SY9\M?9;XCOS_O8ESOA9;>TO[(=1//\J/Q>V3[+Q?L?
M)\M?9?XCS#MT*>%EMKY%_9#J)Y_E0^+VQ_9>,]CX\M?9?AR2_P"VQ)X66Q_V
M+^R'46OO,QS!:[YC-8+Z[E:18(T?=%6Y]E*&D8U<[)2(DDC2()D*B0W:2$"L
M[:E$!X%%<##Q .&<[M1XVVQ^T^5][)LEOV_?6/#N5B-,+M/GM+F^:LNQVW@L
MI^6; \Z"",0X1HX..BGACSWT:-9,XYAK:P-6,>U09,FR4M%E2;M&J1$&Z"90
M; !4T44P* !T  9OX_'4V3BC;%'D=^&-: !RL5  * >8%BG:V!Q+C"^I/JAU
M%ZO/[J/Q>V,?HR\9['#*_+8V6^([_MT2CPKM_:7]D.HJ^?W4?B]L?V8B_8^/
M+8V6^([_ +=$GA7;^TO[(=14'G]J( (_@]LG0 C_ -+Q?J?_ +/CRU]ECH&2
M7_;8E!VLM@*F%_9#J+>>&DB3,/$3"21T$I>+CY1-!0P&413D&:+PB1S% "F.
MF5;@(AT"(9]DY3?LS7*[;-(VED=S;QRAITD"1@> 3PD T)&A=7$\2QMD H'-
M!\\54&;=YE*/IBPQ]:L\/;9%])0B$\@M ,H9RT(T7?R,<1)8\C/12Q7(+1AS
M"!2&)U#%'K<1$ \=WG[_ '9'=1G4&1[0VN8S7=Q:B=IMV0N8&&22.A,D\1Q5
MC)H&D4(TUJ!J<QSRTRR<6\[97/+ [K0TBA)'"YIK5IX-5%%7GY:D^YC9/V)J
MOPQSS;RS]V7O#/.U6OPQ8/A9EWM<_G,[HGGY:D^YC9/V)JOPQQY9^[+WAGG:
MK7X8GA9EWM<_8L[HGGY:D^YC9/V*JWPQQY9^[+WAGG:K7X8H\+<N]KG[%G=%
MK(?=VHC<V"/,8$9L<(Y+5IZN-?[I"=M[M1>!&EL0-?=:,<++W%F,T$.OV@+@
M!^I_ZV<D?&JW9>& VFYGGG)<UP8.2MOPM<./\KI3D^MZ8JLX;;Y?WOYGR4]>
M4K7"STO%^$]5]);-^?EJ3[F-D_8FK?#'.L\L_=E[PSSM5K\,6%X69=[7<=BS
MNB>?EJ3[F-D_8FK?#')\L_=E\7YYVJU^&*/"W+O:Y^Q9W15\_'4GW,;)^Q-6
M^&.1Y9^[*O[/SSM5K\,4^%F7>UW'8L[HLZUKS8:]VE<HJD0$'=64K+IR*C=S
M,Q\"WCDRQD8[E%P758V20<E$Z#(Q2=5(P"<0 > <1#M-@/&6V'WC;40;)Y+:
M9K%F-PV1S73QP-C BC=(ZI9<2.J6M(%&G32M!I659;0V5_<MM(F2B1U:%P:!
MH!<:T>3J'$MG\^B%O4PB81,(F$5R_<C]\OVKD<*E6W)4)A$PB81,(F$3")A$
MPB81,(F$3")A$PB81,(F$3")A$PB\[MVT8-7#Y^Z;,63-%1R[>/%TFK1JW1(
M)UG#ERN8B*""1"B8YSF I2@(B( &$7CAIR$L<:VF*],14_$/"B9I+0DBSE8Q
MV4IS$,9L_8++M7!2G*)1$AQ # (>IBJ*Z81,(F$5.J7K=?JEZX%$H'X!UP*8
M0$Q0-X0*82@(AX!$ ];(T:T5<E$PB\+Z4BXM(5Y23CHU #M$A6D'K9DD"K]T
MFQ8I"JY523!1Z]5*BD''BHJ8"%XF$ R*HO=DU1,(F$3")A$PB81,(F$3")A$
MPB81,(F$3")A$PBBO>7XF=I?Q%LG\&.,\WWP_P K-H?W1<_BG+7YM^S+CW%_
MVI7!;/Q7UZ5Y.LBJ%?/;+95ZJDY39*6:Q0E?(\6 #)-#S,FUC2N5"B<G7(@+
MGKB'$.(!PXAF\V:R=VT>T5AD#'B)U]>0VX>=3.6D;'B.K0W%6G#178(C-.R$
M&A>]K:\6(@5^FMCI/25)LDW/5;7(;!B9"F7"PUVS62]IL7U.\CU:+E9"7G#O
M(&#8NX:3#R.LHE&F*[56;B40.!NMGN.8;J=E<ZS.[R+8P9O:WF6YC/;W-S?!
MC[,PVT4LLL^.&%CX91R3RRWI*YS,)#JU6T=E]O-*^"TY8/BD<USGT+*,!)=5
MK06G17#I)&KA5P:\K39Q56SLUZBD9VP6JNLJ/(G))^YJVUZT4)Y;X4B#((09
MF+G'KEJ9(QG9D4$"IG*8IC"0QLN'<!:29 V8YM W-[J^MV64A$G-KJ"YLGW4
M :SD>6CG>YN$F1S8V!K@YI):54W)RZ /,K1(^1HC.G"]KH\8T8:M<2#Z:@%.
M/78X/E7LD\XCHQM<ZBC.G90LE8HAR$RF:HL+)5Y>U0+J5?>319.DWC.)[)4&
MIUC-U5B=8!+UC!J,L\7[.<T?!9PYIE[<S=%#)<1.Y8<T9<6LMU Z1_)X'![(
ML+N3+C&Y[:@BI%$633RO$;9(Q+1I<TUZP.:7-)-*&H%#2M"5<(_EJA+*RIWN
M1VK 2SV?B+9+NUE8V?0;OD:]9 @42U>.7B&LG(+*'.!3HFZRQC)G4('9\ '8
M6NXG*LYMLM.SV?6L\]W;W4KW&.8->+>XY!O-HS$R1[B31S-+SA<YH+:*8\IC
MG;'S:=CGO:\ZG $-=AZT$ GH@Z:Z1H6LEBA'-:L$[77AR*NX&8DX9RJFDY0(
MJO%O5F2JI$7J#9XDFH= 1*55--0H#P,4IN(!X'G>5S9'G-WDMP0Z>TN9(7$!
MS071/+"0U[6O )%0'M:X#TS0="U,L;HI71.],UQ!\PTX=/GT*LV:K"J%W'Y8
M^G0>M/G0[\/_ -_S&?L7XO>C<UD _N;OQTB]2R+]D0?8N^W<N<O.A^/F=_P%
M5?X$:Y\%>-GHWRW1_N5K^*7&;3?M=_V+/M0M4L^:USZ81,'4I3(;J1,GH(F!
MH1,@Z-*+<?D:_'2Y_B3/?W="Y]5^)Y_-B3]TW'XR%=)LK^U#[B[T6KHES#?B
M/V?_ !2D?^#S[MWY_P H=H?W;)]1=CG/[*G]S*X39^,]=-%Y4F*::HF0=2)D
M@41,$T1,$T1,$T1, U1=_-1!QU/JP/\ [MJ)]ZL5G[<;M-&[?9_]R6/Z+$O6
M\M_9EM^;Q?BVKC;S&_CTVA_&EU_6&V?E-O[_ )PY_P#G[OM6KS;.?VM<>Z'T
M H4SQ[45K57*@.%$P[4B9(U(F4C643)"*F11%TA]'WX-M?R%^I<L^]_$@]-M
M-TLO_P#6KL]D-=Q_N_1>ME>;'_5ZV+_4JS]^M:_H9]">,O\ R0SWW.U_3K9;
MK:+]CS?ZGXQJXE9^0NI>9)D U*)@Z31$R3H")D#1I1,D&J)D:M**AOTIO]Z.
M2TU-%!]*>DOZ%:-_D/2_XI5K^!6.?N7L=_E'*OW;;?B6+V&T_)8O<V?:A<R^
M?7\:U3_S;QOWTV[/SV\=(5WBY9^Y6?I5TN&VL_:,?YNW[>1:/Y\>G0*+F%3*
M1K15RHG@1,:@BID'3I15Q_I(F5*%LUR>_P"L%2O[4MWWFS^?0_BKC_YLRP_^
M#=_HLJWNS?[9AZ3_ ,6]=HQ\(_1S]9UZ8-281,(F$3"*Y?N1^^7[5R.%2K;D
MJ$PB81,(F$3")A$PB81,(F$3"*O1T]''UOG814PB81,(J\>@ ];]'"*F$3")
MA$PBTBY_M;WO9ND(&.I%3?;)8UC<.K;WLC4D:^9,GNW-6U2>%[<J"W)).V$3
M+J2+<R3D(YXL1O("T[$>L8Q"FBB@K3>%U9M&Y6S7374FDMR<AN@+[O\ V#,[
M%9:[M*= N,E1HO0QT&=UN5"A'\W2=(IVK8,4A&-FL61-TMV8/C]DZ.BY".@G
MH?1]'_Y4$ZPL'.?M:I'N"^Q-X;!U!JS<U5Y=+=*<OET2>WG<FI=?N-G25RWG
M0Y=H]9+34W9;%*4M@]D81T:8/&Q\@1!;@9P&%'H*W/YGGN7EHF@+S/-@YWK$
M<NVN;3K>#K5HK"<-#62;YH=ZQM*F^:1NVE$:S)+O-'P44TL"RA7#15PT5*\
MST&Q\GI:D%>%2)M#77I!8ZA,K5!7WF7D'UTW[S%I;&K=;E7DW/4:C0%NV0UY
M:SZOK$99*-/-Z5-(R2;R04++"5T08A-^48AH9N2-/"IZI^JO9.Q/I-&&UI)U
M6Y#<MEM;_1[IDR":2J],T[ W='EK?(M9E!LRNVPM.6-R^W:DCUV"K")L#2<6
M(H60=5])<J\\*C5]'0^BJ^&D]:<\=XLFG*UL'8O-S3=5R.PKJ[V!+N7LM2;S
M%QS+3M<<C$NK//7G8UG6J<YLAF*;-PH5HF@\5?DBBILU$%"1K4^BOA.5_P!(
M@%1V A.FYBG9*AM.B\N]-=T6ZOV$];-5TZR;3L4YS(3$?%*(V^S%OC22J<2Y
M5B).$FE"M%3'E&K0'95&I%$AM%\Y$VOKZ\7VC[WM6Q;1H7EI@+:_EW"<W&,[
M7K;G'K<G=(VUP;B4<L64@VU7'(S"*ID%BN%!=O4U3.#K*BX4I77T%(TE"^DE
M<06T$F3GF;97YQ6+8WV2_<SM?4I*^P5N8VLJ:S><JR#!\X6C:XTTD+\9,&B"
M+(S4 (^(=V)@&=.HJ*'@74;D_K^W:E7]W53;$SL*QM:YS);.CM1V#9\H:>M,
MSID["IOJD]&?6*5W-18RCV2(V77XJ%(GV0<$TDRE*1H*VYR5*81,(F$3")A$
MPB81,(F$3")A$PB81,(F$45[R_$SM+^(MD_@QQGF^^'^5FT/[HN?Q3EK\V_9
MEQ[B_P"U*X+9^+!XEY.OHDJJW5370541614(JBLB<R2J*J1P.FJDH02G343.
M4#%, @)1 ! >.5Q2202MFA<YLK'!S7 D%I!J""-((.D$:0@)!J-:GZP7GF):
MP=.OMBL5O8P[N4D!J4N].C'^6GZ,2S1?RIVH(H.+(FZAY$C<9!XFY3=(F.CV
MIP!4H>R9QM;OHM<IRS:W.KW,(<MEGDYK(\B,S/;$P/E<RC77 ?%(&&>5LC9&
ME\>-P#FK927.:B..YF?((RXX''14T%3JZ[0:8G5!%14Z59EK?O9X>&?K.+LK
MWN5:6FN*^0EP:KR,'!*Q;%_ )%C :"UB:^)DTT6I>ZHM^(@0 Z<UDFTN]NY=
M;7DCLT<)+AEU;GD'8#)! 8XWP 18,$5N2UK8QR;&:F@:509\R.%]9-+L3>MX
M0V@+=&H-T -ZT#319'4Y?F1LLU%4>O/+AY6AS)QR+5VR2CSQ?]XY.,9M9^3D
M62)DD48-^Y;LRR*PD136$B %$0S=[/9GOOS_ #.#9C*9,PY_;$,#7QB/DOO$
MD3&SRR,:0!!)(R(3.(:U^&,"H5V!^;2R-MH'28VZ *4IUI Q$CU)(;C-!6@H
MOAK9/?<E41<:_>G/5:ZO.-6,:Y?5$ =NBM4;//Q<+!6)0SZR+-6Q$Y%5JW1<
M]@?@L4A5# 8:=AF;X<PV;=/LC*79#9/G:R-[[7KW86W,\4,%P<5P6-PSNC8U
MX8ZD@ >033:=\C!6T/WAI( JS2:8W!K7:74'7$ .IKI503*RDA.2<A,RSQ>1
ME)9ZZDI)^Z4%5R]?/5CN'3I=0>DZJZRAC&'UQSQ[,K^]S6^FS/,I7S9A<2ND
MDD<:N>]Y+G.<>$DDDK7O>Z1YD>27N)))UDG34KP9A4"I7<?EB_$%K3_!#_\
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M%"Q+E-F9"2,F@W4.8$3*<")F,/ "B.:6+8_:RXM[>ZARO,7VMU40O;;S%LI
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MQ?ZE6?OUK6?0?C+_ ,D,]]SM?TZV6YVB_8\W^I^,:N)6?D(=:\R4EZ_U=,[
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M=1KB"0#4;2Y;&971O$3:5)% *UIKZ1Z7#K"]]*U7=]A-GKJJQ39ZBQ729?\
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M,?%@8[DXGL(J[2YK6.91QII)Q5)I312B]->YM6E?2A'*%.E#RZ$548B9,-G
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M12;1:BJJJA@(FFDF2-$ZBASCP   1$>C*V>,#OJF>(H<]O'2N( :&1$DDT
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M:%9])Q&N8-K/5K7\Q;"47:4G)N+!$R[R3->(RSLG.LXI=9JZ;(':2$8=8#I
M D<(%!)8X$^L'S_8[/=U>6[%6D.;6F4W&T RK,I9'3Q2ODYY%<M=E\;BTAI:
M]A=5HT/8,$AP]:M=;S9>RT:V6.%T_)3$EP)/*!XY)I((T.;6HX10$@:#G<J[
MY60:W<T8E2/)ZSBY+&1486<]H.[<P46K0":W<D+W"-AV5@.N#Y-QP+V93E4
MR74 .HO;K<*+?-39MRH6CY+QQ:67)N"]\$1L>8.])'"RX+^6:\4 #@X.9A"R
MY'9)23 (^3J_@=C]*,')'4 #7%7S="]+N\\O[-;8S^O,J7"+,S[4@:@VA6,^
MS;6BNJQ]*?U'RTW[<Q90)*:+))@144T^Q**0D(F4@9?FVKW0VMQF]UE#,MM'
MPOS2"U; R=@N;<LLI+4RBOWSE)N< !V%N$%A:U@:!+KG*F\N^%L37 2M8 '
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MBTKB-4KR.UU73MJRDPL>O8-C;&MG@K2,O(-FQ1K\S#L#,':B@@X5</D0.0#
M?A<R+YL=XN6VFR$<=EX/63<S+G,9)R]A#'=-N8+DRR-:.0EAC,$CG4<Y\S,3
M0ZJKA.77S&68#! T2U(!QQM#PYK\1^M<!A<=9+A7A6J[9G1$=NZ]MUC;UN/U
MI>YQ6UN:PBU=D85BGEMDW!I0TLT!,Z@F(TANT,*77 Y#@8!XB(9X RSV3M]Y
M.3;19NVRBV)S:Y-TZV#7B.VM.=30B&5M*FC8<56U#@0034K3,%MSV*>8,;92
MO+BVFAK,3F@$=)O IEC[#RPRE$6>RE9HL78';Z7"5C$36:/>,7C:PLF]54KR
M+2+EY!:OJUIH0[[J2"/:J'=&5*9<Y!#TRTSK<9F.RCKN^LLI@S1\L@EB!N(W
ML>VX8RU, 9%+(Z#FS6F:D[,6*8O!D<PC/CDR5]L72,B;,2ZH&($'$,.&@<<)
M:*NHX5.(D$E9J[8\OTD-@GZJTTPD>&B*V9^,[%SS^E0QI&^*LP[9:-8Q7E!\
M_K:ATTNK'HJ)&*F#@ZBO!4O62VVZ&^==YOD;-FP^VMK;E#+'/):0F2]+=+F,
MBY1[[<N:VD#',HT2N?)1[<AS,J<'RVXMNL#:X@3&*R4X *DMU=:#JQ$G2L0.
M]Y4P2<^3F]2+6!FG M6\HQLRNQ F_P *)U&CCOIR'8_@W+KCLBB@H)E1*!@4
M*+H3&'F777B_\W>+!N7C).=NP-D9<F_Y;OD2QV,C!S#O?A&!U74J' S5*L%V
M1U.$1\A4TJ'<KBY3CU<ER? =/'UU2KC#3O+#(3L>\D(;6$<0%M@Q#IJ=E.LH
MM."8;%C"TZ8[JJPFF#R;>4@5SB*H).'28F BS=<$Q#89=FVXB[S6&ZN+?(X@
M#?PN!;.R,01WT8M90PQRL?,ZTQFK\#Y&U#9(Y<)%44F3OD:9&0-%9 10@81*
M,#J4<"XQU.G2> M-*1YL]SRY?@H[KKYK"+64KAAW-^4TRTM@RI+!(#,J/&#Z
M-=B-9<0 AW<BTHJ4G%$ +VQ3F-P^WL^YCYO3;[(,M'9SC9@>#,RZY83R<L71
MOC>>;NMZ<F'W+@W[U1I>UY=C7AR?F5+0-,]10Z<=<1K6H](6ZJNXA2NE9#3+
M!RY"O58J;@*$*C#4%9=*2\FWE6S61V>Y4:(6IG:GQF$RV.9I&-!%L ,#MP<*
M*GZPJ'(8FZV9SG<ORV7Y?F%IE(EAV=MG\M(V1K),R>6-NF7+RR9M61,^]CD7
M,QN>:E[FEMRWDRBK(YF0FENTDD&AE^O#S0C0!4=;2I)UE?9%]RU)MVR[)+7*
M$ G;)E>PL)N(NDS>5^KLM%:#1J;Y%2,;IT_W @!?^4%'ZPJ@.6ZJY^(78KS<
M@RW9+:MR5F4-S&9UQ'-%=S7KCWR!@%J\&-HM.8T'WP>E#Q+$^1P4XLG%"SD>
M1#R7!S7ND_" @,.@8.3X_P#6:22K=8W^@J;39T\ EK*_70J]L5ATS1E@<QY$
M)>^PQH),051A3.'$)2G#D4R"<4$SD$H]H!0 V%G5WNBV8V;NGY2,DS;:,.NS
M".3G=&!-?PF &HBQ.ALW2%H)P!S2#CI0TRNRNWM7F(02W574T.(H7C#ZGTK*
M] :M/#FS6Q\J#R<OB*]9UXVC(N5CV%>5.6Q1K:;IAH15U)R+!<L9/.3VSW1.
ME$P%))BH1!- J)BE(?K]3;9UXO\ <YKFL4MGD[+.">.. GG$;)K,PN?+(QW)
M3N-T;AQ'6-A<&-C:PAK78LALV1&64.CA$;7 -/7"K,-21H=U^*HT!I  IJTX
MJRG.6AZ#..D8>EL&D*MJ%Q%R24=.%?S+YY1)(EY+;UVI@4DH2,N967E!)%-'
MK)@J9,#F,8PZ"WS7<=<\E97EOE<=M:NRET<@CGQRR/L9.><Z<TUDABNQ )VM
M#:MQE@+G$JPR3)W4:]L;0WDJ&AJXEAQXZ:VA],0%.$BNE7. >\LJ1;(-M;ZR
MD9P[6)+)C7&]M@:F+ :[)EDR4,CN/L+OW0IS8H=91N2/*<W4%+J)E7!3.RJZ
MW'1F^=G[<CFS4LBY7F[;J"U,?-Y.5%ECCN'<X$W)U=&V ..$LPL$H?<A=DH#
MN<" R4%<(>UE,)KR=0XXL5-(P\!%--8LU$K"Z6W)#R%FL[/N!M=R,N:1BUWK
M55JZN&OG+Z+B!<%9JN6$TDM)I("?LA!)80,'0&>?;O!E6Z_>?;W.=W\1LN\\
MDW*1.>TL==V#WQ0XL!>R8&1C*EG6O(=2BPLO='E]\U\[Q@Y$FHJ-+XZ@:C1V
MFFC45*;/FH:.Z)>'3@LQ&V)NSU35ZTQ3OUK;7.P15<=7-S*SDW>X9.,D9%^B
MI.E!8!!%,Z74+U#=41ST"WW_ -G<;*YI=R<Y@SEC<LM;:,7]RR\GAMS=NDGF
MO8@Q\D@,X#ZX6N;@;A.&IS&YR'6LI<'"4-B:T<H\/<&EY)=(W"21BTZA1>6Z
M;0JECT8O$OMAMGDD:B5.'C82'=VEM,OYZ,FV4@ZC+A3YM.9J?9L3E6<GGV#E
MD]=G(4!ZQ5#)FM;4[>;.9SNGDL+G.(Y+YV56L,<$+KELSYXYF2.BNK2836W6
M=>\WT$D,TK@*UQ.:J;B\AFR[DWR@OY)C0 78BX.!(>QV)F@Z>4:6N=HX#1>N
MB+<KJ%$H"-I/17$Z@:DOIY19A-I2YW*LS)ENC"<*+5THZ;-8]9(H&!WW98I2
MG0;("3B>[LK-N)BV2R>+/#E4F9M=923ET<PEQ&:07C)Q1Y<&QN:*\K@< '10
MQD$NKM>\@MHA<<ERH#"[0:UJ<8=HT@"G#0_6M;33ZZ9:N7I.5K%H0;:NK-K;
ML-9R4HE*Q-G-6XL8>\VH]S&NLVHOC-+RI7F\,L@LH*A3B!A*8IS*FS+V:S_<
MZS,;+/X6Y%8Y\R'+I)!)%<\A$(+VZYWR#6XL-XZW;9N8YQ=BHXM(<7DS;S93
MCCF @9.!$35KL H]Q?A K23"&D$\.GC4:TV[1)W^]HZ!V4UUA8[E<&\S6=@+
M+2\<W?5QG99I[)0 3<*U<3$,$H#YJ\*)"%!QW7LC\ 'AG"[+;49<Z\VLLLIS
MN/(\[S+,FS6V8.,L;7V[+B9\D FA8Z6(2XXY10 /Y/ ZE=.)#.PNNF13""62
M2K9-(JT.<2W$WKFUJ':-=*%;),]Y:SD):?4)LB.AX4+0+^>EVXVJHVV?D":[
MK-7E;I"1<:TEZK<6]AD(I8"Q<Q'!V9^*XC^O?6^X6>]786[OKQ[<[AM\N%]C
MGE'.;6ZGD&7VUM+>0QQMEM;MMP^)_P#9KJWZUU9*UD--L,RM'R.I,UL>.KG=
M<Q[CR;6E[0 6O#B/2/;_ *7"N7CD41<N!;&4,W%=44#*D(FJ9$3F[(RI$N"1
M%!)P$0+]: ^#HSX%N#&;B0P$F$O=A) !(J:5 T TI6FBNI<>:5ZW4OAEFM$3
M*0>-$R:HF*D:T3()'FHF*U%.%%3(Z!U(JY4*<")D&OF(MF^3W_6"I7]IV[[S
M9_/HCQ5J?/7EG'R-W^BRK>;.?MF'I/\ Q;UVB'PC]'/UH7I@U)A$PB81,(KE
M^Y'[Y?M7(X5*MN2H3")A$PB81,(F$3")A%7CX.@.CYNG"*F$3")A$PB81,(F
M$3")A$PB81,(GS=(?[N$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3
M")A$PB81,(F$3"+"=D4T-A42T4KRCY(]T<::/"3[IW_N8BLDL"W<N\LN\  I
M<.KVJ?AX\<Y';W97PWV/S#93E^;<^@,?*X.4P5(-<&-F+5JQ-Z:Q;ZVYY:26
MN+#RC:5I6FK@T5\]:+?)^#\;(>\0?AEGQIY$#OE,/X?^NKE?! ^^!VO[M/D_
M!^-LOO#'X88\B!WRE'\/_74\$#[X':_NT^3\'XV@]X@_#''D0.^4P_A_ZZG@
MA_>/6?=I\GX/QM![Q!^&(8\B!WRF'\/_ %U/!#^\>L^[3Y/P?C:+[Q!_0N./
M(@=\IA_#_P!=3P0_O'K/NT^3\'XV@]X@_#''D0.^4P_A_P"NIX(?WCUGW:?)
M^#\;9?H#0Q^&.1Y$#OE,/X?^NIX('WP.U_=I\GX/QM%]X@\/OQR?(@=\IA_#
M_P!=3P0_O [7]VGR?@_&T4?Y"#^C<<>1 X_]3#^'_KJ>"!]\#M?W:?)^#\;1
M?>(/PQQY$#A_U,/X?^NIX('WQ_P_NT^3\'XVRC_(0?T;B&/(@=\IA_#_ -=3
MP0/O@=K^[3Y/P?C:*/\ (,?T;CCR('?*;_\ U_ZZG@@?? [7]VJ_)^#\;9?>
M(;X8X\B!WRF'\/\ UU#L@?? [7]VJ?)^&^-H/>(/PQQY$#OE,/X?^NJ/! \-
MQZS[M5'T?@^'\+9?>(/PPZ,>1 [Y3#^'_KJGP0/OC_A_=I\GX/QM%#^0AOT+
MC\_'D0.^4P_A_P"NIX('WQZS[M4^3\-Q_&T7AZ_N$-]3W8X\B!U/\S#^'_KJ
M>"!]\#M?W:K\GX/QME]XAOACCR('?*4?P_\ 74\$#[X_X?W:I\GX/QM![Q!^
M&./(@=\IA_#_ -=3P0X[C_A_=I\GX/QM%]X@\?OQX8\B!WRF'\/_ %U/! ^^
M/6?=H/H_#>IMHH_R$'X8X\B!W#M,/X?^NIX('WQ_P_NT^3\'H_\ %H/I40WU
M?=B&/(@=\IA_#_UU/!$^^/6?=H'H_!^-LOO$'X8X\B!WRF'\/_74\$'>^/\
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=7O\ UNU[%WU>MW?AU.KW?K];AT\>'#Y^1PJ5_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>tm2030088d23-ph_mainten4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d23-ph_mainten4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!A -L P$1  (1 0,1 ?_$ 1@  0  !04!
M       !!@<("0($!0H+ P$! 0 " P$! 0            $" P0%!@<)"!
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MC!&31BU'W<W/(#FF*FHX3(D.YE $# 4"-ZP-,CG5E@@)1$# )1*(E, AL("
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M8A3;ZC!;%L7M[D5U%3+@R7(J;A,#F'C3BHB53B*4^Q16\HP[^4<3!ML!_$-
M4)W+AAM[DQOED;!G$#'$PJPS$3J (CLF<R:*?"1/?L @%'Q"(Z-X%CF&Q9@/
M11>B:S;Z3ZYKOH=!E0<"TB508WS(B4:Y;KO7R96CU]7Z>H5B\9C86;%XV%R\
M5(X3C@?->6T?/'+5@ZAP60?=L7<8Z8<8>AB]'1<H^JX\QC)]674_!-Q-)1>.
M<32O49=JK9FA@.9O,75RG8Z;6+*W,0.(C.2B"MU1^7-4#]A9S*D@*M_7W[8
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MA,2'\:;JF_W-Z8]9!::N_NCV%U;=9+2FB)HB[&WH(.GM!JUSQUC6)HT;O:G
M2>%<&OYMDB]C4KS=8!Z;(%O;QSHI4Y0:?5'#6/4**B1>78% (<%BE,GC(K;
M-BOEBVV5J(FUKSF::'(^4[#-6,F19R0.>3>/+Q!S2\.1%P_:MVJ$9$PZC9!M
M'1/&1FW2%,B22::8 6+;[*G3-]^@<SG:5,U A$Z%'3<;)-SI%5;OE'D>*QP3
MEB <#N&:W?C&$-A 5R H4?*V&(J?RV,Y"+CI%3S?#U3'R[+NH0+)JLDVDH\Z
M;DSD%62(DY/?&ZJIUA3#FG.8PAL80$*Q3F4YP?35A"/N4[4\3QTBYK%)GI9&
M/DI(K1FO<T:Z]>M(N?L;6&(2+>NE&ZQG#5( V;@J&X"L4XF;5%3?+^(FKFU1
M)H>K((-V*RYI!XDW1,@=LNH@!C-&QD746L^1 ANUZU<D6(8Y5"GW#AA"HQVK
M3A? ^*:$_P MSDF2U,98:\K78BNQ#".+"24@O88PZ$DQ53556+:8#NX.6BHB
MP3(0%CHG,J<$BU&Y-JR2]8>!W77IZ*:NV&$44LF=>F>C1V>:Y,R9U'=ONE4A
MJTUALYX[=K+H%=&FVT>DI.\HYC+JO:NHT*!EE!WL2RDHN%TS/<[.W62XR:(F
MB+UY/:R?]!YT-_6&?_Y5.<M8':5RQY([BSQZBJ:(FB)HBZAOMK?]H"R_Q3KW
M_*\Z*]4;5C/R?PYEYID=(IMH&99<KB7=R$&X24%14"$39)RY5B'2*((J<T79
M.TW:4"B #L)@',K3 L%LCN%U 2(;AW*4_$)1\(**&,8IMP$ ,&WBV#;U=%L<
M[%L#>$XB/;N/#L(^$![3=NXCOHL"5S59K\Q;;%!U>N1CF8L%BE8Z"@HAFF99
MW)R\J[18Q[)NF4-U%W;M<A"AZIO>ZB#E7I;OL18_Z".@KT<W1I+]0H=,5:OT
MN\K75A9Z\\8Q]EM,<CAO*V7LG.V<PU;N9^+6?Y(CS5EN#8QE$U91^1$I7+9J
MY1Q.*V[@-RLK7])G*8H4LV/O1X8QIW3OB2O1[>LQ%GG:;%368;K+)&(DO9'\
MA-H.AAB.8K\L-$C(G7(L8!5,HH!P*YMR JRG(-*CNI>75R=EML.8LGVAY%N+
M3>K^:/L=F>M8Z'81;9$%WS<[=LU1(Q*DU333*FBB " B81,8BM.RYT3X!F\C
MUB521KL)YI?13*0K0K*+KS*TD2376&/X!47?QT$,2H8R;A4C!O\ *P JACD0
M<.YL4P55J)Z.CIPH4Q/W:+BG\9996.F&$*8)!RY@(@TVT.DBX9P[AXF($*S4
M4$4^\@01V H%+L754#=]4EKF->K?IML=)D\./I2]S$9:"2]'>L^X-C+6(71(
M=%\D3DQTM6;LN(IM_.T<<JLJS.5F\%^Q.NR-CBLMJ[E]PH5TZ\NEG+O0=UCX
M-CZKGBP='D7D"NRJ*#%2F2T9/MT4*K)QB22;=.DY*Q?DEJFY/%'1.A%RS,XL
ME58IRJP2O<_#\/PVI@<"O)[L4?(U^;E8"5:%:RE>DY&"D6YDQ342?13Q=DY2
M5X#;BJV<(F)OON/"&^_CR6J1P=<,94QRAV% 3"7M*8X"'")AV G,X *83;^#
M8!#LVU4VCF7)-Y$Y$SI*  I]VDR]BJY>([QLLB4VW,#?@.<!V#8I@^2 VHLB
M<%WEO:17[8/I#?N-Z<OT[S#J25I>2O05UBMB:(FB)HB:(FB)HB:(FB)HB:(K
M9.M?^!KU;?Q9<\_O66K0J'8O'M]+/_#[S;O_ *DP7_)WQ-K;N7'J>4L<NHL$
MT1;EDS<R#QJP9(G</'SE!HU;I )E%W+E0J*"1"AVB=10X  >J.B#%9\LI04-
M@/I<P1A5K6XJQY.-8J/=082*::39DYK5A8V6U*KF(F1VW)9)-%XV7$?+[E&-
ME0*)'I!U@5R0&#*UNTR]XODQ(2-V>M3H%9.2QD5'MU&\+%BN(AR6R"RBRXE,
M'"(**'$V^X]@B.L5657:#CON< TC7*@ND3-DS\Q00!P4J@G731'@(!=BF5,&
M^P![W?59%\+-46C>PU548B.<,64L8!7<@9PO%* S<"SD6Y>(4TEP6$4@5X=R
M<SR1 0T552['6RFJR\6V*5JVE$N [Q,A#\ J!S%.$. "AQ@'A'<.W<?5!N8*
M*@YL>,GCDZ4G7_9#V%56;IO7<*$FW5=%3*P.X8&*H*94$#!QJ@KVCVE$H;:@
MP0J^K%"N%<F]0U0ID[BUMBUI8NF+(V#@*TD#SL58'IF%-C:U#*JB@B^EI(\#
M%R"3,SHJCA)ZY16XU.2<QJ$9==W,&-9K#V3[SC*P(J(RE,LDG"*BH'T2W:N#
M@Q?)FV JB#]B9-8A@[#%. AK8N/(,65-]%BH;;;^OHCK-_[6]_ILN@[[L\J?
MR?,N:DMBV4O+[Q]A>P3K!<A-$31$T1-$6T?_ $"\^M''S$^B=Q>,?Z8$/_W9
MP7\7'IU_>UBM; N/5\H=Q8LM%K4=$5Z'0+@%EU#]2]%JUC,"&/ZZZ->,CO#%
M$Q4J?52C+RC-$HIJHK2$HBU,BV0. %<*#RQ$.+<!V+. >2R6]0>6Y/J:S:X;
M$1;ML5X>?=PK%=*L0D42R)L&K*,(V8D A"HP%?3123$"B"2:31 FY6@''!;@
MIMKT.!FZ!U6J@")P$2B503D$H\ </RL1 #'\7;V>J.FP*JL,%6TUR@4&_&3?
MRP%+;B%0X <> Y!, %( ^H(>#53:N<LV/V[2#=RB+)-=I&,SRIF1&X+J*J1P
M"] . WE*B1=N \)1W$!$  >W4153JU:8*M&\HT2)POV35ZBN4P]V<D50#A41
MW'?B*42B'@'8P".VFU.ZN(F8)--=118AMS<3<Q?"82J#Q%[0 1+N8P;&#M*8
M T3G5IF;<4N+9%O(=HD,,U$I'WGAL7>4+(M54W;%TV<%)Q)KQ[])-?FB(CQH
ME#A'<1 F!',KR%7[KTFWHILHXQLD?YSZB.DR/'(53?G4!](S\;35BT#(#-BF
M#=5V5& CH*),4J9B%3C&BBH@/&MM0L9,0RZA:J2J"JB"R9TED3G2624*)%$E
M4S"11,Y![2G(<! 0'M 0UDM!7ST46\C_ */8_7;;YL30[%E'R@O>+QY^H"C_
M ''UG])66M:Y2G#1$T1-$6/3TJO\ K.O]UQ5^_5CG1%Y 766X%IU[]5[D$R+
M<CJXSPKRE"HF34X,PVHP$.5RFJ@)3;;"!R&*(>$-;3LYV7'/PG?5HQS;F,/@
MW$>P-@#M\6P  ;:Q63K2 ^#?;P^,-^SQZ.@5<.G7 &1.IW+M-PYC*%=R]CML
MPS8"LW:.W+6)9N7"2*\G(BR;.5$FZ/'PIE*0RCA<Z:")3K*)D,5&*]&'JPP_
M@+H?Z&NDC"&3*8QE9O%%DP;9ZG6GB;26D(V+Q/=Z/)7*1/')."QREBR[:%Y:
M/:/E%$3.(*-00!5,R:JFL=ZSV##\/P_#%6BY ],=8;!CFYX[JU1''D')RYYJ
M!@>820?I-&4RR?MPL"[-"/26-)L%3IKM&IBMTR_*R<12@IIS;D?%8CY+(MSR
M]<%;_9WPO)NP.COG2[M4ZRO*<M(UH+!L9,&Y"M2C'^2!@'<HF$?*$QC$WX+C
M+O*2$/LK$*19U2/&R:K=^W;/=X]V15K+"U0=%.F5^#(ZIVRH""J+A,BB1BJ%
M* D4R-)(DO"KC$*"D)4U&SULT J!U&PCPBF/&54GRTI3)F#8 W[3   (Z8(<
M5+4?$).E"II2;Y)L[>F*:.7!!-DHYCVX-6@JQ!$T8]86G+,4IC)&4,8YAXQ
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M[T"7.[>.1D$6T!DF.CXU !,82M)1%F @V;-46Y5W760]L>]%@=*OI";A?:M
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M,J5 !ZN\[ *QR H1(/OQ6H.,Q!$ .4OA$/'K:?)7'/PF'*K/S_)F[?'ZFP?
MUB5D.19N?0+]#;SK3ZUJX4[-N^B\3NH"V((/VS9W")VM62.K7Y>QMG;=TT=0
M=0CXB0FQ;*D,C(/HUJR5*9%TH48_*LAM7I']1%6B3X%EJ/BJX!#P]>K,QCNI
MSS18;0YK-?JTM&QN0;G.*+PEE3G+?9ITCLCY0Y#/5$D"O$C$=%44#':%F5T>
MIJ4JDO'DR5'V(9!OF@4)YG$NXPU?1K<&T<R$!#5V+;-G"[-2,;H1B0G=AW0S
MZ14<BF@1J5MQ50-L5+K%,O#2 (PZ3=TH8.[][63711*ERCCR@5325(9<YBAP
MD 0$H%$>W;AT1;]FLZ[LV5?(D([/Q<TA>!0J>Y"AL8YC\8K%XA#<PAL !X.W
M512KD!X_5K3U.-<-FKA,J!U'+PBB@$:)\M5^04P51$HN&A#D$VX\(#N ]@:A
M."BG^/7.4B)&JIS,P0+QFY90,<IS@4Z@CS!*!@)Y(% 1W$>W?LT&*JVTHM)E
M33+%J%.!R=BBR1A(4XG()^,"J^3PE[2CL("'NAT1<##W:51E736R0J;$8'8Z
M<^=XDPB7D8[*1!-<KQ8K;G.".UDRE9%*Z54Y1]P "B)2%7O]'N8,;8CZH,?M
M;O(3SN:D912[XMAHJ;F*LRL3U:JVE4U>D9MNS<M@C9MO)/4C-5T031=MTS*)
MJAQ@F44/;<>"H:Q6'I?ZX:DV=##93H<-4I.7=M.4YGS P7E8"1=@4A%&BB=9
M2CU1(H!2BI)'*78Q#AJA2072S3VYA-AV\LNP]H;=H>J/B]WHH&W+,K[7Y*8O
MIIN@LIA 3%S+/ 80'B 1#&]] 1 WC#5EY*QA\+X5[%>L%O31$T1-$31$T1>6
M5[:!_A,2'\:;JF_W,Z8]9!:*F_NCV%U;=9+4FB+M_P#M;/#4U;^G[JOMK&*6
M-%OKS&P,O."DV[HR0J-"6D%>\+*N4%#-B-+ZHW6(78W'(("!B[B XRQV+D4]
MG?5OMMSC)Y_I\;-,WT?"U:N99ZASXUK-?C'L0V'&DS=8U*#N,S,R4E+.5[)/
MA"F8<M0!;-F<*@ IB=0RAH5E@^"ILN5_YN:0\ZZF%5WC\2*-ZX9 %Y1H*Y54
MR3:SYT5!"+.W Z2Z;=K^604Y?"0AA4).ZBNEA1>HP,8R2>BB4Z2*KG<Y3&*Z
M7*)D@YZ)> 53)GX_E8$ #&XA#<IA+4]A4#Z@;>EB-E"SK45'#J2GXAA"N$VJ
M"_(E'SX4GO.*1/E@0I$5Q,!50XDCB.^_ 4"-BJ<8RN,C+9/0Q;<%VY;4JQD9
MIH6/;(\A,Z\D=XF4'7&+P%E898IC[@4IDR;%$.("Z.BO'<01X\[A-$R3I-9)
M1+@.3A2$H-VY'0\L@+;$ 5AY8'X@#A[ '8=5T5F&1,?0UDG6L.X*_5DHF1*]
MCT(-TK$+M07%JD](,HDL!P1Y)@.N;<5$TT@.GV$X@G<14MK<7;Z#9[4S@;99
MH^=;UFTQ^.7-<3&+81\I9:O,TNP04@LH5R==M8JY.O8]N<QSBJJX1!4ZI#JD
MU-[*^PLD&)+^CUD] V4ZW8TGKZ\N<?9,Q':W"I&A6LY:,:TM:WXRG$TRQBCI
M>7FI%:O+ H=4A"*F.5$A2B82W>L3R!=2/M\?8/C 0V$!]T/:&LUQDT1>O)[6
M3_H/.ASZPS__ "J<Y:P.U<N/DCN+/'J*IHB:(FB+J&>VMQ__ "!LH?\ NG7O
MWW_%YT5ZHVK&9Z/A_H7F=H\WS<^X4CF2[PPYBP 82)&X'O+(?R1*!E?*VW$!
M\D=M^W;,K1%\I6PT6*OU]&-T]V?J6ZY>G+'L!54[9%,,H4BYWY@Z!4L67'U7
MML&\L:,FX241Y'L@XT8=B45$^]2LDT:E-S%R ,. 6R&U=ROTK5KSK*]<R50L
MB2\-B6 PP[FY*7KE19HUF\76V/XM.$QW 6T[0STU=H<-3:\Y<LT7:3_N[QR"
MXD(^$JF*VX+$$O6[%'N)5TM.2*K4H* 0O#WR75-SDB<*"[Q1!L4"$4$> PE3
M(8R>PD+N)B*9Z?6&</' Z31<K/#&>@#F45([D2]\6,HX45<I@)EC (@0#[B(
M@ "/$(:(IME12:Q3ET\-LD@V.JHJ8G,,5)(H'$3%.00'AX?=CMV (;:*[%3^
MKV-HM=G3E^W29QUBC*A ,GPHJ)+RHO?/KH68+ 3CV)YT* %'P'X@W ! -,$5
MUS*,+' W08%!)- "(HI()I ')*< 2 A2I%*4Z0FX0$O"8!V\'AU5BZHQD>CR
MRZ[M[69J0BK *0GBWA')21R9A.)@*^;B"K9QSP'?RTSAL?Q@ %"8K(8JFE>R
M#9DDUHN=<+2,P_BI%4SY*-:M6:\_"F658I-9 7" ."N5VB#4QD44"%5,4X&,
M1,PB4/+O6<;H\MF-_2$>C;ZY^G.-IR=*MLSC*Y@X8*/5'"JUCAJ16A@YU- [
MEW%FGK10630S8694$S.&+]4B27$H5,C+SEGS-:/=/8]V3@=,G2[9<O$8P)KM
MU3(K$[/)$ 4((;^'LUDM;!:4-QYH)H"H86ZYMBB;=-,B"@J*#\EN4A0XQW\0
M>$ WT0[%WH_:17[8/I#?N-Z<OT[S#J22EO7H*ZQ6Y-$31$T1-$31$T1-$31$
MT1-$5LG6Q_ TZMOXLN>/?_>LM6VB+Q[?2S[_ /'YFW?P^9,%?R=L3:V;L%QJ
MGE+'+HL%]F[==VX0:MDCKN7*R3=NBF'$HLNL<J:2290[3'44,  'C$=$78?Z
MA,&U6.Q/TJ=.)3SL5;:WB:FY,MT"TKSM_#3M>8RCE:1=OILLDDC7U9N8L1UC
M**-U$EUVP)ARS@ &P7)8;-RR 0]=QN;"U?I*S%O'2DI%?E)K/>;T91"V.0,8
M%V#K=!Y^>3'P$ @$253$1$.84M[B*D$*T22=(-VK8Y2J< $24$.,J0'X! G"
M AR2D)N !Q#Y/:)NW9N5598F/V5503Y8EV*/ 43&X7 E$3' 2;")# 7R1WV#
MP .IM3N*1;V[K[&YXJ1DY]6(?.K4X+%LUFAUV<H]/'.6"3915,W$B!5I(@<1
MNP>,0'RMATWH2^"K;*1:A&VQ@44,8A!.*8I@ F,(".P>2 D*._;V[%\.^AV(
M"'5)+I!(E9<]1OPG23/P<9TSF,4-Q$5!(! 63$NVPCX1'L >+?0(583 58EX
MLLY,)LTF$8L\?&.BBFHBFBFDH9LDN78H(JR#H$^8?A\A,P[[AP\6H,2Z!?;H
MD04H/6J^QD[L,A$T.Z,G#F5!%4_ JUFE21,O#N4B#R5T9!O=R"7F)J)\]LV.
M<#%3[+N3?W5@TS%1U\:98R3CYPDNBI3+Q9ZX4CD-G'(BIAVT:G6#A+LHHU3(
M8>P/#K-<:6TJF^BBS>^UO?Z;+H.^[/*8#_\ Z^9<^+J'8ME+RN\5[!6L%R$T
M1-$31$T1;1_] O/K1Q\Q/H@7CN>D_P 1W#)G5.H_K"<<="L].G2TV?\ ?WY6
M9E7]BQP4D*P:@8ARF6?J1*Q>8H*;='A 55$RB ZR!PQ6F<<QPY%AE^+V_ UD
MM*K3TY5XMLSWAZN&3!4LMD6J-3IF !*<GG=JH<! Q% $.%,>SA-OZ@Z'8LH^
M4%V2O2AQE>3ZWX/&;0\/-Q6('$.X8,EFK66AI)UC^PU&G$:3::*;=D_:Q["6
MFG!DU")@F9J=(Q"F3$NL-BY&TK?8Y3J!W0S5UL,;7X-]**(,5) LIYM</UTU
M53(\N+:22XIMBJ<1MR%(FF(!QEWV%N0\RO/3P.M<*M(7;$Q"6U.$(V&>/3"L
MUH9H1JD4PG9G:D5!4Y3+$!4O"H8W]4 "/E'"#E"E9C(*5Q1XUDV\C#*.# H#
M*79+,'*2BJ!$!4224(DJ=NXXC"42@;;B  [.'0*,JM4^33<Q)"I'!0'8*$,N
M4>$>3L8P+G JBI@)N(;=A=]MM@[=J5%4>2?1CIBW[K"14*JV:@U>+18NR'D@
M0.N1FHN"[Y<J(IIB/ DB":0%\H"@81.:8*E<(5)J\BGAUG"!C%1<)F*J04S+
M$;IK*J%6%<X<M7F)$#<NX" !L4/ZI["BLEFVDP[F[%#1JD>1M(H)OG**BR?-
MCV\@0S!(Z95DN]+++E0%,4RGY"?:)A*)^(Y9*P#K I5?D\?.E69HI-]05$C2
MRZ"3LZG*7;.(IR=%=%GW8[R-1E".#IJ."GX$]R@)N$-$(54?3(./9WZ,OT1F
M60;1:*3F!S+4F2S!$CAVLS5EV-P,68DCJJND'R<C..#%9#LDBFH!R% 3F$<A
MM6N;,#SKK-!Z^JM*WD?]'L?KQM\V)H58[1W5[QF/?U 4?[CZS^DK+6M<M3AH
MB:(FB+'IZ57^ 5G7^ZXJ_?JQQH@7DK=6&++J]ZN>K_+,2=HE7Z_U@]0G>%TI
M)HUF6X16<0C';]J@_%!D8K61NT:0H&6*H85A,4@II*F)FX9MZTY9&;\ZQXF$
M1,(\0CZX]HCZH^_T*C+MM>U.9V1#,W6G7*LC&.<AQG3D;)5 0D$5'9PL4!(/
M:-&R:<:0!1E4(28R0T6526V13 06,/$D76)YELB=Q6;+JER7DN!P=E;$2MKB
M<57:T/)GIZ@<H9#-;A/,]0.;C/VRZA:_2:S?;<D]?Q,T_ "L8Y9M#F ACJI(
M$15 J^Y8;<>X2EGY&^,:M"F<EIL8Q@"<U\B=HA$U=!"OMU#2:ADVYUSHLB[&
M*/&NJ852DXA. $'.J:W;',QC.[OZS,Q!X=^Q,D\,V$AE(AXFJEQIS$*[*D5L
M]B7?  IG2'A Q3D'8R1DRT8HN-49@BIP*F'EI@4.6=,Q#\PIN6*8$(*QSJ=G
M:._B'< V'112#>X]CYHD7$P\!M!E9OBO>210ZRQ%2F(5 @<!E%G(\>R9  04
M,8H"'8.T]A&Q4ZU)!$D*95612>D6?.GK%8I#<(QBA$^XMQ7XU"*IE 3F*<@;
MB.W:  &U]A7;L4QBT(HFND*Q4N4= @$$W-%(%CI)\]4I#*%$$RG$1*&YMB]H
MB(#HF"DUVBS.>:0DDR.D$&8I12H-&;Q$H&(IWU5A%NB@==XJ"Z27'PB43J$)
MN3C,48BEW-, ]J=$BK*Q.]"W0,=(R%$F2G*5U49RL.(S-,>T8&;-RN4U)N1Q
M.2"002323!2>6* IIK'*H1=@?TAF+7?5]Z!*[7H*VWD)C%3]3(Z-E<N"*RBB
M-36?0SV>:.5U2%7@'U?K%> %$R<!2KJ)#Q&;J*F;U#B%YRR9=S%[1#RRAY.W
M%VB':4/&.WNM9,L LS/M?X.'TU70<&Z@[9GL ;J[ J.V.+[_ %P ,8 /ZO:/
M;H?)2'POA7L3ZP6Y-$31$T1-$31%Y?OMD6ASN1NK:4KU>[D#U#J+ZQ[$Y5?N
M!;-F\15L9=.-@FG1S$2765,VBXY4Y4TTU%53% I"F,(!K(8;5JF#(D#:_P#0
MNJM9Z[*5"R3]4FTTD9FLS4I 2J2"R;E!.2AWJ\>](BX2$4UTBN6Y@*<H[&#M
M#62TD$;5P>BB[P'0G*+]%OM>O,&8ZE87]6RAD6J7*QM@BG+B'F5)R[RDC6Z;
M.13U)=N\3>NF\E5$ ,T,*B@LD#]G*UB=JY$?)"M1S!'3Z<G+F<,WTCDO&6/*
MA5,B,[F#=@K.95I4:WJMKF7IXY$C82SCU-!Z)5C).)I\+ATHLL9TJ<LW*[^=
M4K)&O7D#&SSZ:++/9^VVAZ"A^]KU=S!0;>!AHY1@VE.!)-RC8CRK!1V8ZJAT
MV0F( ) 5, 5YE<FRBFY&8E6,HV<*,TS-T"IH))(K'3X5N\(_+TU@,W*(F,4V
MQC%+XB:(J!Y^HI,C59&*AER,I6N2#2?A73U(CMLI-Q:BKJ/CI%!VFH4\7)N4
M3D445XS$064V!1,.%4G.I5PE3()2:/EA_-.Y^34BSUB(7<U")HXMHU*2.>7.
M_9(/9YQ*2Z,RD=(CA9V@CW)L0"H 902DG.JKC))4PHJ':+G4XE2NN]$4%%<H
M@51 Z &34(8@&.4I1X1$.$_!N.P;W'>GL*TO,3%Q!).9-N+=\[:.FCJ-2=J@
MDQ)+OE#Q<8Y>K-N0L7NR<H8Z0F.4B9Q QR"4--R@7V-!)LZM8Y6S28M'$FFJ
M=B28E446$(BDN5M'ND2J22;*,=NUB(G5$% YKLY4C**"5,-,$5P7HL)"JQLG
MU=XSN)V+-_#0M@RC77SU-KYOC90]%>#!NHX(YZ]9.$XY:DQS%JJB90 .J0$^
M/MT"8=Y=:7J=@(FJ=2G4/5H!DG&P-9SIEVO0D<D)12CXB$R!88R,8IBF4I!3
M:,6R:91*  (%[ UGN6B8:2H:&_CU<%B6W+UYO:RG]!YT.?6'4!_*ISEK6=JY
M0\D=Q9XM15-$31$T1=0OVUQL& +,/C#I,O8^\_XO.BO5&U8R#C\.9>=5DO!V
M0,.-YZ&M,<W=BUE&S:1D80DL[CXF0B9FSUUTQ>.GD;'$*"LE%N"(."E49O 3
MW;+J@53AR=UK$2 50<Z9P-P\LY1#R3%,40,!@#R@V$-PV$![-58D'!=W/VG/
MTC*6N]]0W5W8XX[2M8ZD:ACR&F'S9(&$D]"*G+E.1A%GB(HF2B)=.N2RBB9A
M,W<L6IA -RF+C([EL@"!BKF+3@G(\O!H]4.0:M-)1_67EG+'5W#3$@XDP)$8
MPR';K!'XPJ4BP?%180#A+$</5) HE7:K(-UR)FW5,<I)SK)8JY>Y6NZ9%/%.
MEB"1L%ED#-XZ*:0<=$04>5.':QI&S5 RDG('=248LBHLHL9N@#CM.HL)M-B<
MZK,G&J-V++BV.4Q$R<0B1--,! IDESE$JG$4QRDXA';?B#;80 -,4[JVSU@E
M(-EVIG()$4:JIJ*@4C@$^8F'EBUX2<\I>$-N,IC^/UM$*I9AMK9[+9'#:Z0T
M2E%5:5;NX7N\4X;JPT@R6;,VT<B9TT;M)0CQ'\N NF=R0O )1X 4(!017?HF
M74,BQ(D "@FB;FMR 4B@@"@G$H<0J["?BX-^PVW8/@U>ZI@J?Y68N7$3)MTS
M%9"I"+J Z #E%OQ)+$4 !04 X?*D@,4"''< #M[0T/XE0VY47QA$L\A$<V!>
M.;NH.%:0T='.$RF(DX="B59NE&HD=.&[=9@V?I@X4$QES.!Y:BFZ1B%@1UDA
M]!0]<QWI +WCZ.,R91-_QHXK5AK\LS378.&^.LE75^Z7:E=<T$YU:C6&(0!T
MBF51,KC@#R1 XD"Z8?7[A]W@7K2ZF<5N6HLDZUEVW.(QJ)!3Y-=L[X;96"<L
MR:1DP]CTZV\D2$,'@$I1 0#+<L""ZM-8I+*J* BBLJ8K&14$$DQ,((I,7*BZ
MIMNWE((E,8X^ I2B(]@#JK%L&7>A]I%?M@^D-^XWIR_3O,.L9+*D,"O05UBM
MJ:(FB)HB:(FB)HB:(FB)HB:(K8^MC^!IU;?Q9<\_O66K;X.B+R4?298.N-\Z
MO^I;(<*YA$H2I0^(4I!"07EDG[@T'TI8OM<CW95O#.X1J!(AH?E"^>,^\K\*
M"/,5.0ALW&Q:91<DK$%JK2KANDVN$M?4AAR%48I2)%+O%OA9+G*FW<'AQ4ET
M4W*A]DR-C+,2\P3>3P[[]FH=BS@'DNSG#]0-)RAG_JMFK97V\M+ST]1L)8XD
M:3(F6JU0H-'BXZ_+PK:34:IB5O9;#=G*)FXE2[P1%1$W8D!=8K?BN6E("9G\
MGUUVLX*:)AK<RLB+,4"LA8Q\(<[QW"JH(&6?_E]NU!/O!1%-,1,(E .$-%-B
MO;HF-<2YQI%NJF(89H.4:+'N).NV9Q-$B(=1F$TR?2\7(NWZJ#,\RC%"Y,CS
MN 2I$$";G#;3<J%:E*0UMI,_)URU1Y8R38N'!%037;ODET@,8J#AJLT4.B9L
MX;B"B0@(&Y9BB(!X-'3#O*T[/*T<]R/@(DDN+=5O> 51$QC\]P7SO6R"0X*"
M8Q0,NJ0H!MXO!XPFTXH5>;)2I%2<L%EE4DW+4%5#IJG6.B &,<B22)D.(3!Y
M   AL)PW'A[-9(I,R"DBK!OWJI%V9F#9Z5R94 13*4&QR$<;AN4IERE*"?E
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M1VX.ND:2.X$P"IWI40 #$$=TPW[/$$66#+@NOYLJT] %Z-<S]85?.'4?F5>
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M%-SKA*S$ELME>3<S"2K&,K\>9O7'CXCR&)(2KB<@Y+SNV;+M1-/0",;#+)I
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MA;V6=17H<(FL9<:R<+/=-EY94.@37FUZN_:4^KUB,/$ED(V.*]F)&*;0K]-
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M".^+\J*PO%=_N>:X^=M=F8Q[%@F'F6OLV:8MTTF48V41:M&[4%3)JHH(F30
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MX3,FX9N-A3=-5$UDQ,0X:JRYE4J)E911V4KM50@?UE0HB)P,/$(<(>4!2;J
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M5UI=/DCZ,[JIB8ROR:.1>F[,],-DS!%\AEEG;&_X*>2+I^VB8=\9%)*5RCB
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M"! \?9K8?)7'_M.^K-%03!=3B$PEYA@W "B/8<=^TI^$PB >(=NWPZBRP?%
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MO45:NH+/=D>.#R+QVVH./&LD_7I.)Z:*I?-U.I46Z7.BR:HHI$,\<@0B\D[
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M,22$LOEW/G67TP9(E6CU*QIU3IJP_,4@S)TNK)2[&IWJR8-S&HVKKH633O?
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M3F)_@R?BB_'T1CR%.8G^#)^*+\?1&*]>;VLD8IO0>=#G"8#;,.H !V$![?\
MBISEZFM9VKE1\D=Q9Y-%4T1-$31%U%?;6;-XMT]V=RDT=*MB=*EW;'<I-UE&
MY'*W5QT8*(MSKE(*17"J:!S%((\1BD$0#8!U1M6,_)Y_^Q>9PGYZ18NX])!^
M5H]7:.7*!47()K*L2NB-3J)E "'%$KQ3A$0$0XAV$-QWSP=<<$LVY;0&#_Z2
M=_8RWXS1,0H]QD/I-W]C+?C-$>2=PD!_R)Y]C+?C-,$>2AW!_P#23O[&6_&:
M*8J?\=9&RWB&P-[9BJYW_&]G:'24:V*BSU@J<V@=!=)RB*<I NF#TH)N$"'
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M ':FOS%IARA,D^0^!/8!?/UD6_\ [M37YBTPY0KU<^0J'WO[YO\ J(N'9_\
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M&\<$>[9E6;NFM>>A(3+ARUD3L9).=CI=B!#IJ)$;OFIU""D4#CJID@#K/+,
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MJ5-J\EWZB-([XT<<I19DR<\RZ*'10)N@0Z2:93[%W$<'.0Y\)AQAL.65*(D
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M\ES#G*L)B D84W-8R'P9?F_.+!M@Z+,VUR#B ^,6%( ^6!'] 9L=OE9G!P#
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MFGKH]:M:HN6CD,<QRQ8_E&#E\#^+0%(FP,$M^3J3Q,<OD8X;_*GMQY#';*>
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MP./-@,1Q^1&<0RG#(P:-:3B05D0B%*W-K3@O80DDY+"OYE11_( RF'+ "\Q
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MZ0*WRN*Z4G,(0X95@U@</'R1I$& E3;MV$2WD2E!GYV%\M)R3I86B#?D\)U
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M.(444,)U%#QS0YSG$=Q.<YD1,8PCV[CV[Z*N=F[Q;%S  !0 I0 "E    [
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MQPNK'-%%EU-@+S%E#HB=0_"4 W$1'8 #4$8C8 '+]_E5<DDG:6_$ !X  !R
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M'\ZR%=:U5[D^G,[0XKK205EFT0HZ6<(BS1DEVC%5V0G(W YD4Q'?P:%1W5Q
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M81=HM]2%S][:?(VE)''CN;;9!<5]XX!!E8(VE$A05D%6:JPE[ZT03*H[7*W
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MRRU9O,P%.F!2EGGT0(@D D@8!;M2U6-C<&$:=*53J148SRSGC(9*8R2SSZ.
M)&) <;5S!>H3!3HBZ2D+,FCW<N]?S#QQC63+#MS1%C0JKV[3BYXWNY85C:U.
MYC*F Y 706.4PI-EE4N5#BKA:M&4>HGU1GFF3;G*,M04C5D<K&(J/'K,<8R8
MM$D9^N=,?*1/*9$D]7+*,LA$U)%L(B>&<X."06B2-U_Q/X=(^C(ILTM;E=1T
MQ:4\&&/YU=O8$7R]AAH^1IAT68D>PSH]8?HD<I FB5!'F")6ZB:I]IXUX=IR
MITH0KGI"-++0D<P/60B:0;&)ZJ8!# 1#X1*OKS3C,4X]89$C*U.33?,!*!;&
M)RRZ08-TGRD$\4CU>=/JJ"8,I1^]%6PQR#-C'U9\[<O5IUK.S\796#9NB<7;
M.7;UY^X04)N^<*H&*5 S@Q2&U0X\X4E[W2F92%4=&--R3(2F)@#=+),C\\R!
MZ+K5_,>D9!*,I%Y@ "$B3F$I"0 &(D(R(;I$A@,S!?=_U48>2D72I55R-("U
MS\':)Z4KDVV09FJM+R5-RKJ&<-H=^:3E&*=!>M0:JBU<'05$R0'YJ!'"MQOH
M K#+Y,;B=.<Y0D&ZNC<SD8'*3*0ZB41$Y28G#:!+*6OZ=&4BYR4YR$Y&,F&2
M%24B"(ER.KD&P+8AWCF^SGJ,PQ&N724A7;9'RT:S?1MFC76,9E&6J4! )U-Z
MY-;$RQYC1E;8Q]YBGA!XU$!;O ,F F*H4JKQ=PS0J&G6H5H5XTR*D3;2$J=.
M'5X5!EZ, *M,@8AI!ED=:TZ)EFC5%6+QF.KEF@(Y"3/#"(%2$N1I.-X'/67,
M5/JV49"BV2J27*BH?&]@0N$=6W<Y%QLED^WVVI,B6!VSCU$:V56;J;(B;DZA
MQ7.XXC@FFV45#DW?$6GV>NU=,O+>75T:5"H*T8&<1*XJ5(=,B+4^E3@TB>DY
M. @MUQJ5M;WOT6O"3"-(YQ$R -6I. S,#E&: #\[EA$E;)7.N-SVS$49!5R1
MG97)IX!6'E&==%%6NU[(57R#;8N:>.%&PJHHR0T!X#U AB'22$[A41*F)385
MN*-'IZEI]"WMS4N;RI&,9B !IPK4J]42=GQ-&0G%PT3*9)RD' :K9SK6\*,)
MSG7$""(GHQJQJ3C(DC!^KDXVC:=BH%,]4>/L6YARUC5MCA!K:394QK"A,NY5
M4$<@!E52@>S)VT?.X]V=NZI/LZ9N%HA,QT5$%BJD!(#J"'D:O&6D:#KU_H].
MRC&]E?THYY2)Z[Z1U9JES$D9,X/5 F+%\ ZZNKKUK9:C7L11:N*]&+DX5.MZ
MK.06P-/K(DPV$$'!RV_B>I"T2;O&JT;@&GM:_E MX:].4LZN;-NNLYJC)]-F
M0M+%I371Z WMM2B'+QL+ TARS)D;KE*)Q,7E4N+;VI4M94]*MHVMWUHL9&H
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M.2EJB\=PM@O%IE("!DK$PD)ZZHXSITS./:U2_.,:V<JOE(UHT21:B9(#)I*
MF;M8\/\ "6A:C1NIM3NJDZL:$)U9F$#4!E5ZFF9&--PYD8@  L\06/+AINCZ
M==PK^37G*8IB52<HQ,@93%*$I&%-XB1EDC%AAL++E<?UG!-KQ03$U 5\YXZK
M:44W;1S.9M+25B=I).X5B;CYQV[:6I _G1)*3B)9!P '.D19JN)2 (<G3+7A
MG5-$.C:814TNGEP$J@E$F76TYQD6F.D!.G,%BP,2P65E;Z17T_U=9]*RI@
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M -)&V\(A](>J&IZK'M_\W\J'B&8_L1YW_P *J-!R8R\4TDA1!N9R5411 _-
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MB.L8%TR_E*DV6[7U2RV0]7JW5+9* LT<2P2E8&G1V+7UA95$U#CZR\F#&EK
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M0,=5N"!C#Q(UY1C&0EF)B'<@L2W<;:<"0NPG;1G4G"<,@C,Y6!!( D>=]@Q
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M*HF+BMF2V % #6J=2K"<X1)+X1?<6!/XG/>7(I4J%2G2JRB 0\I#VPS$ >$
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M5B]HSC\=4IA'VJ5O+1C78UFG<YUVY?S-I4:H W=3LF[>&.Y5>2+M-10_$(\
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MN?\ [5UUP2:LB8B!Y,,!NV8/R\ZO?HOZEH_^Z//],7UT-]^]R[@]@+UVC_\
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MP?5_.MOGE#^?&Z?OW(<Q?BZ+^RG3[OW$GUVQ_;?-H?MP<!C;H^K^=;?.J/\
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M7+)H<+E,$T5$N-ZQO_CZWGR\:@T/1?J=K\E#T55K+[^BXCQG=,E.,5A<$:;
M2$X>N4^GQTI/2A6+=1?D-D$V@@@W#@XG#@_RIJ@!U3^20=#J-_\ 'UO/EXU3
MH>B?4[7Y*'HJUJA]3%0O>5,>4!/#N(:Q"7/'V);:\G[9>2Q-A/9<M8UDLE,:
M%C^JEPZZ@L@2L'%MT"KF6GX5==)919%L84%$A>L=0V"O6\^7C3U'HOU2U^2I
M^BK[#4FF%*8WL/K(\!1,)25^+,8=@WV(4&G$<?4 .T=7UA?_ !];SY>-7U'H
MOU.U^2I^BL7L_P!?>+XT)]DPZ<XQE8XC*F6J*C7<ES%:Q6Y/6,,TW'EKM5NF
MW,S495&J2,FXR&W:QL8\ $.63O3^0CT.<+:>L;_X^MY\O&L/4>B[K2U^2I^B
MLFL75J-*1D=*(T^K%1DV+.02*$/7W0 B\;).$@!PP3=,5P!-0/+1552/X2G,
M40,+UA?[>OK>?+QK/U'HOU.U^2I^BK7+OEV+B<R6O!M'Z>ZY.6VM86?9D0L&
M0WL?BC',VSC+I3*S(Q;"WGHMT,=G$Q-H</WDD5FH@W79%9B0QEE%VT]8ZA\?
M6\^7C6/J/1?J=K\E3]%5%Z=9ICFK#M.RE:\)5#&SRZ-',S%5INZ8W%)2KK/5
MB5:Q)S+JDTIR+:VP2:,FW15CD%T6SI,JI2J\9"WUAJ#_  ];SY>-4:'HOU.U
M^2I^BN)SUD.A8,-BE);#06T^4\N8_P 5I/XFM1;2NU$;Q;H"KC/VNPJ1;II&
M)MO/@'9-#%!64<)B@0Z1>:NB.HZA\?6\^7C0Z'HWU.U;]53]%4NZ8>H_'74G
M;;I6&F(*+6_8U"M+-'.(ZRT^[/589Y;[=3B,+A%1U>BE*=<$'U04<*L$5I=F
M5HZ0.#T3GX-0:C?_ !];SY>-!H6B[?H=K\E3]%7-Y*]@N-:%:[ZXQBG:4JK#
M/)@]?J%+CYJQRH-"<7=8V/1:E$YS>$ZAA*FBD!E#F A3#JG4;_X^MY\O&J=#
MT7ZG:_)4_15B=1ZWL66;(V'J4^P94:]&93C\#LE9*0LU8-:XJZ]0.(3Y;JC.
M#QV>H-9.Y8]BD.7#/K,F[8IDEUP3*R.1)8Z;UCJ'Q];SY>-8^H]%^IVK?JH>
MBLD@4BEAX:A6/"&^T!%#MN(!OV,^W81\0=NAU&_^/K>?+QJ^H]%V_0[7Y*'H
MK%PYZX&Z4U*TY/HZ@OO@QT59+NK4WM_JK0D/CVH4V0O%F9W271QX]2J6;H:&
M:M>\TL47?=S2S$RLHFDL90CUCJ'Q];SY>-3U'HWU.U^2AZ*R24UACF\4VHW>
M%I]="&NE7KUMB.\UR(2=>:[)#LIJ/!RD5L<J2_='Q.,H&$ -N&XZ#4;\_P!O
M6\^7C5&AZ)]3M?DH>BK9[AFV"I.=T,1O^FE65@'T9,K1%HK3*%G;I8GD#1'M
M\DY.N8F8UT964Q\S[H2 4GADT@"T/&K &H@L"Q7K'4/CZWGR\:GJ31=GT2U^
M2AZ*JCTYVRB]0>$<=YG;XL@J@AD*'=3*5:?L(65?0Z:$S)Q)&KQ\C$,$E70E
MC@44*1("IG.) ,?AXQ>L;_X^MY\O&J-#T7ZG:_)4_14F]3>3(7I[@X*?CL"5
M^_1KL\LZL3]5Y7:;&PL?$A&D;0D0\=UJ=/:LH7A])D9U>MHI('FGA%$Q=-^$
M#&>L;_X^MY\O&H=#T5OW.U^2AZ*X/"N987*N7K]BF=Z=(O'SBI5\+7'OGKRM
MSTN2%5MLE5XMCD>L-*U'J8ON-D;1X2\9$JO))1U#*@X%5,Q3)@]8ZA\?6\^7
MC0:'HOU.U^2AZ*KGE<(3'E!L-NKV'H?($W%),@CJHP8P,,#]=_(M8_O4I//(
MMZVKU=ATW)GLF_.@X!FP;K*@DH8H)F'4;_X^MY\O&J=#T3ZG:_)0]%6<5KJR
MA)B8P1YZZ9*A6Z?G&W-L=0UK<WRD.5YFXJS-RA7DGB6NC46;O*V*8P:NU>JV
M0Z\(9:/GHY5JQ<&7X >L=0']O6\^7C4]1Z*?]4M6_50]%9#!H]*V_4A6 #PC
MM7XLW8 [B(%!J)C=GB#M'Q:OK'4-O7UO/EXU?4>B_4[7Y*'HK&':^NRAT&CY
M?L-WZ8V$+<<?M(B0J>,VD[5I>Q6A.:8V2:4@;LX;5%)#%=[I]6K)YJRQ*B<L
M$+%/F"HN%E':2(SUC?\ Q];SY>-3U'HNWZ':O^JAZ*R7QM4H\E&Q\BE4*KRI
M!DU>I 6$B%2\MT@FX3X509%!0O H&QM@W#MT&HZA\?6\^7C67J/11_J=K\E3
M]%6,]0O4[ X NECKS[IB9V6!B:5;I^"GF<A ,9NVSU8QE8,CF1B:4G3Y9^3'
M(.X=M7'MI.Z%-A9)9FT[DL"@J ]8Z@_P];SY>-8^H]%^IVOR4/15QN"INKY=
MI*]FDZ1A=A+,+%,UN7B<<V4N3(F'D8<S<%HZ3FYO&6,)9A8$DW!#N&#B(1.V
M(HF8#JE4*?0:CJ'Q];SY>-9#1-%^J6OR4/14F=3N2H7IZK4/9XK 4%D-@N:;
M=V!T9Y7:9&0<9 L&[E*,92#NN3Q[#DB]2#Q*,JE=202/.RAA0[RVX>8+UC?_
M !];SY>-3U'HOU2U^2AZ*D?IKZC\:]2=TM,#!XAID%7(V*G9NKS+B>J,E:IR
M.KEV=4.36L&.?,<;,U4%I1MSFZC=Q,-"HF*D\79O#$:#/6-_\?6?W<O&@T/1
M7PL[7Y*'HJY3*"$#0:#9K=!8?C<@3,+'\^+IT+%03![./57"#5!!23=,%V\1
M'('<<YX\.FH5HT255X%.#@-3J-_\?6\^7C0Z%HGU.U^2AZ*LTHG4E8+Y:,'Q
M,7TG8K/7<PVF[5P\\RRY'24A&16+)F;A\DY-K<.G@]&,NV)& 1C16%FO.L8,
M\::CTB(-U'( 5ZQO_CZS^[EXU/4>B_4[7Y*'HK(4%'I0F /8E5R@([<0P$5L
M ".W$(=T\ !J^L+_ ./K>?+QK+U'HOU.U^2I^BL6URZZ*]1I.Q05BZ6*=7)N
M.F&Z,2E;\CU"N132&<Q649YLTR9)EQ[+JXXR=(06,.^M:N1O,*F:S\2HL\0!
MR?E3UCJ'Q];SY>-8^I-%V?0[5_U4/161R@LZ%?:-2;VSHE?CV=VJ-:M[2/=P
MU?<NV#6RPK*:;LG*[!)=DNY:(O03.=%0Z1CE$2&,40$7K&_;X>MY\O&KZCT5
MOW.U^2AZ*LVZF>J:J]-%O=Q4WTQ&M5.:U::ETK1"JUIM.S,M#X_M^0'@5ZD*
MUQRXD*% (59&.G[*J_;-X21EFA#MUB&.<CUA?_'UO/EXU/4>BO\ N=K\E#T5
M6/IFR;0>H>KW24'&^.X*=QWD.2QM:V54FZYDZGK3+*NUBV(2%4OL?6ZZWLL,
M[@[>SW5%BU41=%70.3=+B-?6-_\ 'UO/EXU1H>B[[.U^2I^BG4YD")Z>:(-_
MC<%5"]042VGIJYR<K8*ACJ#JE>K\0I)C_P!J2D!..)FWVM[RHNOQ*#0J<E)K
M%27=LD]UAAU&_P#CZWGR\:AT/17_ '.U^2I^BI!Z>^H:E9ZO?L=1P- 56IV.
MKY*N&,;>XD*S./;;"8CR7!8JN@V&LLJXU2IST+%8FRT>1&1ETW;(3'.HBH )
M"]8ZA\?6\^7C0:)HS_N=K\E#T5=!D"(AZI3;'8:SB"'O]AB(Y9S#4N+8UB&>
M6*0XBI-X\)>603CHIL)U .X<J\8(-R'.!%#%*F8-1U#;U];SY>-4Z'HNZSM?
MDH>BK-\==6./;Y8L"U(, 1J$EF7(V9\:R5E@'%?MV*ZS*X699(6E'->R*TK$
M<A??9,OCT58UMW&)<FC'8/%2ID!%)S/6.H?'UO/EXU/4>B[?H=K\E#T5?T6C
M4LQB@-2JQ0$0 3# 16P;CMQ#^5 W -7UA?\ Q];SY>-4Z'HGU.U^2AZ*QQV#
MJQ\P/\E5U[TH4IC;:"C 6%Q&S.4\>Q\/5J!87N0$&EFSA8FM.ET<.RIH^A%>
M!&IH6!,R4[%$[V11R8J3UCJ'Q];SY>-3U'HK?NEK\E#T5?'C1&E9&QS0,A!C
M6*K1;Y2:I<PKLY78@DQ !:(%A.!"RI2LB@62B@?<A?8I?EJ9NP/ #UC?_'UO
M/EXU1H>BG'Z':_)0]%6Y9CS4RQ)E:J8\#IEB;5%WGSA#4F6C[)CV)N%[O#/'
M]ROX0%)Q_*L$O.L$V+4T8F0EGDI' SE9=FFFV<IG.H5ZQO\ X^MY\O&H=#T7
MZG:M^JAZ*G?IMR%5,\P60',KBC'E3L>,\DR.,K-'5>PUK)]84F6%7J5L56A+
MBRK%7-(D9M[<FQ>$4CFXMY)HY2(*R9"+'#4;_P"/K>?+QH-#T7ZG:_)4_14.
MIN^173WCYQD.*P74+W#0C>:F+F^E9ZI8YK]4K4##.I-1RYG)* GG$A9K+(IH
M1$!%H,Q"2EGB22KEHF(JZ'4=0^/K>?+QH=#T7ZG:_)0]%2CA[J%P_FW-UTQ)
M3<902L-3<>UVY>S]5O75HR?EI27>0L_682-:Q;A-\C39%L#1Y))/5&QY$B[9
M,H\@RA@U'4/CZWGR\:HT/1?J=JWZJ'HJXZ]PT+5J=9+%6\0Q5^L$1%.7D-3(
M>.K$5(V21( %:1;>3ET48R-*NL8.8X6$2H) 8_"<2@0U]8ZA\?6\^7C0Z'HK
M?N=K\E#T58!0NM&HWZ[TNEM<(80@PD; ]K%YM$YEQ@>IQ<TUS#-X?9Q^,IR#
MPI,1^37]D?U]9W$)2*E4%]SFJ&Z9G2*AL?6.H?'UO/EXU!H>BG_4[7Y*'HK)
M:6CTK?MJ%7+ZN\!%>^W*S'P>ZU?6%^V->MY\O&J=#T5OW.U^2AZ*QEY!ZVZG
MC7($UBRU=-%-AL@.Y>);8[@93(-))YTAYB7O+1E*Y0-#4J?>8J>/:]1%9QJP
M:M[.NXC9%B F3<+BB1ZQU!FZ^MY\O&H=$T7ZG:_)0]%9 <=-Z/D+']&OJ-%J
M#!&ZU"M6M-@U2J=D:L2V*&92_<F]A@2.H2=0:=[Y9'K10[5T4O-2'@,&]]8W
M_P ?6\^7C5&B:+]3M?DJ?HJW+-N8"8FRA0<=1G3=2K*SR9*,*;3+1.W>FT8M
MBR+-0EJF8V"A:^-1LLP]K$,>O-T;!,"":D6:5:]U92)Q,F$]8ZA\?6\^7C3U
M'HH+"SM?DJ?HJ=^FJV$SC2[%;K?@S'F/O-60K=28(:U9&&2Z]<8ZFNTH*4ML
M%87&.\?K&B#VYK)1J.[$Q' 1HN4E5$%TC"&HZA\?6\^7C0:'HGU.U^2I^BOK
MU)W&+P-CIWD&#P;3[ZSAPDI&TK2TY5,<UNJ5F%@)><?S,Q99. GU3/9)Q'(Q
M42Q;,%U)"7D&R)CMTC'7)?6.H?'UO/EXT.AZ*/\ 4[7Y*'HJCG3YU28SZ@<M
M2V-8O#M(@6+>NVR?BI(]HI4_;#!2WN/&$JC:Z+%P9$JRSEE,C(*1+EM+2W?$
MV3D5B-A( #!J%_\ 'UO/EXU!H>B_4[7Y*GZ*O"N$! 5RIV2?@<3Q5WFX>%D9
M&'IT+$UEE*VB3:-E%64$P>2J;:-9N9)P4J155S@FGQ<0[[;".HZA\?6\^7C5
M.AZ+L^AVOR5/T5C,B?2#8V=VN,J<MT_XXC'<9;8NI9&D&V4*1*Q#->;S&PPP
MQ=X;<A1V3K-IHB:?]_FFX(P"\9%IBL4K@5&_/>L;_P"/K>?+QK$:'HOU.U^2
MAZ*RK^P:E (@-0J_8(@.U?BA\'A\#3<=M/6&H;>OK>?+QK+U'HGU2U^2AZ*Q
MXV[K%QDVRY:,,XQP76LC6AA8L=4:ERCF9@:C5+M>+C*Y*C+2R3FR4ZTJ1M8Q
MPMB^1:OY1%N_47ED%V2;0.3SE7K'4/CZOGR\:GJ31/J=K\E#T5>/A]]CS+^+
M*%D^.Q_ 0S:[UF,GC0KN)A'CF%>.4A)*0JSQNR30?*P\HDLV%=,I2+\KF%*4
MI@#3UCJ'Q];SY>-4:'HGU.U?]5#T54?V$4O]:%7_ $ BOS)J^L+_ ./K>?+Q
MJ^H]%^IVOR4/15KF1N@SIQR[F:(S/D:HA9'D!4(BI1-',9"-H/\ V3-6&:+-
M2\+%MVB\_(N%9\4CI.ECLA11(!D%![0]?I?:/Q3HNA3T+2ZW50J5Y5)5L95N
ME&$<L92)$(C(X,0)N2T@OE7$G8'V=<7\:4N,^(K4W%2A9TZ$+5Q"U][JUJO6
M5*<!&561-8Q,9R-(QC$2A+==M!P4'6(EC 5J&B:[ Q:!6T9"04<SB(B.;$#8
MC9C&QR#9DT0('@(F0I0]37BKBYN+NM*YNZDZMS,O*<Y&4I'E,B22><E?7;#3
M[#2K.GI^F4*-M84HY84J4(TZ< -T80 C$<P "Y76E<Q-$7V_R?\ OVW_ ,#1
M%UO-?@<'*^+J&@&]$T.*+>1_T>Q^O&WS8FN;I@_^HVY_[^'Z01=FJ=_.9M^'
M;?,3Z_=VW^"A[D>POM&X*1^SWONO^76]$T14$O'35B3(EPNU[M$$[=67(.#Y
MGIXLS]O+/6G>,93K]])2#!J@B8J3&8,ZD5."03V<ID*0I3 ! T4(4J/NC3 <
MB[8*.JU*C%-:E TJ0JR%EF6M4LT'6*LO2X EJA6SE)&:=1M:7[J"AC%!8A$Q
M6*H*20DB,N('H@P0X:+-YAG<;(X4AIF#;2UBNTW)S44TEC5-5!>%DCJ$7BI6
M =TJ/<QSU'@=MG:9UQ4.JJ<XF1E=NV0[LV;MN<NX[N@BASW1P5<K\E,J?.<J
M@!>:X5X>(YM@XC"([!JJK[:(I QOC2J8I@9&MTYL\:Q4K<;U?'B;Y^O(K'L6
M1K?,WFTKD7<"*B;9Q89]R=%$/(02,4A>PH:(%/\ X-$5!\A=/%*R1DRC9;EI
M[(T+<L=Q;R%K3BH7J7K<:C&RDDUDYEN[BV0F:N?/9F2*#P^P*.&B8(&-R]RC
M,>\HV_>J\>,?7$? &P>^#P;_  -55;"5C&4W&2,+)H ZC9=B[BY%J8ZB97+"
M0;J-'C<QT3IJD*LV6,41*8I@ >P0'MT147PKT_8RPFI:']$6LDM*6?S)%3L_
M<+M/7R=&.I+9S$UNKDEIY^_<M8FJMW2R*#8! R8J'Y@F.(CK",HR\D@@$C#E
M&!'>V%&8JN^LT5&\N]/N&L[-8I#*N/*M<'$$^B'\)+2T)%NYR(&'L439R,HV
M8=,UW[&*DY&%1(_;)'*D\;"HBJ!B', QD8*L92E*4I0 "E*4"E*4  I2E  *
M4I0V "@ =FJBCV=N_:'K@'PM$5#<6].^-L0V:SW"JIVA[8K1&,*ZK)6ZX6*X
M+P=/B9B8GXFCU49^0>^QZGQLS/O'"3)#8H*+=HF B8%BC*N6JJJ*9IP!CK/3
M""9WM"PHN*VM-'A9NI6F;IUA9-+/#.*[:8@DU .VCT\+9X%T=H_;&,*:Z0AX
M#%*8"$.JJ5^!B*K P=7K[%&+@*W#QD!!QC8# WC8:&8H1L7'MP.8Y^0R8M4T
MR;B(\)0W$?#J! N7U44CU''E9I,QD6>@D'A)/*5T3OMN7>/EGO>I]O3ZG1&I
MF95NQBP;5JE,$4VY/E9#$.8.TYA&,H IXU551W-.*,?93@(7[X#Z9@D:-8TK
MG7;77;1(TV<JT_YFFJH:283\:X;J->^0-I?,%B'$R:J#LY1#?A$-=6I"E U*
MDA&F-I. '=5$3(L Y4ZT*BU?&%)JF.J1%$@ZA2(",K%;B$UG#DK"&AVJ;-BW
M,Y=JKNW*A44@$ZBISJ*'$3&$3"(ZV*#8IM =M$5$*]T]8SK.7K#F^.8S:U\L
M3>5066E++,RT+%&G0AB3CFOP<@Z<,81U*I0#5-0R % B9#D2!,BRQ3QL5&5;
M]554\R)BVG933IB-R8N'Z%"O\!DNOHH/%FB1;36FDLRC%7Y$1 LA'@WFG *-
ME-TU>(.(.S491E)&%.FO%6 %9U?'<=.(KSS*"A3KV&SSEI5B:K5329JO3*Z:
M;>.A@ZC7#3+H6C%#A33%<VXF[-B,JMVNLQ-TJ]DIT\DLM!VR F*U,HMUSMG"
ML5.QSB+D4T'*>RK991FZ.!5"^40P@(=H:JI#JG\'@W'U>M&-;A&L9%.<Q+BJ
M3PQ2UE)9VJ@THDNO3G#UF^;'$4I&0,I18[A<J!S2@F< _KAM%&57]%5:#:>B
M/#%KG$;&H^R97YMME6[YJ:OJED:=KYVN1\@QL+$6"P-TVHF116+'P223, +N
MR*HMRA+S3[Q1E=NV1[LW;MP576[NBDB"SE4R[E;E$*3FN%S^6NNIP[G./:8P
MB(^'555$\D=.N,\K6!W:;8UL(3[JBHX]3EH"U3=:?QD(TN\)D5@]AWD*Z:.H
MR?C;=7FCI!XF<#E!,4S 9,YB#&4(?!35BC$],PQ40IE(:R2<<K-V"S2<A-S$
MA8+!8+/:Y=U.62QV"<E%EW\K,3,H\.JLJH;L["% "%*4#*K<Y"QC3\H-J@TN
M#)R]0I&0*MDV!3;O%6A"6NG+.EX19X5+R7T>0[P_-;* *2P#L8-M"$(?:I1Q
METY85PW;;Q=<7X\K%'FLAMJ\SL@5F&C(6..VK*#E&.1CXV,9M&T<DL9V=5R5
M, !PN *'W, #HRC*JMC@8ZU5Z?J\P156(LL)+5Z6215.W65C)M@XC'Z:+A,0
M405.T=' IR]I#" AVAJE4JWN*Z1,,P]KH=L;M+@NMC=G24ZO77]\M+VDH3&.
MJ6?'M,N#JFK2(P#JY0-0.+1)^*(',/RTX&6 % C*,KGM_4[-O>>/?555I%QZ
M)<"7A:S.IF*M;9]<+W>[_89&!O%CKTD_?Y/K-:I^0J\=]$/&CCV%6^O5"/0>
M1>XH'%#C+PF'?4 49]JNIC8YA#QS"(BVJ3&,BV32-CF3<O W9L&*";5FT0)N
M/ BV;)%(4/$4H:JJI1?<$8^R/-V*PV1M+C+6C"UUP#*NHV:>1@_>YO[YC(V-
MHS(V$"M)=5W')&1>DV61 ! OA'491L55"#AX^NPL/7XE &L3 Q4;"134!X@;
M1L2R0CV#<#;!Q BT;$+OL&^VJJI6R)C2IY3BH.%N#1R]CJ[>*1D6.1:OEV(A
M9L>V)C::VLX.AL+AFA+QR1E4#>0NF D/V#J%%3;#W2[B+!<Y(6"@1<ZA(.Z^
ME3X_SY:9VQ-:O2F\V_LB%,J+26=N$8"M)SDDJY!ND ^6)0$PE(0I:@#*N<VQ
M82D+,1<J;@BI**D8^3-S^Z@2.>LUFSX_>>(O=P*U5./,W#@\._9J2(B#*1 B
M Y)V,F)P&U6X0/2!@R#MF,KPPB)Y[(XHJM(K-&:2-PGY2ML$,?5%6D4Z>- N
M7JD4ZL436%S(D=\LH**F[P8@N2D5 &(<8A1N\KGSD$Y#$XSI\13%YB1N!0G$
M42\:9NWA4*([@/B'555BT;Z.WI[C*JWIJ;W+SF&9R=CE&(N<NW LBQ/=FLFQ
MR"T;RC5VV?'8Y%92RB<Z14Z@R(%3,<W&D0P1E"%>]%1<=!Q47!P[-&/B86.8
MQ,6P;%X6[&-C6J3)BS;D$1$B#5J@1,@=NQ2Z*JB$?TXT:*SO.=14=-9":Y!L
MC"*BIUJ2[RPT^3B82*4BHF(<U4PFC_-3 5CNTVY>%+S@87 E%0=]&493YBO&
M54PUCVKXPHS=XTJ5/8KQT&VD'Z\F\1:N)![)J%7?N1%PY.9T_4-Q&'< ';P
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M F,/8_&IHQM!.ZMCRBUA_*FG'=<J%<@EYD[;N:DJ:(AV<>606; NY!)PZ(W
MZ@ <P"<1'UM<S2K>=IIEO:U)]9.G0IQ,F;-EB Y#G$MCCM6NM(3K3F P,B6[
MI=3KKGK4FB)HB:(FB)HB:(FB*(>/U_@:(H:(FB)HB:(FB)HB:(FB)O[KWP:(
MFB)HB:(FB)M[GOOCZ(FB)[GJ:(FB)HB:(FB)HB:(FB)HB:(FB+[_ -A_\_\
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M!!/-KSOS0J1J4XPHB41)J<(.07 >,09<N#X8[%HZ=Y.(A)NPR\W)R$3&MF<
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M)BKE[3TPY_F^D+%F$"3^-'UWK%\)+7%%V\/'520H19ZZR<968]^7%4[5'<O
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M;6S+/0<_&1M:0LE"ME<AZ:RX9SSR#:4DY]$'2[-1F1)) IBF(< ,7^M9=L7
MVEW=Z8ZE?:M"\NM2NH==1K4Z=N+BQN;>E9Q]_-;+5J5H=9.E*B(BG&42" 1Z
M&6J6D)3(J5*PG4J3&:,P(YH3B(#I/B9!R&  W%B*;9#S93+?AQ.JL4G,7858
M;'#$T$BG-/8F,6J<]D)Q)),9F<=R4FX:JLYUHX3[RZ<J =<Z0'$J8 'A.,NU
M+AGB3LW&B6L94-8E::;#J(BK.E3E:U]0E4C"K6G4J2CDKTJ@-2I4D\Y1SF,
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M>SLVW]?_ )-$4-$31$T1-$31$\6_N_B?'T1-$31$T1-$31$T1-$31$T1??\
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MVAK\)+.SIZAK-&PJU8T:=>YC3-27DP$YB)G+9T8@N<=@7QFG'/.,"0,Q <[
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ML*H;@6W87PO+Z)/4*NM6<[ZYM*$;>M3HQN;>=U6O:(-Q$ALO^BQK081E*G4
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M?#P\O?D;\'#V;>#;6S[IW;1FS_Z%GRY7^EXY=F5\KLV#;$_EC5O:TO/_ "*
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MKI/NG=M E&?^A9X!HGZ7B!R#HX#F"T?ROJOM:7G_ )%I'HLSP)0(+:L"0
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M<3](MP\95)2!8U=X(7S2MP_JTJTY1I.#.1'2AL))'YRXL.D[J# Q3>PT>(A
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M%JZI8_S+;5*0I7->K.XSB?5QG&[F(4HTK<5H]9.O&!!G.E O4A3@2\>3;:U
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M#E<-^55@C(QA"QL=#139-G%1#!E%1C-(H%2:1T<V29L6J12@4I4VS5$I"@
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MJ(B<@,=SG!<'_P 0V<?W4[C^BJGXW73#MR[73_\ D.I_*E:_7.K?6:OG%/\
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M$QEB1EV*ZKH!_4KDK[H8']+7FOZ?^Q-AP[KO^V6_]W->DX0_=[C]9']$J_\
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MK$Z\&RR-.9D&V,27#;FV)ZHU<ES0K/W#XU]%,']0JQB'5Q_D10Z:A54SJ-9
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M31$T1-$31$T11\/J>^V^$&B*&B+[?Y/_ '[;_P"!HBZXS-\]CG!7<>\=L'1
M,!'+)RNT<$ Y1*<"+MSIJE Y1V'8>T-?@O:WEU8UOI%E4J4:X&$H2,9!\#C$
M@XC:OC,92B<T21+E!(/A"W[VQV&20,UD9Z;D&IC%,9L^EI!VW,8@@8AC(N'"
MB0F(8-P$0W =<NZUS6;ZD;>\N[FK0)!RSJSE%QL+2D1ANP64JM68:<YF/(9$
MCP.N%UU>_%:UO(_Z/8_7C;YL37-T[_B5O^OA^D$79JG?SF;?AVWS$^OW=M_@
MH>Y'L+[1N"D?6]$T1-$31$T1-$5O61.J+$.*)"UL,@2%FKB=(@8JT666<T:W
MKP,=79J<3K47->>F4.YCW$>\GE.ZE.D<_P M*;<  HB$S!%O;?U)8GI*V0T9
M>7F'?WIR0BN15J_5[#8FM33L<*%A@S2;N'CG;;>2B3$42*F90YC*$)MQG*43
MH,56^/<EDV#.1;(NR-GK5N\2!TS<LG":3E!-P0CMFZ21=LG!"* !TE2$43-N
M!@ 0$-5'4A1F7L72YI4C+(%0,I"V*R5.337GXQDJVL-0+S+-%BD]<-U%5H1
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M%-]2O>RG0K73-8N?6K7^DPTZ,Z4H2Z-2ZE;PKU*DHP;J*<ZM2-.,#.K(0S2
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MJB1VN7*C#8V";!Z@>/Q>KX??^/4S'E1@H[!Z@>#;P>+U/=:R>1Q=&";!MML
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M,7)'-9&4PVOT?F(K8_D'KB?M\223E;?+NFL"6K1Z1E[>V7;+I (UM?F(11'
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M*>0D%-/XZ,?*NG"K5-NU6Y#IZP4BGKV,7=-%W4,_>Q:IFZSAF=NLJCL0YA*
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M0-N3[6_JS\GTQ54 ]C7U7M_?_P#GTZ2F#<RC]K7U5M_G&WQ].DKAWD^UK?\
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<.G23HJ/VM\O_ "O@XO\ I]^+@]_X-3'F5P7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>tm2030088d20-ph_patien34c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d20-ph_patien34c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!E .2 P$1  (1 0,1 ?_$ 1P  0  !@,! 0
M       !!08'" D$"@L" P$! 0 " P$! 0            $" P0%!@<)"!
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MKTJ"XN/,196R[)'B,5XTON2)1,2@LQHE0G[6X;<6P%%TG!L'PM"#Q![)3@*
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MG@#?W_N<,1AK)[37N1@3J :H,D^4OEHO_-UG['N!,=IHMI>[R@C,V1^0X0%
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MQ>'4T#.-QK28MB9&PVIU9'[-6,:QD,=&5FGQCMFKIB5%R_:XUW&V,,*L]$3
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M<'68Q%5 B+%G#M" F1),"$$W$H&QCFWQW NA"PZ8-D"I"D= "%3,W B8 FB
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M/"(!T% =Q%2H/WR'6VLA49-M)1S629NXQ9-TW>)B<H)@D)SB7;95-<!)Q$,
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M4/.5G7!O#V'(6)9"-5I;BP"Q(XDI$)6ONEXBTMQ0,21@EE'(%,":QVP'2O\
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MM@G#(MGK)G(I/"MG:)45P$SEDLLW>-GBZ) 15$-Q*DIQ$ >(H C+BA6RZ25
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MJ4(S]KM.0]SH%CLF,V$:_EG2:B4QL0@.@46(1 CWM.S*L H"43!Q"8"]GQ;
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M46"XK#'B^95FX&)+#PV><9XHS<W;)( V1/(R\"O1;&Z*W!)$4E7UDH#M=8#
M)A65.81W'HR6PU751G7,U34=H?[T+_UO;'^3+F[X?>:3K">[NFZSM?</5 U#
M<- - - - - - - - - - - - 4;D7][Z]_L-L_\ @1]H#QM/%A 0YCL?;;!_
MU6.7 ?\ ^W[;61A@:^[(W(VD&J15>,@P5:5XB@ET=XKD4X,4 377 1**W".Y
MN+?K H^Q 4I_I$!#R;B(?@M@'?REZ2] AT[>361#MZ> 9CROWGD6SY2TX.-7
ML_,'XAG(/A51\\C&KQTZK4%E.NY6L#!D[?\ XV9+PU)JD_) =,#KE%N E*(B
M7;%E-FO/Y-1MOYQN9":<2#VI"WR1(1B"<\BV=TNQ(U*+A*,#ED1SV\>DJ[/7
MAXQ;JH.^V !. DX=XB/;4TB<QV#,C/LC7"]4^H6JX46Q+JVU:T5^)>3]?C7M
MB,SDIIE(2405\C%$C+!,':E*^,B?@!(1W P'/*,I1]6JDGCJIR#2WN1;/;FL
MU/&TUF]2=*%+%HN5B34ZV1<D:M@3%R0$2B<R@EXP]B [:J&TJ# EH<UN\2,&
MN<JD=*E(U<M2\9FG;F.V(3V':FX4SJ&   3&-Y-QT#*)RA+O;ED]R94H)I-I
M$$6R!"G*BFW03]APIAL5,  O27V([AT^41CV@S0Y/4..Y7B/+L""%<AY4A.D
MR9%C/'C-4R0" F!4Q0*/5Q !>H0Z=6J%*F8LK'M74H1L\32<-'28&,BLV27(
MN*8B'#PJCPEV H!L)1#<=4Q+I\FU=JR//9RMMUXLE8JCRY3<!-R,FJSB:U+*
M6*MST-$U0W$HFFXD+0[= V20[,0?KJ)-A*H"QN%@5',\4K"PYE\!C+L!9'+)
M_D?P[>8.YUA CEPW"=;QF,LYNJ- )G0222$$#X0R _6X=@(H1#M2[E3-PL2[
MCSX3 8-PW'H,("'1U[!T@.VWE\^KL(?9  1#V74(>8>CH\GO!UZ8A&PWPJ$2
M(>+)X>B29P4(GSU\LA"J )1XP+FJG !@$ICE'?;R"(>KK%[#*/E>$]I/4*-
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M5*:OA>&783SLQ1 92=C%3^7@W3LKT4O*&XJ*%]_PZP+B99<IKU0&5JCQ2/\
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M*T[(U]J:Z?8JUFY6:!.EL8.S-$S+UCP;& #!P]AMT].LSC2P91.A#8YX/O\
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M$6,W6U@V;GN8VFR<#2^6"DC%KS!,8<KO+DW=0':MV,@_D+?A:F3-MD@6?*M
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M\_N=\PG@%Y=O@7DDS9D1!ZF9LDA$S2,S1FD6*BKUPW9%<2*!W2*0*")>DQA
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MY&+:-=-&QQ(!>T#;ORNX!OOQ!YM2C"]@X?+C9'4)E"/B04$K6T$6B7*9CB!
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M565 42)!S[C0-SVP1JQSH\U,"8I"#&9]RFWX$^'@(4;C+*%(4"&,4. J@!L
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M8+ZGM&O^U$,62;E.D[0'T!5A!-ZJJNO[*MQ)RJ%.N''V"P#Q)!^!*D)0+[$
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M7>24WV;*Z$70:>L#P&:DJS>I7:2;K-W3-!PB5-PN>M@?V;I(>R,N!2I;\/$
MB[3;RVCXU[9']9.DS=IN(I!*8;E4,>.<L7"3R+=PZK=5N!2M3-"*%22 X$*D
M8^Y  P!H-B.MQS.\N\WA#-4O23L5)&O2CI8*ZJ@V>F1=5N4,<631T<4 )Z3C
MR* @H "8!,0#$,;<HZGM [4/+Q7%'F/*.J\3*BX"J5MNL00.?C,WBHU-7C.9
MR*IG!@()S&-N;CW\G1JA5,MHRC$:M!D$V[A;NJ*"J+=F1(7:ZI)%,!29@J<O
M9K]W#C3,(@83#T&#;5*E3;M+[<MM2-<N8;#Q)%ED*O\ V-*[=<KH&?O4(AG(
M2+"&6QDTKDJG"/ <2\2NEF9U("T?%.EVT:S4 #F3 2QDWG4^^^6;TDOR#\K<
M:Y42[YFWQ#_$-SQ7" '&9WCAMFK(\'2YENL111!1G+UJP1CE)1(3)KHN$U $
M>+<;':87/)[_ -4Z3?J^769Q^<[0_P!Z%_ZWQA_)FS;^>:2'R=83W=TW6=K[
MAZH&H;AH!H!H!H!H!H!H!H!H!H!H!H"C<C?O>WO]AMH_P(^T!XVOBP?;'X^_
MDL\N'P/\G[;61@S N[-D49=HF@<3I^UBGJ")CG4V46J<*LH3B,DB<-E53  <
M.Q>H!$  1M1N7<*1 -M]P#;JZ>$1V#8!'8NVXB CU[>_T!ZJ7@\VN)F^5[P1
M;FBJB>/D.5#F:P(1T0K8%3WMDKCZV%@S\!UU$SC!8(GW ])?R+[(0$P$-A3$
MS3,!<R877QI8LSO\?6"Q14A4;E>8=_ N6WI",?R$-8)2/1,Q,Z8JO4=U&?"4
M&Z@$,8 WW$3!H8^T6VQ\3*[JOMWV3VS [V19@X9JQ,6[9N(AO[$Z9)D[QRJL
MY=.$BAV@$3132$>#A$VYPC*J]XHS-F'&.9:>%0?&!HX,X;R,;($W$J4@V34!
M%0!/U$5_HNL2[[@ CL&HG3N%>PIC&N#ZCR^4E:O&=DEK/*B:2EGA (=PHB5(
M$6;,FR13$9I;B;A]B!C#[+66.[88X4Q*LM.-H7->*R51R=$K]./1=1IE"$ S
M)P5(4TTS@81[,ARF J@%$! X[]1@$9L8K@2[ F$38@IZ\&XX#23R1%P]5(0H
M"<B!=FQ2JD,(J%(&Y2DWZ>+<-M'B5;,2^SJ,D6D,L9C&NY)^= X$;,S-A<)J
M&XS%6X%E4BF)Q#MOQ!ML.W3J;67=@4WC[$I;*#Y'(T5* HF@"IF+Y999JZX2
ME*LZ109O',<X355(!N$NYA)^# -Q <JF*7*;T8&'$*5X*48QAII@K7.9B==(
M-):-19R;>KL.1'G6BE9CN#)=UW.!7"49E167[(PHNFXJIIJJE3T*MQYF'C'O
MZ_)>*GX@3NKE:EA3\V&:$T3,UR+M57K2Y/V<VY;J%$2<#N=0=*[%]B G$ ZM
M9+81FMD@@(COMM[+A$  1\@[#OQ (;!ZNJ0V+^%PF1/Q<^0!-(QC)DY\N6DA
M#'XA,8@9MIX%$PF21,(B'7N0H^IJ-X&<7CX3VB=8@: : : Q^YL_M5^9?^3]
MF7_1S8]"K:>.GXF_VZ^5/V*X"_[N.(]9,U+8C TIA*4P!T"(ATAYO]O0NXWT
M?>_?,U1<2\VMIP7E]428HYOL<S6$+,)Q3[N9W-1\I&-TE@5,0A3R$/-OFZ([
M[BY.F4 W,&CY2[S:!E;$MHE\,IT^74,ID/PXYZY<N^2VS=9PBZF*I"+HC!Y$
M33X2#(5RX4*(B++&N%P(FJU744* CN89SCF,4(.?9.(YPNW7._!J<4$E3@4!
M5$H#L!3%$0.4#%$-P\H:HV(X3F^MVLS%Q3AB8#/RB*KC<.%N'X$H"4#=KN<_
M1N)>'U=!@RN7!DU6QC !5D@ %  A^@> 0, >QZA*(:@+.3-B8#*MV(R!"KE3
M<+% %.D")BDB<AE2<14]^\!TF, >KH1U*NQW,"[6FTR)+E:H*(E(9P(B87"@
M**+@4PF-[ 0$A@V_#:%V$T3OD ZFGM>;*JJR<6<H/TNS I4"JJ*)D.(G,4YT
MCG3, '*!B")1#?<!  +1SM8;6.X3C6=24=M$.P<QCDCM=J9IQ)[+I)G0.02<
M!T^+??K/IM8+T\NT)5\1V#(O,*Y;R[MGA3%-KDC/G\Q(R3<LO.M"1\.T; \.
M[1&15.V$&Z1.R$QU W'AWWC0KX2[GC92"7*UX6'(AR4R"AF^6LL61WS39Q:
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MN,'V5K+8'<Q&O(A5)J#I!ZRDQD$(WB662%D(+(&7.11%!;M0#LP R)0*([G
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MU=>=^V:1[*!BA7^(% WK,88.,Y#[E$SD2B3@22X2;=0#Q&#RF'51A+&G<*9
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M* @7L#F(1,#F !,/"8!$-NLJ[1*NXI/#4Y5Z79[/A)]9(IJO*#)S5;W?%3D
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M)]PX2%( G4$[A7%PND4SJ57?0;U9O##:XN$6>D4/Q(]LL*+8ZJC7<2)K.@*
M'/L G5#<=^DMW4!S8Y:=3R%BZVVI"(BH&#NSF 82$C(,4'%@/888(^*D60K"
M110YI&32;F2(<5C$(<PE.D0QP8CNFTO#M:NKB_RJ<5.-8RI&"3FKS/SK4GH*
MOUH2J2KI.-E$9:/=NK<NV50.Y66_&$,Q,B*Q#KJ)$4H>/<+-<Y7/_C[E0Y4<
ME>([(P\5&8PQ95)_%G(%C:08M8QEF?)^04"L(W+#2-31)),8:T%CEDHD4>[N
M4Z4WF'YN(DH4B:F(;253R6;I<+)D.XVR_7*5=3MNO%EG;?:9MZ<RKR8L5EE'
M4S-RCI0PB8[A_)/553C^&,.LSBMMO$D#5$7#ENW Q""LLDEQJ& B9>,X%XCG
M$!X2%WW$=AV#0)59V@/O0O\ UOC#^3-FW\\TG6$]W=-MG:^X>J!J&X: : :
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MT#]Z%_ZWMB/FY9<W#^::3K7/=W3.UM?</5 U#>- - - - - - - - - - -
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MGC-MMN.WO?(U!4^="'?J^\D1#VO>)%^G/*=^<N8W4>WO?5-B\E=_Z1WN- -
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M.>#[_K5_#F_EJ<MW^E>KZDO)?>]LV6_+7?\ :/:J#J#WP:P.2]I'0@T T T
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MJ,)%OS=DQ.H@8#O6:@\9A[13\$ILH)@"HI2'%T  B&W3L'FWVZ0\FW1J[0?
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M*[+_ #9R8QTA2C3F#<H*E$>(*JK:,#0GSE>-5S_<ZT2O1;QELN+\)=@Y8LL
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MHQEBWFFI3;FJXNL90C5I2>2K5692<77+@G=DTN2+44H\F#4G1-Q6;![4K?\
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MDOJ@HR<)Q$?.&K#**<)-ZL5LF^?D"2:,ED7<=&G!LK!B9!VY<"8JSP!'I77
MP#G?I/,[>V4HOF3RZ;,Z?R4X7HI+^7@G&3:QLM1C%357&$ES^5?IW7)3M-MM
M)9,6G%)\WV[4)DPJ*S,[5:48#76;[L:X='T?&%8XZ1L?;++QR99-TI)U"75
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MT>L5B#E7/HR:++%+4U&::\TZ0)'>V-M9.\(2$3,TJOSP+M%ZWQD*X19BHFY
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MJ-9K#4R.PEXDT0#B38IF%U68.0>G9O[*BX IBLE$9-1C'$5V!1,\H"B9B'3
MX54J25:%)\O5LM]KE;)%6-_+V6%BH9M/IRLS(O9):L2PV2%9LCM%W2RJXIV)
M9\9DJV PIB*I7(E_&HB%=-IC%O?M.Y0U_(S?\12_L9=0S>T_?0#0&/?-?T\M
M^9?V"R_](30&@FMP&.%("%"9EH4\RF=2P6?BF739TC5':+V-7B8A(PH14A<8
M<G=I%FR35.Y<.%#HJI&33,75ET>&W*HM-I?92BY)I/;E>6%%XK<I.348YEBL
M[J\,SDFD\%122:;6S,G*3>U1C'*G*5')%%*DP2R*@>'K#XS9^T"JN$9B6<*=
MP<RB;93T*Y2ED$9 4XGYL!G#951)0PBJF784BZTWT*S_ )WI4I)/=2YFH\?%
M4HQ498U33JZIO8DND>7\WT557EK#+555).+;E'"C35%E#12EM[):B%B8-Q"'
MK;]Y!I2DK*.$V,JE! [8LV[YA)19W[HTDIV1RG XJF+P@0H]&ME%2]&5*JXU
M!_:^Z(QPVU71.4DZ2=%FQ2=3RJY;:_-NVG)?;= Y.KPH^E2C2JQ;C184N<K7
ML8<:JC-O31/W4X,F!K;".C*(E<QO"]5</LMP4<L8R2JH%%9Q&R!O9\<6F4@*
M FE267RLZ[RI<YVOY&*<]F.7-C(9<<[PR56W&5;=<*)['+!J/,Y4PME7E<=M
M()-.U,.]2#ZQ6IBY6B^T=2$;&I0]<+!/4'*%K;,VS-O+.W2A3BQD0=D2.0IA
MV 0D,LI0C*JBXQ;>*Q<W6M57R5C'*GW*X)UBI22692=%7[5X+'^52CJ^^L'<
M-G!8O4>*$?(4Q!V<\NDV:M+JDZ@R5Y*;@2P$^Y>.;C'IGFGL<K()NFI9 KY!
M!-)<L:=013U,<JK13<8YMZBWTJDHTK5*EMUCTE-B4LSRUJ*KEJXJ4LM:)R2R
M4S+!)OQMO1UQJUECFM!<5Z^=K6$H.-@6BIH15>8=0[B8<*.)()N98E*[+*23
MSNQC1C1LL"8(MS_-N,2@!P*6.KG5*BRPPYW"+DMKV2;6UI4IN,J14-J<L\\>
M92:CR;5CL5=N%3]&#FG?8^EHI<QF]S=V:'>MGSF*,JU3A6S"717:-Y-LZ<.6
MY!<+D.N7NH"JH9( XBIF.3*?DPR[FW+<W@\%RK"--F+=<$F86WXT\^^"2WT>
M:+KS.F:NW!*F+:=S'LIA5Z=JM(H(/%$(H$&Y8IG.02*"12Y"E(Q@^(RBV8OI
MAG_R=BWKDW:%4*98R:RW#WHF<NB=YM55MS=7S9XXQ6Y9'+"E4X[,5FQ\96(I
M8WE%>'*JIO>^D3EMV36.#C'CE' C<%!0-(JKQJC9ZR7<>GU@G#,7L"^5C'3-
M2-!FB$PU!^T P@FFF/ <P@'LAT*=R,<Z2Z6,:I.C3DHPHFN1S<VULI!+8Z2S
M<82>1M]'*5&U@U%RN8KG45;I]T]ZPEJLS3%[+5),7U=:(-*JE'ND0A7[Z%C9
M[VN.&;&4D61:1&*R!VUCV=R"/=I(@ 8O8+.RB9-/<E;A<EE=896HMXTQE1;,
M?$45F<4W.3;22S&-5*,7.+\JLHJBP\6M,>7-A6BBL'C0G)U\!/9=0SM)ZV9.
MYERX<OF0V!L"+!S(S3X2-8U*/,W;)(MV[%JD0J8]FDY5-L8Y2BCA=:3?01\7
MQ:5>-$M-5/';XVI3=?\ AP:>/CV*EEK<=;E)5IL;_+4:PP6%EI46$Y)I4I&V
M]S-0%F44K4$%V;[CVEFIW$JY1 JL-!.!%-233+P]UG%I!N4"&-Q))$,83;@<
M\>;.J>11U[N%/#5K^:N7'+Q:.FW"G<\:N[FB_P"<^2BM_P! ?&]7U]9&-&6>
MYAV\R6'Q^^;*%&G'C)-H\(V=)B5*[H3TFL^-/,BJ=J@]<UUS&=Q65("*[9,2
M(&,JB[*2HUR3-F?A0A-%O=0"Q[ _]JV2C017!3A+!3S*U,8\9$52@KW$\QWX
M8X#"(]AQB'S$4=X]IE'8=A?0HT T T T T T T T T T T T!+)K]!Y;]+'_
M .=5= =7ZF5.MS<!-N):=AV=E>+':4F(?2+IH+]]#H$EI-%\=NW,Q8HS"!DF
M#15\Z8HF<+',103)"&JDJ++C<4LSC6B<%123>ZJ<I*C<JVU%)YZK&OC/-A"E
M*[6I2\EI8UHTDZK*E-R;\6A.'47C^,NR[)LRB9RK*56P/V#EW89,2JRK"/GW
MJ*9W,;(Q"Y%$)R/"-1(<I.^M4DW!$P%R0XXQ=(W*8I).#V-JD:-KEE6LHTK"
M588Y6WL23G:4L,TDIJM4FY4:KR16R56I*DM]%*6K.CC8,6&]'-SQ5@8, N#"
M1GG9T&CYS=;%!OEC/&+F-=1""$.U;N$$U%!%)'@.L9;B,<]EXLII4<5!4[N2
M+>S:\U:K9C2F!(Y90C+9)S=>Y54I7%+'#;6E:E;URLX^F(^$D'<(P9G<1T^]
M<H$G5%_2$JA 7-Y&0L6A[>T'*P$?Q[$IFCLT2[*8H%[RN5R01RRI0DUC*D:<
MN.7,]JJEBJIK+@G"3JU7E=RE?$S/?N3HEOHVO&HUXV,E)+Q2E&+"D,7MQ=6&
M(:HMXY]5TXN'=K2S=R1D_,Y-+F9L8NX2#I5X#= IBBK(ND43'#C$ ,!2XQ<,
MBS5;Z6CIM4:3>%:*N$55IJN%7M>#4ZM1HJ6FU78Y9H)5VNE'+!4;2K14HJE1
MJV-UA:K Q*$8HC$+UY<+2P6E[6Y?U25D9F,EH]6?BVC9Q 6)-! 4D%8PYS$[
MGVIW#I!8N-O.E2[3I4VJ+8XY'2YMKC)0>6OV<DDW:E$SDXMR=MO)@TWM4LZ6
M3^@Y8T?D1E51FFZ2N\?48R(<MHB,@RRJ5H4:=]CYZ8E'",;Z&BI/NXHN)(['
M=N_>K-5#=BIV9D12!98Y#+J)?8Y?Y5Q.F-5%Q476FQIMUI'-2J455%A3+.4O
M*I;HGAY2DY85VK*L*O+6C;=&2"F'IQ&=M&S* $BM6)1M6BKM'"[1*74:.#H.
M^-L)CDD".$DDD.,G8@"ISF,42$WRE^9DE^<K&G>G&M.ZJU;V*JQJ8PPO1<OS
M7C5[\73P.G?H\$BXL4GAUS7:PQLC]FBX;%*5\>$2?,YL'8S+MI-+34J,$^1>
MLE&+ILZCBE[;A1;')\R.<Q%+=RYJVZ[$N\_<T75;W%^Z9\M,J;IEBL8.D*/R
MJMOGHK[BER)_D(/=6K7V3.(C%X.43;%/+3""S])(ZAS2+LR<*JNWKK8Z2X$J
MAS/R,G3^0<B8HE[0K,B0;<7$?5)S:I%4;@W5[I='<DES_E(V[5=ZFY;L-E()
MXMM*:7=CTD8M[-N1RN);FE'>2VQ*X^<Q,(G%.(]'T?-"B_0;,@(_F(J/5?,C
MRCIRI"MG[)R^BH]FJ1N5\Y077>'/PHK$5$>0G:=^W-JEBLFUO47<<DFU2LE&
M65\T*IXXZ?&Z&:_XV%'N;4(ITWY7)2DJT>-''92K)I#!;^7<JJ2'8]LZ;-Q5
MK7I"*@VS9-2B,1=LHYQ657"@F8R\PY6XNS$[B+$ +LJ4RO'DVK=8JMVB_I98
M*7>S]).*6&512HG0W>(YTV6\>[3-=E&NW'(K,&^63;;:J4!;F6+V\-_R3>R3
MB9250XE'3Q==NZ2(1)-R8K52"CP;BNHY,H416-V94.'8PG$VLIMJ2Z->*Y^"
M-;V/@A9?_:O^312"33<WXV5=]_D\/OKGFUCCC:L!\^VW7U>L'7JE:*3RLI.M
M,6/Y"MK*-T4[+'M+J[;.@:R#>O/&QD8!)$J:A7:L%)6 ZB4F?8$DW1(Q(1,+
M@2ZJ-<JTYRO.0)[/O<H8[2D%57-9C,UXE;P:SI<5EF,\I82&>Q401PL)DH@\
M04%I J)1!%R2/ P%[?<QT)"IVW-#(: : : HW(O[WU[_ &&V?_ C[0+:=::D
MXV9W&N-S-%WY;1)23EC&H+*$80_8-EJ\@1X99Y&=SDT4CRJW>P2D$G3,I4SE
M;+E.(ZLXT@IK92+==RE<R5IMI6E)+-63RN,4LQ(NK:?++PQAGIW:;4Z4CBF_
M))N&"9@7+5D%BK*BSU9T8JR;U<&;>-914K+K/EUS,^ZG%5")4(5,JW&10O"8
MH@/$&4+;G%M45,NW9XTYVTN>LHUPK2+6W&F35*\R?WJMN6/,KB6+57O6^3-<
M2O2V.EP<E,Q:3:URKV-5D&:ICMHT8I9()'M'3E-!J<Z;5<JJ8[["50I^DATS
MGPM4NW,F-%:5SO.&>BYTL'R/E6VW(2A',J/\HX<U5+*GW'M[G/5*IB8EK 2K
MF)]/R#MPRLUMK3@J)6R#-P]AXV)&";,Y=FTG@[21FI,".%E&A46Z8 7K QRJ
M?DL\<9//3=5QNVX+O.%S-5M5:IXJI)VD<S6R*<.>BE:NS=:;U*UEHJT3<L7@
MK *IF3442,  =,YB&ZAV,F82CL8NY1V$.L.@=8IJ45);&JAQ<9.,EBG3EV'R
M  'D#X75Y.CS=&JS!KD( 7<1$0]4/A^IH9.M,  #Y0]]IW2-<A$0Z?.'DV#J
M^%H@J]\@&_EWZ_B#T#H5\Q]='F^)OU>78?/H8T9,(=F61EHR/.B_<%>R#-H9
MO%($=2:Y7+@B1D8YLH=--=ZJ!N%(AC 43B ".VLH+--*C=>3:^^]G=W;<23>
M2#E@DN7Z/8+T67%<!&1,9)1<C(/1?6&*C'Q%'S)7T(D]=/XEY&*"A$H-I9ZS
MF8ER4KQ!P1)= $U2M024*KI;CGNVH-K)<GEJN1SNJ+7=A;K7%5JGE>527)9+
M=V:KGMQ;H]V6-IRKW)75%K"FU9O&<8J8$E5%'!HVPPZQ47"0F9G0F3/VS!P^
M@&Q'#DR46+-0S5I9FJSCLSB4A05$!V(.M49>*G+;D<G38J6XW);:;%.*QPJZ
MMT39NNP:F[<<5GRKE?CR@MF]N$G3F2I5I%&9@Y'XW.=&6Q%F1&G77'2=KB;.
M\J4\_G&]>6DX.3GVD#+.UFZ;%!TB,C#+]HR[<X<)RG61, ZVR3@W%O%2G%_=
M0G&#6-*XS336&U.DE0TI*:3PQC&2[DH.:[F">#V[55.IM4\,G'!,;0-_B624
M0V@UH#$XP3" ;"UAX>,9L+@S:0+-!-NW9()PK5-- J* =FB0H%* $X=]:FG+
M+OI7NK-*/MQ?M.C32V.VXQ;P=)N/?2C+VI+GHZ[&F]INLS : : : : ZU<["
MUVP9BSR28326.ED^[)-7:DFFW:12;BY6<C^0>((2\7(D2;"DD OR$D6\=N(N
M&+D%4^SDOS#E'RZX/=1*7LU2I5-.F6L6ZD@U*ZHU\7%=]22:[V*DJIIX_8M$
MM5Q52&B;;BR+%KJ/(ELN1<Z94XYHN\@+/*G?*'%\R<JLVZT*BFF!"J!VJX ;
MCZ"'WJU"4Y0S42N15>9W80;V_P F6?'#+7'#,1MY(SHVW&3ISJ#DEX4X8?9?
MT20W/'->KD5//XZV)RRL1-QD<FW,1!N*S=]%1;Q42@HH1=PNW</5"B!" /9)
M ;A$!.*7%C*N2JHI22?-6+D^?Q6LKJMNU1PKOE"*S4DFU!OP3RK'[9>.N9X.
M23:N9]CK"?I$(HE@%9LUCH 9RP)S.[9C(.7DTV70;'=C&I(KR2R#$AC"W?($
M144$HI'$IR[;J<,ZMK-*,THX^6I.TXK#[2<\VRCC%I^)=1JMN$H1<L'*#;^U
MI&:>[^7%9=V+C1N5LM!<X*IQ;"9"/1,VG6<S2TEFJ4\A)1S%*9J<M(6&*9H\
M#ATX&(GV943.#NW D*)$S>SW.IC@XUBZK/)=U++3N)5DMF.VIE*D9T7DY$UX
M6O"U27-5JG):T! .H0^&&J8O':!,&VVX>^W#2@IB?(;!T[EZ>CK#XWDU"M@!
MZ1W$-NGRA\;0-K=M/K</.'PPU:$J-P\X?#^!H*D-PZ>D/('0(;^_\VI0M? 9
M!UZAX^<U^O/W<[&24F^83#B8;IV-%H9APRN.2*J=R'NKE!:KUBQ2KH2&$X.'
MK PB"S=,4CVZE&,LF-+*ERX_E*O^DK<%'>FY=RV<LFE<=&[K7>HJ+OT;<L*5
M2YW3T!3*1*5F/EY:PKQC[T?)+NV;-6.<.'"[(MWDRE[!\_:BU,NQJZ#5,H .
MZ[Y,X@/013;DA6-72JAWLUQ0;[RDI=R+V5JL,U(88O//P1A&4<.=U7=PW%RH
MO"D0P>1ZL3D=8LFHZFFA#UUU&%?E;-G3)LA.(+H3:12Q*K%Z<5TR+*+;E,GM
MQ@LFEQZRZ-S>#5E3YD^B=QIX;*K(J)[4WCXIFDIR2K6MQQW5:Z3(J*NVGC.K
M2HL'2DG6^'J)&#G''$TKD56T2,'=<3NVRKMQVH.R/;GW4[5!S(O!=*H'113=
M-4RE* IN0X!5$NY\KOY-R4<4KF7O?DZ=WRV^91;2:S.%A'/EJZ-VW*G)A-_]
M'+SMTJGE4NP, [AN&J8$= - - - - - =:^S4Z)MN:LWIRBLJFJGEJVL8LC'
MA;(N'LK<[*4J"LBXB9..1>G!J'=F[I1@BZ,)@[VEP>RKC6TW'\Y5T[T6^:M'
M2JJG2K5=A*^/CA%*K[\DN]MVT:K1.FTIMK@>=422,I-UXRKF,;.F[%)\J*_?
MWM<MMD18.54&3YJS%JRJ2YE!5,4BG$4A#EXC')80=RXK:=9.>7FPDX-UY,R[
MM&FZ;!<I;CGEA%)/GH\C6'.KB[]=JVT]:L4RU4CYR1<R\+()P;EB@Y2C%5W9
MQ2?%9$!R)RH"BFD@Z?IH'XC^Q4'81 3) IKK%*#W3E1?T<Z;YFN3>GR,V=%*
MLEOA&K_IY&N\\>XUO+I.< 5QF9I'+W#CEWU8CYLJJ2C$T;'J RFC3!'ADD'7
M;%0EX0[1- 5FRH <51,<$CD'?*U'.[<6\T;BC+^FH8;,9*2DMM*Q3KF36J,F
MX*4L*Q;7<RYEX-DMS:=,(LMU=<>P%::VA5D^G.^0KVB UC)-FR(9&/M< _DW
M)I)VB9(PR*#QH!$DR-TB]@/$8PB8"AQHRS6XW.623Y*2M](J<K6,9/#%;,:1
MY#MI3G"ODVY25-[A>5I]Q.N>.W!K'"LK/[!YO5WVZ?A]>L\#30AL'4   =/4
M&W7U]6F!:,;&W'S:%W<X$!\G7U? T(ERD=O/UZ"@#?<=^KR;_P"QH&N0>;H'
MR[Z8!5+Q43'\)::\\EGRD^1Y%NUCK,8X6X*3$<G"6*3!*&*YBUB%=]Z@NQ%4
M%772<X&;D[,#GW1M*61XI2:3[KDHI]Q5J^7++QHX5UYL9)TJE5/=@E5/GQYO
M*C123=.2RQ"25"629S[5HI$W*T5@[J22=&9N48B;H%<B5$21C1ZY*Y?RMX(*
MHC\R(@F(A[(-C<?,E8C?FZ)P;?>BY8=Y-^ WJ#E=G;A6L902_G=)MY_%2PY>
M0Y[3!UD;-@F$9N"]'B=)-11S&2,@B]AY>$D)!NY-".H=T>;C))JU4;K->[+D
M$3'(J42$6 G(5F>;*Z9LZA_.=WH5WG+&N'BNN+P-&>JS+&.5RKS1ATDN^EA3
MEPWJLP^P788B30ABNJ!%D;'=S*D34X>,ADWKN)59"0R[&MPK#O;]=E* =N9R
M454B'6(0 V.!N*KBE9Z:.,>CA/O3@[GWL5CX5XOC&_HY.:AA5W)0[ZGT>SGE
M6G@\II/LJLQW:MQ\Z"7PNS+YNO6TUG)T T!CSS9'(GRVYF.H8"$+19<3&,8"
ME* $)N)C"(  :C]O#PAX)RV))MOD256WR)+%O<L30A6J-4;%7*Z+F0:5]\\<
M'%]-O9 ''?W!5I<$HB-(SE7B1':[=LBF5DO&-W::A@< Y72,5 VR4%F26S*^
M[A"4O!FBHX4<6U'+*34EC%U3;VU7,E6<8^PI.7.DY9HI-$[;XDHB[A)B7(K(
MH]M+F7?&;D!91-C-346U2:-49%P8=V$<F^5!1(A@()B@<" !QP:61R3V1KW?
M%LRKOP7222QKXKKOR[8Q5:/E7>KTE5NQ\1)X4K)4I]E3K''E2)<*!%R5J;!
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M9VI<4S)F \2"8R!.$W$B'";82O@+G47#?)[DZLQUSQW0<,W:IRY%3QECK$9
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ME>C%^\QL##1[G@,GWAC&,FB_9GV$Z?;-T$U. PE#<-]AVT!.= - - - - -
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M"7\*'P@T!'0#0#0#0#0#0#0#0#0#0#0#KZ] ?/"7\*7X0>]Y- .$OX4OP@T
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MJ9I=DMU-FXFLVV$F).$DJW9E&AU:Y,HR42LC()(,)M%!1PFF;YNW Z1@$AS
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MHK],ZA6W<N9+2;;V+:_I?2)90,MT'* 28TB8=RP0PLPDN]5RT5\6XON\=UX
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ME?)5'V2J[B-"1F*C8IZ CVD.VBY:Q01&Q7I6K=DF97C4311XN MW L5!W7G
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M5<[;EAR<K6Y+>F;-;:MVJ.THJ-7L4MR3^RE+<UL?*G6AN3QE^]S#_P!SR_\
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M : : : : : : : : COT;>KO\3;2F-00T T T T T T T T T T T T T T
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M2[=%KX[9Q-J;-(E\X@T[%E:C5B5>(M9YE(Q"IQA)ER3YN@H0H&XM@$ $(WR
MU_I\W.0L,\P4MB&TYR=9\QA3<@TY\YR\T^QI63LXZ8P)S Y)M>.LD25>J;JL
MR;>!+B]M(@=@$.^;D<I&6<]D11!:*NPPJ76IWB52EOD8*F-L-PT3?K?<L>5V
MJFLU_LM1QR>&R'CNSY-C9NPVFV8J@K7%+$@:HNDW21K[M"2670.U7414[0%3
M+'<<.J>)I/V=%><^P5%IT^O3O+9#W*18917EIUJ3F4N<E0Z^YJ$,VH01UL]
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M>M6\5<K"JU0.X32*X13*=$3I^RU4J%7*;.-4HT T \GP_D: : : : : : :
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MDHRN5:<8567,E)YI167$J_D4R3&9-Y5L.2,1!6F&952CU7'!G%FCV$>G/R5
MK$+6YR<K7<964%]5U)QDY;-W"_=EU%6RH&1(!0$>O[3.$7N#==^(6K]VQ<N7
M]3=U%+<I2R1OW)W(0N9HQRW,CC*45F24HTDZG8=0>*6^*]5-'<LV[MN%FQ"S
M6:2SNU",)3A24JV\RE&+=&W%UBC+G7@SV(T T T T T T T T T T T T T
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M'G7NET9\L4;'P='BK3DE659YW7E&4XO"8T<H0=F"N+PK MIC'B#6XS%<7E&
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M$/(96<('N$P=Y-+QZ46SBUZ[$R:XN(.K2Q8\W<'U@@HLZ:,BZ0*F@L^[7LB
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M)XM][#G9C=T]BS.3:K8C%8U=6Y1326[;COHJFQH-P+TCN(!L8=MMQ .D=N@
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M7O7CXJUOFV7UY]CW^I.$>?B8XK<X?*R9940S[B\0%100$+2QZ0$XB A[/?I
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MQM8>Z(+>N5HLVIS9<KJI#IJYZQ(HDH4Q%$U+E!*)J$, @8ATSN3$.0P#L("
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MT2JYDDC-TBF4*( ]</:%^W+S-CT9%\EKL/W<'E[ZU?IS*S[E5R*]88:<^_\
MLBY*#;R>6VAIZX>T+]N7F;'HR_-:[#GC\#RK_:M7Z<Q9E\ >#W!SMTK,A#K>
MV"AO_1,Q$L9?F&EGLK,DLS6EN8.B)12CT<FSD=<'J44[9USTJY9R!NP7(FH
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MBN[K66ALHB1M47:6G,SCQ6.93[F3:0CI-3(*=70DD)16&="@9H=<%"(F.&Y
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M6JHO*S[5WJ3[TNS8E;.$R(G$%5D2*/7#V@_MRI^IL>C)\UKL.^)Y>^M7Z<R
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MSAL<2"<K90S8HJ@/"7:,A9_E-Y3;SR]W>_6JU9):6YE9:K 4]C&LE;2^&0-
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M1GXOY2DFJ/QL51XK%56)S+UB%O36KT91=R:>9)IM8X8=S;]4R(UZ8X8WT T
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MG[96>N>:@/0(AH!H!H!H"/D#HZO+Y] 0T T T T T T \_J>]T: : : : :
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M??)];0#0#0#0#WOAZ : : : : : : : : : : : : : : : : : : : !T"
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MD=-P4I'3<++LFTE$S$0^:R<5*1SQ(J[-_&R+%9=F_8NVYRG262.=-0A@,41
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M&;-HR!9PX*T;(-BN'BYG+M<$$B(@L[<F]FX<J@3B4./2<XB8>O5[AD<C5 T
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MM//./(M6/EVDF=RZ122$Z*:;T"EN\;JFW  $=4R&@&@&@&@&@&@ Z : : :
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M=;?S>G^ZG_T#6?K\^L%L/$=TR?PM4,8OZ)9;=D=&&*UB\@TFNK/YR4NK%-K
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M1_NGK#_:='^!J#U'5#R=3W;?M7"K.?7]ZRH^ID5F >^]K%HUZ;Y:'^W'#?\
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MRL]<\U#0#0#0#X&WP_DCH!H!H!H!H!H!H!H!H!H!H!H!H!H!H!Y/5Z?D: :
M: : : XK[\@O?[D<_P!@/\/6J_\ F9_<OVF91\I=U%-X\$!QWC_U:/4/B5V.
M#?7%X7^[=/\ V>W^!$RN_GI_=/VV5=KGFL: : : : : : : I>%'_E!<NCI!
M_#?"]!,]<'3_ -;U'W4/P$;)^1#N/VRJ-<XUCX'Q_7T T T T T \W1_LZ :
M H6R=-RQE^FUK'X5+F/7UUFM=-=I/UD__"F;K?YNX]V5?A(KL0V';79FDAH!
MH!H!H!H!H#7EX@'Z%8O_ $PM?YW@ U_"?RV_W?U?_7:O\&P>.ZW?F['W4_\
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M+0_VYX=_G,/\-J3?UM_J-K^T+\"9JAU^:-3P(U-BQ U,00TQ:!'2CI4$-,:
MCHO9!>#E]_?MQ?ZERA_[.&OJG8A7UN=7O\TL_A'8\(_>FG_6Q-[P]8^_'7[.
MGU=;"&@&@->?B ?H7B_;RO[4 ?E>! ?AZ_A/Y;?[NZO_ *[5_@6#Q_6[\WIU
MOS3_ .@80T27N;:LWJO52J2E@0M*5;2DW\9%2LFK#F@)@)MD;@CV[AON[71X
M1*L&PE*/#U:_C_J=Q#K/9X'Q;A'5WA^HUD-<M,KERU;N7'9=B]TT/(BX^.XM
M-3W)M;#R>GNWXV;EFS;E.-S+5J,G3*\RV)[><OC*YURE8X]^\EL6/I.FS$=8
M$;>T4;WDU>F5Y)W&.)&22?IJ@VKQH^5@2'*#8Q03,!TU#&*!2D^M:[M6Z_<9
MTMS6Z[J_=O\ 5K46+\=7%K6NQ>=R=MW+D9J2CI\EVQ%KHZ4>:$W*-%'L+G%-
M=>A+I;#EIY*694N976E779&CCN>&*>S"6)<P5KI96[.1Q5#0<@DTL#>&[ZVL
ML"+&NV6T1=H<Q[*+<K$27;)R<,D1-P8IU.#B#B$1$1ZU=L''^J\(Z7B'5_3Z
M769+\;.9:BQDT^HU-K52MPMRDE**N68J-QIR<:INK;>*XMJ-.TI6(QFE)*JE
M&D924FJ/=6*Q*!CL\V2*GHJPLXR,![%9+N^2R$74=KH.7M[9QT=*1*Y>U3/W
M-NR8"1%4I@6#M1'?< UY'2]L/'-%Q33\6TVGLJ_8XWK>(T<IRC.6NA;A<M2Q
MKEC"VU&2:FLS=:I'&AQ*];O*]%1S1O3N8UI6XDFNXDJ)[<2JG',1<)E5BZ0J
MC=RTJEKI5Z23![8)<(UK1T'<<R9/GKE9VHA%/'4R85%!%(B:BA2)E+OL/?W.
MVGK#Q._;U=CAT9Z;0:_1ZZF>_=Z.&CC.W&$YSE)QMSG?;;K&,92481BG1[I<
M6U-W+2VFK=R$UC*5,F"3>.#;VX;:(_:-SM;D%8^^,\9QBSZ)9,Z]8[JFVLJC
M>5B6E6D*:WAW+U-P:,@5U(B6+QG;B10[A)%3;H$IMNA[6>L5EV.MNEX%9E?T
M]N&GU.L4=0XW;,=-<T<;4I*71V&[5U-RMY92N0MRW-.PXGJ%):I68N:2C*=)
M4:47"C?DQP>[&M"BLF6Y>YQ#:>L%+F(BP2,JQ"$L#L\\O%*4J+K[>.:PD>_F
M7:X2I_2(&=&43(4J8&X2FX#%33\MU]ZQW>L_#+?&>+\+U&FXM?U$.@U$G?=I
MZ.U8C;C9A<O3ETKZ2MQM12CLB\K48<?57WJ(*Y>MRC>;5)/-3(HI**;\K'QJ
M\^VF"NCR0_OWE_8;8S? !6+^+KZ;\D#'M<?^5ZGV[9V/5?\ >J_52]N)M^'7
MZE'T<: >_P#7T T T T T T T T T T T T T T T T T ^/N/R- 1 -]_4#
M?0%:U;\C.OQ<O]CUC(I5.L0=>C(LFXA>:2Z3#->*:NXK-T[(MG$XHLE"H+LK
MFY<I*RJK8IG*<>0Z8"L9,.,";B7IVU^/W737W^%]OW$N)::>GAJ+'66]<C*^
MY*RG#52DG=<:R4$UXSBJI8K$^4:J;M\8N3C12CJI-5V87&\=].6FXR*E2N9B
MB6&WQ#F@O&^/J/?ZQ'2C;+5NE(YO%9 8S SL>]0GZFW)9;:Y6FG81:"3UH41
M4;D516! AA^U<0>HXEU3UG6/03X3<M\(X9K]-:NQXKJ[EJ-K7PN]/;N*_IHK
M4ZIN]=6EMQO6UXUJ,[<^B4GVMR+N::>HMNTXV;5R*:O3DDKB>9/-#QINKRI2
MC]BFG1,Q*P>XE6^2X(\0U0=KBTLQ'8.9@*\DSAU*G.ISTP2>,DX)"NX*#.Y>
MH.Q35[NN@0X$.(<(_P Y=DU[B-CKSI?@VW&Y<=K4YU*][G4;/N6\K][IZ25J
M5BSTEZW=RRZ.<(RRRI1]+H'):R#@DW26_+19)9I9L<N6-6GC1I8;BX>>:LTI
M-<IU:B'H/H=G8;BN!GMJ0M\RVEW<;357[15[&0$##QD8++NBZ#8A5%U#KG<&
M-P+)Z]QVP\#L=6N!<,X+P^[TW#;>MU<LT]4M9>C=G;TKG%W+=BS:MV\G12A;
MCFG)RE=;RW('(XC8CI;4+%MU@I3VR4VFU"JPC&*5*-+;BV\&C:MR;?:OXZ_N
M6Y?MXM.O[V^31_LCP/[G5?X[4GN>KW[FL_S_ ,.1<K7WH[H: : : : : : :
M : : : : : : : : : : : : : TI<T: CS$9N6SA#<U$W)#7<5^X>)R[25_
MB2HRA$#&N*=8E*XD]Q]"9+4O' 9^ZM3=5H$0!=R&;@)1Q1@^<_>Y\W7-[BS'
M5USS9T8V<IU3YFLL8')B\<<HQM@4@$?;'7,0VX]F350<3RKW(;J&:.%FC=NR
M<L-U"%.HH8Y;B9$JR!S?<ZV-HZ^1LTQC7&4J![:V,G1R88F_:JOC.I<N$C?7
MW,H3)*2Q:Z0#Y-CSD+%=MW($!".%J+@.WTQ)7>MA,*7S9\W>1K?B6JTF;82%
M/R+:L,0=@S#+<O%CA&=-F;WB'+ELR34FM?EI",;332BS%6A5F4H90$"+O"-W
M2SI-4"&5WHN.PE3'G(Y[G9\S-9.CU:K/J6UL9'"$GBW)TF%!?Q.7HJJ5[A=5
M^K2C&7:6G':[B0,\%2;1(L4L@1%./*HU+*LF)]-.=OG2DI[$[%MC/T3#V5K#
M)QTA9L<V9(^5)DV:['2[*R2<U^$G&S.,9X\C&4@Q>I)5L7'?BRRB2; 18)*_
M1]'T>P5,GJ7,CSWL<.8+R$8L5:+/S(SEAQ#"UIKAQ6(2P_?9&\LXFB7RWE[Z
MXD'E?;5*!G'<@+HC9@*YFA03(4>)2DJRU&9N:SF\R$SYF<;UAE?:S&QF.LZ/
MJW+5[&]CJ.1Z],XIR96(>MLX:0B$G)FKRVTUTX=*'1D7[MZD8';5..2,1 86
MO(3NG<R_,!2:O<'T$S?P=-L&9^9&1)EE;"=UN<W=;96L2X9F\+P<A4D@(>*+
MFF9E)$KI\FS;(G.P!FU%DN8RFE2,OWACF4YO[/D2C_9,K3"N0=AYCDL,6K'J
M6.9! ]6@7W+#(9;=V%.Y=\.[.$!D>']$I+J =J<KDZ"QU5^R,0*[S;%K(R&@
M'O>]\/0#0#0#0#H^#[[_ &= - - - - 1Z//\,/]O0$- - - - 2R:_0:6_2
MQ_\ G1776\9_<^K_ +-=_ D87/S<NXSKJ>0/?!\;7X23PDWSL^,K8NX1 1*(
M& 1 0$! 0$0$!#I 0$! 0$!UC&3C+/%M-8I[T4R#7SOE]>'93218YBR:V.!4
ME[1&5&*8KVZR5]DJO"MKM--V1?;,Z19"HJ9NY,8%BF,=0IA'BU]EO=K/:3=X
M79XG"-FUH[>ML.[JK>DM0>KU.G@W9CK+RA_ZF2@I2<+C>>KG)-XG:/B>N<%=
MCE24XYI*"3G**JE-I>,Z8T>W>2A3F OXJ0(-S5Z-956Q5>S5V'C(%DPAX:0J
M2LLXBB,V#?@(5HHZFW*K@IA,9=0^YC=  '7S[8^N3NZ2=KW':TVAUFFU.GM6
M[$(6;5S2N\[:A".&5ROW)W$ZNY*2;>"1K?%-32$8Y(PMSC**44E%PJU1+=BV
M^4F\%GK+CMY7HN!)&2$VW<Q*#(S"LLEYZ?2@B/RUZ%DG#9'OTNP@TWR@-D1'
M<I2DXA-V9=NPX1VM]HVIU.CX?PB-B]Q2$[489-+"5^^K"G[GM7)16>["RIR5
MN&ZD:MY(TV6^*:Z4X1M97<JJ4BLTLM<L6UBU&N"[FT_.DY#RRR@F 5NK-+!"
MXX).*A(+TLLX6 ;SCU.>D >R96YSQY$7\:#I,X'252X#>S[(3%&=5^N7:/IN
M%6WP;A]O6<.X+[H?22T73>YXW[BOW%.Y2L%&Y;Z6,E*,HJ,EFR.2<TVKUT;2
M5B"G:LUQR9LJD\SJ]V*KN:Y:%EIZ<DK--RUBF7'>I:<D7DK).>S32!=Z_7.Y
M<J DB1-)(IE5!V*4H%*'0  &OE7&.+:[CO%=1QKB<^DXCJKT[MR5%'-.<G*3
MI%)+%[$J(Z^[<G>N2O7'6<FV^Z]I*-==4P-['+O^\=B_]B;'^G6U^S/87_M!
MU?\ \NA[<CZMP?\ =6G_ %2-<?.V'^7!?]B5<#XCW7\$_*\_W>G_ );IO_,/
M%]:/WJ_U4/IF(>OY<WGG2IY6E6^"BHZ>FJO8(F$EBI'BY>1B'[.-D"K(]X1%
MH]70(W7[9#V9>$P\1.D.C7?\0ZJ]9>$\/L\7XIH-9I^%ZBG17;EJ<+=RJS1R
MSDE%UCBJ/%8K VST]^W!7+D)QMRV-II/?@Z$E)'/CQRTN1HY-%-GC:.7D2HJ
M"R1D'B#IRT9*.0+V)'3ENR6.0@B!C%2,(!L4==;'A^NEHI<2A:N/AT+L;<KB
MB\D;DU*4(.6Q2E&$Y);6HR:V,UJ+<<]'DK2NZKJTJ\KH_ SA='G#U>GJ]_KA
MM-LASG$;(M&<?(.F+MNPEB.E(MXL@JFUD4V3DS-X=DL<H)N2M7:9DE!((@10
MHE'80VUR[W#];IM-9UNHLW(:341D[4Y1:C<4).$W"35)*,TXRIL:H9.,U%2:
M:A*M'N='1TY:/!\C.>%8L@P(VD(&8&M%==R-/A&O/0Y78F @-QD>Q[H"O:&
MNW'OQ='7T:Y:ZO\ ''PA]8%H]3\!JYD]T='+H<U:9>DIEK7#;MPVF70W>BZ;
M++H:TS4>6O)782+744;P-9LR\/S]"<J_IC3/BMK.'R=?H5\B/]T]8?[3H_P-
M0>WZH>1J>[;]JX59SZ_O65#U<B,_VL6C7I_EH?[<<-_SF'^&U)OZV_U&U_:%
M^!,U0Z_,T\"5-#TNWV&.DI>!J\_,Q4,0QY62BXA^^8QQ"(F<*"\=-D%$6_9H
M$$YN(P;$#<>C7?\ #.JW67C6AO<2X3H-7J>'Z9-W;ENU.<+=(N3SRC%I4BFW
M5X+'8;86+]V,IVH3E".UI-I=UHE,7%2<V]3C89@[E9!8BZB3&/;JNW2B;9NH
MZ<'(@@4ZABH-D3J'$ ]B0HB/0 ZZ_0<,XAQ351T/#;-V_K)*34+<7*34(N<F
MDDVU&,7)\B3>XPMPG=EDM)RGR+%\I+MPV =PV'J'<-A]]KA99&%43!G%R4@A
M(N6+%V\;1#4KZ57;-U5T8UF=RBS(Z?*)E,1JW,[<II <X@45#E+ON(!KF:;A
MVOUEF]J-):N7+&GMJY=E&+:MP<XP4IM81BYSC&KPS22WF<82DFXIM157S+95
M\F)SH"L6.U.U&%9@I>P/46YG:S2&CG<DX2:D.FD=PHBT264(B514I>(0VXC
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MP<HP"THL]<'EX%9FL@5J9=/=,5R=J!M@WVZ/YF[/NOG">J'4?B^EOUN<9O\
M$-!=L65._:SJP[KG)W;#C**BY1JL\7*N&*P\[H];:TVBN6W5WG<A)*LH^2W7
M&-/!7$N=.\R;:19XC<)R4BPE4)Z>LE^"#>V9G%P;R7RH[MZJ!*L:0:P%M;&C
MG0\"3DR_L![,R@&Z=>\XGVW:75Z7J_>C?O6M>M7?U.O5B>HC:L3O<4N:N4?<
MW21LZF.2>$;CG6+R2DF<R[QC.M/).49J4I7,KFE%N[GIEJHSPW.O)7$E&5\A
M8SMTICCCL*TPV8WN0EK:E$MKFXJ3:N2DM'.7CAG!7Q\[EVTS)$25.Z:-'(L
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M#XXZ_0GY$?[IZP_VC1_@:@]OU0\C4]VW_P!,JWGU_>LJ(^?(C,0^MFT:]/\
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M-%%K:UROF,U-?UN>G&@(CY.@0^-\#4!#5 T T T T T T T T T T T T T
MT T ][WO/H!H"MJM^1W7XL3^DUC(NXJG6(.M]G[]_'+_ /TEW?\ ;'(Z_%OM
MC_W6ZQ?YSJ__ !IGR/B/[PU'Z^Y^&RT>OFIPAJTPJ".J@;\^3;[5_'7]S7+]
MO%JU^NWR:/\ 9#@?W.J_QVI/I_5W]SV?Y_X<BY6OO1W(T T T T T!1&2+%.
M5"B6NUUZ+B9J1K,#*6#T9-2KR%8O&D,R7DGZ/I%C$3CA!R=DU4!'\;'*97A
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MJ9$9!_[,VC7I_EH8=G/#G_\ ,P_PVI.1UM_J-I?]>OP)FJ#7YH;#P(U*4 U
M-7:!J : :M,*@O#R^]&;<7_LRA_SP&OJ?8@O_P"N]7E_\I9_".QX1CQ33_K4
M;WAZQ]^.OV>/JZV$- - - - 1\_J^]YM 0T T T T T ][X_K: : : : : :
M : : : : : : : : : : : : : : : : K:K?D=U^+$_I-8R+N*IUB#K?9^_
M?QS!_P!)=W_;'(Z_%OMC_P!UNL7^<ZO_ ,:9\CXC^\-1^ON?ALM'KYLE@<(:
M@(ZJ=$#?GR;?:OXZ_N:Y?MXM.OUW^3/_ +(<#^YU7^.U)]/ZO?N>S_/_  Y%
MRM?>CN1H!H!H![WO=>@&@.%)QS&9C9&'E&R;V+EF#R+DF2W%V+R/D&ZC1ZT5
MX#%-V;ELL8AMA VQN@0'4:J"UTQ@/#5A&#-.8ZK<L>M1C&&@#OFRRQXB+C:U
M/T]@S8G%QQ(I-JS:9!F40'B[)T8=^,I#%4)0Y-)PEC/'!GP4J ?0;*15G7#R
M#);+F_JJSFSR*TM8'7M.E;$^JA'4O).%%5E"L@.)E#["'$;=0I,G6),7NJU.
MT\*!4H^M68C4D]$P,&QK2$F+%PF[8+KJUU*+= \CG:)%6RY%"KME2 =,Y3!O
MI04*3'EMP69U+/3XT@%7,W'V2)D553RBPGB+>+\]GB6I%9$Z49%3B\J[7<MF
MI44#NG:Z_""RRBAE!3"A^$QRR8$GUY!Q,8PKSU66--*RO$>513E',_)6:9?O
M9)%K(H)/WZ4Q<Y9VS<*@9>-<R+A1F= Z@CI041\/>6' \J@V;36.V-A2:0RU
M>1&RS5ILJWH11E+QJ$:LYGIV1<NFT2QGWR<<"ISC%%>+=R%N*IQ%046\YK7E
MQP:RD5I5KC.M(/UI!U*=X(D\W;/7Q;"#\T>D+P48MN_5MLHNN@V*B@N[D%W*
MA#.%#*BH*'%7Y9,".#&4/C"O$<"E%I$>MSRC20:A"P]=KT6HPD6DBB_C'#2!
MJ<>R!5LHDJ9JW[(QC$45 Z@HBH:'@_$V,'Z,C0:/$59PUA$JXT)%J2";-G$)
MM85D*#.-5>K1K5PY:5N/3<.4TBNW2;)$JRJ@)E %!0NKJ@: : : : : ='J^
M]ZF@&@&@&@'O?']?0#0#0#0#0#0#0#0#0#0#0#0$=^@0\_R- 0T T!'K#WWD
M\_G^#T:@ = @/JAJ@AH!H!H!H#@2J2B\7)(HD%159@\22(7\$=11NH0A ZND
MQA -<#BMNY>X9J;-I.5V=BXDEM;<&DN^S&XFX22VT9H[#EPSH(!_DOM(] !M
MW9OYO[IU^0$NP3MBSN2X!KZ5P\6/XQ\K7!N+42>FN[.1?5)[8L*<QMKE59R?
MQU:'\LX;Q[9R]&-CFRKDD9'M8QJHY!J=N1=UW-FF"BQ@%58X"=0QCF,8>TXU
MV/\ ;MU@XA+BO%N":^[Q"<+<93R6XN2M6XVH.65I2GDA'--IRG*LI-R;;VW>
M%<:O3=V]8N.XTL:1K@DE6C6Y+':]]22>YRSIU?8PM'Y6;]'GV '7EUU/J%[8
M_B#B'@CW_L]YJ^!>*_L]SP+ZI#W..=/X+[3^54/[YT?8'VQM4? -?3N1_''P
M+Q7=I[G@7U1[G'.O\%]I^"U0ZO-^2=%V!]L:6' -?_1C^.7X%XMOT]SV/JD?
M<XYT_@OM/Y5;]'J?DG?5]0O;)\0:^BYH_CCX&XH__;W/ OJDSA<$\PE=F8J?
MB<9V1&5A9%E+1JZL9&/DT'\>X3=M%U&CX[AFY!)PD4W JF<AMNDHAKG\*[&.
MV_@O$['%]!P'71UVFO0NVW*W;G%7+<E*#<)N4)4:3I)-<J,K?">,6KD;MNQ<
M4XM-.D7BL4Z/!]]4.&]Y?<_2#QT_>XVMKEZ^<KO'CE5NW,JX=.E3KN%U3 Y#
M=198YC&'RB.N+J^PSMJUNIN:S5\"XC<U5VY*<Y-1K*4FY2D_&VMMMDEPCB\I
M.4M/=S-U>"Q;VO:;>,(PTK7<1X^@YQBO&2\76V;20CW12E<-')#*B=%4I3'*
M!R@(;].OU#[(>%<1X'V9<%X/Q>S/3\2T^AA"Y;EY4))NJ=*XGT;A=NY9X;9M
M74XW8VTFGN?(88<TF!,JY%RHM9*?60E88]=A617GI>%9B+IH#KO"0H/I!LX#
ML^U#IX>$=^@1U_)GRC.Q7M'Z]]HTN/=5] M1PMZ&Q;S]+9AX\,^999SC+"JQ
MI0\QQ[A/$-;KW?TUO-:Z.*KFBL56N#:9CG[DG/WZQ@Z?^<-9^K&O@_S8NVFF
M'"%[XTWI3IOX>XQ^A^^A^,0]R3GW]8P?7#6?JQJ?-A[:?BE5_M&F]*/X>XQ^
MA^^A^,/<DY^_6,'UPUGZL:?-A[:OBE>^-/Z4?P]QC]#]]#\8C[DG/OZQ@^N&
ML_5C5^;#VTO'X)7OC3>E'\/<8_0_?0_&'N2,_?K&#ZXJQ]6=3YL/;3\4KWQI
M_2C^'N,?H?OH?C#W).?OUC!]<58'XTQHODP]M2_Y2O?&G]*'U>XO^A^^A^,/
M<D9]_6.'UPUKZKZ?-A[:J_NE>^--Z4?P]QC]#]]#\8SDY/L57O%L=?T+Q"!"
MJS;RLJQA>_QK_O)(]"=3>#O'.W94NR,]3_!B43<71OL.O[&^2UV;=<>SGA_&
M;'6_2^Y;NJO::5I=);N9E;C>4OS<I4HY1VTK7#>>IZM\/U>@A>6KAD<W"F*=
M:9Z[&^5%1\W&.+CDZ@UV%I,2$Q),+HVEG3<7K!CV3 D%/,C+=K(.6J1]G#Q,
MO"4PF]EOML B'>_*;ZA=:>T+J5H>$]4]-[IU]GB<;LHYX0I;5B]!RK<E%/QI
MQ5$ZX[#=UCT6JUVDMVM+'-.-Y2>*6&62WM;VC7Q[DG/OZQP^N&L_5C7\.?-A
M[:OBE>^--Z4\?_#W&/T/WT/QB'N2<_?K&#ZX:S]6-/FP]M.[A*]\:?TI?X>X
MQ^A^^A^,1]R3G[]8X?7#6?JQHODP]M/Q2O?&F]*/X>XQ^A^^A^,/<E9^_6,'
MUPUGZL:R^;%VU?%"]\:?TH_A[C'Z+[Z'XP]R3GW]8X?7#6?JOK'YL/;5\4KW
MQIO2C^'N+_H?OH?C#W).?=_\1P^N&L[?X7T7R8>VI8_!"]\:;TI?X=XQ3\U]
M]#\8>Y)S[^L8/KAK/U8U?FP]M5:_!*]\:?TI/X>XO^A^^A^,7(P]RSYHJV4J
M'8IRH@RAX:RQLA)._3< OW=HW5XU5.Q;RBJZG" =1"F,/D#7O>RSY/G:QU<[
M1>#<>XOPQ6N&:37VKEV?3V)981>+I&XY.G(DV<WAO!.)Z?7V;UZU2U&XFWFB
MZ+N*39MF'K];U=?IJ?05L(: : : #TB(Z : : : : : : : : : : : : :
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M8 AL/FU0-A#K#0#W@'0$=A\P_"TJ@-A\PZE00V'S#JBJ(]/5MZOO?"T!#8=
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F[_)T==XPYCF->Y;&[GV'#Q>S[OP</%L&V_!['BVU"JFXY>@/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>tm2030088d20-ph_patien44c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d20-ph_patien44c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!E@.2 P$1  (1 0,1 ?_$ 2P  0  !@,! 0
M       !!08'" D"! H+ P$! 0 " P$! 0            $" P0%!P8)"!
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M.\\/\*+,_P"C+3*AGN?-0A[KKZ5/^4>YX?X469_T8Z40SS?_ "(C[KKZ5/\
ME'N>'^%%F?\ 1EJ41<]SYJ#W77TJ?\H]SP?PHLS_ ![EI1#/<+G>Z/>EW+B<
M,P&]))SGA7CVLU62C1YJ,W#.J%3:E47L(- M)FY:\A(*I,3+F6*<7BI2%((
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M!0M$PF_;-$VK&4/9;=$*-8I9LJH9>/!E!(& RW L"QU0$O 4@B3*ME2W(M0
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MH^*E!PDX3BXSBZ--4::P::>QKK,/><?T5UQP/5'.>< WR(YG>5AR(O$<CTY
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M# 4"ZP;.1&-$;.(#%U2H4#7HQL+*'.M"*Q*93J)I.Y.440(9.6=.2'(JY?\
M> ,<5C@)MS[!MU:%+F0%+<1M+=[BLVE73)1,KM8Q#.$@$# !Q<B)5ER;D,8!
M.8PCN'1H"S?<9:(D&PN91*P T:G%5F"34KEVJ+T54SI/2*I-B[$$$RD'L@V
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M&N[5-8T T!Z%OM63H]-ORI;?E;YBOA\N64PU)&VUYS\'T4?6QU@;QH!H!H"
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MVQK?<R<@N0)UE/P=Q1C\A<K>19%4[<:9>I!D[>TAVOWQR<T$UR"X6+4+PW,
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MX[5'0HK0@T!Z%OM67_;;\J7U-<Q?\7+*>WP]8RV&VUYS\'L'UL=8F\: : :
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MEFS<0!P\0CCF]]/#L'#N/@V#;27L%CM/L5ZP,AH" ]0^L.B!\E;[8D_;0/\
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M2'6,H;I*4RAB*)"/3\J&_BZ=1U%4RJ#0IT]UR =5,S90Z0;%(0X@43J%.(
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M$#!"F0%3Q:M!6KSH$BN#='C1,#=0"J/60[\#1T)0X5"-U1'A4  4\(#TB.F
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MJTWNSY4GMR)8%4J)&8.G]@7*CYX>@?B"-:]U;(E.;=?LFXF.Y7.OOY9S;B(
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MF2L@>T@67M+/<K(M3PCU5UF1:JXEW:]>(V.Z*5X":<0HB7@7 JZ>W"H4#@8
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M#X0ZSP\9KV8'Y[^]ZNA"[O+]]GO!_A_SPXQ^'=8/XFFXL?.7A/NSZP-PT T
MT T T T!\Y'[8A-0R<S-I4R6,?[3DN;G-:[WSFW,[9^=4.2+&BU3 S0%VI7J
MXVXC $$#J)I++\!%# F8PZR6S PE2N)X_,U!1QR"_<8X%@:GO8*E/H\8\%$$
MS/W=*KRMD.YC%%%AK\DI:#/3.HPBJ[>.<&.W;KN&Z:2ZE5:8FB5*X;"U.J8F
M]K!S>5HOH]N5JP/^W)%W'G5MT_&E;;EXTJ-7H5\J991-<%4U!>,"'*;@ "E(
M!@$W"(!BS?'S4B]./62["@T9BX22352JU=0_L0I.$LDA#-$ET5"D.<2)@9(3
MB(B(&$W2(".VH9%S4$Q*5,3*<:P<(G* ]1A+MVFX )0X3 &_W#< U10FK=V0
M5P 3\:@)G XG.)4@(8. W:^2([% =QV -MNO0IIIRM/M9S)-ZEVI#I-GM@DB
M%$"I" ILUQ9E7(98$C=D<&VY!$H<1-AV !UB"833-%E1,?.1[8KN0:6QTIQ=
MD)#H%L/=# 4$ND>'L2#XP*(CMN(@ =1FKR=6%JXI-@@G#QH[=1$\J\:1:IS@
MJG'R;=$P+G2*!BK(@]05 >D1(.VX!N&]09F"W<"INJV$BITPV$I1*FW VXF
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MJF'82B8IRD*8 #<=7$$_,P;J*($ @ 9(A0$P&V,4Q=MB* "8$("0  &$1]4
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M<]W-+R]>B=?<MM7GW-0K/,5S.YI?2\M 1QT5#U:&295^[U-E-NT558])_*.
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M0@?_ 'R3/^CB]:DMGC1E'SC[%FL2C0$!ZA];0'R5OMB3HYH'_J<S7I!???\
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M1*!]P*J7A$2 ( '7OL(CK('76$H&*<J!2"0IDRF =BAV@" )D#@*40$0#81
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M F !$AMU1,)^'RRE !XO* .GIVVT!:BR2G"98Z:JYD.U\E'M2>68#'$3% 5
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M*BKWDQ52"B3@^9E.4$S'#9,IAVZC])C;CP[![X=J3$E:J($7W.00 @#TE 0
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MD9V47,8Y@,[D72CE1-+M#&,5!#M.!,HB/"F4"^#6=:*AJ?SRE]8BH'U^L/>
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M=KJN73EPH=9=PX74,JNNNJH)CJK+*G$QC"(B8PB(ZR./M/PT!P4_J:GW0_\
M2CIL*MI]X[%?V,,<?4'4/SO1VM9S'M?A*\T(- - - - - - - - - - - -
M- - - ?+X^V?OLIN/W[?-S_HYY6M9+::;FSQ_01Y/]9&D@.@(Z :#89S8/YF
M*XXK[?#W,6S?6K'PF%.LW%-4RUNQTY4X2H+,7QBJ/%X=JIY8)%$3([CP@8H
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M2L=K>W[FFND?7(Y8#2;K&<;(L[!E3(<H)E'::=H>-Q,LX9&4 J8HD(C'H[
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MI4Q-<IYL-QK0U36- - >A;[5D_VV_*E]37,7_%RRGK&6PVV?.?@/K8ZQ-XT
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MBQNY> 0SRX8$+QN6TO4""?MG551546;&-QMBG(GPZC,ZFO@S*':V1E6T<C5
M99ZLNBVBY:2+79D!;.#M'#:7@I9(KMA)(JI"(HG+QJ_SO2(B64'67;M.+$8Q
M@SA&<LTG<BQ+>6G;?6X*?CY)U!QR;N*BBL#PC!!V\7*P6%58KP'*1%$EBE!(
M>-,YJU4%KA8OXLO&,9,K&6(8Q5&T>]70+P%%55 #)-Q*"VP<([FXN(=A O1P
MP;CIPT3..VS^7=LP@8<%E%FTG8P4ANZD*4 6/V4J#95TH94INS20*JH  !C
M7BT!?'#/*?9,UE->[?VV)N6^ %9Y>.8FSD5A)JTQ#8JIG]%Y9HB31:J6N[65
MHB=IYT03=1\3QBNLY(0AD5K0&MKTC7.;7<WR<!@W"$)'T3EQP\(0E(IU;<'"
M !*. Z::HF3,"<]).'2BKN4EU .K-RZJCPYC!V(AE0P>PU;@7<0 -ND=@W';
MX8]&AC1$-O6^#H*$0* B "8 W\(]0? W'4+1%W.7_;Z_>#MOTX<9>'?_ -=H
M/IZ@U=S"\Z/A/NSZP-PT T T T T T!\S3[:6^R9D#]^O;?XLN"=9QV&F[L\
M9Y ]4TC0#0%\N77F(RIROY5JV6\1V^P5*R5N58OE#P,R_B EV39R19Q$R(LE
MT0=,G:91*)5 .4!'BVW#1JJ,HMIUW'HNRGAS$W-ICH>?7T;Y47MR:PL?+\V7
M)U M &[X^LX@B\N63\+TV-!,]@Q[/R8N7MDI;<@@W.HK)0P$)Q%;X8^,WIIJ
MIBQ2\IQT\9"2DF9XI!=J6/;V1LX3?T>2E$S"9=A&V8Q4083A4"',:)DR,I1(
M"GXFP<!AT+M6!>@DF15JD=N3O;9QP]V=*MQV$AAVXCK-E. Y!X3!X0,/0.V@
MZBHF\%;7T<G)QE1?R4(8R\8$C'*LNW7EVI"R#MJT@!34GY-I'1A"+NW21>P0
M,)0XA$QP(!1#N47(DN@LJM%+"?L"J=Q!JN4R@"F.YE0'A43$WRH[#Q= [#H*
M8ELG%D<,_/A*G%.KI)QH",W+)RC*.KU19G*=1!?(N0)MRRJ=+; 8QN%%1R+U
M0@<2:)^C<@Z&0W(7R%,>8.SRG,;S/62*QKR6T"2-9,M9HMR9JHVSNUAW)Y5U
M@OEO/8RLG*>*);A*C8K44B2LNU6,F!MC]B%6!BV:_?3'>D@<<^_, VB<?$1K
M/+!@UF2A8'Q_"(IQM5C8.%2"+)-Q<*U2;LV:3IF@1%J!4R<+4@&V*94X:R6&
MTU3E7!;#3YH8#0' _P H?[H?^E'0JVGWCL6?8QQQ]0=0_._':UG,>U^$KS0@
MT T T T T T T T T T T T T T 'J'0'R^/MG[HRHXZ?^NWS<C_ /ESRM:R
MCCZGT33<V>/Z"/)_K(TC0#0#0#0%S\=9GRCB9PHXQ]=9NME7.51TS9NA-&NS
M%\+J-7!5DON'0(F)OMT;Z&2DULV&4$9S]9#523+?:%C/(KA$ !&0FJVV:/R[
M#TBHJS3[)4>'H^4#W^^VL<O09JYTHJ$?2"2#9L*<3@/#+1T*A52NW4$#_@,5
M,"$X&YTTDPX1#B#I#RA$>OIU:%[3J+;77GOYB;@P7B&EFCZ1#N$SHJ1]%AVE
M>**)R@04P<(%.Z( )AP[E.4??CI0Q=Q[C$60DI&6=*OI1^\DGJQA,L[?N5G;
ME4P]8J+N#J*&'UQU3!MO:=+0@T!Q$ '5J6I$.C4(>E#[4X_VS.'_ -2//G^C
MF2TEL-MKSO$?5W#J#U@UK.0]I'0@T!\K7[98^S*S_?@<_?Y_L::SB:;IY@M4
MTC0$-NG?5J6I'4(<DU%$3D61.=)5(Y5$E$S&(HFH00,0Y#E$#$.0P (" @(#
MH#,3%G/KS0XF209P>2I26BT"$23B[,=28;D2(8IBID<*JIOR '"&WS4=M&D;
M%-K#:C8[C;TXN3(AJT;9$JSZ:%H!N%2(DD7+83\ E**<?,"1-$.GI\LQO!OT
MCJ92JXNLR8<>GHQC'02;ZNX0D$;[P&-YW3@J_'*]Z,D!3.5Y%*Q+$[4QC'V.
M5JH/"<>@!$=3*7M(FF/FZY\,P<VTXHO99!Y!58%3+)UEG)N5TWBPEX"N9E<
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M@=39;MR3;Z*_.='ZCJGUJA]$P.H/6#6)L(Z : ^<UZ=GT=?-#S/9KFD<,5>
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M3 N670R <M7,:/3]8'-6P>$,6WD?_L+5PZ2-26YG+]C1S'?I 9K]3_-9>?\
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M:C,-(5)N#^LV8\?-0TU"R5:?M(Z"78'3C>RIK"=W;& $U$G$HJ+90HD.B0P
M5,T\U51*B^=",>G^"G5YGN;;Q)%K(H/&E:/ZZ<I]'\)JBRK"M%L-W6J0: :
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M_FZ!M^(Y;&#Y7K#UNK1F.&_80'JZ?4W_ )FWJZ;BK;@5=0W589VV$>7!)=Q
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MTPQVD!K=CWZ(";ZMOQI?_B?0JZR(5NQ;;#7YO_!,A\9OI5;".M:HA[6K#O\
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MI#?3:-FT[[2F8OD&R;QA3Z*^9K 8473.O0#ENKP',F?LED6ATU.%0@E$0$0
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M>HXZKVD6Q&X?4*- - - - - - - - - - - - - - - - - - - - - - -
M- - - - - :<?3)?\BN1H/\ _H[RV?\  +[IT^ CVKZY>N;CM"C0#0#0#0#0
M#0#0#0&I3ES_ -K?Z1G]2WE7_. RU=Q%O-M>H4: : : : : : : : U(^B*_
MY%\[_P#_ ').:/\ K=$UD]B(C;=K$HT T T T T T T T T T T T T T T
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MRBG*E*8DD64W2D>87&IHRKGKL:Y>P7,,QE95'$5D<2AFIG*U<L/GQRP<MUS
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M?,R*[UJBJX$R:BQ2G+V:(;E$>D-RI@(?!U&L!B5WK$I@M<AWMMG_ ./Y8/\
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M&@&@&@&@&@&@'Q- 2R4A8>;(Q),Q4=*DBY1A.QI9%DW>E8344MWB,E68.$U
M:R,>MY:*Y.%1(W24P#J,&-<)S:8^L&?[]@./B[0D]QAC>>R'<KC,0$Y 5]M[
M7+8G592$A2S<1'JVD&IA,X/(QYG$<8@%*DHJ8P\),E2E,2<XGUQ[[C:GV3#5
MXQC%9VI%BR+@*VV&9JLNSR-5:NSA)F1&2B8&1=RM%GE:Q8F<HBQ?%.)FJH@9
M0JQ!2TJ*E9YMYJ:5A._X;QC)P5KG[=F;(U&H40G%P,RE7H)O=IIU")6*<N"T
M4>KH$8.F9]HX'02+@1*)4@3$52JBN)3>4.;%_1KW:JE3\'Y R]%8R)5?KM6*
MCR5<%Y4WMM:-9EG URG/WB=FR-9HRJ2+.8?,8Q+C0CWJ E,HJ?LP5%2Z><<V
M-L-5^I/&=0L&0;=D:\0F.,=46OJL(R0LEMG(Z6FB(O96<6:1E;A8J!@'SY^^
M=#P-D&Q@X3J&(F94M3'QCSQ#.P\/#5C!MYF,[2.7KEA.1P<M8Z=&/*[;<>58
M+I<9:7OJ\@K4PI<96G#1=*12%0SE1^W1*B"AQ JHJ9&X%S3#YYQ^%VC8*;J,
ME&V:W42Y4JR@R&P4J^4.P/JS;*Q*J1KAW'.E8Z48&%)=!0R3ALHFJ7;CX0H+
MS: : Z*47&H2+V81CV2,M(M(]A(2:39$C]\RB5)!:+:/'92 X<MHY:6=&0(<
MPE2,X5$H )S;@=[0#0#0#0 >D1'0#0#0#0#0$=_4 />Z_7T!#P;>M\?Y.@+3
M9,SSA7#*T*WRQE2AXZ<6(RP0;>WV:+@UY,C8Z1'*[5%\X25.T:G7("JX@""0
MF#C.&X:"IU[?S"8*H$]6*O=\OXYJMCNB3%Q5(6<MT*PD)YK*N@913U@W6=E.
M>/DWH]@W<#LBNMY!#&-T:@J7@$0 !,;R2E QCB;R0(4H")C&$VP%*4 Z1'8
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MGVG)E)YGT6S"O8_;T%U$W;/J-!<-Y>DRU@M]P3J3^ 4I2[-HNJ=53LI$!67
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M,Y<*LU".FY3D.F8IN$P3<92=68R<IDEB3F(R3%WR)G, U6G5SETLF&,3<M%
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MHE/*C;L)Y$3<+8&1). F(J=C5#JI)2,-(LY1BHH@H9)=,CMBLX;G405()#E
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M#:K1%,-;,K(Y/D(9>/1=MDG%3LZ;<8:P,V8LE)2*>O4053*X/J[B4]0IYSR
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M9"E J[QZQE)JE&@&@&@'5TZ #UCH!H!H!H!H!H!H!H!H!H!H![WJ: : : :
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MNOU- /AZ : : >]OH!H!H!H!H!H!H!H!H!H!H!H!H"(AMX0'UM 0T T T T
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M]5FZ_%@;8\B?NLO^2LAKI^(?UN7B]9'TO!_T;#^-]LR5;=7K!\(-<8[,: :
M: : H5M]E&<_4YIOYZLC:ZRW^F;G^C6_M[IM?X!?7OUHE=:[,U#0#0#0#0#0
M%%Y)(*F.,AI@ "*E#N)  WRHB>N290 WJ"(].N!Q55X7J4MKT]S[1FVSA>@_
MX2]<JIB83LF1Q  %1HV4$ Z@XT"&V#?81VWUS+>-N+ZD:WM.UK,@T T T T
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MOD:XQV8T!'HV'Q^#X^@(: : H5M]E&;_ %.:;^>G(NNKM_IBY_HUO[>Z;7^
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MGOR&^1K[&JZ4< CV"WWF?WQ##\0!TJNE%'8+?>2GOB&'X@:572@.P6^\E/Z
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MDTFRZ0(J].Z*O5T>0;K^!KMZKI7JF@=@M]Y*>_(8/BAIFCTKU0.P6^\S_P!
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M %J:?'CPC]0V?;(>YR?N><SK9SIK/:;WNPA[C?E .KG5MH] CT5.R[[ &X]
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MAOV.G]RA=P??3N[TN9OSCB'^TCE[A7)#TAS-(='BQ2OO[[_.(/3J_&KR6O\
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M:78-]Q#?;[*0>#4^/7A>[@5JOXV'N<?N<\PK_C+5>T7?=AR#T,F1MP$.<RR
M)1 2B%-L!1 0Z0$!^NEOOOI\>G"OU%:]LA[G+^YSS'M7.6J]HN^[3]1]#?E
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MMU[=>GQZ<*_45KVV'N<G[G/,7[9:KVB[[L(^XQ9&#_KF64!\(#3+  @/4("
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M+QBN?B%LF 2ABJU,ZAZ1T1D4/DQM//,;Y!9U5HH_M#RCVQK6V*4JK!+/9YS
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MJ_",9CN\1Z :^WDVD#"-9IV5],M8B-;2ST@ !7<H@S12D'1 V  *X>%.H >
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M-3U.(+&RSK,>/:[(6QOB@(?(=;LJ*6/XUFX9-JYE.XN8)-E(6%XHJTCZN#E
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M^OU_!T!'0#KZ] - - - - - - - -@T T T T Z-P';J][;0#0#KT T T T
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M=;PG^K2_TG4?VBZ;;WX1?60^TB5SKLS4- - - - - - - - - - - - - -
M- - - - - - - - - <B_P ]]U'48*#H7]K6S]4&Y_DPMKK.%[+_ /I-S[8W
M7_.A^+CZQ76NT-(T T T T T T T!0DO]D:A^K6\A[_@])^-KJ]1^E=-^+O?
M^R-T?ZO/ZZ/T2N]=H:1H!H!H!H!H!H!H"@\J?8QR%]1EG_(5YKK>,?HK4_B9
M_:LVZ?\ K$/KEZY7INOX/Q1UV1J(: : : : : : : : : : : : : ='O_6_
MFZ : : : : : : : : : >]\'0#0#0#0#0#0#0#0#0#0#0#0#0$QB?QR9??Y
M/CZCV%+G:P!YZ<B1<=-\T]QAY=8&T3*YRF(Z4<&7*V*C'/;NLV>JBX,<A4 3
M;*&'C$0 G7X-?C_SIH-'Q3Y0/$.&\0FK>@O\SW+=V3>7+;EJVIO-59?)KY55
M3:>4:F$+G&+ENY^#EJY)[L'<:>/@9==ZRMLJM>8FVX\Q;$X]"M7U>"<P[3&$
M7+U=Q"UV:E*>YC)ZOO MTJX6E8]HW6([6>"](L8%"B8W$'H^JT_,W$+G%>'\
MR<)X'8Y+]!U\K#LQX=;O:65G3WKFDE;U%B?I5V3N6[5N:NSN]LIRSIRE5<R=
MN_-W;=ZQ8CI<ES*TK2<<L6X-.+SORDDTZUKBMYCEA<\.7*5+&><,FD2,HH#E
MQ)N5VD8D<T>]*S\Z*M5D')XLSXR17*)# 9P@)T@ >/8?#.ZR7#H\_<-?%9V[
M>A[9YI7)2A:4G;GD[5QE&3M9\JN0BZSAF@D\U#K= [:UMIW6E;S8MNBV.E=C
MI6B:KBL-Y>S*]+=*X\86*;DL.-;7'V"Q(+N*"C%55M+UL&$0JRADXZ&@8&-G
M)Q-^=PJF )"Z*T.4%E!$2E)ZMWC\KZJ[R=;XUQ:]RY;YBLZO4*4M#&UI(WM-
MDM.%GL[5FS;OWL[N2CY/:*VTKDI5BH\_6:=^B*[<EIE>4Y+[W2*<:*BI&,5*
M5:TPKEI5[C9;R4]/+'1/54NO5]6MDU_:WR7?\$.#_7ZS^W:D^RY<_0UKPS^W
MD74^0&OZ$.['O?&T!$/?!ZX;_&'0$- !^1\30#0#0#0#0#0#0#WO>^!H#JO@
M$S%Z!0$QC-'(%  W$PB@<   #I$1'JUJOU[&=-N5^L6/G+PHIZA)*MZ%14'"
M2B"[>E5)!=%8ADE45D:]')*HK)G #I*I*%$IBB "4P" ].N/PV+APZQ&2:DK
M,%1[5Y*P9G=QNR:V9GZY5>N::QH"([=&V_5X?C>IJ A[W^X.J!H!H!H!H!H!
MH!H!HP4=0VKEG /$G;==JL:[91=E2<)'14,UD<HW.18N (< $4'C!TDLD;J4
M24*8.@P#KK^&6YV]/*-Q-2](ONC5,)7[C3\#3372L=C1MO-2FFOJ(_.BJ_/*
MQUV!J&@&@'O>+0#0#0#0#0#0#0#0#0#0#0$? /3U>#QZ !MX=_?:> $- - -
M -  Z1T!;AWF+$L>[=,7^2Z*S>LG"S1XT<VN#1<M73=0R*[==%1\51)9%4@E
M,4P )3 (#KS_ %7>MW9Z'57-%K./\(M:RU.4)PGJ[,90G%TE&47.JE%IIIXI
M[3A2XEP^$G&=^RI)T:<XU37C.O\ 7NPU^FKC[W]O@/Q?K1\<'=7^T7!?SRQ]
MV3WTX9^46/LX^R0^O=AK]-7'WYKH'_&&GQP=U?[1<%_/+'W8]].&?E%C[./L
MD0S?AH-Q#*F/AZ.C_*Z!#_T_1]\'=7^T?!?SRQ]V3WTX9^46/LX^R472<QXE
M:(68KO)=%;"XN]K>( M:H1(5FCJ555;.4@4>AVC==(0,4Y=RF >@===P_O<[
MKK:O9^8>#+-J+C5=98Q3>#\_8]QNN\5X9)QIJ+&$$O/C[)6?U[L-?IJX^_-=
M ?XPUV/QP=U?[1<%_/+'W9J]].&?E%C[./LD?KVX;\&5<>_FO@/\8:GQP]U?
M[1<%_/+'W8]].&[M18]LC[)#Z]V&_!E3'WYKX#_&&J^^#NJ_:/@OYY8^['OI
MPS\HL?9Q]DK2OV:N6Q@,K5YV(L,:5RJT,_A9%I)LRND2)**MC.&:JR15TTUR
M&,01XB@<-PZ0W^OX'S#P+F;1/B/+VLTVNT"FX=I8N1NPSQ2;CF@VLR4DVJU5
M4<FS?L:B'::><9VZTK%IJO15;\4?A8[A4Z>@V<VRRP=:;O5CH,UYR491:3I=
M(@**)-U'JR!%E$TQXA*41$ Z=:./\U<M<JV;>HYEU^DT%B[)QA+4786E.256
MHN;2;2Q:6[$E[4Z?3)2U$X6XO8Y-1KX*M%)?7NPU^FIC[\UT!^+]?+_'!W5_
MM%P7\\L?=G']].&_E%C[./LD?KW8:Z_KJX^_-? ;C_\ Q#3XX.ZO]HN"_GEC
M[L>^G#/RBQ]G'V1]>[#77]=7'WK>V^ W_P"'ZGQP=U?[1<%_/+'W8]].&?E%
MC[./LE$RN9,2J7VEO4\E491DT@;R@Z=$M,(9NV6>J5$6B2ZY7HIHG<@T5[,#
M" G[,VW4.N!?[W.ZZ7$M/<7,/!<D;=U-^F6**O9TKY>^C]0VKBO#.QFO2;%<
MT?IX]?65M]>_#?Z:F/O6]M\!_C#7/^.#NK_:+@OYY8^[-7OIPS\HL?9Q]D?7
MNPT/_2KC[\UT#_C#5^.#NK_:+@OYY8^['OIPW\HL>V1]D?7MPW^FKCW\U\!_
MC#3XX.ZK]HN"_GEC[LGOIPW\HL>V0]DFL'E#&MEDF\-7K]3YR7=@L+6,B;'$
M2#YP#9!5TX%%HU=JKJ@BV1.H;A*/"0HB/0&NSX1WC<@\P<0APK@?&>&:SB=Q
M2<+5G4VKER2C%RE2$).3RQ3DZ)T2;>";-EO7Z&]-6[-ZU.XZT2G%MTQP2;W8
M^ J]^_813%Y*2CQM'1L<V6>OW[U=)LT9M&R9E7#ERX6,1)!!%(@F,<P@4H!N
M(@'3KZG7:[1\,T=WB'$+MNQH+%N4[ERY)1A"$564I2;2C%)5;;HD<F<X6X.Y
M<:4(IMMX));V^@MU]>[#7Z:N/OS70'^,-?!_'!W5_M%P7\\L?=G#]].&?E%C
M[./LD?KWX:_34Q_O]5\ 'PN_ZGQP=U?[1<%_/+'W8]].&?E%C[./LD/KW8:_
M35Q]^:^ _P 8:OQP=U?[1<%_/+'W8]].&?E%C[./LE%Y(S'B5_CV\L&.2Z*\
M>O:E86K1JUM4(NY<N7$2[10;H()/CJ*JJJG I2E 1$1ZM=?Q3O<[KKW#;]JW
MS#P:5R5J226LL5;HZ4\LV6.*\+5Z,GJ+&527T\>GPE:CF[#0CO\ 74Q]T[?^
MM\!X>KK?] ^/U=<_XX.ZK=S'P7\\L?=FM<4X;^46/LX^R/KVX;#KRICWWUP@
M-_R0U?C@[JG_ ,1\%_/+'W8]].&_E%CVR/L@<W8:_34Q]M]5\!O_ ,/T^.#N
MK_:/@OYY8^['OIPS\HL?9Q]DA]>[#>V_UU,??FO@/AAYPT^.#NJ_:+@OYY8^
M[)[Z<-_*+'MD?9+DM735^U;/F+A%VR>MT';1TV4(LW<M7*95F[A!9,QDU45D
MCE,0Q1$#%$!#7H&EU6GUNFMZS23A=TEV$9PG%J49PDDXRC)8.,DTTU@T<Z,H
MSBIQ:<6JIK%-/>?OK>4: Z$I*QD)'.Y>9D&<5%L$A7>R,@Y19LFB(& HJN73
M@Z:""?$8 XC" ;B&N#Q+B7#^#Z&YQ/BM^UIN'68YKEVY)0A"-4JRE)I)8[6S
M"Y<A:@[EQJ-M*K;=$O"W@O&6_'-V&_TU<>_FP@/@?CAKX7XX.ZK]HN"_GEC[
MLXGOIPW\HL>V1]DA]>[#?Z:N/OS7P'^,-7XX.ZO]HN"_GEC[L>^G#?RBQ[9'
MV1]>[#7Z:N/OS70'^,-/C@[J_P!HN"_GEC[L>^G#/RBQ]G'V2/U[L-]?UU,?
M='_M? ?$\X:GQP=U3_XCX+^>6/NQ[Z<-_*+'V<?9(?7NPU^FKC[\UT!_C#5^
M.#NK_:+@OYY8^['OIPS\HL?9Q]D?7NPU^FIC[\UT#_C#3XX.ZO\ :+@OYY8^
M['OIPS\HL?9Q]D?7NPW^FIC[\UT!_C#3XX.ZO]HN"_GEC[L>^G#/RBQ]G'V3
MD7-F'#F*0F4Z 8QC 4I0MT")C"([ 4 !^(B(CT!JQ[W^ZR<E"/,7!7-NB7IE
MBK;W+RR^^?#?RBS]G'V2YP=/2 [@/4(=0AXPUZ*FFJK%,YHU0- - - - - -
M - - - />^)H![WO?!T T T WVZM - - - - - 3&)_')E]_D^/J/84N=K '
MF_S]]G','ZI=V_/%(Z_%SOC;^-?F*GZYU?\ /3/(N)?I#4?C[GV[*P;\OJY\
M>ADY6=6+!C4E9[VN)0#\U],Z21[ 7Z4".S4^/2RNPFL'>0;E9B(BF"WS+7U%
MCN<NSY-7/=W63]ZO>YZCT96+GISFHY<ZL>:] KN+UW:9.R\K(KGWLWKA;>E]
M,<OO>3-EROM*].79V=?^DK3+NK@4KR_IOE<RT!"-1!=^YF%VK5/O"S14%745
M(-P6:O$6,D9D_;@J*C9<R)DD7!"'4$B93G+\WW-PU-WO+X59T4<^JG?E"*S2
MBZSMSBG"<87,ER-<UN;@X0FHRFXQ3DM7#,WOA94<9.=%C3;%[Z.C6U.F#HWA
M5EU.8NQ6^3KE.CKG4,L04LTDEUEY+)#5TA'.'3&KUFLNT*NX6W(\3DU($)-Y
ML(%3=NU 3 Q#=H;T/OLXWS%Q#@?#=#S+PWC^EXA;O2<KO$(2C:E*&GT^GFM-
M)X35UV5J;NZ-R[)0K%YGS.*7=1.U;CJ+>HC-2K6Y6E5"$*1>^N7-+^$W2M:O
M9ER4?M8Z']^77\^MDU_;GR7?\$.#_7ZS^W:D^RY<_0UKPS^WD75^0'Q-?T(=
MX- - - - - - - 4Q=W3AC2;B^9KJM7;.K6%VU<HF$BS9RVB72R#A$Y=C)JH
MJE Q3!T@(;ZC(S2#@7T@N<X'&.&64S%4_(<+#4?DY5R+<KE8;6IDRS.N9S(<
MECM5^R>H]ZAU'T"^*BZ[5T0>U2(9/A,8Y3DE=Q%[!.DO2OY/)6)(SC%V+U[:
MYM5'BHA]#7:-D\;5> N1;\9*;MU\]O;>D+)JK4CNC)-].U:37>N!(XCFA"(G
M=*C'836V<]O-!DK$/,/8,>5[$V*&^&\%X8R78;0_GI*UV5B^RM"S<D!J6$0M
M*467ABJ55VZ;2#EV*)8M=$XIKG,<R8-])F-S#<UEAPS!X=&-G\#,3Y#I=NN4
MEEK)EBL,'@YR-'K,)/*5ZJRM;-+RKZ>O_G@[B#3(=ZH>/9.%$T7JQ2(J7=UC
M'Q&$>1?2;Y/L,YE/'.-H3'T0L&.LY&J-O9/+ [LU6M^)L5Q]YD7CZN6UK5[*
MZ,9RY<H-"O*O',@4314*Y>AVZ":I>DH[%7/=S!4%*\9(L;RM9\HTKE/E7Q\\
MAHN:G5K,C.91Y1:/=5"XF8LQ=U9DWDK:DNX=M3BH+V1?*]F5 2AQP> _<GI)
M\^Y0AL6RD<WQ5B%DIS$\O4=8[4SMM6ME3<4?*4;?%7="O@L+U-NJL[:/*^B+
MI=RM#O'"8EV18'*8AW6B5J5E5O2HYGN3*2/$8.QY%R,E<\:UJIQMAOK47594
MOV81Q/[7,KQ-<L,[;JY9&G:$=]LO$QIBJI.4 8JE23778@W807GWS'#>V@(@
MMF\U1WMB+7C/3P!9WN:/G@(,\D 21H?SCVG=1< "_8</:!Q\0!3);,2::H&@
M&@&@,2.93F]IW+19,55RQ5J<LI\BRY_/KZ$7;)(8VHC6;K59DLE6<CA-0RE=
MC[%<8UJ<I!(<W;'.!MDA*,J1LI"^^D(P#26>1P15N$Q-8\4RM$@S7H]UKU:M
M5SPPV?/[Y1*QD.4K0TV5M$7%1RKX&[=PN<[(HJD*8 $ 5%29N/2 <LS")>RL
MI8KI$GA9V?@[5"2.*,FM;/1TZJPK<I9;->*TI5 FZI2(..N$4LXF'J"+ B<B
MA\TW.( J*G%YZ0/ED:#/$2LEREE:Y;+32GR%>Q5DJQ*NIVBN)XEW+"^9*N_)
M/QM-CZ\H_DWC,RS5FP<-5E%"@Z0 ZHJ0><_7+RX3NQ:?8I*YJ4>+;2<C+Q]3
MOA*(MWEK5)(&!;\PI\W"I2/FBY,G)$N$QUP.)4@.9-7L[45+MXKYE<39HM-S
MJ6.Y6>F7M$>S4=-2KBF6R)JR[RN3Z]7GVT/;)2(:UV6=0\ZV.BLBBY%8 ^:E
M(9'YII45+6'Y^N7%/O"1I7(7?RV&I5R/A0P_E+VQV%W?%K>SI;RL5LU3+.6"
M)L[^BRC=FX;MSE45;AT 51,QY6N(KN9(IWTA.!V[>IC32W._O[5-X8AU6\71
MKO&Q50/FK),=CJ!;Y LS^L# T>QM5EWCL(B36:OG)8Y1(A2G51$RHKZIG8(;
M"(>(1#X&J4AH!H!H"._2 ^MJ4P!#J][QAJ@: >+UODZ : : : : : : : :
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MH,[P: : : : >]XM - - 0,0JA#IJ%*=,Y3$.0X 8IR&#82&*/08IO"'5X]
M25.LUQ(A4TJ_!II$*P(5-.(CB)E)%K=YBR@0C8"@6-<?-&X;;(J>43A-TZ4%
M/5.7M=K_ ':19>8H;N<PN9U+M/-3#NLJY.)1.XDF_=^Q?KF$A=SJ@<P\(;CT
M:4%#]PAX@"OBA%QH%DVB,?)!W!IM(,&S=1HU9/@%$0=LVS54Z2:2G$0B9S%
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M.WB_W=5+RNH;C>?CFPW!/'U$31QV]<HITVL)HN2VBLHE<)$A&)4URI+.RK)
ML0 ,!3 !@WV'IU^UW=_JM='D/@L8Z64HKA6DH\\%7[Q;Z6>QZ"%OT&QY:_ P
MW/ZE=16?MDNOZ6K[\UE6'_TP-?7^EZ_\EE[9;]DY>2W]6O4?L$/;'=?TM7WY
MJZM^+=/2]?\ DDO;+?LC);^K7J/V#"[,66L[3,5GBE3G+X^B,<1<.1M'9*&R
M1[9$J:B4*Z5%9@Z.H2Q"5VN=/M(U02EVV$HF*;7A/?9QCCVH[NN9>'ZKA\K?
M"X:+R;^==-MTROS\<*P=%OV,XG'=/I%P&]<5Y=L[3K&CZ<-FS=M-9^OR6Q1X
MX5/3K7)T>QL+1#D:J24:E*(MR/2+J-N&6B'\*X,<K9PU7[1-K(G,F(*%X5 *
M([@ E'Z'E?F37\I\:M<>X;&W+6V878Q4U)Q^^VIVI.D90E51FW&DE25&ZK![
M;%V>GO1OVZ9XUI79C%Q>RFYX8[2X&,<YW+%;A\ZA48N6<OI"%DSN)]6Q'<%=
M0/? 8D,XA+#!N'\>8'Q^U9.S.62I@(8R7&0A@^QY&[VN9N0KU[4</C8U-^]>
MLW7+4/4.2E8SY%FLW[,IV_+>:S==RS)J,G#-"+7*T?$=1HFW:RMMQ?E9OI:T
M\V4:K'%.L7T5*HK_ #!9081\6VKD)#&5KR57CD9=C"SCN0*WA+7,V&OQ[PQ)
M5:/V7D[ Z:A\P(JX04X.(5  ^N_X1WQ\^VM)9L\&TFFE=TGHT%>MV;\YI6M5
M>U%B$Z77#RKM^Y;\Q2G"66KDE);K/%-9;A&-F,:Q4%51DW2,G**>--LFME6G
M2M<3\)/F1R&\DF[EZPA"*QEJH]H;LWGMKD!9R>/'<XZBVAG$]:)*8.S<NYYP
M9XFLX.J8>$J9T0+MK5K^_#G#4:^-[46-)&Y8U^BU,83]*N9+G#Y7Y6X-W]3<
MNY)3OW'=C*;EL47!*A+G%M9.:<U&L9PDD\SH[;;6,I-T;;S)MOH:/T@>9BZU
MYW!23& IHRM?@6==92HH6IL]5CHU\\D(])^:,MK!!\W;+/U0.U4(+%X4Q>](
M+BFD8F7"N_;FCA%_2ZS2Z/AOI^DTD=/"[34QF[=NY*Y;4^SU4%.,7.2E::[&
MZFNWM77"#C;?%]3:E&<(V^TC%13\NM$VTG2:JL7@UE?TR=$6 <)O7!%995LM
MW=R]62.](V,FQ,^.4'*K9-5-,K4BQ4U0/V11 2D$!VVVUX[?M:R]"7$[EN78
M7+LDYJ#4.T?E.*:2BFDZY5L36"1UC4FL[3HWMIA7;3HKU'!C_;K3^Z4/ZZ34
MX?\ U^S^-A]LA'SD>C%+^II_="?TH:_>'3_@(?6+UCV=[3GK:0: : : : :
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MM.2BDL4]K9TVLE9GV,[2A&;L1<U%46>KS8;G2ALBY&OL*/OJ_G_AP];^1K]
M?D>?X2W/[WU'\W8/M^5/T7+\?+[6!17/W_R/QY]4LS^1;;7Q_P MG_=;@?\
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M&&GC;<H:*55)KM:43;N15+9XAH+<<](1N]LGY-M+R%>;6R-*JWT^5_&#+(>
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MA_[)_3FKX(2_*?\ J_Z0C[G\?]-,GYCS?HCT_<C_ /$/_9/Z<?!"7Y1_U?\
M2#W/Y0?^E0GYCS>#_G'I^Y)_XA_[)_3CX(2_*?\ J_Z0D$!R,JSB<L<<E$;!
M%V"9@O\ DJ97M_-#P[3O/X_I]GV_#OP>5P^,=<;2_(L])4Z<?IDNRA_5-N5T
MK^'WF=SDUPHO2<7%/\'T_P#K"?>Y_'_33)^8\WZ(]<G]R3_Q#_V3^G,/@A+\
MH_ZO^D'N?Q_TTR?F/-^B/3]R1_M#_P!D_IQ\$)?E'_5_T@]S^/\ IID_,>;]
M$>C^1'7_ (@_[)_3CX(2_*/^K_I#+W!>)APQ2EZ>,Z%A%>P2$YW\([S8!>_,
MXUH#;NXO'V_9^;^+CXPWX]M@VZ?ZD[GN[3XJ.4I<K^E^FYM7<O\ :=GV?X2-
MN.7+FGLR5K7?LP/HN$\.?#-*],YYZW'*M,NU15*5?U/3O)+G_!YLXP]=BBV4
M*WYADWD@*PQ0RO>@=M4VW9=F#^/['@[/?BXC;[[;:Z;OL[G_ (X.%Z'AOIWH
M*T>HG=S=EVN;/#)2F>%*;:XUZC7Q?A3XK:A;5SL\DF_-S5JJ?51,7/<_C_II
MD_,>;]$>OYT_<C_\0?\ 9/Z<Z'X(2_*/^K_I![G\?]-,GYCS?HCT_<D_\0_]
MD_IQ\$)?E'_5_P!(1]S^4_33)^8\WK?ECT_<D_\ $/\ V3^G'P0E^4?]7_2%
M/O.1E5I9(& ^N410)N-L,AWKVJF+W;S">%)V?8^V >U[T,QU\1>#L^H=^CC7
M/D6]GJK6E]_Z]I&;KZ)LR9?_ -??F,UR:W;E/TE8-?\ 1]-?X?45![G\I^FF
M3\QYNC_[QZY/[DG_ (A_[)_3F'P0E^4+VO\ I![G\?\ 343_ #'G_1)I^Y'_
M .(7^:?TX^"$ORE>U_TA#W/X_P"FF3\QYOT2:?N1_P#B'_LG]./@A+\I_P"K
M_I"YN'N4(V*<AP5[&^EG A4Y<GFP*X:/%QYUA9&(W[V,T\[+L._]I_4S<7#M
MT;[Z]"[J_DO?%KSOI.<??CTOT:-Z/9>C]GF[6S<L^=VLJ9<^;S76E,*U7-X=
MRX]!K8:MWL^3-ADI6L7';G?37892Y K;BXT6X5-HZ19.K+6IF#;NW!3G0;+2
MD>NS376(D J&32.J!A O2(!K^C>=^ 7N:^3^)\M:>Y&U?U^AO6(SDFXQ=VW*
M"E)+%I5JZ8G?ZRS+4Z2[IX-*5RW**;W.2:J:Z/V MT_+]5?H"8]CU_"'[D_-
M/Z[X?[5>]@^,^"6L_EK?J2'[ 6Z_E_JO^#YCV/3]R?FK]=\/]KO>P/@EJ_Y:
MUZDB/[ 6Z?E^JOT!,>QZ?N3\U?KOAU/Q5[V!\$M9_+6O4D22R\C]PK5>G+$O
M>*RY0@HF0EEFZ+*5*JNE'-%7:B21CI\ *'(B(!OT;CTZT:KY%_-&ETMS52XU
MP^4;<'*G9WL:*O09V^4-9.:M]M:JW39(G?[ 6[>&_54.GYPF/5#[S]36_P#<
MHYJ_7?#_ &J][!A\$M9_+6_4D/V UT_+]5?H"8]BT_<HYJ_7?#_:KWL#X):S
M^6M>I(?L!;I^7ZJ_0$Q[%I^Y/S5^N^'^UWO8'P1U?\M:]21 >06Z" _Y?57I
M ?\ >$QXOOO1?(GYIK7W[X?[7>]@/E+6?RUKU)&R>IPZM=JM:KZZR;E>"@(6
M&6<(E.1)=6+C6S%5=(I_+*DJ= 3% >D 'IU_?G+/"KO N7-!P2].-R[H]'9L
MRE&J4G:MQ@VJXT;C55Q/MM/:=G3V[+Q<(1C7IHDOH$_UWAN&@+)\R'V"<H?4
MPI_PUEKR'O\ /\'N/_Z#_P"T@=9QO]$:C\7]%&BW7XV)T/*C+RG8FH5NQ/4W
MZ3.PIVAX7*-FG'T:B$I.R[#'C*"3+5:G%"_08'7>+3Z2X"HBHMV:"YN+8I2F
M_I;ECNYY0YD[O.'ZN%K5QXY<?$M1?G;7::B];T%NRO1M);SQMMS=^,ZRA*2C
M"Y)ND8Q?>6-#I;^AA-*?;M79MK%M6\OD15:5>9-85P92>6<+US%]:&2/8IN2
MFWUHD82)CC1;!NT;M8Z*K$TY+8E>_F<QTVS;V+NZS=$BY"NDA 3E*'3\UWA]
MV' N1.">FRUFKO<4NZ^Y8LV^RMQA&,+6FO26H?:9H7H1U&2<(*:[2#69)8Z=
M=P^UHK.=SE*XYM)45$DHMYG6JDE*C2KB7'2Y4XU9&!D$)RU.8E>"?R5B<C!M
MHYS'OV<#!2Y&247)G;S8IG6FBDXVK233.EV9DU#F.8B?VUOY/O#KL-%J[6JX
MA/AL]).YJ)=C"W*W.-BQ=RJU=<;U*WDLUNUJ8N.24)2<G&',]XXM1FIS<,K<
MO)I1J*=*/'Z;<I>&I5AN6>@!'&J*;V6+8V-MR2I)VE=NJ$F^@J+7:M+-X*#A
M1<)MTG3LMK0.J95LHL4$7!]BE(1,?I9]Q7)T>'+@$;FH7&+?$.(RNZIQ?:SL
M:*QI[D;%FUF48SFM3!R<[<I4A>E1*,8O;[T:2CTZE+MXSN5D]KC",'EC&N_.
MJX5PEU(D2_+E1E8-.LQS^PKW5Q?[W5(2Q*QJT>QE96,HS"TU2LR\9)=W4B#R
M:RH->+@!479E.$3) 00ZF]W)\HW.#QX)I+NLES+/BVMTMG4.W*W&[=MZ*&IT
MNFO6[N5VG<;5NN52[5RI)PRLU/A.G[/L(.;U/:SC&5*)M6U.,9)[*[.FM=U#
M&'*5%)0;7)P;%61DHF.?+P:<^[9]W92<_!H,V]N:QBZ11:N4(6=64;^0<Y@*
M4@GV$^VO N?^45RAQZ]PS2N_>X=9N.PM1.&6%W468PCJXVY)991M7I2A@VZ*
M+E1NAU&MTZTNHE9BW*$6UF:HG*-%.FYY98>OM*"8_P!NM/[I0_KI-_A:^1X?
M_7K/XV'VR.+':O">B]+^I)_?9/Z4-?O#8_ 0^L7K'M#VGZ:VD&@&@&@&@&@&
M@&@&@&@&@'O_ (OR- - - - - - - - - 3&)_')E]_D^/J/8"YVL"GG6R_-
MOJUS'9'L,8*19&"R_9IA@9=/MD0>QMM=O&PK(B8H*I LB7B+N&X=&OQN[RN+
M:K@7?9QGC6@RK7:3F#47;>99HY[>HE*-5O54JK>>3:V<K7%;UV'G1U,Y+PJX
MVOGHF:V6+PH=\BVQ7CF*E9RL3C@9"'Q6TCI[VN3L'(H2T['/4" Z2:K0CER<
M7A-TP2XCB(E =<Z[WA\V7'=LV. \&L:[5:&_/M+/"X6[_H]^Q<C=OVYQ690=
MF5R3NKR<M76E38];?J\MBS&Y*#QC:I++*+K)/;BF_*V4JRCL(.)!IE6FN(MJ
MD]=IO7YA;N)?VOMQ9^99,LHJO. U>J1*#6+,LJ==-(ZR92"9/90""'S?=/>U
MECO X=>T,%<O1N7*IW>P79]C<[5RO99NU&-O-)SC%SBHMPI*C7'X>YQUMIVT
MG--X-Y5YKKY5'EHJNM&^C&A7F;\>15/AH*2CIA:2,^EW+%9'V^+7ILV34@(*
MQL5"KC0::DQ,\BIYLL3=1P99%0I@V ##K[+O;Y,T'+?#M'KM%JKNH[;4S@XR
MUSUL8IV+-^#3]"TJAGMWK<HUE-SA)-*B;-^NTL+%J,XR3;E3"XYKS8R6/9PI
M523WU3-K')3^UCHF_7VEUW_-K9-?WK\EW_!#@WU^L_MVI/N>7/T-:\,_MY%U
M/%ZP? VZ/A:_H0[P: : : : : : : : : : : : : : >_#WOA: : : : >^
MV^#\<= - - - - - -1[ 4/COHKCW;HWOV7]_?9=O.VNMX3_ %:7^DZC^T73
M;>_"+IR0^UB5QKLS4- - 1'X'K]>@(: : : : : : : : : : : : : CT;>
MKO\ "TW@AH!H 'J^]_N: : : : B'1OZP[: H.@_VM;/U0;G^3"^NLX7YM__
M $JYZYNO[8?BXE=Z[,TC0#0#0#0#0#0$?>^'X- 4'+_9&H?U-Y#^!VU*^/KJ
M]13WVTWXN]_[,W1_ 3^NC]$KP?#ZNNT-)#0#0#0#0#0#0#0%!Y4^QCD+ZC+/
M^0KW76\8_16I_$S^U9MT_P#6(?7+UROC=?P?Z8==B:CCJ@: : : : : LGS(
M?8)RA]3"O_#66O(>_O\ P>X__H/_ +2!UG&_T1J/Q?T4:+=?C92IY47/I-%R
M9;HQ[-4MM)NV%1>)$4<,YM&//$R$PV=K()QR2T@U<=^ERQIDR%;%%1PJ!$@
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MA3;MIC7?5^H95\!_N _ ^)KZ\Z_JWD. WW$?@"'Q>C5+1]#(\!_N(Z5#JMI
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M?;(Z2.U5/1BE_4T_NA/Z4-?N_I_P$/K%ZQ[0]ISUN(- - - - - - - - -
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MJ.9FDU7&#VPM,:RDS7K#(OR'",7;3E7:%:1,.LV% )98KU4X.P5%<B91(0H
M8XCZYW=PY9U/+?,NGXIHK5WC-O@MV]I]1=FFK;C>TL%"U9<:=J\\I*ZI9U&L
M8JCDWV.B["5C41N03NJPW&3>RDHJBC2F;%XUKNPJRO<68;H=MQA*VFQOW#68
M(RN+Y@JTL":14EJRG%*,8YU%C!KLVQI0'"_DKOB.UB!QMT1(10X?8<@]V7*'
M,'(&HX_QF[.'%%;U<X..H2H],K<H6Y6NQ<8]I66$[RNSCY5NWEBY'+T/#]-J
M-([UYM3I-JDMF7+1-96L:O;)-[8IJK58R6%\-F6NKF!1L4DM3K'D:L15/+=X
M;SK?%ZJ[JR;"3C9,T&F5FD5K-.UQ;)(N5%T6I> QC IO]1K.[#NQ>HXC>X3;
MUE^[P[6\0TUK1^G6NTUTM-+2J%RW<=CR4H7[DW;C&Y*<;:RMM29NEP_0-796
ME-NW.Y%0SK-<R9:-.F&UNB3JDJ.M261%9A#\PN1(Z#I],?5Z)C$71"S35G-P
M=7BV[>O+R;Z+JT>U5:7.Q.D.V9LVB*>RCIT*P<'!QDX'"^!<*N=\7&='POAO
M#+O"=/IXR7;1MWK.FMJ-AW)V]-"#AJ]1*.>U:M0BD[MQW%D47*.,;-M\6O0M
M6[;L1BGBDXQ246VH)>7)XJ*6UNN[#%R^&C#76V&A85S7(@UAES1D"\*9-W#L
M#/EA:QSA,QU!25:HB4AB<1N 0VW';?7\_<X^A?"KB/O;I9Z+A_IE[LK$E25J
M&>66W)5='%43572E*NE3IM3V?I%SLHN%O.Z1>U*N"?@*2U\VJ[C0;5>0?['-
MV^KK_P##D,/QM?I3\B[_ '#XI_>W_P /:/O.4?ZG>_'?\R!+N?L/\D,>?5),
M_D6V^1KKOELJO*W _P"\+W\RAS;_ %:S]?+UD:O-?G1E/@S-"'@XDN-:A[5:
M9B:Q5J3Q_9WV2[E;WL:A9Z[<TQG06:)RIG?G^O.(ENW8FB6S5L8L@=0H" @J
M8^OZCX5PGAJY&X=[Q<-Y?UG ;_"-3<XGK-7.VM58UB[>L5<<NWL2M1C9>EMV
MH4ORDJJ6=R7?PM0]$M^CVK$[+M2=R<VLT9XU6:N:-/)R)1>;JK4JV,Q3ARL)
M7.2<QZTNRAJI=&40I+VBNR">1(\F-7=@)=:H4(94*X\CYMNFW;KI%>@W5=D+
MN99,Q1^ET/=[W:<!AQ#6W++U&FL:'60M.]J=/<6OM^]T[_IFE79/T>=N]&-N
MW-=JH2NQ2K<@T]T-#H+,;LI)RC"W-*LHOM%V>;/'R?):E@FE*C:WJA3RN$<1
M**+F;+37FZ29D?+RXW*#*UQHV7Q)6+PP6G$5XM)2=1D;/,N6)#"+4#%;"D4>
MW 0'I;G=5W<3[2=AZGT.];4W=]-L9>'1EPK3:V$KR=I.\KFIO7+$7][KV3@O
MOF!@^&Z"K47/(U5RSJEK[U&:S57E5DVMRPIYQ*K/5\11%-SM!52IOW\W4!QT
M#.Q3%DCY61,9\\D5Y>2@4&D&W4CXB/24(FZ(1947"?9BL<FP!KKN.<![NN'\
MK<U\+Y?X?<N\5X=[WY-1=U%N[<K<E<=VY8C&S%V[5M.,;D5*3FLKFXX(UW[&
MAMV-5:L6Y2N6^SI)R3>+=7&D<$M]&ZJE6BE^7&)C':MEE)RFP5GKT.K#KSZD
MA#C:9UY%G%^FI4*;7 2,9"<L:YTSFE^- (M!L8PJEX^$_P _W(<-T&JGK]=Q
M7AFEUW"=/*R[[N6EJ;\[3[2NDT>GIY-_42RMZO-;]&A;;[2.9*6GA-N,G.=R
MW"=F-'*L<\J8K)"/U4L'GPRI;<3&5QP@NOP)&0)VRG @<PF.B7C-PHF,8 $Q
MDPZ!$>D1#7A&J45J+BA!VX9Y4B\7%5=(M[W'8_ =.9)<H'[82B_?%M_.58=?
MT!\EC_&WA7XK6?V*^=UR]^F+-/X?\W,VJ9P^PSE7]3ZV_D(\U^D7?%_A3S'_
M '-J_P"9F??\55>&:C\1<^U9H4U^+#:WGDQD%@>-AWB61':<+5K3D",K4>MC
MNK7,L<M!RKQ><9H6-P6/EGS"/EY:*@#**MFRIS .YU (<R8!KV7NAT7#-5'C
M&H6FT&NYOL:&#X=I=9V;L79RO0CJ)=G=E"W>NVK#E.W:DW7RIJ+<$=IPV$)*
M]*,(7-6H+LX3HTWF\K!M)M1V)^'$N^MB;'5B<3TC8B5VN2ZSR19V%''=QCAI
MF+3QV/AGF\P]9OF*QWR4U9 [JHT;KE:MEBG;(+&5X2AZ9>[N^2N,7M7K>,1T
M6CXE.Y<CJ(\/UEOT/A;MZ#MU=G;G"3FKVH792LVYJW":E9M3E.B.<]#I+SE.
M]DA<JU+LYK):I;S9FFL<TL*)T3JDZE16G$^%[)9)IVS0/!KPDA&1XP$'/P$5
M'7)P?$*5I8Q<"V&*32K[U_8&7=3G+WLRRBIAX05, !V_'>[ONQXYQF_J=/!Z
M6]I;UNW*Q8U%BU;UDO>A:J%JQ'LE&Q*Y?CV3E]\<Y2>"N22-VHT/#KU^<HK(
MXR2RQE%*?WK,E%4\EN2IOKMVO"21.-L'529I4A+,)&?<SF5:+7%:Z_ML,,74
M$YBK4>S3D5;@\QKDGPKLK*O&*Q0[HFJ'S-82J)G >JX?R/W5<O\ $N&:W7V;
MVKU&JX]H=/Z/<U=EVM(KVFT.HOVM7]YDKZT]V[>LS7WM22<+CC*$D]5O1\.L
MSM3N)S<K\(Y7)4A6$)-3\GRLK;3V)['BF8Y0T0BMFMO#,J>SE&X7MRV:TN8E
MBQT8NW0DEQ2C)67%NF5M$H))@+A3LRAW<ANK?</%.&<-LW>].'#=-PVU?L+B
MTHQT5VZK=IQC<E2W=O-14;44JSE1+(FCJK<*\1[.-M2^^M*#=%M>#=,(K>Z;
M"=\P32*C[=#L(^"8Q+UC5F+6Q/X6L'IM<LM@2D947DU6Z^=)N*$.FW.DS(OV
M*'?#M#+]F7CZ>U[Z-+H-%S'I=)H])9T^IMZ"$=1<L:;T33ZF^KEW->T]BD<M
MI1R65/);=UVG<=N.;'9Q10AJ(PC%1DK:4FH9(RDFZN,?J=BK19J-T+$>/UA^
M)KR!;3K3T#XR^QKC[ZB*E^0##7[@=WG^X/!/[ITG\Q;/7=!_4K'XF'VJ*WU]
MB<L: M'GN*DYS#.18B%CWDK*R%?,@QCH]NJ[>NUA>-#]BV;(E.LLH)""/"4!
M'8!UY?WT\,XCQGNMXUPOA-B[J>(WM&XV[5N+G.<L\'2,8IMO#<CKN+VYW>%W
M[5J+E<E;HDE5O%;$MIIV1PIFMNJ19OC#(J"R8[IJHU6?25(.PAN10C(IRCL/
M@'7Y76>Y[O>L35VSR]QN%U;''2WTUX&HIH\W7#.))U5B]7ZR7L$2X5S8F19,
MF,<C$3< 4'!"U6P%(L4A@4*58H,P*J!3AN'%OL/3JQ[H.]^$90AR]QM0FJ22
MTU]*5'5567&CQQKB7WLXDD_O%_'^!+V#F&&<W@V%F&,\D S,?M!:A5["#<5.
MOM!0[GV0G]7;?6?Q1=\2L>B^\''/1FZN'HU_+7IRY:5ZZ#WMXE3*K%_+]9+V
M#]4L09V02(@CCK)R*"9N)-)*MV1-,ANT*KQ$3*U A1[4@&W  \H 'K#6=ONH
M[Y[-M6K7 ^/0M1=5%:?4))U3JDHT6*3\*3*N'<42HK-^GUD_8">(,[)"44L=
M9-3,1-1$@IUNR$$J2QQ562*)6H;)K*#Q&+U&-TCTZL.ZCOGMM.WP/CT6DTJ:
M?4+"3K)81V-XM;&\63WNXHG7L+_V$O8/S2PWG%NX,[1QMDI%T83B9RE6;$FN
M85!W4$RQ6@*&%01\K<>GPZPM]TG?':O/46> <=CJ'6LEI[ZDZ[?*44\=X][>
M)IYE8OU^LE[!%/#F<T07*EC;):176_>@3K-B3!SQ"83=X C0 6XN(=^+??<=
M6WW2]\MM35O@/'8JYY]-/?6;ZZD?*\95P[B:K2Q?QV^1+'YQQ9X0S&1XU.?%
ME_*4KE 3":I3A0 H*%$1$19    >/HTT7<WWKV]9:G/EWC"@KD6WZ+>HDI+^
M 1<,XE7^KWOL)>P;WDP$$TP$-A A0$!ZP$"AK]EK*:LP3P:BO6/63GK:0: :
M : : >][W@T ][Q: : : CT;>'?X6GK AH!H!H"/@'HZ_#XM 0T T T T T
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M*G/H3*L36;%'2)&4=+R$BZEVD@P*W)'WJ=I30J;>&:V%R*3I2&[95PJ1%HT
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M; X2*J:3;K$( (K(%<G4)U[CJI\@,4M'M6\C>H0910[)S.62(QFA&SKJ9:9
MCLE.KC7'CRY2X4VZV&:CRL9)TS*+52"2;,&[1J1HB<%*E]<ZL%Z.BF1:5(8R
M-S2GHZE24')'!_0H<96[%C[11+8YBLARBDLY+;(6/=45)I -U$$P@HY4$-W7
M8IGTV> E,#]F_H\:A%RM4E86WM&*=1@:5'(5\^/XE2IV"8IZV(7*DK;H%I,Q
MZ4XSL[O$38TBV[1%9;O&X.0,@F<:$D59@CD=K6#;G$W1E;UYM[&.)N0(BE%3
M=>0;N9R(DX(\'#QC&[N:I%T9HQDNW2C3Q3ET1\F58KX" ")2+3P&<VJ4: :
M: CO_N>]X= 0T T T T T T V'Q: : : : : : : : : : : : : : : : :
M : : : B ;B :%-$/,%]F[*0_P#MI,_U_7XR]^5/C>YA?_[E=]<\GXO^E=1^
M.EZY^1\N3:"=+<Q2*+&9JN.Y?&:[U1-)VWDJ_)OK LF<&JR7]BODHZQ*-C'
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M5%;Z^Q.4- - - - - - - - - - - - - - - - - - - - /D?S- - - -
M- - - - - - - 3&)_')EZBY?BB.H]A2YVL >;[/WV<<P?JEW;\\4AK\7.^.
MOQK<Q4_7.K_GIGD7$?TCJ/Q]S[=EH]>:TH<,:N8$0ZP]?4!OIY*1WY8Z(/\
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MBO?X&CA_]&T^#'+?ZOT/M%K[@>C:?ZB'J+V#C[4ZI^5BO?X%COQ/J_!CEO\
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0;_*\1D@ -_7U&"M=8E/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>tm2030088d23-bc_summar4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d23-bc_summar4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!9 -0 P$1  (1 0,1 ?_$ 08  0 !! ,! 0$
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MP6*R0W,E-47Q@F3D)N-EA6.#PX2D"?_:  P# 0 "$0,1 #\ _?Q@# & , 8
MP!@$$U<3>L?N4HF,)2ZGT&8I1$>R4REDWX!Q .O0!,"8=1_@_@S([RGLI8+M
M\MO/[.S.BME7VDO$VDM+7_;N_A\A.V8X=Z, 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M , 8 P"G4/C#\N 5P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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MT1W'%F&MUJ3F).FV5+*-[)#K1QDGK)229J%?)O#-A3=QR1W"0]KHH@43EZE
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MLE[8_3>G1_ZT\=L.0.>IQ<F\"]4&?.:)QD>^*>IES6#Q\2]L?IO3OI3QVPY
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MDYNKNRSM=7AHI!G8-=W-^SXX&J-SK<TY=O6YYNDS_'=N_0*JU%N[\O,@X(=
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M@X!ADMK?7T\]4DIRC5":D5BIE5D):M0LD]4*D7L)E4=/&*RYRIE\!0$P] \
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MGB'_ ,#D"()@NE_>+ 0H' >R'0#JEK-=(Q:QA(.)+&L6HL64>6.:%8LV0@D
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MWO9QXV_:8V%^[;CA<H<[OO-H_2![/Y@^CM^,7>#UD.;_ (_5QXW?:8V#T_\
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M7(JN;7J\K+6Z:>UZM1""KPDM,2\='U^7>M&<6NT2?F*A#6N,?"J*8(BQ?H.
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MNYK4^PD"M"G%X+)\W7[KNUTC&%J?"Z<D*G!T>AWBD1<KMEILN]L->4^/I;N
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MJ=[UJR,5 [Y"6C6AU(]PF(M'Q0[2*IR@)@ N5,Y Z@OMA3IU6OD++6U6$0L
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M,ZKIVTXXO&#35.GV=FVZ&JG,.\/LS=LY'N69S:\OI)E!V@14AP[+<R)B!X3
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M21=S$W.3<DJ4AW\U/34@X>.UNR0%'"YS 4H"!0#8,\P!@# & , 8 P!@# &
M, @BK_Z2&YO\DV@?\9=_YDEY_E2P_OM[_9V1T-K_ )EO?[G:?[=V3OF-G?#
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M K@# & , 8 P!@# & , 8 P!@# & , H( /C !_#@#LA\0?D#    >(.GX,
MK@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M , 8 P!@# & , 8 P!@# & , 8 P!@# ()J_^DAN;_)-H'_&7?\ F27G^5,/
M_OM[_L69T-K_ )EO?[G:?VEV3MF-G?# & , AN"W+ 3N[+YI5L7_ (8HU1J5
MD=.Q.'9<NY]:05E(E-/KU!:!B7,(Z5'^1,)?C[VXP*YML ML?>OZBXGD8B=Q
M&(B-=\3W)*U._$ITMOC=K<8]<8 S[3;012.T[/"*^J4_U41BK_+0F3.B.Z&
M, 8 P!@# & , 8 P#Y NF)S)@8!.4 $Q0$HF+U\7:+UZAUR52M-LNJM*[1]<
MI!@# & .G7P#X0P#CV"?R2_[D/P_%\> .P3^07_<A_<P!V"?R"_[D/[F !(0
M?&0H_A*']S *@ !X@ /P  8!7 & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M , 8 P#B8P%\?P_W.O\ :P#E@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M1%3R945C7ZT3T56NIK45JJUZ.1WDTHJ[<YA!EPP!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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MO"& 5P!@# & , 8 P!@#J'BZ^'XL IU#XP_+@%< 8 P!@# & , 8 P!@# &
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MW@[>LQUIR6T\$F_*^]2YS_!.<?/QZ:MX_P#7/CW?\K<YO-TS>#MZS'L<EL_
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ME>P,H=#8Z\Q N&KH)EUMG83J5EU8NSPMR@B3CUQ/J*R#. L==9.&K;J5K_,
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MHLTA*V"?F'QTR%,NZ<JF(DFFD3LI)ID+ 2%@# & , 8 P!@# & , 8 P!@#
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MJ8?_ 'V]_P!BS.AM?\RWO]SM/[2[)VS&SOBAB@8.@AU#\> 5P"@% O7I\/\
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M./(K*"@9)0Z9DNR)3"40$87\9F[M?R5HY==TNOY,W67[ALD*SE;N4S*=TW1
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MU?>FCV"7I7$O!:>B%?F\Y##_ *_O*S]C^$7]KAUA<UV:?]GPS=7WIH]@J?\
M=<2\%IZ(4^;OD-[?O*W]C^$/X?8ZR^UEET/AFZOO31[!*O\ W7$O!:>B#YO.
M0OM_<K?V.X1?N=8]J[/H;#-U?>FE]@EZ5Q+P6GHAA^Q:AR,@]>7^=:<^N5*S
MJ#I%MF6R2M5X8MDE7$57Y&0034<1?$:.E$$U%6X 8[9PW<$ >J:B9P*<./=9
MJM76LK6X1AS'K$^CD=>U:NJM')6\5*ILI5%2NRBG881D)GK>T27$L0DA6ZB1
MS')::KF\(W6:ZEJBT<E46BHM%T*A^92(Y?<OW<1&.EN6?);OG4<R<K"3=FP"
ME,JNV254,4H3G0H"8P^#/G)^9L>:]6)=3:%I\Y3]2H^ISJN=&C_46&U5$7^H
MC[G\D_3]]S#LS9&U>*EKG]HW^Y;(L$9O.[P#*P7JPR5GG4H9G7J2\:QHRLLX
M<O5&C9S(+&3(8X@05!Z= \&>MY,N[J^P?A[M[I)N%<E7+5:430? GWC\OX+E
MKK&]68!:PVF'I8PNX.)J,;K*LE7:J:*K1*J;<<F>2$YH%[ -V538V0MTJ-^;
MTLCB1<,%9C<<0:K%UYKXYR,W"*#6[C,/.TX$1.AY$(@4P=>F6'@AKJT^\-E7
M*D:]0U8XEHR63HC&/BH20!2P/9NPFXB(6X6R\F6/A",:1*<J48TY%%2K.9*+
M42_FR@J=*T(BD@4_GS698L5!6'6VRFNPK/8K= :_J<! QTB7:1JG<[I6Y)S0
MY%_.QS8Z$+%4QS(2*DJ>*22034.B99,"&--)=";)T:U]X537.NCWBU:]V/&&
M8^2)S16,-#-(2-D9EW)K0< M.V^Q5>/:6 :]'"Z>(.E$"MEO\'[8KK-$G"BB
MIED)]X/Q\GGE>CV;ZW)O[0T1<Q+1S5UDEE%Y:8UY$TZ*< #E0K29V ALV-D(
M1L<04>QQ7"W0G<&+BB[ T%RUGS2H^Y+Q TVA1,TFNK;%Z]9RV5.*:/(UFXH%
MTND#*,TH.6GD0/)J4Y9!9D].TDF0@8'+9$_9*8*H85L?GE#Q0H0>LJ#<K9:I
MK8L?0*>\F(AG%4VVILMPQ6F=A62O2)YQN^E(RB6^1*R.10C-1ZX6;G;]MFH9
MT2T)7:VR:;MRJH]%L]UK\A6]D2T=K=HX&^7.M4]6<J%6G$M?*;0;524=M7?G
M@)Z1IHM7" I,E&/?23)L=R1PZ22-"J8 XYV:T83!:[+4K;D18HY\X:WF!?U.
M(!]K-FUE=>Q:DY=56ME<L/-!PVI!.4SQ:TFJHU=F4*F/D[@J0&)OOO*N/,;7
MU[ ^+=&A26>=K3:*>Q]6CYEZ%98K2,_+%:/[<V1C B6J1>^BI!5G8R*+(I^;
M1471*I:*361-DY3'WA-$,TCEZ5KS9EL"=OD74:N^5B(>#@[E&->2%%XU; LM
M5D7TT+ETSIMROS B9';=F,BL[;E2,"(N%VTH6J&W#_=&I8:Z,]:S.RZ1&[#?
MJL465)?66(:VEXM)I][')-H)5T216.^2_.2 J8BH'A#K@:#5?8_/:@Z]O)XA
M[7K2&OH1[LV%L^RW,4DWK;FTZV- 0\C4Z:Y4?E&5ET+K/IP[DSTC!H1V53NU
MU"(KJ)"51"TS/WDFD6D+!R,+$W2==VBOVA_!-&[>K)H*V>M/K]!?(M1T-I4&
M2DGUGUT^8@]B$Y6(1!5HY5=D:NT%E%!5#*-*\ST-G7:/I=BUO;:2M:'-*CZC
M+.$&,A!*3UJT!&[[7J,W*-9 QVMC:UY*652[ENJS,U8$,JLDNNF@84BB7Y_S
M;7>"-)B-?H2VO0W%)Z/=22<@Q+:TK/7;<2D6>8,T-,)N46L5.+(G29IQCI%R
MQ=LU!D473KR% #9V[<A76O-PNJ3<:L$#K=CH?9VZEMF+S4>[4?!K.>U?%S,-
M&UAD#B22(T;;$[1U7/=J.%R)IMTU $Q@#;->(3F[L>>A=:V%IIV!(VN6VYO6
M$G7AV W?7(SYCN936_FNHPD/#R/GVP5>E(.+985%SM(F/CF2I0=F*/?IVA*_
M#X>$FO<'*QAK.Z05*C:7;+.=2^:YIUPMC*,35IM/5OBIW9(U^];O#S*UI+6T
MROD&Z+%5L<'+9-1<BCA(AH4QFE\^M)7=JY<,4;E&JMU[3&ILY*(AEE7]CK$=
MJN73IT:\A+#,1#RWV6,W'"JQC KGO5C&<HJ=RNT<))J$JGRF4T7FAJ"]ZYVM
ML]F2W1=8U D]<68\I!M595P@U1>J))Q</!R<R^\].U&)D2Q#PC.927.D1=HB
M*J?:;=!5*&'U;G!6WDIO:/O5%O6OG&F'$Q(+PDU%1ZMD6J=<U_HVU3#^1;QL
MO(Q!9567W,DDS2:/'*#ABB5;O2G$R96T5.^7VM\V=6WR(WFYH"$S8IK2-+GK
MNO# :")\L8B(3LZ3-Q77C"9E$F99:3JJR!$9,&#Y(JR"RC8B*Z1S"50[NKN8
M=+V1,46MJU:\UF7NH1,(20EXA@>J,=ER.JPW.XU:,XRE'"[FTLM=)KR8JD;>
M;C)(&2\I!UT;X+5#6::^\)NE<N&RV"VN:W:J_2+ON"C>;*S(6]"U0;K7TL\K
MU2G;M+2%54HD77[Y9$VC #D?^4,UGZ9P27(FJ!+0BJ9_9.4F_J=?H71,]2=1
MJ;BLM@U@,',1UAN!]:J5#9D1NQX59_WL(6S,K!79C2+YF<G8.@]0=H.DQ3'O
MFR#0$KL&V&B=HRFUZ:^F9^ ;5FS5RYWK7MKAXZ4/.0R%EU_:I*JRKB"F58^+
M7DH605CO*&RBK=!8J:H$43*H0P!"DTX P!@# & , 8 P!@# & , 8 P!@# &
M , 8 P!@# & , 8 P!@# & , 8 P!@# & , CC9&G]2;BC6$/M[5VN]IP\4^
M&3BXK8]*K=WC8V2%!1J+]@QLT;)M6;TS94Z8JID*<2&$O7H(AG,L\0O\.>LF
M'SS02.2BK&]S%5-FBJU454KI-B>UMKIJ,N8V2-1=AS4<G@5%(PI7%/A[7YB(
MN^N^-?&^ L$!)+.(*W4W3>LX>:AI>,<N&"[B)GH6N-G\?(L7:"J1CHJD434*
M8O4! 0SGW>-YB>QUI?7EZZ-[4UF/EE5%:Y$5*M<ZBHJ*BI5**E%.-!8X6BI/
M:PP(Y%6CFL8BHJ*J+1439145.\ILMG2'8%H<0$&[0,V=1$:X;G260.@LR;JH
MF1<KD=.4C)G3$@IN'*15#EZ=#J% P]1 !P6JEGA:!2Z\U?LH:LQ#)M*R\[/2
M296A%A?2]EG9JS3;UTHX[Y58[Z<L3YP)3&$B9G1RD I![."5+LC7(!MT\GA8
MI#LM5F)>Y8-DNRR< W*X:!V$R]&JY6:0'3_O# D0!#\T.@')" @FJS-PVAXM
MNO'-4V,>LBQ;)JL6*('*DS:*$2 [9HD50P%3(($ ##T#PX&R7? & , 8 P!@
M'YK^7VG>*6O-Y<NW\KKVD2,A"::I6YG]<W/RYVMK+YU;9:+?;I&V5V@5V,N,
M>Y>P;^J,I)(IE#R+).>4:L6S1J@"P+TB[=>X?H-U(_AY75NN)2O0"U4@)*AT
M^0@ZLX1[AQ6H=[78US&0"Z/0.Z6AV2I&YB_[44^F0I(1@ZE, >,0$/RA@&H]
MAX;:WGV7F\)Z^0[9[)[G5L_F:<BFJERJ^_=H/MN[(U]8CN:\\,%2D+:^_P '
M.P\AEVK0@(IOB@HN*RJBB$IFT-K9U+WB6G:S$VTE]G:I992&MT5#V&!835,K
M,?4X%["QDA&JI,5VL7&D$%!%14%3',0Q 'L@!"I>$6O6TK'3T3=MIPL]49%_
M(:DF(^>K*SC224P^L+R?B==,Y6G2,2XB+"G:7S5RE8&TZ;R!8K5,Z:"#<B0=
M_;,PI'%&@4.?HTK$V#8CR%URDS<T^C3UL&=J<+:&M"2UFK=F_G!@K9?E!)5
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M95CEHDD:[+'MT*BZ4:Y'-;+?J?<AO;EN/7X_5_T!_53.OX;+?13/.+C?G/\
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MR+R?:>0,TBSII07+,:\N=4ZC9-N)1Z)JG,FN5("9RF P=H/$. <L 8 P!@#
M/S@_>F[$N%=Y:4!M(4F$D&4+KI572977%J.WE(7F^R56VI(QYFMM<UR<<MG,
M%M&&KD=\GFZS0Y$I3SDH<$1,8*FP:7+\/"?H,UV_L4K1*9*6^)2@;9)52N/[
M/!H")D(6PNX=FXFXE QCJ&,C&R:BJ)1[0]0)X\G>-:]W;,RP08 P!@# ((J_
M^DAN;_)-H'_&7?\ F27G^5+#^^WO]G9'0VO^9;W^YVG]I>$[YC9WPP!@# *
M !X@Z8 Z /P!@%#D(H42'*4Y1\ E, &*/X0'P#@'S0;H-B"FW131()A,)4R@
M0HF'QCT  #J.*U&P?; & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!
M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M'_&7?^9)>?Y4L/[[>_V=D=#:_P"9;W^YVG]I>$[9C9WPP!@# & , 8 P!@#
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M1>N(.CL,XC^D9-RF_P"<W&[_ "#U *_[3_,SZ\4_ZIX]<0;>'89Q'](<IO\
MG-QN_P @]0&O^T_S-^O)/^J>/7$'1V&<1_2)RF_YS<;O\@]0"O\ M/\ ,SZ\
M4_ZIX]<P='89Q'](O*;_ )S<;O\ (/4 K_M/\S/KQ3_JGCUS!T=AG$?TARF_
MYS<;O\@]0"O^T_S,^O%/^J>/7,'1V&<1_2'*;_G-QN_R#U *_P"T_P S/KQ3
M_JGCUS!T=AG$?TARF_YS<;O\@]0"O^T_S,^O%/\ JGCUS!T=AG$?TARF_P"<
MW&[_ "#U *_[3_,SZ\4_ZIX]<0='89Q'](<IO^<W&[_(/4 K_M/\S/KQ3_JG
MCUS!T=AG$?TARF_YS<;O\@]0"O\ M/\ ,SZ\4_ZIX]<0='89Q'](<IO^<W&[
M_(/4 K_M/\S?KQ3_ *IX]<0]'X9Q'](<IO\ G-QN_P @]0"O^T_S,^O%/^J>
M/7$'1V&<1_2'*;_G-QN_R#U *_[3_,SZ\4_ZIX]<P;>'89Q'](<IO^<W&[_(
M/4 K_M/\S/KQ3_JGCUS!M8=AG$?TARF_YS<;O\@]0"O^T_S,^O%/^J>/7,/1
MV&<1_2'*;_G-QN_R#U *_P"T_P S/KQ3_JGCUQ!T=AG$?TARF_YS<;O\A3U
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M'=EGBP[%!@25L#]-!)],/4VY2D6D7A&Q.]5$.VH)>IA$>HX!E6 , 8 P!@#
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MOHMVJ]C:C#H0K!PL@BV.9FU,<&R0-V_1!NDV1$J::9  A"$    # ,]P!@#
M*=0#X0_+@#M%_E!^4, =0^,, IVB_P HOBZ^,/%\?X, KU ?$(#^,, @BKB
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M\8?E# ':+\8?E# *X P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P#R#YHTGE3N_8R<)6-+7![JFBJ"%;,WLNLF[.U6)5-0CZZ+M)
M"]Q[Y))%LOY''H.$BJHI@LL8"G<=VE\U]<6 =9.=+UF%8'8O]G(--5F@;PTF
MGRU19$5&HFAB.2NRY415HG0XG#?W<G!Q,7@&[&EJ57N[/@K_ *36.D<>N9FM
M[I6-@U+15P:V.IR:<BQ[5LU0DVDFINB4M7I0R>Q53'AK%'"=JY#LF,4IP53
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MJ>TQAC-1)H7:CU8BJY(Y$HK)XD<JNX&=DL*JJJL:J0/J#[IW33#8=L+N;45
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MHZK5JKEB;/T';IBX@IR,ET'C:/<I,G[AJM'NG";A!D\6(BL<@B5)4Y2F$#"
M8%%+R608G=J,"O6IGR3=)VJR!PD+M)HNHLB@Z4; ?OB-UUFRA"'$ *8R9@ 1
M$H] .QWA/Y1?RX%!WA.@#VR]!\0]0\/X,#O%M=3D(Q>-(Y[,1;.0?E7,P8.I
M!HW>O2M6Z[MR9HU55(NY!NU:JJG$A3=E-,QAZ 41 **7,#%'Q& >OBZ" ]?P
M8!RP!@# & , 8 P!@# & 035_P#20W-_DFT#_C+O_,DO/\J6']]O?[.S.AM?
M\RWO]SM/[2[)VS&SOA@# & .O7 & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M\T/&/P>#Q_BP#AWR?\KX.O\ >F^, ^+XQP#D"A##V0'P^'P" AXO&'A /"&
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M1G)/=F_N/NNXJSO:T0)63N>U1AM36F-B:"\4UGR6KZE4=R;^;&O;#H:,S#1
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & 4, B'YH]!^/XOQ?#X< B483>'7P;$UJ >'H
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MK/>^&1K6IW7*K:(G?4VH  ^+IG/,6*=@G\@O^Y#X/Q8 [)?Y)?R!\/C_ "X
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MMW1 [!"Y-LINI@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M P!@'YP_OZJ%=KA9>)LC5=>7J[1T*TW>WF7%-HMJNJ44XDT];^;$Y,E9AI<[
M([[R)84>]*7M@D<2]>R/3SW/MI=W4,#;6-[W(KOFI7N'UM]U7'L!P+$<5EQV
M[MK6)[(4;PKVMUE3A=A%6JTJE:)HJE=D\F.&NHMIH<QN)TB?2FWXMA#;_H4S
M,2LIIK8\#%Q<,P6>G?R,C+2M481[)BU(8IE%%52D*7\X1  $0P[+>&8G!C4$
ML\,J1H]-*HOZ2+I\&R?0G7-G7)6)]6V*6>%XC82WKK=]&LD9K+Y#DHB51555
M5$1$TJNPA^Z//<S\Q3QNI;OG-6F>JG$HELV7)KVD*LI9Y.LYJRK6U_LN+AKA
M9)VYUMO-LI.XS&C(]X,/$-%E2/)!\Q<)D[Q=8.T+W?A\/A\9)\KL3FFZ;-+<
M=M)14+5]C6"-C(&"TG9'TY?J@EH39<K4K?;(%2P+3;6,M6P/D\1:&;H,'<+)
MN3MG3HID# D'=^'P^'Q&)1]RYEV(9>P2K&]U9PVDM6,SR<)1[TXCCUFO<BS-
M+;,PFNYE"/7>OK+I<X/9)'S26062+W2"+=411*!O!QGO^Q-G4F4M%^:P;8S6
MT2%2A'M?(H$5:T*2U8UBS7J).9_(%&M6V_QLNXA"@HH!H3R-4RAS*F'!-DV/
MP!@# & , 8 P!@# & , IT#X@_)@%>G^S_9^' -?J^Q9.^2.Y!=LVKH2:ET$
M!!<-T5A)ULN_^UV14(;L]1\?3,ENW*W*EAJJJ?OM[_9V9T5JJ^TEZB<SM/[2
M[)N\RPW]$QG_ )@U_P#)9CFN_NKX3OJJ/,L-_1,9_P"8-?\ R6-=_=7PBJFL
M=AX/\7;589VU3^JVCZ>LLJ[FYI\2RW1EY;)OC@=PY,V861JT1$W0"E(FF1,A
M"E*4I2E  P;$.KC).*WLF(XCA\4U[,]7/>YSU5SETJOS_P "(B)L)H.$_#[.
M1ZO>Q%>JU5:KXRT^H%Q(^B)O^V&P/ZUYP^RCJ\Z+@\+]^;?JNP^C3PKXR7-3
M\>M0Z.4G%=6U%*K'LH1X3HIR]@E/.'FH'0,!.$W+20)&;@\4 !3[(B!O#UZ!
MTR+ LJX!EELC<!MF6S)517HU7*BTK1:.<J52J[!R8+:"VKP+=6NSL_Z2:<R$
MWQTP!@'R3002,L=)%),[A3O7!TTR$,NKW::7>K&* "JIW212]HW4>R4 \0!@
M'UP!@#H'Q8 P#X.6K5ZB=L\;(.VZG3O&[E%-=%3LF Q>VDJ4Y#=DP (=0\ A
M@'V I2@!2E "@         =   #P  !@#H'Q!@#H'Q!X/%@%< = P!@#H'Q8
M P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & =1
MV]:,$R+/'+=JFJX;M4U'*R3<BCIVL1LT;D.J8I3KN7"A4TR /:.<P%#J(@&5
M$5=A*C9*E>-3.C,>_0\L!N5T+7OD_*/)C*&1!QW':[WN.^*)>WT[/:#IUZXH
MM*[0[YVL@*= ^(, KT#XO%@#H& 4*4I"@4I0*4H 4I2@ %* >    Z   & 5
MP!@# & , 8 P!@# & , 8 P""*O_ *2&Y_\ )-H#_&7?^9)>?Y4L/[[>_P!G
M9'0VJ?\ R6\_N=I_:79.^8V=\, 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@
M# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ?
MG[^_A:11M=Z?D3[KF(.S1MS*YKFAF;P4&MW.1PCY5LQN:'2;3<3/ZV 2JM))
MZX/'MQ4%)L5%^LDJ;T[JQ1TF*2PK:-F@?&J.D7_=HNUI\FCMM*57XDT=S@R5
MG5JL1S532O<_T:3SG^[HOVPMZ?>%:YOVT>45BA+LWKAV"=AG'[5Q+;GA:XFF
MQ)Q]CD/("4MI$/V[=21?ME6Y'+A=!=ZQ(,P920;9AG?#,/P3*[K/#K)'V[I%
M57[*1.7\]51=:J?-3\U$HB^3H.PQ*&*VLN#AC16JM:_HKW>[WD/V.9X"8L>.
ME;W5S/KT3KB2M<%<)5.HT7_E<Z=ZS?/4[_8]CPT-:X>0G8:(90LDV#4$9)(Q
MCQ-FXCBNI KL51 4^R1M5+MT)<C.3W)?R2*LTQJ!N6KJ7RAT^;8L]<;.3L<7
M!.6NB)39.Q/)U7SMTI$0S*\6I)HQ(Q4527A2=MPZ,DNDH[P^,PN(Y*<J(:61
ML<WK:?G6U\MFMTV5*^:N\,V=1J:\-I].VLF$LF_%S$S2:FP)N05=RB#HA#0J
MJ*B:::)^Y#O;1E\1R4Y"?*&FSL]6P=49Y'M&]MC(G1&WHAQ&.5['I=&RNDS3
M"\A/*R%&B[G-H!W*"C1\,:JJ5/M(+)H%_"$TG*)WQRSL#FF3)=<1D E:&"48
MUC']"V'Y%7EI.S<:F,G8+M'+R<>_47CH[8MC48-2+L>[2A7)EU5/Y[R03NEX
MU/RFVCL>SSU1G:S$5R?;::V+=%Z:QJUS:VFNV6I?-<S@TUK!)NUX"72MBUX=
MKIL&[4C^-\F20<"=8JV%IL!*Z#"VO*WDPP:$:N=0.G2L9/5J*<G+JS:KYZ]B
MWZ-@358MG*KR";R%M<!%-'+AP=-C&-".^C?SAVD14)0JHIELERIW[\KZ# P.
MD7[J)EODE&7><=T2_(MH>Z+K5MI<:<R6=.(XJ;8BTG)"TFRED(]N$28%"N"J
M@HF&R>CY.O8+U_DA_%@ARP!@# & , 8 P!@&EMBCMZ/N3&SQT]<-3U=LEJ+1
MP3J>R]<6^]KO5S6?>PL5(A:K[4UR6-103!0%2+)NQ4,8HE,0"B!L^M9<NQY2
ML_7L%[,];Z[U. GBA1$X.SUM9)+:?65=%**VFFJ+5*87=18])F:Z]33V<+>1
MVNOPT$DRJO"7=-567$&K336J.KHHJ46OSV YYQ4>AW6Z-K]QEL[FHU*R6=O6
MXSCWMXLE8%X"&>RR,)'F2Y)OE"O951H""0E06,!U Z$./YHW#&=7F(8C;V#[
M;%X6SSLC61U[:ZK$>Y&Z[JV#=#:U72FA-E-D7OMS9V<UXEUA<BQ1/?J-LKC6
M?JM5VJG[\NEU*)H7XE,N" YMB #\[/%CPAU\/'G;8#X?C#UGO .<'E/5]S+&
M?/;;_#SD\FSQSW"?,KCT\QT1YL!:B5;YS^+?>GKZ\_Y9ZOVV>P!$9)".\F[@
M.30F[1S+]OM]KH %Z=!Z]0Y=.K_D7+.28S3A493EMMMM5U:^K^]L&QJ9WY1R
M?EF%5U-:O(KCNTI]O^'RZ,B\P<V^G_YL\5_%[/.V_P!YW.+RGJ^YEC/GMM_A
MYO\ )L\<]PGS*X]/++6V_-RP5Z"GC;,XO1IIJ&BY<T<YX][;.X8&DF*#TS)<
MP\F41,LU%;L&$2$$1+UZ!X@W[MW5[:W4ELEIC#TCD<W62]MJ.U55*I^X+H6E
M=DV;>//$\#)^5X4U7L:ZBV=PJI5$6B_OZ;%>X?)R'-AM:(>LCM#BT=27@;'.
M$=AQ^VR4B!*](U6/4;&1'DV)E#.AM!3@8# ! 1$.@]L!+J9V?OLY+SD>,T9+
M&RG+;;3KMD=6OJ_:X.E-NO>TG,SNEPVWY9A57,<ZO(KC\U6)2G+]O7V=JFPI
M?Q@.;8 (_.SQ8\'_ +O.V_WGLXW*>K[F6,^>VW^'F]R;/'/<)\RN/3S$J,YY
MP7.M-+"O?^,U=5=/)MH,3(\>MO&=HDB)R2ATG)C*<E&9A2DD6!727\V =TL7
MH)@Z'-S<19U>V%VZU;;8O*B-8NLV]MJ+K,:ZGV!=+57573LHNQL)Q;+VYO+=
M)UNL+C57.356RN*^2Y6U^WIH=3631L*FE=E>M:I7FK5I[6L$KLGBX]/LBZOZ
M8W<IZ"VP@6)58ZYO^PQD%4C<EU1>IJ(T,[3N@,D(&<@KVA!,4SZK.'(%Y;7=
MPVTQEJ6ENDJIRRV7619X8-5%Y!HTS(ZNGYM*::I+EV=[::"%;O"G+<3+&B\C
MN$U52*26J_OZUT1ZM-&EU:T2BYL,!S;#P_.SQ8^SSMO]Y[.!RGJ^YEC/GMM_
MAYR^39XY[A/F5QZ>6*"2YN39),X[+XO,?-TW*0P%7X][;,+DL:X% KY,?693
MZ(N@#M%#P] ^$?'G)N5ZOK=6)R3&':\;7:+VVT:R5I]@V4-F&//,J.5;S"FZ
MKU;]BN--%I7[?M_!2E@)S8@&\>X/M'BTY!_.P<&4I>/VV4A2/-R3>-(X$3<F
MC@8K<[@#"7P=H Z=0\>2U[/[ESFI9XRFK&]_VVV7YC5=3_I^W2@G9GB%J.Y9
MA2U>UOV*X_.5$K]OVJE^" YMCX?G9XL?9ZVW^\]G'Y3U?<RQGSVV_P /-[DV
M>.>X5YE<>GEEBFW.&2?V1FIL?C$Q3@9I");NG''C;H(S*2U>@)PTDQ$W)A,I
MFJ3B949B)3*!WS13\X!ZD+R)G=7D4<3TM<8<LD:N5$O;7R5UWLU5_<-FC$=M
M:')HVUV8X\]2/D:MWA348]&HJV5QY7DM=5/W_8JY6[>E%T[26^Z.N:U,@%9]
M;9O%N032DH".%JEH#;+<YAGK!%P)%@5-R96#HU/)@J)>S^>!.SU+UZAN6#.K
M^_N4MFVF,M56/=5;VV7YC'/I3D";.K3O5J:;I,[VL/#+=X4Y$<U*<CN$^<Y&
MUKR]=BM>_0RKS!S;^EGBQ]GG;7[SV<+E/5]S+&?/;;_#SD<FSQSW"?,KCT\Q
MYD3F^\L<] CL;C$@E"Q\ ])+*<>MNBSD5)HTP"K-M_G,%("\66+(94 .<>CD
MG4I?!VN5)V>LM8[GDN,*Z1STU>6VM6ZFKI7]PV':RTT)\U=G:X[6YY=</M^5
MX6B,:U=;D5Q1=97:$_?]ENJBKI_.30FWV+&AS8KM?G9]3:7%IT2#AI.8.U)Q
M]VRD=R2,9+O3H%5'DVH"9E2H=D#"40*(]>@^+--HO5_=W4=JEGC+5DD:VO+;
M9::RHE?^GIL5-5PS/%O;R7"WF%*C&*ZG([A*T2M/M^V7<D%S;.':#;/%@ 'Q
M?YO6VNO_ ,3N;'*>KY/X+&?/;;_#S>Y-GCGN%>97'IY8R)\W#6=S7/G+XOE*
MW@F$T$F/'O;?DJIGK^28BQ*'K,] <(!'@H;\\>I5 \ >,>2J]7R6:7?),8TR
M*S5Y;;5T-:M?^G["ZU-C:-E(\\K.L/+,*HC$=7D5Q32JI3[?WOPERD8OFU'Q
M[Y^;:W%E4K)FY=BD''O;1!4!LB=84P/ZSANR)P)TZ]!Z9LQ3=7TDC8^18RFL
MY$^VVVVM.CS7)!GAD;GK>X4J-15^Q7&UIY^?&&8\V9B(BY8FU.+*!)2.92)$
M#\?-M*&1*];).02,H')PH'%,%.@B   ].O3-4\G5]!.^!;/&55CU;7EMMIHJ
MI7_IY(H<\2Q-E2\PI$<U%IR*XT52M/MY9'SGG SN]=IQ;_QF<HSU=M4^M8$N
M/6W?-\2I6GU59(1CLH<E3$\IF@LJBB(BJ00*R4 "GZB).1&SJ]?ATM^MMBZ.
MCEC8C.6VNL[A$D57)^X;#.#1%T+\]-*;>P]<],O8[/E.%JV2.1^OR*XU6ZBQ
MHC5_?]EVNJII3YBZ%VLL&!YM '4=L\6.G@\7'G;?PCT]I[.%RGJ^YEC/GMM_
MAYR^39XY[A7F5QZ>85K>5YK;%HU8NZ&R>+D4C98I&43CE=![8>*,RK&.7N3N
MB<EVY%Q+V/[X"% ?BSGXK#U?X7B,V'NM,9>Z%ZMUDO+9*TVZ<@6GA4X=@[.]
M_9QW;;O"F-D;6BV=PM---GEZ?B+Q*I\W(R3K<<&R^+[HM@D7K SI+CWMP$XT
M&<))RX.7(>LR<#)KGCP0#J8G0ZH#U'^]'9A7J]FAEEY)C#5B8CJ+>VWE5>UM
M$_Y?M:U=O0GRF_)'GB.1C.684NNY4KR*XT4:KJK^_P#>I\OR%^" YM]/_P V
M>+'V>=M?O/9QN4]7W,L9\]MO\/-WDV>.>X3YE<>GEAKI>:]A:OG2>T.+;4&4
M[8(,Q#\?MLJBH> F7L.=P40Y-D[)'1F0J 7H/8 W9ZCTZCR;E>K^V>UBV>,K
MK1L?]MMD^>U'4_Z>NQ6G?-B!F=YVN<EYA24>]OV*X_-<K:_;]NE?EIWSG,H<
MW8E2%3#9G%YYYXFF\08R/'O;909 NU>./+5O\YI3M(IBT @A^;X3AX?@&6[N
MKV=)%Y)C#>#C5VF]MM-%1*)_R_9TUV]@U2Q9YC5J<LPI=9Z-^Q7&BJ*M?M_>
M+V,!S; .OSL\6/!_[O.V_P!Y[./RGJ^YEC/GMM_AYN\FSQSW"?,KCT\PBHRO
M-:V2FP(Q/9/%QB:A7(M/664T%MA<)-4U2JMK\O33+R82%HF!+05#NQ%0>J(G
M[7YW9+V%[#U?V4-M,MIC+N4P<*B<MMDU4X22.GV!:_U=:Z-FE-%5X=J_.]U+
M/$EWA35@FX-?W.X76_5QR5^WI3Y]*:=BNV=F[N><-/@O/+>_<9K$KYZJT0$9
M'<>MO [,2R6F'KBSXO=\E'AA0AT94SQ8.QT%) P"8@")RZ,/9U>7USR=UMB\
M2<'([6=>VM/U<;GT^P)I<K=5-.RJ;.PNN[3/-K#PR76%R+KL;1+*XKY;VLK]
MN70W6UET;"+I393+@@.;8_\ .SQ8#_L\[;_>=SA<IZON98SY[;?X><GDV>.>
MX3YE<>GF/LO77>V.>KI=H<6TU()E!O%'0\?MLF(Y";"3["94@Y-E,D+?S8/4
M1,;M=L/ '3P\F3L_CM8[KD>,JDCGI3EMMHU-7;]7Z:ZWR4-AC,\/G?!RS"D5
MB-6O(KC3K5_]?HI3OG9GV?."%A):70V3QAEEHR.=ODHQGQXVZ+N04:H'6(S;
M GR97.*[@Q.P7H0P]1\ #XLT6S^KRXN&0.M,88U[D17+>VM&U6E5_P"7IH3X
MT-4T6>8H72I=X4Y6M5:)97%5HFPG[^NE2[A <VQ#_P#-GBP'X>/.V_WGLV>4
M]7W,L9\]MO\ #S=Y-GCGN$^97'IYA))7FJ?8R^O/G)XN NC2FUS&5^8+;/<F
M1<3KJ#"/\D]9?M@H4[45.\[SH(&Z=GX<Y_ ]7Z86F*<DQG56X6+5Y;;5JC$?
MK5Y!WZ4IWZG"U\[^L%P_E>%:R0\)K<CN-A7*VE.7]ZM:_(93)1G-R.CWS\-I
M\6W(LV;ET#=/CUML%%S-T#K B00Y-G$#JB3LA^:/A'Q#G#BFZOI96Q\CQE-9
MR)7EMMHJM*_]/.6^#/#&.?RS"EHBK3D5QII__?+94D^<-FJM9LCC8O&*#7L-
M?AIQ>$?<>MNB]AUI:.;/U(MX*G)=JH+J/.X%%3M))CVR#U*4? &]>KU>6EY+
M:-M<8D;%*YB/2]M:.U7*FLG[@NAU*II70NRIMVS,\W%O'.MWA;%>QKM5;*XJ
MW61%U5_?TTI6BZ$^)#[.$>;"%@BX =I<6C*2<-.S!'(<?=LE(D6#?5QD= R8
M\F^T<SD;"!@-U "]T(=![74-+5ZOW6S[GD>,T9(QM.6VVG71ZU_Z?M:E/E[Q
M5CSPDS85O,*JYKG5Y%<?FJU*?;]O6K\G?+UY@YM_2SQ8^SSMK]Y[-CE/5]S+
M&?/;;_#S=Y-GCGN$^97'IY;XF/YN2D:QD!VEQ;:"\:H.1;*\>MMBH@*R8'%$
MXCR;3$3)B/0?S0\/P9NSR=7T,KHN1XR[5<J5Y;;::?\ X\VXH<\21MDY9A2:
MR(M.17&C_P#WG5D4>:\?)P,8;:7%I4\\[>-$U2\?=LE*V%G&/)(RAR#R;$5
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MTYP/).;CS[(XQ-4X=9BDD^6X\;=!O)@\8(O3J,Q'DR0IB-3JBD?LF.';*/A
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MW454^4Q%SS5U@:D:MO%=K>SKRWVUK53<D!7J;25Y6UQ.K&C2'=REUL\.X?L
MBF,66=;)BT(JM)NW"G<LVKE4AR%V*&Y5/P$ZRFV*3$ZM7W,>5,^U^G3$K\WE
MHE@^DW,K6W,2G-1R\+%M$%)*5>RS-9,&C5%$SARJJ1-,@J& HVJ[!42B5VB$
M Y?ZV>5NQ^>ZILV!N45;(#6[S2\Q4BEVQ*6N\P:L_5(:"AHF7DH672L5:1<O
MR/D)(T>S9L7BSQ=J1D[%"M<YCD>WYR+5/D(J(Y%:NPN@XI\K:)7ZK4&D?KG<
M3BVRDK8:;%Z7:TCKM&.=:[CFCNV"^8OIIO6C0M=AW31<9-&7<1[\KQL5DNZ6
M<HIJ:I9'RR.FD6LCE557NJJU7PJIHC:V-C8V)1K4HGQ(A/T'LNG6#6<;M]E+
M$2H<G3$+\E-2#=S'@VJZT.$Z9](LG:23Z-5:1HB9P@LF1=N<AB*$*<HE#;T[
M!N=\UUC^<&HUX&U3EAA=F4/Y.U2I7J,A;E1)!A9+Y3]@6-&GT";H4%&KR[^;
M5N%M=MHMM&JE;3#=\\;I/&C8RZ?::4)5#L1O*_7E?J#AJXU]M.J6BM6>K:SB
M]*2558'V;)SMFA32U*CJ['QUCE*S)QDS LW#@D@$N$>T2CW@/'#<[1R5+<ED
MDGE=-*NM*]RN55VU5:JORJ:8V,AC2*-*,:B(B=Y-"(3[J_9E<VU4&-UK 2#=
M@X?3L)(1DVR/&3M>LM4G9*K6VKST><ZH,IRLV>&=L71"G42%5 3)**I&(H;;
MKM&LCR>Y1Z<K5YVE09FS"TE=+ZN'<&RWPQSU:$J]-(#Q5<SN30243<3+5@R%
MVJQ0*JX3;*HG,4.^3 P53;(\K/)W5%4HUSE7%(V9KAQ7K#&S+G6UJJ#A#8EC
MEM]7.6D:E*5JNLI2:&4#9]YE7R+1(7"2C-\1PW>)LC-EDTN1<W,]W(DMP[6>
MD;&(NCYL3&QL30GYK&-;WZ56JFU##%;L6.%*-5[G*G^L]RO<ORN<J]ZM$HA/
M&IMLUW<5=D)R#83\$\@+#+4^VU2V1I8BU4ZWP1T@E*[/L$G+]D5VBW<H.$EF
MKETR>,W*+ELNL@LFH;C[!NEEF.0>L(':3_4$K8$VENA]567<T^*J"I86N4.J
MRU<B)-_.S0AY#'O#*V=NLFV,85C-2G7,4J?8,<FG2%5$T*113>7NFGT??[#)
M1%\UDTAZ(7>SM78E-D(%Y=-7"S1BT-D5B-;N)61=L3$BD&AXYRBSG6RAFY7$
M>CY4V,MNODED1K7K5K&ZK>\E5=3PN5?E-#6QL5SFI17+K+WUHB5\"(GR$MZ@
MWE6]PA:&;&!N=*M%+>1+>STC8<"6N6N):V*,)-5B8.S2>R;%W#6*+.*C9=NY
M5 JR*[98$G;9P@EM&NI<[5N:AU#9.L=2R\H?Y<;;<6)&I1#1LHZ$4*M6YBTR
MTA*N$_YB+8A'P:Y$#*B!G*X"1,I@(J*8&).]W:=K.W+YKE65(RNU?U>GNC83
M\6ZYH6(I\4L6'37F9@IC,V\NT8%3<&9% 7";!1)PH4J:Z)E-Y\\LD;(GJJQL
MKJIW*K5:?+I-ML<;7N>U*/=2J]VB43P%=-\C:;NN0F(:'@[Q49R+K]7NB4%L
M&M*5F5FM?7DTP2F7V%2\J?(N*]8CP#LA4U3HR3%9 R+]HT6$J8[)N;/Q&2[#
MW90]86?5=-L\@NG8MR7)2CT:,8-%'[EW*-X"6L3U^^*B(>;H)@SB136>*=$B
M.7#='KWBZ8"'<[Y'4!R1UU/[,=0D36;ZJU=S$_KEOMX*B[-JR9MFN5+"XM%-
M9V=-THY(XJS]A*MU7Z[)O#*OVSAF@]6=)&0+N+))P20JOZI'*Y$[ZHB*ORHB
M> T:C$D61$\M41%7O)543\*^%2Z:CY.4+<EC&L0<3=8!W)5'YQ:.[N%<&$C=
MGZT&29Q1=AT%V1X^\X5SRR39=M-X5C)HI/VBRC4B+INHIHV#6BU,PW+O#7VA
MJY"6;8,FX9,K'>*9KJ":Q[%>4DY6TWF=:0,*Q:,6H"H9-%5T+EVJ82IM62"R
MQQ[).@S9!%%CY2ZKK>T)"!>UZ\O"5>U5O4%MVM&UL'>N*1>]@$J<M6Z#89D)
M-.4))3 6B%.HX:Q[N.9*/T$W;INH<2!NI+)P2P(OZI7(ZG?1%1%\"JAH5C.$
MX6GEHE*]Y:+3PHA>ZGRIU]<=C(:[8P]YCO.\[?*I3+O-U9:-H.PK7JYW),M@
MUNG39W:CQS)5I:%?FZO&C)"21CW2T>H[1;K*$VC76NP93L_>U<U9.5VKN:OL
M2ZV6S0\]8&$!K>FR%QDV\'6GL!&RLK(-V"B?D+).0L[)$ACF_G%%?S0'LFZ7
M2I*HFR8K?N5%"UU:D*W/P-_49M&=-?72XQE45>T[6"6P99>$IY-@R?EB3R+7
ME)!N8JI&K9Z,<B)7+[R9LHFL9M#;.+'E?KE_LU'6R,7=BMWE^E=31NR%:TH3
M6$IMB BWTS.ZY967RLSLU@C&44[3,NHS3BE)!JLP2>*/DS-@A:I4V=P!@# &
M , 8 P"@]0\612H1=I[;,!NJF!>*TPF8V+&PVRM@VG46*#\7M/L<E6)%?NX^
M0DF_DCA]%J'0'O>V*1BB<I#=2AC64LU6.<<(]<X<R6.VX>:*DB-1VM#(Z)RT
M:YR45S55NFM*51%T&6YVR;B.1,<]08K)!+=\FMY]:)7JS5N863L2KV,=K(V1
M$=Y-$<BT54HJREF3&(FH&N.:FG[_ %J(M+F6CZNPL2\.Q@F;FQ5JTR[F;FVA
M7K*I2,;1):T*P-X514#NX5X*4DY,FL""2H-UQ3=Y"F<QO*C1,LE'JL;\T5\Y
MKLR,TE(6S-71XY^WCG+.U+,W<,B[9T%=&6:B%C6(G _X0F'E?4Y0$I$+<3EO
MI%=_'M&=CE'[>3B)F9:2K*G7!Q'*I1<G08I@S;F)!B\DI&Y.MEQ'R>2:(N G
MBND_(C+&6;@LVBERA^3NI[->JU0:I/#:)&R0<S8"R<.U<*P46SAH"O691M(R
MC@C=N,NK"6I@X,Q0%9XT2=HF=)(%71%0$V"VQO+[CU+E5-'[#;K]VU;.4RC7
M+B@J_._)5UHB.AT'->16G)RQ-;M#.(J.9E7?RK669KLT5T7"2AA"CGEIICSM
M&1<19D9]*03AUU9R-34+68]*;G:!!-"N;&^*TAUWR:NRHI5=HW66=-4W"?E"
M:1ED 4#16A<X/E-HVQSL=6(B\HJ6&3?L8I*(>P%KB7K&1EN\\R-)Y&6@V(UI
M:PE(4T:61\E&2*N@+7O0<("H!!UC^\ UM5W]B8R=8FB! VVS4T[D;1K-NBC(
M5/>M1T!*R=E1=WAN^H]:/:;DV?(2,LBU:'BTSG,<BYF[=<5-*T,@6Y*O-L/9
M_4>ITFU3VA)5QF\KUJGYZA34-&L9B&@)I6_U^%B+!/R]XK<1!V QHZ30CUJ[
M(SK4(]9VDF<5L$VZ&UE'"WDJ%72OYH-2[I0$2E;EJR=XI7G%D28H)S+F#-(-
M&#T(IS(%440*JB10B9@*8!$!$0,JP!@# & , 8!Q/U[(]/"/@_C_  #@'FC1
M-8;A=7;0&O)S6UCK5<X[\A][[BEMI.I^L.*Q=JU:(?>]9UQ'UM*/F'EF?3MB
M8[I;NIA!Y',4V!XUTGWA^VV%:Z":3TO+X@_ '^SPY"D)\B)BZ0&I;'+:ZUJC
MMB[M'$"-;I[II'OVAI)2P1:2=A=,9&5@DGR%/*<TL*";QJX7%F":*R2IB*%!
M31Y+5MQ!*A;LA-9;MLFRZ1R?8[FVXRV$2A5R[[2CY'1^P-'K?(&#C+<ZIT=7
M]<5^^MC0T,=ZR'R>+6 ZKN1<*NG=)XS;/BE1[A3->V9[>H9U6;'L7;FVMKN*
MF\DF,JYJ;'85YEYZ%K[MW%+NXKSDSA5VYGA&R[A!-ZHL4BJA0 XPI)^X:W>+
MAK>VU?7%N;4*YST.XBH6Y.HIS-)UX[TZ2#Q^E'M)*(7.^)'&6*V4*X(+=P8B
MO0_=]@SXP>7M8XR\C:?';K%]7:K,Q]2Y;<7=R:ZJE C7U6-?Z=IC5O'JJ69"
MMJ6[8-F230;U:EN&$6QE'+=9>PPQU5796SI#N+MDVO ;T\8:C<HH=X;!NU;E
M:2_W5NF2V#$TF;?Q;^8K=:8TFCZ_A"S 0CV3B&4Q--Z4,BX;MW3DJ NRD,H)
MRF (4FC:E1=7_6&QJ(R?FBGMTHENJ;23(/0T<YL4!(1"#XH]A3H+55X!_P"]
M-_>^(< \D*SQKW8I5&$!3]8;(UP^K?'5_ [D;7K:32=@]_[VJ\MK.>H(UD"W
M.S,115?TV815LCAI#"2)F$6(H=V'<L+5#3337;-[]#P5[G]T;LWI;J'9]7Q=
MYK.I:#5J?;I"O.+"NTURG>).7LTK'U>9L41&^7R]].S;!Y:HLJW8 H8A"G(&
M3:H7OFW"P&,D<"]!,(>#J'4.O7X0ZAU#\88*>'+;B#NN::N:M$57:U>N*^KN
M6.OMG6K9>Q86QZ*DT=TT^V-(-CQUIB=ELR^IXN2V2Y@Y!H2&BH D96&"T=(E
M=+&2(-J:52OQZ3?+2$%LJW[YF-U776=HU%%Q6A*7IQA6[5,59\_GK*VM<U;;
M7+HM:E.6)@,%"*+-FD>[5726=]ZX,")$^R8TV$H:MNIN1+(J.(YZBD3O%%6K
M@A"!XS'.@H4A0\(  B<0\?@P#S=KFM]N:MI? 38#?5]HNTYHOCG(Z<V/K.MR
M]7;V>+D;MKC4R9I9LG8)V%KDF>NV[5:4:Y[$@!DF\DJNF"Q$SY5(E4\!![/C
M7R U3K"T4^+US+;%L&]N&PZ)?!%6JM&A=7[3>V3;<T*=F=S<E#J?-\R;[G5
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MZWN-4M<1"\8XJO4.L:XB+)(;>U%*VQ1.WWIC)UZ9%)Z]AI>;.U\S%CI%H+!
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MT,L0A7!$SB03=DW0#)< 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M8FG)5I'M&TE,FC&PLXTTJ^12(ZD1CV@]T@*QC]TG^:7H7P8!=L 8 P!@# &
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MJU\TDMY/\\GR!^47)+R?R'Y'^</)/4\'Y1^0]]^9Y!\VO9\T]O\ G?.W3O\
M_!^N4GY3UXUKY7\WM%\X><O./R-K'E_GGS+YW\M\RLO*_.OR<_Y/^<O*.UW_
M )!_@7>]>X_F^SD-2F;X(, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!
M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P
-!@# & , 8 P!@'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>tm2030088d23-lc_tcell4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d23-lc_tcell4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ V .2 P$1  (1 0,1 ?_$ .X  0 " @(# 0
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MFVN.K>@YW>=+UU/\VJ1UH(],_AYUU#.F3IN"(%4(MZ@999P0< < < < < <
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M' +M$42$1,0I0  YU)0%#T@ ?J#Q_A^/ .> . . . . . . . . . . . .
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MX>LOJ]1?(>0XO6+^//T\B$X7*<))Q?V.@.]YQ < < < < < < < < < < <
M< < < < < < < < < < < < < < < < < < < < < < < < < < K-]ON:FI
M?9/=-;R\S+2K>!]Q"5A8-O)R+Q^A"PY.I?5"1)%1*3I95.-C2OY%PN""($2!
M5=0_I]1S"(?3[D69< X$0#\1 /X^ <\ < < < < < < < < < < < < < <
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M%N,E22? ]PMW+=VW&[:DI6I)------5336C36J:T:/9Y#[' ' ' ' ' ' '
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MB A\!#@/X7["S&-_YN8?\2:_[PGP#W> . . . . . . . . . . . . . .
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M=[37J;6(OZ89.QVJ9CZ]!1P/'C>.9_72\NX9Q[3ZN0=I()?,4+\Q94A"^3&
M! XMEUIU#@'MKO-KKE,JT:=BG(V6US4=78!@I*2#6(C$WLS+N&<<U4D99^@U
M0*HH45G*R:1/)SE*(")NM.GY>RU^"M5=FI^F.X^/N$'$S4=(S-4?RT:A,Q;&
MRQ;-PL^@GDE#NDG;=)TFD=9LH54@"0P&$#(Q53#_ +H/P\_I_#QY\_A^'@.
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M'DXKE^4?/W".C+MV;B]0E@8QY:K7E0CJ8PA(9A,9^#I4@KNT9Z88NWXRA_\
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M.-ZM:_M@66 ]3IRV4BYXL+(2\.269JMS)KE:NW2!5"B!%5"@!S5!^!N+@@X
MX X!P(^ $1_1\> 4_P#;/WB^H>0UG;:!FF]T>5[49^YL-(KF7RM6OTB9QJ\)
M,FKRM3>%:0C!@\73F45&X_*?D2,<ODJHE^/!:/C0M\1,)DRB8?(^/B/X?'^+
M]'!#]> . . . 5=^W7_Y:O=B_P"DBE__ %/^HG YOZ<D6=O':#!JY>NE 2;-
M&ZSIRJ;P!4D&Z9E5E#"(AX*1,HB/\ <J571<6?,I*$'.6D8JK]B-,]:FBS7
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MO)F1VW<<?=<..;C54&Y1E%TZH3A)PN6YI-I3MSC*$TFTI1:3:U,SYQ'?' '
M' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' -8;#M>1=?*'*ZCN6
MDTO)<X@UXUK,7C0+%&5:KQKF8?H1<4W>S,NX:L6ZTA(NDT$2F. J*G*4/(B
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MDTE3^IFU;E1.U*YR22DO4CQKJOXO(E, ^H $/P'FOG$<\ < < < < < < <
M< < < < < < < < < < < < < < < < < ^9SL#J0I>[1-T"8WBNU&,KMZZM
M,ZEF-I]PG<.M+MT6Q0==F95&E]<,BK#W.=D86.8?F]25G=DDY63,X9.3%BC1
MX\?B5T)R>XMV,V+(-@ZRT/$NR=>I6BZ?:*VRK/78^>T*;4TF*;ZC1FVI:-L^
MB7N246S[ J#F3Q\V,:"3AYY[87[1%F^=N%$8\T'D1R[N>XKNN4]YLQRS']*H
MK7.&*?3([3-_L59L[[L\_P"S/<M;K-KT+%699=U8(Y?#*:V-+MBUXS=9K*^3
MR?U+,HM@%H>>/>X1[@&^Y5W640RK*L.O&$T>;G\3N][S'?V%2V&EPE^UR#D>
MPL#!V]*#.U@)"LT(B$-39!VG,_>V:SQZY"'>L1,(T^JA'>/]S?MLXU'J$Q>:
MW5(T)_*?9BD)_(7E'HR<KVAD?<1M=OIW8G0V[P[5M985'&HZO%E(M"J_;V#%
MRDN,BFZ:B1!(5<"Q; M3]Q'$,ANLOV0Z_P"H=I-*D]VE(ZMP&4V# :\_BZ X
MJ+%ZYL#9.VZ13Z\E0FEQ9.VD6!GYIA=%RBJJP:$]29*2A[OM#V><NE'[MVRR
MT2PYA/3_ +D':.2EL^MKRN2%FJ#UP2A&5A)M[4)JQUAS(-!#P<[%\Z;B(_LJ
M&XY$YEMW ' /4>L6D@T<L7K5L\9O4%FKQHZ02<-7;5RF=%PV=(*D.DNW72.)
M3D, E.41 0$!Y]0G*$E.+:DG5-:--<&O-!:$1C&F^IP,FYS.[%U=*N9L5R?U
M+V/K<T74 &:"RA/2:<Z^1)/"9#G*9_2VX!\Q1Q!I@,+LOY7<C;5+?<+5:<(Y
M3YT_=R9<?W;[X)7G^;S>Y<CX7?N?\OW$O&SI!X@DY:JIN&ZZ2:Z#A!0BJ"Z*
MQ 425163,9-5)1,P&*8HB4P" @/CFLRC*+Z9)J2XI\4<+T=#V.0#@#@#@#@#
M@#@#@#@#@#@#@#@#@#@#@#@#\> 5F=[?:*Z,>XC1("A=@,C:LT*K:1M]=M.7
MKH9O=8R5<(_2RZ0SD$Q DE&SK,?ENV[Q%PF80*J3T+IIJD<. :3XDO\ #^L^
M$=<:10<_QK+:;1X'-*1 YW4EHJ#8??FE4KD2QA8YB^LRR"E@F'"C*.2%TX=N
M5G#Q8!56.=0PF$#J>PG7TVZ-LZ>P^I7_ !>]Y->W6@4#1,X;T62FHF6E*%=<
MRG&+Z#TNF7ZF3D/,4W0)%$Z+J-4,BZ^0Y2.15N0>"_@1PP[VU,GP"]9U8J5H
MVN/*-DYV$]0\=L<G3)&DQ&EM<%K76M]J3B7;4>/T&5LLSEE9]#AHXF3PWW:2
MD) C,JZZ8H2@J3,QW+XG&,WJ^9P,C)RL14V;ADQ?S!FAI-PFYD'DD<SLS%JR
M:"<JSTQ2^A(@>@ \^1\B-(;-X X X X!P80 HB(>0 !\AX\^0_BX!\P?N.7,
M!]T"-K%NT^,JU'C^N/7.2IU>T/L%WMRJGKW"3V??&ER<4"O].7T-3I2T.X^,
MADILMU,\4<IIQI6ORVJ;PAA=?J/HGTS;\;PZ$C)[:-7SC)H.6D!B(J:TR\5B
MBQ,G+_2.) (J/D;3*135Y(BQ:*K BF<RORDS&\>DHB AV-IU[*Z.XI[2ZZ10
MZ@[T*30A:$VM%OKT O=IER1-5O$U%*5D6BEDDETU2&(@S!94Q3@(%'R' ,Y5
M?-T$E%ESE1112,NLJJ=---)$@>HZJJASE(FF0GD1,(^  !X!K)/>L153SM5/
M7LP.GKRYFV3G)?JH8FG.")?.40STP2PA<U2(_M"6.^I,!?CX\<5%#O*9J% T
M1];XZD6N'LSR@V1]3[BE$.BO K]IBUUFLG 2"R8"@24C73=1%PD4QC(+)F3/
MZ3E,4 *^/;K_ /+3[L7_ $D4O_ZG_4/@?3[D38[)2;V(Z_[2^BS^B7+E]Y;0
M@^GU":?D*W(Q\"D4@&**AUIATB0I0'R83>/T\[FW1C+/LQG\'JQK[*IO[C7.
M\+UVQVIN5VPVLA8-]0HJOK=N2A1<VY-)+FS;4/%M(.*C(9B42,HF/91C,AA]
M1B-6#9-JW*8W@/4)4D@#SX#G4E)SDYRXMM_:9ZQ9ACV86+>EN$5%>Q*B^Y'9
M<ARC@ 0 ?@/Q#^'@$=KU%/LKLLGLM0:J.(&4,P6VZH-2>22<-%,@8#J4"U1)
M\PUZJ,,@@F^3)ZE)R"9$:@11TSCBAW[$HY5M8=WXU7TY>#;^!_S9.M/W9.NB
M<C4]TL7=CRY]QX";Q;G2\VURE;A%K]3;2_T]J*BII5=ZQ!0I*=NREOR-DF$Q
M'LI:+=MI"-DFK=]'OV:Z3IF]9.DBKM7;1R@<Z+ALY1.4Y#D,)3%$! ?'.C*,
MHR<9)J2=&GR9M%J[:OVHWK,HSLSBI1DG52354TUHTUJFCW>0Y# -'TVFY36G
M5INLLE%QR _*;) 'SI"6?'*)D(N'8D'Y\A(N?'@B9 ^  )C"4@"8,!W)W+L_
M:FV3W7>KRM8T=$N,[DN4+<>,YRY)>UT2;7#?OVL>WZEUT7X^2\61A=[QV4>Q
M3R^U_KNW:9_&ME94["U6@(_0)>%;%,X7>1\&W2,#%R+0@G(@J14YOP)ZQ$//
MF-WOOYE7\2>_[?V[&/;UJ+N=%^_T9=RW%5<HVDGTOIU49*3?+JT.B\O.E'UH
M64K*UU?O->S^ E5GMYA-*I=;O-=444A[+%H230%@*5= QQ,DZ9.2E,8A73!X
MDHBJ!1$H*)CX$0^//5.W]\P>Y=EQM]VYMX>3:4XUXKE*,J52E"2<9*KU3HV=
M^S>A?M1O0^&2K]/89GS,G*. . . . . . . . . . . 85=](S[,XQK-:->*
MA089]*,H-E+7.RPM7C'DU)J_(C8AJ_G'S%JXDY!8/2@W(<553? I1'@&7I+$
M7*!TQ]1#%*<IP$!*8IP\E,40$0$I@^(#^G@&D]W[)XIUGKL1:=MO+2DPT]+G
MA(90\7/3S^2?H1SV:D!:0M8BIJ:68PL'&N7\B[!O]+',&ZKERHDBF8X 8'7N
M\?4VU6ZZTB!W.D/IK/:G,WFUNA>.6E69U.LMH9W;9N/O+UHWI-B:TIO8X\TX
M$;(.SPGU[<'Q6XK)@86A("@WNI:A2:GH]"FFMDI-ZKL-;:E86(+%93E<L$>W
ME866:%<I(. :R$>Z353]9"&])@\@'!#+N . . :WV)\>+R?3)5)9PU<15"MT
MHU>,QB2/F;N.@'[UL]8JSR:T(B^:KH%.B=X0S8BA0%4/0!N 4->Q!I4IIE?F
MINP[I7M;MTGAV-SUI:M?< W+MC:XFPS#)9Y-O;CCVGUF%K&"S#R355*X:PR[
ME--R51D _);D,(<R9>(=AMXC?<)[K8]V1UW,4<HH>9]7+/B]=@H9G2H"H'V7
M0-RJL3&R]KM$F[G[CH-R3JT,@X$SANQ4D#$;1[!,?4HY<R\GXE2.'^Z9[@TI
M'[%/4DL?VXTAU0L]THG78,X:!^Y77;-W>W/KG,=1XZ=R5E6IO/DR9?G#-Z6>
MT%:;4B)%HYE'JJD:[3;IAI0FU<.XO?,EP]HJTS;BAYC4>TENLE6[ X@TR>Y0
M>DN]3C.L?:#49S/'KO2966?UFBT2PYY M6ZT>@63L,B@N](\;QAT6CJ/P+%5
M5>9$GJ1VY[Y]Q,YV.GTK>9/<KR_P/J-V/<C3(W+,]EL1UG1M*T\FK=3V\S49
MG'%XFF0L9G3!J]0EIP+RSC5GQBR9W"[8"5<:'RZ4)1^[UKG;1AT?[&9K,=1
MDLT',LX96KL-%;_15()D_=/\_?6M_'9S.(DTB3CX2TJN8](5O#IX1$''@ .
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MTC(K*^OW7"%N4KM%;46VWPISKY4,E5-5Y$S.BJ2Z?6FE'5]7R',G=7,>40$
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ML%C4K5?B8(]@GG0%!U-S9XMHU-*R[D"A\QRO\Q8_@/)AX!7?[RI0#VR.W7@
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MI*+C<C[DXB4::KX7]*/P-X\Q1\#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@'
M@ _B #X_#R'G@'C\M,#"<$R <WI\F])?4/I\^GR;QY'T^?A^K@'D!2@ @
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M+:>W[>#CU='N-]VKM/Y^/:C*Y:EXQGJCHN]N$G[EE07\]T?^"JM'=#9NX<8
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M-8LHR:490=N$8]$ZKII+FEQT/J>U)ZW[EZ?MEIX\$28#HMUO'P<U5GC+^/\
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M8/+-73D3/9AM 9K/LZF\D5!,+VP5>3$1]1#@7U4R*X$O^ . . . . . . .
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MXD?L=:[-X2_LA?'SJDKJ--CKDU$3G2*#ZGRDNRLS QU4CE*"S1,1$H@'GP/
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MLUUT'I54UC@.,/@X-C\4>1<R0W/504=:DSU8S4NEVLL<C(LJM'U0M-;, ?\
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MP/,?<MSM3=NXG&:XIZ,W#%RL;.QXY6'<A=QIJL91:E%KR:T.U^_07_SU$_\
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M#@#@#@#@#@#@' F*7QY, >?P\B >?XO/ .> . >('*/CP8/C^'Q_P_7P#RX
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M6^BY":C2$I*5QQD^F,Y*-J#?QW;D(1JWIN$VV9N4 $DU(//(>0&-JEOE2F\
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M5SVK])9QSJGYQTIE%92AO]1:Q*V5Y%#V,N<Q1F1).\.ZM-5J/L<=5F!I)O\
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M>3(>T7W$JJXZ>=).Q>@TJT.]*[J9MD=@H.%X[$+7FW3]]T/(D]=GJK4$I1U
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MN1=&XS@I0DM8R:U,RG\8J,&VL$I3$?<%@W\)2JI=6JU1[(:]>23:MG=R4?\
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M>\K<EIHKW0[+='5*-UMZT- ^\SUIR+W,>G<_CE,WW)>O6\'=5][4-#UT7U!
MT0TDDWEDR^RSLA&QUN:TJUE\&=H-D729G;5!4[5;T>.?HZW@;A*"F[,VZ*JC
M[]'S58U6CTJ9)]W=LJD,C-L6)RX*]+T)<*\+J@].>AV'M5]*MOZC],,9ZY17
MN6P.DV>BQL\#B-J=?RG5LMAUYFSS$^6O4E[.1L7JDA58-.3(V1!U*M@$"&%%
MNS3,1!+XNXV19=+UN<'YQ:_%&1P=YV?<H*6VY>-D1X5MW83J_#W9/@6*6.J]
M]HJ"F_R;N/66VS@1D@:$;WCKWH59;GD@9+?;T'LG5]_?E005? 0#JE9'$A!$
M03.( 4> RA1'[)UF_P"L&'MG:TW?.!H-\KD;H3*&K[#<M9@Z1*U^]-Q=/+<Q
MRYWB.::XS6SY*'>1XD;/$6;(AE4CL3G$SH ^I0E#IZDU5555Q7BO(X+.1:ON
MXK4X3=N;A+I:?3-)-QE3A))IT>M&GP:/HD_/_8F,;%4G>O=>EW7D1,WS/;8B
MQ)^GT@8OH7T>E8YZCG_#P)"@!OT^/CSYUYG-RJ8>Z[)ZK&']4MT=[4HLDP.+
MF5BIKJ39FJ($^(&3BZ_VE?VYZ"GC]D$(M0_Q^)2\ ]1OW4H: @G:<@[=T]T*
M(.!:NNGO8RZD(F/GP4\MD>=Z- %5_63ZL3 'Q$  0$0Y%879S_K&_1;K!VZR
M#J#9:SV!L=LU)Q0&\K<(W+7-3K69#I-C-6Z\-R@M1?T31SJM%"E>R";*$<F;
ML%"BE]0X]38M2TJ1R55'FR_\IO)2C^L '\!_3R%H<^?X_P"0?]S@M!Y_P\#P
M0UQI&0Y'K[&-C=<R_.]0C8=TJ^B(_1:37+LQBWRZ/TZSV/:62,DV[)TJA^P9
M1,I3&)\!'Q\.31\2ZG,+CN25J5CYVN9?GE?FXBI,*!%3,)3*Y%2L90XHGRXR
MDQ\BPC4';*HQR8>E"-3.5FB7X$3 .4A[U9S'-Z4Y*]IM I=2>$KT/42.ZS5X
M2!<DJ=>6?.*_5R+Q3%HJ6NP3B3<J,V0#],U.X5,F0HJ'\RB%6SU6>1Y5'HP+
M=AFM!8MZLUL;&L(-*?7FR-<97#U_FUG I(QQ"1#6T?,-]Q3;@F1]ZA^<!_(\
MI:G61.$XE QS&'@L?R^$B8R#LE8C8N(H-5C8Z.K5R60<V^O,63.)1;-(.U.&
MJ:DDT3*5N^.F4RQ#B4! 0Y4PK$E4!;*X_EZC87L;)"W4H-5.@,C"U <^AWXI
M&BA(+V)H1AA&JOCYC>($69!*V'Y? /8J&*XYGSQK(4+*,VI+]BV79LGM1HU8
MK;MHT=,(6+=-6SB'BV:J#9Q&5N.;J$((%.@P;)B D02 H&S> . . . . 0J]
MPS';OO'4C3\WSVMQ]WLSV4RNU)Y]+2,;$QFFPF:[%0-+MV5O7\V4T$@AJ%1J
M#ZOC]P],>;[D!71BMQ4, $3.EG3CLE0>F\=G"VNWOI-<IGL9V'V]M4\@A>NN
MB.Z!G>NZS?[K3\4=DTO,M>S)JUKL79FB[@8!LD1!\D**#HS?U@K"^PC?[?75
MWLY+G[M!%^XSV>H7V_W!NR49(?:,=Z/O1N<FT+2S.K[*?FWJA.BUE[$"I?G(
MQGT40F")?IVJ/D_JH:H6&_U0^V/]ZQVU_P A_MY?ZF?)J0?U1.V/]ZOVU_R(
M>WE_J9<:CZ?34Z2R]5^W$+7IR7;>ZGVR6<1D/)R""2N'^WJ*2JS)BNY234!/
MIF4XD.=( $"B B _ ?/&H-,]3L<[I[SU=ZW;=</="[10-MV/ L<U6TP<+A7M
M_MXB%L6AYW7+=-Q,4VD^GCV3;QT=)RZJ*!'*RRY$B%*H<YP$PM02!_JB=L?T
M>ZOVU_R(>WE_J9#R@?U1.V7]ZOVU_P B/MY?ZF/)]H^PAMWTIW>;JQURDM@S
M_P!S7LS:K,RU/KO1TH:Q8-T'>1:D1KG87+\FL[XZ$)U"BY 7D/6;L\>-3 L"
M2;E!,ZI5$BG3,*M63')U%[8F#S_:K]M?/X?^1#V\A^/@!_\ 0R#S^/!#R_JA
M]LO[UCMK_D/]O+_4SY2G']43ME_>K]M/\B'MY?ZF7("-&EY9W9I?9'K#CD7[
MGW:![6-L:;@O:YEUA'0(\I"'S*GP5A@2Q*[?I\BP;A*/)11-Q]0DOZR$ $_0
M8!'C6GF0DS_5#[8_WK';;_(A[>/^IEQJ!_5$[8_WK';7_(?[>7^IGQJ!_5$[
M8_WJ_;7_ "(>WE_J9\:@C=7<F[KS';;6\#<>Y_VA1IU Z^X'K$//IX3T!+,O
M[)JFB=C:C8XAZY/T]/%JQD5&9!%K-B)()KD5>+BJ<Y3HE3H)(_U1.V/]ZOVU
M_P B'MY?ZF7 /'^J)VR_O5^VG^1#V\O]3+DU\_N!S_5$[8_WJ_;7_(A[>7^I
MEP/I]-2)733/^\78O-=$N5V]SCLW792H=H>VF(QK.#P?H,T:/*I@G8[2\?IL
MVY3ENH$@X/+SU7IK1X]43.5LJ[64.@DDB)$RT$M?ZHG;']/NK]M?\B'MY?ZF
M0<@.?ZHG;'^]8[:_Y$/;R_U,N-0:<[$8-W,R+ -RU>M>Z/VGE[#F./:7H4!%
M2>%^WXO'2<U3*7-6.*CY!%ATY:O5F3U]&II*D1535,0P@0Q3" @U*3^ZS6ZS
M:!UQP&^75X,A<;KBN66RV/S,FD:9]9;%1H*7G7AHZ/;,V# 7,H\5.*"**227
MGTD(4H  4AN_@#@#@#@#@#@#@#@#@#@#@#@#@#@$1N^W7BP=LNFG9'KA4YR+
MK=IV#*+33JW,SJ;E6!:3[YD96&)/D9%4>?E]Y(H)(/Q1(HJ#1502$.8 *($(
ML7]O;<;7BW8F,W3:='ZI:?V8[D6+M=,EZ([$>!D* S<YIG.4Q>;M=,MF;">S
M0\K'9PE+2@A!LP.]=%3(/A#YBK\0B#?3KVG+K,Z7W\:S?N#^[-F+:O\ <Y_#
M5Z<KG8F#J#[88,G7/KL])J%KD9/%G+>]6)>1>.(8TPS*BU.UAT6WH^:V5.86
MNKX4_D1.?^Q[E/[V+WD/]+^F_P"8ODU%1_8]RG][#[R'^E_3?\Q?&HJCT)7V
MA)MG%R3MK[KOO'K.FK!XY;(F[>5!0%5T&ZBJ*8II8:510#J% /!1 P^? ?'C
M45(M]$_;:V[?.H>![%N_N:>\-1-?T"A,9^_U!EV<BZBV@+ NZ>).&"-;M&-2
MD_#D(DB0?DNEU%0\^1'P(<:E;2>G EG_ &/DI_>P^\A_I?TW_,7QJ*HY_L?)
M3^]B]Y#_ $OZ;_F+XU)7V$)_<2]N[?\ K=U U+9>NWN5^\)HNOU25R=I5J@^
M[*LKJVE6MOV;/:3:U%*U4<=B9^0&)IECD'I3(."%;G;@LKZD4U"&:\RU3T)K
M%]GV4,4!'W8?>0 1$?@';ZG> \"(?#SA@C^C@E?8<_V/<G_>Q>\A_I?TW_,7
MQJ*C^Q\E/[V'WD/]+^F_YBQXU%2)6P>V]M=+[-]1,LJ'N:^\),9GL;S=T-=L
MRW9V,DW-02H&<-K+1#-9Z.QMM"UL9VQJ&;G&00< [ /E(@10!-P*_B2T#V?)
M40 ?[6'WC_B #_\ B_IOZO\ S%\:EJCG^Q\E/[V'WD/]+^F_YB^-14X'V>Y/
M\1]V#WC_ " #X_\ [OJ:/Z/C_P#T+XU%?L(>Y_[<NZ6+NSV4PRP>YC[PK#$L
MQQ'K+><TO"79B/9.K->-0G][C].@U[6[QQ:LSR5:84" .FT9-T7+#ZTQG!E
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M=<F+>,P>1_=Q5OK<DCV:R+IDTH3C[;\VN(LWK<CE$&XD^4Z+\\GA41.($F
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M.FJ[AXNJ8Y4@\RZ /@ !^H X(<\ < < < < < < < < < < < < < < < <
M< < < < < < < < < < < < < < CMVB[(TKJMD[_5KPFY>,$)J @(Z'CSIE
MDYJ3FY%-$S2-*I\%7#&(2=OSD_$6[-3Q\?'-I[.[4W#O/>X[+MS4;CMSG*4O
MAA&$:UEX*4NF"_G21KW='<F%VKM,MVSDY6U.,5%?%)R?"/BU'JFUX19E6DU"
MO]A<(OU&86$J%9W#)[34FEMB$T) 4H#2*B^AT+!&$4,1![\J.F0<(%,8I%/
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MAVHTA%RE/IC6J2E-RE15HDW2*I%4226<<QQWAP#@0 ?Q !_CX!SP#@  /P
M_B#@''I+_-+^O\ X!Y< < < < < < < < < < < < < < < < < < < < <
M< < < < < < < < < X$/(?CXX!4&UZ_94'NV.93[!(_<T>LZV\)2(W"["]#
M4@U:(J'Y@%Q^8_FG8&JSQ6.-$B(PYF9Q2%J)/V>>YS[GWK_T05GU8>D]W6'T
M^E9I^G_32N]%/3^+U$I^K_6]2ZNNIX_'8=J_]7W/TY]2VO\ 5U]2[7U_U"M=
M=>OX?3;AZ?\ 5].G10M\ /  'X^  /Y _P!CGAA[ <\ < X  #\  //Z@\<
M> '\0 > <^ _5P   'X!X_BX X X X X X X X X X X X X X X X X X X
M X X X X X X X X X X!6_[E(?_ ,)]31_5WPZU_P#[TL//6/E+_ON]_P#E
MK/\ \FV>9?,[_==F_P#,6#_E3+(.>3GIHX X X X X X X X X X X X X X
M X X X X X X X X X X X X X X X X X X X X X X X X!6S[MW_X$-:_
M_;F5?_>K3>>L_)#_ -R,+_5Y/_RUT\W^;7_^#R_]9C__ #-HLD)_B$_[TO\
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@:E2IP+3.0#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>tm2030088d18-lc_increabwlr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d18-lc_increabwlr.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!R@.0 P$1  (1 0,1 ?_$ ,   0$  @(# 0$!
M       (!PD%!@,$"@(!"P$! 0$! 0                (! P00   & @$!
M P,-"P@(! 0$!P$" P0%!@ '"!$A$@D3%!8Q(M/4%565U9:V5Q@90916UA<W
M=[<X6'A1TB.35#9VEV&1,D)29]<*<8$SM:$D)29B<S0G@K)#4[-&*!$! 0 "
M @$$ @$$ 00" P$!  $1 C$242%!<3)A@1.1(D(#L?"AP=%B<E*"0^$C_]H
M# ,!  (1 Q$ /P#[^,!@,!@11S\Y9-.'7':R;.;),7UT?N&U9UW#R!#*M)"U
M28F%)5V@FNW558Q3%-9TJ!3=1!("CV".5IKVOKPS:XGY9NX[;JKO(C2FN-QU
MA0GN?>:Q&2SEF!RG4AYD[9,DY!N1*(AYS#2Q5FY_N"*?4.P0S+,7!+F99IS&
MF P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&!\S7C::.Y6;1L4
MGM4(!@CQDT)58]:+>GM,01R\DK(>'1LT\%=(N,B9T$JZ08E\H7O>0; <O0IA
MSKI9)CW1MG/X5AX.^D.6G'>IVJF[EK<>EIVZ1L#L#6\DTML-+*PDM)MA6E&8
MQ354SQNWL$>[:K&]4$UVYNH!WQ$<WNM^37/Z;M<YK,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@," /%,_8 Y+?X.A_GI6,K7[1FW"M]-_FAU
M5^C>C?-B+S-OM?DG#)&8TP& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MFUOXAG+M;5=^CB<IWVPX2Y17&B<OF_TJ["(#Q)G]M2KN.V?4VY^X:.20J2*
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M\F@@1-(G?.(B/0 ZB/7+VXGPS7W^5DY"C U9^(SX7=/\01BP>O=S[3T_=(:
M95:*F*=,.5*^, %T@;A,,Y.KE>1Z+Y:35@4DP6!=,Z1BE.'7N]!O7;$PRS/J
MZ/L#PG&=_P!S1%KD-\V,-,.I35]SV1JIS5F;ZQ[ V1J2H2-.K5E<[(-+HNXY
MF]:/2.G[<&*QW#M+O^5#O#TW^3'MZLZLF<,?#J<\5=H3&RK%NJ0VLI%ZRC]%
MZDACU!I4VU"T_#6J8MD7#2B[:9EC6FR>>S!DUY Q&I5$DDP!(H@/7-M\S!)A
MW/GMJ37%]8:(F+E6&\V_3Y ZIJ/G*CV4:*&K=BFW24S#J P>M2J,Y !#R@&
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M)8I=V5C&HIPT0V9RZ+0SD>BIU"$43+Z[R8E[0WJ94US!\:W<^B^>$OP*XY<
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M?X_Z,[-FO"'E6?EMI=W?IJH)Z]O5/OM[U7LVEH2Q)Z/KUZUY/NX"=1B)PB2
M2T*X4; LV7%-,QTS]I0$,C:8JI<N$X:S\%:K#RXGZS+L)Z$?<H+2FTE8QPFZ
M9+K,:E3F3]%-9(QBBHR?(*(J!ZI5"" ]!#-W]OAFOO\ *X,A31=X\'#[?_,;
M2G%ZJ\?*6G=Y[77,'4>TK6Q4DXV,+'TNL.G2LS*=Z3703<^;$.']$01.81[
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M3G%^MP<H6X7G4FX[Q=-MV"V(P*PM;5,M9J&9,[%/6JR))GDW2Y^^!53F+TZ
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M29_=*Y7?(:H?C[C^/\P[7Q76;ISIEJ=4K':C\.N7LL6OP[^6&,B]>UAY(/\
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M9[%V!H7=UJY"MI]LS;:SE=.ZVFZ?8:/ U,S;TB%>;EW*(Q9D3"B5@JJ"IB'
M._4WD]?">MX9U\-/B7R7U3O9Y<MX:VKFLZ]ICCI"<4ZE(1%G:6%QN?T<V#8K
M>&TTT&3=(T5#OF$PDFDD[$'8+@J!DRE IU)WVEC9+G-7'S7A[(N\XW3;.V*L
M:S'<EM/MIFG!#QKAO/O'<\X*PD%)E8@R<>>,-V@FB($4_P![,T]_ANWE=F0H
MP.F6+7&O+>[3?VRATRT/D4P11>V*KP<T[21 >H))N9)BY6(F _[H& ,V6SBF
M(Y=]6:W*0HUN3K\'(UTR*;<T ^B6#N%,@B)3(H#%N&ZC$44C% 2E\GW2B =
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MO+HS[>2AHU^A.-T46Z$NB[9HN$Y))!N=1!!-Z10% (0PE*!N@"/3(O*G.X#
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MKG-36YAQ]V9*+RJ*\>J^U'LN2.+9&XQ2;I1/T%E%' F2].ZPU[@%*591219
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M!<#KMX"XA7#("Z8QHH-2M/(#Y/H!>D[XQ^6Z\MG7-B6N3>5XT1#&HL9"C/\
MDGJ-Q9+>I9",Y""DFTZY]R8]I6QC5E)9.14'UZP.4@1 .G=-UZY.F/7SANW_
M &7ED*,!@,!@,!@,!@,!@,!@,#CI:49P<8_F)$ZJ;&-:K/'9T&SEXL5! @J*
M"DU9I+NG!P*'85,AC#]P,<E]/5BZG[_T]>JC.7VNWJ(4IU:>R<;/6*5!U7HV
M+?0O?+,-G:\^WC 35BE4CIN Z?T2I#$-T, AE77:>GNSM+ZL32W*PME.W9<=
MM;6C?BL@W[[.XP8E@M0MU#'62+Y]LF0;JQSHB9T1[X1Z3T_W.@=HAO3'KM<,
M[>/5YTM.;LV2H*^[=Q+Q-8>D3<+:LTVV<TUHB99(HJ1<MLA-WZ:S+5L(F(/F
MQX\JQO7] Z% ';6?6>IBWED.,TWK+4]'NJ% I\7 *R-?G5Y63(#A_.S+D8QX
M)G<U8)-=[-2[LXG$14<+J''KZN9VMOJW$D]$[<?]%TO87%_C;:BIN:ELN-T=
MKIO7MGU94\9;H84:RP.V15<H'21GH<BINJD<_*X9+!V&3Z]#!5VLVL]F22S\
MLDP.YKCJZ6"D\DT&S1J5-N$#ON*C3Q>M[4HNHFW(PLC<AW:.O+'Y<W8DY7%B
MN40%);O=29EUFWKI_0S9Z;*L171<I)KMUDET%2@=)9%0BJ2A#!U*=-0@F(<H
MAZ@@(AD*>7 8# 8$>\W?S15;]//'W];E4R].?TG?C]K"R%& P& P& P& P&!
M 'BF?L <EO\ !T/\]*QE:_:,VX5OIO\ -#JK]&]&^;$7F;?:_).&2,QI@,!@
M,!@,"->*?]^.8?\ $[/_ #)I.7OQ/A.OO\K*R%& P& P&!*.S=A26V%K'H[2
MCI)Y-."+0&RM@]UT-=UG"2")VLD1L[0\@G/7=PBH9-M'MW"8HCWU554_) 4]
MR8_NV3;GTC ?'3PD^#_%-A:6>B=:2^O%KO)#*VZ3JMZN5=DK$[%%-,AI9Q!3
M4<#TJ"Q3K) <!%-54XE$.\.9WOM@ZSW9QDN(<*=<HU?=O)*BL03*52*K>Y[6
MHS77#KWGBIYUS,O!<*!V#T5 O9V &;WOB?T.OYKAS<:=X1R@K5SF;MM,&1O*
MPK"UUJDVJ/*+<>^R;6!4T?&3$\S$Q2E<CYT@NN3O?TA3#W@=M??6'6^7HR59
MY^4Z.D)B$VMH?=LJ1B[3CZ5-ZMFM-L5WID#F:NE+?&WG82Z?DURE**0L.Z8#
MB83AW>@LZ7F8/[D><"=2>)1LE]?)/Q6T=:NHR%M3Z6U%2-5V]20IDDS?SDHL
M9GL&J%A&C2?1K39HQ-#K.'*@"DH;RK<JG7-[23TQDQF^N<-SJ""#5!%LV12;
MMFZ2:#=N@F1)!!!(@)I(HI)@5-))),H%*4H !0#H&<U/+@,!@,!@,!@,!@,!
M@,!@,",^!WE?R"J^6Z^6_*IN/RO7IU\K^4BQ>4Z]WLZ]_KZG9E_[/M^DZ\+,
MR%&!P3BK5EVR+&NZ[!.HXKLS\K!Q$1ZS(KXRAEC/2M5&YD =F5,)A4[O?$PB
M/7KC-'F7@()R^8RCF$B'$G%D%.-D5XUFJ^CDQ#H)&+M1$SAH00#U$S%#&1BO
MDCY/ZONZ_+=/)?DMO/?Z]>G=]')#_A[<W7[3Y9>'L<=?V?=%?H<UC\R83-W^
MU^37ZSX9CR6F P& P,+;]V2]UEKI_(5]D:7O=F>M*/K2"()BJ3=_LI'#: :]
MXI#]ULR\DJ^<F'H!&C14PB'3J%:S-]>&6XCVM'ZK;:CH,=7EG03-J?F-.7^V
MK%$TE<KK)%(K.6&3<'$RRZSEP'=3 P]$T"$(4  H!C:]K^"3$9?R6L ;'T6T
MGI,+YK26)J_;314'*-LAVBA(JT&!5(ZL9LJOQ[F.0O$6N@51,@NS'79F5%5
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M[IP$!*(@/7)NMG+9962\QI@,"/>;OYHJM^GGC[^MRJ9>G/Z3OQ^UA9"C 8#
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M?W<T9_%+HWYPN,O3W^$[<+!R%& P& P& P& P& P& P& P& P& P& P& P&
MP&!'O-W\T56_3SQ]_6Y5,O3G])WX_:PLA1@,!@,!@:OT=JZUU=XC^_W6Q[W5
M:,VEN.&D&\8O:9MA"I/UV]DNZBZ+11\LB5=1),X&,!>H@ YTQ;I,)SC9QW G
MEIJ(..4"EL_?]-&Z'O>V_.27"^1YY\S!3:5M& !7W4?F>"V-#&;^; /K?(=S
MN]G3&^MM])Z,UN)ZMI;==%T@BZ;*IKMW**:[==(P'2616(51)5,Y>I3IJ$,
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M8TP,>WG;>J]8N*^TV1LJAT!U;'QHRKM[I;H"L+6*1**0&8PB4T_9'DW1!7(
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MIC^3?R=8?48XN?1L[_S"V?\ CIC^3?R=8ZHEX>O&E.\O;@-9L"D>[J4=625
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MI%#*!I2HB8_7J!@E#IAU$!'NI'DC)$[0^X =,?R;^3KKX?U7A1Q65 "GTG4
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M''B%TR\;%X.\K*+K6F%V'?+7HK8\'5*2+]Q&FLDW(5F008Q:3ELL@J+ARN<
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M79.N8F9SZMHF0HP/6>@Y%F[!FJB@\%LN#1=R05&Z+D4C^0573*8ACHIJ]!,
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M&;<*WTW^:'57Z-Z-\V(O,V^U^2<,D9C3 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# QIMC36JM[5%>A[BU_5MD4]PZ
M;OU*_;8EM+,"/V@F%J^;D<$$[1Z@"A@*LD8B@%,8O7H80'9;/6&,NR4RE5'7
M=8AZ70ZU"5"I5]FG'PE<KL<UBH>+9I!T(@S8LTTD$2?='H'4QA$1$1$1S+<\
MCL^ P.B;$UCKW;=>)5-F4^!N];3EHB=)"V)BE(1Y9B!?(R<-(E05 2@ZC9!
MBR1O5*<H#FRV<%F7>$TR(III)$*FDD0J:9"AT*0A"@4A"A]PI2AT#,'[P&!+
M&V^$?$W?%Y;;,W!H:@7_ &"SC6D.TN$]&K+3[:)8K X:1J$B@Y0728HN"@H"
M0"!!. &$!'MRIMM/2,Q%/,V;6.9M(]D@FV9,6R#-HV2#NI-VK9(J+=!,.WHF
MDD0"@'\@9+7LX# Q/?-$:6VB[A)#8NJZ%=)"N66*N,&_L-7B))]&VB#*H2(G
M&SQPU,Y!_'E4$$S"8>[V=G8'39;.&8C*X !0 I0 I2@ %*     !T   .P
M,QK^X# GV4XH\;)K;T=OR5TCKA]N6*53<L=BKUB/-947J*!FJ$B9X"0 XE&[
M8PIINE"G<)DZ 4X  =-[7&/9F%!9C3 Q5N;1VHN0]%?:RWAKVL[/U_)NF;V1
MJ%NCRRD$^<QZ@K,E7;%0P)./-U1[Q2FZE[W0>G8&;+9PRS+&D-PKXGP&M[#J
M",T!K,NM+6=^>PU![76TM%2AI-!!L_\ . EO/7( Y1;$ P$4*'K>H=!$1'>^
MWDQ%%P<%#5F'C:_7HMA"0<.R;QT5$QC5%E'Q[%HD5!LU:-4"D21112(!2E*
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MZ7#WN@=/NAF]9YAVOBO)^62W_N_;<_U4?\<,SK/,.U\5^3[EN(%$2<?-N',
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MR%F P& P& P& P& P& P& P& P& P& P& P& P&!''.01#3E; !$ -O+0X&
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M  _;/\OTKC(:8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M@V7IFO\ )>3TS3M6ZCTML6;846!@Y]E*6.:8HA,Q\0YGF1W!(24<BY.?R@G
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M8E$QMFVOO)DZWVOHM+C!4]VT70.JJCR-V!#;2W97JA%1>Q+] 0ZT%%V:P-$
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MDP( \4S]@#DM_@Z'^>E8RM?M&;<*WTW^:'57Z-Z-\V(O,V^U^2<,D9C3 8#
M8# 8$@<Q_P"[>DOXH-!?/R/R].;\5&_$^5?Y"S 8# 8# 8# 8# 8# 8# 8#
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MB_\ "=N/VL/(48# G*/Y9\?Y;>MQXWQFQ(I_MS7M!)LR\5YJ1RLVJM2.^68
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M3&DJSI"/O,=6'TL^2OVS;EM.6/+JMU3MYRZO4WTBT9>;MVX$CFZB8 D4W>.
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M!@]7)QXX;G^K%^R>0+BA<A-):02K*,FVVW2-T6]S8321FRL(;5,76Y%LS18
MV5(]+-#.&(<XJ)^1\F @!NHAFS7,R6XN'H\5.2;?D/H&$WA8(B-U^A)2-F8/
MF+B:3<1T>6O3[Z%!<\J\28D C@K0#CWBE[HFZ=N-M<7$)<S-4"TNE/?Q))YE
M:ZV[@U%TVI)EM.1BT6=RJ<$TFQ9!-R9J*ZAS !2=_O"(@ !F8K<QRYY.-3?H
MQ2D@Q3E'*!W3>-.[0(_7;)B)5'"+,R@.%4$S%$#'*42@(=HY@P[LG9MIKM@U
MC$T"L0%Y9V78R51V$\6ND'"+T2#-#R#Y:719/'1%YJ53>(H$!@B!G IJ";N=
M [P5)F>K+?#(TA>J3$'23E;A5HTZ[Q6.1(_GXIH95^@( NR3*X=IB=VB(@!T
MP]>41[0#,Q3,<A-V2NUEB63L<]#0$:=5-$DA-2;*,9'66ZBDD1T]601,JJ #
MW2@;J(!V9F&O/'S4/+"L6*EHR3,V\EYP$>_:O10\X3!9#RP-E5!2\LB8#D[W
M3O%'J'4,#!7)3D_JCBQ0U+ML^;\T4? ]:5"LL6[I_8KM8&S8%TH&OQS)!RX7
M<JF.0%%1*"+<A^^H8I<K76[7T9;ABJ-YHU]OPHJ_,&V5Q>,2M5'B['%46-<F
M>OY*RV)<S&LTR.>'0*!W\S**(MBJG(4A3'$P]@9O7^[K&9],NOZ=Y:[;DMQ5
M+3')/09-&3^UJS.VO4$C'WB(N\3925ILA)6"J2CF+#NQ=LB(AR#DZ0B!%4R&
M$H!V *ZS&=;F$MSBL1VWQ$]AMU]I;&USQQ?W[C'HV[3%(V5M5&XQ<?87"]9D
M?<RV3U,IRQ!=S<%6UP$RQQ,!U$^I@[H%-TWI.+?5G:^T]&SNJV6&N=8KMPKK
MQ.1K]J@XFQPC]+KY-[$S3%"2CG1.\ & J[1R0W00 0Z]O;G.S%Q5N>P-<^R>
M?+76?.W7/#Z;I3<D#?JO#2A=CGEURGCY^QA9B04*>)*P.AY-^[KWDBJ&7*(F
M4[ $>S+FF=>R>WKAY/$$Y[,>$4'K91E3F^P+9L6RKQS>NK2KB((PKK!N 25A
M7=(,7W1-"1=M&Y2F H&,MZO7IU::]C:X;$$C^4224Z=/*)D/T]7IWR@;IU^[
MTZY"GDP& P& P& P& P& P& P&! 'BF?L <EO\'0_P ]*QE:_:,VX5OIO\T.
MJOT;T;YL1>9M]K\DX9(S&F P& P& P) YC_W;TE_%!H+Y^1^7IS?BHWXGRK_
M "%F P& P& P& P& P& P,1;.W!#:Z,QA&D5,738-@;.UJIKVKMR.I^;\T A
M5GBZBRB$?"0;158@.'SQ5%!,#= $QQ @U-;?7B,MQ\NGZWU)//)UKMO=;YK9
M-GKQP(Q,$W00"H:K8/!,Y7@*FU[SCSN3(97R3N75.=R[!,H%[B8  KM_CK]6
M27F\J-R5& P& P& P& P& P(WYR_F=K7Z<]#_K0KF7IS?BIWX_:R,A1@,!@,
M!@19Q"_O1S _BPOO_L-4R]^)\)U]_E:>0HP&!PEDKD);X"7K%DCF\M!3L>YC
M)2.=$ Z#IF[2,BLF8![2CW3=2F#H8I@ 0$! !S9<7,Y.4PZPL\QI.TPO'C8K
ME5S6AC&K'1^S9$R@!;&+4X-4->6-V<ZJ7I_ L@("2AQ1"5:@!TP,N14,JR;3
MMK^TSTN*KG(48# 8# 8# 8# U)>*=XHI_#5C=(2+?1=@WTKN/8+.@&A*9-"C
M8ZNK(@8K*P/H5")E';B 4<E!N98H%Z.%"$#J)@RIKF9]66J:B=N\L=FUAA(T
M'0=:U>]?,8]Z$KN^U%?QYBNFA%U095FA/3SBQ"K") %TX8* '=,)!ZB ;UTG
M-S\,SM>(_9N,6P=D&0=\A=]W2SLS&!TOKK6*AM6T%%P9051:+NX18;G/QZ)#
MF0[CN0!-9+_U"&-VX[2?6&+>:SW2-':AUP1(*5KFHP*Z2B*X2#6%9'ECN6Y3
M$2=+2SA):26=D*80\H943]OJYEVVO-;))PESEO>Z94]Y<(T;-:X"O+CN:SO@
M2EY=E'*&8GU=<8T'($=+)&%N=\Z30[WJ"H<"^J(!FZRV7#+S%%[-T#K/;0IR
MLU&.(JU(H%")O]0D758NL6)>AVRS.Q0ZC9ZJFF;H/DEC*HG+U*8HE,(#DVNO
MI[-NLOK[L6-%N3>DDEFL@T#DY0V8(&:RS)2&J^ZV2!S"1PG(QSA:)IMM08IE
M*8AFYF;U0!-U*H;H&;_9M^+_ -F?W3\QG#7&YM;[7;KFI=G8R$DP* 35<<">
M/L]?<@8R:[.;K[XK>4CUVS@ADS"=/R8G*/=,8.@CEUNO+99>'(R6UM9P]K:4
M25O]0CKH^%N#*J/+!&-["Z%WU\U!")4<E?*BXZ>LZ$'O?<S,7GV,QW_,:8#
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M*+XGSM=Z35NDCZRXXV%JU(X\T.-TH%@G]A* U43\[%PQMEP:H]_N& 2JD[1
M"F#>LQU\F;G+)5;HTO6]<^'!>[6U,A>=^<YY;>UP44$HJJOM@0,^]BD^SUQ$
M6U=1:$(01'NCWNG0![H+>9[2$]OEEC6/%_1^U*7XE%\V+0H:X6E';N^XZ&EY
MD@NW=9;P58"58GKIS*&]QG02:GESJ) 10Y@+WNI>G7+;+)[-QRQKQV85+=O(
M+B/5>4:C.VTQOP#@K#JN O:PNJQ9MD*2T5'6=^NWD2"RDK)'5HKKND4.)RII
MB<.HD+T7,UO7RR8M]51^&)7M8U;=W/J#TTX9.=9QFY:XRJHQCHKV,;MD*^KY
M\PBW13*%7BXV5.NW;& YRBBD7NCTZ",_[,XF>5:^[:'L^N0$K5YV;DX6+D)B
MNU*XF@9-XQ;N7T,>2@ETGYXQRLF=5D=XDW(50R8E$Q2@ ]@9$MX;>&DZQMG"
M7A.<(;0J4WHW0KEQLNMU7[QRH,*G!W]HO*R3TI $3LF)1*=4.@@)?5SK_P#T
MOPC_ !5SRKE8W8G+'P]:K19J/EYQK9=O;->$BW*#OS*A?DBDXQ":=*HF.5M&
M2S^1210.(@"Y@$I>N3KZ:VUM];,);XYW2IZ_\,#E?7+A,1T5/:\M7)>GW.&>
M+IIR3*SR=@F&,:P<,R@*QGD\Y>)>;@0IO*BH'3KV]-OKO*3ZMHW"B"F*QQ#X
MT0-@:K,9F,TCK=O(LW'_ *[1QZ+1IS-U^HB(+(E.!3 /:!@$![<C;[56O#4W
M#[@OZ?AT2UJ_*3:"W >;SBIHSZEHD0L Q1N1;-D>NIOSO ?>9>X!S)^:@;N>
M:#T[O<SIB=_QASS>O_7A^>:NL)#<7*7E6M2O)/KKKCB#HW<6O7C)9-15&UZR
MVO<9U(6"Z1Q*+E9HU<MNZ B)A4$O01[,:W&L^6WUO_7X3WRDNT7S!U!O?F*S
M*HI5JS2M Z4H)%$U44V$_,V>IWW;8MDW!2K$<,Y\6T>*I>A5$T3%ZF#MRM9U
MLU9?7U?4"U__ $K;_P#(1_\ \9<\[I.'GPTP& P& P& P& P& P& P( \4S]
M@#DM_@Z'^>E8RM?M&;<*WTW^:'57Z-Z-\V(O,V^U^2<,D9C3 8# 8# 8$@<Q
M_P"[>DOXH-!?/R/R].;\5&_$^5?Y"S 8# 8# 8# 8# 8# FZZ;JE)>V2&H]'
M,XNT;,C3$"U34V21+0=9LSI@H=S9Y%@B8TG8% .0K6':G\X4.?OK&11*8PU-
M?3MMPFWVG+MFI],06L@E)YPY5M&R[<1FOL#8DH0ONQ9Y!N4Y@32( F)%0+)5
M8Y63!$?)-D>Z7J<P"<6VV?ALF/EF7):8# 8# 8# 8# 8# 8$><X?)?D:@?*=
M>_\ ENT-Y#IU_P#5_*O5NO7IV=/(]_U>S_SR].;\7_A.W'[6'D*,!@,!@,"+
M.(7]Z.8'\6%]_P#8:IE[\3X3K[_*T\A1@,!@=)V-0H+9M,GZ384U/<^<8K-R
M/&PE)(1#\"B:.G(AP("9G,0SP".&JQ>ADEDRF#U,V6ZW,99F88;U)L&TU^UC
MQ_VVJ1[>H.MIS-3OR!3HQ&U*FV639&DO).![\==(DRA$I1B!U@.8IG21O(J
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MY]ZD9ZRKL579A]P@WBPCD*_'-XSSM_&OXA&NI*)L$DO+J-7)R D(@8P=G3U
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M.8'\6%]_]AJF7OQ/A.OO\K3R%& P& P& P& P& P& P& P& P& P& P& P&
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M%\+Q_MC&*9AZ45G\(H+X7C_;&,4S#THK/X107PO'^V,8IF'I16?PB@OA>/\
M;&,4S#THK/X107PO'^V,8IF'I16?PB@OA>/]L8Q3,/2BL_A%!?"\?[8QBF8>
ME%9_"*"^%X_VQC%,P]**S^$4%\+Q_MC&*9AZ45G\(H+X7C_;&,4S#THK/X10
M7PO'^V,8IF'I16?PB@OA>/\ ;&,4S#THK/X107PO'^V,8IF)!YM3<*_U#6T6
M4S$NU@WCH<_D6TDR66,7\J=9)U(DFN90_0QP["@(].WU.N5I+F_%3MQ^UMY"
MS 8# US^)WN+8NFN/E>D-=WP=2'N^YM5:TN.X@C4),VIJ%=K0TAK5?DRO2'B
MV:T!&+F5(X=AYJ@;H=3UH"&5I,UER[#X>&Y-G;>XC5B][,=N[[:XZ1O, QN+
M=G%Q;K:\'4;)+0];NC5HBHTAT'%NC&*2P&(=-JH=3OD$$S .;O)-L1FMS&-]
M$7[>6LY[?SV<X=;W6;[)WC9MB5\S&8TRN)8.8BX-DV*\[^T$01>>7C5!,F'>
M[I1+VCUZYMDN/6>D)F>U4/\ 61VE^YIR&^$=*_\ 5;,ZSS&YOBGUD=I?N:<A
MOA'2O_5;'6>89OBGUD=I?N:<AOA'2O\ U6QUGF&;XKK]9Y;WZW1"4W#<-.2O
MF*SE\U)[I)ZGAG?EHYXNP<]YA+;,9O2)^<-S=PXI@14G0Y!,0P"*Z8]XSM^*
M[!]9':7[FG(;X1TK_P!5L=9YC<WQ3ZR.TOW-.0WPCI7_ *K8ZSS#-\5XEN2^
MST$CK*<-.10D3(<YO)O-,K'[I"&.;NII;4.H8>Z7L  $1'L#M$,=9YC,WQ7%
MU_E=L.S0T?/1?#3DE[GR:'G#7S\=1Q3SR7?.3_YB.DMG-7[0_>(/K54R&Z=O
M3MQTGF&?Q7,_61VE^YIR&^$=*_\ 5;'6>8W-\4^LCM+]S3D-\(Z5_P"JV.L\
MPS?%<!:N7%YI=;G+;8N'G(QI!5R,=S$LZ04U#(K-X]BB9=RLFQCMGNGSHR:1
M!'N))G.;[@#CI+[QF?Q7+,^3FRW[-J^:\-N1!VSUL@[;G,]TPD8Z#E(JR1C)
M*[4(JF8R9P$2F #!Z@@ XZSS#-\5[/UD=I?N:<AOA'2O_5;'6>8W-\4^LCM+
M]S3D-\(Z5_ZK8ZSS#-\5U>V\P[E1XUK+67B!R,9,'LU"U]NJ@;4DB<\K8)%"
M*BD!0CMFNER$</G)"&4,4$TP'O',4H"..F?>,[8]J[1]9':7[FG(;X1TK_U6
MQUGF-S?%/K([2_<TY#?".E?^JV.L\PS?%/K([2_<TY#?".E?^JV.L\PS?%<#
M+<M-@0K^OQK[AIR5\ZLTDK%1?FA-3/T/.T6+J1/Y^Z9;,7;13?S9F?HLY.DD
M8_0@&$Q@ 72>8SM^*Y[ZR.TOW-.0WPCI7_JMCK/,;F^*?61VE^YIR&^$=*_]
M5L=9YAF^*?61VE^YIR&^$=*_]5L=9YAF^*X=WRMV$QEXB$7X:\DO/YPD@=@"
M7Y)'#02QB!'#KSN00V<HQCQ\F</)@NHF*IO6D[P]F.D\QF?Q7,?61VE^YIR&
M^$=*_P#5;'6>8W-\4^LCM+]S3D-\(Z5_ZK8ZSS#-\4^LCM+]S3D-\(Z5_P"J
MV.L\PS?%<#ID^R+MR4V+MFT:;O&IJNYTY1*/%%O;ZEK2$Q-1MMM\R_\ ,VM3
MM%D%-LU9R"/>.L*7KC@ =<7$UQG-RR9MRM;(48# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# @#Q3/V .2W^#H?YZ5C*U
M^T9MPK?3?YH=5?HWHWS8B\S;[7Y)PR1F-,!@,!@?DY"J$.F<.I%"F(</Y2F
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M7*UUNTS&9]<+R8/FLFP923)3RS.1:-GS1;NF)Y5J[1(X;J=PX%.7OI* /00
M0Z]N2U[>!P]AGXFJ0$U9YYV5A!UZ*D)N8?&355*SC(MJJ]?.3)($464!!LB8
MW=(4QAZ=  1S9,W$Y&MS4GBT\5-IZ^W7LE^;8>J('1E7CKY8V^VJ:[J4M.T&
M?9N'53N%38&6=GF8RW':G1CDP$KI98 **1>N5=*SM%O:%W34.16GM>[NH*4P
MC3MEUF-M==2L$<>)FB1DH@5PV+)1BAU%6+L$S!WTCCWR#V& ! 0R;,7%)<QE
MW,:8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M 1[?4 .>US<JDPJK,:8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MF'CK6O:#3$YU&GT>GU-*T23J9LR5:K4+!)V*8>E$CR5G21;)J67DG91$%5W
M**J!_M&'-S;R8CQ0&M==52K+T>K4"E5JE.AD#.J? 56"AJLY-+&.>4,O7XY@
MVB5ADCJ&%P)D1\L)A$_7KC-SGW,1TVB<<>/NKYMU9M;:.U)0K$],<7,[3]=U
M*N3!P5*4JB19&)B6CM)N<"AU3(<J8CV].HCC-O-9B,SYC4#ZHXX6K2?*_?=A
MKD&RG>/O*",;7:W-5GD0BWI&UXT7S*9;&K;QQYQ+Q&P8^3.JLHW1,0JY.ZL'
M=$#9=LNL_P#RB<8OX69"4*BUJJ%HE<I=3K]'(U>,24V$KD/%50C*1.LI(,RU
MU@S0B"M7RCE0RR8(]Q45#"8![P]9S<Y]U8CUDM;:Z0I@:X0H-*1UX5F,<6AI
M5:#3IA8\5!6%B%7(Q"#!F*H][R7D.YWNWIUQFYS[CK6NM":0U"ZD7^JM0ZTU
MR^E@,62?4FDURLO7J)CE4\U<.XB.:.#LB'(!B(=[R)![2E <6V\LQ(\%QX]Z
M'V'96%SOFF-6W*W1@H"QLUFH=9FYU &@F,T)[J2,8X>JI-#G$R1#G,1(XB8H
M /;B;6<4Q*YDVF]0FKLW3S:JUN:I6674L%CJYJ-6!KM@GEG"3M:;FX08OW,E
M9=5V@14SE=)18RA"F$W4 '&:8CMDU6*U8X)U5[#7H.>K+YG[GOJ[-1+"4@GC
M#N GYBZB'S=>/<,_)@!?)'3$G=#ITZ9F;S[M8UUSQTT%J"3?S6K-+ZOUY,28
M&(_EJ;1JY7I-RB8YE!;'?QD<W= T\H<3 B!P2 1$0+US;M;RS$3;IKCQ?'?+
MO>?*[<C%K'R#MJQU3H>MI/V$L>!UC"^54D+0[<L';QNTE;L^5*H+8/)JMDB&
M*IU$X]*MG7K&27.:OC(48# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
3# 8# 8# 8# 8# 8# 8# 8'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>tm2030088d18-tbl_cancerbw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d18-tbl_cancerbw.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ P ,X P$1  (1 0,1 ?_$ *H  0 " P$! 0$!
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MH^R6-%N]?OLGFQL-L.*&QI20Z)T[LK1GEG$'$X $6,CEGF$=0>13@. X#@.
MX#@. X'\5(3QISP)32R%(R3 ISSB<J"B3Q S@HTU.$U.(\LLS.,B!@P&18QT
M\0>O7 <D^VAM?M%L];/<$BE[R"E%L8U$VZG.K,*(J^IIC!'J3$Q)DB<C(G,G
M=)+<]D(\*%:21B3";TJ,D 3"\'8/Z9\K%J/W<MX;PUA1_<FMY':FM;DHU':;
M&D51L:G7&PBR'=NK_7>'7YEOL1:7LW@QT6.PI.8T>>VEMH" D!5^69D>4P;D
MX]SE;?1&T+7O'477^[KH=X,Z3VY*L@]H.9==0QY@T5903B+M$@+8$#/()U8;
MHH]DFK3"\JC''JHQTSY1?3IF7BX12;&Q6\DG[G]VZ11>U-9XW7, U<K/9V,2
M5^UGL:5S 9-D6E/8 &!OIZ#:J(M"WV(FA7G^U"$B7*D2CIZJ7X.H[QFGLS-/
M;W7=>VI^]\Q:X]75=7_I':&QE+KY*8R22Q:*L>4:^-PWS,NB[,&3P.48CDN0
M%A3*6T3R-4Q+A&E"5K,D=3&<X;PJA$>YON/7G;:U8[FMX$Z[6I7=UE:YJK.I
MFL:RL&H)W"&?8";,,""Z5Q,)#=5R-EAO42>94B.]BJV=IRY)2S\@6IS @ )D
M^YS]EW]T[4WNI9D+O:GG>EWB(,UDUY#6O5-XJJ42.S;F9)9/V>(.)S/<;5:+
M4EBDV7-+F:ZMJ$F*N"1O3)1>O&G>(T25DZ+O;J1S*G <!P' <!P' <!P' <!
MP' <!P' <!P' <#&/3TSQMH<Y!(75N8F)E0JG1X>GA:F;6IJ;41(U"QP<7!8
M82E1(DA!8AF&F#"  <9SG.,8X'^6%_B-H'1C0+N3]OUJ;;=N>HK*N/4F^8"Q
MJ\$F3^@=C+FEJ2. G. E'+D#=35GNS-+$X32 #"V.!ZS O5^@A[\YX1-2G^6
M5&][;0&K"YTUN.*WT V#KZ:S1Q.1(BGBY+(L>&2D8YBYIQ9:&NT+=>T3H_F-
MYYI:Q<I6Y-+ /S@9%.X*R,=6,.\[O_N6M7JYG\7#-=III"#:&5C>TQ#38*^*
M:RPM"B<XTYX,P1)8@FL.*!:W5<WB4DI 9,\>?HQF_P _H==]&.X30Q^L]*UW
ML%-XUK;LY6=:0JMK?UTN1T20"TV*PX1&V^-OZ>+PV0B;7R>1QX<&P:AE<&1.
MN2N:,XH1 A"SD 99;S.C6S[:6^CO)91FI=>6%&JCLN^74RS7!)<T!6R0HFJ*
MD>V]\+8I569%@5G(3%EOR8#4F;V<]W:W!:RX=1B*\2)4G"DSD[<[G5TL7MV=
MX>N+6OF[*@F\)[EE6YJ6\U%9U/)*7:*[LVAD76@;<GT;?[IO 25IF#,X+X@-
M_-7-: L:8@LP&1%C-X[@_P!*F,XSC&<9QG&?3C.,]<9Q^W&<?3S*O> X#@.
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MH_\ =.^XX'U_!I\T*1^C_P!T[[C@?7\&GS0I'Z/_ '3ON.!]?P:?-"D?H_\
M=.^XX'U_!I\T*1^C_P!T[[C@?7\&GS0I'Z/_ '3ON.!]?P:?-"D?H_\ =.^X
MX'U_!I\T*1^C_P!T[[C@?7\&GS0I'Z/_ '3ON.!]?P:?-"D?H_\ =.^XX'U_
M!I\T*1^C_P!T[[C@?7\&GS0I'Z/_ '3ON.!]?P:?-"D?H_\ =.^XX'U_!I\T
M*1^C_P!T[[C@?7\&GS0Q/7_V?^Z?_?\ R/!]?RFF?]T,3^C_ -T_/_D<#Z_D
M-/FA2?T?^Z=]QP/K^#3YH4C]'_NG?<<#Z_@T^:%(_1_[IWW' ^OX-/FA2?T?
M^Z=]QP/K^#3'^Z&)_1_[I^/_ ".!]?P:?-"D?H_]T[[C@?7\&F?]T,3_ &=G
M_NGY_P#(X'U_!I\T*3^C_P!T[[C@?7\&GS0I'Z/_ '3ON.!]?P:?-"D?H_\
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MG9V=FMA:G)\>W!$T,S,@5NCLZN*DI&WMC:WIS%2Y>N5J!ED)4:-,4(PTP8L
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M:J9HS<%A>U5+= %^L;='')>A=,&$)2#I(F+.2E@,&:4+.2@WY9J3I+W>]_\
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M)(W94J-7&(52K  C5*_7$S?-[,_"RA)19!19!)8"B22P%%%%AP LLLL. @
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MW9;;[N^3BZ51E4L[/+7J3QM8!S&V(64I"XK5+4D(($6>=D7BG=X.HXEO\:[
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MW.LU>(F]9?5'VQLO/Z6CSTJ0I$L]BUSSF=79K^\K%BW&$9,:F:U\/C:U;G.
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M@DK6RJ[0N%<LKQM3L,*S%<P26D;"8O-%L3;G*&Q-/EKR^/RQM<'18Z#Z!P0
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MN1!&'*D2UQF:<]NAEVQN>V!'HI5+6F$F9)^N"@N29-:XML*C]>MR'UV4LS
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M,;J\'IDJ,YT<!)RR\K' Y(A)+&<9XC! *!C.<X#CH&5X#@. X#@. X#@?D8
M& &68' P#"( P"QU"( L9"((L9]&<"QGIG@?$UM;:QMJ%G9F]$U-+8E)0MS8
MW)2$2! B3 P4G2(T:8!2=,F(*#@(  "$(0XZ8QP/OX#@. X#@. X&*=V-F?T
MY"1\:F]W2I7!N=DR9R1IUI!#HSK2')I<B2U!9@2ES8X)BSTYH>AA1H B#G L
M8SQUT,KCT>C@. X#@. X#@. X&-.9FE0Z(WP]M0G/+<E5HF]U-2D&."%&X"3
M#7I4BP9>5"9.N&C*R<  L!,R4'Q=?#CH&2X#@. X#@. X#@8M R,[6J=5K:U
MMZ!8^K .+TI1HTZ8]V<"DA" M<XFDE@&M6 0I"B<&F9$/RB@!Z^$.,8#*<!P
M' <!P' <!P&?3Z,_1G@8QF96B.M:)D8&MO96=M)PF;VMK1IT#>B(#G(L$I4:
M4LI.07XA9ST"'&.N<Y^G/ J$^[FMN;CMJF:PI6W;P>M?D</.O%TKL5;)D$%=
M)[%\S:+1-"BG-A0]ZFLO61$U.Y'(VE,I"2F6$!\P2DP*?ESA-3[2%MQZ^:BK
MRY8H@?&J.V3%FN6-#7)V[+1)&Q(ZDX. W/[2(TX36](1=2E2<0A"(. (&<]0
MYXLRXJ4^O(' A.]KL14?$TCV"!V%:\K?W3[/P:K*J:&MWGDZD&&Y>\&MK1]H
M7J,Q1H2H69J5*U;@\.C:VI2",^,_!HR2S;)I>$':;[TP'<0^X(BCKFV:,NS7
MJ3,$4O&A+P8&9CL2OELO9!2.%NII\6D,NA\AB\R9"C3VUQ;7-42>$@SK@&0X
M\2S!=WD#@. X#@.!\JY<D;$2QQ7GEI4*!*H6K51N?"4F2)2AGJ#S<_V%DDEY
M%G_EC@4*:.X!'<;#U70-A4#L#3Z?8%1+F[7>V[ 9:]Q7-OOL'CCI-'N.HDT4
ML>46! GM7"6=2\-R>4L;(8M0IS<8P6H+$1BXFLK?.]".EK+S5L8U8V^V4=T3
M>SJ)1(-;*QB,XAL$=7[ E+9%IH_R6R(0%GDYC*8F=!I@E'8);%R8\8@A.!C+
M/)K>+IVVC51SZ'4\T5_8-OW3+X3*;0Q5U9EQ(;W'JNA DJ:3SV2N\UE<-BK2
MT >W!*T-Q8U^53J[JRB$Y62PJ3TZ31L42V,;["M=BKB#0>8N#0;6N;-F<ZDC
M,\P5MAS<\+2&ZOV(MCE+.AD$A?IX>2Y')\DD%-Y"-F5C&JR=@E.:LR<FZL [
M.S8PM;D^/2]&U,[.@5NCJZ."@I(@;FU 08J6KEJH\0"4R1(F*$888,6 @ '.
M<YQC'(JH]A[J0.#1>EG=NA=@S:6;*S0Z%:\5FR(H\S3*T3"(^[S(V3DXF<BC
M+'$HBF@;"J?U"EY6(52=K"# TV%II:(5SG$U_>/;=%.X+[;W6A;TB\VUVB42
MF,QK]Y;ZX \25IF"26+VY36TD)L@==3%&!)#%N1GX>DP & \@?@5!&0%G]FJ
M\U-W6:NMG7B(;<)-<MMHKK%,8\NER6Y'JOZWE#6SQ)N6K4*Z3R&#U);UEVXV
ML:,;:>8>?B.F!3IRA&F^67CQ<8KHC6]D0*X('$[0J^6L4\KR=L:"2P^81EP(
M=&*0,;F2$]$XMRY.(19Q)H!=,X] @#QD(L!$'.,0;KUQU\/7'7Z>G7'7I^WI
M]/ UJ8RQK@\9=Y4\%N"A"T)P&91-"$YT>'-6H/*1-K.RMB?&5#D]/+DI)2HT
MX/XSU)P 8](N6314>B=VVRW+TF.M<\H>[];;IC5=(KD8XC<Q%8KB+ J17)!1
M!1-8?)JALNTHJ=A@DPR$3HWJUJ5P1FK$XO)&69XPK.-&,1]P>G5L?9K0*99<
M'7>176+7]BV%,+80P)PL#[<K*M*<_9_MO,K1ULKM5 ;&2)">A+2G.F FX!AK
M,)<C+^OY3?PVJ6;H0MBNN5TG&*^L^SW.JRZ]-O:50!H8%\9I?-J'$8@[=) .
MLE:)')I(XM*LIX/:HZWO#@D93 *1E>(Y,2>DTMQ)-<7H.TY=;3-&(#*D\7JT
M3(R%3"2)SHN*93M>UJ7I]BC%&7Q&B>D),30'-P%:UQPDP)8OR4 K("!FYEF?
M4U(M>V'&[,CXI!&SU'@2.;DP/C2XD>I/D9D[(I&A?8S(6[(S!M[TT+ 9 :#Q
M#+,!D!I(S2#"C1K,5O/(' JWLGLTJH1&V-\.H>Z]F;*>D#B]M]442V0Q1)B8
MPSFID[K*7IYL::5["61H3K5I"8@LYS]H."HWP(TJC!2@1%DWZ)K1J,W]HR_=
M7I+M5%DD_8XM!7.:Q2PJ\ET2,9[?@MF5\Z"8I+4S_"BUJT/\PBWT1"1*D3JC
MREIBQ-DDT03@BXSG#?+Z:/W22VTPVA+YYK;M#J?"JEC?VJDDLVO@L,K9I7,Y
M"-V<WA8P9C]CSA4N2QEK9C5#D<<6F)3EF%>$1@A"P!@P$)W^@DLKMSM1UJ"_
MH3"E%7@NNO'!^@!#HMLVK%B58L9Y,UM,->Y.N@ZE[3)R32&^7!CRX!2]-YQ9
M1F5!:>_K35P:[?I-*8)$)+,H@97\I?XZT/+[!CW=,_*H@Y.2(E8ICJYY1IDB
M)P<&@9WD*#" >1DX O+$,'A&*7M6,D%G1UAG,3K0 5SS.9>C<7Q(P-!)9Y[3
M$650B1O4SD*@XXA*T1Y"O<DR4L1@\GK%9X2DQ1V0'9*9Y%))'W(X@V0:][DB
MM!7Y9]":]2"TX?-;?KYNKAS;7*44FXNC!:A$3A+C8K59C\PPB5L:]I6N9;-@
MC*Q H,)"<B+];S?U_*:V6^NX-":%V5H+5-71]_67:6S;#8<BIP=:(J:.B\E0
MU3'4DJGY:EYGMTP$QC4Q]D6EFY"M(("JR+PIA'"]')BZWZL]UZAG]O!UVDC=
M/:1V(/C*R;-=)W7&T\7ELGAK<I*1N,G@C\QNTIK:QFMJ5'! M^S[ZYGM^<XR
MJ+)",&1,%O>0>8SC.,9QG&<9].,X].,_W9X%"MJM[0ZSGOH(]JWL_LRC@#2&
M27$ZZ^16"/"&IXYENR]>LO(9W8<#7RM^&PXRO"T1PAX< )/ 8> G!R?SK(FI
M!*W!@\PH>K[YH*'SW91KNV+-LRJ2'U4FBZ"4S".+T21P4/)ZFS)37\1B;6Q$
M+2@N!SPZ(<$*3"TH,&JS22#&&H_K_N*41*M9KCV>FS?/J4C^N<KG5>W_  &S
M(\DQ9%6V17AC<6^05<TPMVF#-*GMR"^-IC0)A7NB=W+=$GJQ@QF^ +.<-95P
MW3&SUU*I)(-=;WBMDLV8NCC=,2!EC2A_F3[8F&M-6K"GG,,DLRJJ.N,F?G@I
MK/+<GM.>WKB5&!%&%!(-47]?P:LP^V2UP]W@S/,TI['F>*R8^UO@!@6Q9/-U
M)034$-6NV<)5:-P?\ /"UJ#TA*1:>1ZMYA:P](F43..!)'(IP&<]/3P*1,>]
M5;OT>JVS4D5F7\AKHLMHJBNKMQF,FQIVDLIDZ^$P5W7,),A,F#3"K!F24AJ:
M' Q#DX:MQ295)DJ<T2@&OU_*;^&0G.ZL(B*78!_9X5.)Y"=5'4QDV!ET6Q&,
M$0QV00>/V5)6UH97F1-3[+UT)@4L;75V"D(P#!"O!*,:Q:6>D*F&LA:^X\(K
M^8UY6<*ALZO6S[+KY^N!B@M5@B>'!#4$9 @]I6,_N\ZE,+C3,R+USHF;VHHY
M:%6[.1^"2"\@*4FITGJ:VJ'[(M-C6E'Z\@<,F+FT*:X_F;+9W(V%]@S3%FIW
M5$(8.RD-$I94#X_O\S/];/)P622B(0MR@T2D1F"R#%F3DW5BEBQ*WI%2]<I(
M1HD2<Y6L5JC2R$R5*F+$<H4J#S1 *)(()!D8QBS@(0XSG.>F.150+'W9K2O:
MTKJR2XU/)B5>%I1RH-?(K&VUD2R:[Y7+F]R>(VLB!<ID$=:6J+.;$PN3F!R>
ME;81EJ0#5A\11J;S[G*:R,#VL43&>635#I0%W0FTJQK6(6<X0Z1)JX&1,6>:
M.\L9&M+6\V;+%6U]*%1#A#E):KS75%A&(TD*CR1F8#AGX-5EHGNPUIL'K^T;
M60K6/<,C7-T,E^3K14U]5TC"SH(%)'6*2]W<*YK:Z)Y<:EN8WEB6A-RACBPX
M1249I98R\@$)BNA-16_6-]UQ%+=IJ<1ZQZTG#66\1291=>6XLSRWF"&7DP@X
M'A&4<0<6(LXDT(#R#@"+,  81!Q.A(_7'7&.N.N>N<8_MSTZ=>F/^77@:K.9
MHPUW$)#-Y,<K*8XTV*'-?AN;5[TZ*0DXP$E SLK2G5NKV\N2D8$Z-$E)-4JU
M)H"B@",&$.4F\"BE&=Q>-VGL=C52SM=-C]5+CD$&D5G52S; Q^O4S5<D"B*]
MH;Y8Z061UC8]E, GN+F/R,UP9UBE*XIDZ@)GEB"$SP6Q-3^OVIKMOVPB.G1S
M1.<6A,Z9L&\VMX.BRE# <P^MI7 8=(4I4G<#DF'1]P[60W9 2A(5$@)R/)QQ
M0\  -G&JTRSMU8-7MOR"EV6"65:,DKB"QNT+Q<J];(\L8J1KZ8.SBTQ=XF)S
MY)6)Q>7Q^+9')>F8F!,[O0VML/4Y3!\Q$!6DU+<2? KQS9-H6)!XU!Y,3%ZT
M9HZ%\GDE2+XH%7/)(FP]$P-KB+\UH9&)0TQ0](XKEJH"0HL#DC"2 _!HS"EF
M336]UW9,<LMK<UK)E4C<HZ]K(M,(RZ@((D$.EC:60:XQR0)4RE8F*7)R511I
M9I!QZ16E.*4)CCDYI1HYF*D#@.!%=W7!%J!J6P[FFZ.3KXE64-DDYDB:'1MS
ME<@$QQ5F6OSL)O9VLHPTXXMO;S,X$8(H@.<8\PP&/3Q.1]M.V<QW74M8W'&$
MKD@C=K5_#['CZ)Z*3$.Z1DFL?;Y(UIG4A&J6I"7$A"Y "> HXXL)F!8",6,8
M%FV9<$-U9N)4%NVGM#5\66.10]254);[1F#LF);X>8X3&,.\M.+C[F:H\QS0
MQ=K:1!<%GE@2A49&66,S)1F0K,^Z:T&K]]Z[LR&!M,-:W5%*>D,"=;5JNT7V
M$D.+!:U8,ZC):F=,[3#GB42R%L2QN/0NB(<K;V#*IH=4B@.,"RH*37]?0V+3
MU1+Y!8%<PZ<R>#NM:O$M8T<A.@3^M2KI'%4SK@2QL:),8A+"A32=.UG$>TDI
M U!")=DU.6H4@*PH,EXN*_C+;1C,2ED*@!N5;M.[ $YJ(U$V@D*ES-C\=.:2
MY=,'$1AA*1HB42 ]I,+%J@PL&5"M,D)P<L5)DYK//@5"=.X/%S#-@GFNZ+O.
MYJUU@ELPKJW+)K)!7;FA1V-7S,VO<\B$3AKW8;#8LW40LEU+3.)[<TFDX7!,
M(3>LB*.\MGY37\[I[BL!I:>:FUP?2=]V3(]TR73^10ZT1TZI:7EP88038K^U
MO*Z=7+ AL"AIAYHE@C5!04IX2Q (---Z%Y?J:D*$;PU#(KC8-=)^S6%K[L!,
M&EW?X)4UXQYMC[O8K''R,*7YPKB7Q-_FM63\UB3"P:N1-#^L<4)/^HH3EE_Q
M<8:N/R*\QG&<=<9QG'[<>G' K/M9M97&G]9IK3L]KF[I'ULWKRODI4*BZJ0'
M@D-H3J/5U%,N:L1B)F8VLV3R=(6<H6*B<! /.0!,'C ,V34MQL-O;!0^HY/4
MM=JDCG)[2O:0R"-517S#E !UD:F(Q5RFDO>EJYU6-[6PQ.)1QL$>X+U)N, &
M<0G) >K4ITYJ3?HJ,6+>>AE$$V0FLV>EE6G:@NCFS[*Q::DI<2"KE*&,H)JW
M+%8(^L?$$@9)?#G5(Y,:ML/5 <2%(2@X L >E)8FM=0[S,V:UE,_D5![#0YS
M:8G%YQ%*^>84TNTLL".V 0J#7.&M5"Y)*HE%7^8O:$YJ TR)S:')(XEY+/)
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M!O7%*[5[5:JTK&GPS8&HVX;3!-CZ8L:-S[[ 3D^/&A,.@\M(7LZ_VDT!-"B
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M.(?B#X_+!BS.EB@.I;L\2/N,=UISEA9OM2%O>G56P@)V!Y$EJ%NH(^RF<*
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M]IQ*+ZMQ)75(7K$W9,2EQ/JV2VM,4[D17CIZXGA*A\)6(1GK6TA2DW[>6?\
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M''3KG&/%GH'KG_JSTSGIC]N>F,Y_NQP/> X#@. X#@. X#@.!^<B#@6 9%C
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MV<I>$6ZA3-T2/FJJ6)4\0/DS>]N2,R+S:1PWIE220W"5#<,Q[*D(0IP^ )V
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M%L41:TAL"Y*<FUNJ;^7SBNYV4KLA]76V[8=&J4FHUZ-C,2.:E(WA(\CU1J0
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M;EU]L.(3=QL=>SO4;9),P$+6^).M:2%D:9<O8_;IAX\.B!P:A'ICR?/\8_\
M63X(,9XO8YL:S:3S2B;X[GM_U-0SM3E-[50.M6ZLM665UKAB62RX&**3%OL2
MY3(RDF0*VK Z8N$E2)O5Q.*90K"D4+%)0#!DDYO$L&2[<L,WJU&[;NN.J1FH
MAB>^ZKK=?"E;_.KIILFFFQ^4/\@7H7UP>*_F4^G;NQH2W0DXU,D8PJ5& "*"
M,K.<&8<>IRL=K1IK3FC6A4ZIV^3&J[HU(@W1<FW3ZYUDX31FN28W"\/4TN9:
M=4C4US)UDD=7A<1-B%E*1N*H]J2$$"+/.R+(YNW@SAQMD%<=BE=ME65DM6GE
M&I:'C]'VK$)G L=I^_B$KU94DF%:.D'DQD3*T[RQ.9S$P1YX3A7'"PI2X6Y+
M*QD)QF<:SCW/\=Y:ZE%=0?3$4D[=FN32^11H89.=1VOD2A"/5!C=)$.1.)"Q
MO^RUH,=6)Z\:3Y.:J6KCU2!,8>3YIZ<M08:5@W.<\GT1'J5.-RE,Z+9+;T.=
M*13R\Y7*K@V#G&PU%V,Y2EY;FC*)J9VJ&50].[V0(9N$Z-K3C$4U,S209CQF
M'= J+;*37\OY/W</N^CV8S4[R"@R]"$^N8+&S*JV$6;8X+]76:,(8F";"G 6
M ,=5A#ZV)MP+*G&0>7X>@\MXP\ZM[<42E-IR:#UF)M-3U )3F:VZ\&#0C2R]
MOC:M,9&J="D&IRL,;Y=(!E+GW(TXT2IB;3VPWQ!<Q>"3)-\EY5&T;UQLJKXW
M'2+@8%G\YT5S7A<UZ7*K5,2T=R3><+YQ'(T6Q+$3FX/)L&*@4H0B0I50$8&9
M*R($ $X<EB 3JW@;)J[7BR0;I[V;<$^/[$6@@UWU\K59T_[65L^M[)8#C,IP
MTG!%D"MB66)<#DQIC<?PFFQX\TO(B32ABEXDGDCHWS*G HCNO/-K&)'"X?KE
MJO*M@XY+#W/^;SO%KHJ"GG=DBJ9/DLJ)1]RLJ4,RTEUF2D[!2IR1IS3&]L >
M%,82N/3JT=F=U+J0-9)G=KW6KTKM;59/JR7$,$QRNJ3;[#KRR'E7'6!D(.)<
MB7RN' <#9FYR4'A;6YJ ,)R7V>,X\S!:@H!*X,9HK4\NJ;7&,!LQI&RW+:<A
MG=_W:U'K43HJ9;9O>9/5H2Z(G.[>I5HG9/71\D+C*(\HXTG+<S)PE"R4$'%Y
MOL15C;76ZZ=B84_2-4S.V,2/8"D(Y+:G1/+-[7>='*WNF./EMU^D4"<VMG4*
M]@FMB->)$VF*L#<X^80P'8-,)\LS4R<'NZ*U5'%3$WR9:HCB&'E2B5GOK=%$
M)3<3[":4["P1EL3K -!I[4!R6(XZ!6H G&842:HR7@8_!XLYMTBEE'P!51W<
M,W5&\!$FCVYC/1=ZUF\'C!@AUFE45UFDKB@J46>N N<888G%'P!0\A&I3/AX
MR C B5"*MY^,/*I._NN%S[\:#R/72X=0 R':T]O7ME.6T5*JN3P^KK,:GTMN
MB&Q[;8*.3-LQKKPHT*5_=&5L;C5H@9-:2@+B^@QLG>\'+ZM@-;=K<=P;M1WS
M&ZGF-^0+2JG-CX5=UEI9S34:?YE++?I>,5^T/K+'9W9<9=7)2MD3,>K<Q&A3
MA)P=U+$=QL$[6CK)=.\&R>K-BW]"&ZD]<M-[2'L)"ZI6RMAG-FW%L&UL+C'J
MUE$R40\YQAD$@]4)WYP7)D21T=EKNZG%".RF(38 >XG0^/?A+VIE5DLY>\FM
M=:7%;PZZ3%Q24S/1&PMGW)KA0WB1A:FE//8E1%HH&1&FD.7 \+8)<2<2,\1^
M2 A/",R24M4Z[6,%[3U:L>I,$@^MU5-^[<,K&,QAQN=C[>ER5K(7"Q6>OS6^
M>2(F]YSK3 LHSWX@E?YBYP<T9R\)XBQ>(P[RQ6R^.CA?7;BP-PS;4;H)7>A,
MHV0UZ:&IL?'QU:]A* K!'8DSPK)7(HZ]LE@RY)(#8-%!)0F*T9J0LM\6B  [
M.4!!I#@F2>Y=^RQQM@[(K]5)G8JVB\1/8T^"S=SA] -\VBDK6M,K*3N:6"1=
MVL%(ZIH2\."Y04E5+5:<XE"G"H$2$1GD^<;.-&U:QU&'7K6^GZB%C+@Y5]73
M"V258F" :F237* +E.I&9D1OA4.DNF2M<X'C$/.35*L8A"ZBSGB\U5 [:UFN
MNU)7JO;5@QEXD#$KV4,NS9^DV=[952A+$8C6$[2ZL5BI3.4B2QR6Q:DK+6LK
MN^H$ZLUN<):-8]DDB*Z!!K9U&?>MTW^K24SSMXW1K P-R0BVMNVB9TG#(FB4
MD+"F9XV"DCL*2*2S2P)R%;'4$'D#F]NRDL)964#(H.#C&1 #EW=\+X=*8HPI
MXK%HW%TA@S4L;8&=A3&F=?&8G9VY.WDF#ZYSGQC+3XSGTY].>85G^ X%+VNL
M[ E>^DFNN7LRIKK*G=<FJHJ/4'+6\]-*)A<<S!.+[DX&].M.6H<LC76,):$A
MBD@DP0A.&"\Y+&+(KO&)Y0+NG3-X61NQVQ+1KFJ'B8UQK/;UX3RWY6DE5<,P
M6)HL#7^955'B6QCE$S8Y#(%GM^3%G*0I4H@DI2A""(P><%\LZ*N]>:.Q9#%$
M$&K42]E<[!>4T7D-@MZE$E4UG"%!"A5+I8V"4#$<9+!LJ4UO8<E$J IWI:F4
MGEY3$'8S)G=*HC3NI<JA%Z[&+WV$!&1,;DH#-)SY.&-CAM7ZET)&ZK=H73<+
M;?:PG^,&(IQ$GHA2@3(DY1Z]RPZ#&:'&,\UO&IB>NY!0<DV8TEOJH861E9-G
M./,,OA#9@P!7MR:U1-(S;$2C@CC1 *)!))%"$R 0QYP &%'B%TQC/,SMIF5]
MSVQ+$>M=JT1 _P":%3S=)(R+GC!;Q&(W,H@D51XE4U.R,$K7M)9LN@<T8U3
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M1:U1=G5%4R4RMS):#^>>BPF-JNO&IG:DM5B(PM(=%"ZU1B(1*QDD"3 84SF
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M @YSC/ _*%"B;$21M;4B5O;T"8A&A0HB"DJ-$C3%A)3)4J8@("4Z9.2#
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M.&(6;U#RZ<<BG C^<R:+UVWKILYMV%3TJ(01UM2M*$A3+)<X9/6G1V&,@/\
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M5E_+6G$,9J1M8XBIB]=)8U$FHJ*5_DIM.1QTUKA*#+2SF-+ I$6:%O!E.2:
MO)?B!@77$5SA=]+=\7Z<0RRGCN#UHX3NO&N7LT)DZC12$9<XXUSX#""8HFX8
M+C 4 F0 B[?A1@0!>+U4'3IT]-U%S&:D9Q*]?9!2FR%QN]LO<S:9/&YC9-<-
M+AKF^.$;D)RHH*!A_EY+%+W#5Z-F4>J>OMSJ2L%TR: PHS./"WT5!-)]LK6J
MA)[#[$AT@VAD3M O/%%&&VMR]JKIKYJ/-95K G6 K6U;>ET#/6-3:O,P@-,;
MQC0&^$U/DLT !A;4R+;)Z@AY%SN5\F <ED_7UHTU,F/6KLGM3%#FV3.TN6)H
M^VY+P!L6R9[<B!NQX19$N"UMX18QA*#C>,5FGVO8_))E"IN\>T%;C7Q<B'&&
MX2TS#"C=Y*C2M:J2G-(<8(5R1 RE*4*%69XAHTCDM 7C'K)F<M$>5GKC65/G
M+!05N<D;1B9678K%$3W#"J-12:W#*7Z<6:_1=$H*P<@<)?*Y4Z*AB.//"A Y
MJDR'U5&>8GRVYB8Q5,4D;$)_;UZ3(295;MYG1%+(?4C,J&N'P*NT3JAKNMV-
M2,LHQ8EC_M]R7+E@@%Y7NSHJ-" LC!!12WQ.B+(<BG A^UJ-@-Q*Z]>I2D7H
MY?4DOS/*MG4>7":9= I4<RND9<'!B<<%GIS4;Y&'Q:VN3>L(5MCFA5#)5)S0
M=,8LN#YZTH6 5(V6&FA)3LA?K9EKY8%D3I6XY<9K,)V_MR)H4RIT=E9)B<*Q
MO:6M&D;TI"<EL;$:,A,E3$IR@E8:8U59JE41J:DLMC>[QQ\UY%(<U7+V-T$5
M*V,$T8%4;GQ:QS7DN!;YB?-ZP9CL-84<:I7X+6X$!:22H VIB?&)D;(TS-<?
M9D^4K4S(4S<@3B/4JS"TR4H)17G+%ARA:L4"P'Q&''F&''#SD9@Q#%D68K+<
M!P' <!P' <!P' <!P' <!P' K<KU6JQ;LPV;<'FS?-V,]:N%.MKL"=20N-)J
MQ=I(@F#G$<04"[$/,3+Y*UIU9BH:(3AD9( X48+#@'+O&#'3O4*H9W)[4EAN
M)9%7*^(6TUW>I4'DZV-HK=A[$A>6EH;Y62G":8@=T3(_JV_#VSC:Y )O,"E$
MNR02064VIC*/&JU0*GFHI1%F=36$NH>'/=<5/)JU,1QU9$JVDB)A0OE= :SD
M+C&'J#KP15K."VN2!8F2K&U*J3A)4D%G!:8V2O*!KFI*I<*?K!$Z0>..@YJX
MN#NSNZLV9KI98CH[R":V XRMV$Y.KM/Y')GU4YJG56(]0:O-R9G.>@0X;MVJ
MPCEK!4JAQJ]X8FIP@KO3T!?JG@CG!7(V/+FFJY0GC*>05Z6I* >:4PN.86T&
MA-)R4XHU#<2<E4D&X$,3]JF)V:VQO9&QO9FE&G;FII0I6UM0)"@D)42!"0!,
MD2)B08P HA.G*"  <>C <8QR*^_@. X#@. X#@. X#@<@3.^_P!L0H8RQW)<
M6!@$( L8TCWJ'C @BR$6,"!K6((NF<?3C.<<91^/SX^V%[Y+C^"'>S\-7&!^
M?'VPO?+<?P1;V?AJX-A^?'VPO?+<?P1;V?AJX38?GQ]L+WR7'\$.]GX:N%/S
MX^V%[Y+C^"'>S\-7 ?GQ]L+WR7'\$.]GX:N,H?GQ]L+WRW'\$6]GX:N#8?GQ
M]L+WRW'\$6]GX:N#8?GQ]L+WR7'\$.]GX:N,H?GQ]L+WRW'\$6]GX:N$V'Y\
M?;"]\MQ_!%O9^&KA=A^?'VPO?)<?P0[V?AJXP/SX^V%[Y+C^"'>S\-7&4/SX
MNV%[Y;B^"'>W\-7 ?GQ]L+WRW'\$6]GX:N$V'Y\7;"]\MQ?!#O;Z/_[:N%V'
MY\7;"]\MQ_W?T0[V_AJX#\^/MA>^2X_@AWL_#5P'Y\?;"]\EQ_!#O9^&KC _
M/C[87OEN/X(M[/PU<&P_/C[87OEN+X(M[.O[OZ:N,#\^+MA>^2X_@AWL_#5Q
ME#\^/MA>^2X_@AWL_#5Q@?GQ]L+WR7'\$.]GX:N,H?GQ]L+WR7'\$.]GX:N
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M^?'VPO?)<?P0[V?AJXRA^?'VPO?+<?P1;V?AJX-A^?'VPO?+<7P1;V8Q^_\
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HV]?)96[HV)C1KI+*M?62,1]&I<UY0#%KBL2(4H!9,/.+*"(>+E'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>tm2030088d18-bc_cancerbw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d18-bc_cancerbw.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!H@(L P$1  (1 0,1 ?_$ -8  0 " 04! 0$
M       ("0<! P4&"@($"P$! 0$!                  $" Q    4# @("
M!@T1#A *!P8' 0(#! 4 !@<1""$),1)!45(3%#AAD2(R,Q46MA<W5W<8<8%"
M8K(C<].5-G9'MRAX&0I38S5UM29&UB>'F+A)6:&QP=%#)#2T95;'2%@I.8F2
MU$55EF>7I]=I\.'Q9"5F:'*"@Y2%B*+BPU2EJ-@1 0$  @(" @(#  ,
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M]I/,/O69!]:4O0<1MM\7C!/O.XU]9L-2C-5 H% H% H% H% H% H% H% H%
MH% H% H% H% H% H-I?T!;Z$I\P-!4'I_J-].S^+WT\G7V'=-?BT%P- H% H
M% H% H% H(L[3?K4RW^%!N5^Z]<_]2@E-0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!08LSG[2>8?>MR#ZTI>B73B=MWB\X)]Y[&OK-AJ*S30*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*#:7] 6^A*?,#05!_R&W1Q_%ZZ^
M3K[#G3\6J+@:@4"@4"@4"@4"@4$6=IOUJ9;_  H-RGW7;GJU$IJBE H% H%
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MG2X"JI0*!0*!0*!0*!01:VG?6IEO\*#<K]UZY_ZE6I$I:BE H% H% H% H%
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M"@4"@B9LP]J.Z-?](C=1_&.R?5J1+.HI0*!0*!0*!0*!0*!0*!0*!0*#:7]
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M+-,TT"@4"@4"@4"@4"@B9LP]J.YP[6X?=0'_ /L=D^E2)9T4H% H% H% H%
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M.2WNX99U-N5P<HQNC/>#\VV!CO'MKLK^B9"Z,C.[D]D!TR:REE,&@/FA7A?
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M=NUB4VH#VA'Y/3LJ=L/)Z*<C"#4--]>W'7_1OW?!TZ_LYV=>0%2M>JQBLM%
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MEAC^L6R^(?6A;0^?XA_\"C^GS0 '171CMVL1X]C_ (?DGX^?Z*#"+,==]FW
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M6UVO^88[Y0>%;Z8KM8B.O W9Z.';/VR4,,(-!'X=>W#CK][?N_[7#]?&SGR
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MS[JB/; ![-2KZIYUEHH,<YA]J3*7O=7L'EVU)T'5-L?BX8#]YK&?K-AJ#.-
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M^%K;/R)@Z<-9MX:B 5*3:RVLNA0*# >ZSQ7MR'O"Y@^Y[<5$K$EAAK8MEZ%
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M?8ZM57P :=)0_P" /3U5.T7A_P"JF%=YV:>-[N"X:?>U[;N !II^ZIND[ @
MTK/:U>HI0*!0*!0*!0*!0*#C9G]!Y7]+7W]ZJT%!>UL/O9=N8Z![0V(/D1'[
M75O\?.]BJ33._0/$H#Q /.#W28]SIT:T\C\]B!INMVH<-/UT9;[ A]I"]^V
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MKVX:B(_>X;O^QI^S?9P.G0'16?9KU6,U&B@4$.^8-XDFZ#3L8<O']35*#G'
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MQK3( <>)0Z0[!-!XI]GO8AT4'7]A?#;SI_UW[I^UV=SN7NUPK';I,8X3+H%
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MDK[ +Q];LC2CJ&V;Q<L"Z^XWC3UG0]!F^@4%2V\ ?OU\.!IK]ZCFKL@'VYL
M]&M4[=6U'B AV.Z+VC=@>FEJQN)B(*)\ $.N7Y(NGHA:I4NN73XD>W/[ 2?J
MQ*UEF)J44H(.\R7Q']P?V+P_KQMNA443Z]8_1Y\?DR<?-$_H:U5:<>P :_\
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M0H.G$Q_(Z-.W0VQQC?QRW'$!#X,)N@1'[:B';[-9K7KA/*HT4&/\L>U9DK[
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MY>-\>6KC6=Q9!IV5CR/OP+C:(H*90R!CZ)- -+FGI!JW19+N%$C!U>]E3+J
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MVL43,1NWA;C1RMM=SQC>P]O.[R9O.\\9W1 6S$J[8\KQ2<E,OH]5-BQ-)2D
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MS3DVW8FS^1WS0;0@6J;*"M3G43EL0K)$A4TF<1;YK&B8QJDF3JE33;LF9"%
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M(8RNW-& LQ8EL/)<]AJ],CXZNNS;6RQ:RCU*Y,=3MP1#J.C;Q@U(V2AWY)2
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M#MWB1DE2J&O(]0H:Z!KIKH&NG1KY%16M H% H% H% H% H% H% H% H% H%
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D[XDWZ(./$U^MWT</T<_PAW?R]&>TVJ*4"@4"@4"@4"@4'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>tm2030088d18-ph_genetic4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d18-ph_genetic4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!M@*8 P$1  (1 0,1 ?_$ 04  0 !!0$! 0$
M       ! @4&!P@)! ,* 0$!  $% 0$              08" P0%!P@)$
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M >H.(M>64?.W"2I7""#6)XU:,>^\P[C<<TMJ?N1V?A6IL@P;<.A.Z39D1KK
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M@"0!O%.7<O3?)<LQG#8)[D^5ST5CV/1R N7TS+O4&,>V1 +@=1RN<B=S\BE
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M7'>UN]O2V#, BL$R&,W7M>:$\=@NIM92K/)<DR;(%#"W:,WJT2,@UQJ*1<B
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M*(E$2B)1$HBTOO5;<:6$/":6AL<F,E7*J@X3GG:*:R+-0@%.>)8R"1821>B
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MJ_7^6IMY$R#E(!'S8R+%((R.LH-R& BBY+!_"B(7K2Z1SN8*B-K5U4  4
M           .0  > 5H6M31$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B
M)1$HB41*(E$2B)1$HB418AF6 87L*+&&S;&8;)8ZXG31E62+D[54Q1**[)P8
MH.6#GI,( HB=-0 $0 >-4$C$*$!VU<CMNU3*]-S[C,.VO.%8H'(IFF-:YPLY
M?8GD**0J6;C*- !XS603.8&ZBJ*ZR9SC_#D(8P#N=8'8/'=6C)EQ8NI\(S9W
MDC8K/),:D\(R]JB097&I44W*15/I%4<P4ZS\R(R.*$Q+@LV4$Z93%!=-$X]%
M;9%-F(6L5.W K8%15*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$
M2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB4
M1?*NQ9N5FSAPT;N%V9S*-%ED4U5&JARB0RC<YRF,@H8@B43%L(E$0Y41?5RH
MB41*(E$2B)1%;'<LS9J>2<QU%K7%)!,53E >0G .!;W]M=3>:U8V4O42%SI]
M[6#,1T\BYMOI]S<,ZQH CY7&@/0OE^T#/] ^_JP_G5Q/M+9>KN/J_C6_[HN/
M3B_*^)3]H&?Z!]_5A_.I]I;+U=Q]7\:>Z+CTHOROB4?:!G^A>^SW8?SJ?:2R
M]7<?5_&GNBY]*+\I/M S\47P>UL/YU/M)9>KN/J_C3W1<>E%^5\2G[0,_P!
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MISJX[4'U6'U</EITJ=*D?A[*B*/&UOCJ[DW*1&WXO74HE*J+^D #\=5%//P
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M8"%P]E6IWH .3!5  >@ \;6#V7]M*J4&Y0)0\"A\@6H#RJBF]0!"%  *4"@
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MVKAB_:MWK)X@JU=LW:*;EJZ;+IBDNW<MUBG17062.)3D, E,41 0$!J8[E:
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MFNW9-!60.*:H-C'!PJX*0Y1#J$A $0X7#B/>6?"=W<P-FED;&'"H%"30[*[
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M+5;9M[82-EMG["T]\'D(W@T(WJZW'EPO\/GKC>!<W#N('+A\_P"U0\Z'G46
M+>VJE:J;!\M2J55/J#V#>KSE7G*D $/12H2H4AP_#ZZBBCGP'V\*O.$V8A+A
M:W&P\*)O4\@_9J*;5%^8>GA^*K16F]<TYQOU7%<S5Q]G#MG\;%+-T)9PHLH5
MVJJ<A%71&'0<$4C-BJ='\(4W4H40X!8:SS2>#6ZCI8O997,GD!+!04 Q S;S
M6E<*4!&U>1\1]IS]&U]VEV]NR6TA<T2N).8D@%P90T&6M/*!JX'8,5T'#RT?
M/Q;*9BG!7+"00(X;JAP$2G_*(<O$4UDC@)3D'B0X" \0K"[JVFLKA]K<#+,Q
MU"/NW':#O&*]1T_4+74[*._LW9[:5H<T\W(>0@X$;B""KF(7'UV^*N.,%RQA
MT+7>?;.QS7J2!94R[J1=IG59Q;(J9W2J91$GG+&44(FV;"H E YKB80'I*:P
MV[O1N'[[6B3;T; TT<]U: \@H"2:;AS5(JL4XFXPTGA>-HO"Y]W("6QLH7$;
M*FI :VN%3MQH#0TT4U[G%U)IN#G&F[7'SG!-ST/%74JB0QK"Z(J*;=JH"8#U
M"EY0"(!8#^-9?)P"P6KNKG<Z]I45: P\U*DBO+7N+SB'MAD?J#.NLV,TPFCJ
M.+I /2!HUIIMRY<=F;>NL5';5)L#U9R@BU!,JHN554TD 3. "4XJJ& A2B A
MQ$:\X$4CI.J:TF2M* 5->@+VQUQ#'#U[WM;!0',2 *<M3A1:^V!]9Y/@DVE@
MLH@YDC$1\I:*?IF4621<I*O&C=TU4-Y;EPV3,4 Z@ZK]/"]=UHO4:?J\3M7C
M+8034/;@"00TD$; :'FV[EC'$_M>L<-W#.&YFONR!0QO%2 X%S6N:<'.:" *
MXUIO7F,39^X< VYAD-C$2Z#%96/RM?-IQT+M0D5*Q(,AB8YZS54!H4S]910A
M@63,L<1$4C)BD<3>_?9_A?6N&+N[U"5OO..2$01B@SL?FSN:0,WD@ C*0T?*
M#LPI\B1\6\;\,\965GI,3QI4L=P;J5V8B.2/+U;'M)R^6<P.9I<<<A:6FOJ'
MK/.4L_QE*9]V!F]0<*,)-J03&13>HII*&,V,:YC-UDEBG* W$O5TB(B%Q^?=
M?TAVC7YM<V:(MS-.\M)(QYP00>7;OHOL#A+B1G%&D-O\G5W#7%DC1L#P 26U
MQRD$$5Q%:$FE3A69[YQG$Y9U!I1\C,/V"ODO3-S-VS1!8"E$Z .%3'4562$W
M2< 3Z2F 0N(UVNE\'7^I6S;QSXXH7BK:U)(Y:#8#NQ[BZ#7^TS2-$OGZ>R*6
M>ZB-'Y:-:#O&8DDD;#Y- <*JZ89NK#<Q<)1Y5EX656$"(LI;R4B.E##8$F;M
M-4Z*Z@\+$-T'-X%&N/JG"NJ:8PSD"6V&US*F@Y7 X@<^(YUS>'^T/0=>F%J"
MZWO';&24&8\C7 D$\@-"=P6W[6]H_)6,U6=U[RGV^'*G0IT*.0@/IO3F5VX*
M0MQ&G,ICL5NE LU_QR'\<2NIUH_T']8SYP7,L36?\5W@*\Z=@Z_RC#9Q^G*L
M':C)=\N9E-$1448R!%E#J)J%<D*9,KDY#7.D(@<IK\+6$?I+3-3L[^W:8'-S
MAHJRN+>YMIR'85\:\1</:IHM_(V[C>872'+* 2UX)J#FV9CO;M!7;VE6\ACF
MK8PV3F-&D;ED7X!(F]W%A$F75<)"X\\2>[I@GU*6-;I(8.5>?<0.BN]9>+3R
MR<H\G&KJ4-*;>3I"]TX(BN--X5B.JDQ!H>[R\,D=216NP4J<=@*O\)MW7612
M?U/%9.S6D!4\E%%=%XQ(Z4ZN@$V:[YNV0=G.;@4J9C&/S !#C7%N-$U2UAZ^
M:%PBIB00:=(!)'=V;UV%CQAPYJ5U[':73'7%: $.;F.RC2X ./( 23NJ%SIW
M ZIR)YD+K-X%FZF6DBDS+)LV:2CEZP<,VB+$BJ;5(IUEF2K=J01,4#"F?JZ@
M MAK*>&=9M66K=/N'-C>PG*2:!P)S4KL!J3MVBE,5YOVA\)ZC-J+]=L&.FAD
M#<[6@N<PM:&U#1B6EK1B-AK7!:ETKI">89/D6P-@S,^VPAN_8Y"C&Y*U;,6T
M46)8I)A%P:)639XI&.W+?SW!U?-$YA$A!$QS#60<1<26DUA;Z3I<,/O(,=&7
MQDN,F=Q.>0EQ <T'*T"E!B<  L1X)X%U"WU2YXAXAGN&:$V1LP9. QL?5M R
M1#*'%CB,SR[-4^2W%Q*M>T-A/]AY&O(*'62B&ICMX2..:Q&C2X76.0!Z/?'@
ME ZIN?(M^DI0!I.F1Z7:B)M#,[%[N4\G0-@[^TE<3BGB*XXBU)UPXN%FPTB8
M?DMY:>D[:X] V *SX7G.08)+)RD&[.F G(#Y@H8QF$DW*-Q0>(7Z37*(@4X6
M43$;E$.-^1?Z=:ZE 8;D5.YV]IY0?O;#O7#T37M0T"[%W8O(Q&9A\QXY'#P'
M:-Q6]<QR70&<@A.2">2PD^Z*FI)! LDDW!EK?PA7OO::L6Z.!A'^&3#S#A;J
M'P#'+"TXETZMM&89+9OFYW84YJ>4.@X!9YK6I]GVNY;^X%S!J#P"_JF@&N_-
MF!C=C\H>4=YW+IS5;S"5L18LL$>>]1,<!D5"KF,$BDZ5,998TDD<J2B;E=0P
MFOT@0P?D?1 *Q+66:B+UTFI-I.[93S2!@,IQ%!W^7%>H<)S:&_1XX=!?GM(\
M#7SPXXG.#0AQ-3L /R<*+D79FB,NAI>1E,?8.,B@WCM=TE[@0SF39^\*'5,W
M<L2%]X6!,PB *)%.42VZND1M6;:3Q%8W$#(;EPBN6M .;!IIA4'8.@TYEY!Q
M1P#K%C>27>G1NN;![RX9/*>VI)HY@Q-.5H(IMH<%QM.87E;C9F*9>TSW(,?A
M<882;&7P)NW*2.G7[@5 0?2!U%"*HNF)S%MU)G.F*)?+%,3*";T2TU;3HM N
M=+ELH9KR=[',N"3GC:*5:T4Q#L=X!S',#1M/%K_1-6DXGM-8AU"XM[*UC>V2
MT \B5QK1SZD$.::;02,HREM75]#]);Q?R;]CAF8+&=N75FT-.'L+A98I/X)C
M)F$0\Y54"=*:_P"6<X@!^H3=5>3\0</111NO[ !K&XO9N WEO(!O&P#938OH
MW@;CJXNKB/1-9<7R/PCE.TFF#7\I.P.VDX.J35=>5@Z]A2B)1$HB41*(L.A_
M]'H#X76_CU*PS0_[+CZ7?.<LCU'][>/Y/S0KG:X!;T_LUV^]<'>I ?W?"HA3
MQ]OPXT1/ :** YA\WLM5W+5N4@  /KJ*52X#2A2A3PO?CQXTWIO5/'A?T\O&
MK@K@JK^D.511.=A]%Z;$V8*!^>KX$\"F_'U?CJ42F'.@<^'+\=/"GA4> 7]/
M&KOP3?@I"P7_  U"AJG +C3%,5%POQ^+U!Z*J8T4CQ#A4V(,$ >'&A0C'!+@
M >JFU-J7#G3%*'8@\?CY?AHFQ1Z!YV"W"JG,EQ^/X</;1,%/C^/\53<FY0(A
MRMZZJ"J@;_+3!4457A\53>IO6.Y9CZ64XW,8^HL=J649G;@X(%S(J )5$5!+
M<.LA5B%$Q;AU%N'C7.TV]=I]_%>M <8W5IRC81WEU6N:8W6=*GTM[BP31EN8
M;CM!YP"!4;Q@O+UZT58/';%< !=FY7:K 4;E!9NJ9)0"F_NB@<@\:]_C>V6-
MLK/,>T$=!%0OCFXADMIWV\OZ6-Y:>EI(/PA?-6I;*5469X;GN28(Z<N8!TDD
M5Z1,CQJY0*Y:N 1$XHG.F82F*HB*ANDQ3%&PB%[#:NKU/1['5XVQWK22P^20
M:$5VX\AIL-5D&@<3:OPW*^72WM D #FN&9KJ5H2.45-""#C38K5DN1RF63+N
M=F5DUG[P4O-%)(J*12((D01222+P*1-), #B(CS$1$1&N38V-OIUJVSM01 R
MM*FIQ-22>4GXEP=6U6\UN_?J6H.#KF2E:"@H   !N   Y=Y-58:Y2ZU9[@&P
M9K )8KV.4%9@X,F64BU##[L^0(/.W))TD41\M0.);B W*(@/4ZQHUKK-MU,X
MI,VN1^]I^^#O&_IHLEX9XHU#AF^%Q:G-;.H)(SYKQ]YP^2[:-FPD+T;AI=ED
M$3'34<IYC*3:(O&YQL!@(J4#"FJ!1,!%DC7(<M[E. @/*O#[JVELKE]K.*2Q
MN+3W-XYCM!WA?6&G7UOJ5C%J%J<UO,P.;RT(K0\A&PC<00KK8 Y</V*XRYE:
MJ>8445'^Y#U_CJK5RJ;" ^V_#QHIM"D>(5%-Z!R]'MHB@;7X@(\*H5&Q0%[\
MJ%4T4B/@(>SX!12G(G/@'#T_ :(>=>=^W,(R/'\LG9-ZS<N(F6E7DBSETDCJ
M-#D?N%'!6RRQ $K=T@)Q()#])C=/46Y1 :]LX;U:RO=-A@B>UMS'&UKF$T/D
M@"H&\&E:CEH<5\K\<\.ZMI>MW-Y<1O?93S.D;* 2TA[B[*2,&N%:4-":5%0:
MKI;MY9RL=@*RLL55LT<RSM]%E=73Z8XS5H4ZY04Z?+;+.DU#E\!XG#@8!K ^
M-I;>?66MMJ.E;$&OICY5788;2!0'O;EZYV6V][:<,N=>AS('SN?&'8>06MJX
M5V-+@XCEQ=L*S=GM?7DA*?4S7*H\[\5 2)U Y0:+*"8"E2;R*Z"4>X.<P@!0
M(J;J$;%O752\.:W!;^U26[Q#2NXN'.6@EP[HPWK(X.-N%;F]]@AO(C<5H/.#
M2=E&R$!CB=U'&NZJTWO_ %K.3CUME\$@O* W8(Q\C&MB&6>))H++JHO&B! ,
MHY3'WD2J$( F+8#  @)A+D_!NNVEI"[3+PB.KRYKB:-)( +2=@.&!.!V;:5P
M#M-X2U'4;AFNZ:UTV6(,DC:*O !)#F@8N'E$. Q&!H033G;66D,LGLXE,DR&
M7GF."'8Q97,3+LF<;$1 1(NU'Z\.[.S;R#AU+@H .#JJ*)H%)>X !"!F^O\
M%FFV>CQ6%E%"_6 ]]'L<YSWYZ!H>,Q:&LIY( !=6G*5Y=PCV>ZSJ>OS:IJDM
MS%P[U<>9DK6LCCZO,7F)Q:U[G25\LDD, K7!K1D&V]BJYO-F:1ZIT\7B%!0B
M6Q;IIN12#RC22B?T;G6 !\H#  II" 6 1-?@\-Z(W2;7K)@/>$@J\[Q7'(#S
M;Z;3W%V/''%<G$6H&"U<1HT!I$W8'4PZPCE/R:[&X8$E8+C&53F(2B,M!/56
MCE,0!5,!$S9XB W,V>H7\MP@?T&"Y1^D40, "';W^GVNIP&VO&!T9V<K3RM.
MT'P[#4+&M(UG4=#O&WNFR%DHVCY+AO:\;'-/(=FT4-"M^Y+E>E=@,&<OD1)B
M#RDZ*1) T&S,+DRJ10*<%5%45HYZ@-OX,Y_X<$P*41"UJP^PT[BK1IGVMB8I
MM/!.7K'84Y@"'-/*!Y-:G':O3M7UKL^XGMH[[51/;:P6@/ZEOE5&&)(+'M]$
MGRZ4!I2BWIIY;!$\9&/P>06?(-W)W,D#\0)+@[<E*0%GR'E(%(4Z2!2)B0OE
M"4E@$1 PUB'$[-7=?]?JS Q[FT;E\R@W--3O-34UQY*+TC@1_#3=(]EX<E=)
M&UQ<_/A)F=O>*"E0 &T&6@P)(*T'MO3.3ER"6R7'6BT['RSQ>1<-6@>;),7+
MH_FN" T  5=H&7.84Q1 YBEX& +7',>&^*+ V45A>N$,\;0T%V#7 8#'8#3;
MFICL.Y>9<<< :P-3GU?2V.N;6=[GN:W&1CG&KAEVN!)-,M2!@1A4\49UA.8R
MV5X'(1><36%,\-FWCW*<:;L""3+FZJ;8B<7*>\F34;%;"BH6QB'  7,<"E4(
MF<OK&CZOI=KIE[!<V<-W-=1-;#*78P$5J]E*@UJ#M'F@$EI<#X%K^A:W=:Q8
M7%K?3V,-E.YT\ 9^\ @ 1R9J%M*$8@^>2 '-:X=QZ@W8_;/&&*98X,\9.E46
M49,+&ZG3)90P)(-WZQQNX9F.8 !0UU$K_2$2?D^1\3<*021OU'36ALS07/8-
MC@,26C<[F&!W ';]"\"=H=S%/%HNN.,EL\AD<I\YA. :\_*;78XXMWDM\WLC
MV@->7]"]]V[%5PMPJ*;U'#PY\ZO3L3IV*W2?\T\?\.AS_P"5)74ZU^Y?K&?.
M"YEC^\?BN\!7R[&R\^"8E(Y*G&FE#,CM$P; L#=,IG;E)JFLNMY:IB(IJ*A?
MI*)A$0#A?J#T/2K$:C>LM"_('5QI78": 88X?=L6 \2:P=!TB34VQ=:6%HRU
MH/*<&@DT. )&P5.S#:-?K23[=VG)<8QBK#R<B46R;=RH(-G#R*=M'IB-G5B^
M8R>&1\H#F H%/U ;\D1'LQ%'P]KS!,X20MQJ!B X$8CE%:T&T;-JQU]S/QSP
M9-[-&8;J090'' NC<UWDNWM=3*"0*&H.Q< 2L3)P,BYBY9FXCI)DIY;AJX(*
M:J1[ 8HAS Q#E$#$.41*<H@)1$! :]+AGBN(Q- X/B<,"-GW<R^>[NTNK"X=
M:WC'1W+#0M(H1\1&((P(Q&"V;!;TV1 1H1;:;*[03*";=64;)2#IJ0I"D*FB
MX7NH8B90#I*H)P+R#APKJ+CA[2;F7KI(\KM^4EH/2!]ZBRBQX\XET^V]DBG#
MXP* R-#W-PV G'#=6M%BN1[&S;+&PLI_(G\@R%8%_<C"B@U%4M^@QD&J2)%/
M+O\ 1Z@-T^%<RUTS3[)W66L3624I7::=)JNJU+B37-7CZC4+F22"M<N ;7=@
MT &FZNQ:PR)],QL*^>X_!ADLP@1(S*#&4;0H/SG7235(,F\35;-/*0.=2YRB
M!NCI#B(5W5A#:W%VR&^F]GM23FDR&3+@2/(:034T&!PK58MJ,][;6,D^G0>U
M7C0,L76-BSDD ^6X%K:"IQ&-*;U>2B(E 3!TF$ $2WOTB(<0OR&PUQ#MPV+F
MBM,=JGT>OEZ_9Z>5 *HMTZ%RX,6S]@DY6\J,R!,T(\ZSF!(BS@Q3QRYBA]#J
M*_3(GU#^014_$ O70\26)O-,<6"LL1SCN><.]4]("S?@#5QI7$,;)74MK@=4
M[D!.+#^6 VIV!Q6WW6[LH;;C^S[ITV98JWR08)9DHR1*86QE/<@=K.CD%R!Q
M6$%0$# 4"C:UJZ-G#]F[0O:6-+KTQ9P:G;2M -FS!9C+QSJL7&?NZ5S6:2VY
MZHM+1LKES%U,U:^5@0*;J+--ZZF0RUHGDL0I&1L['DZ7ZSYPE'M)-B  !/>7
MJO0W3=-1"R9U!*!B#TF,  6W X<UIUD\VDX>ZW=YH +BT\P&-#O WXTVKNN/
M>$6:O"-3LS%'?QCRR\AC7LW9G' .;N+J"F!. IK73^DY)')(;*Y"<QA['P[D
MSL6D)+%EW(O4TC"S3579IF8) FN8JANE8XB!+6XW#M=<X@A-I)91QS-F>*5>
MW**;Z ^5LPV#:L:X-X'N6:E#J]Q/:OMH79LL4G6.S >2"6C(*'$^4=E-Z[8K
M %[>E$2B)1$HB418?#V^KT \+K?QRE89H?\ 9D?2[Y[ED6H_OCST?-"N7( ^
M'"NWVE</:4N/A2B43CZ;_BHF"!X\>="H5/H]-13P)R'Q$;45\"<_ ?CHFQ0'
MMJH>A3POZ_@-3%,>XIY_L444>H/V:=*O2@V#B//X>%$Q[BI#T#RYU><*\X4C
MP  ]?.@Y4'*GM 1#PM13PH-K</D^'&BHVJ;AZ:BF*6"E2E2GI *=*=*I#CP'
ME5*IPQ57/AQ#]BISJ;,4L%*E*E1P'AZ. 5=F*;,5(>/MJ%"H&_$0&J@Y%(<N
M=ZA0JGCX<_3X55? IX\. \[C1%HO8>](O!IE;'V\,XFI)JDW4=C[XFP:-S.4
MBKIH^<*#M554&ZA#B )@6QP#JO< R[1>$;C5K47LDK8H'$Y?)+G&AH32K0!6
MHVUPV+S7BGM&L^'+]VF1V[[B[8UI=Y08UN89@*Y7$G*03Y-,1C6M-/3'<QD;
MQLLA$P4?$*JD,0KM1RK(K(=0"'6D0R+5'S"WX"8I@OX5DUMP'8Q/#[F9\K1N
M #0>G$GO46"7_:]JL\+H[&VB@>13,7&0CG HT5Y*@CF7-:BBBRAU53F454,9
M110XB8YSG$3'.8PW$QC&&XCXC6= !H#6BC0* +R1[W/<7O)+R:DG:2=I[JHH
MM*YVR+NP[>\5FG6/S.R8TLFR6%!X2.B\@G&K9<H])T5)&$B)"/,JD:Y3E*J8
MQ# (& !"U9W8=F?'&I6C;VUL)#;O%6YGQQDCE#9'M=0[B0*C$57G&I=K?9WI
M-Z[3[W4X_:F&C@R.:5H.\%\4;V5&\!QH<#0A;$PO;FL=B 7[%9SC>0+F QO<
M&<DB26*4H=1CJP[D4)5$H%XW.B4+5T>K<+\0Z$?^]K.X@8/E.8<G<>*L/<<5
MDFB<8<+\1@>Y+^VN'GY#7@2=V-U)!W6A;%KH5D:41*="+TQUC"K8_@.,13H#
M%<HQI7#@AP$ID5Y!5215;G ;"!VYW8ICZRUX/K]TV]UFXN8_,+Z#G#0&@]VE
M>ZOKS@_3Y=*X:L[*:HF;"'.!V@O)D+?Q2ZAZ%G8\;>CYO774!9*/A01M:U.E
M*5VIS$!^6]$YDOSI1*)QYWMZ*)@HX^(^/P&BN&Y5>P?QU%$'PY\Z! @^'IN%
M @4>/X?DX5=R;ECV63P8QC<QD LE) (IH=T+1,Y4C+ 0Q0XJF*H":1.KJ.;I
M-TD 1L/*N;IMF=0OXK+.&=8ZF8XT[F%3N J,=ZZK6]2]SZ3/J9C,HAC+LH-*
MTYZ&@&TFAH 30[%K;',K6W#KW)V[9BI!R"[20A#"=0ZS SITS-Y)T'14P4.A
MTJE!8O1U$ WB @(][?:<SAC6K=[WB6%KFR;*.H'8U%:5P.4UH>98GI.MOX\X
M7O(HHS;W3F/AJ35F9S32CJ5(Q&84J*[\"N$YN"E\<D5HJ;8KQ[]"PG07*'TB
M&$0(JBH43)+H*=(])R"8AK#8:]=M;RWOH1<VKP^$[QX"-H/*#BOFW4=-OM)N
MG66HQ.BN6[0>3<01@0=Q!(/*L^QO<F?8LQ"-92A7;,A>ENE*H>_"T* 6 C95
M0Y52)E#D03&('@ 5T]]PQH^H2]?-&6R[RPY:](V5YZ5YUDND\>\3:-;>R6\P
M?;@4:)!GR\S234#FJ0-P5IG]GYUDS9=C+Y Z68.1#SV2)&[1LH4I@."9R-4D
MA.D!@ >DPB'"N19Z#I%A();6%HF;L<:DCODX\ZX6I\8<1ZO"ZVOKI[K9^U@#
M6M.^A#0*CF)HM83#I^RB91[%1AIN4:1SUU&PQ7C>/-+OV[955G&%?N_\E8F?
MN"%2!97^#2Z^HW !KO[6.&:ZCBN9.JMWR-#WY2[(TD!S\K<7914Y1B:4&*Q"
M]EN(+.6>TBZ^[9$YS(\P9UCPTEK,[O);G-&YG8-K4X!?0R6<.&;1=VT&/=K-
M6ZKIB9=)R9DX42(==H+E"Z+@6RIA()R?1/TW#@-:)FQLF<R%V>,.(#J$9@#@
MZAQ%1C0XA;D#Y)(&23,ZN9S 7-J'97$5+:C T.%1@:5"^G]KX?'6WX5NK8FJ
M\J^R&;PTFLL*,>LO]7RHB<Q$@8/OX!194 _*(S4,5?D/%.NEX@T_WEI4MNT5
MF S,Y<S<0!_*Q;W5E7!FL^XN(;>\D=EM7.R28T&1^!)YFDA_XJWSG>YLEQ_9
MGU&V6;-,<C'\2B^*LS(=1XT<(LW#Y8ZYRG5(3RW!O+%/I^B4!XUB&D<+6%[H
M/M<@<Z]D8\M(=@""0T4V;1C7?4+TOB3C_5]+XN]W1%C-)AEB#P6 ES7!KGFI
MJ0*..6FX XK86X=9M\YARRL8+%M/QJ8JH/5SD00?Q_2)U&;MW^20A0^FBH>Y
M"&N B4IS&#I>&->?I-R;:XSNLY#0M&):[8'!OP$#$\Y "RGCSA&'B2P%[9]6
MS5(15KW$ /9M+'.V4WM<< :C .)&B-=Z3FG\U%2S^4QL8Z+DVCM^S8S*$N],
M5JN5<J A& Z9)@X,ETB)EP$ $1L(A:LNUKBJU@M9+:*.?KY(R&N<PL;B*5\N
MCC2M<&KS;A3L]O[K48;VYFM#:0S-<]C)1*_R37+^;S,&:E,7C"J[E#B''XZ\
MD.U?1FQ.%,4Q3A?UTQHF-%;I7^:_XY#^.)74ZU^X_K&?."YEA^G_ !7> IG;
MC%D,5F S)=)#'G#8S9^*AE"F4!40!--N" "X.[%0 %,$P$_4 "'*O0=-;>.O
M6&P!-T#4?'7"G+7"BP;7Y-*9I,PUIP;ISFY7UKOV 4QS5Q;3&N.Y:SQ+>.J5
M@:X]&N%\=:,T$VL>$JT*QCQ23L0B2;DB[DB0VXW6%/J](C7;7O#VM"MU*!*]
MQJ[*:N[U!7N5[RQC1^.N$GY=.MG.MH6-#6=8W*R@W!P+@/QJ5Z5SKW$Y?B^4
MY)$DQT[=\K$,G#:2F&UC(/#+K)JMF:2H!9P2/Z5!ZRW*)EQ !'I&LHX7L;RR
MM7FZJT/<"UAVB@Q/-FPPVX+SCM'UC2M6U*%NFELCX6%KY&['5(+6@[PS$U&%
M7$;ER;BV$X[AJN2K0#5RV/EN2R.6S@KR+]^5>;E02!ZNW*^<N 9(*"B @BCT
M)$_N2@'"LZU'5[[56V[;US7-M;=L,=&M;2-E<H.4#,17SG5)WE>1:5H>G:*^
MZ?I[7-=>73[B6KWOK+)3,1F)R@T\UM&C< KM/3T+C$1(3^0R;.&A8MN9U(24
M@L5NT:H$$ $ZBAAXB8P@4I0N8YQ I0$1 !XUE97>HW3+*QC=+=R.HUC14N/1
M\).P#$X+F7]_9:79R:AJ,K(;*)I<][S1K0.4_ !M)H "2N(9S[P?4K5VI'XM
MC&=Y@[*HHFW.UCH^-8O?+ZQ\QL9U(*2O0<I>H.IF4P%N(@%K5Z_9]AW$TL8F
MU&XL[6*E2'.<]S:\N5H9WGTKO7AE_P#Q$<(Q3&WTFUO[V4$@%K&,:ZE<6YGF
M3GQC!IWEK'_])7'^\E+^IYV#3KL=7[<HBX EP#J*A]E 3,>W'I%0 X6ZO&L@
M_P"7^?JR?>C.LY/9S3O]=6G<[BQ?_F;M^L ]S/ZK>?:A7O>ST^'NK>N"=X?;
MULR:@CR;EYA^41QW"4']LF:;1%%S+HD8O4V,S'NW\40KE*Q!%R= 3%Y  WMA
MVL]EG''#]I,+<-NM.D ,G4.))##F:7,<&OP./D!U#O6>:#VR]G7$][ Z[<^R
MU6(D1>TM#0'2#*X-D8YT8S#"KRRNX+LXHB @8HV$.(& >/J$!"O*#R%>U T-
M0NN=?[RP]PV:M-D0S0TNT*DBEE/U.VD1=(H% $5) "(*R"+M("@'6D10#VN(
M$'GA&I\/7S7%^E2'J'5)CSEM"=N7'*0>0D4YU[!P]QWHTD3(>)H6&\8 !/U8
M?F V%] 7APY6AU=OD[]=[MVN7/Y5"/@UG!<6BP'W<%"'0&4?&_PL@J@8"J%2
M(2Q$2*!U% #&$ $_2':</Z-[LA,MP ;Q^W?E&YM>7>2.8;ECG''%HX@NVV]@
MYPTJ+96HSNWO(VT P:#B,3@30:KQ?*IO#Y=M-03P[5VW.43$N8S=VB @)VKQ
M&X%7;*EX&*-A"]RB!@ 0[F[M+>^@-O<M#HSWP>4'<1]V"Q/2]5OM&O&WM@\L
MF:=GR7#>UPWM.\=T$&A7J9C4XADN/PT^W3,BC+QS5^5$X@)T1<)%.=$XAP$R
M)Q$HB' 1#A7CMW;NM+J2V<:N8\BO+3?W5]6Z9?,U/3H=0C!#)HVOH=HJ*D=P
MX*^5QUSDHB41*(E$6'0W^CT/1=;XA\]2L,T/^RX^6KOGN61:A^]OY</FA72U
M_DM7;+A546M?CX5:I6J!;TT-4-5/ +<+<ZFU-J@>''G^*JG,G+B/R4YDVX*1
M$>0!42B@ M^SZ?552JJX?'443Q_'1%2("'+Q&K@K@=JU!LW;S/ 'D+C<7CTQ
MG.?9,1PKCV&0(H).W+9H4YG4G)R#L0:0\.W%,2G<' X]7(@@!A+YUQMVAVW"
M5S;:+86=SJO%M\'&WLH,H>YK <TLLCSDAA;0@R.S8[&D!Q'5W^ILLGM@C8Z:
M\DKE8W:0-Y)P:WG^#:M?_K5[DQ_^E*]^(7WG@11MX7*,=<!K$/M]VU;N ,/_
M %RP_9KA^\==W:=A_P!HC\2?K4[E/_RI7X__ (Z8%_9U/M[VU?W _P".6'[-
M/>.N@X:=_M$?B3]:O<F'_P!*7L_UZ8%_9W&GV][:_P"X'_'+#]FGO'7?_+O]
MHC\2C]:O<ES_ -E+GR_UYX%_9PT^WO;7_<#_ (Y8?LU?>.N_^7?[1'XE/ZU.
MY,?_ *4?;_KTP+^SJOV][:P/_8/_ !RP_9I[QUX?^'?[1'XE'ZU>Y/D':EQ_
M^.F!?V=4^WO;7M^P'_'+#]FGO'7=ON[_ &B/Q*0VIW)A_P#2D'_]],"_LZAX
M^[:S_P#@'_'+#]FAU'73_P"'8?\ :(_$@;4[DPX?[*7'_P".F!?V=0\>]M?]
MP,/_ %RP_9J'4==/_AW^T1^)1^M7N3O?_92#C_\ UTP+^SJ?;WMKI_[ _P".
M6'[-7WCKM*>[O]HC\2G]:G<IX=J7M_UZ8$-__-U/M[VU_P!P/^.6'[-3WCKO
M_EW^T1^)1^M3N3 ?_E2XB/#_ %Z8%_9U7[>]M?\ <#_CEA^S5]XZ[_Y=_M$?
MB57ZU.Y/_P#*C_\ YSP+X_\ P=4^WO;7_<#_ (Y8?LU/>.N_^7?[1'XE'ZU.
MY,/_ *4N'H_7I@7]G>JGV][:S_\ @&/_ *Y8?LT.I:[_ .7?[1'XE\[K>^U\
M504F=D]N,_BV(LR&5EI['L_Q3.W$4V+_ (1ZYA(E%F[%BW+<ZJ@'^@0!&P\J
MV9^U;C_0HCJ?&O!EW8\.Q F6>WO[6^=$T;7NAB#'9&C%[LWD@$T.Q1VL:C;M
MZZ_L7QVPVN;(R0CG+10T&\KI>'EXV?B8Z<AGB,A%2[%M)1KYN83(NV3Q$B[5
MPF)@*;H51. @ @ A>P@ U[;I^H66K6$.J:;(V;3[B)LD<C?->Q[0YKAS$$''
M'E *[V*1DT;9HS6)P!!Y0<0KCX<:YG0MQ><^[CD/M'+#)B E!>,((@-PZTX*
M+34#VE4*(#ZPKV_A4$</6P.W*_\ ^8^GP+Y2[0W!W&5Z6FHS1CO0Q@]X@K55
M9"%A:41<8]\>TY376H2Q4 Z.RFL_DQQP'J*ADG+.$3:JNYU=HH4;E672!)H(
M\RINC&*(& HAZQV.\.6VN\3FYO6A]I91];E(J'2$AL8(Y :OZ6 '"J\4[=N*
MKKAS@X6FGO++W4)>IS T<V(-+I2TC>1ECY@\D8@+PQY\?G&OL5?"*^HQ'L:Z
M #E<L'K<R:A;@JV<HF,4JJ2A?R%4Q,0P&*(6N @(5M@Q3Q?)?$X$;B#N/-S%
M;I$UM+CFCF:0=[7#>#N(PH0>ZO2SL2W3L+)-B.-?Y9G4C+X\GB$F]A8J:.@_
M<J2D>[C 31:2CI-24 K>,6<*"CYPD$B=[6+7S_VR\):)8:$W6]-LXXKXW3&R
M/CJT!CFOJ7,'D8O#1FRUJ=N*^F^P7C;B+4N)'</:O?RS:<+-[HXY"'N,C',H
M&O<"_!A>[+FI1NS!>LU?,W.OKE??%N$&LG'.G2?FMF[YHX<)!Q%1!%PFHJF
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M,KYZ2B+XVX2'O+\71F1F8K(C%E;IKE<IMP:(@X*_.JH=)587WF"04RD*"0E
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M+7/D0FM,\T+C6/8[(A"LCZMDF+K']@:R"#QR3CVDSCS9)XJ5VR717!BZ-YP
MDX % U9Y1R[:]U3)'7#DHOSVEH3M#V8D.7[0Q[7\FRUM!'U].SS[*%H*+C\1
MC%T'RVNMD/(R=BXZ?PUD[5(NK!9"+J.*LJ*AF_4H(F-=*,!6I0MC(\K8JFG;
M7VB3\\GON/PO )/WJ0CL[)DL9.K.-;/IZ$BT(>*V$IC+*9-K&0R>)AV2;="=
M.Q4?H((E*5P!2%L+Y!Y!3)'YP7XZ^TGV>=NTC&9WAD7KO7ZLK"/H/#9B2S,Z
MD/%8H^<,I21QO5Z.3Y"]A,.Q%VY3;+K1V/)LH\YB)&,D/22QQE<*&OW?=O0"
M-N(HMC9AH30^XGDCE^78/C&:NLMPF)P=_.**K.DYO!HS*V.>P\,#ED\*W<1;
M?+(]"02,GQ%9,!ZA+P'2'O;Y(5+&/-0K)FVANVK;45F^4YGB&%97&YTGB4GE
MV6GD3%!9;42LPIAF0-,HC9%NMCDKK]>0?&:23!PT=,3J*""I1 ;4/D!H/NJA
M;&<?DK%V/9+VHCARN+16JH9#'I?/X[<8R$3D&5M9]WLQK IX\VV4VSF/R%++
MB9>]@+H.)1*0*Z?)+*BNHJ*ZICTRR5VXT3JF4PV*J2[%>TV3Q7'L+4TMC;''
ML4=YHZQUM /)_&7L638TDXF,_BV\WCDQ%S@XYFL@Z4/*Q9W)HU^4W0L@=, *
M$ZV2M:IU3*4I@KSD?9IVPY7*X],3>FL157QF$Q'&8^/CTGT%C;W&\ 63<X'C
MF2XE!/8W%LQ@,)72*>(92[-ZUC3% 6Z:8T$K^5.J836F"M$WV@=I^0;-6S";
MUCB;W8DCDT9MHS167EDD5,WQI]%%9[4:X0C,I8\CF31RT:MUY])@5^LF;W==
MP=-4R9[UCZ8'!.KBKS[5UEQ#D%;/2MS#>N+.W'$&V<=HF$0*YBI+J%R]S'.3
MA<K22;YYE1FJXV 1\L1$2*6XBF<P!Q&O(?X4M3DTGLDT*\:*L'M@<.5IO[JH
MZ=XYP%@ T*+B+@ENF24;([.YCO1D;(_*>C<[\$D+G.3C7L/(/(N2;G:OF#A1
MJZ0/;J362-TF ! 1*<HVN4P")3%$! 1 0K[I@GBN86W$!#H7@$'E!^[$;MA7
MS->6EQ874EG=M++F)Q:X'<1X1R$8$8C!?#6XN,E$2K@B\1OO <=DHO>@3KE)
M3ZMRG%X5S&.1#^ ,>)1&)?M"&Y><W4;D4.7F!5R#_=!7U[V)7]O<\'^Q1D>T
M6]Q('#?1YSM<>8@D \K3R+X;_B$TVYM.//;Y ?9KNUB<QVZL8ZMS1S@M#B-P
M<#O"X<KV#IVKPI;WUT=[E[K!\3QE?HS&-+-0K0,BRIO%M)F,S!V]CW^*8TY<
M$BFT6S*RF%W)63B0*1R\=OA(54[L&XXGK(BTYEUJ%\/^[7Y'GJXBXL="&N;+
M*!G+S5C6E[8ZM8R*I:(\ZSOATSZQ+8Z3ICJ:Q'UD;>NG:QLC+ASFO@A+@QK&
MY9'.$3Y0'R/G+0]TW5G76P(>0A<PGV\@FVNYDWTBR>1S&)CH:5C'[M=PPEX)
MKCX!CR4)(MS@HV+'W9$2$"(V(4 #NM'N8;G387P%WDQM:X.<]SV.: ',D,GY
MPO:<'&3RR<78E8[Q!9W%EK%Q'<AM72N>US&1LCD8YQ+)(FP_F1$\8L$/YH-P
M9Y("M^(Y3-81DT'EN.O%6,S 2#>18N$CF(/F(F^FW5Z!**C5VB)D5DQ^BHD<
MQ# )3" Z]4TVTUC3YM,OFA]K-&6N!Y]XY"TT<T[00",0N/I&JWNAZI!K&G/+
M+VWD#V$<HV@TVM<*M<-CFD@X%?TQ8]*?7L!!S?E>0,Q#QDJ*'/R1D&2+ORKC
MQ'R_.M\5?GW?6WL=]-9@YNJE>RO+E<6U[M%^GFG7?M^GP7U,IFA9)3DSM#J=
MRJO%<5<Q93B.'3N;2I(J":^<H  HZ<JCY;-@W$P%%P\7L()D#P* &.<>!2F'
MA77ZCJ=II5N;F\=1NX#%SCR ?<!O(7=:'H.I<0WHLM.9F=M<XX-8/2<=PYL2
M=@!*[JUSJ* P),CRP2N0')TK2SA,H>[@8O2HC&HCU U2-<0$UQ5. V$>GZ->
M2:YQ+>:PXQ?H[(;&#?R%QWGFV#DKBOH_A3@72^&6]>?SVJ$8R.'F\HC'R1RG
MSCL)I@MM<./X/"L:6<*+>CD/P"K5*JR91 ,\KQK(,6D5'*+#)8.5@'RK,Z:;
MM-G+L%X]RHU45262(X(BX,)!,0Y0-:Y1#A58XL>'C:#5:7-SM+3L(7#SK[O/
M323=PHED6R3JIH*J)$^ML>-UJ$(8Q"])<5 QNHP6L W&N>-1E)V-^'QKB&RB
MI6KO@7-^F>PW,,M50F]G.'&$XT93S$(5/RC9=(M[E,F*Z*B:K:"35(-A!<IG
M)1N HEX#7)GOXV81>4[X/C7'BLW.Q?@WX5ZIX#K;!]8PJ<#@^/1\"Q+T"N9L
MF)WL@LF7I!S*2*PJ/9)ST\.M90X@' +   '522R2FKR2NR9$V,48*!9U>X"/
MR?%6TM:@;VJX53"JQ[)\:C,NA7L#+)B=H])8%"=(+MER?20=-SF*8"+H'XE$
M0$!Y" @(A7-T^_N-,NF7EL:2-.S<1O!YBNLUG1[/7-.DTV^!,#QNVM(V.;MH
M0=G>-02N0G_;3F"3T$HZ4A'C!100*[<+.6BR*75]$SAL#5?Z?3S!,QZ]+AX[
MTMT6:>.9LP'F@!P/0:CX0%X1==D>NLN<EI-;R6Q/G.+FD#\)N4[O1)6:RVOM
M<:LPE^KE!$IZ?E6;AJR5724%961]V,*:42B0?\@0;*& YUS"!P"US<2DKJ[;
M6M<XAU9C=/K#91N!< < VNUY^43L#=G-M*R*^X7X4X,X>E?K %SJ<['-87#$
MORX"(?(#3B7DUY3B&KCE0_EIG/TG/T$,?H3+U*'Z0$>DA>'4<UK 'B->EM&9
MP;@*G?L[J\%<<K2ZA-!L&WN<ZU0JUB-]:DD([(,9R;%XS-XN3CG,%EL46)R:
M(.@^<-6;]>.44<E;.F[QDF]:"(F 0\L_C:LG;)<\%\31S6-Q;W%Q:2L<)(7Y
MXG@M!<T. %6EKC&_#T@L1?%9]H'"$EOJ-K=6MK?1/8Z*XCZN>,M>0UQ82X!S
M7-;+&:^B5_/CL/ Y[6>9S^#Y*AY$K /E&JAR%.#=ZV$ 4923(RA2F48R30Y%
MDC" ")#A< &X!]P:'K5EQ!I,&KZ>ZMM,P$<K3L<QU/E-=5KARC#!?GAQ'H&H
M<+ZU<:'J;<MW;R%I(K1PVM>VN):]I#FGD/*L+KMMZZ1;%U7J_*-P9E'X3B2"
M)Y%X11TZ=.E!28Q46V,F#R4?*%*=0&S;S2A8A3'.<Y2% 3& *Z+B3B+3>%M*
M?J^IDB!I   JY[S7*QHY30[2  "2: K).%.%M5XQUJ/0]':#<O!<YSC1D;!3
M,]YVY6U&P$DD  DA?T):EUS':FUWB^OXQ<[M''V)TW#Y0@)G?R3QTO(2CX4P
M,?RB.9%VJ8A.HWEIB4EQZ;U\.\3Z]/Q-KMSK=P,KYWU#1CE:T!K&UWT:T G"
MIJ:"J_1'A#ANVX1X<M>'K5Q>RWC(+S@7O<XO>ZFX.>XD#&C:"II5;<C8">F
M,,1"R\J4@@4XQL<\? 0P\@.+5%4"C[:QF>[M+6GM$L<9/I.:WPD+,K33=2OP
M38V\\P&WJV/?W\H*R5CJ_8<@J5%##YY,Q^ &?,%HQ(/[Y>1!JB3XS!7 FU_1
M81G?=0D#T7!Y[S:E=O;<&\4W;Q'%87(<?388QWY,H'?74>I-*&Q1R3),G]V<
MS9"_YO8)"5=O%&,%CN%%;="[^WT2B2Y$P$1 3"("7S_B3BL:BPV.GYFVI\YQ
MP+^8#<WEKB>;&OLW W9[[EF&JZSD=J('D,&+8Z_*)V%^X4P;C0DFHZ-X</3;
M@%8.O5E/#A>IT)T*!&P^%4! *JW2G\TO<1_AF_\ &DKJ-;_<OUC/G!<VQ_>*
M?@N\!5AVGLAEK> +('1(\EGZAVL-'G.)"+N"D RKAP8OTRLVA3 *G3Q,)BE
M0ZNH/2M&TI^JW/5URP-%7NY!N YSN[IW47FO%?$L/#6G^T$!]W(2V-G*=Y._
M*W"M-M0,*U'%3??FRDITDRM- Y1!0!4A3())Q"B%PZFX-R% Z7T> * ?S0_W
M0UGS^&])=;^SMCH:8/KY5>6OWMB\1C[0.)F7XO7SYF5QBH!&1R4VCIKFYRMT
MY0AC'<3%P[G&9EE#YK$HJ@O#3 JHF,V<"47#<3I(JG=)-UDNM-9 J@%*<04*
M036+T-H;OA>9[+R-TFGO.#V4.(V'$BA(P(--F!-,<VU5FE]H]K#)IDS(=;A:
M:Q25'DG:*@$N (JUS0X4-' $X<^YWJ/+]>MV[V;28.(YPL5L1_&.S.6Y7)B'
M.5!0CA!HZ3,<B9A 13Z!M;JOPK)M.UNQU1QCMRX2@5HX4-.7 D?"O/-?X0UG
MAV)L]\(W6SG90]CLPS8X&H:X;#\FG/5:PKMA@L67D/\ >-X2SC<OP3.V3,$5
MLHBI2&F7") *1P]QU1@=@NY$I0ZG:K"4%(#&&YDFQ0#@2OJ'L'U>6XTN\T>5
M]66\K'Q@[FRY@X#F#F5H-A>3O7QY_$EH<-KK-AKT#*/NX7QR$# NA+,I/X19
M)EJ=K6 ?)7&VH-B/M?S<O[O.91 -LF@)#'E9/%'12248[>%*$?+)L%Y&)8R9
MFBO4D*:KEN)47"AB*D-81]:XDT6+6+6//%;S/@F;(&RCR7!OG,S!KW-J*&H:
MZI:T%I"\7X/XCGX>OIC'/=6\=S;OA+X'4>QSO,D#2]C7Y35M'/91KWD.!7HA
MVO.8V"[F-B8]CSYA(L9'%7</DC=C$/8)PSR_7#K'8"9R-[%JLTV#!CF<TJ_?
MMTVRAB)B\\HQ$3I^57AG:5%-=\!6-]>M>R:.Y#XRYX>'0W+9)&1-?7,YT+!'
M&XN%3DS N#LR^C.RN6VL.T[4M.TZ2.2"6T=',&QNB<VXLW0Q23.C+0UC;F0R
MRM:PT'69"&%N5>UV@M<,,XGWLE-%3<0V-E9JK1YQN$@]>"X]S17);BR3!HH=
M0!$.L0*7B435\J<2ZK+IULV*WJ)Y:@'T0*5(Y\0!R8GD7W!V?<-6^NZA)<WM
M'65ME)8?EN=7*#^",I)Y<!L)73.3;[P'#9-SCPMY=\YBC>YKIP[!J#-HJB %
M,U [MXQ*(H6 !\LIB /"]P&V)6G#6IW\(N@8VL?B,SC4@[\ =O.:KT_4^T#A
M_1;IVG%LTDD1RD1L;E:1\FKG-V;, 0-FY8._[J\?(D88O%IETM;Z!7[IDP2O
MZ3';FD36#T 6NPBX-N2?STS WF!/ARKHKCM8T]K";6TF<_=G<U@[XS^!8.'=
M5E'OA3CC, +#JN9L"LB#LQ./T0>BX,B4WK]W$/578_8VRR4ZZ7K>7R:=ZG_Q
M+HO\6-5ZX.-K;^SU\VK\U/Y5: _B'H73^N=EP>R8YR[BDG+-W'G13DXUV!15
M:'<%.9$Y%DQ%)PW7%$X$,'2;Z ]12CPK#]5TFXTF41S$.8ZN5PV&FW#<145Z
M<"5ZEPWQ/8<36SIK0.9-&0'L=M:36AJ,"#0T.!P-0%L6NK62)1$HB41*(L.A
M@_S>@(>E;^/4K#-#/_=D=>5WSW+(M0_>W<GD_-"NEQ$.%=MO7"P!4"(ASM53
M#<A?'TT*%3^*HHH$WHJT5 2X\QY4HE$\;^KX7HFZB>D?"W#TT1/5\OL&G.G.
MH$ #T\>5*J@E N''T54YES#BG_S9;6_^%^"B/M%ZX&O"M!__ + :_P#^A6/S
MW+'K?_W'<_\ 9X_"5A'?KQT43_GMCW_>LO7'_B0P[.A_ZA#\V5=5Q_\ V#^O
M9X'*Z]C-@[?X?_G%DP>K^?A7+_AXQ[-(.3VJX^>MS@6OV>9_./\ "N ^[O7N
MTYK[QEKM[0PJN]W=O79-BFQ\+Q!1Z=G#[5A_U[Y_%; U!,")BMP'/\.<N&T<
MNI8K*9(S<"8A4S&#WN(M$):[S"[[VU9/*#UM6[0%YSXN\WEOYMVOSG9]E$;K
M/8^V]J_?"9/@N4; C)!A)8Y"9=L9QD"")&C45%<?S-ZS=I,DG"WF$BG"YG E
M4.@4AMXY6$Y\6@-6T,SZ%F!)<NGXC)>W&;1^[P'-L ::R[4]89-W!X7W':XV
M<",AA^K>]N+QS&&V*E[F)'(R#'S4JXE5\D<Q613('1?R;YN[44*HX1MIH\9J
M&KS2G1S+55ODUP8*UZ>=8E&[I[1HG%N[*,VA@&L&6H<0[C>VG/X/#NW'902W
M;AW![:S2'S9G$0+,NS<3P35<5A*KW6I7.5.4#I8^O(Q+A99V=1HH16Y7FA'G
M4(Q&('W;$S,Q'R:C8<#X%7 1?:[B.9]A\EN;/.TW)],93MW[P;/<EAX;)<&S
M#M?U+D&>XUAF1PNH<3EY]!MBZK?$5I)IT"9JR\Z4<JKH-D"*IIA#G(=E!S4'
M3TH,HRYB,M3T;L%Z._=NM\0+DO>$^T0R*P[0Y3>,$Z[=48AFK'8 NN76V+I;
MF?ZK8G319IZ\>[1!X9FHP(6,7< N=H)DA :VI]C:^?O6Y%\K+YF[XEQ_VN=U
MNA(#[KW,=2,=S:B6WO$:5[P5V&HY3(L1FLK7EXL^Z,M1CY'7DLJ\4ET#1#7W
MI=FY:+(+LP-YB9DA, ZG1O,^8@Y,,5I:]HARU&;%8)MGO!VYA^O-Z3ZG<TMH
M[9.H<9[;8G07;]%X9KTL3LS LXU7J/(<EV7]2R^)2,]E2,GD^2SL>BZA'#.*
MQ4D&";E(;G VL1M-*-J"34]]:7/<*U-* 4'>6V'/>MG"'=QB+&*WO)/,>R#O
M5S'MLR'5.8O]*XM$P^&0R.6XTT"'U3$)91N5H\3S&$:^XY7.ST02=.Z1.A$E
M;O&Z(0QC(<-U4$CLU:[Z+ ,7[IN\7#-$:-W&CM3(MTYYOS[N;N-WRXP>?P["
MT\>Q[:NHL?U1,81+X5#X?B\-.K&%KFKOZT8.73\)98@"B1N(D2*+(RXM(H \
M#N% ^3*'5Q+"? L3S?;\CCV[\ES'3G?/ [AR*!^[UDGZ.Y\X;X?*PFO9K+^Y
M_MZ;Y RE,DU+K*9@8!G-P[HWN:4C R:V(G<)O905(\2]%:T9:.;3ROO%"XYJ
MM=4T^^O4;[O3=61;;P_;L/DV999GDEK+9Z6,%R#))W4>P(_W24PC%,I1CL8W
M%I!O$X'M2):*3)S^^#$PTHP.M[D]:%50 Y]B9H:104K]V];T#JUYBMV=F?\
M\MFM[_\ MA_]_<IKP3^&O_\ 2FB__P S_P"_NET_"_\ 84'+Y?\ \QZOF[]6
M#E3$<D@6_5D4:C_E+=(H=<PP3 1%, *6ZC]J'%+Q.2Y.(] !]4<)\0^[Y?8+
MQW]"D.!/R''P-._D..RJPWM%X,.M6QU?36?]ZQ#RFC;*P;N=[?D\HJW$Y5PN
M8HE,)3 )3%$2F*(" E$!L(" V$! :]:P.(V%?.!!:2#M"BJ"HE$7.W<UH]MO
M+7#J%;%01RZ#.I,8<_5Z2%+)$2Z7$4Y6$O41A--R^4?B!2*@DJ-_*L.=]GO&
M$G!^O-NY*G3)@&3M'H5P>!Z49Q&\MS-PS57G':?P+%QWPT^RBRMUB F2W><!
MGIC&X^A(/)/([(\URT7\_LO$2D!*/X6:8N8R6BW2S&0CWB1D7+1TW.)%D5DS
M  E,0P>P0XA<!O7VU:W,%[;LO+1[9+:1H<US34$'$$%?GM>6EUI]U)8WL;HK
MN)Y:]CA1S7# @CF5<'-2..3,9/1*Q6\G$/FT@Q6,BBX3(X:JE53\ULX(JW<H
MF$MCIJ%,FH01*8!*(A2[MH;RVDM+D9H)&%K@"1@10T(H0>0@@@X@U6JQO;C3
MKR*_M'9;F&1KVF@<*M-15I!#ARM(((P((*SO8N9X[EGU.G#XI&0 P\/!L6Z\
M,M*MF9BFBR/LB:+Q,F\DR@<V8/WJZ*R"J)2IJ&()%"BF8G4Z+IE[I_6FYN'S
M"221Q#PTGSLL9#VM9_D6L:X.!J0#4&H/>\1ZSIVK=2VSM(K<PPQ-!C+VM\S-
M,TQO<_\ TATCFN:YH )!#AE+<N[<])3.[=AQ<,@U6+BT4Z:R693 IC[HPAD5
M?,.R\T1*4TC,>6+=NF7J/<QE!+Y::@EZ?COBZUX1T*2Z>X'4)&EL#/E.>10.
MIZ+*YGG9@&US.:#W/9OP/>\<<1164;'#2XGM?<R4\ED8-2VOIR4R, J<2XC*
MUQ']#+=NBT00:MDR(MVR*;=!%,.DB2*)"II)D*' "$(4  /0%?#4CW2O=+(2
M9'$DD[23B2OT5CC9%&V*(!L;0  -@ % !T!?M6FN'.M:[T[=6#=MK\KQ-(A7
M$C*OU'*H '6J#8Y6R!3FYB5(I!Z0Y!U#Z:\?XWF>_6>J).2.-M!R5Q/?^\OI
M;LJMHHN%Q<, $LL[RX[SE.4=ZF'25OGU>VL/YUZ7SJ.5@\*NU-O2IX^JI@F"
MI$?#Y?VJH"H"KJ+2J1X!P]/C5VJ[2IO410(7$;<_FJU5!H@!:]Z'%0FJP[.\
MTC\$Q]Q./B"N8!!NP9$,!%'KY0IA1;E.(&\M, *)CGL;H(41L(V >ST?2I]8
MO6VD. VN=N:T;3SG<!O/(N@XDX@M>&],?J-T"YU<K&#:]YK05W#"I.- ":$T
M!XF=[WV*YF"2J<LDU134ZDXA!LE]5BE<1\E9$X&77 0X"8RG7X@(>'JT?".A
MQVQMS&7.(\\DYZ\H.P=%*<H*^>I^TGBN6_%ZR<,8#A$&CJZ<A!J3TEU>0A;A
MF)'&M_8[&L&<DT@,WC#G<-HV2,<J2AE4TR/V[=<J9A<LW )E.4R93+$\H.M,
M O6,VT%]P;?/FE8Z;29!0N;M%#Y)(K@X5H:T!J:%9[J%WI/:=I,-M;RLMN(H
M27-C?6AJ 'M::>4UU 06@N&49FTJM&YCI_,L(CQE91%@ZC$SI)N'L8[%=)L=
M=0J2(+IN$6KDH*J& H& @EZA !$!$+Y;IG$NEZM-[/;%[;@@D->VA( J:4)&
M QVKS?7N!-?X>M?;;QL3[,$ OC=4-)-!F#@UV)- :4K@=H6KQX?#TA60;JK#
M5Y?_ 'CV$,OJO =B-F@$D"2+K$I5VFF "X;+M%I6)(X,4+F%N=FZ @FY >WH
MKZ'[!=8F]IO="D=6$QB9C3N(<&/ITAS*]%5\M?Q*:'![+I_$<3*7 D=;R.&]
MI:9(Z]!:^G31>45?2I7R6NRNP^==P_<'$,FZ)UD,DQ[(81\!"]7DMR-4YM-P
M;@(%*F[ATP$?080\:\I[9;.*[X(EE>0'V\\4C><UZLCNM>>\O:.P._EL^T2"
M",$QW-O-$ZFX91*#W'1C[BOZ*-08(WSO*0:OSVB8M$)&22*82*NTBJD32:)B
M6QB@NJ8 .8! 03 ;"!A"OA?B75WZ/I_60C^DR.RM.X&E2X] V#EIN7Z3\"<-
M1\2ZSU-R?Z%"WK)!6A<*T#1TG:=S:TQHNM,DVW@.NG88R9N],O'(()C&P<>A
MY#!,Z*:K=$17<L6Q1% Y3=)#&$ 'C8:\XL>&]9UR/V_,S)(X^5(XU<:D$X!Q
MVUV]Q>W:MQQPUPK,-'+).LB:!U<+!1@(!:/*<QOFD&@)YZ+"GG<YBY"&%CCL
M\Y4 +D(Z/'LR&-;@!U$G+\Q0OZ"C7:Q\ WY/YZ>%HYLSO"&^%8_-VP:,QI]F
MM;E[]V;(T=\.>1WBL(6[GI\S@IT,8ATF@' 3(JNGJS@2=07*#D@H)E.)>0^4
M( /A7;,X!LA'1]Q*9*;0&@5Z,3\*QU_;%JAD!BLX!#787/+J?RA0=W+W%T#K
MG:<)L1%PFS0<1TLR236>QKGI4 J9Q OGM72=B.6X*CTW$J9P'F0 $!'"]<X>
MN]$<UTI:^V>2&N&'<(W&F.TCG7IW"G&>G<51N; U\5[& 7QNQP.]KA@YM<,0
MTUVM&"V9RY^/HKH>A9ET)S"_HX4YDV&BMTG_ #6X<O.;\_\ EB5U.M?N/ZQG
MS@N98_I_Q7> KGWNJA5UXG%IY/J,C'/G\:X* "8I?K-%!P@J(A^0 &C3%] B
M8*]GX-G:V::V/G.:UP_%)!^=7N%> ]K%D^2SM-0;7)$][#^. 0>;S".Z%Q/6
M?;UX>M^=ON$/\DS%K/%.NUB<6<(OG#I(1(+A[<1:QI#7#J*L "98 O9(+#;K
M+6.<3:C%:V#K; S3 @#D&]W<W<_05Z#V>:'<:EK++\%S+2T<'%PWN^2P=.)=
M^#@?."VMW39*@2/@<22,4SI=R:;=APNBV0(LT: -AN KK*J"'_)^NNEX.M'&
M26]=Y@&0<Y-">\*=]99VK:G&+>WTAA_.N=UKN9H!:WODGO+BVL]7B2TQNK4F
M'[VQ5Q@602)F;UBY:SD<\C5FJDM"/RI.&S9Z=FJ(BJS<H.%$U$S@4JI3#TF*
M<I3ERWA+B?5>#=1;K5E&'PO:8W-<"&2-J"6YAL<" 014@[002#A7&_!^C<>Z
M2[A_4)2R>-S96.86F2)]"T.+3M:02"#0.&P@@$<))_=J.?>R@KN! 6/6 G,3
M!U"NQ3OQ*4ILK,B4XAXB(@ ^ U[*?X@(S'Y.ENZZF^X&6OU-:+P5G\,DG7 /
MUEI@KNMCFIT=?2O=*[DTQV_X#H]D^+BZ3^1G9@ ^O,IG%TW<U)@!P6\@5$DD
M&[5D5>YP23('4:PJ&4, &KQ[BSC?6N+Y6'42QEI%^CAC&6-FZM"22ZF&8G^2
M&C!>[<%=GO#_  +#(-+$DE_-^EGE(=(_?2H #6UQR@8G%Q<15=J:1V C@F7%
M-(J"G!SB1(Z54^ETM# IULI 2%_**U5$2G]"2IQ !$  ?,N(-,.I6-(OWF,Y
MF\_*WN[N<!>V\#<0LT'6*W)I83C)(?1QJU]/P3@?P7..VBW-MO0DC.2CO+\(
M52?FECB^?PRKA)(RCA8 .=W%NU#$;J)N;]8I*&*(&$1*80$"%Z'1.)(K>%MC
MJ(+0S /H=@W.&VHV5'= VG->+^ +F^NGZSH9$AF.9\9(%2<2YCC0$.VEI(QJ
M02" /.''<=WE [7V:GL64ASX$*K)'!L>08E:34*HE;WDCX18(.;F2$?-%9PX
M!500.EY:8]->PZA><(W7#FG^Y(I1K8#C<2%U6/Y,OE$;?-RM;08.S'%?->FZ
M;QWI_%VJ-XDEA/#]6BUA#0V2,CSLWD!VSSLSWYG4<S*W!?=DB^T4LTP1#%6&
M+.\#7/)%V"]E5W2,ZS(1K>-/!I(KE0-YC@+& 4UA$P@ ]!;G#CV$?#C])O'Z
MD^Y;K(#/9FL ,;L?*$A(K@.<<HJ<%OZF_BIFMV$>DQVC] <7^UND+A*T!OD&
M( TQ/,[' Y1Y2]'>U>">-8S*)YPBHDUE%XYBP.<HE*X"/!ZH[5)<+G3*H[(4
M#<NH#!S ;>1<8W#'2PVK2"]@<YW-FI3P'X%])]E%A-%:W6H2 B*5S&LY\F8N
M(YJN KR@A=9UA2]=2B)1$HB418=#A_F]#TW6L/A_AU.%89H?]EQ_C?.<LBU'
M]\?R8?-"N0@'( ^3T5VX7#%5(6'A3%3%2/AP]EO"H$" %$)46M<?'PJU2M<$
M +\^=Z55JI]?"]111Z@^>KSE.<IZ+\Z="=&Q2(7^*IL38HL-[U:JU%%S#L.+
MR_7>UD-SXIBC_.8*;Q=MA^P,;@O+/DK-".?K2$9DT$T751)**()J"W5; 8!,
M4 $+7$Y/#N,++B'@[CYG:9H&GS:KI5S8-L]0MH*&Y8V-YDBN8&.+1*6@]6^,
M$&E#A4N;CUZRZL=1&J6T;IH7QADC6^< #4.:-]-A'_2-7;=V?KG<V*!AN4ZY
M[DXZ-)*LY;SH'7/NS\'3 CA-)(57Y)5MY(@Y-U "=Q$ L8/'#N-NT;A#CO1O
M<.LZ+QG%:B9LE8=.+7YF!P J_K&T\HU\GDH5U>KW>GZS:>Q7<%^V/.'5;'0U
M%>7,-_(OHU1MC7>GL0;85C6N>Y!]%M7CY\FXG=<&<R K2"WGK%.JP+&-A3*?
M\D 2 0#F(UN<&=I7"7 ^ALX?TC1>,I+)DCWATVG%SZO-34LZMM*[/)Z25JTF
M]L-'LA8VT%^Z(.)JZ*IJ34X@-'P+/O\ :;P[WP7X:DW>#XS8K,SP-5N_>Q9E
M4,L5J+CWOSA;E6,)P)?IZAO:]97_ (]Z*!3W%Q7_ +LD^FNR^T%N<?9[RO\
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M*)^  Z=K$ A/$H=1["!!"N@XDU.#3-,>9 '2R@L8T[R10D\S1B>X,*K,>!M
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ML<_1=JD39-WP^80CE,ZRP%2.4Y3E$]N(?1K'-(U:_P!)F=9F-SXZDNC-0YI
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MJD9=PZ<+J"5-%!!(@F,8P@ %"XUL7-S;V=O)=W;VQVL3"][W$!K6M%7.<3@
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M_C>B5HIM\@5$5JFX=E/Q$A"R!!48R;55HX*4>DX$5+8%$C" ]"J1K&(-AL8
M&N3:74ME=,NH326-P([FX\QV'F7"U"QM]4LI=/NQ6WF86NY:'>.<;0=Q 7%[
MSMMS-.5,V8O8AS%F5LG)K+J-SE0$?REV8)*J L4O,I!. CR&O4HN.=*=;]9,
MR1MQ3%H%<>9U0*=-.A?/]QV2Z^R]ZFVD@?9YL)"XM-.=E":TW D<ZVB_G\9[
M?\9;X['$+-Y2_*+Y<#60\]<Y12!_("3S#MV"9B=**(&$Y@ ;" B8]=!%9W_&
M=^Z^G/5:>PY1OH-N5NRKM[G;/@"S.YU+1^R_2&Z7:TN-:E&=VZI.&=]*EK!2
MC&5J0#0[7+DS+<MFLUF%9N<7(HY.0B***)!3:LVR8F%-JU2,90R:)#',;B8Q
MC&,(B(B(C7HNG:=:Z7:BTM 1&#4DXEQY2=Y^#<%X?K>MZAQ!?NU#47 S$
M4:UHV-:,:#$G:222222M?*K9 7(6;=&/C#XN>)>*OI-207)+H31'38K%HA&
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M+ST 8-"W>[>-8]H[?OET6;)BW7=O';E0B+=LU;)G6<.%U5!*FDBBB03',80
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M=CAZ33L<T\HZ#0U"L5<W<NL7HOIB9+.:Y@3>[F1&-0&%4*8H FL,<!4 63X
M!B+)"43?[_J#PKQ'BFU-IKDWE5ZP]9SC-C0]!V<U%]6]G^H,U'A6U.3*86]4
M<,#U>%1R@BE>>H6=L\;Q^/=JOV,##LGRPB*KQK&LT'*@CQ$3KI(E5,)AY\>-
M=/+?7LT8AFFE?"-C2YQ [A-%DD&DZ5:SNN;6W@CN';7-C:UQ[H *O?+D'XJX
MFW:N?@HL/#Q\;^JJJH$>/R7I14#!5>%PJ+3O4!XC?U^RJ52@^BW/XJ*\ZCGX
M<:;$V="J]7PM46GG3VAQ_#3P*^!!]MN- @3AP]?ST1:_V?D$KBV$S4U#D*9^
MU(W(B<Y 5(V!PZ1;G="F-RG]W(J)@ ?HW +W#A7=</V5OJ&K16ET?S+B:[JT
M!-*\]*+&>,-5O-&X>N-0L #=,#0"14-S.#2ZF_*#7'#E7'N";9SM'+81%YD+
M^48R4PP9/FDDJ+I$S=\\2;K&0!2YFRB9%1,GY8E*40#@);@/INK\.:._3I71
M0,CFCB<YKFBAJUI(KR@TQK4\]<5X-PWQOQ)'KEO'<74LUM-<,8]KSF&5[P#2
MOFD U%* '=3!>@0W]%Z\87T\K/D+4'T#-,^D#>]Q$BVX^E=FLER_^U7*L9.J
MO(I/1E:>\X%<'5(/:=,N+<_+@D;WVD??7C;M!CGLE@F0LM82L9"9RNV1+!2<
MPGYC%NH#QN9WU_Y,]*FNK'E5(D<R*I2*F*(A8+A]0\.S:+;ZS!+Q#%)-H[7'
MK&L-''R3EIBVH#J%P#@2 0#7 _!O%4'$%UH%S!PM-%!KSFCJGR"K0<PS;G4)
M9F#26D!Q!(IB+QAC;)VF)XXTS5\QD\N;PT>CD<A&)BFP>3)&R97[AH446P^2
MHN B ^4D!N8$( ](<75I-.EU2XETECX]+,KC$UYJYL9)RAV)Q YSR5.U<W1(
MM5ATBVAUR2.76&PL$SV"C'24&<MP&!/X+:\@V#OW2NHVD/'M<JR9@1>;>E(X
MC63Q(#%B&I@ R*QT% L$BL'TKF#J1*( %C=5>-<5<2R7,SM.L'Y;5F#W-/GG
M>*CY(V?A<XHOIGL\X&@LK5FM:O&':A(,T;'BO5-.PT/^4.W'%HH!0U70#^;A
M(RQ9.6BHTQ@#I*^?M&9C /B .%4Q$!K#(;2[N,8(Y) /1:7> %>GW.H:?9$-
MO)X8B=SWM;\XA:MRG4N [$$\NR<),WZMP/+8\LS6;N50M])XBF"K9RH <S )
M%!\3#60Z?Q)K.B4MIFET(^1(' @?@G @=\<RPK6>".&N*:WUN]L=R[_*P%A:
MX_A@5:X\X(=RE:^:]KT:1R0[S+GKAF!RB=!O$HM'!R7XD!RH_=D(82_W7E#;
MT5W,G:!,8R(K9@EIM+R1WLH\*QB'L<M&RAT]](^ '%K8PTD<F8O<!TY>XNA"
MXE!%QD<1!D0L$9@:.%H6_P#@3%'J4\S\KW@3CYGF?E>9]+G6%G4KPW_O/.?;
M,^:O/R=&ZG)@O4AHFFC1_<38Q[MZO)EYCOKZ5<:[:X[5CFO]906NRRH1+A\[
M7E5$177?'2,<C=L*XM6Z944D4P!/W@PF-;J.8;\ L <[6M?N];,?M#6-9&#0
M-KM-*DU).-,.3X5U/"_"&G<*MF-DZ2229PJ7D8-;7*T4 &%34[2>:@&QP 0]
M?XJZ)98<5'"_.W$>'&JJIO;G\ J44IR*VRG\UY6_AF_#_'$KJM:_<?UC/G!<
MRQ_3_BN\!5_E8J.G(]U%2S-!_'O4Q2<M') .DJ01 0N \2G(8 ,4Q1 Q#  @
M(" #6;PS2V\HF@<6RM-01M^[P["L6N[2VOK=]I>,;);/%'-(J"/BV@C$&A!!
M"UQCFE=?8M-IS\3%+E?MS&.R]Y?NG2#$YRF(8[9)90US]!Q #*"H)>86'C7:
MW>OZG>6YMIGCJSMHT GI(^]18UIO!'#NE7PU"TB=[0TU;F>YP97#R03MIO=4
MC<MKUTJRU?@Z:MWS5RR=I$7:NT%FKE!0+D6;N$S)+)'#Q(HF<0'U#6ICW1O$
MC#1[2"#R$8@K;EBCGB=!, Z)[2UP.P@BA!Z0N'LH[8LF;RJOV4>,)&'64,=N
M$BZ]S>LB&-<$70@B=-R"8#8%"6$X!<2%'A7H=GQ=9OA'MK7,G&W**@\XY.@[
M.4KPO5.R[5([L^Z7QR63CAG=E<T<CL*.IRC;Z(6W]6:#CL*<HSV0.49K($@Z
MFB228_5<4H(!=5N"Q05=O"A<"JG*0" /T2=0 :NBUCB22_8;:U:8[4[:^<[F
M--@YL:[S3!9CPIV?VVB2C4-1<V?4!YH \B,\HKBYW(X@4W"M"L)[@-L9+!S!
M\+Q]56'1]P;.)"51 Z4@Z%X4Y@08. $/=VQ$[ 95.R@J )0,4"CU=CPUHMI<
M6XU"Z D=F(:TXM%-[AO/(#A3&AKAT?:%Q=J=C>'1-.)A9U8+Y!4/=FW,=N:!
MM</*K45%,?.R'V OFV9/$L5E,6R3$H,TS#YI*)RSY;)8K-V;AN#>,*T]U.S<
M-!;F4%50RMQ.'T1^B(&]:N]%;I.E-?J<=S!JDV22!I8T1/MW U?FKF#JTH -
MFW;A\XV?$,FN:T]FDRVESH\'61W+Q(\SQW37"C,N7*6Y:YB7;=APH>\>UN9E
MDLAG()-%9Q"NHTK]PI<WDQ[UJL5)NH'4/047B;@Y#%#Z1Q(4>($&WE_&$$)M
M8[@D"=KZ#E<",1W* \W=7OG97>W;-1GL&ASK)\><G&C'-- >3R@2"-IH#L:5
MW#7GB]U2B)1$HB41*(E$2B)1%AT/_HY#TW6_CU/&L,T+^S(^3ROGN61ZA^^.
M_%^:%=. \:[;F7!YE']UQ_=J[E=R#Z+>RBG.I&X<N-1.E.'@(\_A\5$Z4_#Z
M/#]VB>!0/#Q'X>RKM5&*F_R^BIX%/ J?'CS]'A>JKN57XOFJ*)QX\./A[*)@
MG'XZ)@G/B ^JBFQ4\>5O75P6K#:JAL #X7J*;2J;7#CX!PJ[U:XX*;<A#T44
MKN3C:WCX4\"8;=RCB #^.FTJX$J;7 + %-A384MP"_AQIO4WX*+\>'IIN5I@
MEAN-OPTJ$J%H_>^]\7T/C"$Y.(+2TM*+*M,?QUHNF@[E7**8*+J*+J%4!E&M
M"G+YR_0IT"<@%(8Q@*/GW:)VBZ/V=:0W4-0:Z:\F<6PP-(:Z1P%22XUR,;AF
M?E=2H :20%FO W VJ<=:FZQL2V*TB =+,X$M8TF@  IF>['*VHK0DD $KC'O
MCQ[-<SU;J'8ZT>F9&):2#C*F$2#EPVAE,O9P3UBXN<#*G9,QCC-E7!^D/,.0
M0 H'L'A7\0>EZ]KO"&B<4OB!9 QYN&1YG-B-RR%['8U)8W(6.>:>46X .H/8
MNQ'4-&T?B?5^'62'/,]@@?)0.D%NZ5KAR9G9P]K!7 '$Y:GS/QC%I_,YV.QO
M&8MU,34HX3;,V31,3G.=0P%%14WY"#=+JNHH<2D3+<3" !7R?I&D:CKNHQ:5
MI,+Y[^9P:UK14DG>=P:-I<: #$D!?2>IZG8Z-8R:EJ<K8;.)I+G.--FX;R3N
M J2< *K^C36&'AK_ %WA>%&62<+8UCD7%.W*)1*BY?-VI D'*)3 !@3</14.
M6_&QN/&OU$X1T+[-<,6&@%P<^TM8XW.& <]K1G<.9S\Q%<<<<5^>/$VKG7^(
M;W6@TM9<W#WM:=H:7'(T\X;0'H63S,Q&8]$2L]-/T(R%@XU[+RTD[/Y;6/C(
MULJ\?O7*@\"(-6J)U#CX%*(UE5I:W%]=1V5HPR7<TC6,:,2Y[B&M:!O)) '.
ML9O[ZTTRQFU+4)&Q65O$^21[L&L8QI<]SCN#6@DGD"_B@[N>X&4[F=\YKM)X
M9PE#O'1(;#(M=03_ %-AD,)V\(R(42E\I1R4RCQP4 M[VZ5$.=?K-V9\$V_
M'!MIP[%0W3&]9.\?+G?C([G P8W\!C0OP@[9>T>[[5.T*_XMG+A9/?U=M&37
MJK:.K8FCD+L9'C9UDCR-JYIK/11>6K*,*P[(=A9=C."XFP4E,ERZ<C,=@H],
M0*+J3EG:3-HF<X_111!54!44-8B9 $QA H"-<#5M4L=$TRXUC4GB/3[:%TLC
MCN8P%QPWF@P Q)H!B5VNA:+J7$FLVN@:/&9M5O)V0Q,'RGR.#6BNX5.). %2
M2 "OZ]].YUVZ]JVL\1T5#Y4,NXP2+2C\A?XUCDO,%D,G.)E<BE9!Q#,'34CR
M2ES*J"F*JADB"5,1^@%?AAVH_P 4/9_K?'.H:CJNH/FOWSN!CMXI[EL#6G*R
M$OB8YE8V@-(!\X$D DA?NEV>:+PQV7\&V'!&GR!XL8 V1[&$];,<9I790<9)
M"YU"26BC:X+97^V!I#_QKD]O3]A<NO[!_P T5Y__ ,QG9?Z^_P#ZC=_LEFGV
MGTGTI/JW_16+Y5W']N&9L!CI]7)'287%NX)@N6I/6:@A;S6;HL/YB)^ 7#B0
M]K&*8.%=AIW\3_9YI<W7V=W?M=O'L-V6N'(X=50^$;B%T^M7'"NOVAM-38][
M?DNZMX>T\K79:@_ =A!&"T6GD?;D61!53.L]4BP/U>X_JZR,CPQ &_0:2"+%
M+EP$0; (AZ*RX_QE=GG491[4+BGG>Q7F7\GJ:_\ 67FS>!.%Q=![KV[-G7S.
MI(?T=92G>C71L7W6:!A(YI%13O)&;!DB5!LW2P3+^E-,GI,:)$QSF&XF,81,
M8PB(B(C6#W'\2?9K=S.N;FYOW3/-238W?['O#8%ZO8ZSH&G6S+*S#V6T;0&M
M$;Z #N8G>2<2<2:JX!W@Z0#G*Y1?_F+EW]D5L'^(OLO]???U&[_9+E'B;2?2
MD^K?]%1_M@Z2'E*Y1_T%R[^R*?\ ,7V7^OO_ .HW?[)!Q-I'I2?5O^BJO]L#
M2'_C7*/^@N7?V13_ )B^R_U]_P#U&[_8I]I=*]*3ZM_B4?[8&D/_ !KE ^W!
M,NY?^2*?\Q?9?Z^__J-W^R3[3:5Z4GU;_HI_M@:0X_YURBP\O_07+OC_ /!%
M/^8OLO\ 7WW]1N_V2'B;2?2DK_-O\2?[8&D+<)7)_P#H)EW]D4_YB^S"OZ>_
M_J-W^R3[3:3M+I/JW_13_; T@ ?Z5R>__,7+O[(I_P Q?9?Z^_\ ZC=_L4^T
MVD^E)3^;?]%/]L#2%_\ 2N4<O_47+O[(I_S%]F&SK[_^HW?[)/M-I.S-)]6_
MZ*!W@Z0'G*Y/\6"Y=_9%/^8OLOW3W_\ 4;O]DGVFTG<Z3ZM_T5/^V!I .<KE
M%P_]A<NO_P#RBG_,7V8>OO\ ^HW?[)3[3:3Z4GU;_HJ/]L'2/_C3)[?\Q<N_
MLBG_ #%]E_\ K%__ %&[_8J_:72?2D^K?]%/]L#2 _\ A7*.'_L+EO\ 9%/^
M8OLP]??_ -1N_P!DGVFTG<Z3ZM_T5\SSNTT-(-7#%Z]R)VT=)'0<-G& Y8JB
MLBH E.FHF>'$IB&*-;D7\2'9G#*V6*YOVRM-018W8((W_HEM3Z_H=U"ZWN<S
M[=[2US3$\@@[01EQ"U9%[2[3XF:;SC0V8^>S<D=LVJV*9LNQ;.4C@HBJ1)2)
M,JH**A0$H*'.4!#EP"LAN/XM^";BU=:27=YD<VCB-/N@X@X$5ZFF.^@!6%VF
M@< 66H-U&W9/UL;PYK2)2QK@:@@$5-#B XD<RVW_ +8&D0#_ $KE%[_^HN7?
MV16-_P#,7V7^OOOZC=_L5G/VFTBOG2?5O^B@]W^CS%$II3)Q*(" @."9:("
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MM1/]+?W/FA?:LLBW25<.%4T$$$U%EEECE21122*)U%55#F B:29"B8QA$
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M):ZPB,&%P[!<=A\2Q2&]^D)$L1CN/L$(N&BTWLJ[?23E"/CVR:*8K+*'Z"
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M(Z0C91>"\62:C<:JZZOHI(HG5;$'"GD-/C-3SN7H1VF2FP0TQ)8MGV.3T6E
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M,(QW.9^6WI!SN80N+PT7DLQ#1O<3LQI'14G-LV:,B]CF+6':)HHJ*&33(V2
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M@TJ!AR\H6^L@[8=BX5L7;$[K?'>X%NWUS]X'V<KZ+]VSO=$Y"1NB<A8:#?\
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M"GU<ZBBFB*@;\1Y>%5:@K?*!9KSO_#(?QI:ZC6C_ $+]8SYP7+L3^?\ Q7>
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M3BHWFU8B5!<B )'C0$_GETB%F;(:UQ^!4ROIF%-WPK:TGWB=UD#M$_;HZ::
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M[&F"ITB)!]-L00MQO"]]*$X$U4ZMH-:8T6087KS"M=HY*VPC'F..(9=F.2;
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M0"2:;<0>Y18[M7,)#'<QRTD QQJ,E4Y.6:FR5C!QX9 BX6462D%6DGY9R,I
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MV2<B'T4VB:'5X=2RP'Z?;9"OK#1V_G7N&P- [YK]Y>HZ0TF1S^04^'XEN+D
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MMB>4,B=).R4=EK!LDW>HJ@2_2699HD=$,-A47]X_W/'Y>[7^''Z?K8UV!O\
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ME.78H ;!R'UU2%2$#F-_13H3=@@6O?E0H:I?AP#X?/3>I3'%3P']VIB$Q"@
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>+_DESB.\#0<ZCY7&)[+&-WF^4YQ;F#=] #X.\O_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>tm2030088d18-lc_chemop4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d18-lc_chemop4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!= (R P$1  (1 0,1 ?_$ -<  0 " @,! 0$
M       ("08' 04*! (# 0$! 0$! 0$              0(&!0,$$   !@,
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M#])&P'"I;!+M]X2*5O.9;%H!1T@LQGJ:*1&8W:]OMD0.G7N%-\P82).E9HK
MYZ:5)K)F;.SG[^T6E$!.>B5%C(&+U!WO2BV6R/W1/O9.6>!<M<Z6#TUO=*Q*
M]['=HW)XU"%5=0&<L:21,9"5LDP! E\^VRN"<[[$(5)333C@D$FF' ."4I9P
MR;VB[9L"U.!Z^LFV)G(Y[+E3[9WVM)Y*N5/3XK1LTW?4B,HU0;\Q2H"B;TP2
MB@:\[T .@ZU@B>:!'.,0[5]R*J[$ZY:NV;/H1X<YO,6>B*A@*O335K(W1/9
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MXMV),.QRJ0G5:RER9(;3E(T])[931QX7HFU'=EX/J AWAP=MJD 5)[&D:?2
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M>Q>0XUV#6L,K1]E3K!FR%VA$+/0K(\W(%AIZR'H7M"C9AIEOH3D-Z@I[%ZA
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MY[A;C/XP_.4U=X'&ZOX)/;AOL69')CDQ"QVL:6 D"-,4Z[/VU%F$G':2;+$
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MOWY_&_25G&$C1:=A3 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MF ">=Y_+'K7J%^'>17G?]B:RCD%W^Z[SLX[)2E-/>O0=\01 20 @G[J3NX[
MKA\"FT ( _(;Y'580[ '7I!M1KZ/.64CD]'613 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# XUO6_HWK?ZV_.!S@5Q=_>UAR9[C[&D3= 1E]
M*F+)&U43B%F0Z0KF*8P]C<I"S2-Y0M'D:I@4DO*ID++/"M1*@[+%O8=!'H(@
MAM"O?;YY!JVX&_H&$TPP,]VMR4] "S]+GQ5+U;>HB#)!C&QS=ECHH/=6H$=C
MR8LI*H^8G)-"(XL 3AC,$$)[/]C_ )XLNN6&O_SN7S#E#':W3EA_?2)OL.1R
MESC/7ZP2B]ZC<-K(6M9AP*5)RDI)8P) .Z,*,H92P)GK&):5A;_#(BQP&'Q6
M"QE+M%&X7'&.*1]$(P9VT;)'6Q*SM*79QF]F&B3H$98-B%O8A;UYWOSA=%;'
M.#2VR#W /=987I$G<V=X2<D-#FVK2@*4:YM<:+>D:U"J3FA&4>F5)CQ & 6M
MA$$6];UO6\1HG%S[5<@70ZKK4XNDJI6=*^$+5>*):AN1IAS@ZTB<#<DYZD1Q
MYF@_6BU=9K4[?\P.M:V>UFZ^G6\I&BTS(I@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@>>_I&WU]6>Y*^(XA:-I0))*C^>R;&C$;EE4MR6?NH9/5,)96AA@L
MD@SY(Y(29&;)V:I6%N:)4LTA6(TGQ1^LNI/XO0AD4P& P&!Y6N)?53W:%97:
M5\U.PWWVK[KW'<V,(#\HE1( ])2NZ*C,<#=?DG" IC;\G("+XA$;X#\1>,<$
MC\7JEPI@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#C?T;_6W@
M4;2B_IE5_?LVBD5N6<M57S.X*D;I]'5-/064Q5%+E)U!UVZ1../[Y;B&>MQ;
MV&VXL6XKT#'\A(8Z[4I4JK:1:;H+RL!@,!@,"L/E;_O&/=&_5/XZ^'_]E'7$
M:)Q==TQ6UY\^=+C[TYOKO\];4_U>UU7U-S^QK"6>QYM$8@\J7N$V?4BIR/)C
MT@L* $.*]&-D7&(OM5M5""0IT>6648,VFOSITI3?559M=L4E+TTKBJ]0J:UY
M)B=2TR.*R5L,^0]PZ;19T*2OL0F# KULI:W+R"5) _&]AV 01"*WM@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@>=J^K&G\J[+;)4YP>YZUG<?L>AV*A4,J=
M>0FB,ML)U-&9OMQRF3$\S5\LY_2RIM&XJ&8;:>!29\XDH):0PL0ADF7HEPJ#
M=W=^U#S_ -%T]SA8$0N MXNM[C44B]DM4$VMJ1!,9F>[D1.(.\I-=$K@>_//
MV$J,&%M0.)+>26$Q>8E :5L8MBLW]U3A"%UQ:]F%7Y&)NUTQ&U,EF[#79:Z8
M3!( J4N4'2LI$=;4VU>Y$ZS!I.;DR0WY(Q'>D8]@(%HW"6U)._>5Y5K]91*1
MVC=UK";UK.KK7*>FF#MC@P51%[N?DL1J+5P.9$G%N/.$_F2P#4B*;2W?PJUL
M1NP$^#1*+A_;VX_<L;^OJ>F]E73NN*0=F*QRXTV1MPD!3%I,QO,,CDTCZ)R<
M9 ^K6UVDA3<]B^LB2*"AZT#7ST*$W0B-*+5F)=D'>V1U%T3$#"9(OY.]V#I_
ML&.GL:PA:G<&BFNNY/)I=I,J2&&%J$KM5JYX+ULL?@PI1K>M^G?G"<'J$9G9
M _-#6^-2LA>UO+<B=6U<F,T:F6H'!.6K1JTY@?R3"%"<T(P"U\-AWK>&G98#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# XW]&_UMX'F[E<I?K)
M[WA5]HJ?M=@FB&]*2K^NV2:\<LZ*)K:6=E<;89].I_:#\5NQ&*>,)CP[FM:]
M&9]4;P-R( 2S"5*LQ-4XV](N14(NS^^::X498K)KFC=MNL9D2Q0%UDM<U\ME
M[! &1&H0)%LJGSKI8W)&=E3JG(DL)2<2QS4C'X3I#O O#)HS55V]R6BF<CKA
M5?U;$V#$294HD\(&_E;E+$1"(DDG<M.<F0 !.*8ACB*TM<:/9?HV3O?IV(6A
M!T,((.7OJ\1(J,@'0*!%>,CAEE6!=L*C#3'ZQ^MS,;+SJ:/\\5JN<<4OR(UJ
MK"%H1$*U"LXP+CLA63H*+9HMEA)?%C?.ONZ1NP.C^K8I=[O7=+4#3IH1UI/Y
M,:-C22&.ZDK-'F:6R29.LF^S6S4_!(T:MI;U+6WG*$YNAIC%("S1ZHSC@.X*
MKO'NSW/)Y3MA1"SH6M7\B)$LIA#\WR)B4*D--.Z9:F*<FP]0E&>E/+V P.A>
M0BUXW\<G XK@_I^&_P .%5PWQPBZ*K07]0<;V45S)U$X)2TLR7;8MR:DK^;4
MI?I0LM]UB2L;0/*YO%K7U*1-9Z!_1!\E[//(W\C!3"8K[CCQ33TVUG[CM3&\
MH39:K(:F&ZF=P63KD.SEA^PEIQQBVB4)#A7;FJ-\Z$U3%$T&%[UX)4JM;T+"
M7PE:,VN;<\(4CFTKT;FVKR"U2)P;U)*Q$L3&AT,I0E5)QF$*"3 [\A& 6P[U
M]&\*^[ 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# HIN6&RU-[A\PDHXY-$$=D#]
MSL8U/;)Q;$[[8Y"8S-#:A=E"ZX)BJVYUH<W&! F-,:  3H22PJM!VK"<(53B
MO6R*K'ZTX&L'J;I3G&V5G09$4JF@;%@-L-]<$U<R+IVAF\$=EBY4;7MQ$/#4
M^PQCLML4%-DI1*$CH6O0)BRR-IM[,V,E/BJWVH.?Z&)ZS<Z<D%BM$S[%BTY;
M[<?)?*%<S;7V;S-5+5>K)6L:G:$O[QM895M(#24U(2-$E+#L.CMF'#ME8I%:
M8^RFZ29]YKTCZ0 TP2N:IY-JR_HOJL"%3G<B/CFRFJUZO=H9(C)@$RKE:^3-
MPB'0!A+T6>@,T 'RS0_-$LI:_/>/.4;29$<;L7FZD)C'D$D=IDD8W^LH>O:2
M)<_E )?9.! :T[2[D#R44$*I9L.U"C0=>L8O&LBTKD]K>E*Y>.,.P*)01%A9
MJVD7:ON(UL*(,S<F:F)/%E]V3B)%,R1 B+)3I&]*QA+2E%EA"$LDL(0ZUH.M
M82-$B/:3G<@F' ]&QR:*]J[!HI+*N8K ,'K>E I5S;,'RFCU2KS\1*'=MAR5
M?L6_V>E6A>=^?.Q&BR+"F P& P& P& P& P& P& P& P& P& P& P& P& P&
M P&!QOZ-_K;P//7+&.$;]RZ:KY<Q4B.2&]%46JB3E9]#]!6E88DQ,6JPIO.K
M6TXH^,59UZ4G>TYVD1*](N3M3IH:I0,Q./10;A.+T*Y%5H>YAPW:'>=6M=.Q
M*\HY5,$<SSB[!:Y+5**Q%*D0%")9')U7;T7(8N]P"V*_<DNU;&Z 4*4J=2+0
MS4IOI#K!,6[&OO;#H2N^Q7CNMODMJN_04HB9]?3!Z?I8F<&.55[N,1F/-\)>
M& 30%&8R,ZN+DN9(B_0K&X&"$:<87H!012O2V/8VG<TK&/1>$]1,\.G+7:O=
M;LZ2EQJ4V0LCC3?>K@G.LB%)X\.<(5*.;Q=(T-_V4]?7#$WSR3!&HA ,T -B
M4I>+"Z(K2)5G$JN4Q..2EBBT+@L),-DT>974]_05ZP(8_'5+Z%4B-)<%:-(@
M#LO8PBT2(6_E^G60I OC:,1J)>X-[H+/%(\Q1AI)5<?&%M<=:&]D;@&&TLZC
M-, B;4Z9,$PT>_(A>GR+?T[QP./8M8PI@=')8Q&YFPNT6E\?993&7]"H:WR/
M2)J0O3&\MJL&RE2!T:G(A2@<$2DO>PC*-+& >M^-ZW@5:K?;^M;E\]3*/;1N
M,%1M6E1KBX<CW.)[L3E*0B,]0U**()1K]6!1"M2/0?DCCCA]CIQ;WL368'>P
MXO@E<F1CZ>]S)I"$MW]LB%OAA8 A/50KMZ(*BE!@=:T88E1R>FHV846,6O(0
MF';%K7TB\_'"NMW[E4ZK89GZ5?!'65"M!!8E"N>1*.-G2E:-Z3]B!0[26DCW
M]V9=>OX#^N-:<(-;UOU;UYWH=Z8?//8',W5K:YN//ET06T!,/U4,D:8Z\%&2
M*+G+ [$G32:-J=)WUA4B].P[ J3E;T(.]?3K>!)+ 8# 8# 8# 8# 8# 8# 8
M# 8# 8'F_P"L+%JJS.N:T0/=3Q6MWB8W-3#7#;2LOCOH%OOY^>:YGD06+&^%
MS9U3M4&>FQ68UA0EF_(4I2VE7ZCM;#O0LO<S-6](&1HP& P&!5C[2GC\R_3/
MC]\7[]_TE)OB4AQQH<*JNW_<7YP.\IFM[G=;=;P!"67HE$6P7="&Z.3G:,K7
MI#K?YSX XFG; 'QLU1L6]^199(6GY%,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@>9VQ>@N=KL[DJYRK:=P".NK_T112AFGKM:7=+;)IAIAE,
M.3KH411AU:H*02JY.<D^R2Q&+2$.M'!5*30[$9Y4DYFWIBPI@,!@,"L/E;7_
M +1CW1M__>..O\"CK_(Q&B<5GF%,!@,!@/&L"#/47!E8=$NK19T8>I%S]TU#
M '&5UTQ3FV^/V7'S#!:-&S2,0TAK59$$<C0ZTO87TE:WJBQ"\ +,WHS2SQ:*
M@O<UF<[32/45[DL<CU:/<A=4D8K'KF%IUI'+MVNBKTEM36[KUQZI51EF.?[$
MQF?C"FY2J\A;UIX1%@PFFJU@LP!H &%#"868$(P#!O0@# +7D(@BU\!!%K?G
M6]?3K"OW@,!@,!@,!@,!@,!@,!@,!@,"CB#T+2T3Z5=;B:O=/8GVUY;-T:%W
M:7Z1<XRJ7+FL+^4$%0LKF^&.LOC4?4^D+;IL:1I/^+H)?S0@\7L3M7CY%1=L
M?M3ERHKK@7.MCW%&XK<MF#:"H9"ER=Z-/<3Y$O/:HTE7O")K51Z.JY0YI3D[
M62Y*T9KF>28!*$T0!:T2X9U/.C*'K"#2ZRY];M?1B"02.KY;+I*X2EHVWL<=
M;5:MN5NBO:=4><(@#H@.2 "6 8S5A>R"PB._(PK0<J]R?B&%.=+,LGZ BS.[
M]#1!JGE0(5;9*@#E42?]DEQYZ5F_8.TT12R)6H E;_MPQM$N6;^KDZ&?K9>A
MA_'A/O.N>\:SD]H0://4*:(],MQ@EKERQO*?5J!7'V:3,3\J:P"*6-)3VT/1
M9I)9H-@, '9A!IY.PF[%PTU[20PCI;I@0!:$'?N+=^;"(.];UO6^E)OO6];U
MYUO6];PD'0QI5.>YQQ!<9NC"&7HBOKBXSDRT8]$H2Y&D0#Z!J8*DSX!&J4GP
MB2(TX1_28LT$/Y0L'%:?A3 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# XW]&_UL"G"HN0[(B/0:"\I7WU45W3QPD[82H4S:B6!UF2*&&.Y!KG65
M5NX[Z7H*N0O:41J8!C0T_,^<?\PPM1O6B]WL1<AD5"OL+O>AN'FR//%V%62>
MW/B1^>EBNO:VD\]31&(10E.IE,ZFRIC2&)(Y$H\G5 $H4&F;-WK?@HHS>MZT
M&?A[(Y3&^N<6UT+46Y0R)) N>(U]^H_]X6Q'%(DCG<D4KF32[;DF(98<O*<C
MQ"*UH"07K\^-"\!!IS]\#@UOI&!= )I)9K] ;*L"X()$P1ZK)(ZR98CH0PS5
MN6*KC900N+96<(1Z*5+'11HL04ZHG>B=B,T#"6R;E'W.8STYTQT53(8TRPJ!
MU'I:; )\[2-0!99;4POK9'7V4 0JFM(SM4?4KWQ$-!Y6B5&DJ0"$5KU? -?T
M*\MSK[A_N8+65T1.2,:CD<.E;6N(6)AB+I5=H0='I#3"A" +SK>O/PWGO>S1
M'^/J76L>$O"]YF8W].IX3^2P+YYV_P#Y4W_Q@O\ ];/:\NWE#Q/-ONKES\X[
M_G3?_&"_DX\NWE!YMW.7'SSO.M?--^/_ ,X+\'\7'DV\H/-NYR?/.W\?G&_^
M,%_)QY=O*#S;N<FSC_P&F?Q3!_R<>7;QB#S;N<N?GG?\\;_XP7\G'EV\H/-N
MYRXV>=KQ^VF_'?C^6"_#_%QY-O*#S;N<N@E$(B%H,3C7]C1IEF\(EA.V2312
M4-R5Z87QI7[TG6-[FV+RSTBM,>2/>MA&'?\ 'SY=?;M_P[\1^F?"7UZ&[=_G
MV9G]4>,($IU<N]IB>$M+@"U[-]M2:I/E,3DF12RW9AP[,&X(Q:8EZ-J2ODY=
MN99(U^/J9I1"X<25I! .WI&>$1?&NST6M5/=%2WM$6^>TS9$*L^'.90#$DB@
M\C:I&V"V,(1;3J#FQ4I^I+B?5Z34Y^BU!(]; 8 (M;UJ*V;@,!@,!@,!@,!@
M,!@,!@,!@>:RWC851O;S=6IDOM-]^S)C64D.,7O'*3"YOC[.K.JM&F8(E# \
MJ'2M^9F]NLCY^E 'U,O7":UJ<DXHT@:L-2:NGI3R*I-[0Y1[/O\ [VYHF\?@
M/.<BXKIR35Q8LM:7NR9)!;=E]LQ20*%3!-9,0T57)02Z/TJB5GKHW']O"!(N
M=E S%9@0:"'528F6 57['L+IUJ[;4&S>/W>KZWB4S4$0JRJ[8$4,KVQG"536
M8P\<#^1IY'#H&PNT@1GZ;"DZG13FF,7@%ZQ@* 2N:/=A>S_U5)W?EM@;GBDE
M$&3T3PC4_1[V[R*3&2: KN,+F9;@4K*C:PQ$QOG#98_U,UM,+7G,PDPM!4;^
M9K>RM"IA;JO]KCA5?$-P0-'B9HL.:+;!-;(G9MPPL9\J7,Z2/C5GN,1L!D=#
MVY$R(24J)N&>)M;R"] 2D$Z^&1JD-O:-C;54U WK H"%>R16.=X]Q-#2W'/+
MP^'IT#+T1-&)M+.=9 N=7A<:0U-9!8CE"@TXX0-C,$(P0QB][VOT_0ZWIYW]
M7;&[=YYC/=#P/<_4]?I=>-O2W3MV^2)_&6:>Z87)3.4UUWM&SG25\=V35?84
M:*'OR+Y="3AGELV2%A!H(S-/E9EO;<,&OB,M8+7C?GQO?N/IO3]+TT[^GLB-
MWFC+'MWJ?4=7U/DZF_=NVU*X%C>&Z1,K1(&A46N:7QL0O#6M)WY)6-SDE*6H
M516]^-[+4)C@C#^IO.>=$[3 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MI2-C4\$N*-&4N5JTZ%:W/)!@ *P)E0?/Y90=>-[" _MI_P!K'I#_ %@?>_\
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MD3CV)2Y.[PZK2BBRB@"WKU>H7I!K8M!L4;ZR%B. :\-91B?:H*@!C@D -.)
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M5-J0&[JZA]L5=)6Z7P&>,2*11>1-1OSD;BV+R_64/7PT,E02/0BSB1Z":0<
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M.NKJ4!)LLY3L6U PZTH\[)'-A/MO\E=HS*K[_<6#W&I/!DZ#N?M-C7-Q'+5
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M4T355;6=:<5-AS9*K]Z;A]]7?.IC>,34.B::M,E9Y+7LJ:&\]Z6(PJE))NB
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ML^$.?W-&TOWS'N;^J-&?XF\?W?5_R;OB?T_2_P >SX0_0/;4M0L83 >YEW.
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MSD?8,O;ED@4&NXWM[W)7S2!I<WA<P1<I^D>]KUY;2D0EK5N]GGZ,,WZL"5.
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MZ7=;(VQR2.$EM:Q9"_1UD99KNQ61!7D@=9$I>8(!EFN_M!(-O/*-(.UK01:
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MOJ*9M;8G!JD@B& 5K7<=1)3!E%,47:R51P1[T$9JE><(6M:].M!*# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M#W#]J&7ZA.J_S 8# 8# K']L#^MSM_\ UG'<G^%8S>66=O'O6<9&C 8# 8#
M8# 8# 8# 8# 8# 8# P>SO[6UA?]AY9_U"OP.JI3^TU4G]S*!?\ HJU8(T;-
MP& P& P& P& P& P.-_1O];>!Y_;K:25WN,-3RX0-G?I"T7Y1+=&J@D$5Z'D
M#M/XJK10X]VZ4CTU;)5^8>*IJF5*5"DE"I:QEA%'5&U)A2H]/LPDU?:] >%,
M!@,!@5C<<?Y=_N\_W?\ E;_05H#+.C.W6?MP6<Y&C 8# 8# 8# 8# 8# 8#
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MBH7JNU35I(X@VP*5P2)S*'M1#22CCTQ8&J4M.A,:$MN:E1J!\2+DIRY$C+T
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M)T! X+(S-:W\TAEA\)+'Z !&+6MBV$J4!%;]02(Q>GE5_0JMHV<F"6PM//\
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M%*QZ?#D:=W+:5BL;:>J*)&,L!V@"&$.]AUO6MX2$YL*8# 8# HOLJ$3N1]:
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MBVO-@7I<L.3FM:#H656!'(NYP=@A3T8Z-CB(9QFDJ71:E298B:9W3%ZU*0U
M6)[M]P]2]6TY:IK[07/14<Z+;^1.B3>;H,H=G9T17I'&-CDD[:7*Q9 UM#M6
M43/4(8"C6( H[#8339 N 9M)\HR86+^Y13=/5?5L5X,]OU]6]7=+,DS=>3NT
MY;3\T:;6G;;*.D>\(+U_54/HRL[#<VA>4;;ZIRKET?PHX<YB4M;@D^LB^IF
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M]:&'SK?I%X%O7G7Q^.!^\"L;CC_+O]WG^[_RM_H*\_Y9T9VZSW_E"SG(T8#
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M-:"./]F:?"4_Y9$<CK0SURQ*A:WZB279\Z&K_P!P>Q#RP^-!,&G>DHA@WO\
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M.M3T8[%O]E&N;="%+?HW6P:)9TBA;HH[9@Q+!:"#YB9MC;T_*OF7\B]FICS
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MXT/^9\GK;F0WY1@R3?EWU58_EG%^/64/TRO?H,!O?Q#OXZ_#A;A_;]-'CO\
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MITJIJ:X5.3F4UK@;@B.2_7/G'FKE.S3MC"6(LHM,FW9$0L<_<8_;'_S38?\
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MR+ZK<*4D;8SLXC79L5-SF<J*)+%L9MX)4W][U/9EHP& P& P& P& P&!^0@
M#SH 0AUL0A;T$.@^1#%L8Q;\:U^4,8M[WO\ #O?G _6 P& P& P& P& P'T_
MJX'Y" ( Z" (0!#KQH(=:"'6OQ:UK6M:U@?K 8'&]:WKQO6MZW].MZ\Z_C8'
M   +  LL 2RP!"   !T$  !UH(0@"'6@A"'6O&M:^&M8'ZP& P/P$L 1#$$
M B,WH0Q!#K0ABT$(-"'O6O(MZ #6M;W^#6M8'[P& P& P& P& P& P& P& P
M& P& P& P& P& P& P&!UCN\L\>;E+N_.K:R-230!*W-V7)6UO3:-, 27M0M
M6&DIB=&'&! 'U"UY$+6OIW@?S9) PR9 !UCCVT/[888,H#BR.2-U0C-*WK1A
M05:$X].(PO8M>K6A>=>?C@=OYU^/ 8# 8# 8# 8#QK\6 P& P& P& P& P&
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M8K6?H!6,9K8;:RRJ2LE6NJK[2,+$0E4*!Z-"\6>-QB'RPCM;WE6J!<45Q-+
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MO7]:_;_/GS^'"LWP& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P&!QOQX^/T8$$I7^Y^?I]UE]]/S,?NAOYIG_\ -!]X?E_GA_-7\A_^
M\_W ^O?M/R?LS[3^N_4?YN^SOK'S/YE]>7-=B8OM3M^'G]7Q_O9%<X# 8# 8
+# 8# 8# 8# __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>tm2030088d18-lc_mgmt4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d18-lc_mgmt4clr.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!8 ," P$1  (1 0,1 ?_$ .P  0 !! ,! 0$
M       ( 0('"0,&"@4$"P$! 0$  P$! 0$           $" P4&" D$!Q
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MGE_16[B: ?8HVW/\? QA8O97ZLYX]/"W\3_]PNW?N_C_ /M9,)FU@QO/0/\
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M2DHB5"+L$?%3<>5VR7(?T739!<G7H<A3>&%9(%=(/:<H"'3P$0 ?E]X_8'"
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M!@,!@,!@,!@,!@,!@,"#_<"_>.J?Z1W%_P#AXH>$E-G^L8:O\W/A# 8# 8#
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M]:9B*;&;$EMKZQC*)-]?J>Z2&P:JSJ,KY7!VAOJZR.)0D,]\KI,R8^DL<?.
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M;F90T[)U^*?)JE>I@03&3-U,8!$ 3^!$SI+T7&,'I=1'IU+\W[&18U0VXBG
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MM2]FK+0D?(RK-&H0$A(&0A$TW"HDBRH%/Y5 .4).MKQN(K9OAR*8# 8# 8#
M8# 8# 8# @_W OWCZG^D?Q>_AXH>$E-G^L8:O\W/A# 8# TG?K"=JVK4.U1R
M.D=3Q3F1?.B4.(N[EC56%UD(+5LI?ZTUV'8&-;E6$G'/EXVMF6$3JH'!LF8R
MY1(=,JA4$YAY([+K#3=Y#GCI;M&35LWSQ/D."&O]I;DDE6MANBS#=NNIV!FX
M^ BKY=FBEQ"6D*M'.5%(-L[4:(*@H1) OD#I=-6<3HW&\2M_:Q[AO=I[=6U^
M,LRM?*-Q'[;\HRW]8X^-E48C7NP=AQ[2O16L)AY)M(\27!J]0<"L@4JG0C<1
MZ^7Q";-1F<;0]<%D@RV*ORL(:2E8@LK'KL1DX-ZI'3$>#DAB"ZC)!'JHS>I>
M;J10H")3  X7N0FX)U4*:;E97$YRPV-&(Y7WMJ69MDLO.V-^)Z3K1V"LI+N"
M$6?*D%<4R"8 \B1"%#P*&-DTGN3Y#V8# 8# 8# 8# @EW.H&<M/;RYM5FL0<
MO9+)8.+6\H>!@8"+>34U,2\CKR;:1\7%14<@Y?R,B^=*E3111(=50Y@*4!,(
M8C4_IEY1MN=L.T5G]7QT(KQAXWV&D<CM@)\4K_S0BH/7TM:=U7RM4JP/9FP%
MM.L+6N,[=WE)L<RA*GK1"-O5;-5$?3!#S$#6?@S7\N/BZEQIX74I_K;N2W+8
M^T.:>QM9;QT'0Z#L*KZ_[3MIX5C"V8M[KY:[L/66F:U:5(O9]CHD7&**RL;&
MP14WL:[5]=183'2.(C-HM;6H',39_;[YAZL8<1I^T4V"Y'<-R:AW_1.!\QQ%
MVKR*KT!:+J^EAN_'*LU]!0KC6K:7.FM*M& ()@L(*N%Q.109^94S"8._:)?=
M7]Q)"W\3>,>U^1MVVIR.U&?=FB.1/ V8D:% J5AE6EGFY=)<Y)=AZ])B&)H9
M!8L>$BC%-_,J=0@@3T1NW<>&7=*%IBW\6N6O?CH="[<L_<=L;@K2=DX+KM^.
M:+O2,C3"ZHN#78%6KNRVD$%)KB,]%6M#SP*3Q TX]0&,.078^EDO<B*OMV1#
M[1^C>0\?W*^)6U+)KSD@O".^(W(*O[9E;=P/8<0J#KO8[RAV!7\F;$]&J5?@
M[_&M'CQI\%,R9 6=K'*F@7JF*:=O#.;O9TZ+X W>N=G'1NQ(+B)LB)YB,^[A
M#623LS'4%X2WS#ZTC[':BMI<IDX;\<H'7S5LV:K%.D1O%%5$KC^K']0TO+7E
MQWQ+<UQ0T3 <</UA3FS+[ X?VV-I>_JUK.;XK[9K''MQ8M5U>RM(!^^V#.EV
M17X%W6M6RTV0[M%ZX6<LG+ET84E_OUB =-TL:]S-W>LHG#':>S*O!<@N-//.
M/W#4]9&F]"\U.%^K-K7:<ILNYFGBKZB(R&J5GB OV;E@@X6:SK(J MWH_".F
MZHG531>A43G9!_6^H><>_*A^K_AS]UGLG8UR;;SYC,=VJ7.BNE)J!TC:M46*
MK:Z/OH(!D6/J4M9:H=! ZDDHW>JBJF1P87H+ -\$F)Q;JG'GBIRJXL]X7B#Q
M:F=6[,LW$WBTIS*G>,F\6M:L4S1(S1F]]:.9.K:OG[=Z$LUC9^AVN,>1R24A
M(*.G":R0_P!$0N3:UW:>M(\5+-'<7-+0NE^)G/"O=URJ\[/Q\IMFG-/\AV?'
MB-HY[Y()0LM<6]\1_('#PS")D".EY-K'MY5(Y .JY]'ULMYMGRXJ=7N<U+KC
MG1Q<7W%R"YB<\)/EMIJ'U_9[)&\>=;<*J93;72G3=XA.IHU::UK/6:_;5D8:
M%;K1;5@+,JLB8Y5A+ZO0@YFK;BX\&C?MT;0UI?YKNY:,WYQ3YD.J#S?W[O/=
M--@[)Q7W94HR[:@8:84DG<8O:)JN1$?5KU-C55FL,Q<.D7;F6,V21ZJJ)];E
MF,VAWQTX*SVY^;O;NU_QO>=S"S<9N'E_6VU8;KSBUY:]5:STM7:Z*3JO:@UM
M3[;3*RZLEGF7;<B7UB1P9-!KY4DT@3 1*([GO$FK'#5*"DK!89%C$0<,S<R4
MM*R#I)FPCV+5,5%W3ERL)$DD4R$$1$1Z?('4>G69;Q/BU$6S;.\NX%8W^N>-
MKZ>U3QQ;H/8V\[QEX(R#RZB=XJU6B*2BZ39/ ;&1;!^Z-G":X J(+^D >F=I
MF4UTT;7-6:^BM5:]J6NX1P^=Q51AFL,S=2;Q>0D'1&Y?W1T[=N3J+++N5C&4
M-U,(%$W0.A0  &CO^ P& P& P& P& P& 'Q^D/V!ZX$&M?A_TA/),?\ BY<<
M?[[-R_SL$:IRX# 8# 8# \JW?G3U;'\H>%=MYUZVV)LKMKP-;VXCL%E3H"X6
M6O0G(>29IL]:R]WC]?%"U^@> 5?(,NAP1^(/YO:4P B29SW->&E9+=O$;CQV
M?^=G):A[B9:%XZ[NY3U&3(^ID_8]B:FXP[B,7\ADY<:W'M)&UC&,H>!%(#J-
MCN2HK-@'\-/SV4C2&]OL"4:X1W%S=6Y+=4[!24N4G+#>>_Z3!VF,>0=@#7=Q
MLGEIDI(P[TB+N.&;B6972::J9#^DH4PAT, C)@C"9/._5J;ZFQVRU;ML-LXA
M]M<6&B5/8VY\UU^_ >3FIFGKRM433^$?.O\ 3PG\YS=?.FF/] &([%FIAL02
MZ@0 $>OM#K\PB&"7)@,!@,!@,!@<*Y#J)B5,P$,/3H8?L#]O!=($\8NW-H'B
MN7E6WI1+/98WF-M*S[9W%#WJ5:3L6[G;A%K0\]%0[=I$Q/P-=>1ZYTQ;J"N?
MRF']TP5&91GXV]D/BIQ4W7#;=U/>^33> I[BR.]<:"GN0^PIOCYK=U9&4A%J
M*5;7;I]]^E%QDP^19I2+M^BA\6<X$%0B)TZE.JZA["/#356UW6YY2U<BMS7B
M/K=MJNM'>\MVVG8K'241=XN9@[ CJJ,D"H,H@RL+-J-41>DD/ATB$$@ ?SF.
ML\L;NO6?]7YXDV+16B>.C3;G+.G:MT74=@T)"OT3?<Q3VFSJ;LC8D_LJ<K^V
M&<)#M8NU,T)NU2*#<R;9JJ5D\.D<Q^A3%1)3,^U^R?PEV8[XB2,- 7_3LKPB
MC6=8T1+Z:V5;J5,QE!;.$'3G7U@G!>R<S8*W*JIJ@Z,JX"05([<E^) KE<%%
MR3$4CU?OU<#M\; V+LS8#HV\8!KLS9$5N-?7%;V]-1^J:EMB/GHJ<=[$I]$6
M9.XEK:)@C%RQ76>@^*DPE':3<J'G2%)?:5";I^V+H17;?.'<YI:_A;N?^H(G
M2>\4RV%D,2TI\-19'7C56DM/J,%H*7/ R:ACK+*NR&< !@3 H>7(N,]Z/E][
M%?#78/'WBEQ\D)3=4 SX7G=AH;:-(V?*TS<%;:2C@R\Y'+W"N,X]!PUG2"5-
M<Q6B:Z9"]4%$C"8QK94-EV]>.VI^2VF+?H'>-/CMAZIOT8VAKC3YAU*MV<W'
MLG[.3:)K2$4]CIANLTD(Y!PFN@NDL59$I@. Y,ZF*K9J\XV]A+A3QNV_3MS-
M)3>VYIO59W"NDJOR!W/:MHT+2*ZZJQDW&N*G*BE'L73!!;TFRKT'RB %*H0P
M+AZN6TB(A^/:?8'X5[LW#=-F[4M7)ZYTS8>PIG:ERXXRO)7:!N.T[>IZ47GY
M&67H;:4;OVK52Q+_ !I&+>118HG(5%-$C4H-P61':F5M;MU:$W+R&XJ\B;H%
MF5F.&R4H;2.OXV3:,-8PDK(LTX]O87M;)$F=/IF#8MFZ3$P.TT4 ;ICZ8B'4
M5DQV,5<W.TUI#G/?Z_L6][<Y/ZKFXBI.*)--]![VM>L(2]U%9Z#Y&%N< R^.
MB'Z3-59T4JJ"3995-ZH58RH$1]*1A:OQ3$XN<5M'\-=.5;07'6C,=<ZGIGUB
M>O59E(SLV+=Q-2KV<F7SZ;L\I,V&8D926D5EUG#QTNL<Q_$WE H DA(O 8#
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MPGOB#L\;9;,L]C^/7(^Q:BUXDF[E5E$P3J"]0L9DYPQ0_P!/K_$B5RX 3@
M.7OIQWQC67J$[*.L.W1JW1FTX7MW[_?<FJ[+[:D;1NO;5BNZM]NEBVG.QC-T
M=:VS)H:OMA?A BV\GIM"&5)U45.JJ8YQF9U;BJ_EENB  #P   /L>&!7 8#
MM-^";_X(_<P(;<1O[H^87Z7=W_@\U;@3+P& P& P& P& P& P& P& P& P&
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M,".=HYJ<6*?+&A+#O77C*1(W1=BW2F@?E]!SY_04,YC4W37[_P!,?#U.H?*
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M9UFC-\TI3G8-TK]%)>'S-\DX;.VU0"P_'^B=-0BQT"D.7R&,(%VP@WO><M_
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MEY0P& P& P& P& P& P& P& P& P& P& P& P&!PKJ>DD=3^E*(_)\@=?E$
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M1.(E$BQ$V1R@'1J4.H&OYF?@W?5RGU>G0S&O5. B:U 1;;X6,@X)@UB8B.;
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M8G1,PP]4Q\0]GR>SKA8U0WXBCUL7,(>OC^=U>.O_ .GVK\54)O*9F P& P&
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M2Z@/L$,(=0]X8#J ^P0^G[?W,"N P(,Z_P#^L*Y)?HX\<?[[=S8(UE.; 8&
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MRAX\O]21LPI7I#:;3<^MW&N&E@0;MWB\&YO"5D-66\N@U=)J&;'<@J4JA1$
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M 8# 8# 8&@W]8;[E>S^V9PMC-C:03BR;=VEL-AJVG2DY$JRT772/Z]8)B8L
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MS'XOR"J]=L@LVWUB"9B+N?A4#>L D 1EUF"HEM/9(^@V32Z" $ "AYA$1\H
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M8W3\'<O%<0Z^(=?SJ-,%Z]!]OWN(U79+\H !0 /=]WQ']G"+L!@,!@,!@,"
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MK8GJ;Z2LM;N#1TUE8H5!(9($.IV_H*G3,F8#>#)4:;-@^O\ 0&N-<Z3@>/\
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MY;4O&+7IJ-5Y.<=VNRNW]@G[79[E;9%-).1M%MM-HD9:;FIAZ5$H"*BP(HE
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M@!/*%F$C3N>FG(I@,!@6*?@&^;"QJAQQ'_NCYA#[^75W_@]U?A-Z3*P& P&
MP& P& P&!0WL_F^?$X&MON!HN'*>M2MFSAP*2MD,?T$5%?+^YQ/@;R%-T$>G
MA[\^(/WA^F]3ZGA['Q]-T^?4F)]1,^6)FJCI3FNW9T7OD<N4=*.,3,Q,_P '
MTNW\@X;0>PRN&ZZ J2\08@+)'2$P Q7 1+YREZ]/EZ9W'[1.AU_2?3?N7'U/
M#GT^<^JN(Y1,3,>6.U_1[-PY<?25RQ,<OX-B0>(9]CQH[57 8# H80* F'V
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MWS=JFZ:]-\9JVWFG,]LIBA**LXA.OS)H"6)(17P 3C5PTE  @I&; H8ARG*
MD,4PPB8F+8AW[WBNWIQ?N<!K[>&_XNE6^T:UK6WH*$/6[A+NGVN[<9Z6 LH#
M"P$@D@Q?&CE@#U#%.02]# 7J'5G8F8B:E.;3>[M6\@M;UC;NFKK7MB:WN4>G
M*5JW5B20DHB49J  "*2Z0]47""G5-5%0"+(JE,10I3 (8&#+!S^XD5KE!2>&
M,CNJG*\F]@IS"M<U'%R S%G (*KOKI($G$8I)XC67 5:.6?))2!VRB[<GG3*
M8H@(VI)F(FF+>0G=DX <6=J(Z4WOR0HU!V68L.>2K3]22>*UA&PBQ^HW%P>Q
MC!['5-O+)R**B!WZJ *)'!0/O/'%$U#8' 3T/:(>-L%?DF,S!S+%K)Q,O%O&
M\A&2<<^2*X9OX]^T45;/&;IN<ITU4S&(<A@$HB Y!]C @U0/^L)Y(_HX\<O[
M[=RY9T(U3ER!@:-/UA#F+OCA5V[K7LGCK**5/85LV'1-6?E)38MGY]8PEW>O
M&DI<DD7K5XS2>MD6X-VZRJ9BH++E4#]T*0<1F29J$G>*'$Q"I\!8?C^[Y);5
MVVILB@3+V?Y R-M;R%[D)39\661GK'5+ BFY;L&A'LDJO&A^[_#$.'0P^'1N
M5/EKM:GNRWO#D3K7GCSS[8&P=]3_ "MTSQ*8ZXD]0;EM@QS^WUYE:F /W=$L
MMBCD1"87:!(E0 JZRJB"S!0""4HBF2SVIQG-2]1^13 8# B#SC_> <?[\G%;
M_E4Z8Q&J[)>%'J4H_8#"+L!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,"#_ ' OWCZG^D?Q?_AXH>$G->*;/]8R-_JPIR#XWZ2Y3:QG
M=/;^UM5]I:XL::992K6J+;R3$ZR"Q'#5^S.L47,9*,5TBG0=-CI.$3AU(<,K
M-M-C3]6Q[;Z,RV<2)>2UCI[:33=CJ2Q\B+Q*:G=1R*X*H5EY4SF("]80*!4R
MMC+?U(H%$1Z=<MRE1;>%JW5.N=*4BO:UU-2JWKR@5..1B:W3JC#L("NPK!$3
M'*A'Q48W;-&_G4.8ZA@+YE%#&.81,(B,:9#PA@,!@6F#J4P?8'Z?DP1JAMQ&
MZ_C'S"Z_QNKO_![J[K@W[TR\!@,!@,!@,!@,!@4'V?+[0]F2;V'XUVB*YRF6
M135$O7RBHF13H(]!'R@<IO+U$ Z^_IG\_5]/T.O,?YW&.7/C\MQ=:75]NZW-
MZ87-V;=L(^@DFEYO$P)D*F C]D"%* _;R]/H='I1/#I1'&)FYJ*_(Q$8A^L/
M9G/&8M%!$ ]H@'S^&4<9UDTPZF,'3['C\G7Y.OR#@12Y)\WN+?$J%0FM^;JI
M>OP=(O%XZ'>R'QMGFO@DU3JHPU7C$7\[)K"*!R%*D@;S*%$H=3 ( -^YI[D>
M\QR5Y4R,A3NV5P@ONU3IB@L3<^\V*U$U.E'I*F3D5D$B2T620<&=,G;-(@S"
M"B:Q"F%)0W^E\;7L1=X<#KL_<K.9S9:2[FW-+85F@9=F<QM \<Y->B:YC F"
MA]>0DH_>-EDIQD1+S-DE/@A<"D/7UP*(E%OW%8SJQAV[OU8#C7P'Y>M^5S?<
MVS=JO:3,2\AIFD3T-6HB(I:4LW>L2.+5(((/W5RFHAFY &CAN6*3(H'JF1,;
MR^2S-Q21QCCF'J(23*D0"%]@?*/3J(^\>G0.N118H'24*8>@&*("(>WQ\,:9
M'DGX^L^3G(WN_=TM%YR^Y&0.C^WOO34VVZ7QOIERG@KNV)W8^EY#X;7EB4<2
M3\S36,:IK==5.NQ[,&[J4FE7(D]8 \^HTB=F=;[FG+@)S"[M.\MP\>^84!:N
M05G/L[DX2E[O:;1YEZ,;<4G>JY#8HT:2U]1^'D^I3KAKR\U*+323:NT7*K^0
M>H"L@V.+LI3I2/-\&Q^H[KVOHSO :^4YI<G^7-O9\@^6.P=?\2);CIRDU[>>
M"5LILQ,62DTK3NY.,,$Q;677-PIRLPQ:R#]5=^=.7("JA@3:++ \5W0DTW>^
M>NZ>VA4[13N4.]K)7JKS6YCR6_:!KKF%$Z+Y?WS5]7D*HE6E]1;@VD%G=J5J
M@S$@8[V%:IIIN!=$(0WG5 N+V(BXOO=2WMK_ $]RKW/^KW;AAN;?<#K^L^3:
M/)S6!]I;EY$1-7W1IY;2<TQJ(SE5N;>-<P-/VE:[*Z4A9N:2.X_&5K'1PE*4
M_030[,RZEW->:')"E\H^;.V^)/(_FPVA>$FX=':OE9^U\[*76].Q]D<.*Q27
M<'#\+ J*$_M^OS\C$2Z;F1+(*@X645DW(>BD9$+^23>K;CN5IR-YJ=UFY<:D
M^:O*?C=JJ1[3VN.3MGB>.>RGU$>O[[$SE10;!6W+Y.79T5"1G+N5Q*N(MNB]
MDF;(K)5?TCB.1=ZVIIAVNXOO,[BG^KW\@N2?*S?\'9[GS*;\2+9L*'W YIB%
M5J="WE,PT7R&8S,LC(E@N2477W1$G%X<+'6.G'-E5TC*)G4-? UKM>P7ND\0
M=#<E^W PXI[=Y3#IRN23_1U;U]R)VG8X>Q*S5]J4E"K4=Y>)>;?5Z(N\KL#Z
MK.FZ,HZ9B_>//52'U1(0TB=]FIC%2T0V7E'O)I1^Z=P0Y7:\XD[3WSJSMM6B
M]PW.+B97H:,)==4ND(Q-GK[:RS5E\="S)I:73<-6)!CF@F9'6*R.51%RI<VS
MLACRI@W';.X=;@ULP;*L>(G=;X-ZXV-1D6\8^:UO4?,*ET;7X6JFQY&I@KT:
MRW+#IK2B($03<+.R D(^DV V()_!*?=E5V[=N\MKJ"TIOO1O'6SN.PKJDTE>
M^05!AM@:_=UP;>S;2%9,PG;! ,(*3?NW+9P64$[GX-JT7_TLJ!Q '&+@FXY]
MU,]=CKF5R=UGP-X\::XP=L2W;NUC6]D[#U[MO>];Y!TFNTPU\9;%,G>=C5B.
MN44E)6VK2[.7)*)C&@1H1<KADB'5#S#)K25B9C1E7FA5^..HOUAOLWVBB1>H
MZ%(V4O.RT;QLT$-7B9::N4CI*P)H26T+$B9-^_F 4>';,QE%SG01,#= "(E(
MF",Q,$UYHF$-.Y3QXW/Q'>=X[<M0V?V[MM\;>;[.'LVQU^0=IL<_R0U-;BU=
MXVJFM=>4JM,W[.5FWMEM[ :NFL<?A$3QKLQ4R(*'$DQK5/3YV<ZO>Z7VO.#5
M7V8TF6%XA^.NO6\ZQL*KI6;9J*1GQ+)I(_&_Z;17;1BZ!/1/T,@4H)] \O0)
M.K4:-EF!!F@#_P!(5R1#_BX\<?[[=RX(3FP&!B3=VD-6<B-96[4&YZ-7MCZW
MNT2XA[+4+/&MI2)E&BP 8ACH.2'!%VT7*55!=/R+MUB%42,4Y"F!E<:-$7_\
M=77M=;K5O3_<9[IFC]5D\Z,)IS7?*95G0ZQ'*D(FM#P3)[6'+MK%G* E!(5C
M>0G@ ],MI7>VG<&^WAQD[?&OY*A<>:>_CW-IDPGM@[#M<B:S;-V3/@JZ63EK
MW='*",C.+MCO52H$,!$$"'$"$ 3&$TNY(PG5@,!@,"(/./\ >!7_ -^3BO\
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M)'R*[%^^KD'$-&[)PX257;D:(B4X&23,45"?Z")4"^0O0"@!2E*4H%*0I0$
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MMWC1N4$?,F(AX=2]?V.N"$-^(X];+S#^QRZNW[.O=7CB(J#=,O 8# 8# 8#
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M6_Y5.F<1\Q/R_%+PH="E#[ 8%V P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P&!!_N!?O'5/]([B__#Q0\)/\4V?ZQD;_ %<^5DP& P&
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M^L9EJ_S<^5DP& P& P&!8I^ ;YL+&J''$?\ NBY@_I=7?^#W5V-DGYI3*P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P(+Z_Z
M?\X5R4Z?Q<>.(C]JV[GZY93C\TIT9%,!@,!@,!@,!@1 YR?O N/]^3BM_P J
MG3&6-2<Q\4O2^)2_,'W,@NP& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P(/]P+]XZJ?I'<7OX>:'EA)39_K&1JOS<^$,!@,!@02[DW*
MYWPFX7[[Y*140UGK#KBFJNJG#R JA'2-ME'+>'K;>1!!9NX.P&6?)"L5-0AS
M)E$ $!$,+I#45P'Y;<^-5<W='\3>=.V:;O5AS7XEI\JM5V.NTE*CR.IKK&%0
MD+AI[X1DY62FZ\RBY#J@Y7*+@QVX")^@B MDO.7I;,8"I"!A\>@^_P ?$?V@
MPL:H<\1E"#9.80 /C^=Q=S>/AU*.O=7  AU^R&-B8S,IF=0]X?3A*E7J X#%
MP*>8H>TP?2&+@J3J ^P0'[> Z@'M$ ^W@.H>\/IQ8=0#VB&!:8Y2AU$P '4
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M@HZA[P^G IYB_P!,7Z0PM2>8O],7Z0P5*OF+[P^D,(M%0@=/$/$0#P$!\1\
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M67D"-P2%[Z7Q":!CID.4IS@-A)TN-4.B6*O:^[IM,G-@R,? 0=B[);HE9DK
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M1.Y243-Y0-TZX)[M7ESUKW;OUB'9_)_<'$>N<,>)CS=''^.I$]MNMC97+1M
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MS3NF]J:1TM<[4FRV7R'L$M7-65-LU4>R<ZY@8ES,S,@JFE_W%#QK)J/J.5!
M@*&*0.IC &([=DTP_!HWE'7]Y;-Y :SB:1M&J/\ CQ;(.G6&;OM)>5>KW)[/
M1;F6;RFMIERH=.W0C1)J9-RX2 I4E3$*(??AC02B*<IO8(#]O]D/L8%^ P&
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M=/V>Y("UM]CUC0I^UMA1%L9"R3-3B)&=1,V$YS-A3E'*H>F(]2 '3,MLOX#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# BCSL#K
MPOY5>'7IQ\VYU^;\1IL1Z>(?(&6-4G1XS>U'R^[O='X-<9*)HOL^:YWQHZ-K
M*$=4]X2]LB64I;:^O/OQ<SZ[)Y+(JIJMSK*D IB!U](/ ,NZ1,U58>O#47'W
M?4%RJW9O*\\B)6UZ(VCKFAU_7O%IU#*)UK3=C@6,>C:)J,D1EEV3\]A625!0
MJ35$ !00$P^'68^+53&=FI3;M*J)/UD[B5"EJ]=+%+\%MP.5XTL+'?5R[@CJ
M;$JZK'X;X=18HE#H<Q1$.@=/9C9-_MW)6_K![%LP[,_-YJS10:-$-<5=)%LW
M031;H)$V91P*1)),")I$*'0  .@ 'ADBSEH\G6Q]]\[N>M<X9=IG='"_CUPY
M2VTRTO?*'O&]RJC.:NFO];DBW@2- ES XBU;A,1S<3? H+&>JF/Z D(*@#FL
M),S.-$].^;RBY;<<=US56UWW-JWQ;I>B>,]0LNG-":F0M-]W1NJZM'CB+E"[
M?B(&/%*E0SEM&MQ0?2:ZC$K43&*F<QEQ"1DFXG7+ O)ZL\N></-GL.[VC.6<
MOIN^\I>,%4M4*M5X!V=EJJ[1=0)9-G3L"U;V!H55+9I'H-U4 ,C\.F0.ICAX
M V)BY[TF=L]S'FGH^0[M-!U[M&4NVWS<W^*G$;B@ML%S\=4M1OMOU9ZWL$[&
MLU0^'CT/,D=R0BGJI@[%(YRJ%(8ITQ$KF+I)[B+?^Y5VY^Y-QHX2\V^5Y.:^
MJ^<U*OTU2+S,,7[.WZSV1JNJJ6&P0[('3M=<:N\,J1 !44.FL7RJ$2;F*8AA
MF)J?M]OXO6%D4P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P-87<2[2O$WN@-=:M.4"&RU4M4O)U_4C:^NWXGJI.+"FS2D!?G")E
M/BP\K!/T_P  2#U'J/7P7),1.J)?%/\ 5R.W=PVWY1.1VF@W_P#E#URM*K5X
M+;MQ2P5\QYF%?P3T9"'&OLP> #"24\@>H4"J !AZ],7*1$1G=LKX7\(=*\$-
M=W'6&C"W+\6+OLZX[=FOQUL8V>2&W7I5FM.@T?"R8BA%@9DGZ*'E-Z0=?OC=
M<+3\6L.".C-2<NM^\U:DC<2;IY)P-'K6RE9*Q@]JBD9KZ,;Q-?""@ 8(C%+E
M:-2 L85E04-U$ +[ '>[MS#XF:HYP<?[MQIW<G8UM9[!- FL:=3FOQ>GS?BW
M8XBTQGP,O\(^!KTE85'U %(P'2\Q? 1 09C08SY,=O/C;RUXM,>(.YZ[-S.I
MHB/J+2"<,)9)C=:Z\I"*+:O3T#:#1SA:,L+5LD9,SI-/S'354+TZ'$,7),7%
M(L<E^QEP+Y>../DIOZIW^]6;CG6:[2:Y='5X41M]]IU9%J,=6MNS:<9Z][BS
MBV,*P* BH;XA8 , *' 5DQ#]4?V/>!\=Q)W)PB2J-Y/QYW1LE7:TM4E;@ +T
MVWGD8V5;N-;/D(A#\4F4>[BD?00*18A"%$H^8!'&;LP[/QZ[./#[C)LSCOMC
M6C;:)K5QATI<=!ZS_&>]C/19Z#>K'9K18"66/6B$234NM)VYYZ:_F1*FD)">
MF($#$I$1JPFP_5V>UI'<HB<K6NBWJ-M1LJ-R;:W)/^71[6UMQ171GF^M"QWU
M>DZ)(H@\!(%?A0=")_2 .A0ME0WB-D4VZ144B FFG]ZF0  I2$   I"%*  4
MA #H ?( 9%<^ P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P,*<CM;RVX]#;@U-"/F<9*;*UK=:,PDY!-95C'/+/79"':OGJ3<!7
M.U:KNRG4 G4XE 0#QP/*9H;LU]_SC/J>F:.TMW6-.TG5U CAB:I5F>NI9VUB
M8\72SL6Z:[^M.'2H"NX.;J<YA^^Z=<U<:L_S53T$<8]'\X]?[]OERY \D:]M
M72DSI34-3I>N8R /&OZYMFL0$,SVA>UWQH]J59C=IQN\<HH^H84R+% 2E$!S
M+4:YTIT.Z\#[]9^['I/N"MKE6F]"U?QWO&F).C+,Y(;3)2MK/(';3#)Z0/JM
M./:B\#U"''U!Z" !X^%V)U[F7.Y[Q,MG.?@IR#XI4>S05-M.XZS$0439K,V?
MO(*)5CK97[$JM(MHP!?*IJ-H8Z9/3 1!0Y1'PZXC5)RA)SQ[2MDY;<*^-FG:
MC>ZSKWE!Q0<:DL6F]Y'C'YV<':=?M(EG-H^JQ*%B1KUC2CNIDTCE."A$C&ZB
M4<D+,7#7_P D>P1S-WUR&W9MZ YQ1NIJMRYT75*;REKM:JSF0GYN_5VH*Q+^
M'HD_*M%G<)J>?GTR*+-Q43>A'+KMS@KU();;-3VZLG;E[*',*?UEVK#:(Y0:
M^T_OWMW:Y8ZRE;M^+,W,5RSQ!(B+A9&3K#=TBX=MWSQE'J$%-VD)/*N/0P"
M=)OW+,:4[5=>P[8]Q5SN50.T-T,8V6YD;OT?OO2U_HD?(MK7IW8>EJ\JSC9^
M6^-]$CE:1EU!]4&"B9P:JJ@10AO();.J5J[#P![._*_6O+6L<TNXWS+?<P=P
M::ITCK_CTPC63Z.JM%B;'%.(6U6!^VF6P*N+)+1YRE]5N5$YSB=1=5<PE B9
:O"Q<9EZ.,BF P& P& P& P& P& P& P/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>tm2030088d18-ph_resid4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d18-ph_resid4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X )D%D
M;V)E &3      0, %00#!@H-   VV@  O'(  /-T  $^1O_; (0  0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0(" @(" @("
M @(" P,# P,# P,# P$! 0$! 0$" 0$" @(! @(# P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#_\( $0@!D@)D P$1
M  (1 0,1 ?_$ 4$  0 !! ,! 0             (!08'"0$#! (* 0$!  (#
M 0$              00% @,&!P@0   % P$"#00" @$"!P$   ,$!08'  $"
M$#$6,$ 1$A,S%#05-A<W"" R-1A0.( A02-#8'"0H")"1"41  $# 04"!@D+
M#0T$" 0' 0(! P0% !$2$P8A%! Q02(5!U%A,B,SLS1U-R!Q0E)CTR34-G:6
M,$"!D6)3<U1DM#65%J&QT7+"TN)#DW24Q"6RP[4(@I*CI"9&%T=0HD1%8'#P
MX?&$53@2  $" P,)!@0$!P$       $  A$2 R$Q<1 @0%"!,A,S!$%189&A
M(C" @A1@P5)RH/"Q0I(D-",3 0 " @$"! 8# 0$! 0$   $ $2$Q01!1(/!A
M<3! @:&QP9'1\>%08'" _]H # ,!  (1 Q$   '?X #@Q$7X4 R" #5TM%*Z
M9A)8I#$M%9@I1C BW^EH+ALR.GG6NET),\ CDL&C+!@,SB;(DU!++=+JMJTD
M)UV*IKU7(Z2W(A+C(VF)5CI-("R%+))2))0UVG:LY4Z2 2[+$UM+?)P4@QL;
M1DR(   "DD0C.AE\L,T 6S]D^%G"G09G!I/61YC4ZS9BFLE9Z)X"VUP$4\KY
M%4E 9',;%<-B*6Z7$1S(B+V%P&4C.28 )JD&RMD-EFT0\)0I05Q01&-]B5@\
M)J%7-!;9<9L,376NP),-GA6!1.Q(.+Z2J%GE--B22E   !"(PZLRTSH62:TC
M'2Y4,Z..O*W?; Z3Y/HX.3@[P"GG<=)[#P'M.DY/60N)H@    %./4>,]IVG
M64\JIBPLPD* <@  IIZCQGI/@\QVE2    ,$&GU=D"39!:9<11RXC4^;8
M #!YA4FT    8-,Y         %HE$,D@   M(@6;(0      "*!&M<A&P%
M!J?-L !@\S@  6H4$R2 ##)F0^@"(!+\         QF6B9Z!AXRD>\ 'B,7F
M70 6F4TOX    @>N*S-9-E  !J?-L ! JVIP  !P<G!R1Z-LB?8!'8D2
M     646X98!$(L1:L #@'( ,?DJTSN    :Q2!1M<)I@A49%,8K-Y-3YM@
M,-UDN*R    "U2Z3D BP2G         ,?%JF:P6N7$=P    *<>8K0   !"L
M@^N?C9LF(S1'>6QAQ]DM(('I^AL A-R2YXK@       (>$PP        #&19
MYGT            B<01MV;29I*:156L)C\G(:GS;  16J5$<@      &"3.P
M        !:!0C)@           !&DP:M9)WH  -3YM@ (JU*F.0      "'A
M,,         QB6B9\            ,&FN)9FI,(  &I\VP $5:E3'(
M!'HD*         666\95            (<$*5SD;*T%)*B>(J1J>-L(!%6I4
MQR       1 )?@Z2!O).GB]X      ,:EGF>@           #%9HC7;0DR"V
M#2XLD2EFRQ-5AMT (JU*F.0      "*Q*D B[9**4      #'A:QFP%LE ,B
M@         $,B$"R+-D*62:WC%ZYO,A)K[K?U $5:E3'(      !&DDL:\N<
MQOD=5LERU7L?LV<=?(     "Q"VC, *411J8<          <%**D=AP8\+T+
M<+S-3YM@(CU$3+Z.+*^6)U=FY#'[      !$8ER:TN[A-[:8/%)(+:W-V<X_
M:     !C8M$SN#@BM4JH          BB:^%E$FQ,  &I\VP$&^3)>VU^2>?$
ML$,+(V?X.2      (^D@C6EW<)O;7!X3D@KK,W9SC]H     %F%OF4P<$5:E
M7          &)C\^%NX&2<X  -3YM@(-\F3-M@9(Y<1!#$R-G^!D@     "$
MI-HUI=W";VTP?FN2"VLS=G./V      8I+*)%@X(K5*J          (0F)%F
M.F<BWS7LN>4H),XU/UM@B#G)DK;8&2.7'FR"&'D[/\#)      $<"1YK1[N$
MX-I@=;E])!;6YFSG'[0*<>T[    606T9<-->1UY5[>NVCT\;,+%[I,R@
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M1@O2;/;_ /-/:91E BI4JX BP2G-:7=PF]M,'BN4@KK,W9SC]NM7)Z;1^O\
MSSKEY+%\!ZW<KY?=@1BY)&\50!CTM8S6:H-AB[#LKHY,<\.5G:K.F/QNFS?Z
MF^/I'C1R=GR+Z#M6Q>\     # 1KH63Z31+D(&KT)9JU(@19^A"(-\F3-M@9
M(Y\.%@CAY&S_  ,FVS23]'\;G_T&I68*T>TV_P#S3VN48 BI4JX BP2G-:7=
MPF_M<#XEYL@MK,W9SC]NM3*Z;2^O?/.N46-\_P#6[E?,;L",52-BH QZ6L9K
M-4&PQ=A^7C\+CKKY6=JLZ8_&Z;-_J;X^D>-6<R]GR+Z#M6Q>\?)!+DFIQ5L
M  $/##AZ#8\"UCDL$S,:GS; 0;Y,E[; R3SX<2P1Q,C9_@9-MFDGZ/XW/_H=
M0EP5I-GM_P#FGM<HP!%2I5P!'$D<:TN_A-[9X/%@@MK,W9SC]NM7)Z+0^O\
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M>5B%]D4N?&0F9C\ CKB]\M.KG%/NZZ/[;S'"BW/-;J=&HV&(*UZ_4_EOOS\
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MD*^LUTST   ")9#ZMM$0!6!%;*9+66>:>\UU+\)=)KLMWDR8/(A+XC;DG(
M       !\'!V'P<'81C).       X/DX .P'0?9V    ^3Y.P^#@[",))X'P
M#Z.H[3DZC@[@      ?!AXS(                               84,U@
M    '2:I"1(                              !@U=I2     <%G%Y
M         %#R>BM8W=BW=ZK)NFVD/O?>-D?Y'TN O4>?H.3TY*U&QQUM=?<F
M)D>#MX9=T.WR?I]IA'T6BOO6;&[<+*JG1W          627L
M      "!WTSP<C_)^CL?8X(B5[KQV;O.;ZF=_50N[JN#'[J%D8]V8.;Z(SAY
MO?89]!I>OEQS%Y_=8,]+HIL_.O;>SK[
M*#E8]<QN_&FXUF1]1LHI>W\E<>)DW9@YF&/0:;(NJV-\ZS.JO3W53I[+DP\J
M@96/CC;ZVZL'+I7?TY'U&R]7#F
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MJ3-D)A,PXLDCW)(4U/K+=)%%V @Z>TL8V'%FE'+>,U@     ZRB%?  +?+@
M        !0"O@ 'P4(N         H!7P #J*,5XM(I)03,(          (,+
M=22] ,?GT7254&'S+1:Q=X  +2/47& 4<I)=P            +,**40S0
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MX5T0=A,,, [8AAX6PPP#QP###^@P5+&\,@0L@QRI8T';'&V)<F4*5D'AG0X
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M8RJ19C82^U0)ZC3  K.D<'#-.*RQDALG!RAMBH1_/Z._RI OMC4@>^6OQO\
MR6KD]QN!DQYPR=5<BBN&EQLNL%91]7R^4=@(K-EY/<ZW4_>XU?(?VS9WE+25
M_.=+'XF-?+>DC^563Y/IR?(1S)#D_9%Z4W)M=;;P_9)YVJ*'P=D!L4WP&?C*
M=3-[AWVZ-G^Q-?(_N5]NC3]\ZFKVP(@ 7)]F+UV<O0006"S;8\<$P1K1D&@
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M)OCU7;2!FL* 9D8@V84F5HYL9.=R8BO^.E]4<>,(N)7)O)A&G-'KX8YEU%C
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MM+-ZCKTM&8S%-C/R'52\W7G&0PMM **3CS[I7"B<JVZT*EJMK(2A.!/I='3
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MC?23T:K.!,&ZJ29..ZZ_]SZTKO3Z2%HW1LGI%(N9O.ZX%S,G)[YF7<5J#^R
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MRZ#,:>:-P39%!>CRD$%%=O+:FTU7SDK A1H>\.>$>W=H6LPNV6'@ZE?GN_\
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MT'+?;=VC>E]^"SE$"0+!GN??R!3'X*^RZO-O3NLNS35]^6V 7]G *#?^Y_\
MEJ=(HP@#T(F2JLF?%E(RU&EQI>[N4]Q,#$R0$ED<88M@K85Z<@Y=\+$'0^U4
M:CN!.1#WS9O4E1,?O:#=MOOLWBKL%53<\S_1KL>6\93;OAG-WEA1$?:*E^VV
MW4-/7O9#^A+N^[VC@N>7=RD/O=WMN=VK$K=<@@*K.PBM(Q*B.FBP$5=\2_=
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MX!2G;=]_^C.]3^^]JU[==@ &?CPK1L2[ON2M9-^^)S]^[[B]KS>W;G5N"J?
M]G1'WMHTF[=\_P#J7511]HB7;;-8J_ 5!;AH]_HMV8ZW(4YAC\-YB28W,%/8
M+MVV4>G(.;D/"CG0_-1\IHNL.X-\[EJ#>TH^R+G=JQY5?@!>LS!?1<>%'#'<
MD7X:F+=0O0OOG:L[AKL%%)R8K2K1[\MMQE!A 2;[SUBO\XE_K$V;+$I5N"36
M:T0@E(N5&A@DTZVI;YM5R>J.HO(*8>W9A2U!3R;$(*/@E$N5TVL[?R$]][VD
MO$&'CR\/+?9,=?IY%<S>246[:,MQQ_9OJ^%AJ+:>U),7+=8LJOP 7*D"%]%Q
MX73F9D=Q?AJ7BS"[TJ>R+G=JQX*] &\IZA?1K\(NMMI3Q7X;SEAN(2FO]8BW
M;+<VN04YSB[:1?S%AJVV/EG&$WOO;'F]NS<ZJRJ;.HX[N-2DI'=@.TYD(I[Q
M-  *9OBR)J"@MH@X!+C6V?B[UEYN+;X/#CQ=GN;:S=5&;BK NCEM5)LE0:='
M\,<WX.X>SCC][^S:H#0^KJ35V($Y^$X_#>D/")M.&"8\N*2"1"-]UO1)5?\
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M!DCCCS([T5X?;-/MDVXG_5*TG1.G]=4K]C9 OQ&'IL CK--IDK$#T:.XG-Q
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MBQ(2X[N(K.=7E.GQVZ@Y19<!:BK9Y&^3L929&!.?A5QQ;4/3K9BXE(IT>'F
M.$3-L>^&(\B$=_#1=;:*KC5!U91([\+%+95^!4H#RH2Q9;:>U6^[U[?^H76+
M6XM;U'%A%3:/%IS"QZ;2H9XE<4!+:3QD:VU9KYE,V@:<IS6D*-)7N)%28/%5
M#9[(L.J0W\2W\.H*/26-YJ$QB.,=C$@8U"9'=+G+L3F MFVATT"HV*"E\EJ_
M9]FWR9;_ ,2W_#;Y,M_XEO\ AM09,[3PLQH-7A2GG!DM\UMM]LG"7^**<!U\
MZ1!<K)M-L+47& <DY327-@)G?@04[%UIK,)T6)CL60W%?-%(69!M&++I(FU4
M;<5%M4GJ)U@Z>9E5B6<VI37J.<F;+?/E=DNBKBBG(G%;=M:UN)7JSO;SF_0X
MNZ-;J2-Y+.7<G. D+;V[4O7&A:XQ0=4TZ([3I.^,*_ JU/,A,8\L!V][5-EM
M95;5FI(]1UGJJE]$,2&67&Z51X&,'%C1V.Z(3)M+_P#][1-&L3F8\F,&G@66
MX!DT70ST-QQ< \[OJ1EN]>VDF&)K,9=.:@I57>5T"+>&H%V-IO#W)G=LOL_'
M<2\'VG&33L@Z"@7[BVZUNI))24VIT^3+&ARY DH.4.N8G&)P"/.($/$A7<2E
M8.KBE5&/$E)0(5&*H&V:LKE"UO;H@//3.,2N]>U*H[5RMTR!%A"J;$+=V0;4
MKN3$HW\+/6!U?5V-1=2%""FU6-46%D4ZJPV41&,P4[EQM$N^Q:HZ]UW6F:]J
MZ;&W&,45I6*?1Z=?C.+# N0RX[:]ZQV>^4>/'C:+HCR\3Y4US-J;S?W OJ@H
MO+?P5DT(Q4*9.)";DC",;HSFT)9HH1B3D-=@\=LW$[?T-BQ[^WG7[M?BZ1PY
M>/W2Z[EMK-%;?!!KC:(3M92I@Y_I\;G,Q$7_ $@/<>7C^JD!HA"2*)"27H0K
ML5%1>-%2S=/I4-B!":5PFHL9M&F6U=<)US  [!Q.&J^J@R9L-B2_37]Z@./-
MH919"@H9S-_<.(*\?']:L58XC!5*,PY%9FJ";PW&>)#<81SNLHC&^[BO]4HK
MM14N5.TMFX%*A1Z?#:4R"-%:%II"<)3<+"*(F(S6]5Y?K)NKE#86IM1CAA.R
MTWE(KAHX4?-[I6E<2^[BO]40&F(#%0)%Y1)+E3[*6:I]+AQX$)A%1J-%;%ID
M+U4BN ;DO(EO7L\%6PYE_1TR[)W?-OW=SP>]_!L?8S.9V;<<C%T3Q_ ]YOW?
MC_$<S_Y+:N-1>3.K+9HKE/A0Q+X!&2]E^*X;T\/='D$^3B^MZKI^4&H9%0HT
MHHD[<*'+F,@\/&B.M7HMAH5-F3H=6<!38A5BGR*8[)1.-(^\(@NG=[%-OJ*_
M08JO[_ILJ>-20V2!E%J4994;(=7FO=Z3;=Q+:H:BK!.A3J8RCTHF&E>=0%,6
MTP-CM)<1VBSHZJK$QAJ2RI)A)6W@0PO%>)<*\- A5@Y /:DGK3:;DL$\)240
M%[ZH^#'OB;;&ZX0MMMB1N&:X1  3$1$2[$$42PU.BS&I\ W7F6Y3-ZM.''=)
MEW+*ZXQ1P%VIL7U=2KM25P8%*B/399- KCB,L#B/ VFTBNM J\%3*'48S4N,
MK@*!JR\.(,0+M%;O43:C)4DC4^)(FR%%,1(Q%9-]U1%-I$C8+LM3JY32,H-4
MBLS(JN@K;BLO@AAC!=HE<OUW6445.^ESN8,09Y%\&<YJ0C(!EJOWM53'Q6PX
M"NZ&NR^C0Q>3=ST5F8+_ '+%=R7VUDJM-!CK;9(3=-DPB<3H^+SG9#ZJW4"]
MT;YO)];]<:/Z9U!7TF:F%W,HT-)(149:5%SU5>8I7VT'5-*Z9FTBD:&U -5K
M%?J*1VG#1@FE*F-(TJNJ98.Y7LVU)0M-ZUH?5[0M)R.CWI]3;CR9U8J7.5<A
MI]10(H*-RVUU#F.4JO:JT@] :8KU,',I4NGU%]& JSL=O\55><G*JVT]5*/U
MA::ZR*1/DL!J6DQV(E-DT:,\.(WHJD8/&K.W8J7[.*W7%,G U*BZ5_99FAQ0
M:;:,IM8I9$+<AY.>\)R[N/B2U7KNH=54FKTRJ4YAZL:?:IF[+38DIQEULX<H
M><3D=2'$A6ZO]$MR6DT].ZNDJ<B+D KA3&&$RW$?[L43#Q6=T<VX#U##03M<
M"GHTV+SM3"4@!=)7:F--EW%:I:CK/6/IGJ_= YCU.TC*CPI)-QV"/(8GRL9D
MK[PA[&^^^W_+UJ*<+8S9^I%WS)\"<EK=FG76NPVZ08D]>VI&J;+"#-*C3\F4
MXSG@U='-3O:O3%B;14[5]H6HX-?BE#D5FDP*53^C@4Z>$K4>[5!7'B+O^\ 1
M7>UOM1:I0I#<>9,U7IVF/FXR+PE#GN.))! /8BF@\?):NZ TE7:=0Z;%H-'J
MKE1DP!E/P4>:3.2,/]:[*=<]EL%!MJ=R-JRC4K_T]J-?HDB>-,%Y_5%0H!ND
MXZZV0X(;!QT#B]DMNKN'I]N%%UUKQ^1"*?(;QP*>%.)S?JAN^W%B;;V)R*MM
M,IKG4L36.F-55$*&K[-.;I\RDU:1<L8TP<UR,9<WLVUW2]/ZJI%$HFC-7.0;
MI5.1YZ5%(UP0^8VYB1EEE5O7"JJ5M;H:XC33-00R1+D(MWYRHG)>MJ7KB/J:
MD!3J-1(U0_8WHQ"%VB0VA,P*<O?-\<C"I=BW5E!IKHLZ8UAH:;J"5"-H">WM
MLI2#W_NARU9NNLQI%F2VE#/0=0K91U8%3Z08<=1MW.[K"F!-G%:7U@U/4=)@
MZ0TK-JC=1IFX(LVN1H#KI$H&+:@R2W@T/.3LVJNNTU)1V:?5*/59+6C3IB8.
M@G(T@"OG)>XD[=KR3DMU1:1T]+@4VNZMH\%KIFIW;E0X+45K.G.@6QP[E7#_
M !;:8H==UW0>L&@ZKEK2TE0&8\6HTFHF!%')QM@E0XIDEUM7,4C55*T]"TW7
MZC#8FG3 D29Q"X:1H>&Y0;C,@WSB[J];5#]I!86N:?J\FBSY,4<MB8;"KAD
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MIQH:,*.&;&+$DES*C*ESFW/=3"'MEV)956K4U$03-56;&N06WMW<+PG<A(7
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MS+O(B56K+9U[U%)E*S1A^D*=V0TQ8"#7+]0+ K %$'4:62P;B]@1XYT/R_\
M9NT+J1JK.>YMI8@T$D:U(_> $LHE 9F$RLT<3&91K''4AT<L !F.@"RZ9GW:
M8>@< 2MC$%ED69D?Q+XE1[  *QC$:4OHN0$/0%JL1*RN0"$I6'<4];VQ,3-J
M0S+!<B'D<57BME=4D]0&0C;UMQK&:5:_Z,]-0@9BEEF"06"I>K"#TIFG/$%C
M&2<) >UYK7W&-SR5E3\@V],0#,">8/V;G--Z%%$LVO84[U,1S+2L_/,E)D'D
M08"[5A3;+_Z6_BY)K4:A):+:IMAS!RM-5+-]52Q_\9V"W-!]KJH'LK$[AO\
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M/Q-B/E U<>543.,B$A7_ -A>!5T9F3I"5]!=;[9[^%5<0!)4$#*6S!*<[UQ
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MDR#JF-S&//J^83GO. &./,E@ U%Q>.Y.P!]>BK8T3"CGAKJ-(['XI[2$E[X
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M_P#[;S_\:?\ QI_\:?\ QI_\:?*\?^P?^4K_ ,,^3N5TN#Y6C_X.T$ER\O\
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M2ZJ J+;T/BH#KUGD2>1)_HD$S2GIG8&_PW/]N/\ :C_8C"8Y3Z>W_P"$G_\
M-QA#<'I$IIW,.P'W%RP^J5JJ[<7JYGV@+N<OJ1LK@E4*VU3@)GZ3%X_>JZ?K
M")ZKH)G/:-P5AWZ_6&6W&-7_ !&H,>^4 JVH)3+]/!O1%;;.3>!?U*X*&KK_
M -U8G*NZR\E1U*Y^FOI]8RQO*/2I65=<W07:\_U<_N0RNL/LQ]DV55:2J[2W
M5#N[!=O-S:X(!6B>M@ %VLV"2@&^Q$A%&[HY8[!'!CRWSVAZ8K79)S,&=7^2
M4(F*$%"E-7?K ,T+\_\ N!W$;]XMMNY6N?P:KE!]438\^]*O4RSME>=4L]V]
M_:8FL+L:A-:T6[;RKWF$-<;T5,Q0Z[P3RA:>_2B<\"#\RSI,Y:]W?^S*P./<
M3]P@P-/8G[GJ2K__  &/2>FSTV49;C\H;@9Y>C/]Q/\ <3F=[E?+&86"5B*F
M?[^?[^$M9*)?R^O@W?RAN?8^O[?EMO #RSL?+\?I>U%I3'?RAN#54J>C_&>C
M_&?80^6-S$/@L>)_A,_PF&\B4]W_ /6G/PC_ ,+CP?_:  @! P,!/R'Y+CXQ
MTWT]/!7MXZS7A?B^OS;TUUQX/3X!TY^!KX?/1\-^'C_\GJ/_ ,P2Y<N7+ERY
M<N7+/GB7+)<N7+ERR7+EGQ<__'/AXF/_ (J__B;S'_\ &G_\:?#Q\RM%^";8
M_P#4XB!J5E?_ (KUQ-G7G_\ $UQ-W7G_ ._%^"O%Q-G_ )6K25A=KYP\'$W=
M=?\ QJW^O_AW'@M?F:X^+O\ -3\'B;/#-S 55UM%6J_^!6_U_P##N)NZ\NOX
M/71[/R-()L&>J?Q/5/XGJG\1M\--_KUU>"Y?S?$W^+^'U^V?AZ^*^Z?B'7;[
MOU\/?Z]=75(R6/S/]R?[D_U(E1W3YGCQW\'KJ]GY&ONGXAUW^_\ 7P7IO]?%
M?<'Y\'VSY,\7'@N?7\'KI]GY&ONWXAUW^_\ 7P]_KXK[@_/@^P?,\3=UY]?P
MNNOV?D:^[?B'7?[_ -?#WZGJ^X/SX/LWS/'@N?7\#KJ]GY&ONWXAUW^_]?#W
M^O75U^X/SX/MW@?E>/ :O7\'K]L_(U]T_$.N_P!_Z\->+?Z^(^X/SX/MGQL_
M#XF[KSZ_@]?LGJ6$C%S_ &I_M10%SZP;S\*ONWX\&_W?KJ(DN@JGE;]SSM^X
M45<QY]>KTW^OB/N#\^#[-^.B=*);/]J?[4_VO^2AN^K/C\2NE>\3$4WT+1)K
MWE>\JR"O6?X3/\)AD"2I7O%7J.;[>D_SX_SX0E8.HH RO>?S4KWEA4M+2TJ5
M*]XR'DG^$S_"9_A,NE;<KWE05!K21_EQ_GQ4PW@>]RO>5[RO>5[Q>DM!C<J5
M[QEA6I_A,_PF>68Q/@E>\PL+/Y)_GQ_GQ_GP[!=;/7WE>\K_ .A/_'[S/@KX
M52_EB<>"YQ\B]'P/PN_3CJ=>(0Z.^F__ .$J" YAG,- 5S/545+T2[*63---
M2@@#4[/)]&&4%O02UE898X:BIG/8NK,]IE*RK?$".1[/\]HF3<,Y?7"[)(\:
MBMEG^^!*VP9!JW[A!5I<U_[HR6#6^6)DSQJ@L%6-_,L[HKRW*-BZ'*_0_P!C
M!Y#)[[9=\21N[FRWIP(U1Q40FRI3>V".2O@' 34WJ5=2Y1[FK>""RGR_P]G>
M(ORX]P-06)NC\(!?-YN4OTKTC4-H?^YG\>(%%&I:@'\A<2_8@5)MZ];F,D?R
MM[,U@8W[F:D'5W'B5BS16@[2U8MGW;BG-E+C*MIE^W2Z3W(3*MB8[*J*,VIG
MZW&)IR>R2K[3_P#3L?#Q_P"4AN>K/5GK?'KQJJ >I/\ 5)_HDQ)>Q^79)*D1
M9/\ #S_#Q(9;L-?+<> U]2'7B,(=<SGQ\3[MUW^CP5XN?#F/C^]]?/._5\//
M@YZ9CXW4%6]5";/D#Q($V6>OT9:6<_"Y^+G'PTE9^D_V#^I_H']1KD0?9\#F
M_P#[*O\ Y@WT/'B5U]O_ &_7PG0G'77PF/\ \3G_ ,'^>IT_GH=6/A)_,_F?
MST-<S^9_,_GI_/3^>G\]7ZS^>G\^'^?#_/@.O\SCQ'A_GI_/3GF/1Z?_V@ ,
M P$  A$#$0  $  (X0  V"\3.$4.  EK$Q]<[%!.>X]>J@ER   !+19U2!UO
M%OMPP)A <E,9TQJ-P!\E%'EY_B0   'J(UG !() !)!!(*     )! (#)(
M!) (@   !40+*.    +P    P        !"   !2       .L   P!P !
M8 .         +P"  !0 "     E   .  "22*8>  P         *!223(22X
M    .V \@P!,    !8 "          @      !    !6@(=N *@       0
M        :            +*!.PP D       .         )
M7@  & ,@      !P        !6             B   P!D       *
M                !R@! . ,@       P)D       "            "B M@
MP!D       & .       "P)@         !6 >EB ,       !QLHP      .
M F          ) (0!0GW@      &'AV      #0$@         !2P  &)>&
M     !PX2P     !2 L          #.   Q D       &&H$      (0$@
M        Q1)^"!-0       QWDP!@    B 86         $J ]D0!Z !
M .&@>!)    ,1UG0        !D1 V&)\()$H    P5 P!P   !B"*J
M   )P   Q!<02Y0   "'N&$JD *P+0^M0)(       S@  $)$B"OJ ,  PL
M@LGP!H  + :'30      /& ( P( 07N8!" .#,V'E\ %@"1A=0X2P      1
MH'\. P^#MK0 P P\"PAD0!, 6!T*,DL       G0>D1!804CH . .&=V(-F
M/@!0;#0D9@)<    _0((.)+B'BA !P @$:PYMP!, J&(:,5\ ,    )8   Q
M&P0>EJ & .&QB(/N -@)@!/1NE  @   !.0  .)_2&DH  P!P\ 0HE1F5P*&
M!J,-H $    /J +!P)R0$BH.>X$/J"!3N#C-11^%0B5 B[    J  TV<X:RA
M"K6TZSP2;?(3)M[^3B4= -5,F;     "@  +#8!8      38      !88!;"
M#0!           @I*50     'Q^YGP   H&T/,W>NL0         %!P.
M   :UKV0   ,8AW!*R7\          !( !0      ()(!(      !P (()
M     (                                0    !/;;W;;=;?;;[;?[;
M;;[7;;?Z[;:9?[KW>                  !&=-4]]@\0          0
M              ,)[QW^0AV0                             2#VM."%
M+>
M                                ^V_RRZ>23:VS?SW.>[3WP^?+WR]:
M7:>WJ7;VZW/"9B11131!C !%_P 4A@$D&" E@"2^"  0@@2-D7HU"B5;)9F'
M-@"<KAK/B?QNB70!D!VM7;./H!K@.HP@L>5/$"Y\ 50,,QYYF7@#_@6_$"<]
M11. %\+,     "   0          @ "            0#9@          )@
M2 0      2             )H           ??7(J68_K'8(1(@
M  [@          5IQI#8MBS5-FIYP           =Z4T@4U56D 2^VVRPX 4
M!RRFR@ PE FT"68466D3^8[+5P< R!#S)L%:F]T$%^")OI7$P. 1+@AC<8?_
MV@ ( 0$# 3\0\"@*H 6JT ;5X"%!^MN"W] (B0PZD"R.318V&F5C+E%(D%,
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MOZC-7-K)>R47#F@'*PW,63;)[3F"M7,QCH2+$J.)+6($0N9I&"FP*-*E4A)
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M*1L,5JI7-V;!*.PX5@;=AD.;Z"4"?,CU)!@2X^GRV![3)-=&F(C@V6!2:V0
MBU'XI-+ J6J5T;57CZ%[OX\-G[1^#Y!:RNH7+PU7*)/E+HU]D@Z+:-X,5>C
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MO&,5]N8WV_7,Q&N6_H=;X3,?RUJRV<,KP4^;$5_B_P">+_!U\P<D8I!@#H&
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MKS7U%9%W7[?ZGY^T.:[9O[_>#+[/?3PS_P 8]CP=_P"" UL4!["V(N+#Y?\
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MS_(28W@KDX@D@LUS$PN5<,U?/IGF;^=6?0#SMI<*A&6R1.!>A/1)B [MS8Y
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M^45K=BJ7GO !SP(8<*$4M4NN=T.HW[RGZSI:TN-!M0!R#/@ ,+<P 3$"B3#
M_ <K@N"*Q+<X"=1E#D(NI]6*'WK@JINS%-$:2 PS-D#;E0QF';F3$)>B@@XH
M!&&@@T]82MG)R N9*0+IT;\[Q0S@(:LCW]\H*-:RQ<X0R-DK&M*@\B[AP(WA
MN %%L^8&QV#<!E7NPQ@Q#$X"P,2EQ8+FKED__P R2T2BU20RL:M8K31H5)X2
M"%U,Q%*W4C%/Q?EZR%5X%/+2KR+,?, ,)_S*I)P":Q/,T^^CPPWNG+E!A&C
M2D,+*(#96;9 9" @D+J8"J"I#J$^D8$P#56+D,!](C_86![G4PR5JCZ4.$>[
M+2H1A64(&L<75JG(RP5&>3 E)X8H(A(.!!<,2J0WZD%-#AGF0O"!>0 Q5Y.^
M,] DZ9" "*;$+I.A*JU1<*> 'E!%AQMC*F,3SR^1(E<.0I6.RO\ J@&7,Q3
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MO:%1J"U@,.-1%T)H1 ;_ (<"S0>HG:$EN8]-8X&Q8LO(J]_Y\&.)Y8_)>S\
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MQ73\>'$W'P5HNI3FT6-T=Y_NI_JO[AE(;51-]^E]?>8J7+AUYC7AOP,+,2Y
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MNCO[?U*YN_2]32G?]?'Q]>GXG\3\=-[FGV_?QC<?3YHW-<Y^G]QO?'C./?\
M71W]OZGW4J5ZS \N/CMUZ=-GL_B&#.X'/$9J]OW\8COYHF#Q]HJ[\ ,TRCCI
MV]_UT=O:<[5Q](8FC[_KX^:].F_V?QTLJ>A-?M^_CN^@)OO/0?X)Z3_!_<"H
M9]B?U\I05+=?U$H\_KJ#MEXQKS_V:+YTP+X8XK9GH[>TP;U_<OM*LF:OO^O!
MZ?#=:QTW>S^(4%L:N9W'9]OWX+QZX^&[Z?D3-RYKA^OE!+S$"79Z=;-(?>"7
MZ2RL=.WO^NCO[3!OK^Y[Q[,V>_Z^/6+Z;O9_$J]2KE8E*UV_?@Y?3X;OI^9E
MYS,5-1ZP_7RE^_\ ,HN\^?I%=>/M[_KHEKVF?O3,:92GW?QTT>\09051NV6_
M\$>X_@EKP6*#X+5'3=[/XAC,O&=SBIH]OWUJ</=\17,:XZD=]/S(>LKUFCWA
M^CP5\@3;<<AXSCW_ %T=O:852R5F:^[]=#9[S97D7I^)3RFO@NN.F[V?Q,5Z
MS5=-/M^^FYLCW!2#Y^TA_P ]#_C(J(E&"L%? )SY[=/SNA7,/\D/T=%#<IWE
M.^99+OXU!E\_>?S_  ?W&J._C[>_Z>CM[?U*?4Z8W'A^OXZ&SWF_R9>EW/..
MWA>/ U]>FWV?Q,<QWZ3%33[?OIYIW325TXWP(;COI^1-O1-GK#]'0O#R#3G+
M^26Y^ZG^BGM_NB+6D7O@^,-0+\^3P (UV82U+='G]=#CW_71V]I:_O&/I-'S
MQT-GO/XOV,_$J>:=H:\"5X..GX'\3B9Z:/;]]//.Z:=?+.W@$-=3#-NGY$(%
MS3[P_75+B9XF9Y)V/C$VT5GSJ9YU'+?3G[?IA"P?7_L'%9_F=O?]=';VFWWZ
M&&:>[]=#9[SR'JP](]IY9VAX%O?@XWTW>S^(_>8U-8@Q]OWT\P[I:LS,/64\
MQKP"&O ].[W='6(,4A^CIY3V0U*=\P9YYV/!?/PB.<C&JKSQUR:Z6]#CW_71
MV]OZ@:O7I:8F@]7\=#9[QT_-N+7M&<_?Z(>![>#CI^)_$RG3\30&J_?3SCNF
M7MTJVY3S&O"-==,>G%ZLUDEFV)2'Z.J0B5*@3<\E'@=>>_P[>[\#M[_KH[^W
M]3;[PJIIFO9;^.AL]YFO-EFI^)7#O]$->!\#KIN]G\3$QJ>DTUV_?3SCNFF-
M=>1\ &^OYTQ4Q45]J'Z.J5\=.9Y%V/!IY[_"S](>F7_8]_&<>_ZZ.WGM-_O'
M/OTL4=_UT-DV>3+-9YCZ;F]S^B&O ^#''3=[/XFM;GYB33[?OIYYW324;\*%
M1)I$KI[ZCOID/=.<3UE:UWA^CJD=?).QX'7GO\(_A]8+&^? %XB)T./?]=';
MV_J9<69?\PW/V?CH;/>>0]Y<N*_,8ZT3()T*%H89_MOZCS?SOZB\C %LJT&H
M IIZ6U7'3\3^)Q?3B:/;]]/..Z&HEF)7@,% 2 !>@&@F?%4G!"#B0@"-<@FF
M.YS+7GI^1$S.)KA^CI]5%='7/R&'2YX2=@+5]@G^V_J<7WW]3_30D-LA995F
MCO\  L=^?XBV^'B&SYYA8O/\2M4.^TI_B+8+SZ15:K>S.TO\,]7[,M+NGT?:
M4_Q &?PCZAI2)Q?;WG%TB V5$H'GWGU?Q*?XBB$J5=TQ2=BKS<3N>;](GE0#
M@1[1[A8!KM*?XE.G^" _Q$J7IXGJ_9GJO\,]5_ABV+UVE/\ $L,%C)JQ/W N
MF4$H5B9M@\UW]I3_ !&^K_B#KPV +IHJ_:<OFO:'FK\0H:"%1!;)JIZOLGH^
MR99<O:4_Q$++,]F=Q?X9ZK_#"ZMKT889O7:4_P 1X!"M&L-]8(/\:+E; P=@
M)Y*CBT.HT* O\RSM>;B<1Y[TF&O-^T=G:JA5**IG$\E2GK_'Q!#<P&/&"ZE2
MF4U?$IZA;7QJ8"M'ZE,K%\2GS4KGP/P:<^DI\I$3<WU"VB5E.24^4E=*93Y3
M^Y5?,Z,SQW?U%>6 ;E->?2!;4JG,OCB+?Q;=<3-'GF8US1^)W)O!C,;YUTKL
MYEUB7QQ\!U"K]W]SW?F90?.V<?6<7%&]0JZXB\&KF:OG/ZFW/G).1._G_LY^
MA^8W>''UF>=P+WJ=QT+?RO9S,N&K_KH\>>T*X]?I+?6&SV_Y\<V>\3S]8'#Y
MU%QZ2W/=_4,3*U-*NF;?"+RXO^^CY?S!7'K+_$5C?4_:6OSW(N)3?T_<V5WE
MXJ9#WJ9K.Z_?SHT)YX_\8:_^:"Q?BJ752YB63'7$Q+Z8Z62YCICIB8EG6R63
M$Q,3'2YB8F)CIB7,3$OIB6=+.F.F)<Q+Z8Z63$Q,2R7+(:?/?_QUR&!6K6C^
M6( -)'-^RU4"<<G$438G^"X N1S04+S;_%Q@)K-E/VA):.,S>EOBKLLB6C/8
M+M*Y@O**Y:DA@JJ.W: +9-5C)&Y-(JTTFRN\(JXJ%$LQ6X2^FG*IKN/$#\HC
MH ME ')F"0'5W97%/,-XM"U-YE9YE<DKD7DO6_EA3_Q[AHL&"N>=ZN I;J:-
M^MNJA*%L)8-:4Y)RQWTU  8%B8%,T..\P[*3]0AV'^D)'>7:[5]U9?*<93>[
M;)446C<)+0-*._UA&NUARK#5-_\ 8_B+430].6+':-RPPIWA(QP58NCL:A+Q
M9 MUH+I?IHCIM9W@=CL:XB.J1#VO+](!^EI50!%;!3"CB;22?=!_]Q6)@JU8
MV?PP P J""L]+LP-F]2\[D?:$ZXBZ@<57](5* HPLE_(S J1N'3ZK^U1W3J%
M M7*W*$W< " &A=U#4:X5=FF>\(6$TNKYJ:$%*KI5UT7(^TE^J7*2M@2(I0\
M:O%0]XZ(NJ&F.T(,P+%F9J^:ES-UG\ ?_FNLNIB6=I<Q!+R3$QVS[RSMT*[?
M>8F.V9CM]YCM,=IB8KUF/6-=OO+])CM/I,=IB7V2SM,=IB6=OO,=IB8[2SM,
M1K@Z,=H)S+.T-9)CM,2SM/IB6=ICRS'UF'6Y9VF.TL[3$^D4X)9VA7,L[3Z3
M%^DL[3$^DQTQVF.T$Y(5%)9VC7GSWEAQ,=L3$P^_1T=ZCM*OJ3T'\D]!_)!6
M@7[G0+E8Z4N>.E)-;@7*S4IJ^/!25GPZS'B(I$J>T0W=TFGE<;H:OO72HE>W
M2IKHB;E,IJ^.E8N4Z\ 7$342O ZM@6AL1;&/DW\SR;^X!,1"H6A:T/3+TH[^
M?YFNM.^)35\=*Q<I\%<NI^(E=#<\^3]1_">7ZSB#,_<C#7K_ +/V)DR\S//G
M4R6\\SA-OK.Z"[QS^(6ZS&G'YCG+=S"R[2/@<Q?T_P!TO^9J>8]^FSSZP+GU
M7[3<6X:]87OB/;T_5S=)O$;U+S7#_D>.]0PT5]9:LE?S^X'/$X\_Q^YQ].KK
MZ1>7YA58F\YFOY[QW"WVE.?/GUAEM\^?O%N71/IB-X<D(;S'-$N\M+'!])[/
MS^I;DK^?W-93$=8UY\_6.L><]#9[SGZS1[3]Z9YKGDN<H#UEW!IN76IJ7+//
MT_J7BO/G,6X-,P8=R\4]1IOF6.YM'?@;JC<LELM)S])[M[G]3_4/ZB;9C=MZ
M[8Z#Q%OHIQ<Q]8-2ZU%SZ?\ *@U;CHH \>?W<O-Z\%U%[313OJEX@GZ"R&U6
ML=%%#&7G[@("LJ@SGI;].BDQQ+X9?:7 Q[S4:H?/IY])>>\>MXS+[1NJ\^?Z
MZ&SWE'WCQ\I?RMM5X][^2]./@FSWG/UBW7M\O:57OX*>8%^"NCCXFVC<SS\V
M;/>7'CV^70<._P#DQ5C [;E<RBI5A,71OSZS=OJ_F5BY1J8X])H]X!F]_P#8
M1W#4WB4W?'FY0^\P5?:&YZI@9W_G]P#$*^GGO+SW3;]/U$*SN-%GKYYC\P;)
MS]?W$P>WR[QY[2[WY]98_P"7/3GSY])KSYN#BL9N?P9>SU?S/Q_V'G_9S_$0
M(]F#A?/>4'.)P[W_ '#"7J_W+*J=W,='M^B&Y5YEWY]OZF#Z0:_B8&^2<\7'
M'O\ 296^K-/J_,&R5QS')CB4RF4RF4S,S*93*>E,1-RF4W7,IZ4]*93JF4RF
M NHB;E/:4RN92\36Y3,RNE3,IE3,IE,IE,I)3*[2H!XE,IU*7I3*94IE/9E,
M1-RF5*>E,IZ4RF4RGI3*=<RFKX@(VZ.AOF?SQ^9QSS'?L8;Y\DYYFW/GS_$-
M<Z^D=,<<^3S4VYG/.IQSY\_Q-G?GM-.8?7R?F<<\>?[]8?7CS_4_GS^Y]7,?
M+^_.IS[H1_._W/(UN//H9Y5#B'9OB<0ZYYWY\XZ#Z^3S])Q]$/K.>9I'#Y:C
MQN=_+4Y-PT;U#ZZ_?G[Q^NF,&N8\;T>?:/UXG\ZCN'?/D_,[[XAHWQ^?-SZO
MW'G>F'.X;/+4^K4/K'Z\^^_/VCKGF<<^2<\[)]7GSCZS^9WWM_,_[^.?.H;=
>[CN#ZP_+]PT[G/\ U]?6;<_OS_V&C?$WY\^<]/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>tm2030088d18-lc_improve4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d18-lc_improve4clr.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!F@+^ P$1  (1 0,1 ?_$ 1D  0  !@,! 0
M       ! @<("0H#!08$"P$! 0 !!0$!              $"! 4&!P@#"1
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M$V=I2\W>=S0@RDC=[62:IPUL.QLV<OA&(D&!T3.W3U>#ATE-2' I0>)B(<#
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MA*D9N= 3 H!QZ1*(Z\-:&6%.XUB94% [->\Y*) GV(1WIKDQ[X?&/&W0SG8
M) Q\/4@L/&$=.C4NNO&E54GX++WMY.XKN;X,Q5&'RFPVS6ABJ^UV-CW;F?$K
M/)=^O<3,KE!*-)/7#"W.UADT6KCUD4DW"2;D@+"!>"AT@/?I)5Y<#YMV&#+/
MVY; =DF([#N9.];8MO=)@]['WBD9N*5SK71=ERW;(SC<6JKAL#20D)Q51$"*
M'*5(2AU#IJ*M,!G1E:.[R^W<!MGW"LX.#P,OMI/95O!/S$K.WREF-)8URP8N
MPC(9I"*6BJD24]7 @JNRCZOXAQ#J H"[QBL\B\'9,[W=O[-MM#<' X"BK";8
MPL8,>+8GN"^9:Y7AO9; "#=36Z82-CFI/9'AZ^JJJ:. ,7ZH:T?<9+OR+>KG
M(4>]+BDHE#_>?7EP\W]4CT-0X\].'Q4PH1YE*^ZCB:*S?NKV#8CE44UF=_P^
M[RW2@KQ(D^>8:9&B'8 '(S"6*@N70. I@/DJ!Y^8MWC,OW)N0VE;/-E+]VX-
ME"\,VHX0W%1QNL)".QIMX=KRN1UU0*(."!*0S"*2 ZA2E.#@X&$NH"-^@8M4
M^7R^7:7)]K3*-@X&[?&2,E9"E6MN6/8V;L]R<FZ5.BD)6S"? 4(V.175;%=R
M+TY"MVC?J ZZYB)AQ&IQIW%6"^7R_4.WV>8CO[>3FI'N ;E8)>'MIEZZRVIX
M4GD7@$LFU%.M%')4Q%O$@:EN2Y6@@L@</$T$P+%, %;B!D[S-/[/:<1\/F&@
M^F?02\]/K>>@/M - T#D'"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M&CS"5>.!5!+8MO@9-$VC/NAY*0;MT$T&S5# >,DFZ"**94D44DTI(H)IHIE
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M03#U#Z6O&K4E'VF4]DF=-(2J 8!Z@^MKKH!0#R@&M0K/MH04 H!0"@% * 4
MH!0"@% * 4 H!0%)\W96@\)XJR!E.XQ4&'L.UY&XWB*!1,X=^IICZLP;%*FJ
M874B\,F@D %-JHH4  1X4'"IYR!SO9S"V[./E"[K'L.]KAA[8=2%IR=TQ+5U
M'2]SL0>M(A--ZY;NG*NO6F00('BBB8Q>%,<A])')V=K4L>)N)C'7!9DGDIC"
M2C^W<>2U[6Y:LI/RC"%]OI18K3+Y$L:56-,5<RRQ0330,"@^AQI3'N+EB=JR
MS;CYHG;T==5[V7;UV3A(=L6VWEUP9I#VW+QZ+]*':%*[(+]<Y%@%$4P,"Q!
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M'0!'4=*#!Y%#LO[N,?V3B/(&4<?3UJ93-CX(Y.6AK:NV*=> ZD95C&$1>.F
MR0LC$![U^D01-TZ!SU"KO)Y#V./<S/KGRYD_$D]%IQ$[8\-8]Z0ADEO64[BQ
M_?S.0;Q4Z411("#EG=-M2\>ND F OJZ:@](*!K&%WEQ5 * 4 H!0"@% * 4
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M6GCIY:]DM;O182%S065T6$"[FG"R2=C_ &E>>IN4Y-8[=LF2.,91=,4B%/>
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M6#!W,FNX(Z70FXNUXQG)-UW*9U4W"S9RB9,YRG.!C%$0,;74<2E;JH% * 4
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M3@1+Q_ -X@B8HB "#RA>4YLB[&MKN7+^-E#(.+TYR\G98H)9T2[;ZAX:XPA
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0'1R5R0$0[9,)6:BXU])* G&LWKYLV=2"F
MH!X3%NLH15VIU" =*8&'40H#N2'*H4#%'4HAJ \>(<?/\(4&1/0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H#C5.)""8-.&G/7[U&58GSMW[-T(E;N45C%-T'*F<#B4
MX  F(;I$>DP /(:$/LH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% -0#F.E 2=8></I_!0$W4'G"@( 8H\
MA"@-3WOLOGS/NO=AUNU?.V[=]N/>)/6Z#E=%!TF%WV" $<I)J$(NF'6(:& 0
MT$?.-5,CX&V F!0(7I#0N@:!Y ^*L44Y*H% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * @(_+\
M'ETH"45" ( (\3<0X#0M!UDZ@)U!U"&NFM"4XG37(8Y(*7.FH<AR1KXY#$X&
M*8K54P&*;3@)--0\O"BS' ULO=Z\JY.R;=W<*0R%?MS7HA:NYJ0BK=2N&2._
M3AHPL'%K$81Y5"AX"'4L(Z!Y1JXT"RJ;--0"@)1,  (\]--0TX\]/HH":@%
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M.GX//I]^MXJJYFMP\YSU2"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MYHVI1DUV-5/0E'AQ$!^&M1&2ED?5DU9$% * 4 H!0"@% * 4 H!0"@% * 4
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M"$:S H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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MKD?450APU P:?'655B^"S,<L.)/5 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MQP#ZHVZN.J29S&\@F,0-1^#4U>MK#YK*;S<57OP1WU6L8]J1V5?4HH!0"@%
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M_DI%@?O1$9(2FTCM])QC-V_42WZ8*=JD:-E7)DFI;)O$IEE"HD/TIE'0!,/
M!^,*[4T.FO:B$(6HN4U!52\F'W3Q'OMZW8W/4SNR48^WN9YTYI5IYC:FMT_7
M!1 @;0?9;#@'+J]42X<?T:U*2KV.M&GP-$VJ/EQC3!G?!Q !JD(T H"4"E#D
M 5*>DM6S5WRME-_ASON7I>C6R9Z_U6^((9A[!MI(YY Q'V+85,70 1N[T1;@
M74_H^4*[#\3^L[_0OPO6^H-+H;FY3MZ])V;<U";YM3*%:N,E1<U<LE3O/KX>
M]&Z;KKQ/EM6LW#3[:K>C;]M?BY6Z43HJ2C1O+CB9.7O<F-%J,2W!MVR/ (2#
M]M'(OI=V#%L#ATH!4R];N';D4-T#J!0-KH U^>=SXK[NCU&FMZ[IK5Z>UJ;\
M+7/._&BE-Q2P]CC3F7%'K'3_  MZ?<K5Z6T=4[9J[UBQ.ZX6[<G+EA%R=/RF
M'U7P[#X^Z&N+C&.$ES!T$<97C5BD-Q.'B6U-'^MKIH & .7,:[+\;=1[YL>R
MWHT4[VX69*+[^5TKA]!^?OBQ;]VM:*S-IQANEJ-:8MJ?#$RDQYP]2:E'4?XF
M2 = 'F5,FORZZUWQIT_80<L)<L<*]R.R8U<8QX-9GW@<?.'Q<=?N5]J=[,O,
M.OX2_./X*E.]E\Q'J$/*7YQ'[@5:=[)7N'4/G+_!?J:E.]CS$.OX2_P7X*4[
MV/,.L?.7^"_!2G>QYAU_"7^"_!2G>QYB/4/G+_!?J:4[V/,.H?.7^"_4TIWL
M>8AUCYR_P7X*4[V/,.OX2_P7X*4[V/,1ZA\Y?X+]32G>QYB'7\)?G'\%*=[+
MYB7K$VNAPYC\X?#I1-95Q1:-/!84.0@B(#J.HASX:5EW\#'Z2>@% * 4 H!0
M"@% * 4 H!0"@% 0,&H?H^F@.FF8UG),'#219-7[(Z1O$9N44ED5>D.H .FL
M!DCCPX:@(:T+W&C5NMWH;[W6Y;< 2T=QN$MJ.#L89[O#!S2.N?#L#,F@/8T7
M$R%L71<$N]M=XJJWNIQ,BS3,D<Z93M1$1#4:M68UJLS:>[5N3[@S+L1V]Y#N
MZZB7O=%PVBZ4G;K1AFL SGWS2X)MB>5813)NU:M63HC8ID@(F4HD$!TJ%[S(
M@770-?)PH"- * Z*Y?W!E_YUR'\B*U5F.#-77W;$-+R[E?\ ?62?TP$.(5,P
M;4] ?,Y 134  UU((::Z?6#2HOKJA4JITS-4I# G=;VN;H=T63]M^%[-N&V,
MOWW<EP(R-RW1:Y0=Q*\N]=QZY&JDRDZ:J@W5#J*8H&'S:UZIN=0^%_5/2VV[
M5O\ ?OPUFCLPA2,<.912>)UQ#2[]MVOOZC2P3A>FVVWDG*M5W\# ;L-G;O>W
MIN2G,F-F4/>CO?K!R-Y,VRJ8L(V:];>J2Z2*I#*$%!!T!]! PAIY:_/[QZ>V
M:3JR-C;TX:6&I@K<G^MPQ?FQ/TM^%C0;EN/AYOEBU%W+D]'=HE]:M'7N[3>B
MW+9$LBY]M%R,H.YX>5?E8P>K1@[377#PYF,ZC"F4=>GH*(ZZ5T]\2VY;?>\%
MM1;A<A.;A:JEQ:O6<?F.F>ANENH-N\1_;:G3WK-FFH?,UP=B[AYVRQ/9B";C
M=W/=91. 6I%E)R#I/X+#I$0X< TK@/PMW+$;^GJG*;L17D^3/#_K7?&[>)33
MHI27?]8ST$.85"DU]'01,(!IJ.N@>ES^BO>E4E5)\U>)W"TWBFJ9'W)@4 'I
M\HZCQUXUE%N6+(Z\3DK(@H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% 0'E^CY^84!KY=Y2^;XP1=%A9^LO<3A*QW%J6G/L5\'Y>MF N
M!7*;9YJ9TRM_Q$QNENL[0*9J(-%"D-XHZ^EI3)$9[/L4;B6NX; =_3K39VGM
M*"*O@[=PU8P#ZWX/(KM\U;/G-U0K6303?&CS+KF33ZSG I2=)= "C:,HHSMT
M(* 4 H#4R[\.@]V3L(E'CKN3>:_)>%@?=UJKB8RX,VRR@ %  Y:!4,B:@+!N
MXQM&>[R,!_B^@Y\MOW=;-P$OFS%'12>QY*XXV%F(UG$SJOA++-HM\26.4ZJ9
M3'2-TFZ3  E-Q#K?IVYU-L4M!II*&MA<C<M2>2G;?,DWP3I1OAG1GH#X:_&+
M3^"GB79ZGW+3RU.QW[4M+JHQ_A(Z>]ZMV=O%5G&+;C&JYFN6JK4UDMYMJ]RS
M=D;(^TR;R+B"2RUM$3@]S$,XFXIK'V\!;$@" M',9>$A&97*RL+>R3GI>,G!
M%'#($O1(<YQT_A%XB=<]+]5[AT[N\M/>NK1I54<.6:DL&DL5P.W_ (J/!KP$
MW/P<V+Q>\*M-N&DTVY;G?ARZA\TI2@XN4FI7+G)RM-*C?-7A0S0>[[[X,\=P
M#M^1&;-Q;ZWI3)D%E7(6+9*9MR#C[=:3C.S!@SQ\JYB8I!K%-'ZB<N9,X-D4
M4C%2*/0!A,(\XNOVDW-_7<FZ^7@>'H+E2I]1*GZIG% -  /@J(RR(T H!0&N
MU#D ?>&+K+H ".#&PB(@ CJ&*(8P"'F_R*[^U?K> &F3?J^_O^>N'#(J2ZW<
MFZQ]UR\\2_'N8I]&,,;& =1-E2$UX^06[C3T=>GAKYM:_,?XMU#]'-GN.*<_
MM:SC3&BNV\*\#VQ\*ZKU1NR>2V;54[OR%TJ%O0V_7GN#Q784+83^*:7#:MR1
MERMTYA0[9FZ($.[CU2"X(DY\!1$'@*!J0P' HE\M=J]=='[KU=TAM^FV9VXZ
MVPK%V//E51B\71Y4KDZY8'BWQ,Z>U_4%OV>USC#7V-9[6'-]6L9/-T?"O H<
MG9W=$23*FGD?&X%*4I0#P('@   :!I:?+A7'H[=X\5Y?>=!R))+NPI_%G"EI
M/&*,:+5:%T[H_P!&<X6AW2?)D;&G[7M_[]I#I1[=X_?G6W^G_1F7NGC%^<;?
MZ%_1D?L?W2?[H^,_\P@/O6CI4^SO'[\ZV_T_Z,>Z>,?YQM_HC_1D?L?W2?[H
MV,_\P@?[$:?9_C]^=;?Z?]&/=/&/\XV_T1_HR'V/[I/]T?&?^80']B-/L_Q^
M_.MO]/\ HR>Z>,?YQM_HC_1C[(=TG^Z/C/\ :]O_ 'K1I]G>/WYUM_I?]&7W
M3QB_.-O]"_HQ]D.Z3_='QG^U[?\ [$=:?9WC]^=;?Z7_ $8]T\8OSC;_ $+^
MC VAW2 YY&QI\B,"'_\ $@J?9_CZL]5H/E_YL>Y^,?#4;?Z(_P!&2_9'ND?W
M1L:?YA ?V)T]P\??SK0_+_S8]S\8_P XT'H7]&3!:'=(_NC8S^5"!'[MI#5^
MSO'[\ZV_T_Z,GN?C'^<:#T1_HQ]D.Z3_ '1L9_M>W_O6CK3[.\?OSK;_ $O^
MC+[GXQ?G&W^A?T8^Q_=)_NCXS_S" _L1I]G>/WYUM_I_T9/=/&/\XV_T1_HQ
M]C^Z3_='QG^UX#[]HT^S_'[\ZV_T_P"C+[IXQ?G&W^A?T8^Q_=)_NCXS_:\!
M]ZT:?9WC]^=;?Z?]&/=/&+\XV_T+^C.5G:?<]!ZR%]D;')F)7C<7A2(0(&,U
M!4HN"E$+4(.HI:@'$.-9V-O\=G>LK4:K0^Q5W\IRO'EKC_R?8??3Z7Q=]O'V
MVHT3L)IRHHUIQI^3^Z90XKUH&3<KTR9W14$@<G3$.DS@$R@J)  I0Z3& 1#@
M'/E7H"US>SCSNMRBKY:*OSU.UX<W(O:4]I3&AV=?0R% * 4 H!0"@% * 4 H
M!0"@% * X'6OJZVG/PS:<M>7DU\M :9G<TSY=NTG,V76TA<>WC>SC_+E['E9
MC::ZLZ-D\M6Z5-UHW8)NK)*A-*N&'A 8AGP*+ ?41$>%7RD9M [&+T:Y$VKX
M4O5EB5S@EI<%D1[Q#$;QD>.<V.0%WB7L=1DHDBHW'T/% #%*;]<X\>(QYE1=
MS0"@% =%<W[@S'\ZY'Z6BH4!J[>[9?UX]RH?-NJD0T^*WX?\% LC:FH"4Q==
M>.E =+*<6CPHZ@'JKCTQXEU%,W+74*)I25,ZK[YFDY>@T<.T%M>PYNCROW0;
M7R_.FB&L'N_F96)\"8)$.3+ ZN #*D-ZPW4.4OA\P$0X#Y:V7JOP\AUI9][U
M]JZTI>K.*JTUA3[AV_X5^-N^>$.J=S8)PC?FZ/F>#J\J%X%E;?&MA;VLKX"Q
M%-2]QPI+*BUHA!]-N)5 RPMV[]=7UA59PF!C'ZN8\*\7>,WA9O6HA?Z5VF%Q
MVG:37-5-UY99>8_0ZYXL+JWP@TO7'5GLK>IG.XI\BIG*5O//)EX;2 SA@3**
M$PTMB.;7[=D:TBHQ$5S*-52LTDR%53T$=%C^KZF#CKY*\T=+;OU]X1]5Z/IV
M\IQU#5(8-<RE+!>8_,WKGPNVJ]IMT\3.A?RFN<WS1>*;PS>/T%X.S+=%EO*>
M1[PL;)2#%%W;_JQ_XD(8IB+*+F252,!N E*0@>;G7O[PL\0-YZJU5S2[GS*_
M;<:UX<S^7R9YBZ$ZOW[==ZU>T[[;A"]9DOJNN#7D1E<0Z2B<"@(>D'/ERXZ5
MZ"57AE0[CGDCZZR/F* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0'2S'M7V3*>R 06E?4'@QI7'45L+\&ZGJ9%Q*('\$SCI V@Z].NG&
MGE#H:GF^.]=U$?N#P2RR=C;M\/MQKF!NTUHJY_;/W48A!DN1@C!_99W)NEFX
M22PJ$.J4VA@.74!  &K0GES,V?;KF-\4I9EY!O0MS UM.6\S'EQDWP*NZ5M]
M:USQK0ZRCM-=TY304!]X@)E)TE\/0?+1F43)2'+Y1^[4(1H!0"@-3+OPCIW8
M^PEY_P I)X(?)>%@U5QH823=/*;928ZD*(\] J&;S)Z XE0$0#0 'GS^$- #
MSZ"-8RI3'L94:Y8E('<^[D!A_>-G]Y@.HB(A_:]Q\/+CKIK74^QX^*NYPC&*
M7N=FM/*^Y'O?Q'E)? MT95X?;VM>2[.+SP*;>Z2FZ.U9)E-P,&ZO.X@4?K<2
M6:(<.>FE=M-UER\4>!U"48)O)FT$''C43355D!5 H!0&N[#?_4-79_M&M]/B
M_%+#??KO_5*G@!IOZ_+^>N'#8NO6;_JWWF7X=S0VF+<:AY?QJP?+R?K"WS<J
M_,KXLVGTWM$'E]JV?YVV>V_A3H^JMV_W+JOYBZ9'(D ]F1PZ /\ $333A_\
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MB/JJ@4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@)1*
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M?+\%;M&:E'GJFNYU-(U1\K33[SZ*^A!0"@% * 4 H!0"@% * 4 H!0"@% *
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MPU_1,1,.-S5L.K9GK9ET(%CZS#0C5Y P2JK,H"!U1\,>E41*/$! #>!8]YL
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M'D(#IST'72J"- * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M#.AH.G.NX?!&,OTNNI9?9^I_FI8G$^M*2VB-94:OVZ/]NOU3-981B_8NTM.
M#;,!H \]?9334?+S&NJ-QPW+4)T_AI_C,Y/IZO3VZM-^SCBO(A?XA]AKRX_^
M*UPA\\0\#2N)]6M?HKN7]0U'\U,WS8%_V[HOZW9_G(ED?;2X;868#Y;VN[3S
M#HZ:>7Y:Z!^$G_"BO_M34_\ Z9Z ^*W'Q9N4_L_3?B,R#@H737B/Q<?G\VM>
MG(R25/PJ5IQ]!YIXDX#J&H?3PKZ$(T H!0"@% * 4 H!0"@% * 4 H!0"@%
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MK\&'HD?D]EXCKJ78U_\ %;=/ZG:/?'B.O_\ #71?^_=:6 ^]7"/V:[8 "/\
M[^%L?TN9B/SUVZCP-+)>4VV*A10"@% ><N"U[<NID,;<\#"7''>,1QZA.QC&
M79^.EKX2WJK]!=#Q4@,/2;IU 1X:5E:OWK$^?3SE"?:FT_2FB2A;FN6:3CWJ
MIKW=U>R+.L_>5VM2VG:=LVP$EEZY_7BV]!1D*#T6MWX9%N+OV:U;^LB@"RG1
MUZ]'6;3ZP@/H3PGU6KU7274_O5R=SET.'-)RIZL\JMT."=2VK-G=M K48QK<
MX)+CW&Q:<H"B :  "  /+333EQX<J\[\'YSGD:T6-#RREAV6X4466M&V5%E3
MG546/!QASJ*G,)CJ'.+;4YSF,(B(CJ(C6S7NG=AU$W>U&CT]RX\VX1K\Z-UM
M;WO.G@H:?5ZB$.Q7)I>A,I#G>Q[/:89R@Y;VI;:*Z5BW*J@JC"QJ2R2A(IR8
MITU"-BG(<I@ 0$! 0&N ^)7373]CH#=KEG1::U-:&Z^90C^L>.2.:^'N^;W=
MZXVJ%W6:AP>NLIIW)O\ #6:<LBDW;HX;5;##I /Y8W=KH'FNB6U^[7 _A.=?
M!S1.M5[>[]$#G7Q0_P",FY^LY86\?VI?/7I4\]B@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * ^=T0#H+ /2&J9PZC!KTZE$->7DUIW@T&
M\]W[LK?;Y=Z<7O\ ,Y[S$[FALSSD?C)IAP;QA[&BL?@BU%C#H)PT8^;N)1G)
M"Z,<_4 BB<G#0*,B-QGM\N<2N]HF$%\%R=ZS6)U;/(:RI3(YGREZOX@)*2*5
MQ<!Y-%N],^%<#AJH0IND U#RT+P+SS$ZRZ&XZ\_T 'P4!A&[C6W7?%E.]9IO
MMXLG;]D7&62<83.-+K99-C8UC=EFO)A(S0;FBIZ0.J>19M$%!,#1)-,QC::*
M!I5X!IU,?EQ]GG=Y@.(PK(;4[CLF^KO2VBSVTK,IKXD20Z2$1<@P0GNN"<OG
M"HN1@TV#@B;8NIE 5U P:5!RMF17'_98V416 \<VSG+!>/,M9(Q_BV(MF6O>
M>AP</9!Y#PX(K'34.<QBH$7(/0 ".@4J**E>)C@]V&M.WK)D.XG:UJQC:&M^
M W..HR(C&91*U8L$H",,DU0((B)$DA..@56$;950"@% 2*?4-Y]*%69^>GW.
MFSIQW@NX,F@BJN<<(XG6Z$B"H<J:*EFJ*J=!-3"0$R"(^8*[V\ [RAU0_:R4
M8QBTJ]_.OI9Q#K*W<N[1*%M5I*O_ !HLV>-F6X2R\_=L2=;VHA()&QQA>X+#
MN)*09J-M9:*LIXF[,AU^BNV4U]$0UX&KK#XCNE;VPZG<[FLDI6[\+MZ%'7"C
M:7S'8_@!NJW+KC8[,4U.WNND@Z]OMK;,?O:6W48(V_Q5]L\L9 C;25=.=69)
M CC0Z97JIM"BDBIST\H!7YX>%F]:#8^K;VIW*3M:>YRT?!M/&N%,%0_6;XRO
M"'K[KW3;3K>E-MN:FW"PU*4,>_T8FP:G&[?=X5CQ-U-R1.0K/=F.M%R"9E!0
M.8AO#.9,3$()>DQ=!X<Z]=:G:]BZUTD+^MM1OZ)KU>\_(OKCP\GMNMGLG6.C
M:UEMXQFJ4*5WQL8VVQ]L3;R/L-BU=-F#A9%3QE1.0Q2@8#$$1 0T^&N%[OX2
M=(6=!<GI-*H3C%O/]0ZWUWA_TA'33N6]):4E!EOW:A23;V=E!),G2BC>BJ1"
M\=" 1N4I=-=?WD K8? 9PM;+J[4:\JU#2\BJ<.\$X1AM6KC;5+:U4TEV*N1F
M "N_DTWWG=Q&L@* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M!R%, @(" " APU*/+A7H]-<#O8Y:R H!0"E0* 4 H!0"@% * 4 H!0"@% *
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ME@6\ _M!'E\]<T\(O\,=B_W;9_%.%>*?^)&^?[TU/\[(KK78QP(4 H!0"@%
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M_7,43%V#9-ZW\C:=OVY)VQ$R+ZW;>?SBB!RQ.3TV[523/'%347! Q@ZNK01
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MR5V'TTXSV;2.#<J6(+T11Y=\58TZ]W:KI_K]_/\ SLBO:*BA0.4!(<-=0T,
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M)_\ U]"LOMKP+X;7N'\H_OF/N76OYUIW^T_5(?B2]X,T_P!]%MTU_P"XG_\
M7ZGVSX%_V9N'\H%H^M?SK3?N/U2(82]X+T#_ -J+;H CY-80?H_)]UI]L>!?
M]F;A_*&7NG6G'5:;]Q^J<9L)>\% (Z[H-N@ZZ:Z>QN8: &H?D^CKK\M8O>?
MQMK[-W"-/^<S]-?F,5I.LU*OO-B7;ZE/1C]\LLD,8]X9/>,SB'&><+GSX-I*
M+-[G*:*-;Q8$MO.%3-3I#A<I/60B2&( F9?7'ZX?6KH75=3_  DKQSL;9?V+
M='XA3TS<+RNS<>3W>=5112JK->/S'>^BV;QS?@1JMQM:[0?W?+<8QN6':_*^
MT]M:2FI\_";C+ZF2IWF4OLZ[K-P^Y6V=P,'N*N>%N^ZL.9+86DTGHN%C8=5P
M1TUE"R+=8(EG&L';5N\BM6RA6B"@IG'KZA$.GN+Q?Z3Z?Z7U^@>P0NV]/JM(
MKKC-MXMT5*KLI7/&ITGTKNFOW&S?^T'"=RU=<%*"HG3'M?RX&:FNHSE H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@.CN7]P9CX(N0_D5
M2JLP\C5T]VQ_KS[E?]]9*?TAB ^]0BR-J>H44 H!0$AP$2Z!SU#\%!6AJ:=O
M+0?>0NZ$4P%,(X>MH/2#R ^L<//4FZI+B6*3>)L []B?^QYN0T3( EQ!?8:C
MKH4!M]X ZZ (ZAY^5<QZ D_TOVY-M+WNW^.C:MZM0GH;BX\C^@L>[%MQ0+[8
M/CBWV<W%OIB&7F_;,4TD&CB1BQ4DE3HD?LD5C.6OC%XE\0A>H!X:US+QYTU^
MWUKJ+TH2C;E&/*Z-*6'!TQ\QLW1MZ$ML=I_@R95#-$U=&*MW-I7T6#!>%N=J
MSMAN[6.!45%7*8MW!1]+K(=$#:AP\E?D9XAW.I^EO'C2=0Z;3MZ1V'&LE*GU
MEQHCVQT58VKJWPFUW3UZXXZG37(WDDU_E<'VT/@[OK"6N+9G.)0T9(2CXEP6
M\[!E%,7,@Z.1)4YS FV:$56, !^^UZU\1[VKW#HA7)6V[SE;DU%-TS;[6?;X
M1-9M^R>,EJ]N5R-O3/2W8<TI**J^5+%M(M>PGW<K Q[B^Q;*F,'9Y<R%LVO#
MQ#Q9K8[D6IEXZ/;,U03$XD/H*J0Z:^2MGVOQ)TNVZ"UIO=;[<()5Y7FECP.Q
M?$'X6-ZWGJO6[UHMTVYZ;5:F[<BN=-I3G*2K22X,J6GWK<,A*Q;*3P_F:WTY
M1^VC6[V9MIO&-3+N5"I)@*SMTD!AZCAP 1'2M3J/%711OV[4[-R%RY))55$J
M^6AQ>U\&?6NILWKNBUNDU%ZS:E.4;=9445S.O*W3!<3,_;LLC/14;--P,1O+
M1S*10*IT^("#QLFY3 X!P!0"*!KS *[FT]Q7+,+BRE!/TH\>Z_37-'JKNCNJ
MEZS=E;EV5BVG]!Z0.05]31B@*49FBI&;QO=T5$H&=/WT%(MFK<H>DJL=HH4A
M"\!^N(UL746FNZK9M38L1YKL[327:;9O=F]J-LO6+"K=E;DDNUT9@PP?<6\O
M;PPF[>M#"SN0:/95T[47?1[Q0.LRIA 4C)+)%$IO)PY5Y1Z8CXE=%QU%O9]O
M]I:G>;]:U=EG)_K6CSUTSJ_$+I>S/;='ML9697)/F=>ULKJ.YW?^0OB!@0A>
MH>*A8F1X_P#70<ZYI<Z^\7W!)[1&N'_(7_WYR-=4>*"=5M=OTR'Y4O< #G@@
MO'EK%2.OTNA"M-'KOQ>6'V7"/ELWOWY]'U;XI<-JMOSR [IM_P!Y<#ET^"*D
M?]-UG^G?B\\%MEMO_,W?WQB^K?%#\/:H*/[8?E2;_1_] _/_ +5R0!Y@_P!%
M:4_3CQ?R^RX_R5W]\3]+?$S^S(5_; -TF_\ #41P03^A+_3^3"\:GZ<>,/\
M9MO^0O\ [\?I=XI_V5;^<B&Z/?\ #_Z!BZZZZC%2/S?QY1]<^,']F6_Y"_\
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M8Y#EU)IH/F^76L518(^LJJ33S3/JK(Q% * 4 H"&@>8*B260)0(0O$I2AY.
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MW"K5>)BY[F&]3NWY1WO]LB^]Q/;C@\(9GQ9EM>:VX8N:WJC*H9NNLT_:[A6
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M7L>6I_NLLM/]?%/5[25EV >ZC[Q__P 1Y:H?^MIE_9O3U>TM9=C(#W4/>/\
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M*W$$5#IB!-0$>=1X&47S5J9V*GT@50* 4 H!0"@% * 4 H"!N0_  C\W+Z:
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MYGLOVJC^HH![+C/YGLOVJC^HH"/LN-_F>S_:R/ZB@(>RXWE[/9<>?\3(_J*
M@$3%ARCV7[61_44!#V3&_P#4#3]K(?<\/2@.%2/B"%$5&3$A0YF,W1 >>O,"
M '(*%Q+$NY+@>:W*[%-RF$,8M[?4O7)^-W]M6PJ_79,8]206D8YTD"T@H)$D
M$A(V-H<3 &M%4-'F>UCMTNC:?L.V]X-RLT@$;VQW9#*"N)1@Y92$>#UN8YCF
M2D$3&;K$T,'I 80I4D5@9$T6\,ZT,BVCER"'HF2104*/PZE*("&H#0I]'LJ,
M_F>R_:J/ZBA#A-$1@F$P1S3@'/U9$ X!PTT)Y*P<6YUX!**ES4]8Z(UHP"LB
M#WV8R!T   G!LAIT^;Z@>;C\-:=Z/3._[QRKVM,Z=A\9Z6S.7O$XQ]K\YWQ(
MF-+H 1S/I --/5D= ^+4GGK6=O:?;*B1R^RHS^9[+]JH_J*@'LJ,'_L>R_:J
M/ZB@(#$Q@_Z 9_$#9#_.Z A[+BRAIZ@RT =/XU1Y\_TE ?,X:0B!3&<-8U$A
M=!$ZJ+=,F@Z!Q.8I2AQ'ST*83^^]LDRGOJV:,\08%:VPK?"&4;"ND@3<C'PC
M8\5!335Y(&(_='33ZB()B(% 1$W*KC0Q>)EXQ>@6TL:V# 2[U@1W"VG;\,]5
M(Z0%L+V.BFK1P5%8# FH KI& -!XU'@9<"I0.D!3%;Q"^$ :B?4.G34 UUUT
MTU'GRH0^B@% * 4 H!0'RNRB9/0HZ#KS'4/ATU#CQ !K%TPK7Y)E55E3F[S0
M2[C=SXTMC)'>;QAEXT,7<;E_*6 'VUV%G8U,^0KH@2FCFT4OBY9\"\LO'P\B
M@H"_J"@)H'(<QBEUTK9NF;>KGMFBL6>:6XPZBU3N4;YE;]M>E&4GGRNU51JZ
M*+4<*T.0;S<C;U]^]JG'[*EL5N-JN,/;1M1C+ECBE)W<6TJUJVS>5P&TF&&%
M,3L+@!P$^RQQ9;:8];5,X=>TT+?CTG@.%SF.997U@AM3"(ZC7*]U=J6Z7YV?
MX!WIT\E70X=M*NQVNQ&]_#JS'F\M,2L(<@^*MOQXFX$: 4 H!0'&?R<=!X^;
MC\'DJ.OF)5K+,UZ?>%;<PG?^!]N&.-QF7LE8%PW=FYVS"75ENP+9BI6/M;V=
M&33N.4O&Y)B;C6E@1/KX$41ES-)(J#E,@"W,)@TVS3^[RZKT=JXG"[#3W[MN
M;:4>=*$>1O%IR4Y4P_!H:^[/4V^G-;[",;D;LK5NXEC*-IMR<U%+%*<8)T:I
M6O::Y.'\R&:7!LMNC.N57N5MB^WON3YBL6RMR&9&7KT!=N.VEA07V7NO(5R2
M*/L"=*FJL)$I=PCX;@5 ,0X$Z2UNVAU%^[K+>MWRU;MZN]L%^W&.'*[JNP4)
M05**Y<MIOF?*\75YFEOZ>YIMLU6W[)?=R%K<M+<G*-8MVY6JW(MX5MQG*BC5
MI46"H;(ON\!$'VU_.UV6RW<-\3WINVS?<&(1*(I0CJS'-UO@3?VTQ QFS.$>
MO"**(BB4J2H&ZRAQU'73C.UTQL^GUD7'<8::?M%+&23NS=I-XMM6N59X9+ V
MZ4K=SJ?=;VE_[NE>L^SX)M6+:N467\+S9>5XLV"B\OE&MNQJ:TC5 H!0"@.@
MN:)).PDG#*/'T>24CWT<9]&./5)%F5\U5;"Z8.0 1;O&X*=21P 1(H " #I7
MPU%J-ZT[,FTI*F!]+5WV-R-VE>5ITX8=O<:PG;?VW69M?[E_='P[B-Y>,BBA
M@;$LRE.WC<DC=UY3MWSKZ\U'L[-SSQ5%X]DY&1(4YQ)X0=0^B!:V7;[]_5^&
MVZZ2/J>RWRY9M<N#2MK41C2E*-Q6+7?F;KO&GBNN=NW&[)/V^UVYSB\G*4K,
MI2QX5;PSQ7 PC8#E[4NW\W7A#%2K%3>UCS=OO)E\RQ%OMC,,FVK$N&]Y@M(Y
M#6;*-I]*/F5#D,V%ZN)7(=($.8=!K=H0O:K3Z._M"DMJL]+V(ZCE?+;]I&S:
MA.%R."E/VO\ DNM!K)PTLMQT&Y\D]=>WYW+#:YI>S=YN'+)IM)6\TFJ+@7";
M&;NQ'>><.QEBK%*\"[W.8<R1O>=;F8BVFK:*OZR(=Q<.27CY'+)D"H3#4+@8
MK)JM4Y$QO741 2=05OFVN%[?O?MJPZ?CT_9A<IA!W%8L1HHJB<E?6=,D\:X&
MQ[Y"]:V._H]?+FWE[YS0>+E[-WY25)/%15EI4JE3#(WQ6XE'7I#3@&G+0 '7
M@.@CQUK;O6Q<J4J9=W&A]5"B@% * \;D&U4;ZLJZ[,<2DW!M[JMV8M]>:MJ0
M-$7#%(S#%=@K(0DJ1-4\=*LTUQ4;KE*(I*E*8 X5I-9IXZJQ+3SE*,9JC:='
MYOH-1I;\]-?A?@DYP=57%5-1K:-AJQ]I]^=^_%F/5,F*6O9F.8),LPR%?)N5
M'*\AC>[C35R 26F896[;I566.[,D9TV]87U*4Q.KAL%W72U?AC<6J@EI+6^Z
MFPK<4L(6KBA&D<(K!)MKL[:&^JQ<_O.T]RRXW-1>V6Q>;FVHN<E*<JUKCS/#
MM9AULA!C8N MQ6!]B6Y+,.[K#%]=N$F3LT1EUL_7G^#;^&?;*25FQD/;;ERU
ML%T]9^(@]MHSEZLU5 PK*N-2GKEFKG*^N37PA]C:/5Z.Y;NIIJY!>SA*,U3%
M)2;ICDC8=#IKMG7V-;HIK[6U=O61N6I5]1M77S1S49R:^NJ-UKQ,V':?O3#.
M6^YO!W;M:=VU+X\LSMO80LW,\QCLC)E:B&14XJ(;-H&X"11&K%Q=<2[:.R.$
MEB&<MENOJ .KAN-KWN6KZAU<5&.PW]PMO3IOZS48>M".48J*DL*8=AH]8XK;
M-ATTVOM:U:OK4<6GS7524LY-MQ=7VFW:F @'$=1$ ^3A6U<<>U_=/KC0Y*R
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M1D(N7BY-LF\CY*-?-5%6KQ@]:K$4253,8AR& 0'0:F)5B=V#M(W(1'7R@&H
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M*4IQUZ3EZBCIKKR'33GKH-!0D2=I*FZ2B.HZZ:E$.7/7S4%#ZJ 4 H!0"@%
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MDW/C?;OC3$EYO;3LBPC13.X9*W9:X(=D]B#/8ID6$1*Z H-I!VJ==11X42D
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MRRWC[)>^S>WN@W[16-70N[<QQF"4386.?T  S250)+STFXCS*HHF42;.60.
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M23;M"*&79.7\)'+(G778N'*#5X<A 4,8M7A0B56\"[;$WN\NY# T$SPUA;O
M[M\<;6F%R.)QEAVVH6WXZ4CHYY+^T7$)'W@WF %DFX2*!5CH-4D5%145]7$3
MB4RI>7O*R;UNP0AN"W8?EI[9=W^8-E&>;AM-A9^3)_&;%!\E?35HT2CUYQT9
MO+P#YI/2<:@BD]U45;.3-TE/#(J!CGE1R]F9#<M[OS:FX/:3LXP*ENES+;>:
M-D]S7;>.+MT<DDSN7(LK<=_WF>_+O?7$B>2CE2J+7,FU<LEF[LB[+U!  .KT
MFZE13TGNH+LC2([H^WQNUR5NZR=EW*FQO'\Y9DE+7M;,4^ELW/9V6R-+JS]Q
MSJLV=U"*L0R(=LDD0CG^)6*)>O43#2HI2G86SYM]VW<S&:MP62-I>_#.>SRP
M-UR\FIGO#M@1#.3M:XDKA6<'N!I&*DGH)5M'R0/W1BI+E641%PH4JP)G%,+7
M@PXE<,P>[R8 O7MC6-VQ\89*NO%5B6GF&$S?-Y15@H:Z[UON^6,=<,;*R]S,
MC.8&-,\F6DVDF!TA(5LW8H(%)TDUJ5Q#CA0N1W@=I*WMW&5NWME&7S%<%G.M
M@4]#3D'$QML1<HAD484UGJI-91TYE&QX'QCV@3J,D1QH"QM $0 1F%"XU,RR
M/7X1/$X'Z0$P>8P\1#R\M: Y* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0"@% * E.4IRF(8H&*8!*)3  E$!#00$! 0$! : XD6R#<H%1122 .0))
MD3*'  X%(4I0Y4*<]"'$JD18HD4(0Y# ("4Y0.4P" @(&*8! P<?E :%J$D$
MD Z44DDBZ:=*9"D*&G(  H!H'P4\N9#EH!0"@% * 4!\ZS5!QU LBDJ!B@4P
M*D!0IB@.O28I@$HEU *?0"<B1""(@1,HCP$2$*4?BU  H,#EH!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H#C42*
MJ!0.0A^DW44#@ Z& ! #!J Z" "/&@PXG$DT;(ATI-VZ1>H3=*21$P QM.HP
M 0H  C]-!Q/IH"4Y0.4Q#%*8I@$!*8-2B \P$!X" T!PHMF[<H%1011*77I*
MBF5,@ (  Z%*4H!KY: ^B@% * 4 H!0$AR%4+TG*4X>8P (<O,- <235!$I2
M)((IE)]0J29$RD#]]*4  /DTIY2UX(^C0 Y!I0@H!0"@% * 4 H!0"@% * 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"
M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% 0U#SA0$: AJ'G#]'_)H"- *
M:T H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0' =<I3"30>K3T?JAU?\
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% 8QNX7VSK![B1\=,\BYMW%XLB,;J3#J.B\&Y&5L%G+R4RFBBI(
MSOJ\>Z6D'35JEX2(B<"D*<P:"(ZU*-2YTO61:*47B^99(QL%]V)VFB/C*[H=
M\2TCP*C.KYM1<W(S1UT.UC[C7MP\W',U@$05117325 =#%-6Z6]YU]G:Y[3;
MFUMMQUE#@W6OTFBN;=I+NJCJ[L5[THTKW%W6R+LK83V+9U:9SL#<#NZR)/-[
M?F[;^SN6LWS5U64LUG$DTW"\C;J:+%I*+M0)UMRN 4226 JP%\0A#%VI.,4H
MQ]6-,$LOE]TUR3SEYC(%O$Q1=V:L(R5@V0G&J3SN[<=31 E7IF#/U&U[]MVX
MI0#.2H.!*L,=&*>&'3Z9] U#74,C&E46.9A[>5XW+N&NF[<=W TM_#68<>9W
M;9)M99R8BUL9@RMC%7&Z^0[0:$2,<2W2P405E6Y%TB \8E<  G5-I:U)3B5"
MPU@_<Q+Y8P#=6:[-QS8%N;8\9W59,"O8UY.[M?Y)FKF@82T#2"K1Q!Q'V:MI
MI#0A71&RIEU_6U.GZA /4P+0N;W!XKO+)%X[89JVDXTT=B;/D=D:[O7W@M5P
MMQOCS(-M*#&)E15]<?%E+E:Z(ZD 4^LW5Z( (O$MSS'L[OC+#;?O%"]C89ON
M3#%*V/I-"0<>."V/,96U G;7$5JFB[C&3BYX55/]9444]65,J7TM H1EMD+L
MNW1(6CG"YK:MJ Q9ERX\561C*S59K/N1<X/Y9*'O1O=UZ"%RY#";A++AY)NB
M=K!G3B5W\>Y6.Z,<AA E7,C.A0V.[I!)N#N1K:-O,9O($!MZD++A;SS]>64Y
MJ5N7#65)>]I-C>=\7-%N5(<]P,'9 3".2&,:F]$B74*IS*K@*-8\2X:2VH9K
MN:V<R*2T):,9<>4=X6W;< E&H7$+]HSM7'LK@N4O&/<2?LM'QG[ ]BRB;1/P
MNER4J0ZD%3T0S*89VV&9HO/,MXYJMUA%S8L\_!D:VK+8Y2NG%<K==GSNW>P\
M07!_5W:";:5M"Y8B:MUPY;D RJ#QN)TE#%(N8*50IB>UP1LGR?85W[?KTF+<
MM6#/:^5LZY0O^$;9$O7(#Z*<9'LQ2V[?(2[+Y=R<K=L[XR2(OW)!:(=0F,FG
MS$RO 4.UQ5M<W 8IR9A.\V=OV7-1]N9@WEKWFS&ZU&"L/CS<=EQO?=MW/#@6
M&52F9>*BHM(CF--X'ZXN)05$""-0J37D,L:?5T%Z] -H'5IRUH">@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M.'+703!KIR\FO_)H#E(<#EZ@^;RA\ _#0$U * 4 H!0"@% * 4 H!0"@% *
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MM+3\BG#M$D%Y%-D@A('2]83#I4 1/YBJE,<R]6H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@
M% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
M H!0'$8/2Y^3EK\G /)6#JGGAY"JGG("7D(B(:<OK<!^+30=:<R7JOZOD)))
MNO$F$H#T@(CSU#F&NGPZ:U4G3#!>8.CSS/+7L6(7M^083C]M&QTJU=12[MTY
M;M$RE?MED#E(LZ,5 %3)&,)0-J&H<0TK(%%<08GQ%9>(L?8 CG5O9$M;'5GP
M%JQ3:X30%S.W49;#!M%M9&78D2.R5>B"93**@@4OB'X &NE,7B.%$7"1L7'Q
M#5!E&M&C%FV2(@V:,VZ31LW1( $(BW;(E(BBB0H: 4H  :< H4XT(6+:OW<F
MU8,F[^0%O[0>HM4TG3X&B9DFGK;E,I57/JJ1Q*GUB;H*(@&FM0?2=;<-FVI=
MGJP7);L#/ T73=-"S<0PEBMG*8@*;AL1^@L#=<FGHG)H8!Y#5[B'2/K4L.9F
M6+B3MJV).?A4R.8QW(1,0^EXA!555-)=@JZ36>1Z9UDS@0Q!(74!  '0=&.9
M<.X[PEH6RFN+LD#!INS/W$J+HD4R(Y]IO&R;)W(@OX0J^O.F2145%NH5#I%
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M$Q@H9<,<RI5""@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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MY=>=M6;EGKV4<NY27AY-P94CI<ZBQQT*<QB%*4#"IYRYLH 0"EU#0I0*'DX
M !P#Y* FU#SA\] 1H!0"@( (#R$!^(0'[E 1H!0"@% * 4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M^V7:.G+99JZ3,!^KJ(4U0M45VH04 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M:D_&Q23.UX.VHUE&,$F:0H(-V92&,9;Q##61+AQ+^*A10"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0'"/[)_TGEY?V3R?14X\ B).0_L7+]XY>7G\%']T+(D/]<O\ &_\
MS?U_^9JLG F4Y)_L/UP_9.7E_8_W_P U"GS'Y%_C#ZO[WRY?O/[[]ZJ/O$Y_
MV$/XS\OU_P!AY&Y?HY:T")@^HK_&O,_+ZG(?V7X?TU3B.!PCS']S^9>?/R<_
MA\U",#]8?W/_ 'GG];R\_O4+Q.3R?Z#YC\7(WT_Y- 0'ZA_XRY#S^IR'Z_P?
M>IQ' #];_07EY_6Y!0OW@/,/XR^7GS#E0G$E#D;^,/J&Y<O)];]\\]!P.<_(
MG\;_ /-\OJ#]3]'U:%(%_9 _C;D'U?V3ZOD^#S?!0'TT(* 4 H!0"@% * 4
IH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>tm2030088d18-ph_cells4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d18-ph_cells4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!: -, P$1  (1 0,1 ?_$ -P   $$ @,!
M       $!08'" D" PH! 0$  04! 0$             ! $" P4&!P@)$  "
M @(! P0! P(% 04# 1D" P$$!08'$1(3 "$4""(Q%0DC%D%1D3(7)&%Q0C,8
M\%(T)1F!H4,FL=%B-38G./%RM#<H>(*2U;;&EPH1  $"!0($ P4%!@,%!@,
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MVKCGCS>TT*V[Z-IVY5\4PG8NOM6MX;84XUQ" DZ@K+T[@4VD*QB27 ST&/\
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MCTA!,Q'ZS$?]_I"#K'^<?Z^D(.L?YQZ0@ZQ_G'^OI"#K'^<?^W_Y/2$'6/\
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M-P2I),Y$H)( T*48T!HN/2%,3UVG;\7E8+T<5<1]3R0+G/<X*7$R4FC0&D
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MON)G-NL[-Q1Q4[(LTW6GG1VO(:Y8).8WS,U+44LAK>/MPZN*M5HO(U7.A?\
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MA<2O;[/(U[4 <2 IJ0BJ"?\ O$$F8H)F?/=ZV[VN!):,3E1Q"$.M#2$E+I4
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M+3\;)Y'%91!HNYVM;N/7!5O+UIP,1%A,+'U6YT[P9 H=)(A!!D/OF4,7!Y<
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M$:S]I<9+&7.Y[S8U&@XV]-H<I-P+= +4$ZJ04*18J*8LN-;;KA*VKUZW)57
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M>\%K&@RM: 3/J:'M)-M%N'^%KUAHRO*&UYJ7D6=LAA+5<@5C\=6JT/!"''X
M?_T=228YJ"(VB<=!&(*)B9DI6+9X<72UC?-!J5*J/?[A&#%V+M^),N1I.X )
MO>XHM"G6H :9JH4J"" !*N']XG5>1EA-M]?#<CX#)\4;=^X9)MZU2U+?5XG$
M6LA\7'-IS+=6M#6R20BQ6EC*<)AOY,8O%O=N<^V4_7B=YC4 '4Q3JOU3!*%%
M4Z \_P"K>R[7?=@?F:UHWW;G,WF$AI##EVY+PRXKTY&W8G(#)UX;0%'R+C,G
MH6?R>H6;+_%K.:R5#(6PRUJUY7T;V3QB"^.ZK\L:;4RXQ!CXE2W# CTCNB[;
M.9GQ#,/JR %"!21XU5*":5B7Z=S;?O.TP]Q8UOEG$US!:9%[&O.MIJAX$&1$
M1"<TM]F*7R M"T*@*LI41$3)@3-93<LF$RAQ2,D"NT^WK$#UB!.Q%K;P+467
M\ /ME2<=?M\2VO>TJ2%!0  $I, F@+D59DRG#D>0FA7D99"&0H"D+]]-8WKF
M&M./!68@O=D3U& ,IF?;I'3UA;COJJ+H%2G%?MI&1UASM..QY3I13/BX\)3E
M6=([*K'9"D$K 4M;8*.VIC[#FF1D*_<W.0F#<J)GI#>D3T]O:2&C@UKR#PU(
M3Y F1Y0<U^W>V=^, $J4=\S27^(E9*:J1U[.V2\[,>=0A;9("R%X@EU-R:Y0
MCX5>7+AB_#^L-Z]%043VF2XL=EQL%@<H2@ 15,UKKJ->,XLQ;S:NR7BPNN$V
M-??*2=5H"T)!0D!00%CFO4J2,>+,E:6NK"&PR*U50Q7JUTI4\6RXLC-T5O80
ME'],H+_"(GWN.9SG'&!U>)F2?<DDG$=W<L@S7;(7ESP+7.0F2H@0 A"XA3.0
M,=.0PN"F#4P&9%!*[&R9N>Q\0KL-+4]]A8*;7[NX17$0,^_ZS'HU^;4HX^ZO
M.4UC*S<OSA,;6LQ@(B*+04" FY"M5)I4TJKE+4T<GZ1R?Q;LE;*X[6>2=&V;
M3,QG,9:IU[Q8S;\/?UW+GCWWDWQ3E:*;C"KL=3<N&$,DLXCI.0X\63"<1)F"
MT@5 (11)*'W)$'?]FVG=NTY>T/>&;/<;=^+H#6EF-S2PALG %H*@D$*1*J17
MA'BS7N#N%=$X/T[+9F]K/&NOUM;P]K86)R.<N5$,;8%V0MX[&Z_B[-B'VCDC
M532$3,1(S,=/6'!MV;,-Q8P3B 07$+75-?MTC9>F?3FR],=DV_9]D[*<6T:U
MK7.0EP =-]K6ATW:-"),3C<?\9__ ,RM^%U/S?W=\;KVU_)_^M#M[NWL\7?T
M]^G3KU_QZ^_K17C_ %1YB2M77^2/";&?_4SY=[4_)UFB_DE7BJS\95G&'%FD
MC"8^I7Q]*O;R=9(U[-&<<,UJU'QA6KKJ(";0J<%>L^$ !TT3Y93,CXX(NYQE
MV0GS')CT(*$GG34@FIDNL<"0_&KVR:2$5Q* 5.EH$P)T"DU K3)4MF0VBO)I
MKV<?5HY6Z>&.MC/V>C&/,2HT5VIU]=ZVU;;H=MUSUR(U9D5E/<R)3'8RMFKJ
MJ;JC14T)M%#KPHU@:YS7%Q-J@2M43'A6J&DQQQ/W;#E3RU; M78L#:J8Z\3;
M%"E9P%*CEV6*->E^PUI&R^B^,4]M> )DFDVBPEGX7LW6US-<SS 0LZ$K+4G2
M9KJ0=&D#4;[%8\X3< !44::$!ONH$0).<Z/O8M6O9"O4KG8PABS%V4XNNAV*
MIKM62[+[Q*[9FQ2AEQ+0^,P[9B+96?4"!,;-KPYESD+)A34H93E[Z?*-6['B
M \G&'*0$MH%4F94I[U GXRK&XG(VR5>;CX-@9+)L4RU<Z8RE3L#*>\ 3-*U:
M:A]9]:5V+*UU&/1WB85QE.%Y19S28''A0\J KU4)*X<6$M>Q[$+ J DE5E]1
M/-"$D;4^D1?_ !X-!CMIQ-\-5OU"R['51L8=E2Q7&TO&_-J?#+,6ZS%K<+J\
MD1*Z/7'F@RF.NJWC2ZTBX.M *%9A9JBJ9'61ERZ/MV0M#F/_ )IA))(%H!T1
M1HATJ3)[HI6BI0PM59AD6U+R:ZB)5H:* 4VI6"<A5R-2Q4&NH5PY78(",Q+?
M/,&6#&TM+BY  $Y+J9(G%/DDHVCL\VX<9<2' G3I10 "$($_A55,4ER+>Q^&
M@<"]^4O*Q]&F1(7;J42O7:EJWC9O)LDA_P I#;=@JAB0-77*(D86X =ZVFU8
M<K?,<@N6=4H40HG$3F*J%$<YW+*6NL#B2*@A"9N"D@FM*=)1)B*2S&QY,V*V
M$HKT,C4M$ I7D[9XH5=M@K%AU]%3 HO$(S_1DP-4($B);8B$CLF8P 6#AP"Z
M2 ZD]IBL:D,??YN5+P56:3H5"7<EER10&7)9?'U5,_N2[M&.V5>15$8G7C2Y
M-XWCD<L Y6XJ[6B6U13"J]-*K#S4PW%"R1'DR!KB0[&&^2E3\)!/&<N$],CL
MEA<W(%>LD)!!F0$"@M(JLP@3\4-%PF_N#6+7F4?OJW(MHR":5=C\B:L8MTW+
M*F*;\>O8>+%P"6$R!F/+(+$AN:%UDT_(+3QH>' 3BQK3?<4)(1Q,NI JSHWY
MZI#+2L)G%96[&/K6K"^VMU^#4M8.66EX^ADBS5K*HN-*Q*KA/"J0@D#"),F$
M0A.0E]P!)"B<YZD(G,(O#A&7&T%K\KA<ZU  DSJ#7BON"DR,)H0\:T7\ED3K
MN:5>S0.Y:R^'B[CBLL;%>ICK.)"A8R"&L"5>5@J7TDPF($9]5#[2;1<E4M)"
MRK*6LA[H$7 9 H<"$FE#,>,T ^<=V, \D!K8_&UZJ:=A20"W#&9$A=5)F/F/
MVBJE5U#4D%FQC&U_&J0)XLGO/T>YK2)]1(32>AJ2B*B@A:)*+MOARN-[&N.%
MH),@0GCT@S(6>HJ053Y;'MR=9E6O@:MC(XM!I&K7O0^O;Q*ZFOQ??7R@.R(7
M\F3:IOL,-'E0A@P#_CB@H!]KE+D!,UDDRDDD)@5F118O>QSL2XV7/'TZJJ%R
MS*&J232E72\[)WL7C\E0QHY4<>M5S,U[V,FY0=1<"V >9R7AQ(9--5N843H2
M0*NPD!8$>08BX@,>11Q*!#-50("9*A3@3(U6Y[_-:K2KFM4@B1%9D(J$B=2&
M_!'??DKN6C8K&/R-V<C)'D3=4OTFJ)L5&LHLB@$55UL?-Z4U5BF5%X(B?&E1
M#-6.QM:<0,FE>/O554ZSKQ6,>5KWGSG WO":@E$20'TA44+*J0XT\G3O5+,U
M!954U('Y*M0B!=+(VAJRLG'1LS89BJ#!<E105A-FL,PP%C+#O#3()U+J34"J
MRJ0A(0(Z84I&,O<HO4-M5!.1,P9+(4$S<TI("/9-_%'9KV_H)P&^I5720:^2
MX&LEEEJ5$OF#D!;84=RW>M>(F@4C!L[A&8B1#IV#\[>O X>K-U=/_*^'DXTT
M"R2:3K-5CSGOR?W;*@(^BM5L:LII/02%!(1L/]<A&G@](1J2_EEP.#RVE\+W
ML[8\%;#[GL+H"#8N;7GPE:"K]ZB\G0Y2,S @93T]NWI,^NR]''-^8S,P!7E@
M]QF%X4)$Y3H8^A/^G[?,V'=.YY7!7':8P/\ \HIYZ"B4J!72TFTD M+PV-8$
MM-K1RKC8DH)C":)QU YF1+I$G'<41T_2?7?' QA#MP\$@#I$^2?N,?263>]R
M[@WRMNTLPT4M "5)1)3)F)K.B&.>/0N%B=U2W&8#!5VQ-[L\LF1@%DBA[(JN
M;^)F)3T[?88]O5K]S:ODBVO+Y<^ BG]DS92W\WER/,E(4+:2B\DD>*\2".-H
MZ=>)9-1*9&9:?=!0LA9VB9P1AT(9%,STCV[IG_.>MGGYLA2XSI&SVO9-GB80
MU@( "S6B$ ^Y)<Q4&(/F\N*&^5!,A36&<K%_8SJ0CWS$ V>@Q'MVA[3T_P"[
MI*P^89+U >W[9QL&=IVKL;AFPL,Y*%1!/0T)1 >)!G%3;'L>5I-%21MV)881
M ^>U!"!O!<@"I64,1XFSW%UZQ S^7M/K>[4-RXBYZ2\)_#6.6[IVK;[#>8V[
M8$!ZJ WZ0HFE *!=)HFDVQAW"HUV]J:LD,>.H^!L#7!B^R :3 Z24MF(F8CV
M*>L>\>M-DM.4@*9F8U*Z1V>-K<.U:<QE8$FB!HD"E"$G,K/247)PAQQL6^ZW
MMF1I_5[;N;L7G=JS6#P^X<;[#6PN1XS_ +7Q2<_N]UF2R6O;FG9;5_'[%COV
MC FA4Y:U1(%,60-F=;WCN;=AEQM&X#,K$7&YJAX>'6J+F6!IQN#GA4.1JB8C
MQ+UWZD/9.X[?'L=]AVF0;=SWC*"[S&G*UK+0"SJ<X'^H7(QC7$APE%2[QQAD
MM3S&=BNW( &KY,\9:P]S!9?7K]%N7;%SYN;UW.!A-IU_/6,2M=G]K>A;U*<+
M@DDBBQ:VVWW6WWC&OQD*Z:@J)! %"@M"_5K(&9(;UGICU9_=,&)V6U7L)+5:
M[K".3&0#C(<3]0<A,P1$;LU+52TQ5T?C'3"^IE[#LHV:EB]3\GB\;SEEKR'9
M:(%!,\\?B,K.3]\[2C X3#D,UD#QTTX)S"2Z_'N,&[<,6$FH!9DN#@H:K0#I
M;,(JJH)%9)B+CABPK,D"2H6JR6TAJ!7NAUL,E@R5EZZK!K$HO,H5FZ &8&2F
M>HX<K6Y$=B_$TFJBG(+-9:??'=C?LR!C!?A<[ZG>]!<I4@6H5 ,EF8>*H+,F
MAC"!MD6P0"[Q"-D9;,R@:\PYLRJ'1!*D9D.DS'X]9+"]0AR_1RT]\JI7V&1N
M1JEI-N0_,<4*H IG]YA5"+93!RT/)8*>Y==$ ($3QB9B7*?)DQ,E_MB)&(@8
M*.G=-I< JT&I\/$:_MY1:WRA:&M<C4DLDH$13PK5 *=4+ZMJ<>! ;7V($396
M58L-84'_ $PAG1/2/E$,R(D0G$P<STF>WIC+#E<H0 U('O\ AQ$O=%[W8VL
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M6"'=3 @L"4B1#/Z3ZR8\./$0'!<4Q-)S$DDAD4*C022-UCV8O.3(YSLH-&A
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MS4H4O*#+Y3F,?B[%)%:LYHWK!,R=0E(1*I%(L$/<2/U)O;Y:E00L^"@E:!)
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M9=I,-O29#K'<,^\=L>MGM-OE<0\M QI-0)<?APB%W#?L:RUQ=^9/TM:H)F0
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M496'X;G6?+%]-.%6C96 !:Z#"6RN15WNJ3CJZ32XSX$3IQE\T)%!0A)$.<2
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MZ6.L HP-0 ]%F5F[R,B)*8.!(OR()GM]HQW@D#(*- D![J^WVQ1X8T2 <TE
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M=TUH.R4E0]7>7,%&.#0K")!Q;)6R)AJQJGO=>6VRNK+:K:^+=92ULJ;5MTG
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M5+E(2?X0I"R(0JBG41;&FZOD[K;=3%&A8C+V#C6M9D7S2JA:LV/*RE3MV75
MHJ:ULD/B5 %,Q$1Y!C9G  .<#/6DRE 3QD.,O".,[KZ@V&%K/S;U>T!7*@4R
M"EQ:QKBH'U+I<X*#,Z.&P4Y+,4;#0MD%MLL91Q%MN.10IT\@VTXFY/(Q>8V4
MCT1W4D&E<EWQ!=@!%=^81KVCI+1JA51PDE*'XUC4?W3=VMW#GL&T<E@+@,EY
M( #BP.:A*_B,P0I!,2,@URC,)IY6[DE&FNU!$O\ H@V*PVE8P#)+:X&?7QI
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M(%GBJFA*B2++@DTE$F^+I6R/7-G(Y/'U@RT5S?%)1IISDXR@^=%1U$T'8^1
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M-5)MG61EXUH2!'K\'](_[O7CQC\Q8^^D(/2$:A_Y'*3[W(W%J:P'+)U/-=3
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M@5Z00IH1*(M<1+NK$A7[XKK:4G+"DG->SN/N"OX)@6&(Q[3$"/6>G3K.1A1
MY44^U5C;#I<\ DJ9(?#PX5J/?$!;CYL92)9D'P*GK^/"EV/E%$A/@7VF+%$L
M&$P9893!=_7I$CT]3L>2QE)I.GO_ &\HNW35PNM *D?42A"@:4(X(;DGH1%<
MSKC,;=.&7+2\K-\7JK  C6FNPY;5N8VP1!$#'E'I$Q)P8]O20Z%$QF89&@M
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M;!R*6$4="Z$!S %^DR4X$/6JB2$3!F/A_&.E:\9< QL?9D8]]P+*@N,_]D@
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M 'VQ';Y"9'68A<^D9CD"@DEW(H$(G[AIQ0!=8^_-^Q^1[7-2VYM3,(\%9*:
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M:K_@N?2O(W_>'-Q]N>[:[<86'/Y@:]QR.:P"YB$J0U2\EIR @V:Q]&8<O?\
MUV-OV_TP_-VY^/ [S<>8M?;C:]X8P8W*7-)+VW/#"X-<'7DF,6^4^?XYMYPM
M<VS\^KG]5QV:J\=19S,9VWAM8RV%QN(OUMCR"=?URGR!D0QF--2[6318-(V3
MF2-RT60Z';]HP8-EBVCT.-N49"BM'F-4 A'.+6J[Z5(5")*(]%]-?I[_ &7:
ML[=NLIR8W8G-R!A=C9EO<7.'EAUK05!Z+51.F8-#Y39LGF+B\@R[:-B9_I^-
M2XNPV$0#K#7>>#<KWB(F(D9@I"8*(F/6U1K6AF("9X\R0$T\*JB)'J.T[=M<
M> X<P P,"AH:1:@ )#B9@4!$NHJ#K8NM94,G5.'C60V@L0LL=8-59E8V$P;/
M2)A"NZ0GK$S ]OM_MGMF+D)#Y7%Q/":@?/Q$UYB,QV^/$V=HPM$B*.:2>" #
MBTJ)RD0([]>Y!K8O)9!M-D7Q/&Y7!WTC"!J7\9F<<^AD* _@TEP5.TP1DA[U
ME$,CJ41/K'DQ-S6AI M(<-4((0UGS21!(I%KMFW?[?)@SEQ=>"LFH]IO86J"
M 6N (5/I"@S6,!L@ZWDBOT;^0O8K%Y#XM#_I0?=LTK95Z=>,@.*IJKS>%+TA
M=8H0%<BSL(1@2C(]A?A(>$>@)130+2I"S JB+4QB'5@ W;PW.>C(A47%P:2T
MSM!$UHTD\(OW@"A1W=AZM@I-6?W\^1N,Z6"/,C4J[GB-\XUR&&MX7;[ER^O&
MXS':MD:R<U0L%1=VK"]+H8-=(^M5W3*<6(YLBG'CL=28+7_ADJO4M*G^5!U+
M'G/ZC.S[?MIS[HM.T8['D 0*Q^++>'XVVEV0V7M>TN%<=I"OB^_Y L+.(R/&
MUW==DT[;.6<AQKIN-Y1L:?E*N7U]F>U;+7<'K&4\=;Y3PS>;TS#TWW*YNA:7
M21*,DF$S$]*A=N_!A8]NR9D>,8<"'%I0E5T#B4*31#,&-3^CV[W638;QF#!G
MP]H;O79<!S,+7AF1C7Y6-0 %@RW(9_4)71BIHNCWLMK6Z<@5W@>U:5K-//MQ
MF51;IW,YA\]LC-+R67\LD:6?!V7,8Q3QGL8:\F+(F>Q@^MONMSBQ9\>R,L&1
MY"A#U-:'@?\ =!.OT^$>I;SNS-MW'8]H?CN_./R8V.!%C7XF><6.:JJYC'VD
M(AD1,&&G)Y)V4PM:WD\=B\#M!4^N1ISBZE_'7+&.M6OV^RBL,>/&72PT EP)
MJ+01"QGD&)[1O8$)M).,.E,J!+62SYDTEQE[':[O9;PX0YV78O*M=>;F7J'-
M<H-[ 02SJ5MQ: 6A1&L'FE9!+;^25?.'6KD 27X_$2L:U98!\&DFNR^]3V+D
MUR3#=W=TD4"41ZN\M^-6M329G^Y./C&[W.-[\K&XW$L-_3:H0H="""IN"K6D
M@ ^T\L-VG9L4UD-2I;);ZN1OUH=%JW#B1C:E4IDK#+:Z+28/Y$(K,CZ1$=MC
MV%CA<A)%6CAKR1>6G.,Y\EF3'MBZW=/#BT(1TL !5TUJ!U'E6<);]'*W;=5M
M6MCJI)-/B*VEED(60B\NLH@1<WM&8AA24=>LQ$=8B+6Y&M:0"2M=/X>$3G8<
M0%SK7/$QPF1))^%Q)D28DKV6%-FM9FQD*KK*%C8<VLIF/*9L7 ;(M+OF@IK2
M4-<!CH#YB((9ZQB#FD L"."JB\$^,@IF9#A$3\L]C[F- NDLBID2-$H41)S,
M+L?DK&2OG4L5!K%677F9J]4UX!T=Y!WH(TD*PCNGM;!1)2$@':$^KGM;C:H,
MN<^.DOO\9F-/9:55[FFBR)21#C,%:ARA54J@,+*EZC8R)5:38=?K5F,.LNT1
M KYK"943"082JS6PN!1WC,RKVB2Z2,QR5!$BT$+[IDG6DS\95B9Y1QD9,KW,
M>X(U9<  *-!60E-4F!:95ADWI<XJQ60.;+4$F\V92(FB&Q9I5[ "^P'> A$1
MU'I/;'48*(PY7-M <&D()BO@2"G/CK5#&'+Y)>]S0YI)U)U H4'(2EH)2BU-
M9*O_ '-@U6K37WTWL(9+<^O4BNM]P%+<<@L[#0#P&$1Y8B?>)]^V8U[S_3>6
MCH-VA*H%\)J-%UXQJNZMRGMSP&M:F%P!"'0@KP0M,J++@GK<'](_[O7DT?F3
M'WTA!Z0C47_([%D=[XW8H&>/^TLJOOE'>CR'F!GL)D]HB4+B2F)+ITB/T]NO
M7^F[?(R HMXUG(>P]\?2?Z'.;_:.X-)GY[)<BVIY!%]WNC6E<JL^(U0,%G18
M-DUJ1+4BD;)% L"#L*#QV9CQC(B<P,E'7I$=6'7S20-.)EQD:>R1[3M[-ONV
MJ?JZ3,@ &1D"DBCE(EI]1$0::K438"97+09"B<,"XSL,.)GPA5:J&+GN@1$(
M#\YF(ZQ[>LQ>')*54Y<R0?%2LN!C?X4M+BZ2(I552<@12B?:V&64>5C"AK%*
M[W,27A&"A?B8=AT,[TB:X&)*(*3D?:8B9&(]9%0 $*Z2SUT"?+37C&4DH',/
M2V[30R):3*O%9IH(3Y*J 2+75&PVIYJBU_$)SJL=[ND1(A+E2J0B)[8#VGWG
MK$1%&NY@@H1.M(DXLF3(T>21UM(<9 %%0+PY3UX2>2L.OTJZ2NF+$P^!7%8E
MU;!"V+L%;-K/D5QEB [E$<SY.W\_:)]6M:&J6A&^,^%$YR(T\8UG5BW!?F:Q
M^1S@9$EK"GX2H454'B00 $,:?8N))1N2!6VL)464QWU7B+!802 0(+AAC$]W
MMTF?UF?Q]7AK"K5_IC342]I?96-]C>+!DQSS'DE9J0NIUXUH8C=R;K+'EI-$
M07(J=4* 6H_ZPK+X["6TH[9D9$>LP,LB)B8]O4AH8T)D6<UUXSF/8&*KF+2&
M >:T(!0+R,RB? D*#IUMH96P 7'I8^O50;9DK*B<PVS(^1"1GPPI(E(RP4P4
M%,C)%'3UE;DQ@VCZSR^7[)TB*@8PXB1C8[(E.D*&]2@ S0@BA*:+$3NZS!JH
M?UD Z)BX>+\9BN!6]@DY\I*&16LTH&&?U!9'3\2"/]LK'N)F1(HLM=/$'W1D
MRO> ]P<YJD@%5M24@5"K223"@D3ER-GIAC\9A\LYV9IT$6<<6;"E0ET"B5AC
MJZ<BY Y"^BLBN*T^8YBNB9A< /MZC.V[[SD8 UY0HI]Y2@JI2O.(0VH.;)N-
MN0QSW76SM)_&K6NM!)*G^9P%RF<2-=7&9VJ5G'U@8GP31%#C*;%2TB8^3$V#
ME=D9D@&>SH(PR9F.L3,>L1<[";'R<"OB-)4XQ'8[<;=ZNR7 E5;J*H2A53)1
MH I,, X0:15VTF-0^W)U,I0N1$#XS>;GDX+*W>=3JW83#("D1*.G;W3Z.=YB
MM>.D4+3^SG&Q_,,S-+\DPSJ:2%2A"?26EI!  <A -P,DC84LE69\8TY!^/%*
MFV8:Z)"4I7;$JPN36,:Y7 ?$")$T8."]IZR/K,7,/44N7]FG+W1-7%D>'8G-
M%U)+U=)8XJZ?TJLBB%09E;+\]=HIPS+Q-@LK5R##0+[UNT^N7S%8]2K[2,/C
M7+'5QQY.LD?8(1)!&%,3''( DDX>]?L^<5&#!YSLEK>EK[1*T!Q(5 $*M:J
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MRLNR:M=BQ<78SI$+A9L >A3';^7O,ST'MV[,A4!QDOOI/QGX^Z.L&-B%P!O
M$BI!X>!326J@UA"3:*&U%$JL7R$*=\:+,O<@6BVLLS!/@>M@O24J">HR C/0
MH*1FJ.<"2LE\#.DUJ/F8S-<[J9C-MI"&U"B-*C0@4,A('A$27&7NY2]F<FC]
MC1#+^-Q];(Q#\C?JME]--Y]1@P./??2F6"@^]BZLC#86SO4N4XL:TX6 N#2)
MBDD5$T#E .IF)$19V[,,FT8YP_K9'7HHX@M!( !-J$Z R4AJE,2$Q\A5:PIS
M88THF?%W).N4^X"*UP9PN%P$%';T$X]IF.E X@AS@4EX%?8_*-MD#WXK9 :"
M9*BOA/70:P@RZ77E6H>0JKKJ-13191#R 8)G4DL2";-:; M+N,"&963(B)AD
MQ-^(M8X$<9D%/W%/#APC*PY,:>7/,4Z4D2.DDK5IT!Z5 .@,8Q9"CN> :;V8
M7(T:9D7P'2IMFD2D+\83C+9UU$:5"^(Z211$S E/6.GK=-.VR&T.!.L_?,<8
MZO:[CM^[8YQR-=NFA'-!M+32T@%&KX!9D4E'UV74&*7;5#$5TI)H,)P(LK$0
M(%VEB$7.PF3UDI8+27,P!C[1$D@/"M12?;E^^,N)@<#:7MR6FU#<6F?4"XN5
M!0$$(EP-8=L=<A#JAFETV%V%,L$(1(LL+;$$M:23)R#T]IM!@ST*8+\.O9.+
M(VX%$ 3V_=[&+G-(#L;GAV-)+4-<TJ210-*@$)(HIJ+9P,7614@LKBO/<R^$
MQ<JN6*6/%CB;:552]JW+6U;['8E:?_,<XQ[)D_PG5YSCQW.<"&AIFG%(U>]W
M.U;C RA[6!KW @EP,A0.!*JY022 .DB8,-F<QTQ8($ 8H3#96 ?U[W@^+7;$
M_P#4?)K%,"<P0 ,D1?X^X^LV-X\L$F?P"J? _.+]AF/G.N N> '.<#:E$!:B
M?3*31-$AHPH&FKD;"P>MLUU)M.NUZR7DAEM%QD@R4K&7JMHAG5< <KB8F8&>
MV64J]K2EJT'P^"2FH6-KN QP8'/"EW]-'&V\-=5*@BX31543F'%PMN3C#.PD
MD@F:RY8Z M5UH@;< F#&52+FL.?'(JB([YB9GJ06,(:'-*W+PE/V372,>9C6
M/.3 UMI!<HE<9M(0(;ND$&?\I(U=(L_$9#U)8(O(*[3[);7*8,)3"H.)"5-A
MO<0]Q=9F.OMTZV%MPM- %''G[2B,&G( I:7JXN1*&EP%#HJ$R-2L2FW75?JA
MD5+Z,;*SL+: A\<WCU6:5&D@8E4"/M,S$S[3$]>I1&N=B?:Z0!T6?O7V^RK'
M-R?T6%S^DH3;)H.M""X2XH=(^6H8JG86+!:NN#&('L& )*RDF2PE=("4B'7]
M9Z?K,?I/H KP0JFLZ17"_&K6Y1C8LE0]3J$!55042?(A(@ZGDY;+9O6Q:H/L
M4X@ZS!3!3,#'9+/&8B4C[S ])GKW>IP(;T6UUB_<[9SGXW-?U$A$!#9@*OU5
MFA4!941%-?)&KPR5BN1BQ3)2WH2@@OU9 @(R8O"?>8_'V]_?W]4=CNF!)-(Q
M6E@>QX<3-.J9D'(I5""9+H9<MF7\8$RSGG:F?@P1X?SJP>" 3#H_O30N\H(!
M$'1)CUF8ZP,_I[3$>N8]4A-@SAYPU_PO]\>!?]0#V_Z/P-0LR'NN(N%0OY?<
M"1!0)1)$UG6-[OK@8^/X/2$5#]@G#6X%YML$EMD4<1\D.*ND@!SQ5IV9.4J-
MA L&M@>T9*8B)GWF(]2]@+M]A"HN5D^'4)QU/H8./K7LX9]?]TVB>/GXTX1Y
MNL)EZ*:JTE6>WRUZ\_!N;/1M0LRM@]B3D:-R^U#JI0$@MTP1GW]TC';/I&7'
M<ZY434-.@3B )KHND?=N7!OFO-KA:7DDAA!0B2$N(<5((<92D*&)UB\O6JS'
M9BZEFS929P)RQB5,&KU<E?R&UAF9/L9V#V1$0?O Q$S@R8EJX@ Z:S*47F%\
M(TN5F=YD]QQ@HI0&C.6AF05F9$PXHV.R9+JU:;*RR<#5WTX:M0K(8-NL+YKY
M*NI]AOG64JE+8COB8+I$B,^K_*;:7/<"XBBDZ$S!(I50HK&FS;5HSM#% 89@
MN4EI%MH$@BD&2.!:!])(B8TJ-K.8]?AM%1?BK^/BP<40RUO*KM6KC<L45IG]
MNLI6B_8H,K6TDAU1KP<4A$#.)[FXR6OFQP)$T H@6JR#E!JB3,:3<>3CR >5
MYC'M<TS\MH+6M:TN1'-!<%#FHYI8VT%%%*9W!;#GD-MZ[E5TVU9DWV[%  3:
M:A[S>VO;H$MI+L8Z',[WE PU/8/4?<I R8<9\O*U5TGJFAU!02T*F<=]VO=8
M=F]OYQIL1  ]I( " (YJ%JE4:.DR! E#3K-1U-"$9V]BLNVL[(-H,Q^-96R=
M-MRL"<B?R&%D+2RMUCA1FY@@8 (0/;/2+=P\N)=B!8)*ID1/P%0#(<8VS]OM
M7;A^7!C<'96M#U=TN\LCRE 0=-S@HFI!4FC?D+>-J+J,6R'E39D@I$E:560Q
M]NI3JW,8U=7SL<P!1,$2S69S)1(E'K(SS%F"%3XJ4.B Z*):1+Q[3\T' (),
M#A4%S3<UUSA.T$ H2J3AF'(/$(K4*Z@0RFWPA2HB;!M^):VRY5A=AJB;"X=^
M,"0L(^X9@9F;G,;=>XZA5.G(_+X(9Q/P80<3AN)Y Z1)*<1*2M4( 5DBTEU9
MW)(SF-NT<YD_AO!$XJM/47L7(QXIFH!#\@ L0(@$?U! I_$ ]H]6XVNPY1DP
M-)"J?WZ2KI$O;[-N%H:0TMD01*[D3JBF>IU)(B+*H5D8_(8RA9S%X\]=Q[;T
M6)<U#E5+I7%W#(G@M/@>91W=X.@;+8 X$S];!NYRN<'Y+&L:TTJOM.B2"A1&
MLWG:L#<[,Y8#GP76!&_B;:6E 0EH(0J%M/X0(196K<#X.O.L3CDT\MD\Q2 G
M0BDI&1IXC'9.JYIUF0=*U2UBNP(;$^,4R702-I>I>'<,<#F!#B6@'4R)(UJ"
MXTX^$:4]K:,K]RW$5\MH< @*M+GL< #]2Y'-*54"@ +M7L9ZXS%YS$Y:\FNQ
MAA%"Q3,0IQ(B^O7ML:#,?D::VB2DG76MSDFN9@6+D9J3L@QS,[07?;X:B55)
M (.AC3?D^[8LF39,:UI"*]K@550YQ%6N7J31RS=<L+K^2MD[/0Y.0:*K=GXJ
M1A8?]*AH)0:0DBKQ\B"&16UC"CR=9CK/X1V[9I+#C+9HO(\%K[P!&RVF];AP
ML_,.<'6@DH"24*E!]*(9"2"<H9ARM:U=!*XL567%Q_UF0-ENA8L2JV0&0R2*
MU65HDB_\R!+H<P,].L4=@=A8K[2T&C9$4]Y^"\XW>#<#<H["7EXT(1R&:H1,
M* -0)"L2'^W5N0LVL%X6&O\ %95(V*LFF6$R8E8$RNSQCTD <WKT">L3$]8I
MS&Z2@A):_O\ %!&5F[.)R !#HY 6A!($ JVM159F0B/V*\81"(Z69HK-=A9-
M=V/.2DFE+/R!@38$?)!0)=O;VQUGTN\YQ,KT3EP^5/W1OMLYV;I*%RHH - J
MH*!1P"E#(F(=E^0\%C\85Z\[M9,_'=5#QM:3H:OO6(7'FD;(=GXE)?E,=/:.
MOJYVUR!]K:+(Z)/P*?96-WLMIE#/,<T^5P,C=(IP/ *)T6(->WW&6UA8HB*A
M!A.9\=5=H_TUK0P/ZC(D+/8V)F.^>TAG]8F?4ANR==:2I1*GBOP!E3EI&[V[
MGX<3G/ ..Y2"@ ('!:D327&-P'[E7_\ F1WS^^QX_P"^>_R?)_J=_P#RUW=/
M+Y.WL[OZ?9W=O_AZ?X>N3_+N_P!6>3);.'_R_8_./E?\]C_^J;\VHM_)\9?\
M@B+\N')(U5?W%X&$BY_1JK^4CY)O6ZM56BPZPD;A6;#JQ>:G6AK&'/<B9[8F
M";,3Z2,8+;L8ZUFDB3(*$YDH!RE*7-E@%KPC6N5"5G(_5=-;6@.+@HU18=RS
M%$K'A;\NX8KQ\ ^XRM5Q]FOD)BED5,07BK2=1-5KR3(SXR HB0@ICUC+,@D4
M )TF9*G$\EI1>,1<GEOQS5[4"J4"&T<M9HBU0Z1BMS/I&=3L.2VK%6[>2H(\
M-SM5:2^S@*4P%BNZO\1I&C%#98[Q%V+()613W=)9/S!^KWH?U$.X.]9[/+DW
M.S %P"C)MACI: G])IZKF3:27/F2\_2OZ0>M>Q?VUGHS?XL6WWJNM*+CW/F$
MI>7$_P!4A&%KI. #6(+6!\X[YS"48[";I)S-"8&IEEEX!>I(K8I5^%>-DW.M
M:%"<$"F PH=$]9DMI^G/ZOX]P&=C]69 W=%&X]R[Z7K(#,3)KI_YI"&1>05<
M=9^HWZ19-L7]\])8UVH5V7;-^IJ3+L  )<)?Y0-P!1BA&C(VQ=H*[:RJU:SE
MFU;+L+B\[8L1\BZL&=A .0>DQ"?G!#6PN954,I""(8&?HIEQZG$MQT);1"E2
M AXCB8^;MRI8UV%E^4*6M?4HJH'?2X*E)4)2$&HY!&2IXW+T\?:Q=K-?$"YB
M&T;17\3G1L)QS\;84M*;ENLR9GM8<2L 4+8*0(>C.+7.#R"6J%5014$?NJM
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M4X7C'215Y^I3,B4=\S/6([HF->7-4F0'[T]I?9&'/)Q&1K&@BH("E&F84S*
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M4O?,IEC#7-@@!'N!' 0?3I[>K6YG9'*H 0@^Q3WK2E8U()9D1Q:MP+4T4JT
M$$2 )1O!2@F([>O9S+V:M]GCQUFLEPU[ L\3#6Y"ZWM3ZP)/&1*1)I]L=Y1$
M3TZ>KL6+#CZ)EB_/VX<N,;/*]C \L!=D<%(D@JA4TDO D*#2(S8BO$V$+KNM
M,F8#YJ>_Y,GY[!,E%0HIL_JN(I*6D41Y)]^LQ,3;RP E .!I[S,4X<$B+AQ/
MR96.NZ7DJ)3*44A12119@TK(]9NY%]R,)>7$X%F-GKC[ETL53==&P-FC:<1V
M%N7>8QW9\D6>8%279,C';,+<V-3+C/\ 7#J@*4H12G(R]\2<FS: YX#E<'3
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M4)(!X_'P4Z>]8NP.&(HVC:$$I)9'DV4R%"H-8CU_6,1:?UN(L#"9)\-5#,>
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M$'2';=R"M2?)?6B$KH/&H7U9^O'8^#(/2$'I"-'?V=6$?8#D:284^3.8B($
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MN(8AIUQ:+IU7;NT[CN>0[C.2,"J3^)W^ROVF0'%$CSW]/OTC]2_J5O\ ^_\
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M:[ &I.*KH8&17=<;VN[Y%-3P*>4RDW,(3(1D?ZI%$2,%$>L>1S,K2TK>2H1
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M,AY&P)B(G)V[']PR%F B=>4Y5/!.9_"J@Q%_--WC" \AC0:(9T1$24U0)J2
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MZ>T=?7I&U#GDY''X> \3*D]*SC[)[KE\K$W#Y<S(DA:DT24T4\U(D%BWKY9
MWB$>+QRV0 IM&DDJ$/(760[F092';^(S$&43UB(ZQ(4(H2Y*>TOL/C$!F)^.
M3 2TN0DJ21/ZIW+(D2*U0 1\GQ3X_-:$@5#ALA*N[MEOQ1_*1KCW?'@.T9ZC
MUDBZS_AZH"0%3617@JU.NO@(E%SRZ9M>&D%H0*3)D@V23**2-24A1\A-A<E=
MLS9%=5* M6;$F::H*[4#T(FK4JMT$5^WXQ,Q'M$^JEX;]"!LY<UG\=?=$7'M
M@QQ<YC!E+FN)'2MP^HT!.@52J@SA]I%BM6L*/]O>SY5:7JLS6(J8JB>K%#87
M7 H(PB2)G<,#VQU+MCUC)?D1C?I!*H0OBB_*?.<:?>*[ ]^7)82X  @HTRDX
MA)^("2 D$AX_<@[+<UD$>1N")0(G8GMI]A/49J5:*J<>41,9((DYGK,E$=/0
M N0N/0$G*M)2426D4_*,8X-F<0ND"&TU<5M)4@!:3(UB![-D,D7Q* #1L6@[
MEMKQ_1*4>6P'BA/<1#,0Z([N_N_I]8B(_$9>!K0N28!F/D:^U?CEP8GMQU#F
MJ%- A)21<=$$I%%U "["E=Q^-L-=D1L((H6X/(R*H3UF# R[S%CX<R8F.A1,
M@,=)]HC#G+,CPT-1PU2?NY)X1L\.(@>:YTG&B@ :3(-9-I/WE [Y6BL,)059
MMY/'T%R48Z$S6K"[RI8]JWO,08#"L2QG4C[I]RF/RZ>L+'_U2YK6N<1/4B?
M'A*B19@<R]^,NLR7 D*0'$!H;:YS1(H#(DW+4@B(]CJ6,QUL+IML5"J-'PKN
MW[!)L)6Z'0\(17@6M[?R%;"  F8GN&(]C[GA  >8%%\3\4C8/&5S2VN,AS2%
M"D(5*@\2$534:DAYRV,A^7M9DBPI!-)0JRC*0E<J54DDG+JMN=@UHKMA?]0!
M3,0Q@3U$Y[L#"&@,*J-%J9S->?&@,9MNW%GVZV@*\H'(0$D @*$2NZBDR3U
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M?5+<5^(^*,"5I&01C:5,)<[:]ZAJ9B]G;+F'(L*LB!K@,E'[!L.^'*[N_?\
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M+WY_*1;U7&9^ECK52N.6Q5W'"R5+="FV15UN[[OV#%A;F[7ER,W0L4-\QKB
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M3TF(]MOD[UV)\AN,;2#S)K*:#2?[Y1TP_5G]- T!_>-F\R_$6@2F4 ((!D
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MN6X%H=>ES2"47Z7-(!!B-6_KIS38^/85Q7RM5?5L197X-#VX&&2FM\5>TO\
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MF?\ =<>X[4F_S,5RC\31\-4BT>L/3N-GE_W'8 %I)3/BF2563T7D>,I0Y?\
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MQBQ?I;MW$#+O2TJ04:QR%H4_C7W("*D"'O'_ ,K^SW.^"X6PH2KH3/!NERU
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MR'_F6ZCO-JJU*BM5L(9!B3!.#]^S\>K_ $5M 6AVZ>%F>@&6A^O5#*7OB_\
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MZ#%16&=5.-A*^]8\B]5.&3OVXR-2UUAE2>-AXD_%#Q ,AG;ZY>.>@](1@?\
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M=J#>K2@Z0@+&S.@(9]/XPQS4TB3C:-MYG]OQ@;EP8XFX @-.-N,*AMQ#Z'
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M \EDK#4K,*)D=M>Q*V20#Y"G#O,JX7-*EY<%"E:A$5.,ZD@$5*#89AB=@+'
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M:(0U8VF?-P?_ ,S[_=?#9\__ *EOD^/SS\S^X_\ C'X_D_\ BN[O[/R[.O\
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MIG8-EBR3;R2<2"94NP!0VVOQ%W,? *GJWVGOO<I%@/7=PD$'B*^"<HC9-N7
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M:#\(1HD(@Y6+2FD5B4L41KJCVP/_ )I2<?U&28&!%*X@?Q*.XO;MGU0-+@G
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M^X3557D52(]8 FB^3MF05;1HZB](#+2(>U9EX",UD)C/3KW3/7KUZ>L[2 A
MJU:&GQ33X12PE&_B#A(),UK76G$<)1T4R@'#Y"\CNL+,BEDF;'F8+9+ 6J8]
M_P#<,C,& _X?KZN<WH*?3[O;YQ5^0G(&R67&<]927PU5$"'L-*JDVHE_;)C
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M".L?[N_J4=LR!076.GMUX/UF2[;X723S#XT]O?'S7_U(#&WLG;6-D\;IZ_\
MY.O[)"6D;X?7GT?(L'I"&?89Z8#.3_EB,E_^AN_[8]7X_P#,;_M#[8D[+_G,
M7_JM_P!X1Y5:]SN0#/:/QZS(=HL"U  0GV3(>.>L%U@IZE^L=LST]>I%;I4/
MV??IX:K'Z0Y-LP L<07-,B$0%1[@D]9RG =G'?+6Q].VRF/9%I2'0+"B7"1*
M48"\4&2&%VLA3!"1GJ)%$=*VY2VUI%_/PK\11=1I(X7XW#$Y^-S6N1 2% 0A
M)26I$B-:&8<\?C:->L1,<(]X-GNZ&1K,XG\2AW4H%41!3VE$QW3UF)GIZM?D
M<\H!($</N]J2C"YSP\6J7.!HJ!)4F#4 363IU ^LQ]=K00@[3@$!<,H!#>C%
M]2Z R&*6<RR([8/VF/UF(_+U4/+6W.13*:T/SBQV=UQ5H:X3-$!"SG(.(/"7
MNCXY,S32,':L6PNRLJ]X:W2.TG 3(ZB)E 3T*/\ 84D0S'O/;ZO8)DE VW\*
M\C_&LEB*[<#S &-5EQ*DGP*<ZV_3[EET"[+4N^7TQZFH1D0DP&07*F0 +4SQ
MMZI@Y@_Q[HGV]O:,I;C=]),O9?W3B*N!X2\(3))J9W"E E9)Q6. L2TDMF;5
M-TPRS!=RK$K6!PEID836E9&^1]N\ICMCKUZQZN#;5$BVG#Y?'2,#W.<@%I<0
MIX+I,K-*\=.4&R>WMOW3Q&J-5F\PJ!"\Q(!<"H+'5<>JWD&0=6F-=MRW =WF
M4,^PP<=1F9#<3<0#L_2TJ@,N)*5-!P*<(G8=CC.$Y=X[R\ '2J N*4#5F1,T
M"@+01G_]-^#M9WG=,G0Y/J-R67QR\?:I:Y3D%6K\U[&,R>5LYN#9\C#T*J'K
M!A]P*.+BPKL\K%]W.=\W^?#@#]F;<3E!.DP0 .*_&1)E'D7ZC>K\G:NW,_L&
M1EUSFNR$?1(M%HFU[[IA"XMM-S4:Y-X>EZ)J&@8UV+TS"5,%CK=HKUBM3-[%
MNN$E-8K+"L.>9NE%983/=_M 8_2(]<!FSYL[[\SBYP"3X</G'S!W3NW<>\;@
M;GN>5V;<!J!S@%124D!J2??$A$LG^XL DTHQ TTDFS%EYY%M\WV(L)93^(%9
M%.O6!4K9#V&TV%$@N%P3<<D'\R_P^_PYK* ?+\M5/FK1)(@0JJJ2JA !*95!
MV9"_2Q5"[E,C932Q^.J6+]^Y8.%HJ4ZB3L6K+V%T$$H0LB*9]H&)GU5K7/<&
M-"N)01=APY=SF9M\#2_/D<&M:)DN<4  U))01K0WC^5'@G RQ&FZUO>_VU.)
M;6(QU;7<8E<RP4N;9RUDLH(OE<E$11F1")DNV8@9Z;#Z5WSD.X?CQM/BX_*7
M_P 7A'O':/\ IV]:]PZM]EV>T8@D7G(Y3HC 6RUZZ\IC)#ZR_;?0/M#6V*-1
MP^S8'*ZDC$-S^-V*MC!!99@LDM/[9>Q>4R2K]=3,8<2;!KF0F!0OW* UG=.T
M9^UEOFN:YCU0A=$J" E>?C'#>O?TU[Y^GN3 .[9-OEP[EV08W8G./^78MX<U
MMI(>T@ NUG(+E5ZU4>=QKZ_D-TC*;;Q=K^1H(O6:FL[*+<FBL4>/MS*48FBP
MJ_@L-<\KMD$+8 D*8><ETCK(]'Z;W+<&[<PD![V2]TSJ- J:H(]A_1ON.SV7
MJ#+AW18'9L/27?X+G. -!(*09E @)E&B<()ML<)659MVA5;6BVP>ZD@*M5R:
M[; *Q29N M\3XD*E;&F<].@C)#WQ%K?-<0 H4:S/,RYF:"/KB\9&G*\68EEQ
M)-0 M)JI$N<P7M.J_N 36LXPEC>&PVRY%ZN+:J)MK92*.['W)-Q+3W?C"2[?
M;K'7H%GY@L-P=22$5*3U%/>.1U@OW#6IDQ9%(<+4!0C65P$R9AW&X6I&17BO
M?^@O^W_VR/E_^L+]B\'R$^?Q_P##/S?G_P#POE\O@_K>/P^;Q?X=/6OO;_J'
MSE%OY&Y=/\U$^,JHNL<+9@_]WO.\Q]G^GK_IG_SB6I>B6S5472,2-3HE# %M
M@EU%190&)=6&NV(+& :Y<FJFLLX35K/ZHCO0,G,#VRH!7VFZ<"J!7E#<LOJ0
MH2IF2)R,E-2O..R>5C-Q3&% ;+@+0@280@"<R@,HICD#B=.2VO0]Y3;G#7-'
MNYQOQ*51_BOT=FJ4\;?5)I0FU4R":?BA/:8D+;)M[OZ7YXCMV;SN.WWF5SB_
M;-R6M-J$Y&6DE30(H030-(G+4[_M6+<;[9]TQ90P[0Y9-7J\UH8BB8HG&9*]
M*17]OZQW\=:R68R6U9BC@[6V6N6<%JM;$A>MA>S.!R\1G;^5KUZ>8M:_<RL/
MK8Q=-[+EF4ODJZX[;'J"WL>W?N0]NXR>0=X<QQD,#1D)(<%*GZ7!;K6LH"\_
M3P6Y[1O-SW'+M.V9B[9,W+MPXAK7!N5[4=:0CW$*2UBN #FW=1*\"X/Q];%X
M2ID=BR3EXSA7,\<I1^VU;UY>$S0"M]ZQ0<RW8G)TK;S*IX84 ^ (]NTEQ8WT
M_M_+&'$]Q#=N_;K0&^=ZH!)$(,BJZK'1[3TC9B8S/D>QC=ADVX:&@N(>I<XM
M_GZKD%W,E(;\QP/-JOE,)0VG+X[ 976./<5MF!LQK]%6WU=$Q5+&5K:\P:W9
M# $O'8Y8792LH:TI'])(QP?Z<PO:&'/D&VR-8S(&MNN\L!K9D*TN2:&E)H(F
M9?2.-S,NRQ;G-CVC\6!F=I&,C,,+0 6O*NQ]+0'4&B@3BX=*XU'1:NT5:C,E
M>_N+:+VRF=AES'8;"'FU'- &!CI2%D+;,3(+= +&81*X84B$.VNRV^+9C(,9
M%N3*[(9-+E=:K02OTRU)FI%4W7:]CM^V9,NWQ/NSY\[\MI) :7B2-80HZ44A
M$%1(F:CB$65B+IR,BFJ7S'+K)*2%TJIW8CYR(-=-!X]+H IL*? A+1GV;ZEC
M*05"*3(+[Q34J1H1-.$;C<84F9(VTGZ:H%"@E !*9!J03.#$!<D,<VI7"S9Q
M[F1=!(.LF-:U,V".G!4U6E=Z[D_' I=*O(:Y[BZEZORVJYKBC' 6S&DNKJ(6
M4R$5 >40 Z8R-)+FJ'R3ZJ6W!I0 KH LRBF.G(W[V'7<C'UK VLMDU5I +%5
M5E]Q2X"U 7V4V/\ )%6D42LC[1FO,E" [FA1C692 Y.EO!1RDJ5-0%G)2@@]
MC\+3E*C&YQ)-Z( )N'05)D$<:*;@)%D3C,R]R'*OY'Y3+%5#8Q'RALULK=Q&
MQ5$W;]V,K5K]DXVS66M+A%7>$%!R9'(Y3DPAI%K U"0M" 6K)"LP9UY( (';
MWY1D>][WR)4"YKB%:%&@!$@$7J^J<26H#\=<R%=C/)%6Z%Y4?M]4F3;R=IQS
M^WW/@@EUFNXK P*UN<<1$PP&1)''>&Y&M<U$(2IH!J%D*53F")#.QY+K'J)W
M(0U 250( "?J5%)G.2Q6IY9^.1D7$T+6<L9/'8O'T*U_&,O.RV'K+Q]6D#,=
MB*Z_[AR]][!>%E;_  O"4K2P(CI-;BN(:03A )4@HCIDS=-H !%I"B=8AY]Y
MCVNU_,7-;F(1"6DJ *HV3B%O!'$*@C%"Q\JUC78:MM&QNV'.9.LFUK.$V"IE
M57;GEMV;*:URW=R.-H5J^-X_6M5.MC<54\T$;Q#Y7<C?>6UCCD<W^FA*E01X
M:E5.IU02CCG[HG(W"Y/-6BB2 ZD*TJ&HU&@*9BXH_P"R8NY@K^6PV01K>>V3
M9</JN:O;%D<J65Q=7]^V8LU;+#77(JZ75NM>:A)RL:$5SL6UKBKW*5:LPVN9
M?A+QCQO<+:'Z4"B;B!H+A)#.::]V5NX9=B(Z0FKKOI".N$W N+AJ>E45L0ZG
M2,*^K90J5.KG<K<NY!M3!4FTFU9QN+Q&&?E:>>RN8S"VHOXBB=Y$17BY-&TM
MS6&ZY7:G+C!!>V98 )DF<R2 -)A A0$'03L8&9;24QD@2% 5ZG*3,(11QJB-
M((@PN@]<EC8NY?.'LM'(,Q5Y5H81A-@L8.90%XMII5G9I];#U\4L[5L%5[3@
M@;%8>_N7-QS7L<6H,);P <-"K2+2I)0&2@* )B0=ON,(1I!(#;4-P(DY"0:E
MH+2DZA;D!Z6Z0M.9JU3O474Z>1NKQNOU,4[(XNW1/-:S<R]\,8>4U^KF<GB*
M@P8DG'V5WWRU1V)\*C56]P!*:$*3,'J 23B I /4VU04J#+PLQ%WF8078OJM
MF%0@S (T4T,@DBBMN0M7,9F<[*DX2MC[; JGD:%"-2-%)>1MUS6A=9[,:MRL
M4ZM)L\EV:UBI+H-[8,XNQ@MQAKG.)"N0FZH\ 4N!(D%!MD+4FXVH'.<P=10(
MK;>HS59FUX$U1%G,1[%_XE1[/X_N!U=F07*'\MUI#*N.QDHFOS?R2B?FO-%;
MRV9E?4B$("9_VR0]"GYY]?)_JS=IPQ:(O]#'-.=>,YSCQKU.;N^9RI/T5*I_
M39)9*E%U2-C?KCXT$'I",%_Y'81/U,Y "STA++^II,_(*95Y]FQ:1=#9$R7*
M29!?B#)GIV]AQ,C.Z]/+_=<:51W^Z9>^D_%0D>J_HL,Q_439' 3>!E,IJ!C<
M2$U4224_Q-K'FHV"WB3U)$*4 7,IEZZ,;B<JMRFXZ-9P"=7J-OUZE.E:R.>;
M;#Q]EACJL*EQE6\C2Z^BX\8?N#D:1:R1*?5<?,/45Z4</IMGK()]E8=ONQW$
MLRWG$W"7.>PJOG9?,-I>YPQX^DN^GS C&#-:T&*G3?"E9#(-IT[?9=P&/LX_
M( (HNKQSL7:;+Z=/P-$61A%JNL.6,L"\R,H,^OK+EPG(SRRYZD3(*$%P0VFH
M,RA$QH@ C<9,&/%A)878WD97M>PW%MWF!H)<TAP;>2QI#0VQK2H!C*#DO7[=
M+92U?)FK+;8O3=0V79+*<D%X=?Q^2Q&5S^ZU=CL8A(T*5N_MV8J/14:5WW.F
MKM6Q@U0U6TS$[7'N  S&XN:UJ('*18X"11N,."BT@7N2V<<+V3<L?MLFZVY+
M.W,W>;'C) N>_&YF'",0R E_]-CFY'"T$C)-UKLIK7,XZPF->R&2OURS&XSL
M.TV%%8F^M:;6TNUBEC1_9JV4.KE;67TQY.0B%3\<JZH8HH,1V&'*VS)BPA,6
M&UJHB(RYQ0D&T->U"50KTH%,]FX9C\W*T!NSV_EX02C"YP:,E[G/+6EMN8 %
MQ0N#LA#U$+\+@GPO7/W'Q6:%&E:E]JEY+H4J%K+9$V5E0J0HU7D]C%>28592
M9-D73^'J0]Y(<[&$R&:*BN#1,U/,R.DI%<>\<W\QN'8'VW. %P#07HP!2;7.
M" 2!+'!%:5,2NH/[8M$RFPQMX,C8;C<6U5O'U*[QL*,RMY<W3(51L#/?XE"\
MR*8]XB(NFX&DB-"I,OY4K7D(UQ+" +Q>T!MSZMH4+6JA)$NHD=*J)Q0.ZYK]
MV:="HRO%(;<0NXA55H+HM)'@#K74ZK$TLB)FPY6,2VP<QWQV0K8;=@QME]7L
MIYR3W?/?;3:%B#(H!:;@5'4A%2 Z;4 4DVM 03+G_6J%G _">I8MIU98V:%F
MRMK,B9(?%NFM1BRK _#47;TDHB0@IAIQ$LLS6Y9*;B1,21"$,N.M)<!#.!DQ
MN8>@$?7;19M*)^$D)J22*4LJA:KMQG[MB;Z\?D:N9_:J(9['*NQ5*ICZ3,O<
M1>M#XF(U;#MJT37XEQXF?]-Y343(UI!\SR7M5M@<;2E20 @.I5U9&1C!D']0
MX=P,CDQ7$L):7=5K04"@Y7A[@Y2I!.1 X-AQU7"X!&C8S>\&@0I["=W'YL;9
M(JDK9M;8K$W*MZ]:R$69QEG^]:K:Q#)$R+2T0'?)S)^7S<[L3B/,9()/I,Y2
M/\J$<EX1%S;IV/N[MAN2Z]@#FT)./)U!S6AJ @X7-==(6EX(E#7;.Y8Q]K'K
MP[<=9H?#^#D44\97R.2MV\_EJU0<S<QBBD[-[!-'P&N5QVT@9(R9"1W- 8^]
MSBX.502Y) ?2#H':)J0J1GVX?YX>"'%]UXF0QHQAR,;1R/$R0?K(:  D1;+I
M.C3PC6KMRG^GC<%;JF;+>2.AE%U[%VR=,OD_NTV)&&39,+":QJ[?Z15RC,'>
M8YP!1PF1I,**I+PD2NJQNMN&A[V/)+QU/"3 <R0ZK@6H".GI+E"+>JRHJS%:
MD'D*U-6:H?$M3-J)Q[0H+HKR80:V-H 50U>[1@!A*@\<B,1:H4@I,%#SF?:7
M%5!C,[%CQ#(UMS<;G.*A!;]5Y:)]4P5((FYQ6<=]1%I,$&25-9BUBR:RZADB
MS4KWZGEQJK9C5M4W0RM$+*8(>H'V_P"XI*IM)5A6:+PD9G3VY1<,O\C66S4K
M-0$'3,/6[JG*2M1")E\6+-.G:-C_ (SQ92$5(;"%_$I4KK()C!B>JCRQ#/O$
MI]Y[1$Q&+6.0EK4OKXZ?=[)&JW;WG*:!C4<5)4![GA4F4+6U_$YIFH,=O@$+
M#TD:X>*&! BQ!(F6UT)#N 8J"O\ ILGJ4]D,*>L]2Z^CIM!'&J3K[_OBW$\$
ME;O+M#D)*@SU"N"%"&J$"(D**&/>*WMB!BK#R[CACRKOER^O=U4JOY19U5$"
M(E,#W3)=8F8Q/<PD-3J(]\O8\.49?.>+WM<;VN0H@J#4$G@HF9I).F)=J^)K
M'M>!M%7Q\N')4X5U^.NVQ1/[W/60S#)%R(D8[2%?='3M*>HQ&RN(Q.,UM,^%
M)?Q7W5C#W(L=MLLR>@RE.3IGWF=H:A13'K'C](_]O_;KZ\DC\ZH^^D(/2$5M
MNS6)O4V2Q2ZBZ+SLDR#DND'/9*Y$ND3!1[]1GK'7T;_F #ZC&LWX!<!.Y)<*
MZQI!^W>S7MRRVR[%\B#PFM9]6I89OP+E1-B,=23;=9)UU:9O5V6LH\9<@C1
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MD :U!](G+PT\24/@(B'$ 'L>)MD%1P&KI\!54D!,G3,'X5/_ -(/?\1?S/\
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MGX,>-NZ87/>;R 2BZ!Q_$FK00%$KFJNJVFQR]T8<V[RC'M^I<0GTO:P6N<%
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MQTL.5C)18?L%MRA?E<.BZS(7)P+J]I1V8K+6<UI>7R%B6+,"_J?< ;7  F:
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MO^O9?!2)0L!,8E0KFM+,0L!ZG*5)K.?P724UGKOLP#'?4?,) :Y0THT450$
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M$^L;<1!-H53I+[#.O[HH_>-\MBN"EJ@*LJ@K0! LR#7E'-]54,:FR[Q,! 3
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M&T0IUK[<55,&X#)Y*XRQ1BPI!VJCZ/="F@3EG>U[W,+<)NQ(TM<"-5,B:M
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MHVWLG;%().[R'XL!6OQJI52"HC>_ZX"/D&#TA#-L4==?SD1TZSB,ETZ_I_\
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M?(%HJ1,73"B8)()H><D,1F-.%SGO:&.:0'$H0CPZ04CJ+0Y$1$TTS.\&:_\
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MBB;)SO/ELM<1B$VFWJ0)KI0I,(FJE-CM,>!KLB,;>!8^<KC- T K_-/BI)
MAQKY&Q5.R^KKAY-5"O9FBY)L1B&XNYB<5<R!NL/*9IA5L5XK_'0+!&0'NCIU
M/U8[&UX:TY+2XA1^)07 2%5JI2*G,1EN\L] 1KY):X \[4H&I/1-%@YBE2QU
M'*Y>XW]R"A6J-K5\1\1T9"DFVRK<JXSX61L5+==EAD%WV8J+)(@4C/<1VC#D
MR9CBQ#^G=J5"$@D%RA1PDI!,HP->,>W.XW.0@Y&B8:B2+02"" [B+D#D 5(Y
M5:LYJZQ-^<;L+;:6:]<38CMJLK_ KTLDU3,JRVO*7L=E<?6AW@\9'+?)/8R)
MF8G<]EL-_P!OR;+>X0_89&FYC@'!P)) ( "*%35I$C(1D[;N=WLM_CWFTS6[
MO&X%KVDM+2*ELW+-%_"6R*DD1BWDN$]KJS;V:H&(P.K(RSXJW\YG:U9=&JB'
M.6^S9M*3#A4T%(GL$R)[@[1)?>P/D_)^A_JK-WA^?MK=IM=KYM^+%DS9,CVL
M#E:TNQX7J4GR *DD3^FS^M?I;:]M;M>XG=;K=C F7)BQ8V-+D0D!^9B*: <1
M(*@R>;RCC<%E*&/>L79FN&+NE%6YAW+SI96Q4PE=+:ERT&.B3R@/"?):!8=D
M=(;(E'KZ[Q]MRY,-^0A2$-9$!3::IPZ9ZHLOE#)WK%8<5A9@4 -) ?:XEJN2
M5U%"\PY:X];EF<+M2(*R>2IHRR<E3VA=E:]87AOEBK!VJRFB[)UUDVZQM"U=
MAU_RLL,2D6G)-#;8&.V[1=: "VT%7$DT5$XA$  15I&I[AN,.X1Q"@-<2 2)
M@$!%5%(,_P 4PG&$X;2=;TU.;_;O//[UDPRF1R6=@;N1S(OL*MX:MC$HJ!C4
M91;[,05>+M45QV-;95T"&3"\O25104!2:S5/^R5H!5-7_3V9=:TA)%Y<'D"Y
M6AO2BK*O34E4B0X'(6;M3&93"['1S=*GE<[6I4ZDU<)K]ZFYN+8]#,MGK(Y:
M9QUB^#\7=[TN%[(01E^(NQV,!>'@AY XDA B(T)-)B82?,4?N79FX@"3@!(
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M[4594S$<C7N_H^6YP>%!6E'!4T:I 12X!458OR^<<C?)  0L,YR*%*A5D"9
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M+RAEQO;D1K<:D-(<50%IH&H!25 B W@B,7KJ3-%BRA9#634BO84R E=ESDW
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MC$A)1A9GR.W;]N\]* C@$ 4?,FD<UV;NV?'WS<]EW3R6LM=C4!4 %S5"$DW
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M0.U"+2-D_&&JJQFHZ;J%9*P9C==Q&$JKL.KTE-:FI52PK5RTRM7KN3*H_,F
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M!75[UPMIPR"\EI\E!?B)0TR+_&!Z079R5>^;E*@+6?#3[(U>?*7W/Z79 VJ
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MC,8#+M9#ZF41_<^'MU,>FI7N 2(,,S9H?*6#H(E@1=/( JF-W/;%_;LP5Q>
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M3+#(0F>\(]P]9\DLKD55_;\O=';;8.?_ $G/<7&2*-22V6BG5 I$M##MY4(
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M5GWS/>]D_(:A[$2YZ9$7=I#^70OPDI]8LF4H15P5*^&G+24-QNW#"WR&EHM
M E($=*M68!(X\D*1(K6.JY_&O#*1E@K,BL#[&+R69Q=ZI E\BE77D<795:0H
MRK'+% X L";0/O$R L#Q*QI0J")HJ'W<ODL:9^,-RG$U;7%RT6:$GBA1%0R6
MT"L2#*9VSE+J[;%HJTZ&/Q^(KTI[:M'%A7@8:FI3&%+JKR-_Y-U@J_";%@SG
MJ1E,!B#&6JKB2>)/CX! %X1#VF+%LQY3%+WY'.+R%)NFMQ)4M!;C!,RUH DQ
M R12"3ZFDY:$%"#CY/B&)AX0UGC6:>]HO@^[JLF&<3'7ITBX/*UE[E\ OAS0
M5C9YPPX@Y"CG%Q60)'\R4E]/!)$%"7:CB:UU#;T2,JIL@A2(2"9Z1_NMG,>-
MW:3)_$0D D>WNF8[1MRY#A !_P QPJOV>//QYQ!8]V?<MP#_ )=I!2BDC4<0
MA,M:\]IG\>_&-/%ZIM'+%U:'YC<,F[7\(\E@3\;K& <(7*Z6S),KEE=BATV0
MB8A@TZ\EUD(Z<GW_ '+G96;8?0T7'F33X"GB8\&_7#U$[=]TV_IK 2-ILL8?
MD$Q=FR"1(H;,5MAJ+WC6-C'KG8\+@](0>D(T=_RNQ!\B\1*;619K,U+,BWY*
MY):1+,3$G!0AD01=(CM,A NG^NRV*AKB-#[<^-*?9ZC^GX7:;@@HZ\)_W?;W
MIX'5@#:5=@1CV3<&!KPE-2PB9D0*!\2?/9!280AD%[R/0)Z#$ST'U,>>A0*#
M^ ^2<DTCO+7N=_6*357#05,E4GP)G[X?5A)]L0R+']3\&@26%'='E7#NLB$(
ME?\ 3">TFS';/?UF2G&3(E$DOW2^$]%5!(1#<X-< 9'Y<:'6?P\8C%E2JEFN
MRPBT%MEY;YKUR$J[;,6/$\65A*7,09/B0ZF<=W;)1$1,Q4DN5$MG/5 "1SH)
MI]\9F%6R,BT>,_L2=1RY'O*P*;795LC2C(V;"ZKT#-HQ>53YI]J_&05Z*EH*
M>\N@29 /=W2,31SF@ E2Y1^S2E/"O$1?AQ'()Z30IQD.=:53DL6'JC#:%R%6
M";:\C)JLMKK$%>&!$PA<5(1+*=>WU$8/H8^XD7MW>L='*92T^V?%%/.F@B)O
M0C0'4^ZLZS0IPESB\N%ONCL'!>R4N+\SJ:,YQRS.;'L52UB</>G9UAF[49*P
MT,D-U6&MA7R&5DP U^1U8"[&%(=(P;SMOG!VZQN_JNM4%$4-24E Z:H0M46.
M([[Z/V?>\9WN+*_'W6QHFY<:--H!%I()"! Z10VS,;>>/?L/PMR#766J\D:Y
MDF%%8!J7+_[7DR8YTU0 *>8#'W7L.T,JF(7,BV.R8@_Q]:7+@SXG$9&.:9^'
MM]W*/)]YZ=[WV\D[K;9 P5+1<T(%,V$M 2=4U"B*0^WWWTXB^I5'"IV#)8O.
M;;L%"_E</I%/)+_N+,XZA=QV*>S$T$"^Y?>.0RJA%-=3[+)&1!4^Y#(V>Q?N
M&WE6XU*%)* "1XH0??)8F=E["_NI<[(XXL (%Q!*D@E !60K(!02X:Z(M,RS
M>7=XV3EJ\W)XC-YC)Y'-6]4RE+)5,M2S=\*B:;;RKW=E+-!==?\ TCQMM0Y0
M$R'2XBA/39,V.UN$@MMJ"E)@$)(@\0LP09M,>Z;08=OMF;/$GE8F!@5 0$)-
MS4 :2JD!H4N5+45KXIVS_G/G/(\*:[>*OD,_E&Z9%Y=#'#1<_%JJ5,M>!5O,
M!7?0\=<H&M+!FPSJN8DY$HF;C#^1V+=WD0R"J=#04K/5:+&A[AW/'M"_=3+<
M3'$ *2J+4 ZU,T$Z"/51P[QEJW#/&6E\7Z:JPK7=+P5'!X\[U^UE,C<&HJ(L
M9#)9.^Y]W(Y')6I8][VL(V-813,]?7"9,CLN8Y,GUN*GVY1XMN-SEWF=^YSE
M<V1Q)/.+,CIUZ_XSU_7_ +X_[9B?^SU0)&&- 7\I3;]_GS6\=:IC4JHXK0S6
M\UB["V7/F6\OFL0\,BDZ;UU9<S,,6B3[X* GK$+ELQT_9T_*.(F?,*U6@_9'
MKOZ?M9^0+L1'F'.;K@$"-:1:A4Z$F0'%0(IL+%&YB,;<KOBYCF2@$/MXXOD
MI)6:]HC.XV'1-B/_ #8:<1+%QW]LQV3)(<')^*?M1)::IJ:QWK ]I==+( 9
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M7N(,(>B!A[1F>JO.70MM@RXW-.3^9*FB-1 "=-#0> EZQV?<;+\FW.]H.7S
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M2#OVXK#9.K8&7$K;';8 6AH:&DNN:@0 %J-10?Q36H'U"2Z/-OMWD9UO<I
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M2 (#K8%#@.%66S5RD59974!L%-RFLFG7?6"TZ5-L7&RN&)ERS79)A]&=RQH
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MLGKF41E\[:/7F%<7DXR!LQTV,4O),K[4;*;VKA1GY:\C1$([#+W;2@.,@%I
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MM]Z:('>,95"CO]TQZ3^DN3R_7&V=_P#+S#XXG<Q'F\!:D]_Y.7U\JH\R%RR
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M!'J749D&&\RAI@+BB6G^?]2(_)?;)1[^J.1P22^PI[:R6,[2/K:"TN:1S!*
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ME!)"6@> \(U/;?3>799+,VZW.XP)TMR>4^T-!7K8S'D<I+9.<312Z:,=H%V
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M8"28%ACW5P!Z&I::[C^TYB%]&>.)+VGJ8^MKM]N+J@-1?@"9J)?)>58PY=R
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M89V5;\NZ;"\[S:,)6J*ZJ_!]N[_M^ROR;''B&7:X\F1N/('=1Q^82TS614N
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M[$XA?IO9>K^UY,1W?YW;':JT+Y@4EX!! 5' :I-I6Y#$+R'&&_BEM"=*VR'
MPW-8K!Y@I@I$ *9)-$>DA$QVQUGO&2Z1/YQ,K'NML'!U[+= 2/V_PERC;_Z@
M[1G!RMW6W)0?^(RO_>"#]_,1P'CG>E*)9:QN1MK3TK'.#S?AK""Y\B1%5(W'
M!@;&3,#!%,EV]9+KZI^:V[BMS+36;9SYE)2%3\HN/>NT-F-WM1,$?U&\+2I5
M9H=!+F9I+_'NY D'AQ_LWBAC8@;&O9B'AV,;,M(QI]#7VKGI'6)Z=LQ'Z%%K
M=QB+BT9&W)H0AI[:Z^$;+#WWLQM\W>[>Q=<K.GC1U*T33BL5XWC+D=[CZZ'M
MZ0&#D7/P68KI7,1,*A;)I=)F!,NOCZC,=9*?TGU+_-[9J)D8? @G[>0KK&V9
MWOL%B?G=NH" ',P#A_,BH3193$-#N.^1<>"[%C2=N>T@\P=-6V)DD<5W'72Z
M?@0,+[8[I;$'/DGI,_YY1N=L]0U[4I]3>(!(G[DX1D'>^R'(T,WNS:4J<N-*
M$H>I 5)*BIJ8[:>C;[?K5EEH.]B#NXRG^V]@0#VC:8"9:!X\4G"%P4S'L)3'
M7W[O5IW&''<;\<CQ:=/%9R]A&5_>.PNS#_C]H7@#_P 5B#4ZEO$R5:3A?_QO
MR!XG&.B;J1MD2<*=:S(A! Q)N7845"0LQT$@[?R@>L].@SU]6C<;:0=DQIHI
M' HATXKKXQBS>HNT%X\G>[8%?_.QSF"0A?*B(" !5&PR(X;Y,2=T5Z+N;46;
M06^V=5S""J*=UK'5\B*TH()B#DIB9/H4=T^X^KSO]J47)CN 3Z@>:_Q]U(SX
MN_\ 9&$G)W#;6ET@,F,!&B8 O,I^_FHA9>XHY,AU9B-$W-+:L*E7DUK+K2(.
M3W60[AI]HG!5X'J8]XB?Z1T[9MQ[S: %N3(RT\' T,M>>DH9?4/8LUN7#O=H
M7JI7,QIZ@.+IR"(9A!)$1:KCOD>%#:3QSOTD"U%%16OY$&FH%B)0PR4* EGM
MT$BCIV]O6.OJW\QMBK79<2\5U^WX<5G&/-W[L+,K0W>[6RY/\[&5$_\ &9(D
MR%"&06%1:)OBU]]G0MN= C7#NC3]F84-?*:L,$$XTSZR+8F>P([1ZRR1'KTH
M<^"C,C09_B;03X_:?!8C8^]=CR7+O=H&GJGG8BIHKM0J *I*(ICF?'O(,V6/
M_L;;@5U$TI3J><B1CN_'N8[&$RV\IF3+H72.Z.O3]9N_-8 T"]MU"2X?8'(!
MI\8PM[IV$J#O=I8)C^KCFM:S-: T20E"A_&VV@U[<AI&Y-1Y1R72UJF::NFR
MG7 :YA571(62$]Q@74B YGI$%VSZQMW6.T!F1BHDG!2IFA7W'CX1E=WSLST:
MS<[,/=(?UL8! 3ZRL@O$IJ0#(0C:>)MZSMU6#+0MB=C\M4L5]A-^H[*.1IXP
M)F #$"G$-K1:F^"^XS,?<.HCU$"B'W?8=J[[V7<=G[F6OV.XQEC@'M!*B159
M%IZFE"00#Q$<UZD'I7U?V3=^F>][C:/[-O<#\65OGM:C' "]A#C_ % 0K'4:
MX-=41V5>$=UJ8:OC<7HNY5$?$740A&L91+*P1TBS,.BD=F7P)S/<SK,D/3NB
M9Z^I/:,79^R;;#VSMK<6+MVW:C&!T@T*0)F:E222222XK.)7;LGI7TSZ;P^G
MNPY=CMNV;?$W%@QX\K"&-OTOR.-3<XE7$W$JXSDU+C+D:;3'*TS>/$@5VG"K
M5=@)*T-,$^[OVU<]L&L8B(Z_[_>>D3,27[G;EB.<PE46YJKX*>)^$;%_J/L.
M(M:-_LVDA /,9-)E'%P60$J\%C./^R-D_P#0]^R_VGLW[Q_ZI?W'X/['D_G]
M/^(?C_NWPO!\KX7G_I^7M[/-[=>GKG?-9_>_,O9Y?Y7^8(GF?2O'E5(\P_OW
M:_\ WA_,?F,7Y;_3_E7JVV[\[?\ 4MM.I5I/E&U$/HM]-U]O9]9>%HD)IR$_
MV#@)D8H+)5,8DJ<SXZX',"/^WWZ].OKG_P#5/J,E?SVY5"/\QU"BZZH/@.$?
M'Q[UW8DD[C,I*_4>?_XQ^)XF._\ ]#_T]A<JCZS\*"J4-K>,>/-;$(0_XL.
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M-QFB(LYH@1> BJ1^D'U!$J9Q];N'2+',)N/(]'PC)H-.LNHQM*652^*UE9<
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MBY+QM3/Y#+V..L<FKJ+\?QI*:SO,0V]AS5''*:=>?W,R06*YP/\ )-D\S/\
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MHP-N]G>4P13V5US:>/->3A- C!:WM$9O<U5>0%V#Q\MDA>NO7828MF^E1(1
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MRFIXOA/-+JUMVNOU2CA^:]=TK.)S>W;/>U/'V-?U[CP-L<_.WQI6%JQ>.;;
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M[A\G[:O7L^_B;5L%J>P[GLVO>'(;UFXW/%8[5OM%0^M-T\CA/[$7C SEBQE
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M"EF@S'[CL61PE:A4A> \EUC3KOFLG $>^,@.2OM3Q/Q'F]JQ^XX[;:-+1J-
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M:_I3]<UNK]3[C[NGXKD&EKE0MG#1+\X78+=5.5L5<SV5G"!+"'C")=SEQ_\
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M_!;?F<)B=4_MJB.!_;<9D*F0U_6&_5ZY3Q3;%GMM*LMR7U4PK&6NXY,+]P"
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M75N,,;D>2]]XM9LV(C$;-N?(.;RN;C#GL.R:74Y$WNEK6&0EN-/]DTU5S'Y
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M[X_<Z$YO-5L3C,EG<"P<8A=:E977^3"(M8ZHMM()$IY+^GVY[LCZV5Q^!/\
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AHV'9$2G&J>I*0:VT71QM25(1GAZ0@](0>D(/2$'I"/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>tm2030088d18-tbl_treat4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d18-tbl_treat4clr.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@"2@.8 P$1  (1 0,1 ?_$ 08  0 !! ,! 0
M       ( 08'"0(#!00* 0$! 0$! 0$! 0$          0('" 8% P0)$
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MS<T2NX_I><=O](R?^3%R_P W-6A7<?TO..W^D9/_ "8N7^;FE"NX_I><=O\
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M!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H*"(!U$0 /GT#</E#H&_C[-
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MK;R/M7YY<-VL=$RSKDCB5G&3V,'6:8:0>VV/:,I'%+(P$=7QJX7.FFK74#F
MHK@.W<.P!OHC+F&,\8?Y#4U'(.%,A5K)--7>.XXE@J[X'S '[%3RG;,YNTBB
M3ANIT,0Q0$-#HR9;T#0- T#0- T#0-!01 H;B.P?+H-:7JB^HO7/3AP+$Y//
M1);+V0;I<HRCXTQ%6UNVRW><>%4</$HM$A%7"OPUBD*R@$(8W;HDS3I0XSUZ
M[^#L5>G]QOYHU*L)W.Q<J;O5<6XUQ4]L;*"-&Y#F%54+;&7.?< =O!QF/G#9
M0DDJ< ,D82AMU'5H>M9(KC-ZSG!;/&&K7E6;SGC?&JF-+ %+R?'V.ULTV,3<
M4%&<6]3KLFIV%L]?DK(HNVB738IS2"3?S2$[1U*4R6M821M_J1<#Z!6Z3<;I
MRPP?6:MD>"D;)1IV7OD.TCK-#Q"P-I5S%+*+;.#QKH?*62Z+IJ?5$@& 0TS+
M;4QX69BK%$1L]!OVLK#3#%M)1<DR5!=F_8/$2.&KMLL7ZJJ#A%0IBF#H(#H/
M3T#0- T#0- T#0- T#0- T#0=:N_8;8 $=O;X>(=?R>/RZL9F5VBGDMZZO'7
MA[ZBB_!OD=$NL=5,</5K)3?/;MX"E492UE3EW#&MSC4A#*QA7(10HHKB/89P
MH4FW74B*I,^K+Y>$OKW<3N4]$SSF'($O"<<<1XJRX?&--N&3[ VC#9#9J,EI
M*/EVL<H0'+-9Y&I X]W[3&31,!C;  CI2DT(FMVP69]2;@77(U27GN6>#XJ-
M"B0.34'SV\Q#=O)T*T2C&$@+/"**+ $Y&24Q)(-4S-//-YZ@$$ -N&J6\B9L
M?*L9:,8RS%<%X^28M9)DN!%" LR>($<M5O+5*FJ0%D5 $ , #UV$ '4BZWB6
MHG._K(\8\9<K./\ Q/HERH>6;GE#*DUC/*)J[=HK?""D#&.G\E)6],3"V2*P
M.T43<)F4 43$-W]NPZM$K$2E/4O4CX&7.-R3,UCEK@F7B,1PREDR1)-\@09&
M54KR4JT@CV"1<+N$DA@QFWZ#,':8G0,[731*85#E*,B"9C1\\MZF' :&J52O
M4MRRPM&U2]2,S$5.6>W!DV+-/J\JDE/E;-5@(^*A"'6)[VL=(B+<# )S% 0T
MZ%C;*E2YCQ^1N9,EQCH$''VNJU[ U=S98,KQ,ZW?1"25UD?=J?$1Q69EFSU.
M9CP]Z36*<0%+8Q=P'?52)K>$Y40 I1*&W0P^ ; '0!$ #P#KJ*[=!Y<J9XBS
M>N&+0'KQ%FX4:M!4!'WMPFD=1!J*QNB8+J@!>X>A=]]!^<Z>]8?G9#<MFG"P
MOII^\YQF,;3N8(*"'-U<*TDL:P,XC!.ILT@+?R$5S.'!.U ?K#W;^ #I35*S
ME,-N#7GQQ$0R,&#K#R)PW YYCV2)+-BM:^PBEA@+"G&!*2M8<=JX(*3D4F<Q
MCM0-[T4FYA3#<-*3DOK15@7''K+>G+D6C6O(B7*'&M9K%/O$Y1)!Y:9I.)47
MD81^NQ*_CT%"BH\C)0K8Z[51,#=S8/,-L7KI?(K"\Z/ZA5!R?S@IW$W&[2+N
M]0OO$-YRQJV:ZQ8F,K69R#0R!!45O$QA&AE2NDW99KW@K@IQ*4";#ID=&;8T
M4  I0#J %  'IU#;IX=-!RT#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0
M- T#0- T%#&*4.XP@4H>(CT /G$?  T&#^2=/R9D? 68<?X7ND/CO*MUQW:Z
MK1;Y/Q[R5B:?8)^&>1;*QNXU@J@\>?"1<BNF1,P&\TA1]FG43%GYB*'_ ,,C
M+X"IW$BXX)YA7EOR9XP7B%R*O)7E65F<-RTQ)/BS.5&-1I#19K)UUG>)%,0*
M8[@XF*4OO F$3ZM?,4TC3&.EK:P)P6SIF+G[R+Q=DWB7GBNXSS-?N8%7J4W)
MTS+-4K_$:!RZK--WF6&5RL-5C,+Y-0N#ER#MJWBIN6<@FIV%(D&^RK-YT?HI
M])#TE;QZ=-NM=IOUVPU=G3_$-:P['SV.ZU>X:SV"&K$TC(1\W>W-NLLU&$<I
M,FY42MHUNW;IB)C= Z!)R:B+M[Q%"==S!ON4!#P-N(   8NVX'$>FWCTU#<Y
M^80  1-L CMU 0Z_)X=#?-XZH>8381[@V =A'KTZ[#OTZ  CX^&@IYJ?3ZWB
M.WV3=!\-C=/J]1]NVAN<N\NV^_[P_P#)IF9*>80/$VWS]=O'M\=MM]_9H*"J
MF ["8-_DZ[^SKT#PZAU\.NE!R[R_+\@^ ^ ^ ^'A\^F8Y:!H&@:!H&@:!H&@
M:!H&@:"@B!0W$0 /E'H&@X^:GOMW!X;C\P?*/R!H*]Y?EWZ[= $?#Z T-*N/
MFI[;@<!#Y0W$ Z /40Z!T'05!0@^ ^S?J @&WTB   Z+251.4/$0#^S^ /X-
M$WJ>83;??IMOX#X?+X>&@Y@._70:GN>WIEPG.KE#P6R_D!S0+!B#BQ9<KS61
M\07RK+65ME-E?Z,M6H=@U ZY8IM\#FP;OC>]IJ%$4 [0[MM6NB3%<8Q+'V6?
M2 Q'D/FYQ#Y M*UA^(X_<6<'Y2Q6QX]&H:'PU6:OK^0D8FQP+9N4E>CDH5Z_
M%7M50.H=4O>!N_KJ5KM68BM=$'^.W_#UIX5Y(V:Y6.ZX;R)@.5R+F"Y14/,5
M.\!EV-K.84Y=O-8\/($LJ>/DXA)G+F0]Y+'BX,D0H?/JUTO5*:Z+$HG_  VS
MG'>$"X\A\^P4K?OZ=F"^2*V0;'#6%^HE@?C[,R"]$PE&F]^([9NX^&==I%RC
M[HBON)2]A0TK'H2E?E+PQ3_P]USI>4JC'V;D33I+CCB/*7(W+N+X^O4!_#YX
MEI[D&G(@YA<I9!6D58ZQP%85DSE*"2)5':1"D4 H &RN:TI><5QFL^B>@'R>
M8>YQF5.0O''*]/HW#>Z<.\8U&6Q/<H^,/4Y=^"]=E[XHPL2;N2?MT"E,Z49*
M-U2+E R(AL BT2FW)N/]*_A)E#@-Q9B<!92S$VS/.1EGL4RQFHUE*L(2NPDN
M\,XC:G!A/OI*==14(@;RTCO%E%1#8/#;:3>BQ%&R[130=0+)"(@!R[@( (;]
M0$=P !#Q =P$-O'?1:2Y>83?;N#?;?8>@B'7J&_CX:(>801$-^H=1W 0V#Y>
MH>'S^&@ H0?;M[>H"'T^(!X>WY/;H '(8=@, CT'V^ @!@'?PZ@.@YZ!H.E<
M-R>S<!W#<0+^3<>FPAX_-HL5K;-HT]0KTCKIZB'+O 66;_R1G<:X#P!6YA:K
MT/%XRM?RB&4)0W2XM+CYB\<R3;-Q%(I01\T4A[0'VZ1:-[,\->*NB$.//^'C
MR3BR&QWAZN\G*I9^.V'?4IPWSFQK7LA529G;S&56DA,$ON+Y&:(Y2B7;^[*O
MD52K%1*W\\JAU2&[NW2I2G1.*K9N7_#H9BLF(+I@UIR0Q*SHM:Y>6OE?QU[L
M<6%G-,9*YV20G96C9GD8:78+6.OM&<JH@S^''14;J 50I@#ZA=59CAVY)&XC
M]"-&NY:X;7[*4O@6S5#C@.:Y:VXFAJ)9W%2L=GRS+I3#-Y7@N<U/NDR0SHIS
M*JR!EE5U#]Q=M2K5(K9^CJ,9M6#!JR8MT6K)J@DW:-6Q")MF[=$A4T46Z:0
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M0@>)@^;V[[?( >/Y-#<J!BF'8!W$.HAU#;Z=]#)RT#0- T#0- T#0- T#0-
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MYFC7AW7WV0L?T<C-&OPN0G"+50\\HT08))"YW37\DG;W  ZD5I=9B/*NNO\
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M+!$5!PW=U.)G&JD&9&6C*PZ9HJ1R"Y5$V2B1#(E(8I1"UCR);TKC;8CQ:TR
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M1EV5/M#MX+]U9:LU5@3(P%@</A\]1XU!)PHK]8QQ$=]2OG*12FC-PEW#8=A
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M.$\0994A5,IXJQKDLU;=ED:\?(%&K-P/!2)#E53?0IK!%2'PIX10A3 JAV*
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M3\.>07[0[?\ 5?6OTK2L;"G%M/PYY!?M#M_U7UK]*TK&PIQ;3\.>07[0[?\
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MI^'/(+]H=O\ JOK7Z5I6-A3BVGX<\@OVAV_ZKZU^E:5C84XMI^'/(+]H=O\
MJOK7Z5I6-A3BVGX<<@OVAV_ZKJU^E:5C84XMJGX<<@OVAV_ZKJW^EZ5C84G:
MK^'/(+]H=O\ JNK7Z5I8IQ;5/PXY!_M#M_U75K]*TL?5'X<<@_VAV_ZKJU^E
M:6/JC\..07[0[?\ 5=6_TO2L%)/PXY!?M#M_U75O]+TK&PI.T_#CD%^T.W_5
M=6_TO2L%)VJ_AQR"_:';_JNK?Z6.E8V%)TD_#GD%^T.W_5?6OTK2L;"G%M/P
MYY!?M#M_U7UK]*TL4XMI^''(+]H=O^J^M?I6EBG%M/PXY!?M#M_U75K]*TL?
M5'X<\@OVAV_ZKJU^E:5C84XMI^'/(+]H=O\ JOK7Z5I6-A3BVJ?AQR"_:';_
M *KJW^EZ5C84G:K^''(+]H=O^JZM?I6E8V%.+:I^''(+]H=O^JZM_I>E8V%)
MVJ_AQR"_:';_ *KJU^E:5C84XMI^'/(+]H=O^J^M?I6E8V%.+:I^''(/]H=O
M^JZM?I6ECZH_#CD%^T.W_5=6_P!+TK&PI.T_#CD'^T.W_5=6OTK2Q]4?AQR"
M_:';_JNK?Z7JUC84XMJOX<\@OVAV_P"J^M?I6I6-A3BVGX<\@OVAV_ZKZU^E
M:5C84XMI^'/(+]H=O^J^M?I6E8V%.+:?AQR"_:';_JNK7Z4&E8V%.+65/PXY
M!?M#M_U75O\ 2QTK&PI.DJ_ASR"_:';_ *KZU^E:5C84XMI^''(+]H=O^JZM
M?I6EBG$I^''(+]H=O^JZM?I6ECZI7\.>07[0[?\ 5?6OTK2L;"G%M/PYY!?M
M#M_U7UK]*TK&PIQ;5/PXY!?M#M_U75K]*TL?5*_AQR"_:';_ *KJU^E:6*<1
M^''(+]H=O^JZM_I8:5C84G63\..07[0[?]5U:_2ATK&PIQ:2?ASR"_:';_JO
MK7Z5I6-A3BVKLI5-RK#3)GURRRE<XL6BB)8HE*AX 2N3&**;D7C%=14X)  _
M5$-AWTF;6:BNK,6H,49DS+3L&4*3R#=1E%8YDNSC8R%@602MHMECEG)&,!4J
ME#^<W^+V6Q22I&S-N*B0'5/]8Y" 8Y0QE2>05P6;2-ASOA[^C)1DXU)[%6;)
M^6\7.%G+Q03*FB)F.@)Q\SK[]*.34<'[GJZ92I'*)NX--:#,41EG&4^_EHN"
MR%19J3@'T5%ST?$V^O23V$E)T$C0D7+M&4@NXCI&8*N3W5%4I5''>'E@;0BD
MV6[(\A<(0]]A<72^5:#$Y#L;99U7ZC)6F(93,V5O(?"ET(ALNY($F_1DOS)F
MR G< ?\ B:&[5QS[FZL<><-Y#S1;FDI)PN/ZZZF/@<"B1W8+1+G4285VFUMH
M8R:;RSV^PO&L9'HF,4BCUVD03  B(#+-V8@S56<P82QUG6-0=5^L9!QS7,C>
MY3BC8LA664Y!MIIY#3YFBJ[1"7KQECMGA2G,0CA X 8=M.@ZT6(CGNA>'L56
ML08+R)E6\65H_M4#786:I<+'L,6!(+1U:RA>K38IJ.B*9!7H417AV8^]RKQJ
M8JH-@*;0K'E>?;.>=MHL];XB?XHY3E6N(:;5KKGM]0K;CJY/<8Q-G1=2!EX^
MNISD5-Y%) 0+09%\2'25>>ZC_>[=PJ'EBZRNU<4OS3LKG,^-<7XQP)(97J^7
MJ 7*N/\ *T!E?'<96IO':;6ON75G&)E7*<ZU;&^\:)6I#I=SL2F$HEZ::TE(
MGS>\DCFK/.-\!T"PY!R-9(2 80D!-3;*-EIZ%A).S.(>.7D @ZZE,OF)).7D
M#)%1133$PBJH7?8!WTUHNE='SU_D/B*:@9"8>9 HM>=UNOQ-COD!-WBIM9?'
M3"8214:GO*'Q<2ULG<N4O>Y%,AC="B8=@%28FDYI$UBJZ(S+V+IJ4K\'$9%H
M<I-VV!-:*M"QMSK4A+V2M$,L4]@@(YG)KNYN#*9NH O&I%FVZ9@[]RCIK1;>
M1ZM@R!2:DM!M;;;*Q5G=FDT86MM;'8(F$<6&8<]H(14$C).VRLO(K&, $0;@
MHJ<1^J4=.I9I&JVG^<\-Q1+:I)96QG'(T Z*=[6?Y J3-*E'=.2LFI+8=Q+I
MA7#NGJA$DP>>0)U# 4-S" "1XUVY%X:HD G.2^1:0JI(U-6ZU>&:W&LFF;M7
MP9KO6DC3F*LJDK86<DDW-[NNW Z*NVX&$O70MN6[_2PP7$8^K.0,A9%I6+$[
M'CJ/R>:M7NY5F*M,76'U?)95%W,,$FH\='91AA,I[N14IA*($$P[!H=+[FO*
M#"SB++;7%]IT3C-U U:>B,KSEXH\/09HEP4=DA(UC)/[(B_1DG(-=R%<MD$E
MO,*5(ZA@.4H9"/E?&:=F:4E7(-&2NC]F,@QJ"EM@2VAZP!D22,^9P OOBSMF
M$:<''FIHF3% 04 PD$!TWB']WYMV>O8UGLT5G $I:\35Q>Y)O[@\RE0:D#E&
MHS3R#2<0L3+J*OYP+,Z9B$:FV ZCE0Z:92B<Y0TH5C8S+C?DU V?']8L&28-
M/"63+#0)#)"^ KG<Z9(98AZW&L5Y-TNY@X*7=F=^[QZ/F+G;@HBW$1*H<HE'
M9-J1C&(*Y[L:V9 Q5E^%RCA>@YO^'/:?6K]0*_D=LSLSB.1>PU?L<*VGV)YA
M=JZ<1J)R1;LBJABK&(4H[[]-)-*RMZL\I^.5QK<;;ZWG'%$E6I=G(R,;+C?:
MVS;.X^(,X+*/DBOG[=8K2/!JH950Y2%(F7O$>P0-H1>T+LD\VX?A*M#WB9RG
MCB(I=B%(L!;I.\UAA6)PRR1G"18>P.I-*'E!4;D,</(64*)"B;?M 1 :T6/!
M\M^,EC:6J0BL\XF/'4FZ26.[1(/+Y7(MA$76'18KR5?6>2;]FV5>M4Y)'<4S
M'(83;%,(@.DV%Z&SEALL/.6$V5\9A7ZQ))0]DG37^I%AJ_*K" )QDW)&EP9Q
M,B<3 !4'!TUC;AL7KIT$VS?<_P P8JBYMA6I+)6/X^QRK)62C*^]NE;:3DE'
MH,#RR[^/B7$DF^?,D(M(SDZJ1#$(@45!'L 3 UH:TU87Q5S&POFR[U&N8KL;
M&\UG(.-9K)%'R-7I%F^JED1J]L&J6>O-3%.5ZA-PBJS9R<BJ9 4;+]Q?L_6:
M5-;8Q\:5X=0 ?ET#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T
M#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T
M#0- T#0- T#04$=@$?D^C^WL&A%YH\*R6BN4V#DK/;IZ&J];AFBS^7G[#)LH
M:'BV2!1.LZ?R4BLV:-$$B!N8ZARE /;K_-VOMG9>P=GXNU]MYG!R>S<$5XN+
MCXHX>&.F9F(?I]T=S=[>(.\N3W-W%V;M';>]^T<<<'*Y/(Y?'S>;S./BFD</
M!R^7'%Q<7%,Y1PQ,H5.?4_X M'"K97E/BXZB)S)G,UD)%ZW$Q1VW1=LHUPT<
M)C[#)G,4?8(Z^)X_:CX$Y?'/!Q=OBL32W)Y\QYXY4Q/3$O0_)^AK]*'G\KAY
MW!X*[ZCAXHK'K<'+X.+R\/'S.'BX9W<41+I_\4?T_?VI<:_^EF_YFUG_ !4\
M!_G_ /[CM'XE_3_1A]*/]R^]_-R?QI_XH_I^_M2XU_\ 2S?\S:?XJ> _S_\
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M[PT#0-!0>@"/CL'A_P!/30=?F> [=!$ #8=QW';I\XCOT]FVIUK0!01[>@"
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MW@[[_M_:OQKK_ S!N_7"V*0 /$?P[IP_0(;0W4!#\NG[(^%/_+.[_P"S<G[
M_P 3?:1^\'??]O[5^-=A<#X-,/\ ]!?%&VV^XXZIX]>G3I# .X;Z?LCX4_\
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MIL<-1=^2<D;B$J>9=V(\4HFJOOL=F#8NX%'^,.K,32YE-KPE)Y(?W0@&P@(
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MXYP!E.] I.\#$[NX!#4RS6L9:IC@B [&W'V#L/7;Y _)_#JHKY)=]]Q /84
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MQ=\>4JW2T6PD$91C&RECK<;-/XYE(H'41D&C)T]4326(8Q54R@8!V'1=63]
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M*M!XQL]=H<W,RE@->,498KK2T/VK>'>73"..Z%0:9$R[EK$K*)5^7:8Y9*2
ME3.J*BRHD$I1*4LZ<C2S#_I8\>.0G'.$N]5RYCBN4NONVL"Y8S"JM!=W^PVT
MI%@G0=/<<V"S1;VC1I5/)B%'RS>1(@!2G;I!N4+70C*N4MNV@:!H&@:!H.)B
M@;H._P"3I[0'Q\?9H,>O,1XOD'CN0D*!47S]^X4=O7CJ C5G+ITL83K.%UCM
MQ.JLL<1,8PB(B(Z#[X/'-#K#T9*N5"NP3\R1D3/(F(8L'!D3#N9$RS9!-0R9
MA\0WV'07H   ;!H*Z!H&@:#"V9<-P&9V='C[!(RD<E1,G4O*,8:,.W(9U-4A
M\H^CV3LKA%<3QSA1406 H%,(?9, ]=9K25I,[:(\2?!J '.-BS+3,F6Z@M[Q
M.DN-WI</$4Q]&SUT2ACPR5A;S<U 2-F@Q<@5%9VV9.T6SQ5$/,(8#' VK3FE
M)B;98]QD'BIQ:B>,%>OT8UNM@O4MDK(+W(]HF)F/@*^R";>0T+!&2A*M5(J$
MK4"U5:022JY6C5+WAVHHNH)E#F,*2*PE?H&@:"@^ ^WIH(&91X*4+*67'60W
MMWN\'4KA/X[M>7\0P[F-"AY@L>*)&/EZ%(6U)U'KRJ2#%Y",?>T&:R+>3(Q1
M3<E4* E%E!-U]S?%2K7.K8T@K[:;!>+!CG)4!DY.^S[2OJVJS257M2]EA(N>
M=(1":*\6S1428$*F0IP9-B )NX!'5KJ4SB<\8JX<C<.VZXV_!&5L?I-WMMPO
M?32;F%<OV\<>>I5E:EA+<P9/GI08(RC1@<'3<'!DTUC(B03 )@U/(3>&%\2<
M&,@8KG<HS2?+[,TZKERSJ7.T+2E<Q4G/C.?'8*4;I%LL?2TI<\3'0<.,*BR%
M<S8D8N<A2[@!P5T2E\UAR/ >0Q-!6-WA2PVK($PPKEVQQQZHUYGX&,H?'2N9
M?FE5[J^B79&:$Y,Q$&B^.#9)P=^^1C4P9-  @@75X=NBTIC&+;6Q'#F/8_$N
M+L<XMBW*CR/QU1JM2&;M4.U1VA5X1C"D=JD$P]BSD&?>8/E-J;[FF]DQ0W8
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MJLP1:$;R/O++W%)-N"7EID*%JE$M<6<9:YCG$%ZQ7(V.?N[C*3F[RF2KC/\
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MOC^B$E'#8TA*V&?G[!(+3%GMMKL#U23L-ILTPY.HO)3<W(.#++*&'Q-L  4
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M-@C.(&<W%5MMFH5A/44F<5=:7)FA;;6',E-Q4=\9KDJ4BGN,NR3=&.BH)3%
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M"PSQ>8I-,/05(QDH&,YMCE(E#(DPD75=LDT^?.XZ^SL6Y6=.UIN5>)*KHOY
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MF,!Q$1-I.S0C-L/QXC1VU/K;?&A*NG0$H9F6HDI8QHU8D$5(A6!8'X/O%_#
M0 OE>1NGV^&JB]]!K(]-CQY@_P"UWEO^7'6N3^R_[KWU^M.;]?QO8WTN_D^
M?X$[L^9X6S?76'CDT%!* ^(:   '@&V@H8I3>(;^S^'\GMTWBH !0V#PT%=
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M<L9#S9>.2./*/0(#*R= >3F.\46Z<6;WK)%&E%Y5ME^W2R*C03SI69FL:@W
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MC%-GJ;NMYR3]\BW]A3$ZBAXU51LL<A?S9#@&^B:UG7&UL[T4T#0=*YA*F(@
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M?^K5PX8Y$;T%&US\FV<L:D8+U'1,<M3B6&^X^BLHU&EF04G4+NK99ND3S!T
MI0JD>W6>I-EW23@3HDMRMJXQT=+/O&3F5C7E$XD8ZJU3*M$EV=5KE]CH/+=+
M"FR]DQ];DBJUJ\0C9*5F 4A)0I@ $W)FS]$P@"S=,1UE:QG"7X  >  'T!MJ
MHKH&@ZE1   1ZAUZ=IC"/S !0'<WR!XCHL,/2'(; ,/(/HB9SAAV)EHQTLRD
MHN4R33&$C'OFRITG31ZR=S:+EJY06()3)G*!BB'73IS2L3ED]JJYBQ%>9$T-
M1LIXXN,L1 S@T54KO6K#(E;IB '7,QAY-ZX!$F_4XE  ^70UNR20=PWZ_E_M
M#UWZZ#GH&@:!H-:_+WE9F#C]GS"L%3:=%7C%+^DY$O\ F^';-7[G(;2D4Y-L
M=_8L?H,BJ)2K^LM%%'J\<8OG/6Z1BH=RW:0S2IJM=;U$Z]&9OM]99L)O+M+L
MT#A0W'6M87KB%JON3I_(M+M=[GTXLSR7A8!.+AZI5'<DZ>2+U@Q8,VJAE52F
M$A36DXQYY*QC&>R.E./!^;:CGVDFN]-0L,6#*PS]/LU6N4(K7+I1KK4Y%6(L
M],N,$N9?X78(211$ARIG7;JI'360560.14T-*,V!X!] :"N@:"AAV*8=M]@$
M=OEZ>'B&@CK=<EV* Y!X*QFQ*R-7\C57,LQ/F61$7Z3NAHT5:%*R7%0@)$$U
MB< L7M[C@!=O#4Z5UIB44^8V>\TX$S1QY6IMXA'E6RUD*H8P:XGF<;.AB)IS
M)2:P6N?F\XJ*-(#'[EE"G!2-;/%T@D7*)4&Z3E54"A>I)V8QCHS?RHS])XC4
MQC4:P@V4M&2K.]36>N6J,@C7J12X\]IOLT# YB^]OR0+,Z#-,P=@N% ,/0NJ
M:VQ\*/7%_D-R+MMUP[,9@L%&D<>\M\;WR^8GJ]5K9V$SB61I@5^=:5^;G3+*
M)VME)TZ=,=1R<"F)(M1*4 34*&EHOC'I(K-L8]#'UKO'/.H9FR%5:WFW'66:
M[A;$1,OY AWN)86"+\5EIU\K1\7HS42\6>LYVP56OR+U94Q2G;-O=E@Z+E 4
MQMM*16<J5C&/0VDXIOT/E;'=#R?7B+)060J96;I$HN@ KM&.LT,SF&:#HA1$
MI7"*#P"GVW#N =AVU*4E:Q.3("WV0'?8 , C\@[;B #[?M;= ZCX>W3(I5K+
MYF\@,RX8S)B9)C9I_&''-[67DCDC++#"#O+-:A;0%LB(V+A+O.L =KX^@G<*
MY64-)F;';I#L=51,GUM0WO.QWR,S$IS3N>*LNVR9HF/)6P2\?@6LR>$GC2GY
M9@6<2U?)2=7SJ@5]$2DV@"AU5&"BS=91/JFF<O75M$5*UE[[>P\K8GFC0L1F
MSI4KG0'E?N^7<G50V*H:&=5?%K=4:K1(=E9V3HS]2SV&[2:1414)VJ1\6^4-
ML;R]UL]"DUWLH9YY 2% R_3J(VDX:LTNK8]M7(3.UTFVB3XL1BBF/B0:<5#-
M_$DW/61P4@JD*8S9JW5,'U^W3K-;9(^\*><TYS5E.4L15;7C:$6JKFM.\*M(
MAPWLEAKU,N-65?P$_DB)1> D>?!Z9-5TP(<"-C"#<Y^\#[6D3F7I9A.B<X,\
MP,#F2\W*RP&3L<\7>1U,QME&QKXV<XJOUFH-R- U.TOHW',L+67A7V,[E:FK
M]M(*I-&-@A6BYD/, Z*AY:4RBU\8]YO$1^QT$#!N.PEV$/9X"7IT'I_SZ0U(
M<VP[ (@/3;QV$-^H^'\&^B-?V4\I9XP[R8PXWF;_ $6TXBS5<K75"8M:4]2,
MLM%I%0Q9;+_8,M.+N,@NJ[1K$A6FC9^DX2*U4)+I)H "XI@>:4.*D7QE7W.G
M=+"'&[F7<.== R59L%9OQ=C>6E96$M6,J].4&PREQI>!U#*-&=WML7:T:_'V
M2:O2K=5P"T?[[!PW<FS.LLY27U8NN,8ZDMN.><;%:N-KG+F5W$:L:J_B$,M<
M(*.-'PUTK>.Y*7:#D"%BQ45]QCK%'PYW2:93G3Z[IB*8E'2<]S,2U+<F/4<Y
M)X:QSBC)IY6JU!OES'V0L\TRML\73&2%9A"+F:VRQ]A*_JP *KXKKTC!3I%9
MF^RIV<*R=]Q#/4RD[#L8^(K2,8W9^26U&9RKE*8SHMA:JJ5NN+3/$ASF*)?&
M;(3Y(K)3F^-:VV*=XBL1E,UY-%SL/8&S@WUP-UU(IIDU69NROQLRX\S5B&MW
M279I1=I25E*M>8IJ)@91E[J,FYKMM:1RB@]RL:6;CUC-A,/?Y!B=WUM]7H2)
MKG"0&@:"AM^T=O'8=OIVT&H[U2>9N2.(L+C%S2+&VI;6SLLL3CRPHXIL.;I2
M4F,;4I2TP%"6I=62<RU<JUL4*J63M*Z9(^'*@FFLX:BX(J",KDYV;)L26V5O
M>,,9W>=8Q<5.7*AU"T3<7"2;><AHV6L%>CY:081,TU55;2L:T<NC)H.4SG(N
MD4#@(@.FLE;1M9,T#0- T&+,QPV4Y^D.8K#MV@<=W-S(1O9;K!5PN#>*B$W(
M*2XL8%5RU9N95PU**:)W(G02$XG,0X@!1=)?3&.I$3 &7LV9^XBSUU;W2MUV
M_,;?E6HUG,<'17-AJU]JF-,@V"IQ&6JS0#N'*SEG>X.!!XU:D,NF<ZH&0\Q$
MZ8:%\\? O;@3G*[\@\#MK]>7L9,/4;?<:O&V1A!.*>\M4-69EQ%Q]CL%">[2
M= GY(B F<1#LB+IL.WF(HB8" Z$K,YIL:*:!H&@:!H/E5W QC /:!0 1$>T
MZ;"(B81 H%$H"'4=M_WVJZ5:R.-G([+LSG#.U!Y"6"8J]CKSW*<YC3#D]AY>
MCMYK%-/O#V,KE]H>2SJ.XW)C!U6TVAWR:;@KQHL[ RJ!$P3.=G=+QNV8L\G
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M!BPC6_<*BWFK*JW7U8SG-T4_APYC+QC.RW_D;F_,<%A]PE*XWI%['&;:&AK
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M!$8%]/J\/<C6J2M>>.6^(+)DB3^.O3H3+;(%.R7/2M12("XI!3FYTVZ2$>4
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MC+ $S 5.6SUG'F!4Y7D%8$I9],NJ13V!:FRMC?&- 8HND5&+5HT?$8-3;@4
M*+EP AOIJD94A,_C?R_R)E[/$UC6_4*"Q;$KT5"V4*(E'KU];[B@BTK+F=EX
MR59J.*K(,*^^GCLWK9$_O;54J9C@)#".F_4K-8AL<#P#Z T&K#B%_KX>H/\
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MQ_++OT+II30I?>MBN8BQG4RU4E;HU6A?N,6P%I_PV):M_NVG:7+QW8B0QBD
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MU#5<V../N&<02MAF\98VJ-*FK6Y4>6&2@8=LP>RJJRRCI3WIRBF4QB&<J&4
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M!+Y.DDTS?=U0A'!%79/+.=B@(K+@5+<VK1:TFRWG?JA8A3LTE5XC%/(&SO\
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M8M/7#*2,)!NYM:P21;@A)ULR1WCI=LW5(]$WE]I-BZ4S*S7>VGE^R'T!\O\
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M%A P$'S4 WZ=0W#0I5E9J@#9!) O=V(ID2)W#N/:F4"EW'Y=@Z_/H/HT#0-
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M,F+I;*=60@83)5ZQ9)M)!!^WLM#?-V<D8$RG(JQ>HNT5VS^/<IJ""B1@ !,
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MU"$EE9*Q0L8VA(F;=NG+0SM23CH1HFR26[P.1F0$ _-!VZ=)7<L-UP5X<OK
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MUM*(E1*J)&;X9\/<Q3.("#CZ@_6Z:4,YIJS^50A_L& WMZ;^ ]0Z_.&@Y"(
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M>U& =7N*BH.X+QR*EBB(-\>2B(^4-W>\-8Y^H4BCIJF/V3B "(:C73FNK0-
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M   D0DS:LI6<4;QR 5Y6V&J96M60\B0LYBU"QLY<E4LU,QU19-@VJ#5S7Y:
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M'R] #^'2Q?+2KZ #8 #Y #^SP#05T#0-!P[-P#?81_>Z[_0.P;Z#YA;"(]1
M0V$.T>OCOL.^VX>/LV'Y].L<BMP*8I@V#M[0$ V^MVAL41Z .X?)X:6,[ZOJ
MT&J_B%_KX>H/_C)1/Y')KCW@K_,/Q#]\CKA[6]O'\LOLL_1.V_.RVG'+WE,7
M8!W#;8? ?F';KL.NPO%+YS("8=Q$!^KV[C]K\@[; !A\0ZAI-"LGNX;=0((_
M1T#YPWW^M\^ATN:*0I^(AOV[=/;UW$1Z==Q^7?4HM?,[]5&LCTV/'F#_ +7>
M6_Y<=:Y/[+_NO?7ZTYOU_&]C?2[^3X!_@3NSYGA;-]=8>.30- T#0- T#0-
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M3IMOO[?8(;:+1RT1U@H F[=A^3<?E_L#0=F@:!H&@:!H&@XF,!?'Y_WM!4#
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MP@'R[]>@!\N@>:']R;?8>G3Q /#Q^704,L4H"(@;H(=-MQZAW>'B [ /[F@
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M;:?.T>N-IIC'N8=V4JK51_Y_?LH'UD^H;>&K2PV Z@:!H&@:!H.)C 7;V[]
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M=1J,#6I^]Q6,\>2%0M$'=;E7JO+1[9E>82TRR*->ML4,>X\UTFP.JHB5<AC
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M T#0- T#0- T#0- T#0- T#0- T#04$-P$/E#;IN'[X;#H.'EAMMN'AMT*
M'R!VAT$"^S?<0^704!( , [CT\ ]@!UVVZ[EV[A\-AV'KOH.1B"8-NX0Z=!#
M;</G#??K].X:#BFGV?QA-[ W\ _)OMU_<^3;2BS-7;HAH&@:#@<@'  'V#O\
MH?N#T_MZ 0G8 @)C'$1W$3;;_N!L ?DV#0<5$04$HB8X;?W)C%]A@#J4P;"
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M/-LE&7YI;(^K56HJ43D&KAC%#*R.+# 8SMF7JX[JD'76SMP*B:$9 Q:GF@=
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M\-9OQ;G6HPD^[,P@K8_QW-*+2%2E)$@&-&I6"OR+QNBYV,#=T9)00V*.@BY
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MAMT#4I>NJUM1VZJ&@:#K!(@#N ;#UZ@(^WV?0&W30 2( @(!U#P$1$=OF#Y
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M9X6S?76'CDT#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0- T#0-
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MVK"%MB9/RYE_5):Q5EU!5G)T97Y)6+GYK'<TL86UHC8Z00,"BR6W<3\X&Y1
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M5>7;JG560EDHEV)E0(+4!()M*W2GF;A]%- T'2N/:GOX"!BB @!A$-NHB %
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M9K?-L1+OVEWZ#L'3^P1T'+0- T$6.3^3<L8:I265<?U:%O%7H\@$UEJHN4)
M;C(8W;)&/.R>.W+5^V9J6J#;E%TFS<)JD?$3,B7M5,404B<\RLQ%LL8]U%EE
MZCM5Q]C:L9@Y%L5:=7<WK25OP#1Z;4+;9\CJX581*<ZE?,A0[$)!S&+'@%2R
M#PI6[=&-1,":FZ@&VG63Z$H<.\N\.YUR#9,?XR=6>R.*I&-).7M3:I3Z6/\
MS'C2(DV\2TN:K%"OOIOX?-H+>[)JF5\OO'8>PPAJ^=J%K=&,="5@=>NH-5_$
M+_7P]0?_ !DHG\CDUQ[P5_F'XA^^1UP]K>WC^67V6?HG;?G9;3%=^PVP[#T
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MKLL]E29'N\)=Y(SIBPCF[%]"XDQ=B)!E&,HQ)!DT8GB<7-G)4R$*1)1P<A
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M3='R%1I5.:JMIC4G'][.CL'B0D605_-.6RJJ)_JJ#H(JK>GRREJ!;*A9,X9
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M[5 (]VW2'R7)P Q-(V8Q*5C/&(CSHS$D,GUC!2C''N4,IMT,R)9ZY4UA>P9
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M^UPU"CD6IV<GE]"4>Q3L01(XE(5V8JQ3$.(:;I,KOTVH%[2=H    CL #OL
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M($4(HF)3D P;@ [AO\FII0U=A6X)$(FBD0B92E I" 5,A ('U" !1V(F =
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ML>R5MC5)/\,+8G>JG''>KEAV]M;1<A$1<V_BR'(SE'<$A*+JLA7(H#5R(+)
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M;.7^$YGV!_1:YC] _'&  1\ &\WONWVW$ #[G;B(?-J?X->WW]X^R_VSMO\
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M;_"X9,Z\5%GAH*MQD5&B1B4X-D&B:2:JAS$*4!V!;R5&M*F95S'E22MD%?\
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M;=HB.1EKO$/WLJTNELMDA;K7[V]K<E43^;-3TB\>+((5N7=,T4A-V)(N% *
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M@_\ #MMW^FM'_)R3_P X]?!_Z5^_?WAC\!S/Q[\O]A^U_G?_ "S]DXF].ZW
M4PCFM+8"B(__ ".2@] #KT"Q"(_N#J_Z5^_?WAX?P',_'G[#]K_._P#EG[)
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MM)A?>/@U/KD)5XGWI4R[GX9 1K:*8>\+G_.+K^ZM"]YS=3&W$=15T:!H&@:
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M(H@L4Z1R![ $!#1:NUHT;L4$VK1%)NV1(5-%!!)-%%%,@ 4J:2212)ID* =
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M#D*J3?<(MKUU9,8L&T<V:LF2*39FQ;(LV;1NDFBV:M6Z9$6[=LDF4"((()$
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MZ%8D+3%)LC&F$:G(R R<>W\Q)!*50;NCE4.W2[;49D3)V%$-]^HC]D"@ =
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M5J9!1U>@61U3N5D8^,;)MD3.G2HBL]>K@GYBRZ@F566,8YQ$QA'07MH&@#U
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MMO\ 6.<W<<X[B/UCCXCXB/4=!\\FS2D8Y\P6(11)ZT<-5"' #$,1=(Z8@8!
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M-N7S./M5>F8CBCTRYOW5/VKQEVC@C6>/WVUS7M1T@T#0-!Q$VP[?]'[NV@J
M[AO_  :"N@:!H&@H([ (_( C[/9](@&@@TER2S/E:\98K_&C&&/K/4\&WQWB
MR\77*]_G:.UM.286*BYBVU3',=7*;<7CMI4DIMJS=RTD#)H>4%=N@58K=170
MTJ^I+D?F"I9EQ5C[+^'ZG5J_FV2FX"CO*AD=:YVJ&FZ]!(S;]6X1"E9A8LD$
MY(<Z:;E@[=&1$H"L0H&#9H:IN:!H&@ZU#"4H"&VXB!0[O#<=]A'J'0!_>T$"
MJUZ@6*K/E7,]50;N8S$N%\='NSW.TFY;H4N[OXFXS5*N4;0B$,H[GX>GV&%5
MC5I,I2MWDLBX;M?-*@*I[2O09326)3>I:BO@T<N(8:LL5-/\FY4ID%CNTR*$
M78/NWBJ%D;)+6FQ%13<C7W+B 9IKF8J%,LU,N"2NRA3 $,8U2>XG9^G>0525
MM\I+X D&CEC#/F3'">5'F2WT*:39 \5CKH"\!#(0DFB4Y0*FF98#_6'<-@W"
M6N@P=R2R^K@3!V2,O(Q3&;5HE=5F4HR3DQAHURK[RV:)?$I4K=V:.CDE'0'7
M6!)02)%,(%$=!$+%?J5XC?0.1I+/EHQ-BMOC>[1]$&^UK)C2\XDR%/25*0OH
MPV.;2$9$2DW:H6#54+(P_N(R#9PV53*100#2^A6-;,\P7.OB)9Y>R0-=Y"XM
MFYBHU$+W8F,99FSM6.JA8AG/.93N2 4W@QT0_1<.T$#*N6B:A?/32$P!INU6
MSRI;U!.',-5J[<7G(''IH.W$F!K2K:1<NGLHI G%*70"(;M%99DNP<@"*I7*
M*/8L()B('$ %2:,S-%_<?.4>)N3.&H?.V,9]-Q0)1@YD'$C,D/#&A$V)#J21
M)OWX$46 QB29CKG,?RB$ 1[A -])MEC&+-11CAMZB'"UW66]T;\B<>*U%W;5
MJ.TLH.Y$L([L:#)K)J(-9(\>5HXC C7R+@)$I_AQD%2G*N(#T;D75&\W.)TQ
MD*T8KC.0.+'=]I+"<D[;74[0T\^!9UIL+RQ'D'I^R+04@68"N\3%?S6Z(>8H
M4I/K:7*TS6JX]1'A6UI##)+KD9CAI19.V.J1'61Z_?,V,A8V#,LE(MV .&";
MEW'Q<8<'3I^1,T<V;""RJY$A[]-:$95QCXV3(GE=QUGLKC@R#S'0)G+94/>%
M*+$SS:2FD4S5^(MB7O!&0K-VZKJL3S.00344*=PR<$62 Q!WU*K2N6:0P#N
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M&N6V!B++ 2*91*F_AIR/;R<:[( B)B@NS<D,)3;&(([#UZ:BT7&H?L !^4P
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MU*SJ.7,VU.@../PU^+<0B>*$861>Y8O*KU'NF&ZE/9M2OQD3[(IN%4&H]7!
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MW.)=S=(O(M4?)9N;K19=W5[(^9I .R;60D8PZZ9.O857M]FEJEZ)*Z!H*#T
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M-.&/+-_,G9B"BIXVQM3Z84J0.(6%9H2)TA Q%90R15)%0#[!Y@"Z,8 -XB4
MUZ.\#>'>#PIX3[#W!$1]L[/V?@CCIKS*5XYW_55OLH^P[L[''8.P<KLEO6X.
M"(FFW7TLDZ^L?[S0<3%*8! P;[AM\_[N@\OX#!]?\#10[CN(C'M!$1'Q$1%(
M=QT'>VBXYD<RC-BT:&.  <6S=)#O / #>40G< ?/H;GW  %#8 V#Y/9^3Y-!
M704$0#Q'05'P'01AY2UKE/<<:_">(N5L<X?RG\98+?>S)U#7R%6_@B9C?$F'
MP-L[:*%>N"B'EK=QBDZ]!TLLQ9K@_ +UZA_^G_X7_P!567_G?5LS?;Z/A4_
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M6E_ /_QQH4G;Z/A4#C_Z] >'/_A?X;;?T5I?;;;;P^,;:%]OH5_ #UZ?V_\
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M '@'"_\ JJRW\[Z%)V^@_ 'UZOV_^%_]566_>_POTT*3M]!^ 7KU?[P#A?\
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ML'4/ ?\ O?Q#0I,:^@_H_>O1[>?W"X=O#?BK+" ?0 R_30I.WT.7X!>O5_O
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M#POF_#'=G:.W=JXN_P#O"OVSBXIG@K&<_P"U39$?)]&3(08#]>H?_J@'"_\
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MK>/.4QS#]4_0?'2EDK&>C*P/VQD2K@\0%!0I3I+ ND*1R''8IBJ ;M,4XF
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M3J%2>(+"FH")R$72,=)8.HHJ% VZ:@A[! #!\FE+$9OH!80*8YC[%*4W<;8
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M9BE,0Y3%.4X&WV,4Q1$HE$/#8=%I([=(MB=ZRZ2)2["8RJA$R@41 NYC'$
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M3N)!5%'N\PJ93#]H0[=P\=%UW/G5EV*1@(M(,43^8FCVG=()B"RP>8@EVG.
M^:JD("4H]3!U#<-.A'/XBV*X]T%\T][%,50:F72!SY9?$X-P-YO;OXCML&FY
M9C8^@SHI0)NLF7S V( G* G,80 G8(CL.XC[=2M,QV&4, =#"/:'UC '4?G
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MO36;RS8ZE48C"D_E^"N=4N>)<B.,MQ,^ZL63PC;K7FJ\2BBT5=(Q:CM)XFW
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MRM6&Q83KN+<UH7!%"7>,*6I;I5*NITQ&W1[%\@I+B1=%5=J0Z2B9%4>\1*8
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MGISQ*%;P"2M.*?FBOVYO<[?:,H67.&.'N,[+D_+&1YIUD+(F1(V"?.WB_P
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M$IR8C6Y'CU"4AY%Z4YD'R9^QR7ZY?JB BR:SBB%_JK\?,K9:RMAJU&BLUW7
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M*.\FJ5).!C&]XI\W /I*"M%6^.)*L3K-G!CH.4Q(J0@B0-6D1T+$UZ4MS'1
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M[R /34IH5M6%[(V2MJNI!DE/PRCR%3%26:EDV1W,6F0.X#R2!%P49E!,>OF
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M+?&GDFBEJCZ3$2"+Z+:J+&1:+B'84H:II58U3X1I71[BF^8\B>0V:L+R>/\
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MYMGG%F%^.[68P+=+E,RM#A:S7ZW85Z5+2&+W3!J_Q]6[ NG#TQM+V\4_?9%
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M%UC,:S.6,:1&19E1!O"X^E+W6&%WEEG*!7C5*+JCN61G'ZR[-0JI 31,)TC
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MT:'E?$#7"N(;O+Y[:8B!GR4L-GB4[9QX<TJ'JL6DHT;N$36=XZQ._KYY.I?
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M"H^'\3Q#Q\/#^'^UH*?)_P!G_8(^&@J'L^QXCX?1[/GT''_T>@J/C_$_+XZ
M'M^QX#X?V_FT%0\!^Q^3P_+H*#XC_P!GX^WQ_+\^@>S_ ,WXC]'L_?T%1\0^
MS[/'Q\?9H.0> ?VO#\F@XC]K^)XAX_:_Z= _^M^U_9_UM!4?L_Q?9X_9T%/[
MG['C_;_B_/H ^S[/@/C]'L^;0"^W[/\ U?[>@X_^CT'+VA]CV?3^304]G_F_
M$/H]O[^@#X_Q/R^.@K[0^SX?E_)\V@Y:#C[1^SX?E_+\V@#X#]C[7M\/R_\
ME: ;Q_B?];QT%/E_[/\ L$/'05'P#[/L\?#P]F@H/L^QX!X_VOFT ?$?^S\?
M;X_E^?04_P#1Z"H> _8]GAX?ET%1_P"I]D/'Z?\ \W0#>/\ $_ZWCH+7F_\
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IM^S_ -7^WHCEH&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:!H&@:#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>tm2030088d18-lc_alloge4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d18-lc_alloge4clr.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!. (L P$1  (1 0,1 ?_$ .@  0 " 04! 0
M       !"0@" P4&!P0* 0$!  (# 0$!             0(' P4&! @)$
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M09Q2$@IW24;H*/2;&3,@)DC' 4\9+X"[[!OZ=@W]'IVZ?0 !_!H"= - - -
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MK)[GC?IQ7ZDT!/>K)[GC/IU7ZD'0#O5D]SQGTZL/_$8: CO5D]SQOTXK]2:
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M'DEB;?\ +H),F$_V"_BV^+HT0?$UZ : : : : : : : : : : : : : : :
M: : : : : : : : : : : : : : : : : : : : : : : : : : : : : :
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MXVL&7\'9WQQD?&=2<R+2V7* L3,T-57,0S3D9)*RKNS-3P LXY4K@PNRHE[
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MU9O%/[,^"?NZFN[^*>,>'_O%MW^W^Z=R[3O_ '_M>S[OT=7J]7?IVWUYG_\
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M9H5I#ELRMZ>-KM!6U2N.GIG)&:4NG#O'2C$71V2P)B<  XI& !$2CH*&0P"
M@ @.X" " ^L!Z0'0&,_+K;]RW3Z/WO\ &K?^DEB;0CX&2R?[!?Q:%?$UZ :
M: : : : : : : : : : : : : : : : : : : : : : : : : : : : : :
M: : : : : : : : : : : : : : C</7Z- 0)R!Z3!\>I*!X#G_*4=CBD/A%
MJM/62V"I4J348X4S35KLTPW6091<:D<?[V":8G6<+F#LFS9,ZAQV#7G/)MUP
M[=MMUO:\FKS_ /'CLMXW77)_T2JW['Q;AGLTV#YX=]_RVV\W<Z**>\^B*?N.
MOE5Y*I&7*5;LM&QG;Z%&*/%+%5EROI@K]-Q$/4&J*D?(PQ8YT9L^72.('$2@
M)!$!]&M)>,?9[7:+><.JWJW!GT*4WV7?-5ITAIIPZ? UGX_]O<^W[G;K=Q>+
M+CME)5HG,4:A^D,]ZYE^6TCEUSCH>/E9Q9C!*OI6H+65&&3K839I,];\$$W@
M$.MWP\<$<[$!5V%(5_U?VC:]'YQ]J--NN+$O%L&DT62RYN]VV]G=*I^RW\5.
MY\J\*Q;QCQ8]MLP8<N.:]EJX]O-6S*J9?\(L"VOCE@J-QC='</)S;.?L4HJ\
M@S.E6!D9604=-RE,Z;-5A4*F =;<FP&'H'7N/ O'=1XQX[CVW676W:I77MNV
M7QON?%UX-'H?%]IU&Q;+BVS476WY+'>VU_[777+]3, A ^$GHWV#IW#^';7L
M_F7)UYGH)3X2F28O6'T&Z ]>WY-]^D-913MY$GW)*0 $!ZH;[^GHW]'\/IU)
MJE,EY&]K(@T T!2)YBE!\P4_(/C1F7#'(/CAA[C?B"]VBQ7:3R\SFH:(IZ$Q
MAF]TP\MEF0-EFC1&1*A*6BP-&\;%MTD%V,FLU>*'43;&W+J',RN!]_#V9O\
MF'ES'90R%YC7#7D8ZHF!L@TJ#P/Q 528(JI7.]XOF);)^08Y3-^374DG535)
MK&,%2,4$VIYI0HN2BJ"2EK HGQJ76:@*\_-3D,/,?+^Y8M\^9$G,48IL>&[+
M1K-?JO&NYNTP2N0BMZ-7RUB!8KMW5@L4O9["R8L(\BB8OG;E-#KE[3K!4'P*
M?>"A<]U_S#>,:W/_ (_T3B=F%7B#E+%?%: PE$TAS1,YH1;RE7#-SO),_2K'
M,*U/(5&K-8A7,;4%T7$4P1=2#AE*/#F422. DYZF8O+U%KD+S@O+0Q1D%HSG
M\0IX5Y@Y;BJA/QC*2J\YFFHQF/(*L2+EH_:*MG<S6*A8YATQ*<QP(/76*3K)
M@<I< _W(JEOM=91_.J_\=(ZO1!.(-U\\_B$]MU22CV 8Z<Y#?\)LH98M..7U
M;[D,6O%3^3*%2YA^SW[JI( D51,1<J%4<?<Q<3'([#YI%?AL><L>8V/,81C*
MI8IS-PQ\O=?D;7ZD5*"KRDG:N>UVQF]G)IA%))-&\O<L3MCQ+Q1,$%W<8U)V
MG7*(#JE?%TY%CV8,>4#$/G">5BWPM6H&@A>.._.>HY*AJ-'-*\PLN.\>4W"D
MKC).T1L.DV:/F%6M<JX",47)UDU72@$,(!U G(L*:%[H&V; 8N_0B AZ=_V-
MPV^'?^'4+S*LN3V=,_R%6^R,EPWR9#TP<]<=XP^5W65>/+NNHQ3?DCBSN]C/
M6X[*#J]'9/BI$$K<L:+P@+!UTB[& !&68HRDOV9.M77F^P?_ $V,^#HV_5="
M Z!\?_!O>)ROPUU[\]C?:@TH*CQ.4^[KWYY&>U:"H\3E/NZ]^>1GM6@J/$Y3
M[NO?GD9[5H*CQ.4^[KWYY&>U:"H\3E/NZ]^>1GM6@J/$Y3[NO?GD9[5H*CQ.
M4^[KWYY&>U:"H\3E/NZ]^>1GM6@J/$Y3[NO?GD9[5H*CQ.4^[KWYY&>U:"H\
M3E/NZ]^>1GM6@J/$Y3[NO?GD9[5H*CQ.4^[KWYY&>U:"H\3E/NZ]^>1GM6@J
M/$Y3[NO?GD9[5H*CQ.4^[KWYY&>U:"H\3E/NZ]^>1GM6@J/$Y3[NO?GD9[5H
M*CQ.4^[KWYY&>U:"H\3E/NZ]^>1GM6@J/$Y3[NO?GD9[5H*CQ.4^[KWYY&>U
M:"H\3E/NZ]^>1GM6@J/$Y3[NO?GD9[5H*CQ.4^[KWYY&>U:"H\3E/NZ]^>1G
MM6@J/$Y3[NO?GD9[5H*CQ.4^[KWYY&>U:"H\3E/NZ]^>1GM6@J/$Y3[NO?GD
M9[5H*CQ.4^[KWYY&>U:"H\3E/NZ]^>1GM6@J/$Y3[NO?GD9[5H*CQ.4^[KWY
MY&>U:"H\3E/NZ]^>1GM6@J/$Y3[NO?GD9[5H*CQ.4^[KWYY&>U:"H\3E/NZ]
M^>1GM6@J/$Y3[NO?GD9[5H*CQ.4^[KWYY&>U:"H\3E/NZ]^>1GM6@J/$Y3[N
MO?GD9[5H*CQ.4^[KWYY&>U:"H\3E/NZ]^>1GM6@J;"\S(HE RE?=D*(_M&?1
M90#\(B+L/_@UC=VI3<XM57\!,5/D+8GAS]F2"74,/H*G)PYC!^$P=^ 0$-PZ
M/PZX;,V'+<[++[6^*AIS^1E:E<^16-S3\P*]<6,BUVF1&-:]8&L]4$;&9S.2
M[Q%R@HI*R<=V":<29= 4BE8@;<P@<#"(>@ UJ?S_ .Y.K\.W+%I--IL>:S)B
M=W=?<[9X<%1\_0\#Y;Y?J_&]1CQ8M-9EQ7V.[]U:..$GH_$J6LO(1HPY79!@
MFS^;F6LE XZKD:Z0\!QW7FCXS29&-3DG9%G%AL;]F)G;TY 6!L1- @@F!P-V
MOA#U/DN%>7[KV/476]N'%;6W%8X=."[FH3;K"B:N>U\>U%^\Z9;YJ[5WY+5]
M.R:6+FTV^-TUGARH9_DE)7?_ -'GGHW'9Y&"'3\/0[Z=];*YN."YGIE52U%_
M-&YXG*?=Y[\\C?:]4M2?$Y3[O/?GD9[5H"/$Y7[O//GD;[7H/QR)\3E/NZ]^
M>1GM6@J/$Y3[O/?GD9[5H*CQ.4^[KWYY&>U:"I RDH =%=>?E>Q@?[KT!/B+
M[NO;>'+=XZ_5[EVS3K_M]7;M^U[KOV?ZW[?H_#J5,J1P*=/.(P[>\FQ7$"RU
M?BI8^;E6Q#R,5N^2N,+%YCQG4,CU1_CNVTU)[<1R58(>!7<424LB,W$)';OD
MG$BQ*BJ1$JO;)U?U,6JGU<!XFGL<WRJE?\F=WY?3T<?32:F;%8'BY&$FFYI^
MKF/CGM\,V>5M)QFU (_ JB0L_P#>O=00."6KRXCG14+GM0'BO(# F+.3N)KO
M@S-M-CK]BO(D26%M]3E3/$6DJS3>-))HJF\CG3&2C9&*E&#=XS=MET7+1VW3
M614(H0I@<RF&<-Y=U-PS(3&:\7SN6<R\EZAC"^4; MHY2<@LKY3A\<&NC!LC
M(M8$EHEK TKC6==1,>64?-V*LHY9LP0!?LSG*=,LC4<#C*IY76)E>*'&3CKD
MN[9=M]MXR,T)*E<A(7*%_IF<(^_OTY3[9VR'R'$VA2TQS6UJSCU!:-5>.F01
MQTVO4%-%$"69#7YG=Q\L/BB?CW/<;7-3MKVH6?)Z.=)ZZ.\E7U;-4EGIK)QL
MRSS@IF@;$&0TLIQTC#M#-99-\11N@V3;)@5L7L=21R-VI>69Q=KV,,Y8IL==
MN67XWDNV:M,\6W-^1;GE+(N264;'-(R CY2^6:<<V.+C*JBS*I$M8Y9DWC70
MG<-R)N%%%#O80H.S<:O+]P5QCO$KDRL.\JY!R1(4V-QPQOV<\M7W,]JJV.HI
MVJ_:46ER=^GIG[)UI9ZH"SM%BFBH_411,Z.L*"0E-S41!G+U0$O5$ VVV$HA
MT;;;;;#\&@,9.729 PJ.Q2E_Y7N-?2!0#;_VD<3;#T!_H= 9-$ O5*(  !U0
MVV#T;AH#7H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H
M!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H#08=NG?HV >C;4XN.8;A3!XA
MR15*C@C+BQ%0242QW<#)J@H)#)G"#>"4Q#@8!(8IO0(=(#KH?)LF;%L.KOQ)
MNY8+N?;%.,RHCW/BW-]NVY[T^VY8W#ZQ0_,IY>XY7G^1L7$XWN<?6;.ZJ5G3
M3G[2P>6F/B6!46QWCI"",_9HR$B5,HE1(JH1(!.)C#\ _E3[;:[R3</)%AT.
MJO69XFYR7.ZU)-55MSA\:3)HOP;6;SJ]^6/#E5K>-NYY'=<IX2K923B82CD9
MW<LO+FY&Y9O%?LE;R&7*;HM7(UL5FR/.-*^Z&8&3D%S-("NP\,,/"P"+1PGV
M2#<I2@?KF'K&,)C>_P#-/M7Y+O>XV:C%J'JLGTXOORNU5E?MM7;;;[6I(]=Y
M-X-N.\ZK%K,.I>7+9A=K=_RIMM.EMJ5J_(L]X7XDMF$./E(QI>B1OVF@!F!D
M?"7AG[ !D)EZ_1!!T9!J=4 27+N D#8VX!Z];>\+V34;!X[@VG5P\^.U)Q$<
M$N*X\.,R>Z\>V[+M6T8=%F<Y<=J3:X<$98@ !Z  ->L22X'<DZH&@&@&@&@&
M@&@-/4)MMU2[>KJAM^;2!+*L_,9QQF',UKX:8EI\WF"OX(O6>+/$\HY?!LU.
MUFY,*6UPOD2<QQXK::T4DS7*,[R[$PZ,NY360)V2A$S' %  :@RMORIL8W_&
MG,2%K4C3><S22I/&3,5 Y'63D@OFMS@UYE2$SECM+&EFPY;K^_<TR]2.1:0E
M(._]Y^\)-XY #]HW/VJ2Q^O(B58/TY:A3H62,H8[P[3IW(F6+S3\:8_J[9!Y
M9+S?K-"T^HP#5T];1S=>9L=A>1T-%HKR#U% AEUR%,JJ0@;F,4!%Y2>#XHYZ
M\)<\7-ICG"'+WC%F'($@S?2$?2,7YXQA?;:_8Q;<7<D\9UVKV:4F'32/:D,J
MNH1$Q4DBB<XE* B A[1E#,^)\)5)_?\ ,F2J!B>B11FQ).YY)N$#2*LP5>*E
M0:(NYZR/HV+;K.W"A4TB&5 RAS 4H"(AH7E)PL5R)P/.XI4SM"YFQ3+832B'
M5@5R_'9"J;S&",$QZ_?YE>^H2RE50BV0I&!9<[LJ:(E$#B40'94E/@;>+N1^
M LWTQ]D;#.:,597Q]%NGS&4O&.<@U.Z5.+?1B";J38R5@KLK(Q4>\CFJQ%5T
MEE2'22.4QP #!I42?'AWE!QTY##8BX#SOAO-AJ@[18VW]T^3:9D+[+O'7>>Z
M-K"%3F98T0J[%FMV0+@3M>R/U-^J;9[ ]V*/6*!MA#< '8?2'X!T!C-R\_YE
M!_\ 6]QK#X^2.)@T!DP3]@G_ %I?S!H#5H!H!H!H!H!H!H!H!H!H!H!H!H!H
M!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H!H"-]1M@CK
M!_9M_;U>4BG#F3OT;[:GL#08X@&X!O\ ]7;;TAZ=)7]8'_0K_P"2'F)XCXR9
M'+C2\5+),S,&@(RQ=\JD95G<8#.46>H-V_:S%O@W8NR&8'$Y01$H )=C#OL&
MO_)_N/L7BFX6[;N2RO/=C5_R6NY=K;2F/5VL\QO?EVS[!J;=)N-UUN2ZU7*(
M:AMI<Z<'%#C(B:D.>$:Q<HQ=HIO&95NFM)-)0%H"V95D5$>L>&$&*ZPL*;#N
M#%[=9NX.+]RD*93"@ F-\6+/F^X6.V[';EP^+N'=W39?FCC;%&K?7UY,Y<>6
MWR/#W.R^S:VO]7RW9/9*JM7]3V+$O"?CQA2Y-[]CBE&@;,V8/XU)\,S-/P!I
M)$*F[3%!^_<H&!0A"[")=PVUWNR^">,^/ZW_ "&TZ98M5VNV>Z]KM?2ZY^AG
MM?C&R[/J7JM!A[,SM[9[KG3XMF5X) 'P^KHV /R_EUZ[M:X5?4]!-95#< NW
MP_$ !JJU)0@W)JUD0: : : : : : : : H"YU8CAN,K5WEG(WF=>;BS?99R(
MZA,5<>^-;[CE?;I;K5-KNIHF/,+XT#B3/VB8;5^&267ZB[]46D<S,HY<F$H&
M&IA^M3=\L7(U7L7(*W5*8Y(>;H[RQ&8LD)M/C7YG=$Q)C=.1I"EHJ31YE_',
M31,&4%Q:#UB:4:1*[QM..VK/Q<R2[85543I'5!<>9?L!BF] @/\ 9_\ #J X
MJ;A8:>CG49.Q4=,QKI,"N8Z59MY!@Z*0Q52$<,W1%6ZY2JIE, &*( 8H#Z0T
M!2/Q:IU9Y(^:!R*Y15R$K<9ASA56E^%6#0K49 ,XVT9BM#>N9!Y29%06@V#=
M)<8$AX&FMS"LH;M6,D4Q4_0I9H1*:K@;O,9-C?\ SB/+*Q!D%NQG,5,\.<OL
MTP]1GF;62KLQF>EQ./(&IRR\>\3%H[FJM6;1*NV0& YDE!%8A2BF)M$.=>!4
MWD:K03+FOD3BLG6H0>(60_/8XCS-TI98R/\ W<2U\M?"[*.8[ECB7K8MR0[R
M-M.5,;U&:D8\X&06?G #HF,Z."EH3BXZG;O-.AH?'7*CFICC';)E4<4Y^X=>
M7](<C(*JF3KT*YE[3SKN6(96>F48H&K9I)W;#[,89\<#(*.XQB0J@F*&^G2
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M_&>A!XBZ]S2&WX%XG^#:3TX"#X5)A1OU 5C'Y"G'JD%1S%%'K!M^KN,H _\
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M-8?'R2Q,&A&9+D_8+^(/X.C1<#)\35H0: : : : : : : : : : : : : :
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MIP[Y5Q$2?/G'B&'*,I'8#+CA-LSY)8N[.PG78<@)"YC!/A0+V(A"]Z$%2==
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MU;HTU^A[77[3MFYI+7X+<MJ41=[SRCFE^1VFF8MI% I_[OZC7(VOT]--^DE
M1Z:J;!-&2%8[XA2**J'V<F7.)OUO]%K[-)M6BT&A_P =H,=EFWPUV+A%W[E\
M99SZ72:?1Z;^+AMMLTZX6V\%)Y-5>&7&>E3\1:JGAVH0-C@'B<A#S#%NZ(ZC
MWJ0"5-RW,9T8H'( CMN ^G75:+PKQ?0:M:S1Z/#CU"::=J<RJSQXR?!@V#9=
M)E6?3:;'9E3F5QDRA1)U" 7H';<-_P 'H^'IUZI>AW#CEP-W5(1L'J#XM 3H
M!H!H!H!H!H!H!H!H!H!H"-@]0?$&@)T T T T!&P>H-!+)T T T T T T T
MT T T!'5#U!\0: JV\RS+^7:U&<=>/\ AB$Q!X_S S*\PC(Y&S_4G.0L.8WB
MF5!M60WBMIQ\A)02=TFK>WIYXB%CEWS9LYDW"8*&'T"7$-PCP;A2QSIQ-Y@(
M<),CH\2;A3,C\?KIR*K=RXL\<&W&"4JLIC[(./:$]ALG8[A;9<JW(1MJ2OHG
MB99)RDX.M&N$!2$H&.2^PJ7AZ@-I19-+;KF HFZ ^'^S;0J1PL/9JY8TU58.
M<B)M%NZ.T76B9%K(HH/$0*8[955HLJ1)PGU@W(80,&X;ATZ0(/HD)F(A6SEU
M)R+&+8L2=JZ=OW"3-FU2#81.NZ<'3;HIAU@_6,8 #?\ !IR(:49^&<L4Y-O*
ML%XU5MWY*10=(K,%6/4[7O:;Q,YFYVHI_K=H!A)U>G?;2&6#1%62!G61)&%F
M8R8CU>T!%_%/4)!DL*1A*IV3IH=5!02& 0'JF'8="(B'LL!/@Y&$FXF8*S<&
M9NC1;]L^(V=DZ#MG!VRBI47)!Z!3,(&#X0T!SN@,9>7?_,J/_K>XU_\ 21Q-
MH#)=/]@G_6E_,&@?$UZ : : : : : : : : : : : : : : : : : : \XR[
M;).BXQR'<H<C523JE'M%CCTWB9U6BCZ&AGD@T(Y33.D<[<RS< ,!3 (@.P"'
MIU\6XZB_2Z'+J,;2R66-J5*IZG!JLMV#39,]JFZRRYI=4I*-L%>9?RMS=DF(
MQK&T3&DW)6)K*H1Z+!I(P?<7B4<X72FG[]_/O4QB8<Q.\N4B)"LNBF*:>QS
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ME*&$S    #E[C7Z Z.GDEB;X- S)D@?J$#H_9#X/P: UZ ;?#\.@(V ?2 :
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M(0&J!H!H!H!H!H!H!H!H!H!H"-@]0:"63H!H!H"-@]0:"63L'JT T T T T
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M11<"&K5 T T T T T T T T T T T T T T T T T T T T T T T T T T
MT T T T T T T T T T T T T T T T T T T T T T T T T T!5AYP>1;E
M0^&5DB:19)ZFRN7,F81P6[MU8=JQMBK5>R[E.M4ZV2<)+(F*XAY0:T^=((.T
MC$6;*+@HD8BA2G"I!\##NKX*HGEY>:CPHQ+Q;3FJ-B+F/QZY6,LV8V<6NUVR
MO3-LXRQF)K%0\H)-[;.3JD3<Y$V1'[>5D&ID%)0#=9R*JAA-HJDB&?H-(;9
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MT7+1VV5*HFH01*<A@$!$!T!R']:'QR^X_+;^A?R>_FOT!H-YHO' H;FI'+4
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M$?03KB?_ $.I/(L34][T(1L'I^'4A Q[GL*^+<H\;<B0GRMPH&!\UX7&K>'
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MI.PLBH[28R3)ZK'.3LWZ35PDX48NR$*H=L[(D8YFS@B9P$2'ZI@ =]MM <L
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MYYY(Y%<<.)D]G'+[SCW6N-7)+@)G>_8^P!G7CDC VRUVBIY7K<WD9Q)8YO\
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M-74E#J1#<3C7J^+5L<X*"F49)(7P+4.0T]6_+GX;V>2XG<>:,N]IKVB53#^
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MD=CC"&8.4OEC>8(Z7Y)0M3Q!C^2R?G_B)D7.#(+ADVOV;$E;;.I'(&([O=;
MY<+C$&?/8.0[V11%5$R8JWV)5(R'\M'B\PL6*^2,)DC ]GI_$&]\LU<Q\1N-
M^>:>ZK=EQG38HM5L2CB4QA-MR/J-"R>:8N2GH2#?@95JU72%5%+K]@6.)ZE2
MIT/;.2O+#FD7.&1L#\%,%XBR#,<>\7U+*N:+'R!L=ZJ5?L;F^_:-W1\)X:&C
M0DTO+9)GX:HO'2[^1[O$1PKM$SBJ993L4<PWR1@5@+.F4N/8)\Y<%8-RUG_@
M+SOD4,PY5P3AJK.\D\C.)W(^<9I5_(UBK^/(@2N\B8ZL%GA>RGFK!8\G%NVR
MCE)LHF/9&=!P7=R,B_+RXVU+)52YSPMJXY6>@\&<\\EJ_?L!<:<^XSD\=RD0
MRB:/C*7R?/N<06=NSDZ/3+MR KCR?B8E\U;J*'!5VHW33=%(%?$6PZEXS1DV
M8HI-VR1$DD$RI))IE B:29"]4B:9"@!2)D+T  !L !L&H#Z] - - - - - -
M - <:YC&KE<7*K9!54$5$"JG(!EBH*]05D2GZN_9*BF7K%WV-L&_H  %*-<4
M>7IF:C<_<TSF$;IDGBKP$<V^@9:M^$*W8(4D#R$Y#IQREEG[!BQ"((ZF,+X:
M?R3]DG=8XCALI<I9FX;F9I,>NLZ5CJ3]"]%DS09MTD$$$6Z9$R$!)$@)I$ I
M0 ")D*!2E(7T    : V7<<U=+(N56Z"JR!%2)JJ)E.HD18I05*D82B) 5 @
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B0&OH13S/T!HI%1*)2% H;[[!N._0 ;B(](B.@-[0#0'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>tm2030088d18-ph_admin4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d18-ph_admin4clr.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!O +B P$1  (1 0,1 ?_$ 1H  0 !! ,! 0$
M       ' 04&" (#! D*"P$!  $% 0$!              $"! 4&!P,("1
M  8" 0,!! 4%!@P*$0D9 0(#! 4&  <1(1((,4%1$Q1A<2(5"8&1,A87H;'!
M(R<8\-%",]2U-C='5V=84F)RDR2TQ)4FIN'Q@I)C<W24)35U5G:&*'@*TD-3
MLS14A(6EEK9WMVC"1&1%949FAZ=(&H/3I%75QM:7.!$  @$" P0#"@0,$0D&
M!04!  $"$0,A! 4Q01(&41,'87&!D:&QT2(R%/#!%1="4G*2TB,S4Y.S5%7A
M\6*BLG.C-+0U9746-E8G"(+B8X/3)'2414-$9,0E-\*$I-1&P^.5)ACD_]H
M# ,!  (1 Q$ /P#]_& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M & , UP\AKO<:='4]O2WL?&25HMWW(K(R49]\)-6J4'+2YS$8?-LBJG4/' 0
M.5"@ "/KTXVOE'3-/U/.7XZC"4[%K+N=(RX76M-M'LKT'/\ M!U;7M-R.4L\
MNW;=C/YK.1M.Y<AUD8Q:;]CBC793VD0^TM/D"X*!S;'K! . #VAK=,P   /
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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MOU7PQKMV\*[Q-P>@?4&80VK;B5P!@# & , 8 P!@# & , 8 $> $?=_1[>F
M6]239(G^$JN1-4$SJBD<Y"* D3]-42&,!OAE]H\<!@GN'06>B3@S$CYN<LAW
M_)&(JF<KD$T_BJ&2,4P@8A">IO3D0#GD0Y!*N)YSV>$(B]<&?) C'G,F\/SS
M\!4A 4,D8I>3"KV"'V0 1$1  #D0# IW4>I.;C573=DFOWN7*)W":92''A(A
M2'Y5, "5$3E4Y(!Q 3@!NWGM-P>!!=< 8 P!@# & , 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M[:,E,AA,'(_0/U<AR #T#KP.00<\ 8 P!@# & , 8 P!@# & , 8 P!@# &
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M&.\,=YW8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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M?^]FW_:SN_KR_P#VV_\ >_\ 6O\ W-_T3]+_ $N,>@CX?#TF1X P!@# & ,
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MPC8MG8I*J-?CHH V2*V3 J @F%4[CXIK8FTGOP7PH.-4VT\!LU;]YEUUMMA
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M#A\P7D0XZAZAS[/R!BKW*J&'3@=I3]_/ >@^_P!?4/X,E-/OD>8YY(& , 8
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ML4G5=B0#'7:.JZG6;K UJ^5&5EOU7J\/%.0,>2%B\E69UU6?"I"(*BB+<U\
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M>R(H9LYL/E>M>K'5+5"4?7%$/'ZQNT';K(:L7J2MY4B65I8-5M6#EX@]B$A
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M[\/X7S"0J?#[N_M !$O'=V$YY]?0,[O<M]5<<&ZM85+Y/B55L9=LI)& , 8
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M'B[H^6;H-%:.U:BT2KJ#)["S=HK\U'IU*OKU:OIQ\_ 34;-QQ&5;7.R$$7!
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MM)4ZW:V7G;MJJ]YC9VKQEAL$-9*9&$MLA#DCY)BTEX@Z+=FJU?J+-TV;AO\
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MT_5_^6_SA_/?U?[:7O</=_(3LT/_ .WP]F1_0C/?ENF?\Q_FCYR=.WZ?J_\
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MV5:C''N+H+"6F:?/4?E:5FT]1ZJ-OK.%<?!%RDH\6VB<Y-+]4^DS,J12\<=
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M$  .]0Q.X>  .1Z9J&<@K>:G!;%(Z)IER5[3K-V6UP[^]DEY;%\, 8 P!@#
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MM<_^"<3^;X&:KG_W[<^J^)&]:+_%5A/;P?&R6\LS*# & , 8 P!@# & 4'H
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M5XT9>RLLHJ4F?0!B ?+(\#R'PRB7CT[1Y$ #Z #TS#.J;KM,MN710]N0!@#
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M'C^,GO1(<:>UP _]Z41_[1FK9YUSESZHW?2/XML_4?&2UEH9(8 P!@# & ,
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M)?@X:I$%T0U6<\G3$Z9C%$"B/'.;KD^:<M94K=R#;<JNG33=XCEVI\B9G/\
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MDR_9(FF0H  !T ,U63E*<IRQDV= A&,(*$%2"6!<,@J& , 8 P!@# & <3&
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M8RP@4F,? ,*X;38))XW A>52]0 >?M<"''0>1+S]H/W<),8/9L/01=)0>"'
MP^X 'V_6 8(.[ & , 8!3@/<'YOZ/;@ 0Y#C^C]W *^F , 8 P!@# & , 8
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MEAYF_&ROHGCWEB_(B.X5A]WL2$.83NG)C/'JAC<F5>N#"NX4,(\CU4-V@'/
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MSCW_ ,Y)FC&,9.(ON !RIV]PL-XQ9D6Z_ 3R'DIO<%7JNN->[0C-FWCQUO\
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M , 8 P!@# & , ZS&,'H <9'<WDTJ^YO(QO"P/WU>ABB B=_]\O"<^K.)Z)
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M!U$'+1TX;N$#D.0X@;(>TGNHF'C^#VC[,$   /3IR/. 5P!@# & =0()@'
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M]?4?3D>>GY>N105'PB<\CR/UC]''\&*$'(J92B)@#J.2#G@# & , 8 P!@#
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M1-, #UZ!@%RP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M& , 8!UJ_P!;/_J1R5M(>Q]XTA\"/[U.P/\ SBO(/]S:%ASH7:9_'F6_FO)?
MP:V<L[(?ZNYS^>M1_A=TWBSGAU08 P!@# & , 8!CLQ8(^%1*+I?E941*V9(
M_P :^=J<@'PVS8/MK&#NY,/0I0ZB(!SEIF,W8R[^V2^V;HK>7.7REZ_C;C6W
MO>Q(CB5>S=F K1ZT)#09U?X]J#HJTI()@')6[Q1#M08M5#AP<B:BHJ%Z"8N:
M_FLQF<_]JNI6K%:TJO6IN?1M,WEK-C(?;85GF4L'3"+>\M\P9S,O6]/A^4EG
MS=-Q)/2@ %BX0AP064(/L=N.0*@'''?R8>A1SQO+WN[\GY'U8-UG^HBL&EWV
M^X>^7?N5MZCF:.XJI+Z:3QKX$GB3'&Q[:+8M6+1(J*#5%-!$@  =J:92@'Z(
M<B(@'7V\YM5BU#+VHVH)*W%4P\_A-9OWIYB]*]-UNR=:EDO;M1I4YHZ B5=1
MJ#5 2CP<JKTZ30AD_:*A3+\E^G+;4KG5Y"]-;:)>-I?&7.FPZS/VHO96OBJ_
MB,3:K-F8(L!,5(R:*8(EZ$*J0"AS\/T 1*/J'40#KQ[<P]J<+4(V7A1+RJOQ
MF4GQWI.[TM^1T+H \^[\@\_P9ZNCQ6P\J,KD 8!B]LD$6D2[3,<HJKI_!(D
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M%(]FKV@H@0W9QV\B8.WM/WAQP8/0_7Z\@'$8YGU$$>H\#SWJ"(& 0$!#DX@
M@(>N 1EK_26NM9SFQ[%3Z]]TRVV+BI?KXZ-,3DF$W;%8MA"GDTV\I(NVT208
MR+03^79D0;@).[L[C&$0P).^[F8AVBB EZ#VB=02\E'D!X$_'(".*@K\@TX
M/@A]D  .3*#QQQP(<F'[73U]>F*@I]WLQ'N% HF] $3'$0#D!$"B)OL@(@'I
M[L #'LQ#@40$/<)U!#IR/'4_IR//'ISUR:M ]@    !Z   'U!D K@# & ,
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MNF\6<\.JC & , 8 P!@# & , 8 P"RSK DM#R4:IT3?-'#<Q^ $2?$(8I#E
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M! >?;ESRI8ZK2U<DJ2N2;*.:;_6ZH[<7ZMN*B2]FS&M# & , 8 P!@# & ,
M8 Y#WY%4MH*<A[PQ55IO!3N+_HB_G#Z\<4=M50+'85[@]X?G#%52NX%<D# &
M , 8 Y#WX P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M , 8 P!@# & , 8!3D ]1 /RX%2G<7_1%_.&-]-XJBO(>\/SY'%%[&L!0<A[
MP_.&2L=@V8O85P!@# & , 8 P!@# & , X*?H&^K!$O9?>-(/ CG]E6P>?\
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MP!0]>!^U] _Z7@?3)?D)IXSM#T#! P!@# & , 8 P!@# & , 8 P!@# & ,
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M#G+^LN:_;'\1Z=F_]3,G]3/\9,V1S63>1@# & , 8 P!@# & , 8 P!@# &
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M0#TS'3MW(3<;JI<B]AE+<X3MJ4'Q6WL9MZ'H'U9"=54J*Y(& , 8 P!@# &
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M]N7V<M[!5_=KDOVV_P#CIEIIW[SAWY>=FRN=H+P8 P!@'G5'@#]/ZD1YY#V
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M/JS8#U&1,9057LJ]M>OCI,"% @(E(QCX!=81$_>/QN@  "(ZYS%1V;:>Z=?
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M -47Y!__ $T;%G1.TQ4US+?S7DOX-;.5]D#KR[G/YZU'^%W3>+.=G51@# &
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MS FF!'M=MCMS\=+@.2.2')]GD /9CL"PJC9NVND/U6L?)^.Z"EN.0$.>8]P
M<?E'(B_622]6I.S:\:'QJ_#@?-3;ME.QPDH*.D7Z*P)J$4%!4+70Q%-4"B(D
M/P'H.9C44G;@X[*&"TIUS-WBV5/H+YD/$EM/)LD@%1>:O^MHMF4H<G.Y5M\8
MOVD#U$030,/3KTS$;S.M84[IMLWX^"F >P@!^8/7ZAP'M.PQ@*'(_3[!'T#G
MV8((DM6[M<59V_AWL\+V?8-A77@81B]FY5+D@'3(NA&H.",5%0.';\P=$/M
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M?]K\X%VO?UOY0_GI?BKI99O[I8_;?B-K0_I9WQ>RB\WLKDDG6J4QB@!! !Y
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M/;Z\_3_1]&9Y;*'!7M.S)(.)C 7Z\AM+:*T./Q"_Z(G_ #V1Q(BJZ2H'*/\
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MIKI31SVA9OU-H=IM ";XL-"2+QJF0H&5</RH"6.:(@)3E%=V^,FD0! 0$QP
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M9JW2)U.HNX7.FDDF0.HF,(  >W!-#P_K+"?.,X[[Q:?/R#<SMBR%TU^:>-2
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MN?T3%'KU]>N9/+-.S"OTJ\QS364UJF9C_I[G[)F-K:$TZX1(@OKJJJ@D\>2
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M&1MO9O"%OE>U;A%*$;DU3H>&_?NH;.>00I_LJGBJF I%)2G)")AX#^.N]<2
M.?\ 3"?CZQS0,]596;70=!R^-U=\U;L3/Y8&_ <#P'(#_J1'W9SW,)I)R-GL
M-8F159$ICD,;_2AZ=1Y$.>!RYRD(<2?ZGT%MFW3#NFLOEA8G*;N-KM>C8>9G
M:GKZ\;9<,)>0/'$20K:\0VB7#5TFT> =Z#D')B(J<)JB0I5 $@B8FT:<G;M2
M;7JRP7?:JC%7X\=Q1^B2KX#<X%X^:@6$M%N$WL9)LV\A'O$C?%3<LGK=-RT7
M2.(]PIK(*E,'/4.>ON#'YNUPP47[2E\9[0E2$+D6N%M+N[:>? BE=OQ*))
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M/;TXXR'0J6)]H?Z/?@# & , \P(FYY$?;SZ<?5QP/KQD42W>5D*KVM^(YBD
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M!S$R2 D>1[@1('<*9R@< X-W!R&9[E_FC6^6,ZL[HF8N6+ZV\+I&2WJ2KBO
M:WS1R=R[SED7IO,.6M9C+[G)>M%K8X.E4UW#5SQ<\"*%XVS6RSD?M[_7;HO
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M@# & , 8!8[,'%<L ^^&D_W&2V8G7_XBSO\ PEW\7(IE[+[Q _B=_>/J0?\
M1IH?_E=]G+NP?_VSR7[;?_'3+;3_ -Z1[[\[-DP]/R9V<N]_A+7+R[&&;"Z?
MKD;H\B4#G$ [S]HB5),O4RBIP >"E 1'C/&_>LV+?67G2*/:S9N7[BA:59$7
MO;.VLG89%TT)$M2_/K(D<MW;MS\L '#YM!#XA6C=NMVF$@*'.<Y2]P$X$#8#
M,9^SG$E;N-6ZX]XS-G(7\K)\4/7:HGT-F24^,4!)><?I\/Y8J1D$U #XD?%
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M[-]2;VT3<UA7>C^A0S#M1*7GGM I>??VE /X,Z._:/@N/LK&IZL@D8 P!@#
M& , 8!X))J5ZS79G+W)NDE4% Y, _#53,0X<E ?4ILCBE!J4&E-.JJJXCAXT
MXNE&L<:;<#Y)^0'AK2M=4_7;F-NFQUH-K>:'KV6(Z5ISM1A5;4]:5CYIHHC2
MF(DDT9'Y!,CA<RR12'.)DCF[>W=+7/VNV5:5R<'"W&D?56U+#=T]XT2[V=\M
M79W)=7<3O3XITG*F+J]Z\)G=_P#PU]133&RV%]L7=H29F_WT)HVXU^(3+(PD
M4W1CW:7W52F:K9=%**1#N2$@F[ $1$1$1QE[F?5<QF_>Y2CUSV^;HZ#*VN3]
M(R^2>2M1:RU:I/'N]T^='A5XNUW9FTQAYS8NW6B4=1B[#;.8RWLB.OUGAK/5
M"QCQP:1K\FW=IME9-18A%DU.U8I#@("7K=Y_6L_"SP0E2-Q>O38]WF++3=&T
M^[F.-QCQ6W2%*X4[E*+&KP-Z-X^%],JY*HZ/LO9STM^VA7*G:Y*P2-.?O#L;
ME]SP3MVT>A36!63YNQK[4B!U 713 @\I'YRG(\X:GD;#RUB25KAE1-5Q:IOK
M\17J/(^B:A?69S<)2ON2Q4I+8ZXTITGT$T[J"&T]#2\3"2DU,)SL]^LLE(6!
MQ&+/U) 86$@ !,L1$0C!)LE&5]L4I2H]W(&,8QA-TPFI:GFM7S<L[FY)S:2P
M26RNWQF>TG1\IHF4CD<E%JTI-XR;VTZ>\8?NDJ4E?]-Q@_$,K'2]ON %[>4R
MI1E0>5<RX\"/\:4]W(0O3]$YQYX <U_49QX%%[3.Y9;7T&M^\"L'Q=@"X; N
MXH^A]I;"B0'N 6LQ$EA6;9=L)?M"^4C57[5,..1^9, =>!S$Y:$9]>NA/SGO
M-X0?ZHS*O./A,RE[P('>/(>T.?H$1'D..!$.@\=/?F$MR2CP]_SF5NQXION(
MTVW3<G4;->3TL5 1:U_1]4I,8\*4PB:PWN0>%^7(<.0$"*2D>8Q>0'@>>.H<
MYFU=HK+^J_8R,;.#ZF7#MJOV2-[V9RLHYG'HF(5!@S;LTBE#GA)LW31*0!$>
M[DH%XS'W+RZR7?/:%GBX>(B!2#CW-S'8;QH@D[KEQK-"AWXG$7/R\Y6++)3#
M<H !4B(24A*Q0<=3B9GR'00YN+-J+R-R_P#JE\1,I_;81_4OSLF\_$7N#4D^
M<2$;R<;>**8XG H@\L$?$6AEW_HC\NL:@F3]WQSHAT$0S*Y%P]X5=KBF6E]O
M@\'QLW!(/)2C]&9TQQRP!@&J6_P#]IWCB/M_: [_ #?=W7."=KG];^4?YY7X
MJZ6.<^Z6/VU>9FUGM'.]EZMK*^N"2@% !Y .OIS]'NP"N , 8 P!@# & , 8
M P!@# & , 8 P!@# & , 8!I%Y[:1ON^M)-JEKV/BI^7A=D:WO;^ESDF$-#;
M$KU,LS.9G*%*2:I%&;9M8V2(I_[(*9L)BE!4.P1QL#Q1\U&?@EY DM%QV6&A
MM>1]3<^5=(WJGXL-[S65*M=*9%Z;DJ,O7WK]-FG2VTU5[5($DD6;EN$2JND;
MX9NTJ1QFN)&XNFO_ ,./:JMTBIO9NO:$^I#NN>74C&ZU7F(JQ0&H'>ZIYG,:
MTUK!H/4"LW[.H)$5 KMH@5DS6./P *4I38"728,'X?'DZRUM(U"?UA2=M6*_
M^,>L-*UFRVB^P[9?Q8N-(&QMY:T5]R\:2+Z392JTLSDRKP1BR N8TB1OL=@E
M"C1]#?%7P^D-7[Z\@MT;-AHFR7*UV/7B6O=BO'#:2GUZ[ :0I-%M<D@AWKJ5
M=Y9;+$O/G2%$JKM(B7Q#&(1, @GOGT@P!@# & , 8 P!@# & 6.S?W.3_M_[
M#2?^TELQ&O\ \19W_A+WXN13+V7WF0/XG\?L/J(A_P"SS8<_1]\/LY=V"NO9
MIDE_I;_XZ9;:?^\X=]^=FR8^@A]&=H+M;3$KJ\:1\$\>O$45DVZ8"F59 K@A
M7"IRHH*"F8A_T%5 'D Y]W7,?J=^UE\G.Y=CQ1I2E*[<"]R%JY=S,86O:KTT
M(=K"4=9G@0D(Q*G&Q_PB6*2(5)$SD"B58T:4R8$56<OE2=ZI_P!$$Q$>>XX<
M:SIMN.<O]5:A2Q'&<NFNY?H;#9,]*_D+/'F9*=Z5>%)^SA1-TZ.Z;%$233('
M!?0H!P/[WN .<W5))46PT]MMMO:R,C]AYVR& ![_ +R:@8!]@!#10D .?9VA
MS]8CFOW$G=NJ7M]9A]31?HF=M?O2"[GQEDL<T-;8&E!;G<MD5!^801^&5<Q#
MAQWH_$,1,QB&X$0$0 0]N8[4,\LA!77%N"V][X,OLEE7G[SM)TN->8B;=%?;
M7+5,O-NP7:2-:C7EYKBR2_P58Z7A8QV]9*'4*;X9Q%/DIN1 @"/KTYQQK-Y+
MWMX*4>);J+X-!V)6,W[LFFTZ/?4KH9K)OF^N;/:';F4M5AIKQV]>/#_&43BI
M 4)-BV1*!"I-2J$.D=4I [CJ=3#T*!?7(7)2SEBVZ<2LU=*)O".U[]IY9NW&
M&F7,,8YA4\"FO,;=JH)F2.3X?)3)B7M_J1 P=HE$/3@0'-JE%2BTUB:S&5)I
M]TU^N(Q\.FI"RP #G[*T$[6136,<C8$UVYDCJE$%7;5=,I#I]PF/P B'"G.:
M?J74Y-\.97%655A7"IM6E+-9F3EEO8I23K1UIWT]G@)BJ3ID_A8V0CT$FS1^
MT1=I(HI@DB3XR?>?X9 (3@HJ<CZ (^HYLN1N6;V7A.TE%4V)47H->S<+EO,3
MC=DY3KO=3*LOBU& , 8 P!@# & 4$.0$!]H"'Y\ B_8=%5LZ;)[&.TV$U%BL
M9BLX0%RR437  <-WK<IB'.51,!*4Q3 H0#FXY Q@&XLWW;K%I.$E1[\"VS.7
MZZ*<&XW(NJ:;6.&.'>/AW^)+J*JM-+WSR$B*U&1-OU&19MLF'B!;-6UC9D<(
M-$)5 $$RI!((R#Y+EP)1.JB(@<!$A<U+G#3,M#(2U2PFG%5:H?0W^'7G/4M0
MYIL]G^I7;D\OFKZMP<FZPFU%82>U-4WT5'W3X-UO6&X;_P"/\_NV[ZBC6_CV
MZKTU.&EH^Q5-V[<PL=*R<,NLZI S*%I.D[G(=1!%P1H4.\GQN 2 52Z#E=.U
M3,Z=\JW<NO<&Z82CQ.G<JGO/JWF7F[DO1N<_Z)V-9NOFN,U!PZJ[&*F\(P=Q
M6U#P\6_:8Q6?P\KA#7N3H,7XERCJTO8%&>>.+%<*8\I+>NOVR+KXT??9>S*U
M0DF"3TI#,T%_FTE $#<%*)LNX\KZS;S+RD<GZ_#6O'%QIW^+%]PQN>[7N3'H
M]O5<QS#!97KG;@H6LSUSG';Q05FJC^J=%W3P::_#BU[LGS99Z2?P)JU :CAW
MMQW5'!++NG#\L=.0+).I,EROY!F"B[J1314=M5S%!%0YB"(E 1G2-!]_UV6F
M7DK<LLJW,*IXI437Q%?/W:_F>2^RNWSQE9O-7=6N1RV5G2C3G;N7>M<)4:X5
M:IZR7M;#]D_CCX\5]K"U25BH6!J6NX)4BU0I=:C6T>F<T$\!G'OY(6Y$4"H)
MG9B)$2IB<_:!E#B B4>OQ>7R>6CD\G%1MJ-.[X]I^;5W-:KKV<GJVNYB[FLU
M=GUG%<E*3JW6L>)OA3Z%14PI@?01-,$R\!^]P.6_<+MG9@@8 P!@# & , 8
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M2SOJV(O-[*X)& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M"V27'Y4OC/*VW=REB;VJL?K?TST:M7*M#R:A>0#]8)4Q2F 0,4B@IK$ Q3
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MR ^H!F,\YF"$O)=11'Q[WBJFLHW.34.R#%61,8JR0EI\P/Q4S%X,0Y/4!#J
M\#GCF&U9DUMX6>EKVUWS3U76^OIO95.DK%5@=-[)'&H;JP1#Q["2]<D$".G]
M:DD92(<Q[H$))9,\8L43+ HJHP(!"E2$38#1\Y)WHVY^U1_$9#-V:6HS9#A-
M):^A-A;$6/#_ '^XB;[)HQCNTNG5A<-R)P\(F10II15=([X.XY2N3%,X GV
M/VAF(US.7X9YPN)1@U@X[6MU=I?9++QEDE/]5\3,<VC.N+*_0TY4EDAFK&B*
MMRD&Q450J-&5 &LD^5/W@BUFI0'146:)RF[P.90>W@BF8O)05J/O-]OA:?"W
MTEQ>GQ7.JAL1-$%#,("+CX>+03:QT:T;L63=(A4R(MVR)44R 0@$)W=I.3"
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MD3G\F4Z*N"=^W]#UK?CE(KU9)V[$_HG:6/@B2AFP;3!C & , 8 P!@# & ,
M8!">YO(?2_CVQA)3<VQ('7L?9)!6*@7,ZJNF25D6[?YI=FT(W;N%%5TVWVQ
M _1P"/#></B;^J]4NP;[UX:I7:X*:_K$^G-)J1LI=FZ;=9Q607(0WRDPV2>)
M&607!,Z15"B8  <$F<2VW-%2FW&.B)>U51]N(\ :Y1^OGOP75@3KX"X(:<1:
MJH*IH(=[-3[7>4P]G(!QP(J"NX\]AV[HO7\[9H>RVRJU27I%'3OUM.^[(YK6
M:*YE5F*$U.2XMRQ\8Q?RJ"I$DUERG74(<Q"&[3"!>1@B"J>7?A);*/>-B57:
MNLGM*UZT8*[!F$4/DR5=A8GA&D<XG&#J,:22$?./BE!!8R I.C<&*8P<#C$*
MFU&8:Z\I?$[;#*S6C6^X-:6MOKN$7E;7(QTTQ*M4*ZW2,X7?2X._EGL3"I)(
MB<RAP(B %]<G%A-)=*,LU[Y!>/>V(.P;#UULJCW*#I2+Q*SVF&E6+E"L-D6G
MWJ\++NS=BL8U^[VX.A,IVIJ(D^( B4.0I%25*;>JCL&L1-TI5BB[14Y]BG)P
M=AA7:3Z*EH]43%3>,'B F1<MU#$$ ,7ITR2"UUG9=,MULO%,@+ VD+-K=_$1
MEW@RI.47M>=V&#:62$*[(X12!1*4AGR:R*J0J)'#N*!N\BA2J#SDA8 P!@#
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MZ9ZZI=3LV+'TL92^OIYJ>'N'ILB'PI^+<=W/QH^0:=OH F279."<>WN[>_\
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M^K8B\WLY8)& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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M.FT] F O4P@ <!Z_EQO(W%>XO'/<''OYP !RCZ&#TY]W ?2 ]0P#I*FB4PG
M Y,(F'J80^L YX_<REI2>**MV!V<$ZCT_H^K%(O<4XH\XMVP=P@0OVAY$0$1
MZ]>HAW\>T<G8J(D[2_##D"B7WB'4>O =1ZB//&1MQHABL:E1(3U$H<ASU >.
M1'CD! /?BD:UIB*R2IO.7Q$PZ=P / #Q^X'3*J)$8L[, 8 P#5'?X<[.\<>!
MZ_K^[_M>&<"[7OZW\H?SROQ5TL\W]TL?MOQ,VM#Z/3.^+8B\WLKD@8 P!@#
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M +_W?/\ O?S_  9P+M>_K?RA_/*_%72SS7W2S^V_$S:TOH&=\6PO7M.620,
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M;2ZS96E7X]IZWL[?S$>KN-\"W;N_389< @( (<"' <<>F7A:E< 8 P!@# &
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M\3=+'.?=+'[;\1M:&=[6PO=[*X)& , 8 P!@# & , 8 P!@# & , 8 P!@#
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MN 9E4J#5J.252K,6C&IS4W,6*2*D'(N):=?*R,BOW\=Q$U':YS%3#@B8#P4
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M2C*X P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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M!244)4[ZQI!<*/&V*583K<L>W:I@S?.SE2635."@=. X#%/&,? ;DX P!@#
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M*T;*=[6M53@[3:EJM5*DS-9H6"G&D*QIUAM5HBGD&$C&.'L;*'F;:NHLJFN
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MI U^'AUAA(0' 0L09:-:-E#1D05TH5LWY^"W!0P)E* C@@SO & , 8 P!@#
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MH!3" ";C.(=K>BZCE9Y3M Y>CQ:SI4_7M[5>R\T[=V+4:2;A&;G&CHG%-IK
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M#@.?<&0#E@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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MY^LJ5,:U/(3=VTG*Q)U:7T/2^]MKXWN-J:A=*U=H9M/UF79R\6[( IN6BH'
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MW]E^[5K/UMS[ >_Y+[XO$_05_G1:%_QCP_\ SDE_86/GO[,/SK9^MG]B/?\
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MPYU9*555UPW[676Q8'H#/5;"D9(& , 8 P!@# & , 8 P!@# & , 8 P!@#
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M]W'\F?N9'PW%!_8/_DR_)^K/[O.3_=S3_IG[F0Z?1?$<?Y".0Y_9E^7]6?\
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MAI7P;Z4\A4OU.PR7[/;TXY[1^O,M.F%:DG,OH'U!^]E:I3 @KD@8 P!@# &
7, 8 P!@# & , 8 P!@# & , 8 P#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>tm2030088d18-lc_host4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d18-lc_host4clr.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!S .& P$1  (1 0,1 ?_$ 1(   ,  @,! 0$
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M4QA&FO=$Z=/"?SCD/%I(^9,-434T: 5,\?XQQ YGZ8G&>(PBS43U3KX+$K]
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M.^:0 ZD$3TDI&)\N>-N.5^8S;,KL,G2 TK$PQQ'-*D20@Z)2'T9\,*CB7FQ
MCI0<P1Y*<_0<;A0<5SBZ%V#0"!B3D>'+GCC.4D@MA\V(@(/0'+!01C5J[3%[
M<4+A[IXH"F2GG@;<FE"2$X@.4GQ'$^.:1Q*N)/VR%#AD IB#]KFJ\,:A*IE.
M7#*0*805/;^C&7B:]XI6M.17C\EQ.. K"I"0/+JSC\WEA3H#6'G,\]6S9N?V
MR5/$%.:XRR1B7-KH\D^0YXAQ)(09&&9(AAB"&"G28Y'-/9B=L8X&>:<,3C=F
MODZZ7G5UOFR93&:=O%!;)$QCG%U1+K-.66^OFSFN]UCF3KLY@ )!:T8_3GY+
MR\K+S7'+F6NY>9776]BXVOMH?ETV<K\[-RJN[+N5K\[MMO45[+DN%?9.2'(D
M+"'2/U@)C\T'Z^91)&04PXQSP16"FDE,*@D GAX(1Z\;B$9F709 >U.+1\OF
MP6W)8X#=;.&(VY1/V0$/)1[<#JVQ2A0-N:!7(#%(>W 34OT$-)!)ATCAQ.8^
MG"E-.(.E>!< T$9\3Q0IE@::H*:=22H (0<">) 7@B<,- 7-Q  F+1YY9\<S
M@F12@"0H*$&*CQRPIPR:D30X-)ZH*<POH&<(XUS)F>7O&228J GG]6,16#8V
M%"Y8M0>?JRQKN!N*\"'%#" /+D?U8%:VX6(<RCFX ' E&EV<$R^?&N1]P<Z[
M&!4$$$*#XY(?#QQFUI.N!JY2J #S\<O%2/:<5SER5JA0/W0 2%*\>'L3#:U!
MF[$2AR)QX<!@?PC2PJ4C@817Y1Y8H:JRE740BI,1'E@>)*B&X( .)B?1^O$)
M30>GW2%6/R3$0%$ZP[. 3CP/JPP53&L$\25\R?KQ,RE!05H4$$G)O-?IP&A.
M)*_RE"'DAB,2!]P$K'PCB$HID'(.2'/$1/3!05 SX'U8B&WWG*3Y?5B(IR A
MW!$*9JACB(QDE&NX@(3P)/H\,:;3,)<M64"2"$,2O5!(Y\5]F+E8\R?:(0)@
M3FTD9#GZL#M:4DKDW"" 7C!!]> T28)$15!QAABDA-8*XA5*) _,.> 2C"+@
MI/J'AB(85RD$@^@A(\(84I!N#&7.)4$P*1"-<#GZDPKU<3+]:J#,P"1] BGJ
MQEXFEA!E"1:8HF?D/I.(9,84E6\S#EX'%5!*8\P<BX<QP]7/"KKEQ+EM$"0(
M9<2 ,_3@J)7424;#T#/"F\$$)B<C0T<0OZ<+F#*CF[RFNZO=<I\N7KP-RJ&R
M"4<>E0@X_(X(@$Y& C7'@4RS@<,T@HK($@?8C#BL(C$FHA@[6W*)4AV:<5BI
MR)2'/"H6/833!Q1"I/44CG\^"'$\!E3 -<6DJ?=AQRYG"KE$&6G,HLH?>!"I
MSX1^O!<Y%*!!PXJB(G,\\\\!H4"!S6).7AB(I!D%4$J>0]F(AE'@11T>J  /
M(PQ0XG@9YE+1 41'#Z<44DU-8'U9$YA?3#/EGA3@./<2 I3G@$IP 1/T^>&*
M20NEPX>GEB2D@(\5YF,/T8" .S(@L409>WGB(3H(22.KB.?'CEC2Q,750!IZ
M08$>&"[$;?@EB#20!#CQ]2>. T07$PBXKD /G7QPQ*G@9YO6AF0N((@6@HJB
M/R3 W-36%"7G]IK.KD3]7EC5ABX"G2!]CBGIRPM\"5KQ!Y!*@\,8-B !'VD/
M(C$0%I'RS\L11)37 <,LRL>6(AA08Y.5![8^C$1C]@Q$42PC(JD/DN(B20#T
M^]S (_3BBDA*;@;03!47A&/HQ"*(SA].(E4II;Q \R?H,,*4X W&(CTH$\UP
M-02<U&Q%CZ//]>(1HH+E2&7'EB2D@S: AXE> B>/+GB(D=(58^7R&(AJ%/3
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M8'D%JO\ ,<MFS_>9W<;)[U:YT]I/0FW6@]KKELU(?IZJGW&KU/J;;^VZEO\
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M/+$#:6)): #&/+T\<,0B33)(3TA< E/.0:4$,O/+#(0@56D<5X_7@X#@/I"
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M#8K^K&FX5 A3ZV(BL"5ADJXR(PN<5_T(3UXB&Z!RS\^?/AB4\"$O42N7!!E
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M6O:<3=^5SV^,3[IJ?=^B(!+72-86T!K@8(/W<!]N/WV>,74B^'I]NN7?D?\
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MNY]+JLZQ]U[]QR=-K>G-BW*WDU>ET]_>[%/LIHU9U?\ EJ]M.IYSZNRT&K-
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M0IGB*22A8%]01H !)&7EC2?$RXXD%?Y+6Q@@0\?JQIM-&>5JZ>  $Y8P<@1
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M5T(RU+D'('(%4A>>7G@A<1?8"CI//* 0>M>.-757<85L4)<T.80X!S22TM<
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M?K?<[#(!U#WAEQY_3A33X TXQ$?L@ !'>)/S@9X'B*<J26Y\C$#]/JP234A
M?;=$0/BG%<2JRP0RYI!_P8#]'/+&XM,<S))+@(\(?)<9?9P-^Z,-@I*#Z5RP
M"/I/"(YC$B CIZ3Q52L<DPM0RKQ% J>)R$>.>).#-UK;58@IT B$0$1F(QXK
MB6 .9H0T*0,E]/ GPP0;")@(\0%AB"3( %4D*D1\O'"NQB(D(4@>'EX<E&+!
MAP)ZC\/J]*?(8Y(X&'=57'Z*@CXCR#^V[(>? ICB-HPN"A5CQ4)[,13P)#@
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M>"@#//YN& 2@6]1(0A$Z4BI@"%&%IJC!-/ 3B044Y\%X\\ B"M.2GUHOEB(
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M%XF&&_$+,"LGQ$" O$<4\L9-DHCRX!P&7A#CY894&&G(Q$OC$B"+P\#@%)B
M51^UP5?3B- B%'&&?RAB($<(D! 3 HI]*8:&?6P0P2JAI@HAD?&&%1Z17>-'
M.(),0>,#SY8'/H&.)#E),8\Q@(H%$0'Q!PXD40/M$(!P'T@<,3[B);Q*@!<C
MY)].%.A16N + 0*\_+YX8RP13\@N?/&OO1CB2T=1\LUAZL$4DIJ4$!Z4/%%'
MK]!Q2X@.]\#'U  @+U9IY'GC4.UF9YE'$&D .)XCS,5PM\#%E74$* \%QQ\:
MX'+YL2RY'( 2 (H(#S.&D4"LB5N;00>'ZEP&@#<RY1\ZXB(R4G/*"?9+?%.
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M6IM3.#B4<X$%7WB22 ! $E5R$(XZZ+;G-DJWB=I-]ML70[N"1DR:04)/ >C
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MKAA*H)MN!$=);P7/V98P;)(4@A6@9'F<N1CA3@&I*4.(!@.'->7IP-RY)*%
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M$<!SB%]./QN+G7"3]E%:H^$N/:, >Z2(N,8F,>*GD<:<QC0K8EW->LQD!3P
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M#E(&?3EP7EGS3 W+DK:* )<'*8'V8,!) <54!<X<BGUX75T)452FD E<D]>
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M]JLJYN[CMJ-I)^V&IZVP6;5NF7W?:74E'1T%LM^H+C>-,2I\X2V,GUTQU.&
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M'/@/7B:@$YH8R%*\ 01Z./GC2:5L/$&FW*P+: <_4/G/A@5'(OL&O2Z' (<
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M1\NT:4T3J#;:XR+C;-:W.VU]0^IO-_NGW?X%4 ^7+^%-<6^\&=*E-$#E*6?
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M2JC4$B>RF;,E7J=*<0^J:1/>TEI<F,_$YZ?P;O88_':=TY['_P!I>^9&:%T
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M7F]TID#DL./T<<*K3@5,2X_:(014<UAZ<5JK4'W8D,0NYK%.D#B.1POM,IO
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M,00BDBUOI)XG/V84X3!VR((KN1*1XHH.)=A/A $EHR4G[1'S^&-12"YH> *
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MY5P *9;5'\I?-8+X XKFY)(2$I QRAR_1C)HI"&F*1R3/%@1'((?DGSXB+(
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MYCS-'?"CDN3]2&W$7)Q5XQ"P?I"W?#0X,7W<>=O#O8:G'D*Z<W"Y3;\7[/\
M >N?;O8\&\Y?]A?A#.^6AR"C[N#P_P G- /_ $24P_9S<4U-MD/C,_<#[=[&
MUZMV?S?Q$O;YCZ.XFB;#OSM'JS0-TJ[E0::W.T?<+!75MO,F3=*:V7VB?3S9
MU(:B7/E2ZN7*FJWJ8YH<(@XZ3.R[LK-NRG\*UM'UVFU.7K-/9J,KX%]EMR[:
MJ36'3OY?VUFG)6LJ:AU1K::S6O;-:.UJXFIJK2XT^A[+1SZ.FO%(6VMH;J*9
M*J'=;W=5.3_BQCBGAP.?E,6C/R\MG-'/O<O\?UI>Z+4/:EIKM"NEON=9;FR)
MVW>F:6=24UU:^AM]+/E:FJI=0XOG-<)37 %LMJ8I+E.LM$_E@[6;=W^W:[OV
M]F_&J:[2>TNI-I;7<K]K6503=.;?W&E=)I:2QW&Q4%MN=BF:9HF'[O.IYS'.
MB9O6(89[ Y>#P/@VK\I'93\ W8H]3;E;I:ZO^[6W=LVMKM;72KTU17RSZ)H-
M0V?4LJEHV6FPT5!=KC45=@IFOKKC*JJDRFHUPZCBQ#ECVCL/<O\ +3VLW#U1
M?K]1[E[P[?VO<&QZ1T]O+HK0^K&VK2^[UNT79Z'3UH&K:%U+.,JIFV*W2J6?
M-HW2'3974OO/<[!/#@:5M#FEU[ =GZZV=PUBHKKJNQ63N)VLT%M#?;5:ZFW-
MI=):2VYL-3IO3<K2GQZ"=.E3Y-KJ QYJ75#7?#:@&"25L8&X&A=)4&WVB-':
M%M=355=MT9I73VDK;55KI;ZVHH--VBCLU'/JWR62I+JF;3T373"UK6EY* ##
M*C"I)-<3E34(.?40OFGIBAP2V,+@ 1P!,#E#GRQ"(J&@$( ?,Q7$0WM:>!=X
M=2H89CCB"$-JC]D"&?UXN'>#HZ(@% ?=]*Y8AFL&0_;'E]>(3&05*^<,3(?!
ML($Q\3B(DS.DQ:2 8 $""(B\,\;GF4+$XFG:UYSS+[ 9_P!PW1[SM*.!$VU;
MR2[@QI(!^'<J_5U,]P!YBUL6)3J'./LGBCE?&;/T]K\+<S0->?ELR?PCQ[PO
MO65N^^[=C=E:U/V;L[AZ#TW(< "6IXK^US\<>,M0>RIR <<W)T\TR/#$E).5
M7@  =D?'Q]1C@8)MNH@WG#DHS\,\0O#O)<0Q&A8E#'GC;4J68M]5P@50@B6Y
MA$X\^)0XS#=>!IW)."B/L])1QS7T8U;;V@[GP&IZX<LCZ OH."Y"G/$1)1#F
MN8@891Y1QDT!_EG,G+U\CX8")BXKRRB8>LGEC4O! XX@H$2(+&',\N)7%:W,
M!=$&3I"Y"!@G.!X8W!@%!<B+G'UXRH? Y*K!DA.HCJ@N7 ^&>!J<"\Y03I,$
M'/B4XX(@2"BM_9ZLAFOBOIPI29;@<  U%<03GEEQP"G(VE"$;E Y1(Q5= ?*
MGWB*?$*Y(>'D5,>6-13"H3+Q);%W4U4^T>'B!XXU<Y4&;93DOJ4=;4*Y^ ]>
M,_!-)NXDS"5#@##(07BH@<L#KYC3E*5B?'U!J*RZ8M%?J#4-RI+/9;52S*RX
MW.OGRZ>CI*>2Q\R9-G39A:&M8UIYD\ <<^ETNHUN?;I-)9??J;KU;;:E5MQA
M[)^?5:O3Z/(NU.IOMLT]MCN=S=$DF_N'#]M]T-";UZ.EZOT)<Y6HM,7"?76M
MM5-I*BG;-FTI^#54]10UTF14,!#P4>P!S' Y''[]VV;<.G]=^1;A;\5J[8<3
MA+I$3_=.OVK>=!OVA_+=#=SZ6Z4G$IOO7L'*M.Z8L.DK53V+35EMM@LM(Z?,
MI;5:J211T$A]54S:JK=)IJ=DN5*^//GOF/0!7N)S./PZG4ZC59CS]5?=F9[Q
MNN;;?!8G[=-I-/I,E9&DLMR\A55J2A-XL\XNU-K;5WK=Z5H#>A]5<=.702D
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M&37F+Z@U"@+B L4@1RCACBS+NK'$D'W2/3\V)8,3+4$F;,6'\X[AY8&2(!,
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MEV96DRU"MM6,<3D51/E29;ILZ9+DR);7.F39TQLJ6QK6ESW.>\AC6M:"I)0
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M=H_ELO\ "&-8Z1"..J--H,_\N6T1]-2,3VK=/S?4?)W>\7VBV!_[=H_ELO\
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M -(S?INB_6C&/RF>_4_^K^P)SW,V9^G7HQI^*_ATO]NRG_PVH^8-?NU>//\
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M].T7W-4,?E-]^:!K>WZ0>"?Q.V:7T#]_4QI>+7AQ']=R_HVH^8%_V:O'J/\
ME&8_^.T?ZT!_*9[]H ]OTH?^<S9D_P#C\<%WBSX;T_IN7]&U'S +^S5X]8?5
M&;'Z=HOUH7]TOWZ?_0_R2>1W-V: _P##S#^U?PWB7K;/HVH^8!_V:O'I8;1F
M+_C=%^M ?RF>_5#_ ,'VG X_[YNS)/MU\,9_:QX:XO76?1M1\P2_LU>/;_\
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MDNW"UK]'U/S)?NT>/4RMGS%/^_:']:+_ +IKOU!!/;[)5HZ0#N;LR()&+=?
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MF"7]FKQ[5%L^:O\ C='^M$#\I?OTR/;])\AN=LU_\?0<7[5_#AX:VSZ-J/F
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M:.V:<%HM;3*=*I*NL=,GCW3T$N$XJ*FC/95'0*-)(_TIXGD4Q+X1K[TIP1(
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M1<#Q&TKI*H?,D<#%%A#$(Q_)"91SB>*8H;(D'I)](PS!><DD#/(?J^G%,T+
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M!4B3$DE(GAD88+FG1#:FL0*.5H2*KXXR:)#B%3U\L1 TQ\ "?FP\),78AF>
MX<L!L:H"#F% ].>)$#BH:?/Z,1"'+,%%3/G#$13H."$>\(YJ!Q]@PV]O88NF
M4D24* (G,Y\U)\\5SER-JA04>EL&HHS)\(0\8X#00: >)0_,<3(;NH]*)!"0
MJ>?HQJW'T&;E248@Y6CY_)1@NQ*S"I1!!3YL!H"2!T\CB(:F!X! O$PBN'@@
MXL8<(Q"KU<?"&6%?!#[XRSFN=,F'A\1WU8RXF#2,/3QS'$ Q\<3[A8D!)3+@
MN?EB 2*0W(D'/]4,2!A!$:I(@0O$<,CC3B>XDW$\2NI0%!!.8R1((/-,3N>
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M774-=/N^L]*:?M3W_<*%TJ73LGNJ)TR:T,8X!Q$DN 7.ZBCC[1L<B-#0T@@
M!>7 H"1EE'$E+%MI%#W2CN(0IZ,O7@-##5)/[()CY8G1@B3'RR'D,L,LFI+
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MH"B//$0VQ4(3"'(>.(AM+0"<R#$^<(987:[<05R> .S3@Y">(CR48!*( ;E
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MHR.&6%  !0N(<"26@Y"!'I@3AFAF[X7G @A0!X@?X.4"JX'+=32:M5!=30!
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M8+7]YJ:L4-KH)0DTE(VIK)L^JF2Z>2T-:7O<>D +#$E+@&U:I.6!Q=!%2(*
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M6(H)7D?,%".>(BVM0@J2L1"$1EEC2:QXF7S/S&(!%"K$IY8&Y<C:H4%A6B$
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M"D1Z5(\,35)!-RYP&P=(/ >*KBFLLU%. U:7$QB$4_/B=2@A&DD*@X>>7..
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MCHW6^RU%]--+=<G6RA=-GNIJ 53G"4TO<>@ K&$Z49JV,4<R!)0"" *O/]>
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MC;102!!50^8B/#QP1"DL:$I]B)*%2I^;"DNU Y9;HAI!'B"0N?)?#"TBJA
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M]I-T^2V_]4*_@?N61#NKWH2'_6'8OP3_ .1$,2Z@VC_I.C_EZKY\/L1U&_\
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MK/9/:O5FI:QUSU!J+0>F;Q>+BZ12TIK+C7VNGJ*JH--12*:DD_%G/)Z9<MC
MJ  )CH]YRLO(W3/R<BQ69%N8TDFW"[)N;N]EL^QZ4U.IUW3NCUNLO>9J\S3V
M.^YJU<UT5<6I6R_\%)=B.X!]E7'+T+S]6.M6!]#2*C:"08H(X"(<U! @K!1D
M#X\!C2M,MK MJ(CNDIQ!S] 3%<N""UQ,B@?L@KFI(3RSP4BN)JO 60! (,>'
MJ\,L C #E4%>8]<> PKO 'NS 53!8'GGGB!R$6@%?M9P]N*&,PN\3B!EF(^!
M/GEPP\K,\T8H"28^A4X<O3C)L$!"<3DG#Q*'QPHS=@40" %"@ +Y8;E%2M?
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M5!B$(]*A/E' VWB,0,-5R9CGP]>6(@R#F\5S\L4D *  -CP/'GRQ$2T1XGZ
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MP37!O *F&0@M]'3N?U3)$A[QT])=*8XD0@7.#C!.8&"1BAF;*9+0!@8 WH:
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M,>^4Z=15E+,J*=_1-86ETI\' C@@.!+&.!]+[O*!<YK&L$Q2\L8P.F.)*EY
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M*FJR7_KK/\9'7;M_RS5+@]-F?XK.FNUM/[..QR1 VOT<%_\ >:F./V[_ /\
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M>%FS $ ^([//VC&8EC-#$1[H2*$_2OH7"U!3(OLJ#!<O'.!3,XDI8REB,*"
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M:IDHXQR!/%%^?!!26"I:$4@I#).> 1K$AIB5*F('@,7<RIB0C@UQ)5()F"/
M8U,8&*W3(NEWD70!] S\ N!NHVJC!P@&C-N<%$>45Q3[ 0L!^\1GP\EP0;2<
M#8(QY'%#( 5"-15CY<CC6"AXAWHKJ<'10B AP,<9$@AK515!S4_JXX6_<,I5
MD J(.D\$.?H6&)1-1NF*8E!R<#TC,PCY1RQ,+5" @$^\H)Y&'I\<!H1/\E0
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M&*_IQJ[$+1AP#5=$+D?1".&W KA!I.00>.,,VL!J60ASX_HY8B%%QX?-B(M
M(.1"21'+S,.>(B2&KTB!SSAY>>-NVDF.>L"1('YX?(8RZ* 4N^1EH 7BL8X#
M9.(1^ZH1<QG^C$0PUJ@!1$KR,3E'$P0RR,(#A&/HQ$XX@42"#F..&AGUII@(
M=01PRCXH/(X#9* DN]T153#"YHNXS3C!76[S'@%3U$+C2C!@W25@#7%Y(<#Q
M0HB)DL>&!QP)3Q.H+>QT_?S4\YI'3;MI]'4LPDH&NNFK-95$H*A@YEO/C#&:
M<2<R=0]UO^VO:W__ -/:&"<O\V]9CZ,?1;%_F]9^BW'PO6;G4;3_ /V>7_\
MR-NU<SW1TE.:\(?1CYYP?>-5,@]X!<AZ$YX*%6:X'D)^;9H9U[TEL9K^TZ(W
MPNFJ-K]Q9]]L&Y>P=CH]6ZQVGG3OP9S[W5Z,K T:ELUP=1,#V-FR3*FT[/?
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M1CX<UP$421%1#-. YYXJ\ I-3$XDN!:#[.'IQN;8[S#5TSP&>I"L"8P*DG)
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MAA^@.:WN&-XMLFD]6K:!1P^[W#DH_P!AX(8\R[2CO)MD1_NLH0D0LBX!3_\
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M>X+PH+W%*@D<$Q<>XA_LF*Y(N;02>?/&WA4SQH(M:B=61!R7/CEQQE+CW%/
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ME<U@#M3Q+B00$3F?HA# Z^<4HHA.,0!PX<%&6#A ]X.">9*E,_,> Q \!-(
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M?V7>]Y9PX>S )*A53S'CB(: DN$(#YHY98B*ZFC[(7Y>.(B"5 R3A".%@G+
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MX&V\222P'^U$HG/P3RQ"!88D$1R.) Z T%4=R4\O//$*&.@KD ,N)/DL1@(
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M)#E '2 3"'LX8+L1MP$01G@$H /'20($%>,,:6 /VI&8@!H*#CZ^>,B#@5'
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MDHJXI-+OQ* !7]DCD?!>.)UJ$U@%$"H^S$J8'U8N$<3,>M/ R5!_GII7)[@
M4(13'V>C$S2P]!A/4@<.'( 'V#"E23+;GN$2I)XE%]"I\^,MR;&&N(5(1PM1
M4E4EH <"A]I/M.+F8<J++>D^ZJ!2L8*23'!B)*G] A[!B(J 3)5"KP''QQJU
M+B8N?8,&+G-:H0+%$Y8G<TQ5MO B),,R<9-#(<,\O9BD@0GAPY<A^C$10:X
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MY5](#[OTO_IO8OHQ4@JD_P!7Z?\ '?3G_P 3C2B. <>(#[LH_I,QRQF@EO\
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FY<$^28J=Q,R'[LC/Z3@G/AZ,:15@?\PO^,\/EEE@]:#/'C)__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>tm2030088d23-bc_study4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d23-bc_study4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!2@,N P$1  (1 0,1 ?_$ 00  0 !! ,! 0$
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M@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M0QN3\?4W]L]*_H)G,_8=5;_I\WZ6&&O'X7]\E?TDS!X@^\&8 S2ZRN"# & ,
M 8!P4_$-][ -*N *-&0T [3UT^M<C6_IPY,G,YN<3#PLT$^IR'V8I:FY64',
MSS$8=I9CNTH];R@%G#$B2JR2*ICI$ W8P!@# & , 8 P!@# & , 8 P!@# &
M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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MO0D;*2CZ-K==C)":=JMH^.1:LVYG!^[3*!A# ,DONOZKLRN*52Y1[B1A5)2
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@$,;D_'U/_;/2OZ"9S/V'56_N
M$WZ6&'O'X7]\E?VB9@\0?>#, 9E=97!!@# & , X*?B&^]_W?RX!J+PB2?I:
M1<EDM8M]1.?I@Y"&"G-F=E8I*-S[UV"=I:^XMC^2EQ4O;4Q)DYP5\E5,^$[8
MB;<R290TFWN , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M!#&Y/Q]3_P!L]*_H)G,_8=5;_I\WZ6&&O'X7]\E?TDS!X@^\&8 S2ZRN"# &
M , 8!Q. B0P '4>@^# --^";5FTT2[38;%1VDV'=/(]0;6@TM+),KA;?VQU7
M59%"XQ\9-=Y2W!S1!C@D+-0S(3-3J-A24,!N5@# & , H(@'C'I@0 " ^(>N
M 5P!@# & , 8 P#$[S=ZUKBIS=VN$FC#UNO-!?2L@OU$B"/>$2(!2%ZG5666
M5*FF0H"8YS 4 $1 ,YEOH*JZ5LNWT3%?5370:U-U=?J1$BJ[B:3BUM936^E?
M6U;D932TBY5W$_EH3TF4IJ)K)D52.51-0I3D.0>I3D, &*8HAX#%,4>H#\(9
MQ%146"ZSDHJ*D4U'/(48 P!@# .H^?-(UHZ?/5TFS5DW5=NEUC 1)!L@0RJR
MRIQ\!$TTR"(B/@  S4QKGO1C457.6"(FZJZD-+G-8U7N5$:B15?01[J#:M;W
M1KVN['JHN"PUB2>"@@[3%-XT<QTB\B9%D[)T "+LY!@JF;X!$O4/ (#F3O5H
MJK%<YMJK(?>)2I%4U*CFHYJIZ%:Y%3Y3'VBZTM[MLJZ42QIYJ*J?,Y6JGS*B
MH2;F*,D, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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MZ+X_F"HS"]@;1DXZ[AHL"K=VM5I I2)=XJ MC=2AU+VN,;Y=Y&_56'IU@O\
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M+JUHJ(J+K1414TFP:9.[(0@"(@0I2@(^,0* !U'^7P9CCGG/ & , 8 P!@#
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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MF&?(;9C6P3(3 P%;$K6Q3B+A^@T\F$&*+@K?O5^Z[XX&ZF , 8 P!@# & ,
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M=+LV\E,0R[J+?-9!LE+UZ6?0$_%JKM%5DDY&#G8QRR>("(*MG;=1%0I5"&*
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MKGTDY6.1="JFY,;I6,MVF"K!8II1-$=^GJY-5B24NEJP_P#;\AL9G<#DC &
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M-;&3>5<[15Z<?\H*.SJ&??XX*^ ;78 P!@# & , 8 P!@# & , 8 P!@# &
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M!@# '4!\0]< =0#QCTP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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MPO>4?!JW@Y^\SOO^$,<=D9&VV[>Z4_71XOSIL%K][G]4 4/WE/\ JMX.=?\
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M]/G/TBZ)W/6=\:YAM@5GMMBN^\CYR$<F*:1K-D8 F27K\F!.@>4LE5"G34
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MV:PY5L&5Y<R58:9E-+FJBO1JN5%5(P6#G+!=*ZH&_)D29$4DM1J*2V)0'Q@
M]?N@&=@-XIV"?\ O_@A_O8 [)1_[TOA\?@#PX [! _[PO_@A_O8!3NR?\ G_
M ((?[V <NR'7KT#K]WH'7 *X P!@# & , 8 P#\X'.?>&L=ORCUS6)'C'*:Z
MV[#W"IH[-E.(FT-I;MIE7UR=G4MB;I^?49*QC"*U]29E^48B=%FJSZH]XCY0
MDDH<+])I7^8_1)644VU<K[=)^652;PD4BE*%*D0LDFDP03(_*1#\@4KPI04
M"?@!VO!X,AJ+W@# & , 8!#&Y/Q]3_VSTK^@F<S]AU5O[A-^EAAKQ^%_?)7]
M),P>(/O!F ,TNLK@@P!@# & <#CT(8?Y, TE]WZS@6/'YVWK=K=7.,^G'DVN
M,V\A7< L$@ZY$;-<R\1YO>O'ZXI5^4568D7[SL.B-P6(0A3@0 0W=P!@# &
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M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M5UZM-QV_;QM"OUB?>3L'6G-8O&EXO63F/?OX6O2KJ)GXR7CP?D%%FZ06;@=
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M\\H'(^BE.:])C58BHY(05%2*0AH]'_M/3+,<<L8 P!@# & , 8 P!@# & ,
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MD<VE555BNLU(B(D$U&XN0# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M[W+%7.58JJ\&I$T)H,C$H#X_YOY,YIPSCW9>SV>G@Z]?#]W .(HD'IU ?!X
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MDYJ5..J6>U+B?RQRL7RE6::G_+K)'.V%,BOG$)[;[[?+Q$;=L%,/=C-'1XN
MBUV+<CYN&OTE#RWFJQP[*6\I9T!)N,@@V86=-NX%(DP5)%NFF!C$9P49Q]>E
MXL^U[,O,OWZ\RSL+9&;AG[*9<;NE=Y*.5Y"'N3.TOD#3TRNS,/G5)X=L)5#.
M1<E[X1(%JM'#ZRUNAS\/K>X24G;9^"UI"0MA>(-6TG1KM2MM7_9[/;C>=FYB
M5?O$8I]LA^5>,6+(.W[=(B*BZW?+B=N%-\JK6H:F5BN5"N,B1U?JL%$5R#8)
MB8Q&4/!Q[>,C&A3G$3G*V9-2$ 3"(B!?#@%_P!@# & , 8 P!@$,;D_'U/\
MVSTK^@F<S]AU5O[A-^EAA[Q^%_?)7]HF8/$'WLP!F%*X P!@# & <3B(%,(>
M >GCZ=>G\O3^3 -)?=^/:T_X^.UJE69:I0P;SY.I##S=D3M;\99OR*V<A/2H
M2Z5=JQ093DT1=XV:^2"+)NN1N*SD4Q74;H-W, 8 P!@# & , 8 P!@# & ,
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M4"T5B]/36U564<9T!'KF<:D;L6ZZ*R"*13+.2$4.NS<II"1(/V#[P=O7[=R
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MXD(^7(.DU$WH [*L&-T&U^ , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M/HON?M$;D^2-!^@[-GMB@[KH.-6=;-WLRL[PK.+2]6,90HU^4N$M!FY#[?\
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M[PK.+2]6,?AZ'?7TK:V:_(?< (PLRT8,Q)"Z$*<R"];@98XJF'2 @<X.I)0
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M3G75O;,DK+90HC*\OX%2KO[^PUOYU^8K*]/:\L=HI*IL"O#)F$>WVQ$X@;2
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MDZ!!VW35)VR&[*A"F#H( ( 7P/!X \08 P!@# & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & :[[QY"P&B;!JMK:F4JK7=@R]IB'TC U:YW28BUX.M+SK(S6
MN46OV2:=I/%D!354%N"2)?PC&#J&"&0:NW]K?<3^6C:,O<UG4*U0>OPM&K-I
M:]1*W<K&02%JZV#3:NUD514(/:3;G54('03% ! <%B31@# & , 8 P!@# &
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M <N]3[OON\)W78[SO.T'=]CIVNWV^O9[/9\/7Q=, YX P!@# & , 8 P!@#
M& , 8 P#5O?#Y5OM3C$S1E8NIJ26PK(E\\I)J@[6329U![).J%"A(+IQ+67V
M.S:*-!7537739(. :E*Y,FJF!V:;>+,WY*;$U0\NK"]U[YAQ>RF;,D=%-9_5
M3N0L*\"C3IE]"B@A(P]D;H*O8D7K=.13!D[!19RF*0I!IC V;P!@# & , 8
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M1%/1;!1@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
M P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
H8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>tm2030088d18-bc_inb400new4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d18-bc_inb400new4c.jpg
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M<H*2(S.3X5)BTG,4D/&RPH,%HB1T4V,5$P$  @(! @0& @,! 0$!   !$2$
M,4%181!Q@9$@,/"AL<% T5!@X?& D'#_V@ , P$  A$#$0   ?W\
M                                !ARLB*&,,X3 M4^@
M                                        #44@AZ0 <$G-M3(@
M                                    $#\JN\1,O4R.4H],@
M 0TUY(.=@  +*-H@                    0D\A8(  !B#"3$QB>0
M       0CS$<P>>#X.M,.E\>I]_I)?<R$^SM.XDDO>    5B3*?%>%$QZPR?
MH '6;O&2                  (Z?)7Y)9\YHP")!'N2  $).J?,D,M$\I
M           %<8HAGB/&9,S*/)$_:/:8V9HKHJOK\>I'06?R>;+.Y'L   !6
M*(O,6TC@U1CW'3Y/L VC+)                 !U%<SYA!<2"/M/25O'J;I
MF9R"OS+3X]I]F7CU]I             %4PUXNJC S/LB(%16UQ^8NCQ'$O5"
MH+/4I_NN>D]#933DKO"^O6ZV4   !2:,3,7&C[-58]S"8A<3'0<&VQ-P
M             5^2"? [#@'25*B1)]$3FD]9E9\^P')EH]=J0
M  -/K>KJ7WXSWCW6=)9\&;-GL<3:(IWI*N YO$<ZNEL_YWU.,T]O>+(   $*
M1ZI\_!DC@I=,[E2WF8,D=AO(=@                ! 2JIB3HM!Y!(Z2#D^
M/"=9[CL.#DY,J]=T2             !@=3WY=OQWZOO0Z]JX_46'?#O-I\<5
MIV%'7=]6]M5N^^)RO&=%O'D   "G$9"?,W!P<D)30\3'4BY#8@
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M^C.^/O<55;^]F60   (28Z8C,/N?-FG6=IY2#1ZM](  %/=#17#SUZ
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MV!6YW%$GGB<Z;TS         %-=%0W+SM\
M               ,05L50F2H[2')D,+YF)(          #7#K^0V/Y#KP
M                                     !@2MC&D#)"1-.5+P1.P
M
M
M
M   "N"QP
M  #PFO!8T^97'J2
M         '1"E>3L-0^MKMDT[,G(
M                     !"J/<@?Q[HY)UU;*/IU%)9
M                                  8(C*/(=B/)+UIQL3D#%8Z^P\-I
MGMK'I(5['J.(V&F-N@                    # Y]3 ;&EV1ZG.C;
M          #S$?)2        5LCJC-A]2_\ /&3 8=_F//$*-VZO8_:HILQS
MHK4H!-JH^8F)E_3$D     !B=39\&#/E-K6R.Q@            \GO#USY^9
MC'9<'K\Y._Q[^H]<GMQYP            !X?$Q#AK6M^+MI7]PX.VE@
M  !7B(]K7L(TNE]WK7Q&+>Z_$==3,"YN[7NC-[[1M6XX>7>]'PE;$D(F>1-J
MHL0     $'H[K*[.KB]?9F]W3           >+WA\N3#";2C@EKST6WJKQY,
M)'I\Y9+HVD[JN@G%7?<&=UMX           >0UI1K-K9-^.,M)IW%5[LGD
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M]^D22FM8'QW1Q;!F]WU;Y_OO]Y^?ZT]ER,FTMZPZFUZO6*:5UC5"+,3Z3Z
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MD5?=\K%MZKP&C>3F=?ISZER\YVH   %>4^[7/,V^=P9;L^B\L  !BS*
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M?5LYK;XKB]YJE>LX6YN5[>R:#IZ4Z;AJAZ#D(1O562QYYW76^Q'(?2);7W
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M4V>7@BZ  #$:>UCM?8E%I6QBJLN_+CD%AH@            1*RII;6W(
M        %!=3R]^\MU            C!C)\YY    \)[C@P15J=AX]=I0:?"
MCSF$+0(2G'E\HE0 !'Z_>\>'-++:KB=39]_OS);.N
M        H'JN8O[E>G           ^2O9B5O/P  $<G"?H^CL3]F&EF?,Y%-
M:GM(V<F:(@9TL S  !!Z6XS^]I9G<U,+I;>(U-J8W%4           *!+B,2
M0P^BXS6@DIP7F          "@NIYF_>6Z8          #H1V'R?,OA'RG@')
M]')]GU#[.4@                     #\Z#7I,NA3DQLV;!FH!["M3]L
M"I+ZBP.WJ$D D@D@ $D(F=U5I/JRS             'YW1.S$Q6I"DW BTS3
M<FD3AIC?(       T,.2<&6,><GT8<GAL:         #%F.,^?1]&$,Z=(.X
MQ1E0                        #\RTY@F2*WB9(;*3&I99A T_H\@
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M-.?1VF#)J3L \AX3@S0
M      -?$RE%9ID)%(3:4*19J8S#WF"(E*V"ZT
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M=64LJ*>O[C5YFE&,P[2J/33(D.18RXL8,*-[C:KI=QWO6Q?-1J-3NO57D_\
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MJE@T\&B.DJN [F%EA24]LY-0U-,=JVMN'1ZW2:X#)O[.G_S%_P#NLG?5H_\
M+*B.2QT?[=*HIVL7;C4-*85+KU+KP,K*!\24( 0YP[YXT>4S[+3Y]EI\^RT^
M?9:?#T%*<--KU-KP.[)CBEQSS[BH$)+.7)[L]AW#M::592?0"EQZ;7'RV?9Z
M: -[^*ZU&\]W<O\ XU.M.1:++;]ST\^CWI:\Q#JY<F#:D'LDM5\>.C)->)RN
M;"7E3N[*V1.;7O=%KWW,24[5@2*>IJB>>;N[63A47Z-C0\XYQRGA^LG=MM?W
M$/:(^\6#8^JVH+2 DR(O<V&'Z>9@]=4Y>"<=8+RRF+P-WIG[2K=RW%_^ZR=]
M:C_R_9>ZS77S1[#<ZP2#9P+).^JHB,MHT@_M55&Y<2BP:JK\AD#NN=P[)]*H
MYE/'D1HUD_B0$5;N8B(B=R]<B5M._C7Y;I_<=/B(C>\CD>Z$-5R2J./VUCN1
M\MGE/Y_)/W9B/]9LVW5NI#3K!IK7MYW)3L<,_>V1_-8P8)IQGPJR8U['#=JX
M. NV_I&7Q=7U>'J\O>;1-9H=?VBYG[!5>:E7V;"-AX,RUCPGNO8P$6[A9K=D
M"3:__?WIO[-K^6Q(1Y79.^K2KPM>V;%;.AZ?H(--E=PA!B::Z'EC*G%96ZSZ
MC$1$]I).R+'C0)DW)^K4MI&8-HQZ_5N2-W7OXS.VQ=RGU8?+0=VZ@$LH,C6+
MJG;]UE*Z!!F[!)UO69-,?N.>UB&,^0GE^J+BN12]H#HEFJ(J*/RE'+?&8US7
MIVROW/;6?NN]/@FL+J=/$$+'O&[^E>BH&*.O[+&PA54*LV"NG4-17DE+L-ZM
M'*BLKK>/'57![-BKN."$\Y;>D/!BVE$^ .O<C)SFRBV/>O'*V!ZC^[:0;T54
M3)9&D?6OY)]<1Q(/>541*[<+>Q3J90;=MPZ^JLC1(\*+%7OBZGSPL!U-H32K
MC=[R)H<WJE:4=J/J'MDMQ;RE!-N-YNJFWC]3M<DV%/:Q[NMQ8XXE_P!P\E@&
MUJ.,[MN?E2<$IN\8(SL@Q(;]EZ?CBD@]V>!CD\M(S88G"#@/B/@C4YDX8=$0
M^2F<S9 ?4BKXP0C[97[GMK/W7=5>&7%PAEQ\L3##(K'5%LR<SLV>@;LM5N%]
M5]-VQ.M6K/83>.F=\M?'B#!$FF5>R88((P(J5UN"%-"ZBCR8HX-9)GN@5<:O
M;WBB&9DG4J:2ZZIFP'"A$+$H:MMB>-KM7&1K6L;W67CBR/M\Z6[^$C;=B"(
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MOA,KOI]W;=$C[E9[OTJ)35-STEM-FS9.F479[$'1=?1['TR#>0/^)2BJZ3I
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MKS-7BGN1$5<'7S"Y&I6-P8AB3MX<4)1MQ8L8#_- -'SA]B_%>V/@ N*Z;)0
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M56OP8^/99$&H>Y,^AY?.G(J8@TR+]?OB^#?_ !W#?'OADDCXI7D<^TDO"$Q
MN4SI'?D&\@3.,"*JJJYQ!Z?Y9\54%:4F#@1F(UC&XK6KCX,9^2P-CDQ&N7$
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MQ4B_U<5>6-WY?R[87S[UH/F")>4J<[\LW(Z4$BA*UR/;A2B$Y3Q,\^$JND1
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M**2?M^>.AQW>^G18SFP:B)7E\"']3_HXWZ4CZOBS5\.0;Q;),E;7WLQ.5"?
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MT\TWL,*@:%1K"F]: LJ@J:^-S_8Z#QV*V3V1W:8T@Y#$QAYN2"+3X&I<H2J
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MJ:[FBJ0J5 7HEXROVY^<VEA3ALVOF%CF4C[P+8U&D?8K6^F#?N##G36C1DC
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M_M'&OV1C/_ 5?\%Q.U:M!75-M<=&&.(';]9)IL Y;G ^5>*K0*/$-'&I _\
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M*_PW'_#_ #/^L<5_AN/^'^9_UCBO\-Q_P_S/^L<5_AN/^'^9_P!8XK_#<?\
M#_,_ZQQ7^&X_X?YG_6.*_P -Q_P_S/\ K'%?X;BW<B\F7\?)#T2MN[9HVJT9
M:Q$FDL%><3R"7=L[O/5N!9RN!M8*?1/J[$D;+/JO>DBCU6U"NOS94';VM]TD
M7Z2,/QCB-=>4A5C_ ":Z.1\C<@?EX)]0UXE3Z5)$7_PE7G\FD)XP^T?QF$Z
M#<@9K%"N(HR?1OVD<97S3<%<9'RG9RL.&B^RJP;*P3+7J6Y9(I%,M1,:L;R+
MMT>1MZ-H%XQ<N454R-UY;EF-%"IU[%CQDSJJ\HQ-HTVWYN[3MX7]9OS\8S^2
MO_PJ/$L:^]*G20>MW(51^,\6W] @NN?D$$S<5?UY/R5YN,7_ )73_A:?#+A<
MJN4-R&*&5_"TXYH=MB,21Z.UF,D[3ZN,AC<PN2-BUG;61C\)5CFC\/-2QT"[
MF:Q$1)OJMRT[.*=^ONZ%ZK7MP[QM?I68EFCWKJ=K;'Y_!U9RLL4:@5X"NJ))
MVO8?74--Z%Y=P:_2/!1E#(P*LK#564C0J0>1!'P3T9:U87J)$ILI&N^S6MR3
MO7M]78LG5E,;K)_=%;M!!^(0.;R_5HH[6+=WE\NO"KZE _$/@L06$$D;JH*G
ME\]=&5AHR.I[".8/&;9M\NEBK6ALR;-QKI66P(#H==\3VCN;0;]1\0U7P_F2
MZ0B/UL9@KU^KW_FBQ AC+KZ1Z./_ $YYT_W6R?\ @^/_ $YYT_W6R?\ @^&D
MO8_S)B:Z#5K>3\N9:M43GI]9.*TB1#VMHOMXBM59H[%>=%DAFA<212QN-5='
M7564C[XAKO"FR6)'CDGD:%+4KO*C5:TG3=.O L8=@>>CC0>D=.W6LU.7\<H%
MNL2?F P?M0;Y80OMXZ-:]7DGV[O#;PEH+],UI-DX7V[=/ABD8ZO=DLY*1OTL
MC8ENZ<_[6LX7Y!\80!C$CCOR@D.P[VL4+::+(0O,ZZ@=G/F+JM[L?C$@WDL1
M+';E2GWFU8RK,$VGMW>WX]YNT^)5/D5*U?1?WS$_A^Z^'Z\/7_M/53J]F[^+
MUW^[\ WLJ[F"#<0-6;DJC7M9CV?&Y\^P_A','\!^X^(R%RM2@UV]:U/'!'N/
M8H:5E!8^KMX)_P!HL2 .W6Y$OXM6&O#/)Y@I%5YGH]:P?P+!%(QX3&&G=K8J
M:?P\&>F91"69MD4\M+9UX*LK?.)W*#JRCGI)<R-RM1J1<Y+-N>.O"GI[TDK*
M@[.&M8'*T<K!">C(].=)3 WT)D!ZD+,%U&X#4<^SB4^J-S_4GBBY]V6$5_WX
M>ON^2-K:D^SC&PR:@''4>8Y,K"O'HP/_ #U'+LX,IJ8Z>5BI\0U>/?O7;H\F
MX;AV<MN[3\'-I'.^9AMY>ZB\M0#H&.I'_/F2OZS?GXQG\E?_ (='A7&FD'U[
M$^C81TM/63,5_!KQ-N[7VP(/I-*W?7_PR2'\'$C?VN+\1E;N_A(C;C%?Y71_
MO@^$SW,3C;<Y !FLT:L\I"\E!DEB9]%'9QD8/-/ERFE^3S!;GKC(5*-J;P+4
M<:D1232?;%UHY-!KVZ\+'&JQQQJ$1$ 5$11HJHHY*JCL'Q<M*3WDJ8JJ$]/3
M3QU@2?NY+3#]Q\&Z1@O]/Y!VG@[%T ^?(>7[T>O@7+.[:IUA1M06;T2,OS8P
M#W1Z^?J^&7Y ?Q,#QE%]601OQXZ@/_=^.58!E8:$'F"#V@CT@\>;\/!W<=6N
MX_(4:X/<J?:]+K6Z\":!8:_BH6947NKN^7[X:.5$DC;DR2*'1AZF5M0>%<4E
MJ2+[LE!WH\]==9(ZS1P6-/[JKCA?"Y$':=>CDZ4-RMR]W9'4.,*/^D2_R<>)
MH21MV*:M&[M1EY^Y0R,,6,0^MMP?V\:7L+:N*=J[$I31V8R6 9GL5!;HSA?4
MJH-/G'@^&ZT-S'T7A>.6!I%6S2JE"'DKF6 !9XR&5F#*1HP'$&-EMK,]M=8$
M.G6.R&&202".-(='ZGU;<MQ!'"LO,,-1P9)9(XD':\CJB#Y68@#A88+<4SOJ
M5Z1+JVGJD4&,_CXD1%^M^SKUU&/NCPGAUT8=I&ZP"?8.&Z%OJRZD6!9,EN-9
M.1Y&)J\<17MV;?DV\5L;&9):U.QXV_, @BDDBM"Y%V,=BODHM$7M9$D]&TMP
M%30.PW;C\U?7PEBM#D[,$@#K8BJSR0NC<PZ;AK,C#F"BL".SB2(Z/)#H)HBK
MU[,.ON]6O*JR)N]&JC7CN-WOH'DW_M^"_$#S9H9]/6>DD+Z#]'I+^/[KD,A1
MP<\ZSYOR=?HY*2OACCDBQ$5 WC9O3.,Y35#">[5TZFFC!@=./*:U<EF;%>6A
MB+.2EL2UK2U,U++#]MPY91=H'[-CK#2-=E@#O;1U#O-A98\G74Y;#7Z+9>:M
M?JXZ_3SLSFU&$M.)*M:FZL1'% CJNG2Y;CC5RD-ZODDA*7TR-E;=EK:2.L\W
MB$=T>"Q(-\6F@6-@-%TVC[F9;$T4$8[9)I%B0?*[D*.)Z^+F7+9+IL(36*R4
M(9CJJF>R&VR!#STCW:Z::CB2]DK4UR>1B27;E&"?<BB 5(HE]"IH!ZN/6#PR
ML3M4.=/I *3H?P?CX"(IT_I#L'%7!Y7,7;F+QY7P5"PX:*)44B/4[>I/T@Y5
M-[-L7DN@XMYZHB-BK%*7'WH9971;,^Z&:!HHUU!DKE?>/8&8>D\/!;A:C))&
MZJ^\2P%BI !?:C1[CV<M/;QW?>A[XTY'9M*R:'V(=?:1QBBW,_9M'4]G/PT>
MO+T<_A7]9_S\8I$4N[QWPB+[SG=1Y#CI]UG)#RNO86^:B^M(@>7K.I]/ A[N
MVON,C:Z_7L!O!/8/#H-OZQ8<#=[\IZK^S=IM4Z^E4 U]O&)_RRA_?Q]RBR&.
MDABN*GAYUFW"&Y5U9TCD=%<QR02L61MK^\PTYZ@C;BXOT_%6)-/;L^SUW?C'
M'C+642Q(+%5&ACI=* QV+45=EUDL6)]Z]74-NTY=G Y:^EF/S5'T=?=U]G&@
M[!P&/SN\/U3[O]3\$J^N-M/ETXR<!]V:K0M1^UT>U7L?O5$7X_N'G/\ D_+7
M^8VOOPK+;K1L.U9)XD8?*&8'B]!'3K6^K>LV#/*FQI*5YDLE)4T22Q6\9-.J
M[^YHG+ALG6N)6SF)MQ1IN3>L]6M7JK2$W>5UW*CG7LWNPX26.S-!7)"RE)8B
MD?>TL(D,HD]TJ0#IKKZN MJ[D9M'ZFGB=$#<QW8]A5>1T]8]? FKU0LJ]DCR
MSS,/1VS22<+)&(NO$D\:B8-TIH;"A9ZDVWO"*?8IU&NUE!T.FAAHPV'Q]% _
M4FD,,ES1M2(DDA=VL]X_QI,#^D[CKP*]5-!W3)(VG5GD5%CZDS*%!;8@ T 5
M0-  .7P9(@^[5LJNGHVPN.7[KA(HU"1QHL<:+R5$0;54#T!0. \T>VS&C)!=
MA/2MP!O1',O,INY[&W1L>T'A1=97KEU2OE(M(UW%>278M?V69F&@8:Q.=/=)
M"<:-M?VGD?R<"UIJVIW >F)]-Z#\6H]HX#J=58:@^L'[X:25TCC0:L\C!$4>
MMF;0 <%9\Y4FD']BHL;SZ_1)JB2-#^LPXEK>7:W@83W5OV!'+=8>EHX._7KZ
M]G/J'T\CQXC(6;E^?YKVIS*1[%ZCG8OL''U@])(VL->9UTV:@D GEIQW9$;]
M8[6_I?P>"LF[4G=VJPY_JZ?FXT .W0@Z\M=?5IV;>-(7?MY[E#-_4[>SB+K!
M,ED9>;P.XE:(ZZ!$K1-RU'TM3PE?&X"W#"O\4K5Q1K@'GJK3=./0GB26]9JT
M(TC=]D7[5.=JZ[3H4B77UACQIV\M#QBP.P8ZF!\@KQ_"OZS?GXQ^FFI@OC73
MF 7I:@'M&O'H-AAK%&="(Q_;IU/8O/N#YY]FO'4<:P(Q+$Z'KRZ[F!^EWCJY
M])Y>OX,1_EF/_P X'W2^8EZDL,/BXXQVR/3=+:QCVR&'3CKJ=1-H5/K334$?
M+KPL0)#6&Z0V^\%[96U^;MB!Y^O3C3T#D/AI2;=8Y))L;8/]K6T4,$GM_;*Z
M1_\ 6?</.?\ )^6O\QM??:PQ7IJ(W'J-#N)E0J08SI)&-#KZ=>%?IM<F0L5E
MN%9-A;77IP*J5D]X\]F[GV\4LQ)X<1U)%JW&F"_XI=DCB5T<CNRUK6QA^@7
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MLXY]FO9VKO'8=#L777T\_P /&0BHV.DKVXGF&Y CGH:!NLE=IB5'H0HIX_\
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MQ68(GEFKR5[:*EB"Q7?9-$X1Y$.A["#S'J[/OCZQ?K%5ECF3NS1[M-=K_1U
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M*7<-8E:*2ODL?++'8K2PR!P=(IH#+&ZZJR%@"#Z]#P,UYM\S)E[D&(R&&I^
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M= NI(XQT-6&G2GL^<H,!)#=CS+]?&66*U[52>+')!'D9RI^JE($>G?TU''V
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M9NETY99)HXS*D*1&)>^D>LY+M,--J-Z==!Q$@>TW5(Y^ N@('3<C/O@4Z.2
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M*(A<*I_9K\2!=]K'LW>:,%N\A[\?IY:$\?:;4IL@6NTJ,52O)%%)+/?L+7A
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M!?$W \R#6:E,.C=A'+O- 3JT?/WUW)KZ?@+NZJ@[6) '+MY\-#!7,JR(RMU
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M"6)]8IQ)%TQO169?=YAOBEY72-!VN[!5'RLV@X84XFL,#MZC:PU]?2=[*7D
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MYYOCV$3DB"'JRGW8DZ,?,]FI]0X^SL=W:X_CYOG66[&Y_0/Y?DX5T8JZG<K
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M73QM6:J7FJC*&S&HF1"6@ZR[O5N'W!X91N212K#_ )]A'$NZ[>C#=(QK%-I
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M !#G_P!U\#_6<?\ $.?_ '7P/]9Q_P 0Y_\ =? _UG'_ !#G_P!U\#_6<?\
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M7\BWN3%[^AVIE"W]%"R*6-G:&BHL3,)\H/3@L^F(4P[DCPTY\'I QP Z-PU
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M//*9%R59C Y*K;7!RY/A?CNM.@3N ")I[%6!$  0 4 : Z>!LS7P<?B%<O!
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M60.2"@5GH?,AP&-8\N.B9+B)!\!-"%!(E@98SA"LA5[V! &7>>+&X"NV\ 9
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M;"5: &1>(;^"6_K&, @NP8F<LES=$G0VP#W,]S#$\;4Z=@IC5)PM#:27G$Z
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MQ:4@1:L=MFS6JL'*96.3^!NVX),"%+8D,=P(_P "%$7=8KA63\Z)?)JA@?H
M,B_6:0 P]L84H ,"&6Q9BXQJ0Z"5((G>8-,TR(Q,WH(2>\Q=!0!4F6?0>#QS
MB-&*029=!:Z=,=3: U/3V @)W-.V*HL,;<N!3'*865B)&+B!%U #K,)22:]
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M3A%R%9)RXD >A!WM!\,+5[KT"0$KD. 2IQ0B*.QWEDL#"Y8R!,Y=4990AWL
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MZ",5P>1^*1LDD(*H FG;PK:@0\+4# EW@&L9A$OU-CX#*$W@IX5X<2T$*8I
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M+\KODZ)L P;7!WVO[PGM%?'WVD2VQN"!,L%Y)$\?Z'WC@2*H#\4I'9,S7+%
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MZ?WX"$R_0=7>)@S)DQ$\ O,J<PPCU1:Z[<NXE@2^!/.(U0PW\+$ $P@V*OJ
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MP><E7M^3^_X];W]A_;]LWG]U\O[RM+\^/D@GRYRG-#ZH5J.BBM>,VN<-_O.
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M?Z8-13)>:D4[9]1_7*+RA_F91/M412V)OQ+B,[CML[175QD[$+I[N+^#'11
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M _?\&?V_C#A%!+MB8.K OEFV/T]<$;->-R?U\?UX6 &NIN?M7_N7Z9]0$_\
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M<GPG_P#@'__:  P# 0 "$0,1   0
M         @L,@
M      M! A                                          QB
M   " ((-                     F   $H              K9SC-J0
M"EY !(                  $D(H  "D8             "CQ7X62@    PE
M%!!@                  %EIP@ MN              NS!9[&B    &L$B
M@                  V$M';3)&X              AR1K&5    #9E(X%@
M                PULB<[LH-              'Q<R7-T    7$L+(H
M             !,%)8<$$AX              @0OYJ]0  $ -IAEH
M          "$ %K%DF-O$)---))-/     %0!#SO8 + L@(-L< %V(
M     !@ L%(IMI,XB8   $$  #    3"GCD^^O %@  ]W@-X  'P
M   G].4HJEQB'M+    .Q     'HLBR2L&&/    $C<4W   $
M   3JPFO$*<.H         #0ZRV$WM"5AX     C-U@   P
MVU%IL  3T           PNG5Z$HM<HH     $&$C   $              1%
MMH_  47          #AO>GP BH<5@     'L$H   0$-             HMV
M   D@          $=@7JW(   8     #-MG[    )(            'S0
M             P7,D/0<        '%&HGD  P
M          '^Y^G/^         H%D N  &               $D&=EMM,
M         04@     -]H  $EL--U+  P              E(M-I)IHH
M               &@   @+[OL   "               H%IH))IL
M         &H1A@@IH         0              "!MW@,DMH
M       HWH )I>
M      %!(5           @
M   !)-@
M
M
M                @
M             (
M        "KD
M     !S0                                                   #
MS.QN&7(                     @@                $@        9D_!
MT%E_H     #$            "\X>H             !\H        9A&:Q -
M!!      S@           1AB)"B            !L         DM8X#&P
M     &#    @     %<3UG;>;      D    :,         "V>^\>"
M  %)"   "&:   $3(7?[%0@    $*N(              P\+T"9@ %05   #
M4U2   $-X   ]&Y2C^#F1    <I, '(  JE       '>S*NH(( K_H   8V>
M@  %V.   33?;ODB^7.   !'^X"^  \<        ?A6TWW  "R6   #R=^!Z
M8-]0E1 ?75 $%DS>P#\8QW%W! @,0  RVK  $.L FSG$  :ZP   &3":!%$7
M1"AC506 BP LB^H0P'LWC&N#$   <DG@   %H!(58  "9-   UH=&@  0O8
M 48"@%96 RRW   *:' ^X   %      $AMM*DR   PX0  GLU&6  !HM  $'
M]H"3WH"@+@  '51@ 3  F/@     CL/L%DE0  'GP  ELVQ7@X Y4(   5#
MMLU #C6   &;WX   YN   $$$ %& H+LG@  %K  'U$SO#Z !@A  'O^ %\K
M[ -E0   [HX  &9     .!,@ 5JVE%8   !(  ^ >.P$@ Z0(  CPKHC3B 2
M$H    -    @      A'X@ *2VM"@   R    "98   $VC   AJJ =<@6I,
M   %I   @?&Z    *T   #U=D6   '8    ,V(   !2   "KL,&0X+<)8
M  0   @DD@   $L@   %!L&P   P    #5N    Z;   &8;^  FW7(  $$E
M    $H$@         CEE.@  <     H3(   H!(   P08@ !GBV   +/M$L(
MD0LI498       FLEAP@ 9     %@8          C? ;/8;Q     $  @D-(
M@D $       GI$?9"&6      Z!H  I1%+H   !X$D<(=     %_(E?*UL]X
M        "(LZ"]N^        >  $H%AA    ! _/ 0P     %L-,$@$DI
M     '!H (+#0IMM (  :"X             8             @
M   @   D%8 %-,E   (R                           '           $
MCL@%<3"C%-II@  A&X            E@ $           P           _P,
MD @[                       L[5I(   %%(()I!V              Q(-
MJ(       )M)-H           $ $                          %%R)L
M      $%D(M          <= KCEH                    $-,(I%H!-)A)
M,    A-H          $))-@)-                    DLK )J@'F&E= H
M  !$(                                        $EI]I!I( D(
M                                           $$FEFS(
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M[0B@ZCK>#%(DK(U1RP<_%VO(^5%0G&3R):[!,CWB;>!WP$ :2.,-<,(A4^"
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M$_K=^U,DD#DH.ID+'H@1TI"6)\#JHRL91,)\G9(:U)F@F'@E")&       H
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MF)I1:8TX8;;F#H+>6BT8QBR1P3#NOI.,3/MR B,F%LE,K\!\(: 5FU6$JN9
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MLRANZ4V8S8" "(Q-.>A_S&6NLST7@U&;!T[?/MA)N6)LD+N;':'       @
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ML"PL,DC)T05/3L#8U[$808I,8+ -M.0*&*;(Y,(\HP@&6621%*Q^E6&!0,
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M:2KCT]>F+R5!+V#;A;1J00F"TSDA=,-+Q(0G#<@*)G@PU>F)YBVR0G0"6;[
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MNX9!8DW$EP^3Y0UG"SZS0RPB "$TB1VJP.6.@<'V2ZX80!DH?'H$3?8SD$6
M$#)'[.!>8Y?""8P.?" 3<->/P\L IL\;/P40"DYQDU5/Y\#632S:V#MBCX;Y
MH @"QG/69&C"HP3^1@XVRN.3V88P$/?(GL1 (>0C)T )ZKT#+*"R\)]4P</<
M&?LZ]O8=P.1-G EGBL@2'R%J:XP07,+H@^N2GD,43BD0H\LQR%ZBO?O@6Z(1
M.N-S;$?@SN/3-U;S+OTDQ321WW^L>+MMW3/I^3!@( $G+W,:4=)^-@TKA ;D
M;9(:4U.00C3(@^0>J+?E&>E+A!/$!=4\L8Y2KZ,AROH;2@JQ20TMC"KI]L;&
MQ+48R "R%K^&%!TAIY/4!(CSA7;J\K_G3TR-KH!KDA J04@68(,TTI76!R@0
M%82A46V":%1M#8P-!] (3<62JO0 $ @B"(R(V(E(F!Q&!3H 7>#KJ )<(+!]
M-'(5 !CJA+2>]U,MBJ72-[&%"^!#)#!3@7-_&;=\[3X;;/=F:(&U9,G3("$0
M9Q(\%-R*$E0"I5P.@RLZ8$034/6[P =V!R3<V*9A;*L )H# 5 *>FU6  +5<
MJ 7,2(EE2 #R!^68F<<O  T-(QD)38IVNW9"R;^,HRC,@+LF,7T4'0S[AP<[
M]\14#CD/$)-96J(&@Y='._?(.A[>;^7(.AG8.>#G?O@D?LV#)$EP-GR"H.P?
M,GM^'%%YN')'XA-KQ!T+W6^/W@!H"=P!/U/R$2EO!=ZB%D[81J \*SHM&"&T
M0V8X<8Q(L3RO#,WY.&24PE0 H$UB3J7SQ6-1WG 'EGZ_>5GK(E@%*;'@DC4$
M=P87#2%B?D ;J[2QE0XHB 4^5%3?0D$CPC4YQ7R  (=7Y,#=<=A.1X>.S L"
M,B"E!2)9&$(*E1<)R6P677R&@Q3CN)MV7R>$J/4]/*2R5G"?C+ JA>'DV\D:
MTH%IFQ^0 :<@&:(HMDQD2JPES$=#S(F21(T#"N3'E)"&9@\ S2'9_*0HABLG
MMD %$S]9+")+ Z Q3>*U)QP6R+2"?"SR*@<,>%.2B=L)3 8!"B%  XF:D&00
MJJI57$A3)?*3)7B&5@B@V+3E3J@4;@P-  101$I$QU-FBM1"HN0<E?C<OZZ+
M1'<D*<.:NUK,3R(M#/+&OC 9\+Y4H@7&?TE=#@>Q*WB:1]A3]6QFL!,3K/?4
MP_"Z4/P'9 \.4P 2K09$9MUC=A.Q0P?"!+<?I*^"@3-N2.QC4GKV5@9B+\-7
MTRDU_.%8-?+, .,U@ZV[L()1X>@%@BZ4#:0Q_ 5/8L]O@8N 9#0/9# DEN).
MJHRIE5-2W>\&.,-7?9:X^^5$E=RN3!W$VT"%'(C>,P/ZA: 0W#82A$PFW(?D
M"UMZ-UOA0'1,>"=AZ8+Z$8MIHG03<3N@+_+,!)B3:3=-6^9P(*B8HL$DH$&
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M;$%9FYQ4U_9A,1 0#(YTD77WVR_D:[W17;GZ64)^/GSKZ?\ V^!TZ5?3O[?
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MPI.%,F!3Y7&5XNX_QA1D$]7X#'X=^6=O QW_ #4;:R2I*M!;.K@D53T,.>M
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M]\ 5W?SAU1V_Y@**^='[RJ$^CE_YC,6O5O.9DG1Z3!]>N((">&?O&):Q\_\
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MXP4SHO$M00$H)2M8,+(6(#0X"6 !+!?A(Z3H\^7T.>J1D!6/1KRQH+!SA \
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MG*')X9?I+HL= ?$ >RE[,C\#!0S3\H9)HQ)/)>6&L ZJ?D /O->3\4K5Y4)
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M1"DFCW/PHG $KT,Z(E SP=4W '5 AXDVK=0TAC1FUDRXD@E*)2E ;P$*7!_
M-8_">&L?D1Z5)1LL9^V3U4D%%>>LN0T>7.N<ZP81*W'%[@]<8 R&"(AGSO\
M[\+\ <K!D-ZVH1T#,%+(%$F0A.'&ME)]>.B0-M8XN3/RB.WY*W'CJW6!_=A
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M2>4+3E%>OR._QS\@,GGX&_D&E!I,=]L86 G<>.#%@84BRWV#P=JZ_$.9EJ!
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M2H#:!J62D%EED\4)$')ET,0@%&D9T]3%%4(.G\SO_#"=?*!V##'3<'[ZZ:R
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MNAG0T%ZI?MBIL0]R,,&@WU.1BX[?(ASF,9F<.V$<9Y9#S@76L.N+U9J_\*X
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MZ:#NOV')AS,]Z_+E'4?J4GV#U[YMZ>,ISA-/B.L-Y''&1.:RUK!ES1!AH^-
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M1@!!H\7S0 106)Z6%GID(2*7N4,P4$BOJ#5E)4&B5"*14 6&$E"Q6R@8@7I
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MRLKHO[W^\-@'9/P^?L],#Q+A0NQ>&E5U;2H(DFL(:&(*71)7 <IL,B(@$+$
M)#& @X!H!B\RV7442ZEEN4F5,  A,M$"32B=E+IA%=@W13;*"E+YZ<8VR#A
M9/)D.&.N0A+06!T)M?;W,(]1.V)$/4F*[76 8P"C"T@#"A"1*3>:K!3T0/QD
M2@WD!+_=Z?1KY;@Y9"=1V9&Z(H.5@%!*_/\ Q\F:CY:0QD&L=]LF-X1EF$ZQ
M\?(;8^71O_7_ -,*"[_5Q_1&'C8>JF(@(1C&\(Q?3U^0/N!*-H#-[(K5[/\
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M,)-D/LV>3>/MT[U >DG_ (RC D7A9(F!HWJHG&@ R$8&4 TD0($49"3CM:1
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M@G$&C0V:F"@^<6)&FQ)L2)-BQ(D:)=/&>!DL<(TP$ %8)#_,0CZ_K]Y&17?
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M<G%7>3XSDN#&+P:_Q3]\B<(V^M8=XGT^OKSR)+WZ:]\B3(X'CZ_KRPQI[?\
M<B3O@RSQ/;WC+F_KZWG$<1A$=_\ S!BJ1]?UAWR%)T_O-?7UK]YI_P"?O.8^
MOK6,<=/UA1Q])G'7M7;)KMKZ\_UC/G[>6-OR7Z]9R:^N^+IZ81I^OM^L63W^
M_P#J882,AR'@R'C)1/& NL"><8$X"ZR' 7614_$,?[")%^ RXRWA#RQ9W@DS
8S@#C/)QF@=,&H-Y1[?7U]4L@?[__ /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>tm2030088d20-ph_inb3004c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2030088d20-ph_inb3004c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@"I )X P$1  (1 0,1 ?_$ /$  0 !! ,! 0
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M?96I.U<M_;BT25K(L7U6U.,O0SNU89A0"@% * 4 H!0"@% * 4 H!0"@% *
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M_>K2\4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MV$ZJ/)L4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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MO[S!&9LO82,GQYQ.7"AZ"W*^1NC=S*0I(_W/-@/K:8QK@5?^W,.+9)L75ND
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M-6J20H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M.-T/AN?M:U1\Y)Z&>*=:DN@1+E.FM:-VXDC;L6G.5.1/\/C"LH/@!)MUUMJ
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M-C>"T)I Q][?#UMK;LJ,O7NDG<;&J^&A,(6.T3\(OV>NX_.HN[?\63F/BT7
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ME(%^QQ*F7+#N!:3[ZA]SAK"?I7YSI^WKM5=L^#3]NC^I&3ZBCI10"@% * 4
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MBW<!]W?4-?F=3AV>#IHB?8Z)HFR>EM=.O7M/8*B+]RBH=)C6E4G$&'?PZ>L
M?;I>HJ]=H3V/8KIR)C!QPLD^$Z]G\:C+U^E2=Q\1-59)F,9H/AU(!T 'IZ@&
MM"60R6MXNFB.\<6?#J@^[N[:P_'5>)G^Z45:%MDXT6_1W]G\0*V(7WXFK<Q$
MTZHBT_'>$*/AUUZ===3IH.E2%F_6A$9&-2M"'3X@%P1T/L_'MJ3M7'R(')LK
MP(+DHHUN.S3\/NM4K9N:>L@<FUQ(!DXP\*Q;76WV]M3%BYJCFLRSQ,<Y*/\
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MX,9NO9N[<5%SFVMR862F9BLUB)S8=B9"!)1\+\:0V;I4.HH"4T H!0"@% *
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M)BK>,B2RKY*%-)0I5:Z^13CZ3Z1JL+Q0"@% * 4 H!0"@% * 4 H!0"@% *
M4!@#>I*]RY&Q.AC)U/=$8%O5<5T6$FL6'K^MG#;LT]PN>K_A1%AI8'6YT[?Q
MK:([CP*T*"@!Z55^ 0'36J!G'7Q?;NIS*_JEEW0TI_;6X64V\3V#RS2="?B<
MQ\A -AJ;$UN;>^G/L3?!7H/_ 'D1F\1<]IRH+[3Q[B]L)'Q0M(++BVC^II9:
M5I;5L^$Z'4?IK]4Z]23\=3\+;ZZ='R)3C_S]NH%:M_@C!#CYDT@:> ]]B/1V
M&HV>FAGAK1KF9!PROC2>P@]._3V]143E<"=VQ^\F9DPJKM-G30FWN]U<WD_:
M9Z+A-2MQ?F90Q*A=(O\ TI]_YU!Y*.KP7HO$R7BB/A]7V^\U!9">IUF&U1>C
M\YDG&&X3K;T].W2H+)5/2=5B/3R,D8I0L@'MM[Z@;]:LZO#EHC)6(4 /4+^V
M_P#"H?)3.JPI>)DG&+L$C3L/X"H2^JMG6XDM*F1L:L$(U_R^KW>JH6\F=)BO
M0R+B71\'L&I[Q;OJ$R8UU.IPIJE#)6)?&@)[;_AH=:@LF%3JL*XC(N.F!'A!
M(]![+BH&_;9U.+>2)"K(@H\/B%AW$FWH'3K6FK/O5H2CRETTJ13)20HG46&G
MX]-:D,>VT0V7>J8YRSZ5*7W?%^ Z>RI['BTD<IFW$VS&F5=T-NH)/XVJ>QHG
M*YLE0QWDUCXK'36_L!J:L(YC+EQ,<Y1?ZQ^?9;\ZFK"U1S69)4=>*,;9=5B?
M0"/;\1J;QEI4Y'-E5M&-<JH?%K;[*J8L*NARN:S"#N\L!DLKD<)&FI_?P7G(
MY;<'@1*<0 ET1'+E+_R5W0H#6X-@1K47LG?G;&Z[Y?[<QLF*W3'N.'3+W5<<
M5[WPG6D^F58M*CJFTFM3-OO8O<VU['8[AR<=_P"EW[:GU1K)VT_LNZJ5AU1I
M)-Z4:JT]".Y0BY]OXWKT^PJ'DN8ZHQIEB/B]5ON_G4YC\-3D\UZOR,6YTCY:
M];=2/1:X/W5.XOVD<GN7]&GI_+V&&\M^ISTJ!M]]=+C\$><YVLV_WB!3CU]/
MYVJ3M\?40[=51<*D,GG]79HK\*DK/V3#/[5?,S9Y08W[OS4\!,_+2[X>3MLR
M? LBP$&9^\+FI'Q-!CQ#O*17'_,NY\/Y>[Q*M%]PNK_:C3Z:T/5?DO9^+\U>
MWH)5?^K8\O\ 9N1E7U4K]!]=O>/=W"XOI[Z_-EG[+KS.(![3<>LU37U%U5RX
MG+I]O35:-%J=2E];=OW57RYBG/D=J&;3(A[I4?\ _*IK'<^Q+T,R6=+L'^\C
M9ZN5/2!0%+#N'N';U_"@'A3W#W"@'A'</<* K0"@*>%/^4>X4 L+6L+=UM/=
M0"PZ6%NZU /".X>X4!3PIZ^%-^^P]'\![J KX4]P]PH!X4]?"+]]A0%/ G_*
MGW#^% /"G_*GW"@*^%/6POWV% 5H!0"@% * 4 H!0"@% * 4 H!0"@% * 4!
M@#>8\.Y,E_THY]\5@_G7183KBQ]?ULX7=E3<;GI7_"B+UM$<4)%[=] D^(MK
MH;>BA6IRJY:Z%OF*M*E*"IP<:1(0N.X"6WDEERUM4.#P*U.@T555-P:DN*U]
MFI;.U&[!PE]F2H_7H?%;O/%.X'?&\L&^VIE[#;LW'BW6E:*;7C\Q,BE!T%E)
M+7=7ZG[3DQS-IQ<N#3C=QK4Z_P 4(O\ .?AEW#ARV_><S!FG&5G+NVZ/BNBY
M*-/H$!6HUZV-K]U9;U>D@HI=1-("OT=.M1UQ<3/!\*>+^LGV)<LM))[OO%_?
MK49DJL70F,"34T9BPC@^4FQ&A/;U]/H-<SDQ]X]&V^5;"\C*.*6!X-1>P]VE
M0F2F=7@-:&2L4Y<IZ=-/7IV5!WUQ.LPY+@9(Q;@^$'^0ZFH+(B]?,ZK$E55,
MCXMT?!KW?;WU WX\^1U.%/@9'Q#P\5K]1W^K[ZB,B+:.JPYT9DC&/6*?B!U'
MV-0E^"U.JP[G R'C9 LG47%OMI4/>AX<#I,6YK1^)/L9*"2FY[NWLN*B+]NM
M3I,2ZHLGN/G 6LKNUOUMVU"WK6M&=)C7Z4=2:P\H D74+^SW=147>QJLGK&8
MJ:O4N9RB;?\ :7]OX:D7%:ZQ77@;;S%3B66;E 0H!0)[.P>WLK;LX]#0R,Q-
M:/4A,^:"%?%KKK?T>NI6S:U6FA 95]:D R,GQ>+XKVZ^R]3-B%#FLJ[4@.3?
M&NOW]^I]E2]B.ISN5<,=Y-VX6;Z7/;W5,6(G,YEQ49CC*O J5K8 ^^U[U-V(
MNE#E,R>KH:P<S[[.V<8,9 <*<UEVW$L+1<&'"OX'IGC'1Q1)0W_Q7/\ 37GO
MS3[W?:NSK V^36]YD6HM<;=O[,KE?VOU8>=7^J=9\MNS%W1O#SLZ*>RXDDY)
M\+ESC&W3]G]:?E1?K&EB7%I<#J5K#H4'$N!2DN)<!\06E8/B"PK6][WKX_A>
MNV[ROVY2C?C+J4DVI*2=5)-:IUUK6M=3ZQG9M7+3L3C%V'%Q<6DXN+5'%IJC
M36C7"FAEK:^:S&3AOIR'^O'C)"&9SA/SG%Z796;6?\*3<K/Q#0$F]?;/R&[M
M[P[GP;]G?H_&VO&2C;RI55R=RJ_EOE<Z8UD[FDHOI4NIRJOB+Y^]I=G]LYV/
M>V&7P=UR9.5S%CK;A"C_ )BUK:ZI44;?V6NIQZ5&CZN6<%UZ^WT 5],8ZT/E
M7-GJZ^)BO/.:+%[_  ]O>=2:G,6/!^9RFYSI#I?@8@RB[E9.MBK7O/B_*NDL
M+1(\ZS)-SKY_G().5U!-C4E;6I&MO2O$AF0()5KI_.U2=E4BC WU2]IM?]/?
M"KSOG#X=;0W\Q.,R.XLVZ"+A#>*VAGY7S/1\MP)-SVUYG\Z<N.)\L]S;='<A
M;MKTSO6U3UH]Z_#=@7,[YR;)&"K&U=O77Z+>/=E7U.C/JO)[;=Y^\FOSR/UR
M10&]5H5X'YNNM,-./ON-LLLH4Z\\ZI*&FFFTE;CKBUD)0VVA)*E$V %ZLN7;
M=FW*]>DHVH1<I2DZ*,4JMMO1)+5MZ)%UNW.[.-JU%RNRDE&*56V]$DEJVWHD
MM6]#0/D;SI.P,S*QO'&#Q>3QT-Q3!W!G1+<:R#B%%*WL; ARH:DPR1_IN.N$
MN#7P $$_$W?OXMKF'NUS;NP</'R,&U)Q^\Y'Q&KK6CE:MPE;:M_LRG)N2UZ$
MJ5^Q^Q_PKV\S:K>X=\Y>1CYMV*E]VQ^A.VGJE=N3C-.?[481I%Z=;=3O[ \[
M^.<F0V>1-KKQR?W+!=S.V7')<5E(=02Z_AYKQF-M(3<GY3S[EA\*"3:LW:?X
MOL'(:Q>^-MEC]6COXC<X*NE96;C^(HKB^FY<EII%\#'W1^%#,Q_\UV9N*OJ.
MOP<I*$W3E&];70V^"ZK=N/C)4J>INQ.8N,.2V&WMD;VV_GW%M!U4"-D&6LNP
MC0$RL-*+&5B^%1 /S&4Z].HKWWMWOKM#NRVKG;VX8V3)JO1&:5V/\5J5+D?[
MT4>4[YV?W/VU-PWS!R,>*=.N4&[;_AN1K;EZI,R776'-B@% * 4 H!0"@% *
M 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * P-OE'@W'-5_WC41
MP>H1FV_Q;-=#M\O\M'R;^LXC>H_^H3\U'ZD1&MPBBA3K?[=;U0K70J: I;2U
M!76H&FGN]/\ A0/74#J?9^%!R*]H]!N/93B4K0^27SJ;37LGS7\XX@MJ;9E[
MWF[EB$CPA<3=K,?<J%H'_=E>36$]EA7Z/_*K<5NOR[VG(K[\<2-I^FRW:?K]
MS7TGXZ_/3:);-\V-^PY)]$MPG>C5<8Y"5]4\OYE%Y(U[@&Q&OHM]O77=WEH>
M.1JI5YDT@KT3KVIO_#2HNXM3/'1$YQ;MBGMZ?=:_X5'9$23Q)4GY&7< ^%!(
MOI;IWGO/NKG,N#39Z%M=WK@D95Q;H^ ]FGNL":@[ZJCK,.33,D8IX? +V/;I
MZA4'?BUP.LQ):F1L6]H+ZV_B.@J$R(49U.'<5/,R+C'Q= !T%OXVJ!OPU9U&
M)<2:,@8F8VXE#C:T+2;@+;6EQ)*5>%8"D%224JN#KH14-/HN1ZK;4H-\4TUI
MIR\&J/P>AU6/*=N71--27)JC\5Q\5JO+4R1CI0/AL>I'=V5$7[?$Z7#O527B
M3[&S!9.OK]';J141>M5])TN/>HD3:!-%QKZC?J=-*B[UJI.X]_F3"%D?#;XK
M=/?_ !J-O6$]";Q\NBUX$D9RF@^(?X^ZU:$L=DM;RU2IW#E-.H/H!%_QK%]W
MH9_O>G$M\C*:'XN[6]]:SV\?75&M=RTEQ(Q-R/BN+]X[.M^MZD+5A(ALC);9
M#YTP '7MZW]?HJ2M6VB$R+^A!\E+OXB#UOW^FI2S;IQ(+)O$ R4JR5Z];]M_
M\*F+$#FLR]JV8YR<C16NI-Q]]ZF+,#ELJY6M68@WAA,1N2(N'EHC<ANRBTY8
M)DQUG_TD=X#QM+'HT/0@BL6\=K[-W1@O;]YLQNV7]F7"<'XPEQB_H?--&GM7
M=&\=LYRW#9[TK=U?:7&$U^S./"2^E<4TS5',\9Y7'91J/$6F9C9$@H1-L$N1
M622?%-:/A'B0V#\2+I41V$@5\V[K\A>YL;?;&'MDHY&R9%_I^/P=B%:N5Z.F
MJC6CC6,Y)1]V4E$^A=L^>_;5_8[^9N:EC[UCV>KX+U5^?!*S+724J54J2@JO
MWE%LF2XT;&0VH44>%F.CP)_S*.I4M9L;K<5J?37VAVSL.W]M[38V7:X=&'8@
MHKQD^<I/G*3JY/Q9\2]U;_N'<FZW]ZW.?5F7YN3\(K@HQ\(Q5%%>'G4@66>!
M\6MB3H?:>E=ICQHEY'GF7-.7I,3[@?'QZ]A^Z_6IW#@ZHX[>+JZ68GR3A/B]
M0'K'8?1716$<%D2;E3E2A"9RM3V_;0>ZM^V:+7O$,FK)4KVZ>BI.VJ))F):R
M/2GZ2NW4Y;S+[CSSC7C:VGQ5N&6R[8V:R&8SFVL&P0KPV"EX^7+%K@D7M< U
MX+^([.>-V)8PT_>R=QMIKQC"%VX_]Z,/RH?7'X/=LCE_,^_G3C58>TWII^$[
MEVQ97+G"Y<7CQ\SZ/:^'C]-10&*N<$Y!?$/(Z<7\S][_ +2RW@#-_FEC]N3-
M"+:W_9)<KSGYP+.E\K.X%MO5][_TN_3IX]*C6=/_ "^KU'H7RFEA1^9>Q/<>
MG[I_J=FM>'5U>Y7_ ,SI/$BOR#7#3@?JYP>O$54H=F),EX^2U,@RI,*9'4%L
M2X;[D:2PL=%LOLJ0ZVH=X(-9+-Z_C78W\:<[=^+JI1;C)/Q3337J99=M6;]I
MV<B$;EF2HXR2<6O!III^LV_XQ\\7-G'X8A9?(L<@X-HI286Z"XO)MM  %$7/
M,6F@@#3YXD =W2WN':/XA?F!VRHX^;=CN>W1?V,BKN)>$;T??_VU/T>'D/<W
MR0[*[@ZK^);EM^<_UK%.AOQE:?N^GI<#T'XZ\_?"V\7(L#<IR_'N5?2VA2L^
MPW)P*I"@/$EK-XU;X89\7_I);,5 [2*^F^UOQ*=@[[*&-NWQ]KS)45;R4K/4
M^2NP;HOWKD;:\6?/W<7R#[TV>,LC;?@[ABQJ_P"4VKM/.W-*K\K<IOP-T<3F
M,5G8+&3PF2@9?&RFTNQLAC)D>?"D-JZ+9E17'6'4^D*->]X6=A;EC1S-ONVK
M^)-5C.W*,X27BI1;3]3/&,O#R\"_+%S;5RSDP=)0G%PDGYQDDU["Y5MFL* 4
M H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% 84Y#;\&<
M9<_[W','VH?DI-3NVNMAK]]_4CCM_5,U/QMKZV0.M\A2M 4UOTT[[T!2VMZ"
MNE"M5II4I74K5"I2@/G@^KCL%6#YOV3R$PR4Q-][(;QTUX)/A7F-H350U>-=
M@"ZK#3X:0+W\+8K[5_#=O/WOM7+V63_FX>6Y17[EY=6GEUQGZV?FU^,7MW[A
MWUA=PVX_R=PP%"3UUNX\G!U?"OPY6M%R1Y;0UV4-?;Z_QKZ(FJH^-Y+4F4%S
M]'J ]W\JC+J,L:57A2A-,:[J-;5H7HZ5-K'=)^2,HX*58HN;GM/HL!Z>ZH#+
MMT.XVG(JU5_E0RWBY'Z=?:/M>H&_%':XMSIDC(^+D6\.OH^WLJ$OP.JQ+O R
M)C)6B=>X'OO_ #J&OPT.FQ+NM>1T]_;[_P!L814:"M/]YRC+C$0@GQ0V%I*'
MIYLH%*V[V:[W->B2*\/^;?>]OM+9WA84E_KN9&4;:YVX<)7GX-<+?C/751:/
M=OE-V9<[LW99F7%K9,2497'RN36L;2\:\;GA!4T<DS!FP^3=R;#EJ7 >_>XV
M0OQS<3-6XN*\I2@I;[)"@N++(O\ ZB=%7^,*KY9[3[]WSM*^_NLOC8$W6=FX
MVX-OC*/.$W^TN/ZRD?4G<_96S=SV5]YC\+-@J0NP24DN49<I07[+X?JN)Z&<
M:<B8K?>&3E<6)# :>_:SHLE!#L.:&VW5L_,'^D^CP. A:"00=0#I7U/VWW+M
MW=^V?ZEMRG'IETSA)4<)T3:KPDJ---:4\'H?.N][%G]K;C_I^<X2ZH]4)1>D
MHU:3IQBZIII\^%5J9L@SK6-[_I[3Z+=M;]ZUK4NQ<E42)C!R&@U/JZVU'2HV
M[:KKS)RQ?IP)/&R( %E=W;:VGNK1G9J2EK)\R\M9(@ ^/I:VI]?>*UY6*F]#
M+HN)V#E#;]0OZ_QK']W\#+]\?CH=1[)7O\7\_?:LD;!@GE%DE9$&^O?6U;M,
MT;N21:;D-#\70:#W]:W[=JA%7\CGS(9.FWN?%TOJ>NGH]M2=FS0@LK)KS(+D
MYOC\6N@OUO[^M2UBW0YO*OU9 ,C+T.O?W^PU*6;=3G,R_1$ R4D'Q&]NM[^S
M\ZFL>WRYG-95TQ[DY-_'KJ;CV=*G+$#E\JYQ,<Y600%#3M_ U,XT/$YC-NZ:
M<3'&5D6\9)_2D]W?_"IJQ#@O,Y?)N:RD^"1B'.2O$IS7KXCZ==2?NKHL2W1(
MX/=;ZE)I&-,@X+F_^&A/Y5-VES.1N4<M>#(9.<T/V]HUK>M+5,UY/3TD/E+N
MI7M^WNJ2BM#';7O>D]W/H^\?&#L7EGE"2VI+NY=R8O9V+=4D6,#;,)63R/RU
M$!5G9V>:"NP_)':#7Q]^)?>/B[OMW;\'6-BQ.]-?O79=$?9&W*GI9^BGX,>W
MO@;)N_=5R/OY&3;QH/3[-F/Q+E'QUE=@GR]U>![(="!UO7S&G14/MAKJU*E5
MM+51LJEH6;.9S;^#@+E;DRF*Q.-=\3#CV7F1HD5WQI4%,$R5H2Z7$7^ 7*A?
M2HK>-XV39<*63O\ DXV+@2K%ROSA"#JG6/OM*557W=:KD2>T[3O.[YBQMBQ\
MC)SHTDHV82G-4:I+W$VJ.FNE'S//;=_EAVIO.9D<QPAOK;>0;4MR0[M9[*,2
M&X;JUE:F,?-B%YR/&%[-MOMGPC0.$6 ^&NZ/P[=M=V9=_=?D]O.WW[;DY/#E
M=C)0;;?3:N0ZI1A^S&Y'1:?$:X?:/;7S^[B[6Q;&U_-G:<^S-148Y:M2BYI*
MG5<MSZ5*?[4K<E5Z]"?'4S=_'.]]AR51MV;:RF'\*RA$IZ.IW'OV) 5&R,?Y
ML)]*K7'A<O;LKYF[I[#[P[+R'C]S;?DXM'13E&MJ7G"[&MN2\*2X'T=VUWOV
MEWA85_MS/Q\FJJX1E2['^.U*ER+7.L?60JN0KR.KH*J4%"I.]B\G<@<9Y#^Y
M;$W;FMM2%*N^U EJ_83!VIGXM\/8V>DVZ/-+L0"+$ CH>W>[>Y>TLK[WVYFY
M&)=;U4)>Y/RG;=837\47XK5(@M][:V#N;'^[;]B6<FVN#G'WH_P35)Q_NR7@
M]&S?3COZCN[,>J-#Y.VAC=PQ4A+;F9VP58?+$&UWI&.E/OXJ4[I<AHQ$6Z#O
M^C^UOQ4;UC.%CN[!LY5A:.[C_P J[Z90DW;D_P"'X:\CPCN+\.6TY"E>[8R[
MN/=>JMW_ .9;]"FDIQ7I^(_,]"^,_,KPWRNF.UM?>,!K+OH03MW-+&'SK;BD
M@EE,*84"6I!TO'6\@D&Q(KZ>[2^;'8G>BC;V?.MK.DOZ%W^5>3\%"5.KTP<E
MQHSY[[F^6O>/:CE/<\.X\./^-;_F6FO'JC7I_OJ+\C/%>CG""@% * 4 H"Q[
MBW-MW:.*DYW=.=P^V\+#25RLMG<G#Q.-C) *BI^;.>8CM"P[5"L5Z_9Q[;NW
MYQA;7%R:27K>ALXF'EY]]8V%:N7LB7",(N4GZ%%-LU2E?4(\EL+*JPLCS'<9
M#()?$926\TN1$#RE!"4_W&/%=QWA*C^KYOA U)M4!+N_MF,_AO-L==:<=/;2
MGTG<6_E3\Q;EC[S':,SX5*_8HZ?PMJ7T&VF$S>(W'BL?G<#D\?F<+EH;$_%Y
M;%3&,ACLA"DH2XQ*AS(JW(\F.\VH%*T**2.E=!:NV[UM7;,E*U)533333YIK
MBCA<G&OXE^>-E0G;R;<G&49)QE%KBFG1IKFFBZUD, H!0"@% * 4 H!0"@%
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MYA[Q0"X[Q[Q0"X[Q[Z $@&Q(![B1>@'B3_F'O% 5H!0"@% * 4 H!0"@% *
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M8J,O-[>6RDD!_P#NV,3)CQ6UA-_#(^2Z!U0*^8^Y_EAWYVC.:WK;<B.+"O\
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M.8[@QW6&3'A]E_6OSF+?54L<TOH*&]Q;IV]*%0;W]';5"NE/,=$_;OHPM7J
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M-Y8Z?%V>C7\-:UY8QN0S5P;.XC+=/CM[3^)K$\;G0S1SEXGZ_P!VT_6/:1_
M53[N_/Z2[[Y7@?BO+::J'O/WZU58U2UYJXU.F[E3K\7N(]W?6:..8)YNM$6I
M[*WO\0]A/VM6Q#'1I7<U\&RR2<H=?BOVD7]?IUK:A81H7,N3X$>F94)2?$OO
MT!]MB>RMNW8;>A'7LF,56;(;D,Y<$ A([-?Q]9J1LXK(',W.*34=$02?E"X2
M?%8&^ES:I:SCJ)RF7GNX^-*D3ES2;ZWZC^/6I"%M(A9W7)^9&I,KJ+Z=?MV=
MM;4(5,#:(S,E==>SUWU-;UNW0PRE71$=?>N5'LMW^W[ZVEHO,OMPJ_(]E/IE
M^3IW+9+&^9/DS#J&)Q;QD<48/(-E(R65864C?$J*XFZH>*<21C?$ %R1^X&C
M395\N_/GYFQQ[-SL78KO^9N*F7./ZL'_ (":_6FOZM.$/<?VI4^Y_P +?R5E
MF95KYF]SV:8%F5<"U/\ Q+B=/O,H\X6VOY->-S^8M(1K[NGQ7OV]O3\]:^0S
M] ]"N@T[Z%-7J5  H'KQ% <2#<$?;K0JJ4U*@=+];_RHBDGIIP,Z;%QA@X9,
MAQ-GLBX9)N+*#%@B.D]MBD%?_6J!W"[\2_TK[,53U\SL]DQW9P_B2^W<=?5R
M_3ZR:5HDP* 4 H!0"@*$@=: Q9R5SCP_P[ &2Y1Y)V=L6*I*EM?[CSD+'R9(
M2DJ(AP''?W\U=@?A::6H]U:&=NFW;;#XF?>MVH_O22;]"XOU(F]G[;W_ +@N
M_!V3#R,JY77X<)22],J=*];1KOM[ZCWDFW1GF=N8GS!;-_N4I]$:(K(HS&&Q
MTIYW1M#66RV,A8P>(Z J=2F^EZAK/>G:]^[\&WF6NMNBK6*?KDDOI.MR_E%\
MQ\+%>7?VK(^#%5?3T3DE_#"3E[$;FNM8W-XYQE]N'E<3E82V7FG4M3(&1Q\Y
M@H<:<;4'(\N'+C.D$$*0XA5M0:Z9J%R%'25N2]*:?T-,\\4KV/=4HN4+\)53
M55*,D^/)IIKTIF@N<^EEY&,]G)&>D<'P8+\J093^.PFY=W83!_-4LK<#.%QN
M=C8Z(RLD_P"DRAMM(T2E(L*Y"[V%VK=O.\\5)MUI&4XQ_P!E227H6GD>I8WS
MM^9>+BK$AN4I1BJ*4[=J<_7.4')OS;;?-LVEXF\O?"/!<!S'<1\8;/V&R^+2
MY."Q+#65G@6 _N6;?^?F<F4@"W[A]RUJG]OVC:]JA\/;K%NRN?2E5^F7VGZV
MSB-][J[C[FNJ]OV;D94EP4YMPC_#!4A'^[%&IGG?BN;4Y9\BW,T%"TR]J^9O
M$<8Y-U!2A/\ M;F[!9':>4_=+!2XMAB=%BJ0B_A*S<@U =T1=C/VK<X?:MYT
M;3_@OQ<'7UI'=?+::SMB[F[=N4^'?V6>3%?][ASC=C3S<7.K\#T6'0>H?A78
MGDI6@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0&#]\X?^WY0S&D
M>&-D;NCPBR42$V^<CN!5^OVFI[ O?$M=#^W'ZCC-ZQ/N^3\6*_EW-?7S_20<
MWOITK>(?3UE: &]M*J%0H.XZG[&J%7X\BNM_1V#W577U%-/6*H"E[]#K5:UT
M*TIJP 1U^W?15*-HB>^]B;1Y,VGFMC;ZP<+<6U]PPW(63Q<YOQ(6A5BW(C.@
M?-AY"&Z$NQY#12\P\A+B%)4D$2.T;ON6P[C:W;:+TK&?9EU1G'CYIK@XR6DH
MO246TTTR%[@[>V;NG9[^P[_8AD[5D0Z9PDO9*+XQG%TE"<:2A)*46FCY9_-S
MY2]W^5G?+D)T3<_QKGGW9&R-Z_M7/DOQUK=6G;^>=;:$6'NG&M(LZV"$26@'
MV@$J4AO]!/EK\Q]M^8&TJ['IL[[95+]BNJ>G\RVN,K4F]'QBZPEJJO\ )KYR
M?)[>?E5OTL>[UY';>1)O%RNETE&K_E773IC?MI>_%:25+D=&U'5=B04VUM;H
M:]'<:GB<X-<.!(8LSIKJ.V_JK4NVO#@Q&?CQ+_&F$@:CW]E:DH4,JDWQ)!&G
M$6^+NMK;V=:UI6TS+&Y):IT)%$R2DV^(#M'Q=3Z?56I<LIDA8S)0>NB)1#S:
MDV^.VM]56U]%:%S$\"=QMU<::DJB9X$#Q*"NG]0[1U';4=<Q6N1/X^ZQEI*C
M+_'S*%#_ +0 ]UQ^?=6K/':UH2=K,MS_ %DBZM98:6<2?^M_.L+L>1LQR:NL
M9([:,J=/BOZ?&+>BVM8W97@9UD32XZ>D_0Y51_J^\_PJWX*959$UPJ?DK*DZ
M>(:#J2D>X U56"CR9OBSINY86U=2/4H:^RLL;-=-3!+)IJVO:6A_--@7^8"+
MCM^ZL\<:3Y&G/.M0U;3(_,S]KV6 -3HJWM]5JW+>(_ B\C=DN#25.1%)>94N
M_P >A/6_W5OVL5+7F<_E;G*=4WH1B5DB;GQ7MZ>GNJ0MV4B$OY4I:(CTF<2?
MU V]/9W=];4+=#1<W+[18),NXOXK"W8?MVULP@8I2JM=$1V7,ZV4+>NMVU:Y
MLQSDWHBP/R"HG7UZ_;2ME1H5MPJST@\A?D=RW.VX,?RAR7C)6,X:V_/CS(42
M;'6TYR;D(;WC&)@H>""K:C+K7AR$Q(*7M8S)\9=6QX5\X/FSC=HX4]@V&Y&Y
MW/>@XR<758L6OMRI_C-.MN'%?U)Z*,9_5/X??D-F=_;C;[H[FM3M=D8]Q2BI
M1:>;.+3^%"J5;%52]=6CUM6WUN4K7TDQ(<3'Q8T&!%CP8,..S$APHC#4:)$B
MQVTM1XT:.PE#+$=AI 2A"$A*4@  "OAJY=N7KDKUZ4IW9-N4I-MMMU;;>K;>
MK;U;/T\LV+&-9ACXT(V\>W%1C&*48QC%448Q2222T22HEHD=FK%3F92E4!36
M_73M^VM5?D%3F5J@.))N */CH525-2\[?Q3F9RL:&+EDK^;*4/Z(S1!=-]+%
M>B0?\RA6#(O? M.;XTT])MX6+][R8V5]FM7Y)<?;P]+-CD(2VA*$)"$(2$(2
MD62E*19*4@:  "U<VW5U?$[Z*45TK1(Y50J* 4 H!0$)Y!Y(V)Q3M;);UY'W
M7A-F[6Q+1=G9K/SV($-LV);CM%Y0<ES9"AX66&DK>>79*$J40*ULO-Q,#'EE
M9MR%K'BM92:2_M?@EJ^1([5M&Y[WFPV[:+%S(SKCI&$(N3].G!+G)T26K:1\
MU?G$^LCR#OR3F=B>6$2>.]D>.3 ?Y*F,I&_]Q1[EI4G;S#H6QLN!);!+;A2[
MD_ 0H+BN I'B7<GS+R\IRQ-BK9Q=5\5K^9+SBOU$^3UE37W7H?87R_\ P][5
MM<+>Y]Z4R]RHI+'3_D6WQI<?&\T^*JK=:IJY'4\4MP[GW'N[*2,YNS<&<W3F
MYBE.2\SN/+3\WE9*U$E2I&0R;\J6^HG6ZEFO+KV1?R;CNY$YW+KXRDW)OUNK
M/HW$PL3 L+&P+5JQC1X0MQC"*]$8I)>I%B]?V]=8:FT?:)]*K=&Z=V>1CAF?
MNV7,GSH WCMW'2YZG7)#FW-M[VW!A=N-?.>*G'F(>'A,L-&Y ::2D6"0!].=
MA9&1D]K8T\AMRCUQ3?'IC.2CQ\$J+R2/SN^=^%A8'S+W&U@1C&U/X5R2CP^)
M<LPG<T7!N;<GYML]$*[$\F% :#?46?C1.%>/I[[K448SS.^6>?\ O7UH91!;
MC<O;:5+F*?<*4,-1X!>4XLD)0SXE*(2":Y/O'_VVRUQ6=C/T?S8U?L^@],^5
M=VW:W[,E?E&-G_1-Q3<FDM<6Y1-O35TIYT7$V>P'/?".ZLZUMC;7+7'6>W#(
M4I$;#8C>&"R&0EN("E+:AQXLYU<QY"4DE#7C4 "2*Z.&9B7)_#MW;<I^"DF_
MK/+HWK4WTQE%OTF6ZV3** 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@+!N7#_ -ZQ3\5'A$A%GXBE: /M@^%)/8EQ)*3Z[UL8M[X%Y3_5>C]!H;CB
M??,9VU_46L?2OT\#7=06VM3;B5(6E12I*A8I*24E*KZW!%=)&CC5'"233H]&
MN*\!?6U5*"J 4!2QO>^GKJHKH5J@*=-;4H*^(-R--*!4YE?M]O=0$*Y#X[V;
MRMM#,;$W]@H>XML9QCY,['RTD%+B#XH\V'(04OP<A#=LME]I27&U#0VN#+;-
MO6Y]O;G:W?9[TK&X6G6,H^'.+3TE&2TE%Z,@.Y.V=D[OV6]L'<./#)VJ^J2C
M+BFOLSC):PG%ZQE%II^53YE?-UY(N0O+%EY.?AMO[LX@R60=;PF\(;;CLC!A
M]]28>#WHPEM/]LR@24H;D@&',-O M+I4RC[Q^6OS7V7OS'CAW6L?N6$%\2S)
MI*Y1:W+#K[\.+<?MPYIQI.7Y:?.3Y$]Q?*_,GGVU++[.NW&K63%-NW5OIM9*
M_P .YP2E3X5S3HDI5MPTK8D%-K=/\/=7K#C4^?YPZ7IJ7R-- L"=-+ZUK3M5
MX<2R+HVF7UB8--3T]P]YK4E;9E37(O+$T:?%;\/M:M>4&7J26O!EW8GD#K;V
MZ>^L4K:9EA<<=>!=V,E8"RK=#<&WYUKSLU-JUE2BJEX9RZDVLOL[=-1Z0;&M
M:6*F;]O<7'2I<FLTH=I[+Z_Q(K7EB)F];W62Y\CO(SIM?QJ_\XC[KZUB>'K0
MVX[NTJZ_EZ#E_?E#^M7M\5/NE0MW2X5.#F=4KJHW[CXK?E3[F_44EN[EQJF6
M][,DCKJ="2>SV$VK/'%-.[NC?C4MCV6)_J/6_=[=36>&,ER-&YN$GI6KJ6A_
M)?\ %Z.O\ZV86#0NY4GKP+0_/N#\7W_G>L\;=.!K2N-K4LS\T'M)]7H]M9XP
M,3DGPJZ%FD3!VG[_ ,=:V(6F^!C<E77B6.3-\5^NM_X#MK;A:Z2QOJ99'Y'4
MJ.G??IZ2=+ 5G2,L+=>.AZD>2CZ=^;Y@.'Y4YFBR]O<6%Y$S"[8>$B#N+?[3
M7RG6)A2IM"\5L^2I13\\J3(F!)^2E+2DOGY[^:OSKQ.VOB]O=KRC?[AITSNJ
MDK>.W5./[]Y?LT<85]YN2<#ZZ^17X;L_O/X/=G><9XW:55*W9?5&]F)4:DM$
M[>/+AUZ3N)?RTHM7']$.,QF.PN-Q^'Q$&+C,5BH47'8W'06$1H4"!"91'B0X
MD=H):9C1F&TH0E( "17Q5?R+^5?GE9,Y7,BY-RE*3K*4I.KDV]6VW5L_27$Q
M,; Q;>#A6X6L.S",(0@E&,(173&,8K11BDDDCNUBYFSR**OV:=;TH$U6C*Z_
MX50''Q"_;V4*TT.="AQ4H)!4HI2$@DJ60$I ZJ4HD ) H->!H/QYYY^?>6W.
M2MV^37RE-\X<1\:;ISFS<OR3O/EG$<7O<E9C::UM[DQ?"F >P.>7N)$*8GY+
M<S)/XR+)> 2% BU0>=D*]+HB_<C]+_+@=EM&"\2W\:Y_5FEZEX&1L!]4?:>\
M)WD<9V[Q+OK&M^<G?&^^/IF+WV3M'=?$6Y./4!O/0-PX%V%-3EW$3TJ0TMA]
MMMUGP.A7Q%*="C)FJY<#*WG2\U?F#\K.$W1R'LKRM-\R</[ XZRG(&_=^#F+
M:VR9> :P2<E,S./8VIE<;/S.85"Q,)$@+820[\SP)3=)HD4;?J-?_P#_ &#^
M;7&^7K*^:'<GD)G1>*L7L;:/*K0VYSQM/=F[L]QMN!$7(9G-8+;&+V^91RFV
M=M3D9-Z'+,0+C-/7=0ML(6HGS%69KVO]0C:',?.?"7#7EKVXOF;&\C\3XSGC
MD#DJ+G&L3M/B'BW<'S&MJJSY;A9.9)WYN:='>8CX-2(SS1;\3RVT^(I4IQ%:
M\#T8&H'J'X50J8/\PGF#XX\L_&.;Y4Y-RJX&#Q($:#CH@8>S>Y<Y(;=7C]N;
M>@O/QTS\QD"RKP)*TMMMH6ZZI#3:UIB]XW?"V3!GN&?+IM1X)?:E+E&*YM^Q
M:MT2;.E[4[5WCO'>;6Q[-;ZLFYJY.JA;@J=5RY))],(U5=&VVHQ3DTG\<GG)
M\Z')GG#W\K/;G?>P>Q<*\^UL7CV)*<7BL!"4XYX9T_PE#.5W+,:4/W$Q2!I9
MML(;2 ?FWN7N?.[DR_C7ZPQ(M_#MIZ17B_&;YOU*B/T$^7WR[V;L#:_NN$E=
MW.XD[U]I=4Y4X1YQMI_9A7S=6ZFG%<P>@E* E&R=F[AY#W?MG8NT\>[E=R[N
MS>.V_@\>RE2ER<EDY+<6.D^$$I:0ISQ.*Z(;25'0&MC$QKV9DV\7'3E?N348
MKQ;=$:6Y;AB;3M][<\^:AAV+<ISD^48JK]?@N;T/O+\OO%<+A#A+B[B6$67$
M[#V7@]OS),<*#4_+Q8;:LYE$^()5_P#97,N/R#<#5WH.E?6FT8$=KVO'VZ%*
M6;48NG-I>\_7*K]9^8/=6]W.Y.X\W?;E4\K)G<2?&,'+W(_W8=,?49AJ1( U
MB\RWFFV#Y:]NLR]P%W,[MS#3QVQL['.-)R&2+=TF=-=62G&81A[X7)"DJ)5=
M+:'%@@1^?N-C A6>MQ\(KB_/R7Y(P7\B%B-9:RY+\N1\[W.7F.Y3\P&;?R.^
ML_(5B$2W)&(VA =<C[9PC94KY+<;'I4$293+2O"9+WC?7K=0&@X;,W#)S9]5
MZ7N\HK@OTOS>I#W+UV\ZS?N^'(CO!> SNZ.9^*L'MI+O]ZE[^VJY#=8\07$1
M!S$7(2YY4V/$VSCH,1U]:M+(;-68<)W,NW"W]OK5/;6OL+;<9.[&,.+DCZWQ
MT'J'I[._MKTPZ$K0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H##
M>_L'^UF(R\=NT>6?#*"1\+<OL6;#1+R=?^F#WU-[?D=</@R^U'AZ/[/J.2WS
M#^%=^]6U_+F_>\I?V_68\J2($XZ^(:Z7Z>PTIS%:Z<T<J%"FMR>SNJBXE6U0
MH3?0:$495::O@5!OIK<?E0->PK0H4 (O>A5Z\ #<'T"E>91JFA;LSAL3N+$Y
M+ Y[&P<SA<Q"DXW*XG)1FYD#(P);2F),.9&>2IMZ.\TLA22-:V,7*R<+)AF8
M=R=K*M34H3BW&49)U3BUJFFC3S\##W/#N[=N%JW?P+]MPN6YQ4H3A)4E&47H
MTT]4>%?FQ^EWD-O-Y'?GEJ9R.=QGS7YF4XMER4R\QC8Y*W5G9DUXMO9B''
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M['8MME97WR\J3:]U>"?/TOZO22F%CN/\Z?%K3])ZT#I72D@* 4 H!0"@% *
M4 H!0"@% * 4 H!0"@% * 4 H!0"@% =6;#8GQ7H<E <9?04+!ZB_123_2M!
MU![#5\)RMS4X_:1BO687[3M7%6$D:ZY?&/X>?(A/I5_IK)9<(LE]@D_+=0=
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MD=\*K0H*H5%"@M55H5=6+VL._2CXA(50'Z,,NRG6V6&U.O.K#;;:02I2E&P
MM?O]E4<HQBY2T2+HPG.:MP3<Y/1(V'V_AFL+C68H2DOJ"7);@U+DA0'BU[4-
M_I2.X>FN;R;SOW7/]7EZ#O,#$CAXZMJGQ'K)^+_0N"._(QN.ENL/RH$*2_&5
MXXSTB*P\['5K\3#CC:EM*UZI(K ;I^KT2+("0_&COA%_"'F6W0F_7P^-*K7[
M: XH@P6TN(;AQ6T.I\#J41V4I<3K\+B4H 6G7H=* _14:.H-!3#*@P4E@*:0
M0R4BR2T"FS92.EK6H Y'CO%!>89=+:O&V7&D++:AT4CQ)/A4.\4!XM_6L\PL
M_CG@W:O"VW,@[!S7->5GIW$Y%?\ E2$<?[63#>RL)?@4EU+&?R^0B1U@72[&
M;?;5HH@^9?,_>)X6U6]LLRI=RI/JIQ^'"E5_>DXKS2DCZ+_#GVG:W?N:_P!Q
M9D%+&VV$?AU55\>Y51EX5A",Y+PDX26JJOE5KY_/M\4!^T>/(ER&(D5AZ5*E
M/-1XT6,TM^1)D/K2TRQ'8:"G7GWG5A*$)!4I1  )JZ,7.2C%5DWHO'R+9RC;
MBYS:C"*;;;HDEJVV]$ES9Z]^3_RI8[@/D_C3EGSW<2;BVWQ1NIID;!S>Y(V,
ME[!VYOJ7*0,!_P".&)4X[/VG"E,H*X2<FTU#$E;9E )0L(]([;[>AM&=8W'N
MO'G#;[B7PY22=N%QOW?CKC!/]7J25:=7!T\"[_[YN]T[-F[#\L,^S>WRPW\>
M%MR5^Y947\3[G+2-UIZ3=MN72GT5JJ_3IN7@[@ODEI$W>/$?%.^6Y;#2FINX
MMB;3W)^XBK;26'&I>0Q<LN,J:4"@I44D&XKW*]M>U9JZ\G'Q[M5QE;A+3TM,
M^,L/N7N;:&[>W9^=BN+U5N_=MT?/2,EKXF%,G]/;R699TNR/+CQM&45^,IQ&
M+D8!J_Q:)8P4S&L(1\7Z4I"=!IH+1=SL_MFXZO"LK^%./_"T=)8^:_S&L1Z8
M[OF27[TE/Z9J3_+TU\X?J#>5KAG@C:?'F:X:X@V_LJ/D<_EX.Y-R8>+/?E$J
MQ[#V+Q4S)3IDYYF++4V\XELJ2E:V!VI J(W38=JVJW"[MN/"U*3:E)5;IHTJ
MMMT_0<QW=WSW=W/B6\/?LZ_DX4+G6H2:4%-)Q4NF*BJI2DDWXOQ/-C:FRMW[
MZR3>(V7MC/;KR;JD(3"V_BIN6?25D)"G4PV71':%]5N%*$C4D#6HFU9NWI=-
MF,I2\DV<%&,I.D4VSV@\I/TZH^TI6*Y&YY9@Y7<<=4?(8+CQM34[#X.0D!UF
M5NEX!<?,Y2.NQ$5LJALK3=2W[@(ZS;-B5IJ_FZW.*CQ2]/B_+@O,DL?#I2Y>
MU?)?I/6&:"S D_)LT6HKW@*/A\'@95X?!X;6\) MTM73$@?'_P"3?DSCOFOC
M<9;S'_5"^HKQWS-E^4^1-L?[.XWWURM-VC$QD/?.2PVT!"R,/BO>>+CN2L<E
MHN7R:DM*/Q):L4U?RT1:M3V.\A6_^2,OY]/J?<5[KY,W[OO9/#L_RH8;CO%;
MSW)/SD;;C&6XTW:[GY>,B25B'CIVYIF/:E9!<=IH29*?&I-P+6O@$3CZG>_^
M3YVV^!/*MP+R+FN+N9/-?S-B=H(W]M;)O8O=''?$^R<=-WYRGR!C9423$EQD
MXO'X:+!)#K0>.1^2%>)824?$J_ TZA?4CY6V%]);*\I3'&\KYO.)=[)\FF[!
MN5:L@(?F$Q.ZXO'T7=>Y?GE*L@9^#DQ-P*4Z5-RGI 2M2DJ4JJT5:<A72HY<
MXCD>4_$\8[N<^JUOW:GG$\.S=]YK:WFI\SC4?@GFG'/9V CD7"O\19=I>.VM
MLZ<VF?&Q#N&BI>QRFVV@M2KNH?4*>T]_<5-;R..A3V7H\EF;$C2V9$-\2H;[
M4F.V\V]$DI 3(C.I6%-K&BTD'MJTJ7"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% 1?=.WD9V"0V$IG1DJ7$<.GB-KJCK5_P!V[;V*L>^MK$R7CW-?Z;X_
MI(W<L%9MFL?ZT=8_H]?UF G&ELK6PZE3;K:U(<0M)"D+22%)4.P@BNA332:X
M,XF2E&34E1IT:. TTO5U-"QNK*?U'U?PJBXE7]DJK448B^94=!ZJ%&<2+]OL
M^W;0)HY7'>/?0496@.*C;VWH52J<4FP^WVO0JU5G(&]"UJA7L/M^^JAZFIW-
MWDF\O'/*9,O=.R8V#W0_=2=Z;,#.WMQ?.((#DU4=A>-S(N=1,CO*(T"@;$>B
M=J?-3O7M!QM[?ERO;>O\"_6Y:I^[5]4/+HE%>3X'CW?7R*^6_?\ &=[<\&.-
MNLM?O.-TV;U?&=(NW<\_B0DZ<&G1KRMY,^D-RAB)$J5Q-R%M;>&-0A;D?%;N
M_=;6W"L@J\$5J3%BY3;\ETIM9QUZ$@J)N$@7/T+L/XE-@R(1M]QX61C7ZT<[
M-+MOTT<HW%Z%&;IXGR7W3^#;NK#G.[VCN&)FXJJU;R.JQ>?A%.,9V9/]Z4[2
MK71'GYR-Y8_,-Q(N0K?O$>]L/ CJ*5YV+B'L[MH@%024[CP!R>%3XPFX2M]"
M_#K:U>S;'W_V7W(HK:-RQ+MZ7^&YJW=__=7.F?KZ6J\SYP[H^5'S![/<GW#L
M^=8L1>MU6W<L<Z4OVNNUK3AUU\4C!2)0-_"L$I)"@#<I(-B"!<I(KL''Q1YY
M\*NL'5'[B4?\WV^ZJ4*?!=>".8DJ[Z41:[-SR.7[H]I]UOXU1KP**U)\3@91
M';?TWJM$5^')Z.C.!DG_ #>RE"JLOT'!M;LA]J-';=D27E>!F.PVMV0ZL]$M
M,-A3CBO0 35).,(.<VE!<6W1+TOD986'.<;<4Y7).B2U;?@ES?DM39WC;R7^
M:'E?]O(VQQ#N>%B9)26\]NYAO9>&4TH7_<,2=S.8UZ='M_7&;?%]!<Z5P&^_
M-/L#MVL-PW+'ED1_P[+=^=?!JTI*+\IN/L/6>UOD=\T>[E&]M&S94<.7"[?2
MQK5'S4K[M]<?.VIJNAZ$<5_2!RSDB--YKY0Q\:&E33K^ XXCR9LI]&BG8[FX
M]P0(3,51'P%3<%X:DA6FOB_<7XEL>,)6NU<"<KM&E<R6HI>#5NW*3?C1W(^@
M^D.TOP9YL[D;O>^Z6H64TW:PE*<GXIWKT(J/A56IKS\?5OASRS\(<"Q4M\9;
M"Q&&R"F Q*W++0O+;JG)T\8E9_(J?GI;<4 5--*:9N!\&@M\[]S]^=U]X7.K
M?LRY=L5JK2]RU'T6XTCIXRK+S/KGLKY5=B?+ZVH]K[?9LY?3TN_+^9D27G=G
M623YQATQX>[HC.Q_S7O]K5R!Z&OV2HU-^\>[I0/A0%0% HME15=2W@*H5*T!
M3KV_;["@* 6H&ZE3W_8VZ4%3,>R-MF$T,M.;M+?1_P JVL'Q1XZP/C4D@>%U
MX>T)]9J%S\GKE\&V_<7'S?\ 8=7LVW_"C][O+^;)>ZO!>/I?U&1*C3H!0"@%
M * 4!\X_UU>)-[SLQP]S7C\;.R6P\)M[-[&W#,BLO2(^V,M)S#67QDO)_+0I
M$&'G6GG&4/K(07HJ6U$*4WXO&?FMMV5.>-N<(N6)"#A)K]5N54WX*7"OBJ>%
M?KC\,N_;;:L;AV[>G&&YW;L+UM-I.Y!0<)*/[3@TFXK6DF^";7SQJ*4)*EJ2
MA(_J4H >@7) N>RO&:'UDM=(ZLW"\O'D1\S7F9?C/\?\>9#';4>=#;_(&]$2
M=L;,CIT*UQ\A+C+FYLH!U1CH\Q:3H0+UTFS]H[[ODD\2RXX[_P 2=8P]3:K+
M^ZF<!W9\S^S.S82CNN7">>EI8LTN7GZ8ITA_YDH+PJ?23Y+_ *7/$'EB<Q>^
M=WJC<I<R14LR&MR9.$!MS:<WP)+@V9A7PH-2&EW"<A)"Y9MXFPP"45[;VSV)
MMVQ=.5D4R-R7ZS7NP?[D7_Q/7PH?'WS$^=6_]Z*>VX'5@]O.J=N+_F75R^--
M4JO^[C2/CU<3T=WSLC:W(^T=P[&WMA86XMJ;HQ4O#YW"Y%H/1)\"6TIMUM8T
M4AQ-PIMQ)"VG$I6DA201VF5BV,W'GBY45/'N1<91>J:?Y>KD>1[;N6;M&=:W
M/;KDK.=8FIPG%T<9)U3_ $K@TVFFFT:(^4;.9W@/D/<OD;Y(W#+SSNT\2YOW
MRY;JRKH=F;KX-E37(+.V9TQPH7*W-QSDV78CR GXH7REI_TTIKD^WKM[:<R?
M:V;-S=N/Q,:3XSL-TZ6_VK;T?[M&M#TWOS&Q>Z-IL_,K:+4;4;]Q6,^W%:6L
MU14G<2Y6\B+4D_VZI^\ST:KLSR0M^4Q6,S<)_&YC'0<KCY*0F1!R,1B;$?2"
M"$NQI"'&G "+ZC0U;*,9KIDDX^91I-4>J.G@]L[=VS',3;N"P^"BFQ,?#XV'
MC621VJ;ALLH4=>T52%N%M4@E%>2H%&,?LI)%\J\J=6:A3L60TDI"GF76DE1(
M2%.-K0"; FP)OTH#0OZ:WE7WSY./+)$X3Y%S6UMP[DC<D\J[S7DMGR,I)PIQ
MV^M[93<N+C)=S.+Q$W]Y%A3T(?!9\ =20E2DV4:M@U2;\J'U"N&?.'YQ?,)Y
M:<[Y2,AM/S3YSB[).XGF7(\KM[@P;'&6T9> A)#.T-LKQ[3LV7F)BW/^8?!;
M2T04GQ"FG,I1K@=^+]/'E#S/^8I/-WU&H/!W(& VGPG$XVXVXVXCW#R>Q@<%
MN_([L5N#=N^B[DXVU<G&?R.,CQX"$B3)\;7C\8 " DG1:"E>)&\I](7;@_\
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M-MI\"&X/(;;:;^(H0CEC?:4)\1U5X4BUSUK9PO\ EXKT_61NZ_\ N%Q_P_\
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M(0A( 2E*19*4@:  #05"MMNKXG6QBHI1CI%'.J%10"@% * 4 H!0"@% * 4
MH"AZ'U4!YT;#:_\ #WZF'.&WD7:QO/?EYXXY1:024LN;DXWS<_C_ "/R&@D(
M#CN(ELN.JN2I0U[!7&XM</O?*L\(9>';N_WK4G;=/[K39ZWN<O\ 5?DYMF4]
M;VU[MD8S\?AY$%?C5^'6I)+V'HQ79'D@H!0"@% * 4 H!0"@% * 4 H!0"@%
M * 4 H!0"@% 4N.\=W7MH"M * 4 H!0"@% * 4 H"(;CVC$S05(9\,7(@:/
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MD[<S*\5XU)/@4DH5(4CTBXK4W:OP8T^SU?FT)+MSI>5<<OM]&GHJJ_F/$<U
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MIJ/O;9B7\B.3./\ ,BZZ<_3X_E4P3QK4YJXU[R?M])LX    + =!4@9RM *
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M^-(OK5N?7!5DG*/3+6L7%O@ZK0R"OS&<RJ24G>*@#VHPFW$*]A3AP1[ZW/\
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M?Z"3PM@X.-93XD3EBW_;NE#=[:_Z3 ;T)[RJM6>XY$OLTBO+^VI)6MBPK?\
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MX5>-2C*&]%4*B@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M%"W TT%*!<<+;2E>$7-DDVT-4;2!^XU%^^J@4 H!0"@% * 4 H!0"@% * 4
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M=9@8/DJ/'+\H%PM,QH6[8$5LNR3XOA3/82IU5Q\YM1\3QW=MWYZ6<ZK\)_\
MQ+\Z]:YF;'S:4A>]OZ3VC;6EUM#B#=#B$K21T*5@*21ZP:ZPDSG0"@% * 4
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M2"D^NN@Q-_N0I#+75']I<?6N#^CUF[;S7PN*OFC,>)SF+SC'[C&2VI* !XT
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ML?()84=;F 5 =A-35W\*._+.Z+&ZXCVZOVY6[BN4_@58U_\ ,H<Y8_'EVO\
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MJ+ZU*8&Z7\*2C7KQ^<7R]'AZ.'UFS9R)6M'K#P-CL1FL;G(J9>.DH?;4!XT
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MKXZFMPYKQU__ )@S;]W[V/\ _">ZOI3[NZ5J=FY/@97XRRQY..9&/BG&'"B
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M<+C/E'WUP#QYLK/[;V0C>.-E<(<E[TQVW\GROMY3J"PI;\)2G8;C<E7RU.H
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MJ+CMT T[??6962]0(=RG!2WQKOE:4 >':^6(-O\ ZU7]]A7>_+&S3YA[*_\
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M.$N ]_;EY=G;@Y3YUYBW5MAW8\[E+G[?4WD?=4'9<@_\WM?!JG,QL?AL5/
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MZ.^\// GS:>:W<W+G(_E2C9=V+NSF'-9C;.TL[F-TX1Y[/;-@J0SD<-EXS<
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M<^E%%7F2KBWGCZB7G/VQO_G[RW[I\O/#G".*WGOS \![3Y XSW1R!NSG'%[
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MU) !_;!E)U3>OD#Y@]Q__4O<5RY9=<#'_E6_-1;K/TSDV^"]WI3X'F.]9_\
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M+;?C4D+6NNJV["C@XRM+6;UD_%_H7!$E8LJQ;Z?UN?I-D*WS,* 4 H!0"@%
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M'Z)N[>+.7<=NCR\<=<I^:F?NOG++29<Q.XMTRL7M%7(&^-WY,0FWG<]N3?\
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MCRJ7K';AW[S_ /4MBXS*[\W_ (;R_P#(.%\UG VV=K;6W?F]LLRF_+UM':V
MW=OO%OXN6AB/E9O)&ZLJQ#G-I+S*<:BR@L$)W;=FSB;-[L(/+B[5QMI/^HVU
M%^2BDVO,R0MQM8O!?%5'7S=73V)>TR[Y3/+7A,OYT_.!L_+<J>8O*;=\LN^O
M+_+XPQ&1YWW_ #H2?]S;#.\<S%W3&D9%UC=./F9J,CQ,R4^ LW;(*2:V<B_)
M8%B<86E.[&?4U!<G14\-#+.;^!&73'JDM=%YGO'%A^(@@=>NG3OMII6A;M52
M-:,"0Q\22!<#LT(/;V]*W(VC*H5.ZK$6%[>KX>G?W5?\%^&I=\/RT+3*Q:D=
MGN'X@7K#*TN9CE$C<N';Q:=AO?2X[^G2M&Y:T,4H\R%YK$0\C%DP9\2-.A2V
MEL2HDMAJ1&D,K!2ME]AU*VW6U#J"+5'W(49@E'FN!CG$;.V]L[#LX#;&*BX;
M#QER'6(,0*#:')3SDA]PJ<4MQ2ENK.JE&R; ?" !&WHN3J^)@G6M66/(Q[%>
MG2_3J?;45>A[3!)$&R+-_%I^7NZ:"HJ[&J,$US+CQ-A6,SROL;'R4)<85N"-
M*<;4/$E:<<V[D @@Z$*5% K8[>QHY/<&+:FJP=U-^?3[WYB_"MJYFVH2I3K7
MT:D?\R^7D9[F#>[SZUN(QN2&$B)7<AB-B6&XORVP=$H7)0XYIH5+)ZFYU.]<
MF>5W'E2F_=A/X:\E!4I[:OULP[O<=W/N-ZJ+HO5I]>IJY/;L5$=IO[CK>N&O
MQJB)DESX$'R+=B1W'T]#>HJ_'F:\E0@T]NWBZZ$GIZ/PJ+NKB8Y<"$Y!'PGO
M'B]9T/O_ )U%WUR->:U('.1HH>OW U$WT:L^9#9[9 .FEK_;W5&W$:LB'301
M\224J *DJ!L4J&H4#V$'45'7*Q::XIF!UH?3]QWF_P#<_'VQ=QA7B.>V?MO,
M+L-0YD<-"ENI-M+H<=(/I%?<FT9/WW:<7,?&[CVYOTR@F_IJ>OX]SXV-;N_M
M0B_:D3"Q[C[JD:F8_6X!)%S?NUM:K ;+\:/E[:<-).L>1,8MV@?/4\D'_JO"
MN[V*?5MT5^S)KZ:_G)?$=;*\FR?5,&R* 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4!0]#ZC0'GQYF?*'O_G7DS&;GQ_($&#M
M-&.@07,-F!DGU[>5'^&=)P4".#"DN9--G%^-;"RX+*64A/AS0N1C&E-3'.#D
MZUT-H^$>$-G<%;2&U]J(DR'94C]]F\WD/DG)YO(E ;_<2E,---ML,MCP,LI'
M@:1WJ*E*QSDY.K+HQ45YF9"+V]%6EQU94"#.;4S-B19C*TE*VI4=F0TM*K@I
M4V\A:5 @V-QJ*5!C3,\%<,;A!_O'%>P9Q))*W-JX9MPD]5?-9B-N^*_;>]7*
M<EP;*.,7Q2,+[O\ )?Y;Y6+RDYKCY.)D,P9+Z',-G=P04I6RRXXDHB_W-R"G
MXAT#5JQ9&1<LX\[L7[T8-KU(QSC&,&UR1IK.\G?&,CQ*B97>&./]*6LCC)+2
M2?\ AEXAYU0'_3!]-<I#N?<%]J-J7J=?H:(W[Q/G0O''/EFV]QSO&%NZ'N;,
M95W'1YK<.%+BPX[8=G1783CDAY@W>2W'?79(2@%1!)TL<6=OU_.Q7C2MQBI-
M5:;?!UT]A2=_KCTTXFRM01KGEE]3G(*&-X;Q((\#N0WGDG4]ZV(^WHT<C7^E
M,IWL[?77A'SONM8VWV576=U^Q6TOSG']VR]RQ#DW-_0E^=GEG 'Z=+:7M[;_
M )UX1:7)<#C%Q)C !^'32X_*]2-M(V8\2;XP?&D]>@/=;2]ZE;*-N' GD%)\
M0/JJ5L&Q%:(FV/3I?TC3[R:D[.NAGYD\QR=$GOMZM+5+65JD98HG&.1JDVZ#
M7V'LT[JE;*T-A<3%F\_++LGDS*<O9'<F1S2D<S<5;<XHSL&/^Q2QB,=M;*;A
MS.(S^$<=B./-YZ-DMP%Y*W%.-H7&:*4@@D];MV]Y6';QK5F,?\MD2NQ>M6YJ
M,7&6M.FD:::ZLDK&5<M1MQ@E[DW)>;:6C\M"1<?>43C_ &?EN"<I!RF>FHX*
MXSWOQEC,;DD8N5$W?"Y$3!5NO.[N)@I>E9K+3HSDEXM*;:<>E.E2"" )9[WE
M9,<E3C%?>;T+C:K6+A7IC'71)42K5T2U\=J67<FIII5N23]%."7D6>/Y L9_
MLO.\.87S!\Z;<\O>X$Y=B1PKBYVRUXN!B\T\_)D[4PV\YNT9.^\=LDR9!)QJ
M)Q\39+)=^4M:53=G?ISOQS+N/8EN$:?S6I5;7ZSBI=#EYTXZTJ;4<QN?Q90@
M[Z_6U]K5:5\S,[?D4XRRV"W+M[+[@W3D<9NGRM<?>526AW^T(=B[8XVF9W([
M?WE"<;QP#.\49'.%\J(,5#D9LH:'Q7W+.ZY'5&<8Q4HY,KW/C.B<>/V:*GB9
M(Y5RJ=%53<O;R,D<4>27CSC+</E?W#M_<.ZG9'E=X[Y0V#MUF:K$N(WFKEQO
M$JWANG>+R(")#VXIN5Q:YQ7'4RA<F4Z5I5<6WWN%Z_&]&<8_SYQD^.G36B7E
M1T-A7Y34JT]YI^SD9]XD\N6VN,>9_,+S9B<YG<CG?,;E./<IN;#Y'^W_ -HP
M#O'6UE[3QC> ,6&Q-+4^&X7'_P!PXZ?FCX"E.E;T;TKMFU8DDHVDTGXU==3)
M\1SMQA3@;>XR$#8D>KU7[-*W+4#+")-H>.ND'P]?1UL.M;]JS4V8Q+@K&FWZ
M>S70?SK.\?0O=O3R+%-@A(O8=.WMU]72M2Y:HS%.*Y\""9.($$FVA!MZ^T#V
M5'78<35FM2$3F.MP#<&WKU-15Z)KR6I!Y[.JN[OMZ2=:B[T:&K-:4(3.BNR'
M0PPTX\^\M+;3+2%..NN.*\*&VVT J4M2C8 #4U%W+<IR48)N3T26K9A:KHN)
M?X_ G)>:8#S6$9@MK%T?W6<Q#<4#T)8'SGT'3HI*36W#M+?,F/7&TH+]^2B_
M9JUZTC/';,RY&O31>;.SMG@_E78F]-M[L5MMG+Q<+E&IDIC#Y;'.REQ0%MR$
MLMRY$%*W2RL^%-Q<VK)@]K=P;5N=C/=A7+=JXI-0G%NG!TJXZT96SMV=CY$+
M[AU*+KHU7Z:&$^<]E[SRF_\ =>Y(FQMXQL7FLB9T?]U@I:G4J<C,"4'/V8EL
MV$D+LH+*2FQO7,]T;9N5_=\C-MXN3&Q=GU*MMUU2KPJN->=*$?N5C(GE3O*U
M<4).NJ?YO,UZ:X\WYG)28>(V;N:?*<5X$M1\)D5?%>UEK,=+;0UZJ( KD8[/
MNN5<^%CXU^=Q\E"7Z/SD7'%R;CZ;=N;EZ&9EW'Y<MJ<7\/Y_=?->8DXG?N9:
M#6P]KX:;&D2H\IH!QM,]D)<:F*D+)$HA1:C,CX5ETBW1YG9F!L?;=W<.Y;KM
M[O=7\BU!IM/C[RX.OZVM(QX/J9(W=JL8>#.]N$G')E]B*?/S\?/P7F>>V13J
MO3O]HU/WUY#<1SCU31"9Z?A5T)_G:HN^C6DG0@61%BJW6W3UFHFZN3-66I"Y
M]SXP=-#T](/XBHRXM-#6D0V8-+=NONM4;>,#X'T5^53(KR?ETX@E*/C<3LZ'
M"4;WUQK\G'VT4K]/[:W73T=*^QNQ;OQ^T-OFW_\ ATO]EN/YCU+9Y=6U6'_W
M:7LT-@/$>X5UM$214$))[1I5*-@V&XF63MV8@DGP9=^U^P*AP=![0:[/MU_Y
M.2_[Q_5$E</^F_XOS(RC4^;8H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0
M"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0%CW-_\ .[G/_M5/_P#E9RM7._Y*
M[_X<OJ9CN_TI>AFH9%[6U(Z_X]]><<.)!G"J@_6R1W>W6K-6#R,^IPL?WSA]
MOPKTQ6[E^+P_ 0J9A$!(5VK'AN1ZJ^?_ )WO_,;>M?L77Y<8'&=V_P!3'7/I
ME]:/-:%U%OL-+UXK9JJ''1XZDQ@7'@ UZ??U_"I*TE5&W$G.+ N/6G\_X5*6
M?!>!MQX$[@=4>FP/WU+649X<4B<8[HGU_P :D["X&QS9/,?8A'N^^I:SQ,L7
MIZR<XWJ >S\.WW5+63.OM5YD\QXU3]WNZ5)6:&U#B9!Q=O"CV#V  _C4M9X?
MEYFQ%:^1/<;^I-^X?C4M8X&S'5F0,:D>%-]/X:'[ZE[*H9X_:H5W?R)M?C/!
MJSFY990E9+6/QT?P.9'*RDHO^V@QU*3XRD$%QQ12TTDW4H7 ,;W-W=LO9FU_
MZGO-SIBW2W;CK<NRI]F$:JM.,I.D8JG4U55[?LGLG?N_-U6U;%:ZI12=RY*J
MM685IU7)4=*ZJ,564WI%.CIKC&\\7R,@/_\ '*58H+\/_P \1&2^65#_ % ?
M[5^U\83KX.E]/%VUXE#\3'1E?^T5P:__ #'\RGC_ $NFM.7#EU<SZ5C^%I+$
M_P#>?\_3_P"7_EU\/ZO53S]?3R-_N&>5=G\N8 9S:LISQ17$Q<KBIJ$L93$R
MR@.!J8PE;B%-.))+3J%+:< -E>)*@GZ2[%[VV+OO:_\ 4]DF_<ETW+<TE<M3
MI6DXIO1\8RBW&23HZII> ]X]C;[V)NO^F;W"-)KJMW8-NW=C6E8.B=5^M%I2
MBZ55&F]C(#:? G0?RL!;WUZ18C&B9S4$B\N1T);"M+Z:6'0]U;DH+IU,KBJ$
M6R3:;$6'3L ZW_.U1F1%&O<B8ZRZ!97_ $M+>FYM4/>XFG-&.YX&OKM]^GX5
M$WUQ\35GJ07(I%S;L!]77^ J)O&K/BS*$(8OBK94?=TR%&R&\-Q-?,P+4E(6
M(++S0<96/%\;;;;"TN/%-EJ4M+8(!O4[96/L&V1W&Y&,]ROKW$_U4U6ODDJ.
M7-U4=.)O04,+&5^23R)_9\OR7'V&LVY>0M[YE]Z1.W3FR5JO\B+/D082+_TM
M0HCC,9M(!M^FY[2:X?.WC=<F;G=OW=>2DXKGPBFE]!$WLK(N-N4Y>UI>S@8]
M<W_OG&N(5"WGNN*E*TJ\#&XLLT@A)U!;3++:AX1VI(J'EO&ZV95M961%>5R:
M_/3VFL\G(AK&Y-?WG^DSQS7RAR?P_FMNQ=L;XRF5PN>VQ%SC0W1!P&7DHD.2
M9#;[*9K>)B/*C!GY5KJ*[DW4:ZWN;?=\[<R[-O RKES&O6(W/YL;<W6K35>A
M.E*>?BR3W#,S,&Y"-FY*5N4$_>47X\Z(U]S?G!YRD1UQXN>PV**@M)?QNW<:
MF01;PGXIJ)R$*UN"E*2#T-<GE?,3NF4'"%VW;KSC;C7Z4_JJ14]]W)Q:C.*?
ME%?GJ:B;UW3N3=^1<RVZL]EMPY):"C]YEYS\UY#?C6L,LEY:D1HZ5DE+382V
MF^B17G>Y9^;N-UY.?=N7K_[4Y.3IQHJ\%Y*B7)$-D7;M^;G>E*4_%NIB7(_U
M?;2PO7/735?,A$\:*M_P_CK]U1E[Z#!/@0+(?J5ZOXU$7J^LU9T^@A<W4K^V
ME[5&7#5GIZ2&SK"Y'?\ ?K^-JC;O,P>)] GDL?4[Y9>+EE(240<\Q8&]PQNS
M/LI5ZU);!/IKZY^6LNOLG!K^S<^B[-'I>P-O:+/H?_$S:2P*AZ=3;OKN>")@
MX54&PG$G_P Q<E_]M";=@)C,7M[ *Z_MW_EKGA\3_JHE,+^F_P"(RO70FX*
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MRXR?B^?Z%Y$W9LJS;4%QYOS,_5NF84 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M*8L=27'0KJ '2 V/2H5O[?C/*S(6OU$ZR]"X^WAZS/8M]=Q+E^8VS    %@
M  .@ Z 5Z&3)6@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M\VYP_AY>WC["5Q+71#J?%_5^7YC)M3IMB@% * 4 H!0"@% * 4 H!0"@% *
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MUF5W0O4F=]N?XBE(\2E*(2E(N222  D =2?;6:-U\%Q+E+VGHIL?"_\ LO\
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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MT=GMK!.]YEKDRSR,D3<!73TU@E=+'(LK\R_57W_SK5G>,4IEED3?\JK]YO\
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M2 E("4I 2D 6  %@ !T  KM$DE1$H5JH% * 4 H!0"@% * 4 H!0"@% * 4
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H#\W6FWD*;>;
M0ZVL64AQ"5H4#U"DJ!!%4E&,ETR2<?,43X\"$Y3CO;.2\2TQ%8]U5_\ 4@*#
M(O?K\E06Q[DBHJ_LN#?U4>B7C'3Z.'T&O/&M2Y4?D0.=Q'-0HG&9:*ZCL1,:
M<87_ .6RF0E7_DBHB]VY=7]&Y%K]Y-?54UI83_4:]9$IG'6[(ES_ &[]T@=%
MPWV7@?4V5H?_ /,K0N;-N-O_  ^I>33^CC]!@EBWH\JKR(X_A\K#"A+QD^.
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MHC=@/#'90T#;_-X "H^NIBU9LV5TVHQBO)4-B,(QTBDD=VLI<* 4 H!0"@%
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K>BVE;*I33@7E: 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@/_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
